data_2luz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2luz _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 29' ' ' ARG . . . . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 121.14 0.495 . . . . 0.0 111.935 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.6 m -88.07 131.16 34.78 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.715 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -119.16 103.6 9.68 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 171.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -83.25 132.48 35.04 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.901 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.583 ' HB1' ' HB ' ' A' ' 25' ' ' ILE . . . -143.92 171.36 14.34 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.893 -172.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 177' ' ' LEU . 0.5 OUTLIER -138.69 165.43 26.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.943 1.297 . . . . 0.0 108.242 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.56 -162.29 30.78 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.174 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -120.35 145.6 46.97 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.231 1.012 . . . . 0.0 109.91 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.436 ' HB3' ' HB1' ' A' ' 115' ' ' ALA . 12.2 tpt180 -164.27 125.85 2.26 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 20.0 m -77.04 142.2 39.97 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.884 0.474 . . . . 0.0 110.756 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.432 HD11 HG23 ' A' ' 117' ' ' THR . 16.7 pt -133.07 165.75 34.38 Favored Pre-proline 0 CA--C 1.557 1.222 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -49.02 -30.92 19.22 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.355 2.704 . . . . 0.0 115.377 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.5 -37.32 71.27 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.164 0.586 . . . . 0.0 111.995 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.33 -174.95 34.84 Favored Glycine 0 N--CA 1.471 1.014 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 2.8 mp0 -71.65 93.9 1.29 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.82 167.1 22.42 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.888 0.875 . . . . 0.0 113.115 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HB3' HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -95.17 149.12 21.65 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.339 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.0 p -134.7 130.77 36.79 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.125 0.421 . . . . 0.0 111.376 -169.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.427 HG22 HD22 ' A' ' 122' ' ' LEU . 2.7 pp -88.86 140.08 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.583 ' HB ' ' HB1' ' A' ' 10' ' ' ALA . 4.0 mp -126.86 124.27 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.446 HG22 ' HG3' ' A' ' 28' ' ' GLN . 25.6 mt -107.23 107.73 23.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 85.6 mtt180 -106.92 98.78 8.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.446 ' HG3' HG22 ' A' ' 26' ' ' ILE . 73.1 mt-30 -109.98 133.24 53.39 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.991 0.916 . . . . 0.0 109.001 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 17.5 mmt85 -87.44 127.5 35.22 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.42 0.688 . . . . 0.0 109.837 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -120.14 135.94 54.78 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.403 1.081 . . . . 0.0 108.842 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.7 45.43 1.2 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.372 0.606 . . . . 0.0 111.557 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.07 159.03 72.54 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 124.547 1.139 . . . . 0.0 109.883 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.06 157.05 63.63 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.237 2.625 . . . . 0.0 113.562 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.8 t -49.15 -47.95 17.65 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 C-N-CA 124.688 1.195 . . . . 0.0 110.474 171.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -43.44 -47.3 7.02 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 125.05 1.469 . . . . 0.0 111.754 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.54 -46.46 85.89 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.071 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.437 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 18.3 t -76.86 -31.0 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.513 -171.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -75.29 -30.26 60.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.811 1.244 . . . . 0.0 109.967 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.6 m -65.0 -44.46 89.16 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 172.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -62.94 -38.53 91.43 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.25 0.62 . . . . 0.0 112.584 176.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.451 ' SG ' HD23 ' A' ' 99' ' ' LEU . 65.5 m -71.86 -40.57 68.88 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -175.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.3 p -104.15 -38.93 6.72 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -168.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.429 ' O ' HG13 ' A' ' 47' ' ' ILE . 29.3 t70 -79.03 113.35 35.1 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.812 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -46.66 -38.55 22.34 Favored 'Trans proline' 0 C--N 1.39 2.719 0 C-N-CA 124.7 3.6 . . . . 0.0 115.227 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -66.14 -24.79 66.73 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 123.651 0.594 . . . . 0.0 110.8 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.552 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 5.8 mmp_? -91.95 -25.07 19.05 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 173.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 43' ' ' ASP . 83.1 mt -74.31 -40.71 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 118.235 0.471 . . . . 0.0 110.53 -172.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -65.37 -14.96 62.03 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.002 0.521 . . . . 0.0 111.895 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -83.18 -5.14 59.01 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.379 0.672 . . . . 0.0 111.181 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.402 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 56.7 p-90 -142.93 -15.84 0.7 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.519 0.727 . . . . 0.0 112.098 175.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.402 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 20.6 t80 -141.27 -122.53 0.1 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -173.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.8 mt -132.74 140.57 47.13 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 C-N-CA 123.404 0.681 . . . . 0.0 109.62 -167.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.61 105.02 0.83 Allowed Pre-proline 0 CA--C 1.573 1.858 0 O-C-N 124.871 1.357 . . . . 0.0 110.239 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.17 124.1 3.24 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.655 2.237 . . . . 0.0 112.498 -172.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -112.41 117.42 32.39 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.647 0.779 . . . . 0.0 110.304 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.17 -152.18 22.7 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.644 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 8.2 m-20 -66.55 -41.86 88.01 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.386 0.698 . . . . 0.0 110.758 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.7 mt 59.65 22.03 10.74 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.758 1.223 . . . . 0.0 111.792 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.644 ' HG2' ' HB3' ' A' ' 57' ' ' ASP . 17.3 ptp180 -133.48 151.7 51.81 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.511 1.124 . . . . 0.0 108.862 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -66.41 135.02 53.71 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.696 0.622 . . . . 0.0 110.492 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.18 -7.2 81.01 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.588 -167.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.92 -175.73 14.97 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-N 117.119 0.46 . . . . 0.0 112.641 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 11.2 p30 -109.05 171.26 7.54 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.586 0.754 . . . . 0.0 112.228 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -145.66 158.77 43.81 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.712 169.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.77 105.21 4.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.651 0.78 . . . . 0.0 109.514 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 70.4 mt -75.51 127.54 33.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -80.21 112.99 18.05 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.866 0.467 . . . . 0.0 110.564 -172.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.84 46.38 8.52 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.98 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -162.6 -83.71 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.851 0.46 . . . . 0.0 111.449 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.63 156.71 36.99 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.35 0.595 . . . . 0.0 111.017 -170.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.4 m -109.09 -175.34 2.74 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.484 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.75 -160.06 30.03 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 53.6 m-20 -129.48 174.22 9.84 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.24 0.616 . . . . 0.0 109.454 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.3 116.2 51.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 86' ' ' SER . 31.6 mt -84.22 -44.47 13.88 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.927 0.891 . . . . 0.0 110.317 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.53 ' HB2' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.37 155.19 44.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.134 1.374 . . . . 0.0 109.223 -177.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 26.2 p -157.18 120.78 4.16 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 166.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -141.63 100.48 6.13 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -165.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 85.9 Cg_endo -83.84 135.25 6.61 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.754 2.303 . . . . 0.0 112.849 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 24.9 Cg_endo -100.41 29.47 12.63 Favored 'Cis proline' 0 C--N 1.376 1.976 0 CA-C-N 119.399 0.821 . . . . 0.0 112.561 -4.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -77.85 -66.97 0.77 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.992 0.917 . . . . 0.0 112.397 -168.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.499 ' HB3' ' HG3' ' A' ' 100' ' ' ARG . 16.5 ptt180 -160.86 141.31 11.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.769 0.427 . . . . 0.0 111.073 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 77' ' ' CYS . 2.2 pt? -107.72 144.04 35.39 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 163.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 76' ' ' ARG . 32.8 m -134.79 128.42 32.79 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.107 0.963 . . . . 0.0 108.701 -171.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.7 pt -133.35 146.49 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.451 1.1 . . . . 0.0 109.137 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.453 ' HB2' HD12 ' A' ' 75' ' ' LEU . 33.3 t -96.14 139.54 32.16 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 8.4 t-105 -125.64 109.21 12.36 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.801 1.24 . . . . 0.0 107.891 -163.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.18 102.27 13.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -93.48 133.65 36.55 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.57 133.68 54.19 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.126 0.57 . . . . 0.0 111.342 -170.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.78 -45.14 3.44 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.306 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.403 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 13.2 mptt -80.55 163.0 58.69 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.714 1.206 . . . . 0.0 110.094 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 177.39 5.41 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.36 2.04 . . . . 0.0 112.376 175.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.31 162.57 29.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.805 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.558 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.2 m -141.51 165.21 28.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.579 0.752 . . . . 0.0 110.042 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -125.45 106.83 10.09 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 167.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.39 149.0 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.668 1.587 . . . . 0.0 109.004 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.17 153.08 39.43 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.701 165.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.451 HD23 ' SG ' ' A' ' 41' ' ' CYS . 2.8 tt -114.66 128.31 56.24 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 169.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.539 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 36.8 ttt180 -138.39 137.85 37.68 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.272 1.029 . . . . 0.0 108.389 -164.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 110' ' ' LEU . 96.7 mt -129.5 132.5 46.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.872 0.469 . . . . 0.0 110.827 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.4 t -125.25 127.17 46.3 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 172.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -69.92 152.74 44.14 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.73 0.812 . . . . 0.0 109.014 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -167.47 79.36 0.19 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -168.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 65.16 -117.38 10.18 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 123.709 0.671 . . . . 0.0 113.306 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.64 32.66 1.07 Allowed 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.91 -171.9 38.06 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-O 122.001 0.778 . . . . 0.0 114.475 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.2 m -140.43 131.01 25.5 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 113.78 -1.21 . . . . 0.0 109.463 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' A' ' 27' ' ' ARG . 64.0 tp -82.77 106.87 14.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.468 171.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.0 tt -84.22 131.98 34.7 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 172.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 22.2 mt-10 -129.32 106.62 8.92 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -174.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.402 HD11 HD21 ' A' ' 133' ' ' LEU . 9.0 tt -115.47 126.45 54.32 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -124.66 137.83 54.34 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -131.88 114.89 15.21 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 14' ' ' ARG . . . -109.96 104.01 12.85 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.118 0.567 . . . . 0.0 110.972 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.442 HG23 ' HG ' ' A' ' 122' ' ' LEU . 5.3 t -124.2 156.13 37.32 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.206 0.527 . . . . 0.0 109.64 171.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.432 HG23 HD11 ' A' ' 16' ' ' ILE . 20.8 p -77.44 -18.57 57.07 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.433 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.5 t -88.49 111.85 22.3 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.333 0.653 . . . . 0.0 110.079 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.43 ' HA ' HD11 ' A' ' 122' ' ' LEU . 37.4 tt0 -62.63 -29.21 70.45 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.397 1.079 . . . . 0.0 110.878 172.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -60.35 -47.89 84.09 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.554 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.403 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 27.4 ttt -68.49 -37.62 80.27 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.787 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 116' ' ' THR . 37.7 mt -61.1 -38.18 85.37 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.591 0.756 . . . . 0.0 112.763 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 68.8 t -64.51 -51.78 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 O-C-N 123.392 0.432 . . . . 0.0 109.888 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -63.65 -41.8 98.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.27 0.628 . . . . 0.0 112.544 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.37 -34.56 58.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 CA-C-O 118.992 -0.528 . . . . 0.0 109.994 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.03 -32.18 74.89 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 121.389 -0.434 . . . . 0.0 112.217 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.09 -54.52 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 123.869 0.393 . . . . 0.0 110.894 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.96 73.45 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.944 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -80.2 -49.52 11.52 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 38.5 mt-10 -63.35 -23.09 67.26 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 118.415 0.552 . . . . 0.0 111.599 176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 56.4 ttp -66.46 -44.71 82.0 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.074 0.549 . . . . 0.0 109.54 170.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.62 -35.79 81.67 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.036 0.534 . . . . 0.0 111.275 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 130' ' ' GLU . 4.0 mm? -74.75 -18.38 60.5 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.6 1.16 . . . . 0.0 111.367 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -69.87 -55.26 10.23 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -66.15 -32.81 74.48 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.879 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.1 tp -75.01 -37.63 61.76 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.189 0.596 . . . . 0.0 109.931 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.5 -46.52 52.89 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.598 0.562 . . . . 0.0 112.925 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.0 mtp -69.23 -39.71 78.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.94 0.896 . . . . 0.0 111.205 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.62 -33.15 68.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.137 0.575 . . . . 0.0 111.345 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.9 mm -72.51 -63.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 65.0 mmt-85 . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.739 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.487 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 64.8 mt . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 63.7 p -75.36 -41.6 56.09 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 48.1 mt-30 -55.65 -63.7 1.09 Allowed 'General case' 0 C--O 1.2 -1.524 0 O-C-N 124.123 0.89 . . . . 0.0 110.751 172.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -41.76 -45.37 3.53 Favored 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 27.7 mmt85 -58.01 -48.26 80.58 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 174.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -81.51 -15.53 75.86 Favored Glycine 0 C--O 1.214 -1.128 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.581 -174.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 36.0 mm-40 -70.66 -39.42 73.59 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 117.699 0.75 . . . . 0.0 108.991 176.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.48 -58.45 7.55 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.188 173.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -62.73 -28.12 69.74 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.955 0.785 . . . . 0.0 113.065 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.54 -64.11 0.94 Allowed 'General case' 0 C--N 1.353 0.724 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -46.9 -41.28 15.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.881 0.872 . . . . 0.0 112.526 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.508 ' HB3' HD22 ' A' ' 11' ' ' LEU . 51.5 mt -65.25 -40.78 94.44 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.0 p -85.66 -28.08 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.023 0.829 . . . . 0.0 109.442 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -67.71 -29.38 68.62 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.077 170.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.475 0.799 0 C-N-CA 123.23 0.612 . . . . 0.0 109.837 176.079 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.564 ' HB1' ' HB2' ' A' ' 29' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 120.637 0.256 . . . . 0.0 111.376 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 m -79.52 119.02 21.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.101 0.56 . . . . 0.0 109.725 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 43.1 mt-10 -114.48 112.65 23.31 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -176.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.409 ' HB3' HD13 ' A' ' 177' ' ' LEU . 97.6 mtt180 -72.44 133.31 44.8 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.266 0.626 . . . . 0.0 109.776 171.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.419 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . . . -156.66 169.69 24.12 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.743 0.652 . . . . 0.0 110.525 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.497 HD21 ' HA ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -144.91 150.19 36.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.8 -146.66 4.61 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -149.27 152.65 36.27 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.408 ' HB3' ' HB1' ' A' ' 115' ' ' ALA . 30.6 tpt180 -154.75 135.67 13.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.7 m -78.74 137.64 37.86 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.5 pt -126.63 159.61 62.75 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 124.081 0.952 . . . . 0.0 109.925 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.32 -27.3 56.91 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.333 2.689 . . . . 0.0 113.644 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.46 -39.23 77.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.965 0.506 . . . . 0.0 111.937 175.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.35 -146.95 11.96 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 -173.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -83.83 137.98 33.44 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.66 160.4 38.22 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.946 0.498 . . . . 0.0 110.838 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -100.49 162.59 12.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 165.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.7 t -141.28 133.54 28.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.375 0.27 . . . . 0.0 110.86 -167.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.497 ' HA ' HD21 ' A' ' 11' ' ' LEU . 43.5 pt -85.48 134.84 26.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 3.0 mp -111.17 111.56 36.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 171.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.0 mt -103.81 104.66 17.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.541 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 87.9 mtt180 -91.01 159.86 15.92 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 122.999 0.52 . . . . 0.0 109.805 173.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 6.3 tt0 -168.92 119.68 0.74 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.227 1.58 . . . . 0.0 111.477 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.564 ' HB2' ' HB1' ' A' ' 6' ' ' ALA . 6.0 mmt180 -88.44 106.23 18.13 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.532 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 91.4 m-85 -85.42 126.56 33.89 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.525 168.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -89.35 76.74 7.5 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 168.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 30' ' ' TYR . . . -179.82 139.83 0.32 Allowed Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -157.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.445 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 85.4 Cg_endo -74.18 150.18 42.01 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.223 1.949 . . . . 0.0 113.504 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -47.78 -39.99 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.453 170.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -47.85 -49.3 29.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.393 1.058 . . . . 0.0 111.391 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 31.0 mt-10 -80.64 -29.84 36.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.565 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.7 t -73.13 -32.9 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 123.628 0.58 . . . . 0.0 110.631 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -81.51 -25.9 35.58 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.698 1.199 . . . . 0.0 109.753 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m -68.03 -50.16 57.01 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.566 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -60.55 -41.56 94.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.137 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.651 ' SG ' HD22 ' A' ' 99' ' ' LEU . 17.0 t -61.82 -45.18 94.94 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.4 p -104.05 -45.25 4.79 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -165.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.445 ' O ' HG13 ' A' ' 47' ' ' ILE . 5.5 m-20 -68.79 116.7 43.74 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.993 -175.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.88 -34.89 23.29 Favored 'Trans proline' 0 C--N 1.388 2.627 0 C-N-CA 123.622 2.881 . . . . 0.0 113.953 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.57 -33.49 72.78 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.631 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.566 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 30.7 mmt180 -90.0 -33.37 16.39 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.172 0.989 . . . . 0.0 111.512 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 43' ' ' ASP . 71.6 mt -73.3 -36.03 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -168.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -71.67 -1.03 12.33 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.558 0.743 . . . . 0.0 112.715 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.5 -48.83 7.05 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.413 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 62.7 p-90 -101.56 -16.4 16.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.413 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 44.0 t80 -137.64 -114.16 0.17 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.584 0.754 . . . . 0.0 109.771 -176.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.451 HD13 HD11 ' A' ' 66' ' ' LEU . 49.4 mt -136.96 144.3 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -171.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.96 113.55 12.68 Favored Pre-proline 0 N--CA 1.485 1.295 0 O-C-N 124.801 1.313 . . . . 0.0 110.214 174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -92.15 143.51 2.66 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.056 2.504 . . . . 0.0 111.742 172.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -143.9 135.93 26.5 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.99 -151.93 23.58 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -71.04 -49.1 48.6 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.7 mt 59.36 25.43 14.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.239 0.962 . . . . 0.0 110.602 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -122.94 148.66 45.22 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.436 1.495 . . . . 0.0 109.674 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -70.42 130.83 42.96 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.377 0.608 . . . . 0.0 109.771 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.71 -2.08 82.0 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.781 -168.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.24 178.03 18.3 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 8.2 p30 -117.98 178.0 4.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -172.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -150.85 162.39 40.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.04 0.936 . . . . 0.0 109.266 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.88 146.06 36.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.899 0.88 . . . . 0.0 109.513 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 69' ' ' ASN . 86.9 mt -83.64 -89.83 0.09 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.175 0.59 . . . . 0.0 110.187 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -140.89 -57.59 0.51 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.27 9.62 0.52 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.412 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.457 ' HB3' HD12 ' A' ' 66' ' ' LEU . 42.6 t-20 -77.37 -85.07 0.06 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.3 158.58 43.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.703 0.763 . . . . 0.0 112.134 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.5 p -132.96 147.98 52.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.421 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.04 171.66 44.56 Favored Glycine 0 N--CA 1.464 0.502 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.581 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 24.9 m-20 -85.78 171.35 11.65 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.479 0.657 . . . . 0.0 111.298 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.23 119.53 59.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 168.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.438 ' HB2' HG22 ' A' ' 84' ' ' THR . 59.0 mt -84.63 -38.4 19.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.005 0.522 . . . . 0.0 110.622 -176.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -166.18 111.54 0.83 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.493 0.717 . . . . 0.0 109.61 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 10.6 p -107.3 103.1 12.38 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -99.94 102.17 16.63 Favored Pre-proline 0 N--CA 1.482 1.125 0 C-N-CA 124.132 0.973 . . . . 0.0 110.521 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 96.6 Cg_endo -80.66 129.55 7.34 Favored 'Trans proline' 0 CA--C 1.564 2.013 0 C-N-CA 122.786 2.324 . . . . 0.0 112.896 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.537 ' HD2' HH11 ' A' ' 81' ' ' ARG . 16.1 Cg_endo -103.84 33.37 6.97 Favored 'Cis proline' 0 C--N 1.38 2.193 0 CA-C-N 119.802 0.965 . . . . 0.0 112.783 -10.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.537 HH11 ' HD2' ' A' ' 80' ' ' PRO . 3.7 mpt_? -65.93 -69.24 0.31 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.923 0.889 . . . . 0.0 110.437 -176.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.9 ptt-85 -161.86 154.68 20.29 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.322 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.453 ' H ' HD21 ' A' ' 83' ' ' LEU . 1.8 pt? -107.04 146.61 30.96 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 167.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.438 HG22 ' HB2' ' A' ' 75' ' ' LEU . 94.1 m -131.53 121.83 25.11 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.664 1.585 . . . . 0.0 107.167 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.9 pt -141.58 142.99 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.779 0.832 . . . . 0.0 109.464 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.9 t -88.84 137.66 32.12 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -123.7 102.83 8.04 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.4 t -99.18 101.48 12.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -93.77 146.19 24.05 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.463 172.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -62.05 121.78 13.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.693 0.797 . . . . 0.0 111.331 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.82 19.65 61.09 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.323 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.468 ' HD2' ' HB2' ' A' ' 121' ' ' MET . 72.8 mmtt -132.4 147.89 67.47 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 123.917 0.887 . . . . 0.0 109.754 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.27 149.8 64.19 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.781 2.321 . . . . 0.0 111.418 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -59.8 116.61 4.21 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.872 0.869 . . . . 0.0 111.818 -169.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.8 m -90.59 160.76 15.76 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.554 -172.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -104.25 140.66 37.53 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.275 1.03 . . . . 0.0 108.361 166.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 54.2 t -138.14 118.37 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -126.46 111.87 14.94 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.651 HD22 ' SG ' ' A' ' 41' ' ' CYS . 38.2 tp -96.91 119.58 35.65 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.5 ttp-105 -127.14 114.57 17.88 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.618 0.767 . . . . 0.0 109.285 -160.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.1 mt -104.77 153.79 20.86 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.464 0.706 . . . . 0.0 110.564 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.6 m -141.85 123.01 14.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.784 0.834 . . . . 0.0 109.859 170.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -83.34 106.31 15.0 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -120.32 80.26 1.58 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.411 1.084 . . . . 0.0 110.238 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.56 -103.18 1.82 Allowed Glycine 0 C--N 1.35 1.31 0 C-N-CA 122.96 0.314 . . . . 0.0 112.539 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -106.47 5.08 28.99 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.416 0.686 . . . . 0.0 109.291 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.32 163.29 12.42 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.39 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 m -140.16 112.83 8.01 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.627 1.171 . . . . 0.0 108.438 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.8 tp -80.74 107.75 13.82 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.1 tt -90.66 131.46 36.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 172.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.53 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 43.9 mt-10 -132.9 109.22 9.44 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.5 tt -95.26 121.2 36.66 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 4.8 tp10 -112.6 102.7 10.76 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.461 ' HB3' HG12 ' A' ' 24' ' ' ILE . 6.5 t60 -114.58 112.67 23.29 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 14' ' ' ARG . . . -114.28 107.68 15.91 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.404 1.082 . . . . 0.0 110.189 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.484 HG22 ' HG ' ' A' ' 122' ' ' LEU . 5.1 t -127.64 156.03 42.96 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.663 0.744 . . . . 0.0 110.528 174.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -23.77 58.87 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.196 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.1 t -91.19 115.89 28.38 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.236 1.015 . . . . 0.0 110.795 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -69.93 -25.58 63.73 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.758 0.823 . . . . 0.0 110.942 175.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -63.45 -47.76 80.53 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.528 171.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.468 ' HB2' ' HD2' ' A' ' 92' ' ' LYS . 23.3 ttt -67.58 -33.61 75.36 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.114 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.484 ' HG ' HG22 ' A' ' 116' ' ' THR . 19.7 mt -63.06 -43.87 97.42 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.255 0.622 . . . . 0.0 112.045 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.421 ' O ' HG22 ' A' ' 127' ' ' VAL . 89.3 t -63.78 -42.23 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.954 173.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.65 -44.99 76.58 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.582 1.153 . . . . 0.0 111.807 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -79.65 -18.84 12.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 C-N-CA 123.37 0.668 . . . . 0.0 109.505 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.49 -34.09 89.02 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 166.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 123' ' ' VAL . 48.7 t -75.6 -50.76 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.97 -33.48 79.45 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 114.676 0.63 . . . . 0.0 114.676 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -86.04 -41.02 15.17 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.703 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.71 -34.05 76.35 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.91 0.777 . . . . 0.0 109.604 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 53.4 ttm -60.83 -50.13 74.67 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.837 0.855 . . . . 0.0 109.74 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.52 90.79 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.739 0.816 . . . . 0.0 112.154 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.16 -21.51 33.52 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.518 0.727 . . . . 0.0 111.6 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.65 -44.4 70.66 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -72.7 -35.82 67.7 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.166 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 29.1 tp -70.43 -38.66 74.61 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.824 0.45 . . . . 0.0 110.557 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.01 -52.77 50.21 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.744 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 31.1 ttp -61.75 -38.89 89.68 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.121 0.568 . . . . 0.0 110.799 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.16 -56.69 18.57 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.857 1.263 . . . . 0.0 111.042 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 58.9 mt -72.46 -19.19 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.8 0.84 . . . . 0.0 111.145 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.553 1.083 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 12.2 tt . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 111.39 0.144 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.9 p -77.78 -40.91 39.2 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -54.63 -59.03 5.26 Favored 'General case' 0 C--O 1.206 -1.211 0 O-C-N 123.922 0.764 . . . . 0.0 110.664 166.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -41.44 -49.58 3.9 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.153 1.381 . . . . 0.0 112.437 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -56.59 -55.79 29.54 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.007 0.523 . . . . 0.0 110.385 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.42 -17.52 79.11 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.435 -168.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.23 -29.07 31.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.023 0.929 . . . . 0.0 110.042 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.52 -53.67 17.96 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.78 0.832 . . . . 0.0 109.503 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -69.1 -25.87 64.64 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.846 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.04 -60.53 3.32 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 172.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.16 12.52 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.662 1.185 . . . . 0.0 112.911 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 78.1 mt -68.7 -46.25 69.48 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.096 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.03 -23.74 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.115 0.871 . . . . 0.0 110.682 -166.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -70.39 -25.25 63.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.424 0.69 . . . . 0.0 110.072 171.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 CA--C 1.556 1.18 0 C-N-CA 124.059 0.944 . . . . 0.0 110.692 172.025 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 85.6 m -85.81 122.25 29.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.628 -176.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -124.6 112.06 16.37 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.571 1.548 . . . . 0.0 107.596 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.27 159.54 31.39 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.8 173.26 10.82 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.504 0.722 . . . . 0.0 109.095 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.42 HD11 ' N ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -145.32 154.86 42.78 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -177.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.42 ' N ' HD11 ' A' ' 11' ' ' LEU . . . -162.47 -153.95 7.37 Favored Glycine 0 C--O 1.238 0.404 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.4 ptt85 -157.1 160.28 38.7 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.211 0.604 . . . . 0.0 110.129 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -168.53 162.42 12.1 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.917 171.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.1 m -96.37 144.03 26.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.763 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.426 HD13 HG21 ' A' ' 117' ' ' THR . 42.5 pt -135.5 162.31 57.95 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.933 1.293 . . . . 0.0 108.497 -174.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.97 -35.37 31.76 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.568 2.845 . . . . 0.0 114.767 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.83 99.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.647 0.779 . . . . 0.0 111.779 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.06 -149.05 18.28 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.66 139.27 38.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 117.314 0.557 . . . . 0.0 109.622 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.12 158.55 44.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.295 0.569 . . . . 0.0 111.479 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -97.11 161.37 13.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 165.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 78.4 p -138.48 124.56 20.17 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.514 HG12 HG23 ' A' ' 125' ' ' VAL . 2.6 pp -86.61 131.0 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mp -113.19 119.58 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.0 mt -105.65 111.03 33.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.547 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 61.3 mtt180 -92.18 140.85 29.21 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 123.364 0.415 . . . . 0.0 110.335 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.618 HE22 HD23 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -137.33 139.6 40.94 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 167.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.471 HH12 ' HA3' ' A' ' 107' ' ' GLY . 24.6 tpt85 -107.83 102.79 11.97 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.428 ' HE1' ' HA2' ' A' ' 137' ' ' GLY . 63.1 m-85 -85.95 144.46 27.62 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.931 1.292 . . . . 0.0 110.929 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.512 ' HB3' ' HD3' ' A' ' 141' ' ' ARG . 26.5 t70 -87.82 26.44 1.33 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 123.807 0.692 . . . . 0.0 110.696 170.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.27 155.09 68.79 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.049 0.94 . . . . 0.0 110.604 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.38 156.63 59.0 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.549 2.833 . . . . 0.0 113.174 175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 101' ' ' LEU . 11.3 t -59.97 -42.51 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 O-C-N 124.473 1.108 . . . . 0.0 110.628 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -48.66 -52.05 25.29 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 125.107 1.504 . . . . 0.0 109.88 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -64.92 -62.87 1.3 Allowed 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.65 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.507 HG21 HD12 ' A' ' 140' ' ' ILE . 62.9 t -46.54 -39.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 C-N-CA 124.697 1.199 . . . . 0.0 112.248 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -65.93 -41.16 91.73 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.114 0.966 . . . . 0.0 110.316 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.4 m -69.78 -25.79 63.97 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 123.469 0.48 . . . . 0.0 110.512 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.56 -47.91 21.02 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.527 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.426 ' HB3' HD21 ' A' ' 99' ' ' LEU . 84.7 m -75.82 -16.9 60.02 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 43.7 p -101.63 -33.22 9.98 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 118.403 0.547 . . . . 0.0 111.66 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 47' ' ' ILE . 19.9 t70 -83.45 112.41 39.12 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 122.75 0.42 . . . . 0.0 110.004 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.472 ' HB2' ' HG3' ' A' ' 53' ' ' GLU . 58.4 Cg_endo -64.46 -27.34 62.37 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.151 2.568 . . . . 0.0 112.869 -171.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -63.9 -39.34 93.95 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.758 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -79.48 -24.29 42.44 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.59 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 43' ' ' ASP . 79.1 mt -74.82 -38.5 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.59 0.356 . . . . 0.0 111.52 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 10.9 p30 -73.87 -0.42 15.94 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -73.26 -29.94 63.09 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.768 0.827 . . . . 0.0 110.714 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.436 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 40.7 p-90 -129.31 -11.7 4.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.015 0.926 . . . . 0.0 111.484 -171.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.436 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 16.2 t80 -147.96 -163.72 1.84 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.525 0.73 . . . . 0.0 109.13 -174.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 mt -87.1 171.34 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 31.3 tt0 -108.63 121.51 43.05 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.668 1.187 . . . . 0.0 110.12 -172.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.69 84.69 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.337 2.691 . . . . 0.0 111.0 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -77.47 126.22 30.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.989 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.22 -165.89 36.8 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.633 -0.318 . . . . 0.0 112.722 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.84 -37.96 73.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.443 0.697 . . . . 0.0 110.279 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.0 mt 59.22 -171.37 0.12 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.922 1.289 . . . . 0.0 111.885 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 72.59 166.64 0.3 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.882 1.273 . . . . 0.0 110.598 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 41.3 tt0 -60.02 111.7 1.6 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.165 0.586 . . . . 0.0 111.149 -173.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.08 11.52 58.61 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.436 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.34 -146.56 20.36 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.633 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 29.8 p-10 -156.0 160.42 40.03 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 117.571 0.685 . . . . 0.0 111.705 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -140.07 147.91 40.99 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.72 112.17 5.28 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.756 0.823 . . . . 0.0 109.884 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 69' ' ' ASN . 79.1 mt -78.39 146.89 34.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.706 0.802 . . . . 0.0 109.262 172.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -69.41 122.07 18.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.551 0.74 . . . . 0.0 110.631 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 56.69 40.9 89.45 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 124.29 0.994 . . . . 0.0 114.468 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 66' ' ' LEU . 18.4 t-20 -147.17 -84.27 0.11 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.704 0.252 . . . . 0.0 110.402 -171.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.35 151.03 31.19 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.98 0.419 . . . . 0.0 111.707 -171.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -132.0 145.25 51.34 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.224 1.009 . . . . 0.0 109.796 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.19 -163.08 26.99 Favored Glycine 0 C--O 1.241 0.548 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 4.8 p-10 -127.04 173.89 9.3 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.158 0.479 . . . . 0.0 110.731 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.476 ' HA ' HG22 ' A' ' 85' ' ' ILE . 19.6 mm -97.49 102.8 13.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.53 -47.84 71.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -167.66 142.52 3.76 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.794 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 22.0 p -127.36 106.24 9.07 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.64 99.47 8.84 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 9.9 Cg_exo -74.56 137.81 23.3 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.147 2.565 . . . . 0.0 112.984 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 42.7 Cg_endo -100.83 30.53 11.11 Favored 'Cis proline' 0 C--N 1.375 1.932 0 CA-C-N 119.481 0.85 . . . . 0.0 112.153 -9.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -71.34 -69.43 0.38 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.285 1.034 . . . . 0.0 111.998 -170.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -152.95 146.9 25.36 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.417 0.627 . . . . 0.0 111.452 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 99' ' ' LEU . 58.1 tp -98.31 143.99 28.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.702 -1.136 . . . . 0.0 107.954 169.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.9 m -134.79 123.34 23.42 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.476 HG22 ' HA ' ' A' ' 74' ' ' ILE . 21.0 pt -143.74 149.56 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.619 0.768 . . . . 0.0 110.285 -174.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 p -88.16 138.51 31.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 36.8 t-105 -130.2 101.02 5.61 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -170.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -107.91 102.46 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -78.74 154.85 29.68 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.63 111.04 1.45 Allowed 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.065 0.46 . . . . 0.0 111.784 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.04 21.99 66.75 Favored Glycine 0 C--N 1.351 1.361 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.375 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.459 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 69.0 mmtt -126.48 153.14 75.08 Favored Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 123.711 0.805 . . . . 0.0 109.593 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 118' ' ' SER . 23.4 Cg_exo -64.72 162.5 31.39 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.962 2.441 . . . . 0.0 113.506 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.93 103.59 1.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.962 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -100.46 179.29 4.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.824 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -142.42 128.81 20.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.974 0.909 . . . . 0.0 108.634 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.6 t -113.66 121.46 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.241 0.544 . . . . 0.0 110.292 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 37.7 mm-40 -91.41 138.66 31.4 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.906 165.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 83' ' ' LEU . 55.0 tp -127.63 110.57 12.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 171.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -128.97 121.91 29.0 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 122.151 -0.343 . . . . 0.0 110.385 -160.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.514 ' HB3' HG22 ' A' ' 34' ' ' VAL . 90.0 mt -115.61 141.28 48.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.645 0.778 . . . . 0.0 111.233 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.4 t -144.51 115.24 7.74 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.523 1.129 . . . . 0.0 108.791 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -81.96 120.45 25.25 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -129.39 121.81 28.14 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.301 1.44 . . . . 0.0 108.129 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.93 -135.28 16.44 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -102.63 62.57 0.84 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 165.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.471 ' HA3' HH12 ' A' ' 29' ' ' ARG . . . -179.24 -177.79 47.9 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.101 -0.954 . . . . 0.0 114.408 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.3 m -134.26 141.33 46.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.311 1.044 . . . . 0.0 110.081 -170.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.9 tp -102.27 112.98 25.9 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.618 HD23 HE22 ' A' ' 28' ' ' GLN . 7.3 tt -95.89 134.61 38.67 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 173.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.547 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 39.8 mt-10 -132.69 106.28 7.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.591 HD12 HD23 ' A' ' 133' ' ' LEU . 8.9 tt -98.27 122.05 40.96 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.679 ' HB3' ' HB2' ' A' ' 98' ' ' GLU . 38.7 tt0 -122.01 100.78 7.16 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.807 0.843 . . . . 0.0 109.28 -172.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 23' ' ' SER . 8.3 t60 -99.29 113.77 26.25 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 22' ' ' ARG . . . -104.38 111.74 24.51 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.714 1.206 . . . . 0.0 111.095 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.437 HG21 ' HG ' ' A' ' 122' ' ' LEU . 10.6 t -136.99 160.76 37.97 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 170.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.426 HG21 HD13 ' A' ' 16' ' ' ILE . 66.8 p -86.13 -15.08 42.24 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.582 1.153 . . . . 0.0 111.489 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.482 ' HB2' ' HG2' ' A' ' 93' ' ' PRO . 46.4 t -87.17 108.98 19.15 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.062 0.545 . . . . 0.0 109.797 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.503 ' HA ' HD13 ' A' ' 122' ' ' LEU . 39.7 tt0 -62.03 -31.04 71.4 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.787 0.835 . . . . 0.0 110.796 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -61.24 -58.05 9.88 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.158 175.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.459 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 24.3 ttt -64.16 -26.92 68.74 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.706 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 119' ' ' GLU . 13.8 mt -65.15 -44.6 88.05 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.463 0.705 . . . . 0.0 111.864 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.89 -45.44 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.256 0.551 . . . . 0.0 109.81 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.79 -50.5 72.14 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.042 1.337 . . . . 0.0 112.081 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.514 HG23 HG12 ' A' ' 24' ' ' ILE . 35.8 m -72.03 -29.37 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.876 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.7 -38.23 91.36 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 172.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.457 ' O ' ' HG2' ' A' ' 131' ' ' MET . 59.6 t -75.69 -59.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.051 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.63 -37.04 94.15 Favored Glycine 0 C--N 1.345 1.038 0 O-C-N 123.725 0.64 . . . . 0.0 114.446 -172.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.464 ' HB2' ' O ' ' A' ' 125' ' ' VAL . 10.7 m95 -67.05 -53.38 31.68 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -57.76 -31.47 66.53 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.156 0.285 . . . . 0.0 110.746 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 95.7 mmm -61.48 -48.45 81.06 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.204 0.602 . . . . 0.0 110.331 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.31 -38.96 85.32 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.26 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.591 HD23 HD12 ' A' ' 112' ' ' LEU . 2.8 mm? -77.37 -19.88 55.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.985 0.514 . . . . 0.0 111.731 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 138' ' ' MET . 72.0 m-20 -66.82 -53.5 32.08 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.403 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 68.9 m-85 -72.59 -25.4 61.31 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.749 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.1 tp -70.39 -39.21 74.64 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.428 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -58.14 -39.41 92.19 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.615 171.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 89.3 mmm -70.22 -38.16 75.17 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.531 0.732 . . . . 0.0 110.183 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -69.01 -37.26 78.57 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.2 1.0 . . . . 0.0 111.276 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.507 HD12 HG21 ' A' ' 37' ' ' VAL . 50.5 mt -80.03 -57.42 5.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 123.338 0.655 . . . . 0.0 110.193 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.512 ' HD3' ' HB3' ' A' ' 31' ' ' ASP . 21.2 ttt180 . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 121.709 0.766 . . . . 0.0 110.179 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 61.8 mt . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 119.751 -0.166 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 62.2 p -70.69 -39.76 73.32 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.235 0.334 . . . . 0.0 110.52 -171.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -59.7 -59.7 5.02 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.293 170.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -43.17 -36.75 1.82 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 172.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -64.77 -52.36 57.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.248 0.619 . . . . 0.0 110.733 175.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.25 -20.01 75.92 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.264 -174.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -81.37 -28.17 34.54 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.63 1.172 . . . . 0.0 110.088 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.25 -48.76 55.44 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.405 ' CZ3' ' HB ' ' A' ' 24' ' ' ILE . 91.7 m95 -69.05 -23.1 64.01 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.035 177.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.01 -61.08 2.24 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 173.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -47.11 -47.1 23.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.837 1.255 . . . . 0.0 112.733 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 56.6 mt -64.83 -46.51 81.61 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.592 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.9 p -74.57 -26.94 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 118.867 0.758 . . . . 0.0 109.953 -169.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -76.29 -10.09 59.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.64 0.776 . . . . 0.0 111.583 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 CA--C 1.549 0.909 0 C-N-CA 123.593 0.757 . . . . 0.0 109.54 168.889 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 121.382 0.611 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 m -89.11 130.92 35.47 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.824 0.85 . . . . 0.0 111.161 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 19.8 mt-10 -119.16 109.13 15.52 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 173.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -82.48 136.13 34.97 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.047 0.539 . . . . 0.0 110.259 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.13 179.44 9.23 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 123.843 0.714 . . . . 0.0 110.144 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.544 ' HG ' ' HA ' ' A' ' 178' ' ' VAL . 0.2 OUTLIER -143.61 148.46 35.89 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.55 166.28 23.91 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.436 ' HD3' ' H ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -110.33 148.53 31.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.623 ' HG2' ' HB1' ' A' ' 115' ' ' ALA . 6.5 tpt180 -148.33 150.3 33.35 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.206 0.527 . . . . 0.0 112.134 -164.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.3 m -111.13 137.9 48.22 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 161.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 pt -140.03 159.77 63.01 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -51.1 -26.59 19.62 Favored 'Trans proline' 0 C--N 1.386 2.549 0 C-N-CA 123.065 2.51 . . . . 0.0 114.294 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.71 -44.81 63.52 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.029 0.532 . . . . 0.0 111.307 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.43 -151.21 21.71 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.071 0.232 . . . . 0.0 112.609 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -73.75 123.14 23.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.409 0.684 . . . . 0.0 109.644 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.03 166.95 19.07 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.542 0.737 . . . . 0.0 111.205 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -125.15 171.78 10.03 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 162.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.9 m -134.45 135.67 42.67 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.289 0.636 . . . . 0.0 109.797 -170.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.521 HG12 ' HB3' ' A' ' 114' ' ' HIS . 35.4 pt -85.91 133.69 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 168.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.652 HG13 ' HG2' ' A' ' 113' ' ' GLU . 2.0 mp -110.57 111.8 37.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 174.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.5 mt -107.29 106.65 21.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 168.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 28.4 mtt180 -89.74 161.19 16.18 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.547 174.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 110' ' ' LEU . 4.2 tp-100 -162.11 117.88 1.98 Allowed 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.337 -174.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -95.4 105.68 17.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 165.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.534 ' HB2' ' HB ' ' A' ' 108' ' ' THR . 50.3 m-85 -87.58 150.7 23.53 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 123.857 0.863 . . . . 0.0 109.398 169.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -114.66 85.74 2.3 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 162.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 179.71 137.45 0.28 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.932 2.093 . . . . 0.0 105.617 -163.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.46 137.07 78.37 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.76 2.307 . . . . 0.0 113.286 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.572 HG22 HG23 ' A' ' 108' ' ' THR . 54.3 t -48.99 -40.47 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 124.329 1.018 . . . . 0.0 110.528 167.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -48.88 -45.48 41.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.474 1.109 . . . . 0.0 111.308 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.11 -25.64 34.27 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.451 HG22 HD12 ' A' ' 140' ' ' ILE . 50.6 t -72.29 -44.18 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.074 0.464 . . . . 0.0 110.359 174.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -68.51 -28.02 66.64 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.593 1.157 . . . . 0.0 109.726 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 t -65.79 -48.27 72.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.932 0.893 . . . . 0.0 109.928 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.23 -28.41 63.14 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.338 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.3 t -76.95 -24.39 52.35 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.6 p -111.18 -43.01 3.8 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -172.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.428 ' O ' HG13 ' A' ' 47' ' ' ILE . 15.0 t70 -76.66 120.07 80.11 Favored Pre-proline 0 N--CA 1.483 1.22 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.917 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.1 -46.54 30.42 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.903 3.069 . . . . 0.0 114.391 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.426 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 41.3 t-20 -58.65 -32.64 69.26 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.768 0.827 . . . . 0.0 111.314 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -89.82 -20.06 23.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.219 0.608 . . . . 0.0 111.217 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 43' ' ' ASP . 85.7 mt -75.99 -42.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.059 0.544 . . . . 0.0 110.331 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.426 ' ND2' ' HA ' ' A' ' 45' ' ' ASN . 10.6 p30 -69.78 -0.89 7.86 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -172.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -91.82 -11.06 37.63 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.365 0.666 . . . . 0.0 110.246 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.434 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 57.9 p-90 -137.17 -25.21 1.07 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.3 1.04 . . . . 0.0 111.338 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.434 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 5.1 t80 -130.66 -160.66 1.06 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.329 1.052 . . . . 0.0 108.523 -177.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.62 143.64 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 122.833 0.453 . . . . 0.0 110.661 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -63.6 115.06 15.59 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 124.753 1.283 . . . . 0.0 109.767 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -83.07 148.06 13.25 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.446 2.097 . . . . 0.0 112.877 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -134.96 125.87 27.49 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.61 -175.45 39.82 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 121.507 -0.377 . . . . 0.0 112.902 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.8 -44.06 86.82 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.177 0.574 . . . . 0.0 110.307 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.6 mt 66.95 5.15 3.88 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.133 1.373 . . . . 0.0 113.126 171.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -103.71 168.1 9.36 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.297 0.639 . . . . 0.0 109.917 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.434 ' HG2' ' H ' ' A' ' 77' ' ' CYS . 31.2 mt-10 -58.56 122.76 14.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.746 0.819 . . . . 0.0 110.794 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.35 13.94 77.57 Favored Glycine 0 N--CA 1.469 0.862 0 CA-C-N 116.467 -0.333 . . . . 0.0 113.112 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.95 -168.17 19.03 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.299 -0.32 . . . . 0.0 112.299 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -117.31 167.24 11.41 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.564 0.746 . . . . 0.0 110.095 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -146.95 149.4 33.11 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.15 116.3 9.44 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.203 0.601 . . . . 0.0 111.032 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.3 mt -91.7 133.58 35.46 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.672 1.189 . . . . 0.0 109.3 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -68.23 106.08 2.32 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.565 1.146 . . . . 0.0 110.0 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.81 40.55 84.94 Favored Glycine 0 C--N 1.348 1.206 0 N-CA-C 114.385 0.514 . . . . 0.0 114.385 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -144.54 -86.77 0.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.579 0.352 . . . . 0.0 110.128 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.69 156.31 42.64 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 120.773 0.321 . . . . 0.0 111.631 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.1 m -131.0 143.21 50.55 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.222 1.009 . . . . 0.0 108.538 174.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.93 -153.81 8.09 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.431 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 2.4 m-20 -121.36 171.07 9.02 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.771 0.828 . . . . 0.0 109.828 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.447 ' HA ' HG22 ' A' ' 85' ' ' ILE . 3.5 mp -108.24 112.65 41.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 170.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.573 HD11 HG22 ' A' ' 84' ' ' THR . 74.9 mt -69.95 -49.97 46.53 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.451 ' HD2' ' HB ' ' A' ' 84' ' ' THR . 0.1 OUTLIER -168.65 154.88 6.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.059 0.944 . . . . 0.0 109.376 169.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.434 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 24.9 p -146.31 120.36 9.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -121.23 110.14 34.61 Favored Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 16.8 Cg_exo -68.38 129.52 19.28 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.851 2.367 . . . . 0.0 112.693 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 19.9 Cg_endo -103.42 23.96 13.15 Favored 'Cis proline' 0 C--N 1.376 2.014 0 CA-C-N 120.048 1.053 . . . . 0.0 112.626 -13.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -64.18 -67.14 0.46 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.0 0.92 . . . . 0.0 112.006 -171.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -138.03 158.42 44.36 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.588 0.755 . . . . 0.0 110.651 -171.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 tt -142.32 127.5 18.61 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 171.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.573 HG22 HD11 ' A' ' 75' ' ' LEU . 19.3 m -139.46 130.3 26.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.227 0.611 . . . . 0.0 109.378 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.447 HG22 ' HA ' ' A' ' 74' ' ' ILE . 10.4 pt -141.24 146.6 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.026 1.33 . . . . 0.0 109.91 -171.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 73' ' ' ASP . 18.0 p -89.95 145.57 25.02 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.669 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 22.0 t-105 -140.98 107.33 5.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.101 0.864 . . . . 0.0 109.397 -159.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.15 103.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -101.51 94.96 6.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.566 1.146 . . . . 0.0 110.432 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 47.8 -73.1 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 126.618 1.967 . . . . 0.0 115.278 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.6 33.58 2.54 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 117.957 0.344 . . . . 0.0 112.553 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.606 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 72.3 mmtt -115.65 159.31 39.24 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 124.174 0.989 . . . . 0.0 110.656 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.12 161.02 41.93 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.419 2.079 . . . . 0.0 112.759 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.58 107.08 1.97 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.901 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.669 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 13.4 m -87.71 155.58 19.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.188 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -116.51 103.08 10.07 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.63 142.7 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.938 0.895 . . . . 0.0 108.622 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -147.83 156.87 43.18 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.253 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.5 tt -139.81 139.85 36.48 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 21.2 tpt180 -135.25 122.86 22.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.777 0.831 . . . . 0.0 109.521 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.4 mt -115.32 137.86 51.58 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.688 0.795 . . . . 0.0 110.16 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 t -143.98 137.1 27.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.172 0.589 . . . . 0.0 109.898 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -84.97 96.14 9.29 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.528 1.131 . . . . 0.0 110.425 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -100.7 78.23 1.96 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.01 -117.42 4.69 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -91.37 9.73 30.41 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 168.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 30' ' ' TYR . . . -100.82 159.32 19.03 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.485 -173.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.572 HG23 HG22 ' A' ' 34' ' ' VAL . 53.1 m -135.15 108.13 7.62 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.757 1.223 . . . . 0.0 108.63 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.8 tp -81.04 106.04 12.73 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 28' ' ' GLN . 8.1 tt -91.0 130.89 36.88 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 42.4 mt-10 -131.67 107.09 8.57 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 tp -104.23 128.68 51.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.998 0.919 . . . . 0.0 109.636 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.652 ' HG2' HG13 ' A' ' 25' ' ' ILE . 45.5 mt-10 -127.12 103.67 7.56 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.775 0.83 . . . . 0.0 109.43 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.521 ' HB3' HG12 ' A' ' 24' ' ' ILE . 6.8 t60 -92.97 111.7 23.42 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.623 ' HB1' ' HG2' ' A' ' 14' ' ' ARG . . . -109.91 101.79 10.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.141 0.576 . . . . 0.0 110.54 -174.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.409 HG21 ' HG ' ' A' ' 122' ' ' LEU . 9.8 t -123.78 152.22 42.44 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.268 0.556 . . . . 0.0 110.77 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.3 m -66.42 -29.32 69.44 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.367 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 t -92.36 125.43 37.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.096 0.558 . . . . 0.0 111.384 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -62.48 -34.04 76.06 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.56 1.144 . . . . 0.0 110.126 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -44.93 81.78 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.212 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 23.2 ttt -68.48 -32.94 73.29 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.159 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.409 ' HG ' HG21 ' A' ' 116' ' ' THR . 25.5 mt -63.01 -42.52 99.86 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 118.42 0.554 . . . . 0.0 112.104 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.6 t -67.82 -42.13 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-O 121.155 0.502 . . . . 0.0 109.868 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -58.15 -50.17 74.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.18 1.392 . . . . 0.0 111.638 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.4 m -82.6 -18.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.565 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.86 -36.44 92.02 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 169.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.46 -46.81 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 114.669 -0.766 . . . . 0.0 109.94 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.11 -35.81 92.45 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 114.845 0.698 . . . . 0.0 114.845 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -87.67 -28.26 21.93 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.987 0.515 . . . . 0.0 110.853 -176.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.419 ' HG3' ' HD2' ' A' ' 170' ' ' ARG . 43.9 mm-40 -62.45 -38.81 91.22 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 72.4 mtm -70.4 -33.96 71.99 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.926 0.766 . . . . 0.0 110.692 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.67 -46.15 83.67 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.028 0.531 . . . . 0.0 111.054 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.91 -22.2 46.2 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.381 0.673 . . . . 0.0 110.741 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.459 ' O ' ' HG2' ' A' ' 138' ' ' MET . 24.8 t70 -65.49 -62.34 1.58 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 171.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -64.75 -29.64 70.63 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.1 0.56 . . . . 0.0 111.846 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.433 HD12 ' CE2' ' A' ' 50' ' ' TRP . 39.5 tp -67.83 -42.64 81.14 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -61.43 -39.05 96.76 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.9 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 97.3 mmm -69.4 -43.18 73.98 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.766 0.826 . . . . 0.0 110.524 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -68.21 -50.76 52.07 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.342 1.057 . . . . 0.0 111.064 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.451 HD12 HG22 ' A' ' 37' ' ' VAL . 67.0 mt -62.6 -43.52 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.309 0.644 . . . . 0.0 110.756 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 C-N-CA 123.417 0.687 . . . . 0.0 109.264 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 119.79 -0.148 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 42.1 t -70.24 -54.79 11.26 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.527 ' HG3' ' H ' ' A' ' 169' ' ' GLU . 10.6 pt20 -61.14 -59.77 4.82 Favored 'General case' 0 C--N 1.364 1.207 0 O-C-N 123.676 0.61 . . . . 0.0 111.368 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.527 ' H ' ' HG3' ' A' ' 168' ' ' GLN . 15.8 mm-40 -44.35 -47.84 9.68 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.419 ' HD2' ' HG3' ' A' ' 130' ' ' GLU . 13.7 tpp85 -66.17 -41.3 90.51 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.886 0.474 . . . . 0.0 110.675 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -76.74 -26.66 62.34 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.057 -174.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -75.79 -22.36 56.46 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.994 0.518 . . . . 0.0 110.787 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.54 -47.84 58.39 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.208 0.603 . . . . 0.0 109.413 170.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.4 ' HE1' ' HG3' ' A' ' 130' ' ' GLU . 98.9 m95 -69.31 -26.02 64.52 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.792 0.683 . . . . 0.0 112.005 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.83 -58.13 6.34 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -47.38 -42.66 22.29 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.257 1.023 . . . . 0.0 112.923 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.7 -48.22 75.47 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.698 0.623 . . . . 0.0 111.69 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.544 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 12.0 p -79.22 -29.59 13.8 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 C-N-CA 123.595 0.758 . . . . 0.0 111.427 -167.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -66.98 -31.39 71.93 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.373 0.669 . . . . 0.0 109.967 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.47 0.526 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.128 176.925 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 m -96.31 130.02 43.51 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.871 0.868 . . . . 0.0 109.689 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -120.49 110.68 16.77 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.834 0.854 . . . . 0.0 108.75 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.66 149.78 28.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.861 0.363 . . . . 0.0 110.724 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HB1' ' HB ' ' A' ' 25' ' ' ILE . . . -157.65 176.59 12.41 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.391 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 177' ' ' LEU . 1.2 tm? -144.69 149.97 36.52 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.53 -162.1 10.95 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -132.0 140.21 48.87 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.279 1.032 . . . . 0.0 108.918 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -155.0 131.03 10.17 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.527 0.731 . . . . 0.0 109.985 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -79.74 141.94 35.87 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 117' ' ' THR . 49.8 pt -129.61 160.55 64.03 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.083 0.953 . . . . 0.0 109.365 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -54.1 -28.67 51.98 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 123.233 2.622 . . . . 0.0 114.004 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.85 -34.86 60.08 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.565 0.746 . . . . 0.0 111.918 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.98 -148.9 14.92 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-O 120.015 -0.325 . . . . 0.0 112.321 -175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -87.92 135.38 33.43 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.49 162.97 30.44 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.815 0.446 . . . . 0.0 111.781 -175.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.543 HH11 HG23 ' A' ' 178' ' ' VAL . 91.0 mtt180 -102.44 159.0 15.81 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 166.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.6 p -133.7 125.94 29.7 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -172.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.494 ' HB ' ' CZ3' ' A' ' 174' ' ' TRP . 27.7 pt -85.96 135.2 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 3.5 mp -117.98 116.77 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.459 HD11 ' HB3' ' A' ' 129' ' ' TRP . 38.1 mt -106.99 107.19 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.568 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 95.1 mtt180 -91.97 161.68 14.7 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.705 174.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 5.6 tt0 -167.29 116.6 0.83 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 125.233 1.583 . . . . 0.0 109.951 176.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -92.23 108.42 19.94 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.514 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 60.5 m-85 -92.3 144.2 25.63 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.767 1.227 . . . . 0.0 111.507 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -102.26 72.91 1.32 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 162.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 30' ' ' TYR . . . -166.32 141.26 3.7 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.752 1.621 . . . . 0.0 106.639 -163.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.33 141.92 32.73 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 121.953 1.769 . . . . 0.0 112.579 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 80' ' ' PRO . 56.5 t -50.89 -43.69 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 124.487 1.117 . . . . 0.0 111.742 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -54.11 -35.6 62.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 124.462 1.101 . . . . 0.0 111.514 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -78.57 -32.56 47.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 t -74.63 -30.05 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 123.784 0.677 . . . . 0.0 110.171 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -78.21 -25.93 47.25 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.149 0.979 . . . . 0.0 110.425 177.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.8 m -65.67 -50.93 63.13 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -59.9 -37.68 80.1 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.421 0.688 . . . . 0.0 112.119 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.78 -45.51 93.59 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.0 p -117.58 -39.53 3.14 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -166.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.415 ' O ' HG13 ' A' ' 47' ' ' ILE . 12.1 t70 -69.21 118.16 59.22 Favored Pre-proline 0 N--CA 1.485 1.285 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.38 -33.55 97.55 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.412 2.741 . . . . 0.0 114.217 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -72.37 -23.28 61.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 123.606 0.567 . . . . 0.0 110.574 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.545 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 12.8 mmt85 -87.46 -30.39 20.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.995 0.918 . . . . 0.0 110.876 174.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 43' ' ' ASP . 60.1 mt -71.5 -41.19 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.187 0.595 . . . . 0.0 110.067 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -70.75 4.21 2.67 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -175.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -97.94 -11.44 23.11 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.828 0.851 . . . . 0.0 111.872 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.436 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 42.9 p-90 -139.04 -24.96 0.88 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.307 0.643 . . . . 0.0 111.614 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.436 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 12.9 t80 -132.57 -172.22 2.85 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.717 1.207 . . . . 0.0 108.839 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.13 144.84 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.043 0.937 . . . . 0.0 111.256 -171.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.71 113.53 5.45 Favored Pre-proline 0 CA--C 1.568 1.653 0 O-C-N 125.138 1.524 . . . . 0.0 111.812 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -93.15 121.41 0.43 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.069 2.513 . . . . 0.0 113.307 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.406 ' HE2' ' HA ' ' A' ' 55' ' ' LYS . 9.7 mmpt? -112.45 125.33 54.11 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 171.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.33 -171.4 36.55 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.37 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 63' ' ' ASN . 25.0 t70 -71.2 -43.86 66.58 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 123.936 0.433 . . . . 0.0 110.502 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.1 mt 73.64 -17.12 0.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.047 1.739 . . . . 0.0 113.499 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -97.49 164.71 12.33 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.167 0.587 . . . . 0.0 110.973 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.58 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 35.5 tt0 -55.97 126.2 24.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 112.968 -172.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.85 84.52 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.955 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -103.98 -147.48 17.6 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.439 ' H ' ' HB3' ' A' ' 57' ' ' ASP . 35.6 p-10 -148.39 167.65 24.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.43 0.692 . . . . 0.0 111.301 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -144.24 141.63 29.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.22 120.23 26.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.521 0.729 . . . . 0.0 110.493 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.8 mt -106.14 119.98 40.63 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.691 1.196 . . . . 0.0 108.1 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -69.99 123.83 22.52 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.137 0.975 . . . . 0.0 111.33 -171.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.11 31.46 64.07 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.859 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -149.77 -91.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.548 0.339 . . . . 0.0 110.828 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.13 152.46 18.95 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.147 0.499 . . . . 0.0 111.272 -169.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.9 p -137.77 137.29 38.1 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.36 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.6 -162.59 12.31 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 23.7 m-20 -101.22 172.28 7.1 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.34 0.656 . . . . 0.0 110.869 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 mm -106.97 116.68 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.444 HD22 ' HB2' ' A' ' 86' ' ' SER . 85.8 mt -82.09 -51.34 8.09 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.682 0.393 . . . . 0.0 110.951 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.73 120.8 2.42 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -173.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 27.4 p -135.66 110.72 8.88 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.828 0.451 . . . . 0.0 109.941 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -116.57 111.15 41.86 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.89 137.12 23.93 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.75 2.3 . . . . 0.0 113.096 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.509 ' HB2' HG12 ' A' ' 34' ' ' VAL . 27.2 Cg_endo -100.52 30.01 11.92 Favored 'Cis proline' 0 C--N 1.376 1.977 0 CA-C-N 119.413 0.826 . . . . 0.0 111.818 -9.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -65.22 -71.14 0.2 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.109 1.364 . . . . 0.0 111.991 -169.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 15.5 ptt180 -163.11 156.64 19.72 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.804 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.5 tp -111.12 145.5 38.47 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.232 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.439 HG23 HD11 ' A' ' 75' ' ' LEU . 26.1 m -142.01 130.54 22.58 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.83 149.29 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.355 1.062 . . . . 0.0 110.254 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.444 ' HB2' HD22 ' A' ' 75' ' ' LEU . 46.8 t -91.27 133.03 35.75 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 172.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -123.22 95.98 4.82 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -169.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -91.55 104.26 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -72.25 178.34 3.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.051 0.94 . . . . 0.0 109.791 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.37 -4.43 39.36 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.563 0.745 . . . . 0.0 112.858 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.64 57.97 0.06 OUTLIER Glycine 0 C--N 1.351 1.385 0 C-N-CA 121.783 -0.246 . . . . 0.0 112.974 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.452 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 74.5 mmtt -132.75 156.15 80.39 Favored Pre-proline 0 N--CA 1.496 1.844 0 C-N-CA 123.798 0.839 . . . . 0.0 109.645 173.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -86.87 72.06 3.46 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.614 2.209 . . . . 0.0 111.745 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 67.06 149.36 0.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.651 1.58 . . . . 0.0 113.273 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 63.7 m -136.64 127.09 26.74 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.601 ' HB3' ' HB1' ' A' ' 115' ' ' ALA . 4.6 tp10 -94.0 105.66 17.66 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.83 131.98 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -150.43 145.07 25.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.793 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.516 HD12 ' HG ' ' A' ' 110' ' ' LEU . 30.6 tp -107.86 152.52 24.3 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.662 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 31.0 tpt180 -138.28 122.31 17.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.142 0.977 . . . . 0.0 108.395 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HB3' HG11 ' A' ' 34' ' ' VAL . 81.2 mt -121.95 126.86 49.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.671 0.788 . . . . 0.0 109.299 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 m -145.14 125.45 13.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.552 0.741 . . . . 0.0 110.655 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.64 124.93 21.84 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.714 0.806 . . . . 0.0 110.905 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -142.27 128.39 19.71 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.719 0.808 . . . . 0.0 111.08 166.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.87 -135.94 17.23 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.65 -42.95 99.89 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 117.05 0.425 . . . . 0.0 110.923 161.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -107.89 -146.33 12.43 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 115.445 0.938 . . . . 0.0 115.445 -157.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.426 HG21 HG23 ' A' ' 34' ' ' VAL . 99.0 m -130.06 149.85 51.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.664 1.986 . . . . 0.0 109.055 -168.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.3 tp -109.07 127.5 54.19 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 166.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.516 ' HG ' HD12 ' A' ' 99' ' ' LEU . 9.2 tt -100.0 130.57 46.18 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 173.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 42.2 mt-10 -135.12 107.79 7.45 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 54.6 tp -102.51 143.07 32.68 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.258 0.623 . . . . 0.0 109.412 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 32.5 tt0 -132.29 142.24 49.29 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.723 0.809 . . . . 0.0 109.64 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -141.95 116.5 9.67 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.601 ' HB1' ' HB3' ' A' ' 96' ' ' GLU . . . -126.42 111.0 13.94 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.97 0.508 . . . . 0.0 112.012 -168.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 t -141.51 164.5 30.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.863 0.465 . . . . 0.0 110.359 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.498 HG22 HD11 ' A' ' 16' ' ' ILE . 58.1 p -74.73 -28.74 60.91 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.817 0.847 . . . . 0.0 110.695 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.6 t -79.86 110.45 15.24 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.832 0.853 . . . . 0.0 110.804 -175.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.77 -28.28 69.34 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.667 0.787 . . . . 0.0 111.04 171.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -59.02 -55.23 37.87 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.17 0.919 . . . . 0.0 109.189 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.452 ' SD ' ' HG3' ' A' ' 92' ' ' LYS . 12.4 tpt -56.63 -52.23 65.68 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.674 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.8 mt -54.5 -47.93 72.47 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.383 1.073 . . . . 0.0 113.614 -173.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.3 t -70.5 -42.98 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 122.413 0.285 . . . . 0.0 110.32 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.7 -49.9 73.27 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.726 0.811 . . . . 0.0 111.249 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 121' ' ' MET . 21.6 m -71.51 -23.12 22.44 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 C-N-CA 123.203 0.601 . . . . 0.0 110.461 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.71 79.41 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.5 t -78.27 -51.95 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.095 -0.553 . . . . 0.0 109.569 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.15 -31.75 81.74 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.753 0.658 . . . . 0.0 114.161 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.459 ' HB3' HD11 ' A' ' 26' ' ' ILE . 15.0 m95 -79.79 -41.17 27.04 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.2 -34.38 72.08 Favored 'General case' 0 C--N 1.368 1.401 0 CA-C-N 118.271 0.487 . . . . 0.0 110.785 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.8 mmt -68.88 -48.52 63.19 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.767 0.667 . . . . 0.0 109.711 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.03 -46.48 75.29 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.324 0.65 . . . . 0.0 111.519 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.458 HD21 HD23 ' A' ' 112' ' ' LEU . 4.1 mm? -80.54 -23.04 40.27 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.459 0.704 . . . . 0.0 111.329 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.65 -54.07 32.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -69.91 -18.47 63.39 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.46 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.0 tp -76.95 -44.08 32.73 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.082 0.401 . . . . 0.0 110.531 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.442 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -60.74 -34.47 86.84 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.6 mtp -81.29 -25.7 36.3 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.72 0.808 . . . . 0.0 111.809 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -66.45 -54.83 19.65 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.93 -58.01 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.727 -172.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 120.546 0.212 . . . . 0.0 111.367 -169.82 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 57.5 mt . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 61.2 p -76.72 -45.92 27.43 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.442 0.464 . . . . 0.0 111.077 -173.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -46.78 -60.38 2.44 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.033 0.833 . . . . 0.0 110.192 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -42.34 -42.38 3.14 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 20.6 mmt180 -62.59 -59.78 4.45 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.278 0.361 . . . . 0.0 110.346 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.06 -37.42 32.79 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 122.307 -0.246 . . . . 0.0 113.092 -166.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -59.77 -34.98 73.71 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 124.125 0.97 . . . . 0.0 111.181 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.6 -61.25 2.74 Favored 'General case' 0 C--N 1.36 1.038 0 O-C-N 123.932 0.77 . . . . 0.0 109.516 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.494 ' CZ3' ' HB ' ' A' ' 24' ' ' ILE . 95.4 m95 -68.54 -22.56 64.5 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -172.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.17 -63.08 1.13 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.45 ' HA ' ' NE2' ' A' ' 179' ' ' HIS . . . -54.32 -34.7 61.55 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.457 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 37.8 mt -69.07 -46.83 66.84 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 118.988 -0.53 . . . . 0.0 110.072 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.543 HG23 HH11 ' A' ' 22' ' ' ARG . 9.4 p -70.18 -31.6 47.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 CA-C-N 119.117 0.871 . . . . 0.0 109.563 -169.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . 0.45 ' NE2' ' HA ' ' A' ' 176' ' ' ALA . 11.3 p80 -92.45 16.72 11.24 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 58.9 m . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 169.575 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.831 0.348 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 m -93.83 106.38 18.35 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.778 0.831 . . . . 0.0 110.225 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 30.3 mt-10 -96.02 132.56 41.24 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -101.58 147.23 26.65 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.571 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -154.14 122.56 6.15 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 1.4 tm? -98.98 138.29 36.31 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 169.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.77 -178.45 16.31 Favored Glycine 0 C--N 1.333 0.411 0 O-C-N 123.287 0.367 . . . . 0.0 112.429 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.03 166.96 12.11 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 123.581 0.753 . . . . 0.0 109.658 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.653 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 6.1 tpt180 -163.82 157.07 18.46 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -138.27 94.2 2.84 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 117' ' ' THR . 36.5 pt -88.6 161.88 40.79 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.13 -21.93 13.89 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.13 2.553 . . . . 0.0 114.65 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.63 5.8 37.74 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.435 0.694 . . . . 0.0 112.763 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.38 -178.2 16.44 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 123.09 0.376 . . . . 0.0 112.967 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.53 109.39 5.44 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.111 0.564 . . . . 0.0 109.85 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.85 167.35 10.98 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.543 1.137 . . . . 0.0 110.397 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HB2' HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -101.82 170.52 8.1 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 156.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 p -136.25 133.08 36.63 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 29.8 pt -83.86 145.42 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 166.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.665 HG13 ' HG2' ' A' ' 113' ' ' GLU . 4.1 mp -129.96 105.25 11.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 175.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 58.9 mt -104.57 107.2 21.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.589 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 45.2 mtp85 -98.15 134.52 41.1 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.835 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -141.01 140.38 34.3 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.571 HH11 ' HB2' ' A' ' 109' ' ' LEU . 36.0 mmt180 -98.74 103.76 15.74 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.18 125.87 35.61 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.207 1.003 . . . . 0.0 109.958 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.52 59.81 3.66 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.597 1.189 . . . . 0.0 110.672 171.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.25 150.13 33.92 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 113.316 -1.765 . . . . 0.0 106.77 174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.65 172.24 7.16 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.086 1.857 . . . . 0.0 113.179 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 101' ' ' LEU . 67.8 t -70.87 -41.32 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.412 -173.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -58.77 -43.5 90.4 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.184 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.57 -65.86 0.62 Allowed 'General case' 0 C--N 1.356 0.852 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.057 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.2 t -53.54 -38.26 33.08 Favored 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 124.299 1.04 . . . . 0.0 111.184 -175.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.417 ' HE3' HD13 ' A' ' 101' ' ' LEU . 63.8 t-105 -59.18 -57.2 14.1 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.472 0.709 . . . . 0.0 111.018 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.7 m -59.47 -42.5 92.18 Favored 'General case' 0 C--O 1.21 -1.011 0 O-C-N 124.489 1.118 . . . . 0.0 110.13 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.87 -34.42 73.12 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.414 ' SG ' HD21 ' A' ' 136' ' ' LEU . 84.0 m -85.43 -11.05 55.32 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.993 0.917 . . . . 0.0 113.118 -178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.8 p -113.28 -32.79 6.17 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.329 0.513 . . . . 0.0 112.016 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -66.88 116.82 39.26 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 123.133 0.573 . . . . 0.0 110.506 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.14 -18.31 45.42 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 122.273 1.982 . . . . 0.0 110.991 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -74.81 -15.83 60.73 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.324 1.45 . . . . 0.0 111.3 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -108.55 -21.69 12.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.006 0.522 . . . . 0.0 111.932 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.8 mt -84.88 -32.61 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.253 0.621 . . . . 0.0 110.205 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 28.2 p-10 -60.39 -25.61 66.04 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.092 175.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -63.49 -23.63 67.48 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.509 1.124 . . . . 0.0 112.609 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -128.39 -62.02 1.06 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.059 0.543 . . . . 0.0 112.158 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -102.03 -163.42 1.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.025 0.93 . . . . 0.0 108.979 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.504 HD13 ' ND2' ' A' ' 69' ' ' ASN . 36.7 mt -85.94 131.64 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 11.2 pt-20 -63.36 140.21 97.69 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 126.368 1.867 . . . . 0.0 112.328 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.444 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 85.8 Cg_endo -89.05 99.19 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.045 2.497 . . . . 0.0 111.668 169.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -82.2 162.42 22.4 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.364 0.602 . . . . 0.0 111.885 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.28 -161.76 15.24 Favored Glycine 0 N--CA 1.465 0.575 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.583 -174.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.89 -48.72 67.86 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.574 1.15 . . . . 0.0 111.358 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt 68.44 3.9 4.0 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 125.543 1.537 . . . . 0.0 112.164 -170.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -100.48 147.4 25.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.323 1.049 . . . . 0.0 108.716 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.756 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 32.0 tt0 -62.58 107.71 1.0 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 123.757 0.661 . . . . 0.0 111.625 -172.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.7 -27.99 6.63 Favored Glycine 0 N--CA 1.476 1.343 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.982 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.39 -167.72 42.13 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -125.67 158.9 33.61 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.384 1.592 . . . . 0.0 111.067 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 13.1 p90 -103.92 168.31 9.21 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 157.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.04 115.35 0.83 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.419 1.088 . . . . 0.0 108.873 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 78.9 mt -70.97 169.69 14.35 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.846 0.459 . . . . 0.0 110.513 170.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.44 ' H ' HG23 ' A' ' 52' ' ' ILE . 16.7 tt0 -74.07 107.14 6.09 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.26 0.624 . . . . 0.0 109.33 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 45.41 25.12 1.18 Allowed Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.504 ' ND2' HD13 ' A' ' 52' ' ' ILE . 98.4 m-20 -107.15 -80.3 0.57 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.733 0.766 . . . . 0.0 109.957 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.79 157.03 47.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.275 0.63 . . . . 0.0 110.257 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.1 t -144.78 143.47 30.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.86 149.54 19.21 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -74.07 156.33 37.57 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.449 0.642 . . . . 0.0 110.216 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.636 ' HA ' HG22 ' A' ' 85' ' ' ILE . 19.3 mm -87.42 94.29 4.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.75 -57.47 10.82 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 124.376 1.048 . . . . 0.0 110.901 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -146.45 113.78 6.28 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.496 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.4 p -111.27 125.1 53.47 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 171.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -134.53 81.6 47.92 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.75 140.08 28.7 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.624 2.216 . . . . 0.0 111.895 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.415 ' HB2' HG11 ' A' ' 34' ' ' VAL . 31.1 Cg_endo -94.91 20.54 32.32 Favored 'Cis proline' 0 C--N 1.378 2.091 0 CA-C-N 119.924 1.009 . . . . 0.0 114.358 -3.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 80' ' ' PRO . 5.9 mpt_? -81.89 -84.27 0.11 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -128.1 147.81 50.55 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.741 -0.6 . . . . 0.0 112.035 -164.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.414 ' HB2' ' CH2' ' A' ' 38' ' ' TRP . 65.1 tp -138.18 102.47 4.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.543 1.137 . . . . 0.0 109.251 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.5 m -95.92 119.35 34.27 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 170.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.636 HG22 ' HA ' ' A' ' 74' ' ' ILE . 2.6 pp -128.94 160.5 39.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 124.915 1.286 . . . . 0.0 109.55 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.6 m -81.19 172.13 14.03 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.031 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 34.5 t-105 -154.69 94.26 1.65 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.1 t -105.88 102.95 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -92.3 149.39 21.47 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -90.0 -43.32 10.61 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.268 0.485 . . . . 0.0 111.612 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.14 -37.53 37.27 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.366 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -107.83 161.79 22.04 Favored Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 124.701 1.2 . . . . 0.0 109.085 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.42 ' HG2' ' OG ' ' A' ' 118' ' ' SER . 52.3 Cg_exo -58.16 -176.89 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.337 2.692 . . . . 0.0 114.646 175.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.68 173.55 12.47 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.927 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.5 t -172.78 173.96 3.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.53 0.732 . . . . 0.0 110.537 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -138.19 127.62 24.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.538 1.135 . . . . 0.0 108.289 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.3 t -112.51 143.79 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.698 0.799 . . . . 0.0 109.384 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 33.4 mt-10 -131.65 133.38 44.85 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.81 120.33 31.41 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -120.89 132.59 55.05 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.001 0.92 . . . . 0.0 109.994 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.419 ' HB3' HG13 ' A' ' 34' ' ' VAL . 72.1 mt -130.89 132.42 45.13 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.096 0.959 . . . . 0.0 110.067 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.2 t -155.27 148.2 24.51 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.433 1.093 . . . . 0.0 108.142 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -63.79 148.81 48.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.839 0.856 . . . . 0.0 110.818 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -146.9 111.33 5.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 51.89 -103.67 0.12 Allowed Glycine 0 CA--C 1.536 1.349 0 O-C-N 123.562 0.539 . . . . 0.0 114.246 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.62 -10.21 18.59 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.99 0.916 . . . . 0.0 111.208 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.27 -150.84 8.13 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 123.657 0.646 . . . . 0.0 111.714 -172.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 82.7 m -146.83 136.14 22.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.252 1.021 . . . . 0.0 110.015 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.571 ' HB2' HH11 ' A' ' 29' ' ' ARG . 60.7 tp -90.56 137.54 32.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.84 0.856 . . . . 0.0 109.925 174.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tt -123.72 115.17 20.97 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.697 1.199 . . . . 0.0 107.82 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.589 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 33.4 mt-10 -113.78 108.09 16.62 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.56 HD13 HD23 ' A' ' 133' ' ' LEU . 10.0 tt -105.97 112.27 25.25 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.665 ' HG2' HG13 ' A' ' 25' ' ' ILE . 40.9 mt-10 -93.11 137.79 32.14 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 123.752 0.821 . . . . 0.0 110.719 170.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.441 ' CD2' HG21 ' A' ' 125' ' ' VAL . 6.9 t60 -129.84 121.67 27.18 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.653 ' HB3' ' HG2' ' A' ' 14' ' ' ARG . . . -124.53 118.64 27.05 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.386 0.674 . . . . 0.0 111.824 -167.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 t -151.02 155.93 40.06 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.577 0.751 . . . . 0.0 110.368 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.439 HG22 HD11 ' A' ' 16' ' ' ILE . 75.7 p -79.96 -19.39 48.03 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.42 ' OG ' ' HG2' ' A' ' 93' ' ' PRO . 50.5 m -89.96 122.37 32.92 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.909 0.484 . . . . 0.0 111.349 -174.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -57.83 -45.31 86.37 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.763 1.225 . . . . 0.0 112.545 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.14 -57.92 10.74 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 122.929 0.492 . . . . 0.0 111.068 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.5 ttt -50.38 -35.91 30.24 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 124.284 0.99 . . . . 0.0 112.54 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 22' ' ' ARG . 29.0 mt -61.94 -46.47 89.17 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.678 0.791 . . . . 0.0 112.297 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.404 ' O ' HG21 ' A' ' 127' ' ' VAL . 41.2 t -70.18 -46.93 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -47.93 -52.64 18.72 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.954 1.701 . . . . 0.0 113.132 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.441 HG21 ' CD2' ' A' ' 114' ' ' HIS . 27.9 m -74.94 -25.79 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 123.452 0.47 . . . . 0.0 110.484 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -56.04 -45.97 85.87 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 124.155 0.909 . . . . 0.0 110.829 170.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 123' ' ' VAL . 45.0 t -74.85 -42.32 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.564 0.746 . . . . 0.0 109.678 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.53 -63.1 5.59 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.922 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -64.93 -26.5 68.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.8 0.84 . . . . 0.0 113.005 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -54.26 -51.92 63.02 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.489 0.586 . . . . 0.0 109.858 169.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.449 ' HA ' ' HE2' ' A' ' 131' ' ' MET . 29.2 mmt -68.71 -45.11 72.44 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 124.032 0.833 . . . . 0.0 110.716 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.6 -65.2 0.69 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.722 0.809 . . . . 0.0 111.033 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.56 HD23 HD13 ' A' ' 112' ' ' LEU . 3.8 mm? -62.03 -24.55 67.13 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.92 -43.31 65.53 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 118.676 0.671 . . . . 0.0 110.579 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.495 ' HD1' ' SD ' ' A' ' 138' ' ' MET . 20.9 m-85 -68.9 -26.5 65.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.172 0.589 . . . . 0.0 110.672 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.414 HD21 ' SG ' ' A' ' 41' ' ' CYS . 61.5 tp -66.22 -51.65 55.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.976 0.511 . . . . 0.0 109.866 169.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 141' ' ' ARG . . . -44.55 -43.29 7.76 Favored Glycine 0 N--CA 1.474 1.213 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 168.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.495 ' SD ' ' HD1' ' A' ' 135' ' ' PHE . 85.2 mtp -63.72 -45.95 87.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.882 0.473 . . . . 0.0 110.179 173.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -63.15 -34.92 78.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.775 0.83 . . . . 0.0 111.498 -176.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 25.6 mt -75.94 -48.47 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.96 0.904 . . . . 0.0 111.11 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 137' ' ' GLY . 12.9 ptp180 . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 19.4 mt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.8 t -61.27 -32.55 72.37 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.537 0.735 . . . . 0.0 111.842 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -90.4 -30.35 17.44 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -60.83 3.07 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.837 0.855 . . . . 0.0 110.259 172.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -67.51 -33.24 74.69 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.595 0.758 . . . . 0.0 110.173 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.69 -58.38 11.49 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.248 172.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.33 -31.34 71.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.676 0.79 . . . . 0.0 111.448 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.7 -62.39 1.83 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.205 0.941 . . . . 0.0 110.174 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -73.17 -20.06 60.98 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.421 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.41 -41.7 80.07 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.528 0.331 . . . . 0.0 110.504 173.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.07 -40.21 78.61 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.564 0.697 . . . . 0.0 109.687 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 74.7 mt -66.46 -47.73 72.17 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.222 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 4.6 p -70.29 -27.01 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 122.586 0.354 . . . . 0.0 111.242 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -75.95 -22.66 55.74 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.301 0.641 . . . . 0.0 110.69 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 CA--C 1.549 0.907 0 C-N-CA 122.763 0.425 . . . . 0.0 111.051 171.795 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 m -119.69 109.82 16.1 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.071 -173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.37 129.24 48.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -99.32 156.55 16.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.333 0.653 . . . . 0.0 109.37 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.25 -173.99 1.87 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.977 0.511 . . . . 0.0 111.257 -166.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.9 mt -140.67 168.66 19.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.519 1.127 . . . . 0.0 111.112 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.17 -174.93 26.57 Favored Glycine 0 C--O 1.245 0.807 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.837 170.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.15 139.49 24.65 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 123.699 0.799 . . . . 0.0 108.921 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -168.38 163.09 12.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.85 0.86 . . . . 0.0 109.858 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 23.2 m -105.67 113.82 27.61 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 172.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.8 pt -90.69 167.18 16.97 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -49.07 -23.51 6.42 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.917 2.411 . . . . 0.0 115.043 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.07 -8.01 56.15 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.06 177.85 15.1 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 117.66 0.209 . . . . 0.0 112.732 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 45.1 mt-10 -65.19 108.11 1.78 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.158 0.583 . . . . 0.0 110.343 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.23 142.4 34.24 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.368 1.067 . . . . 0.0 111.175 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -85.03 158.52 20.44 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 163.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.8 p -128.74 130.55 47.24 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 122.544 -0.097 . . . . 0.0 110.814 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 pp -86.2 136.09 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -120.38 122.01 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mt -115.2 107.53 23.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.539 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 95.4 mtt180 -92.61 139.44 30.56 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.736 0.815 . . . . 0.0 109.565 172.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 19.7 tt0 -146.51 139.5 25.5 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.818 0.699 . . . . 0.0 109.211 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.39 128.96 43.8 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.446 ' CE2' ' HA2' ' A' ' 137' ' ' GLY . 83.5 m-85 -116.19 116.86 28.58 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.865 0.866 . . . . 0.0 109.44 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -75.64 49.32 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.24 1.019 . . . . 0.0 110.743 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.51 162.34 51.9 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.445 1.498 . . . . 0.0 108.228 -171.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.447 ' O ' HG23 ' A' ' 37' ' ' VAL . 31.7 Cg_exo -62.34 157.77 43.83 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.375 2.05 . . . . 0.0 113.292 172.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 80' ' ' PRO . 99.1 t -76.65 -37.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.497 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -59.65 -42.18 92.2 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.978 0.799 . . . . 0.0 109.649 174.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -62.51 -64.18 1.0 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.373 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.587 HG21 HG22 ' A' ' 140' ' ' ILE . 58.2 t -48.25 -36.29 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.642 1.177 . . . . 0.0 111.763 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.46 ' HE3' HD12 ' A' ' 101' ' ' LEU . 72.1 t-105 -63.59 -59.48 4.57 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.291 0.636 . . . . 0.0 110.16 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.8 m -53.96 -46.36 71.6 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.774 0.671 . . . . 0.0 110.322 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.609 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -50.36 -39.35 46.22 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.366 175.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.544 ' SG ' HD23 ' A' ' 136' ' ' LEU . 58.0 m -102.65 6.35 39.59 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 47.9 p -120.57 -54.96 2.05 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 118.959 0.799 . . . . 0.0 111.723 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.76 137.92 97.3 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.508 1.123 . . . . 0.0 112.017 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -59.2 -42.29 51.72 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.698 2.932 . . . . 0.0 113.557 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -74.45 -6.42 48.18 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.958 0.903 . . . . 0.0 110.827 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.609 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 14.7 mmt180 -100.31 -42.62 6.57 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.741 1.217 . . . . 0.0 110.626 176.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.563 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 58.1 mt -77.32 -38.07 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.769 0.427 . . . . 0.0 111.47 -171.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -62.81 -20.38 64.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.489 0.493 . . . . 0.0 111.8 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -64.83 -27.18 68.7 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.563 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 39.4 p-90 -122.78 -41.91 2.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.107 0.563 . . . . 0.0 112.136 -174.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.434 ' HE2' HD11 ' A' ' 66' ' ' LEU . 2.1 t80 -106.0 -163.57 0.94 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.358 0.663 . . . . 0.0 110.097 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.3 mp -83.48 153.8 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -53.87 119.39 18.79 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.572 1.549 . . . . 0.0 112.164 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.0 101.76 1.47 Allowed 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.348 2.032 . . . . 0.0 110.017 169.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -93.3 164.96 13.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.315 0.646 . . . . 0.0 110.887 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.4 -166.81 12.39 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.565 -174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.604 ' HB2' ' HA3' ' A' ' 62' ' ' GLY . 4.5 m-20 -68.2 -37.64 81.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.286 0.634 . . . . 0.0 110.525 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 49.3 mt 64.83 15.04 9.62 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.896 1.278 . . . . 0.0 112.74 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -125.47 167.52 14.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.827 0.851 . . . . 0.0 110.543 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -50.34 107.2 0.15 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.82 1.248 . . . . 0.0 111.427 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.83 -11.05 56.07 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 112.248 -0.341 . . . . 0.0 112.248 174.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 57' ' ' ASP . . . -88.58 -156.33 30.98 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 169.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -144.33 158.23 43.85 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 118.41 1.105 . . . . 0.0 110.745 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -102.81 169.3 8.69 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 165.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.31 144.94 9.66 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.67 1.188 . . . . 0.0 107.951 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.434 HD11 ' HE2' ' A' ' 51' ' ' PHE . 41.3 mt -131.2 157.09 44.14 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.583 1.153 . . . . 0.0 108.279 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -97.96 127.25 43.79 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -173.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.59 10.81 45.79 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.797 -175.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -124.63 -92.92 0.51 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.839 0.456 . . . . 0.0 110.036 -172.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.39 174.94 12.76 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.19 0.45 . . . . 0.0 111.739 -170.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.5 p -149.78 136.58 19.41 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -154.99 161.66 30.46 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -86.87 155.14 20.37 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.528 0.731 . . . . 0.0 111.049 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.466 ' HA ' HG23 ' A' ' 85' ' ' ILE . 11.6 mm -89.28 91.66 3.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 172.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.411 HD11 HG21 ' A' ' 84' ' ' THR . 42.4 mt -70.39 -49.66 46.73 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.134 0.896 . . . . 0.0 109.691 -171.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -158.84 155.29 27.55 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.834 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 7.8 p -155.79 122.08 5.14 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.399 1.079 . . . . 0.0 108.251 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -121.85 88.86 47.71 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 13.1 Cg_exo -72.62 137.38 27.47 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.74 2.293 . . . . 0.0 113.101 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.467 ' HB2' HG12 ' A' ' 34' ' ' VAL . 83.7 Cg_endo -99.64 31.14 11.3 Favored 'Cis proline' 0 C--N 1.374 1.909 0 CA-C-N 119.283 0.78 . . . . 0.0 112.339 -10.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -68.92 -75.14 0.11 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.631 1.172 . . . . 0.0 111.278 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -158.74 160.23 36.12 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.881 0.472 . . . . 0.0 111.337 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.83 146.27 50.48 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.308 1.043 . . . . 0.0 108.28 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.411 HG21 HD11 ' A' ' 75' ' ' LEU . 32.6 m -123.44 111.94 16.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 166.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.466 HG23 ' HA ' ' A' ' 74' ' ' ILE . 22.7 pt -113.64 144.53 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.683 1.193 . . . . 0.0 108.256 173.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.4 t -83.31 172.73 12.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.804 0.335 . . . . 0.0 111.25 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.696 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 25.0 t-105 -153.42 110.25 3.42 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.607 -171.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.7 t -116.39 103.45 15.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 168.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 18.2 t80 -77.83 90.9 4.09 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 63.14 -82.55 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.751 0.82 . . . . 0.0 110.155 -174.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.85 30.22 1.24 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 48.2 mmtm -95.01 162.62 24.37 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.401 1.081 . . . . 0.0 110.21 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -35.32 129.0 0.28 Allowed 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 125.039 3.826 . . . . 0.0 115.576 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.4 148.13 42.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.98 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.696 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.7 m -145.08 143.86 30.65 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.441 -174.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.51 111.75 24.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.979 0.912 . . . . 0.0 109.185 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 50.8 t -93.95 119.3 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -117.92 131.18 56.55 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.9 tp -125.63 125.4 43.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -130.24 124.18 31.87 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.97 0.508 . . . . 0.0 110.173 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.46 HD12 ' HE3' ' A' ' 38' ' ' TRP . 62.8 mt -120.95 133.03 55.27 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.656 1.182 . . . . 0.0 109.335 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.9 m -144.59 145.64 31.9 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.102 0.961 . . . . 0.0 109.09 177.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.24 141.54 58.18 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.177 0.991 . . . . 0.0 111.17 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -136.74 101.49 4.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.63 -98.55 0.05 OUTLIER Glycine 0 CA--C 1.541 1.658 0 CA-C-N 118.846 0.748 . . . . 0.0 111.868 -166.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -125.86 15.22 8.02 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.132 0.968 . . . . 0.0 110.534 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -113.9 -155.66 11.58 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.167 0.889 . . . . 0.0 111.603 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.5 m -147.7 136.39 21.85 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.709 1.204 . . . . 0.0 109.393 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.3 tp -91.55 127.04 36.84 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 164.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.431 ' HA ' HD21 ' A' ' 101' ' ' LEU . 9.7 tt -108.05 123.26 48.41 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.539 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 31.5 mt-10 -119.68 106.18 11.9 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 169.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.5 tt -103.99 102.56 12.33 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -95.74 142.62 27.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.541 1.137 . . . . 0.0 109.659 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.464 ' CD2' HG21 ' A' ' 125' ' ' VAL . 5.8 t60 -132.74 116.15 16.22 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 171.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.57 117.94 35.41 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.905 0.882 . . . . 0.0 111.383 -174.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.551 HG23 ' HG3' ' A' ' 121' ' ' MET . 8.0 t -146.19 161.31 40.51 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.449 0.7 . . . . 0.0 110.594 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 74.2 p -88.65 -19.97 25.52 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.653 -167.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 m -101.96 133.23 47.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.299 0.64 . . . . 0.0 111.469 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -59.12 -47.78 84.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.552 1.141 . . . . 0.0 113.166 -174.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -64.06 -52.42 59.44 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.816 0.28 . . . . 0.0 110.884 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.551 ' HG3' HG23 ' A' ' 116' ' ' THR . 15.2 tpt -46.16 -37.02 6.47 Favored 'General case' 0 CA--C 1.563 1.472 0 O-C-N 124.152 0.908 . . . . 0.0 111.702 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.429 ' HG ' HG21 ' A' ' 116' ' ' THR . 22.5 mt -67.24 -50.45 60.55 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.79 0.836 . . . . 0.0 112.012 176.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 127' ' ' VAL . 61.7 t -61.49 -56.2 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -47.61 -50.94 22.92 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.73 1.612 . . . . 0.0 113.273 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.464 HG21 ' CD2' ' A' ' 114' ' ' HIS . 33.2 m -72.02 -31.68 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 119.799 -0.144 . . . . 0.0 111.155 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.57 -34.48 90.01 Favored Glycine 0 C--N 1.35 1.313 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 123' ' ' VAL . 97.6 t -71.8 -51.8 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.05 -59.72 8.46 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.694 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -54.31 -32.91 57.69 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -66.3 -35.3 80.04 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 120.41 1.459 . . . . 0.0 111.957 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -60.78 -52.73 63.87 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 167.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.5 -27.83 64.82 Favored 'General case' 0 C--O 1.208 -1.105 0 C-N-CA 124.127 0.971 . . . . 0.0 112.045 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.31 -27.71 22.71 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.32 0.648 . . . . 0.0 109.914 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.01 -48.67 34.32 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -62.64 -42.56 99.67 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.637 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.544 HD23 ' SG ' ' A' ' 41' ' ' CYS . 51.0 tp -66.14 -27.61 68.17 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.82 0.848 . . . . 0.0 111.303 176.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.446 ' HA2' ' CE2' ' A' ' 30' ' ' TYR . . . -73.89 -46.57 22.69 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 86.4 mtp -60.84 -41.2 95.33 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.589 -1.305 . . . . 0.0 110.807 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -62.59 -54.57 37.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.607 0.763 . . . . 0.0 111.416 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.587 HG22 HG21 ' A' ' 37' ' ' VAL . 64.1 mt -71.0 -26.95 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.247 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 . . . . . 0 N--CA 1.476 0.864 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.882 175.882 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.526 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 32.5 mm . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 39.6 t -72.66 -19.72 61.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.376 0.67 . . . . 0.0 112.631 -175.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.48 -31.71 17.54 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.116 0.416 . . . . 0.0 110.342 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -50.59 -56.4 11.94 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.39 0.614 . . . . 0.0 110.399 166.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 2.0 mmt180 -73.62 -39.74 64.33 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.113 -175.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -55.35 -55.15 29.89 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.735 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.29 -42.14 90.58 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.878 0.871 . . . . 0.0 111.038 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.53 -54.26 45.49 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.225 0.953 . . . . 0.0 111.799 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -70.22 -25.89 63.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.437 0.695 . . . . 0.0 111.847 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.08 83.82 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.995 0.426 . . . . 0.0 109.86 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -68.69 -35.96 77.88 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.8 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 55.5 mt -72.58 -53.82 10.85 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.232 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -66.28 -32.32 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 122.999 0.519 . . . . 0.0 112.003 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -76.66 -7.09 54.62 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.077 0.551 . . . . 0.0 111.501 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 CA--C 1.553 1.085 0 C-N-CA 124.696 1.198 . . . . 0.0 109.262 169.847 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.589 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.6 m -97.4 136.75 37.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.203 1.001 . . . . 0.0 110.306 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 20.1 mp0 -123.95 107.81 11.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 172.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.589 HH22 ' HA ' ' A' ' 170' ' ' ARG . 98.2 mtt180 -74.47 161.75 29.49 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.544 0.211 . . . . 0.0 110.602 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.54 177.99 5.64 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.621 0.768 . . . . 0.0 110.323 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.2 mt -133.22 158.91 41.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.414 1.086 . . . . 0.0 109.413 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.16 138.15 5.24 Favored Glycine 0 C--O 1.223 -0.59 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 173.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -91.7 137.76 32.11 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.5 tpt85 -138.99 128.46 24.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.741 0.816 . . . . 0.0 109.507 -168.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -85.67 136.6 33.3 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 117' ' ' THR . 47.5 pt -129.62 159.14 71.05 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -177.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -48.07 -37.01 29.57 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.125 2.55 . . . . 0.0 114.285 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.64 77.13 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.468 0.707 . . . . 0.0 112.443 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.18 -150.82 20.49 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.16 137.88 33.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.82 164.58 27.25 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.777 0.831 . . . . 0.0 109.122 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -120.58 157.56 29.24 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 3.6 m -128.87 145.63 51.16 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 122.682 0.393 . . . . 0.0 110.792 -174.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 2.8 pp -98.05 135.57 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.408 HG13 ' HB3' ' A' ' 113' ' ' GLU . 2.2 mp -121.42 126.24 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 129' ' ' TRP . 57.0 mt -110.48 108.91 26.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.568 ' HB3' HD11 ' A' ' 109' ' ' LEU . 58.9 mtp180 -91.05 153.11 20.35 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -168.88 129.79 1.18 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 125.164 1.54 . . . . 0.0 111.219 174.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.503 ' HD2' HD12 ' A' ' 109' ' ' LEU . 9.7 mpt_? -87.26 105.41 17.21 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 172.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -79.21 150.64 31.57 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.995 0.518 . . . . 0.0 110.118 170.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -87.78 27.03 1.2 Allowed 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.989 0.9 . . . . 0.0 110.325 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.77 148.67 70.87 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.32 1.048 . . . . 0.0 109.782 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.56 165.04 33.18 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.241 2.627 . . . . 0.0 113.147 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.6 t -51.26 -44.63 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 114.053 -1.431 . . . . 0.0 112.616 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -56.18 -39.36 72.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.291 0.995 . . . . 0.0 110.071 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -75.49 -36.57 60.59 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.685 0.794 . . . . 0.0 111.167 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.3 -30.48 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.385 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -74.76 -20.7 59.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.192 0.997 . . . . 0.0 109.998 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.5 m -72.17 -47.41 51.02 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.25 77.12 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.298 0.639 . . . . 0.0 111.91 172.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.0 t -63.31 -52.3 62.52 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 59.4 p -94.91 -41.16 9.32 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -167.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.447 ' O ' HG13 ' A' ' 47' ' ' ILE . 26.4 t70 -81.68 115.23 55.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 122.972 0.509 . . . . 0.0 110.889 -169.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.11 -20.39 71.07 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.47 2.78 . . . . 0.0 114.094 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -74.16 -31.2 62.61 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -84.11 -30.02 26.29 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.821 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 43' ' ' ASP . 91.2 mt -71.43 -43.37 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.263 0.625 . . . . 0.0 110.371 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -65.52 -3.29 4.25 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -86.64 -43.06 12.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.891 0.876 . . . . 0.0 110.364 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.437 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 49.7 p-90 -114.65 -25.08 8.45 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.137 0.975 . . . . 0.0 111.414 -173.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.437 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 11.1 t80 -129.55 -171.89 2.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.505 1.122 . . . . 0.0 109.104 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.6 mt -89.5 139.99 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.614 0.766 . . . . 0.0 111.41 -173.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.6 ' HG2' ' HZ2' ' A' ' 55' ' ' LYS . 44.4 tt0 -64.46 110.5 4.07 Favored Pre-proline 0 CA--C 1.566 1.576 0 O-C-N 125.348 1.655 . . . . 0.0 110.993 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -90.89 148.99 3.93 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.354 2.702 . . . . 0.0 113.592 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.6 ' HZ2' ' HG2' ' A' ' 53' ' ' GLU . 2.1 mptp? -130.54 130.47 44.15 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.87 -166.91 32.59 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 121.63 -0.319 . . . . 0.0 112.477 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -69.5 -46.94 65.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.415 0.686 . . . . 0.0 110.948 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.4 mt 62.25 22.85 13.46 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.872 1.269 . . . . 0.0 110.695 -172.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -124.97 146.93 49.16 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.594 1.158 . . . . 0.0 109.749 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.53 117.86 4.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.183 0.993 . . . . 0.0 111.981 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.57 12.14 57.35 Favored Glycine 0 N--CA 1.47 0.907 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.96 -174.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -119.58 -158.21 10.55 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 10.9 p30 -138.34 174.39 10.6 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 117.723 0.761 . . . . 0.0 112.036 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -145.02 153.55 41.6 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.864 1.266 . . . . 0.0 107.894 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.97 109.94 5.1 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.651 0.78 . . . . 0.0 110.878 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.7 mt -77.72 138.11 38.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.697 0.799 . . . . 0.0 109.177 173.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -77.82 110.23 12.52 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.2 56.73 5.06 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.607 0.567 . . . . 0.0 113.356 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -168.77 -84.05 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.965 0.506 . . . . 0.0 111.339 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -152.78 155.68 37.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.275 0.56 . . . . 0.0 111.559 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 m -132.45 143.09 49.55 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.378 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -156.56 -170.51 21.75 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 5.5 m-20 -118.24 168.7 10.35 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.252 0.621 . . . . 0.0 110.749 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.491 ' HA ' HG23 ' A' ' 85' ' ' ILE . 9.8 mm -103.58 107.05 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.45 HD22 ' HG ' ' A' ' 86' ' ' SER . 85.1 mt -75.51 -58.11 3.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.71 0.404 . . . . 0.0 110.994 -175.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.07 151.2 13.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.692 0.797 . . . . 0.0 109.41 175.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.5 p -148.3 133.08 17.95 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -107.82 89.84 5.75 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.53 132.39 33.06 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.639 2.226 . . . . 0.0 112.53 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -102.74 22.85 14.97 Favored 'Cis proline' 0 C--N 1.375 1.924 0 CA-C-N 120.031 1.047 . . . . 0.0 113.597 -8.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -67.45 -52.72 36.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.812 1.245 . . . . 0.0 112.366 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.449 ' NH2' ' HD3' ' A' ' 100' ' ' ARG . 26.4 ttm-85 -148.93 154.62 39.68 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.32 0.581 . . . . 0.0 111.134 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.5 tt -135.07 140.97 45.97 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.14 1.376 . . . . 0.0 107.338 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.445 HG22 ' HG2' ' A' ' 98' ' ' GLU . 40.6 m -137.9 134.87 35.54 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.302 0.641 . . . . 0.0 109.287 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.491 HG23 ' HA ' ' A' ' 74' ' ' ILE . 12.6 pt -147.78 147.14 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.055 1.342 . . . . 0.0 109.895 -172.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.45 ' HG ' HD22 ' A' ' 75' ' ' LEU . 71.5 m -86.86 153.7 21.43 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 163.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 23.1 t-105 -143.13 109.62 5.41 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -167.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.749 HG11 ' HB3' ' A' ' 93' ' ' PRO . 61.1 t -108.79 103.07 14.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -83.85 141.56 31.24 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -58.25 -30.04 66.23 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.94 -53.8 5.14 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.397 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -138.7 119.57 9.96 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.61 0.764 . . . . 0.0 110.349 -174.167 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.749 ' HB3' HG11 ' A' ' 88' ' ' VAL . 3.1 Cg_exo -83.18 -166.86 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.701 2.934 . . . . 0.0 113.016 -176.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.5 t70 52.67 85.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.593 1.557 . . . . 0.0 113.373 174.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 71.0 m -147.09 122.32 10.22 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 171.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -101.33 105.68 16.77 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.2 t -97.69 147.85 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.202 1.001 . . . . 0.0 109.824 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 84' ' ' THR . 33.9 mt-10 -137.7 155.96 48.54 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.68 0.792 . . . . 0.0 109.603 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.0 tp -126.75 139.24 53.28 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.449 ' HD3' ' NH2' ' A' ' 82' ' ' ARG . 1.5 ttp180 -140.08 106.96 5.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.47 0.708 . . . . 0.0 109.736 -172.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 110' ' ' LEU . 96.2 mt -111.53 131.18 55.42 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.371 1.069 . . . . 0.0 110.78 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.1 t -143.46 128.38 18.43 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.014 0.925 . . . . 0.0 108.796 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.62 124.37 22.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -136.46 117.98 14.83 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.97 -144.77 38.6 Favored Glycine 0 C--N 1.345 1.057 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -86.91 55.38 3.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.566 0.698 . . . . 0.0 109.227 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.64 -154.4 13.25 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 114.939 -1.028 . . . . 0.0 113.689 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.4 m -148.75 129.69 14.34 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.809 0.843 . . . . 0.0 111.119 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 27' ' ' ARG . 43.0 tp -81.21 109.55 15.85 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 101' ' ' LEU . 10.2 tt -88.05 130.97 34.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 170.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.455 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 45.3 mt-10 -132.13 105.86 7.63 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.5 tt -103.97 124.16 48.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 9.4 pt-20 -122.06 129.38 52.35 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.488 ' O ' ' HA ' ' A' ' 23' ' ' SER . 8.1 t60 -117.0 111.1 19.1 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.94 102.37 11.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.674 0.79 . . . . 0.0 111.171 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.2 t -130.72 153.33 49.11 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.237 0.542 . . . . 0.0 109.934 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.498 HG21 HD11 ' A' ' 16' ' ' ILE . 76.1 p -71.14 -21.53 62.18 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.166 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.4 p -94.49 118.26 31.38 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.698 0.799 . . . . 0.0 111.137 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.418 ' HA ' HD12 ' A' ' 122' ' ' LEU . 45.0 tt0 -65.81 -24.8 66.99 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.256 1.022 . . . . 0.0 111.147 174.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -61.65 -53.75 52.04 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.054 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 10.1 tpt -62.63 -41.34 98.96 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.48 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 119' ' ' GLU . 37.0 mt -52.93 -53.03 55.37 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.098 0.959 . . . . 0.0 113.278 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.55 -44.72 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.788 0.435 . . . . 0.0 110.488 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.98 -44.14 96.84 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.541 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.0 m -75.23 -26.87 19.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.06 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.229 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.48 -29.05 60.24 Favored Glycine 0 C--N 1.351 1.361 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 170.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.26 -51.61 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 123.592 0.231 . . . . 0.0 110.396 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.03 -30.17 76.44 Favored Glycine 0 N--CA 1.476 1.353 0 CA-C-N 115.625 -0.716 . . . . 0.0 114.209 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.402 ' HB3' HD11 ' A' ' 26' ' ' ILE . 9.4 m95 -79.13 -46.96 16.95 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -54.9 -38.95 68.24 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.478 0.311 . . . . 0.0 110.785 174.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.6 tpp -64.99 -41.41 95.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.501 0.72 . . . . 0.0 110.69 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -72.77 -36.02 67.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.42 0.688 . . . . 0.0 111.729 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.56 -25.11 38.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.662 0.785 . . . . 0.0 110.289 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.22 -45.15 77.66 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.543 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.64 -30.57 52.23 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.431 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.1 tp -71.74 -29.64 64.74 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.21 -48.23 81.62 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.633 168.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 90.3 mmm -69.2 -37.11 77.93 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.074 0.95 . . . . 0.0 111.13 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -67.52 -56.77 8.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.972 0.909 . . . . 0.0 110.793 -175.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 28.9 mt -67.2 -29.91 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.23 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? . . . . . 0 N--CA 1.486 1.333 0 C-N-CA 122.64 0.376 . . . . 0.0 110.103 172.654 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 30.5 mm . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.1 m -68.77 -54.49 15.66 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 122.701 0.4 . . . . 0.0 110.396 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 11.6 pt20 -61.5 -56.0 24.92 Favored 'General case' 0 C--O 1.209 -1.072 0 CA-C-O 117.726 -1.13 . . . . 0.0 111.304 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -43.45 -46.07 6.6 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.942 0.792 . . . . 0.0 113.064 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.589 ' HA ' HH22 ' A' ' 9' ' ' ARG . 4.8 mmp_? -53.64 -52.44 59.89 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.574 0.546 . . . . 0.0 109.841 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -80.95 -17.4 72.51 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 116.284 -0.416 . . . . 0.0 113.65 -173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 24.0 mm-40 -71.7 -37.3 70.69 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.51 0.724 . . . . 0.0 109.712 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.504 ' HB3' ' NH1' ' A' ' 9' ' ' ARG . . . -76.22 -36.21 58.68 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.737 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -67.09 -29.9 69.78 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 119.249 -0.405 . . . . 0.0 111.43 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.42 -61.18 2.62 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 123.59 0.556 . . . . 0.0 109.659 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.39 -35.27 51.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.409 1.084 . . . . 0.0 113.565 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 35.3 mt -66.8 -59.56 3.44 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 123.297 0.373 . . . . 0.0 110.159 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.8 p -72.88 -20.37 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 123.721 0.808 . . . . 0.0 111.357 -158.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -57.38 -21.16 34.19 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.259 1.024 . . . . 0.0 112.104 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 CA--C 1.547 0.834 0 C-N-CA 123.568 0.747 . . . . 0.0 109.452 172.161 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 120.636 0.255 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -79.14 111.37 15.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.317 1.047 . . . . 0.0 110.956 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 30.9 mt-10 -93.8 134.33 36.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.694 1.198 . . . . 0.0 108.56 172.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.0 ttm105 -99.78 139.44 35.43 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.855 0.462 . . . . 0.0 110.0 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.16 179.35 9.23 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.77 0.428 . . . . 0.0 111.628 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.404 HD13 ' N ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -145.15 153.12 41.04 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.957 -176.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.404 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -167.24 -151.98 7.2 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.45 163.22 35.55 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.207 0.603 . . . . 0.0 109.759 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -166.42 152.46 8.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.874 0.869 . . . . 0.0 109.483 167.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.5 m -82.95 152.66 25.38 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.043 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.8 pt -144.1 155.51 58.46 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.64 -30.29 28.16 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.941 2.428 . . . . 0.0 114.317 175.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.47 -7.84 59.64 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.82 -172.9 28.05 Favored Glycine 0 C--N 1.356 1.678 0 CA-C-N 119.258 0.935 . . . . 0.0 112.577 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -84.57 110.78 18.96 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.17 146.96 23.28 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.991 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -87.98 156.84 19.12 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 164.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.4 p -139.17 137.98 36.53 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.954 0.407 . . . . 0.0 111.609 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.586 HG12 HG23 ' A' ' 125' ' ' VAL . 2.9 pp -87.79 141.16 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.265 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.35 111.02 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.9 mt -100.91 108.63 23.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 97.2 mtt180 -99.54 140.59 33.5 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.474 HE22 HD23 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -138.78 144.15 39.25 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.294 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.457 ' NH1' ' HG2' ' A' ' 104' ' ' GLU . 12.2 mmt85 -103.73 101.96 11.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 173.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.457 ' CE1' ' HA2' ' A' ' 137' ' ' GLY . 70.1 m-85 -83.63 129.36 34.96 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.903 0.881 . . . . 0.0 110.624 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.72 48.25 0.67 Allowed 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 122.889 1.328 . . . . 0.0 109.785 170.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.56 152.42 41.7 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.058 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.719 ' HG2' ' HB2' ' A' ' 36' ' ' GLU . 56.4 Cg_endo -71.64 165.75 31.56 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.629 2.219 . . . . 0.0 113.454 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.453 HG13 ' HB2' ' A' ' 80' ' ' PRO . 58.1 t -71.89 -43.7 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.954 -169.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -63.87 -34.03 77.02 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 124.055 0.847 . . . . 0.0 110.109 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.719 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -69.53 -62.79 1.24 Allowed 'General case' 0 C--N 1.355 0.813 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.776 179.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.7 t -51.17 -33.3 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 124.939 1.296 . . . . 0.0 111.06 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.427 ' HE3' HD11 ' A' ' 101' ' ' LEU . 65.2 t-105 -61.43 -57.42 12.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.19 0.596 . . . . 0.0 110.063 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.2 t -54.35 -40.7 68.33 Favored 'General case' 0 CA--C 1.552 1.023 0 O-C-N 123.92 0.762 . . . . 0.0 110.614 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.04 79.26 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.4 m -93.51 -4.48 51.0 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.752 0.821 . . . . 0.0 112.954 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 77.8 p -116.57 -48.37 2.69 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.439 0.563 . . . . 0.0 111.438 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.423 ' O ' HG12 ' A' ' 47' ' ' ILE . 20.6 t70 -63.12 119.94 56.93 Favored Pre-proline 0 N--CA 1.483 1.197 0 C-N-CA 123.878 0.871 . . . . 0.0 111.033 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.0 -26.76 43.22 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.008 2.472 . . . . 0.0 113.335 -171.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -61.82 -48.06 82.31 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.777 0.673 . . . . 0.0 109.646 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -72.13 -26.05 61.96 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 174.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.518 HG23 ' HD3' ' A' ' 54' ' ' PRO . 36.7 mm -71.24 -42.18 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 118.849 0.75 . . . . 0.0 111.474 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.07 -16.01 64.07 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -80.54 0.91 31.74 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.468 0.707 . . . . 0.0 112.408 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.439 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 46.2 p-90 -141.64 -47.44 0.37 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.916 0.486 . . . . 0.0 110.489 173.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -111.65 -164.28 0.91 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.069 0.948 . . . . 0.0 109.859 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -86.92 126.02 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 166.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.67 139.45 88.76 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 118.87 0.759 . . . . 0.0 111.794 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.518 ' HD3' HG23 ' A' ' 47' ' ' ILE . 15.2 Cg_exo -69.71 101.98 0.97 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.627 2.218 . . . . 0.0 110.932 173.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -74.88 136.01 41.51 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.767 0.827 . . . . 0.0 110.682 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.27 -164.74 27.21 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 116.023 -0.535 . . . . 0.0 114.308 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -68.46 -39.06 81.58 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.721 1.208 . . . . 0.0 111.104 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.3 mt 66.29 12.28 8.49 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -98.97 165.34 11.8 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.234 0.47 . . . . 0.0 110.079 173.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.746 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 38.5 tt0 -71.02 98.03 1.56 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.25 -31.03 4.36 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -170.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.11 -174.01 46.65 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 114.776 -0.712 . . . . 0.0 112.432 169.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 22.9 p-10 -134.96 155.26 51.05 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.842 0.857 . . . . 0.0 111.861 -170.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -116.91 169.6 9.27 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.163 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -163.4 144.23 9.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.701 0.8 . . . . 0.0 109.017 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.431 HD12 HD21 ' A' ' 69' ' ' ASN . 68.8 mt -118.5 153.29 34.41 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -93.28 -45.66 7.74 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.41 -12.27 84.0 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.33 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.431 HD21 HD12 ' A' ' 66' ' ' LEU . 80.8 m-20 -127.52 -92.7 0.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 118.106 0.953 . . . . 0.0 111.31 -174.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.61 175.08 14.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.087 0.555 . . . . 0.0 110.821 -169.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 27.7 p -131.96 145.29 51.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.154 0.582 . . . . 0.0 109.616 -172.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.71 -148.87 5.37 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 112.319 -0.313 . . . . 0.0 112.319 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -151.23 163.75 38.16 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.223 0.609 . . . . 0.0 110.861 179.457 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.532 ' HA ' HG22 ' A' ' 85' ' ' ILE . 2.5 mp -94.34 102.42 13.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 86' ' ' SER . 88.4 mt -76.24 -45.53 32.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.785 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -135.45 141.69 45.44 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.511 -173.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.746 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 31.8 p -158.38 122.43 4.06 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.646 ' HG2' ' HD3' ' A' ' 81' ' ' ARG . 41.8 tt0 -144.78 90.46 6.35 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -63.46 139.99 73.64 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.973 2.449 . . . . 0.0 111.858 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.453 ' HB2' HG13 ' A' ' 34' ' ' VAL . 27.2 Cg_endo -96.61 27.06 18.63 Favored 'Cis proline' 0 C--N 1.375 1.954 0 CA-C-N 120.097 1.07 . . . . 0.0 113.094 -8.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.646 ' HD3' ' HG2' ' A' ' 78' ' ' GLU . 4.3 mpt_? -77.9 -82.21 0.09 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.569 0.748 . . . . 0.0 111.385 -175.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.5 ptt-85 -150.96 154.11 36.48 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.795 0.438 . . . . 0.0 111.451 -171.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.8 tt -134.86 114.09 12.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -112.82 137.39 51.23 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.139 0.976 . . . . 0.0 108.907 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.532 HG22 ' HA ' ' A' ' 74' ' ' ILE . 13.0 pt -133.29 151.56 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.81 1.244 . . . . 0.0 109.885 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.474 ' HB2' HD11 ' A' ' 75' ' ' LEU . 35.2 t -87.96 163.56 16.27 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.991 0.424 . . . . 0.0 109.978 166.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 35.6 t-105 -144.25 96.92 2.96 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -166.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.44 125.06 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.607 0.763 . . . . 0.0 109.373 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.451 ' HB3' ' HE3' ' A' ' 92' ' ' LYS . 59.6 t80 -144.72 171.71 14.03 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.13 0.972 . . . . 0.0 108.655 -176.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.76 154.64 38.27 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 122.531 0.333 . . . . 0.0 110.549 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.44 -63.72 4.1 Favored Glycine 0 N--CA 1.471 1.011 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.451 ' HE3' ' HB3' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -103.68 133.64 20.17 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 124.308 1.043 . . . . 0.0 109.708 177.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.12 -73.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.019 2.479 . . . . 0.0 112.433 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -125.47 165.93 17.55 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.283 0.563 . . . . 0.0 110.682 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.5 m -152.19 169.77 21.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.912 1.685 . . . . 0.0 107.464 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -133.83 123.81 25.45 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 118.509 0.595 . . . . 0.0 111.139 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 t -110.83 147.62 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.989 1.316 . . . . 0.0 107.869 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -143.09 127.86 18.21 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.066 0.46 . . . . 0.0 110.98 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.48 119.08 38.22 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 33.0 ttm180 -124.88 128.5 48.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.996 0.918 . . . . 0.0 109.145 -173.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.448 ' HB3' HG12 ' A' ' 34' ' ' VAL . 72.9 mt -135.6 128.74 31.74 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.934 0.894 . . . . 0.0 110.792 -175.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.2 m -148.82 152.67 36.91 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.653 1.181 . . . . 0.0 108.559 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.03 150.84 32.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.609 0.764 . . . . 0.0 111.291 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.457 ' HG2' ' NH1' ' A' ' 29' ' ' ARG . 11.0 tp10 -148.09 112.24 5.2 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.83 -101.75 0.2 Allowed Glycine 0 C--N 1.35 1.317 0 O-C-N 123.252 0.345 . . . . 0.0 112.924 -171.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -119.6 2.05 11.16 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.381 0.61 . . . . 0.0 110.345 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -112.88 -150.68 10.9 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.223 0.916 . . . . 0.0 111.718 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.0 m -148.09 127.09 12.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.481 1.112 . . . . 0.0 110.135 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.429 HD13 ' NE ' ' A' ' 29' ' ' ARG . 40.5 tp -82.44 133.34 35.21 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.4 tt -117.84 113.39 21.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 33.4 mt-10 -109.37 106.2 15.89 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.7 tp -98.83 103.26 15.19 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -101.65 108.85 20.51 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.937 0.895 . . . . 0.0 109.666 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -106.51 122.18 45.78 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.42 125.18 48.34 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.561 0.744 . . . . 0.0 111.308 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.9 t -141.69 159.75 41.58 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 123.982 0.802 . . . . 0.0 109.611 173.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.4 p -90.68 -2.51 57.83 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.233 1.013 . . . . 0.0 111.886 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.6 t -97.16 119.19 35.19 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.162 0.985 . . . . 0.0 110.149 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.532 ' HA ' HD12 ' A' ' 122' ' ' LEU . 38.3 tt0 -62.32 -42.4 99.35 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.269 1.027 . . . . 0.0 112.645 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.16 -58.44 8.64 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.415 ' O ' HG21 ' A' ' 125' ' ' VAL . 25.2 ttt -51.32 -29.62 15.64 Favored 'General case' 0 C--O 1.208 -1.115 0 O-C-N 124.794 1.309 . . . . 0.0 112.762 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.532 HD12 ' HA ' ' A' ' 119' ' ' GLU . 47.6 mt -64.26 -53.76 43.96 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.394 0.543 . . . . 0.0 111.896 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.443 ' O ' HG21 ' A' ' 127' ' ' VAL . 47.2 t -63.48 -49.58 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -44.39 -56.16 4.44 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.264 1.826 . . . . 0.0 113.818 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.586 HG23 HG12 ' A' ' 24' ' ' ILE . 34.6 m -72.44 -26.39 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 122.265 0.226 . . . . 0.0 110.635 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.51 -39.12 97.42 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 169.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 123' ' ' VAL . 92.6 t -78.09 -60.48 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.37 -57.06 12.48 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 114.436 -1.256 . . . . 0.0 114.517 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -66.03 -40.94 91.44 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.875 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.18 -32.17 73.07 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 120.319 1.418 . . . . 0.0 111.125 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.0 mtm -71.98 -35.04 69.4 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.666 0.386 . . . . 0.0 110.272 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.06 -59.82 2.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.357 0.663 . . . . 0.0 110.97 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -54.56 -30.4 54.08 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.089 1.356 . . . . 0.0 113.008 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.99 -46.62 84.91 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.505 0.722 . . . . 0.0 110.311 169.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -64.18 -37.38 87.25 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.656 172.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 52.5 tp -68.88 -20.66 64.26 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.148 0.579 . . . . 0.0 110.544 175.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.457 ' HA2' ' CE1' ' A' ' 30' ' ' TYR . . . -71.06 -47.27 38.82 Favored Glycine 0 C--N 1.35 1.328 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.3 ptm -80.27 -24.33 40.15 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.499 -0.851 . . . . 0.0 111.58 174.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.505 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 82.7 t80 -67.17 -42.77 83.7 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.838 0.455 . . . . 0.0 110.562 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.2 mt -76.74 -51.54 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.781 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.563 ' NE ' ' HA ' ' A' ' 141' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.356 0.878 0 CA-C-O 121.564 0.697 . . . . 0.0 111.332 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.503 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 86.9 mt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.442 0.163 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.3 p -62.12 -27.25 68.8 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.294 1.037 . . . . 0.0 113.787 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 1.4 pp0? -86.69 -33.89 19.9 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.16 -34.5 78.21 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.635 0.774 . . . . 0.0 110.413 174.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 28.7 mmt180 -57.2 -57.77 11.17 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 169.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -53.13 -37.02 53.63 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-N 114.707 -1.133 . . . . 0.0 115.138 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 38.4 mm-40 -67.37 -54.78 17.5 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.069 0.548 . . . . 0.0 110.857 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.48 76.53 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.399 -173.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -71.69 -36.13 70.48 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.981 0.513 . . . . 0.0 111.5 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.18 83.52 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.467 0.479 . . . . 0.0 110.569 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -68.32 -40.65 81.59 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.176 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.2 mt -71.55 -49.79 37.37 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 123.275 0.63 . . . . 0.0 112.228 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 p -61.85 -29.64 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 117.936 0.334 . . . . 0.0 110.804 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -87.74 -11.39 48.3 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 173.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 39.4 t . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 169.784 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -103.44 119.37 38.75 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.298 0.639 . . . . 0.0 111.05 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -104.81 122.58 46.04 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 165.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.496 ' HG3' HD12 ' A' ' 177' ' ' LEU . 17.0 ptp180 -91.76 155.11 18.5 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -159.18 -177.75 6.7 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.062 0.458 . . . . 0.0 111.033 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.88 157.02 44.63 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.03 -176.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.02 -172.95 23.23 Favored Glycine 0 C--O 1.239 0.445 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.415 ' HD3' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -134.07 136.93 44.3 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -136.37 117.45 14.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -170.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.0 m -92.26 99.4 12.19 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.9 pt -104.06 161.21 23.61 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.233 1.013 . . . . 0.0 108.996 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -50.05 -28.9 20.33 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.36 2.706 . . . . 0.0 114.267 172.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.81 0.32 35.4 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.48 177.82 15.07 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 117.841 0.291 . . . . 0.0 112.894 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.57 91.6 0.8 Allowed 'General case' 0 C--N 1.348 0.516 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.46 157.08 26.3 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.068 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.3 165.7 11.42 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.8 p -136.95 140.7 42.41 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.583 HG12 HG22 ' A' ' 125' ' ' VAL . 2.7 pp -92.4 136.52 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 170.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 mp -122.74 114.93 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.3 mt -106.26 108.48 25.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.442 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 99.6 mtt180 -97.38 134.26 40.88 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 172.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 10.0 tt0 -158.91 142.04 14.64 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.023 0.827 . . . . 0.0 110.405 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -116.55 121.77 42.74 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.433 ' O ' ' HA3' ' A' ' 107' ' ' GLY . 57.1 m-85 -94.9 148.23 22.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.689 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.61 34.46 0.49 Allowed 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.921 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.23 146.98 45.15 Favored Pre-proline 0 C--O 1.243 0.718 0 C-N-CA 124.045 0.938 . . . . 0.0 109.251 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HG2' ' HG2' ' A' ' 36' ' ' GLU . 72.2 Cg_endo -67.86 169.03 17.1 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.871 2.381 . . . . 0.0 112.823 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.1 t -53.0 -53.01 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 114.086 -1.416 . . . . 0.0 111.856 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -48.07 -47.14 34.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 124.283 0.989 . . . . 0.0 112.292 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.462 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 21.6 mm-40 -70.27 -27.52 64.49 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.985 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' A' ' 108' ' ' THR . 62.9 t -81.41 -36.08 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 123.862 0.726 . . . . 0.0 110.997 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -68.61 -36.81 79.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.678 0.791 . . . . 0.0 108.884 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -68.78 -55.41 11.35 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HB2' HD12 ' A' ' 136' ' ' LEU . . . -58.61 -28.96 66.1 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.445 ' SG ' HD21 ' A' ' 99' ' ' LEU . 49.7 t -96.11 -24.95 16.06 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.1 p -105.08 -46.83 4.15 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 119.115 0.871 . . . . 0.0 112.007 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.18 125.77 88.87 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.562 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 58.0 Cg_exo -55.59 -35.02 91.93 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.652 2.901 . . . . 0.0 113.052 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.63 -17.88 37.14 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.38 1.472 . . . . 0.0 112.295 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -100.97 -42.42 6.42 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.374 1.07 . . . . 0.0 109.188 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.4 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 73.5 mt -73.69 -36.82 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.544 -167.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -58.25 -18.96 30.32 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -41.46 64.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.21 0.604 . . . . 0.0 112.024 173.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CE2' HD13 ' A' ' 136' ' ' LEU . 66.7 p-90 -118.66 14.04 13.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -171.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.1 t80 178.07 -175.31 0.17 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.115 0.566 . . . . 0.0 109.797 -169.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -88.81 131.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 44' ' ' PRO . 13.5 pt-20 -75.64 140.48 71.54 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-N 119.438 1.017 . . . . 0.0 111.634 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.495 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 93.5 Cg_endo -83.75 111.51 1.73 Allowed 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.352 2.701 . . . . 0.0 112.742 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -78.24 133.53 37.7 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.176 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.77 -156.58 24.31 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.927 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.29 -47.95 46.14 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.145 0.978 . . . . 0.0 111.202 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.8 mt 62.69 29.54 16.83 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 124.472 1.107 . . . . 0.0 111.296 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -118.63 151.57 37.68 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.013 0.925 . . . . 0.0 109.129 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.676 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 3.9 tm-20 -64.54 103.66 0.7 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.39 0.676 . . . . 0.0 109.348 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.84 -32.45 4.79 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.99 -170.29 45.84 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.261 -0.469 . . . . 0.0 112.112 171.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 8.8 p30 -131.55 160.23 35.89 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.146 0.973 . . . . 0.0 112.43 -171.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 21.9 p90 -120.91 158.8 26.88 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.092 166.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.06 114.12 0.79 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 69' ' ' ASN . 80.6 mt -57.86 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 118.395 0.543 . . . . 0.0 111.734 -171.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -159.88 -29.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.392 0.615 . . . . 0.0 110.862 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.85 -31.15 0.03 OUTLIER Glycine 0 N--CA 1.466 0.688 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 91.3 m-20 -89.58 119.59 30.14 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 124.033 0.933 . . . . 0.0 108.491 171.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 72.38 122.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.946 1.298 . . . . 0.0 113.258 173.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.4 p -149.57 139.51 21.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.858 0.863 . . . . 0.0 108.847 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.57 -166.72 30.75 Favored Glycine 0 N--CA 1.464 0.551 0 O-C-N 123.233 0.333 . . . . 0.0 112.394 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 17.9 m-20 -109.31 170.1 8.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.297 0.639 . . . . 0.0 110.515 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.48 HG13 HG23 ' A' ' 85' ' ' ILE . 2.3 mp -97.74 110.01 24.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 171.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.36 -59.88 2.5 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.053 0.845 . . . . 0.0 110.627 -173.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -136.49 150.08 48.5 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.567 1.147 . . . . 0.0 108.988 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.9 p -159.77 134.34 7.74 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.366 0.666 . . . . 0.0 109.295 172.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -134.91 98.86 12.82 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.1 130.85 18.33 Favored 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 122.026 1.817 . . . . 0.0 111.877 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -103.97 20.17 13.37 Favored 'Cis proline' 0 C--N 1.371 1.741 0 CA-C-N 119.411 0.825 . . . . 0.0 113.972 -3.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -54.4 -70.35 0.1 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.203 1.001 . . . . 0.0 111.465 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -145.0 159.67 42.57 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.933 0.397 . . . . 0.0 111.666 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 tt -135.91 113.63 11.01 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.8 m -109.26 128.34 54.99 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.424 1.49 . . . . 0.0 109.431 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.48 HG23 HG13 ' A' ' 74' ' ' ILE . 14.2 pt -121.25 173.09 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 125.109 1.364 . . . . 0.0 111.389 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.5 t -112.81 134.35 54.37 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.656 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 42.1 t-105 -126.53 105.67 8.9 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -167.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.9 t -110.88 144.29 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 21.2 t80 -148.75 151.03 34.14 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -65.12 110.37 2.5 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.139 0.576 . . . . 0.0 110.72 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.43 -20.39 50.63 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.3 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.493 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 70.3 mmtt -97.73 131.1 27.53 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.39 -73.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.891 2.394 . . . . 0.0 113.431 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -161.17 147.61 14.67 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.505 0.722 . . . . 0.0 109.364 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.656 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 19.8 m -141.97 158.96 43.16 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.728 0.811 . . . . 0.0 109.707 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -129.85 114.79 16.34 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 t -105.03 148.45 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -148.88 153.19 37.69 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.178 0.514 . . . . 0.0 110.65 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.445 HD21 ' SG ' ' A' ' 41' ' ' CYS . 39.7 tp -123.93 146.42 48.47 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.263 1.425 . . . . 0.0 107.372 175.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -140.97 109.9 6.11 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.53 148.8 22.11 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.686 0.794 . . . . 0.0 110.694 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.1 t -160.64 135.01 7.29 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 167.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.93 146.92 50.83 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.964 0.906 . . . . 0.0 109.831 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -164.52 108.76 0.94 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.907 1.283 . . . . 0.0 108.861 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.95 -132.01 10.83 Favored Glycine 0 C--N 1.342 0.885 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 172.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -92.42 31.59 1.3 Allowed 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.223 1.009 . . . . 0.0 110.245 171.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 30' ' ' TYR . . . -171.62 -150.43 7.14 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 120.452 -0.88 . . . . 0.0 114.883 -174.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.463 ' HB ' HG23 ' A' ' 37' ' ' VAL . 62.8 m -151.09 141.17 22.13 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.204 0.602 . . . . 0.0 111.079 -170.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.38 144.53 25.73 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.033 0.933 . . . . 0.0 109.378 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -127.14 143.64 51.22 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 166.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 40.9 mt-10 -122.57 107.51 12.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 167.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.434 HD21 HD21 ' A' ' 133' ' ' LEU . 27.7 tp -99.16 104.4 16.37 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 50.8 tt0 -102.69 116.95 33.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.357 0.663 . . . . 0.0 110.429 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -108.03 120.07 41.26 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -113.83 118.38 34.07 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.756 0.822 . . . . 0.0 110.831 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.1 t -139.16 159.94 40.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.241 0.616 . . . . 0.0 111.076 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 50.4 p -89.86 -20.61 23.23 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.221 1.008 . . . . 0.0 111.76 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.8 m -86.71 123.5 31.94 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.231 0.612 . . . . 0.0 109.995 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.572 ' HA ' HD13 ' A' ' 122' ' ' LEU . 28.8 tt0 -73.42 -30.39 63.2 Favored 'General case' 0 C--O 1.25 1.102 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -170.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -60.89 -58.9 6.5 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.493 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 23.8 ttt -49.44 -32.7 12.41 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 124.782 1.301 . . . . 0.0 112.67 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.572 HD13 ' HA ' ' A' ' 119' ' ' GLU . 36.7 mt -61.24 -52.59 64.11 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.869 0.468 . . . . 0.0 111.896 175.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.45 ' O ' HG22 ' A' ' 127' ' ' VAL . 48.0 t -63.26 -50.04 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -45.05 -54.11 7.06 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.927 1.691 . . . . 0.0 113.574 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.583 HG22 HG12 ' A' ' 24' ' ' ILE . 30.5 m -75.93 -24.18 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 122.422 0.289 . . . . 0.0 110.807 -177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.17 96.1 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 169.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 123' ' ' VAL . 58.8 t -78.17 -59.33 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.77 -56.45 9.82 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 114.517 -1.22 . . . . 0.0 114.023 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -65.42 -49.73 68.1 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.402 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 119.05 0.841 . . . . 0.0 111.07 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 89.7 mtp -75.56 -35.26 60.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.492 0.317 . . . . 0.0 110.518 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.26 76.06 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.193 0.597 . . . . 0.0 110.89 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.434 HD21 HD21 ' A' ' 112' ' ' LEU . 4.5 mm? -57.4 -38.14 73.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.332 1.053 . . . . 0.0 112.386 170.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.42 -38.37 90.9 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 120.856 0.36 . . . . 0.0 110.854 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -72.32 -25.18 61.46 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.459 0.704 . . . . 0.0 110.849 173.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 40' ' ' ALA . 41.5 tp -71.01 -52.33 20.2 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 123.162 0.585 . . . . 0.0 109.561 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.78 -36.23 40.64 Favored Glycine 0 N--CA 1.472 1.081 0 N-CA-C 115.016 0.767 . . . . 0.0 115.016 169.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.2 mmm -61.44 -44.93 96.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.655 0.382 . . . . 0.0 110.47 170.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -68.12 -34.93 77.27 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.663 0.785 . . . . 0.0 111.953 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 67.1 mt -78.16 -61.65 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.346 0.658 . . . . 0.0 110.018 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.559 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.6 mm . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.609 0.719 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.2 p -65.94 -51.91 54.39 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.586 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -53.56 -30.83 43.89 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 172.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -58.44 -50.24 74.41 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.641 0.655 . . . . 0.0 109.449 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -60.21 -52.72 64.11 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.185 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.75 -48.0 45.09 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 124.66 1.225 . . . . 0.0 115.955 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.8 -29.2 61.02 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.851 0.46 . . . . 0.0 111.391 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.89 -41.21 68.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.653 0.381 . . . . 0.0 110.037 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -74.79 -23.86 58.57 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.41 0.684 . . . . 0.0 111.255 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 178' ' ' VAL . . . -75.24 -31.85 60.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.941 0.496 . . . . 0.0 110.393 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.72 72.26 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.289 0.636 . . . . 0.0 109.736 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.496 HD12 ' HG3' ' A' ' 9' ' ' ARG . 95.4 mt -71.42 -61.17 1.87 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.102 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 175' ' ' ALA . 11.1 p -57.04 -39.21 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.588 0.755 . . . . 0.0 112.644 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -68.65 -26.66 65.44 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.234 0.614 . . . . 0.0 111.419 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.484 1.263 0 C-N-CA 122.989 0.516 . . . . 0.0 111.065 175.477 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 C--O 1.225 -0.23 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 33.1 m -130.31 103.12 6.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.86 0.864 . . . . 0.0 110.085 -176.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -92.23 142.04 27.91 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.143 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 145.17 41.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.317 0.647 . . . . 0.0 109.262 170.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . . . -160.24 -175.42 5.04 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.882 0.873 . . . . 0.0 110.636 -170.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.6 mt -141.53 165.8 26.49 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.782 0.833 . . . . 0.0 110.889 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.91 -179.75 36.76 Favored Glycine 0 C--O 1.24 0.515 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.041 173.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -109.93 147.91 32.56 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -146.29 126.66 14.0 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.8 m -72.98 141.75 47.76 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.338 0.655 . . . . 0.0 110.026 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.452 HD11 HG23 ' A' ' 117' ' ' THR . 49.3 pt -143.19 152.45 57.89 Favored Pre-proline 0 N--CA 1.478 0.938 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.26 -15.83 6.07 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.214 2.61 . . . . 0.0 115.042 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 93' ' ' PRO . . . -109.3 9.02 25.87 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.92 -165.58 26.17 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 119.021 0.828 . . . . 0.0 114.229 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -94.81 100.73 12.57 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 175.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.09 155.9 21.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.6 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.451 ' HB2' HD12 ' A' ' 122' ' ' LEU . 48.0 mtm180 -101.95 158.24 16.28 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 166.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.5 p -133.53 141.27 47.66 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.41 0.444 . . . . 0.0 111.218 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.491 HD12 HG22 ' A' ' 125' ' ' VAL . 36.0 pt -84.15 148.2 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 47.6 mt -133.83 110.85 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.448 HD12 HD13 ' A' ' 24' ' ' ILE . 7.0 mt -113.32 110.3 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.466 ' HB3' HD12 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -101.53 145.3 29.19 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.128 0.571 . . . . 0.0 110.217 176.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -157.31 142.78 17.3 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.76 0.663 . . . . 0.0 110.992 175.018 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -104.57 107.27 18.13 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -87.52 144.3 26.78 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.774 0.83 . . . . 0.0 111.469 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -79.15 40.98 0.43 Allowed 'General case' 0 CA--C 1.566 1.575 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.133 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.0 150.08 70.32 Favored Pre-proline 0 N--CA 1.474 0.769 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.12 170.94 8.32 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.252 1.968 . . . . 0.0 113.168 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.78 -46.38 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.518 -171.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.61 -34.09 76.32 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.821 0.7 . . . . 0.0 110.99 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.73 -63.53 1.14 Allowed 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.443 0.465 . . . . 0.0 111.298 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.1 t -55.77 -31.8 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.194 0.997 . . . . 0.0 111.064 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -59.98 -56.87 16.29 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.962 0.505 . . . . 0.0 109.872 174.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.0 m -52.83 -42.08 64.82 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.035 0.834 . . . . 0.0 110.737 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.43 ' HB2' HD12 ' A' ' 136' ' ' LEU . . . -60.01 -34.6 73.57 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 82.4 m -95.58 -4.76 44.03 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.635 0.774 . . . . 0.0 113.07 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.2 p -118.02 -51.82 2.44 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 118.314 0.506 . . . . 0.0 111.936 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.51 117.02 30.38 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.784 0.834 . . . . 0.0 110.096 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.27 -20.06 43.4 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.197 2.598 . . . . 0.0 113.869 -170.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -71.38 -49.57 40.82 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -59.02 -37.99 78.23 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.576 172.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.5 mt -67.91 -35.72 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.039 0.535 . . . . 0.0 110.763 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -62.69 -17.45 60.65 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -73.04 -25.61 61.0 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -138.37 11.7 2.77 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -178.87 -178.76 0.56 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.251 0.621 . . . . 0.0 109.402 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.4 HD11 ' OD1' ' A' ' 69' ' ' ASN . 78.3 mt -91.0 137.01 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.999 0.92 . . . . 0.0 108.565 171.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.65 132.8 85.97 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.119 0.968 . . . . 0.0 111.442 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.12 120.28 2.93 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 122.476 2.117 . . . . 0.0 110.352 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -90.65 158.08 17.13 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.514 0.726 . . . . 0.0 111.062 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.71 -166.09 12.23 Favored Glycine 0 N--CA 1.466 0.634 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.178 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.76 -38.43 91.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.059 0.944 . . . . 0.0 111.755 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.2 mt 66.1 12.53 8.56 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.718 1.207 . . . . 0.0 112.518 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -126.82 154.53 44.19 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.139 0.976 . . . . 0.0 108.646 -176.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.93 121.6 10.95 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 123.869 0.731 . . . . 0.0 112.119 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.47 -27.8 17.64 Favored Glycine 0 N--CA 1.475 1.29 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.946 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -97.87 170.4 25.12 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 165.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -119.17 161.39 20.42 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.617 1.209 . . . . 0.0 112.527 -169.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -105.83 172.17 6.95 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.244 168.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.34 143.27 7.32 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.444 1.098 . . . . 0.0 109.74 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.3 mt -116.84 167.73 10.85 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.073 0.949 . . . . 0.0 109.008 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -73.88 -42.78 60.22 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.023 0.529 . . . . 0.0 111.66 -171.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.17 16.83 2.12 Favored Glycine 0 N--CA 1.467 0.731 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.033 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.4 ' OD1' HD11 ' A' ' 52' ' ' ILE . 12.6 m120 -126.91 44.95 2.79 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.266 1.026 . . . . 0.0 108.694 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 68.6 179.25 0.24 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.936 1.295 . . . . 0.0 113.729 175.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.3 p -145.09 140.69 28.23 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.542 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.03 177.7 32.13 Favored Glycine 0 N--CA 1.468 0.828 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.905 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -102.67 156.63 17.5 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.98 0.912 . . . . 0.0 110.128 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.3 mp -92.9 110.43 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.6 mt -73.4 -44.16 59.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.23 0.612 . . . . 0.0 109.796 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -160.52 140.18 10.99 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.273 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.8 p -141.54 126.68 18.45 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.21 1.004 . . . . 0.0 109.181 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -126.47 104.41 24.73 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 125.047 1.339 . . . . 0.0 107.39 -170.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 89.7 Cg_endo -80.27 131.32 8.61 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 122.353 2.035 . . . . 0.0 113.254 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 40.8 Cg_endo -101.05 34.32 7.75 Favored 'Cis proline' 0 C--N 1.377 2.066 0 CA-C-N 119.507 0.86 . . . . 0.0 111.482 -10.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -74.04 -77.87 0.11 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.375 1.07 . . . . 0.0 111.298 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -152.11 157.85 42.16 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.197 0.599 . . . . 0.0 110.611 -174.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -141.41 132.13 25.68 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.059 0.543 . . . . 0.0 109.681 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.491 HG21 ' HB3' ' A' ' 98' ' ' GLU . 58.5 m -118.73 120.13 36.49 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.298 1.039 . . . . 0.0 108.471 174.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 pt -121.19 144.59 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.865 0 C-N-CA 125.779 1.631 . . . . 0.0 108.63 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 74.5 p -84.01 170.44 13.93 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.149 -0.969 . . . . 0.0 110.169 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -153.04 117.82 5.05 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -166.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.14 103.58 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.528 ' HB3' ' HG3' ' A' ' 92' ' ' LYS . 36.8 t80 -101.6 162.62 12.77 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.836 0.854 . . . . 0.0 109.381 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -51.75 111.64 0.63 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.912 1.285 . . . . 0.0 112.379 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.52 19.47 72.84 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.663 -0.698 . . . . 0.0 114.834 173.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.528 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 11.0 mmpt? -100.5 140.97 21.83 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 117.223 0.511 . . . . 0.0 109.76 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.536 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . 57.7 Cg_endo -69.14 -36.73 11.84 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.433 2.089 . . . . 0.0 112.401 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -174.33 153.94 2.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.117 0.967 . . . . 0.0 109.494 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.7 t -146.3 158.32 43.87 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.921 0.889 . . . . 0.0 108.764 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -147.69 115.09 6.29 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.243 0.617 . . . . 0.0 110.167 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.16 147.93 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.491 ' HB3' HG21 ' A' ' 84' ' ' THR . 0.0 OUTLIER -146.55 156.81 43.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.4 tt -145.75 137.73 25.33 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -130.11 139.92 50.86 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.754 1.221 . . . . 0.0 108.688 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.0 mt -120.79 132.34 54.97 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.064 0.945 . . . . 0.0 109.084 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 t -129.95 169.41 15.26 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.914 1.285 . . . . 0.0 108.219 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.49 130.52 55.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -173.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -144.12 111.66 6.03 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 58.42 -106.42 0.84 Allowed Glycine 0 C--N 1.346 1.116 0 O-C-N 123.538 0.524 . . . . 0.0 113.264 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -113.1 2.77 15.8 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.566 0.746 . . . . 0.0 111.185 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -127.44 -162.25 11.07 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.7 m -144.48 137.64 27.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.869 0.868 . . . . 0.0 110.523 -171.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.466 HD12 ' HB3' ' A' ' 27' ' ' ARG . 43.3 tp -90.07 141.12 28.99 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 173.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -124.69 115.81 21.35 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -108.83 106.12 15.98 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 98' ' ' GLU . 43.7 tp -105.57 104.64 14.4 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.69 0.796 . . . . 0.0 108.933 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 44.3 tt0 -107.75 119.69 40.16 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.272 0.629 . . . . 0.0 110.301 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -119.57 124.85 47.38 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -115.91 129.94 56.62 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.531 1.133 . . . . 0.0 112.04 -170.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.6 t -151.39 158.78 44.18 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.518 0.727 . . . . 0.0 110.335 171.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.452 HG23 HD11 ' A' ' 16' ' ' ILE . 22.0 p -77.52 1.32 19.77 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.435 1.094 . . . . 0.0 112.841 176.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.6 m -109.17 127.55 54.3 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.693 0.797 . . . . 0.0 111.919 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -67.62 -47.79 68.63 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.406 1.083 . . . . 0.0 112.167 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.5 -44.8 70.37 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.125 0.17 . . . . 0.0 111.017 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.8 ttt -50.77 -41.35 56.7 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.942 0.776 . . . . 0.0 112.061 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.478 HD21 HG21 ' A' ' 24' ' ' ILE . 48.6 mt -59.66 -44.32 93.61 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.45 0.3 . . . . 0.0 111.087 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.453 ' O ' HG22 ' A' ' 127' ' ' VAL . 28.3 t -63.37 -56.02 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -48.72 -49.65 37.14 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.208 1.403 . . . . 0.0 112.992 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.491 HG22 HD12 ' A' ' 24' ' ' ILE . 22.5 m -77.23 -27.56 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 122.476 0.311 . . . . 0.0 110.316 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.1 -36.39 92.26 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 123' ' ' VAL . 60.5 t -81.17 -49.65 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.07 -60.08 8.97 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 114.312 -1.313 . . . . 0.0 113.759 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -58.08 -41.75 84.12 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.444 0.698 . . . . 0.0 111.953 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.602 ' HB3' HH11 ' A' ' 170' ' ' ARG . 21.4 mt-10 -64.97 -25.88 68.06 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 119.451 1.023 . . . . 0.0 112.311 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.9 mtt -75.69 -44.39 42.45 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.961 0.504 . . . . 0.0 109.773 174.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.21 -62.44 1.83 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.201 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.62 -26.98 64.27 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.381 1.472 . . . . 0.0 113.132 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 18.0 t70 -60.0 -53.3 59.46 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 169.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -67.21 -26.06 66.42 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.36 0.664 . . . . 0.0 111.628 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 40' ' ' ALA . 27.4 tp -62.91 -58.01 8.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.266 0.626 . . . . 0.0 110.234 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.28 -43.74 34.27 Favored Glycine 0 N--CA 1.475 1.289 0 N-CA-C 115.057 0.783 . . . . 0.0 115.057 170.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 96.4 mmm -65.27 -30.32 71.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.133 0.573 . . . . 0.0 111.552 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -77.3 -42.98 34.82 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.083 0.953 . . . . 0.0 111.015 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 45.1 mt -57.78 -55.88 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.805 0.842 . . . . 0.0 110.274 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 48.7 ttp85 . . . . . 0 C--O 1.216 -0.68 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.883 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.439 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 42.7 mm . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.6 t -63.91 -30.99 72.02 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.514 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -71.47 -59.96 2.49 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.348 0.659 . . . . 0.0 110.173 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.17 -43.63 87.57 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.924 0.89 . . . . 0.0 112.481 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.602 HH11 ' HB3' ' A' ' 130' ' ' GLU . 19.7 mmt85 -74.08 -41.37 61.8 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -56.0 -35.65 64.74 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.408 -0.814 . . . . 0.0 113.721 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -78.24 -42.92 29.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.699 0.8 . . . . 0.0 110.475 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.7 72.0 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 124.18 0.925 . . . . 0.0 110.934 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.406 ' CZ2' HG12 ' A' ' 26' ' ' ILE . 97.1 m95 -83.44 -27.37 29.57 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.904 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.35 87.75 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 171.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.76 93.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.476 0.71 . . . . 0.0 110.773 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.08 -57.62 6.47 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.546 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.96 -31.79 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 122.847 0.459 . . . . 0.0 111.915 -168.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -66.65 -29.2 69.16 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.356 0.662 . . . . 0.0 110.668 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 171.204 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.1 m -120.33 115.35 23.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.555 0.742 . . . . 0.0 110.451 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 32.1 mt-10 -89.55 136.95 32.73 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -111.3 142.13 43.94 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.811 0.445 . . . . 0.0 110.313 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.37 127.57 7.7 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.931 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.748 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -85.56 121.97 29.01 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.59 -154.82 12.1 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-O 121.332 0.407 . . . . 0.0 113.376 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -148.09 148.28 30.46 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.245 1.018 . . . . 0.0 109.712 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.446 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 27.8 tpt180 -168.93 120.39 0.75 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.429 0.691 . . . . 0.0 109.46 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.2 m -83.21 97.6 8.94 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.9 pt -78.3 160.44 73.05 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.369 1.068 . . . . 0.0 110.295 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.3 -21.24 22.3 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.453 2.769 . . . . 0.0 114.463 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.9 -53.14 22.77 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 170.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.7 -157.38 27.62 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.225 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.436 ' HB3' HH22 ' A' ' 22' ' ' ARG . 48.9 mt-10 -68.74 106.15 2.55 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.253 0.621 . . . . 0.0 110.651 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 14' ' ' ARG . . . -114.71 153.42 30.3 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.572 0.749 . . . . 0.0 111.401 -175.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.436 HH22 ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -91.67 169.71 10.51 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 164.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -141.71 142.49 33.31 Favored 'General case' 0 C--O 1.217 -0.63 0 O-C-N 122.305 -0.247 . . . . 0.0 110.946 -172.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.558 HG12 HG21 ' A' ' 125' ' ' VAL . 2.7 pp -98.73 144.8 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 168.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.506 HG12 ' HG3' ' A' ' 113' ' ' GLU . 44.3 mt -131.79 106.28 11.26 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.6 mt -101.7 107.54 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 49.0 mtp180 -107.17 133.56 51.58 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.292 1.037 . . . . 0.0 108.791 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -141.25 152.97 44.98 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.768 0.427 . . . . 0.0 110.068 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.534 ' NH1' HD13 ' A' ' 109' ' ' LEU . 67.3 mmt-85 -108.48 102.33 11.43 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -79.17 124.32 28.22 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.15 44.79 0.25 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 123.916 0.76 . . . . 0.0 111.295 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.88 148.06 37.57 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 125.292 1.437 . . . . 0.0 107.143 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.45 175.62 2.64 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.8 2.334 . . . . 0.0 114.487 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -73.59 -42.71 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.921 -171.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.35 -43.6 98.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.687 0.795 . . . . 0.0 110.508 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -59.96 -63.97 1.11 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.686 175.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.47 -34.49 46.85 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 124.177 0.991 . . . . 0.0 111.936 -175.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -61.31 -58.47 8.1 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.994 0.518 . . . . 0.0 110.206 178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 80.0 p -57.91 -46.11 85.48 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.886 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.57 ' HA ' ' HD2' ' A' ' 46' ' ' ARG . . . -53.43 -40.23 65.0 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 79.9 m -78.95 -16.81 56.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 50.3 p -108.31 -26.53 10.48 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 1.2 p30 -85.54 124.24 71.66 Favored Pre-proline 0 N--CA 1.484 1.241 0 CA-C-N 118.533 0.606 . . . . 0.0 110.325 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 50.9 Cg_exo -55.71 -27.34 60.83 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.971 3.114 . . . . 0.0 114.278 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -63.48 -53.51 50.97 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.322 1.014 . . . . 0.0 110.665 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.57 ' HD2' ' HA ' ' A' ' 40' ' ' ALA . 65.8 mtt85 -71.32 -32.27 68.38 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.117 175.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.473 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 82.7 mt -65.04 -39.43 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 118.129 0.422 . . . . 0.0 111.837 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 13.8 p30 -67.07 -11.68 57.82 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 15.4 mmt180 -72.14 -41.39 67.21 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.475 0.71 . . . . 0.0 111.161 170.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.494 ' HB2' ' O ' ' A' ' 132' ' ' ALA . 70.5 p-90 -115.77 9.35 15.1 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -170.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -173.42 180.0 2.01 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -170.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.1 mt -84.88 133.59 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 34.0 tt0 -67.34 127.23 93.41 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.724 1.21 . . . . 0.0 111.001 -171.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.435 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 89.9 Cg_endo -79.88 102.14 1.43 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.797 2.332 . . . . 0.0 111.045 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.43 160.49 24.02 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.634 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.19 -171.76 15.09 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.96 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.52 -47.91 66.36 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.001 1.72 . . . . 0.0 112.277 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.9 mt 69.23 0.66 2.93 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.293 1.437 . . . . 0.0 113.474 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -103.01 154.83 18.84 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.703 0.801 . . . . 0.0 110.028 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -63.96 107.09 1.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.615 0.766 . . . . 0.0 111.233 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.2 -24.48 6.96 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.0 -161.74 37.72 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -141.13 157.32 45.44 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.95 1.375 . . . . 0.0 111.212 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.435 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 25.8 p90 -101.32 171.72 7.42 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.59 163.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -165.83 135.39 3.35 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.596 1.159 . . . . 0.0 109.024 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.9 mt -93.05 174.63 7.13 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.597 0.759 . . . . 0.0 109.817 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -106.18 134.37 49.43 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 171.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 53.84 36.34 55.14 Favored Glycine 0 CA--C 1.532 1.1 0 O-C-N 124.927 1.392 . . . . 0.0 114.873 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -149.95 -95.66 0.07 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.04 -179.16 5.93 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.195 0.598 . . . . 0.0 110.841 -171.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.1 p -152.05 146.2 25.36 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.61 146.73 15.81 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 118.823 0.738 . . . . 0.0 112.346 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -80.94 148.81 29.66 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.501 0.721 . . . . 0.0 110.278 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mm -83.26 95.05 3.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 86' ' ' SER . 67.2 mt -70.77 -50.0 40.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.38 0.672 . . . . 0.0 110.41 -173.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -155.76 130.31 9.02 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.37 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 88.7 m -116.25 136.05 53.35 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 167.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -133.34 88.15 36.06 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 95.0 Cg_endo -76.75 136.63 17.14 Favored 'Trans proline' 0 CA--C 1.559 1.768 0 C-N-CA 122.775 2.317 . . . . 0.0 112.425 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 40.8 Cg_endo -102.81 27.76 11.52 Favored 'Cis proline' 0 C--N 1.381 2.26 0 CA-C-N 119.468 0.846 . . . . 0.0 113.256 -5.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.422 ' NH1' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -77.14 -74.63 0.24 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.349 0.66 . . . . 0.0 110.179 -174.03 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -147.9 160.75 42.46 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.25 0.62 . . . . 0.0 110.772 -171.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -141.95 127.91 19.5 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.494 0.718 . . . . 0.0 109.215 171.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.431 ' HG1' ' HG2' ' A' ' 98' ' ' GLU . 24.7 m -104.5 112.26 25.25 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.506 HG13 ' HB ' ' A' ' 97' ' ' VAL . 15.3 pt -110.05 170.56 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.465 1.106 . . . . 0.0 109.544 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.486 ' HB3' HD13 ' A' ' 75' ' ' LEU . 23.3 p -105.37 170.9 7.62 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 69.3 t-105 -146.04 92.85 2.25 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -175.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.65 101.92 13.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -117.71 127.37 53.85 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.14 126.99 30.38 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.909 0.883 . . . . 0.0 110.855 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.38 -54.18 0.81 Allowed Glycine 0 C--N 1.349 1.287 0 O-C-N 123.496 0.497 . . . . 0.0 112.512 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.575 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 0.0 OUTLIER -99.27 148.56 34.81 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 123.993 0.917 . . . . 0.0 110.0 -173.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -50.53 140.88 34.99 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 123.882 3.055 . . . . 0.0 114.21 -173.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.43 117.96 5.45 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.55 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 8.2 m -100.41 173.81 6.4 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.141 0.977 . . . . 0.0 110.636 -173.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -128.07 117.38 21.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.506 ' HB ' HG13 ' A' ' 85' ' ' ILE . 40.7 t -98.34 135.51 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.431 ' HG2' ' HG1' ' A' ' 84' ' ' THR . 0.8 OUTLIER -138.74 114.71 10.1 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.297 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.4 tt -111.43 126.51 55.02 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -177.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.422 ' HG2' ' NH1' ' A' ' 81' ' ' ARG . 23.8 ttm180 -132.42 105.32 7.2 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.899 0.88 . . . . 0.0 110.09 -165.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 88.5 mt -97.1 139.25 33.38 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 110.985 176.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.7 t -138.68 174.16 10.83 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.695 1.198 . . . . 0.0 108.353 172.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -104.74 132.89 50.44 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.405 ' HG2' ' HE ' ' A' ' 29' ' ' ARG . 13.3 tp10 -147.69 99.64 3.13 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -169.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 58.47 -105.72 0.7 Allowed Glycine 0 C--N 1.35 1.314 0 C-N-CA 123.317 0.484 . . . . 0.0 113.966 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -100.93 -15.14 17.63 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.189 0.996 . . . . 0.0 110.43 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.62 -161.01 12.24 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.719 -169.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.2 m -142.79 134.2 26.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.248 1.019 . . . . 0.0 109.71 -173.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.534 HD13 ' NH1' ' A' ' 29' ' ' ARG . 33.6 tp -89.3 122.86 32.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.401 ' HA ' HD21 ' A' ' 101' ' ' LEU . 9.0 tt -111.61 108.82 18.43 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.555 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 28.1 mt-10 -109.62 104.85 13.94 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.47 HD13 HD21 ' A' ' 133' ' ' LEU . 8.0 tt -102.0 101.05 11.39 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 171.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.506 ' HG3' HG12 ' A' ' 25' ' ' ILE . 32.7 tt0 -97.23 117.61 31.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.322 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.434 ' ND1' HG23 ' A' ' 97' ' ' VAL . 5.2 t60 -116.74 118.62 33.03 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.4 132.32 54.53 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.371 0.668 . . . . 0.0 111.328 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.647 HG22 ' HG3' ' A' ' 121' ' ' MET . 7.6 t -154.73 161.15 41.64 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.055 0.942 . . . . 0.0 110.27 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.7 p -88.53 -0.2 56.98 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.881 -166.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.0 m -120.19 129.61 54.18 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.589 0.756 . . . . 0.0 110.963 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -61.46 -41.23 96.9 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.095 0.958 . . . . 0.0 112.187 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -63.68 -56.67 13.94 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.174 0.589 . . . . 0.0 111.229 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.647 ' HG3' HG22 ' A' ' 116' ' ' THR . 14.9 tpt -49.79 -34.25 18.93 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 123.939 0.775 . . . . 0.0 112.369 174.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.46 ' HG ' HG23 ' A' ' 116' ' ' THR . 17.5 mt -67.01 -47.27 71.99 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.678 0.791 . . . . 0.0 112.06 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 127' ' ' VAL . 59.8 t -60.86 -50.39 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -50.21 -46.18 54.38 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.28 1.432 . . . . 0.0 113.222 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.558 HG21 HG12 ' A' ' 24' ' ' ILE . 35.9 m -81.26 -26.41 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.693 0.397 . . . . 0.0 110.913 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.71 -38.33 96.28 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 171.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.51 HG23 ' HB3' ' A' ' 170' ' ' ARG . 62.0 t -78.42 -50.71 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.679 0.792 . . . . 0.0 109.499 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.48 -62.32 6.32 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.9 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -63.27 -40.12 96.49 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 118.417 -0.801 . . . . 0.0 112.313 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.1 -40.73 96.86 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.868 1.213 . . . . 0.0 110.864 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 47.3 ttm -68.91 -36.92 78.58 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.744 0.818 . . . . 0.0 110.078 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 50' ' ' TRP . . . -65.07 -65.02 0.73 Allowed 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.864 0.727 . . . . 0.0 110.449 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.47 HD21 HD13 ' A' ' 112' ' ' LEU . 4.0 mm? -55.19 -30.24 59.53 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.05 0.94 . . . . 0.0 112.53 174.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.31 -45.2 84.44 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.216 0.462 . . . . 0.0 110.973 171.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -65.2 -31.52 72.73 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.519 0.512 . . . . 0.0 111.224 175.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.27 -48.09 79.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 172.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -45.59 -52.7 8.92 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.715 0.634 . . . . 0.0 113.982 166.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.52 -34.42 77.75 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.96 0.904 . . . . 0.0 111.603 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -69.66 -52.02 29.51 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.355 0.662 . . . . 0.0 110.209 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.4 mt -64.97 -29.39 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 124.186 0.994 . . . . 0.0 110.757 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.247 0 C-N-CA 124.266 1.026 . . . . 0.0 109.6 175.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 50.6 mm . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.1 t -51.53 -47.3 63.41 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.421 1.088 . . . . 0.0 112.411 172.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -88.9 -25.28 22.2 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -63.42 -57.34 10.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.566 1.147 . . . . 0.0 110.079 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.51 ' HB3' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -60.16 -43.82 95.49 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.684 0.615 . . . . 0.0 109.828 173.468 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -54.71 -44.15 79.99 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 124.028 0.83 . . . . 0.0 113.195 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.26 -59.39 4.12 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.762 1.225 . . . . 0.0 109.866 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 177' ' ' LEU . . . -51.44 -57.05 10.04 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 124.997 1.435 . . . . 0.0 111.834 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -70.29 -25.86 63.53 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.725 0.81 . . . . 0.0 113.101 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.1 -36.62 64.26 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 118.177 0.444 . . . . 0.0 110.452 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.97 -35.09 74.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.908 0.483 . . . . 0.0 109.943 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.748 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 67.8 mt -69.47 -53.22 20.29 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.943 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.516 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 9.8 p -70.28 -29.3 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 48.4 m170 -80.22 2.41 24.51 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.874 0.47 . . . . 0.0 111.304 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 37.6 t . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 124.184 0.994 . . . . 0.0 108.354 171.828 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 120.999 0.428 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.2 m -97.1 120.65 37.86 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.739 0.815 . . . . 0.0 110.048 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -114.35 116.24 28.63 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.437 1.095 . . . . 0.0 109.024 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -76.22 139.36 41.14 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 170.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.544 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . . . -152.63 170.61 19.8 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.06 0.457 . . . . 0.0 111.444 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.428 HD13 ' N ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -143.88 162.04 37.13 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -176.022 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.428 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -173.28 -160.71 22.28 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -137.65 151.68 48.54 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.072 0.949 . . . . 0.0 108.495 178.021 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -156.95 133.21 9.78 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.566 0.746 . . . . 0.0 109.298 -170.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 m -83.16 137.78 33.92 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.443 HD12 HG22 ' A' ' 117' ' ' THR . 47.7 pt -137.65 160.88 63.29 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.507 0.723 . . . . 0.0 109.1 -174.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -45.07 -31.29 5.52 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.984 3.123 . . . . 0.0 115.324 174.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 -41.75 65.61 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.042 0.537 . . . . 0.0 111.265 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.93 -150.09 21.67 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.913 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.8 115.82 9.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.587 0.755 . . . . 0.0 109.817 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.78 164.75 18.54 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.677 0.791 . . . . 0.0 110.907 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -112.61 161.95 16.23 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 p -138.81 128.99 25.5 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.47 0.308 . . . . 0.0 110.655 -168.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 45.5 pt -87.32 135.69 24.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 169.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 3.5 mp -112.99 110.75 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 171.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.9 mt -101.67 109.57 26.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.469 ' HG3' HD12 ' A' ' 109' ' ' LEU . 59.7 ttm-85 -113.76 148.46 36.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.736 0.814 . . . . 0.0 110.385 -172.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.482 HE21 HD22 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -165.91 138.22 4.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 124.215 0.947 . . . . 0.0 112.496 -176.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.497 ' NH1' HD13 ' A' ' 109' ' ' LEU . 46.0 mmt-85 -96.69 115.39 27.35 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.273 1.029 . . . . 0.0 108.84 167.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -93.67 147.93 22.57 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.765 0.826 . . . . 0.0 109.998 170.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.17 28.03 0.86 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.371 0.668 . . . . 0.0 111.352 172.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.46 151.78 44.74 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 124.451 1.1 . . . . 0.0 109.768 176.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.32 152.02 60.69 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.014 1.809 . . . . 0.0 111.026 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.9 t -46.63 -49.85 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 124.444 1.098 . . . . 0.0 111.094 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -49.21 -47.2 46.36 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 125.371 1.669 . . . . 0.0 111.55 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.81 -34.84 72.15 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.305 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.2 t -75.05 -32.41 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -71.48 -31.24 66.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.428 1.091 . . . . 0.0 110.179 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.8 m -75.09 -37.44 61.55 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -65.03 -44.64 88.47 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.266 0.626 . . . . 0.0 110.744 171.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.9 t -68.13 -24.86 65.05 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -176.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.9 p -113.85 -38.59 4.2 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -172.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.94 122.86 88.57 Favored Pre-proline 0 N--CA 1.484 1.274 0 CA-C-O 119.106 -0.473 . . . . 0.0 110.269 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -49.97 -51.68 10.41 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.868 3.045 . . . . 0.0 114.596 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -52.39 -33.54 43.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.844 1.258 . . . . 0.0 111.841 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.517 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 5.4 mmp_? -81.33 -38.45 26.71 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.862 0.465 . . . . 0.0 111.662 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.3 mt -73.39 -29.51 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -57.68 -24.64 57.79 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.033 1.733 . . . . 0.0 112.084 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -87.89 -60.21 2.03 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.382 0.673 . . . . 0.0 110.208 -173.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -82.29 -15.04 54.39 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -140.27 -108.41 0.15 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.2 mt -143.01 144.25 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.627 0.771 . . . . 0.0 109.52 -169.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -59.44 109.52 2.0 Allowed Pre-proline 0 CA--C 1.57 1.715 0 O-C-N 125.31 1.631 . . . . 0.0 111.654 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -100.06 156.83 0.52 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.208 2.605 . . . . 0.0 113.82 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -144.73 159.0 43.56 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.6 1.16 . . . . 0.0 108.441 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.74 -148.2 19.84 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.62 -53.69 7.28 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.376 0.67 . . . . 0.0 109.423 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt 59.88 19.7 8.65 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.617 1.167 . . . . 0.0 110.962 -170.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -114.55 149.65 36.17 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.678 1.191 . . . . 0.0 109.153 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.502 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 42.3 tt0 -59.7 122.27 13.73 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.476 0.71 . . . . 0.0 110.88 -177.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.67 14.77 64.8 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.908 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -115.8 -147.54 9.03 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -151.26 172.64 15.55 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.491 0.662 . . . . 0.0 111.605 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.63 164.94 26.08 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.897 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.37 122.13 9.28 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.037 0.935 . . . . 0.0 109.873 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.483 HD11 HD21 ' A' ' 69' ' ' ASN . 25.9 mt -89.8 142.11 28.0 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.624 1.17 . . . . 0.0 108.927 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.06 101.18 12.21 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.52 32.35 8.77 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.423 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.483 HD21 HD11 ' A' ' 66' ' ' LEU . 64.1 t30 -150.67 -88.09 0.07 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 117.32 0.56 . . . . 0.0 111.689 177.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.77 159.42 40.63 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 121.304 0.573 . . . . 0.0 112.207 -167.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.0 m -125.62 148.53 48.94 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.476 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.88 159.48 30.33 Favored Glycine 0 C--N 1.338 0.673 0 O-C-N 123.196 0.31 . . . . 0.0 112.381 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.43 164.34 14.32 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.638 0.775 . . . . 0.0 110.586 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 mm -106.72 103.75 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.417 HD12 ' HG ' ' A' ' 86' ' ' SER . 72.2 mt -80.03 -43.08 22.54 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.79 0.436 . . . . 0.0 111.053 -174.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -166.49 146.74 6.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.131 0.572 . . . . 0.0 109.521 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 12.8 p -160.37 110.77 1.82 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.749 0.42 . . . . 0.0 111.155 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.79 112.4 60.3 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 169.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 70.9 Cg_endo -75.52 132.39 14.7 Favored 'Trans proline' 0 CA--C 1.558 1.707 0 C-N-CA 122.153 1.902 . . . . 0.0 111.897 169.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 43.8 Cg_endo -98.97 21.71 23.32 Favored 'Cis proline' 0 C--N 1.375 1.949 0 CA-C-N 119.659 0.914 . . . . 0.0 112.967 -4.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -66.79 -68.41 0.38 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.151 0.98 . . . . 0.0 112.982 -171.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.452 ' HB3' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -154.58 148.96 26.14 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.627 0.648 . . . . 0.0 112.491 -174.358 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.5 tp -108.14 145.45 34.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.342 1.457 . . . . 0.0 108.572 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.7 m -137.49 125.85 23.32 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.2 pt -144.01 147.37 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.502 1.121 . . . . 0.0 110.211 -170.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.417 ' HG ' HD12 ' A' ' 75' ' ' LEU . 50.3 m -88.33 154.28 20.52 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 166.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 43.7 t-105 -134.98 106.74 6.96 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -174.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.02 107.43 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -94.34 162.98 13.61 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -48.76 111.24 0.44 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.237 1.415 . . . . 0.0 112.648 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.65 25.4 75.77 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 124.023 0.827 . . . . 0.0 113.88 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -116.03 159.73 38.19 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.796 0.838 . . . . 0.0 110.334 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.33 167.25 26.81 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.323 2.015 . . . . 0.0 110.98 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -69.25 108.88 3.84 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.5 m -83.92 167.02 17.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.381 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.03 119.98 18.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 40.6 t -130.13 145.15 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.591 1.157 . . . . 0.0 109.605 -165.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -135.57 145.25 46.77 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.97 -0.456 . . . . 0.0 109.887 171.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.427 ' HG ' HD23 ' A' ' 110' ' ' LEU . 9.2 tt -123.38 115.64 21.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.452 ' HA ' ' HB3' ' A' ' 82' ' ' ARG . 41.6 ttp180 -121.93 117.47 26.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.98 0.512 . . . . 0.0 110.462 -171.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.4 mt -95.55 132.17 40.96 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.321 1.048 . . . . 0.0 109.525 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.8 m -137.23 125.66 23.46 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.653 1.181 . . . . 0.0 107.985 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.97 152.12 28.61 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.362 1.065 . . . . 0.0 110.45 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -167.19 85.95 0.26 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.403 0.681 . . . . 0.0 110.617 -162.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.31 -137.3 23.56 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -87.68 51.99 2.36 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 166.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.91 -165.24 31.5 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 114.547 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 90.9 m -148.01 132.92 18.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.203 0.601 . . . . 0.0 110.968 -171.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.497 HD13 ' NH1' ' A' ' 29' ' ' ARG . 32.6 tp -83.29 120.24 25.59 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.674 0.79 . . . . 0.0 109.486 167.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.482 HD22 HE21 ' A' ' 28' ' ' GLN . 7.3 tt -102.87 132.59 48.97 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 170.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -128.5 105.63 8.43 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.415 HD23 HD21 ' A' ' 133' ' ' LEU . 41.9 tp -101.47 133.01 46.76 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 33.1 tt0 -131.43 105.47 7.62 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.695 0.798 . . . . 0.0 108.943 175.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -96.26 115.55 27.62 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.54 107.37 15.42 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.575 0.75 . . . . 0.0 110.237 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.0 t -130.92 156.94 44.22 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.086 0.554 . . . . 0.0 109.684 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.443 HG22 HD12 ' A' ' 16' ' ' ILE . 68.7 p -74.35 -31.4 62.4 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.864 0.866 . . . . 0.0 110.535 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 m -79.38 111.41 15.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.999 0.92 . . . . 0.0 111.337 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.496 ' HA ' HD11 ' A' ' 122' ' ' LEU . 45.3 tt0 -60.42 -30.93 69.93 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.907 0.883 . . . . 0.0 111.86 176.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -66.96 -49.41 65.53 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.61 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.5 ttt -59.8 -37.29 78.71 Favored 'General case' 0 C--O 1.203 -1.383 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.897 176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 119' ' ' GLU . 25.7 mt -61.54 -38.56 87.87 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 123.43 0.692 . . . . 0.0 112.404 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.6 t -65.85 -49.04 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.427 0.632 . . . . 0.0 109.826 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -62.55 -40.32 96.46 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.934 1.294 . . . . 0.0 111.832 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 m -83.62 -22.63 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.549 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.09 -34.84 85.56 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 168.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.98 -52.16 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.05 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.8 -38.13 95.7 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.339 -172.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -80.77 -39.43 26.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.923 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -61.48 -37.04 82.18 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 119.357 0.98 . . . . 0.0 109.636 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 93.1 mtp -69.4 -35.62 75.96 Favored 'General case' 0 C--O 1.218 -0.584 0 O-C-N 123.758 0.661 . . . . 0.0 110.723 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.84 86.35 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.706 0.402 . . . . 0.0 110.701 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.415 HD21 HD23 ' A' ' 112' ' ' LEU . 3.7 mm? -79.29 -20.38 48.16 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.278 0.631 . . . . 0.0 111.498 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -71.46 -42.92 67.54 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -81.54 -22.82 37.63 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.867 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 32.4 tp -71.26 -31.68 67.8 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -56.76 -52.96 47.49 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.978 164.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 94.4 mmm -63.61 -33.84 76.5 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.922 0.889 . . . . 0.0 112.334 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.415 ' HZ ' ' HD3' ' A' ' 46' ' ' ARG . 43.8 t80 -75.08 -51.42 13.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.766 0.826 . . . . 0.0 110.599 -174.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.0 mt -65.35 -28.97 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.009 0.924 . . . . 0.0 110.769 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 C-N-CA 123.597 0.759 . . . . 0.0 109.593 174.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.402 ' O ' ' HG3' ' A' ' 170' ' ' ARG . 72.9 mt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.3 p -75.84 -53.35 8.59 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -176.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -59.99 -45.62 92.14 Favored 'General case' 0 C--O 1.205 -1.26 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.819 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -42.37 -49.96 5.12 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 124.61 1.164 . . . . 0.0 113.194 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 166' ' ' ILE . 54.3 mtt180 -63.86 -40.05 95.66 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 120.767 0.318 . . . . 0.0 111.084 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.39 -33.15 44.81 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.137 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 12.8 pt-20 -82.91 -18.32 40.56 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.829 0.851 . . . . 0.0 109.896 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.99 -51.45 58.31 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.676 0.79 . . . . 0.0 109.2 172.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -72.73 -34.2 66.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.7 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -65.25 -28.68 69.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.621 0.369 . . . . 0.0 110.926 174.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -76.62 -43.24 39.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.7 mt -63.63 -41.17 98.28 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.279 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.2 p -90.66 -26.43 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 118.426 0.557 . . . . 0.0 109.632 -166.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -75.35 -17.88 60.12 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.895 0.478 . . . . 0.0 110.795 173.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.8 m . . . . . 0 N--CA 1.476 0.865 0 C-N-CA 123.024 0.53 . . . . 0.0 109.912 172.968 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.509 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.9 m -104.75 104.12 13.86 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.444 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -80.06 135.9 36.45 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.136 0.494 . . . . 0.0 109.989 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.409 ' HB3' HD13 ' A' ' 177' ' ' LEU . 32.3 mtt180 -109.21 140.21 43.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.941 1.296 . . . . 0.0 109.227 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.65 -173.22 2.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.287 0.635 . . . . 0.0 111.272 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.593 HD11 HH11 ' A' ' 22' ' ' ARG . 81.3 mt -139.16 163.7 31.76 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.548 1.139 . . . . 0.0 109.502 175.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.68 -163.04 11.34 Favored Glycine 0 C--O 1.241 0.575 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.69 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.53 124.07 9.06 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -133.29 116.24 15.91 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.4 m -84.42 120.0 25.77 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 pt -110.88 163.57 16.96 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 124.9 1.28 . . . . 0.0 109.329 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -55.24 -24.19 40.71 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.392 2.728 . . . . 0.0 114.741 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.34 -22.2 61.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.24 0.616 . . . . 0.0 112.189 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.49 170.95 14.71 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -169.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -67.43 116.67 8.44 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 173.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -104.63 152.02 22.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.94 0.496 . . . . 0.0 110.151 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.593 HH11 HD11 ' A' ' 11' ' ' LEU . 22.4 ttm-85 -97.8 154.41 17.64 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.6 p -123.71 143.27 50.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.737 0.415 . . . . 0.0 110.841 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.428 HG21 HD23 ' A' ' 122' ' ' LEU . 2.7 pp -90.92 135.66 26.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 166.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.592 HG13 ' HG2' ' A' ' 113' ' ' GLU . 1.7 mp -114.39 115.8 50.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -174.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.0 mt -114.69 106.46 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 170.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.51 ' HB3' HD11 ' A' ' 109' ' ' LEU . 52.3 mtp180 -105.21 136.45 44.69 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -144.61 136.47 25.88 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -92.81 103.06 15.45 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -86.39 122.57 30.54 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.191 0.996 . . . . 0.0 110.557 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.39 43.14 0.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.475 171.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.24 143.86 20.13 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' A' ' 36' ' ' GLU . 21.3 Cg_endo -62.58 165.27 16.05 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.1 2.534 . . . . 0.0 114.633 -176.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.49 -45.09 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.405 -174.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.3 -35.51 79.26 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.438 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.593 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 8.5 tp10 -65.12 -62.76 1.36 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.957 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 33' ' ' PRO . 11.3 t -53.37 -35.0 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.042 0.937 . . . . 0.0 111.078 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -62.5 -58.31 8.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.312 0.645 . . . . 0.0 110.664 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.6 p -59.18 -39.37 82.31 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.524 -177.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.4 74.1 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.799 171.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -80.33 -9.56 59.74 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.8 p -104.3 -32.3 9.14 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.824 0.45 . . . . 0.0 111.596 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.47 ' O ' HG13 ' A' ' 47' ' ' ILE . 10.2 t70 -79.96 116.28 60.11 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 123.882 0.873 . . . . 0.0 110.298 -174.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -61.91 -33.25 84.55 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.142 2.561 . . . . 0.0 113.195 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.42 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 13.9 m120 -70.42 -17.51 63.01 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.25 0.62 . . . . 0.0 110.89 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -101.59 -25.59 13.83 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.603 0.761 . . . . 0.0 110.853 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.504 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 76.4 mt -76.96 -40.22 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 122.908 0.483 . . . . 0.0 111.417 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.42 ' ND2' ' HA ' ' A' ' 45' ' ' ASN . 13.9 p30 -59.66 -21.83 61.06 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -60.12 -56.54 20.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.362 0.665 . . . . 0.0 110.91 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.504 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 36.3 p-90 -91.44 -54.74 3.78 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -172.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.429 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 10.7 t80 -108.46 -166.18 1.1 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.11 0.564 . . . . 0.0 109.638 176.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.8 mt -86.12 124.77 40.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 164.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.22 136.23 96.44 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 123.208 0.603 . . . . 0.0 110.695 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.602 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 54.3 Cg_endo -68.67 131.12 22.08 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.227 1.951 . . . . 0.0 111.76 171.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -89.87 155.71 18.96 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.425 0.69 . . . . 0.0 109.294 172.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.0 -163.01 17.87 Favored Glycine 0 N--CA 1.466 0.681 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.057 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.26 -39.34 92.55 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.943 1.297 . . . . 0.0 111.202 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.0 mt 62.75 12.8 5.92 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.008 1.323 . . . . 0.0 114.342 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.0 mmm-85 -108.1 161.51 14.9 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.591 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 39.0 tt0 -67.18 109.38 3.04 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.594 0.757 . . . . 0.0 110.436 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.55 -23.33 11.18 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -175.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.93 -170.63 45.4 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 166.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -132.31 163.1 29.4 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.037 0.918 . . . . 0.0 110.946 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.602 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 20.2 p90 -119.82 165.28 14.79 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.114 175.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -166.83 102.65 0.56 Allowed 'General case' 0 C--N 1.348 0.524 0 C-N-CA 125.226 1.41 . . . . 0.0 107.824 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.42 HD12 ' CH2' ' A' ' 87' ' ' TRP . 70.7 mt -56.56 -65.74 0.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.397 0.679 . . . . 0.0 111.704 -171.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 132.49 -61.58 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 128.025 2.53 . . . . 0.0 109.177 171.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.86 31.52 8.09 Favored Glycine 0 N--CA 1.473 1.113 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.16 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -158.27 -80.86 0.06 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.83 -167.39 2.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.224 0.61 . . . . 0.0 111.019 -171.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.649 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 33.0 t -148.61 -166.11 2.46 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.1 -156.99 27.06 Favored Glycine 0 C--N 1.347 1.163 0 C-N-CA 121.554 -0.355 . . . . 0.0 113.609 171.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -141.45 146.53 36.61 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.917 0.887 . . . . 0.0 109.403 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.423 ' HA ' HG23 ' A' ' 85' ' ' ILE . 10.6 mt -96.61 106.5 18.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-O 121.497 0.665 . . . . 0.0 109.948 -177.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.63 -59.53 2.65 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.929 -171.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -146.3 155.03 42.36 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.268 1.027 . . . . 0.0 110.503 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 21.6 p -155.56 117.11 3.99 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 176.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -108.89 94.49 14.7 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.282 1.433 . . . . 0.0 107.458 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.28 134.26 15.56 Favored 'Trans proline' 0 CA--C 1.566 2.098 0 C-N-CA 122.709 2.273 . . . . 0.0 113.06 -175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -99.07 24.86 19.44 Favored 'Cis proline' 0 C--N 1.385 2.487 0 CA-C-N 119.808 0.967 . . . . 0.0 112.285 -8.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -67.4 0.49 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.494 1.118 . . . . 0.0 111.084 -170.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -142.61 159.72 41.69 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.232 0.613 . . . . 0.0 110.604 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 tt -136.07 110.81 8.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.6 m -114.42 110.91 20.59 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.185 0.994 . . . . 0.0 109.077 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.423 HG23 ' HA ' ' A' ' 74' ' ' ILE . 23.3 pt -125.55 160.4 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.731 1.212 . . . . 0.0 109.792 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.7 p -83.84 -175.24 5.71 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.906 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.475 ' HB3' ' HG ' ' A' ' 95' ' ' SER . 18.9 t-105 -170.18 100.59 0.28 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 120.673 0.273 . . . . 0.0 111.215 -169.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.3 t -92.01 103.5 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.648 0.779 . . . . 0.0 109.09 176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.569 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -102.57 143.82 31.77 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.108 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -57.5 121.41 10.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.391 1.077 . . . . 0.0 111.778 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.54 -1.04 79.1 Favored Glycine 0 C--N 1.346 1.099 0 O-C-N 123.23 0.331 . . . . 0.0 113.762 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.569 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 47.0 mmtm -120.82 163.96 26.22 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.179 0.992 . . . . 0.0 109.598 -175.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.11 -178.26 4.07 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.635 2.224 . . . . 0.0 112.44 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.27 96.97 7.44 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.475 ' HG ' ' HB3' ' A' ' 87' ' ' TRP . 78.4 p -80.58 168.03 19.38 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.895 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.24 119.14 29.3 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.641 0.777 . . . . 0.0 109.637 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.75 142.86 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.28 1.032 . . . . 0.0 109.327 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -139.8 115.84 10.36 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tt -99.36 124.0 44.11 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.651 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 32.3 ttt180 -126.25 105.22 8.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.412 0.685 . . . . 0.0 109.896 -173.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 91.0 mt -88.78 134.27 33.98 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.256 0.623 . . . . 0.0 109.822 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.6 m -125.71 171.89 10.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.706 1.202 . . . . 0.0 109.158 172.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.88 123.46 49.83 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -177.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -141.84 109.34 5.63 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -171.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 53.91 -103.86 0.19 Allowed Glycine 0 CA--C 1.531 1.089 0 O-C-N 123.976 0.797 . . . . 0.0 113.852 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -109.13 -9.12 15.06 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.608 1.163 . . . . 0.0 110.669 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.84 -163.74 13.28 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.064 -171.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.4 m -146.12 126.54 14.05 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.482 1.113 . . . . 0.0 109.225 -172.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 27' ' ' ARG . 44.7 tp -86.81 129.04 35.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.464 HD21 HD11 ' A' ' 133' ' ' LEU . 8.6 tt -108.67 108.81 19.81 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.651 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 32.2 mt-10 -107.12 105.63 15.72 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.22 103.58 12.01 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.569 0.748 . . . . 0.0 109.935 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.592 ' HG2' HG13 ' A' ' 25' ' ' ILE . 38.0 mt-10 -100.3 115.1 29.14 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 173.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -107.85 113.25 26.33 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.18 117.62 33.08 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.91 0.884 . . . . 0.0 111.598 -168.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.7 t -143.6 155.83 44.4 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.663 0.785 . . . . 0.0 110.694 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 p -79.8 -8.38 59.24 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.188 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.2 m -98.62 117.68 33.61 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.652 0.781 . . . . 0.0 110.67 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.39 -37.05 85.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.578 0.751 . . . . 0.0 111.774 -178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -60.54 -54.74 41.85 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.694 173.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.438 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 26.8 ttt -49.63 -36.81 25.73 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 124.121 0.888 . . . . 0.0 113.026 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.428 HD23 HG21 ' A' ' 24' ' ' ILE . 63.6 mt -60.64 -47.92 84.1 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.916 0.486 . . . . 0.0 111.528 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 127' ' ' VAL . 46.9 t -62.48 -55.2 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 123.505 0.503 . . . . 0.0 109.796 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -43.61 -62.42 1.1 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.559 1.943 . . . . 0.0 113.038 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.2 m -66.52 -33.27 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 122.815 0.446 . . . . 0.0 110.575 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.82 -37.23 90.08 Favored Glycine 0 C--N 1.35 1.349 0 O-C-N 123.723 0.639 . . . . 0.0 112.136 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 123' ' ' VAL . 89.8 t -74.28 -45.7 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.167 0.587 . . . . 0.0 109.648 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.99 -61.25 7.65 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.833 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 20.0 m95 -51.76 -36.99 49.42 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -57.49 -44.18 84.72 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 120.016 1.28 . . . . 0.0 111.21 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 88.5 mtp -64.14 -46.89 82.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 174.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.414 ' HB2' ' HE3' ' A' ' 50' ' ' TRP . . . -68.12 -22.98 64.86 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.667 1.187 . . . . 0.0 112.76 -176.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.464 HD11 HD21 ' A' ' 110' ' ' LEU . 2.7 mm? -86.58 -30.77 21.6 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.6 -37.83 55.8 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.681 0.792 . . . . 0.0 109.637 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -68.48 -46.28 70.14 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.266 0.626 . . . . 0.0 109.735 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.33 -24.24 66.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 122.972 0.509 . . . . 0.0 110.104 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -68.96 -54.8 12.51 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 8.6 mtm -68.52 -33.93 74.99 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.306 0.642 . . . . 0.0 111.332 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -62.62 -55.45 26.95 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.954 0.902 . . . . 0.0 110.686 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.0 tt -72.7 -26.39 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.936 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 . . . . . 0 CA--C 1.538 0.482 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.952 178.315 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.535 0.207 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 46.8 t -62.0 -34.27 75.87 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.113 0.565 . . . . 0.0 111.102 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -72.32 -56.68 5.09 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.094 0.558 . . . . 0.0 110.024 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -48.85 -53.34 19.77 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.381 1.072 . . . . 0.0 112.299 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -70.84 -45.36 64.64 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.226 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -59.07 -58.87 12.23 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 124.148 0.905 . . . . 0.0 114.246 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -54.28 -43.73 71.3 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.152 0.981 . . . . 0.0 111.682 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.01 -38.24 87.9 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 123.675 0.609 . . . . 0.0 111.389 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -78.11 -24.47 47.47 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 119.201 -0.428 . . . . 0.0 112.03 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.91 -42.4 73.39 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -71.34 -26.53 62.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.258 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.497 HD21 ' HG ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -82.65 -49.23 10.03 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.597 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.44 -29.51 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.459 0.704 . . . . 0.0 112.533 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -64.89 -6.99 9.57 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 122.822 0.449 . . . . 0.0 111.321 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.353 0.721 0 C-N-CA 126.993 2.117 . . . . 0.0 112.737 164.43 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.473 ' HG1' ' HG2' ' A' ' 28' ' ' GLN . 55.5 m -115.27 108.94 17.22 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 124.856 1.262 . . . . 0.0 109.815 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -109.72 124.67 51.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.362 1.065 . . . . 0.0 109.268 -176.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -81.88 154.29 25.91 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.511 0.725 . . . . 0.0 110.895 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.519 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -160.06 172.83 16.8 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.31 0.644 . . . . 0.0 109.963 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.5 141.68 25.04 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.887 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.42 -151.52 5.44 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 32.3 ptt180 -144.66 170.81 15.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.353 0.661 . . . . 0.0 109.377 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -163.4 115.32 1.46 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.6 m -86.23 100.94 12.6 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.7 pt -93.88 168.76 11.15 Favored Pre-proline 0 CA--C 1.557 1.225 0 C-N-CA 124.738 1.215 . . . . 0.0 108.682 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.36 -17.49 27.02 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.865 2.376 . . . . 0.0 114.045 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.13 -0.33 56.95 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.95 178.31 15.26 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 118.214 0.461 . . . . 0.0 112.271 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.48 95.29 1.77 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-O 121.737 0.78 . . . . 0.0 109.984 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.65 166.32 19.26 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.29 174.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 20.2 ttm180 -118.42 161.1 20.54 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.436 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 79.7 p -134.11 144.16 48.42 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -173.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.4 pt -93.08 150.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 166.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 3.1 mp -129.22 116.03 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.8 mt -109.84 108.35 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 7' ' ' THR . 99.9 mtt180 -95.03 132.77 39.54 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.642 0.777 . . . . 0.0 109.919 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.473 ' HG2' ' HG1' ' A' ' 7' ' ' THR . 73.8 mt-30 -143.41 140.19 30.31 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.316 1.01 . . . . 0.0 108.875 172.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -110.77 115.0 28.8 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -87.8 137.36 32.4 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.181 1.393 . . . . 0.0 110.008 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -78.52 38.07 0.3 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 123.936 0.773 . . . . 0.0 111.881 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.43 156.0 53.51 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 123.892 0.877 . . . . 0.0 108.771 -171.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.05 168.39 22.06 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 122.878 2.386 . . . . 0.0 113.695 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 80' ' ' PRO . 89.0 t -67.47 -47.59 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.217 -172.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.34 -37.76 84.48 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.069 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -66.52 -63.49 1.06 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.99 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.1 t -51.62 -34.26 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.739 1.216 . . . . 0.0 111.71 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.409 ' HE3' HD13 ' A' ' 101' ' ' LEU . 51.0 t-105 -58.46 -56.24 24.62 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.453 0.701 . . . . 0.0 110.198 176.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.9 m -57.17 -33.36 67.36 Favored 'General case' 0 CA--C 1.555 1.154 0 O-C-N 124.403 1.064 . . . . 0.0 111.396 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' A' ' 136' ' ' LEU . . . -68.15 -38.26 81.95 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 174.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.1 m -74.63 -27.76 60.58 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.232 0.613 . . . . 0.0 112.034 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.9 p -99.0 -46.19 5.69 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.196 0.598 . . . . 0.0 112.244 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.84 119.13 51.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 123.221 0.609 . . . . 0.0 110.904 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.68 -29.07 87.63 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 123.621 2.88 . . . . 0.0 112.899 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.4 -52.65 57.12 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.275 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -65.02 -31.0 72.02 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.733 173.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.509 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 40.5 mt -58.27 -41.6 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.255 0.622 . . . . 0.0 110.926 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -57.19 -29.13 63.43 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.994 0.918 . . . . 0.0 112.337 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -75.76 -5.35 45.36 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.667 0.787 . . . . 0.0 112.807 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.509 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 59.0 p-90 -149.2 4.31 0.61 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -165.83 -172.74 2.45 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -166.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.502 HD12 HD12 ' A' ' 66' ' ' LEU . 59.4 mt -86.61 140.86 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.076 0.95 . . . . 0.0 110.34 -171.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.68 110.93 3.61 Favored Pre-proline 0 N--CA 1.48 1.051 0 O-C-N 125.021 1.451 . . . . 0.0 110.225 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -90.88 179.61 1.69 Allowed 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.654 2.236 . . . . 0.0 112.799 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -152.39 157.55 41.42 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.101 0.96 . . . . 0.0 109.418 173.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.82 -166.94 25.51 Favored Glycine 0 N--CA 1.462 0.433 0 CA-C-N 116.623 -0.262 . . . . 0.0 113.608 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -78.45 -35.66 46.51 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.17 0.988 . . . . 0.0 110.334 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.7 mt 67.58 10.98 8.14 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.239 1.416 . . . . 0.0 113.453 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -102.34 178.15 4.67 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.721 0.809 . . . . 0.0 110.637 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.48 99.81 0.79 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.577 1.151 . . . . 0.0 109.902 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.55 -11.79 58.08 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.185 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.76 -169.32 30.23 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 169.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 34.7 p30 -128.13 155.2 44.82 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.868 -0.784 . . . . 0.0 112.222 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -119.7 161.77 20.14 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 165.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -163.24 112.85 1.33 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.502 HD12 HD12 ' A' ' 52' ' ' ILE . 72.5 mt -66.42 164.0 17.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.378 0.671 . . . . 0.0 110.935 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -81.3 112.68 18.83 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 40.94 54.97 3.5 Favored Glycine 0 CA--C 1.539 1.581 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -143.97 -76.78 0.23 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 117.197 0.499 . . . . 0.0 110.31 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.36 160.93 40.79 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.287 0.635 . . . . 0.0 109.749 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 35.0 t -127.3 158.04 38.28 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.35 -171.28 31.39 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.222 -0.513 . . . . 0.0 114.043 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 4.4 m-20 -137.94 161.99 35.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.01 0.924 . . . . 0.0 109.621 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -92.87 98.87 8.87 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.412 HD12 HG22 ' A' ' 84' ' ' THR . 97.4 mt -67.69 -46.38 72.43 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.095 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -161.31 115.11 1.97 Allowed 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.687 0.795 . . . . 0.0 109.965 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.3 p -98.12 114.91 27.25 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 164.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -127.12 84.93 62.21 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -170.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.14 144.66 21.18 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.935 2.424 . . . . 0.0 113.182 -171.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.504 ' HB2' HG11 ' A' ' 34' ' ' VAL . 22.2 Cg_endo -97.78 23.95 22.54 Favored 'Cis proline' 0 C--N 1.374 1.907 0 C-N-CA 124.617 -0.993 . . . . 0.0 112.318 -8.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.68 ' HG2' ' HG3' ' A' ' 82' ' ' ARG . 60.7 ttt180 -73.09 -73.49 0.2 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.852 0.861 . . . . 0.0 111.167 -171.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.68 ' HG3' ' HG2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -155.36 158.7 39.1 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.424 0.69 . . . . 0.0 111.483 -178.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -130.27 129.25 43.04 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.422 ' HG1' ' HG2' ' A' ' 98' ' ' GLU . 19.4 m -103.08 135.7 44.25 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.223 1.409 . . . . 0.0 108.179 172.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.3 pt -131.19 163.4 37.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 124.122 0.969 . . . . 0.0 109.648 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.5 t -101.42 148.34 25.29 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.651 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 24.7 t-105 -140.65 92.93 2.55 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 109.769 -172.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.8 106.75 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.466 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 58.2 t80 -90.05 163.31 14.95 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 169.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.67 118.73 6.95 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.785 0.434 . . . . 0.0 111.027 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.88 25.13 75.48 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.833 0.708 . . . . 0.0 113.287 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 73.8 mmtt -132.43 147.48 65.85 Favored Pre-proline 0 N--CA 1.488 1.438 0 C-N-CA 123.975 0.91 . . . . 0.0 110.003 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.48 -178.18 3.83 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.69 2.26 . . . . 0.0 112.854 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.91 87.74 0.55 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.48 0.712 . . . . 0.0 109.554 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.651 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.4 m -71.86 136.54 47.0 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.699 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -102.45 108.93 20.42 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -172.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.0 t -108.31 136.24 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.111 0.964 . . . . 0.0 108.662 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.422 ' HG2' ' HG1' ' A' ' 84' ' ' THR . 29.6 mt-10 -138.05 115.93 11.54 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.006 0.922 . . . . 0.0 109.433 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.431 ' HB2' HD12 ' A' ' 112' ' ' LEU . 8.2 tt -105.31 130.56 53.41 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.528 ' HD2' ' HB3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -131.08 143.62 50.81 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.023 0.44 . . . . 0.0 110.392 -177.18 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.481 ' HB3' HG13 ' A' ' 34' ' ' VAL . 97.9 mt -132.43 123.7 27.2 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 125.247 1.419 . . . . 0.0 109.436 -174.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 t -151.97 138.43 18.58 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.872 0.869 . . . . 0.0 108.972 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.08 146.0 44.55 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.04 0.936 . . . . 0.0 111.783 -173.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -153.15 118.04 5.08 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.79 1.236 . . . . 0.0 107.924 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 64.11 -111.84 4.49 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 123.427 0.454 . . . . 0.0 113.003 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -111.74 5.66 19.29 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.035 0.534 . . . . 0.0 110.188 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.39 -153.97 8.87 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.087 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.7 m -147.04 134.39 20.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.122 0.969 . . . . 0.0 109.568 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 42.4 tp -80.77 117.42 21.42 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.7 tt -101.23 106.13 17.31 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 164.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 100' ' ' ARG . 35.6 tt0 -121.95 109.72 14.95 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 99' ' ' LEU . 52.4 tp -107.17 114.35 28.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.551 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.436 ' HG3' ' HB2' ' A' ' 23' ' ' SER . 34.6 tt0 -94.06 127.2 39.73 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.249 0.62 . . . . 0.0 109.377 168.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -114.64 116.27 28.46 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 168.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.5 120.16 41.65 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.59 0.756 . . . . 0.0 110.291 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.3 t -139.45 154.82 47.83 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.258 0.623 . . . . 0.0 110.114 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.1 m -71.9 -16.29 62.12 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.458 1.103 . . . . 0.0 111.311 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 121' ' ' MET . 17.6 m -100.33 117.84 35.36 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.843 0.857 . . . . 0.0 110.201 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.617 ' HA ' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -68.48 -29.25 67.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.806 0.842 . . . . 0.0 112.088 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -67.34 -54.41 20.88 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.532 0.52 . . . . 0.0 110.71 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.442 ' HB3' ' HB2' ' A' ' 118' ' ' SER . 28.1 ttt -50.13 -31.94 14.71 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.842 172.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.617 HD11 ' HA ' ' A' ' 119' ' ' GLU . 50.3 mt -65.44 -42.67 92.14 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.952 0.501 . . . . 0.0 111.96 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 127' ' ' VAL . 45.8 t -64.26 -51.05 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -44.31 -57.82 3.27 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.526 1.53 . . . . 0.0 112.754 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.7 m -75.68 -20.03 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 123.848 0.718 . . . . 0.0 110.726 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.72 -39.81 96.95 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 171.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 123' ' ' VAL . 48.4 t -74.73 -53.42 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.36 -61.45 7.21 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 114.537 -1.211 . . . . 0.0 114.207 -176.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -63.99 -39.49 94.24 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 118.405 -0.807 . . . . 0.0 112.922 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -58.57 -45.86 88.12 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 119.549 1.068 . . . . 0.0 110.375 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 40.8 mtm -67.08 -42.82 84.0 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.95 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.37 -61.16 2.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.63 0.772 . . . . 0.0 111.501 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.98 -33.67 69.14 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.205 0.602 . . . . 0.0 112.617 174.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.96 -37.33 82.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 118.321 0.51 . . . . 0.0 110.695 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -66.91 -40.13 87.58 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.985 0.514 . . . . 0.0 109.773 171.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.467 HD12 ' CD1' ' A' ' 50' ' ' TRP . 41.6 tp -64.46 -23.08 67.16 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.06 0.544 . . . . 0.0 110.52 175.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.38 -46.84 11.51 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 79.6 mtp -65.53 -42.17 92.28 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.85 0.86 . . . . 0.0 110.717 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -57.4 -55.55 33.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.06 0.944 . . . . 0.0 111.445 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 44.2 mt -71.35 -28.21 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 123.326 0.391 . . . . 0.0 110.367 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 . . . . . 0 CA--C 1.563 1.464 0 C-N-CA 122.936 0.495 . . . . 0.0 110.589 174.003 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 99.9 mt . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.8 t -64.5 -25.0 67.8 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.358 0.663 . . . . 0.0 112.204 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -73.04 -47.68 42.71 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -58.48 -49.6 76.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.533 0.733 . . . . 0.0 111.658 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -74.67 -48.39 26.45 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.648 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.46 -52.23 29.21 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 123.791 0.682 . . . . 0.0 114.225 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.08 -31.23 67.56 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.518 0.727 . . . . 0.0 112.111 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.74 -56.91 7.44 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.926 0.491 . . . . 0.0 110.54 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -67.71 -22.19 65.27 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.522 0.729 . . . . 0.0 111.829 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.45 84.78 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.999 0.428 . . . . 0.0 110.077 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -75.97 -29.12 58.14 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.11 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 57.7 mt -74.66 -52.3 12.04 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.781 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.26 -29.15 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 122.51 0.324 . . . . 0.0 111.791 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -69.16 -6.82 31.1 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.286 0.634 . . . . 0.0 112.615 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 125.029 1.331 . . . . 0.0 109.433 174.63 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 110.939 -0.023 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -93.84 119.75 33.19 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 3.5 tm-20 -114.87 127.87 55.96 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -106.39 156.52 18.44 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.23 0.538 . . . . 0.0 112.305 -173.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -161.91 -175.41 4.64 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.693 -171.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 mt -140.82 167.34 22.42 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.431 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.83 -162.59 16.19 Favored Glycine 0 C--O 1.246 0.888 0 CA-C-N 113.395 -1.729 . . . . 0.0 109.712 168.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.42 160.68 35.69 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 168.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -162.35 117.54 1.89 Allowed 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -173.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 92.3 m -87.58 98.0 11.17 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.2 pt -78.66 166.08 45.1 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 125.475 1.51 . . . . 0.0 110.537 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.27 -27.71 5.01 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 123.748 2.965 . . . . 0.0 115.038 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.71 -49.58 45.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.013 0.525 . . . . 0.0 110.839 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.99 -160.11 32.15 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-O 119.711 -0.494 . . . . 0.0 112.023 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.66 105.09 0.74 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.204 0.602 . . . . 0.0 111.104 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -107.96 154.41 21.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.935 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' A' ' 23' ' ' SER . 7.0 tpp180 -83.95 155.66 22.71 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 165.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.454 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 77.0 p -132.41 135.14 45.9 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 110.919 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 pp -93.71 142.15 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 170.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -123.61 118.17 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -176.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.0 mt -111.27 106.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.585 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 66.9 mtt180 -92.09 147.66 22.78 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -156.42 130.64 8.64 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.86 106.85 19.16 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.544 1.138 . . . . 0.0 108.175 -172.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.71 134.0 34.73 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.691 0.797 . . . . 0.0 110.559 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.36 46.88 0.87 Allowed 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 122.039 0.923 . . . . 0.0 110.236 170.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.27 154.79 57.75 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 123.928 0.891 . . . . 0.0 109.359 -171.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.26 165.74 31.47 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.579 2.186 . . . . 0.0 113.188 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.409 HG11 ' HB2' ' A' ' 80' ' ' PRO . 88.7 t -73.21 -40.77 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.564 -172.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.18 -47.95 71.47 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.218 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -65.01 -64.47 0.86 Allowed 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.329 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.3 t -50.01 -35.22 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.214 1.006 . . . . 0.0 111.667 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -58.62 -57.73 11.71 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.847 0.859 . . . . 0.0 110.209 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 m -61.22 -35.75 78.06 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.392 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.44 ' HB2' HD11 ' A' ' 136' ' ' LEU . . . -62.57 -33.62 75.33 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 122.05 -0.406 . . . . 0.0 112.082 172.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.425 ' HA ' ' HZ2' ' A' ' 50' ' ' TRP . 83.1 m -85.41 -18.28 34.13 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.663 0.785 . . . . 0.0 113.067 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 p -113.05 -40.21 4.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.18 111.33 5.25 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 123.657 0.783 . . . . 0.0 110.829 175.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 66.7 Cg_exo -54.13 -33.61 74.93 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 123.703 2.936 . . . . 0.0 113.868 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -61.04 -49.83 75.8 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -65.68 -35.37 80.57 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.516 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.505 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 87.9 mt -66.51 -41.46 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.556 0.743 . . . . 0.0 111.911 -174.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 27.5 p30 -60.21 -15.38 23.83 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -78.88 -45.78 19.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.828 0.851 . . . . 0.0 111.562 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.505 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 67.8 p-90 -108.59 8.17 27.01 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.258 0.623 . . . . 0.0 112.603 -172.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -174.47 173.83 2.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.319 0.648 . . . . 0.0 109.39 -168.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.1 mt -86.46 123.08 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 32.3 tt0 -63.32 130.35 94.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.793 1.637 . . . . 0.0 112.086 -174.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.574 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 83.0 Cg_endo -81.58 129.28 6.42 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.525 2.15 . . . . 0.0 112.154 175.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -93.85 160.36 14.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.873 1.269 . . . . 0.0 109.45 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.46 -168.79 15.63 Favored Glycine 0 N--CA 1.47 0.964 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.47 -36.79 68.56 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.212 0.605 . . . . 0.0 110.603 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.8 mt 71.9 -10.17 0.89 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.241 1.416 . . . . 0.0 114.095 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -86.39 171.03 11.46 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.535 0.734 . . . . 0.0 109.891 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.708 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 41.2 tt0 -67.82 102.22 1.2 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.248 0.619 . . . . 0.0 110.489 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.54 -15.07 17.56 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.85 -160.43 36.35 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -143.04 155.15 44.57 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.805 1.303 . . . . 0.0 111.188 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.574 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 17.1 p90 -106.02 163.35 12.83 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.464 166.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.94 108.05 0.86 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.218 1.007 . . . . 0.0 109.919 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.1 mt -69.29 170.67 9.82 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.449 0.7 . . . . 0.0 109.65 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -76.51 -17.95 58.99 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 122.084 -0.385 . . . . 0.0 111.805 -169.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.79 47.49 0.04 OUTLIER Glycine 0 N--CA 1.467 0.728 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -128.0 -62.3 1.06 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.156 0.982 . . . . 0.0 108.894 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.11 161.34 36.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.977 0.511 . . . . 0.0 111.205 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.6 p -152.81 130.74 11.75 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 86' ' ' SER . . . -161.19 174.61 37.79 Favored Glycine 0 C--N 1.344 1.005 0 C-N-CA 121.663 -0.304 . . . . 0.0 113.449 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -86.55 159.22 19.33 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.216 1.007 . . . . 0.0 111.05 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 mm -93.22 98.74 8.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.405 HD13 HG23 ' A' ' 84' ' ' THR . 87.0 mt -63.81 -51.78 63.2 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.794 0.838 . . . . 0.0 111.123 -174.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -160.78 152.45 19.58 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.661 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.708 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 26.2 p -148.13 138.25 22.65 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.57 0.748 . . . . 0.0 109.209 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -138.56 93.58 10.99 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.87 141.49 13.4 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.94 2.426 . . . . 0.0 112.703 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.409 ' HB2' HG11 ' A' ' 34' ' ' VAL . 18.3 Cg_endo -95.81 25.13 22.64 Favored 'Cis proline' 0 C--N 1.378 2.131 0 CA-C-N 119.537 0.87 . . . . 0.0 112.523 -5.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -78.99 -75.84 0.22 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.427 0.691 . . . . 0.0 111.673 -171.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -142.37 139.53 31.75 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 118.549 0.613 . . . . 0.0 112.39 -169.128 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.6 tp -124.48 124.41 42.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.939 1.696 . . . . 0.0 108.404 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.405 HG23 HD13 ' A' ' 75' ' ' LEU . 61.7 m -113.41 114.05 26.06 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.725 0.81 . . . . 0.0 109.917 175.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.0 pt -110.4 168.78 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 124.483 1.113 . . . . 0.0 110.431 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.447 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 14.4 m -103.51 136.39 43.33 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -175.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 44.6 t-105 -128.5 104.58 7.77 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.612 0.642 . . . . 0.0 110.402 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.29 103.67 15.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.531 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 47.2 t80 -90.22 163.66 14.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.751 0.82 . . . . 0.0 109.886 -177.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -52.52 106.49 0.16 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.864 1.265 . . . . 0.0 111.774 177.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.74 2.45 51.04 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 114.433 0.533 . . . . 0.0 114.433 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 41.5 mmtm -101.09 159.47 29.4 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.145 0.978 . . . . 0.0 109.262 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.95 -176.94 2.86 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.119 1.879 . . . . 0.0 112.113 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.58 144.75 56.24 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.178 174.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.471 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 30.0 p -146.99 156.34 42.96 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.121 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -116.23 117.58 30.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.487 0.715 . . . . 0.0 109.103 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 54.2 t -94.31 130.14 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 36.2 mm-40 -116.72 111.93 20.48 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.131 1.772 . . . . 0.0 107.182 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.464 HD11 HD11 ' A' ' 112' ' ' LEU . 59.6 tp -107.33 114.0 27.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -119.65 137.85 53.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.138 0.975 . . . . 0.0 109.601 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 67.9 mt -127.7 142.8 51.23 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.562 1.145 . . . . 0.0 109.221 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 t -137.03 170.77 15.55 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.956 1.303 . . . . 0.0 108.968 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.69 128.01 56.28 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -141.77 106.32 4.86 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.47 -103.9 0.36 Allowed Glycine 0 CA--C 1.534 1.277 0 CA-C-N 117.845 0.293 . . . . 0.0 113.342 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -115.71 2.27 13.66 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.565 0.746 . . . . 0.0 111.069 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -130.13 -173.58 13.44 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 123.891 0.758 . . . . 0.0 111.911 -174.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 89.0 m -121.33 148.22 44.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.848 0.859 . . . . 0.0 110.424 -176.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.9 tp -103.22 134.58 46.39 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 166.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 tt -119.74 109.73 15.97 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.585 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 31.7 mt-10 -109.54 105.57 14.94 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.495 HD13 HD21 ' A' ' 133' ' ' LEU . 8.6 tt -105.4 107.4 18.37 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.454 ' HG3' ' HB2' ' A' ' 23' ' ' SER . 32.8 tt0 -92.4 128.18 38.15 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.898 0.879 . . . . 0.0 108.973 173.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -113.77 118.42 34.24 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 171.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 14' ' ' ARG . . . -106.12 114.86 29.24 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.083 0.953 . . . . 0.0 110.889 -173.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.599 HG21 ' HG3' ' A' ' 121' ' ' MET . 4.4 t -150.26 150.67 31.86 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.596 0.758 . . . . 0.0 110.921 176.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 74.1 p -73.23 -42.68 62.32 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.922 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.1 m -76.62 131.82 39.09 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.472 0.709 . . . . 0.0 112.384 -165.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -60.78 -50.66 72.56 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.78 1.232 . . . . 0.0 113.243 -170.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -62.49 -53.35 56.11 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.599 ' HG3' HG21 ' A' ' 116' ' ' THR . 13.7 tpt -44.14 -38.94 3.97 Favored 'General case' 0 CA--C 1.56 1.351 0 O-C-N 124.873 1.358 . . . . 0.0 112.711 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.562 ' HG ' HG22 ' A' ' 116' ' ' THR . 13.4 mt -66.54 -47.07 74.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.541 1.136 . . . . 0.0 112.733 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.5 t -64.16 -51.45 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -46.94 -47.5 21.69 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.647 1.979 . . . . 0.0 113.713 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 m -83.39 -25.77 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.479 0.312 . . . . 0.0 111.491 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.61 -39.73 98.26 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.81 -51.15 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.369 1.068 . . . . 0.0 108.99 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.64 -61.75 6.48 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 114.545 -1.207 . . . . 0.0 114.132 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -63.74 -44.32 93.87 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 118.69 -0.671 . . . . 0.0 112.439 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.21 -39.87 91.85 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.344 0.974 . . . . 0.0 110.944 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.9 ttm -70.99 -37.76 72.7 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.738 0.815 . . . . 0.0 110.48 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.66 -59.5 4.19 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.502 0.721 . . . . 0.0 111.202 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.495 HD21 HD13 ' A' ' 112' ' ' LEU . 3.6 mm? -58.5 -29.16 66.05 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.321 0.648 . . . . 0.0 112.061 173.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.01 -38.5 91.28 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 118.395 0.543 . . . . 0.0 110.607 174.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -64.76 -31.2 72.31 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.178 0.591 . . . . 0.0 110.663 171.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 40' ' ' ALA . 53.2 tp -66.76 -42.15 86.59 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.855 0.462 . . . . 0.0 110.074 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -47.48 -45.99 22.91 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.304 0.378 . . . . 0.0 113.741 165.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 73.4 mtp -74.15 -30.13 62.13 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 123.589 0.756 . . . . 0.0 111.485 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -71.43 -54.92 9.04 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.195 0.998 . . . . 0.0 110.122 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 40.6 mt -64.14 -31.38 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.416 1.086 . . . . 0.0 110.972 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 . . . . . 0 CA--C 1.554 1.132 0 C-N-CA 123.611 0.765 . . . . 0.0 111.243 175.496 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 61.9 mt . . . . . 0 CA--C 1.545 0.759 0 CA-C-O 119.8 -0.143 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 31.1 t -51.62 -42.14 61.78 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.942 0.897 . . . . 0.0 112.471 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -89.47 -29.32 19.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -61.79 -50.26 73.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.666 1.587 . . . . 0.0 110.408 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -60.69 -53.09 61.66 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.42 174.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.66 -50.0 38.39 Favored Glycine 0 C--N 1.351 1.407 0 O-C-N 124.545 1.153 . . . . 0.0 115.204 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.07 -32.96 69.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.033 0.533 . . . . 0.0 111.345 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.38 68.77 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.972 0.509 . . . . 0.0 111.133 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -70.72 -27.21 63.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.25 0.62 . . . . 0.0 111.599 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.47 73.71 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 123.506 0.504 . . . . 0.0 110.155 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -70.6 -33.83 71.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.4 0.28 . . . . 0.0 110.499 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 63.1 mt -73.05 -62.12 1.58 Allowed 'General case' 0 C--N 1.349 0.56 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.595 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.466 HG21 ' HB3' ' A' ' 122' ' ' LEU . 4.4 p -73.43 -22.17 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -166.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -87.14 4.89 40.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.273 0.629 . . . . 0.0 111.188 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 123.672 0.789 . . . . 0.0 111.299 -179.59 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.592 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 121.234 0.54 . . . . 0.0 111.454 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 m -81.94 117.62 22.32 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.743 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 35.6 mt-10 -118.94 110.48 17.19 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.788 0.835 . . . . 0.0 108.847 -175.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -68.62 147.67 51.57 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.511 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -157.94 161.65 38.2 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.749 0.419 . . . . 0.0 110.48 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -144.64 143.85 30.96 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.63 171.47 33.65 Favored Glycine 0 C--O 1.238 0.348 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 173.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -94.68 160.41 14.63 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.28 122.06 2.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -169.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.3 m -86.36 129.91 34.69 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.452 HD11 HG23 ' A' ' 117' ' ' THR . 48.9 pt -125.28 165.43 26.25 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.473 1.109 . . . . 0.0 109.005 -174.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.5 -33.35 38.11 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.054 2.503 . . . . 0.0 114.735 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.17 -31.61 67.87 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.459 0.704 . . . . 0.0 111.935 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.24 -164.66 31.04 Favored Glycine 0 N--CA 1.47 0.9 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -74.86 138.42 42.47 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.033 1.417 . . . . 0.0 109.051 172.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.83 168.17 20.41 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.006 1.322 . . . . 0.0 109.871 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.436 HH21 ' HB2' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -104.59 166.64 10.26 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 168.443 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 23.6 p -140.1 130.21 24.99 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.767 -174.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.547 HG12 HG23 ' A' ' 125' ' ' VAL . 2.6 pp -86.92 135.95 24.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 168.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 4.8 mp -124.98 115.48 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.451 HG12 ' CZ2' ' A' ' 174' ' ' TRP . 25.2 mt -105.68 107.17 22.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.565 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 54.0 mtp180 -95.48 162.0 13.83 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.642 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 5.1 tt0 -168.72 120.9 0.79 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 125.029 1.456 . . . . 0.0 111.039 -178.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.592 ' HB2' ' HB2' ' A' ' 6' ' ' ALA . 2.5 mpt_? -88.95 103.57 16.16 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 170.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.443 ' HE1' ' HA2' ' A' ' 137' ' ' GLY . 77.6 m-85 -84.08 141.37 31.17 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.661 170.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.36 -11.47 59.93 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 123.69 0.619 . . . . 0.0 111.346 174.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.28 152.61 83.96 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 122.551 0.34 . . . . 0.0 110.774 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 28.0 Cg_endo -62.61 148.64 93.08 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.818 2.346 . . . . 0.0 112.576 171.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 108' ' ' THR . 68.6 t -47.45 -40.92 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 125.062 1.345 . . . . 0.0 111.981 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -50.04 -50.49 47.48 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.833 1.333 . . . . 0.0 111.111 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 36.8 mt-10 -71.29 -29.79 65.47 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.264 -177.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.6 t -74.56 -40.01 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.465 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -74.52 -28.24 60.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.671 0.788 . . . . 0.0 109.825 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.406 ' HB3' ' NH1' ' A' ' 46' ' ' ARG . 74.1 m -69.14 -44.09 73.04 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.305 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -44.69 93.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.821 0.848 . . . . 0.0 111.51 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 72.7 m -68.36 -33.83 74.98 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.1 p -111.31 -34.72 6.06 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -169.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 47' ' ' ILE . 32.6 t70 -71.02 114.9 31.1 Favored Pre-proline 0 N--CA 1.486 1.354 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.777 -178.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -52.07 -34.78 59.11 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.568 2.845 . . . . 0.0 113.8 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -72.03 -20.61 61.67 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.318 1.011 . . . . 0.0 110.604 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.406 ' NH1' ' HB3' ' A' ' 39' ' ' SER . 72.8 mtt85 -94.81 -25.98 16.41 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.331 0.652 . . . . 0.0 111.7 172.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 43' ' ' ASP . 82.2 mt -76.61 -31.5 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -73.43 -4.29 32.72 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.263 0.625 . . . . 0.0 112.318 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.34 -30.75 13.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.403 0.681 . . . . 0.0 110.701 -173.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -119.09 -20.15 8.15 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.125 0.57 . . . . 0.0 111.875 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -127.75 -102.25 0.34 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.272 0.629 . . . . 0.0 109.803 -175.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.459 HD13 HD13 ' A' ' 66' ' ' LEU . 89.5 mt -149.42 142.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 124.157 0.983 . . . . 0.0 108.876 -170.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.06 108.06 1.34 Allowed Pre-proline 0 CA--C 1.561 1.385 0 O-C-N 124.657 1.223 . . . . 0.0 110.753 172.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -96.03 139.37 0.77 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.068 2.512 . . . . 0.0 113.463 -177.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -129.98 141.77 50.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.702 1.201 . . . . 0.0 109.417 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.59 -163.12 35.51 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.49 ' HB3' ' H ' ' A' ' 63' ' ' ASN . 29.3 t70 -75.09 -41.03 59.59 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.1 mt 70.81 -10.01 0.77 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.572 1.549 . . . . 0.0 113.708 170.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -93.59 165.91 12.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.883 0.873 . . . . 0.0 110.064 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.519 ' HG2' ' HA ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -64.78 123.46 19.42 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.815 0.846 . . . . 0.0 109.861 -176.394 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.39 7.14 69.93 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.646 -0.707 . . . . 0.0 112.991 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.66 -147.78 20.5 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 112.149 -0.38 . . . . 0.0 112.149 178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.619 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 26.2 p-10 -139.88 169.88 16.9 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.643 0.777 . . . . 0.0 110.969 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -142.69 154.64 44.5 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.65 142.37 25.58 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.891 0.877 . . . . 0.0 109.824 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.459 HD13 HD13 ' A' ' 52' ' ' ILE . 90.4 mt -94.74 -101.93 0.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.309 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -155.76 -56.68 0.09 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.82 0.848 . . . . 0.0 108.928 174.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.96 43.07 1.16 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.777 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -135.2 -74.04 0.46 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.024 0.93 . . . . 0.0 109.358 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.63 154.31 32.78 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 121.763 0.792 . . . . 0.0 112.713 -169.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.9 m -131.2 154.19 48.67 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 113.153 -1.84 . . . . 0.0 108.182 168.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 86' ' ' SER . . . -169.32 -156.88 11.14 Favored Glycine 0 CA--C 1.504 -0.655 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.073 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.619 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 24.8 m-20 -121.88 171.54 8.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.323 0.649 . . . . 0.0 110.462 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.6 mm -103.41 106.65 20.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.8 mt -77.56 -41.03 40.44 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 123.502 0.501 . . . . 0.0 110.212 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.519 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 36.9 ttm180 -175.77 113.96 0.13 Allowed 'General case' 0 C--N 1.363 1.162 0 O-C-N 123.955 0.784 . . . . 0.0 111.508 168.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.3 p -107.05 103.44 12.85 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.529 0.732 . . . . 0.0 109.512 174.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.481 ' HG3' ' HG2' ' A' ' 76' ' ' ARG . 48.8 mt-10 -104.73 112.29 65.3 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.651 1.18 . . . . 0.0 109.517 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 6.1 Cg_exo -79.81 126.33 6.5 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.913 2.408 . . . . 0.0 112.423 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.5 Cg_endo -103.73 25.06 12.07 Favored 'Cis proline' 0 C--N 1.376 1.989 0 CA-C-N 120.421 1.186 . . . . 0.0 112.717 -8.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -61.5 -67.55 0.4 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.156 0.982 . . . . 0.0 112.02 -171.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.489 ' NH2' ' HD2' ' A' ' 76' ' ' ARG . 14.8 ptt180 -152.5 157.15 40.72 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.169 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 tt -119.93 138.18 53.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 169.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.6 m -137.31 130.17 30.38 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.452 HG13 ' HB ' ' A' ' 97' ' ' VAL . 14.1 pt -144.18 146.82 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.296 1.038 . . . . 0.0 109.677 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.436 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 24.6 p -90.86 132.89 35.63 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 171.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 24.4 t-105 -121.68 104.62 9.74 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -171.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.7 t -102.77 103.11 14.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 170.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.524 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 42.8 t80 -77.34 147.11 36.33 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.8 113.59 2.85 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.374 0.669 . . . . 0.0 111.576 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.05 6.7 86.3 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 124.191 0.932 . . . . 0.0 113.354 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 12.4 mmmm -125.98 155.07 73.74 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.519 1.128 . . . . 0.0 109.169 -172.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.1 179.16 4.09 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.635 2.223 . . . . 0.0 114.243 -174.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.62 150.09 39.78 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.253 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.507 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.4 m -140.36 156.91 46.24 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.852 0.72 . . . . 0.0 110.951 178.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -112.06 108.61 17.97 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 165.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 52.6 t -94.33 119.58 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -124.32 115.86 21.68 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.452 0.644 . . . . 0.0 110.418 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -89.78 136.36 33.08 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 57.1 mtt85 -135.42 129.87 33.94 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -177.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 46.5 mt -116.54 147.06 42.16 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.914 0.486 . . . . 0.0 110.401 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.1 t -150.79 125.27 9.54 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.512 0.725 . . . . 0.0 110.528 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.29 124.22 26.02 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 173.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.59 125.79 12.99 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 124.144 0.978 . . . . 0.0 109.051 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.81 -89.14 1.34 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 171.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -160.97 39.88 0.15 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.13 -168.09 33.12 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.395 -172.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.475 HG23 HG22 ' A' ' 34' ' ' VAL . 32.1 m -137.66 131.11 30.99 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.095 0.958 . . . . 0.0 110.498 -166.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 55.1 tp -80.98 106.47 13.01 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 160.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.414 HD22 HD12 ' A' ' 133' ' ' LEU . 7.9 tt -87.45 128.2 35.22 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 160.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 31.7 tt0 -136.4 104.68 5.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.4 131.94 43.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 33.3 tt0 -123.2 143.62 49.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.457 ' CD2' HG22 ' A' ' 125' ' ' VAL . 8.6 t60 -138.87 114.71 10.02 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.1 104.52 11.64 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.352 0.661 . . . . 0.0 111.184 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.2 t -131.49 158.71 40.16 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-O 121.499 0.666 . . . . 0.0 109.743 173.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.452 HG23 HD11 ' A' ' 16' ' ' ILE . 40.4 p -80.05 -21.46 43.42 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.052 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.8 t -82.44 113.73 20.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.928 0.491 . . . . 0.0 110.473 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.436 ' HB2' HH21 ' A' ' 22' ' ' ARG . 36.7 tt0 -65.84 -29.3 69.75 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.946 0.899 . . . . 0.0 110.297 175.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -61.45 -50.48 72.61 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.287 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.9 ttt -68.77 -30.25 68.8 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.02 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.9 mt -66.1 -44.14 85.24 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.269 0.628 . . . . 0.0 112.314 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.3 t -65.43 -45.1 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -50.82 -51.55 49.91 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.605 1.162 . . . . 0.0 112.166 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.547 HG23 HG12 ' A' ' 24' ' ' ILE . 33.4 m -79.85 -21.72 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.845 0.458 . . . . 0.0 111.439 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.32 -34.9 86.76 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 168.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.24 -53.63 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 114.415 -0.892 . . . . 0.0 110.054 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.63 86.1 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.604 -0.726 . . . . 0.0 114.281 -175.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.428 ' CD1' ' HB ' ' A' ' 125' ' ' VAL . 34.2 m95 -85.47 -36.39 20.61 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.884 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -69.9 -29.2 66.34 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.112 0.869 . . . . 0.0 110.289 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 65.5 mtm -71.81 -37.43 70.36 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.76 -35.08 79.9 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 122.538 0.335 . . . . 0.0 111.255 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.414 HD12 HD22 ' A' ' 110' ' ' LEU . 3.3 mm? -81.5 -23.38 37.37 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.77 0.828 . . . . 0.0 110.723 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.52 -51.58 41.49 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.106 172.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -71.52 -24.56 61.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.647 0.779 . . . . 0.0 111.424 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -77.94 -31.05 50.73 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.778 0.431 . . . . 0.0 109.876 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.443 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -67.76 -34.34 82.77 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.033 171.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 89.5 mmm -66.35 -49.29 67.43 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.492 0.717 . . . . 0.0 109.474 170.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -56.11 -55.6 31.05 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.972 1.309 . . . . 0.0 111.726 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 59.4 mt -78.87 -55.75 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.459 0.704 . . . . 0.0 111.028 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 . . . . . 0 CA--C 1.551 0.988 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -170.92 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.458 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 71.7 mt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.2 p -71.0 -50.44 34.24 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.353 0.408 . . . . 0.0 110.645 -173.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -57.03 -48.82 77.58 Favored 'General case' 0 CA--C 1.557 1.224 0 O-C-N 124.044 0.84 . . . . 0.0 111.062 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -44.23 -48.03 9.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.315 1.046 . . . . 0.0 112.401 171.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 15.0 mmp_? -60.24 -52.03 67.03 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.375 0.422 . . . . 0.0 111.485 178.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -72.52 -37.85 58.06 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.285 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.17 -25.5 47.24 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.166 0.586 . . . . 0.0 110.985 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.03 -53.12 28.17 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.451 ' CZ2' HG12 ' A' ' 26' ' ' ILE . 97.5 m95 -71.35 -25.65 62.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.495 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.75 -59.56 4.1 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.31 -38.53 42.04 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.779 1.232 . . . . 0.0 112.975 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 53.9 mt -66.95 -49.1 66.53 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.614 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.7 p -81.93 -30.07 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 122.95 0.5 . . . . 0.0 111.218 -165.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -57.56 -30.06 64.92 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.639 0.775 . . . . 0.0 110.925 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.477 0.876 0 C-N-CA 124.274 1.03 . . . . 0.0 112.315 179.553 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.482 ' HB1' ' HD3' ' A' ' 29' ' ' ARG . . . . . . . . 0 C--O 1.242 0.671 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 m -96.11 98.28 10.22 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.764 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.04 140.36 29.72 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.129 175.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.451 ' HG3' HD12 ' A' ' 177' ' ' LEU . 16.9 ptp180 -108.87 147.09 32.67 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 170.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.525 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . . . -159.2 -177.84 6.76 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.273 0.559 . . . . 0.0 110.736 -169.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -144.98 150.52 37.07 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.986 -176.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.38 -177.86 23.86 Favored Glycine 0 CA--C 1.507 -0.406 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 175.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 30.6 ptt180 -125.16 131.36 53.24 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 171.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -135.81 114.83 12.24 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.9 m -78.67 98.19 6.12 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.9 pt -81.16 166.9 35.76 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.674 1.59 . . . . 0.0 111.068 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -38.84 -34.42 0.43 Allowed 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 125.028 3.819 . . . . 0.0 115.198 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . . . -67.74 -56.59 8.69 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.682 0.393 . . . . 0.0 110.961 173.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.76 -157.58 30.12 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.494 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.67 105.25 1.2 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.53 0.732 . . . . 0.0 111.326 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.8 165.81 11.96 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.887 176.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 82.6 mtt-85 -105.94 168.01 9.41 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 165.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.3 p -138.5 141.95 39.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.285 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.2 pt -84.77 145.97 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 166.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 48.7 mt -129.92 107.39 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.9 mt -106.28 103.9 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.465 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 80.9 mtp180 -95.44 143.77 26.5 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 6.9 pt20 -162.65 138.84 7.41 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.2 0.937 . . . . 0.0 111.665 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HD3' ' HB1' ' A' ' 6' ' ' ALA . 7.5 mpt_? -95.72 105.94 17.99 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -76.04 132.77 40.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.594 0.757 . . . . 0.0 109.7 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -79.95 45.09 0.69 Allowed 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.132 0.968 . . . . 0.0 109.787 171.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.66 147.9 34.66 Favored Pre-proline 0 C--O 1.24 0.592 0 C-N-CA 124.102 0.961 . . . . 0.0 109.141 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.8 167.33 21.58 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.844 2.363 . . . . 0.0 112.992 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.93 -50.21 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.315 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.52 -40.01 81.73 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.224 0.953 . . . . 0.0 111.244 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.43 -63.16 1.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 123.847 0.717 . . . . 0.0 111.082 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.5 t -49.99 -41.77 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.648 1.179 . . . . 0.0 111.253 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -58.82 -55.6 33.08 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.976 0.911 . . . . 0.0 110.183 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 t -54.98 -45.34 74.98 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 124.222 0.951 . . . . 0.0 110.975 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.08 -36.28 79.23 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.673 176.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.478 ' SG ' HD21 ' A' ' 136' ' ' LEU . 74.6 m -77.69 -25.2 49.27 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.8 p -108.26 -43.02 4.46 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -168.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.96 126.04 88.0 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 123.209 0.604 . . . . 0.0 111.679 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.1 -38.2 92.51 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.325 2.683 . . . . 0.0 112.802 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -63.37 -22.12 66.69 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.252 1.021 . . . . 0.0 111.676 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.6 mtt85 -100.76 -29.76 12.09 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.804 0.841 . . . . 0.0 109.945 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.462 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 91.9 mt -71.72 -42.37 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.881 0.872 . . . . 0.0 111.642 -178.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 12.4 p30 -57.57 -22.46 44.96 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.402 ' HG2' ' CD1' ' A' ' 139' ' ' PHE . 7.1 tpm_? -68.81 -46.5 68.46 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.577 0.751 . . . . 0.0 111.989 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.462 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 65.1 p-90 -112.5 6.99 18.83 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.598 0.759 . . . . 0.0 112.685 -170.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.429 ' HB3' HG21 ' A' ' 47' ' ' ILE . 20.8 t80 -174.59 173.92 2.79 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -166.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.5 mt -84.61 126.39 40.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 33.4 tt0 -70.31 119.93 75.22 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.716 1.206 . . . . 0.0 109.917 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.572 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 89.9 Cg_endo -78.86 124.34 6.15 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.453 2.102 . . . . 0.0 112.983 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -67.41 145.84 54.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.042 1.337 . . . . 0.0 111.245 172.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.32 -164.89 13.23 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 124.0 0.812 . . . . 0.0 113.427 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HB2' ' HA3' ' A' ' 62' ' ' GLY . 34.7 m-20 -75.08 -31.07 61.13 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.709 0.804 . . . . 0.0 111.926 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.0 mt 66.95 12.12 8.76 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.007 1.323 . . . . 0.0 113.049 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -123.35 171.46 9.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.784 0.833 . . . . 0.0 111.153 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.608 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 33.1 tt0 -65.51 106.29 1.39 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.932 0.893 . . . . 0.0 111.811 -171.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.63 -27.94 8.08 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 57' ' ' ASP . . . -84.68 -175.13 50.65 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 167.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.517 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 8.2 t30 -129.48 149.45 51.25 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.266 1.026 . . . . 0.0 110.053 -170.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.572 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 20.5 p90 -109.66 154.46 22.81 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 165.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.66 119.61 1.68 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.994 0.815 . . . . 0.0 110.612 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.456 HD11 ' HB3' ' A' ' 69' ' ' ASN . 61.8 mt -87.02 166.32 15.14 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -88.88 -24.28 22.55 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.143 0.577 . . . . 0.0 109.748 -175.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.28 67.81 0.27 Allowed Glycine 0 C--N 1.342 0.867 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.052 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.456 ' HB3' HD11 ' A' ' 66' ' ' LEU . 54.3 t30 -162.59 -67.38 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.803 0.841 . . . . 0.0 109.542 170.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.02 172.49 6.47 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.796 0.438 . . . . 0.0 111.328 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.3 t -145.36 143.98 30.44 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.564 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.56 164.38 36.22 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 9.0 p-10 -94.91 168.93 10.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 117.925 0.863 . . . . 0.0 110.16 176.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.8 mp -95.75 106.02 17.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.2 mt -72.36 -53.34 12.59 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.333 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -135.18 132.15 37.6 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.681 1.193 . . . . 0.0 108.474 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.1 p -126.18 118.29 24.88 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 166.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.37 74.75 23.36 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.72 141.89 22.29 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.215 1.943 . . . . 0.0 112.785 -171.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -98.46 28.03 16.17 Favored 'Cis proline' 0 C--N 1.375 1.965 0 CA-C-N 119.269 0.775 . . . . 0.0 112.03 -5.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -79.23 -62.15 1.79 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.044 0.937 . . . . 0.0 110.696 -169.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -153.69 162.89 40.84 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.996 0.918 . . . . 0.0 110.413 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 pp -135.71 143.3 45.3 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 166.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.2 m -122.84 110.17 15.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.6 pt -105.96 173.76 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.049 1.34 . . . . 0.0 110.599 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.7 p -109.57 168.54 9.32 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.557 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 34.0 t-105 -156.62 106.07 2.28 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -172.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.2 t -106.89 112.95 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 62.8 t80 -100.81 162.24 13.05 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 125.029 1.332 . . . . 0.0 108.42 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -50.19 -40.47 47.14 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.61 -6.54 19.39 Favored Glycine 0 N--CA 1.47 0.958 0 CA-C-N 116.529 -0.305 . . . . 0.0 112.75 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.729 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 67.3 mmtt -106.72 104.43 51.19 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.63 -30.32 42.53 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.824 2.349 . . . . 0.0 113.348 -168.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.669 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 26.2 t70 -152.47 134.94 15.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.269 0.557 . . . . 0.0 110.359 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.557 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 36.7 m -144.07 164.02 31.87 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 125.63 1.572 . . . . 0.0 106.9 169.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -142.92 119.12 10.79 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.5 t -109.16 148.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.279 1.031 . . . . 0.0 109.517 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.08 157.66 41.77 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.63 1.172 . . . . 0.0 110.197 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.3 tp -142.49 118.12 10.4 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.49 ' HE ' ' HB2' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -122.36 117.13 25.31 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.841 0.856 . . . . 0.0 109.597 -174.093 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.4 mt -107.04 136.18 47.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.933 0.893 . . . . 0.0 110.368 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.6 m -143.38 124.24 14.28 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.472 1.109 . . . . 0.0 108.803 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.37 143.72 57.69 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.237 1.415 . . . . 0.0 111.291 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.97 118.45 4.13 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.5 -102.92 0.94 Allowed Glycine 0 C--N 1.347 1.151 0 C-N-CA 123.098 0.38 . . . . 0.0 112.252 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -125.38 7.11 7.71 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.729 0.812 . . . . 0.0 110.278 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -114.92 -165.12 14.78 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.8 m -150.13 135.41 18.03 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.393 0.677 . . . . 0.0 109.777 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 45.7 tp -81.19 128.15 33.46 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 167.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.6 tt -115.22 113.59 24.11 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.49 ' HB2' ' HE ' ' A' ' 100' ' ' ARG . 51.2 mt-10 -113.12 105.53 13.56 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 171.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.57 HD12 HD21 ' A' ' 133' ' ' LEU . 7.0 tt -99.44 104.6 16.46 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 171.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -104.46 119.26 38.56 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.696 0.798 . . . . 0.0 109.712 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -109.72 114.93 28.92 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.92 121.68 44.23 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.335 0.654 . . . . 0.0 110.834 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.43 HG22 ' HG ' ' A' ' 122' ' ' LEU . 7.8 t -140.21 158.6 43.79 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.637 0.732 . . . . 0.0 110.176 172.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.9 p -85.23 -3.15 58.72 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.792 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.3 t -105.25 121.88 44.78 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.749 0.82 . . . . 0.0 110.203 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.435 ' HA ' HD12 ' A' ' 122' ' ' LEU . 43.0 tt0 -66.34 -37.4 85.27 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.362 0.665 . . . . 0.0 111.528 -177.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -62.38 -58.57 7.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.253 0.221 . . . . 0.0 110.996 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.729 ' SD ' ' HG3' ' A' ' 92' ' ' LYS . 21.2 ttt -46.72 -41.02 14.45 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.493 1.121 . . . . 0.0 112.176 175.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 119' ' ' GLU . 26.9 mt -57.35 -50.9 71.5 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.361 0.664 . . . . 0.0 112.111 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 127' ' ' VAL . 41.4 t -62.53 -50.07 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -61.0 -36.42 79.44 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.182 0.993 . . . . 0.0 113.296 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -80.17 -23.13 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 118.56 0.618 . . . . 0.0 110.031 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 130' ' ' GLU . . . -62.06 -37.75 94.96 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 171.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 123' ' ' VAL . 44.4 t -79.41 -49.52 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.792 0.837 . . . . 0.0 109.204 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.98 -60.32 9.11 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.972 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -61.44 -36.13 79.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.498 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 21.5 tt0 -59.65 -37.59 79.14 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.783 0.72 . . . . 0.0 110.317 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 67.6 mtt -72.25 -39.89 68.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.113 0.565 . . . . 0.0 110.927 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.85 -58.29 9.08 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 123.812 0.695 . . . . 0.0 110.853 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.57 HD21 HD12 ' A' ' 112' ' ' LEU . 3.4 mm? -60.36 -26.16 66.41 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 172.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.15 -38.68 88.71 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -66.71 -36.78 83.31 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.1 0.56 . . . . 0.0 110.234 174.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.478 HD21 ' SG ' ' A' ' 41' ' ' CYS . 42.4 tp -70.91 -56.71 5.65 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.383 0.673 . . . . 0.0 111.14 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -43.52 -42.06 5.67 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 167.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.2 ttm -66.7 -45.11 79.8 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.394 0.677 . . . . 0.0 111.121 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.402 ' CD1' ' HG2' ' A' ' 49' ' ' ARG . 18.1 t80 -61.35 -59.87 4.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.813 0.845 . . . . 0.0 111.087 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.2 mt -57.89 -36.63 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.795 1.238 . . . . 0.0 112.037 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 . . . . . 0 CA--C 1.551 0.993 0 C-N-CA 122.955 0.502 . . . . 0.0 111.019 175.669 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.448 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 82.9 mt . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 110.399 -0.222 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.5 t -59.32 -27.07 65.56 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.94 0.896 . . . . 0.0 111.869 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -77.03 -50.3 13.43 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.512 ' HB2' HH11 ' A' ' 170' ' ' ARG . 45.8 mt-10 -55.65 -50.58 69.84 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 124.168 0.918 . . . . 0.0 110.692 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.512 HH11 ' HB2' ' A' ' 169' ' ' GLU . 15.1 mmt-85 -67.12 -50.28 62.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.776 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -49.46 -44.04 36.19 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 124.193 0.933 . . . . 0.0 114.553 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -67.27 -41.15 85.97 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.777 0.831 . . . . 0.0 111.371 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.1 -41.57 73.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.419 0.688 . . . . 0.0 111.466 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -78.38 -27.36 46.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.502 0.721 . . . . 0.0 111.676 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -71.82 -31.83 66.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.75 0.42 . . . . 0.0 110.373 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -73.3 -31.76 64.22 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.287 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 54.9 mt -71.55 -55.61 7.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.949 0.9 . . . . 0.0 111.51 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.21 -32.32 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -172.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -78.52 -4.12 47.05 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.481 1.107 0 C-N-CA 123.884 0.874 . . . . 0.0 110.527 171.841 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 m -97.72 142.07 29.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.924 0.889 . . . . 0.0 111.99 -172.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -122.91 108.82 13.39 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.157 0.983 . . . . 0.0 108.644 169.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.29 141.92 57.04 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.917 171.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.577 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -157.63 164.86 36.8 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.413 ' HG ' ' HA ' ' A' ' 178' ' ' VAL . 0.2 OUTLIER -142.51 149.06 38.65 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.43 -158.32 8.51 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -135.35 164.93 26.63 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.989 0.915 . . . . 0.0 109.342 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 21' ' ' ALA . 15.8 tpt180 -152.39 152.99 32.72 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.978 0.911 . . . . 0.0 108.572 -174.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -111.85 129.61 56.09 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.4 pt -136.05 161.99 59.27 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.015 0.926 . . . . 0.0 109.941 -175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.31 -21.05 16.45 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.533 2.822 . . . . 0.0 114.836 175.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.05 -43.33 58.21 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.004 0.431 . . . . 0.0 110.975 174.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 151.42 -129.24 2.79 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -79.2 136.75 37.17 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.182 0.491 . . . . 0.0 109.891 174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . . . -127.17 155.51 43.27 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 3.9 mpt_? -114.31 161.05 18.38 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 165.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.8 p -134.46 130.27 36.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.183 -168.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.9 pt -85.97 135.65 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 168.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 4.0 mp -121.16 119.05 58.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.9 mt -104.76 108.64 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 33.9 mtm105 -105.28 101.78 11.31 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.459 ' NE2' ' HB3' ' A' ' 133' ' ' LEU . 70.8 mt-30 -108.0 118.59 37.15 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.6 tpt85 -91.09 103.53 16.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -86.69 149.73 24.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.27 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -102.7 72.97 1.26 Allowed 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.452 ' H ' ' HA2' ' A' ' 107' ' ' GLY . . . -168.15 150.7 5.29 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 125.833 1.653 . . . . 0.0 107.943 -164.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.64 146.0 23.64 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.679 2.253 . . . . 0.0 113.45 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.3 t -49.63 -35.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 124.535 1.134 . . . . 0.0 111.915 173.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -52.81 -42.62 65.27 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 123.508 0.505 . . . . 0.0 110.951 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -86.66 -30.88 21.39 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.08 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.481 HG22 HD12 ' A' ' 140' ' ' ILE . 52.7 t -69.12 -49.48 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 123.601 0.563 . . . . 0.0 110.44 175.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -65.88 -26.29 67.57 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.903 1.281 . . . . 0.0 111.096 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.3 t -65.95 -48.91 69.76 Favored 'General case' 0 C--N 1.353 0.761 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 173.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.559 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -59.62 -34.74 73.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.912 0.885 . . . . 0.0 112.515 174.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.465 ' SG ' HD21 ' A' ' 99' ' ' LEU . 79.4 m -69.41 -38.04 77.75 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.2 p -105.73 -43.91 4.79 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -167.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.487 ' O ' HG13 ' A' ' 47' ' ' ILE . 65.4 m-20 -76.32 118.46 71.54 Favored Pre-proline 0 N--CA 1.478 0.933 0 CA-C-O 118.131 -0.938 . . . . 0.0 110.298 -175.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -57.39 -23.78 57.01 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.151 2.568 . . . . 0.0 111.72 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -59.46 -44.36 93.0 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.75 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.559 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 12.2 mmm180 -89.37 -26.12 21.22 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.283 1.033 . . . . 0.0 111.396 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.512 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 87.0 mt -73.91 -34.72 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -174.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.563 HD22 ' HB3' ' A' ' 53' ' ' GLU . 69.7 m-20 -66.79 2.89 1.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.66 -9.89 33.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.925 0.89 . . . . 0.0 110.833 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.512 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 37.7 p-90 -146.49 -27.57 0.41 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.595 0.758 . . . . 0.0 112.36 -174.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.457 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 16.6 t80 -147.11 -145.06 0.16 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.412 1.085 . . . . 0.0 108.847 -175.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.82 139.74 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.821 0.848 . . . . 0.0 111.813 -159.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.563 ' HB3' HD22 ' A' ' 48' ' ' ASN . 10.0 pt-20 -65.33 110.42 4.3 Favored Pre-proline 0 CA--C 1.566 1.576 0 O-C-N 125.122 1.514 . . . . 0.0 110.555 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.453 ' HB2' HD23 ' A' ' 58' ' ' LEU . 4.1 Cg_exo -80.23 98.98 1.13 Allowed 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.0 2.467 . . . . 0.0 111.982 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -72.92 97.97 2.38 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 64' ' ' PHE . . . -176.09 169.65 42.32 Favored Glycine 0 C--O 1.241 0.578 0 C-N-CA 121.547 -0.358 . . . . 0.0 112.955 -172.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.69 -34.55 78.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.443 0.697 . . . . 0.0 111.253 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.453 HD23 ' HB2' ' A' ' 54' ' ' PRO . 96.1 mt 56.11 70.73 0.61 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.747 1.219 . . . . 0.0 112.718 172.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.462 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 9.3 ptp85 -171.37 171.21 5.63 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.057 0.943 . . . . 0.0 109.495 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 76' ' ' ARG . 28.7 tt0 -54.96 116.17 2.61 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.906 0.882 . . . . 0.0 110.263 174.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.85 8.76 83.83 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 113.945 0.338 . . . . 0.0 113.945 -177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.0 178.16 20.66 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 27.4 p-10 -112.66 177.29 4.68 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 118.043 0.921 . . . . 0.0 112.471 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.526 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 48.4 p90 -149.8 139.31 21.54 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 170.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.09 121.65 24.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.812 0.445 . . . . 0.0 110.721 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.6 mt -94.3 132.55 38.77 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -33.63 -56.97 0.44 Allowed 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 126.264 1.826 . . . . 0.0 114.491 -172.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -136.36 5.56 3.86 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.916 -0.584 . . . . 0.0 113.514 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -90.1 -86.9 0.19 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.984 0.892 . . . . 0.0 110.045 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.74 154.56 39.77 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.241 0.543 . . . . 0.0 111.046 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -131.81 149.5 52.44 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.388 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.52 -154.43 9.18 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 11.5 m-20 -129.39 178.2 6.62 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.997 0.519 . . . . 0.0 110.214 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.568 HG13 HG21 ' A' ' 85' ' ' ILE . 3.4 mp -108.49 117.46 54.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 173.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' A' ' 86' ' ' SER . 62.0 mt -74.7 -39.9 61.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.072 0.949 . . . . 0.0 110.282 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.411 ' HA ' ' HG3' ' A' ' 60' ' ' GLU . 16.9 ptm180 -168.32 149.76 5.05 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.922 1.289 . . . . 0.0 108.634 173.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 22.0 p -147.91 119.86 8.19 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.933 0.493 . . . . 0.0 110.388 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -121.18 97.35 47.77 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.173 0.989 . . . . 0.0 109.834 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.91 142.16 24.88 Favored 'Trans proline' 0 CA--C 1.56 1.813 0 C-N-CA 122.502 2.135 . . . . 0.0 112.297 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -97.59 20.96 27.03 Favored 'Cis proline' 0 C--N 1.376 1.983 0 CA-C-N 119.665 0.916 . . . . 0.0 113.043 -5.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -74.43 -60.92 2.05 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.51 0.724 . . . . 0.0 112.199 -169.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -153.19 159.85 42.74 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.859 0.838 . . . . 0.0 111.691 -169.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 99' ' ' LEU . 63.4 tp -134.08 145.44 49.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.626 1.57 . . . . 0.0 107.647 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.414 HG22 HD13 ' A' ' 75' ' ' LEU . 23.9 m -137.11 121.68 18.42 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 172.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.568 HG21 HG13 ' A' ' 74' ' ' ILE . 31.0 pt -134.47 141.88 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.342 1.057 . . . . 0.0 109.703 -176.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.507 ' HB2' HD22 ' A' ' 75' ' ' LEU . 22.7 t -90.73 140.75 29.49 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 168.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.476 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 28.5 t-105 -128.97 100.56 5.7 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.178 1.391 . . . . 0.0 107.644 -167.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.3 t -96.35 102.64 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.42 ' HD2' ' HG3' ' A' ' 92' ' ' LYS . 37.4 t80 -98.07 162.04 13.42 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 174.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.44 115.8 4.97 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.386 0.674 . . . . 0.0 112.015 -168.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.93 14.99 79.82 Favored Glycine 0 C--N 1.356 1.664 0 O-C-N 123.71 0.631 . . . . 0.0 113.775 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.485 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 67.1 mmtt -109.28 153.45 42.69 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.793 0.837 . . . . 0.0 109.895 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.96 143.45 60.47 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.181 1.921 . . . . 0.0 110.391 170.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.21 107.62 0.93 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.916 0.865 . . . . 0.0 109.73 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.5 m -77.75 145.59 36.4 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.427 -172.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -103.53 105.38 15.61 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.0 144.41 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.592 1.157 . . . . 0.0 108.623 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -132.35 148.62 52.43 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.636 0.774 . . . . 0.0 109.603 171.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 83' ' ' LEU . 39.9 tp -125.3 108.56 11.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -107.27 145.76 32.33 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.545 0.738 . . . . 0.0 110.149 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 110' ' ' LEU . 82.9 mt -134.34 141.35 46.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.696 1.199 . . . . 0.0 109.233 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.2 m -136.54 122.57 20.23 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.126 0.97 . . . . 0.0 109.411 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.57 101.43 9.97 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.69 100.96 7.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.922 -170.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.78 -126.09 8.27 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.806 0.717 . . . . 0.0 112.897 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -90.91 27.09 1.9 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.294 0.638 . . . . 0.0 109.647 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.452 ' HA2' ' H ' ' A' ' 32' ' ' ALA . . . -161.7 -172.05 28.57 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 120.363 -0.923 . . . . 0.0 115.245 -172.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.1 m -136.54 125.17 23.73 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.1 1.36 . . . . 0.0 109.386 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.9 tp -82.27 116.04 21.62 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 167.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 1.7 tm? -83.38 133.97 34.92 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 165.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -140.48 105.37 4.96 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.5 tp -103.9 132.63 49.97 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.292 1.037 . . . . 0.0 109.015 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -129.18 102.67 6.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.254 0.621 . . . . 0.0 110.095 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -95.53 113.96 25.66 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 172.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -117.57 103.79 10.41 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.153 0.581 . . . . 0.0 110.78 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 t -121.52 161.83 21.63 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.684 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 5.94 14.85 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.671 1.188 . . . . 0.0 111.781 -175.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.537 ' HB3' ' HG2' ' A' ' 120' ' ' GLN . 66.6 m -132.37 123.47 26.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.442 0.697 . . . . 0.0 110.7 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.518 ' HA ' HD12 ' A' ' 122' ' ' LEU . 4.7 mp0 -72.53 -29.36 63.53 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.0 0.92 . . . . 0.0 109.828 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.537 ' HG2' ' HB3' ' A' ' 118' ' ' SER . 5.2 pt20 -58.73 -44.91 90.57 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.491 1.119 . . . . 0.0 110.821 173.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 24.3 ttt -71.23 -33.96 70.34 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.778 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 119' ' ' GLU . 36.6 mt -64.74 -39.53 93.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.0 t -69.58 -41.62 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.303 0.573 . . . . 0.0 109.712 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -59.56 -58.35 8.98 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.03 1.332 . . . . 0.0 111.453 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.0 m -74.2 -14.85 16.32 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 C-N-CA 123.262 0.625 . . . . 0.0 110.339 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 130' ' ' GLU . . . -61.61 -37.28 93.95 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 166.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.73 -47.17 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 O-C-N 124.114 0.538 . . . . 0.0 109.732 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.69 -30.38 76.21 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.916 0.76 . . . . 0.0 114.498 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -88.05 -41.04 13.36 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -60.37 -32.64 71.48 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.575 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 41.0 ttm -66.16 -56.03 13.4 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.316 1.046 . . . . 0.0 110.49 175.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.17 79.73 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.88 0.738 . . . . 0.0 111.43 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.524 HD11 HD22 ' A' ' 136' ' ' LEU . 4.5 mm? -82.65 -20.85 35.46 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.422 1.089 . . . . 0.0 110.904 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.65 -51.98 43.58 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -74.29 -24.55 59.26 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.35 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.524 HD22 HD11 ' A' ' 133' ' ' LEU . 31.7 tp -70.82 -41.57 71.37 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 171.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.03 -42.97 95.27 Favored Glycine 0 C--O 1.219 -0.832 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.151 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 87.5 mtp -75.2 -32.96 61.35 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.43 0.692 . . . . 0.0 111.559 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -63.19 -46.25 87.97 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.487 0.715 . . . . 0.0 110.704 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.481 HD12 HG22 ' A' ' 37' ' ' VAL . 80.6 mt -76.46 -61.16 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.148 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 . . . . . 0 N--CA 1.482 1.147 0 C-N-CA 124.178 0.991 . . . . 0.0 109.665 -176.826 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 33.5 mm . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 121.366 0.603 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 10.2 t -73.84 -47.74 36.23 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.194 -177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -59.02 -60.65 3.54 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.227 0.954 . . . . 0.0 112.67 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -39.57 -53.98 2.04 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 124.19 0.996 . . . . 0.0 113.371 174.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -68.85 -37.1 78.89 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.474 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -72.15 -47.88 28.34 Favored Glycine 0 C--N 1.348 1.212 0 C-N-CA 121.818 -0.23 . . . . 0.0 112.555 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.79 -23.65 67.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.137 1.375 . . . . 0.0 111.428 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.07 -50.75 18.26 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.365 0.666 . . . . 0.0 110.071 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -63.28 -25.13 68.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.303 0.641 . . . . 0.0 111.249 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.89 -59.21 3.22 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.091 0.556 . . . . 0.0 109.99 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.3 -30.64 62.78 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.349 1.06 . . . . 0.0 112.686 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 38.4 mt -66.88 -46.27 75.45 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.855 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.413 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 7.3 p -80.5 -27.97 11.67 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 118.65 0.659 . . . . 0.0 110.369 -171.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -69.27 -27.33 65.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.561 0.744 . . . . 0.0 110.389 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 38.9 t . . . . . 0 CA--C 1.547 0.831 0 C-N-CA 123.56 0.744 . . . . 0.0 110.678 175.343 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 10.3 m -83.87 128.03 34.25 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.593 -1.185 . . . . 0.0 113.638 -165.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 33.5 tt0 -113.57 120.16 39.99 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.538 1.535 . . . . 0.0 107.445 166.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.404 ' HB3' HD13 ' A' ' 177' ' ' LEU . 66.6 mtt180 -85.52 144.41 27.94 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.159 0.583 . . . . 0.0 110.536 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -158.43 -179.6 8.25 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 122.851 0.46 . . . . 0.0 111.343 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.0 mt -142.59 167.06 22.99 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 122.397 1.094 . . . . 0.0 111.36 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.14 176.81 29.48 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 113.059 -1.882 . . . . 0.0 109.494 166.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 37.0 ttm180 -132.38 122.17 24.6 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -131.36 128.09 38.94 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.576 0.751 . . . . 0.0 109.037 -173.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.2 m -93.21 117.86 30.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -173.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.408 HD12 ' OG1' ' A' ' 117' ' ' THR . 26.2 pt -107.36 164.96 13.69 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.577 1.551 . . . . 0.0 108.036 175.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.46 -26.96 30.12 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.091 2.528 . . . . 0.0 114.127 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.24 -20.98 60.73 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.86 0.864 . . . . 0.0 112.993 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.72 167.83 14.08 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 123.389 0.519 . . . . 0.0 111.938 -172.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.33 95.29 1.3 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.8 163.92 20.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.292 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.461 HH21 HG23 ' A' ' 178' ' ' VAL . 2.7 mpp_? -105.57 170.79 7.68 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 167.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -139.27 128.15 23.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.929 -170.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 2.8 pp -88.19 135.2 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 mp -121.58 111.18 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.2 mt -99.76 107.85 21.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.567 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 82.1 mtt180 -94.72 137.38 33.89 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.632 ' NE2' ' HB3' ' A' ' 133' ' ' LEU . 40.4 mt-30 -142.87 136.52 28.76 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 166.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -104.96 114.3 28.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.559 0.695 . . . . 0.0 109.453 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -96.95 131.68 43.5 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.238 1.415 . . . . 0.0 110.06 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -77.74 48.89 0.72 Allowed 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.589 1.185 . . . . 0.0 110.073 172.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.59 154.72 41.43 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.425 1.09 . . . . 0.0 108.285 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.46 166.44 27.22 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.745 2.297 . . . . 0.0 113.116 176.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' A' ' 101' ' ' LEU . 59.1 t -72.17 -43.4 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.404 -174.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -56.09 -41.54 75.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 124.258 0.974 . . . . 0.0 110.341 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -66.58 -64.57 0.83 Allowed 'General case' 0 C--N 1.348 0.526 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.655 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.1 t -50.19 -34.73 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.546 1.139 . . . . 0.0 111.315 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.408 ' HE3' HD12 ' A' ' 101' ' ' LEU . 58.5 t-105 -61.96 -57.49 11.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.601 0.76 . . . . 0.0 110.211 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.1 m -58.39 -34.13 70.39 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 123.913 0.758 . . . . 0.0 111.057 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.1 -31.23 71.98 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 174.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.486 ' HB3' HD12 ' A' ' 99' ' ' LEU . 73.7 m -90.8 -14.17 32.45 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.947 0.899 . . . . 0.0 113.152 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 49.3 p -110.96 -47.07 3.26 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.198 0.454 . . . . 0.0 111.985 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 47' ' ' ILE . 18.2 t70 -66.16 125.68 90.6 Favored Pre-proline 0 N--CA 1.484 1.244 0 C-N-CA 123.495 0.718 . . . . 0.0 110.47 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.79 -30.09 68.53 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.57 2.847 . . . . 0.0 113.602 -171.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -64.76 -48.61 73.92 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 124.359 1.037 . . . . 0.0 109.073 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -58.62 -38.67 78.53 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.156 171.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.482 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 68.7 mt -71.85 -45.68 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -172.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -61.77 -20.57 63.73 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.768 0.427 . . . . 0.0 111.964 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -57.75 -48.16 80.4 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.153 0.581 . . . . 0.0 110.932 174.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.482 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 22.7 p-90 -105.68 -55.85 2.27 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.355 0.662 . . . . 0.0 111.502 -173.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.42 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 6.6 t80 -91.47 -164.25 1.15 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.087 0.555 . . . . 0.0 110.893 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.466 ' HB ' HD23 ' A' ' 66' ' ' LEU . 40.5 mt -84.57 148.1 5.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 C-N-CA 124.359 1.064 . . . . 0.0 108.358 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.81 112.31 5.96 Favored Pre-proline 0 CA--C 1.566 1.569 0 O-C-N 124.173 0.921 . . . . 0.0 110.649 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.65 ' HG2' HD11 ' A' ' 58' ' ' LEU . 90.8 Cg_endo -90.29 96.11 0.27 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.295 2.663 . . . . 0.0 112.293 -175.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -71.21 109.89 5.53 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.561 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.9 -157.56 27.69 Favored Glycine 0 C--N 1.342 0.872 0 O-C-N 123.564 0.54 . . . . 0.0 113.884 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.81 -48.32 16.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.486 1.514 . . . . 0.0 112.054 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.65 HD11 ' HG2' ' A' ' 54' ' ' PRO . 84.7 mt 63.98 25.46 13.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 124.583 1.177 . . . . 0.0 111.483 -170.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -126.31 155.1 42.51 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.44 1.096 . . . . 0.0 109.894 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.602 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 35.6 tt0 -64.55 106.51 1.17 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.437 0.695 . . . . 0.0 111.101 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.3 -35.68 3.14 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.88 -169.59 45.44 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 114.149 -1.025 . . . . 0.0 112.124 170.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 72' ' ' GLY . 9.1 p30 -144.15 177.53 8.52 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.31 0.576 . . . . 0.0 111.907 -170.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -133.16 172.46 12.63 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.921 169.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -158.3 116.95 3.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.72 0.808 . . . . 0.0 109.276 178.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.466 HD23 ' HB ' ' A' ' 52' ' ' ILE . 70.0 mt -80.94 167.2 20.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.461 0.704 . . . . 0.0 110.862 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -86.8 128.25 35.03 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.879 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.47 39.48 22.29 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.997 1.436 . . . . 0.0 116.158 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -142.2 -79.86 0.23 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.407 ' HB1' ' HD1' ' A' ' 89' ' ' TYR . . . -161.79 154.89 20.72 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.106 0.562 . . . . 0.0 110.887 -172.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.0 p -100.42 165.46 11.43 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 170.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 63' ' ' ASN . . . -150.65 178.41 28.1 Favored Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -147.31 142.94 27.68 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.167 0.987 . . . . 0.0 109.321 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.442 HG13 HG23 ' A' ' 85' ' ' ILE . 2.6 mp -100.78 94.64 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.54 -34.07 67.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.407 174.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.478 ' HG2' ' HB ' ' A' ' 84' ' ' THR . 7.3 ptp180 -151.48 132.87 14.62 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.044 0.45 . . . . 0.0 111.313 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 26.3 p -128.46 118.73 23.6 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 168.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -133.05 88.5 36.52 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -173.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.63 141.78 38.64 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.534 2.156 . . . . 0.0 111.553 175.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -96.91 20.82 28.63 Favored 'Cis proline' 0 C--N 1.367 1.52 0 C-N-CA 124.938 -0.859 . . . . 0.0 112.998 -4.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -75.49 -71.62 0.36 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.065 0.946 . . . . 0.0 111.974 -167.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -161.74 159.58 27.39 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.478 0.656 . . . . 0.0 110.73 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 tt -133.33 114.56 13.86 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.478 ' HB ' ' HG2' ' A' ' 76' ' ' ARG . 23.0 m -108.95 127.38 54.01 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.473 HG13 ' HB ' ' A' ' 97' ' ' VAL . 11.8 pt -123.29 150.26 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 126.723 2.009 . . . . 0.0 109.684 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.5 t -84.87 164.92 18.11 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 167.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.654 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 35.7 t-105 -144.39 94.81 2.61 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.086 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.52 101.76 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.489 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 84.8 t80 -102.69 168.06 9.5 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.059 1.344 . . . . 0.0 109.932 -173.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -56.25 103.26 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.111 0.965 . . . . 0.0 110.72 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.23 4.27 83.52 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.019 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 42.1 mmtm -134.67 75.17 63.38 Favored Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 123.916 0.886 . . . . 0.0 110.12 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.52 135.06 25.6 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.371 2.048 . . . . 0.0 112.005 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 66.39 80.71 0.22 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.516 1.126 . . . . 0.0 112.018 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.654 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 35.4 m -109.97 146.18 35.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 168.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -103.44 107.71 18.66 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.153 0.501 . . . . 0.0 111.07 -170.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.473 ' HB ' HG13 ' A' ' 85' ' ' ILE . 10.6 t -112.05 147.97 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.675 1.19 . . . . 0.0 108.413 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -150.84 142.73 23.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.084 0.554 . . . . 0.0 111.075 171.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 41' ' ' CYS . 6.7 tt -109.46 123.79 49.96 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 172.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -122.58 123.0 40.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.471 1.108 . . . . 0.0 109.556 -166.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.487 ' HB3' HG13 ' A' ' 34' ' ' VAL . 92.7 mt -123.31 135.04 54.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.542 0.737 . . . . 0.0 110.982 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.6 m -146.87 145.22 29.77 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.191 1.396 . . . . 0.0 108.609 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.47 143.64 44.91 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.774 0.829 . . . . 0.0 109.169 168.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -150.11 111.06 4.34 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.88 -102.12 0.22 Allowed Glycine 0 C--N 1.348 1.199 0 O-C-N 123.353 0.408 . . . . 0.0 112.407 -171.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -117.11 -5.06 11.4 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.612 0.765 . . . . 0.0 110.81 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -117.63 -150.93 9.18 Favored Glycine 0 C--N 1.352 1.424 0 C-N-CA 124.24 0.924 . . . . 0.0 111.436 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.2 m -143.0 121.99 12.79 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.218 1.007 . . . . 0.0 110.227 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.7 tp -81.74 131.65 35.27 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.7 tt -118.85 109.22 15.76 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.567 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 30.6 mt-10 -111.02 105.8 14.68 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 176.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.505 HD12 HD21 ' A' ' 133' ' ' LEU . 6.2 tt -102.3 104.33 14.85 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 175.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 61.2 tt0 -93.65 128.65 39.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.475 177.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -121.88 113.32 19.46 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 170.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.39 119.53 38.9 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.157 0.983 . . . . 0.0 110.046 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.474 HG21 ' HG ' ' A' ' 122' ' ' LEU . 6.0 t -148.08 151.83 36.32 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.584 0.754 . . . . 0.0 109.71 172.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.408 ' OG1' HD12 ' A' ' 16' ' ' ILE . 1.8 m -74.25 -19.41 60.52 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.326 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.542 ' HB2' ' HB3' ' A' ' 121' ' ' MET . 11.7 m -89.83 119.33 30.12 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.027 0.931 . . . . 0.0 110.778 -173.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -64.32 -40.65 96.32 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.065 0.946 . . . . 0.0 112.141 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -63.76 -55.81 20.36 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.079 0.237 . . . . 0.0 111.389 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.542 ' HB3' ' HB2' ' A' ' 118' ' ' SER . 26.1 ttt -51.15 -33.35 26.51 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.01 0.819 . . . . 0.0 112.644 175.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.474 ' HG ' HG21 ' A' ' 116' ' ' THR . 19.9 mt -64.77 -46.24 82.95 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.33 0.652 . . . . 0.0 111.669 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.405 ' O ' HG22 ' A' ' 127' ' ' VAL . 61.4 t -62.89 -53.11 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -44.76 -53.34 7.49 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.51 1.924 . . . . 0.0 113.335 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.8 m -78.68 -25.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 122.794 0.438 . . . . 0.0 110.697 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.22 88.1 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 170.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 123' ' ' VAL . 89.2 t -81.83 -52.66 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.402 0.681 . . . . 0.0 109.4 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.59 -59.7 9.32 Favored Glycine 0 C--N 1.341 0.816 0 O-C-N 124.42 1.075 . . . . 0.0 113.634 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -57.25 -56.34 23.03 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.073 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.04 -30.31 69.1 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 119.905 1.23 . . . . 0.0 112.294 -171.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.434 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 47.2 ttp -70.73 -44.07 67.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.045 0.938 . . . . 0.0 110.187 174.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 50' ' ' TRP . . . -63.06 -63.53 1.17 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.0 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.632 ' HB3' ' NE2' ' A' ' 28' ' ' GLN . 4.3 mm? -42.31 -38.79 1.92 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.499 1.52 . . . . 0.0 113.992 169.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 131' ' ' MET . 12.4 t70 -52.79 -50.15 64.19 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.231 0.613 . . . . 0.0 110.059 173.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -74.43 -19.84 60.26 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.342 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.3 tp -72.57 -24.53 61.12 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 169.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.73 -41.37 24.08 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 87.2 mtp -63.05 -40.75 98.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.069 0.948 . . . . 0.0 110.567 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -64.06 -56.02 18.0 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.432 0.693 . . . . 0.0 110.753 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 53.0 mt -69.42 -36.24 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 123.275 0.63 . . . . 0.0 111.725 -173.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 176.66 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 70.5 mt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.308 0.099 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.9 m -68.47 -22.7 64.55 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -80.37 -31.42 37.86 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.38 -42.54 92.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.731 0.412 . . . . 0.0 109.935 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -62.62 -60.79 3.03 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.819 0.699 . . . . 0.0 110.214 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -53.84 -58.88 10.89 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 124.232 0.957 . . . . 0.0 114.022 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.01 -20.97 65.96 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -175.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.94 -55.11 11.99 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.107 0.412 . . . . 0.0 110.663 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.38 -22.29 61.16 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.193 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -70.13 -46.74 64.12 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 123.77 0.669 . . . . 0.0 109.464 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -64.43 -33.38 75.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.098 0.559 . . . . 0.0 110.118 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 9' ' ' ARG . 47.6 mt -68.06 -61.77 1.71 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.625 173.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.461 HG23 HH21 ' A' ' 22' ' ' ARG . 9.6 p -65.04 -31.38 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.034 0.534 . . . . 0.0 112.417 -166.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -67.61 -35.24 78.57 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.721 0.808 . . . . 0.0 110.231 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.482 1.149 0 C-N-CA 123.632 0.773 . . . . 0.0 110.919 175.431 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 121.022 0.439 . . . . 0.0 111.146 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.61 63.04 7.76 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.6 p -161.49 170.18 20.42 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.074 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.66 117.44 9.99 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 174.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -62.85 86.81 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.412 0.713 . . . . 0.0 109.644 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 29' ' ' ARG . . . -68.06 87.97 0.27 Allowed 'General case' 0 C--N 1.348 0.531 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.935 -167.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.6 m -88.07 131.16 34.78 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.715 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -119.16 103.6 9.68 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 171.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -83.25 132.48 35.04 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.901 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.583 ' HB1' ' HB ' ' A' ' 25' ' ' ILE . . . -143.92 171.36 14.34 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.893 -172.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 177' ' ' LEU . 0.5 OUTLIER -138.69 165.43 26.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.943 1.297 . . . . 0.0 108.242 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.56 -162.29 30.78 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.174 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -120.35 145.6 46.97 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.231 1.012 . . . . 0.0 109.91 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.436 ' HB3' ' HB1' ' A' ' 115' ' ' ALA . 12.2 tpt180 -164.27 125.85 2.26 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 20.0 m -77.04 142.2 39.97 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.884 0.474 . . . . 0.0 110.756 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.432 HD11 HG23 ' A' ' 117' ' ' THR . 16.7 pt -133.07 165.75 34.38 Favored Pre-proline 0 CA--C 1.557 1.222 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -49.02 -30.92 19.22 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.355 2.704 . . . . 0.0 115.377 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.5 -37.32 71.27 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.164 0.586 . . . . 0.0 111.995 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.33 -174.95 34.84 Favored Glycine 0 N--CA 1.471 1.014 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 2.8 mp0 -71.65 93.9 1.29 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.82 167.1 22.42 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.888 0.875 . . . . 0.0 113.115 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HB3' HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -95.17 149.12 21.65 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.339 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.0 p -134.7 130.77 36.79 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.125 0.421 . . . . 0.0 111.376 -169.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.427 HG22 HD22 ' A' ' 122' ' ' LEU . 2.7 pp -88.86 140.08 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.583 ' HB ' ' HB1' ' A' ' 10' ' ' ALA . 4.0 mp -126.86 124.27 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.446 HG22 ' HG3' ' A' ' 28' ' ' GLN . 25.6 mt -107.23 107.73 23.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 85.6 mtt180 -106.92 98.78 8.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.446 ' HG3' HG22 ' A' ' 26' ' ' ILE . 73.1 mt-30 -109.98 133.24 53.39 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.991 0.916 . . . . 0.0 109.001 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 17.5 mmt85 -87.44 127.5 35.22 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.42 0.688 . . . . 0.0 109.837 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -120.14 135.94 54.78 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.403 1.081 . . . . 0.0 108.842 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.7 45.43 1.2 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.372 0.606 . . . . 0.0 111.557 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.07 159.03 72.54 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 124.547 1.139 . . . . 0.0 109.883 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.06 157.05 63.63 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.237 2.625 . . . . 0.0 113.562 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.8 t -49.15 -47.95 17.65 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 C-N-CA 124.688 1.195 . . . . 0.0 110.474 171.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -43.44 -47.3 7.02 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 125.05 1.469 . . . . 0.0 111.754 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.54 -46.46 85.89 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.071 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.437 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 18.3 t -76.86 -31.0 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.513 -171.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -75.29 -30.26 60.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.811 1.244 . . . . 0.0 109.967 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.6 m -65.0 -44.46 89.16 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 172.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -62.94 -38.53 91.43 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.25 0.62 . . . . 0.0 112.584 176.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.451 ' SG ' HD23 ' A' ' 99' ' ' LEU . 65.5 m -71.86 -40.57 68.88 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -175.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.3 p -104.15 -38.93 6.72 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -168.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.429 ' O ' HG13 ' A' ' 47' ' ' ILE . 29.3 t70 -79.03 113.35 35.1 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.812 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -46.66 -38.55 22.34 Favored 'Trans proline' 0 C--N 1.39 2.719 0 C-N-CA 124.7 3.6 . . . . 0.0 115.227 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -66.14 -24.79 66.73 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 123.651 0.594 . . . . 0.0 110.8 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.552 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 5.8 mmp_? -91.95 -25.07 19.05 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 173.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 43' ' ' ASP . 83.1 mt -74.31 -40.71 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 118.235 0.471 . . . . 0.0 110.53 -172.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -65.37 -14.96 62.03 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.002 0.521 . . . . 0.0 111.895 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -83.18 -5.14 59.01 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.379 0.672 . . . . 0.0 111.181 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.402 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 56.7 p-90 -142.93 -15.84 0.7 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.519 0.727 . . . . 0.0 112.098 175.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.402 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 20.6 t80 -141.27 -122.53 0.1 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -173.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.8 mt -132.74 140.57 47.13 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 C-N-CA 123.404 0.681 . . . . 0.0 109.62 -167.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.61 105.02 0.83 Allowed Pre-proline 0 CA--C 1.573 1.858 0 O-C-N 124.871 1.357 . . . . 0.0 110.239 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.17 124.1 3.24 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.655 2.237 . . . . 0.0 112.498 -172.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -112.41 117.42 32.39 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.647 0.779 . . . . 0.0 110.304 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.17 -152.18 22.7 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.644 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 8.2 m-20 -66.55 -41.86 88.01 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.386 0.698 . . . . 0.0 110.758 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.7 mt 59.65 22.03 10.74 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.758 1.223 . . . . 0.0 111.792 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.644 ' HG2' ' HB3' ' A' ' 57' ' ' ASP . 17.3 ptp180 -133.48 151.7 51.81 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.511 1.124 . . . . 0.0 108.862 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -66.41 135.02 53.71 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.696 0.622 . . . . 0.0 110.492 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.18 -7.2 81.01 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.588 -167.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.92 -175.73 14.97 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-N 117.119 0.46 . . . . 0.0 112.641 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 11.2 p30 -109.05 171.26 7.54 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.586 0.754 . . . . 0.0 112.228 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -145.66 158.77 43.81 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.712 169.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.77 105.21 4.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.651 0.78 . . . . 0.0 109.514 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 70.4 mt -75.51 127.54 33.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -80.21 112.99 18.05 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.866 0.467 . . . . 0.0 110.564 -172.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.84 46.38 8.52 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.98 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -162.6 -83.71 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.851 0.46 . . . . 0.0 111.449 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.63 156.71 36.99 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.35 0.595 . . . . 0.0 111.017 -170.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.4 m -109.09 -175.34 2.74 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.484 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.75 -160.06 30.03 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 53.6 m-20 -129.48 174.22 9.84 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.24 0.616 . . . . 0.0 109.454 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mp -110.3 116.2 51.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 86' ' ' SER . 31.6 mt -84.22 -44.47 13.88 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.927 0.891 . . . . 0.0 110.317 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.53 ' HB2' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.37 155.19 44.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.134 1.374 . . . . 0.0 109.223 -177.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 26.2 p -157.18 120.78 4.16 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 166.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -141.63 100.48 6.13 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -165.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 85.9 Cg_endo -83.84 135.25 6.61 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.754 2.303 . . . . 0.0 112.849 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 24.9 Cg_endo -100.41 29.47 12.63 Favored 'Cis proline' 0 C--N 1.376 1.976 0 CA-C-N 119.399 0.821 . . . . 0.0 112.561 -4.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -77.85 -66.97 0.77 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.992 0.917 . . . . 0.0 112.397 -168.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.499 ' HB3' ' HG3' ' A' ' 100' ' ' ARG . 16.5 ptt180 -160.86 141.31 11.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.769 0.427 . . . . 0.0 111.073 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 77' ' ' CYS . 2.2 pt? -107.72 144.04 35.39 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 163.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 76' ' ' ARG . 32.8 m -134.79 128.42 32.79 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.107 0.963 . . . . 0.0 108.701 -171.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.7 pt -133.35 146.49 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.451 1.1 . . . . 0.0 109.137 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.453 ' HB2' HD12 ' A' ' 75' ' ' LEU . 33.3 t -96.14 139.54 32.16 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 8.4 t-105 -125.64 109.21 12.36 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.801 1.24 . . . . 0.0 107.891 -163.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.18 102.27 13.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -93.48 133.65 36.55 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.57 133.68 54.19 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.126 0.57 . . . . 0.0 111.342 -170.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.78 -45.14 3.44 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.306 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.403 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 13.2 mptt -80.55 163.0 58.69 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.714 1.206 . . . . 0.0 110.094 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 177.39 5.41 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.36 2.04 . . . . 0.0 112.376 175.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.31 162.57 29.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.805 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.558 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.2 m -141.51 165.21 28.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.579 0.752 . . . . 0.0 110.042 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -125.45 106.83 10.09 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 167.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.39 149.0 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.668 1.587 . . . . 0.0 109.004 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.17 153.08 39.43 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.701 165.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.451 HD23 ' SG ' ' A' ' 41' ' ' CYS . 2.8 tt -114.66 128.31 56.24 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 169.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.539 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 36.8 ttt180 -138.39 137.85 37.68 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.272 1.029 . . . . 0.0 108.389 -164.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 110' ' ' LEU . 96.7 mt -129.5 132.5 46.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.872 0.469 . . . . 0.0 110.827 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.4 t -125.25 127.17 46.3 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 172.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -69.92 152.74 44.14 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.73 0.812 . . . . 0.0 109.014 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -167.47 79.36 0.19 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -168.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 65.16 -117.38 10.18 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 123.709 0.671 . . . . 0.0 113.306 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.64 32.66 1.07 Allowed 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.91 -171.9 38.06 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-O 122.001 0.778 . . . . 0.0 114.475 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.2 m -140.43 131.01 25.5 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 113.78 -1.21 . . . . 0.0 109.463 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' A' ' 27' ' ' ARG . 64.0 tp -82.77 106.87 14.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.468 171.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.0 tt -84.22 131.98 34.7 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 172.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 22.2 mt-10 -129.32 106.62 8.92 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -174.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.402 HD11 HD21 ' A' ' 133' ' ' LEU . 9.0 tt -115.47 126.45 54.32 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -124.66 137.83 54.34 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -131.88 114.89 15.21 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 14' ' ' ARG . . . -109.96 104.01 12.85 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.118 0.567 . . . . 0.0 110.972 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.442 HG23 ' HG ' ' A' ' 122' ' ' LEU . 5.3 t -124.2 156.13 37.32 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.206 0.527 . . . . 0.0 109.64 171.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.432 HG23 HD11 ' A' ' 16' ' ' ILE . 20.8 p -77.44 -18.57 57.07 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.433 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.5 t -88.49 111.85 22.3 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.333 0.653 . . . . 0.0 110.079 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.43 ' HA ' HD11 ' A' ' 122' ' ' LEU . 37.4 tt0 -62.63 -29.21 70.45 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.397 1.079 . . . . 0.0 110.878 172.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -60.35 -47.89 84.09 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.554 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.403 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 27.4 ttt -68.49 -37.62 80.27 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.787 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 116' ' ' THR . 37.7 mt -61.1 -38.18 85.37 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.591 0.756 . . . . 0.0 112.763 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 68.8 t -64.51 -51.78 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 O-C-N 123.392 0.432 . . . . 0.0 109.888 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -63.65 -41.8 98.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.27 0.628 . . . . 0.0 112.544 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.37 -34.56 58.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 CA-C-O 118.992 -0.528 . . . . 0.0 109.994 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.03 -32.18 74.89 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 121.389 -0.434 . . . . 0.0 112.217 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.09 -54.52 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 123.869 0.393 . . . . 0.0 110.894 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.96 73.45 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.944 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -80.2 -49.52 11.52 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 38.5 mt-10 -63.35 -23.09 67.26 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 118.415 0.552 . . . . 0.0 111.599 176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 56.4 ttp -66.46 -44.71 82.0 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.074 0.549 . . . . 0.0 109.54 170.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.62 -35.79 81.67 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.036 0.534 . . . . 0.0 111.275 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 130' ' ' GLU . 4.0 mm? -74.75 -18.38 60.5 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.6 1.16 . . . . 0.0 111.367 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -69.87 -55.26 10.23 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -66.15 -32.81 74.48 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.879 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.1 tp -75.01 -37.63 61.76 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.189 0.596 . . . . 0.0 109.931 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.5 -46.52 52.89 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.598 0.562 . . . . 0.0 112.925 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.0 mtp -69.23 -39.71 78.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.94 0.896 . . . . 0.0 111.205 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.62 -33.15 68.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.137 0.575 . . . . 0.0 111.345 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.9 mm -72.51 -63.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 65.0 mmt-85 -154.87 104.47 2.5 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 178.91 -52.46 0.09 OUTLIER Glycine 0 C--O 1.244 0.727 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 175.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.6 t70 141.76 127.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 127.975 2.51 . . . . 0.0 109.012 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -159.57 86.69 2.09 Favored Pre-proline 0 N--CA 1.479 1.003 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.73 -16.62 11.5 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.824 2.349 . . . . 0.0 112.434 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.42 105.02 0.22 Allowed Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -60.76 112.35 4.55 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 119.049 -0.862 . . . . 0.0 112.309 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.18 -29.21 47.61 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.919 2.413 . . . . 0.0 112.1 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.9 m -110.55 106.59 57.94 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 123.769 0.828 . . . . 0.0 109.296 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.2 -58.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.791 2.327 . . . . 0.0 110.989 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -147.97 80.21 1.48 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -137.73 49.0 1.99 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.2 -84.53 0.37 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.609 -1.632 . . . . 0.0 108.357 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -172.47 94.33 0.13 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.652 0.781 . . . . 0.0 109.449 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.75 130.48 35.37 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.665 0.786 . . . . 0.0 110.062 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 65.9 -79.78 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.028 1.331 . . . . 0.0 110.766 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -159.84 90.8 0.94 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -109.67 113.81 57.43 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.743 0.817 . . . . 0.0 108.89 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -44.76 97.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 124.011 3.14 . . . . 0.0 114.318 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.0 p -163.25 108.13 1.0 Allowed Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.751 1.22 . . . . 0.0 108.082 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -49.75 -53.88 6.35 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.997 3.132 . . . . 0.0 114.368 -168.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -63.94 -51.48 64.21 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.347 0.659 . . . . 0.0 110.577 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.2 mmt -72.96 -33.36 65.82 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.721 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 55.7 mtm -66.01 -51.48 57.9 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-O 119.123 -0.465 . . . . 0.0 109.936 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.442 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 13.3 ptm180 -63.27 -42.68 99.16 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-O 119.256 -0.402 . . . . 0.0 110.816 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.487 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 64.8 mt -63.03 -36.69 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 122.939 0.496 . . . . 0.0 111.296 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 63.7 p -75.36 -41.6 56.09 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 48.1 mt-30 -55.65 -63.7 1.09 Allowed 'General case' 0 C--O 1.2 -1.524 0 O-C-N 124.123 0.89 . . . . 0.0 110.751 172.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 38.9 mm-40 -41.76 -45.37 3.53 Favored 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 27.7 mmt85 -58.01 -48.26 80.58 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 174.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -81.51 -15.53 75.86 Favored Glycine 0 C--O 1.214 -1.128 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.581 -174.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 36.0 mm-40 -70.66 -39.42 73.59 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 117.699 0.75 . . . . 0.0 108.991 176.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.48 -58.45 7.55 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.188 173.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -62.73 -28.12 69.74 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.955 0.785 . . . . 0.0 113.065 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.54 -64.11 0.94 Allowed 'General case' 0 C--N 1.353 0.724 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -46.9 -41.28 15.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.881 0.872 . . . . 0.0 112.526 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.508 ' HB3' HD22 ' A' ' 11' ' ' LEU . 51.5 mt -65.25 -40.78 94.44 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.0 p -85.66 -28.08 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.023 0.829 . . . . 0.0 109.442 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -67.71 -29.38 68.62 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.077 170.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 66.2 m -83.38 -30.81 27.09 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.23 0.612 . . . . 0.0 109.837 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -61.56 -43.19 99.62 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 124.193 0.933 . . . . 0.0 112.022 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.254 1.297 0 C-N-CA 124.768 1.227 . . . . 0.0 111.989 173.425 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.61 92.2 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.806 1.242 . . . . 0.0 111.216 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.595 ' HA ' ' HB3' ' A' ' 31' ' ' ASP . 60.7 p -74.84 86.3 2.23 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.195 0.598 . . . . 0.0 112.344 -175.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.39 108.71 2.75 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 170.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -75.36 85.76 2.51 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.421 0.689 . . . . 0.0 109.216 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.564 ' HB1' ' HB2' ' A' ' 29' ' ' ARG . . . -76.47 78.22 3.18 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.376 -171.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 m -79.52 119.02 21.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.101 0.56 . . . . 0.0 109.725 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 43.1 mt-10 -114.48 112.65 23.31 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -176.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.409 ' HB3' HD13 ' A' ' 177' ' ' LEU . 97.6 mtt180 -72.44 133.31 44.8 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.266 0.626 . . . . 0.0 109.776 171.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.419 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . . . -156.66 169.69 24.12 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.743 0.652 . . . . 0.0 110.525 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.497 HD21 ' HA ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -144.91 150.19 36.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.8 -146.66 4.61 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -149.27 152.65 36.27 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.408 ' HB3' ' HB1' ' A' ' 115' ' ' ALA . 30.6 tpt180 -154.75 135.67 13.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.7 m -78.74 137.64 37.86 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.5 pt -126.63 159.61 62.75 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 124.081 0.952 . . . . 0.0 109.925 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.32 -27.3 56.91 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.333 2.689 . . . . 0.0 113.644 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.46 -39.23 77.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.965 0.506 . . . . 0.0 111.937 175.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.35 -146.95 11.96 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 -173.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -83.83 137.98 33.44 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.66 160.4 38.22 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.946 0.498 . . . . 0.0 110.838 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -100.49 162.59 12.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 165.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.7 t -141.28 133.54 28.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.375 0.27 . . . . 0.0 110.86 -167.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.497 ' HA ' HD21 ' A' ' 11' ' ' LEU . 43.5 pt -85.48 134.84 26.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 3.0 mp -111.17 111.56 36.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 171.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.0 mt -103.81 104.66 17.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.541 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 87.9 mtt180 -91.01 159.86 15.92 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 122.999 0.52 . . . . 0.0 109.805 173.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 6.3 tt0 -168.92 119.68 0.74 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.227 1.58 . . . . 0.0 111.477 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.564 ' HB2' ' HB1' ' A' ' 6' ' ' ALA . 6.0 mmt180 -88.44 106.23 18.13 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.532 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 91.4 m-85 -85.42 126.56 33.89 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.525 168.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.595 ' HB3' ' HA ' ' A' ' 3' ' ' SER . 11.1 t70 -89.35 76.74 7.5 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 168.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 30' ' ' TYR . . . -179.82 139.83 0.32 Allowed Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -157.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.445 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 85.4 Cg_endo -74.18 150.18 42.01 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.223 1.949 . . . . 0.0 113.504 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -47.78 -39.99 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.453 170.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -47.85 -49.3 29.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.393 1.058 . . . . 0.0 111.391 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 31.0 mt-10 -80.64 -29.84 36.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.565 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.7 t -73.13 -32.9 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 123.628 0.58 . . . . 0.0 110.631 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -81.51 -25.9 35.58 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.698 1.199 . . . . 0.0 109.753 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m -68.03 -50.16 57.01 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.566 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -60.55 -41.56 94.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.137 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.651 ' SG ' HD22 ' A' ' 99' ' ' LEU . 17.0 t -61.82 -45.18 94.94 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.4 p -104.05 -45.25 4.79 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -165.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.445 ' O ' HG13 ' A' ' 47' ' ' ILE . 5.5 m-20 -68.79 116.7 43.74 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.993 -175.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.88 -34.89 23.29 Favored 'Trans proline' 0 C--N 1.388 2.627 0 C-N-CA 123.622 2.881 . . . . 0.0 113.953 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.57 -33.49 72.78 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.631 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.566 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 30.7 mmt180 -90.0 -33.37 16.39 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.172 0.989 . . . . 0.0 111.512 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 43' ' ' ASP . 71.6 mt -73.3 -36.03 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -168.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -71.67 -1.03 12.33 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.558 0.743 . . . . 0.0 112.715 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.692 ' HD2' HD21 ' A' ' 144' ' ' LEU . 0.2 OUTLIER -89.5 -48.83 7.05 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.413 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 62.7 p-90 -101.56 -16.4 16.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.413 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 44.0 t80 -137.64 -114.16 0.17 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.584 0.754 . . . . 0.0 109.771 -176.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.451 HD13 HD11 ' A' ' 66' ' ' LEU . 49.4 mt -136.96 144.3 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -171.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.96 113.55 12.68 Favored Pre-proline 0 N--CA 1.485 1.295 0 O-C-N 124.801 1.313 . . . . 0.0 110.214 174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -92.15 143.51 2.66 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.056 2.504 . . . . 0.0 111.742 172.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -143.9 135.93 26.5 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.99 -151.93 23.58 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -71.04 -49.1 48.6 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.7 mt 59.36 25.43 14.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.239 0.962 . . . . 0.0 110.602 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -122.94 148.66 45.22 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.436 1.495 . . . . 0.0 109.674 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -70.42 130.83 42.96 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.377 0.608 . . . . 0.0 109.771 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.71 -2.08 82.0 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.781 -168.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.24 178.03 18.3 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 8.2 p30 -117.98 178.0 4.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -172.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -150.85 162.39 40.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.04 0.936 . . . . 0.0 109.266 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.88 146.06 36.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.899 0.88 . . . . 0.0 109.513 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 69' ' ' ASN . 86.9 mt -83.64 -89.83 0.09 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.175 0.59 . . . . 0.0 110.187 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -140.89 -57.59 0.51 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.27 9.62 0.52 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.412 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.457 ' HB3' HD12 ' A' ' 66' ' ' LEU . 42.6 t-20 -77.37 -85.07 0.06 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.3 158.58 43.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.703 0.763 . . . . 0.0 112.134 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.5 p -132.96 147.98 52.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.421 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.04 171.66 44.56 Favored Glycine 0 N--CA 1.464 0.502 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.581 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 24.9 m-20 -85.78 171.35 11.65 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.479 0.657 . . . . 0.0 111.298 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.23 119.53 59.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 168.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.438 ' HB2' HG22 ' A' ' 84' ' ' THR . 59.0 mt -84.63 -38.4 19.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.005 0.522 . . . . 0.0 110.622 -176.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -166.18 111.54 0.83 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.493 0.717 . . . . 0.0 109.61 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 10.6 p -107.3 103.1 12.38 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -99.94 102.17 16.63 Favored Pre-proline 0 N--CA 1.482 1.125 0 C-N-CA 124.132 0.973 . . . . 0.0 110.521 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 96.6 Cg_endo -80.66 129.55 7.34 Favored 'Trans proline' 0 CA--C 1.564 2.013 0 C-N-CA 122.786 2.324 . . . . 0.0 112.896 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.537 ' HD2' HH11 ' A' ' 81' ' ' ARG . 16.1 Cg_endo -103.84 33.37 6.97 Favored 'Cis proline' 0 C--N 1.38 2.193 0 CA-C-N 119.802 0.965 . . . . 0.0 112.783 -10.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.537 HH11 ' HD2' ' A' ' 80' ' ' PRO . 3.7 mpt_? -65.93 -69.24 0.31 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.923 0.889 . . . . 0.0 110.437 -176.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.9 ptt-85 -161.86 154.68 20.29 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.322 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.453 ' H ' HD21 ' A' ' 83' ' ' LEU . 1.8 pt? -107.04 146.61 30.96 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 167.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.438 HG22 ' HB2' ' A' ' 75' ' ' LEU . 94.1 m -131.53 121.83 25.11 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.664 1.585 . . . . 0.0 107.167 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.9 pt -141.58 142.99 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.779 0.832 . . . . 0.0 109.464 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.9 t -88.84 137.66 32.12 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -123.7 102.83 8.04 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.4 t -99.18 101.48 12.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -93.77 146.19 24.05 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.463 172.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -62.05 121.78 13.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.693 0.797 . . . . 0.0 111.331 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.82 19.65 61.09 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.323 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.468 ' HD2' ' HB2' ' A' ' 121' ' ' MET . 72.8 mmtt -132.4 147.89 67.47 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 123.917 0.887 . . . . 0.0 109.754 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.27 149.8 64.19 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.781 2.321 . . . . 0.0 111.418 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -59.8 116.61 4.21 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.872 0.869 . . . . 0.0 111.818 -169.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.8 m -90.59 160.76 15.76 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.554 -172.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -104.25 140.66 37.53 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.275 1.03 . . . . 0.0 108.361 166.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 54.2 t -138.14 118.37 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -126.46 111.87 14.94 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.651 HD22 ' SG ' ' A' ' 41' ' ' CYS . 38.2 tp -96.91 119.58 35.65 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.5 ttp-105 -127.14 114.57 17.88 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.618 0.767 . . . . 0.0 109.285 -160.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.1 mt -104.77 153.79 20.86 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.464 0.706 . . . . 0.0 110.564 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.6 m -141.85 123.01 14.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.784 0.834 . . . . 0.0 109.859 170.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -83.34 106.31 15.0 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -120.32 80.26 1.58 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.411 1.084 . . . . 0.0 110.238 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.56 -103.18 1.82 Allowed Glycine 0 C--N 1.35 1.31 0 C-N-CA 122.96 0.314 . . . . 0.0 112.539 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -106.47 5.08 28.99 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.416 0.686 . . . . 0.0 109.291 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.32 163.29 12.42 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.39 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 m -140.16 112.83 8.01 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.627 1.171 . . . . 0.0 108.438 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.8 tp -80.74 107.75 13.82 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.1 tt -90.66 131.46 36.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 172.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.53 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 43.9 mt-10 -132.9 109.22 9.44 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.5 tt -95.26 121.2 36.66 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 4.8 tp10 -112.6 102.7 10.76 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.461 ' HB3' HG12 ' A' ' 24' ' ' ILE . 6.5 t60 -114.58 112.67 23.29 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 14' ' ' ARG . . . -114.28 107.68 15.91 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.404 1.082 . . . . 0.0 110.189 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.484 HG22 ' HG ' ' A' ' 122' ' ' LEU . 5.1 t -127.64 156.03 42.96 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.663 0.744 . . . . 0.0 110.528 174.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -23.77 58.87 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.196 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.1 t -91.19 115.89 28.38 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.236 1.015 . . . . 0.0 110.795 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -69.93 -25.58 63.73 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.758 0.823 . . . . 0.0 110.942 175.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -63.45 -47.76 80.53 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.528 171.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.468 ' HB2' ' HD2' ' A' ' 92' ' ' LYS . 23.3 ttt -67.58 -33.61 75.36 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.114 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.484 ' HG ' HG22 ' A' ' 116' ' ' THR . 19.7 mt -63.06 -43.87 97.42 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.255 0.622 . . . . 0.0 112.045 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.421 ' O ' HG22 ' A' ' 127' ' ' VAL . 89.3 t -63.78 -42.23 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.954 173.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.65 -44.99 76.58 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.582 1.153 . . . . 0.0 111.807 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -79.65 -18.84 12.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 C-N-CA 123.37 0.668 . . . . 0.0 109.505 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.49 -34.09 89.02 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 166.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 123' ' ' VAL . 48.7 t -75.6 -50.76 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.97 -33.48 79.45 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 114.676 0.63 . . . . 0.0 114.676 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -86.04 -41.02 15.17 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.703 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.71 -34.05 76.35 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.91 0.777 . . . . 0.0 109.604 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 53.4 ttm -60.83 -50.13 74.67 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.837 0.855 . . . . 0.0 109.74 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.52 90.79 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.739 0.816 . . . . 0.0 112.154 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.16 -21.51 33.52 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.518 0.727 . . . . 0.0 111.6 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.65 -44.4 70.66 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -72.7 -35.82 67.7 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.166 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 29.1 tp -70.43 -38.66 74.61 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.824 0.45 . . . . 0.0 110.557 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.01 -52.77 50.21 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.744 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.503 ' HE1' HD11 ' A' ' 144' ' ' LEU . 31.1 ttp -61.75 -38.89 89.68 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.121 0.568 . . . . 0.0 110.799 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.16 -56.69 18.57 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.857 1.263 . . . . 0.0 111.042 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 58.9 mt -72.46 -19.19 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.8 0.84 . . . . 0.0 111.145 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.03 -39.37 69.17 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 173.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.58 -50.81 0.3 Allowed Glycine 0 C--N 1.356 1.685 0 C-N-CA 121.474 -0.393 . . . . 0.0 113.985 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -105.26 170.73 7.71 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.452 0.701 . . . . 0.0 110.669 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.692 HD21 ' HD2' ' A' ' 49' ' ' ARG . 20.2 tp -159.07 77.79 3.05 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 122.544 0.338 . . . . 0.0 110.626 168.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -101.79 172.94 0.27 Allowed 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 123.436 2.757 . . . . 0.0 113.023 165.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.77 77.63 1.98 Allowed Glycine 0 C--N 1.343 0.919 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 165.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -66.47 -80.67 0.17 Allowed Glycine 0 C--N 1.348 1.228 0 CA-C-O 119.242 -0.754 . . . . 0.0 113.557 -173.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.45 -45.41 11.73 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.232 2.621 . . . . 0.0 112.236 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.404 HG11 ' HB1' ' A' ' 153' ' ' ALA . 14.2 m -78.89 121.32 83.28 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.666 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -82.39 -23.89 3.98 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.927 2.418 . . . . 0.0 113.168 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -83.43 -73.31 0.42 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.787 0.835 . . . . 0.0 110.792 -168.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -175.74 -39.45 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.141 -174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.404 ' HB1' HG11 ' A' ' 149' ' ' VAL . . . 67.38 47.8 1.23 Allowed 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.117 1.367 . . . . 0.0 110.173 -174.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.67 -91.47 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.435 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -158.69 -172.16 3.72 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.002 1.321 . . . . 0.0 109.231 -166.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 56.72 -91.13 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.993 1.717 . . . . 0.0 112.262 169.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -172.04 121.68 0.47 Allowed 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.587 1.155 . . . . 0.0 108.18 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -108.52 112.26 60.89 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.653 1.181 . . . . 0.0 108.607 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.35 93.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 122.86 2.374 . . . . 0.0 111.748 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 29.8 t -165.04 119.11 0.96 Allowed Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.5 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.74 -38.74 91.53 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.617 2.211 . . . . 0.0 112.193 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -68.97 -49.7 55.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.942 0.497 . . . . 0.0 111.517 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -43.14 74.79 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -173.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -64.13 -35.23 80.1 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -67.05 -43.25 83.21 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.401 0.68 . . . . 0.0 111.562 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 12.2 tt -76.14 -28.89 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 122.428 0.291 . . . . 0.0 111.39 -176.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.9 p -77.78 -40.91 39.2 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -54.63 -59.03 5.26 Favored 'General case' 0 C--O 1.206 -1.211 0 O-C-N 123.922 0.764 . . . . 0.0 110.664 166.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -41.44 -49.58 3.9 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.153 1.381 . . . . 0.0 112.437 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -56.59 -55.79 29.54 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.007 0.523 . . . . 0.0 110.385 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.42 -17.52 79.11 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.435 -168.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.23 -29.07 31.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.023 0.929 . . . . 0.0 110.042 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.52 -53.67 17.96 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.78 0.832 . . . . 0.0 109.503 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -69.1 -25.87 64.64 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.846 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.04 -60.53 3.32 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 172.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.16 12.52 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.662 1.185 . . . . 0.0 112.911 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 78.1 mt -68.7 -46.25 69.48 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.096 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.03 -23.74 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.115 0.871 . . . . 0.0 110.682 -166.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -70.39 -25.25 63.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.424 0.69 . . . . 0.0 110.072 171.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.0 m -96.08 12.35 30.94 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.059 0.944 . . . . 0.0 110.692 172.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.45 -46.67 54.88 Favored Glycine 0 C--N 1.356 1.654 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.473 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.555 1.147 0 CA-C-O 118.355 -0.831 . . . . 0.0 109.268 173.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.32 120.93 28.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.605 1.162 . . . . 0.0 110.989 -172.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.8 m -151.86 2.11 0.37 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.05 0.94 . . . . 0.0 111.623 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.19 42.97 1.17 Allowed Glycine 0 C--N 1.343 0.953 0 N-CA-C 112.027 -0.429 . . . . 0.0 112.027 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.9 32.01 1.27 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.952 0.501 . . . . 0.0 111.455 -175.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.67 71.52 7.56 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.226 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 85.6 m -85.81 122.25 29.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.628 -176.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -124.6 112.06 16.37 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.571 1.548 . . . . 0.0 107.596 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.27 159.54 31.39 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.8 173.26 10.82 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.504 0.722 . . . . 0.0 109.095 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.42 HD11 ' N ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -145.32 154.86 42.78 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -177.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.42 ' N ' HD11 ' A' ' 11' ' ' LEU . . . -162.47 -153.95 7.37 Favored Glycine 0 C--O 1.238 0.404 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.4 ptt85 -157.1 160.28 38.7 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.211 0.604 . . . . 0.0 110.129 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -168.53 162.42 12.1 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.917 171.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.1 m -96.37 144.03 26.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.763 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.426 HD13 HG21 ' A' ' 117' ' ' THR . 42.5 pt -135.5 162.31 57.95 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.933 1.293 . . . . 0.0 108.497 -174.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.97 -35.37 31.76 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.568 2.845 . . . . 0.0 114.767 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.83 99.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.647 0.779 . . . . 0.0 111.779 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.06 -149.05 18.28 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.66 139.27 38.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 117.314 0.557 . . . . 0.0 109.622 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.12 158.55 44.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.295 0.569 . . . . 0.0 111.479 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -97.11 161.37 13.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 165.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 78.4 p -138.48 124.56 20.17 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.514 HG12 HG23 ' A' ' 125' ' ' VAL . 2.6 pp -86.61 131.0 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mp -113.19 119.58 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.0 mt -105.65 111.03 33.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.547 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 61.3 mtt180 -92.18 140.85 29.21 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 123.364 0.415 . . . . 0.0 110.335 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.618 HE22 HD23 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -137.33 139.6 40.94 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 167.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.471 HH12 ' HA3' ' A' ' 107' ' ' GLY . 24.6 tpt85 -107.83 102.79 11.97 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.428 ' HE1' ' HA2' ' A' ' 137' ' ' GLY . 63.1 m-85 -85.95 144.46 27.62 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.931 1.292 . . . . 0.0 110.929 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.512 ' HB3' ' HD3' ' A' ' 141' ' ' ARG . 26.5 t70 -87.82 26.44 1.33 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 123.807 0.692 . . . . 0.0 110.696 170.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.27 155.09 68.79 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.049 0.94 . . . . 0.0 110.604 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.38 156.63 59.0 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.549 2.833 . . . . 0.0 113.174 175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 101' ' ' LEU . 11.3 t -59.97 -42.51 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 O-C-N 124.473 1.108 . . . . 0.0 110.628 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -48.66 -52.05 25.29 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 125.107 1.504 . . . . 0.0 109.88 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -64.92 -62.87 1.3 Allowed 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.65 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.507 HG21 HD12 ' A' ' 140' ' ' ILE . 62.9 t -46.54 -39.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 C-N-CA 124.697 1.199 . . . . 0.0 112.248 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -65.93 -41.16 91.73 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.114 0.966 . . . . 0.0 110.316 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.4 m -69.78 -25.79 63.97 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 123.469 0.48 . . . . 0.0 110.512 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.56 -47.91 21.02 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.527 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.426 ' HB3' HD21 ' A' ' 99' ' ' LEU . 84.7 m -75.82 -16.9 60.02 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 43.7 p -101.63 -33.22 9.98 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 118.403 0.547 . . . . 0.0 111.66 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 47' ' ' ILE . 19.9 t70 -83.45 112.41 39.12 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 122.75 0.42 . . . . 0.0 110.004 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.472 ' HB2' ' HG3' ' A' ' 53' ' ' GLU . 58.4 Cg_endo -64.46 -27.34 62.37 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.151 2.568 . . . . 0.0 112.869 -171.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -63.9 -39.34 93.95 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.758 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -79.48 -24.29 42.44 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.59 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 43' ' ' ASP . 79.1 mt -74.82 -38.5 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.59 0.356 . . . . 0.0 111.52 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 10.9 p30 -73.87 -0.42 15.94 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -73.26 -29.94 63.09 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.768 0.827 . . . . 0.0 110.714 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.436 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 40.7 p-90 -129.31 -11.7 4.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.015 0.926 . . . . 0.0 111.484 -171.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.436 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 16.2 t80 -147.96 -163.72 1.84 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.525 0.73 . . . . 0.0 109.13 -174.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 mt -87.1 171.34 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 31.3 tt0 -108.63 121.51 43.05 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.668 1.187 . . . . 0.0 110.12 -172.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.69 84.69 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.337 2.691 . . . . 0.0 111.0 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -77.47 126.22 30.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.989 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.22 -165.89 36.8 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.633 -0.318 . . . . 0.0 112.722 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.84 -37.96 73.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.443 0.697 . . . . 0.0 110.279 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.0 mt 59.22 -171.37 0.12 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.922 1.289 . . . . 0.0 111.885 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 72.59 166.64 0.3 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.882 1.273 . . . . 0.0 110.598 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 41.3 tt0 -60.02 111.7 1.6 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.165 0.586 . . . . 0.0 111.149 -173.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.08 11.52 58.61 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.436 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.34 -146.56 20.36 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.633 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 29.8 p-10 -156.0 160.42 40.03 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 117.571 0.685 . . . . 0.0 111.705 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -140.07 147.91 40.99 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.72 112.17 5.28 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.756 0.823 . . . . 0.0 109.884 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 69' ' ' ASN . 79.1 mt -78.39 146.89 34.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.706 0.802 . . . . 0.0 109.262 172.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -69.41 122.07 18.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.551 0.74 . . . . 0.0 110.631 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 56.69 40.9 89.45 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 124.29 0.994 . . . . 0.0 114.468 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 66' ' ' LEU . 18.4 t-20 -147.17 -84.27 0.11 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.704 0.252 . . . . 0.0 110.402 -171.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.35 151.03 31.19 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.98 0.419 . . . . 0.0 111.707 -171.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -132.0 145.25 51.34 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.224 1.009 . . . . 0.0 109.796 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.19 -163.08 26.99 Favored Glycine 0 C--O 1.241 0.548 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 4.8 p-10 -127.04 173.89 9.3 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.158 0.479 . . . . 0.0 110.731 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.476 ' HA ' HG22 ' A' ' 85' ' ' ILE . 19.6 mm -97.49 102.8 13.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.53 -47.84 71.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -167.66 142.52 3.76 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.794 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 22.0 p -127.36 106.24 9.07 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.64 99.47 8.84 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 9.9 Cg_exo -74.56 137.81 23.3 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.147 2.565 . . . . 0.0 112.984 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 42.7 Cg_endo -100.83 30.53 11.11 Favored 'Cis proline' 0 C--N 1.375 1.932 0 CA-C-N 119.481 0.85 . . . . 0.0 112.153 -9.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -71.34 -69.43 0.38 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.285 1.034 . . . . 0.0 111.998 -170.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -152.95 146.9 25.36 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.417 0.627 . . . . 0.0 111.452 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 99' ' ' LEU . 58.1 tp -98.31 143.99 28.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.702 -1.136 . . . . 0.0 107.954 169.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.9 m -134.79 123.34 23.42 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.476 HG22 ' HA ' ' A' ' 74' ' ' ILE . 21.0 pt -143.74 149.56 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.619 0.768 . . . . 0.0 110.285 -174.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 p -88.16 138.51 31.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 36.8 t-105 -130.2 101.02 5.61 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -170.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -107.91 102.46 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -78.74 154.85 29.68 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.63 111.04 1.45 Allowed 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.065 0.46 . . . . 0.0 111.784 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.04 21.99 66.75 Favored Glycine 0 C--N 1.351 1.361 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.375 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.459 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 69.0 mmtt -126.48 153.14 75.08 Favored Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 123.711 0.805 . . . . 0.0 109.593 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 118' ' ' SER . 23.4 Cg_exo -64.72 162.5 31.39 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.962 2.441 . . . . 0.0 113.506 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.93 103.59 1.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.962 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -100.46 179.29 4.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.824 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -142.42 128.81 20.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.974 0.909 . . . . 0.0 108.634 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.6 t -113.66 121.46 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.241 0.544 . . . . 0.0 110.292 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 37.7 mm-40 -91.41 138.66 31.4 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.906 165.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 83' ' ' LEU . 55.0 tp -127.63 110.57 12.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 171.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -128.97 121.91 29.0 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 122.151 -0.343 . . . . 0.0 110.385 -160.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.514 ' HB3' HG22 ' A' ' 34' ' ' VAL . 90.0 mt -115.61 141.28 48.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.645 0.778 . . . . 0.0 111.233 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.4 t -144.51 115.24 7.74 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.523 1.129 . . . . 0.0 108.791 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -81.96 120.45 25.25 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -129.39 121.81 28.14 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.301 1.44 . . . . 0.0 108.129 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.93 -135.28 16.44 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -102.63 62.57 0.84 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 165.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.471 ' HA3' HH12 ' A' ' 29' ' ' ARG . . . -179.24 -177.79 47.9 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.101 -0.954 . . . . 0.0 114.408 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.3 m -134.26 141.33 46.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.311 1.044 . . . . 0.0 110.081 -170.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.9 tp -102.27 112.98 25.9 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.618 HD23 HE22 ' A' ' 28' ' ' GLN . 7.3 tt -95.89 134.61 38.67 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 173.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.547 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 39.8 mt-10 -132.69 106.28 7.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.591 HD12 HD23 ' A' ' 133' ' ' LEU . 8.9 tt -98.27 122.05 40.96 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.679 ' HB3' ' HB2' ' A' ' 98' ' ' GLU . 38.7 tt0 -122.01 100.78 7.16 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.807 0.843 . . . . 0.0 109.28 -172.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 23' ' ' SER . 8.3 t60 -99.29 113.77 26.25 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 22' ' ' ARG . . . -104.38 111.74 24.51 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.714 1.206 . . . . 0.0 111.095 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.437 HG21 ' HG ' ' A' ' 122' ' ' LEU . 10.6 t -136.99 160.76 37.97 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 170.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.426 HG21 HD13 ' A' ' 16' ' ' ILE . 66.8 p -86.13 -15.08 42.24 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.582 1.153 . . . . 0.0 111.489 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.482 ' HB2' ' HG2' ' A' ' 93' ' ' PRO . 46.4 t -87.17 108.98 19.15 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.062 0.545 . . . . 0.0 109.797 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.503 ' HA ' HD13 ' A' ' 122' ' ' LEU . 39.7 tt0 -62.03 -31.04 71.4 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.787 0.835 . . . . 0.0 110.796 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -61.24 -58.05 9.88 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.158 175.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.459 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 24.3 ttt -64.16 -26.92 68.74 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.706 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 119' ' ' GLU . 13.8 mt -65.15 -44.6 88.05 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.463 0.705 . . . . 0.0 111.864 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.89 -45.44 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.256 0.551 . . . . 0.0 109.81 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.79 -50.5 72.14 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.042 1.337 . . . . 0.0 112.081 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.514 HG23 HG12 ' A' ' 24' ' ' ILE . 35.8 m -72.03 -29.37 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.876 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.7 -38.23 91.36 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 172.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.457 ' O ' ' HG2' ' A' ' 131' ' ' MET . 59.6 t -75.69 -59.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.051 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.63 -37.04 94.15 Favored Glycine 0 C--N 1.345 1.038 0 O-C-N 123.725 0.64 . . . . 0.0 114.446 -172.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.464 ' HB2' ' O ' ' A' ' 125' ' ' VAL . 10.7 m95 -67.05 -53.38 31.68 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -57.76 -31.47 66.53 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.156 0.285 . . . . 0.0 110.746 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 95.7 mmm -61.48 -48.45 81.06 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.204 0.602 . . . . 0.0 110.331 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.31 -38.96 85.32 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.26 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.591 HD23 HD12 ' A' ' 112' ' ' LEU . 2.8 mm? -77.37 -19.88 55.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.985 0.514 . . . . 0.0 111.731 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 138' ' ' MET . 72.0 m-20 -66.82 -53.5 32.08 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.403 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 68.9 m-85 -72.59 -25.4 61.31 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.749 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.1 tp -70.39 -39.21 74.64 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.428 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -58.14 -39.41 92.19 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.615 171.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 89.3 mmm -70.22 -38.16 75.17 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.531 0.732 . . . . 0.0 110.183 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -69.01 -37.26 78.57 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.2 1.0 . . . . 0.0 111.276 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.507 HD12 HG21 ' A' ' 37' ' ' VAL . 50.5 mt -80.03 -57.42 5.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 123.338 0.655 . . . . 0.0 110.193 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.512 ' HD3' ' HB3' ' A' ' 31' ' ' ASP . 21.2 ttt180 -163.42 69.52 0.21 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.709 0.766 . . . . 0.0 110.179 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -154.41 4.35 0.27 Allowed Glycine 0 CA--C 1.527 0.787 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.107 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 65.94 94.77 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.804 1.242 . . . . 0.0 111.268 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.22 121.83 62.37 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 124.467 1.107 . . . . 0.0 110.463 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.49 92.7 0.35 Allowed 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.01 2.473 . . . . 0.0 111.464 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.62 88.67 1.38 Allowed Glycine 0 C--O 1.242 0.615 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.872 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.72 -129.82 1.23 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-O 118.882 -0.955 . . . . 0.0 111.818 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.22 -19.01 39.25 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.694 2.263 . . . . 0.0 113.037 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.9 t 65.69 127.98 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 C-N-CA 125.584 1.553 . . . . 0.0 110.098 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -41.71 -58.53 1.11 Allowed 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 124.278 3.319 . . . . 0.0 114.749 -171.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.4 -18.03 13.65 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.9 0.88 . . . . 0.0 110.563 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.9 t70 67.54 7.58 5.72 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.932 1.293 . . . . 0.0 112.037 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 56.33 23.89 7.74 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.892 1.277 . . . . 0.0 111.962 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.69 170.97 8.83 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.893 0.877 . . . . 0.0 111.324 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -93.34 70.39 4.36 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 122.6 1.19 . . . . 0.0 110.169 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -105.5 79.51 1.47 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.071 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -76.51 84.0 3.21 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.146 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 44.0 mt-10 -118.61 147.63 42.47 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.58 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.507 ' HA ' ' SD ' ' A' ' 164' ' ' MET . 5.1 Cg_exo -79.97 38.33 0.74 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.594 2.863 . . . . 0.0 114.04 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.2 m -66.49 105.55 0.86 Allowed Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.506 0.723 . . . . 0.0 109.258 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -57.2 -35.94 98.99 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.249 2.632 . . . . 0.0 114.019 -165.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.82 -54.0 22.5 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 6.7 tpt -62.75 -37.61 87.28 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.028 0.531 . . . . 0.0 110.835 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.507 ' SD ' ' HA ' ' A' ' 159' ' ' PRO . 88.8 mtp -60.79 -55.51 32.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.969 0.507 . . . . 0.0 109.844 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -58.14 -49.66 76.21 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.912 0.757 . . . . 0.0 111.071 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 61.8 mt -55.59 -47.61 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.254 0.622 . . . . 0.0 110.943 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 62.2 p -70.69 -39.76 73.32 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.235 0.334 . . . . 0.0 110.52 -171.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 164' ' ' MET . 21.6 mt-30 -59.7 -59.7 5.02 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.293 170.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -43.17 -36.75 1.82 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 172.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -64.77 -52.36 57.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.248 0.619 . . . . 0.0 110.733 175.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.25 -20.01 75.92 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.264 -174.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -81.37 -28.17 34.54 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.63 1.172 . . . . 0.0 110.088 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.25 -48.76 55.44 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.405 ' CZ3' ' HB ' ' A' ' 24' ' ' ILE . 91.7 m95 -69.05 -23.1 64.01 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.035 177.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.01 -61.08 2.24 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 173.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -47.11 -47.1 23.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.837 1.255 . . . . 0.0 112.733 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 56.6 mt -64.83 -46.51 81.61 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.592 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.9 p -74.57 -26.94 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 118.867 0.758 . . . . 0.0 109.953 -169.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -76.29 -10.09 59.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.64 0.776 . . . . 0.0 111.583 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.6 t -85.69 -21.89 28.11 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.593 0.757 . . . . 0.0 109.54 168.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -80.65 -41.78 10.73 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.446 172.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.247 0.938 0 C-N-CA 124.5 1.12 . . . . 0.0 108.063 176.564 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.05 98.04 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.978 1.311 . . . . 0.0 110.923 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.3 m -128.95 103.47 7.04 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.594 0.757 . . . . 0.0 109.9 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.76 80.74 1.31 Allowed Glycine 0 C--N 1.345 1.038 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 61.94 68.53 0.68 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.359 1.064 . . . . 0.0 110.749 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.51 75.34 4.06 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.382 0.611 . . . . 0.0 110.645 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 m -89.11 130.92 35.47 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.824 0.85 . . . . 0.0 111.161 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 19.8 mt-10 -119.16 109.13 15.52 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 173.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -82.48 136.13 34.97 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.047 0.539 . . . . 0.0 110.259 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.13 179.44 9.23 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 123.843 0.714 . . . . 0.0 110.144 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.544 ' HG ' ' HA ' ' A' ' 178' ' ' VAL . 0.2 OUTLIER -143.61 148.46 35.89 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.55 166.28 23.91 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.436 ' HD3' ' H ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -110.33 148.53 31.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.623 ' HG2' ' HB1' ' A' ' 115' ' ' ALA . 6.5 tpt180 -148.33 150.3 33.35 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.206 0.527 . . . . 0.0 112.134 -164.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.3 m -111.13 137.9 48.22 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 161.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 pt -140.03 159.77 63.01 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -51.1 -26.59 19.62 Favored 'Trans proline' 0 C--N 1.386 2.549 0 C-N-CA 123.065 2.51 . . . . 0.0 114.294 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.71 -44.81 63.52 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.029 0.532 . . . . 0.0 111.307 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.43 -151.21 21.71 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.071 0.232 . . . . 0.0 112.609 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -73.75 123.14 23.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.409 0.684 . . . . 0.0 109.644 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.03 166.95 19.07 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.542 0.737 . . . . 0.0 111.205 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -125.15 171.78 10.03 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 162.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.9 m -134.45 135.67 42.67 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.289 0.636 . . . . 0.0 109.797 -170.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.521 HG12 ' HB3' ' A' ' 114' ' ' HIS . 35.4 pt -85.91 133.69 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 168.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.652 HG13 ' HG2' ' A' ' 113' ' ' GLU . 2.0 mp -110.57 111.8 37.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 174.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.5 mt -107.29 106.65 21.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 168.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 28.4 mtt180 -89.74 161.19 16.18 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.547 174.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 110' ' ' LEU . 4.2 tp-100 -162.11 117.88 1.98 Allowed 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.337 -174.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.3 mmt85 -95.4 105.68 17.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 165.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.534 ' HB2' ' HB ' ' A' ' 108' ' ' THR . 50.3 m-85 -87.58 150.7 23.53 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 123.857 0.863 . . . . 0.0 109.398 169.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -114.66 85.74 2.3 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 162.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 179.71 137.45 0.28 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.932 2.093 . . . . 0.0 105.617 -163.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.46 137.07 78.37 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.76 2.307 . . . . 0.0 113.286 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.572 HG22 HG23 ' A' ' 108' ' ' THR . 54.3 t -48.99 -40.47 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 124.329 1.018 . . . . 0.0 110.528 167.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -48.88 -45.48 41.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.474 1.109 . . . . 0.0 111.308 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.11 -25.64 34.27 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.451 HG22 HD12 ' A' ' 140' ' ' ILE . 50.6 t -72.29 -44.18 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.074 0.464 . . . . 0.0 110.359 174.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -68.51 -28.02 66.64 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.593 1.157 . . . . 0.0 109.726 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 t -65.79 -48.27 72.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.932 0.893 . . . . 0.0 109.928 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.23 -28.41 63.14 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.338 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.3 t -76.95 -24.39 52.35 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.6 p -111.18 -43.01 3.8 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -172.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' O ' HG13 ' A' ' 47' ' ' ILE . 15.0 t70 -76.66 120.07 80.11 Favored Pre-proline 0 N--CA 1.483 1.22 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.917 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.1 -46.54 30.42 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.903 3.069 . . . . 0.0 114.391 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.426 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 41.3 t-20 -58.65 -32.64 69.26 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.768 0.827 . . . . 0.0 111.314 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -89.82 -20.06 23.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.219 0.608 . . . . 0.0 111.217 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 43' ' ' ASP . 85.7 mt -75.99 -42.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.059 0.544 . . . . 0.0 110.331 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.426 ' ND2' ' HA ' ' A' ' 45' ' ' ASN . 10.6 p30 -69.78 -0.89 7.86 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -172.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -91.82 -11.06 37.63 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.365 0.666 . . . . 0.0 110.246 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.434 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 57.9 p-90 -137.17 -25.21 1.07 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.3 1.04 . . . . 0.0 111.338 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.434 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 5.1 t80 -130.66 -160.66 1.06 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.329 1.052 . . . . 0.0 108.523 -177.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.62 143.64 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 122.833 0.453 . . . . 0.0 110.661 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -63.6 115.06 15.59 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 124.753 1.283 . . . . 0.0 109.767 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -83.07 148.06 13.25 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.446 2.097 . . . . 0.0 112.877 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -134.96 125.87 27.49 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.61 -175.45 39.82 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 121.507 -0.377 . . . . 0.0 112.902 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.8 -44.06 86.82 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.177 0.574 . . . . 0.0 110.307 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.6 mt 66.95 5.15 3.88 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.133 1.373 . . . . 0.0 113.126 171.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -103.71 168.1 9.36 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.297 0.639 . . . . 0.0 109.917 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.434 ' HG2' ' H ' ' A' ' 77' ' ' CYS . 31.2 mt-10 -58.56 122.76 14.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.746 0.819 . . . . 0.0 110.794 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.35 13.94 77.57 Favored Glycine 0 N--CA 1.469 0.862 0 CA-C-N 116.467 -0.333 . . . . 0.0 113.112 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.95 -168.17 19.03 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.299 -0.32 . . . . 0.0 112.299 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -117.31 167.24 11.41 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.564 0.746 . . . . 0.0 110.095 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -146.95 149.4 33.11 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.15 116.3 9.44 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.203 0.601 . . . . 0.0 111.032 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.3 mt -91.7 133.58 35.46 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.672 1.189 . . . . 0.0 109.3 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -68.23 106.08 2.32 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.565 1.146 . . . . 0.0 110.0 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.81 40.55 84.94 Favored Glycine 0 C--N 1.348 1.206 0 N-CA-C 114.385 0.514 . . . . 0.0 114.385 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -144.54 -86.77 0.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.579 0.352 . . . . 0.0 110.128 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.69 156.31 42.64 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 120.773 0.321 . . . . 0.0 111.631 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.1 m -131.0 143.21 50.55 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.222 1.009 . . . . 0.0 108.538 174.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.93 -153.81 8.09 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.431 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 2.4 m-20 -121.36 171.07 9.02 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.771 0.828 . . . . 0.0 109.828 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.447 ' HA ' HG22 ' A' ' 85' ' ' ILE . 3.5 mp -108.24 112.65 41.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 170.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.573 HD11 HG22 ' A' ' 84' ' ' THR . 74.9 mt -69.95 -49.97 46.53 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.451 ' HD2' ' HB ' ' A' ' 84' ' ' THR . 0.1 OUTLIER -168.65 154.88 6.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.059 0.944 . . . . 0.0 109.376 169.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.434 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 24.9 p -146.31 120.36 9.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -121.23 110.14 34.61 Favored Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 16.8 Cg_exo -68.38 129.52 19.28 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.851 2.367 . . . . 0.0 112.693 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 19.9 Cg_endo -103.42 23.96 13.15 Favored 'Cis proline' 0 C--N 1.376 2.014 0 CA-C-N 120.048 1.053 . . . . 0.0 112.626 -13.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -64.18 -67.14 0.46 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.0 0.92 . . . . 0.0 112.006 -171.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -138.03 158.42 44.36 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.588 0.755 . . . . 0.0 110.651 -171.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 tt -142.32 127.5 18.61 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 171.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.573 HG22 HD11 ' A' ' 75' ' ' LEU . 19.3 m -139.46 130.3 26.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.227 0.611 . . . . 0.0 109.378 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.447 HG22 ' HA ' ' A' ' 74' ' ' ILE . 10.4 pt -141.24 146.6 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.026 1.33 . . . . 0.0 109.91 -171.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 73' ' ' ASP . 18.0 p -89.95 145.57 25.02 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.669 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 22.0 t-105 -140.98 107.33 5.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.101 0.864 . . . . 0.0 109.397 -159.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.15 103.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -101.51 94.96 6.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.566 1.146 . . . . 0.0 110.432 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 47.8 -73.1 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 126.618 1.967 . . . . 0.0 115.278 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.6 33.58 2.54 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 117.957 0.344 . . . . 0.0 112.553 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.606 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 72.3 mmtt -115.65 159.31 39.24 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 124.174 0.989 . . . . 0.0 110.656 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.12 161.02 41.93 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.419 2.079 . . . . 0.0 112.759 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.58 107.08 1.97 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.901 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.669 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 13.4 m -87.71 155.58 19.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.188 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -116.51 103.08 10.07 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.63 142.7 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.938 0.895 . . . . 0.0 108.622 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -147.83 156.87 43.18 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.253 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.5 tt -139.81 139.85 36.48 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 21.2 tpt180 -135.25 122.86 22.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.777 0.831 . . . . 0.0 109.521 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.4 mt -115.32 137.86 51.58 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.688 0.795 . . . . 0.0 110.16 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 t -143.98 137.1 27.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.172 0.589 . . . . 0.0 109.898 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -84.97 96.14 9.29 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.528 1.131 . . . . 0.0 110.425 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -100.7 78.23 1.96 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.01 -117.42 4.69 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -91.37 9.73 30.41 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 168.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 30' ' ' TYR . . . -100.82 159.32 19.03 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.485 -173.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.572 HG23 HG22 ' A' ' 34' ' ' VAL . 53.1 m -135.15 108.13 7.62 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.757 1.223 . . . . 0.0 108.63 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.8 tp -81.04 106.04 12.73 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 28' ' ' GLN . 8.1 tt -91.0 130.89 36.88 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 42.4 mt-10 -131.67 107.09 8.57 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 tp -104.23 128.68 51.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.998 0.919 . . . . 0.0 109.636 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.652 ' HG2' HG13 ' A' ' 25' ' ' ILE . 45.5 mt-10 -127.12 103.67 7.56 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.775 0.83 . . . . 0.0 109.43 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.521 ' HB3' HG12 ' A' ' 24' ' ' ILE . 6.8 t60 -92.97 111.7 23.42 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.623 ' HB1' ' HG2' ' A' ' 14' ' ' ARG . . . -109.91 101.79 10.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.141 0.576 . . . . 0.0 110.54 -174.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.409 HG21 ' HG ' ' A' ' 122' ' ' LEU . 9.8 t -123.78 152.22 42.44 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.268 0.556 . . . . 0.0 110.77 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.3 m -66.42 -29.32 69.44 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.367 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 t -92.36 125.43 37.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.096 0.558 . . . . 0.0 111.384 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -62.48 -34.04 76.06 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.56 1.144 . . . . 0.0 110.126 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -44.93 81.78 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.212 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 23.2 ttt -68.48 -32.94 73.29 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.159 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.409 ' HG ' HG21 ' A' ' 116' ' ' THR . 25.5 mt -63.01 -42.52 99.86 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 118.42 0.554 . . . . 0.0 112.104 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.6 t -67.82 -42.13 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-O 121.155 0.502 . . . . 0.0 109.868 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -58.15 -50.17 74.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.18 1.392 . . . . 0.0 111.638 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.4 m -82.6 -18.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.565 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.86 -36.44 92.02 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 169.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.46 -46.81 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 114.669 -0.766 . . . . 0.0 109.94 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.11 -35.81 92.45 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 114.845 0.698 . . . . 0.0 114.845 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -87.67 -28.26 21.93 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.987 0.515 . . . . 0.0 110.853 -176.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.419 ' HG3' ' HD2' ' A' ' 170' ' ' ARG . 43.9 mm-40 -62.45 -38.81 91.22 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 72.4 mtm -70.4 -33.96 71.99 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.926 0.766 . . . . 0.0 110.692 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.67 -46.15 83.67 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.028 0.531 . . . . 0.0 111.054 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.91 -22.2 46.2 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.381 0.673 . . . . 0.0 110.741 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.459 ' O ' ' HG2' ' A' ' 138' ' ' MET . 24.8 t70 -65.49 -62.34 1.58 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 171.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -64.75 -29.64 70.63 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.1 0.56 . . . . 0.0 111.846 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.433 HD12 ' CE2' ' A' ' 50' ' ' TRP . 39.5 tp -67.83 -42.64 81.14 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -61.43 -39.05 96.76 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.9 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 97.3 mmm -69.4 -43.18 73.98 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.766 0.826 . . . . 0.0 110.524 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -68.21 -50.76 52.07 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.342 1.057 . . . . 0.0 111.064 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.451 HD12 HG22 ' A' ' 37' ' ' VAL . 67.0 mt -62.6 -43.52 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.309 0.644 . . . . 0.0 110.756 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER -61.83 -41.17 97.47 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.417 0.687 . . . . 0.0 109.264 178.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.86 -10.96 12.04 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.884 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -86.79 83.26 7.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.028 0.414 . . . . 0.0 110.359 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.4 81.38 3.6 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 174.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -79.74 -172.83 1.64 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.998 2.466 . . . . 0.0 112.685 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.67 71.05 2.17 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.01 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -98.36 106.44 3.27 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.07 120.68 8.73 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.073 2.516 . . . . 0.0 112.808 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.9 m -67.68 148.34 98.56 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.016 0.526 . . . . 0.0 109.62 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -55.83 -35.92 94.54 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.436 2.091 . . . . 0.0 111.679 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -170.29 -34.68 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.821 0.848 . . . . 0.0 110.427 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.2 t70 67.31 79.37 0.23 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.616 1.166 . . . . 0.0 109.347 -170.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -154.18 99.86 2.27 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.01 94.44 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.364 1.066 . . . . 0.0 112.411 -173.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -128.5 121.75 29.58 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.365 1.066 . . . . 0.0 108.851 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -54.34 -34.69 61.6 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.477 1.111 . . . . 0.0 112.935 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -90.45 32.61 0.94 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.555 0.742 . . . . 0.0 111.786 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -54.65 120.1 25.46 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 124.757 1.223 . . . . 0.0 110.056 174.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -88.21 20.08 1.22 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.099 2.532 . . . . 0.0 113.936 -166.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.6 p -98.97 129.43 29.67 Favored Pre-proline 0 C--O 1.239 0.532 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -54.91 -44.14 52.63 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.433 2.756 . . . . 0.0 113.316 -171.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -67.64 -50.94 55.47 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.395 0.435 . . . . 0.0 111.365 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 6.0 tpt -68.0 -41.91 81.54 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.446 0.298 . . . . 0.0 110.372 -173.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 10.6 tmm? -59.28 -43.17 92.55 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.203 1.001 . . . . 0.0 110.746 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.446 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 31.7 tpt180 -64.71 -54.61 28.8 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.243 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 65.1 mt -58.44 -30.27 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.719 0.808 . . . . 0.0 111.192 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 42.1 t -70.24 -54.79 11.26 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.527 ' HG3' ' H ' ' A' ' 169' ' ' GLU . 10.6 pt20 -61.14 -59.77 4.82 Favored 'General case' 0 C--N 1.364 1.207 0 O-C-N 123.676 0.61 . . . . 0.0 111.368 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.527 ' H ' ' HG3' ' A' ' 168' ' ' GLN . 15.8 mm-40 -44.35 -47.84 9.68 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.419 ' HD2' ' HG3' ' A' ' 130' ' ' GLU . 13.7 tpp85 -66.17 -41.3 90.51 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.886 0.474 . . . . 0.0 110.675 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -76.74 -26.66 62.34 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.057 -174.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -75.79 -22.36 56.46 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.994 0.518 . . . . 0.0 110.787 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.54 -47.84 58.39 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.208 0.603 . . . . 0.0 109.413 170.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.4 ' HE1' ' HG3' ' A' ' 130' ' ' GLU . 98.9 m95 -69.31 -26.02 64.52 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.792 0.683 . . . . 0.0 112.005 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.83 -58.13 6.34 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -47.38 -42.66 22.29 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.257 1.023 . . . . 0.0 112.923 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.7 -48.22 75.47 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.698 0.623 . . . . 0.0 111.69 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.544 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 12.0 p -79.22 -29.59 13.8 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 C-N-CA 123.595 0.758 . . . . 0.0 111.427 -167.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -66.98 -31.39 71.93 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.373 0.669 . . . . 0.0 109.967 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 27.2 m -81.56 -33.67 31.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.128 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 79.25 1.16 85.36 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.463 -174.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.8 m . . . . . 0 CA--C 1.552 1.03 0 C-N-CA 124.907 1.283 . . . . 0.0 107.999 -177.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.447 0.642 . . . . 0.0 109.637 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.29 169.74 10.55 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.46 1.104 . . . . 0.0 109.472 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.71 ' HA ' ' HA2' ' A' ' 142' ' ' GLY . 56.2 p -142.0 85.31 1.92 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.121 0.486 . . . . 0.0 110.077 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.56 70.01 3.25 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.614 175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -99.77 87.13 3.46 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.758 0.823 . . . . 0.0 109.844 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -133.32 70.23 1.47 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.373 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 m -96.31 130.02 43.51 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.871 0.868 . . . . 0.0 109.689 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -120.49 110.68 16.77 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.834 0.854 . . . . 0.0 108.75 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.66 149.78 28.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.861 0.363 . . . . 0.0 110.724 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HB1' ' HB ' ' A' ' 25' ' ' ILE . . . -157.65 176.59 12.41 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.391 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 177' ' ' LEU . 1.2 tm? -144.69 149.97 36.52 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.53 -162.1 10.95 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -132.0 140.21 48.87 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.279 1.032 . . . . 0.0 108.918 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -155.0 131.03 10.17 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.527 0.731 . . . . 0.0 109.985 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -79.74 141.94 35.87 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 117' ' ' THR . 49.8 pt -129.61 160.55 64.03 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.083 0.953 . . . . 0.0 109.365 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -54.1 -28.67 51.98 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 123.233 2.622 . . . . 0.0 114.004 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.85 -34.86 60.08 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.565 0.746 . . . . 0.0 111.918 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.98 -148.9 14.92 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-O 120.015 -0.325 . . . . 0.0 112.321 -175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -87.92 135.38 33.43 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.49 162.97 30.44 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.815 0.446 . . . . 0.0 111.781 -175.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.543 HH11 HG23 ' A' ' 178' ' ' VAL . 91.0 mtt180 -102.44 159.0 15.81 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 166.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.6 p -133.7 125.94 29.7 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -172.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.494 ' HB ' ' CZ3' ' A' ' 174' ' ' TRP . 27.7 pt -85.96 135.2 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 3.5 mp -117.98 116.77 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.459 HD11 ' HB3' ' A' ' 129' ' ' TRP . 38.1 mt -106.99 107.19 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.568 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 95.1 mtt180 -91.97 161.68 14.7 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.705 174.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 5.6 tt0 -167.29 116.6 0.83 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 125.233 1.583 . . . . 0.0 109.951 176.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -92.23 108.42 19.94 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.514 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 60.5 m-85 -92.3 144.2 25.63 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.767 1.227 . . . . 0.0 111.507 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -102.26 72.91 1.32 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 162.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 30' ' ' TYR . . . -166.32 141.26 3.7 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.752 1.621 . . . . 0.0 106.639 -163.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.33 141.92 32.73 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 121.953 1.769 . . . . 0.0 112.579 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' A' ' 80' ' ' PRO . 56.5 t -50.89 -43.69 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 124.487 1.117 . . . . 0.0 111.742 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -54.11 -35.6 62.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 124.462 1.101 . . . . 0.0 111.514 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -78.57 -32.56 47.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 t -74.63 -30.05 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 123.784 0.677 . . . . 0.0 110.171 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -78.21 -25.93 47.25 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.149 0.979 . . . . 0.0 110.425 177.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.8 m -65.67 -50.93 63.13 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.545 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -59.9 -37.68 80.1 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.421 0.688 . . . . 0.0 112.119 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.78 -45.51 93.59 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.0 p -117.58 -39.53 3.14 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -166.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.415 ' O ' HG13 ' A' ' 47' ' ' ILE . 12.1 t70 -69.21 118.16 59.22 Favored Pre-proline 0 N--CA 1.485 1.285 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.38 -33.55 97.55 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.412 2.741 . . . . 0.0 114.217 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -72.37 -23.28 61.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 123.606 0.567 . . . . 0.0 110.574 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.545 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 12.8 mmt85 -87.46 -30.39 20.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.995 0.918 . . . . 0.0 110.876 174.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 43' ' ' ASP . 60.1 mt -71.5 -41.19 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.187 0.595 . . . . 0.0 110.067 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -70.75 4.21 2.67 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -175.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -97.94 -11.44 23.11 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.828 0.851 . . . . 0.0 111.872 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.436 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 42.9 p-90 -139.04 -24.96 0.88 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.307 0.643 . . . . 0.0 111.614 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.436 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 12.9 t80 -132.57 -172.22 2.85 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.717 1.207 . . . . 0.0 108.839 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.13 144.84 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.043 0.937 . . . . 0.0 111.256 -171.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.71 113.53 5.45 Favored Pre-proline 0 CA--C 1.568 1.653 0 O-C-N 125.138 1.524 . . . . 0.0 111.812 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -93.15 121.41 0.43 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.069 2.513 . . . . 0.0 113.307 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' HE2' ' HA ' ' A' ' 55' ' ' LYS . 9.7 mmpt? -112.45 125.33 54.11 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 171.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.33 -171.4 36.55 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.37 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 63' ' ' ASN . 25.0 t70 -71.2 -43.86 66.58 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 123.936 0.433 . . . . 0.0 110.502 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.1 mt 73.64 -17.12 0.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.047 1.739 . . . . 0.0 113.499 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -97.49 164.71 12.33 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.167 0.587 . . . . 0.0 110.973 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.58 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 35.5 tt0 -55.97 126.2 24.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 112.968 -172.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.85 84.52 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.955 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -103.98 -147.48 17.6 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.439 ' H ' ' HB3' ' A' ' 57' ' ' ASP . 35.6 p-10 -148.39 167.65 24.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.43 0.692 . . . . 0.0 111.301 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -144.24 141.63 29.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.22 120.23 26.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.521 0.729 . . . . 0.0 110.493 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.8 mt -106.14 119.98 40.63 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.691 1.196 . . . . 0.0 108.1 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -69.99 123.83 22.52 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.137 0.975 . . . . 0.0 111.33 -171.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.11 31.46 64.07 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.859 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -149.77 -91.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.548 0.339 . . . . 0.0 110.828 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.13 152.46 18.95 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.147 0.499 . . . . 0.0 111.272 -169.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.9 p -137.77 137.29 38.1 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.36 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.6 -162.59 12.31 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 23.7 m-20 -101.22 172.28 7.1 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.34 0.656 . . . . 0.0 110.869 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 mm -106.97 116.68 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.444 HD22 ' HB2' ' A' ' 86' ' ' SER . 85.8 mt -82.09 -51.34 8.09 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.682 0.393 . . . . 0.0 110.951 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.73 120.8 2.42 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -173.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 27.4 p -135.66 110.72 8.88 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.828 0.451 . . . . 0.0 109.941 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -116.57 111.15 41.86 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.89 137.12 23.93 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.75 2.3 . . . . 0.0 113.096 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.509 ' HB2' HG12 ' A' ' 34' ' ' VAL . 27.2 Cg_endo -100.52 30.01 11.92 Favored 'Cis proline' 0 C--N 1.376 1.977 0 CA-C-N 119.413 0.826 . . . . 0.0 111.818 -9.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -65.22 -71.14 0.2 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.109 1.364 . . . . 0.0 111.991 -169.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 15.5 ptt180 -163.11 156.64 19.72 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.804 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.5 tp -111.12 145.5 38.47 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.232 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.439 HG23 HD11 ' A' ' 75' ' ' LEU . 26.1 m -142.01 130.54 22.58 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.83 149.29 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.355 1.062 . . . . 0.0 110.254 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.444 ' HB2' HD22 ' A' ' 75' ' ' LEU . 46.8 t -91.27 133.03 35.75 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 172.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -123.22 95.98 4.82 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -169.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -91.55 104.26 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -72.25 178.34 3.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.051 0.94 . . . . 0.0 109.791 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.37 -4.43 39.36 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.563 0.745 . . . . 0.0 112.858 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.64 57.97 0.06 OUTLIER Glycine 0 C--N 1.351 1.385 0 C-N-CA 121.783 -0.246 . . . . 0.0 112.974 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.452 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 74.5 mmtt -132.75 156.15 80.39 Favored Pre-proline 0 N--CA 1.496 1.844 0 C-N-CA 123.798 0.839 . . . . 0.0 109.645 173.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -86.87 72.06 3.46 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.614 2.209 . . . . 0.0 111.745 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 67.06 149.36 0.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.651 1.58 . . . . 0.0 113.273 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 63.7 m -136.64 127.09 26.74 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.601 ' HB3' ' HB1' ' A' ' 115' ' ' ALA . 4.6 tp10 -94.0 105.66 17.66 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.83 131.98 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -150.43 145.07 25.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.793 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.516 HD12 ' HG ' ' A' ' 110' ' ' LEU . 30.6 tp -107.86 152.52 24.3 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.662 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 31.0 tpt180 -138.28 122.31 17.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.142 0.977 . . . . 0.0 108.395 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HB3' HG11 ' A' ' 34' ' ' VAL . 81.2 mt -121.95 126.86 49.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.671 0.788 . . . . 0.0 109.299 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 m -145.14 125.45 13.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.552 0.741 . . . . 0.0 110.655 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.64 124.93 21.84 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.714 0.806 . . . . 0.0 110.905 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -142.27 128.39 19.71 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.719 0.808 . . . . 0.0 111.08 166.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.87 -135.94 17.23 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.65 -42.95 99.89 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 117.05 0.425 . . . . 0.0 110.923 161.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -107.89 -146.33 12.43 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 115.445 0.938 . . . . 0.0 115.445 -157.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.426 HG21 HG23 ' A' ' 34' ' ' VAL . 99.0 m -130.06 149.85 51.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.664 1.986 . . . . 0.0 109.055 -168.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.3 tp -109.07 127.5 54.19 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 166.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.516 ' HG ' HD12 ' A' ' 99' ' ' LEU . 9.2 tt -100.0 130.57 46.18 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 173.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 42.2 mt-10 -135.12 107.79 7.45 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 54.6 tp -102.51 143.07 32.68 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.258 0.623 . . . . 0.0 109.412 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 32.5 tt0 -132.29 142.24 49.29 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.723 0.809 . . . . 0.0 109.64 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -141.95 116.5 9.67 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.601 ' HB1' ' HB3' ' A' ' 96' ' ' GLU . . . -126.42 111.0 13.94 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.97 0.508 . . . . 0.0 112.012 -168.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 t -141.51 164.5 30.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.863 0.465 . . . . 0.0 110.359 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.498 HG22 HD11 ' A' ' 16' ' ' ILE . 58.1 p -74.73 -28.74 60.91 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.817 0.847 . . . . 0.0 110.695 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.6 t -79.86 110.45 15.24 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.832 0.853 . . . . 0.0 110.804 -175.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.77 -28.28 69.34 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.667 0.787 . . . . 0.0 111.04 171.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -59.02 -55.23 37.87 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.17 0.919 . . . . 0.0 109.189 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.452 ' SD ' ' HG3' ' A' ' 92' ' ' LYS . 12.4 tpt -56.63 -52.23 65.68 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.674 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.8 mt -54.5 -47.93 72.47 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.383 1.073 . . . . 0.0 113.614 -173.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.3 t -70.5 -42.98 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 122.413 0.285 . . . . 0.0 110.32 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.7 -49.9 73.27 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.726 0.811 . . . . 0.0 111.249 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 121' ' ' MET . 21.6 m -71.51 -23.12 22.44 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 C-N-CA 123.203 0.601 . . . . 0.0 110.461 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.71 79.41 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.5 t -78.27 -51.95 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.095 -0.553 . . . . 0.0 109.569 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.15 -31.75 81.74 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.753 0.658 . . . . 0.0 114.161 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.459 ' HB3' HD11 ' A' ' 26' ' ' ILE . 15.0 m95 -79.79 -41.17 27.04 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.2 -34.38 72.08 Favored 'General case' 0 C--N 1.368 1.401 0 CA-C-N 118.271 0.487 . . . . 0.0 110.785 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.8 mmt -68.88 -48.52 63.19 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.767 0.667 . . . . 0.0 109.711 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.03 -46.48 75.29 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.324 0.65 . . . . 0.0 111.519 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.458 HD21 HD23 ' A' ' 112' ' ' LEU . 4.1 mm? -80.54 -23.04 40.27 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.459 0.704 . . . . 0.0 111.329 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.65 -54.07 32.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -69.91 -18.47 63.39 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.46 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.0 tp -76.95 -44.08 32.73 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.082 0.401 . . . . 0.0 110.531 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.442 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -60.74 -34.47 86.84 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.516 ' HE3' ' HA ' ' A' ' 144' ' ' LEU . 91.6 mtp -81.29 -25.7 36.3 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.72 0.808 . . . . 0.0 111.809 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -66.45 -54.83 19.65 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.93 -58.01 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.727 -172.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -152.74 32.66 0.5 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 120.546 0.212 . . . . 0.0 111.367 -169.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.71 ' HA2' ' HA ' ' A' ' 3' ' ' SER . . . -130.19 -5.16 4.33 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-O 119.67 -0.516 . . . . 0.0 113.635 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 60.49 88.77 0.08 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.923 1.289 . . . . 0.0 111.241 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.516 ' HA ' ' HE3' ' A' ' 138' ' ' MET . 2.9 pp -63.38 149.13 92.34 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.089 0.556 . . . . 0.0 110.682 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.03 -20.85 62.68 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.813 2.342 . . . . 0.0 113.728 -171.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.68 29.42 63.47 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.395 173.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -142.2 162.24 27.2 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.477 -0.624 . . . . 0.0 112.738 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.07 105.44 1.93 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.875 2.383 . . . . 0.0 112.101 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.4 m -66.06 111.25 6.05 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 123.096 0.558 . . . . 0.0 110.481 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.13 -24.8 14.42 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.773 2.315 . . . . 0.0 113.157 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -150.44 66.18 0.95 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.769 0.795 . . . . 0.0 109.619 -172.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -88.71 -13.4 39.73 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.971 173.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.0 -42.37 80.17 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 123.207 0.603 . . . . 0.0 109.95 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -158.27 -70.9 0.09 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.519 170.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.05 122.12 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.123 1.369 . . . . 0.0 108.392 -161.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -153.7 1.77 0.25 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.516 0.726 . . . . 0.0 110.286 -177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -78.34 -78.18 0.15 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.635 0.774 . . . . 0.0 109.693 -171.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -171.37 -52.47 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 125.368 1.467 . . . . 0.0 112.29 -170.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.09 -33.52 64.0 Favored 'Trans proline' 0 C--N 1.396 3.076 0 C-N-CA 123.417 2.745 . . . . 0.0 115.61 -164.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.6 t -127.21 85.19 61.57 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.19 -21.25 72.23 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 122.811 2.341 . . . . 0.0 111.974 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -62.1 -56.2 21.22 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.901 173.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 52.1 tpp -73.85 -24.35 59.75 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.256 0.622 . . . . 0.0 110.768 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.439 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 81.9 mtp -58.8 -53.78 54.48 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 171.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.468 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 18.2 tpt180 -61.06 -51.34 69.59 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 123.678 0.611 . . . . 0.0 110.418 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 57.5 mt -51.38 -42.59 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.397 1.079 . . . . 0.0 112.136 -176.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 61.2 p -76.72 -45.92 27.43 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.442 0.464 . . . . 0.0 111.077 -173.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 164' ' ' MET . 14.1 mm100 -46.78 -60.38 2.44 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.033 0.833 . . . . 0.0 110.192 167.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 16.2 mm-40 -42.34 -42.38 3.14 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 20.6 mmt180 -62.59 -59.78 4.45 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.278 0.361 . . . . 0.0 110.346 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.06 -37.42 32.79 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 122.307 -0.246 . . . . 0.0 113.092 -166.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -59.77 -34.98 73.71 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 124.125 0.97 . . . . 0.0 111.181 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.6 -61.25 2.74 Favored 'General case' 0 C--N 1.36 1.038 0 O-C-N 123.932 0.77 . . . . 0.0 109.516 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.494 ' CZ3' ' HB ' ' A' ' 24' ' ' ILE . 95.4 m95 -68.54 -22.56 64.5 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -172.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.17 -63.08 1.13 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.45 ' HA ' ' NE2' ' A' ' 179' ' ' HIS . . . -54.32 -34.7 61.55 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.457 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 37.8 mt -69.07 -46.83 66.84 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 118.988 -0.53 . . . . 0.0 110.072 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.543 HG23 HH11 ' A' ' 22' ' ' ARG . 9.4 p -70.18 -31.6 47.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 CA-C-N 119.117 0.871 . . . . 0.0 109.563 -169.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.45 ' NE2' ' HA ' ' A' ' 176' ' ' ALA . 11.3 p80 -92.45 16.72 11.24 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 58.9 m -73.6 145.42 45.45 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 84.44 39.61 8.91 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 -175.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 CA--C 1.558 1.253 0 C-N-CA 124.301 1.041 . . . . 0.0 109.408 -175.519 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.3 mtp . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.35 119.51 8.29 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.508 0.723 . . . . 0.0 109.487 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -79.45 83.28 5.48 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.57 -58.22 4.99 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -169.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -164.0 150.92 11.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.139 1.376 . . . . 0.0 109.017 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.04 28.08 9.07 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.74 0.816 . . . . 0.0 111.142 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 m -93.83 106.38 18.35 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.778 0.831 . . . . 0.0 110.225 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 30.3 mt-10 -96.02 132.56 41.24 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -101.58 147.23 26.65 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.571 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -154.14 122.56 6.15 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 1.4 tm? -98.98 138.29 36.31 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 169.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.77 -178.45 16.31 Favored Glycine 0 C--N 1.333 0.411 0 O-C-N 123.287 0.367 . . . . 0.0 112.429 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.03 166.96 12.11 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 123.581 0.753 . . . . 0.0 109.658 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.653 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 6.1 tpt180 -163.82 157.07 18.46 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -138.27 94.2 2.84 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 117' ' ' THR . 36.5 pt -88.6 161.88 40.79 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.13 -21.93 13.89 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.13 2.553 . . . . 0.0 114.65 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.63 5.8 37.74 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.435 0.694 . . . . 0.0 112.763 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.38 -178.2 16.44 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 123.09 0.376 . . . . 0.0 112.967 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.53 109.39 5.44 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.111 0.564 . . . . 0.0 109.85 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.85 167.35 10.98 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.543 1.137 . . . . 0.0 110.397 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HB2' HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -101.82 170.52 8.1 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 156.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 p -136.25 133.08 36.63 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 29.8 pt -83.86 145.42 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 166.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.665 HG13 ' HG2' ' A' ' 113' ' ' GLU . 4.1 mp -129.96 105.25 11.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 175.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 58.9 mt -104.57 107.2 21.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.589 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 45.2 mtp85 -98.15 134.52 41.1 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.835 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -141.01 140.38 34.3 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.571 HH11 ' HB2' ' A' ' 109' ' ' LEU . 36.0 mmt180 -98.74 103.76 15.74 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.18 125.87 35.61 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.207 1.003 . . . . 0.0 109.958 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.52 59.81 3.66 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.597 1.189 . . . . 0.0 110.672 171.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.25 150.13 33.92 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 113.316 -1.765 . . . . 0.0 106.77 174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.65 172.24 7.16 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.086 1.857 . . . . 0.0 113.179 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 101' ' ' LEU . 67.8 t -70.87 -41.32 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.412 -173.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -58.77 -43.5 90.4 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.184 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.57 -65.86 0.62 Allowed 'General case' 0 C--N 1.356 0.852 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.057 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.2 t -53.54 -38.26 33.08 Favored 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 124.299 1.04 . . . . 0.0 111.184 -175.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.417 ' HE3' HD13 ' A' ' 101' ' ' LEU . 63.8 t-105 -59.18 -57.2 14.1 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.472 0.709 . . . . 0.0 111.018 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.7 m -59.47 -42.5 92.18 Favored 'General case' 0 C--O 1.21 -1.011 0 O-C-N 124.489 1.118 . . . . 0.0 110.13 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.87 -34.42 73.12 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.414 ' SG ' HD21 ' A' ' 136' ' ' LEU . 84.0 m -85.43 -11.05 55.32 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.993 0.917 . . . . 0.0 113.118 -178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.8 p -113.28 -32.79 6.17 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.329 0.513 . . . . 0.0 112.016 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -66.88 116.82 39.26 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 123.133 0.573 . . . . 0.0 110.506 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.14 -18.31 45.42 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 122.273 1.982 . . . . 0.0 110.991 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -74.81 -15.83 60.73 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.324 1.45 . . . . 0.0 111.3 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -108.55 -21.69 12.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.006 0.522 . . . . 0.0 111.932 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.8 mt -84.88 -32.61 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.253 0.621 . . . . 0.0 110.205 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 28.2 p-10 -60.39 -25.61 66.04 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.092 175.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -63.49 -23.63 67.48 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.509 1.124 . . . . 0.0 112.609 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -128.39 -62.02 1.06 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.059 0.543 . . . . 0.0 112.158 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -102.03 -163.42 1.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.025 0.93 . . . . 0.0 108.979 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.504 HD13 ' ND2' ' A' ' 69' ' ' ASN . 36.7 mt -85.94 131.64 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 11.2 pt-20 -63.36 140.21 97.69 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 126.368 1.867 . . . . 0.0 112.328 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.444 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 85.8 Cg_endo -89.05 99.19 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.045 2.497 . . . . 0.0 111.668 169.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -82.2 162.42 22.4 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.364 0.602 . . . . 0.0 111.885 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.28 -161.76 15.24 Favored Glycine 0 N--CA 1.465 0.575 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.583 -174.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.89 -48.72 67.86 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.574 1.15 . . . . 0.0 111.358 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt 68.44 3.9 4.0 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 125.543 1.537 . . . . 0.0 112.164 -170.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -100.48 147.4 25.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.323 1.049 . . . . 0.0 108.716 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.756 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 32.0 tt0 -62.58 107.71 1.0 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 123.757 0.661 . . . . 0.0 111.625 -172.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.7 -27.99 6.63 Favored Glycine 0 N--CA 1.476 1.343 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.982 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.39 -167.72 42.13 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -125.67 158.9 33.61 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.384 1.592 . . . . 0.0 111.067 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 13.1 p90 -103.92 168.31 9.21 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 157.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.04 115.35 0.83 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.419 1.088 . . . . 0.0 108.873 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 78.9 mt -70.97 169.69 14.35 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.846 0.459 . . . . 0.0 110.513 170.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.44 ' H ' HG23 ' A' ' 52' ' ' ILE . 16.7 tt0 -74.07 107.14 6.09 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.26 0.624 . . . . 0.0 109.33 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 45.41 25.12 1.18 Allowed Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.504 ' ND2' HD13 ' A' ' 52' ' ' ILE . 98.4 m-20 -107.15 -80.3 0.57 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.733 0.766 . . . . 0.0 109.957 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.79 157.03 47.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.275 0.63 . . . . 0.0 110.257 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.1 t -144.78 143.47 30.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.86 149.54 19.21 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -74.07 156.33 37.57 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.449 0.642 . . . . 0.0 110.216 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.636 ' HA ' HG22 ' A' ' 85' ' ' ILE . 19.3 mm -87.42 94.29 4.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.75 -57.47 10.82 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 124.376 1.048 . . . . 0.0 110.901 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -146.45 113.78 6.28 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.496 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.4 p -111.27 125.1 53.47 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 171.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -134.53 81.6 47.92 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.75 140.08 28.7 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.624 2.216 . . . . 0.0 111.895 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.415 ' HB2' HG11 ' A' ' 34' ' ' VAL . 31.1 Cg_endo -94.91 20.54 32.32 Favored 'Cis proline' 0 C--N 1.378 2.091 0 CA-C-N 119.924 1.009 . . . . 0.0 114.358 -3.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 80' ' ' PRO . 5.9 mpt_? -81.89 -84.27 0.11 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -128.1 147.81 50.55 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.741 -0.6 . . . . 0.0 112.035 -164.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.414 ' HB2' ' CH2' ' A' ' 38' ' ' TRP . 65.1 tp -138.18 102.47 4.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.543 1.137 . . . . 0.0 109.251 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.5 m -95.92 119.35 34.27 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 170.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.636 HG22 ' HA ' ' A' ' 74' ' ' ILE . 2.6 pp -128.94 160.5 39.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 124.915 1.286 . . . . 0.0 109.55 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.6 m -81.19 172.13 14.03 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.031 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 34.5 t-105 -154.69 94.26 1.65 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.1 t -105.88 102.95 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -92.3 149.39 21.47 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -90.0 -43.32 10.61 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.268 0.485 . . . . 0.0 111.612 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.14 -37.53 37.27 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.366 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -107.83 161.79 22.04 Favored Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 124.701 1.2 . . . . 0.0 109.085 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.42 ' HG2' ' OG ' ' A' ' 118' ' ' SER . 52.3 Cg_exo -58.16 -176.89 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.337 2.692 . . . . 0.0 114.646 175.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.68 173.55 12.47 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.927 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.5 t -172.78 173.96 3.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.53 0.732 . . . . 0.0 110.537 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -138.19 127.62 24.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.538 1.135 . . . . 0.0 108.289 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.3 t -112.51 143.79 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.698 0.799 . . . . 0.0 109.384 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 33.4 mt-10 -131.65 133.38 44.85 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.81 120.33 31.41 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -120.89 132.59 55.05 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.001 0.92 . . . . 0.0 109.994 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.419 ' HB3' HG13 ' A' ' 34' ' ' VAL . 72.1 mt -130.89 132.42 45.13 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.096 0.959 . . . . 0.0 110.067 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.2 t -155.27 148.2 24.51 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.433 1.093 . . . . 0.0 108.142 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -63.79 148.81 48.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.839 0.856 . . . . 0.0 110.818 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -146.9 111.33 5.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 51.89 -103.67 0.12 Allowed Glycine 0 CA--C 1.536 1.349 0 O-C-N 123.562 0.539 . . . . 0.0 114.246 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.62 -10.21 18.59 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.99 0.916 . . . . 0.0 111.208 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.27 -150.84 8.13 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 123.657 0.646 . . . . 0.0 111.714 -172.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 82.7 m -146.83 136.14 22.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.252 1.021 . . . . 0.0 110.015 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.571 ' HB2' HH11 ' A' ' 29' ' ' ARG . 60.7 tp -90.56 137.54 32.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.84 0.856 . . . . 0.0 109.925 174.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tt -123.72 115.17 20.97 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.697 1.199 . . . . 0.0 107.82 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.589 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 33.4 mt-10 -113.78 108.09 16.62 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.56 HD13 HD23 ' A' ' 133' ' ' LEU . 10.0 tt -105.97 112.27 25.25 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.665 ' HG2' HG13 ' A' ' 25' ' ' ILE . 40.9 mt-10 -93.11 137.79 32.14 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 123.752 0.821 . . . . 0.0 110.719 170.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.441 ' CD2' HG21 ' A' ' 125' ' ' VAL . 6.9 t60 -129.84 121.67 27.18 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.653 ' HB3' ' HG2' ' A' ' 14' ' ' ARG . . . -124.53 118.64 27.05 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.386 0.674 . . . . 0.0 111.824 -167.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 t -151.02 155.93 40.06 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.577 0.751 . . . . 0.0 110.368 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.439 HG22 HD11 ' A' ' 16' ' ' ILE . 75.7 p -79.96 -19.39 48.03 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.42 ' OG ' ' HG2' ' A' ' 93' ' ' PRO . 50.5 m -89.96 122.37 32.92 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.909 0.484 . . . . 0.0 111.349 -174.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -57.83 -45.31 86.37 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.763 1.225 . . . . 0.0 112.545 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.14 -57.92 10.74 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 122.929 0.492 . . . . 0.0 111.068 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.5 ttt -50.38 -35.91 30.24 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 124.284 0.99 . . . . 0.0 112.54 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 22' ' ' ARG . 29.0 mt -61.94 -46.47 89.17 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.678 0.791 . . . . 0.0 112.297 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.404 ' O ' HG21 ' A' ' 127' ' ' VAL . 41.2 t -70.18 -46.93 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -47.93 -52.64 18.72 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.954 1.701 . . . . 0.0 113.132 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.441 HG21 ' CD2' ' A' ' 114' ' ' HIS . 27.9 m -74.94 -25.79 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 123.452 0.47 . . . . 0.0 110.484 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -56.04 -45.97 85.87 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 124.155 0.909 . . . . 0.0 110.829 170.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 123' ' ' VAL . 45.0 t -74.85 -42.32 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.564 0.746 . . . . 0.0 109.678 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.53 -63.1 5.59 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.922 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -64.93 -26.5 68.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.8 0.84 . . . . 0.0 113.005 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -54.26 -51.92 63.02 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.489 0.586 . . . . 0.0 109.858 169.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.449 ' HA ' ' HE2' ' A' ' 131' ' ' MET . 29.2 mmt -68.71 -45.11 72.44 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 124.032 0.833 . . . . 0.0 110.716 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.6 -65.2 0.69 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.722 0.809 . . . . 0.0 111.033 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.56 HD23 HD13 ' A' ' 112' ' ' LEU . 3.8 mm? -62.03 -24.55 67.13 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.92 -43.31 65.53 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 118.676 0.671 . . . . 0.0 110.579 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.495 ' HD1' ' SD ' ' A' ' 138' ' ' MET . 20.9 m-85 -68.9 -26.5 65.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.172 0.589 . . . . 0.0 110.672 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.414 HD21 ' SG ' ' A' ' 41' ' ' CYS . 61.5 tp -66.22 -51.65 55.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.976 0.511 . . . . 0.0 109.866 169.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 141' ' ' ARG . . . -44.55 -43.29 7.76 Favored Glycine 0 N--CA 1.474 1.213 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 168.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.495 ' SD ' ' HD1' ' A' ' 135' ' ' PHE . 85.2 mtp -63.72 -45.95 87.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.882 0.473 . . . . 0.0 110.179 173.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -63.15 -34.92 78.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.775 0.83 . . . . 0.0 111.498 -176.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 25.6 mt -75.94 -48.47 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.96 0.904 . . . . 0.0 111.11 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 137' ' ' GLY . 12.9 ptp180 -76.17 -14.05 60.17 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.87 9.32 57.44 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-O 120.008 -0.329 . . . . 0.0 113.894 177.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -77.09 -13.74 59.91 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.95 0.9 . . . . 0.0 112.106 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.84 104.9 5.95 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -64.13 -33.83 59.75 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 123.247 2.631 . . . . 0.0 113.883 -173.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 175.97 -54.27 0.12 Allowed Glycine 0 N--CA 1.467 0.711 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -112.44 144.95 17.98 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 166.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.62 -30.14 35.43 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.153 1.902 . . . . 0.0 110.376 173.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.5 m -152.23 147.53 19.8 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.442 1.897 . . . . 0.0 107.457 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.99 -38.7 36.25 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.473 2.115 . . . . 0.0 112.621 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -158.3 -0.72 0.1 Allowed 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -176.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.81 50.56 1.84 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.579 0.704 . . . . 0.0 110.359 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -90.33 7.87 36.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.209 1.004 . . . . 0.0 112.554 -167.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 67.29 153.11 0.08 Allowed 'General case' 0 C--N 1.36 1.035 0 C-N-CA 125.217 1.407 . . . . 0.0 111.795 -173.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -153.85 -62.37 0.14 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -148.85 -67.99 0.22 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -120.22 107.2 12.71 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.495 ' HG2' ' HG2' ' A' ' 163' ' ' MET . 15.7 tp10 -87.35 121.58 71.19 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.393 1.077 . . . . 0.0 109.516 -176.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.67 -10.07 25.13 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.862 2.374 . . . . 0.0 114.978 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.2 p -81.99 118.17 71.08 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-N 118.215 0.461 . . . . 0.0 110.481 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -59.1 -35.88 97.15 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 123.521 2.814 . . . . 0.0 113.354 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.409 ' O ' HG13 ' A' ' 166' ' ' ILE . 1.1 mp0 -68.01 -41.96 81.41 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.896 0.478 . . . . 0.0 111.765 -177.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.495 ' HG2' ' HG2' ' A' ' 158' ' ' GLU . 4.9 tpt -66.31 -38.42 87.66 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 117.894 0.315 . . . . 0.0 110.309 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 72.9 mtm -69.03 -30.8 69.24 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.286 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -68.78 -39.44 80.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.894 0.478 . . . . 0.0 110.659 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 162' ' ' GLU . 19.4 mt -73.04 -37.89 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.8 t -61.27 -32.55 72.37 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.537 0.735 . . . . 0.0 111.842 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -90.4 -30.35 17.44 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -60.83 3.07 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.837 0.855 . . . . 0.0 110.259 172.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -67.51 -33.24 74.69 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.595 0.758 . . . . 0.0 110.173 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.69 -58.38 11.49 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.248 172.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.33 -31.34 71.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.676 0.79 . . . . 0.0 111.448 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.7 -62.39 1.83 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.205 0.941 . . . . 0.0 110.174 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -73.17 -20.06 60.98 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.421 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.41 -41.7 80.07 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.528 0.331 . . . . 0.0 110.504 173.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.07 -40.21 78.61 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.564 0.697 . . . . 0.0 109.687 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 74.7 mt -66.46 -47.73 72.17 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.222 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 4.6 p -70.29 -27.01 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 122.586 0.354 . . . . 0.0 111.242 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -75.95 -22.66 55.74 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.301 0.641 . . . . 0.0 110.69 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.5 m -81.31 -22.8 38.27 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.763 0.425 . . . . 0.0 111.051 171.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -98.52 -0.94 57.85 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.588 -0.562 . . . . 0.0 113.893 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.559 1.294 0 C-N-CA 123.216 0.606 . . . . 0.0 111.54 -176.717 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.666 ' HE1' ' HB3' ' A' ' 106' ' ' ASP . 16.4 mmt . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.85 72.08 0.44 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.207 1.003 . . . . 0.0 111.818 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 m -127.35 151.75 48.37 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.018 -171.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.91 -43.74 0.29 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -92.11 28.25 1.93 Allowed 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.646 0.736 . . . . 0.0 111.024 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -110.6 68.29 0.66 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.202 1.001 . . . . 0.0 108.525 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 m -119.69 109.82 16.1 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.071 -173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.37 129.24 48.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -99.32 156.55 16.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.333 0.653 . . . . 0.0 109.37 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.25 -173.99 1.87 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.977 0.511 . . . . 0.0 111.257 -166.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.9 mt -140.67 168.66 19.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.519 1.127 . . . . 0.0 111.112 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.17 -174.93 26.57 Favored Glycine 0 C--O 1.245 0.807 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.837 170.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.15 139.49 24.65 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 123.699 0.799 . . . . 0.0 108.921 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -168.38 163.09 12.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.85 0.86 . . . . 0.0 109.858 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 23.2 m -105.67 113.82 27.61 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 172.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.8 pt -90.69 167.18 16.97 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -49.07 -23.51 6.42 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.917 2.411 . . . . 0.0 115.043 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.07 -8.01 56.15 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.06 177.85 15.1 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 117.66 0.209 . . . . 0.0 112.732 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 45.1 mt-10 -65.19 108.11 1.78 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.158 0.583 . . . . 0.0 110.343 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.23 142.4 34.24 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.368 1.067 . . . . 0.0 111.175 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -85.03 158.52 20.44 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 163.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.8 p -128.74 130.55 47.24 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 122.544 -0.097 . . . . 0.0 110.814 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 pp -86.2 136.09 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -120.38 122.01 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mt -115.2 107.53 23.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.539 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 95.4 mtt180 -92.61 139.44 30.56 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.736 0.815 . . . . 0.0 109.565 172.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 19.7 tt0 -146.51 139.5 25.5 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.818 0.699 . . . . 0.0 109.211 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.39 128.96 43.8 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.446 ' CE2' ' HA2' ' A' ' 137' ' ' GLY . 83.5 m-85 -116.19 116.86 28.58 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.865 0.866 . . . . 0.0 109.44 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -75.64 49.32 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.24 1.019 . . . . 0.0 110.743 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.51 162.34 51.9 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.445 1.498 . . . . 0.0 108.228 -171.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.447 ' O ' HG23 ' A' ' 37' ' ' VAL . 31.7 Cg_exo -62.34 157.77 43.83 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.375 2.05 . . . . 0.0 113.292 172.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 80' ' ' PRO . 99.1 t -76.65 -37.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.497 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -59.65 -42.18 92.2 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.978 0.799 . . . . 0.0 109.649 174.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -62.51 -64.18 1.0 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.373 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.587 HG21 HG22 ' A' ' 140' ' ' ILE . 58.2 t -48.25 -36.29 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.642 1.177 . . . . 0.0 111.763 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.46 ' HE3' HD12 ' A' ' 101' ' ' LEU . 72.1 t-105 -63.59 -59.48 4.57 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.291 0.636 . . . . 0.0 110.16 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.8 m -53.96 -46.36 71.6 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.774 0.671 . . . . 0.0 110.322 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.609 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -50.36 -39.35 46.22 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.366 175.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.544 ' SG ' HD23 ' A' ' 136' ' ' LEU . 58.0 m -102.65 6.35 39.59 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 47.9 p -120.57 -54.96 2.05 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 118.959 0.799 . . . . 0.0 111.723 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.76 137.92 97.3 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.508 1.123 . . . . 0.0 112.017 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -59.2 -42.29 51.72 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.698 2.932 . . . . 0.0 113.557 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -74.45 -6.42 48.18 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.958 0.903 . . . . 0.0 110.827 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.609 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 14.7 mmt180 -100.31 -42.62 6.57 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.741 1.217 . . . . 0.0 110.626 176.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.563 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 58.1 mt -77.32 -38.07 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.769 0.427 . . . . 0.0 111.47 -171.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -62.81 -20.38 64.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.489 0.493 . . . . 0.0 111.8 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -64.83 -27.18 68.7 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.563 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 39.4 p-90 -122.78 -41.91 2.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.107 0.563 . . . . 0.0 112.136 -174.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.434 ' HE2' HD11 ' A' ' 66' ' ' LEU . 2.1 t80 -106.0 -163.57 0.94 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.358 0.663 . . . . 0.0 110.097 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.3 mp -83.48 153.8 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -53.87 119.39 18.79 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.572 1.549 . . . . 0.0 112.164 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.0 101.76 1.47 Allowed 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.348 2.032 . . . . 0.0 110.017 169.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -93.3 164.96 13.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.315 0.646 . . . . 0.0 110.887 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.4 -166.81 12.39 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.565 -174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.604 ' HB2' ' HA3' ' A' ' 62' ' ' GLY . 4.5 m-20 -68.2 -37.64 81.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.286 0.634 . . . . 0.0 110.525 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 49.3 mt 64.83 15.04 9.62 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.896 1.278 . . . . 0.0 112.74 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -125.47 167.52 14.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.827 0.851 . . . . 0.0 110.543 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -50.34 107.2 0.15 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.82 1.248 . . . . 0.0 111.427 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.83 -11.05 56.07 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 112.248 -0.341 . . . . 0.0 112.248 174.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 57' ' ' ASP . . . -88.58 -156.33 30.98 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 169.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -144.33 158.23 43.85 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 118.41 1.105 . . . . 0.0 110.745 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -102.81 169.3 8.69 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 165.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.31 144.94 9.66 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.67 1.188 . . . . 0.0 107.951 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.434 HD11 ' HE2' ' A' ' 51' ' ' PHE . 41.3 mt -131.2 157.09 44.14 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.583 1.153 . . . . 0.0 108.279 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -97.96 127.25 43.79 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -173.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.59 10.81 45.79 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.797 -175.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -124.63 -92.92 0.51 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.839 0.456 . . . . 0.0 110.036 -172.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.39 174.94 12.76 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.19 0.45 . . . . 0.0 111.739 -170.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.5 p -149.78 136.58 19.41 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -154.99 161.66 30.46 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -86.87 155.14 20.37 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.528 0.731 . . . . 0.0 111.049 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.466 ' HA ' HG23 ' A' ' 85' ' ' ILE . 11.6 mm -89.28 91.66 3.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 172.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.411 HD11 HG21 ' A' ' 84' ' ' THR . 42.4 mt -70.39 -49.66 46.73 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.134 0.896 . . . . 0.0 109.691 -171.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -158.84 155.29 27.55 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.834 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 7.8 p -155.79 122.08 5.14 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.399 1.079 . . . . 0.0 108.251 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -121.85 88.86 47.71 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 13.1 Cg_exo -72.62 137.38 27.47 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.74 2.293 . . . . 0.0 113.101 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.467 ' HB2' HG12 ' A' ' 34' ' ' VAL . 83.7 Cg_endo -99.64 31.14 11.3 Favored 'Cis proline' 0 C--N 1.374 1.909 0 CA-C-N 119.283 0.78 . . . . 0.0 112.339 -10.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -68.92 -75.14 0.11 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.631 1.172 . . . . 0.0 111.278 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -158.74 160.23 36.12 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.881 0.472 . . . . 0.0 111.337 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.83 146.27 50.48 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.308 1.043 . . . . 0.0 108.28 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.411 HG21 HD11 ' A' ' 75' ' ' LEU . 32.6 m -123.44 111.94 16.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 166.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.466 HG23 ' HA ' ' A' ' 74' ' ' ILE . 22.7 pt -113.64 144.53 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.683 1.193 . . . . 0.0 108.256 173.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.4 t -83.31 172.73 12.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.804 0.335 . . . . 0.0 111.25 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.696 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 25.0 t-105 -153.42 110.25 3.42 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.607 -171.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.7 t -116.39 103.45 15.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 168.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 18.2 t80 -77.83 90.9 4.09 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 63.14 -82.55 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.751 0.82 . . . . 0.0 110.155 -174.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.85 30.22 1.24 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 48.2 mmtm -95.01 162.62 24.37 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.401 1.081 . . . . 0.0 110.21 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -35.32 129.0 0.28 Allowed 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 125.039 3.826 . . . . 0.0 115.576 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.4 148.13 42.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.98 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.696 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.7 m -145.08 143.86 30.65 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.441 -174.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.51 111.75 24.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.979 0.912 . . . . 0.0 109.185 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 50.8 t -93.95 119.3 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -117.92 131.18 56.55 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.9 tp -125.63 125.4 43.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -130.24 124.18 31.87 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.97 0.508 . . . . 0.0 110.173 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.46 HD12 ' HE3' ' A' ' 38' ' ' TRP . 62.8 mt -120.95 133.03 55.27 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.656 1.182 . . . . 0.0 109.335 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.9 m -144.59 145.64 31.9 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.102 0.961 . . . . 0.0 109.09 177.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.24 141.54 58.18 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.177 0.991 . . . . 0.0 111.17 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -136.74 101.49 4.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.63 -98.55 0.05 OUTLIER Glycine 0 CA--C 1.541 1.658 0 CA-C-N 118.846 0.748 . . . . 0.0 111.868 -166.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.666 ' HB3' ' HE1' ' A' ' 1' ' ' MET . 31.9 t70 -125.86 15.22 8.02 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.132 0.968 . . . . 0.0 110.534 176.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -113.9 -155.66 11.58 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.167 0.889 . . . . 0.0 111.603 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.5 m -147.7 136.39 21.85 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.709 1.204 . . . . 0.0 109.393 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.3 tp -91.55 127.04 36.84 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 164.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.431 ' HA ' HD21 ' A' ' 101' ' ' LEU . 9.7 tt -108.05 123.26 48.41 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.539 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 31.5 mt-10 -119.68 106.18 11.9 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 169.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.5 tt -103.99 102.56 12.33 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -95.74 142.62 27.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.541 1.137 . . . . 0.0 109.659 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.464 ' CD2' HG21 ' A' ' 125' ' ' VAL . 5.8 t60 -132.74 116.15 16.22 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 171.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.57 117.94 35.41 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.905 0.882 . . . . 0.0 111.383 -174.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.551 HG23 ' HG3' ' A' ' 121' ' ' MET . 8.0 t -146.19 161.31 40.51 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.449 0.7 . . . . 0.0 110.594 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 74.2 p -88.65 -19.97 25.52 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.653 -167.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 m -101.96 133.23 47.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.299 0.64 . . . . 0.0 111.469 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -59.12 -47.78 84.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.552 1.141 . . . . 0.0 113.166 -174.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -64.06 -52.42 59.44 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.816 0.28 . . . . 0.0 110.884 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.551 ' HG3' HG23 ' A' ' 116' ' ' THR . 15.2 tpt -46.16 -37.02 6.47 Favored 'General case' 0 CA--C 1.563 1.472 0 O-C-N 124.152 0.908 . . . . 0.0 111.702 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.429 ' HG ' HG21 ' A' ' 116' ' ' THR . 22.5 mt -67.24 -50.45 60.55 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.79 0.836 . . . . 0.0 112.012 176.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 127' ' ' VAL . 61.7 t -61.49 -56.2 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -47.61 -50.94 22.92 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.73 1.612 . . . . 0.0 113.273 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.464 HG21 ' CD2' ' A' ' 114' ' ' HIS . 33.2 m -72.02 -31.68 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 119.799 -0.144 . . . . 0.0 111.155 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.57 -34.48 90.01 Favored Glycine 0 C--N 1.35 1.313 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 123' ' ' VAL . 97.6 t -71.8 -51.8 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.05 -59.72 8.46 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.694 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -54.31 -32.91 57.69 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 173.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -66.3 -35.3 80.04 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 120.41 1.459 . . . . 0.0 111.957 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -60.78 -52.73 63.87 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 167.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.5 -27.83 64.82 Favored 'General case' 0 C--O 1.208 -1.105 0 C-N-CA 124.127 0.971 . . . . 0.0 112.045 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.31 -27.71 22.71 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.32 0.648 . . . . 0.0 109.914 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.01 -48.67 34.32 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -62.64 -42.56 99.67 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.637 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.544 HD23 ' SG ' ' A' ' 41' ' ' CYS . 51.0 tp -66.14 -27.61 68.17 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.82 0.848 . . . . 0.0 111.303 176.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.446 ' HA2' ' CE2' ' A' ' 30' ' ' TYR . . . -73.89 -46.57 22.69 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.403 ' HB3' ' HB2' ' A' ' 143' ' ' ASP . 86.4 mtp -60.84 -41.2 95.33 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.589 -1.305 . . . . 0.0 110.807 172.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -62.59 -54.57 37.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.607 0.763 . . . . 0.0 111.416 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.587 HG22 HG21 ' A' ' 37' ' ' VAL . 64.1 mt -71.0 -26.95 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.247 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -78.39 -28.27 46.9 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.882 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.48 -7.53 20.43 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 114.052 0.381 . . . . 0.0 114.052 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 138' ' ' MET . 1.0 OUTLIER -61.16 -45.0 96.43 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.31 1.044 . . . . 0.0 110.614 179.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.2 tp -103.52 105.36 46.76 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.059 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.11 -25.79 8.35 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.345 2.03 . . . . 0.0 111.454 170.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.01 135.8 1.99 Allowed Glycine 0 C--O 1.245 0.79 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.77 83.57 0.04 OUTLIER Glycine 0 C--N 1.336 0.579 0 CA-C-O 119.553 -0.582 . . . . 0.0 112.034 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -89.28 -158.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 123.067 2.511 . . . . 0.0 110.651 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.9 m -83.05 107.46 9.62 Favored Pre-proline 0 CA--C 1.56 1.337 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 162.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.84 -68.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.151 2.568 . . . . 0.0 112.896 -175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -151.95 20.14 0.68 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.661 0.385 . . . . 0.0 111.353 -174.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -53.55 -46.4 70.2 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.627 0.771 . . . . 0.0 111.426 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 59.56 13.01 3.08 Favored 'General case' 0 CA--C 1.556 1.176 0 O-C-N 124.492 1.12 . . . . 0.0 112.16 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.03 88.85 7.18 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.275 1.03 . . . . 0.0 110.474 -171.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -111.0 -51.48 2.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.294 -176.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.62 -46.62 0.41 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.016 0.526 . . . . 0.0 112.406 -169.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -68.33 -30.1 69.0 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.836 0.454 . . . . 0.0 110.273 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -86.87 124.41 69.04 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.02 56.1 5.71 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.887 2.392 . . . . 0.0 110.322 173.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.6 m -61.63 107.63 1.21 Allowed Pre-proline 0 C--O 1.21 -0.991 0 C-N-CA 124.579 1.152 . . . . 0.0 109.762 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -64.34 -37.25 40.89 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.8 2.334 . . . . 0.0 113.77 -163.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.473 ' O ' HG12 ' A' ' 166' ' ' ILE . 46.4 mt-10 -72.89 -51.16 19.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.834 0.454 . . . . 0.0 110.018 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.3 tpp -63.41 -29.12 70.46 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.234 0.614 . . . . 0.0 111.133 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 37.5 mmm -63.31 -52.89 60.06 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 169' ' ' GLU . 41.2 ttp180 -53.5 -48.78 68.65 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 124.734 1.271 . . . . 0.0 110.772 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.526 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 32.5 mm -65.2 -45.4 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 O-C-N 123.64 0.588 . . . . 0.0 110.055 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 39.6 t -72.66 -19.72 61.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.376 0.67 . . . . 0.0 112.631 -175.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.48 -31.71 17.54 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.116 0.416 . . . . 0.0 110.342 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 165' ' ' ARG . 66.1 mt-10 -50.59 -56.4 11.94 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.39 0.614 . . . . 0.0 110.399 166.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 2.0 mmt180 -73.62 -39.74 64.33 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.113 -175.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -55.35 -55.15 29.89 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.735 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.29 -42.14 90.58 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.878 0.871 . . . . 0.0 111.038 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.53 -54.26 45.49 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.225 0.953 . . . . 0.0 111.799 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -70.22 -25.89 63.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.437 0.695 . . . . 0.0 111.847 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.08 83.82 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.995 0.426 . . . . 0.0 109.86 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -68.69 -35.96 77.88 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.8 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 55.5 mt -72.58 -53.82 10.85 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.232 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -66.28 -32.32 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 122.999 0.519 . . . . 0.0 112.003 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -76.66 -7.09 54.62 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.077 0.551 . . . . 0.0 111.501 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 18.4 m -114.74 -163.64 0.89 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.696 1.198 . . . . 0.0 109.262 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 155.32 -66.97 0.31 Allowed Glycine 0 C--N 1.346 1.134 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 173.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 52.7 m . . . . . 0 C--O 1.252 1.203 0 C-N-CA 124.379 1.072 . . . . 0.0 108.263 176.427 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.0 ttm . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.27 -54.69 15.87 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.271 0.628 . . . . 0.0 109.95 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.5 t 65.21 173.39 0.21 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.943 1.297 . . . . 0.0 112.434 175.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.97 56.05 0.05 OUTLIER Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.31 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 29' ' ' ARG . 27.9 pt20 -70.66 84.26 0.63 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.389 1.09 . . . . 0.0 111.203 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.14 163.09 38.6 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.223 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.6 m -97.4 136.75 37.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.203 1.001 . . . . 0.0 110.306 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 20.1 mp0 -123.95 107.81 11.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 172.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.589 HH22 ' HA ' ' A' ' 170' ' ' ARG . 98.2 mtt180 -74.47 161.75 29.49 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.544 0.211 . . . . 0.0 110.602 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.54 177.99 5.64 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.621 0.768 . . . . 0.0 110.323 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.2 mt -133.22 158.91 41.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.414 1.086 . . . . 0.0 109.413 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.16 138.15 5.24 Favored Glycine 0 C--O 1.223 -0.59 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 173.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -91.7 137.76 32.11 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.5 tpt85 -138.99 128.46 24.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.741 0.816 . . . . 0.0 109.507 -168.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -85.67 136.6 33.3 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 117' ' ' THR . 47.5 pt -129.62 159.14 71.05 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -177.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -48.07 -37.01 29.57 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.125 2.55 . . . . 0.0 114.285 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.64 77.13 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.468 0.707 . . . . 0.0 112.443 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.18 -150.82 20.49 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.16 137.88 33.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.82 164.58 27.25 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.777 0.831 . . . . 0.0 109.122 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -120.58 157.56 29.24 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 3.6 m -128.87 145.63 51.16 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 122.682 0.393 . . . . 0.0 110.792 -174.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 2.8 pp -98.05 135.57 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.408 HG13 ' HB3' ' A' ' 113' ' ' GLU . 2.2 mp -121.42 126.24 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 129' ' ' TRP . 57.0 mt -110.48 108.91 26.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.568 ' HB3' HD11 ' A' ' 109' ' ' LEU . 58.9 mtp180 -91.05 153.11 20.35 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -168.88 129.79 1.18 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 125.164 1.54 . . . . 0.0 111.219 174.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 9.7 mpt_? -87.26 105.41 17.21 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 172.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -79.21 150.64 31.57 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.995 0.518 . . . . 0.0 110.118 170.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -87.78 27.03 1.2 Allowed 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.989 0.9 . . . . 0.0 110.325 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.77 148.67 70.87 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.32 1.048 . . . . 0.0 109.782 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.56 165.04 33.18 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.241 2.627 . . . . 0.0 113.147 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.6 t -51.26 -44.63 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 114.053 -1.431 . . . . 0.0 112.616 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -56.18 -39.36 72.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.291 0.995 . . . . 0.0 110.071 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -75.49 -36.57 60.59 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.685 0.794 . . . . 0.0 111.167 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.3 -30.48 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.385 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -74.76 -20.7 59.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.192 0.997 . . . . 0.0 109.998 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.5 m -72.17 -47.41 51.02 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.25 77.12 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.298 0.639 . . . . 0.0 111.91 172.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.0 t -63.31 -52.3 62.52 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 59.4 p -94.91 -41.16 9.32 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -167.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.447 ' O ' HG13 ' A' ' 47' ' ' ILE . 26.4 t70 -81.68 115.23 55.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 122.972 0.509 . . . . 0.0 110.889 -169.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.11 -20.39 71.07 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.47 2.78 . . . . 0.0 114.094 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -74.16 -31.2 62.61 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -84.11 -30.02 26.29 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.821 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 43' ' ' ASP . 91.2 mt -71.43 -43.37 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.263 0.625 . . . . 0.0 110.371 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -65.52 -3.29 4.25 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -86.64 -43.06 12.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.891 0.876 . . . . 0.0 110.364 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.437 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 49.7 p-90 -114.65 -25.08 8.45 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.137 0.975 . . . . 0.0 111.414 -173.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.437 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 11.1 t80 -129.55 -171.89 2.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.505 1.122 . . . . 0.0 109.104 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.6 mt -89.5 139.99 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.614 0.766 . . . . 0.0 111.41 -173.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.6 ' HG2' ' HZ2' ' A' ' 55' ' ' LYS . 44.4 tt0 -64.46 110.5 4.07 Favored Pre-proline 0 CA--C 1.566 1.576 0 O-C-N 125.348 1.655 . . . . 0.0 110.993 -178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -90.89 148.99 3.93 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.354 2.702 . . . . 0.0 113.592 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.6 ' HZ2' ' HG2' ' A' ' 53' ' ' GLU . 2.1 mptp? -130.54 130.47 44.15 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.87 -166.91 32.59 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 121.63 -0.319 . . . . 0.0 112.477 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -69.5 -46.94 65.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.415 0.686 . . . . 0.0 110.948 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.4 mt 62.25 22.85 13.46 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.872 1.269 . . . . 0.0 110.695 -172.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -124.97 146.93 49.16 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.594 1.158 . . . . 0.0 109.749 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.53 117.86 4.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.183 0.993 . . . . 0.0 111.981 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.57 12.14 57.35 Favored Glycine 0 N--CA 1.47 0.907 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.96 -174.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -119.58 -158.21 10.55 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 10.9 p30 -138.34 174.39 10.6 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 117.723 0.761 . . . . 0.0 112.036 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -145.02 153.55 41.6 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.864 1.266 . . . . 0.0 107.894 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.97 109.94 5.1 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.651 0.78 . . . . 0.0 110.878 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.7 mt -77.72 138.11 38.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.697 0.799 . . . . 0.0 109.177 173.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -77.82 110.23 12.52 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.2 56.73 5.06 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.607 0.567 . . . . 0.0 113.356 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -168.77 -84.05 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.965 0.506 . . . . 0.0 111.339 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -152.78 155.68 37.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.275 0.56 . . . . 0.0 111.559 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 m -132.45 143.09 49.55 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.378 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -156.56 -170.51 21.75 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 5.5 m-20 -118.24 168.7 10.35 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.252 0.621 . . . . 0.0 110.749 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.491 ' HA ' HG23 ' A' ' 85' ' ' ILE . 9.8 mm -103.58 107.05 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.45 HD22 ' HG ' ' A' ' 86' ' ' SER . 85.1 mt -75.51 -58.11 3.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.71 0.404 . . . . 0.0 110.994 -175.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.07 151.2 13.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.692 0.797 . . . . 0.0 109.41 175.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.5 p -148.3 133.08 17.95 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -107.82 89.84 5.75 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.53 132.39 33.06 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.639 2.226 . . . . 0.0 112.53 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -102.74 22.85 14.97 Favored 'Cis proline' 0 C--N 1.375 1.924 0 CA-C-N 120.031 1.047 . . . . 0.0 113.597 -8.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -67.45 -52.72 36.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.812 1.245 . . . . 0.0 112.366 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.449 ' NH2' ' HD3' ' A' ' 100' ' ' ARG . 26.4 ttm-85 -148.93 154.62 39.68 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.32 0.581 . . . . 0.0 111.134 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.5 tt -135.07 140.97 45.97 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.14 1.376 . . . . 0.0 107.338 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.445 HG22 ' HG2' ' A' ' 98' ' ' GLU . 40.6 m -137.9 134.87 35.54 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.302 0.641 . . . . 0.0 109.287 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.491 HG23 ' HA ' ' A' ' 74' ' ' ILE . 12.6 pt -147.78 147.14 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.055 1.342 . . . . 0.0 109.895 -172.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.45 ' HG ' HD22 ' A' ' 75' ' ' LEU . 71.5 m -86.86 153.7 21.43 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 163.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 23.1 t-105 -143.13 109.62 5.41 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -167.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.749 HG11 ' HB3' ' A' ' 93' ' ' PRO . 61.1 t -108.79 103.07 14.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -83.85 141.56 31.24 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -58.25 -30.04 66.23 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.94 -53.8 5.14 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.397 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -138.7 119.57 9.96 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.61 0.764 . . . . 0.0 110.349 -174.167 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.749 ' HB3' HG11 ' A' ' 88' ' ' VAL . 3.1 Cg_exo -83.18 -166.86 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.701 2.934 . . . . 0.0 113.016 -176.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.5 t70 52.67 85.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.593 1.557 . . . . 0.0 113.373 174.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 71.0 m -147.09 122.32 10.22 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 171.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -101.33 105.68 16.77 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.2 t -97.69 147.85 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.202 1.001 . . . . 0.0 109.824 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 84' ' ' THR . 33.9 mt-10 -137.7 155.96 48.54 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.68 0.792 . . . . 0.0 109.603 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.0 tp -126.75 139.24 53.28 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.449 ' HD3' ' NH2' ' A' ' 82' ' ' ARG . 1.5 ttp180 -140.08 106.96 5.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.47 0.708 . . . . 0.0 109.736 -172.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 110' ' ' LEU . 96.2 mt -111.53 131.18 55.42 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.371 1.069 . . . . 0.0 110.78 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.1 t -143.46 128.38 18.43 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.014 0.925 . . . . 0.0 108.796 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.62 124.37 22.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -136.46 117.98 14.83 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.97 -144.77 38.6 Favored Glycine 0 C--N 1.345 1.057 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -86.91 55.38 3.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.566 0.698 . . . . 0.0 109.227 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.64 -154.4 13.25 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 114.939 -1.028 . . . . 0.0 113.689 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.4 m -148.75 129.69 14.34 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.809 0.843 . . . . 0.0 111.119 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 27' ' ' ARG . 43.0 tp -81.21 109.55 15.85 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 101' ' ' LEU . 10.2 tt -88.05 130.97 34.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 170.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.455 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 45.3 mt-10 -132.13 105.86 7.63 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.5 tt -103.97 124.16 48.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 9.4 pt-20 -122.06 129.38 52.35 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.488 ' O ' ' HA ' ' A' ' 23' ' ' SER . 8.1 t60 -117.0 111.1 19.1 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.94 102.37 11.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.674 0.79 . . . . 0.0 111.171 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.2 t -130.72 153.33 49.11 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.237 0.542 . . . . 0.0 109.934 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.498 HG21 HD11 ' A' ' 16' ' ' ILE . 76.1 p -71.14 -21.53 62.18 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.166 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.4 p -94.49 118.26 31.38 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.698 0.799 . . . . 0.0 111.137 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.418 ' HA ' HD12 ' A' ' 122' ' ' LEU . 45.0 tt0 -65.81 -24.8 66.99 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.256 1.022 . . . . 0.0 111.147 174.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -61.65 -53.75 52.04 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.054 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 10.1 tpt -62.63 -41.34 98.96 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.48 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 119' ' ' GLU . 37.0 mt -52.93 -53.03 55.37 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.098 0.959 . . . . 0.0 113.278 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.55 -44.72 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.788 0.435 . . . . 0.0 110.488 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.98 -44.14 96.84 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.541 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.0 m -75.23 -26.87 19.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.06 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.229 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.48 -29.05 60.24 Favored Glycine 0 C--N 1.351 1.361 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 170.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.26 -51.61 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 123.592 0.231 . . . . 0.0 110.396 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.03 -30.17 76.44 Favored Glycine 0 N--CA 1.476 1.353 0 CA-C-N 115.625 -0.716 . . . . 0.0 114.209 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.402 ' HB3' HD11 ' A' ' 26' ' ' ILE . 9.4 m95 -79.13 -46.96 16.95 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -54.9 -38.95 68.24 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.478 0.311 . . . . 0.0 110.785 174.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.6 tpp -64.99 -41.41 95.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.501 0.72 . . . . 0.0 110.69 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -72.77 -36.02 67.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.42 0.688 . . . . 0.0 111.729 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.56 -25.11 38.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.662 0.785 . . . . 0.0 110.289 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.22 -45.15 77.66 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.543 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.64 -30.57 52.23 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.431 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.1 tp -71.74 -29.64 64.74 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.21 -48.23 81.62 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.633 168.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 90.3 mmm -69.2 -37.11 77.93 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.074 0.95 . . . . 0.0 111.13 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -67.52 -56.77 8.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.972 0.909 . . . . 0.0 110.793 -175.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 28.9 mt -67.2 -29.91 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.23 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -62.28 -30.09 70.88 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.64 0.376 . . . . 0.0 110.103 172.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.85 13.32 78.08 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.656 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -122.98 71.61 1.06 Allowed 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.13 159.8 81.76 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.772 173.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.21 -177.67 0.68 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 122.237 1.958 . . . . 0.0 111.732 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.03 63.61 2.43 Favored Glycine 0 N--CA 1.476 1.328 0 N-CA-C 112.332 -0.307 . . . . 0.0 112.332 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.03 -161.29 12.82 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -169.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -88.41 -167.45 0.31 Allowed 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 123.158 2.572 . . . . 0.0 112.382 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.426 HG21 ' HB2' ' A' ' 152' ' ' ASP . 20.8 m -75.89 155.07 84.99 Favored Pre-proline 0 N--CA 1.481 1.115 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 167.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.6 -57.83 1.57 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.249 1.966 . . . . 0.0 111.414 174.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.26 -18.81 0.2 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.343 0.657 . . . . 0.0 111.384 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.426 ' HB2' HG21 ' A' ' 149' ' ' VAL . 27.2 t0 58.75 71.81 0.56 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.832 1.253 . . . . 0.0 110.634 -170.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -179.22 -24.54 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.26 -1.337 . . . . 0.0 110.691 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 66.96 52.93 0.86 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.14 1.376 . . . . 0.0 111.103 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.72 -44.83 14.04 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 174.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -83.18 159.38 22.03 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.955 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 61.72 91.23 0.06 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.868 1.267 . . . . 0.0 111.651 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.417 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 4.1 mp0 -56.51 -45.41 99.93 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 168.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 29.2 Cg_endo -59.97 94.91 0.1 OUTLIER 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 122.478 2.119 . . . . 0.0 111.083 164.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.447 ' N ' ' HD3' ' A' ' 161' ' ' PRO . 22.8 p -150.33 49.98 0.69 Allowed Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 123.319 0.647 . . . . 0.0 110.668 175.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 160' ' ' SER . 14.5 Cg_exo -66.6 -34.01 34.16 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 122.309 2.006 . . . . 0.0 111.289 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 166' ' ' ILE . 46.4 mt-10 -59.49 -54.37 47.42 Favored 'General case' 0 C--O 1.212 -0.87 0 O-C-N 124.382 1.051 . . . . 0.0 110.418 173.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 91.1 mmm -65.46 -44.03 88.48 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.175 0.59 . . . . 0.0 112.423 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 76.6 mtp -61.87 -39.22 91.15 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.694 0.621 . . . . 0.0 110.671 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 38.4 ttp180 -65.99 -48.79 70.05 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.998 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 30.5 mm -53.49 -40.01 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.831 0.852 . . . . 0.0 110.504 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.1 m -68.77 -54.49 15.66 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 122.701 0.4 . . . . 0.0 110.396 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 11.6 pt20 -61.5 -56.0 24.92 Favored 'General case' 0 C--O 1.209 -1.072 0 CA-C-O 117.726 -1.13 . . . . 0.0 111.304 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 9.5 mm-40 -43.45 -46.07 6.6 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.942 0.792 . . . . 0.0 113.064 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.589 ' HA ' HH22 ' A' ' 9' ' ' ARG . 4.8 mmp_? -53.64 -52.44 59.89 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.574 0.546 . . . . 0.0 109.841 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -80.95 -17.4 72.51 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 116.284 -0.416 . . . . 0.0 113.65 -173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 24.0 mm-40 -71.7 -37.3 70.69 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.51 0.724 . . . . 0.0 109.712 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.504 ' HB3' ' NH1' ' A' ' 9' ' ' ARG . . . -76.22 -36.21 58.68 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.737 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -67.09 -29.9 69.78 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 119.249 -0.405 . . . . 0.0 111.43 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.42 -61.18 2.62 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 123.59 0.556 . . . . 0.0 109.659 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.39 -35.27 51.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.409 1.084 . . . . 0.0 113.565 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 35.3 mt -66.8 -59.56 3.44 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 123.297 0.373 . . . . 0.0 110.159 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.8 p -72.88 -20.37 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 123.721 0.808 . . . . 0.0 111.357 -158.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -57.38 -21.16 34.19 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.259 1.024 . . . . 0.0 112.104 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 16.3 m -68.35 88.82 0.32 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.568 0.747 . . . . 0.0 109.452 172.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 138.37 36.51 0.15 Allowed Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.946 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.3 t . . . . . 0 C--O 1.249 1.042 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.118 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.908 0.385 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.45 -166.38 2.11 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.728 0.811 . . . . 0.0 109.63 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.0 m -68.3 83.76 0.25 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 168.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.33 112.04 3.49 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.886 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -77.2 73.6 3.78 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-O 123.51 1.624 . . . . 0.0 110.598 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.53 0.73 48.78 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.604 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -79.14 111.37 15.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.317 1.047 . . . . 0.0 110.956 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 30.9 mt-10 -93.8 134.33 36.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.694 1.198 . . . . 0.0 108.56 172.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.0 ttm105 -99.78 139.44 35.43 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.855 0.462 . . . . 0.0 110.0 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.16 179.35 9.23 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.77 0.428 . . . . 0.0 111.628 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.404 HD13 ' N ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -145.15 153.12 41.04 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.957 -176.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -167.24 -151.98 7.2 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.45 163.22 35.55 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.207 0.603 . . . . 0.0 109.759 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -166.42 152.46 8.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.874 0.869 . . . . 0.0 109.483 167.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.5 m -82.95 152.66 25.38 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.043 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.8 pt -144.1 155.51 58.46 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.64 -30.29 28.16 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.941 2.428 . . . . 0.0 114.317 175.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.47 -7.84 59.64 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.82 -172.9 28.05 Favored Glycine 0 C--N 1.356 1.678 0 CA-C-N 119.258 0.935 . . . . 0.0 112.577 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -84.57 110.78 18.96 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.17 146.96 23.28 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.991 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -87.98 156.84 19.12 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 164.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.4 p -139.17 137.98 36.53 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.954 0.407 . . . . 0.0 111.609 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.586 HG12 HG23 ' A' ' 125' ' ' VAL . 2.9 pp -87.79 141.16 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.265 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.35 111.02 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.9 mt -100.91 108.63 23.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 97.2 mtt180 -99.54 140.59 33.5 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.474 HE22 HD23 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -138.78 144.15 39.25 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.294 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.457 ' NH1' ' HG2' ' A' ' 104' ' ' GLU . 12.2 mmt85 -103.73 101.96 11.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 173.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.457 ' CE1' ' HA2' ' A' ' 137' ' ' GLY . 70.1 m-85 -83.63 129.36 34.96 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.903 0.881 . . . . 0.0 110.624 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.72 48.25 0.67 Allowed 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 122.889 1.328 . . . . 0.0 109.785 170.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.56 152.42 41.7 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.058 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.719 ' HG2' ' HB2' ' A' ' 36' ' ' GLU . 56.4 Cg_endo -71.64 165.75 31.56 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.629 2.219 . . . . 0.0 113.454 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.453 HG13 ' HB2' ' A' ' 80' ' ' PRO . 58.1 t -71.89 -43.7 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.954 -169.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -63.87 -34.03 77.02 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 124.055 0.847 . . . . 0.0 110.109 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.719 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -69.53 -62.79 1.24 Allowed 'General case' 0 C--N 1.355 0.813 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.776 179.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.7 t -51.17 -33.3 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 124.939 1.296 . . . . 0.0 111.06 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.427 ' HE3' HD11 ' A' ' 101' ' ' LEU . 65.2 t-105 -61.43 -57.42 12.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.19 0.596 . . . . 0.0 110.063 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.2 t -54.35 -40.7 68.33 Favored 'General case' 0 CA--C 1.552 1.023 0 O-C-N 123.92 0.762 . . . . 0.0 110.614 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.04 79.26 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.4 m -93.51 -4.48 51.0 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.752 0.821 . . . . 0.0 112.954 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 77.8 p -116.57 -48.37 2.69 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.439 0.563 . . . . 0.0 111.438 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.423 ' O ' HG12 ' A' ' 47' ' ' ILE . 20.6 t70 -63.12 119.94 56.93 Favored Pre-proline 0 N--CA 1.483 1.197 0 C-N-CA 123.878 0.871 . . . . 0.0 111.033 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.0 -26.76 43.22 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.008 2.472 . . . . 0.0 113.335 -171.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -61.82 -48.06 82.31 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.777 0.673 . . . . 0.0 109.646 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -72.13 -26.05 61.96 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 174.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.518 HG23 ' HD3' ' A' ' 54' ' ' PRO . 36.7 mm -71.24 -42.18 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 118.849 0.75 . . . . 0.0 111.474 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.07 -16.01 64.07 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -80.54 0.91 31.74 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.468 0.707 . . . . 0.0 112.408 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.439 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 46.2 p-90 -141.64 -47.44 0.37 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.916 0.486 . . . . 0.0 110.489 173.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -111.65 -164.28 0.91 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.069 0.948 . . . . 0.0 109.859 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -86.92 126.02 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 166.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.67 139.45 88.76 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 118.87 0.759 . . . . 0.0 111.794 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.518 ' HD3' HG23 ' A' ' 47' ' ' ILE . 15.2 Cg_exo -69.71 101.98 0.97 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.627 2.218 . . . . 0.0 110.932 173.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -74.88 136.01 41.51 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.767 0.827 . . . . 0.0 110.682 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.27 -164.74 27.21 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 116.023 -0.535 . . . . 0.0 114.308 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -68.46 -39.06 81.58 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.721 1.208 . . . . 0.0 111.104 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.3 mt 66.29 12.28 8.49 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -98.97 165.34 11.8 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.234 0.47 . . . . 0.0 110.079 173.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.746 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 38.5 tt0 -71.02 98.03 1.56 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.25 -31.03 4.36 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -170.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.11 -174.01 46.65 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 114.776 -0.712 . . . . 0.0 112.432 169.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 22.9 p-10 -134.96 155.26 51.05 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.842 0.857 . . . . 0.0 111.861 -170.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -116.91 169.6 9.27 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.163 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -163.4 144.23 9.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.701 0.8 . . . . 0.0 109.017 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.431 HD12 HD21 ' A' ' 69' ' ' ASN . 68.8 mt -118.5 153.29 34.41 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -93.28 -45.66 7.74 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.41 -12.27 84.0 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.33 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.431 HD21 HD12 ' A' ' 66' ' ' LEU . 80.8 m-20 -127.52 -92.7 0.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 118.106 0.953 . . . . 0.0 111.31 -174.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.61 175.08 14.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.087 0.555 . . . . 0.0 110.821 -169.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 27.7 p -131.96 145.29 51.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.154 0.582 . . . . 0.0 109.616 -172.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.71 -148.87 5.37 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 112.319 -0.313 . . . . 0.0 112.319 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -151.23 163.75 38.16 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.223 0.609 . . . . 0.0 110.861 179.457 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.532 ' HA ' HG22 ' A' ' 85' ' ' ILE . 2.5 mp -94.34 102.42 13.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 86' ' ' SER . 88.4 mt -76.24 -45.53 32.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.785 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -135.45 141.69 45.44 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.511 -173.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.746 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 31.8 p -158.38 122.43 4.06 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.646 ' HG2' ' HD3' ' A' ' 81' ' ' ARG . 41.8 tt0 -144.78 90.46 6.35 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -63.46 139.99 73.64 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.973 2.449 . . . . 0.0 111.858 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.453 ' HB2' HG13 ' A' ' 34' ' ' VAL . 27.2 Cg_endo -96.61 27.06 18.63 Favored 'Cis proline' 0 C--N 1.375 1.954 0 CA-C-N 120.097 1.07 . . . . 0.0 113.094 -8.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.646 ' HD3' ' HG2' ' A' ' 78' ' ' GLU . 4.3 mpt_? -77.9 -82.21 0.09 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.569 0.748 . . . . 0.0 111.385 -175.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.5 ptt-85 -150.96 154.11 36.48 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.795 0.438 . . . . 0.0 111.451 -171.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.8 tt -134.86 114.09 12.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -112.82 137.39 51.23 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.139 0.976 . . . . 0.0 108.907 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.532 HG22 ' HA ' ' A' ' 74' ' ' ILE . 13.0 pt -133.29 151.56 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.81 1.244 . . . . 0.0 109.885 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.474 ' HB2' HD11 ' A' ' 75' ' ' LEU . 35.2 t -87.96 163.56 16.27 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.991 0.424 . . . . 0.0 109.978 166.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 35.6 t-105 -144.25 96.92 2.96 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -166.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.44 125.06 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.607 0.763 . . . . 0.0 109.373 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.451 ' HB3' ' HE3' ' A' ' 92' ' ' LYS . 59.6 t80 -144.72 171.71 14.03 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.13 0.972 . . . . 0.0 108.655 -176.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.76 154.64 38.27 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 122.531 0.333 . . . . 0.0 110.549 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.44 -63.72 4.1 Favored Glycine 0 N--CA 1.471 1.011 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.451 ' HE3' ' HB3' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -103.68 133.64 20.17 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 124.308 1.043 . . . . 0.0 109.708 177.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.12 -73.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.019 2.479 . . . . 0.0 112.433 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -125.47 165.93 17.55 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.283 0.563 . . . . 0.0 110.682 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.5 m -152.19 169.77 21.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.912 1.685 . . . . 0.0 107.464 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -133.83 123.81 25.45 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 118.509 0.595 . . . . 0.0 111.139 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 t -110.83 147.62 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.989 1.316 . . . . 0.0 107.869 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -143.09 127.86 18.21 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.066 0.46 . . . . 0.0 110.98 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.48 119.08 38.22 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 33.0 ttm180 -124.88 128.5 48.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.996 0.918 . . . . 0.0 109.145 -173.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.448 ' HB3' HG12 ' A' ' 34' ' ' VAL . 72.9 mt -135.6 128.74 31.74 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.934 0.894 . . . . 0.0 110.792 -175.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.2 m -148.82 152.67 36.91 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.653 1.181 . . . . 0.0 108.559 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.03 150.84 32.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.609 0.764 . . . . 0.0 111.291 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.457 ' HG2' ' NH1' ' A' ' 29' ' ' ARG . 11.0 tp10 -148.09 112.24 5.2 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.83 -101.75 0.2 Allowed Glycine 0 C--N 1.35 1.317 0 O-C-N 123.252 0.345 . . . . 0.0 112.924 -171.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -119.6 2.05 11.16 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.381 0.61 . . . . 0.0 110.345 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -112.88 -150.68 10.9 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.223 0.916 . . . . 0.0 111.718 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.0 m -148.09 127.09 12.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.481 1.112 . . . . 0.0 110.135 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.429 HD13 ' NE ' ' A' ' 29' ' ' ARG . 40.5 tp -82.44 133.34 35.21 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.4 tt -117.84 113.39 21.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 33.4 mt-10 -109.37 106.2 15.89 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.7 tp -98.83 103.26 15.19 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -101.65 108.85 20.51 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.937 0.895 . . . . 0.0 109.666 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -106.51 122.18 45.78 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -119.42 125.18 48.34 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.561 0.744 . . . . 0.0 111.308 -173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.9 t -141.69 159.75 41.58 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 123.982 0.802 . . . . 0.0 109.611 173.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.4 p -90.68 -2.51 57.83 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.233 1.013 . . . . 0.0 111.886 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.6 t -97.16 119.19 35.19 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.162 0.985 . . . . 0.0 110.149 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.532 ' HA ' HD12 ' A' ' 122' ' ' LEU . 38.3 tt0 -62.32 -42.4 99.35 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.269 1.027 . . . . 0.0 112.645 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.16 -58.44 8.64 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.415 ' O ' HG21 ' A' ' 125' ' ' VAL . 25.2 ttt -51.32 -29.62 15.64 Favored 'General case' 0 C--O 1.208 -1.115 0 O-C-N 124.794 1.309 . . . . 0.0 112.762 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.532 HD12 ' HA ' ' A' ' 119' ' ' GLU . 47.6 mt -64.26 -53.76 43.96 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.394 0.543 . . . . 0.0 111.896 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.443 ' O ' HG21 ' A' ' 127' ' ' VAL . 47.2 t -63.48 -49.58 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -44.39 -56.16 4.44 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.264 1.826 . . . . 0.0 113.818 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.586 HG23 HG12 ' A' ' 24' ' ' ILE . 34.6 m -72.44 -26.39 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 122.265 0.226 . . . . 0.0 110.635 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.51 -39.12 97.42 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 169.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 123' ' ' VAL . 92.6 t -78.09 -60.48 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.37 -57.06 12.48 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 114.436 -1.256 . . . . 0.0 114.517 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -66.03 -40.94 91.44 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.875 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -67.18 -32.17 73.07 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 120.319 1.418 . . . . 0.0 111.125 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.0 mtm -71.98 -35.04 69.4 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.666 0.386 . . . . 0.0 110.272 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.06 -59.82 2.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.357 0.663 . . . . 0.0 110.97 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -54.56 -30.4 54.08 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.089 1.356 . . . . 0.0 113.008 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.99 -46.62 84.91 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.505 0.722 . . . . 0.0 110.311 169.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -64.18 -37.38 87.25 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.656 172.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 52.5 tp -68.88 -20.66 64.26 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.148 0.579 . . . . 0.0 110.544 175.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.457 ' HA2' ' CE1' ' A' ' 30' ' ' TYR . . . -71.06 -47.27 38.82 Favored Glycine 0 C--N 1.35 1.328 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.57 ' HE1' ' HA ' ' A' ' 144' ' ' LEU . 20.3 ptm -80.27 -24.33 40.15 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.499 -0.851 . . . . 0.0 111.58 174.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.505 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 82.7 t80 -67.17 -42.77 83.7 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.838 0.455 . . . . 0.0 110.562 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.2 mt -76.74 -51.54 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.781 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.563 ' NE ' ' HA ' ' A' ' 141' ' ' ARG . 0.3 OUTLIER -146.87 99.27 3.16 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-O 121.564 0.697 . . . . 0.0 111.332 177.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.52 -20.69 0.11 Allowed Glycine 0 CA--C 1.523 0.57 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.534 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.4 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 7.5 m-20 68.44 103.9 0.05 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.459 1.903 . . . . 0.0 111.189 -178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.57 ' HA ' ' HE1' ' A' ' 138' ' ' MET . 3.2 tt -88.97 107.13 15.74 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 123.959 0.904 . . . . 0.0 109.027 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 143' ' ' ASP . 57.6 Cg_endo -89.51 130.11 1.91 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.648 2.232 . . . . 0.0 111.27 175.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.63 -112.12 3.73 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.16 -75.46 0.41 Allowed Glycine 0 C--N 1.345 1.041 0 CA-C-O 119.041 -0.866 . . . . 0.0 112.842 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -46.26 105.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 124.022 3.148 . . . . 0.0 113.95 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 152' ' ' ASP . 16.8 m -80.87 118.62 73.18 Favored Pre-proline 0 CA--C 1.556 1.187 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.597 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.72 -65.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.422 2.081 . . . . 0.0 112.593 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -123.4 1.84 9.03 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.228 0.611 . . . . 0.0 110.557 -173.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' A' ' 149' ' ' VAL . 2.1 m-20 -72.02 79.61 0.93 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.565 1.146 . . . . 0.0 109.728 -174.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -154.11 43.27 0.54 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.432 -175.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 68.28 77.56 0.24 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.049 1.34 . . . . 0.0 110.866 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 158' ' ' GLU . 2.1 mp0 -82.86 88.28 6.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.975 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -64.99 -61.52 2.11 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.328 -170.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -89.87 -30.37 17.95 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.858 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 155' ' ' GLU . 32.7 mt-10 -71.83 118.17 64.36 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 122.939 0.495 . . . . 0.0 110.139 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.03 89.8 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.789 2.326 . . . . 0.0 112.895 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.5 m -119.48 67.75 10.23 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.133 0.973 . . . . 0.0 108.631 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -38.12 -52.86 1.76 Allowed 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 124.318 3.345 . . . . 0.0 115.128 -162.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.442 ' O ' HG13 ' A' ' 166' ' ' ILE . 37.3 tt0 -72.99 -51.23 19.09 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.253 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 10.3 tpt -69.75 -46.45 65.84 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 118.13 0.423 . . . . 0.0 110.98 -173.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -50.19 -47.01 54.79 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.383 1.073 . . . . 0.0 110.212 171.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 168' ' ' GLN . 60.0 ttt180 -61.67 -45.05 95.65 Favored 'General case' 0 C--O 1.21 -0.994 0 O-C-N 124.145 0.903 . . . . 0.0 110.842 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.503 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 86.9 mt -53.76 -60.05 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 122.809 0.444 . . . . 0.0 110.584 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.3 p -62.12 -27.25 68.8 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.294 1.037 . . . . 0.0 113.787 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 1.4 pp0? -86.69 -33.89 19.9 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.16 -34.5 78.21 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.635 0.774 . . . . 0.0 110.413 174.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 28.7 mmt180 -57.2 -57.77 11.17 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 169.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -53.13 -37.02 53.63 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-N 114.707 -1.133 . . . . 0.0 115.138 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 38.4 mm-40 -67.37 -54.78 17.5 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.069 0.548 . . . . 0.0 110.857 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.48 76.53 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.399 -173.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -71.69 -36.13 70.48 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.981 0.513 . . . . 0.0 111.5 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.18 83.52 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.467 0.479 . . . . 0.0 110.569 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -68.32 -40.65 81.59 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.176 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.2 mt -71.55 -49.79 37.37 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 123.275 0.63 . . . . 0.0 112.228 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 p -61.85 -29.64 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 117.936 0.334 . . . . 0.0 110.804 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -87.74 -11.39 48.3 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 173.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 39.4 t -73.58 92.22 1.91 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 169.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 134.4 -36.89 2.03 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.096 -173.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 C--O 1.254 1.306 0 C-N-CA 123.459 0.704 . . . . 0.0 109.924 -178.647 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.52 0.2 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.44 21.31 4.74 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.517 0.727 . . . . 0.0 111.368 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -67.42 -45.88 74.82 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.076 0.551 . . . . 0.0 110.602 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.95 -58.69 4.79 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.629 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.427 ' HB2' ' OE1' ' A' ' 28' ' ' GLN . 22.2 pt20 -148.73 118.58 7.1 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.447 1.099 . . . . 0.0 108.282 173.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -121.34 114.83 21.89 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.789 0.836 . . . . 0.0 108.958 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -103.44 119.37 38.75 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.298 0.639 . . . . 0.0 111.05 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -104.81 122.58 46.04 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 165.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.496 ' HG3' HD12 ' A' ' 177' ' ' LEU . 17.0 ptp180 -91.76 155.11 18.5 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -159.18 -177.75 6.7 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.062 0.458 . . . . 0.0 111.033 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.438 HD12 ' HA3' ' A' ' 181' ' ' GLY . 0.3 OUTLIER -143.88 157.02 44.63 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.03 -176.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.02 -172.95 23.23 Favored Glycine 0 C--O 1.239 0.445 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.415 ' HD3' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -134.07 136.93 44.3 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -136.37 117.45 14.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -170.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.0 m -92.26 99.4 12.19 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.9 pt -104.06 161.21 23.61 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.233 1.013 . . . . 0.0 108.996 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -50.05 -28.9 20.33 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.36 2.706 . . . . 0.0 114.267 172.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.81 0.32 35.4 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.48 177.82 15.07 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 117.841 0.291 . . . . 0.0 112.894 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.57 91.6 0.8 Allowed 'General case' 0 C--N 1.348 0.516 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.46 157.08 26.3 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.068 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.3 165.7 11.42 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.8 p -136.95 140.7 42.41 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.583 HG12 HG22 ' A' ' 125' ' ' VAL . 2.7 pp -92.4 136.52 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 170.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 mp -122.74 114.93 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.3 mt -106.26 108.48 25.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.442 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 99.6 mtt180 -97.38 134.26 40.88 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 172.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 10.0 tt0 -158.91 142.04 14.64 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.023 0.827 . . . . 0.0 110.405 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -116.55 121.77 42.74 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.433 ' O ' ' HA3' ' A' ' 107' ' ' GLY . 57.1 m-85 -94.9 148.23 22.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.689 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.61 34.46 0.49 Allowed 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.921 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.23 146.98 45.15 Favored Pre-proline 0 C--O 1.243 0.718 0 C-N-CA 124.045 0.938 . . . . 0.0 109.251 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HG2' ' HG2' ' A' ' 36' ' ' GLU . 72.2 Cg_endo -67.86 169.03 17.1 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.871 2.381 . . . . 0.0 112.823 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.1 t -53.0 -53.01 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 114.086 -1.416 . . . . 0.0 111.856 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -48.07 -47.14 34.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 124.283 0.989 . . . . 0.0 112.292 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.462 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 21.6 mm-40 -70.27 -27.52 64.49 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.985 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' A' ' 108' ' ' THR . 62.9 t -81.41 -36.08 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 123.862 0.726 . . . . 0.0 110.997 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -68.61 -36.81 79.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.678 0.791 . . . . 0.0 108.884 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -68.78 -55.41 11.35 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HB2' HD12 ' A' ' 136' ' ' LEU . . . -58.61 -28.96 66.1 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.445 ' SG ' HD21 ' A' ' 99' ' ' LEU . 49.7 t -96.11 -24.95 16.06 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.1 p -105.08 -46.83 4.15 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 119.115 0.871 . . . . 0.0 112.007 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.18 125.77 88.87 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.562 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 58.0 Cg_exo -55.59 -35.02 91.93 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.652 2.901 . . . . 0.0 113.052 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.63 -17.88 37.14 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.38 1.472 . . . . 0.0 112.295 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -100.97 -42.42 6.42 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.374 1.07 . . . . 0.0 109.188 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.4 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 73.5 mt -73.69 -36.82 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.544 -167.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -58.25 -18.96 30.32 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -41.46 64.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.21 0.604 . . . . 0.0 112.024 173.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CE2' HD13 ' A' ' 136' ' ' LEU . 66.7 p-90 -118.66 14.04 13.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -171.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.1 t80 178.07 -175.31 0.17 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.115 0.566 . . . . 0.0 109.797 -169.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -88.81 131.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 44' ' ' PRO . 13.5 pt-20 -75.64 140.48 71.54 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-N 119.438 1.017 . . . . 0.0 111.634 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.495 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 93.5 Cg_endo -83.75 111.51 1.73 Allowed 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.352 2.701 . . . . 0.0 112.742 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -78.24 133.53 37.7 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.176 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.77 -156.58 24.31 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.927 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.29 -47.95 46.14 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.145 0.978 . . . . 0.0 111.202 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.8 mt 62.69 29.54 16.83 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 124.472 1.107 . . . . 0.0 111.296 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -118.63 151.57 37.68 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.013 0.925 . . . . 0.0 109.129 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.676 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 3.9 tm-20 -64.54 103.66 0.7 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.39 0.676 . . . . 0.0 109.348 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.84 -32.45 4.79 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.99 -170.29 45.84 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.261 -0.469 . . . . 0.0 112.112 171.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 8.8 p30 -131.55 160.23 35.89 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.146 0.973 . . . . 0.0 112.43 -171.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 21.9 p90 -120.91 158.8 26.88 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.092 166.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.06 114.12 0.79 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 69' ' ' ASN . 80.6 mt -57.86 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 118.395 0.543 . . . . 0.0 111.734 -171.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -159.88 -29.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.392 0.615 . . . . 0.0 110.862 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.85 -31.15 0.03 OUTLIER Glycine 0 N--CA 1.466 0.688 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 91.3 m-20 -89.58 119.59 30.14 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 124.033 0.933 . . . . 0.0 108.491 171.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 72.38 122.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.946 1.298 . . . . 0.0 113.258 173.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.4 p -149.57 139.51 21.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.858 0.863 . . . . 0.0 108.847 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.57 -166.72 30.75 Favored Glycine 0 N--CA 1.464 0.551 0 O-C-N 123.233 0.333 . . . . 0.0 112.394 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 17.9 m-20 -109.31 170.1 8.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.297 0.639 . . . . 0.0 110.515 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.48 HG13 HG23 ' A' ' 85' ' ' ILE . 2.3 mp -97.74 110.01 24.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 171.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.36 -59.88 2.5 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.053 0.845 . . . . 0.0 110.627 -173.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -136.49 150.08 48.5 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.567 1.147 . . . . 0.0 108.988 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.9 p -159.77 134.34 7.74 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.366 0.666 . . . . 0.0 109.295 172.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -134.91 98.86 12.82 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.1 130.85 18.33 Favored 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 122.026 1.817 . . . . 0.0 111.877 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -103.97 20.17 13.37 Favored 'Cis proline' 0 C--N 1.371 1.741 0 CA-C-N 119.411 0.825 . . . . 0.0 113.972 -3.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -54.4 -70.35 0.1 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.203 1.001 . . . . 0.0 111.465 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -145.0 159.67 42.57 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.933 0.397 . . . . 0.0 111.666 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 tt -135.91 113.63 11.01 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.8 m -109.26 128.34 54.99 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.424 1.49 . . . . 0.0 109.431 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.48 HG23 HG13 ' A' ' 74' ' ' ILE . 14.2 pt -121.25 173.09 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 125.109 1.364 . . . . 0.0 111.389 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.5 t -112.81 134.35 54.37 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.656 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 42.1 t-105 -126.53 105.67 8.9 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -167.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.9 t -110.88 144.29 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 21.2 t80 -148.75 151.03 34.14 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -65.12 110.37 2.5 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.139 0.576 . . . . 0.0 110.72 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.43 -20.39 50.63 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.3 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.493 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 70.3 mmtt -97.73 131.1 27.53 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.39 -73.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.891 2.394 . . . . 0.0 113.431 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -161.17 147.61 14.67 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.505 0.722 . . . . 0.0 109.364 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.656 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 19.8 m -141.97 158.96 43.16 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.728 0.811 . . . . 0.0 109.707 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -129.85 114.79 16.34 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 t -105.03 148.45 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -148.88 153.19 37.69 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.178 0.514 . . . . 0.0 110.65 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.445 HD21 ' SG ' ' A' ' 41' ' ' CYS . 39.7 tp -123.93 146.42 48.47 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.263 1.425 . . . . 0.0 107.372 175.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -140.97 109.9 6.11 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.53 148.8 22.11 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.686 0.794 . . . . 0.0 110.694 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.1 t -160.64 135.01 7.29 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 167.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.93 146.92 50.83 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.964 0.906 . . . . 0.0 109.831 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -164.52 108.76 0.94 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.907 1.283 . . . . 0.0 108.861 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.95 -132.01 10.83 Favored Glycine 0 C--N 1.342 0.885 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 172.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -92.42 31.59 1.3 Allowed 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.223 1.009 . . . . 0.0 110.245 171.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 30' ' ' TYR . . . -171.62 -150.43 7.14 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 120.452 -0.88 . . . . 0.0 114.883 -174.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.463 ' HB ' HG23 ' A' ' 37' ' ' VAL . 62.8 m -151.09 141.17 22.13 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.204 0.602 . . . . 0.0 111.079 -170.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.38 144.53 25.73 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.033 0.933 . . . . 0.0 109.378 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -127.14 143.64 51.22 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 166.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 40.9 mt-10 -122.57 107.51 12.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 167.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.434 HD21 HD21 ' A' ' 133' ' ' LEU . 27.7 tp -99.16 104.4 16.37 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 50.8 tt0 -102.69 116.95 33.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.357 0.663 . . . . 0.0 110.429 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -108.03 120.07 41.26 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -113.83 118.38 34.07 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.756 0.822 . . . . 0.0 110.831 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.1 t -139.16 159.94 40.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.241 0.616 . . . . 0.0 111.076 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 50.4 p -89.86 -20.61 23.23 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.221 1.008 . . . . 0.0 111.76 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.8 m -86.71 123.5 31.94 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.231 0.612 . . . . 0.0 109.995 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.572 ' HA ' HD13 ' A' ' 122' ' ' LEU . 28.8 tt0 -73.42 -30.39 63.2 Favored 'General case' 0 C--O 1.25 1.102 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -170.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -60.89 -58.9 6.5 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.493 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 23.8 ttt -49.44 -32.7 12.41 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 124.782 1.301 . . . . 0.0 112.67 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.572 HD13 ' HA ' ' A' ' 119' ' ' GLU . 36.7 mt -61.24 -52.59 64.11 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.869 0.468 . . . . 0.0 111.896 175.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.45 ' O ' HG22 ' A' ' 127' ' ' VAL . 48.0 t -63.26 -50.04 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -45.05 -54.11 7.06 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.927 1.691 . . . . 0.0 113.574 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.583 HG22 HG12 ' A' ' 24' ' ' ILE . 30.5 m -75.93 -24.18 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 122.422 0.289 . . . . 0.0 110.807 -177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.17 96.1 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 169.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 123' ' ' VAL . 58.8 t -78.17 -59.33 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.77 -56.45 9.82 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 114.517 -1.22 . . . . 0.0 114.023 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -65.42 -49.73 68.1 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.402 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 119.05 0.841 . . . . 0.0 111.07 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 89.7 mtp -75.56 -35.26 60.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.492 0.317 . . . . 0.0 110.518 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.26 76.06 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.193 0.597 . . . . 0.0 110.89 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.434 HD21 HD21 ' A' ' 112' ' ' LEU . 4.5 mm? -57.4 -38.14 73.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.332 1.053 . . . . 0.0 112.386 170.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.42 -38.37 90.9 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 120.856 0.36 . . . . 0.0 110.854 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -72.32 -25.18 61.46 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.459 0.704 . . . . 0.0 110.849 173.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 40' ' ' ALA . 41.5 tp -71.01 -52.33 20.2 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 123.162 0.585 . . . . 0.0 109.561 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.78 -36.23 40.64 Favored Glycine 0 N--CA 1.472 1.081 0 N-CA-C 115.016 0.767 . . . . 0.0 115.016 169.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.2 mmm -61.44 -44.93 96.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.655 0.382 . . . . 0.0 110.47 170.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -68.12 -34.93 77.27 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.663 0.785 . . . . 0.0 111.953 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 67.1 mt -78.16 -61.65 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.346 0.658 . . . . 0.0 110.018 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -144.62 93.89 2.48 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.57 -17.65 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.305 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 68.31 99.14 0.06 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 125.969 1.708 . . . . 0.0 111.089 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 22.8 tp -111.6 94.81 24.7 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -75.15 -21.37 15.65 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.792 2.328 . . . . 0.0 112.367 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.8 -49.24 0.05 OUTLIER Glycine 0 C--N 1.334 0.463 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.41 177.43 50.57 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.735 -0.732 . . . . 0.0 112.698 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.34 -177.18 0.35 Allowed 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.352 2.702 . . . . 0.0 112.344 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.438 HG21 ' HB2' ' A' ' 152' ' ' ASP . 17.2 m -61.3 125.92 85.16 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.188 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.01 -40.28 3.49 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.598 2.198 . . . . 0.0 111.041 171.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -155.61 89.59 1.19 Allowed 'General case' 0 C--N 1.346 0.437 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.438 ' HB2' HG21 ' A' ' 149' ' ' VAL . 21.9 t70 -71.38 -34.72 70.67 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.836 174.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 76.27 18.46 1.88 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.405 1.482 . . . . 0.0 113.049 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.37 79.95 7.6 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.707 0.765 . . . . 0.0 111.26 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -101.87 -63.97 1.1 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.651 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -117.9 84.58 2.19 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.994 0.902 . . . . 0.0 110.303 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -172.03 -64.66 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -134.29 101.62 12.2 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 169.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.75 106.13 0.31 Allowed 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.794 2.329 . . . . 0.0 111.322 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.405 ' N ' ' SD ' ' A' ' 164' ' ' MET . 15.9 m -81.12 103.41 1.94 Allowed Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.463 1.105 . . . . 0.0 110.401 -173.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.45 -52.38 7.8 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.005 2.47 . . . . 0.0 114.05 -167.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -67.81 -53.81 24.02 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.558 0.343 . . . . 0.0 111.877 -176.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -43.22 76.32 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 123.016 0.198 . . . . 0.0 110.633 -170.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.405 ' SD ' ' N ' ' A' ' 160' ' ' SER . 78.6 mtp -63.75 -34.45 77.91 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.36 177.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 7.3 tpm_? -61.07 -49.89 75.5 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.32 0.387 . . . . 0.0 110.504 173.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.6 mm -51.67 -52.74 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 124.411 1.084 . . . . 0.0 111.695 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.2 p -65.94 -51.91 54.39 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.586 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -53.56 -30.83 43.89 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 172.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 11.8 mm-40 -58.44 -50.24 74.41 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.641 0.655 . . . . 0.0 109.449 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -60.21 -52.72 64.11 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.185 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.75 -48.0 45.09 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 124.66 1.225 . . . . 0.0 115.955 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.8 -29.2 61.02 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.851 0.46 . . . . 0.0 111.391 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.89 -41.21 68.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.653 0.381 . . . . 0.0 110.037 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -74.79 -23.86 58.57 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.41 0.684 . . . . 0.0 111.255 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 178' ' ' VAL . . . -75.24 -31.85 60.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.941 0.496 . . . . 0.0 110.393 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.72 72.26 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.289 0.636 . . . . 0.0 109.736 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.496 HD12 ' HG3' ' A' ' 9' ' ' ARG . 95.4 mt -71.42 -61.17 1.87 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.102 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 175' ' ' ALA . 11.1 p -57.04 -39.21 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.588 0.755 . . . . 0.0 112.644 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -68.65 -26.66 65.44 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.234 0.614 . . . . 0.0 111.419 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 49.6 m -86.28 -22.64 26.69 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.989 0.516 . . . . 0.0 111.065 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.438 ' HA3' HD12 ' A' ' 11' ' ' LEU . . . -96.34 24.66 29.4 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.224 -0.443 . . . . 0.0 113.062 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.2 m . . . . . 0 CA--C 1.553 1.066 0 C-N-CA 123.454 0.702 . . . . 0.0 109.439 178.338 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HG2' ' NH1' ' A' ' 141' ' ' ARG . 63.2 mtt . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 179.39 -14.73 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.232 1.413 . . . . 0.0 110.001 -174.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.9 m -54.83 -44.58 74.02 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.14 0.976 . . . . 0.0 111.308 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.96 79.25 1.73 Allowed Glycine 0 C--N 1.337 0.638 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -69.03 94.26 0.63 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 120.931 0.396 . . . . 0.0 110.479 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -70.86 84.47 0.67 Allowed 'General case' 0 C--N 1.346 0.417 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 166.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 33.1 m -130.31 103.12 6.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.86 0.864 . . . . 0.0 110.085 -176.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -92.23 142.04 27.91 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.143 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 145.17 41.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.317 0.647 . . . . 0.0 109.262 170.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . . . -160.24 -175.42 5.04 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.882 0.873 . . . . 0.0 110.636 -170.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.6 mt -141.53 165.8 26.49 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.782 0.833 . . . . 0.0 110.889 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.91 -179.75 36.76 Favored Glycine 0 C--O 1.24 0.515 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.041 173.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -109.93 147.91 32.56 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -146.29 126.66 14.0 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.8 m -72.98 141.75 47.76 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.338 0.655 . . . . 0.0 110.026 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.452 HD11 HG23 ' A' ' 117' ' ' THR . 49.3 pt -143.19 152.45 57.89 Favored Pre-proline 0 N--CA 1.478 0.938 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.26 -15.83 6.07 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.214 2.61 . . . . 0.0 115.042 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 93' ' ' PRO . . . -109.3 9.02 25.87 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.92 -165.58 26.17 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 119.021 0.828 . . . . 0.0 114.229 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -94.81 100.73 12.57 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 175.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.09 155.9 21.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.6 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.451 ' HB2' HD12 ' A' ' 122' ' ' LEU . 48.0 mtm180 -101.95 158.24 16.28 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 166.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.5 p -133.53 141.27 47.66 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.41 0.444 . . . . 0.0 111.218 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.491 HD12 HG22 ' A' ' 125' ' ' VAL . 36.0 pt -84.15 148.2 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 47.6 mt -133.83 110.85 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.448 HD12 HD13 ' A' ' 24' ' ' ILE . 7.0 mt -113.32 110.3 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.466 ' HB3' HD12 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -101.53 145.3 29.19 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.128 0.571 . . . . 0.0 110.217 176.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -157.31 142.78 17.3 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.76 0.663 . . . . 0.0 110.992 175.018 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -104.57 107.27 18.13 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -87.52 144.3 26.78 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.774 0.83 . . . . 0.0 111.469 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -79.15 40.98 0.43 Allowed 'General case' 0 CA--C 1.566 1.575 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.133 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.0 150.08 70.32 Favored Pre-proline 0 N--CA 1.474 0.769 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.12 170.94 8.32 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.252 1.968 . . . . 0.0 113.168 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.78 -46.38 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.518 -171.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.61 -34.09 76.32 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.821 0.7 . . . . 0.0 110.99 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.73 -63.53 1.14 Allowed 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.443 0.465 . . . . 0.0 111.298 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.1 t -55.77 -31.8 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.194 0.997 . . . . 0.0 111.064 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -59.98 -56.87 16.29 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.962 0.505 . . . . 0.0 109.872 174.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.0 m -52.83 -42.08 64.82 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.035 0.834 . . . . 0.0 110.737 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.43 ' HB2' HD12 ' A' ' 136' ' ' LEU . . . -60.01 -34.6 73.57 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 82.4 m -95.58 -4.76 44.03 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.635 0.774 . . . . 0.0 113.07 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.2 p -118.02 -51.82 2.44 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 118.314 0.506 . . . . 0.0 111.936 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.51 117.02 30.38 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.784 0.834 . . . . 0.0 110.096 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.27 -20.06 43.4 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.197 2.598 . . . . 0.0 113.869 -170.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -71.38 -49.57 40.82 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -59.02 -37.99 78.23 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.576 172.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.5 mt -67.91 -35.72 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.039 0.535 . . . . 0.0 110.763 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -62.69 -17.45 60.65 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -73.04 -25.61 61.0 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -138.37 11.7 2.77 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -178.87 -178.76 0.56 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.251 0.621 . . . . 0.0 109.402 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.4 HD11 ' OD1' ' A' ' 69' ' ' ASN . 78.3 mt -91.0 137.01 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.999 0.92 . . . . 0.0 108.565 171.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.65 132.8 85.97 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.119 0.968 . . . . 0.0 111.442 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.12 120.28 2.93 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 122.476 2.117 . . . . 0.0 110.352 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -90.65 158.08 17.13 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.514 0.726 . . . . 0.0 111.062 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.71 -166.09 12.23 Favored Glycine 0 N--CA 1.466 0.634 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.178 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.76 -38.43 91.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.059 0.944 . . . . 0.0 111.755 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.2 mt 66.1 12.53 8.56 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.718 1.207 . . . . 0.0 112.518 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -126.82 154.53 44.19 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.139 0.976 . . . . 0.0 108.646 -176.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.93 121.6 10.95 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 123.869 0.731 . . . . 0.0 112.119 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.47 -27.8 17.64 Favored Glycine 0 N--CA 1.475 1.29 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.946 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -97.87 170.4 25.12 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 165.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -119.17 161.39 20.42 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.617 1.209 . . . . 0.0 112.527 -169.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -105.83 172.17 6.95 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.244 168.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.34 143.27 7.32 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.444 1.098 . . . . 0.0 109.74 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.3 mt -116.84 167.73 10.85 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.073 0.949 . . . . 0.0 109.008 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -73.88 -42.78 60.22 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.023 0.529 . . . . 0.0 111.66 -171.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.17 16.83 2.12 Favored Glycine 0 N--CA 1.467 0.731 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.033 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.4 ' OD1' HD11 ' A' ' 52' ' ' ILE . 12.6 m120 -126.91 44.95 2.79 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.266 1.026 . . . . 0.0 108.694 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 68.6 179.25 0.24 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.936 1.295 . . . . 0.0 113.729 175.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.3 p -145.09 140.69 28.23 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.542 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.03 177.7 32.13 Favored Glycine 0 N--CA 1.468 0.828 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.905 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -102.67 156.63 17.5 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.98 0.912 . . . . 0.0 110.128 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.3 mp -92.9 110.43 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.6 mt -73.4 -44.16 59.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.23 0.612 . . . . 0.0 109.796 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -160.52 140.18 10.99 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.273 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.8 p -141.54 126.68 18.45 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.21 1.004 . . . . 0.0 109.181 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -126.47 104.41 24.73 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 125.047 1.339 . . . . 0.0 107.39 -170.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 89.7 Cg_endo -80.27 131.32 8.61 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 122.353 2.035 . . . . 0.0 113.254 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 40.8 Cg_endo -101.05 34.32 7.75 Favored 'Cis proline' 0 C--N 1.377 2.066 0 CA-C-N 119.507 0.86 . . . . 0.0 111.482 -10.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -74.04 -77.87 0.11 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.375 1.07 . . . . 0.0 111.298 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -152.11 157.85 42.16 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.197 0.599 . . . . 0.0 110.611 -174.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -141.41 132.13 25.68 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.059 0.543 . . . . 0.0 109.681 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.491 HG21 ' HB3' ' A' ' 98' ' ' GLU . 58.5 m -118.73 120.13 36.49 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.298 1.039 . . . . 0.0 108.471 174.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 pt -121.19 144.59 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.865 0 C-N-CA 125.779 1.631 . . . . 0.0 108.63 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 74.5 p -84.01 170.44 13.93 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.149 -0.969 . . . . 0.0 110.169 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -153.04 117.82 5.05 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -166.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.14 103.58 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.528 ' HB3' ' HG3' ' A' ' 92' ' ' LYS . 36.8 t80 -101.6 162.62 12.77 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.836 0.854 . . . . 0.0 109.381 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -51.75 111.64 0.63 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.912 1.285 . . . . 0.0 112.379 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.52 19.47 72.84 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.663 -0.698 . . . . 0.0 114.834 173.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.528 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 11.0 mmpt? -100.5 140.97 21.83 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 117.223 0.511 . . . . 0.0 109.76 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.536 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . 57.7 Cg_endo -69.14 -36.73 11.84 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.433 2.089 . . . . 0.0 112.401 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -174.33 153.94 2.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.117 0.967 . . . . 0.0 109.494 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.7 t -146.3 158.32 43.87 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.921 0.889 . . . . 0.0 108.764 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -147.69 115.09 6.29 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.243 0.617 . . . . 0.0 110.167 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.16 147.93 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.491 ' HB3' HG21 ' A' ' 84' ' ' THR . 0.0 OUTLIER -146.55 156.81 43.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.4 tt -145.75 137.73 25.33 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -130.11 139.92 50.86 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.754 1.221 . . . . 0.0 108.688 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.0 mt -120.79 132.34 54.97 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.064 0.945 . . . . 0.0 109.084 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 t -129.95 169.41 15.26 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.914 1.285 . . . . 0.0 108.219 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.49 130.52 55.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -173.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -144.12 111.66 6.03 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 58.42 -106.42 0.84 Allowed Glycine 0 C--N 1.346 1.116 0 O-C-N 123.538 0.524 . . . . 0.0 113.264 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -113.1 2.77 15.8 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.566 0.746 . . . . 0.0 111.185 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -127.44 -162.25 11.07 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.7 m -144.48 137.64 27.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.869 0.868 . . . . 0.0 110.523 -171.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.466 HD12 ' HB3' ' A' ' 27' ' ' ARG . 43.3 tp -90.07 141.12 28.99 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 173.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -124.69 115.81 21.35 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -108.83 106.12 15.98 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 98' ' ' GLU . 43.7 tp -105.57 104.64 14.4 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.69 0.796 . . . . 0.0 108.933 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 44.3 tt0 -107.75 119.69 40.16 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.272 0.629 . . . . 0.0 110.301 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -119.57 124.85 47.38 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -115.91 129.94 56.62 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.531 1.133 . . . . 0.0 112.04 -170.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.6 t -151.39 158.78 44.18 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.518 0.727 . . . . 0.0 110.335 171.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.452 HG23 HD11 ' A' ' 16' ' ' ILE . 22.0 p -77.52 1.32 19.77 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.435 1.094 . . . . 0.0 112.841 176.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.6 m -109.17 127.55 54.3 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.693 0.797 . . . . 0.0 111.919 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -67.62 -47.79 68.63 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.406 1.083 . . . . 0.0 112.167 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.5 -44.8 70.37 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.125 0.17 . . . . 0.0 111.017 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.8 ttt -50.77 -41.35 56.7 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.942 0.776 . . . . 0.0 112.061 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.478 HD21 HG21 ' A' ' 24' ' ' ILE . 48.6 mt -59.66 -44.32 93.61 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.45 0.3 . . . . 0.0 111.087 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.453 ' O ' HG22 ' A' ' 127' ' ' VAL . 28.3 t -63.37 -56.02 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -48.72 -49.65 37.14 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.208 1.403 . . . . 0.0 112.992 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.491 HG22 HD12 ' A' ' 24' ' ' ILE . 22.5 m -77.23 -27.56 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 122.476 0.311 . . . . 0.0 110.316 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.1 -36.39 92.26 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 123' ' ' VAL . 60.5 t -81.17 -49.65 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.07 -60.08 8.97 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 114.312 -1.313 . . . . 0.0 113.759 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -58.08 -41.75 84.12 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.444 0.698 . . . . 0.0 111.953 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.602 ' HB3' HH11 ' A' ' 170' ' ' ARG . 21.4 mt-10 -64.97 -25.88 68.06 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 119.451 1.023 . . . . 0.0 112.311 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.9 mtt -75.69 -44.39 42.45 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.961 0.504 . . . . 0.0 109.773 174.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.21 -62.44 1.83 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.201 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.62 -26.98 64.27 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.381 1.472 . . . . 0.0 113.132 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 18.0 t70 -60.0 -53.3 59.46 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 169.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -67.21 -26.06 66.42 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.36 0.664 . . . . 0.0 111.628 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 40' ' ' ALA . 27.4 tp -62.91 -58.01 8.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.266 0.626 . . . . 0.0 110.234 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.28 -43.74 34.27 Favored Glycine 0 N--CA 1.475 1.289 0 N-CA-C 115.057 0.783 . . . . 0.0 115.057 170.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 96.4 mmm -65.27 -30.32 71.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.133 0.573 . . . . 0.0 111.552 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -77.3 -42.98 34.82 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.083 0.953 . . . . 0.0 111.015 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 45.1 mt -57.78 -55.88 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.805 0.842 . . . . 0.0 110.274 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.415 ' NH1' ' HG2' ' A' ' 1' ' ' MET . 48.7 ttp85 -175.53 81.94 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.68 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -148.46 17.66 1.3 Allowed Glycine 0 N--CA 1.464 0.511 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.957 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.427 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 32.0 t70 57.96 88.24 0.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.966 0.906 . . . . 0.0 109.841 -174.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.32 101.33 2.99 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 143' ' ' ASP . 75.2 Cg_endo -81.17 -25.84 3.76 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.657 2.238 . . . . 0.0 112.888 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.28 -79.3 0.15 Allowed Glycine 0 C--N 1.343 0.927 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.16 153.9 7.01 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.318 -0.712 . . . . 0.0 111.388 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.552 ' HG2' ' SD ' ' A' ' 163' ' ' MET . 91.2 Cg_endo -78.76 15.7 1.42 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.586 2.857 . . . . 0.0 113.341 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.532 ' HB ' ' HA ' ' A' ' 152' ' ' ASP . 4.4 m -106.32 123.07 40.05 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.33 1.052 . . . . 0.0 110.128 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.07 -50.23 2.26 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.902 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -109.4 -15.24 14.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.443 0.697 . . . . 0.0 110.847 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.532 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 28.8 t70 70.25 82.09 0.16 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.717 1.207 . . . . 0.0 110.498 -173.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -108.63 -41.11 4.89 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.675 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 62.81 16.77 9.35 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.793 1.237 . . . . 0.0 112.134 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -94.03 -16.49 23.82 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.338 1.055 . . . . 0.0 110.561 -175.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 70.26 23.05 5.23 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.216 1.407 . . . . 0.0 108.545 -162.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -76.16 -38.88 56.11 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -59.73 121.16 55.65 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.511 168.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.532 ' HA ' ' SD ' ' A' ' 164' ' ' MET . 77.2 Cg_endo -84.02 28.28 0.58 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.453 2.102 . . . . 0.0 112.074 172.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.9 p -73.91 112.82 18.18 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.396 1.078 . . . . 0.0 110.306 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -42.51 -56.34 2.15 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 124.766 3.644 . . . . 0.0 115.566 -171.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.419 ' O ' HG12 ' A' ' 166' ' ' ILE . 44.8 tt0 -63.26 -43.92 96.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 123.488 0.493 . . . . 0.0 112.186 -175.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.552 ' SD ' ' HG2' ' A' ' 148' ' ' PRO . 5.0 tpt -65.48 -41.95 92.74 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.131 0.491 . . . . 0.0 110.456 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.532 ' SD ' ' HA ' ' A' ' 159' ' ' PRO . 80.4 mtp -65.78 -35.37 80.52 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.575 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -63.28 -38.23 90.35 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.822 0.849 . . . . 0.0 110.558 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.439 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 42.7 mm -63.23 -45.44 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 175.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.6 t -63.91 -30.99 72.02 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.514 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -71.47 -59.96 2.49 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.348 0.659 . . . . 0.0 110.173 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.17 -43.63 87.57 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.924 0.89 . . . . 0.0 112.481 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.602 HH11 ' HB3' ' A' ' 130' ' ' GLU . 19.7 mmt85 -74.08 -41.37 61.8 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -56.0 -35.65 64.74 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.408 -0.814 . . . . 0.0 113.721 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -78.24 -42.92 29.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.699 0.8 . . . . 0.0 110.475 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.7 72.0 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 124.18 0.925 . . . . 0.0 110.934 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.406 ' CZ2' HG12 ' A' ' 26' ' ' ILE . 97.1 m95 -83.44 -27.37 29.57 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.904 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.35 87.75 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 171.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.76 93.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.476 0.71 . . . . 0.0 110.773 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.08 -57.62 6.47 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.546 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.96 -31.79 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 122.847 0.459 . . . . 0.0 111.915 -168.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -66.65 -29.2 69.16 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.356 0.662 . . . . 0.0 110.668 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 33.4 t -76.44 85.06 3.17 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 171.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 176.7 23.95 0.03 OUTLIER Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.626 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--O 1.254 1.334 0 C-N-CA 123.942 0.897 . . . . 0.0 109.001 -178.886 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.38 -35.99 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.958 0.903 . . . . 0.0 110.148 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m -75.15 77.66 2.3 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.142 0.577 . . . . 0.0 109.639 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.99 56.91 0.03 OUTLIER Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.156 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 29' ' ' ARG . 98.9 mt-30 59.56 58.38 2.93 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.073 1.349 . . . . 0.0 112.455 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.46 158.42 18.97 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.884 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.1 m -120.33 115.35 23.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.555 0.742 . . . . 0.0 110.451 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 32.1 mt-10 -89.55 136.95 32.73 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -111.3 142.13 43.94 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.811 0.445 . . . . 0.0 110.313 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.37 127.57 7.7 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.931 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.748 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -85.56 121.97 29.01 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.59 -154.82 12.1 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-O 121.332 0.407 . . . . 0.0 113.376 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -148.09 148.28 30.46 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.245 1.018 . . . . 0.0 109.712 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.446 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 27.8 tpt180 -168.93 120.39 0.75 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.429 0.691 . . . . 0.0 109.46 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.2 m -83.21 97.6 8.94 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.9 pt -78.3 160.44 73.05 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.369 1.068 . . . . 0.0 110.295 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.3 -21.24 22.3 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.453 2.769 . . . . 0.0 114.463 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.9 -53.14 22.77 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 170.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.7 -157.38 27.62 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.225 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.436 ' HB3' HH22 ' A' ' 22' ' ' ARG . 48.9 mt-10 -68.74 106.15 2.55 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.253 0.621 . . . . 0.0 110.651 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 14' ' ' ARG . . . -114.71 153.42 30.3 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.572 0.749 . . . . 0.0 111.401 -175.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.436 HH22 ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -91.67 169.71 10.51 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 164.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -141.71 142.49 33.31 Favored 'General case' 0 C--O 1.217 -0.63 0 O-C-N 122.305 -0.247 . . . . 0.0 110.946 -172.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.558 HG12 HG21 ' A' ' 125' ' ' VAL . 2.7 pp -98.73 144.8 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 168.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.506 HG12 ' HG3' ' A' ' 113' ' ' GLU . 44.3 mt -131.79 106.28 11.26 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.6 mt -101.7 107.54 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.558 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 49.0 mtp180 -107.17 133.56 51.58 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.292 1.037 . . . . 0.0 108.791 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -141.25 152.97 44.98 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.768 0.427 . . . . 0.0 110.068 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.534 ' NH1' HD13 ' A' ' 109' ' ' LEU . 67.3 mmt-85 -108.48 102.33 11.43 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -79.17 124.32 28.22 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.15 44.79 0.25 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 123.916 0.76 . . . . 0.0 111.295 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.88 148.06 37.57 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 125.292 1.437 . . . . 0.0 107.143 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.45 175.62 2.64 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.8 2.334 . . . . 0.0 114.487 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -73.59 -42.71 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.921 -171.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.35 -43.6 98.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.687 0.795 . . . . 0.0 110.508 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -59.96 -63.97 1.11 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.686 175.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.47 -34.49 46.85 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 124.177 0.991 . . . . 0.0 111.936 -175.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -61.31 -58.47 8.1 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.994 0.518 . . . . 0.0 110.206 178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 80.0 p -57.91 -46.11 85.48 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.886 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.57 ' HA ' ' HD2' ' A' ' 46' ' ' ARG . . . -53.43 -40.23 65.0 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 79.9 m -78.95 -16.81 56.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 50.3 p -108.31 -26.53 10.48 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 1.2 p30 -85.54 124.24 71.66 Favored Pre-proline 0 N--CA 1.484 1.241 0 CA-C-N 118.533 0.606 . . . . 0.0 110.325 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 50.9 Cg_exo -55.71 -27.34 60.83 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.971 3.114 . . . . 0.0 114.278 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -63.48 -53.51 50.97 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.322 1.014 . . . . 0.0 110.665 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.57 ' HD2' ' HA ' ' A' ' 40' ' ' ALA . 65.8 mtt85 -71.32 -32.27 68.38 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.117 175.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.473 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 82.7 mt -65.04 -39.43 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 118.129 0.422 . . . . 0.0 111.837 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 13.8 p30 -67.07 -11.68 57.82 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 15.4 mmt180 -72.14 -41.39 67.21 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.475 0.71 . . . . 0.0 111.161 170.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.494 ' HB2' ' O ' ' A' ' 132' ' ' ALA . 70.5 p-90 -115.77 9.35 15.1 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -170.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -173.42 180.0 2.01 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -170.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.1 mt -84.88 133.59 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 34.0 tt0 -67.34 127.23 93.41 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.724 1.21 . . . . 0.0 111.001 -171.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.435 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 89.9 Cg_endo -79.88 102.14 1.43 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.797 2.332 . . . . 0.0 111.045 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.43 160.49 24.02 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.634 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.19 -171.76 15.09 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.96 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.52 -47.91 66.36 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.001 1.72 . . . . 0.0 112.277 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.9 mt 69.23 0.66 2.93 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.293 1.437 . . . . 0.0 113.474 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -103.01 154.83 18.84 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.703 0.801 . . . . 0.0 110.028 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -63.96 107.09 1.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.615 0.766 . . . . 0.0 111.233 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.2 -24.48 6.96 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.0 -161.74 37.72 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -141.13 157.32 45.44 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.95 1.375 . . . . 0.0 111.212 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.435 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 25.8 p90 -101.32 171.72 7.42 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.59 163.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -165.83 135.39 3.35 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.596 1.159 . . . . 0.0 109.024 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.9 mt -93.05 174.63 7.13 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.597 0.759 . . . . 0.0 109.817 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -106.18 134.37 49.43 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 171.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 53.84 36.34 55.14 Favored Glycine 0 CA--C 1.532 1.1 0 O-C-N 124.927 1.392 . . . . 0.0 114.873 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -149.95 -95.66 0.07 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.04 -179.16 5.93 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.195 0.598 . . . . 0.0 110.841 -171.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.1 p -152.05 146.2 25.36 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.61 146.73 15.81 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 118.823 0.738 . . . . 0.0 112.346 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -80.94 148.81 29.66 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.501 0.721 . . . . 0.0 110.278 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mm -83.26 95.05 3.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 86' ' ' SER . 67.2 mt -70.77 -50.0 40.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.38 0.672 . . . . 0.0 110.41 -173.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -155.76 130.31 9.02 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.37 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 88.7 m -116.25 136.05 53.35 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 167.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -133.34 88.15 36.06 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 95.0 Cg_endo -76.75 136.63 17.14 Favored 'Trans proline' 0 CA--C 1.559 1.768 0 C-N-CA 122.775 2.317 . . . . 0.0 112.425 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 40.8 Cg_endo -102.81 27.76 11.52 Favored 'Cis proline' 0 C--N 1.381 2.26 0 CA-C-N 119.468 0.846 . . . . 0.0 113.256 -5.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.422 ' NH1' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -77.14 -74.63 0.24 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.349 0.66 . . . . 0.0 110.179 -174.03 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -147.9 160.75 42.46 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.25 0.62 . . . . 0.0 110.772 -171.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -141.95 127.91 19.5 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.494 0.718 . . . . 0.0 109.215 171.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.431 ' HG1' ' HG2' ' A' ' 98' ' ' GLU . 24.7 m -104.5 112.26 25.25 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.506 HG13 ' HB ' ' A' ' 97' ' ' VAL . 15.3 pt -110.05 170.56 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.465 1.106 . . . . 0.0 109.544 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.486 ' HB3' HD13 ' A' ' 75' ' ' LEU . 23.3 p -105.37 170.9 7.62 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 69.3 t-105 -146.04 92.85 2.25 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -175.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.65 101.92 13.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -117.71 127.37 53.85 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.14 126.99 30.38 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.909 0.883 . . . . 0.0 110.855 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.38 -54.18 0.81 Allowed Glycine 0 C--N 1.349 1.287 0 O-C-N 123.496 0.497 . . . . 0.0 112.512 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.575 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 0.0 OUTLIER -99.27 148.56 34.81 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 123.993 0.917 . . . . 0.0 110.0 -173.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -50.53 140.88 34.99 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 123.882 3.055 . . . . 0.0 114.21 -173.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.43 117.96 5.45 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.55 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 8.2 m -100.41 173.81 6.4 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.141 0.977 . . . . 0.0 110.636 -173.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -128.07 117.38 21.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.506 ' HB ' HG13 ' A' ' 85' ' ' ILE . 40.7 t -98.34 135.51 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.431 ' HG2' ' HG1' ' A' ' 84' ' ' THR . 0.8 OUTLIER -138.74 114.71 10.1 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.297 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.4 tt -111.43 126.51 55.02 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -177.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.422 ' HG2' ' NH1' ' A' ' 81' ' ' ARG . 23.8 ttm180 -132.42 105.32 7.2 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.899 0.88 . . . . 0.0 110.09 -165.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 88.5 mt -97.1 139.25 33.38 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 110.985 176.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.7 t -138.68 174.16 10.83 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.695 1.198 . . . . 0.0 108.353 172.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -104.74 132.89 50.44 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.405 ' HG2' ' HE ' ' A' ' 29' ' ' ARG . 13.3 tp10 -147.69 99.64 3.13 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -169.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 58.47 -105.72 0.7 Allowed Glycine 0 C--N 1.35 1.314 0 C-N-CA 123.317 0.484 . . . . 0.0 113.966 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -100.93 -15.14 17.63 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.189 0.996 . . . . 0.0 110.43 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.62 -161.01 12.24 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.719 -169.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.2 m -142.79 134.2 26.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.248 1.019 . . . . 0.0 109.71 -173.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.534 HD13 ' NH1' ' A' ' 29' ' ' ARG . 33.6 tp -89.3 122.86 32.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.401 ' HA ' HD21 ' A' ' 101' ' ' LEU . 9.0 tt -111.61 108.82 18.43 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.555 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 28.1 mt-10 -109.62 104.85 13.94 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.47 HD13 HD21 ' A' ' 133' ' ' LEU . 8.0 tt -102.0 101.05 11.39 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 171.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.506 ' HG3' HG12 ' A' ' 25' ' ' ILE . 32.7 tt0 -97.23 117.61 31.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.322 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.434 ' ND1' HG23 ' A' ' 97' ' ' VAL . 5.2 t60 -116.74 118.62 33.03 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.4 132.32 54.53 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.371 0.668 . . . . 0.0 111.328 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.647 HG22 ' HG3' ' A' ' 121' ' ' MET . 7.6 t -154.73 161.15 41.64 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.055 0.942 . . . . 0.0 110.27 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.7 p -88.53 -0.2 56.98 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.881 -166.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.0 m -120.19 129.61 54.18 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.589 0.756 . . . . 0.0 110.963 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -61.46 -41.23 96.9 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.095 0.958 . . . . 0.0 112.187 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -63.68 -56.67 13.94 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.174 0.589 . . . . 0.0 111.229 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.647 ' HG3' HG22 ' A' ' 116' ' ' THR . 14.9 tpt -49.79 -34.25 18.93 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 123.939 0.775 . . . . 0.0 112.369 174.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.46 ' HG ' HG23 ' A' ' 116' ' ' THR . 17.5 mt -67.01 -47.27 71.99 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.678 0.791 . . . . 0.0 112.06 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 127' ' ' VAL . 59.8 t -60.86 -50.39 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -50.21 -46.18 54.38 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.28 1.432 . . . . 0.0 113.222 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.558 HG21 HG12 ' A' ' 24' ' ' ILE . 35.9 m -81.26 -26.41 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.693 0.397 . . . . 0.0 110.913 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.71 -38.33 96.28 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 171.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.51 HG23 ' HB3' ' A' ' 170' ' ' ARG . 62.0 t -78.42 -50.71 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.679 0.792 . . . . 0.0 109.499 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.48 -62.32 6.32 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.9 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -63.27 -40.12 96.49 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 118.417 -0.801 . . . . 0.0 112.313 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.1 -40.73 96.86 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.868 1.213 . . . . 0.0 110.864 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 47.3 ttm -68.91 -36.92 78.58 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.744 0.818 . . . . 0.0 110.078 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 50' ' ' TRP . . . -65.07 -65.02 0.73 Allowed 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.864 0.727 . . . . 0.0 110.449 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.47 HD21 HD13 ' A' ' 112' ' ' LEU . 4.0 mm? -55.19 -30.24 59.53 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.05 0.94 . . . . 0.0 112.53 174.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.31 -45.2 84.44 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.216 0.462 . . . . 0.0 110.973 171.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -65.2 -31.52 72.73 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.519 0.512 . . . . 0.0 111.224 175.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.27 -48.09 79.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 172.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -45.59 -52.7 8.92 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.715 0.634 . . . . 0.0 113.982 166.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.52 -34.42 77.75 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.96 0.904 . . . . 0.0 111.603 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -69.66 -52.02 29.51 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.355 0.662 . . . . 0.0 110.209 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.4 mt -64.97 -29.39 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 124.186 0.994 . . . . 0.0 110.757 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.3 OUTLIER -65.93 -29.18 69.55 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.266 1.026 . . . . 0.0 109.6 175.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.32 1.21 62.65 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.847 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.38 -45.75 75.33 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.147 0.979 . . . . 0.0 111.023 -176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.1 mt -72.6 111.07 9.72 Favored Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 122.976 0.51 . . . . 0.0 109.875 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -97.69 -173.58 0.18 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 123.556 2.838 . . . . 0.0 112.901 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.67 77.98 2.05 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.87 168.59 33.43 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.219 -0.767 . . . . 0.0 111.924 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.73 157.7 46.12 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 123.641 2.894 . . . . 0.0 113.522 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 152' ' ' ASP . 28.9 m -75.09 121.04 84.4 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.554 175.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.09 -47.06 13.38 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.975 2.45 . . . . 0.0 113.724 -168.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.08 -17.59 61.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.636 0.774 . . . . 0.0 110.96 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.531 ' HA ' HG22 ' A' ' 149' ' ' VAL . 33.3 t70 60.2 40.52 17.97 Favored 'General case' 0 C--N 1.367 1.345 0 C-N-CA 124.978 1.311 . . . . 0.0 110.439 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.445 ' HB2' ' HG2' ' A' ' 158' ' ' GLU . . . -164.89 96.85 0.73 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.594 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.86 -17.34 62.73 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.543 165.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -67.85 -28.71 67.78 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.075 1.35 . . . . 0.0 111.93 173.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.46 ' HG2' ' H ' ' A' ' 157' ' ' PHE . 3.7 tt0 70.75 -158.71 0.14 Allowed 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -166.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.46 ' H ' ' HG2' ' A' ' 156' ' ' GLU . 68.1 t80 65.91 54.74 1.0 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.376 1.084 . . . . 0.0 109.654 176.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.445 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 0.0 OUTLIER -147.84 154.92 44.36 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.601 -174.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.54 87.04 1.3 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.199 1.933 . . . . 0.0 113.165 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 63.2 m -139.85 118.47 8.7 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 168.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -47.07 -43.26 25.32 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 124.165 3.243 . . . . 0.0 113.748 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.405 ' O ' HG12 ' A' ' 166' ' ' ILE . 7.8 mp0 -64.2 -54.46 33.2 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.396 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.434 ' HE1' ' HA ' ' A' ' 163' ' ' MET . 31.5 mmt -70.73 -31.47 68.32 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 122.992 0.517 . . . . 0.0 112.051 -174.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 75.5 mtm -70.45 -36.5 73.98 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.654 173.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.47 ' HA ' ' HG2' ' A' ' 168' ' ' GLN . 31.5 ttt180 -68.97 -43.66 74.51 Favored 'General case' 0 C--O 1.205 -1.266 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.63 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 162' ' ' GLU . 50.6 mm -59.65 -43.22 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 122.868 0.467 . . . . 0.0 110.06 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.1 t -51.53 -47.3 63.41 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.421 1.088 . . . . 0.0 112.411 172.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.47 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 10.4 pt20 -88.9 -25.28 22.2 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -63.42 -57.34 10.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.566 1.147 . . . . 0.0 110.079 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.51 ' HB3' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -60.16 -43.82 95.49 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.684 0.615 . . . . 0.0 109.828 173.468 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -54.71 -44.15 79.99 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 124.028 0.83 . . . . 0.0 113.195 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.26 -59.39 4.12 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.762 1.225 . . . . 0.0 109.866 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 177' ' ' LEU . . . -51.44 -57.05 10.04 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 124.997 1.435 . . . . 0.0 111.834 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -70.29 -25.86 63.53 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.725 0.81 . . . . 0.0 113.101 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.1 -36.62 64.26 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 118.177 0.444 . . . . 0.0 110.452 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.97 -35.09 74.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.908 0.483 . . . . 0.0 109.943 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.748 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 67.8 mt -69.47 -53.22 20.29 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.943 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.516 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 9.8 p -70.28 -29.3 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 48.4 m170 -80.22 2.41 24.51 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.874 0.47 . . . . 0.0 111.304 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 37.6 t -117.76 121.7 41.51 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.184 0.994 . . . . 0.0 108.354 171.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -114.52 70.62 0.24 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 112.195 -0.362 . . . . 0.0 112.195 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 CA--C 1.556 1.198 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.811 178.085 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.36 -31.76 54.57 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.275 0.63 . . . . 0.0 110.845 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.9 m 73.42 -73.2 0.1 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.038 1.335 . . . . 0.0 112.933 175.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.74 79.13 1.35 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -168.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -64.01 93.95 0.09 Allowed 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.405 0.621 . . . . 0.0 110.879 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -78.11 73.34 4.67 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.294 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.2 m -97.1 120.65 37.86 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.739 0.815 . . . . 0.0 110.048 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -114.35 116.24 28.63 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.437 1.095 . . . . 0.0 109.024 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -76.22 139.36 41.14 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 170.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.544 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . . . -152.63 170.61 19.8 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.06 0.457 . . . . 0.0 111.444 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.428 HD13 ' N ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -143.88 162.04 37.13 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -176.022 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -173.28 -160.71 22.28 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -137.65 151.68 48.54 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.072 0.949 . . . . 0.0 108.495 178.021 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -156.95 133.21 9.78 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.566 0.746 . . . . 0.0 109.298 -170.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 m -83.16 137.78 33.92 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.443 HD12 HG22 ' A' ' 117' ' ' THR . 47.7 pt -137.65 160.88 63.29 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.507 0.723 . . . . 0.0 109.1 -174.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -45.07 -31.29 5.52 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.984 3.123 . . . . 0.0 115.324 174.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 -41.75 65.61 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.042 0.537 . . . . 0.0 111.265 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.93 -150.09 21.67 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.913 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.8 115.82 9.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.587 0.755 . . . . 0.0 109.817 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.78 164.75 18.54 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.677 0.791 . . . . 0.0 110.907 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -112.61 161.95 16.23 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.4 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 p -138.81 128.99 25.5 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.47 0.308 . . . . 0.0 110.655 -168.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 45.5 pt -87.32 135.69 24.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 169.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 3.5 mp -112.99 110.75 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 171.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.9 mt -101.67 109.57 26.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.469 ' HG3' HD12 ' A' ' 109' ' ' LEU . 59.7 ttm-85 -113.76 148.46 36.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.736 0.814 . . . . 0.0 110.385 -172.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.482 HE21 HD22 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -165.91 138.22 4.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 124.215 0.947 . . . . 0.0 112.496 -176.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.497 ' NH1' HD13 ' A' ' 109' ' ' LEU . 46.0 mmt-85 -96.69 115.39 27.35 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.273 1.029 . . . . 0.0 108.84 167.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -93.67 147.93 22.57 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.765 0.826 . . . . 0.0 109.998 170.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.17 28.03 0.86 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.371 0.668 . . . . 0.0 111.352 172.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.46 151.78 44.74 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 124.451 1.1 . . . . 0.0 109.768 176.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.32 152.02 60.69 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.014 1.809 . . . . 0.0 111.026 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.9 t -46.63 -49.85 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 124.444 1.098 . . . . 0.0 111.094 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -49.21 -47.2 46.36 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 125.371 1.669 . . . . 0.0 111.55 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.81 -34.84 72.15 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.305 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.2 t -75.05 -32.41 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -71.48 -31.24 66.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.428 1.091 . . . . 0.0 110.179 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.8 m -75.09 -37.44 61.55 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -65.03 -44.64 88.47 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.266 0.626 . . . . 0.0 110.744 171.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.9 t -68.13 -24.86 65.05 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -176.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.9 p -113.85 -38.59 4.2 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -172.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.94 122.86 88.57 Favored Pre-proline 0 N--CA 1.484 1.274 0 CA-C-O 119.106 -0.473 . . . . 0.0 110.269 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -49.97 -51.68 10.41 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.868 3.045 . . . . 0.0 114.596 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -52.39 -33.54 43.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.844 1.258 . . . . 0.0 111.841 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.517 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 5.4 mmp_? -81.33 -38.45 26.71 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.862 0.465 . . . . 0.0 111.662 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.3 mt -73.39 -29.51 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -57.68 -24.64 57.79 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.033 1.733 . . . . 0.0 112.084 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -87.89 -60.21 2.03 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.382 0.673 . . . . 0.0 110.208 -173.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -82.29 -15.04 54.39 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -140.27 -108.41 0.15 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 89.2 mt -143.01 144.25 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.627 0.771 . . . . 0.0 109.52 -169.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -59.44 109.52 2.0 Allowed Pre-proline 0 CA--C 1.57 1.715 0 O-C-N 125.31 1.631 . . . . 0.0 111.654 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -100.06 156.83 0.52 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.208 2.605 . . . . 0.0 113.82 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -144.73 159.0 43.56 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.6 1.16 . . . . 0.0 108.441 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.74 -148.2 19.84 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.62 -53.69 7.28 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.376 0.67 . . . . 0.0 109.423 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt 59.88 19.7 8.65 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.617 1.167 . . . . 0.0 110.962 -170.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -114.55 149.65 36.17 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.678 1.191 . . . . 0.0 109.153 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.502 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 42.3 tt0 -59.7 122.27 13.73 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.476 0.71 . . . . 0.0 110.88 -177.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.67 14.77 64.8 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.908 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -115.8 -147.54 9.03 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -151.26 172.64 15.55 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.491 0.662 . . . . 0.0 111.605 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.63 164.94 26.08 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.897 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.37 122.13 9.28 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.037 0.935 . . . . 0.0 109.873 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.483 HD11 HD21 ' A' ' 69' ' ' ASN . 25.9 mt -89.8 142.11 28.0 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.624 1.17 . . . . 0.0 108.927 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.06 101.18 12.21 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.52 32.35 8.77 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.423 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.483 HD21 HD11 ' A' ' 66' ' ' LEU . 64.1 t30 -150.67 -88.09 0.07 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 117.32 0.56 . . . . 0.0 111.689 177.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.77 159.42 40.63 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 121.304 0.573 . . . . 0.0 112.207 -167.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.0 m -125.62 148.53 48.94 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.476 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.88 159.48 30.33 Favored Glycine 0 C--N 1.338 0.673 0 O-C-N 123.196 0.31 . . . . 0.0 112.381 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.43 164.34 14.32 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.638 0.775 . . . . 0.0 110.586 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 mm -106.72 103.75 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.417 HD12 ' HG ' ' A' ' 86' ' ' SER . 72.2 mt -80.03 -43.08 22.54 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.79 0.436 . . . . 0.0 111.053 -174.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -166.49 146.74 6.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.131 0.572 . . . . 0.0 109.521 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 12.8 p -160.37 110.77 1.82 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.749 0.42 . . . . 0.0 111.155 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.79 112.4 60.3 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 169.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 70.9 Cg_endo -75.52 132.39 14.7 Favored 'Trans proline' 0 CA--C 1.558 1.707 0 C-N-CA 122.153 1.902 . . . . 0.0 111.897 169.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 43.8 Cg_endo -98.97 21.71 23.32 Favored 'Cis proline' 0 C--N 1.375 1.949 0 CA-C-N 119.659 0.914 . . . . 0.0 112.967 -4.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -66.79 -68.41 0.38 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.151 0.98 . . . . 0.0 112.982 -171.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.452 ' HB3' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -154.58 148.96 26.14 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.627 0.648 . . . . 0.0 112.491 -174.358 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.5 tp -108.14 145.45 34.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.342 1.457 . . . . 0.0 108.572 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.7 m -137.49 125.85 23.32 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.2 pt -144.01 147.37 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.502 1.121 . . . . 0.0 110.211 -170.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.417 ' HG ' HD12 ' A' ' 75' ' ' LEU . 50.3 m -88.33 154.28 20.52 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 166.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 43.7 t-105 -134.98 106.74 6.96 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -174.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.02 107.43 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -94.34 162.98 13.61 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -48.76 111.24 0.44 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.237 1.415 . . . . 0.0 112.648 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.65 25.4 75.77 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 124.023 0.827 . . . . 0.0 113.88 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -116.03 159.73 38.19 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.796 0.838 . . . . 0.0 110.334 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.33 167.25 26.81 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.323 2.015 . . . . 0.0 110.98 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -69.25 108.88 3.84 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.5 m -83.92 167.02 17.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.381 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.03 119.98 18.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 40.6 t -130.13 145.15 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.591 1.157 . . . . 0.0 109.605 -165.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -135.57 145.25 46.77 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.97 -0.456 . . . . 0.0 109.887 171.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.427 ' HG ' HD23 ' A' ' 110' ' ' LEU . 9.2 tt -123.38 115.64 21.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.452 ' HA ' ' HB3' ' A' ' 82' ' ' ARG . 41.6 ttp180 -121.93 117.47 26.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.98 0.512 . . . . 0.0 110.462 -171.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.4 mt -95.55 132.17 40.96 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.321 1.048 . . . . 0.0 109.525 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.8 m -137.23 125.66 23.46 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.653 1.181 . . . . 0.0 107.985 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.97 152.12 28.61 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.362 1.065 . . . . 0.0 110.45 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -167.19 85.95 0.26 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.403 0.681 . . . . 0.0 110.617 -162.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.31 -137.3 23.56 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -87.68 51.99 2.36 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 166.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.91 -165.24 31.5 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 114.547 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 90.9 m -148.01 132.92 18.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.203 0.601 . . . . 0.0 110.968 -171.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.497 HD13 ' NH1' ' A' ' 29' ' ' ARG . 32.6 tp -83.29 120.24 25.59 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.674 0.79 . . . . 0.0 109.486 167.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.482 HD22 HE21 ' A' ' 28' ' ' GLN . 7.3 tt -102.87 132.59 48.97 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 170.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -128.5 105.63 8.43 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.415 HD23 HD21 ' A' ' 133' ' ' LEU . 41.9 tp -101.47 133.01 46.76 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 33.1 tt0 -131.43 105.47 7.62 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.695 0.798 . . . . 0.0 108.943 175.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -96.26 115.55 27.62 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.54 107.37 15.42 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.575 0.75 . . . . 0.0 110.237 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.0 t -130.92 156.94 44.22 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.086 0.554 . . . . 0.0 109.684 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.443 HG22 HD12 ' A' ' 16' ' ' ILE . 68.7 p -74.35 -31.4 62.4 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.864 0.866 . . . . 0.0 110.535 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 m -79.38 111.41 15.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.999 0.92 . . . . 0.0 111.337 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.496 ' HA ' HD11 ' A' ' 122' ' ' LEU . 45.3 tt0 -60.42 -30.93 69.93 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.907 0.883 . . . . 0.0 111.86 176.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -66.96 -49.41 65.53 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.61 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.5 ttt -59.8 -37.29 78.71 Favored 'General case' 0 C--O 1.203 -1.383 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.897 176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 119' ' ' GLU . 25.7 mt -61.54 -38.56 87.87 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 123.43 0.692 . . . . 0.0 112.404 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.6 t -65.85 -49.04 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.427 0.632 . . . . 0.0 109.826 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -62.55 -40.32 96.46 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.934 1.294 . . . . 0.0 111.832 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 m -83.62 -22.63 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.549 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.09 -34.84 85.56 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 168.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.98 -52.16 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.05 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.8 -38.13 95.7 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.339 -172.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -80.77 -39.43 26.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.923 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -61.48 -37.04 82.18 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 119.357 0.98 . . . . 0.0 109.636 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 93.1 mtp -69.4 -35.62 75.96 Favored 'General case' 0 C--O 1.218 -0.584 0 O-C-N 123.758 0.661 . . . . 0.0 110.723 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.84 86.35 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.706 0.402 . . . . 0.0 110.701 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.415 HD21 HD23 ' A' ' 112' ' ' LEU . 3.7 mm? -79.29 -20.38 48.16 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.278 0.631 . . . . 0.0 111.498 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -71.46 -42.92 67.54 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -81.54 -22.82 37.63 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.867 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 32.4 tp -71.26 -31.68 67.8 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -56.76 -52.96 47.49 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.978 164.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 94.4 mmm -63.61 -33.84 76.5 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.922 0.889 . . . . 0.0 112.334 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.415 ' HZ ' ' HD3' ' A' ' 46' ' ' ARG . 43.8 t80 -75.08 -51.42 13.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.766 0.826 . . . . 0.0 110.599 -174.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.0 mt -65.35 -28.97 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.009 0.924 . . . . 0.0 110.769 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER -63.04 -26.23 68.75 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.597 0.759 . . . . 0.0 109.593 174.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.4 2.74 41.07 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.162 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -93.44 -87.23 0.24 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.133 0.573 . . . . 0.0 110.424 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 45.45 76.1 0.58 Allowed Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 124.445 1.098 . . . . 0.0 110.531 -163.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.43 -0.67 10.81 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.271 2.648 . . . . 0.0 112.187 172.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.34 -114.6 4.77 Favored Glycine 0 C--O 1.24 0.474 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -110.48 94.39 0.79 Allowed Glycine 0 C--N 1.338 0.641 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.01 114.99 4.13 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.27 1.98 . . . . 0.0 110.879 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.1 m -64.12 111.55 5.67 Favored Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 123.141 0.576 . . . . 0.0 110.439 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.427 ' HG2' ' HG3' ' A' ' 151' ' ' GLU . 72.0 Cg_endo -71.6 -29.58 15.97 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.679 2.253 . . . . 0.0 112.821 -174.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.574 ' HG2' ' HB2' ' A' ' 162' ' ' GLU . 0.0 OUTLIER -110.24 -34.16 6.44 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.168 0.987 . . . . 0.0 111.019 -174.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.6 t70 55.44 88.21 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.152 1.381 . . . . 0.0 111.07 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -141.2 97.51 3.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.701 0.8 . . . . 0.0 109.444 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.06 140.39 41.87 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.96 101.64 1.43 Allowed 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.407 0.623 . . . . 0.0 111.676 -172.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -94.53 -38.85 10.69 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.285 172.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -141.54 -60.59 0.48 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -89.57 130.62 42.71 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.934 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.71 -83.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.61 2.873 . . . . 0.0 113.436 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.4 m -154.14 85.94 3.8 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -174.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.86 -50.14 13.41 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.149 2.566 . . . . 0.0 112.768 -169.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.574 ' HB2' ' HG2' ' A' ' 151' ' ' GLU . 13.0 mp0 -72.01 -37.6 69.78 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.4 -175.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 15.0 tpt -72.58 -39.6 67.27 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 118.175 0.443 . . . . 0.0 111.058 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 59.0 mtm -60.91 -36.5 79.44 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 173.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -68.22 -47.19 68.52 Favored 'General case' 0 C--O 1.206 -1.203 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.862 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.402 ' O ' ' HG3' ' A' ' 170' ' ' ARG . 72.9 mt -59.72 -35.35 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 124.468 1.107 . . . . 0.0 111.776 -178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.3 p -75.84 -53.35 8.59 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -176.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -59.99 -45.62 92.14 Favored 'General case' 0 C--O 1.205 -1.26 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.819 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -42.37 -49.96 5.12 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 124.61 1.164 . . . . 0.0 113.194 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 166' ' ' ILE . 54.3 mtt180 -63.86 -40.05 95.66 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 120.767 0.318 . . . . 0.0 111.084 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.39 -33.15 44.81 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.137 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 12.8 pt-20 -82.91 -18.32 40.56 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.829 0.851 . . . . 0.0 109.896 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.99 -51.45 58.31 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.676 0.79 . . . . 0.0 109.2 172.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -72.73 -34.2 66.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.7 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -65.25 -28.68 69.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.621 0.369 . . . . 0.0 110.926 174.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -76.62 -43.24 39.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.7 mt -63.63 -41.17 98.28 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.279 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.2 p -90.66 -26.43 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 118.426 0.557 . . . . 0.0 109.632 -166.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -75.35 -17.88 60.12 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.895 0.478 . . . . 0.0 110.795 173.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.8 m -83.76 -62.24 1.62 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.024 0.53 . . . . 0.0 109.912 172.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 63.5 36.66 93.67 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.095 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.249 1.049 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -175.783 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.97 95.43 6.78 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.1 p 66.78 -68.57 0.14 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 126.379 1.872 . . . . 0.0 112.887 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.48 9.71 71.91 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 -170.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -130.76 23.2 5.01 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.352 0.661 . . . . 0.0 110.22 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.67 88.61 7.37 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.136 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.9 m -104.75 104.12 13.86 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.444 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -80.06 135.9 36.45 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.136 0.494 . . . . 0.0 109.989 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.409 ' HB3' HD13 ' A' ' 177' ' ' LEU . 32.3 mtt180 -109.21 140.21 43.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.941 1.296 . . . . 0.0 109.227 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.65 -173.22 2.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.287 0.635 . . . . 0.0 111.272 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.593 HD11 HH11 ' A' ' 22' ' ' ARG . 81.3 mt -139.16 163.7 31.76 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.548 1.139 . . . . 0.0 109.502 175.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.68 -163.04 11.34 Favored Glycine 0 C--O 1.241 0.575 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.69 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.53 124.07 9.06 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -133.29 116.24 15.91 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.4 m -84.42 120.0 25.77 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 pt -110.88 163.57 16.96 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 124.9 1.28 . . . . 0.0 109.329 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -55.24 -24.19 40.71 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.392 2.728 . . . . 0.0 114.741 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.34 -22.2 61.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.24 0.616 . . . . 0.0 112.189 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.49 170.95 14.71 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -169.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -67.43 116.67 8.44 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 173.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -104.63 152.02 22.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.94 0.496 . . . . 0.0 110.151 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.593 HH11 HD11 ' A' ' 11' ' ' LEU . 22.4 ttm-85 -97.8 154.41 17.64 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.6 p -123.71 143.27 50.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.737 0.415 . . . . 0.0 110.841 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.428 HG21 HD23 ' A' ' 122' ' ' LEU . 2.7 pp -90.92 135.66 26.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 166.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.592 HG13 ' HG2' ' A' ' 113' ' ' GLU . 1.7 mp -114.39 115.8 50.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -174.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.0 mt -114.69 106.46 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 170.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.51 ' HB3' HD11 ' A' ' 109' ' ' LEU . 52.3 mtp180 -105.21 136.45 44.69 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -144.61 136.47 25.88 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -92.81 103.06 15.45 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -86.39 122.57 30.54 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.191 0.996 . . . . 0.0 110.557 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.39 43.14 0.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.475 171.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.24 143.86 20.13 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' A' ' 36' ' ' GLU . 21.3 Cg_endo -62.58 165.27 16.05 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.1 2.534 . . . . 0.0 114.633 -176.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.49 -45.09 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.405 -174.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.3 -35.51 79.26 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.438 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.593 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 8.5 tp10 -65.12 -62.76 1.36 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.957 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 33' ' ' PRO . 11.3 t -53.37 -35.0 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.042 0.937 . . . . 0.0 111.078 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -62.5 -58.31 8.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.312 0.645 . . . . 0.0 110.664 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.6 p -59.18 -39.37 82.31 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.524 -177.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.4 74.1 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.799 171.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -80.33 -9.56 59.74 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.8 p -104.3 -32.3 9.14 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.824 0.45 . . . . 0.0 111.596 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.47 ' O ' HG13 ' A' ' 47' ' ' ILE . 10.2 t70 -79.96 116.28 60.11 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 123.882 0.873 . . . . 0.0 110.298 -174.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -61.91 -33.25 84.55 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.142 2.561 . . . . 0.0 113.195 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.42 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 13.9 m120 -70.42 -17.51 63.01 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.25 0.62 . . . . 0.0 110.89 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -101.59 -25.59 13.83 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.603 0.761 . . . . 0.0 110.853 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.504 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 76.4 mt -76.96 -40.22 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 122.908 0.483 . . . . 0.0 111.417 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.42 ' ND2' ' HA ' ' A' ' 45' ' ' ASN . 13.9 p30 -59.66 -21.83 61.06 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -60.12 -56.54 20.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.362 0.665 . . . . 0.0 110.91 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.504 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 36.3 p-90 -91.44 -54.74 3.78 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -172.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.429 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 10.7 t80 -108.46 -166.18 1.1 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.11 0.564 . . . . 0.0 109.638 176.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.8 mt -86.12 124.77 40.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 164.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.22 136.23 96.44 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 123.208 0.603 . . . . 0.0 110.695 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.602 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 54.3 Cg_endo -68.67 131.12 22.08 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.227 1.951 . . . . 0.0 111.76 171.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -89.87 155.71 18.96 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.425 0.69 . . . . 0.0 109.294 172.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.0 -163.01 17.87 Favored Glycine 0 N--CA 1.466 0.681 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.057 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.26 -39.34 92.55 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.943 1.297 . . . . 0.0 111.202 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.0 mt 62.75 12.8 5.92 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.008 1.323 . . . . 0.0 114.342 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.0 mmm-85 -108.1 161.51 14.9 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.591 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 39.0 tt0 -67.18 109.38 3.04 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.594 0.757 . . . . 0.0 110.436 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.55 -23.33 11.18 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -175.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.93 -170.63 45.4 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 166.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -132.31 163.1 29.4 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.037 0.918 . . . . 0.0 110.946 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.602 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 20.2 p90 -119.82 165.28 14.79 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.114 175.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -166.83 102.65 0.56 Allowed 'General case' 0 C--N 1.348 0.524 0 C-N-CA 125.226 1.41 . . . . 0.0 107.824 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.42 HD12 ' CH2' ' A' ' 87' ' ' TRP . 70.7 mt -56.56 -65.74 0.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.397 0.679 . . . . 0.0 111.704 -171.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 132.49 -61.58 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 128.025 2.53 . . . . 0.0 109.177 171.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.86 31.52 8.09 Favored Glycine 0 N--CA 1.473 1.113 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.16 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -158.27 -80.86 0.06 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.83 -167.39 2.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.224 0.61 . . . . 0.0 111.019 -171.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.649 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 33.0 t -148.61 -166.11 2.46 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.1 -156.99 27.06 Favored Glycine 0 C--N 1.347 1.163 0 C-N-CA 121.554 -0.355 . . . . 0.0 113.609 171.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -141.45 146.53 36.61 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.917 0.887 . . . . 0.0 109.403 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.423 ' HA ' HG23 ' A' ' 85' ' ' ILE . 10.6 mt -96.61 106.5 18.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-O 121.497 0.665 . . . . 0.0 109.948 -177.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.63 -59.53 2.65 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.929 -171.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -146.3 155.03 42.36 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.268 1.027 . . . . 0.0 110.503 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 21.6 p -155.56 117.11 3.99 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 176.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -108.89 94.49 14.7 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.282 1.433 . . . . 0.0 107.458 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.28 134.26 15.56 Favored 'Trans proline' 0 CA--C 1.566 2.098 0 C-N-CA 122.709 2.273 . . . . 0.0 113.06 -175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -99.07 24.86 19.44 Favored 'Cis proline' 0 C--N 1.385 2.487 0 CA-C-N 119.808 0.967 . . . . 0.0 112.285 -8.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -67.4 0.49 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.494 1.118 . . . . 0.0 111.084 -170.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -142.61 159.72 41.69 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.232 0.613 . . . . 0.0 110.604 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 tt -136.07 110.81 8.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.6 m -114.42 110.91 20.59 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.185 0.994 . . . . 0.0 109.077 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.423 HG23 ' HA ' ' A' ' 74' ' ' ILE . 23.3 pt -125.55 160.4 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.731 1.212 . . . . 0.0 109.792 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.7 p -83.84 -175.24 5.71 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.906 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.475 ' HB3' ' HG ' ' A' ' 95' ' ' SER . 18.9 t-105 -170.18 100.59 0.28 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 120.673 0.273 . . . . 0.0 111.215 -169.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.3 t -92.01 103.5 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.648 0.779 . . . . 0.0 109.09 176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.569 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -102.57 143.82 31.77 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.108 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -57.5 121.41 10.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.391 1.077 . . . . 0.0 111.778 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.54 -1.04 79.1 Favored Glycine 0 C--N 1.346 1.099 0 O-C-N 123.23 0.331 . . . . 0.0 113.762 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.569 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 47.0 mmtm -120.82 163.96 26.22 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.179 0.992 . . . . 0.0 109.598 -175.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.11 -178.26 4.07 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.635 2.224 . . . . 0.0 112.44 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.27 96.97 7.44 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.475 ' HG ' ' HB3' ' A' ' 87' ' ' TRP . 78.4 p -80.58 168.03 19.38 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.895 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.24 119.14 29.3 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.641 0.777 . . . . 0.0 109.637 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.75 142.86 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.28 1.032 . . . . 0.0 109.327 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -139.8 115.84 10.36 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tt -99.36 124.0 44.11 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.651 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 32.3 ttt180 -126.25 105.22 8.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.412 0.685 . . . . 0.0 109.896 -173.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 91.0 mt -88.78 134.27 33.98 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.256 0.623 . . . . 0.0 109.822 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.6 m -125.71 171.89 10.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.706 1.202 . . . . 0.0 109.158 172.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.88 123.46 49.83 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -177.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -141.84 109.34 5.63 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -171.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 53.91 -103.86 0.19 Allowed Glycine 0 CA--C 1.531 1.089 0 O-C-N 123.976 0.797 . . . . 0.0 113.852 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -109.13 -9.12 15.06 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.608 1.163 . . . . 0.0 110.669 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.84 -163.74 13.28 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.064 -171.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.4 m -146.12 126.54 14.05 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.482 1.113 . . . . 0.0 109.225 -172.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 27' ' ' ARG . 44.7 tp -86.81 129.04 35.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.464 HD21 HD11 ' A' ' 133' ' ' LEU . 8.6 tt -108.67 108.81 19.81 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.651 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 32.2 mt-10 -107.12 105.63 15.72 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.22 103.58 12.01 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.569 0.748 . . . . 0.0 109.935 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.592 ' HG2' HG13 ' A' ' 25' ' ' ILE . 38.0 mt-10 -100.3 115.1 29.14 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 173.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -107.85 113.25 26.33 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.18 117.62 33.08 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.91 0.884 . . . . 0.0 111.598 -168.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.7 t -143.6 155.83 44.4 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.663 0.785 . . . . 0.0 110.694 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 p -79.8 -8.38 59.24 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.188 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.2 m -98.62 117.68 33.61 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.652 0.781 . . . . 0.0 110.67 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.39 -37.05 85.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.578 0.751 . . . . 0.0 111.774 -178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -60.54 -54.74 41.85 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.694 173.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.438 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 26.8 ttt -49.63 -36.81 25.73 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 124.121 0.888 . . . . 0.0 113.026 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.428 HD23 HG21 ' A' ' 24' ' ' ILE . 63.6 mt -60.64 -47.92 84.1 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.916 0.486 . . . . 0.0 111.528 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 127' ' ' VAL . 46.9 t -62.48 -55.2 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 123.505 0.503 . . . . 0.0 109.796 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -43.61 -62.42 1.1 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.559 1.943 . . . . 0.0 113.038 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.2 m -66.52 -33.27 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 122.815 0.446 . . . . 0.0 110.575 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.82 -37.23 90.08 Favored Glycine 0 C--N 1.35 1.349 0 O-C-N 123.723 0.639 . . . . 0.0 112.136 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 123' ' ' VAL . 89.8 t -74.28 -45.7 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.167 0.587 . . . . 0.0 109.648 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.99 -61.25 7.65 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.833 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 20.0 m95 -51.76 -36.99 49.42 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -57.49 -44.18 84.72 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 120.016 1.28 . . . . 0.0 111.21 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 88.5 mtp -64.14 -46.89 82.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 174.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.414 ' HB2' ' HE3' ' A' ' 50' ' ' TRP . . . -68.12 -22.98 64.86 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.667 1.187 . . . . 0.0 112.76 -176.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.464 HD11 HD21 ' A' ' 110' ' ' LEU . 2.7 mm? -86.58 -30.77 21.6 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.6 -37.83 55.8 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.681 0.792 . . . . 0.0 109.637 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -68.48 -46.28 70.14 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.266 0.626 . . . . 0.0 109.735 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.33 -24.24 66.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 122.972 0.509 . . . . 0.0 110.104 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -68.96 -54.8 12.51 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 8.6 mtm -68.52 -33.93 74.99 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.306 0.642 . . . . 0.0 111.332 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -62.62 -55.45 26.95 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.954 0.902 . . . . 0.0 110.686 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.0 tt -72.7 -26.39 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.936 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -77.28 -27.26 53.05 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.952 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.73 -84.14 0.07 OUTLIER Glycine 0 C--N 1.349 1.277 0 O-C-N 123.216 0.322 . . . . 0.0 113.808 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -95.92 -113.03 0.13 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 118.456 -0.783 . . . . 0.0 111.408 -162.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 50.0 87.57 0.13 Allowed Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 125.496 1.518 . . . . 0.0 111.417 -174.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.05 -13.62 15.57 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.854 2.369 . . . . 0.0 112.16 174.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.14 -178.31 18.67 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.278 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.29 62.78 0.07 OUTLIER Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.427 -0.652 . . . . 0.0 112.11 173.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.94 -52.64 1.15 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 122.802 2.335 . . . . 0.0 112.259 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.7 m -117.25 136.15 23.34 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 123.992 0.917 . . . . 0.0 110.367 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.58 ' HG3' ' HG3' ' A' ' 163' ' ' MET . 32.5 Cg_exo -62.39 -58.2 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.585 2.857 . . . . 0.0 112.753 174.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -134.03 -35.0 0.96 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.591 0.756 . . . . 0.0 110.604 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 31.5 t70 63.19 70.27 0.55 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.794 1.238 . . . . 0.0 110.166 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.78 53.53 1.68 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.461 1.105 . . . . 0.0 109.587 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 61.75 80.9 0.21 Allowed 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.993 -175.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.734 ' HB2' ' HA ' ' A' ' 159' ' ' PRO . 8.1 pt-20 -151.26 79.34 1.3 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.902 1.334 . . . . 0.0 110.737 -168.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -106.4 -62.02 1.44 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.874 -176.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -61.4 -44.45 97.12 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.656 1.183 . . . . 0.0 111.643 -171.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.475 ' HB2' ' SD ' ' A' ' 164' ' ' MET . 10.7 pt-20 -151.74 92.83 3.57 Favored Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 123.885 0.874 . . . . 0.0 108.794 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.734 ' HA ' ' HB2' ' A' ' 155' ' ' GLU . 35.5 Cg_exo -59.67 -76.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.996 2.464 . . . . 0.0 114.951 -172.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 43.2 m -147.77 147.4 27.15 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-O 118.545 -0.74 . . . . 0.0 109.458 -168.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.39 -46.24 32.64 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 124.167 3.244 . . . . 0.0 114.714 -166.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -68.72 -42.31 77.86 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.612 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.58 ' HG3' ' HG3' ' A' ' 150' ' ' PRO . 25.6 mmt -67.05 -35.85 80.78 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.242 0.617 . . . . 0.0 110.851 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 158' ' ' GLU . 78.7 mtp -67.76 -41.2 83.72 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.608 0.763 . . . . 0.0 110.114 177.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -65.2 -46.38 80.93 Favored 'General case' 0 C--O 1.216 -0.687 0 O-C-N 123.805 0.69 . . . . 0.0 110.535 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 68.5 mt -58.98 -41.54 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.558 0.743 . . . . 0.0 111.046 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 46.8 t -62.0 -34.27 75.87 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.113 0.565 . . . . 0.0 111.102 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 164' ' ' MET . 78.7 mm-40 -72.32 -56.68 5.09 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.094 0.558 . . . . 0.0 110.024 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -48.85 -53.34 19.77 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.381 1.072 . . . . 0.0 112.299 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -70.84 -45.36 64.64 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.226 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -59.07 -58.87 12.23 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 124.148 0.905 . . . . 0.0 114.246 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -54.28 -43.73 71.3 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.152 0.981 . . . . 0.0 111.682 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.01 -38.24 87.9 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 123.675 0.609 . . . . 0.0 111.389 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -78.11 -24.47 47.47 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 119.201 -0.428 . . . . 0.0 112.03 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.91 -42.4 73.39 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -71.34 -26.53 62.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.258 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.497 HD21 ' HG ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -82.65 -49.23 10.03 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.597 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.44 -29.51 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.459 0.704 . . . . 0.0 112.533 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -64.89 -6.99 9.57 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 122.822 0.449 . . . . 0.0 111.321 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.5 t 74.92 102.67 0.07 Allowed 'General case' 0 C--N 1.353 0.721 0 C-N-CA 126.993 2.117 . . . . 0.0 112.737 164.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.8 21.36 11.45 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.528 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 35.8 p . . . . . 0 CA--C 1.556 1.19 0 C-N-CA 123.791 0.837 . . . . 0.0 110.232 175.904 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 tpp . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.81 73.61 2.75 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.565 0.746 . . . . 0.0 110.251 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -111.35 9.78 21.57 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.519 1.127 . . . . 0.0 110.31 -175.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 29' ' ' ARG . . . -86.4 57.17 4.74 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.422 ' HA ' ' HB2' ' A' ' 29' ' ' ARG . 10.1 mm100 -110.49 98.49 7.68 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -174.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -153.54 -173.68 4.67 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.597 0.759 . . . . 0.0 110.567 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.473 ' HG1' ' HG2' ' A' ' 28' ' ' GLN . 55.5 m -115.27 108.94 17.22 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 124.856 1.262 . . . . 0.0 109.815 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -109.72 124.67 51.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.362 1.065 . . . . 0.0 109.268 -176.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -81.88 154.29 25.91 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.511 0.725 . . . . 0.0 110.895 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.519 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -160.06 172.83 16.8 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.31 0.644 . . . . 0.0 109.963 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.418 HD12 ' HA2' ' A' ' 181' ' ' GLY . 0.3 OUTLIER -148.5 141.68 25.04 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.887 -175.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.42 -151.52 5.44 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 32.3 ptt180 -144.66 170.81 15.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.353 0.661 . . . . 0.0 109.377 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -163.4 115.32 1.46 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.6 m -86.23 100.94 12.6 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.7 pt -93.88 168.76 11.15 Favored Pre-proline 0 CA--C 1.557 1.225 0 C-N-CA 124.738 1.215 . . . . 0.0 108.682 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.36 -17.49 27.02 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.865 2.376 . . . . 0.0 114.045 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.13 -0.33 56.95 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.95 178.31 15.26 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 118.214 0.461 . . . . 0.0 112.271 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.48 95.29 1.77 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-O 121.737 0.78 . . . . 0.0 109.984 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.65 166.32 19.26 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.29 174.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 20.2 ttm180 -118.42 161.1 20.54 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.436 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 79.7 p -134.11 144.16 48.42 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -173.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.4 pt -93.08 150.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 166.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 3.1 mp -129.22 116.03 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.8 mt -109.84 108.35 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 7' ' ' THR . 99.9 mtt180 -95.03 132.77 39.54 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.642 0.777 . . . . 0.0 109.919 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.473 ' HG2' ' HG1' ' A' ' 7' ' ' THR . 73.8 mt-30 -143.41 140.19 30.31 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.316 1.01 . . . . 0.0 108.875 172.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.422 ' HB2' ' HA ' ' A' ' 5' ' ' GLN . 72.3 mtt180 -110.77 115.0 28.8 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -87.8 137.36 32.4 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.181 1.393 . . . . 0.0 110.008 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -78.52 38.07 0.3 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 123.936 0.773 . . . . 0.0 111.881 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.43 156.0 53.51 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 123.892 0.877 . . . . 0.0 108.771 -171.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.05 168.39 22.06 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 122.878 2.386 . . . . 0.0 113.695 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 80' ' ' PRO . 89.0 t -67.47 -47.59 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.217 -172.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.34 -37.76 84.48 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.069 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -66.52 -63.49 1.06 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.99 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.1 t -51.62 -34.26 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.739 1.216 . . . . 0.0 111.71 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.409 ' HE3' HD13 ' A' ' 101' ' ' LEU . 51.0 t-105 -58.46 -56.24 24.62 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.453 0.701 . . . . 0.0 110.198 176.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.9 m -57.17 -33.36 67.36 Favored 'General case' 0 CA--C 1.555 1.154 0 O-C-N 124.403 1.064 . . . . 0.0 111.396 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' A' ' 136' ' ' LEU . . . -68.15 -38.26 81.95 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 174.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.1 m -74.63 -27.76 60.58 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.232 0.613 . . . . 0.0 112.034 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.9 p -99.0 -46.19 5.69 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.196 0.598 . . . . 0.0 112.244 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.84 119.13 51.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 123.221 0.609 . . . . 0.0 110.904 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.68 -29.07 87.63 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 123.621 2.88 . . . . 0.0 112.899 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.4 -52.65 57.12 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.275 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -65.02 -31.0 72.02 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.733 173.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.509 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 40.5 mt -58.27 -41.6 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.255 0.622 . . . . 0.0 110.926 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -57.19 -29.13 63.43 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.994 0.918 . . . . 0.0 112.337 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -75.76 -5.35 45.36 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.667 0.787 . . . . 0.0 112.807 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.509 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 59.0 p-90 -149.2 4.31 0.61 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -165.83 -172.74 2.45 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -166.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.502 HD12 HD12 ' A' ' 66' ' ' LEU . 59.4 mt -86.61 140.86 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.076 0.95 . . . . 0.0 110.34 -171.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.68 110.93 3.61 Favored Pre-proline 0 N--CA 1.48 1.051 0 O-C-N 125.021 1.451 . . . . 0.0 110.225 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -90.88 179.61 1.69 Allowed 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.654 2.236 . . . . 0.0 112.799 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -152.39 157.55 41.42 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.101 0.96 . . . . 0.0 109.418 173.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.82 -166.94 25.51 Favored Glycine 0 N--CA 1.462 0.433 0 CA-C-N 116.623 -0.262 . . . . 0.0 113.608 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -78.45 -35.66 46.51 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.17 0.988 . . . . 0.0 110.334 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.7 mt 67.58 10.98 8.14 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.239 1.416 . . . . 0.0 113.453 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -102.34 178.15 4.67 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.721 0.809 . . . . 0.0 110.637 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.48 99.81 0.79 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.577 1.151 . . . . 0.0 109.902 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.55 -11.79 58.08 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.185 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.76 -169.32 30.23 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 169.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 34.7 p30 -128.13 155.2 44.82 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.868 -0.784 . . . . 0.0 112.222 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -119.7 161.77 20.14 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 165.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -163.24 112.85 1.33 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.502 HD12 HD12 ' A' ' 52' ' ' ILE . 72.5 mt -66.42 164.0 17.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.378 0.671 . . . . 0.0 110.935 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -81.3 112.68 18.83 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 40.94 54.97 3.5 Favored Glycine 0 CA--C 1.539 1.581 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -143.97 -76.78 0.23 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 117.197 0.499 . . . . 0.0 110.31 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.36 160.93 40.79 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.287 0.635 . . . . 0.0 109.749 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 35.0 t -127.3 158.04 38.28 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.35 -171.28 31.39 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.222 -0.513 . . . . 0.0 114.043 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 4.4 m-20 -137.94 161.99 35.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.01 0.924 . . . . 0.0 109.621 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -92.87 98.87 8.87 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.412 HD12 HG22 ' A' ' 84' ' ' THR . 97.4 mt -67.69 -46.38 72.43 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.095 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -161.31 115.11 1.97 Allowed 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.687 0.795 . . . . 0.0 109.965 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.3 p -98.12 114.91 27.25 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 164.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -127.12 84.93 62.21 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -170.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.14 144.66 21.18 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.935 2.424 . . . . 0.0 113.182 -171.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.504 ' HB2' HG11 ' A' ' 34' ' ' VAL . 22.2 Cg_endo -97.78 23.95 22.54 Favored 'Cis proline' 0 C--N 1.374 1.907 0 C-N-CA 124.617 -0.993 . . . . 0.0 112.318 -8.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.68 ' HG2' ' HG3' ' A' ' 82' ' ' ARG . 60.7 ttt180 -73.09 -73.49 0.2 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.852 0.861 . . . . 0.0 111.167 -171.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.68 ' HG3' ' HG2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -155.36 158.7 39.1 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.424 0.69 . . . . 0.0 111.483 -178.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -130.27 129.25 43.04 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.422 ' HG1' ' HG2' ' A' ' 98' ' ' GLU . 19.4 m -103.08 135.7 44.25 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.223 1.409 . . . . 0.0 108.179 172.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.3 pt -131.19 163.4 37.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 124.122 0.969 . . . . 0.0 109.648 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.5 t -101.42 148.34 25.29 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.651 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 24.7 t-105 -140.65 92.93 2.55 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 109.769 -172.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.8 106.75 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.466 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 58.2 t80 -90.05 163.31 14.95 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 169.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.67 118.73 6.95 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.785 0.434 . . . . 0.0 111.027 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.88 25.13 75.48 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.833 0.708 . . . . 0.0 113.287 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 73.8 mmtt -132.43 147.48 65.85 Favored Pre-proline 0 N--CA 1.488 1.438 0 C-N-CA 123.975 0.91 . . . . 0.0 110.003 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.48 -178.18 3.83 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.69 2.26 . . . . 0.0 112.854 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.91 87.74 0.55 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.48 0.712 . . . . 0.0 109.554 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.651 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.4 m -71.86 136.54 47.0 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.699 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -102.45 108.93 20.42 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -172.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.0 t -108.31 136.24 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.111 0.964 . . . . 0.0 108.662 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.422 ' HG2' ' HG1' ' A' ' 84' ' ' THR . 29.6 mt-10 -138.05 115.93 11.54 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.006 0.922 . . . . 0.0 109.433 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.431 ' HB2' HD12 ' A' ' 112' ' ' LEU . 8.2 tt -105.31 130.56 53.41 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.528 ' HD2' ' HB3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -131.08 143.62 50.81 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.023 0.44 . . . . 0.0 110.392 -177.18 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.481 ' HB3' HG13 ' A' ' 34' ' ' VAL . 97.9 mt -132.43 123.7 27.2 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 125.247 1.419 . . . . 0.0 109.436 -174.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 t -151.97 138.43 18.58 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.872 0.869 . . . . 0.0 108.972 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.08 146.0 44.55 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.04 0.936 . . . . 0.0 111.783 -173.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -153.15 118.04 5.08 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.79 1.236 . . . . 0.0 107.924 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 64.11 -111.84 4.49 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 123.427 0.454 . . . . 0.0 113.003 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -111.74 5.66 19.29 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.035 0.534 . . . . 0.0 110.188 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.39 -153.97 8.87 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.087 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.7 m -147.04 134.39 20.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.122 0.969 . . . . 0.0 109.568 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 42.4 tp -80.77 117.42 21.42 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.7 tt -101.23 106.13 17.31 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 164.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.528 ' HB3' ' HD2' ' A' ' 100' ' ' ARG . 35.6 tt0 -121.95 109.72 14.95 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 99' ' ' LEU . 52.4 tp -107.17 114.35 28.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.551 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.436 ' HG3' ' HB2' ' A' ' 23' ' ' SER . 34.6 tt0 -94.06 127.2 39.73 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.249 0.62 . . . . 0.0 109.377 168.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -114.64 116.27 28.46 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 168.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.5 120.16 41.65 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.59 0.756 . . . . 0.0 110.291 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.3 t -139.45 154.82 47.83 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.258 0.623 . . . . 0.0 110.114 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.1 m -71.9 -16.29 62.12 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.458 1.103 . . . . 0.0 111.311 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 121' ' ' MET . 17.6 m -100.33 117.84 35.36 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.843 0.857 . . . . 0.0 110.201 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.617 ' HA ' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -68.48 -29.25 67.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.806 0.842 . . . . 0.0 112.088 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -67.34 -54.41 20.88 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.532 0.52 . . . . 0.0 110.71 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.442 ' HB3' ' HB2' ' A' ' 118' ' ' SER . 28.1 ttt -50.13 -31.94 14.71 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.842 172.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.617 HD11 ' HA ' ' A' ' 119' ' ' GLU . 50.3 mt -65.44 -42.67 92.14 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.952 0.501 . . . . 0.0 111.96 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 127' ' ' VAL . 45.8 t -64.26 -51.05 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -44.31 -57.82 3.27 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.526 1.53 . . . . 0.0 112.754 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.7 m -75.68 -20.03 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 123.848 0.718 . . . . 0.0 110.726 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.72 -39.81 96.95 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 171.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 123' ' ' VAL . 48.4 t -74.73 -53.42 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.36 -61.45 7.21 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 114.537 -1.211 . . . . 0.0 114.207 -176.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -63.99 -39.49 94.24 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 118.405 -0.807 . . . . 0.0 112.922 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -58.57 -45.86 88.12 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 119.549 1.068 . . . . 0.0 110.375 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.539 ' SD ' ' HE2' ' A' ' 163' ' ' MET . 40.8 mtm -67.08 -42.82 84.0 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.95 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.37 -61.16 2.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.63 0.772 . . . . 0.0 111.501 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.98 -33.67 69.14 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.205 0.602 . . . . 0.0 112.617 174.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.96 -37.33 82.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 118.321 0.51 . . . . 0.0 110.695 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -66.91 -40.13 87.58 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.985 0.514 . . . . 0.0 109.773 171.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.467 HD12 ' CD1' ' A' ' 50' ' ' TRP . 41.6 tp -64.46 -23.08 67.16 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.06 0.544 . . . . 0.0 110.52 175.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.38 -46.84 11.51 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.44 ' HB3' ' HB3' ' A' ' 143' ' ' ASP . 79.6 mtp -65.53 -42.17 92.28 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.85 0.86 . . . . 0.0 110.717 173.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -57.4 -55.55 33.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.06 0.944 . . . . 0.0 111.445 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 44.2 mt -71.35 -28.21 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 123.326 0.391 . . . . 0.0 110.367 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -67.84 -16.58 64.16 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 122.936 0.495 . . . . 0.0 110.589 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.71 43.88 2.21 Favored Glycine 0 C--N 1.355 1.62 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 173.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 138' ' ' MET . 1.4 t70 -130.85 -168.48 2.0 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.746 0.818 . . . . 0.0 108.818 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.2 mt 66.96 73.34 0.38 Allowed Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 125.132 1.373 . . . . 0.0 111.26 -174.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.02 -38.48 94.66 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.141 2.561 . . . . 0.0 112.932 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -104.19 -56.69 0.73 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.434 -0.667 . . . . 0.0 111.434 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.59 -169.88 13.59 Favored Glycine 0 C--N 1.349 1.274 0 C-N-CA 123.762 0.696 . . . . 0.0 111.987 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -72.81 139.58 30.74 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.881 2.388 . . . . 0.0 111.669 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.1 m -62.22 147.25 91.41 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 122.677 0.391 . . . . 0.0 110.393 172.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.64 -24.49 77.87 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.348 2.032 . . . . 0.0 112.335 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -98.16 19.96 13.24 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.112 0.965 . . . . 0.0 111.539 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.87 82.94 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.955 1.302 . . . . 0.0 111.557 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -175.67 -40.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 112.922 -1.945 . . . . 0.0 109.478 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 64.15 -150.76 0.3 Allowed 'General case' 0 C--N 1.363 1.173 0 C-N-CA 124.744 1.217 . . . . 0.0 110.727 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 67.08 16.71 10.34 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.05 0.94 . . . . 0.0 111.9 175.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -50.34 -62.54 1.52 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.615 1.566 . . . . 0.0 110.315 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -166.75 -45.57 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -67.06 116.72 38.79 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.893 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.53 85.35 0.28 Allowed 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.662 2.241 . . . . 0.0 111.13 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.6 m -66.4 103.88 0.52 Allowed Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.908 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.75 -49.96 15.41 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.41 2.74 . . . . 0.0 114.13 -161.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.41 ' HA ' ' NH1' ' A' ' 165' ' ' ARG . 4.9 mp0 -65.81 -53.96 33.2 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.415 -176.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.539 ' HE2' ' SD ' ' A' ' 131' ' ' MET . 14.0 tpt -76.84 -32.84 57.84 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.782 -169.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.6 ptm -71.04 -36.22 72.26 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 41.4 ttm105 -55.64 -47.8 76.02 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.895 0.878 . . . . 0.0 110.278 173.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 99.9 mt -57.32 -52.31 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 124.17 0.918 . . . . 0.0 110.267 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.8 t -64.5 -25.0 67.8 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.358 0.663 . . . . 0.0 112.204 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -73.04 -47.68 42.71 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 12.1 mm-40 -58.48 -49.6 76.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.533 0.733 . . . . 0.0 111.658 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -74.67 -48.39 26.45 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.648 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.46 -52.23 29.21 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 123.791 0.682 . . . . 0.0 114.225 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.08 -31.23 67.56 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.518 0.727 . . . . 0.0 112.111 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.74 -56.91 7.44 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.926 0.491 . . . . 0.0 110.54 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -67.71 -22.19 65.27 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.522 0.729 . . . . 0.0 111.829 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.45 84.78 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.999 0.428 . . . . 0.0 110.077 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -75.97 -29.12 58.14 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.11 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 57.7 mt -74.66 -52.3 12.04 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.781 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.26 -29.15 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 122.51 0.324 . . . . 0.0 111.791 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -69.16 -6.82 31.1 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.286 0.634 . . . . 0.0 112.615 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.9 m -136.44 -164.24 1.53 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.029 1.331 . . . . 0.0 109.433 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.418 ' HA2' HD12 ' A' ' 11' ' ' LEU . . . -140.25 69.13 0.47 Allowed Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 177.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 C--O 1.251 1.137 0 C-N-CA 123.944 0.898 . . . . 0.0 109.498 -175.449 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.81 -61.92 1.68 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.15 0.58 . . . . 0.0 109.834 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -80.34 91.07 5.61 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . -171.31 48.65 0.19 Allowed Glycine 0 C--N 1.343 0.964 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.048 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -175.94 92.09 0.05 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.276 1.03 . . . . 0.0 108.807 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -156.15 114.09 3.31 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.939 -176.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -93.84 119.75 33.19 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 3.5 tm-20 -114.87 127.87 55.96 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -106.39 156.52 18.44 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.23 0.538 . . . . 0.0 112.305 -173.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -161.91 -175.41 4.64 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.693 -171.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 mt -140.82 167.34 22.42 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.431 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.83 -162.59 16.19 Favored Glycine 0 C--O 1.246 0.888 0 CA-C-N 113.395 -1.729 . . . . 0.0 109.712 168.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.42 160.68 35.69 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 168.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -162.35 117.54 1.89 Allowed 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -173.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 92.3 m -87.58 98.0 11.17 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.2 pt -78.66 166.08 45.1 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 125.475 1.51 . . . . 0.0 110.537 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.27 -27.71 5.01 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 123.748 2.965 . . . . 0.0 115.038 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.71 -49.58 45.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.013 0.525 . . . . 0.0 110.839 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.99 -160.11 32.15 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-O 119.711 -0.494 . . . . 0.0 112.023 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.66 105.09 0.74 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.204 0.602 . . . . 0.0 111.104 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -107.96 154.41 21.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.935 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' A' ' 23' ' ' SER . 7.0 tpp180 -83.95 155.66 22.71 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 165.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.454 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 77.0 p -132.41 135.14 45.9 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 110.919 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.9 pp -93.71 142.15 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 170.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -123.61 118.17 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -176.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.0 mt -111.27 106.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.585 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 66.9 mtt180 -92.09 147.66 22.78 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -156.42 130.64 8.64 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.86 106.85 19.16 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.544 1.138 . . . . 0.0 108.175 -172.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.71 134.0 34.73 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.691 0.797 . . . . 0.0 110.559 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.499 ' HB2' ' HA3' ' A' ' 4' ' ' GLY . 10.4 t70 -80.36 46.88 0.87 Allowed 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 122.039 0.923 . . . . 0.0 110.236 170.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.27 154.79 57.75 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 123.928 0.891 . . . . 0.0 109.359 -171.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.26 165.74 31.47 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.579 2.186 . . . . 0.0 113.188 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.409 HG11 ' HB2' ' A' ' 80' ' ' PRO . 88.7 t -73.21 -40.77 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.564 -172.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.18 -47.95 71.47 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.218 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -65.01 -64.47 0.86 Allowed 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.329 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.3 t -50.01 -35.22 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.214 1.006 . . . . 0.0 111.667 -176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -58.62 -57.73 11.71 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.847 0.859 . . . . 0.0 110.209 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 m -61.22 -35.75 78.06 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.392 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.44 ' HB2' HD11 ' A' ' 136' ' ' LEU . . . -62.57 -33.62 75.33 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 122.05 -0.406 . . . . 0.0 112.082 172.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.425 ' HA ' ' HZ2' ' A' ' 50' ' ' TRP . 83.1 m -85.41 -18.28 34.13 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.663 0.785 . . . . 0.0 113.067 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 p -113.05 -40.21 4.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.18 111.33 5.25 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 123.657 0.783 . . . . 0.0 110.829 175.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 66.7 Cg_exo -54.13 -33.61 74.93 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 123.703 2.936 . . . . 0.0 113.868 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -61.04 -49.83 75.8 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -65.68 -35.37 80.57 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.516 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.505 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 87.9 mt -66.51 -41.46 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.556 0.743 . . . . 0.0 111.911 -174.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 27.5 p30 -60.21 -15.38 23.83 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -78.88 -45.78 19.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.828 0.851 . . . . 0.0 111.562 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.505 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 67.8 p-90 -108.59 8.17 27.01 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.258 0.623 . . . . 0.0 112.603 -172.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -174.47 173.83 2.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.319 0.648 . . . . 0.0 109.39 -168.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.1 mt -86.46 123.08 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 32.3 tt0 -63.32 130.35 94.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.793 1.637 . . . . 0.0 112.086 -174.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.574 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 83.0 Cg_endo -81.58 129.28 6.42 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.525 2.15 . . . . 0.0 112.154 175.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -93.85 160.36 14.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.873 1.269 . . . . 0.0 109.45 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.46 -168.79 15.63 Favored Glycine 0 N--CA 1.47 0.964 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.47 -36.79 68.56 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.212 0.605 . . . . 0.0 110.603 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.8 mt 71.9 -10.17 0.89 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.241 1.416 . . . . 0.0 114.095 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -86.39 171.03 11.46 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.535 0.734 . . . . 0.0 109.891 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.708 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 41.2 tt0 -67.82 102.22 1.2 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.248 0.619 . . . . 0.0 110.489 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.54 -15.07 17.56 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.85 -160.43 36.35 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -143.04 155.15 44.57 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.805 1.303 . . . . 0.0 111.188 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.574 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 17.1 p90 -106.02 163.35 12.83 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.464 166.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.94 108.05 0.86 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.218 1.007 . . . . 0.0 109.919 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.1 mt -69.29 170.67 9.82 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.449 0.7 . . . . 0.0 109.65 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -76.51 -17.95 58.99 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 122.084 -0.385 . . . . 0.0 111.805 -169.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.79 47.49 0.04 OUTLIER Glycine 0 N--CA 1.467 0.728 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -128.0 -62.3 1.06 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.156 0.982 . . . . 0.0 108.894 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.11 161.34 36.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.977 0.511 . . . . 0.0 111.205 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.6 p -152.81 130.74 11.75 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 86' ' ' SER . . . -161.19 174.61 37.79 Favored Glycine 0 C--N 1.344 1.005 0 C-N-CA 121.663 -0.304 . . . . 0.0 113.449 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -86.55 159.22 19.33 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.216 1.007 . . . . 0.0 111.05 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 mm -93.22 98.74 8.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.405 HD13 HG23 ' A' ' 84' ' ' THR . 87.0 mt -63.81 -51.78 63.2 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.794 0.838 . . . . 0.0 111.123 -174.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -160.78 152.45 19.58 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.661 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.708 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 26.2 p -148.13 138.25 22.65 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.57 0.748 . . . . 0.0 109.209 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -138.56 93.58 10.99 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.87 141.49 13.4 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.94 2.426 . . . . 0.0 112.703 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.409 ' HB2' HG11 ' A' ' 34' ' ' VAL . 18.3 Cg_endo -95.81 25.13 22.64 Favored 'Cis proline' 0 C--N 1.378 2.131 0 CA-C-N 119.537 0.87 . . . . 0.0 112.523 -5.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -78.99 -75.84 0.22 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.427 0.691 . . . . 0.0 111.673 -171.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -142.37 139.53 31.75 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 118.549 0.613 . . . . 0.0 112.39 -169.128 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.6 tp -124.48 124.41 42.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.939 1.696 . . . . 0.0 108.404 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.405 HG23 HD13 ' A' ' 75' ' ' LEU . 61.7 m -113.41 114.05 26.06 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.725 0.81 . . . . 0.0 109.917 175.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.0 pt -110.4 168.78 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 124.483 1.113 . . . . 0.0 110.431 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.447 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 14.4 m -103.51 136.39 43.33 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -175.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 44.6 t-105 -128.5 104.58 7.77 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.612 0.642 . . . . 0.0 110.402 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.29 103.67 15.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.531 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 47.2 t80 -90.22 163.66 14.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.751 0.82 . . . . 0.0 109.886 -177.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -52.52 106.49 0.16 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.864 1.265 . . . . 0.0 111.774 177.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.74 2.45 51.04 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 114.433 0.533 . . . . 0.0 114.433 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 41.5 mmtm -101.09 159.47 29.4 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.145 0.978 . . . . 0.0 109.262 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.95 -176.94 2.86 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.119 1.879 . . . . 0.0 112.113 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.58 144.75 56.24 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.178 174.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.471 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 30.0 p -146.99 156.34 42.96 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.121 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -116.23 117.58 30.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.487 0.715 . . . . 0.0 109.103 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 54.2 t -94.31 130.14 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 36.2 mm-40 -116.72 111.93 20.48 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.131 1.772 . . . . 0.0 107.182 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.464 HD11 HD11 ' A' ' 112' ' ' LEU . 59.6 tp -107.33 114.0 27.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -119.65 137.85 53.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.138 0.975 . . . . 0.0 109.601 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 67.9 mt -127.7 142.8 51.23 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.562 1.145 . . . . 0.0 109.221 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 t -137.03 170.77 15.55 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.956 1.303 . . . . 0.0 108.968 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.69 128.01 56.28 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -141.77 106.32 4.86 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.47 -103.9 0.36 Allowed Glycine 0 CA--C 1.534 1.277 0 CA-C-N 117.845 0.293 . . . . 0.0 113.342 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -115.71 2.27 13.66 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.565 0.746 . . . . 0.0 111.069 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -130.13 -173.58 13.44 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 123.891 0.758 . . . . 0.0 111.911 -174.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 89.0 m -121.33 148.22 44.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.848 0.859 . . . . 0.0 110.424 -176.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.9 tp -103.22 134.58 46.39 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 166.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 tt -119.74 109.73 15.97 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.585 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 31.7 mt-10 -109.54 105.57 14.94 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.495 HD13 HD21 ' A' ' 133' ' ' LEU . 8.6 tt -105.4 107.4 18.37 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.454 ' HG3' ' HB2' ' A' ' 23' ' ' SER . 32.8 tt0 -92.4 128.18 38.15 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.898 0.879 . . . . 0.0 108.973 173.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -113.77 118.42 34.24 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 171.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 14' ' ' ARG . . . -106.12 114.86 29.24 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.083 0.953 . . . . 0.0 110.889 -173.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.599 HG21 ' HG3' ' A' ' 121' ' ' MET . 4.4 t -150.26 150.67 31.86 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.596 0.758 . . . . 0.0 110.921 176.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 74.1 p -73.23 -42.68 62.32 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.922 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.1 m -76.62 131.82 39.09 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.472 0.709 . . . . 0.0 112.384 -165.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -60.78 -50.66 72.56 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.78 1.232 . . . . 0.0 113.243 -170.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -62.49 -53.35 56.11 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.599 ' HG3' HG21 ' A' ' 116' ' ' THR . 13.7 tpt -44.14 -38.94 3.97 Favored 'General case' 0 CA--C 1.56 1.351 0 O-C-N 124.873 1.358 . . . . 0.0 112.711 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.562 ' HG ' HG22 ' A' ' 116' ' ' THR . 13.4 mt -66.54 -47.07 74.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.541 1.136 . . . . 0.0 112.733 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.5 t -64.16 -51.45 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -46.94 -47.5 21.69 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.647 1.979 . . . . 0.0 113.713 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 m -83.39 -25.77 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.479 0.312 . . . . 0.0 111.491 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.61 -39.73 98.26 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.81 -51.15 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.369 1.068 . . . . 0.0 108.99 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.64 -61.75 6.48 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 114.545 -1.207 . . . . 0.0 114.132 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -63.74 -44.32 93.87 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 118.69 -0.671 . . . . 0.0 112.439 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.21 -39.87 91.85 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.344 0.974 . . . . 0.0 110.944 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.9 ttm -70.99 -37.76 72.7 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.738 0.815 . . . . 0.0 110.48 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.66 -59.5 4.19 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.502 0.721 . . . . 0.0 111.202 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.495 HD21 HD13 ' A' ' 112' ' ' LEU . 3.6 mm? -58.5 -29.16 66.05 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.321 0.648 . . . . 0.0 112.061 173.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.01 -38.5 91.28 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 118.395 0.543 . . . . 0.0 110.607 174.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -64.76 -31.2 72.31 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.178 0.591 . . . . 0.0 110.663 171.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 40' ' ' ALA . 53.2 tp -66.76 -42.15 86.59 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.855 0.462 . . . . 0.0 110.074 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -47.48 -45.99 22.91 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.304 0.378 . . . . 0.0 113.741 165.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 73.4 mtp -74.15 -30.13 62.13 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 123.589 0.756 . . . . 0.0 111.485 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -71.43 -54.92 9.04 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.195 0.998 . . . . 0.0 110.122 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 40.6 mt -64.14 -31.38 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.416 1.086 . . . . 0.0 110.972 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -62.99 -24.63 68.0 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.611 0.765 . . . . 0.0 111.243 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.07 39.33 32.75 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -173.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -108.91 -33.84 6.81 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.983 0.913 . . . . 0.0 111.013 -169.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.8 mt -75.59 115.21 43.72 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 123.491 0.717 . . . . 0.0 111.456 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -87.03 -8.84 6.51 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.754 2.302 . . . . 0.0 111.318 164.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.05 -175.51 44.06 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.288 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.17 114.07 3.78 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.986 -0.897 . . . . 0.0 111.63 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -83.39 7.84 4.97 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.121 2.547 . . . . 0.0 113.672 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.3 m -82.1 134.28 49.62 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 122.661 0.384 . . . . 0.0 110.222 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -85.55 11.23 3.41 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.683 2.255 . . . . 0.0 112.997 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 77.06 65.45 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.844 1.658 . . . . 0.0 109.598 170.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -103.78 61.05 0.75 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.153 176.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -70.18 -33.82 72.2 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.496 171.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -87.06 120.67 28.57 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 164.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.3 -42.2 99.16 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 122.908 0.483 . . . . 0.0 111.75 -175.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 61.97 162.81 0.08 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 125.205 1.402 . . . . 0.0 113.532 170.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -72.15 89.78 1.18 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.809 0.843 . . . . 0.0 109.932 171.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.486 ' HG3' ' HE2' ' A' ' 164' ' ' MET . 37.0 tt0 50.38 68.28 3.56 Favored Pre-proline 0 CA--C 1.569 1.681 0 C-N-CA 125.599 1.559 . . . . 0.0 113.267 172.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.65 ' HD2' ' SD ' ' A' ' 164' ' ' MET . 47.7 Cg_endo -87.55 -29.42 0.36 Allowed 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.296 2.664 . . . . 0.0 113.953 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.7 t -159.33 104.46 1.52 Allowed Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 124.479 1.112 . . . . 0.0 108.264 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.5 -42.21 63.58 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.83 2.353 . . . . 0.0 112.655 -176.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -63.58 -48.66 76.48 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.622 0.769 . . . . 0.0 111.931 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 6.2 tpt -66.48 -43.37 85.61 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.399 0.437 . . . . 0.0 110.714 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.65 ' SD ' ' HD2' ' A' ' 159' ' ' PRO . 61.9 mtm -65.94 -37.2 85.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.665 0.386 . . . . 0.0 111.162 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -55.22 -58.13 8.94 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.503 1.127 . . . . 0.0 109.17 -178.177 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 61.9 mt -63.28 -45.77 97.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 O-C-N 124.609 1.193 . . . . 0.0 111.053 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 31.1 t -51.62 -42.14 61.78 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.942 0.897 . . . . 0.0 112.471 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -89.47 -29.32 19.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 4.9 tm-20 -61.79 -50.26 73.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.666 1.587 . . . . 0.0 110.408 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -60.69 -53.09 61.66 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.42 174.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.66 -50.0 38.39 Favored Glycine 0 C--N 1.351 1.407 0 O-C-N 124.545 1.153 . . . . 0.0 115.204 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.07 -32.96 69.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.033 0.533 . . . . 0.0 111.345 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.38 68.77 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.972 0.509 . . . . 0.0 111.133 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -70.72 -27.21 63.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.25 0.62 . . . . 0.0 111.599 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.47 73.71 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 123.506 0.504 . . . . 0.0 110.155 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -70.6 -33.83 71.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.4 0.28 . . . . 0.0 110.499 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 63.1 mt -73.05 -62.12 1.58 Allowed 'General case' 0 C--N 1.349 0.56 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.595 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.466 HG21 ' HB3' ' A' ' 122' ' ' LEU . 4.4 p -73.43 -22.17 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -166.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -87.14 4.89 40.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.273 0.629 . . . . 0.0 111.188 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 28.8 t -92.85 175.93 6.62 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.672 0.789 . . . . 0.0 111.299 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 160.64 -39.2 0.44 Allowed Glycine 0 C--N 1.342 0.877 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 C--O 1.251 1.152 0 C-N-CA 124.118 0.967 . . . . 0.0 109.276 176.819 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.04 97.06 1.83 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.523 0.729 . . . . 0.0 110.672 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.4 m -73.35 -59.24 2.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.257 0.623 . . . . 0.0 109.817 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.49 142.19 3.59 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.302 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -88.19 92.1 9.03 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 165.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.592 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . . . -68.69 80.8 0.28 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.234 0.54 . . . . 0.0 111.454 -171.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 m -81.94 117.62 22.32 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.743 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 35.6 mt-10 -118.94 110.48 17.19 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.788 0.835 . . . . 0.0 108.847 -175.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -68.62 147.67 51.57 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.511 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -157.94 161.65 38.2 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.749 0.419 . . . . 0.0 110.48 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -144.64 143.85 30.96 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.63 171.47 33.65 Favored Glycine 0 C--O 1.238 0.348 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 173.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -94.68 160.41 14.63 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.28 122.06 2.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -169.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.3 m -86.36 129.91 34.69 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.452 HD11 HG23 ' A' ' 117' ' ' THR . 48.9 pt -125.28 165.43 26.25 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.473 1.109 . . . . 0.0 109.005 -174.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.5 -33.35 38.11 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.054 2.503 . . . . 0.0 114.735 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.17 -31.61 67.87 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.459 0.704 . . . . 0.0 111.935 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.24 -164.66 31.04 Favored Glycine 0 N--CA 1.47 0.9 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -74.86 138.42 42.47 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.033 1.417 . . . . 0.0 109.051 172.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.83 168.17 20.41 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.006 1.322 . . . . 0.0 109.871 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.436 HH21 ' HB2' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -104.59 166.64 10.26 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 168.443 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 23.6 p -140.1 130.21 24.99 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.767 -174.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.547 HG12 HG23 ' A' ' 125' ' ' VAL . 2.6 pp -86.92 135.95 24.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 168.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 4.8 mp -124.98 115.48 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.451 HG12 ' CZ2' ' A' ' 174' ' ' TRP . 25.2 mt -105.68 107.17 22.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.565 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 54.0 mtp180 -95.48 162.0 13.83 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.642 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 5.1 tt0 -168.72 120.9 0.79 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 125.029 1.456 . . . . 0.0 111.039 -178.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.592 ' HB2' ' HB2' ' A' ' 6' ' ' ALA . 2.5 mpt_? -88.95 103.57 16.16 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 170.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.443 ' HE1' ' HA2' ' A' ' 137' ' ' GLY . 77.6 m-85 -84.08 141.37 31.17 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.661 170.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.36 -11.47 59.93 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 123.69 0.619 . . . . 0.0 111.346 174.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.28 152.61 83.96 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 122.551 0.34 . . . . 0.0 110.774 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 28.0 Cg_endo -62.61 148.64 93.08 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.818 2.346 . . . . 0.0 112.576 171.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 108' ' ' THR . 68.6 t -47.45 -40.92 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 125.062 1.345 . . . . 0.0 111.981 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -50.04 -50.49 47.48 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.833 1.333 . . . . 0.0 111.111 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 36.8 mt-10 -71.29 -29.79 65.47 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.264 -177.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.6 t -74.56 -40.01 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.465 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -74.52 -28.24 60.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.671 0.788 . . . . 0.0 109.825 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.406 ' HB3' ' NH1' ' A' ' 46' ' ' ARG . 74.1 m -69.14 -44.09 73.04 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.305 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -44.69 93.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.821 0.848 . . . . 0.0 111.51 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 72.7 m -68.36 -33.83 74.98 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.1 p -111.31 -34.72 6.06 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -169.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 47' ' ' ILE . 32.6 t70 -71.02 114.9 31.1 Favored Pre-proline 0 N--CA 1.486 1.354 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.777 -178.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -52.07 -34.78 59.11 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.568 2.845 . . . . 0.0 113.8 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -72.03 -20.61 61.67 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.318 1.011 . . . . 0.0 110.604 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.406 ' NH1' ' HB3' ' A' ' 39' ' ' SER . 72.8 mtt85 -94.81 -25.98 16.41 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.331 0.652 . . . . 0.0 111.7 172.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 43' ' ' ASP . 82.2 mt -76.61 -31.5 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -73.43 -4.29 32.72 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.263 0.625 . . . . 0.0 112.318 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.34 -30.75 13.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.403 0.681 . . . . 0.0 110.701 -173.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -119.09 -20.15 8.15 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.125 0.57 . . . . 0.0 111.875 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -127.75 -102.25 0.34 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.272 0.629 . . . . 0.0 109.803 -175.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.459 HD13 HD13 ' A' ' 66' ' ' LEU . 89.5 mt -149.42 142.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 124.157 0.983 . . . . 0.0 108.876 -170.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.06 108.06 1.34 Allowed Pre-proline 0 CA--C 1.561 1.385 0 O-C-N 124.657 1.223 . . . . 0.0 110.753 172.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -96.03 139.37 0.77 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.068 2.512 . . . . 0.0 113.463 -177.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -129.98 141.77 50.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.702 1.201 . . . . 0.0 109.417 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.59 -163.12 35.51 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' HB3' ' H ' ' A' ' 63' ' ' ASN . 29.3 t70 -75.09 -41.03 59.59 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.1 mt 70.81 -10.01 0.77 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.572 1.549 . . . . 0.0 113.708 170.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -93.59 165.91 12.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.883 0.873 . . . . 0.0 110.064 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.519 ' HG2' ' HA ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -64.78 123.46 19.42 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.815 0.846 . . . . 0.0 109.861 -176.394 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.39 7.14 69.93 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.646 -0.707 . . . . 0.0 112.991 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.66 -147.78 20.5 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 112.149 -0.38 . . . . 0.0 112.149 178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.619 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 26.2 p-10 -139.88 169.88 16.9 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.643 0.777 . . . . 0.0 110.969 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -142.69 154.64 44.5 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.65 142.37 25.58 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.891 0.877 . . . . 0.0 109.824 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.459 HD13 HD13 ' A' ' 52' ' ' ILE . 90.4 mt -94.74 -101.93 0.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.309 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -155.76 -56.68 0.09 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.82 0.848 . . . . 0.0 108.928 174.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.96 43.07 1.16 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.777 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -135.2 -74.04 0.46 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.024 0.93 . . . . 0.0 109.358 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.63 154.31 32.78 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 121.763 0.792 . . . . 0.0 112.713 -169.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.9 m -131.2 154.19 48.67 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 113.153 -1.84 . . . . 0.0 108.182 168.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 86' ' ' SER . . . -169.32 -156.88 11.14 Favored Glycine 0 CA--C 1.504 -0.655 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.073 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.619 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 24.8 m-20 -121.88 171.54 8.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.323 0.649 . . . . 0.0 110.462 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.6 mm -103.41 106.65 20.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.8 mt -77.56 -41.03 40.44 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 123.502 0.501 . . . . 0.0 110.212 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.519 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 36.9 ttm180 -175.77 113.96 0.13 Allowed 'General case' 0 C--N 1.363 1.162 0 O-C-N 123.955 0.784 . . . . 0.0 111.508 168.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.3 p -107.05 103.44 12.85 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.529 0.732 . . . . 0.0 109.512 174.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.481 ' HG3' ' HG2' ' A' ' 76' ' ' ARG . 48.8 mt-10 -104.73 112.29 65.3 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.651 1.18 . . . . 0.0 109.517 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 6.1 Cg_exo -79.81 126.33 6.5 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.913 2.408 . . . . 0.0 112.423 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.5 Cg_endo -103.73 25.06 12.07 Favored 'Cis proline' 0 C--N 1.376 1.989 0 CA-C-N 120.421 1.186 . . . . 0.0 112.717 -8.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -61.5 -67.55 0.4 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.156 0.982 . . . . 0.0 112.02 -171.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.489 ' NH2' ' HD2' ' A' ' 76' ' ' ARG . 14.8 ptt180 -152.5 157.15 40.72 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.169 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 tt -119.93 138.18 53.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 169.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.6 m -137.31 130.17 30.38 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.452 HG13 ' HB ' ' A' ' 97' ' ' VAL . 14.1 pt -144.18 146.82 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.296 1.038 . . . . 0.0 109.677 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.436 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 24.6 p -90.86 132.89 35.63 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 171.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 24.4 t-105 -121.68 104.62 9.74 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -171.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.7 t -102.77 103.11 14.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 170.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.524 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 42.8 t80 -77.34 147.11 36.33 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.8 113.59 2.85 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.374 0.669 . . . . 0.0 111.576 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.05 6.7 86.3 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 124.191 0.932 . . . . 0.0 113.354 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 12.4 mmmm -125.98 155.07 73.74 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.519 1.128 . . . . 0.0 109.169 -172.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.1 179.16 4.09 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.635 2.223 . . . . 0.0 114.243 -174.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.62 150.09 39.78 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.253 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.507 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.4 m -140.36 156.91 46.24 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.852 0.72 . . . . 0.0 110.951 178.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -112.06 108.61 17.97 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 165.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 52.6 t -94.33 119.58 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -124.32 115.86 21.68 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.452 0.644 . . . . 0.0 110.418 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -89.78 136.36 33.08 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 57.1 mtt85 -135.42 129.87 33.94 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -177.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 46.5 mt -116.54 147.06 42.16 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.914 0.486 . . . . 0.0 110.401 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.1 t -150.79 125.27 9.54 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.512 0.725 . . . . 0.0 110.528 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.29 124.22 26.02 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 173.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.59 125.79 12.99 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 124.144 0.978 . . . . 0.0 109.051 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.81 -89.14 1.34 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 171.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -160.97 39.88 0.15 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.13 -168.09 33.12 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.395 -172.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.475 HG23 HG22 ' A' ' 34' ' ' VAL . 32.1 m -137.66 131.11 30.99 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.095 0.958 . . . . 0.0 110.498 -166.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 55.1 tp -80.98 106.47 13.01 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 160.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.414 HD22 HD12 ' A' ' 133' ' ' LEU . 7.9 tt -87.45 128.2 35.22 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 160.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 31.7 tt0 -136.4 104.68 5.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.4 131.94 43.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 33.3 tt0 -123.2 143.62 49.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.457 ' CD2' HG22 ' A' ' 125' ' ' VAL . 8.6 t60 -138.87 114.71 10.02 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.1 104.52 11.64 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.352 0.661 . . . . 0.0 111.184 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.2 t -131.49 158.71 40.16 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-O 121.499 0.666 . . . . 0.0 109.743 173.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.452 HG23 HD11 ' A' ' 16' ' ' ILE . 40.4 p -80.05 -21.46 43.42 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.052 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.8 t -82.44 113.73 20.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.928 0.491 . . . . 0.0 110.473 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.436 ' HB2' HH21 ' A' ' 22' ' ' ARG . 36.7 tt0 -65.84 -29.3 69.75 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.946 0.899 . . . . 0.0 110.297 175.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -61.45 -50.48 72.61 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.287 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.9 ttt -68.77 -30.25 68.8 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.02 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.9 mt -66.1 -44.14 85.24 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.269 0.628 . . . . 0.0 112.314 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.3 t -65.43 -45.1 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -50.82 -51.55 49.91 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.605 1.162 . . . . 0.0 112.166 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.547 HG23 HG12 ' A' ' 24' ' ' ILE . 33.4 m -79.85 -21.72 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.845 0.458 . . . . 0.0 111.439 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.32 -34.9 86.76 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 168.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.24 -53.63 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 114.415 -0.892 . . . . 0.0 110.054 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.63 86.1 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.604 -0.726 . . . . 0.0 114.281 -175.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.428 ' CD1' ' HB ' ' A' ' 125' ' ' VAL . 34.2 m95 -85.47 -36.39 20.61 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.884 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -69.9 -29.2 66.34 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.112 0.869 . . . . 0.0 110.289 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 65.5 mtm -71.81 -37.43 70.36 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.76 -35.08 79.9 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 122.538 0.335 . . . . 0.0 111.255 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.414 HD12 HD22 ' A' ' 110' ' ' LEU . 3.3 mm? -81.5 -23.38 37.37 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.77 0.828 . . . . 0.0 110.723 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.52 -51.58 41.49 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.106 172.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -71.52 -24.56 61.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.647 0.779 . . . . 0.0 111.424 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -77.94 -31.05 50.73 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.778 0.431 . . . . 0.0 109.876 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.443 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -67.76 -34.34 82.77 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.033 171.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 89.5 mmm -66.35 -49.29 67.43 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.492 0.717 . . . . 0.0 109.474 170.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -56.11 -55.6 31.05 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.972 1.309 . . . . 0.0 111.726 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 59.4 mt -78.87 -55.75 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.459 0.704 . . . . 0.0 111.028 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -97.53 -75.04 0.55 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -170.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.47 13.64 6.15 Favored Glycine 0 N--CA 1.474 1.215 0 CA-C-O 118.87 -0.961 . . . . 0.0 115.489 -161.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 69.14 128.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.195 1.398 . . . . 0.0 111.153 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.4 tt -111.01 90.99 12.05 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -87.96 -2.32 7.2 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.279 1.986 . . . . 0.0 112.055 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.71 83.98 1.66 Allowed Glycine 0 C--N 1.333 0.417 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -172.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -137.12 72.47 0.45 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -87.11 -172.94 1.0 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 123.025 2.483 . . . . 0.0 111.675 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.9 m -65.05 111.34 5.68 Favored Pre-proline 0 CA--C 1.561 1.369 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 170.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.13 -19.15 39.5 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.159 2.573 . . . . 0.0 113.332 -168.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -108.77 6.7 25.85 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.898 1.279 . . . . 0.0 110.29 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.8 t70 73.14 -2.91 2.59 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 124.723 1.209 . . . . 0.0 111.388 -173.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 71.11 -69.84 0.17 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.279 1.831 . . . . 0.0 110.739 -174.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 56.83 -162.24 0.19 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.479 1.112 . . . . 0.0 111.758 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -120.66 -30.43 4.49 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.253 0.621 . . . . 0.0 111.79 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -106.22 91.22 3.63 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.628 0.371 . . . . 0.0 110.478 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -147.07 115.4 6.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.368 0.667 . . . . 0.0 110.148 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -84.84 -54.79 0.44 Allowed Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.715 0.806 . . . . 0.0 112.15 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -85.84 18.06 1.64 Allowed 'Trans proline' 0 C--N 1.4 3.245 0 C-N-CA 123.242 2.628 . . . . 0.0 113.045 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.1 t -106.46 88.79 3.55 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.29 -40.76 5.63 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.786 2.324 . . . . 0.0 112.43 -171.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -66.21 -46.88 75.72 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 124.122 0.889 . . . . 0.0 110.815 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 6.6 tpt -69.28 -40.96 77.44 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.393 0.277 . . . . 0.0 110.777 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 59.8 mmm -54.21 -44.13 71.37 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.582 0.551 . . . . 0.0 110.202 171.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -69.56 -57.1 5.62 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 124.113 0.883 . . . . 0.0 111.008 -173.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.458 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 71.7 mt -51.92 -46.52 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.698 0.799 . . . . 0.0 111.982 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.2 p -71.0 -50.44 34.24 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.353 0.408 . . . . 0.0 110.645 -173.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -57.03 -48.82 77.58 Favored 'General case' 0 CA--C 1.557 1.224 0 O-C-N 124.044 0.84 . . . . 0.0 111.062 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -44.23 -48.03 9.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.315 1.046 . . . . 0.0 112.401 171.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 15.0 mmp_? -60.24 -52.03 67.03 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.375 0.422 . . . . 0.0 111.485 178.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -72.52 -37.85 58.06 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.285 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.17 -25.5 47.24 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.166 0.586 . . . . 0.0 110.985 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.03 -53.12 28.17 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.451 ' CZ2' HG12 ' A' ' 26' ' ' ILE . 97.5 m95 -71.35 -25.65 62.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.495 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.75 -59.56 4.1 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.31 -38.53 42.04 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.779 1.232 . . . . 0.0 112.975 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 53.9 mt -66.95 -49.1 66.53 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.614 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.7 p -81.93 -30.07 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 122.95 0.5 . . . . 0.0 111.218 -165.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -57.56 -30.06 64.92 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.639 0.775 . . . . 0.0 110.925 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 17.6 m -62.43 -26.18 68.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.274 1.03 . . . . 0.0 112.315 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -85.51 16.79 38.15 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 114.238 0.455 . . . . 0.0 114.238 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.255 1.382 0 C-N-CA 123.739 0.816 . . . . 0.0 108.877 175.049 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.1 78.64 3.63 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 169.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.7 m -148.48 17.35 1.04 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.267 -172.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.67 118.66 11.96 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.64 125.73 32.91 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.502 0.667 . . . . 0.0 110.868 -175.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.482 ' HB1' ' HD3' ' A' ' 29' ' ' ARG . . . -153.51 75.25 1.04 Allowed 'General case' 0 C--O 1.242 0.671 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 m -96.11 98.28 10.22 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.764 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.04 140.36 29.72 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.129 175.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.451 ' HG3' HD12 ' A' ' 177' ' ' LEU . 16.9 ptp180 -108.87 147.09 32.67 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 170.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.525 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . . . -159.2 -177.84 6.76 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.273 0.559 . . . . 0.0 110.736 -169.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -144.98 150.52 37.07 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.986 -176.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.38 -177.86 23.86 Favored Glycine 0 CA--C 1.507 -0.406 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 175.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 30.6 ptt180 -125.16 131.36 53.24 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 171.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -135.81 114.83 12.24 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.9 m -78.67 98.19 6.12 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.9 pt -81.16 166.9 35.76 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.674 1.59 . . . . 0.0 111.068 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -38.84 -34.42 0.43 Allowed 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 125.028 3.819 . . . . 0.0 115.198 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . . . -67.74 -56.59 8.69 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.682 0.393 . . . . 0.0 110.961 173.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.76 -157.58 30.12 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.494 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.67 105.25 1.2 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.53 0.732 . . . . 0.0 111.326 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.8 165.81 11.96 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.887 176.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 82.6 mtt-85 -105.94 168.01 9.41 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 165.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.3 p -138.5 141.95 39.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.285 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.2 pt -84.77 145.97 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 166.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 10' ' ' ALA . 48.7 mt -129.92 107.39 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.9 mt -106.28 103.9 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.465 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 80.9 mtp180 -95.44 143.77 26.5 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 6.9 pt20 -162.65 138.84 7.41 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.2 0.937 . . . . 0.0 111.665 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HD3' ' HB1' ' A' ' 6' ' ' ALA . 7.5 mpt_? -95.72 105.94 17.99 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -76.04 132.77 40.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.594 0.757 . . . . 0.0 109.7 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -79.95 45.09 0.69 Allowed 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.132 0.968 . . . . 0.0 109.787 171.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.66 147.9 34.66 Favored Pre-proline 0 C--O 1.24 0.592 0 C-N-CA 124.102 0.961 . . . . 0.0 109.141 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.8 167.33 21.58 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.844 2.363 . . . . 0.0 112.992 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.93 -50.21 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.315 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.52 -40.01 81.73 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.224 0.953 . . . . 0.0 111.244 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.43 -63.16 1.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 123.847 0.717 . . . . 0.0 111.082 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.5 t -49.99 -41.77 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.648 1.179 . . . . 0.0 111.253 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -58.82 -55.6 33.08 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.976 0.911 . . . . 0.0 110.183 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 t -54.98 -45.34 74.98 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 124.222 0.951 . . . . 0.0 110.975 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.08 -36.28 79.23 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.673 176.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.478 ' SG ' HD21 ' A' ' 136' ' ' LEU . 74.6 m -77.69 -25.2 49.27 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.8 p -108.26 -43.02 4.46 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -168.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.96 126.04 88.0 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 123.209 0.604 . . . . 0.0 111.679 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.1 -38.2 92.51 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.325 2.683 . . . . 0.0 112.802 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -63.37 -22.12 66.69 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.252 1.021 . . . . 0.0 111.676 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.6 mtt85 -100.76 -29.76 12.09 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.804 0.841 . . . . 0.0 109.945 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.462 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 91.9 mt -71.72 -42.37 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.881 0.872 . . . . 0.0 111.642 -178.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 12.4 p30 -57.57 -22.46 44.96 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.402 ' HG2' ' CD1' ' A' ' 139' ' ' PHE . 7.1 tpm_? -68.81 -46.5 68.46 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.577 0.751 . . . . 0.0 111.989 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.462 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 65.1 p-90 -112.5 6.99 18.83 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.598 0.759 . . . . 0.0 112.685 -170.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.429 ' HB3' HG21 ' A' ' 47' ' ' ILE . 20.8 t80 -174.59 173.92 2.79 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -166.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.5 mt -84.61 126.39 40.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 33.4 tt0 -70.31 119.93 75.22 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.716 1.206 . . . . 0.0 109.917 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.572 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 89.9 Cg_endo -78.86 124.34 6.15 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.453 2.102 . . . . 0.0 112.983 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -67.41 145.84 54.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.042 1.337 . . . . 0.0 111.245 172.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.32 -164.89 13.23 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 124.0 0.812 . . . . 0.0 113.427 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HB2' ' HA3' ' A' ' 62' ' ' GLY . 34.7 m-20 -75.08 -31.07 61.13 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.709 0.804 . . . . 0.0 111.926 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.0 mt 66.95 12.12 8.76 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.007 1.323 . . . . 0.0 113.049 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -123.35 171.46 9.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.784 0.833 . . . . 0.0 111.153 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.608 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 33.1 tt0 -65.51 106.29 1.39 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.932 0.893 . . . . 0.0 111.811 -171.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.63 -27.94 8.08 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 57' ' ' ASP . . . -84.68 -175.13 50.65 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 167.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.517 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 8.2 t30 -129.48 149.45 51.25 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.266 1.026 . . . . 0.0 110.053 -170.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.572 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 20.5 p90 -109.66 154.46 22.81 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 165.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.66 119.61 1.68 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.994 0.815 . . . . 0.0 110.612 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.456 HD11 ' HB3' ' A' ' 69' ' ' ASN . 61.8 mt -87.02 166.32 15.14 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -88.88 -24.28 22.55 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.143 0.577 . . . . 0.0 109.748 -175.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.28 67.81 0.27 Allowed Glycine 0 C--N 1.342 0.867 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.052 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.456 ' HB3' HD11 ' A' ' 66' ' ' LEU . 54.3 t30 -162.59 -67.38 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.803 0.841 . . . . 0.0 109.542 170.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.02 172.49 6.47 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.796 0.438 . . . . 0.0 111.328 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.3 t -145.36 143.98 30.44 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.564 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.56 164.38 36.22 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 9.0 p-10 -94.91 168.93 10.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 117.925 0.863 . . . . 0.0 110.16 176.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.8 mp -95.75 106.02 17.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.2 mt -72.36 -53.34 12.59 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.333 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -135.18 132.15 37.6 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.681 1.193 . . . . 0.0 108.474 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.1 p -126.18 118.29 24.88 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 166.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.37 74.75 23.36 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.72 141.89 22.29 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.215 1.943 . . . . 0.0 112.785 -171.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -98.46 28.03 16.17 Favored 'Cis proline' 0 C--N 1.375 1.965 0 CA-C-N 119.269 0.775 . . . . 0.0 112.03 -5.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -79.23 -62.15 1.79 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.044 0.937 . . . . 0.0 110.696 -169.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -153.69 162.89 40.84 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.996 0.918 . . . . 0.0 110.413 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 pp -135.71 143.3 45.3 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 166.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.2 m -122.84 110.17 15.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.6 pt -105.96 173.76 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.049 1.34 . . . . 0.0 110.599 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.7 p -109.57 168.54 9.32 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.557 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 34.0 t-105 -156.62 106.07 2.28 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -172.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.2 t -106.89 112.95 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 62.8 t80 -100.81 162.24 13.05 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 125.029 1.332 . . . . 0.0 108.42 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -50.19 -40.47 47.14 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.61 -6.54 19.39 Favored Glycine 0 N--CA 1.47 0.958 0 CA-C-N 116.529 -0.305 . . . . 0.0 112.75 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.729 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 67.3 mmtt -106.72 104.43 51.19 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.63 -30.32 42.53 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.824 2.349 . . . . 0.0 113.348 -168.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.669 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 26.2 t70 -152.47 134.94 15.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.269 0.557 . . . . 0.0 110.359 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.557 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 36.7 m -144.07 164.02 31.87 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 125.63 1.572 . . . . 0.0 106.9 169.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -142.92 119.12 10.79 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.5 t -109.16 148.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.279 1.031 . . . . 0.0 109.517 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.08 157.66 41.77 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.63 1.172 . . . . 0.0 110.197 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.3 tp -142.49 118.12 10.4 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.49 ' HE ' ' HB2' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -122.36 117.13 25.31 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.841 0.856 . . . . 0.0 109.597 -174.093 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.4 mt -107.04 136.18 47.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.933 0.893 . . . . 0.0 110.368 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.6 m -143.38 124.24 14.28 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.472 1.109 . . . . 0.0 108.803 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.37 143.72 57.69 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.237 1.415 . . . . 0.0 111.291 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.97 118.45 4.13 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.5 -102.92 0.94 Allowed Glycine 0 C--N 1.347 1.151 0 C-N-CA 123.098 0.38 . . . . 0.0 112.252 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -125.38 7.11 7.71 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.729 0.812 . . . . 0.0 110.278 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -114.92 -165.12 14.78 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.8 m -150.13 135.41 18.03 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.393 0.677 . . . . 0.0 109.777 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 45.7 tp -81.19 128.15 33.46 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 167.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.6 tt -115.22 113.59 24.11 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.49 ' HB2' ' HE ' ' A' ' 100' ' ' ARG . 51.2 mt-10 -113.12 105.53 13.56 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 171.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.57 HD12 HD21 ' A' ' 133' ' ' LEU . 7.0 tt -99.44 104.6 16.46 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 171.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -104.46 119.26 38.56 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.696 0.798 . . . . 0.0 109.712 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -109.72 114.93 28.92 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.92 121.68 44.23 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.335 0.654 . . . . 0.0 110.834 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.43 HG22 ' HG ' ' A' ' 122' ' ' LEU . 7.8 t -140.21 158.6 43.79 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.637 0.732 . . . . 0.0 110.176 172.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.9 p -85.23 -3.15 58.72 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.792 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.3 t -105.25 121.88 44.78 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.749 0.82 . . . . 0.0 110.203 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.435 ' HA ' HD12 ' A' ' 122' ' ' LEU . 43.0 tt0 -66.34 -37.4 85.27 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.362 0.665 . . . . 0.0 111.528 -177.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -62.38 -58.57 7.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.253 0.221 . . . . 0.0 110.996 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.729 ' SD ' ' HG3' ' A' ' 92' ' ' LYS . 21.2 ttt -46.72 -41.02 14.45 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.493 1.121 . . . . 0.0 112.176 175.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 119' ' ' GLU . 26.9 mt -57.35 -50.9 71.5 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.361 0.664 . . . . 0.0 112.111 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 127' ' ' VAL . 41.4 t -62.53 -50.07 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -61.0 -36.42 79.44 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.182 0.993 . . . . 0.0 113.296 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -80.17 -23.13 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 118.56 0.618 . . . . 0.0 110.031 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 130' ' ' GLU . . . -62.06 -37.75 94.96 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 171.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 123' ' ' VAL . 44.4 t -79.41 -49.52 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.792 0.837 . . . . 0.0 109.204 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.98 -60.32 9.11 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.972 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -61.44 -36.13 79.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.498 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 21.5 tt0 -59.65 -37.59 79.14 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.783 0.72 . . . . 0.0 110.317 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 67.6 mtt -72.25 -39.89 68.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.113 0.565 . . . . 0.0 110.927 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.85 -58.29 9.08 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 123.812 0.695 . . . . 0.0 110.853 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.57 HD21 HD12 ' A' ' 112' ' ' LEU . 3.4 mm? -60.36 -26.16 66.41 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 172.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.15 -38.68 88.71 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -66.71 -36.78 83.31 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.1 0.56 . . . . 0.0 110.234 174.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.478 HD21 ' SG ' ' A' ' 41' ' ' CYS . 42.4 tp -70.91 -56.71 5.65 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.383 0.673 . . . . 0.0 111.14 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -43.52 -42.06 5.67 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 167.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.447 ' HG2' ' HB2' ' A' ' 144' ' ' LEU . 50.2 ttm -66.7 -45.11 79.8 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.394 0.677 . . . . 0.0 111.121 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 143' ' ' ASP . 18.1 t80 -61.35 -59.87 4.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.813 0.845 . . . . 0.0 111.087 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.2 mt -57.89 -36.63 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.795 1.238 . . . . 0.0 112.037 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -58.75 -35.24 72.42 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.955 0.502 . . . . 0.0 111.019 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 123.28 33.92 0.8 Allowed Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.046 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 29.5 t0 -135.08 -167.88 2.07 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 138' ' ' MET . 18.3 tp 65.15 47.34 0.59 Allowed Pre-proline 0 CA--C 1.576 1.959 0 C-N-CA 125.359 1.463 . . . . 0.0 112.01 -172.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -85.29 -18.92 3.89 Favored 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 121.777 1.651 . . . . 0.0 112.798 177.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.61 50.01 0.89 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -112.58 77.69 0.24 Allowed Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -70.82 -20.11 30.26 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.186 2.591 . . . . 0.0 113.414 -167.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.4 m -122.12 119.76 28.57 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 122.907 0.483 . . . . 0.0 110.317 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.02 -11.3 29.0 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.76 2.307 . . . . 0.0 111.842 165.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -88.48 26.53 1.44 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.202 1.001 . . . . 0.0 109.606 171.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.48 -15.9 52.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.609 1.164 . . . . 0.0 111.642 169.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.04 -12.94 9.31 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 124.418 1.087 . . . . 0.0 112.104 169.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 79.21 -26.13 0.18 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.612 1.565 . . . . 0.0 114.176 165.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 69.88 143.08 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.917 1.287 . . . . 0.0 110.039 -163.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -73.6 76.21 1.49 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.658 1.183 . . . . 0.0 111.089 -173.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -164.95 174.53 10.42 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.56 1.944 . . . . 0.0 108.049 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 59.8 102.92 0.03 OUTLIER Pre-proline 0 N--CA 1.479 1.018 0 C-N-CA 125.292 1.437 . . . . 0.0 111.082 -175.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.616 ' HA ' ' SD ' ' A' ' 164' ' ' MET . 18.7 Cg_endo -57.52 84.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.143 2.562 . . . . 0.0 112.943 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.9 m -104.07 109.84 63.08 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.577 1.151 . . . . 0.0 108.095 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -50.74 -55.41 4.1 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.419 2.746 . . . . 0.0 113.918 -170.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.45 -40.89 85.43 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.246 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 12.2 tpt -71.76 -46.2 59.23 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 120.57 0.224 . . . . 0.0 111.036 -175.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.616 ' SD ' ' HA ' ' A' ' 159' ' ' PRO . 89.5 mtp -59.29 -41.08 88.1 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.396 175.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 169' ' ' GLU . 19.7 tpp180 -52.83 -52.02 58.67 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.878 0.736 . . . . 0.0 110.541 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.448 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 82.9 mt -59.36 -52.26 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 124.013 0.82 . . . . 0.0 110.399 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.5 t -59.32 -27.07 65.56 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.94 0.896 . . . . 0.0 111.869 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -77.03 -50.3 13.43 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.512 ' HB2' HH11 ' A' ' 170' ' ' ARG . 45.8 mt-10 -55.65 -50.58 69.84 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 124.168 0.918 . . . . 0.0 110.692 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.512 HH11 ' HB2' ' A' ' 169' ' ' GLU . 15.1 mmt-85 -67.12 -50.28 62.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.776 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -49.46 -44.04 36.19 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 124.193 0.933 . . . . 0.0 114.553 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -67.27 -41.15 85.97 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.777 0.831 . . . . 0.0 111.371 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.1 -41.57 73.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.419 0.688 . . . . 0.0 111.466 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -78.38 -27.36 46.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.502 0.721 . . . . 0.0 111.676 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -71.82 -31.83 66.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.75 0.42 . . . . 0.0 110.373 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -73.3 -31.76 64.22 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.287 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 54.9 mt -71.55 -55.61 7.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.949 0.9 . . . . 0.0 111.51 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.21 -32.32 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -172.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -78.52 -4.12 47.05 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.7 m -100.73 -172.7 2.23 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.884 0.874 . . . . 0.0 110.527 171.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.8 -61.62 2.69 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.477 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 CA--C 1.562 1.415 0 C-N-CA 124.823 1.249 . . . . 0.0 112.2 -179.737 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ptm . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.46 -75.26 0.33 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 169.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.9 m -114.56 64.02 0.67 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.59 -62.99 2.66 Favored Glycine 0 C--N 1.35 1.328 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -172.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.641 HE22 ' HA3' ' A' ' 137' ' ' GLY . 15.2 mm100 -121.98 -169.68 1.92 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.883 1.273 . . . . 0.0 109.441 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.26 56.54 1.0 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 m -97.72 142.07 29.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.924 0.889 . . . . 0.0 111.99 -172.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -122.91 108.82 13.39 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.157 0.983 . . . . 0.0 108.644 169.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.29 141.92 57.04 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.917 171.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.577 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -157.63 164.86 36.8 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.453 HD13 ' HA3' ' A' ' 181' ' ' GLY . 0.2 OUTLIER -142.51 149.06 38.65 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.43 -158.32 8.51 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -135.35 164.93 26.63 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.989 0.915 . . . . 0.0 109.342 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' A' ' 21' ' ' ALA . 15.8 tpt180 -152.39 152.99 32.72 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.978 0.911 . . . . 0.0 108.572 -174.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -111.85 129.61 56.09 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.4 pt -136.05 161.99 59.27 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.015 0.926 . . . . 0.0 109.941 -175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.31 -21.05 16.45 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.533 2.822 . . . . 0.0 114.836 175.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.05 -43.33 58.21 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.004 0.431 . . . . 0.0 110.975 174.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 151.42 -129.24 2.79 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -79.2 136.75 37.17 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.182 0.491 . . . . 0.0 109.891 174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . . . -127.17 155.51 43.27 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 3.9 mpt_? -114.31 161.05 18.38 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 165.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.8 p -134.46 130.27 36.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.183 -168.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 36.9 pt -85.97 135.65 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 168.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 4.0 mp -121.16 119.05 58.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.9 mt -104.76 108.64 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 33.9 mtm105 -105.28 101.78 11.31 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.459 ' NE2' ' HB3' ' A' ' 133' ' ' LEU . 70.8 mt-30 -108.0 118.59 37.15 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.6 tpt85 -91.09 103.53 16.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -86.69 149.73 24.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.27 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -102.7 72.97 1.26 Allowed 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.452 ' H ' ' HA2' ' A' ' 107' ' ' GLY . . . -168.15 150.7 5.29 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 125.833 1.653 . . . . 0.0 107.943 -164.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.64 146.0 23.64 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.679 2.253 . . . . 0.0 113.45 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.3 t -49.63 -35.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 124.535 1.134 . . . . 0.0 111.915 173.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -52.81 -42.62 65.27 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 123.508 0.505 . . . . 0.0 110.951 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -86.66 -30.88 21.39 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.08 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.481 HG22 HD12 ' A' ' 140' ' ' ILE . 52.7 t -69.12 -49.48 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 123.601 0.563 . . . . 0.0 110.44 175.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -65.88 -26.29 67.57 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.903 1.281 . . . . 0.0 111.096 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.3 t -65.95 -48.91 69.76 Favored 'General case' 0 C--N 1.353 0.761 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 173.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.559 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -59.62 -34.74 73.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.912 0.885 . . . . 0.0 112.515 174.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.465 ' SG ' HD21 ' A' ' 99' ' ' LEU . 79.4 m -69.41 -38.04 77.75 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.2 p -105.73 -43.91 4.79 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -167.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.487 ' O ' HG13 ' A' ' 47' ' ' ILE . 65.4 m-20 -76.32 118.46 71.54 Favored Pre-proline 0 N--CA 1.478 0.933 0 CA-C-O 118.131 -0.938 . . . . 0.0 110.298 -175.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -57.39 -23.78 57.01 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.151 2.568 . . . . 0.0 111.72 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -59.46 -44.36 93.0 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.75 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.559 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 12.2 mmm180 -89.37 -26.12 21.22 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.283 1.033 . . . . 0.0 111.396 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.512 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 87.0 mt -73.91 -34.72 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -174.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.563 HD22 ' HB3' ' A' ' 53' ' ' GLU . 69.7 m-20 -66.79 2.89 1.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.66 -9.89 33.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.925 0.89 . . . . 0.0 110.833 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.512 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 37.7 p-90 -146.49 -27.57 0.41 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.595 0.758 . . . . 0.0 112.36 -174.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.457 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 16.6 t80 -147.11 -145.06 0.16 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.412 1.085 . . . . 0.0 108.847 -175.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.82 139.74 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.821 0.848 . . . . 0.0 111.813 -159.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.563 ' HB3' HD22 ' A' ' 48' ' ' ASN . 10.0 pt-20 -65.33 110.42 4.3 Favored Pre-proline 0 CA--C 1.566 1.576 0 O-C-N 125.122 1.514 . . . . 0.0 110.555 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' HB2' HD23 ' A' ' 58' ' ' LEU . 4.1 Cg_exo -80.23 98.98 1.13 Allowed 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.0 2.467 . . . . 0.0 111.982 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -72.92 97.97 2.38 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 64' ' ' PHE . . . -176.09 169.65 42.32 Favored Glycine 0 C--O 1.241 0.578 0 C-N-CA 121.547 -0.358 . . . . 0.0 112.955 -172.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.69 -34.55 78.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.443 0.697 . . . . 0.0 111.253 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.453 HD23 ' HB2' ' A' ' 54' ' ' PRO . 96.1 mt 56.11 70.73 0.61 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.747 1.219 . . . . 0.0 112.718 172.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.462 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 9.3 ptp85 -171.37 171.21 5.63 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.057 0.943 . . . . 0.0 109.495 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 76' ' ' ARG . 28.7 tt0 -54.96 116.17 2.61 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.906 0.882 . . . . 0.0 110.263 174.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.85 8.76 83.83 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 113.945 0.338 . . . . 0.0 113.945 -177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.0 178.16 20.66 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 27.4 p-10 -112.66 177.29 4.68 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 118.043 0.921 . . . . 0.0 112.471 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 48.4 p90 -149.8 139.31 21.54 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 170.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.09 121.65 24.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.812 0.445 . . . . 0.0 110.721 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.6 mt -94.3 132.55 38.77 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -33.63 -56.97 0.44 Allowed 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 126.264 1.826 . . . . 0.0 114.491 -172.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -136.36 5.56 3.86 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.916 -0.584 . . . . 0.0 113.514 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -90.1 -86.9 0.19 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.984 0.892 . . . . 0.0 110.045 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.74 154.56 39.77 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.241 0.543 . . . . 0.0 111.046 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -131.81 149.5 52.44 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.388 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.52 -154.43 9.18 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 11.5 m-20 -129.39 178.2 6.62 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.997 0.519 . . . . 0.0 110.214 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.568 HG13 HG21 ' A' ' 85' ' ' ILE . 3.4 mp -108.49 117.46 54.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 173.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' A' ' 86' ' ' SER . 62.0 mt -74.7 -39.9 61.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.072 0.949 . . . . 0.0 110.282 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.411 ' HA ' ' HG3' ' A' ' 60' ' ' GLU . 16.9 ptm180 -168.32 149.76 5.05 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.922 1.289 . . . . 0.0 108.634 173.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 22.0 p -147.91 119.86 8.19 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.933 0.493 . . . . 0.0 110.388 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -121.18 97.35 47.77 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.173 0.989 . . . . 0.0 109.834 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.91 142.16 24.88 Favored 'Trans proline' 0 CA--C 1.56 1.813 0 C-N-CA 122.502 2.135 . . . . 0.0 112.297 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -97.59 20.96 27.03 Favored 'Cis proline' 0 C--N 1.376 1.983 0 CA-C-N 119.665 0.916 . . . . 0.0 113.043 -5.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -74.43 -60.92 2.05 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.51 0.724 . . . . 0.0 112.199 -169.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -153.19 159.85 42.74 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.859 0.838 . . . . 0.0 111.691 -169.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 99' ' ' LEU . 63.4 tp -134.08 145.44 49.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.626 1.57 . . . . 0.0 107.647 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.414 HG22 HD13 ' A' ' 75' ' ' LEU . 23.9 m -137.11 121.68 18.42 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 172.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.568 HG21 HG13 ' A' ' 74' ' ' ILE . 31.0 pt -134.47 141.88 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.342 1.057 . . . . 0.0 109.703 -176.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.507 ' HB2' HD22 ' A' ' 75' ' ' LEU . 22.7 t -90.73 140.75 29.49 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 168.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.476 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 28.5 t-105 -128.97 100.56 5.7 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.178 1.391 . . . . 0.0 107.644 -167.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.3 t -96.35 102.64 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.42 ' HD2' ' HG3' ' A' ' 92' ' ' LYS . 37.4 t80 -98.07 162.04 13.42 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 174.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.44 115.8 4.97 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.386 0.674 . . . . 0.0 112.015 -168.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.93 14.99 79.82 Favored Glycine 0 C--N 1.356 1.664 0 O-C-N 123.71 0.631 . . . . 0.0 113.775 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.485 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 67.1 mmtt -109.28 153.45 42.69 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.793 0.837 . . . . 0.0 109.895 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.96 143.45 60.47 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.181 1.921 . . . . 0.0 110.391 170.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.21 107.62 0.93 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.916 0.865 . . . . 0.0 109.73 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.5 m -77.75 145.59 36.4 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.427 -172.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -103.53 105.38 15.61 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.0 144.41 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.592 1.157 . . . . 0.0 108.623 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -132.35 148.62 52.43 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.636 0.774 . . . . 0.0 109.603 171.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 83' ' ' LEU . 39.9 tp -125.3 108.56 11.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -107.27 145.76 32.33 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.545 0.738 . . . . 0.0 110.149 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 110' ' ' LEU . 82.9 mt -134.34 141.35 46.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.696 1.199 . . . . 0.0 109.233 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.2 m -136.54 122.57 20.23 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.126 0.97 . . . . 0.0 109.411 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.57 101.43 9.97 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.69 100.96 7.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.922 -170.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.78 -126.09 8.27 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.806 0.717 . . . . 0.0 112.897 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -90.91 27.09 1.9 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.294 0.638 . . . . 0.0 109.647 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.452 ' HA2' ' H ' ' A' ' 32' ' ' ALA . . . -161.7 -172.05 28.57 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 120.363 -0.923 . . . . 0.0 115.245 -172.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.1 m -136.54 125.17 23.73 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.1 1.36 . . . . 0.0 109.386 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.9 tp -82.27 116.04 21.62 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 167.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 1.7 tm? -83.38 133.97 34.92 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 165.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -140.48 105.37 4.96 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.5 tp -103.9 132.63 49.97 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.292 1.037 . . . . 0.0 109.015 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -129.18 102.67 6.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.254 0.621 . . . . 0.0 110.095 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -95.53 113.96 25.66 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 172.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -117.57 103.79 10.41 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.153 0.581 . . . . 0.0 110.78 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 t -121.52 161.83 21.63 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.684 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 5.94 14.85 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.671 1.188 . . . . 0.0 111.781 -175.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.537 ' HB3' ' HG2' ' A' ' 120' ' ' GLN . 66.6 m -132.37 123.47 26.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.442 0.697 . . . . 0.0 110.7 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.518 ' HA ' HD12 ' A' ' 122' ' ' LEU . 4.7 mp0 -72.53 -29.36 63.53 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.0 0.92 . . . . 0.0 109.828 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.537 ' HG2' ' HB3' ' A' ' 118' ' ' SER . 5.2 pt20 -58.73 -44.91 90.57 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.491 1.119 . . . . 0.0 110.821 173.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 24.3 ttt -71.23 -33.96 70.34 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.778 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 119' ' ' GLU . 36.6 mt -64.74 -39.53 93.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 95.0 t -69.58 -41.62 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.303 0.573 . . . . 0.0 109.712 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -59.56 -58.35 8.98 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.03 1.332 . . . . 0.0 111.453 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.0 m -74.2 -14.85 16.32 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 C-N-CA 123.262 0.625 . . . . 0.0 110.339 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 130' ' ' GLU . . . -61.61 -37.28 93.95 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 166.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.73 -47.17 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 O-C-N 124.114 0.538 . . . . 0.0 109.732 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.69 -30.38 76.21 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.916 0.76 . . . . 0.0 114.498 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -88.05 -41.04 13.36 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -60.37 -32.64 71.48 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.575 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 41.0 ttm -66.16 -56.03 13.4 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.316 1.046 . . . . 0.0 110.49 175.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.17 79.73 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.88 0.738 . . . . 0.0 111.43 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.524 HD11 HD22 ' A' ' 136' ' ' LEU . 4.5 mm? -82.65 -20.85 35.46 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.422 1.089 . . . . 0.0 110.904 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.65 -51.98 43.58 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -74.29 -24.55 59.26 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.35 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.524 HD22 HD11 ' A' ' 133' ' ' LEU . 31.7 tp -70.82 -41.57 71.37 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 171.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.641 ' HA3' HE22 ' A' ' 5' ' ' GLN . . . -58.03 -42.97 95.27 Favored Glycine 0 C--O 1.219 -0.832 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.151 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 87.5 mtp -75.2 -32.96 61.35 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.43 0.692 . . . . 0.0 111.559 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -63.19 -46.25 87.97 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.487 0.715 . . . . 0.0 110.704 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.481 HD12 HG22 ' A' ' 37' ' ' VAL . 80.6 mt -76.46 -61.16 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.148 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -148.76 93.36 2.11 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.178 0.991 . . . . 0.0 109.665 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.12 5.73 0.05 OUTLIER Glycine 0 N--CA 1.474 1.181 0 CA-C-O 119.685 -0.509 . . . . 0.0 113.839 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 61.36 82.43 0.17 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.976 1.31 . . . . 0.0 111.706 174.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.04 -47.73 96.28 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 124.078 0.951 . . . . 0.0 111.324 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.44 -7.86 20.42 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 122.254 1.969 . . . . 0.0 113.208 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.56 59.63 Favored Glycine 0 C--N 1.349 1.297 0 O-C-N 123.378 0.424 . . . . 0.0 112.318 171.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.92 76.83 0.19 Allowed Glycine 0 C--N 1.347 1.146 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.99 -12.55 23.79 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.909 2.406 . . . . 0.0 112.255 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.27 149.89 72.58 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.95 1.3 . . . . 0.0 108.577 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.57 -59.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.242 1.961 . . . . 0.0 108.706 164.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 172.06 82.36 0.0 OUTLIER 'General case' 0 C--N 1.342 0.251 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 167.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -77.68 68.71 3.81 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.688 0.756 . . . . 0.0 110.958 -173.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.21 -50.29 14.87 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.455 170.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -165.91 130.5 2.3 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.8 169.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.42 ' HG2' ' HG3' ' A' ' 156' ' ' GLU . 38.1 tt0 -78.98 -50.19 11.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.917 1.287 . . . . 0.0 110.435 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.42 ' HG3' ' HG2' ' A' ' 155' ' ' GLU . 48.1 mt-10 -133.59 160.04 38.66 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.475 1.11 . . . . 0.0 110.731 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 74.32 -44.92 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 126.756 2.022 . . . . 0.0 113.601 174.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 31.3 mt-10 -99.32 124.7 43.91 Favored Pre-proline 0 C--O 1.244 0.772 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.425 ' HA ' ' HG3' ' A' ' 164' ' ' MET . 2.6 Cg_exo -74.37 84.35 1.56 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.871 2.381 . . . . 0.0 112.444 -177.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.7 m -90.31 96.23 0.86 Allowed Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 168.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -30.74 -60.83 0.14 Allowed 'Trans proline' 0 C--N 1.387 2.56 1 C-N-CA 125.315 4.01 . . . . 0.0 115.648 -161.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.464 ' O ' HG12 ' A' ' 166' ' ' ILE . 9.9 tp10 -78.62 -44.91 22.8 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.22 -172.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 12.0 tpt -68.89 -44.61 72.88 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 118.747 0.703 . . . . 0.0 110.843 -173.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.425 ' HG3' ' HA ' ' A' ' 159' ' ' PRO . 3.4 tmm? -54.69 -44.31 73.26 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.37 173.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -63.47 -44.75 93.54 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.133 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 162' ' ' GLU . 33.5 mm -54.78 -43.05 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 C-N-CA 123.917 0.887 . . . . 0.0 110.605 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 10.2 t -73.84 -47.74 36.23 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.194 -177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -59.02 -60.65 3.54 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.227 0.954 . . . . 0.0 112.67 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -39.57 -53.98 2.04 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 124.19 0.996 . . . . 0.0 113.371 174.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -68.85 -37.1 78.89 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.474 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -72.15 -47.88 28.34 Favored Glycine 0 C--N 1.348 1.212 0 C-N-CA 121.818 -0.23 . . . . 0.0 112.555 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.79 -23.65 67.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.137 1.375 . . . . 0.0 111.428 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.07 -50.75 18.26 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.365 0.666 . . . . 0.0 110.071 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -63.28 -25.13 68.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.303 0.641 . . . . 0.0 111.249 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.89 -59.21 3.22 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.091 0.556 . . . . 0.0 109.99 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.3 -30.64 62.78 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.349 1.06 . . . . 0.0 112.686 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 38.4 mt -66.88 -46.27 75.45 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.855 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.413 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 7.3 p -80.5 -27.97 11.67 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 118.65 0.659 . . . . 0.0 110.369 -171.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -69.27 -27.33 65.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.561 0.744 . . . . 0.0 110.389 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 38.9 t -90.26 -24.15 21.02 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.56 0.744 . . . . 0.0 110.678 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.453 ' HA3' HD13 ' A' ' 11' ' ' LEU . . . -101.4 7.42 56.26 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-O 119.609 -0.551 . . . . 0.0 114.337 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.6 p . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.921 176.233 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.57 ' HB2' ' HB3' ' A' ' 143' ' ' ASP . . . -78.4 78.85 4.86 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.105 0.562 . . . . 0.0 109.692 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.2 p -77.83 114.28 16.53 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.976 0.911 . . . . 0.0 110.139 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.719 ' HA2' HH11 ' A' ' 141' ' ' ARG . . . -116.1 -13.25 8.53 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 123.191 0.307 . . . . 0.0 113.352 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.5 150.13 46.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.583 0.753 . . . . 0.0 111.446 -177.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -141.14 52.22 1.58 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.34 1.056 . . . . 0.0 108.555 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 10.3 m -83.87 128.03 34.25 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.593 -1.185 . . . . 0.0 113.638 -165.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 33.5 tt0 -113.57 120.16 39.99 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.538 1.535 . . . . 0.0 107.445 166.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.404 ' HB3' HD13 ' A' ' 177' ' ' LEU . 66.6 mtt180 -85.52 144.41 27.94 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.159 0.583 . . . . 0.0 110.536 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -158.43 -179.6 8.25 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 122.851 0.46 . . . . 0.0 111.343 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.0 mt -142.59 167.06 22.99 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 122.397 1.094 . . . . 0.0 111.36 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.14 176.81 29.48 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 113.059 -1.882 . . . . 0.0 109.494 166.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 37.0 ttm180 -132.38 122.17 24.6 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -131.36 128.09 38.94 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.576 0.751 . . . . 0.0 109.037 -173.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.2 m -93.21 117.86 30.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -173.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.408 HD12 ' OG1' ' A' ' 117' ' ' THR . 26.2 pt -107.36 164.96 13.69 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.577 1.551 . . . . 0.0 108.036 175.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.46 -26.96 30.12 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.091 2.528 . . . . 0.0 114.127 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.24 -20.98 60.73 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.86 0.864 . . . . 0.0 112.993 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.72 167.83 14.08 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 123.389 0.519 . . . . 0.0 111.938 -172.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.33 95.29 1.3 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.8 163.92 20.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.292 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.461 HH21 HG23 ' A' ' 178' ' ' VAL . 2.7 mpp_? -105.57 170.79 7.68 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 167.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -139.27 128.15 23.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.929 -170.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 2.8 pp -88.19 135.2 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 mp -121.58 111.18 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.2 mt -99.76 107.85 21.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.567 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 82.1 mtt180 -94.72 137.38 33.89 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.632 ' NE2' ' HB3' ' A' ' 133' ' ' LEU . 40.4 mt-30 -142.87 136.52 28.76 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 166.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -104.96 114.3 28.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.559 0.695 . . . . 0.0 109.453 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -96.95 131.68 43.5 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.238 1.415 . . . . 0.0 110.06 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -77.74 48.89 0.72 Allowed 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.589 1.185 . . . . 0.0 110.073 172.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.59 154.72 41.43 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.425 1.09 . . . . 0.0 108.285 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.46 166.44 27.22 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.745 2.297 . . . . 0.0 113.116 176.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' A' ' 101' ' ' LEU . 59.1 t -72.17 -43.4 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.404 -174.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -56.09 -41.54 75.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 124.258 0.974 . . . . 0.0 110.341 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -66.58 -64.57 0.83 Allowed 'General case' 0 C--N 1.348 0.526 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.655 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.1 t -50.19 -34.73 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.546 1.139 . . . . 0.0 111.315 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.408 ' HE3' HD12 ' A' ' 101' ' ' LEU . 58.5 t-105 -61.96 -57.49 11.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.601 0.76 . . . . 0.0 110.211 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.1 m -58.39 -34.13 70.39 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 123.913 0.758 . . . . 0.0 111.057 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.1 -31.23 71.98 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 174.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.486 ' HB3' HD12 ' A' ' 99' ' ' LEU . 73.7 m -90.8 -14.17 32.45 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.947 0.899 . . . . 0.0 113.152 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 49.3 p -110.96 -47.07 3.26 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.198 0.454 . . . . 0.0 111.985 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 47' ' ' ILE . 18.2 t70 -66.16 125.68 90.6 Favored Pre-proline 0 N--CA 1.484 1.244 0 C-N-CA 123.495 0.718 . . . . 0.0 110.47 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.79 -30.09 68.53 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.57 2.847 . . . . 0.0 113.602 -171.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -64.76 -48.61 73.92 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 124.359 1.037 . . . . 0.0 109.073 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -58.62 -38.67 78.53 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.156 171.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.482 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 68.7 mt -71.85 -45.68 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -172.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -61.77 -20.57 63.73 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.768 0.427 . . . . 0.0 111.964 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -57.75 -48.16 80.4 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.153 0.581 . . . . 0.0 110.932 174.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.482 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 22.7 p-90 -105.68 -55.85 2.27 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.355 0.662 . . . . 0.0 111.502 -173.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.42 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 6.6 t80 -91.47 -164.25 1.15 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.087 0.555 . . . . 0.0 110.893 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.466 ' HB ' HD23 ' A' ' 66' ' ' LEU . 40.5 mt -84.57 148.1 5.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 C-N-CA 124.359 1.064 . . . . 0.0 108.358 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.81 112.31 5.96 Favored Pre-proline 0 CA--C 1.566 1.569 0 O-C-N 124.173 0.921 . . . . 0.0 110.649 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.65 ' HG2' HD11 ' A' ' 58' ' ' LEU . 90.8 Cg_endo -90.29 96.11 0.27 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.295 2.663 . . . . 0.0 112.293 -175.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -71.21 109.89 5.53 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.561 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.9 -157.56 27.69 Favored Glycine 0 C--N 1.342 0.872 0 O-C-N 123.564 0.54 . . . . 0.0 113.884 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.81 -48.32 16.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.486 1.514 . . . . 0.0 112.054 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.65 HD11 ' HG2' ' A' ' 54' ' ' PRO . 84.7 mt 63.98 25.46 13.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 124.583 1.177 . . . . 0.0 111.483 -170.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -126.31 155.1 42.51 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.44 1.096 . . . . 0.0 109.894 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.602 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 35.6 tt0 -64.55 106.51 1.17 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.437 0.695 . . . . 0.0 111.101 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.3 -35.68 3.14 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.88 -169.59 45.44 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 114.149 -1.025 . . . . 0.0 112.124 170.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 72' ' ' GLY . 9.1 p30 -144.15 177.53 8.52 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.31 0.576 . . . . 0.0 111.907 -170.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -133.16 172.46 12.63 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.921 169.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -158.3 116.95 3.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.72 0.808 . . . . 0.0 109.276 178.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.466 HD23 ' HB ' ' A' ' 52' ' ' ILE . 70.0 mt -80.94 167.2 20.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.461 0.704 . . . . 0.0 110.862 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -86.8 128.25 35.03 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.879 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.47 39.48 22.29 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.997 1.436 . . . . 0.0 116.158 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -142.2 -79.86 0.23 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.407 ' HB1' ' HD1' ' A' ' 89' ' ' TYR . . . -161.79 154.89 20.72 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.106 0.562 . . . . 0.0 110.887 -172.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.0 p -100.42 165.46 11.43 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 170.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 63' ' ' ASN . . . -150.65 178.41 28.1 Favored Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -147.31 142.94 27.68 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.167 0.987 . . . . 0.0 109.321 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.442 HG13 HG23 ' A' ' 85' ' ' ILE . 2.6 mp -100.78 94.64 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.54 -34.07 67.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.407 174.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.478 ' HG2' ' HB ' ' A' ' 84' ' ' THR . 7.3 ptp180 -151.48 132.87 14.62 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.044 0.45 . . . . 0.0 111.313 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 26.3 p -128.46 118.73 23.6 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 168.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -133.05 88.5 36.52 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -173.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.63 141.78 38.64 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.534 2.156 . . . . 0.0 111.553 175.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -96.91 20.82 28.63 Favored 'Cis proline' 0 C--N 1.367 1.52 0 C-N-CA 124.938 -0.859 . . . . 0.0 112.998 -4.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -75.49 -71.62 0.36 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.065 0.946 . . . . 0.0 111.974 -167.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -161.74 159.58 27.39 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.478 0.656 . . . . 0.0 110.73 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 tt -133.33 114.56 13.86 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.478 ' HB ' ' HG2' ' A' ' 76' ' ' ARG . 23.0 m -108.95 127.38 54.01 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.473 HG13 ' HB ' ' A' ' 97' ' ' VAL . 11.8 pt -123.29 150.26 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 126.723 2.009 . . . . 0.0 109.684 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.5 t -84.87 164.92 18.11 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 167.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.654 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 35.7 t-105 -144.39 94.81 2.61 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.086 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.52 101.76 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.489 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 84.8 t80 -102.69 168.06 9.5 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.059 1.344 . . . . 0.0 109.932 -173.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -56.25 103.26 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.111 0.965 . . . . 0.0 110.72 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.23 4.27 83.52 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.019 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 42.1 mmtm -134.67 75.17 63.38 Favored Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 123.916 0.886 . . . . 0.0 110.12 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.52 135.06 25.6 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.371 2.048 . . . . 0.0 112.005 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 66.39 80.71 0.22 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.516 1.126 . . . . 0.0 112.018 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.654 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 35.4 m -109.97 146.18 35.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 168.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -103.44 107.71 18.66 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.153 0.501 . . . . 0.0 111.07 -170.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.473 ' HB ' HG13 ' A' ' 85' ' ' ILE . 10.6 t -112.05 147.97 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.675 1.19 . . . . 0.0 108.413 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -150.84 142.73 23.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.084 0.554 . . . . 0.0 111.075 171.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 41' ' ' CYS . 6.7 tt -109.46 123.79 49.96 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 172.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -122.58 123.0 40.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.471 1.108 . . . . 0.0 109.556 -166.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.487 ' HB3' HG13 ' A' ' 34' ' ' VAL . 92.7 mt -123.31 135.04 54.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.542 0.737 . . . . 0.0 110.982 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.6 m -146.87 145.22 29.77 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.191 1.396 . . . . 0.0 108.609 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.47 143.64 44.91 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.774 0.829 . . . . 0.0 109.169 168.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -150.11 111.06 4.34 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.88 -102.12 0.22 Allowed Glycine 0 C--N 1.348 1.199 0 O-C-N 123.353 0.408 . . . . 0.0 112.407 -171.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -117.11 -5.06 11.4 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.612 0.765 . . . . 0.0 110.81 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -117.63 -150.93 9.18 Favored Glycine 0 C--N 1.352 1.424 0 C-N-CA 124.24 0.924 . . . . 0.0 111.436 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.2 m -143.0 121.99 12.79 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.218 1.007 . . . . 0.0 110.227 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.7 tp -81.74 131.65 35.27 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.7 tt -118.85 109.22 15.76 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.567 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 30.6 mt-10 -111.02 105.8 14.68 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 176.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.505 HD12 HD21 ' A' ' 133' ' ' LEU . 6.2 tt -102.3 104.33 14.85 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 175.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 61.2 tt0 -93.65 128.65 39.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.475 177.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -121.88 113.32 19.46 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 170.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.39 119.53 38.9 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.157 0.983 . . . . 0.0 110.046 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.474 HG21 ' HG ' ' A' ' 122' ' ' LEU . 6.0 t -148.08 151.83 36.32 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.584 0.754 . . . . 0.0 109.71 172.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.408 ' OG1' HD12 ' A' ' 16' ' ' ILE . 1.8 m -74.25 -19.41 60.52 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.326 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.542 ' HB2' ' HB3' ' A' ' 121' ' ' MET . 11.7 m -89.83 119.33 30.12 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.027 0.931 . . . . 0.0 110.778 -173.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -64.32 -40.65 96.32 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.065 0.946 . . . . 0.0 112.141 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -63.76 -55.81 20.36 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.079 0.237 . . . . 0.0 111.389 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.542 ' HB3' ' HB2' ' A' ' 118' ' ' SER . 26.1 ttt -51.15 -33.35 26.51 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.01 0.819 . . . . 0.0 112.644 175.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.474 ' HG ' HG21 ' A' ' 116' ' ' THR . 19.9 mt -64.77 -46.24 82.95 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.33 0.652 . . . . 0.0 111.669 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.405 ' O ' HG22 ' A' ' 127' ' ' VAL . 61.4 t -62.89 -53.11 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -44.76 -53.34 7.49 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.51 1.924 . . . . 0.0 113.335 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.8 m -78.68 -25.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 122.794 0.438 . . . . 0.0 110.697 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.22 88.1 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 170.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 123' ' ' VAL . 89.2 t -81.83 -52.66 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.402 0.681 . . . . 0.0 109.4 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.59 -59.7 9.32 Favored Glycine 0 C--N 1.341 0.816 0 O-C-N 124.42 1.075 . . . . 0.0 113.634 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -57.25 -56.34 23.03 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.073 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.04 -30.31 69.1 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 119.905 1.23 . . . . 0.0 112.294 -171.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.434 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 47.2 ttp -70.73 -44.07 67.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.045 0.938 . . . . 0.0 110.187 174.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 50' ' ' TRP . . . -63.06 -63.53 1.17 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.0 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.632 ' HB3' ' NE2' ' A' ' 28' ' ' GLN . 4.3 mm? -42.31 -38.79 1.92 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.499 1.52 . . . . 0.0 113.992 169.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 131' ' ' MET . 12.4 t70 -52.79 -50.15 64.19 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.231 0.613 . . . . 0.0 110.059 173.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.525 ' HE1' ' HD3' ' A' ' 150' ' ' PRO . 71.5 m-85 -74.43 -19.84 60.26 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.342 176.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 51.3 tp -72.57 -24.53 61.12 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 169.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.73 -41.37 24.08 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 87.2 mtp -63.05 -40.75 98.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.069 0.948 . . . . 0.0 110.567 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -64.06 -56.02 18.0 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.432 0.693 . . . . 0.0 110.753 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 53.0 mt -69.42 -36.24 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 123.275 0.63 . . . . 0.0 111.725 -173.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.719 HH11 ' HA2' ' A' ' 4' ' ' GLY . 49.2 mtp180 -81.27 -14.34 57.51 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 176.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.29 12.88 75.12 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 114.028 0.371 . . . . 0.0 114.028 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 14.0 m-20 -63.82 -38.04 89.62 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.098 0.559 . . . . 0.0 110.683 173.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -56.94 108.58 1.27 Allowed Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 125.114 1.365 . . . . 0.0 111.498 -169.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -93.03 -14.94 1.03 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.733 2.289 . . . . 0.0 112.496 170.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.26 -171.4 28.7 Favored Glycine 0 C--N 1.346 1.095 0 C-N-CA 123.982 0.801 . . . . 0.0 111.355 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.98 112.39 0.22 Allowed Glycine 0 CA--C 1.536 1.389 0 CA-C-O 119.044 -0.864 . . . . 0.0 112.395 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.49 -47.87 0.65 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.422 2.081 . . . . 0.0 112.864 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.401 HG13 ' HB1' ' A' ' 153' ' ' ALA . 17.9 m -124.69 148.57 59.57 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.724 0.81 . . . . 0.0 110.861 -168.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.525 ' HD3' ' HE1' ' A' ' 135' ' ' PHE . 84.7 Cg_endo -79.25 -23.38 7.57 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.517 2.145 . . . . 0.0 111.955 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -111.97 -77.41 0.59 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.107 0.963 . . . . 0.0 109.915 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 27.9 t70 174.68 -23.92 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.373 1.069 . . . . 0.0 109.235 -162.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.401 ' HB1' HG13 ' A' ' 149' ' ' VAL . . . 76.61 29.37 0.67 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.092 1.357 . . . . 0.0 110.131 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -90.41 -174.14 4.03 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.633 171.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -41.84 5.44 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.017 0.527 . . . . 0.0 110.085 173.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -149.05 78.58 1.39 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.963 0.905 . . . . 0.0 109.768 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -138.35 167.67 21.38 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.833 0.853 . . . . 0.0 109.104 172.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 62.25 90.9 0.08 OUTLIER Pre-proline 0 CA--C 1.556 1.178 0 O-C-N 124.53 1.144 . . . . 0.0 109.943 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.61 7.59 1.51 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.256 2.637 . . . . 0.0 113.241 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 50.1 m -62.7 129.82 93.21 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.707 1.203 . . . . 0.0 110.939 176.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -60.92 -64.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.425 2.75 . . . . 0.0 114.039 -168.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -69.53 -19.91 63.7 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.078 0.551 . . . . 0.0 112.329 -172.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -57.95 3.68 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.506 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 52.8 mtm -52.78 -40.56 63.29 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.517 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.529 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 6.8 tpt180 -50.46 -47.91 56.79 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 124.676 1.235 . . . . 0.0 111.441 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 70.5 mt -55.25 -50.65 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 123.848 0.718 . . . . 0.0 110.835 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.9 m -68.47 -22.7 64.55 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 164' ' ' MET . 14.0 mm100 -80.37 -31.42 37.86 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 13.6 mm-40 -65.38 -42.54 92.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.731 0.412 . . . . 0.0 109.935 174.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -62.62 -60.79 3.03 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.819 0.699 . . . . 0.0 110.214 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -53.84 -58.88 10.89 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 124.232 0.957 . . . . 0.0 114.022 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.01 -20.97 65.96 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -175.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.94 -55.11 11.99 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.107 0.412 . . . . 0.0 110.663 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.38 -22.29 61.16 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.193 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -70.13 -46.74 64.12 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 123.77 0.669 . . . . 0.0 109.464 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -64.43 -33.38 75.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.098 0.559 . . . . 0.0 110.118 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 9' ' ' ARG . 47.6 mt -68.06 -61.77 1.71 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.625 173.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.461 HG23 HH21 ' A' ' 22' ' ' ARG . 9.6 p -65.04 -31.38 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.034 0.534 . . . . 0.0 112.417 -166.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -67.61 -35.24 78.57 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.721 0.808 . . . . 0.0 110.231 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.5 m -84.54 -20.14 32.03 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.632 0.773 . . . . 0.0 110.919 175.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -76.27 -14.34 82.43 Favored Glycine 0 C--N 1.358 1.753 0 C-N-CA 123.351 0.501 . . . . 0.0 113.413 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.25 1.106 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.936 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 29' ' ' ARG . . . . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 121.14 0.495 . . . . 0.0 111.935 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.6 m -88.07 131.16 34.78 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.715 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -119.16 103.6 9.68 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 171.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -83.25 132.48 35.04 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.901 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -143.92 171.36 14.34 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.893 -172.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.597 HD23 ' HB3' ' A' ' 177' ' ' LEU . 0.5 OUTLIER -138.69 165.43 26.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.943 1.297 . . . . 0.0 108.242 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.56 -162.29 30.78 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.174 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -120.35 145.6 46.97 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.231 1.012 . . . . 0.0 109.91 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 12.2 tpt180 -164.27 125.85 2.26 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 20.0 m -77.04 142.2 39.97 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.884 0.474 . . . . 0.0 110.756 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.503 HD11 HG23 ' A' ' 117' ' ' THR . 16.7 pt -133.07 165.75 34.38 Favored Pre-proline 0 CA--C 1.557 1.222 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -49.02 -30.92 19.22 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.355 2.704 . . . . 0.0 115.377 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.401 ' H ' HG13 ' A' ' 16' ' ' ILE . . . -71.5 -37.32 71.27 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.164 0.586 . . . . 0.0 111.995 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.33 -174.95 34.84 Favored Glycine 0 N--CA 1.471 1.014 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 2.8 mp0 -71.65 93.9 1.29 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.82 167.1 22.42 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.888 0.875 . . . . 0.0 113.115 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HB3' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -95.17 149.12 21.65 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.339 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.0 p -134.7 130.77 36.79 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.125 0.421 . . . . 0.0 111.376 -169.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.467 HG23 HD22 ' A' ' 122' ' ' LEU . 2.7 pp -88.86 140.08 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 4.0 mp -126.86 124.27 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.442 HG22 ' HG3' ' A' ' 28' ' ' GLN . 25.6 mt -107.23 107.73 23.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 85.6 mtt180 -106.92 98.78 8.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.442 ' HG3' HG22 ' A' ' 26' ' ' ILE . 73.1 mt-30 -109.98 133.24 53.39 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.991 0.916 . . . . 0.0 109.001 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.506 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 17.5 mmt85 -87.44 127.5 35.22 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.42 0.688 . . . . 0.0 109.837 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -120.14 135.94 54.78 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.403 1.081 . . . . 0.0 108.842 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.7 45.43 1.2 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.372 0.606 . . . . 0.0 111.557 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.07 159.03 72.54 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 124.547 1.139 . . . . 0.0 109.883 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.06 157.05 63.63 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.237 2.625 . . . . 0.0 113.562 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.8 t -49.15 -47.95 17.65 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 C-N-CA 124.688 1.195 . . . . 0.0 110.474 171.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -43.44 -47.3 7.02 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 125.05 1.469 . . . . 0.0 111.754 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.54 -46.46 85.89 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.071 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.3 t -76.86 -31.0 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.513 -171.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -75.29 -30.26 60.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.811 1.244 . . . . 0.0 109.967 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.6 m -65.0 -44.46 89.16 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 172.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -62.94 -38.53 91.43 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.25 0.62 . . . . 0.0 112.584 176.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.468 ' SG ' HD22 ' A' ' 99' ' ' LEU . 65.5 m -71.86 -40.57 68.88 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -175.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.3 p -104.15 -38.93 6.72 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -168.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 47' ' ' ILE . 29.3 t70 -79.03 113.35 35.1 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.812 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 43' ' ' ASP . 4.3 Cg_endo -46.66 -38.55 22.34 Favored 'Trans proline' 0 C--N 1.39 2.719 0 C-N-CA 124.7 3.6 . . . . 0.0 115.227 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -66.14 -24.79 66.73 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 123.651 0.594 . . . . 0.0 110.8 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.553 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 5.8 mmp_? -91.95 -25.07 19.05 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 173.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 43' ' ' ASP . 83.1 mt -74.31 -40.71 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 118.235 0.471 . . . . 0.0 110.53 -172.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -65.37 -14.96 62.03 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.002 0.521 . . . . 0.0 111.895 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -83.18 -5.14 59.01 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.379 0.672 . . . . 0.0 111.181 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.418 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 56.7 p-90 -142.93 -15.84 0.7 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.519 0.727 . . . . 0.0 112.098 175.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.418 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 20.6 t80 -141.27 -122.53 0.1 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -173.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.4 ' HB ' HD22 ' A' ' 66' ' ' LEU . 60.8 mt -132.74 140.57 47.13 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 C-N-CA 123.404 0.681 . . . . 0.0 109.62 -167.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.405 ' HG2' ' HE2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -68.61 105.02 0.83 Allowed Pre-proline 0 CA--C 1.573 1.858 0 O-C-N 124.871 1.357 . . . . 0.0 110.239 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.17 124.1 3.24 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.655 2.237 . . . . 0.0 112.498 -172.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HE2' ' HG2' ' A' ' 53' ' ' GLU . 74.4 mmtt -112.41 117.42 32.39 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.647 0.779 . . . . 0.0 110.304 -175.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.17 -152.18 22.7 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.672 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 8.2 m-20 -66.55 -41.86 88.01 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.386 0.698 . . . . 0.0 110.758 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.7 mt 59.65 22.03 10.74 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.758 1.223 . . . . 0.0 111.792 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.672 ' HG2' ' HB3' ' A' ' 57' ' ' ASP . 17.3 ptp180 -133.48 151.7 51.81 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.511 1.124 . . . . 0.0 108.862 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -66.41 135.02 53.71 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.696 0.622 . . . . 0.0 110.492 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.18 -7.2 81.01 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.588 -167.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.92 -175.73 14.97 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-N 117.119 0.46 . . . . 0.0 112.641 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 11.2 p30 -109.05 171.26 7.54 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.586 0.754 . . . . 0.0 112.228 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -145.66 158.77 43.81 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.712 169.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.77 105.21 4.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.651 0.78 . . . . 0.0 109.514 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.4 HD22 ' HB ' ' A' ' 52' ' ' ILE . 70.4 mt -75.51 127.54 33.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -80.21 112.99 18.05 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.866 0.467 . . . . 0.0 110.564 -172.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.84 46.38 8.52 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.98 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -162.6 -83.71 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.851 0.46 . . . . 0.0 111.449 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' ' HD1' ' A' ' 89' ' ' TYR . . . -154.63 156.71 36.99 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.35 0.595 . . . . 0.0 111.017 -170.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.4 m -109.09 -175.34 2.74 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.484 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.75 -160.06 30.03 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 53.6 m-20 -129.48 174.22 9.84 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.24 0.616 . . . . 0.0 109.454 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.417 HG13 HG22 ' A' ' 85' ' ' ILE . 3.4 mp -110.3 116.2 51.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 86' ' ' SER . 31.6 mt -84.22 -44.47 13.88 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.927 0.891 . . . . 0.0 110.317 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.512 ' HB2' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.37 155.19 44.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.134 1.374 . . . . 0.0 109.223 -177.488 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 26.2 p -157.18 120.78 4.16 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 166.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -141.63 100.48 6.13 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -165.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 85.9 Cg_endo -83.84 135.25 6.61 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.754 2.303 . . . . 0.0 112.849 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 24.9 Cg_endo -100.41 29.47 12.63 Favored 'Cis proline' 0 C--N 1.376 1.976 0 CA-C-N 119.399 0.821 . . . . 0.0 112.561 -4.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -77.85 -66.97 0.77 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.992 0.917 . . . . 0.0 112.397 -168.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.499 ' HB3' ' HG3' ' A' ' 100' ' ' ARG . 16.5 ptt180 -160.86 141.31 11.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.769 0.427 . . . . 0.0 111.073 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 77' ' ' CYS . 2.2 pt? -107.72 144.04 35.39 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 163.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 76' ' ' ARG . 32.8 m -134.79 128.42 32.79 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.107 0.963 . . . . 0.0 108.701 -171.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.417 HG22 HG13 ' A' ' 74' ' ' ILE . 28.7 pt -133.35 146.49 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.451 1.1 . . . . 0.0 109.137 -175.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.477 ' HB2' HD11 ' A' ' 75' ' ' LEU . 33.3 t -96.14 139.54 32.16 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 8.4 t-105 -125.64 109.21 12.36 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.801 1.24 . . . . 0.0 107.891 -163.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.18 102.27 13.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.401 ' HD1' ' HB2' ' A' ' 70' ' ' ALA . 31.2 t80 -93.48 133.65 36.55 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.57 133.68 54.19 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.126 0.57 . . . . 0.0 111.342 -170.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.78 -45.14 3.44 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.306 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 13.2 mptt -80.55 163.0 58.69 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.714 1.206 . . . . 0.0 110.094 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 177.39 5.41 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.36 2.04 . . . . 0.0 112.376 175.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.31 162.57 29.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.805 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.564 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.2 m -141.51 165.21 28.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.579 0.752 . . . . 0.0 110.042 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -125.45 106.83 10.09 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 167.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.39 149.0 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.668 1.587 . . . . 0.0 109.004 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.17 153.08 39.43 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.701 165.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.468 HD22 ' SG ' ' A' ' 41' ' ' CYS . 2.8 tt -114.66 128.31 56.24 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 169.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 36.8 ttt180 -138.39 137.85 37.68 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.272 1.029 . . . . 0.0 108.389 -164.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 110' ' ' LEU . 96.7 mt -129.5 132.5 46.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.872 0.469 . . . . 0.0 110.827 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.4 t -125.25 127.17 46.3 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 172.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -69.92 152.74 44.14 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.73 0.812 . . . . 0.0 109.014 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -167.47 79.36 0.19 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -168.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 65.16 -117.38 10.18 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 123.709 0.671 . . . . 0.0 113.306 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.64 32.66 1.07 Allowed 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.91 -171.9 38.06 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-O 122.001 0.778 . . . . 0.0 114.475 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.2 m -140.43 131.01 25.5 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 113.78 -1.21 . . . . 0.0 109.463 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.498 HD11 ' HB3' ' A' ' 27' ' ' ARG . 64.0 tp -82.77 106.87 14.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.468 171.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.0 tt -84.22 131.98 34.7 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 172.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 22.2 mt-10 -129.32 106.62 8.92 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -174.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.424 HD13 HD21 ' A' ' 133' ' ' LEU . 9.0 tt -115.47 126.45 54.32 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -124.66 137.83 54.34 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.528 ' HD1' ' HE1' ' A' ' 129' ' ' TRP . 7.6 t60 -131.88 114.89 15.21 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . . . -109.96 104.01 12.85 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.118 0.567 . . . . 0.0 110.972 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.433 HG23 ' HG ' ' A' ' 122' ' ' LEU . 5.3 t -124.2 156.13 37.32 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.206 0.527 . . . . 0.0 109.64 171.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.503 HG23 HD11 ' A' ' 16' ' ' ILE . 20.8 p -77.44 -18.57 57.07 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.433 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.5 t -88.49 111.85 22.3 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.333 0.653 . . . . 0.0 110.079 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.411 ' HA ' HD12 ' A' ' 122' ' ' LEU . 37.4 tt0 -62.63 -29.21 70.45 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.397 1.079 . . . . 0.0 110.878 172.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -60.35 -47.89 84.09 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.554 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.404 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 27.4 ttt -68.49 -37.62 80.27 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.787 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.467 HD22 HG23 ' A' ' 24' ' ' ILE . 37.7 mt -61.1 -38.18 85.37 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.591 0.756 . . . . 0.0 112.763 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 68.8 t -64.51 -51.78 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 O-C-N 123.392 0.432 . . . . 0.0 109.888 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -63.65 -41.8 98.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.27 0.628 . . . . 0.0 112.544 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.37 -34.56 58.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 CA-C-O 118.992 -0.528 . . . . 0.0 109.994 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.03 -32.18 74.89 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 121.389 -0.434 . . . . 0.0 112.217 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.09 -54.52 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 123.869 0.393 . . . . 0.0 110.894 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.96 73.45 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.944 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.528 ' HE1' ' HD1' ' A' ' 114' ' ' HIS . 17.4 m95 -80.2 -49.52 11.52 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 38.5 mt-10 -63.35 -23.09 67.26 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 118.415 0.552 . . . . 0.0 111.599 176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 56.4 ttp -66.46 -44.71 82.0 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.074 0.549 . . . . 0.0 109.54 170.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.62 -35.79 81.67 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.036 0.534 . . . . 0.0 111.275 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 130' ' ' GLU . 4.0 mm? -74.75 -18.38 60.5 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.6 1.16 . . . . 0.0 111.367 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -69.87 -55.26 10.23 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -66.15 -32.81 74.48 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.879 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.1 tp -75.01 -37.63 61.76 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.189 0.596 . . . . 0.0 109.931 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.5 -46.52 52.89 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.598 0.562 . . . . 0.0 112.925 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.0 mtp -69.23 -39.71 78.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.94 0.896 . . . . 0.0 111.205 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.62 -33.15 68.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.137 0.575 . . . . 0.0 111.345 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.9 mm -72.51 -63.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 65.0 mmt-85 . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.739 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.5 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 64.8 mt . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 63.7 p -75.36 -41.6 56.09 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 48.1 mt-30 -55.65 -63.7 1.09 Allowed 'General case' 0 C--O 1.2 -1.524 0 O-C-N 124.123 0.89 . . . . 0.0 110.751 172.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -41.76 -45.37 3.53 Favored 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 27.7 mmt85 -58.01 -48.26 80.58 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 174.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -81.51 -15.53 75.86 Favored Glycine 0 C--O 1.214 -1.128 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.581 -174.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 36.0 mm-40 -70.66 -39.42 73.59 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 117.699 0.75 . . . . 0.0 108.991 176.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.48 -58.45 7.55 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.188 173.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -62.73 -28.12 69.74 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.955 0.785 . . . . 0.0 113.065 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.54 -64.11 0.94 Allowed 'General case' 0 C--N 1.353 0.724 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -46.9 -41.28 15.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.881 0.872 . . . . 0.0 112.526 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.597 ' HB3' HD23 ' A' ' 11' ' ' LEU . 51.5 mt -65.25 -40.78 94.44 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.0 p -85.66 -28.08 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.023 0.829 . . . . 0.0 109.442 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -67.71 -29.38 68.62 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.077 170.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.475 0.799 0 C-N-CA 123.23 0.612 . . . . 0.0 109.837 176.079 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.589 ' HB3' ' HB2' ' A' ' 29' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 120.637 0.256 . . . . 0.0 111.376 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 m -79.52 119.02 21.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.101 0.56 . . . . 0.0 109.725 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 43.1 mt-10 -114.48 112.65 23.31 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -176.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.418 ' HB3' HD11 ' A' ' 177' ' ' LEU . 97.6 mtt180 -72.44 133.31 44.8 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.266 0.626 . . . . 0.0 109.776 171.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.66 169.69 24.12 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.743 0.652 . . . . 0.0 110.525 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -144.91 150.19 36.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.446 ' H ' HD13 ' A' ' 11' ' ' LEU . . . -158.8 -146.66 4.61 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 174.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -149.27 152.65 36.27 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.441 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 30.6 tpt180 -154.75 135.67 13.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.7 m -78.74 137.64 37.86 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.415 HG13 ' H ' ' A' ' 19' ' ' GLY . 41.5 pt -126.63 159.61 62.75 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 124.081 0.952 . . . . 0.0 109.925 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.32 -27.3 56.91 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.333 2.689 . . . . 0.0 113.644 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.46 -39.23 77.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.965 0.506 . . . . 0.0 111.937 175.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.415 ' H ' HG13 ' A' ' 16' ' ' ILE . . . 164.35 -146.95 11.96 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 -173.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -83.83 137.98 33.44 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.66 160.4 38.22 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.946 0.498 . . . . 0.0 110.838 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -100.49 162.59 12.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 165.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 40.7 t -141.28 133.54 28.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.375 0.27 . . . . 0.0 110.86 -167.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.489 ' HA ' HD22 ' A' ' 11' ' ' LEU . 43.5 pt -85.48 134.84 26.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.17 111.56 36.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.0 mt -103.81 104.66 17.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.559 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 87.9 mtt180 -91.01 159.86 15.92 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 122.999 0.52 . . . . 0.0 109.805 173.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 6.3 tt0 -168.92 119.68 0.74 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.227 1.58 . . . . 0.0 111.477 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.589 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 6.0 mmt180 -88.44 106.23 18.13 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.531 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 91.4 m-85 -85.42 126.56 33.89 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.525 168.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -89.35 76.74 7.5 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 168.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 30' ' ' TYR . . . -179.82 139.83 0.32 Allowed Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -157.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 85.4 Cg_endo -74.18 150.18 42.01 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.223 1.949 . . . . 0.0 113.504 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -47.78 -39.99 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.453 170.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -47.85 -49.3 29.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.393 1.058 . . . . 0.0 111.391 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 31.0 mt-10 -80.64 -29.84 36.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.565 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.7 t -73.13 -32.9 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 123.628 0.58 . . . . 0.0 110.631 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -81.51 -25.9 35.58 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.698 1.199 . . . . 0.0 109.753 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m -68.03 -50.16 57.01 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -60.55 -41.56 94.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.137 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.666 ' SG ' HD23 ' A' ' 99' ' ' LEU . 17.0 t -61.82 -45.18 94.94 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.4 p -104.05 -45.25 4.79 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -165.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 47' ' ' ILE . 5.5 m-20 -68.79 116.7 43.74 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.993 -175.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.88 -34.89 23.29 Favored 'Trans proline' 0 C--N 1.388 2.627 0 C-N-CA 123.622 2.881 . . . . 0.0 113.953 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.57 -33.49 72.78 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.631 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.579 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 30.7 mmt180 -90.0 -33.37 16.39 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.172 0.989 . . . . 0.0 111.512 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 43' ' ' ASP . 71.6 mt -73.3 -36.03 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -168.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -71.67 -1.03 12.33 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.558 0.743 . . . . 0.0 112.715 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.5 -48.83 7.05 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.433 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 62.7 p-90 -101.56 -16.4 16.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.433 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 44.0 t80 -137.64 -114.16 0.17 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.584 0.754 . . . . 0.0 109.771 -176.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.475 HD12 HD13 ' A' ' 66' ' ' LEU . 49.4 mt -136.96 144.3 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -171.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.96 113.55 12.68 Favored Pre-proline 0 N--CA 1.485 1.295 0 O-C-N 124.801 1.313 . . . . 0.0 110.214 174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.414 ' HB2' HD21 ' A' ' 58' ' ' LEU . 60.5 Cg_endo -92.15 143.51 2.66 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.056 2.504 . . . . 0.0 111.742 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -143.9 135.93 26.5 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.99 -151.93 23.58 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -71.04 -49.1 48.6 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.414 HD21 ' HB2' ' A' ' 54' ' ' PRO . 40.7 mt 59.36 25.43 14.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.239 0.962 . . . . 0.0 110.602 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -122.94 148.66 45.22 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.436 1.495 . . . . 0.0 109.674 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -70.42 130.83 42.96 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.377 0.608 . . . . 0.0 109.771 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.71 -2.08 82.0 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.781 -168.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.24 178.03 18.3 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 8.2 p30 -117.98 178.0 4.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -172.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -150.85 162.39 40.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.04 0.936 . . . . 0.0 109.266 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.88 146.06 36.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.899 0.88 . . . . 0.0 109.513 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.475 HD13 HD12 ' A' ' 52' ' ' ILE . 86.9 mt -83.64 -89.83 0.09 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.175 0.59 . . . . 0.0 110.187 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -140.89 -57.59 0.51 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.27 9.62 0.52 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.412 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.473 ' HB3' HD12 ' A' ' 66' ' ' LEU . 42.6 t-20 -77.37 -85.07 0.06 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.3 158.58 43.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.703 0.763 . . . . 0.0 112.134 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.5 p -132.96 147.98 52.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.421 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.04 171.66 44.56 Favored Glycine 0 N--CA 1.464 0.502 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 24.9 m-20 -85.78 171.35 11.65 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.479 0.657 . . . . 0.0 111.298 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.23 119.53 59.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 168.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 84' ' ' THR . 59.0 mt -84.63 -38.4 19.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.005 0.522 . . . . 0.0 110.622 -176.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -166.18 111.54 0.83 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.493 0.717 . . . . 0.0 109.61 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 10.6 p -107.3 103.1 12.38 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -99.94 102.17 16.63 Favored Pre-proline 0 N--CA 1.482 1.125 0 C-N-CA 124.132 0.973 . . . . 0.0 110.521 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 96.6 Cg_endo -80.66 129.55 7.34 Favored 'Trans proline' 0 CA--C 1.564 2.013 0 C-N-CA 122.786 2.324 . . . . 0.0 112.896 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.56 ' HD2' HH11 ' A' ' 81' ' ' ARG . 16.1 Cg_endo -103.84 33.37 6.97 Favored 'Cis proline' 0 C--N 1.38 2.193 0 CA-C-N 119.802 0.965 . . . . 0.0 112.783 -10.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.56 HH11 ' HD2' ' A' ' 80' ' ' PRO . 3.7 mpt_? -65.93 -69.24 0.31 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.923 0.889 . . . . 0.0 110.437 -176.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.9 ptt-85 -161.86 154.68 20.29 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.322 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 83' ' ' LEU . 1.8 pt? -107.04 146.61 30.96 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 167.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 75' ' ' LEU . 94.1 m -131.53 121.83 25.11 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.664 1.585 . . . . 0.0 107.167 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.9 pt -141.58 142.99 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.779 0.832 . . . . 0.0 109.464 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.9 t -88.84 137.66 32.12 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -123.7 102.83 8.04 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.4 t -99.18 101.48 12.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -93.77 146.19 24.05 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.463 172.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -62.05 121.78 13.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.693 0.797 . . . . 0.0 111.331 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.82 19.65 61.09 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.323 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.46 ' HD2' ' HB2' ' A' ' 121' ' ' MET . 72.8 mmtt -132.4 147.89 67.47 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 123.917 0.887 . . . . 0.0 109.754 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.27 149.8 64.19 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.781 2.321 . . . . 0.0 111.418 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -59.8 116.61 4.21 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.872 0.869 . . . . 0.0 111.818 -169.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.8 m -90.59 160.76 15.76 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.554 -172.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -104.25 140.66 37.53 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.275 1.03 . . . . 0.0 108.361 166.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 54.2 t -138.14 118.37 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -126.46 111.87 14.94 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.666 HD23 ' SG ' ' A' ' 41' ' ' CYS . 38.2 tp -96.91 119.58 35.65 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.5 ttp-105 -127.14 114.57 17.88 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.618 0.767 . . . . 0.0 109.285 -160.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.1 mt -104.77 153.79 20.86 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.464 0.706 . . . . 0.0 110.564 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.6 m -141.85 123.01 14.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.784 0.834 . . . . 0.0 109.859 170.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -83.34 106.31 15.0 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -120.32 80.26 1.58 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.411 1.084 . . . . 0.0 110.238 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.56 -103.18 1.82 Allowed Glycine 0 C--N 1.35 1.31 0 C-N-CA 122.96 0.314 . . . . 0.0 112.539 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -106.47 5.08 28.99 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.416 0.686 . . . . 0.0 109.291 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.32 163.29 12.42 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.39 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 m -140.16 112.83 8.01 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.627 1.171 . . . . 0.0 108.438 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.8 tp -80.74 107.75 13.82 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.1 tt -90.66 131.46 36.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 172.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.545 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 43.9 mt-10 -132.9 109.22 9.44 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.5 tt -95.26 121.2 36.66 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 4.8 tp10 -112.6 102.7 10.76 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.471 ' HB3' HG12 ' A' ' 24' ' ' ILE . 6.5 t60 -114.58 112.67 23.29 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.441 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . . . -114.28 107.68 15.91 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.404 1.082 . . . . 0.0 110.189 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.506 HG23 ' HG ' ' A' ' 122' ' ' LEU . 5.1 t -127.64 156.03 42.96 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.663 0.744 . . . . 0.0 110.528 174.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -23.77 58.87 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.196 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.1 t -91.19 115.89 28.38 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.236 1.015 . . . . 0.0 110.795 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -69.93 -25.58 63.73 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.758 0.823 . . . . 0.0 110.942 175.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -63.45 -47.76 80.53 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.528 171.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.46 ' HB2' ' HD2' ' A' ' 92' ' ' LYS . 23.3 ttt -67.58 -33.61 75.36 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.114 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.506 ' HG ' HG23 ' A' ' 116' ' ' THR . 19.7 mt -63.06 -43.87 97.42 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.255 0.622 . . . . 0.0 112.045 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 127' ' ' VAL . 89.3 t -63.78 -42.23 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.954 173.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.65 -44.99 76.58 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.582 1.153 . . . . 0.0 111.807 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -79.65 -18.84 12.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 C-N-CA 123.37 0.668 . . . . 0.0 109.505 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.49 -34.09 89.02 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 166.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 123' ' ' VAL . 48.7 t -75.6 -50.76 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.97 -33.48 79.45 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 114.676 0.63 . . . . 0.0 114.676 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -86.04 -41.02 15.17 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.703 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.71 -34.05 76.35 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.91 0.777 . . . . 0.0 109.604 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 53.4 ttm -60.83 -50.13 74.67 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.837 0.855 . . . . 0.0 109.74 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.52 90.79 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.739 0.816 . . . . 0.0 112.154 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.16 -21.51 33.52 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.518 0.727 . . . . 0.0 111.6 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.65 -44.4 70.66 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -72.7 -35.82 67.7 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.166 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 29.1 tp -70.43 -38.66 74.61 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.824 0.45 . . . . 0.0 110.557 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.01 -52.77 50.21 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.744 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 31.1 ttp -61.75 -38.89 89.68 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.121 0.568 . . . . 0.0 110.799 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.16 -56.69 18.57 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.857 1.263 . . . . 0.0 111.042 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 58.9 mt -72.46 -19.19 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.8 0.84 . . . . 0.0 111.145 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.553 1.083 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 12.2 tt . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 111.39 0.144 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.9 p -77.78 -40.91 39.2 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -54.63 -59.03 5.26 Favored 'General case' 0 C--O 1.206 -1.211 0 O-C-N 123.922 0.764 . . . . 0.0 110.664 166.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -41.44 -49.58 3.9 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.153 1.381 . . . . 0.0 112.437 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -56.59 -55.79 29.54 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.007 0.523 . . . . 0.0 110.385 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.42 -17.52 79.11 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.435 -168.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.23 -29.07 31.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.023 0.929 . . . . 0.0 110.042 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.52 -53.67 17.96 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.78 0.832 . . . . 0.0 109.503 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -69.1 -25.87 64.64 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.846 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.04 -60.53 3.32 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 172.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.16 12.52 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.662 1.185 . . . . 0.0 112.911 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 78.1 mt -68.7 -46.25 69.48 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.096 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.03 -23.74 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.115 0.871 . . . . 0.0 110.682 -166.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -70.39 -25.25 63.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.424 0.69 . . . . 0.0 110.072 171.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 CA--C 1.556 1.18 0 C-N-CA 124.059 0.944 . . . . 0.0 110.692 172.025 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 85.6 m -85.81 122.25 29.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.628 -176.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -124.6 112.06 16.37 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.571 1.548 . . . . 0.0 107.596 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.27 159.54 31.39 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.8 173.26 10.82 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.504 0.722 . . . . 0.0 109.095 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -145.32 154.86 42.78 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -177.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.459 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -162.47 -153.95 7.37 Favored Glycine 0 C--O 1.238 0.404 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.4 ptt85 -157.1 160.28 38.7 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.211 0.604 . . . . 0.0 110.129 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -168.53 162.42 12.1 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.917 171.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.1 m -96.37 144.03 26.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.763 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 117' ' ' THR . 42.5 pt -135.5 162.31 57.95 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.933 1.293 . . . . 0.0 108.497 -174.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.97 -35.37 31.76 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.568 2.845 . . . . 0.0 114.767 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.83 99.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.647 0.779 . . . . 0.0 111.779 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.06 -149.05 18.28 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.66 139.27 38.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 117.314 0.557 . . . . 0.0 109.622 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.12 158.55 44.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.295 0.569 . . . . 0.0 111.479 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -97.11 161.37 13.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 165.021 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 78.4 p -138.48 124.56 20.17 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.508 HG12 HG23 ' A' ' 125' ' ' VAL . 2.6 pp -86.61 131.0 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mp -113.19 119.58 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.0 mt -105.65 111.03 33.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 61.3 mtt180 -92.18 140.85 29.21 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 123.364 0.415 . . . . 0.0 110.335 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.671 HE22 HD22 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -137.33 139.6 40.94 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 167.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.491 HH12 ' HA3' ' A' ' 107' ' ' GLY . 24.6 tpt85 -107.83 102.79 11.97 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.434 ' HE1' ' HA2' ' A' ' 137' ' ' GLY . 63.1 m-85 -85.95 144.46 27.62 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.931 1.292 . . . . 0.0 110.929 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.527 ' HB3' ' HD3' ' A' ' 141' ' ' ARG . 26.5 t70 -87.82 26.44 1.33 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 123.807 0.692 . . . . 0.0 110.696 170.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.27 155.09 68.79 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.049 0.94 . . . . 0.0 110.604 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.38 156.63 59.0 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.549 2.833 . . . . 0.0 113.174 175.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 101' ' ' LEU . 11.3 t -59.97 -42.51 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 O-C-N 124.473 1.108 . . . . 0.0 110.628 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -48.66 -52.05 25.29 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 125.107 1.504 . . . . 0.0 109.88 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -64.92 -62.87 1.3 Allowed 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.65 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.533 HG22 HD13 ' A' ' 140' ' ' ILE . 62.9 t -46.54 -39.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 C-N-CA 124.697 1.199 . . . . 0.0 112.248 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -65.93 -41.16 91.73 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.114 0.966 . . . . 0.0 110.316 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.4 m -69.78 -25.79 63.97 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 123.469 0.48 . . . . 0.0 110.512 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.56 -47.91 21.02 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.527 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.459 ' HB3' HD21 ' A' ' 99' ' ' LEU . 84.7 m -75.82 -16.9 60.02 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 43.7 p -101.63 -33.22 9.98 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 118.403 0.547 . . . . 0.0 111.66 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 47' ' ' ILE . 19.9 t70 -83.45 112.41 39.12 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 122.75 0.42 . . . . 0.0 110.004 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.484 ' HB2' ' HG3' ' A' ' 53' ' ' GLU . 58.4 Cg_endo -64.46 -27.34 62.37 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.151 2.568 . . . . 0.0 112.869 -171.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -63.9 -39.34 93.95 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.758 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -79.48 -24.29 42.44 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.59 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 43' ' ' ASP . 79.1 mt -74.82 -38.5 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.59 0.356 . . . . 0.0 111.52 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 10.9 p30 -73.87 -0.42 15.94 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -73.26 -29.94 63.09 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.768 0.827 . . . . 0.0 110.714 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 40.7 p-90 -129.31 -11.7 4.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.015 0.926 . . . . 0.0 111.484 -171.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.457 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 16.2 t80 -147.96 -163.72 1.84 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.525 0.73 . . . . 0.0 109.13 -174.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 mt -87.1 171.34 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 31.3 tt0 -108.63 121.51 43.05 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.668 1.187 . . . . 0.0 110.12 -172.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.69 84.69 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.337 2.691 . . . . 0.0 111.0 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -77.47 126.22 30.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.989 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.22 -165.89 36.8 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.633 -0.318 . . . . 0.0 112.722 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.84 -37.96 73.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.443 0.697 . . . . 0.0 110.279 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.0 mt 59.22 -171.37 0.12 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.922 1.289 . . . . 0.0 111.885 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 72.59 166.64 0.3 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.882 1.273 . . . . 0.0 110.598 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 41.3 tt0 -60.02 111.7 1.6 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.165 0.586 . . . . 0.0 111.149 -173.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.08 11.52 58.61 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.436 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.34 -146.56 20.36 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.65 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 29.8 p-10 -156.0 160.42 40.03 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 117.571 0.685 . . . . 0.0 111.705 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -140.07 147.91 40.99 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.72 112.17 5.28 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.756 0.823 . . . . 0.0 109.884 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 69' ' ' ASN . 79.1 mt -78.39 146.89 34.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.706 0.802 . . . . 0.0 109.262 172.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -69.41 122.07 18.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.551 0.74 . . . . 0.0 110.631 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 56.69 40.9 89.45 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 124.29 0.994 . . . . 0.0 114.468 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 66' ' ' LEU . 18.4 t-20 -147.17 -84.27 0.11 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.704 0.252 . . . . 0.0 110.402 -171.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.35 151.03 31.19 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.98 0.419 . . . . 0.0 111.707 -171.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -132.0 145.25 51.34 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.224 1.009 . . . . 0.0 109.796 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.19 -163.08 26.99 Favored Glycine 0 C--O 1.241 0.548 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.65 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 4.8 p-10 -127.04 173.89 9.3 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.158 0.479 . . . . 0.0 110.731 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.475 ' HA ' HG22 ' A' ' 85' ' ' ILE . 19.6 mm -97.49 102.8 13.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.53 -47.84 71.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -167.66 142.52 3.76 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.794 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 22.0 p -127.36 106.24 9.07 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.64 99.47 8.84 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 9.9 Cg_exo -74.56 137.81 23.3 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.147 2.565 . . . . 0.0 112.984 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 42.7 Cg_endo -100.83 30.53 11.11 Favored 'Cis proline' 0 C--N 1.375 1.932 0 CA-C-N 119.481 0.85 . . . . 0.0 112.153 -9.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -71.34 -69.43 0.38 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.285 1.034 . . . . 0.0 111.998 -170.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -152.95 146.9 25.36 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.417 0.627 . . . . 0.0 111.452 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 99' ' ' LEU . 58.1 tp -98.31 143.99 28.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.702 -1.136 . . . . 0.0 107.954 169.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.9 m -134.79 123.34 23.42 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.475 HG22 ' HA ' ' A' ' 74' ' ' ILE . 21.0 pt -143.74 149.56 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.619 0.768 . . . . 0.0 110.285 -174.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 p -88.16 138.51 31.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 36.8 t-105 -130.2 101.02 5.61 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -170.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -107.91 102.46 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -78.74 154.85 29.68 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.63 111.04 1.45 Allowed 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.065 0.46 . . . . 0.0 111.784 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.04 21.99 66.75 Favored Glycine 0 C--N 1.351 1.361 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.375 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.463 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 69.0 mmtt -126.48 153.14 75.08 Favored Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 123.711 0.805 . . . . 0.0 109.593 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.519 ' HG2' ' HB2' ' A' ' 118' ' ' SER . 23.4 Cg_exo -64.72 162.5 31.39 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.962 2.441 . . . . 0.0 113.506 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.93 103.59 1.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.962 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -100.46 179.29 4.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.824 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -142.42 128.81 20.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.974 0.909 . . . . 0.0 108.634 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.6 t -113.66 121.46 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.241 0.544 . . . . 0.0 110.292 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 37.7 mm-40 -91.41 138.66 31.4 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.906 165.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 83' ' ' LEU . 55.0 tp -127.63 110.57 12.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 171.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -128.97 121.91 29.0 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 122.151 -0.343 . . . . 0.0 110.385 -160.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HB3' HG22 ' A' ' 34' ' ' VAL . 90.0 mt -115.61 141.28 48.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.645 0.778 . . . . 0.0 111.233 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.4 t -144.51 115.24 7.74 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.523 1.129 . . . . 0.0 108.791 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -81.96 120.45 25.25 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -129.39 121.81 28.14 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.301 1.44 . . . . 0.0 108.129 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.93 -135.28 16.44 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -102.63 62.57 0.84 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 165.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.491 ' HA3' HH12 ' A' ' 29' ' ' ARG . . . -179.24 -177.79 47.9 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.101 -0.954 . . . . 0.0 114.408 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.3 m -134.26 141.33 46.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.311 1.044 . . . . 0.0 110.081 -170.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.9 tp -102.27 112.98 25.9 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.671 HD22 HE22 ' A' ' 28' ' ' GLN . 7.3 tt -95.89 134.61 38.67 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 173.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.577 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 39.8 mt-10 -132.69 106.28 7.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.642 HD13 HD21 ' A' ' 133' ' ' LEU . 8.9 tt -98.27 122.05 40.96 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 98' ' ' GLU . 38.7 tt0 -122.01 100.78 7.16 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.807 0.843 . . . . 0.0 109.28 -172.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 23' ' ' SER . 8.3 t60 -99.29 113.77 26.25 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 22' ' ' ARG . . . -104.38 111.74 24.51 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.714 1.206 . . . . 0.0 111.095 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.454 HG23 ' HG ' ' A' ' 122' ' ' LEU . 10.6 t -136.99 160.76 37.97 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 170.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.433 HG23 HD11 ' A' ' 16' ' ' ILE . 66.8 p -86.13 -15.08 42.24 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.582 1.153 . . . . 0.0 111.489 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.519 ' HB2' ' HG2' ' A' ' 93' ' ' PRO . 46.4 t -87.17 108.98 19.15 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.062 0.545 . . . . 0.0 109.797 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.507 ' HA ' HD12 ' A' ' 122' ' ' LEU . 39.7 tt0 -62.03 -31.04 71.4 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.787 0.835 . . . . 0.0 110.796 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -61.24 -58.05 9.88 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.158 175.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.463 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 24.3 ttt -64.16 -26.92 68.74 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.706 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 119' ' ' GLU . 13.8 mt -65.15 -44.6 88.05 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.463 0.705 . . . . 0.0 111.864 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.89 -45.44 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.256 0.551 . . . . 0.0 109.81 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.79 -50.5 72.14 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.042 1.337 . . . . 0.0 112.081 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.508 HG23 HG12 ' A' ' 24' ' ' ILE . 35.8 m -72.03 -29.37 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.876 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.7 -38.23 91.36 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 172.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 131' ' ' MET . 59.6 t -75.69 -59.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.051 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.63 -37.04 94.15 Favored Glycine 0 C--N 1.345 1.038 0 O-C-N 123.725 0.64 . . . . 0.0 114.446 -172.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.473 ' HB2' ' O ' ' A' ' 125' ' ' VAL . 10.7 m95 -67.05 -53.38 31.68 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -57.76 -31.47 66.53 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.156 0.285 . . . . 0.0 110.746 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 95.7 mmm -61.48 -48.45 81.06 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.204 0.602 . . . . 0.0 110.331 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.31 -38.96 85.32 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.26 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.642 HD21 HD13 ' A' ' 112' ' ' LEU . 2.8 mm? -77.37 -19.88 55.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.985 0.514 . . . . 0.0 111.731 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 138' ' ' MET . 72.0 m-20 -66.82 -53.5 32.08 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 68.9 m-85 -72.59 -25.4 61.31 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.749 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.402 HD13 ' CZ2' ' A' ' 50' ' ' TRP . 59.1 tp -70.39 -39.21 74.64 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.434 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -58.14 -39.41 92.19 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.615 171.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 89.3 mmm -70.22 -38.16 75.17 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.531 0.732 . . . . 0.0 110.183 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -69.01 -37.26 78.57 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.2 1.0 . . . . 0.0 111.276 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.533 HD13 HG22 ' A' ' 37' ' ' VAL . 50.5 mt -80.03 -57.42 5.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 123.338 0.655 . . . . 0.0 110.193 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.527 ' HD3' ' HB3' ' A' ' 31' ' ' ASP . 21.2 ttt180 . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 121.709 0.766 . . . . 0.0 110.179 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 61.8 mt . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 119.751 -0.166 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 62.2 p -70.69 -39.76 73.32 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.235 0.334 . . . . 0.0 110.52 -171.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -59.7 -59.7 5.02 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.293 170.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -43.17 -36.75 1.82 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 172.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -64.77 -52.36 57.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.248 0.619 . . . . 0.0 110.733 175.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.25 -20.01 75.92 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.264 -174.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -81.37 -28.17 34.54 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.63 1.172 . . . . 0.0 110.088 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.25 -48.76 55.44 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -69.05 -23.1 64.01 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.035 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.01 -61.08 2.24 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 173.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -47.11 -47.1 23.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.837 1.255 . . . . 0.0 112.733 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 56.6 mt -64.83 -46.51 81.61 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.592 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.9 p -74.57 -26.94 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 118.867 0.758 . . . . 0.0 109.953 -169.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -76.29 -10.09 59.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.64 0.776 . . . . 0.0 111.583 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 CA--C 1.549 0.909 0 C-N-CA 123.593 0.757 . . . . 0.0 109.54 168.889 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 121.382 0.611 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 m -89.11 130.92 35.47 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.824 0.85 . . . . 0.0 111.161 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 19.8 mt-10 -119.16 109.13 15.52 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 173.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -82.48 136.13 34.97 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.047 0.539 . . . . 0.0 110.259 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.13 179.44 9.23 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 123.843 0.714 . . . . 0.0 110.144 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 178' ' ' VAL . 0.2 OUTLIER -143.61 148.46 35.89 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.701 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.55 166.28 23.91 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.516 ' HD3' ' H ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -110.33 148.53 31.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.624 ' HG2' ' HB1' ' A' ' 115' ' ' ALA . 6.5 tpt180 -148.33 150.3 33.35 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.206 0.527 . . . . 0.0 112.134 -164.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.3 m -111.13 137.9 48.22 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 161.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 pt -140.03 159.77 63.01 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -51.1 -26.59 19.62 Favored 'Trans proline' 0 C--N 1.386 2.549 0 C-N-CA 123.065 2.51 . . . . 0.0 114.294 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.71 -44.81 63.52 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.029 0.532 . . . . 0.0 111.307 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.43 -151.21 21.71 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.071 0.232 . . . . 0.0 112.609 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -73.75 123.14 23.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.409 0.684 . . . . 0.0 109.644 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.03 166.95 19.07 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.542 0.737 . . . . 0.0 111.205 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -125.15 171.78 10.03 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 162.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.9 m -134.45 135.67 42.67 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.289 0.636 . . . . 0.0 109.797 -170.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.537 HG12 ' HB3' ' A' ' 114' ' ' HIS . 35.4 pt -85.91 133.69 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 168.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.661 HG13 ' HG2' ' A' ' 113' ' ' GLU . 2.0 mp -110.57 111.8 37.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 174.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.407 HD12 ' HB3' ' A' ' 129' ' ' TRP . 39.5 mt -107.29 106.65 21.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 168.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.521 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 28.4 mtt180 -89.74 161.19 16.18 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.547 174.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 110' ' ' LEU . 24.2 tp60 -162.11 117.88 1.98 Allowed 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.337 -174.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.402 ' HE ' HD13 ' A' ' 109' ' ' LEU . 26.3 mmt85 -95.4 105.68 17.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 165.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.553 ' HB2' ' HB ' ' A' ' 108' ' ' THR . 50.3 m-85 -87.58 150.7 23.53 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 123.857 0.863 . . . . 0.0 109.398 169.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -114.66 85.74 2.3 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 162.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 179.71 137.45 0.28 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.932 2.093 . . . . 0.0 105.617 -163.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.46 137.07 78.37 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.76 2.307 . . . . 0.0 113.286 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 108' ' ' THR . 54.3 t -48.99 -40.47 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 124.329 1.018 . . . . 0.0 110.528 167.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -48.88 -45.48 41.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.474 1.109 . . . . 0.0 111.308 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.11 -25.64 34.27 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 140' ' ' ILE . 50.6 t -72.29 -44.18 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.074 0.464 . . . . 0.0 110.359 174.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -68.51 -28.02 66.64 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.593 1.157 . . . . 0.0 109.726 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 t -65.79 -48.27 72.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.932 0.893 . . . . 0.0 109.928 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.23 -28.41 63.14 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.338 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.3 t -76.95 -24.39 52.35 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.6 p -111.18 -43.01 3.8 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -172.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.435 ' O ' HG13 ' A' ' 47' ' ' ILE . 15.0 t70 -76.66 120.07 80.11 Favored Pre-proline 0 N--CA 1.483 1.22 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.917 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.1 -46.54 30.42 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.903 3.069 . . . . 0.0 114.391 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.436 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 41.3 t-20 -58.65 -32.64 69.26 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.768 0.827 . . . . 0.0 111.314 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -89.82 -20.06 23.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.219 0.608 . . . . 0.0 111.217 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 43' ' ' ASP . 85.7 mt -75.99 -42.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.059 0.544 . . . . 0.0 110.331 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' A' ' 45' ' ' ASN . 10.6 p30 -69.78 -0.89 7.86 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -172.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -91.82 -11.06 37.63 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.365 0.666 . . . . 0.0 110.246 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.447 ' CE2' HD13 ' A' ' 136' ' ' LEU . 57.9 p-90 -137.17 -25.21 1.07 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.3 1.04 . . . . 0.0 111.338 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.439 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 5.1 t80 -130.66 -160.66 1.06 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.329 1.052 . . . . 0.0 108.523 -177.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.62 143.64 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 122.833 0.453 . . . . 0.0 110.661 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -63.6 115.06 15.59 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 124.753 1.283 . . . . 0.0 109.767 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HG3' HD12 ' A' ' 47' ' ' ILE . 83.9 Cg_endo -83.07 148.06 13.25 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.446 2.097 . . . . 0.0 112.877 178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -134.96 125.87 27.49 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.61 -175.45 39.82 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 121.507 -0.377 . . . . 0.0 112.902 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.8 -44.06 86.82 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.177 0.574 . . . . 0.0 110.307 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.6 mt 66.95 5.15 3.88 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.133 1.373 . . . . 0.0 113.126 171.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -103.71 168.1 9.36 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.297 0.639 . . . . 0.0 109.917 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 77' ' ' CYS . 31.2 mt-10 -58.56 122.76 14.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.746 0.819 . . . . 0.0 110.794 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.35 13.94 77.57 Favored Glycine 0 N--CA 1.469 0.862 0 CA-C-N 116.467 -0.333 . . . . 0.0 113.112 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.95 -168.17 19.03 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.299 -0.32 . . . . 0.0 112.299 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -117.31 167.24 11.41 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.564 0.746 . . . . 0.0 110.095 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -146.95 149.4 33.11 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.15 116.3 9.44 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.203 0.601 . . . . 0.0 111.032 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.403 ' HB2' ' H ' ' A' ' 70' ' ' ALA . 60.3 mt -91.7 133.58 35.46 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.672 1.189 . . . . 0.0 109.3 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -68.23 106.08 2.32 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.565 1.146 . . . . 0.0 110.0 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.81 40.55 84.94 Favored Glycine 0 C--N 1.348 1.206 0 N-CA-C 114.385 0.514 . . . . 0.0 114.385 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -144.54 -86.77 0.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.579 0.352 . . . . 0.0 110.128 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 66' ' ' LEU . . . -147.69 156.31 42.64 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 120.773 0.321 . . . . 0.0 111.631 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.1 m -131.0 143.21 50.55 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.222 1.009 . . . . 0.0 108.538 174.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.93 -153.81 8.09 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.425 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 2.4 m-20 -121.36 171.07 9.02 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.771 0.828 . . . . 0.0 109.828 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.47 ' HA ' HG22 ' A' ' 85' ' ' ILE . 3.5 mp -108.24 112.65 41.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 170.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.599 HD12 HG22 ' A' ' 84' ' ' THR . 74.9 mt -69.95 -49.97 46.53 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.458 ' HD2' ' HB ' ' A' ' 84' ' ' THR . 0.1 OUTLIER -168.65 154.88 6.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.059 0.944 . . . . 0.0 109.376 169.504 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.469 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 24.9 p -146.31 120.36 9.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -121.23 110.14 34.61 Favored Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 16.8 Cg_exo -68.38 129.52 19.28 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.851 2.367 . . . . 0.0 112.693 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 19.9 Cg_endo -103.42 23.96 13.15 Favored 'Cis proline' 0 C--N 1.376 2.014 0 CA-C-N 120.048 1.053 . . . . 0.0 112.626 -13.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -64.18 -67.14 0.46 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.0 0.92 . . . . 0.0 112.006 -171.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -138.03 158.42 44.36 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.588 0.755 . . . . 0.0 110.651 -171.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 tt -142.32 127.5 18.61 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 171.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.599 HG22 HD12 ' A' ' 75' ' ' LEU . 19.3 m -139.46 130.3 26.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.227 0.611 . . . . 0.0 109.378 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 74' ' ' ILE . 10.4 pt -141.24 146.6 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.026 1.33 . . . . 0.0 109.91 -171.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.425 ' OG ' ' HB2' ' A' ' 73' ' ' ASP . 18.0 p -89.95 145.57 25.02 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.673 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 22.0 t-105 -140.98 107.33 5.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.101 0.864 . . . . 0.0 109.397 -159.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.15 103.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.4 ' HB3' ' HE3' ' A' ' 121' ' ' MET . 67.2 t80 -101.51 94.96 6.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.566 1.146 . . . . 0.0 110.432 -169.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 47.8 -73.1 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 126.618 1.967 . . . . 0.0 115.278 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.6 33.58 2.54 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 117.957 0.344 . . . . 0.0 112.553 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.613 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 72.3 mmtt -115.65 159.31 39.24 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 124.174 0.989 . . . . 0.0 110.656 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.12 161.02 41.93 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.419 2.079 . . . . 0.0 112.759 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.58 107.08 1.97 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.901 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.673 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 13.4 m -87.71 155.58 19.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.188 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -116.51 103.08 10.07 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.63 142.7 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.938 0.895 . . . . 0.0 108.622 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -147.83 156.87 43.18 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.253 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.5 tt -139.81 139.85 36.48 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 21.2 tpt180 -135.25 122.86 22.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.777 0.831 . . . . 0.0 109.521 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.4 mt -115.32 137.86 51.58 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.688 0.795 . . . . 0.0 110.16 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 t -143.98 137.1 27.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.172 0.589 . . . . 0.0 109.898 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -84.97 96.14 9.29 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.528 1.131 . . . . 0.0 110.425 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -100.7 78.23 1.96 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.01 -117.42 4.69 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -91.37 9.73 30.41 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 168.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 30' ' ' TYR . . . -100.82 159.32 19.03 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.485 -173.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.617 HG23 HG22 ' A' ' 34' ' ' VAL . 53.1 m -135.15 108.13 7.62 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.757 1.223 . . . . 0.0 108.63 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.402 HD13 ' HE ' ' A' ' 29' ' ' ARG . 39.8 tp -81.04 106.04 12.73 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 170.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 28' ' ' GLN . 8.1 tt -91.0 130.89 36.88 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 42.4 mt-10 -131.67 107.09 8.57 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 tp -104.23 128.68 51.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.998 0.919 . . . . 0.0 109.636 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.661 ' HG2' HG13 ' A' ' 25' ' ' ILE . 45.5 mt-10 -127.12 103.67 7.56 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.775 0.83 . . . . 0.0 109.43 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.537 ' HB3' HG12 ' A' ' 24' ' ' ILE . 6.8 t60 -92.97 111.7 23.42 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.624 ' HB1' ' HG2' ' A' ' 14' ' ' ARG . . . -109.91 101.79 10.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.141 0.576 . . . . 0.0 110.54 -174.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.402 HG23 ' HG ' ' A' ' 122' ' ' LEU . 9.8 t -123.78 152.22 42.44 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.268 0.556 . . . . 0.0 110.77 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.3 m -66.42 -29.32 69.44 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.367 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 t -92.36 125.43 37.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.096 0.558 . . . . 0.0 111.384 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -62.48 -34.04 76.06 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.56 1.144 . . . . 0.0 110.126 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -44.93 81.78 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.212 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.613 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 23.2 ttt -68.48 -32.94 73.29 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.159 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.402 ' HG ' HG23 ' A' ' 116' ' ' THR . 25.5 mt -63.01 -42.52 99.86 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 118.42 0.554 . . . . 0.0 112.104 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.6 t -67.82 -42.13 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-O 121.155 0.502 . . . . 0.0 109.868 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -58.15 -50.17 74.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.18 1.392 . . . . 0.0 111.638 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 121' ' ' MET . 26.4 m -82.6 -18.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.565 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.86 -36.44 92.02 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 169.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.46 -46.81 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 114.669 -0.766 . . . . 0.0 109.94 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.11 -35.81 92.45 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 114.845 0.698 . . . . 0.0 114.845 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.407 ' HB3' HD12 ' A' ' 26' ' ' ILE . 66.8 m95 -87.67 -28.26 21.93 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.987 0.515 . . . . 0.0 110.853 -176.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.464 ' HG3' ' HE1' ' A' ' 174' ' ' TRP . 43.9 mm-40 -62.45 -38.81 91.22 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 72.4 mtm -70.4 -33.96 71.99 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.926 0.766 . . . . 0.0 110.692 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.67 -46.15 83.67 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.028 0.531 . . . . 0.0 111.054 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.91 -22.2 46.2 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.381 0.673 . . . . 0.0 110.741 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.474 ' O ' ' HG2' ' A' ' 138' ' ' MET . 24.8 t70 -65.49 -62.34 1.58 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 171.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -64.75 -29.64 70.63 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.1 0.56 . . . . 0.0 111.846 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.447 HD13 ' CE2' ' A' ' 50' ' ' TRP . 39.5 tp -67.83 -42.64 81.14 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -61.43 -39.05 96.76 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.9 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 97.3 mmm -69.4 -43.18 73.98 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.766 0.826 . . . . 0.0 110.524 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -68.21 -50.76 52.07 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.342 1.057 . . . . 0.0 111.064 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.459 HD13 HG22 ' A' ' 37' ' ' VAL . 67.0 mt -62.6 -43.52 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.309 0.644 . . . . 0.0 110.756 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 C-N-CA 123.417 0.687 . . . . 0.0 109.264 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 119.79 -0.148 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 42.1 t -70.24 -54.79 11.26 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -61.14 -59.77 4.82 Favored 'General case' 0 C--N 1.364 1.207 0 O-C-N 123.676 0.61 . . . . 0.0 111.368 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -44.35 -47.84 9.68 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.407 ' HD2' ' HG3' ' A' ' 130' ' ' GLU . 13.7 tpp85 -66.17 -41.3 90.51 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.886 0.474 . . . . 0.0 110.675 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -76.74 -26.66 62.34 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.057 -174.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -75.79 -22.36 56.46 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.994 0.518 . . . . 0.0 110.787 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.54 -47.84 58.39 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.208 0.603 . . . . 0.0 109.413 170.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.464 ' HE1' ' HG3' ' A' ' 130' ' ' GLU . 98.9 m95 -69.31 -26.02 64.52 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.792 0.683 . . . . 0.0 112.005 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.83 -58.13 6.34 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -47.38 -42.66 22.29 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.257 1.023 . . . . 0.0 112.923 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.7 -48.22 75.47 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.698 0.623 . . . . 0.0 111.69 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.545 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 12.0 p -79.22 -29.59 13.8 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 C-N-CA 123.595 0.758 . . . . 0.0 111.427 -167.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -66.98 -31.39 71.93 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.373 0.669 . . . . 0.0 109.967 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.47 0.526 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.128 176.925 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 m -96.31 130.02 43.51 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.871 0.868 . . . . 0.0 109.689 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 19.9 mp0 -120.49 110.68 16.77 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.834 0.854 . . . . 0.0 108.75 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.66 149.78 28.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.861 0.363 . . . . 0.0 110.724 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.427 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -157.65 176.59 12.41 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.391 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 177' ' ' LEU . 1.2 tm? -144.69 149.97 36.52 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.53 -162.1 10.95 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -132.0 140.21 48.87 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.279 1.032 . . . . 0.0 108.918 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -155.0 131.03 10.17 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.527 0.731 . . . . 0.0 109.985 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -79.74 141.94 35.87 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.539 HD11 HG23 ' A' ' 117' ' ' THR . 49.8 pt -129.61 160.55 64.03 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.083 0.953 . . . . 0.0 109.365 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -54.1 -28.67 51.98 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 123.233 2.622 . . . . 0.0 114.004 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.85 -34.86 60.08 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.565 0.746 . . . . 0.0 111.918 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.409 ' H ' HG13 ' A' ' 16' ' ' ILE . . . 164.98 -148.9 14.92 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-O 120.015 -0.325 . . . . 0.0 112.321 -175.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.402 ' O ' HG22 ' A' ' 117' ' ' THR . 38.3 mt-10 -87.92 135.38 33.43 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.49 162.97 30.44 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.815 0.446 . . . . 0.0 111.781 -175.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.576 HH11 HG22 ' A' ' 178' ' ' VAL . 91.0 mtt180 -102.44 159.0 15.81 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 166.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.6 p -133.7 125.94 29.7 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -172.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.48 ' HB ' ' CZ3' ' A' ' 174' ' ' TRP . 27.7 pt -85.96 135.2 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 3.5 mp -117.98 116.77 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 129' ' ' TRP . 38.1 mt -106.99 107.19 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 95.1 mtt180 -91.97 161.68 14.7 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.705 174.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 33.3 tt0 -167.29 116.6 0.83 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 125.233 1.583 . . . . 0.0 109.951 176.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -92.23 108.42 19.94 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 60.5 m-85 -92.3 144.2 25.63 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.767 1.227 . . . . 0.0 111.507 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -102.26 72.91 1.32 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 162.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 30' ' ' TYR . . . -166.32 141.26 3.7 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.752 1.621 . . . . 0.0 106.639 -163.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.33 141.92 32.73 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 121.953 1.769 . . . . 0.0 112.579 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 80' ' ' PRO . 56.5 t -50.89 -43.69 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 124.487 1.117 . . . . 0.0 111.742 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -54.11 -35.6 62.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 124.462 1.101 . . . . 0.0 111.514 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -78.57 -32.56 47.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 t -74.63 -30.05 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 123.784 0.677 . . . . 0.0 110.171 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.403 ' HE3' HD12 ' A' ' 101' ' ' LEU . 70.2 t-105 -78.21 -25.93 47.25 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.149 0.979 . . . . 0.0 110.425 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.8 m -65.67 -50.93 63.13 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -59.9 -37.68 80.1 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.421 0.688 . . . . 0.0 112.119 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.78 -45.51 93.59 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.0 p -117.58 -39.53 3.14 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -166.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 47' ' ' ILE . 12.1 t70 -69.21 118.16 59.22 Favored Pre-proline 0 N--CA 1.485 1.285 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.38 -33.55 97.55 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.412 2.741 . . . . 0.0 114.217 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -72.37 -23.28 61.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 123.606 0.567 . . . . 0.0 110.574 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.524 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 12.8 mmt85 -87.46 -30.39 20.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.995 0.918 . . . . 0.0 110.876 174.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 43' ' ' ASP . 60.1 mt -71.5 -41.19 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.187 0.595 . . . . 0.0 110.067 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -70.75 4.21 2.67 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -175.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -97.94 -11.44 23.11 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.828 0.851 . . . . 0.0 111.872 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.448 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 42.9 p-90 -139.04 -24.96 0.88 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.307 0.643 . . . . 0.0 111.614 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.448 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 12.9 t80 -132.57 -172.22 2.85 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.717 1.207 . . . . 0.0 108.839 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.13 144.84 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.043 0.937 . . . . 0.0 111.256 -171.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.71 113.53 5.45 Favored Pre-proline 0 CA--C 1.568 1.653 0 O-C-N 125.138 1.524 . . . . 0.0 111.812 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -93.15 121.41 0.43 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.069 2.513 . . . . 0.0 113.307 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 9.7 mmpt? -112.45 125.33 54.11 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 171.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.33 -171.4 36.55 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.37 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.47 ' HB3' ' H ' ' A' ' 63' ' ' ASN . 25.0 t70 -71.2 -43.86 66.58 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 123.936 0.433 . . . . 0.0 110.502 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.1 mt 73.64 -17.12 0.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.047 1.739 . . . . 0.0 113.499 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -97.49 164.71 12.33 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.167 0.587 . . . . 0.0 110.973 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.588 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 35.5 tt0 -55.97 126.2 24.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 112.968 -172.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.85 84.52 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.955 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -103.98 -147.48 17.6 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.47 ' H ' ' HB3' ' A' ' 57' ' ' ASP . 35.6 p-10 -148.39 167.65 24.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.43 0.692 . . . . 0.0 111.301 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -144.24 141.63 29.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.22 120.23 26.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.521 0.729 . . . . 0.0 110.493 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.8 mt -106.14 119.98 40.63 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.691 1.196 . . . . 0.0 108.1 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -69.99 123.83 22.52 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.137 0.975 . . . . 0.0 111.33 -171.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.11 31.46 64.07 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.859 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -149.77 -91.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.548 0.339 . . . . 0.0 110.828 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.13 152.46 18.95 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.147 0.499 . . . . 0.0 111.272 -169.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.9 p -137.77 137.29 38.1 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.36 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.6 -162.59 12.31 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 23.7 m-20 -101.22 172.28 7.1 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.34 0.656 . . . . 0.0 110.869 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 mm -106.97 116.68 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 86' ' ' SER . 85.8 mt -82.09 -51.34 8.09 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.682 0.393 . . . . 0.0 110.951 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.73 120.8 2.42 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -173.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 27.4 p -135.66 110.72 8.88 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.828 0.451 . . . . 0.0 109.941 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -116.57 111.15 41.86 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 65.5 Cg_endo -73.89 137.12 23.93 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.75 2.3 . . . . 0.0 113.096 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.52 ' HB2' HG12 ' A' ' 34' ' ' VAL . 27.2 Cg_endo -100.52 30.01 11.92 Favored 'Cis proline' 0 C--N 1.376 1.977 0 CA-C-N 119.413 0.826 . . . . 0.0 111.818 -9.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -65.22 -71.14 0.2 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.109 1.364 . . . . 0.0 111.991 -169.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 15.5 ptt180 -163.11 156.64 19.72 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.804 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.5 tp -111.12 145.5 38.47 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.232 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.454 HG22 HD12 ' A' ' 75' ' ' LEU . 26.1 m -142.01 130.54 22.58 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.83 149.29 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.355 1.062 . . . . 0.0 110.254 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.472 ' HB2' HD21 ' A' ' 75' ' ' LEU . 46.8 t -91.27 133.03 35.75 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 172.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -123.22 95.98 4.82 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -169.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -91.55 104.26 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -72.25 178.34 3.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.051 0.94 . . . . 0.0 109.791 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.37 -4.43 39.36 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.563 0.745 . . . . 0.0 112.858 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.64 57.97 0.06 OUTLIER Glycine 0 C--N 1.351 1.385 0 C-N-CA 121.783 -0.246 . . . . 0.0 112.974 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.46 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 74.5 mmtt -132.75 156.15 80.39 Favored Pre-proline 0 N--CA 1.496 1.844 0 C-N-CA 123.798 0.839 . . . . 0.0 109.645 173.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -86.87 72.06 3.46 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.614 2.209 . . . . 0.0 111.745 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 67.06 149.36 0.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.651 1.58 . . . . 0.0 113.273 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 63.7 m -136.64 127.09 26.74 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.622 ' HB3' ' HB3' ' A' ' 115' ' ' ALA . 4.6 tp10 -94.0 105.66 17.66 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.83 131.98 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -150.43 145.07 25.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.793 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.524 HD11 ' HG ' ' A' ' 110' ' ' LEU . 30.6 tp -107.86 152.52 24.3 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.668 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 31.0 tpt180 -138.28 122.31 17.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.142 0.977 . . . . 0.0 108.395 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.484 ' HB3' HG13 ' A' ' 34' ' ' VAL . 81.2 mt -121.95 126.86 49.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.671 0.788 . . . . 0.0 109.299 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 m -145.14 125.45 13.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.552 0.741 . . . . 0.0 110.655 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.64 124.93 21.84 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.714 0.806 . . . . 0.0 110.905 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -142.27 128.39 19.71 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.719 0.808 . . . . 0.0 111.08 166.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.87 -135.94 17.23 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.65 -42.95 99.89 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 117.05 0.425 . . . . 0.0 110.923 161.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -107.89 -146.33 12.43 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 115.445 0.938 . . . . 0.0 115.445 -157.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.452 HG23 HG22 ' A' ' 34' ' ' VAL . 99.0 m -130.06 149.85 51.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.664 1.986 . . . . 0.0 109.055 -168.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.3 tp -109.07 127.5 54.19 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 166.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.524 ' HG ' HD11 ' A' ' 99' ' ' LEU . 9.2 tt -100.0 130.57 46.18 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 173.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.668 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 42.2 mt-10 -135.12 107.79 7.45 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.481 HD22 HD21 ' A' ' 133' ' ' LEU . 54.6 tp -102.51 143.07 32.68 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.258 0.623 . . . . 0.0 109.412 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 32.5 tt0 -132.29 142.24 49.29 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.723 0.809 . . . . 0.0 109.64 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -141.95 116.5 9.67 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.622 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . . . -126.42 111.0 13.94 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.97 0.508 . . . . 0.0 112.012 -168.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 t -141.51 164.5 30.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.863 0.465 . . . . 0.0 110.359 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.539 HG23 HD11 ' A' ' 16' ' ' ILE . 58.1 p -74.73 -28.74 60.91 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.817 0.847 . . . . 0.0 110.695 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.6 t -79.86 110.45 15.24 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.832 0.853 . . . . 0.0 110.804 -175.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.77 -28.28 69.34 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.667 0.787 . . . . 0.0 111.04 171.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -59.02 -55.23 37.87 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.17 0.919 . . . . 0.0 109.189 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.46 ' SD ' ' HG3' ' A' ' 92' ' ' LYS . 12.4 tpt -56.63 -52.23 65.68 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.674 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.8 mt -54.5 -47.93 72.47 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.383 1.073 . . . . 0.0 113.614 -173.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.3 t -70.5 -42.98 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 122.413 0.285 . . . . 0.0 110.32 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.7 -49.9 73.27 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.726 0.811 . . . . 0.0 111.249 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 121' ' ' MET . 21.6 m -71.51 -23.12 22.44 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 C-N-CA 123.203 0.601 . . . . 0.0 110.461 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.71 79.41 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.5 t -78.27 -51.95 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.095 -0.553 . . . . 0.0 109.569 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.15 -31.75 81.74 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.753 0.658 . . . . 0.0 114.161 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.511 ' HB3' HD12 ' A' ' 26' ' ' ILE . 15.0 m95 -79.79 -41.17 27.04 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.2 -34.38 72.08 Favored 'General case' 0 C--N 1.368 1.401 0 CA-C-N 118.271 0.487 . . . . 0.0 110.785 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.8 mmt -68.88 -48.52 63.19 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.767 0.667 . . . . 0.0 109.711 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.03 -46.48 75.29 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.324 0.65 . . . . 0.0 111.519 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.481 HD21 HD22 ' A' ' 112' ' ' LEU . 4.1 mm? -80.54 -23.04 40.27 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.459 0.704 . . . . 0.0 111.329 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.65 -54.07 32.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -69.91 -18.47 63.39 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.46 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.0 tp -76.95 -44.08 32.73 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.082 0.401 . . . . 0.0 110.531 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.459 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -60.74 -34.47 86.84 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.6 mtp -81.29 -25.7 36.3 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.72 0.808 . . . . 0.0 111.809 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -66.45 -54.83 19.65 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.93 -58.01 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.727 -172.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 120.546 0.212 . . . . 0.0 111.367 -169.82 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.516 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 57.5 mt . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 61.2 p -76.72 -45.92 27.43 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.442 0.464 . . . . 0.0 111.077 -173.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -46.78 -60.38 2.44 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.033 0.833 . . . . 0.0 110.192 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -42.34 -42.38 3.14 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 20.6 mmt180 -62.59 -59.78 4.45 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.278 0.361 . . . . 0.0 110.346 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.06 -37.42 32.79 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 122.307 -0.246 . . . . 0.0 113.092 -166.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -59.77 -34.98 73.71 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 124.125 0.97 . . . . 0.0 111.181 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.6 -61.25 2.74 Favored 'General case' 0 C--N 1.36 1.038 0 O-C-N 123.932 0.77 . . . . 0.0 109.516 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.48 ' CZ3' ' HB ' ' A' ' 24' ' ' ILE . 95.4 m95 -68.54 -22.56 64.5 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -172.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.17 -63.08 1.13 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.448 ' HA ' ' NE2' ' A' ' 179' ' ' HIS . . . -54.32 -34.7 61.55 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 37.8 mt -69.07 -46.83 66.84 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 118.988 -0.53 . . . . 0.0 110.072 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.576 HG22 HH11 ' A' ' 22' ' ' ARG . 9.4 p -70.18 -31.6 47.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 CA-C-N 119.117 0.871 . . . . 0.0 109.563 -169.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' HIS . . . . . 0.448 ' NE2' ' HA ' ' A' ' 176' ' ' ALA . 11.3 p80 -92.45 16.72 11.24 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 58.9 m . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 169.575 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.831 0.348 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 m -93.83 106.38 18.35 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.778 0.831 . . . . 0.0 110.225 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 30.3 mt-10 -96.02 132.56 41.24 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -101.58 147.23 26.65 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.559 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -154.14 122.56 6.15 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 1.4 tm? -98.98 138.29 36.31 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 169.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.77 -178.45 16.31 Favored Glycine 0 C--N 1.333 0.411 0 O-C-N 123.287 0.367 . . . . 0.0 112.429 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.03 166.96 12.11 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 123.581 0.753 . . . . 0.0 109.658 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.644 ' HG2' ' HB1' ' A' ' 115' ' ' ALA . 6.1 tpt180 -163.82 157.07 18.46 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -138.27 94.2 2.84 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.453 HD11 HG23 ' A' ' 117' ' ' THR . 36.5 pt -88.6 161.88 40.79 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.13 -21.93 13.89 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.13 2.553 . . . . 0.0 114.65 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.63 5.8 37.74 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.435 0.694 . . . . 0.0 112.763 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.38 -178.2 16.44 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 123.09 0.376 . . . . 0.0 112.967 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.53 109.39 5.44 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.111 0.564 . . . . 0.0 109.85 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.85 167.35 10.98 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.543 1.137 . . . . 0.0 110.397 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HB2' HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -101.82 170.52 8.1 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 156.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 p -136.25 133.08 36.63 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 29.8 pt -83.86 145.42 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 166.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.677 HG13 ' HG2' ' A' ' 113' ' ' GLU . 4.1 mp -129.96 105.25 11.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 175.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 58.9 mt -104.57 107.2 21.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.613 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 45.2 mtp85 -98.15 134.52 41.1 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.835 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -141.01 140.38 34.3 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.595 HH11 ' HB2' ' A' ' 109' ' ' LEU . 36.0 mmt180 -98.74 103.76 15.74 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.18 125.87 35.61 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.207 1.003 . . . . 0.0 109.958 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.52 59.81 3.66 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.597 1.189 . . . . 0.0 110.672 171.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.25 150.13 33.92 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 113.316 -1.765 . . . . 0.0 106.77 174.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 37' ' ' VAL . 34.7 Cg_endo -64.65 172.24 7.16 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.086 1.857 . . . . 0.0 113.179 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' A' ' 101' ' ' LEU . 67.8 t -70.87 -41.32 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.412 -173.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -58.77 -43.5 90.4 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.184 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.57 -65.86 0.62 Allowed 'General case' 0 C--N 1.356 0.852 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.057 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 33' ' ' PRO . 38.2 t -53.54 -38.26 33.08 Favored 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 124.299 1.04 . . . . 0.0 111.184 -175.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.434 ' HE3' HD12 ' A' ' 101' ' ' LEU . 63.8 t-105 -59.18 -57.2 14.1 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.472 0.709 . . . . 0.0 111.018 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.7 m -59.47 -42.5 92.18 Favored 'General case' 0 C--O 1.21 -1.011 0 O-C-N 124.489 1.118 . . . . 0.0 110.13 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.87 -34.42 73.12 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.437 ' SG ' HD21 ' A' ' 136' ' ' LEU . 84.0 m -85.43 -11.05 55.32 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.993 0.917 . . . . 0.0 113.118 -178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.8 p -113.28 -32.79 6.17 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.329 0.513 . . . . 0.0 112.016 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -66.88 116.82 39.26 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 123.133 0.573 . . . . 0.0 110.506 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.14 -18.31 45.42 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 122.273 1.982 . . . . 0.0 110.991 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -74.81 -15.83 60.73 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.324 1.45 . . . . 0.0 111.3 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -108.55 -21.69 12.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.006 0.522 . . . . 0.0 111.932 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.8 mt -84.88 -32.61 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.253 0.621 . . . . 0.0 110.205 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 28.2 p-10 -60.39 -25.61 66.04 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.092 175.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -63.49 -23.63 67.48 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.509 1.124 . . . . 0.0 112.609 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -128.39 -62.02 1.06 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.059 0.543 . . . . 0.0 112.158 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -102.03 -163.42 1.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.025 0.93 . . . . 0.0 108.979 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.524 HG21 ' H ' ' A' ' 67' ' ' GLN . 36.7 mt -85.94 131.64 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 11.2 pt-20 -63.36 140.21 97.69 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 126.368 1.867 . . . . 0.0 112.328 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 85.8 Cg_endo -89.05 99.19 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.045 2.497 . . . . 0.0 111.668 169.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -82.2 162.42 22.4 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.364 0.602 . . . . 0.0 111.885 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.28 -161.76 15.24 Favored Glycine 0 N--CA 1.465 0.575 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.583 -174.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.89 -48.72 67.86 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.574 1.15 . . . . 0.0 111.358 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt 68.44 3.9 4.0 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 125.543 1.537 . . . . 0.0 112.164 -170.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -100.48 147.4 25.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.323 1.049 . . . . 0.0 108.716 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.767 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 32.0 tt0 -62.58 107.71 1.0 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 123.757 0.661 . . . . 0.0 111.625 -172.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.7 -27.99 6.63 Favored Glycine 0 N--CA 1.476 1.343 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.982 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.39 -167.72 42.13 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -125.67 158.9 33.61 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.384 1.592 . . . . 0.0 111.067 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 13.1 p90 -103.92 168.31 9.21 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 157.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.04 115.35 0.83 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.419 1.088 . . . . 0.0 108.873 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 78.9 mt -70.97 169.69 14.35 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.846 0.459 . . . . 0.0 110.513 170.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.524 ' H ' HG21 ' A' ' 52' ' ' ILE . 16.7 tt0 -74.07 107.14 6.09 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.26 0.624 . . . . 0.0 109.33 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 45.41 25.12 1.18 Allowed Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.511 ' ND2' HD12 ' A' ' 52' ' ' ILE . 98.4 m-20 -107.15 -80.3 0.57 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.733 0.766 . . . . 0.0 109.957 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.79 157.03 47.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.275 0.63 . . . . 0.0 110.257 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.1 t -144.78 143.47 30.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.86 149.54 19.21 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -74.07 156.33 37.57 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.449 0.642 . . . . 0.0 110.216 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.692 ' HA ' HG22 ' A' ' 85' ' ' ILE . 19.3 mm -87.42 94.29 4.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.75 -57.47 10.82 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 124.376 1.048 . . . . 0.0 110.901 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -146.45 113.78 6.28 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.496 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.767 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.4 p -111.27 125.1 53.47 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 171.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -134.53 81.6 47.92 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 62.2 Cg_endo -73.75 140.08 28.7 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.624 2.216 . . . . 0.0 111.895 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 31.1 Cg_endo -94.91 20.54 32.32 Favored 'Cis proline' 0 C--N 1.378 2.091 0 CA-C-N 119.924 1.009 . . . . 0.0 114.358 -3.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 80' ' ' PRO . 5.9 mpt_? -81.89 -84.27 0.11 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -128.1 147.81 50.55 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.741 -0.6 . . . . 0.0 112.035 -164.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.423 ' HB2' ' CH2' ' A' ' 38' ' ' TRP . 65.1 tp -138.18 102.47 4.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.543 1.137 . . . . 0.0 109.251 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.5 m -95.92 119.35 34.27 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 170.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.692 HG22 ' HA ' ' A' ' 74' ' ' ILE . 2.6 pp -128.94 160.5 39.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 124.915 1.286 . . . . 0.0 109.55 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.6 m -81.19 172.13 14.03 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.031 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 34.5 t-105 -154.69 94.26 1.65 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.1 t -105.88 102.95 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -92.3 149.39 21.47 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -90.0 -43.32 10.61 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.268 0.485 . . . . 0.0 111.612 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.14 -37.53 37.27 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.366 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -107.83 161.79 22.04 Favored Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 124.701 1.2 . . . . 0.0 109.085 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HG2' ' OG ' ' A' ' 118' ' ' SER . 52.3 Cg_exo -58.16 -176.89 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.337 2.692 . . . . 0.0 114.646 175.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.68 173.55 12.47 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.927 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.5 t -172.78 173.96 3.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.53 0.732 . . . . 0.0 110.537 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -138.19 127.62 24.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.538 1.135 . . . . 0.0 108.289 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.402 ' HB ' ' CD1' ' A' ' 85' ' ' ILE . 30.3 t -112.51 143.79 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.698 0.799 . . . . 0.0 109.384 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 33.4 mt-10 -131.65 133.38 44.85 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.81 120.33 31.41 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -120.89 132.59 55.05 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.001 0.92 . . . . 0.0 109.994 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.434 HD12 ' HE3' ' A' ' 38' ' ' TRP . 72.1 mt -130.89 132.42 45.13 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.096 0.959 . . . . 0.0 110.067 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.2 t -155.27 148.2 24.51 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.433 1.093 . . . . 0.0 108.142 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -63.79 148.81 48.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.839 0.856 . . . . 0.0 110.818 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -146.9 111.33 5.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 51.89 -103.67 0.12 Allowed Glycine 0 CA--C 1.536 1.349 0 O-C-N 123.562 0.539 . . . . 0.0 114.246 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.62 -10.21 18.59 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.99 0.916 . . . . 0.0 111.208 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.27 -150.84 8.13 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 123.657 0.646 . . . . 0.0 111.714 -172.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 82.7 m -146.83 136.14 22.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.252 1.021 . . . . 0.0 110.015 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.595 ' HB2' HH11 ' A' ' 29' ' ' ARG . 60.7 tp -90.56 137.54 32.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.84 0.856 . . . . 0.0 109.925 174.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tt -123.72 115.17 20.97 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.697 1.199 . . . . 0.0 107.82 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.613 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 33.4 mt-10 -113.78 108.09 16.62 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.577 HD13 HD21 ' A' ' 133' ' ' LEU . 10.0 tt -105.97 112.27 25.25 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.677 ' HG2' HG13 ' A' ' 25' ' ' ILE . 40.9 mt-10 -93.11 137.79 32.14 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 123.752 0.821 . . . . 0.0 110.719 170.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.457 ' CD2' HG21 ' A' ' 125' ' ' VAL . 6.9 t60 -129.84 121.67 27.18 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.644 ' HB1' ' HG2' ' A' ' 14' ' ' ARG . . . -124.53 118.64 27.05 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.386 0.674 . . . . 0.0 111.824 -167.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.402 HG23 ' HG ' ' A' ' 122' ' ' LEU . 6.5 t -151.02 155.93 40.06 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.577 0.751 . . . . 0.0 110.368 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.453 HG23 HD11 ' A' ' 16' ' ' ILE . 75.7 p -79.96 -19.39 48.03 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.433 ' OG ' ' HG2' ' A' ' 93' ' ' PRO . 50.5 m -89.96 122.37 32.92 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.909 0.484 . . . . 0.0 111.349 -174.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -57.83 -45.31 86.37 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.763 1.225 . . . . 0.0 112.545 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.14 -57.92 10.74 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 122.929 0.492 . . . . 0.0 111.068 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.5 ttt -50.38 -35.91 30.24 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 124.284 0.99 . . . . 0.0 112.54 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 22' ' ' ARG . 29.0 mt -61.94 -46.47 89.17 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.678 0.791 . . . . 0.0 112.297 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 127' ' ' VAL . 41.2 t -70.18 -46.93 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -47.93 -52.64 18.72 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.954 1.701 . . . . 0.0 113.132 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.457 HG21 ' CD2' ' A' ' 114' ' ' HIS . 27.9 m -74.94 -25.79 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 123.452 0.47 . . . . 0.0 110.484 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -56.04 -45.97 85.87 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 124.155 0.909 . . . . 0.0 110.829 170.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 123' ' ' VAL . 45.0 t -74.85 -42.32 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.564 0.746 . . . . 0.0 109.678 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.53 -63.1 5.59 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.922 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -64.93 -26.5 68.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.8 0.84 . . . . 0.0 113.005 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -54.26 -51.92 63.02 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.489 0.586 . . . . 0.0 109.858 169.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 29.2 mmt -68.71 -45.11 72.44 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 124.032 0.833 . . . . 0.0 110.716 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.6 -65.2 0.69 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.722 0.809 . . . . 0.0 111.033 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.577 HD21 HD13 ' A' ' 112' ' ' LEU . 3.8 mm? -62.03 -24.55 67.13 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.92 -43.31 65.53 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 118.676 0.671 . . . . 0.0 110.579 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.492 ' HD1' ' SD ' ' A' ' 138' ' ' MET . 20.9 m-85 -68.9 -26.5 65.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.172 0.589 . . . . 0.0 110.672 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.437 HD21 ' SG ' ' A' ' 41' ' ' CYS . 61.5 tp -66.22 -51.65 55.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.976 0.511 . . . . 0.0 109.866 169.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.406 ' O ' ' HG2' ' A' ' 141' ' ' ARG . . . -44.55 -43.29 7.76 Favored Glycine 0 N--CA 1.474 1.213 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 168.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.492 ' SD ' ' HD1' ' A' ' 135' ' ' PHE . 85.2 mtp -63.72 -45.95 87.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.882 0.473 . . . . 0.0 110.179 173.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -63.15 -34.92 78.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.775 0.83 . . . . 0.0 111.498 -176.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 25.6 mt -75.94 -48.47 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.96 0.904 . . . . 0.0 111.11 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 137' ' ' GLY . 12.9 ptp180 . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 19.4 mt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.8 t -61.27 -32.55 72.37 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.537 0.735 . . . . 0.0 111.842 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -90.4 -30.35 17.44 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -60.83 3.07 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.837 0.855 . . . . 0.0 110.259 172.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -67.51 -33.24 74.69 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.595 0.758 . . . . 0.0 110.173 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.69 -58.38 11.49 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.248 172.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.33 -31.34 71.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.676 0.79 . . . . 0.0 111.448 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.7 -62.39 1.83 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.205 0.941 . . . . 0.0 110.174 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -73.17 -20.06 60.98 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.421 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.41 -41.7 80.07 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.528 0.331 . . . . 0.0 110.504 173.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.07 -40.21 78.61 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.564 0.697 . . . . 0.0 109.687 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 74.7 mt -66.46 -47.73 72.17 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.222 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 4.6 p -70.29 -27.01 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 122.586 0.354 . . . . 0.0 111.242 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -75.95 -22.66 55.74 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.301 0.641 . . . . 0.0 110.69 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 CA--C 1.549 0.907 0 C-N-CA 122.763 0.425 . . . . 0.0 111.051 171.795 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 m -119.69 109.82 16.1 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.071 -173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.37 129.24 48.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -99.32 156.55 16.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.333 0.653 . . . . 0.0 109.37 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.25 -173.99 1.87 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.977 0.511 . . . . 0.0 111.257 -166.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.9 mt -140.67 168.66 19.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.519 1.127 . . . . 0.0 111.112 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.17 -174.93 26.57 Favored Glycine 0 C--O 1.245 0.807 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.837 170.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.15 139.49 24.65 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 123.699 0.799 . . . . 0.0 108.921 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -168.38 163.09 12.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.85 0.86 . . . . 0.0 109.858 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 23.2 m -105.67 113.82 27.61 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 172.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.8 pt -90.69 167.18 16.97 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -49.07 -23.51 6.42 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.917 2.411 . . . . 0.0 115.043 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.07 -8.01 56.15 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.06 177.85 15.1 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 117.66 0.209 . . . . 0.0 112.732 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 45.1 mt-10 -65.19 108.11 1.78 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.158 0.583 . . . . 0.0 110.343 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.23 142.4 34.24 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.368 1.067 . . . . 0.0 111.175 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -85.03 158.52 20.44 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 163.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.8 p -128.74 130.55 47.24 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 122.544 -0.097 . . . . 0.0 110.814 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 pp -86.2 136.09 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -120.38 122.01 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mt -115.2 107.53 23.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.553 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 95.4 mtt180 -92.61 139.44 30.56 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.736 0.815 . . . . 0.0 109.565 172.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 19.7 tt0 -146.51 139.5 25.5 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.818 0.699 . . . . 0.0 109.211 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.39 128.96 43.8 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.454 ' CE2' ' HA2' ' A' ' 137' ' ' GLY . 83.5 m-85 -116.19 116.86 28.58 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.865 0.866 . . . . 0.0 109.44 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -75.64 49.32 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.24 1.019 . . . . 0.0 110.743 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.51 162.34 51.9 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.445 1.498 . . . . 0.0 108.228 -171.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.487 ' O ' HG23 ' A' ' 37' ' ' VAL . 31.7 Cg_exo -62.34 157.77 43.83 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.375 2.05 . . . . 0.0 113.292 172.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 80' ' ' PRO . 99.1 t -76.65 -37.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.497 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -59.65 -42.18 92.2 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.978 0.799 . . . . 0.0 109.649 174.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -62.51 -64.18 1.0 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.373 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.625 HG22 HG21 ' A' ' 140' ' ' ILE . 58.2 t -48.25 -36.29 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.642 1.177 . . . . 0.0 111.763 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.503 ' HE3' HD12 ' A' ' 101' ' ' LEU . 72.1 t-105 -63.59 -59.48 4.57 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.291 0.636 . . . . 0.0 110.16 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.8 m -53.96 -46.36 71.6 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.774 0.671 . . . . 0.0 110.322 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.659 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -50.36 -39.35 46.22 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.366 175.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.578 ' SG ' HD21 ' A' ' 136' ' ' LEU . 58.0 m -102.65 6.35 39.59 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 47.9 p -120.57 -54.96 2.05 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 118.959 0.799 . . . . 0.0 111.723 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.76 137.92 97.3 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.508 1.123 . . . . 0.0 112.017 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -59.2 -42.29 51.72 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.698 2.932 . . . . 0.0 113.557 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -74.45 -6.42 48.18 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.958 0.903 . . . . 0.0 110.827 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.659 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 14.7 mmt180 -100.31 -42.62 6.57 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.741 1.217 . . . . 0.0 110.626 176.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.563 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 58.1 mt -77.32 -38.07 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.769 0.427 . . . . 0.0 111.47 -171.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -62.81 -20.38 64.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.489 0.493 . . . . 0.0 111.8 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -64.83 -27.18 68.7 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.563 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 39.4 p-90 -122.78 -41.91 2.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.107 0.563 . . . . 0.0 112.136 -174.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.442 ' HE2' HD13 ' A' ' 66' ' ' LEU . 2.1 t80 -106.0 -163.57 0.94 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.358 0.663 . . . . 0.0 110.097 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.414 ' H ' HD12 ' A' ' 52' ' ' ILE . 4.3 mp -83.48 153.8 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -53.87 119.39 18.79 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.572 1.549 . . . . 0.0 112.164 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.0 101.76 1.47 Allowed 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.348 2.032 . . . . 0.0 110.017 169.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -93.3 164.96 13.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.315 0.646 . . . . 0.0 110.887 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.4 -166.81 12.39 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.565 -174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.61 ' HB2' ' HA3' ' A' ' 62' ' ' GLY . 4.5 m-20 -68.2 -37.64 81.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.286 0.634 . . . . 0.0 110.525 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 49.3 mt 64.83 15.04 9.62 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.896 1.278 . . . . 0.0 112.74 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -125.47 167.52 14.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.827 0.851 . . . . 0.0 110.543 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -50.34 107.2 0.15 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.82 1.248 . . . . 0.0 111.427 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.83 -11.05 56.07 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 112.248 -0.341 . . . . 0.0 112.248 174.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.61 ' HA3' ' HB2' ' A' ' 57' ' ' ASP . . . -88.58 -156.33 30.98 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 169.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -144.33 158.23 43.85 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 118.41 1.105 . . . . 0.0 110.745 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -102.81 169.3 8.69 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 165.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.31 144.94 9.66 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.67 1.188 . . . . 0.0 107.951 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.442 HD13 ' HE2' ' A' ' 51' ' ' PHE . 41.3 mt -131.2 157.09 44.14 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.583 1.153 . . . . 0.0 108.279 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -97.96 127.25 43.79 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -173.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.59 10.81 45.79 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.797 -175.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -124.63 -92.92 0.51 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.839 0.456 . . . . 0.0 110.036 -172.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.39 174.94 12.76 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.19 0.45 . . . . 0.0 111.739 -170.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.5 p -149.78 136.58 19.41 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -154.99 161.66 30.46 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -86.87 155.14 20.37 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.528 0.731 . . . . 0.0 111.049 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.486 ' HA ' HG22 ' A' ' 85' ' ' ILE . 11.6 mm -89.28 91.66 3.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 172.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.427 HD12 HG22 ' A' ' 84' ' ' THR . 42.4 mt -70.39 -49.66 46.73 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.134 0.896 . . . . 0.0 109.691 -171.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -158.84 155.29 27.55 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.834 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 7.8 p -155.79 122.08 5.14 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.399 1.079 . . . . 0.0 108.251 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -121.85 88.86 47.71 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 13.1 Cg_exo -72.62 137.38 27.47 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.74 2.293 . . . . 0.0 113.101 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.486 ' HB2' HG12 ' A' ' 34' ' ' VAL . 83.7 Cg_endo -99.64 31.14 11.3 Favored 'Cis proline' 0 C--N 1.374 1.909 0 CA-C-N 119.283 0.78 . . . . 0.0 112.339 -10.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -68.92 -75.14 0.11 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.631 1.172 . . . . 0.0 111.278 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -158.74 160.23 36.12 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.881 0.472 . . . . 0.0 111.337 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.83 146.27 50.48 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.308 1.043 . . . . 0.0 108.28 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.427 HG22 HD12 ' A' ' 75' ' ' LEU . 32.6 m -123.44 111.94 16.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 166.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.486 HG22 ' HA ' ' A' ' 74' ' ' ILE . 22.7 pt -113.64 144.53 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.683 1.193 . . . . 0.0 108.256 173.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.4 t -83.31 172.73 12.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.804 0.335 . . . . 0.0 111.25 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.71 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 25.0 t-105 -153.42 110.25 3.42 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.607 -171.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.7 t -116.39 103.45 15.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 168.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.48 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 18.2 t80 -77.83 90.9 4.09 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 63.14 -82.55 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.751 0.82 . . . . 0.0 110.155 -174.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.85 30.22 1.24 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 48.2 mmtm -95.01 162.62 24.37 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.401 1.081 . . . . 0.0 110.21 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -35.32 129.0 0.28 Allowed 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 125.039 3.826 . . . . 0.0 115.576 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.4 148.13 42.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.98 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.71 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.7 m -145.08 143.86 30.65 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.441 -174.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.51 111.75 24.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.979 0.912 . . . . 0.0 109.185 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 50.8 t -93.95 119.3 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -117.92 131.18 56.55 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.9 tp -125.63 125.4 43.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -130.24 124.18 31.87 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.97 0.508 . . . . 0.0 110.173 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.503 HD12 ' HE3' ' A' ' 38' ' ' TRP . 62.8 mt -120.95 133.03 55.27 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.656 1.182 . . . . 0.0 109.335 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.9 m -144.59 145.64 31.9 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.102 0.961 . . . . 0.0 109.09 177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.24 141.54 58.18 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.177 0.991 . . . . 0.0 111.17 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -136.74 101.49 4.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.63 -98.55 0.05 OUTLIER Glycine 0 CA--C 1.541 1.658 0 CA-C-N 118.846 0.748 . . . . 0.0 111.868 -166.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -125.86 15.22 8.02 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.132 0.968 . . . . 0.0 110.534 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -113.9 -155.66 11.58 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.167 0.889 . . . . 0.0 111.603 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.5 m -147.7 136.39 21.85 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.709 1.204 . . . . 0.0 109.393 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.3 tp -91.55 127.04 36.84 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 164.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' A' ' 101' ' ' LEU . 9.7 tt -108.05 123.26 48.41 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.553 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 31.5 mt-10 -119.68 106.18 11.9 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 169.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.5 tt -103.99 102.56 12.33 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -95.74 142.62 27.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.541 1.137 . . . . 0.0 109.659 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.482 ' CD2' HG21 ' A' ' 125' ' ' VAL . 5.8 t60 -132.74 116.15 16.22 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 171.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.57 117.94 35.41 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.905 0.882 . . . . 0.0 111.383 -174.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.609 HG21 ' HG3' ' A' ' 121' ' ' MET . 8.0 t -146.19 161.31 40.51 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.449 0.7 . . . . 0.0 110.594 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 74.2 p -88.65 -19.97 25.52 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.653 -167.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 m -101.96 133.23 47.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.299 0.64 . . . . 0.0 111.469 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -59.12 -47.78 84.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.552 1.141 . . . . 0.0 113.166 -174.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -64.06 -52.42 59.44 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.816 0.28 . . . . 0.0 110.884 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.609 ' HG3' HG21 ' A' ' 116' ' ' THR . 15.2 tpt -46.16 -37.02 6.47 Favored 'General case' 0 CA--C 1.563 1.472 0 O-C-N 124.152 0.908 . . . . 0.0 111.702 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.448 ' HG ' HG23 ' A' ' 116' ' ' THR . 22.5 mt -67.24 -50.45 60.55 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.79 0.836 . . . . 0.0 112.012 176.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 127' ' ' VAL . 61.7 t -61.49 -56.2 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -47.61 -50.94 22.92 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.73 1.612 . . . . 0.0 113.273 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.482 HG21 ' CD2' ' A' ' 114' ' ' HIS . 33.2 m -72.02 -31.68 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 119.799 -0.144 . . . . 0.0 111.155 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.57 -34.48 90.01 Favored Glycine 0 C--N 1.35 1.313 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 123' ' ' VAL . 97.6 t -71.8 -51.8 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.05 -59.72 8.46 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.694 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.418 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 22.5 m95 -54.31 -32.91 57.69 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 173.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -66.3 -35.3 80.04 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 120.41 1.459 . . . . 0.0 111.957 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -60.78 -52.73 63.87 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 167.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 129' ' ' TRP . . . -58.5 -27.83 64.82 Favored 'General case' 0 C--O 1.208 -1.105 0 C-N-CA 124.127 0.971 . . . . 0.0 112.045 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.31 -27.71 22.71 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.32 0.648 . . . . 0.0 109.914 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.01 -48.67 34.32 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -62.64 -42.56 99.67 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.637 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.578 HD21 ' SG ' ' A' ' 41' ' ' CYS . 51.0 tp -66.14 -27.61 68.17 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.82 0.848 . . . . 0.0 111.303 176.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.454 ' HA2' ' CE2' ' A' ' 30' ' ' TYR . . . -73.89 -46.57 22.69 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 86.4 mtp -60.84 -41.2 95.33 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.589 -1.305 . . . . 0.0 110.807 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -62.59 -54.57 37.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.607 0.763 . . . . 0.0 111.416 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.625 HG21 HG22 ' A' ' 37' ' ' VAL . 64.1 mt -71.0 -26.95 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.247 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 . . . . . 0 N--CA 1.476 0.864 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.882 175.882 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.535 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 32.5 mm . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 39.6 t -72.66 -19.72 61.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.376 0.67 . . . . 0.0 112.631 -175.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.48 -31.71 17.54 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.116 0.416 . . . . 0.0 110.342 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -50.59 -56.4 11.94 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.39 0.614 . . . . 0.0 110.399 166.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 2.0 mmt180 -73.62 -39.74 64.33 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.113 -175.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -55.35 -55.15 29.89 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.735 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.29 -42.14 90.58 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.878 0.871 . . . . 0.0 111.038 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.53 -54.26 45.49 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.225 0.953 . . . . 0.0 111.799 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -70.22 -25.89 63.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.437 0.695 . . . . 0.0 111.847 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.08 83.82 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.995 0.426 . . . . 0.0 109.86 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -68.69 -35.96 77.88 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.8 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 55.5 mt -72.58 -53.82 10.85 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.232 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -66.28 -32.32 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 122.999 0.519 . . . . 0.0 112.003 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -76.66 -7.09 54.62 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.077 0.551 . . . . 0.0 111.501 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 CA--C 1.553 1.085 0 C-N-CA 124.696 1.198 . . . . 0.0 109.262 169.847 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.589 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.6 m -97.4 136.75 37.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.203 1.001 . . . . 0.0 110.306 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 20.1 mp0 -123.95 107.81 11.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 172.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.609 HH22 ' HA ' ' A' ' 170' ' ' ARG . 98.2 mtt180 -74.47 161.75 29.49 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.544 0.211 . . . . 0.0 110.602 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.54 177.99 5.64 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.621 0.768 . . . . 0.0 110.323 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.2 mt -133.22 158.91 41.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.414 1.086 . . . . 0.0 109.413 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.16 138.15 5.24 Favored Glycine 0 C--O 1.223 -0.59 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 173.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -91.7 137.76 32.11 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.5 tpt85 -138.99 128.46 24.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.741 0.816 . . . . 0.0 109.507 -168.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -85.67 136.6 33.3 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.524 HD11 HG23 ' A' ' 117' ' ' THR . 47.5 pt -129.62 159.14 71.05 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -177.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -48.07 -37.01 29.57 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.125 2.55 . . . . 0.0 114.285 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.64 77.13 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.468 0.707 . . . . 0.0 112.443 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.18 -150.82 20.49 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.16 137.88 33.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.82 164.58 27.25 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.777 0.831 . . . . 0.0 109.122 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -120.58 157.56 29.24 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 3.6 m -128.87 145.63 51.16 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 122.682 0.393 . . . . 0.0 110.792 -174.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 2.8 pp -98.05 135.57 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.417 HG13 ' HB3' ' A' ' 113' ' ' GLU . 2.2 mp -121.42 126.24 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 129' ' ' TRP . 57.0 mt -110.48 108.91 26.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.582 ' HB3' HD11 ' A' ' 109' ' ' LEU . 58.9 mtp180 -91.05 153.11 20.35 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -168.88 129.79 1.18 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 125.164 1.54 . . . . 0.0 111.219 174.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.493 ' HD2' HD13 ' A' ' 109' ' ' LEU . 9.7 mpt_? -87.26 105.41 17.21 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 172.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -79.21 150.64 31.57 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.995 0.518 . . . . 0.0 110.118 170.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -87.78 27.03 1.2 Allowed 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.989 0.9 . . . . 0.0 110.325 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.77 148.67 70.87 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.32 1.048 . . . . 0.0 109.782 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.56 165.04 33.18 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.241 2.627 . . . . 0.0 113.147 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.538 HG23 ' HG3' ' A' ' 103' ' ' GLU . 68.6 t -51.26 -44.63 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 114.053 -1.431 . . . . 0.0 112.616 -177.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -56.18 -39.36 72.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.291 0.995 . . . . 0.0 110.071 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -75.49 -36.57 60.59 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.685 0.794 . . . . 0.0 111.167 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.3 -30.48 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.385 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -74.76 -20.7 59.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.192 0.997 . . . . 0.0 109.998 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.5 m -72.17 -47.41 51.02 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.25 77.12 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.298 0.639 . . . . 0.0 111.91 172.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.0 t -63.31 -52.3 62.52 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 59.4 p -94.91 -41.16 9.32 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -167.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.448 ' O ' HG13 ' A' ' 47' ' ' ILE . 26.4 t70 -81.68 115.23 55.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 122.972 0.509 . . . . 0.0 110.889 -169.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.11 -20.39 71.07 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.47 2.78 . . . . 0.0 114.094 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -74.16 -31.2 62.61 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -84.11 -30.02 26.29 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.821 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 43' ' ' ASP . 91.2 mt -71.43 -43.37 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.263 0.625 . . . . 0.0 110.371 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -65.52 -3.29 4.25 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -86.64 -43.06 12.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.891 0.876 . . . . 0.0 110.364 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.447 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 49.7 p-90 -114.65 -25.08 8.45 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.137 0.975 . . . . 0.0 111.414 -173.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.447 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 11.1 t80 -129.55 -171.89 2.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.505 1.122 . . . . 0.0 109.104 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.6 mt -89.5 139.99 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.614 0.766 . . . . 0.0 111.41 -173.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -64.46 110.5 4.07 Favored Pre-proline 0 CA--C 1.566 1.576 0 O-C-N 125.348 1.655 . . . . 0.0 110.993 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -90.89 148.99 3.93 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.354 2.702 . . . . 0.0 113.592 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -130.54 130.47 44.15 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.87 -166.91 32.59 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 121.63 -0.319 . . . . 0.0 112.477 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -69.5 -46.94 65.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.415 0.686 . . . . 0.0 110.948 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.4 mt 62.25 22.85 13.46 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.872 1.269 . . . . 0.0 110.695 -172.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -124.97 146.93 49.16 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.594 1.158 . . . . 0.0 109.749 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.53 117.86 4.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.183 0.993 . . . . 0.0 111.981 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.57 12.14 57.35 Favored Glycine 0 N--CA 1.47 0.907 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.96 -174.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -119.58 -158.21 10.55 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 10.9 p30 -138.34 174.39 10.6 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 117.723 0.761 . . . . 0.0 112.036 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -145.02 153.55 41.6 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.864 1.266 . . . . 0.0 107.894 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.97 109.94 5.1 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.651 0.78 . . . . 0.0 110.878 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.7 mt -77.72 138.11 38.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.697 0.799 . . . . 0.0 109.177 173.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -77.82 110.23 12.52 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.2 56.73 5.06 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.607 0.567 . . . . 0.0 113.356 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -168.77 -84.05 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.965 0.506 . . . . 0.0 111.339 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -152.78 155.68 37.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.275 0.56 . . . . 0.0 111.559 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 m -132.45 143.09 49.55 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.378 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -156.56 -170.51 21.75 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 5.5 m-20 -118.24 168.7 10.35 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.252 0.621 . . . . 0.0 110.749 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.497 ' HA ' HG22 ' A' ' 85' ' ' ILE . 9.8 mm -103.58 107.05 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.1 mt -75.51 -58.11 3.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.71 0.404 . . . . 0.0 110.994 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.07 151.2 13.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.692 0.797 . . . . 0.0 109.41 175.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.5 p -148.3 133.08 17.95 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -107.82 89.84 5.75 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.53 132.39 33.06 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.639 2.226 . . . . 0.0 112.53 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -102.74 22.85 14.97 Favored 'Cis proline' 0 C--N 1.375 1.924 0 CA-C-N 120.031 1.047 . . . . 0.0 113.597 -8.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -67.45 -52.72 36.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.812 1.245 . . . . 0.0 112.366 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.441 ' NH2' ' HD3' ' A' ' 100' ' ' ARG . 26.4 ttm-85 -148.93 154.62 39.68 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.32 0.581 . . . . 0.0 111.134 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.5 tt -135.07 140.97 45.97 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.14 1.376 . . . . 0.0 107.338 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.473 HG23 ' HG2' ' A' ' 98' ' ' GLU . 40.6 m -137.9 134.87 35.54 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.302 0.641 . . . . 0.0 109.287 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.497 HG22 ' HA ' ' A' ' 74' ' ' ILE . 12.6 pt -147.78 147.14 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.055 1.342 . . . . 0.0 109.895 -172.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.5 m -86.86 153.7 21.43 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 163.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 23.1 t-105 -143.13 109.62 5.41 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -167.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.738 HG13 ' HB3' ' A' ' 93' ' ' PRO . 61.1 t -108.79 103.07 14.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -83.85 141.56 31.24 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -58.25 -30.04 66.23 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.94 -53.8 5.14 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.397 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -138.7 119.57 9.96 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.61 0.764 . . . . 0.0 110.349 -174.167 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.738 ' HB3' HG13 ' A' ' 88' ' ' VAL . 3.1 Cg_exo -83.18 -166.86 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.701 2.934 . . . . 0.0 113.016 -176.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.5 t70 52.67 85.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.593 1.557 . . . . 0.0 113.373 174.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 71.0 m -147.09 122.32 10.22 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 171.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -101.33 105.68 16.77 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.2 t -97.69 147.85 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.202 1.001 . . . . 0.0 109.824 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.473 ' HG2' HG23 ' A' ' 84' ' ' THR . 33.9 mt-10 -137.7 155.96 48.54 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.68 0.792 . . . . 0.0 109.603 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.0 tp -126.75 139.24 53.28 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.441 ' HD3' ' NH2' ' A' ' 82' ' ' ARG . 1.5 ttp180 -140.08 106.96 5.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.47 0.708 . . . . 0.0 109.736 -172.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 110' ' ' LEU . 96.2 mt -111.53 131.18 55.42 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.371 1.069 . . . . 0.0 110.78 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.1 t -143.46 128.38 18.43 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.014 0.925 . . . . 0.0 108.796 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.538 ' HG3' HG23 ' A' ' 34' ' ' VAL . 43.9 mt-10 -66.62 124.37 22.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -136.46 117.98 14.83 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.97 -144.77 38.6 Favored Glycine 0 C--N 1.345 1.057 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -86.91 55.38 3.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.566 0.698 . . . . 0.0 109.227 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.64 -154.4 13.25 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 114.939 -1.028 . . . . 0.0 113.689 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.4 m -148.75 129.69 14.34 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.809 0.843 . . . . 0.0 111.119 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 27' ' ' ARG . 43.0 tp -81.21 109.55 15.85 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 101' ' ' LEU . 10.2 tt -88.05 130.97 34.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 170.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.451 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 45.3 mt-10 -132.13 105.86 7.63 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.5 tt -103.97 124.16 48.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 98' ' ' GLU . 9.4 pt-20 -122.06 129.38 52.35 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.481 ' O ' ' HA ' ' A' ' 23' ' ' SER . 8.1 t60 -117.0 111.1 19.1 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.94 102.37 11.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.674 0.79 . . . . 0.0 111.171 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.2 t -130.72 153.33 49.11 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.237 0.542 . . . . 0.0 109.934 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.524 HG23 HD11 ' A' ' 16' ' ' ILE . 76.1 p -71.14 -21.53 62.18 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.166 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.4 p -94.49 118.26 31.38 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.698 0.799 . . . . 0.0 111.137 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 122' ' ' LEU . 45.0 tt0 -65.81 -24.8 66.99 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.256 1.022 . . . . 0.0 111.147 174.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -61.65 -53.75 52.04 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.054 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.411 ' O ' HG22 ' A' ' 125' ' ' VAL . 10.1 tpt -62.63 -41.34 98.96 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.48 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 119' ' ' GLU . 37.0 mt -52.93 -53.03 55.37 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.098 0.959 . . . . 0.0 113.278 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.55 -44.72 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.788 0.435 . . . . 0.0 110.488 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.98 -44.14 96.84 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.541 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 121' ' ' MET . 26.0 m -75.23 -26.87 19.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.06 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.229 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.48 -29.05 60.24 Favored Glycine 0 C--N 1.351 1.361 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 170.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.26 -51.61 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 123.592 0.231 . . . . 0.0 110.396 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.03 -30.17 76.44 Favored Glycine 0 N--CA 1.476 1.353 0 CA-C-N 115.625 -0.716 . . . . 0.0 114.209 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.425 ' HB3' HD12 ' A' ' 26' ' ' ILE . 9.4 m95 -79.13 -46.96 16.95 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.44 ' HG3' ' HE1' ' A' ' 174' ' ' TRP . 27.3 mm-40 -54.9 -38.95 68.24 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.478 0.311 . . . . 0.0 110.785 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.6 tpp -64.99 -41.41 95.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.501 0.72 . . . . 0.0 110.69 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -72.77 -36.02 67.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.42 0.688 . . . . 0.0 111.729 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.56 -25.11 38.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.662 0.785 . . . . 0.0 110.289 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.22 -45.15 77.66 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.543 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.64 -30.57 52.23 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.431 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.1 tp -71.74 -29.64 64.74 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.21 -48.23 81.62 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.633 168.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 90.3 mmm -69.2 -37.11 77.93 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.074 0.95 . . . . 0.0 111.13 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -67.52 -56.77 8.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.972 0.909 . . . . 0.0 110.793 -175.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 28.9 mt -67.2 -29.91 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.23 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? . . . . . 0 N--CA 1.486 1.333 0 C-N-CA 122.64 0.376 . . . . 0.0 110.103 172.654 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.527 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 30.5 mm . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.1 m -68.77 -54.49 15.66 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 122.701 0.4 . . . . 0.0 110.396 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 11.6 pt20 -61.5 -56.0 24.92 Favored 'General case' 0 C--O 1.209 -1.072 0 CA-C-O 117.726 -1.13 . . . . 0.0 111.304 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -43.45 -46.07 6.6 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.942 0.792 . . . . 0.0 113.064 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.609 ' HA ' HH22 ' A' ' 9' ' ' ARG . 4.8 mmp_? -53.64 -52.44 59.89 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.574 0.546 . . . . 0.0 109.841 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -80.95 -17.4 72.51 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 116.284 -0.416 . . . . 0.0 113.65 -173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 24.0 mm-40 -71.7 -37.3 70.69 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.51 0.724 . . . . 0.0 109.712 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.507 ' HB3' ' NH1' ' A' ' 9' ' ' ARG . . . -76.22 -36.21 58.68 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.737 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.44 ' HE1' ' HG3' ' A' ' 130' ' ' GLU . 75.5 m95 -67.09 -29.9 69.78 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 119.249 -0.405 . . . . 0.0 111.43 173.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.42 -61.18 2.62 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 123.59 0.556 . . . . 0.0 109.659 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.39 -35.27 51.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.409 1.084 . . . . 0.0 113.565 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 35.3 mt -66.8 -59.56 3.44 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 123.297 0.373 . . . . 0.0 110.159 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.8 p -72.88 -20.37 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 123.721 0.808 . . . . 0.0 111.357 -158.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -57.38 -21.16 34.19 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.259 1.024 . . . . 0.0 112.104 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 CA--C 1.547 0.834 0 C-N-CA 123.568 0.747 . . . . 0.0 109.452 172.161 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 120.636 0.255 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 24.4 m -79.14 111.37 15.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.317 1.047 . . . . 0.0 110.956 -175.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 30.9 mt-10 -93.8 134.33 36.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.694 1.198 . . . . 0.0 108.56 172.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.405 ' HG2' ' CD1' ' A' ' 177' ' ' LEU . 43.0 ttm105 -99.78 139.44 35.43 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.855 0.462 . . . . 0.0 110.0 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.16 179.35 9.23 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.77 0.428 . . . . 0.0 111.628 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.413 HD13 ' N ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -145.15 153.12 41.04 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.957 -176.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.413 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -167.24 -151.98 7.2 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.45 163.22 35.55 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.207 0.603 . . . . 0.0 109.759 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -166.42 152.46 8.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.874 0.869 . . . . 0.0 109.483 167.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.5 m -82.95 152.66 25.38 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.043 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.8 pt -144.1 155.51 58.46 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.64 -30.29 28.16 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.941 2.428 . . . . 0.0 114.317 175.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.47 -7.84 59.64 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.82 -172.9 28.05 Favored Glycine 0 C--N 1.356 1.678 0 CA-C-N 119.258 0.935 . . . . 0.0 112.577 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -84.57 110.78 18.96 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.17 146.96 23.28 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.991 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -87.98 156.84 19.12 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 164.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 80.4 p -139.17 137.98 36.53 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.954 0.407 . . . . 0.0 111.609 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.597 HG12 HG23 ' A' ' 125' ' ' VAL . 2.9 pp -87.79 141.16 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.265 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.35 111.02 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.463 HG22 ' NE2' ' A' ' 28' ' ' GLN . 42.9 mt -100.91 108.63 23.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.555 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 97.2 mtt180 -99.54 140.59 33.5 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.463 ' NE2' HG22 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -138.78 144.15 39.25 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.294 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.477 HH11 ' HG2' ' A' ' 104' ' ' GLU . 12.2 mmt85 -103.73 101.96 11.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 173.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.46 ' CE1' ' HA2' ' A' ' 137' ' ' GLY . 70.1 m-85 -83.63 129.36 34.96 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.903 0.881 . . . . 0.0 110.624 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.72 48.25 0.67 Allowed 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 122.889 1.328 . . . . 0.0 109.785 170.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.56 152.42 41.7 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.058 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.725 ' HG2' ' HB2' ' A' ' 36' ' ' GLU . 56.4 Cg_endo -71.64 165.75 31.56 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.629 2.219 . . . . 0.0 113.454 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 80' ' ' PRO . 58.1 t -71.89 -43.7 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.954 -169.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -63.87 -34.03 77.02 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 124.055 0.847 . . . . 0.0 110.109 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.725 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -69.53 -62.79 1.24 Allowed 'General case' 0 C--N 1.355 0.813 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.776 179.266 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.7 t -51.17 -33.3 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 124.939 1.296 . . . . 0.0 111.06 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.434 ' HE3' HD12 ' A' ' 101' ' ' LEU . 65.2 t-105 -61.43 -57.42 12.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.19 0.596 . . . . 0.0 110.063 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.2 t -54.35 -40.7 68.33 Favored 'General case' 0 CA--C 1.552 1.023 0 O-C-N 123.92 0.762 . . . . 0.0 110.614 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.04 79.26 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.4 m -93.51 -4.48 51.0 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.752 0.821 . . . . 0.0 112.954 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 77.8 p -116.57 -48.37 2.69 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.439 0.563 . . . . 0.0 111.438 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.439 ' O ' HG12 ' A' ' 47' ' ' ILE . 20.6 t70 -63.12 119.94 56.93 Favored Pre-proline 0 N--CA 1.483 1.197 0 C-N-CA 123.878 0.871 . . . . 0.0 111.033 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.0 -26.76 43.22 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.008 2.472 . . . . 0.0 113.335 -171.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -61.82 -48.06 82.31 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.777 0.673 . . . . 0.0 109.646 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -72.13 -26.05 61.96 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 174.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.579 HG21 ' HD3' ' A' ' 54' ' ' PRO . 36.7 mm -71.24 -42.18 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 118.849 0.75 . . . . 0.0 111.474 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.07 -16.01 64.07 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -80.54 0.91 31.74 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.468 0.707 . . . . 0.0 112.408 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.421 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 46.2 p-90 -141.64 -47.44 0.37 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.916 0.486 . . . . 0.0 110.489 173.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -111.65 -164.28 0.91 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.069 0.948 . . . . 0.0 109.859 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -86.92 126.02 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 166.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 9.3 pt-20 -69.67 139.45 88.76 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 118.87 0.759 . . . . 0.0 111.794 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.579 ' HD3' HG21 ' A' ' 47' ' ' ILE . 15.2 Cg_exo -69.71 101.98 0.97 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.627 2.218 . . . . 0.0 110.932 173.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -74.88 136.01 41.51 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.767 0.827 . . . . 0.0 110.682 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.27 -164.74 27.21 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 116.023 -0.535 . . . . 0.0 114.308 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -68.46 -39.06 81.58 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.721 1.208 . . . . 0.0 111.104 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.3 mt 66.29 12.28 8.49 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -98.97 165.34 11.8 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.234 0.47 . . . . 0.0 110.079 173.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.759 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 38.5 tt0 -71.02 98.03 1.56 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.25 -31.03 4.36 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -170.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.11 -174.01 46.65 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 114.776 -0.712 . . . . 0.0 112.432 169.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 22.9 p-10 -134.96 155.26 51.05 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.842 0.857 . . . . 0.0 111.861 -170.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -116.91 169.6 9.27 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.163 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -163.4 144.23 9.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.701 0.8 . . . . 0.0 109.017 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.8 mt -118.5 153.29 34.41 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -93.28 -45.66 7.74 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.41 -12.27 84.0 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.33 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -127.52 -92.7 0.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 118.106 0.953 . . . . 0.0 111.31 -174.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.61 175.08 14.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.087 0.555 . . . . 0.0 110.821 -169.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 27.7 p -131.96 145.29 51.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.154 0.582 . . . . 0.0 109.616 -172.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.71 -148.87 5.37 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 112.319 -0.313 . . . . 0.0 112.319 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -151.23 163.75 38.16 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.223 0.609 . . . . 0.0 110.861 179.457 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.576 ' HA ' HG22 ' A' ' 85' ' ' ILE . 2.5 mp -94.34 102.42 13.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 86' ' ' SER . 88.4 mt -76.24 -45.53 32.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.785 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -135.45 141.69 45.44 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.511 -173.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.759 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 31.8 p -158.38 122.43 4.06 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.646 ' HG2' ' HD3' ' A' ' 81' ' ' ARG . 41.8 tt0 -144.78 90.46 6.35 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 38.0 Cg_exo -63.46 139.99 73.64 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.973 2.449 . . . . 0.0 111.858 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 27.2 Cg_endo -96.61 27.06 18.63 Favored 'Cis proline' 0 C--N 1.375 1.954 0 CA-C-N 120.097 1.07 . . . . 0.0 113.094 -8.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.646 ' HD3' ' HG2' ' A' ' 78' ' ' GLU . 4.3 mpt_? -77.9 -82.21 0.09 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.569 0.748 . . . . 0.0 111.385 -175.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.5 ptt-85 -150.96 154.11 36.48 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.795 0.438 . . . . 0.0 111.451 -171.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.8 tt -134.86 114.09 12.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -112.82 137.39 51.23 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.139 0.976 . . . . 0.0 108.907 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 74' ' ' ILE . 13.0 pt -133.29 151.56 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.81 1.244 . . . . 0.0 109.885 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.481 ' HB2' HD11 ' A' ' 75' ' ' LEU . 35.2 t -87.96 163.56 16.27 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.991 0.424 . . . . 0.0 109.978 166.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 35.6 t-105 -144.25 96.92 2.96 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -166.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.44 125.06 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.607 0.763 . . . . 0.0 109.373 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.449 ' HB3' ' HE3' ' A' ' 92' ' ' LYS . 59.6 t80 -144.72 171.71 14.03 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.13 0.972 . . . . 0.0 108.655 -176.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.76 154.64 38.27 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 122.531 0.333 . . . . 0.0 110.549 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.44 -63.72 4.1 Favored Glycine 0 N--CA 1.471 1.011 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -103.68 133.64 20.17 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 124.308 1.043 . . . . 0.0 109.708 177.224 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.12 -73.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.019 2.479 . . . . 0.0 112.433 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -125.47 165.93 17.55 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.283 0.563 . . . . 0.0 110.682 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 72.5 m -152.19 169.77 21.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.912 1.685 . . . . 0.0 107.464 175.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -133.83 123.81 25.45 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 118.509 0.595 . . . . 0.0 111.139 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 t -110.83 147.62 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.989 1.316 . . . . 0.0 107.869 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -143.09 127.86 18.21 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.066 0.46 . . . . 0.0 110.98 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.48 119.08 38.22 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.459 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 33.0 ttm180 -124.88 128.5 48.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.996 0.918 . . . . 0.0 109.145 -173.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.459 ' HB3' HG13 ' A' ' 34' ' ' VAL . 72.9 mt -135.6 128.74 31.74 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.934 0.894 . . . . 0.0 110.792 -175.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.2 m -148.82 152.67 36.91 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.653 1.181 . . . . 0.0 108.559 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.03 150.84 32.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.609 0.764 . . . . 0.0 111.291 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.477 ' HG2' HH11 ' A' ' 29' ' ' ARG . 11.0 tp10 -148.09 112.24 5.2 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.83 -101.75 0.2 Allowed Glycine 0 C--N 1.35 1.317 0 O-C-N 123.252 0.345 . . . . 0.0 112.924 -171.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -119.6 2.05 11.16 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.381 0.61 . . . . 0.0 110.345 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -112.88 -150.68 10.9 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.223 0.916 . . . . 0.0 111.718 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.0 m -148.09 127.09 12.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.481 1.112 . . . . 0.0 110.135 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.439 HD13 ' NE ' ' A' ' 29' ' ' ARG . 40.5 tp -82.44 133.34 35.21 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.4 tt -117.84 113.39 21.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.555 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 33.4 mt-10 -109.37 106.2 15.89 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.7 tp -98.83 103.26 15.19 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 38.8 tt0 -101.65 108.85 20.51 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.937 0.895 . . . . 0.0 109.666 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -106.51 122.18 45.78 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 23' ' ' SER . . . -119.42 125.18 48.34 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.561 0.744 . . . . 0.0 111.308 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.9 t -141.69 159.75 41.58 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 123.982 0.802 . . . . 0.0 109.611 173.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.4 p -90.68 -2.51 57.83 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.233 1.013 . . . . 0.0 111.886 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.6 t -97.16 119.19 35.19 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.162 0.985 . . . . 0.0 110.149 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.546 ' HA ' HD12 ' A' ' 122' ' ' LEU . 38.3 tt0 -62.32 -42.4 99.35 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.269 1.027 . . . . 0.0 112.645 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.16 -58.44 8.64 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.425 ' O ' HG22 ' A' ' 125' ' ' VAL . 25.2 ttt -51.32 -29.62 15.64 Favored 'General case' 0 C--O 1.208 -1.115 0 O-C-N 124.794 1.309 . . . . 0.0 112.762 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 119' ' ' GLU . 47.6 mt -64.26 -53.76 43.96 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.394 0.543 . . . . 0.0 111.896 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 127' ' ' VAL . 47.2 t -63.48 -49.58 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.418 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 23.5 tt0 -44.39 -56.16 4.44 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.264 1.826 . . . . 0.0 113.818 175.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.597 HG23 HG12 ' A' ' 24' ' ' ILE . 34.6 m -72.44 -26.39 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 122.265 0.226 . . . . 0.0 110.635 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.51 -39.12 97.42 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 169.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 123' ' ' VAL . 92.6 t -78.09 -60.48 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.37 -57.06 12.48 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 114.436 -1.256 . . . . 0.0 114.517 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -66.03 -40.94 91.44 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.875 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 36.9 tt0 -67.18 -32.17 73.07 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 120.319 1.418 . . . . 0.0 111.125 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.0 mtm -71.98 -35.04 69.4 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.666 0.386 . . . . 0.0 110.272 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.06 -59.82 2.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.357 0.663 . . . . 0.0 110.97 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -54.56 -30.4 54.08 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.089 1.356 . . . . 0.0 113.008 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 24.8 t70 -57.99 -46.62 84.91 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.505 0.722 . . . . 0.0 110.311 169.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -64.18 -37.38 87.25 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.656 172.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 52.5 tp -68.88 -20.66 64.26 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.148 0.579 . . . . 0.0 110.544 175.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.46 ' HA2' ' CE1' ' A' ' 30' ' ' TYR . . . -71.06 -47.27 38.82 Favored Glycine 0 C--N 1.35 1.328 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.3 ptm -80.27 -24.33 40.15 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.499 -0.851 . . . . 0.0 111.58 174.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 82.7 t80 -67.17 -42.77 83.7 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.838 0.455 . . . . 0.0 110.562 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.2 mt -76.74 -51.54 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.781 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.586 ' HA ' ' NE ' ' A' ' 141' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.356 0.878 0 CA-C-O 121.564 0.697 . . . . 0.0 111.332 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.511 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 86.9 mt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.442 0.163 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.3 p -62.12 -27.25 68.8 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.294 1.037 . . . . 0.0 113.787 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 1.4 pp0? -86.69 -33.89 19.9 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.16 -34.5 78.21 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.635 0.774 . . . . 0.0 110.413 174.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 28.7 mmt180 -57.2 -57.77 11.17 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 169.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -53.13 -37.02 53.63 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-N 114.707 -1.133 . . . . 0.0 115.138 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 38.4 mm-40 -67.37 -54.78 17.5 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.069 0.548 . . . . 0.0 110.857 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.48 76.53 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.399 -173.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.404 ' CZ2' ' HG3' ' A' ' 9' ' ' ARG . 67.9 m95 -71.69 -36.13 70.48 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.981 0.513 . . . . 0.0 111.5 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.18 83.52 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.467 0.479 . . . . 0.0 110.569 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -68.32 -40.65 81.59 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.176 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.405 ' CD1' ' HG2' ' A' ' 9' ' ' ARG . 42.2 mt -71.55 -49.79 37.37 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 123.275 0.63 . . . . 0.0 112.228 -176.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 p -61.85 -29.64 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 117.936 0.334 . . . . 0.0 110.804 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -87.74 -11.39 48.3 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 173.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 39.4 t . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 169.784 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -103.44 119.37 38.75 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.298 0.639 . . . . 0.0 111.05 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -104.81 122.58 46.04 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 165.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.491 ' HG3' HD11 ' A' ' 177' ' ' LEU . 17.0 ptp180 -91.76 155.11 18.5 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -159.18 -177.75 6.7 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.062 0.458 . . . . 0.0 111.033 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.463 HD13 ' H ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -143.88 157.02 44.63 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.03 -176.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.463 ' H ' HD13 ' A' ' 11' ' ' LEU . . . -155.02 -172.95 23.23 Favored Glycine 0 C--O 1.239 0.445 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HD3' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -134.07 136.93 44.3 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -136.37 117.45 14.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -170.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.0 m -92.26 99.4 12.19 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.9 pt -104.06 161.21 23.61 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.233 1.013 . . . . 0.0 108.996 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -50.05 -28.9 20.33 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.36 2.706 . . . . 0.0 114.267 172.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.81 0.32 35.4 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.48 177.82 15.07 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 117.841 0.291 . . . . 0.0 112.894 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.57 91.6 0.8 Allowed 'General case' 0 C--N 1.348 0.516 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.46 157.08 26.3 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.068 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.3 165.7 11.42 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.8 p -136.95 140.7 42.41 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.595 HG12 HG23 ' A' ' 125' ' ' VAL . 2.7 pp -92.4 136.52 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 170.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 mp -122.74 114.93 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.3 mt -106.26 108.48 25.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.45 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 99.6 mtt180 -97.38 134.26 40.88 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 172.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 51.8 tt0 -158.91 142.04 14.64 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.023 0.827 . . . . 0.0 110.405 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -116.55 121.77 42.74 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.439 ' O ' ' HA3' ' A' ' 107' ' ' GLY . 57.1 m-85 -94.9 148.23 22.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.689 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.61 34.46 0.49 Allowed 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.921 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.23 146.98 45.15 Favored Pre-proline 0 C--O 1.243 0.718 0 C-N-CA 124.045 0.938 . . . . 0.0 109.251 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.479 ' HG2' ' HG2' ' A' ' 36' ' ' GLU . 72.2 Cg_endo -67.86 169.03 17.1 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.871 2.381 . . . . 0.0 112.823 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.1 t -53.0 -53.01 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 114.086 -1.416 . . . . 0.0 111.856 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -48.07 -47.14 34.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 124.283 0.989 . . . . 0.0 112.292 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.479 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 21.6 mm-40 -70.27 -27.52 64.49 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.985 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.458 HG21 ' HB ' ' A' ' 108' ' ' THR . 62.9 t -81.41 -36.08 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 123.862 0.726 . . . . 0.0 110.997 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -68.61 -36.81 79.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.678 0.791 . . . . 0.0 108.884 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -68.78 -55.41 11.35 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.672 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -58.61 -28.96 66.1 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.44 ' SG ' HD22 ' A' ' 99' ' ' LEU . 49.7 t -96.11 -24.95 16.06 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.1 p -105.08 -46.83 4.15 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 119.115 0.871 . . . . 0.0 112.007 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.18 125.77 88.87 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 58.0 Cg_exo -55.59 -35.02 91.93 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.652 2.901 . . . . 0.0 113.052 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.63 -17.88 37.14 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.38 1.472 . . . . 0.0 112.295 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -100.97 -42.42 6.42 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.374 1.07 . . . . 0.0 109.188 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.5 mt -73.69 -36.82 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.544 -167.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -58.25 -18.96 30.32 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -41.46 64.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.21 0.604 . . . . 0.0 112.024 173.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.422 ' CE2' HD13 ' A' ' 136' ' ' LEU . 66.7 p-90 -118.66 14.04 13.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -171.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.1 t80 178.07 -175.31 0.17 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.115 0.566 . . . . 0.0 109.797 -169.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -88.81 131.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 44' ' ' PRO . 13.5 pt-20 -75.64 140.48 71.54 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-N 119.438 1.017 . . . . 0.0 111.634 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.506 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 93.5 Cg_endo -83.75 111.51 1.73 Allowed 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.352 2.701 . . . . 0.0 112.742 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -78.24 133.53 37.7 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.176 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.77 -156.58 24.31 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.927 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.29 -47.95 46.14 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.145 0.978 . . . . 0.0 111.202 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.8 mt 62.69 29.54 16.83 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 124.472 1.107 . . . . 0.0 111.296 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -118.63 151.57 37.68 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.013 0.925 . . . . 0.0 109.129 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.688 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 3.9 tm-20 -64.54 103.66 0.7 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.39 0.676 . . . . 0.0 109.348 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.84 -32.45 4.79 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.99 -170.29 45.84 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.261 -0.469 . . . . 0.0 112.112 171.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 8.8 p30 -131.55 160.23 35.89 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.146 0.973 . . . . 0.0 112.43 -171.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 21.9 p90 -120.91 158.8 26.88 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.092 166.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.06 114.12 0.79 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 69' ' ' ASN . 80.6 mt -57.86 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 118.395 0.543 . . . . 0.0 111.734 -171.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -159.88 -29.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.392 0.615 . . . . 0.0 110.862 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.85 -31.15 0.03 OUTLIER Glycine 0 N--CA 1.466 0.688 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 91.3 m-20 -89.58 119.59 30.14 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 124.033 0.933 . . . . 0.0 108.491 171.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 72.38 122.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.946 1.298 . . . . 0.0 113.258 173.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.4 p -149.57 139.51 21.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.858 0.863 . . . . 0.0 108.847 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.57 -166.72 30.75 Favored Glycine 0 N--CA 1.464 0.551 0 O-C-N 123.233 0.333 . . . . 0.0 112.394 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 17.9 m-20 -109.31 170.1 8.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.297 0.639 . . . . 0.0 110.515 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.504 HG13 HG22 ' A' ' 85' ' ' ILE . 2.3 mp -97.74 110.01 24.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 171.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.36 -59.88 2.5 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.053 0.845 . . . . 0.0 110.627 -173.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -136.49 150.08 48.5 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.567 1.147 . . . . 0.0 108.988 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.9 p -159.77 134.34 7.74 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.366 0.666 . . . . 0.0 109.295 172.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -134.91 98.86 12.82 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 60.3 Cg_endo -71.1 130.85 18.33 Favored 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 122.026 1.817 . . . . 0.0 111.877 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 14.5 Cg_endo -103.97 20.17 13.37 Favored 'Cis proline' 0 C--N 1.371 1.741 0 CA-C-N 119.411 0.825 . . . . 0.0 113.972 -3.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -54.4 -70.35 0.1 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.203 1.001 . . . . 0.0 111.465 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -145.0 159.67 42.57 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.933 0.397 . . . . 0.0 111.666 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 tt -135.91 113.63 11.01 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.8 m -109.26 128.34 54.99 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.424 1.49 . . . . 0.0 109.431 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.504 HG22 HG13 ' A' ' 74' ' ' ILE . 14.2 pt -121.25 173.09 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 125.109 1.364 . . . . 0.0 111.389 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.5 t -112.81 134.35 54.37 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.672 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 42.1 t-105 -126.53 105.67 8.9 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -167.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.9 t -110.88 144.29 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 21.2 t80 -148.75 151.03 34.14 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -65.12 110.37 2.5 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.139 0.576 . . . . 0.0 110.72 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.43 -20.39 50.63 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.3 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.495 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 70.3 mmtt -97.73 131.1 27.53 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.39 -73.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.891 2.394 . . . . 0.0 113.431 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -161.17 147.61 14.67 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.505 0.722 . . . . 0.0 109.364 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.672 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 19.8 m -141.97 158.96 43.16 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.728 0.811 . . . . 0.0 109.707 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -129.85 114.79 16.34 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 t -105.03 148.45 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -148.88 153.19 37.69 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.178 0.514 . . . . 0.0 110.65 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.44 HD22 ' SG ' ' A' ' 41' ' ' CYS . 39.7 tp -123.93 146.42 48.47 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.263 1.425 . . . . 0.0 107.372 175.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -140.97 109.9 6.11 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.53 148.8 22.11 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.686 0.794 . . . . 0.0 110.694 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.1 t -160.64 135.01 7.29 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 167.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.93 146.92 50.83 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.964 0.906 . . . . 0.0 109.831 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -164.52 108.76 0.94 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.907 1.283 . . . . 0.0 108.861 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.95 -132.01 10.83 Favored Glycine 0 C--N 1.342 0.885 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 172.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -92.42 31.59 1.3 Allowed 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.223 1.009 . . . . 0.0 110.245 171.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 30' ' ' TYR . . . -171.62 -150.43 7.14 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 120.452 -0.88 . . . . 0.0 114.883 -174.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.458 ' HB ' HG21 ' A' ' 37' ' ' VAL . 62.8 m -151.09 141.17 22.13 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.204 0.602 . . . . 0.0 111.079 -170.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.38 144.53 25.73 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.033 0.933 . . . . 0.0 109.378 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.437 HD11 ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -127.14 143.64 51.22 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 166.074 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.45 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 40.9 mt-10 -122.57 107.51 12.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 167.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.464 HD22 HD21 ' A' ' 133' ' ' LEU . 27.7 tp -99.16 104.4 16.37 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 50.8 tt0 -102.69 116.95 33.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.357 0.663 . . . . 0.0 110.429 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -108.03 120.07 41.26 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -113.83 118.38 34.07 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.756 0.822 . . . . 0.0 110.831 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.1 t -139.16 159.94 40.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.241 0.616 . . . . 0.0 111.076 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 50.4 p -89.86 -20.61 23.23 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.221 1.008 . . . . 0.0 111.76 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.8 m -86.71 123.5 31.94 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.231 0.612 . . . . 0.0 109.995 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.593 ' HA ' HD12 ' A' ' 122' ' ' LEU . 28.8 tt0 -73.42 -30.39 63.2 Favored 'General case' 0 C--O 1.25 1.102 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -170.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -60.89 -58.9 6.5 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 23.8 ttt -49.44 -32.7 12.41 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 124.782 1.301 . . . . 0.0 112.67 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.593 HD12 ' HA ' ' A' ' 119' ' ' GLU . 36.7 mt -61.24 -52.59 64.11 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.869 0.468 . . . . 0.0 111.896 175.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 127' ' ' VAL . 48.0 t -63.26 -50.04 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -45.05 -54.11 7.06 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.927 1.691 . . . . 0.0 113.574 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.595 HG23 HG12 ' A' ' 24' ' ' ILE . 30.5 m -75.93 -24.18 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 122.422 0.289 . . . . 0.0 110.807 -177.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.17 96.1 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 169.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 123' ' ' VAL . 58.8 t -78.17 -59.33 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.77 -56.45 9.82 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 114.517 -1.22 . . . . 0.0 114.023 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -65.42 -49.73 68.1 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.402 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 119.05 0.841 . . . . 0.0 111.07 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 89.7 mtp -75.56 -35.26 60.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.492 0.317 . . . . 0.0 110.518 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.26 76.06 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.193 0.597 . . . . 0.0 110.89 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 112' ' ' LEU . 4.5 mm? -57.4 -38.14 73.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.332 1.053 . . . . 0.0 112.386 170.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.42 -38.37 90.9 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 120.856 0.36 . . . . 0.0 110.854 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -72.32 -25.18 61.46 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.459 0.704 . . . . 0.0 110.849 173.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.672 HD11 ' HB1' ' A' ' 40' ' ' ALA . 41.5 tp -71.01 -52.33 20.2 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 123.162 0.585 . . . . 0.0 109.561 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.78 -36.23 40.64 Favored Glycine 0 N--CA 1.472 1.081 0 N-CA-C 115.016 0.767 . . . . 0.0 115.016 169.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.2 mmm -61.44 -44.93 96.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.655 0.382 . . . . 0.0 110.47 170.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -68.12 -34.93 77.27 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.663 0.785 . . . . 0.0 111.953 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 67.1 mt -78.16 -61.65 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.346 0.658 . . . . 0.0 110.018 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.559 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.6 mm . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.609 0.719 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.2 p -65.94 -51.91 54.39 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.586 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -53.56 -30.83 43.89 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 172.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -58.44 -50.24 74.41 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.641 0.655 . . . . 0.0 109.449 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -60.21 -52.72 64.11 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.185 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.75 -48.0 45.09 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 124.66 1.225 . . . . 0.0 115.955 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.8 -29.2 61.02 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.851 0.46 . . . . 0.0 111.391 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.89 -41.21 68.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.653 0.381 . . . . 0.0 110.037 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -74.79 -23.86 58.57 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.41 0.684 . . . . 0.0 111.255 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.491 ' HA ' HG12 ' A' ' 178' ' ' VAL . . . -75.24 -31.85 60.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.941 0.496 . . . . 0.0 110.393 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.72 72.26 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.289 0.636 . . . . 0.0 109.736 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 9' ' ' ARG . 95.4 mt -71.42 -61.17 1.87 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.102 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 175' ' ' ALA . 11.1 p -57.04 -39.21 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.588 0.755 . . . . 0.0 112.644 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -68.65 -26.66 65.44 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.234 0.614 . . . . 0.0 111.419 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.484 1.263 0 C-N-CA 122.989 0.516 . . . . 0.0 111.065 175.477 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 C--O 1.225 -0.23 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 33.1 m -130.31 103.12 6.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.86 0.864 . . . . 0.0 110.085 -176.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -92.23 142.04 27.91 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.143 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 145.17 41.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.317 0.647 . . . . 0.0 109.262 170.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -160.24 -175.42 5.04 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.882 0.873 . . . . 0.0 110.636 -170.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.6 mt -141.53 165.8 26.49 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.782 0.833 . . . . 0.0 110.889 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.91 -179.75 36.76 Favored Glycine 0 C--O 1.24 0.515 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.041 173.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -109.93 147.91 32.56 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -146.29 126.66 14.0 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.8 m -72.98 141.75 47.76 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.338 0.655 . . . . 0.0 110.026 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.522 HD11 HG23 ' A' ' 117' ' ' THR . 49.3 pt -143.19 152.45 57.89 Favored Pre-proline 0 N--CA 1.478 0.938 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.26 -15.83 6.07 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.214 2.61 . . . . 0.0 115.042 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 93' ' ' PRO . . . -109.3 9.02 25.87 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.92 -165.58 26.17 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 119.021 0.828 . . . . 0.0 114.229 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -94.81 100.73 12.57 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 175.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.09 155.9 21.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.6 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.471 ' HB2' HD11 ' A' ' 122' ' ' LEU . 48.0 mtm180 -101.95 158.24 16.28 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 166.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.5 p -133.53 141.27 47.66 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.41 0.444 . . . . 0.0 111.218 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.527 HD13 HG23 ' A' ' 125' ' ' VAL . 36.0 pt -84.15 148.2 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 47.6 mt -133.83 110.85 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.544 HG22 HE22 ' A' ' 28' ' ' GLN . 7.0 mt -113.32 110.3 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HB3' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -101.53 145.3 29.19 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.128 0.571 . . . . 0.0 110.217 176.541 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.544 HE22 HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -157.31 142.78 17.3 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.76 0.663 . . . . 0.0 110.992 175.018 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -104.57 107.27 18.13 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -87.52 144.3 26.78 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.774 0.83 . . . . 0.0 111.469 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -79.15 40.98 0.43 Allowed 'General case' 0 CA--C 1.566 1.575 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.133 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.0 150.08 70.32 Favored Pre-proline 0 N--CA 1.474 0.769 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.12 170.94 8.32 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.252 1.968 . . . . 0.0 113.168 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.78 -46.38 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.518 -171.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.61 -34.09 76.32 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.821 0.7 . . . . 0.0 110.99 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.73 -63.53 1.14 Allowed 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.443 0.465 . . . . 0.0 111.298 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.1 t -55.77 -31.8 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.194 0.997 . . . . 0.0 111.064 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -59.98 -56.87 16.29 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.962 0.505 . . . . 0.0 109.872 174.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.0 m -52.83 -42.08 64.82 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.035 0.834 . . . . 0.0 110.737 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -60.01 -34.6 73.57 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 82.4 m -95.58 -4.76 44.03 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.635 0.774 . . . . 0.0 113.07 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.2 p -118.02 -51.82 2.44 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 118.314 0.506 . . . . 0.0 111.936 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.51 117.02 30.38 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.784 0.834 . . . . 0.0 110.096 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.27 -20.06 43.4 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.197 2.598 . . . . 0.0 113.869 -170.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -71.38 -49.57 40.82 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -59.02 -37.99 78.23 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.576 172.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.5 mt -67.91 -35.72 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.039 0.535 . . . . 0.0 110.763 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -62.69 -17.45 60.65 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -73.04 -25.61 61.0 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -138.37 11.7 2.77 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -178.87 -178.76 0.56 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.251 0.621 . . . . 0.0 109.402 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.3 mt -91.0 137.01 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.999 0.92 . . . . 0.0 108.565 171.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.65 132.8 85.97 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.119 0.968 . . . . 0.0 111.442 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.12 120.28 2.93 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 122.476 2.117 . . . . 0.0 110.352 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -90.65 158.08 17.13 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.514 0.726 . . . . 0.0 111.062 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.71 -166.09 12.23 Favored Glycine 0 N--CA 1.466 0.634 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.178 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.76 -38.43 91.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.059 0.944 . . . . 0.0 111.755 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.2 mt 66.1 12.53 8.56 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.718 1.207 . . . . 0.0 112.518 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -126.82 154.53 44.19 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.139 0.976 . . . . 0.0 108.646 -176.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.93 121.6 10.95 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 123.869 0.731 . . . . 0.0 112.119 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.47 -27.8 17.64 Favored Glycine 0 N--CA 1.475 1.29 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.946 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -97.87 170.4 25.12 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 165.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -119.17 161.39 20.42 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.617 1.209 . . . . 0.0 112.527 -169.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -105.83 172.17 6.95 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.244 168.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.34 143.27 7.32 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.444 1.098 . . . . 0.0 109.74 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.3 mt -116.84 167.73 10.85 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.073 0.949 . . . . 0.0 109.008 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -73.88 -42.78 60.22 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.023 0.529 . . . . 0.0 111.66 -171.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.17 16.83 2.12 Favored Glycine 0 N--CA 1.467 0.731 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.033 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -126.91 44.95 2.79 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.266 1.026 . . . . 0.0 108.694 -175.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 68.6 179.25 0.24 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.936 1.295 . . . . 0.0 113.729 175.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.3 p -145.09 140.69 28.23 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.542 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.03 177.7 32.13 Favored Glycine 0 N--CA 1.468 0.828 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.905 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -102.67 156.63 17.5 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.98 0.912 . . . . 0.0 110.128 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.3 mp -92.9 110.43 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.6 mt -73.4 -44.16 59.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.23 0.612 . . . . 0.0 109.796 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -160.52 140.18 10.99 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.273 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.8 p -141.54 126.68 18.45 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.21 1.004 . . . . 0.0 109.181 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -126.47 104.41 24.73 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 125.047 1.339 . . . . 0.0 107.39 -170.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 89.7 Cg_endo -80.27 131.32 8.61 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 122.353 2.035 . . . . 0.0 113.254 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 40.8 Cg_endo -101.05 34.32 7.75 Favored 'Cis proline' 0 C--N 1.377 2.066 0 CA-C-N 119.507 0.86 . . . . 0.0 111.482 -10.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -74.04 -77.87 0.11 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.375 1.07 . . . . 0.0 111.298 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -152.11 157.85 42.16 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.197 0.599 . . . . 0.0 110.611 -174.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -141.41 132.13 25.68 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.059 0.543 . . . . 0.0 109.681 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 98' ' ' GLU . 58.5 m -118.73 120.13 36.49 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.298 1.039 . . . . 0.0 108.471 174.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 pt -121.19 144.59 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.865 0 C-N-CA 125.779 1.631 . . . . 0.0 108.63 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 74.5 p -84.01 170.44 13.93 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.149 -0.969 . . . . 0.0 110.169 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -153.04 117.82 5.05 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -166.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.14 103.58 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.552 ' HB3' ' HG3' ' A' ' 92' ' ' LYS . 36.8 t80 -101.6 162.62 12.77 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.836 0.854 . . . . 0.0 109.381 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -51.75 111.64 0.63 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.912 1.285 . . . . 0.0 112.379 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.52 19.47 72.84 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.663 -0.698 . . . . 0.0 114.834 173.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.552 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 11.0 mmpt? -100.5 140.97 21.83 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 117.223 0.511 . . . . 0.0 109.76 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.546 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . 57.7 Cg_endo -69.14 -36.73 11.84 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.433 2.089 . . . . 0.0 112.401 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -174.33 153.94 2.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.117 0.967 . . . . 0.0 109.494 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.7 t -146.3 158.32 43.87 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.921 0.889 . . . . 0.0 108.764 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -147.69 115.09 6.29 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.243 0.617 . . . . 0.0 110.167 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.16 147.93 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.52 ' HB3' HG23 ' A' ' 84' ' ' THR . 0.0 OUTLIER -146.55 156.81 43.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.496 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.4 tt -145.75 137.73 25.33 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -130.11 139.92 50.86 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.754 1.221 . . . . 0.0 108.688 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.0 mt -120.79 132.34 54.97 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.064 0.945 . . . . 0.0 109.084 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 t -129.95 169.41 15.26 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.914 1.285 . . . . 0.0 108.219 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.49 130.52 55.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -173.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -144.12 111.66 6.03 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 58.42 -106.42 0.84 Allowed Glycine 0 C--N 1.346 1.116 0 O-C-N 123.538 0.524 . . . . 0.0 113.264 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -113.1 2.77 15.8 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.566 0.746 . . . . 0.0 111.185 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -127.44 -162.25 11.07 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.7 m -144.48 137.64 27.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.869 0.868 . . . . 0.0 110.523 -171.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 27' ' ' ARG . 43.3 tp -90.07 141.12 28.99 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 173.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -124.69 115.81 21.35 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -108.83 106.12 15.98 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 98' ' ' GLU . 43.7 tp -105.57 104.64 14.4 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.69 0.796 . . . . 0.0 108.933 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 44.3 tt0 -107.75 119.69 40.16 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.272 0.629 . . . . 0.0 110.301 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -119.57 124.85 47.38 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -115.91 129.94 56.62 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.531 1.133 . . . . 0.0 112.04 -170.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.6 t -151.39 158.78 44.18 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.518 0.727 . . . . 0.0 110.335 171.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.522 HG23 HD11 ' A' ' 16' ' ' ILE . 22.0 p -77.52 1.32 19.77 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.435 1.094 . . . . 0.0 112.841 176.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.6 m -109.17 127.55 54.3 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.693 0.797 . . . . 0.0 111.919 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -67.62 -47.79 68.63 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.406 1.083 . . . . 0.0 112.167 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.5 -44.8 70.37 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.125 0.17 . . . . 0.0 111.017 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.403 ' O ' HG22 ' A' ' 125' ' ' VAL . 25.8 ttt -50.77 -41.35 56.7 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.942 0.776 . . . . 0.0 112.061 173.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.501 HD22 HG23 ' A' ' 24' ' ' ILE . 48.6 mt -59.66 -44.32 93.61 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.45 0.3 . . . . 0.0 111.087 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 127' ' ' VAL . 28.3 t -63.37 -56.02 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -48.72 -49.65 37.14 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.208 1.403 . . . . 0.0 112.992 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.527 HG23 HD13 ' A' ' 24' ' ' ILE . 22.5 m -77.23 -27.56 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 122.476 0.311 . . . . 0.0 110.316 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.1 -36.39 92.26 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 123' ' ' VAL . 60.5 t -81.17 -49.65 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.07 -60.08 8.97 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 114.312 -1.313 . . . . 0.0 113.759 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -58.08 -41.75 84.12 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.444 0.698 . . . . 0.0 111.953 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.61 ' HB3' HH11 ' A' ' 170' ' ' ARG . 21.4 mt-10 -64.97 -25.88 68.06 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 119.451 1.023 . . . . 0.0 112.311 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.9 mtt -75.69 -44.39 42.45 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.961 0.504 . . . . 0.0 109.773 174.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.21 -62.44 1.83 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.201 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.62 -26.98 64.27 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.381 1.472 . . . . 0.0 113.132 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 18.0 t70 -60.0 -53.3 59.46 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 169.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -67.21 -26.06 66.42 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.36 0.664 . . . . 0.0 111.628 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.48 HD11 ' HB1' ' A' ' 40' ' ' ALA . 27.4 tp -62.91 -58.01 8.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.266 0.626 . . . . 0.0 110.234 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.28 -43.74 34.27 Favored Glycine 0 N--CA 1.475 1.289 0 N-CA-C 115.057 0.783 . . . . 0.0 115.057 170.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 96.4 mmm -65.27 -30.32 71.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.133 0.573 . . . . 0.0 111.552 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -77.3 -42.98 34.82 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.083 0.953 . . . . 0.0 111.015 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 45.1 mt -57.78 -55.88 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.805 0.842 . . . . 0.0 110.274 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 48.7 ttp85 . . . . . 0 C--O 1.216 -0.68 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.883 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.451 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 42.7 mm . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.6 t -63.91 -30.99 72.02 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.514 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -71.47 -59.96 2.49 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.348 0.659 . . . . 0.0 110.173 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.17 -43.63 87.57 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.924 0.89 . . . . 0.0 112.481 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.61 HH11 ' HB3' ' A' ' 130' ' ' GLU . 19.7 mmt85 -74.08 -41.37 61.8 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -56.0 -35.65 64.74 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.408 -0.814 . . . . 0.0 113.721 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -78.24 -42.92 29.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.699 0.8 . . . . 0.0 110.475 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.7 72.0 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 124.18 0.925 . . . . 0.0 110.934 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.413 ' CZ2' HG12 ' A' ' 26' ' ' ILE . 97.1 m95 -83.44 -27.37 29.57 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.904 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.35 87.75 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 171.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.76 93.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.476 0.71 . . . . 0.0 110.773 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.08 -57.62 6.47 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.546 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.96 -31.79 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 122.847 0.459 . . . . 0.0 111.915 -168.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -66.65 -29.2 69.16 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.356 0.662 . . . . 0.0 110.668 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 171.204 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.1 m -120.33 115.35 23.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.555 0.742 . . . . 0.0 110.451 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 32.1 mt-10 -89.55 136.95 32.73 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -111.3 142.13 43.94 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.811 0.445 . . . . 0.0 110.313 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.37 127.57 7.7 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.931 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.759 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -85.56 121.97 29.01 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.697 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.59 -154.82 12.1 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-O 121.332 0.407 . . . . 0.0 113.376 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -148.09 148.28 30.46 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.245 1.018 . . . . 0.0 109.712 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 27.8 tpt180 -168.93 120.39 0.75 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.429 0.691 . . . . 0.0 109.46 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.2 m -83.21 97.6 8.94 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.9 pt -78.3 160.44 73.05 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.369 1.068 . . . . 0.0 110.295 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.3 -21.24 22.3 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.453 2.769 . . . . 0.0 114.463 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.9 -53.14 22.77 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 170.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.7 -157.38 27.62 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.225 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.472 ' HB3' HH22 ' A' ' 22' ' ' ARG . 48.9 mt-10 -68.74 106.15 2.55 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.253 0.621 . . . . 0.0 110.651 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -114.71 153.42 30.3 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.572 0.749 . . . . 0.0 111.401 -175.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.472 HH22 ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -91.67 169.71 10.51 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 164.781 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -141.71 142.49 33.31 Favored 'General case' 0 C--O 1.217 -0.63 0 O-C-N 122.305 -0.247 . . . . 0.0 110.946 -172.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.553 HG12 HG23 ' A' ' 125' ' ' VAL . 2.7 pp -98.73 144.8 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 168.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.519 HG12 ' HG3' ' A' ' 113' ' ' GLU . 44.3 mt -131.79 106.28 11.26 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.6 mt -101.7 107.54 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 49.0 mtp180 -107.17 133.56 51.58 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.292 1.037 . . . . 0.0 108.791 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -141.25 152.97 44.98 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.768 0.427 . . . . 0.0 110.068 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.547 ' NH1' HD13 ' A' ' 109' ' ' LEU . 67.3 mmt-85 -108.48 102.33 11.43 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -79.17 124.32 28.22 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.15 44.79 0.25 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 123.916 0.76 . . . . 0.0 111.295 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.88 148.06 37.57 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 125.292 1.437 . . . . 0.0 107.143 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.45 175.62 2.64 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.8 2.334 . . . . 0.0 114.487 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -73.59 -42.71 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.921 -171.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.35 -43.6 98.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.687 0.795 . . . . 0.0 110.508 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -59.96 -63.97 1.11 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.686 175.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.47 -34.49 46.85 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 124.177 0.991 . . . . 0.0 111.936 -175.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.407 ' HE3' HD12 ' A' ' 101' ' ' LEU . 67.7 t-105 -61.31 -58.47 8.1 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.994 0.518 . . . . 0.0 110.206 178.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 80.0 p -57.91 -46.11 85.48 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.886 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.557 ' HA ' ' HD2' ' A' ' 46' ' ' ARG . . . -53.43 -40.23 65.0 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 79.9 m -78.95 -16.81 56.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 50.3 p -108.31 -26.53 10.48 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 1.2 p30 -85.54 124.24 71.66 Favored Pre-proline 0 N--CA 1.484 1.241 0 CA-C-N 118.533 0.606 . . . . 0.0 110.325 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 50.9 Cg_exo -55.71 -27.34 60.83 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.971 3.114 . . . . 0.0 114.278 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -63.48 -53.51 50.97 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.322 1.014 . . . . 0.0 110.665 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.557 ' HD2' ' HA ' ' A' ' 40' ' ' ALA . 65.8 mtt85 -71.32 -32.27 68.38 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.117 175.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.473 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 82.7 mt -65.04 -39.43 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 118.129 0.422 . . . . 0.0 111.837 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.5 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 13.8 p30 -67.07 -11.68 57.82 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 15.4 mmt180 -72.14 -41.39 67.21 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.475 0.71 . . . . 0.0 111.161 170.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.505 ' HB2' ' O ' ' A' ' 132' ' ' ALA . 70.5 p-90 -115.77 9.35 15.1 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -170.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -173.42 180.0 2.01 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -170.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.1 mt -84.88 133.59 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 34.0 tt0 -67.34 127.23 93.41 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.724 1.21 . . . . 0.0 111.001 -171.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 89.9 Cg_endo -79.88 102.14 1.43 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.797 2.332 . . . . 0.0 111.045 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.43 160.49 24.02 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.634 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.19 -171.76 15.09 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.96 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.52 -47.91 66.36 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.001 1.72 . . . . 0.0 112.277 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.9 mt 69.23 0.66 2.93 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.293 1.437 . . . . 0.0 113.474 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -103.01 154.83 18.84 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.703 0.801 . . . . 0.0 110.028 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -63.96 107.09 1.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.615 0.766 . . . . 0.0 111.233 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.2 -24.48 6.96 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.0 -161.74 37.72 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -141.13 157.32 45.44 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.95 1.375 . . . . 0.0 111.212 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 25.8 p90 -101.32 171.72 7.42 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.59 163.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -165.83 135.39 3.35 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.596 1.159 . . . . 0.0 109.024 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.9 mt -93.05 174.63 7.13 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.597 0.759 . . . . 0.0 109.817 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -106.18 134.37 49.43 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 171.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 53.84 36.34 55.14 Favored Glycine 0 CA--C 1.532 1.1 0 O-C-N 124.927 1.392 . . . . 0.0 114.873 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -149.95 -95.66 0.07 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.04 -179.16 5.93 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.195 0.598 . . . . 0.0 110.841 -171.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.1 p -152.05 146.2 25.36 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.61 146.73 15.81 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 118.823 0.738 . . . . 0.0 112.346 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -80.94 148.81 29.66 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.501 0.721 . . . . 0.0 110.278 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mm -83.26 95.05 3.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 86' ' ' SER . 67.2 mt -70.77 -50.0 40.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.38 0.672 . . . . 0.0 110.41 -173.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -155.76 130.31 9.02 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.37 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 88.7 m -116.25 136.05 53.35 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 167.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -133.34 88.15 36.06 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 95.0 Cg_endo -76.75 136.63 17.14 Favored 'Trans proline' 0 CA--C 1.559 1.768 0 C-N-CA 122.775 2.317 . . . . 0.0 112.425 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 40.8 Cg_endo -102.81 27.76 11.52 Favored 'Cis proline' 0 C--N 1.381 2.26 0 CA-C-N 119.468 0.846 . . . . 0.0 113.256 -5.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.43 ' NH1' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -77.14 -74.63 0.24 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.349 0.66 . . . . 0.0 110.179 -174.03 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -147.9 160.75 42.46 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.25 0.62 . . . . 0.0 110.772 -171.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -141.95 127.91 19.5 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.494 0.718 . . . . 0.0 109.215 171.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.7 m -104.5 112.26 25.25 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.514 HG13 ' HB ' ' A' ' 97' ' ' VAL . 15.3 pt -110.05 170.56 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.465 1.106 . . . . 0.0 109.544 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.495 ' HB3' HD11 ' A' ' 75' ' ' LEU . 23.3 p -105.37 170.9 7.62 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 69.3 t-105 -146.04 92.85 2.25 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -175.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.65 101.92 13.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -117.71 127.37 53.85 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.14 126.99 30.38 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.909 0.883 . . . . 0.0 110.855 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.38 -54.18 0.81 Allowed Glycine 0 C--N 1.349 1.287 0 O-C-N 123.496 0.497 . . . . 0.0 112.512 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.577 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 0.0 OUTLIER -99.27 148.56 34.81 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 123.993 0.917 . . . . 0.0 110.0 -173.455 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -50.53 140.88 34.99 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 123.882 3.055 . . . . 0.0 114.21 -173.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.43 117.96 5.45 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.55 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 8.2 m -100.41 173.81 6.4 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.141 0.977 . . . . 0.0 110.636 -173.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -128.07 117.38 21.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.514 ' HB ' HG13 ' A' ' 85' ' ' ILE . 40.7 t -98.34 135.51 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.74 114.71 10.1 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.412 HD12 HD12 ' A' ' 112' ' ' LEU . 6.4 tt -111.43 126.51 55.02 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.43 ' HG2' ' NH1' ' A' ' 81' ' ' ARG . 23.8 ttm180 -132.42 105.32 7.2 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.899 0.88 . . . . 0.0 110.09 -165.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 110' ' ' LEU . 88.5 mt -97.1 139.25 33.38 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 110.985 176.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.7 t -138.68 174.16 10.83 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.695 1.198 . . . . 0.0 108.353 172.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -104.74 132.89 50.44 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.433 ' HG2' ' HE ' ' A' ' 29' ' ' ARG . 13.3 tp10 -147.69 99.64 3.13 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -169.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 58.47 -105.72 0.7 Allowed Glycine 0 C--N 1.35 1.314 0 C-N-CA 123.317 0.484 . . . . 0.0 113.966 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -100.93 -15.14 17.63 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.189 0.996 . . . . 0.0 110.43 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.62 -161.01 12.24 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.719 -169.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.2 m -142.79 134.2 26.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.248 1.019 . . . . 0.0 109.71 -173.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.547 HD13 ' NH1' ' A' ' 29' ' ' ARG . 33.6 tp -89.3 122.86 32.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 101' ' ' LEU . 9.0 tt -111.61 108.82 18.43 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.561 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 28.1 mt-10 -109.62 104.85 13.94 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.471 HD13 HD21 ' A' ' 133' ' ' LEU . 8.0 tt -102.0 101.05 11.39 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 171.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.519 ' HG3' HG12 ' A' ' 25' ' ' ILE . 32.7 tt0 -97.23 117.61 31.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.322 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.436 ' ND1' HG22 ' A' ' 97' ' ' VAL . 5.2 t60 -116.74 118.62 33.03 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.4 132.32 54.53 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.371 0.668 . . . . 0.0 111.328 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.711 HG21 ' HG3' ' A' ' 121' ' ' MET . 7.6 t -154.73 161.15 41.64 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.055 0.942 . . . . 0.0 110.27 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.7 p -88.53 -0.2 56.98 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.881 -166.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.0 m -120.19 129.61 54.18 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.589 0.756 . . . . 0.0 110.963 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -61.46 -41.23 96.9 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.095 0.958 . . . . 0.0 112.187 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -63.68 -56.67 13.94 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.174 0.589 . . . . 0.0 111.229 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.711 ' HG3' HG21 ' A' ' 116' ' ' THR . 14.9 tpt -49.79 -34.25 18.93 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 123.939 0.775 . . . . 0.0 112.369 174.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.529 ' HG ' HG23 ' A' ' 116' ' ' THR . 17.5 mt -67.01 -47.27 71.99 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.678 0.791 . . . . 0.0 112.06 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 127' ' ' VAL . 59.8 t -60.86 -50.39 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -50.21 -46.18 54.38 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.28 1.432 . . . . 0.0 113.222 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.553 HG23 HG12 ' A' ' 24' ' ' ILE . 35.9 m -81.26 -26.41 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.693 0.397 . . . . 0.0 110.913 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.71 -38.33 96.28 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 171.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 170' ' ' ARG . 62.0 t -78.42 -50.71 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.679 0.792 . . . . 0.0 109.499 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.48 -62.32 6.32 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.9 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -63.27 -40.12 96.49 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 118.417 -0.801 . . . . 0.0 112.313 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.1 -40.73 96.86 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.868 1.213 . . . . 0.0 110.864 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 47.3 ttm -68.91 -36.92 78.58 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.744 0.818 . . . . 0.0 110.078 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 50' ' ' TRP . . . -65.07 -65.02 0.73 Allowed 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.864 0.727 . . . . 0.0 110.449 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.471 HD21 HD13 ' A' ' 112' ' ' LEU . 4.0 mm? -55.19 -30.24 59.53 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.05 0.94 . . . . 0.0 112.53 174.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.31 -45.2 84.44 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.216 0.462 . . . . 0.0 110.973 171.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -65.2 -31.52 72.73 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.519 0.512 . . . . 0.0 111.224 175.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.27 -48.09 79.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 172.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -45.59 -52.7 8.92 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.715 0.634 . . . . 0.0 113.982 166.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.52 -34.42 77.75 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.96 0.904 . . . . 0.0 111.603 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -69.66 -52.02 29.51 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.355 0.662 . . . . 0.0 110.209 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.4 mt -64.97 -29.39 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 124.186 0.994 . . . . 0.0 110.757 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.247 0 C-N-CA 124.266 1.026 . . . . 0.0 109.6 175.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 50.6 mm . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.1 t -51.53 -47.3 63.41 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.421 1.088 . . . . 0.0 112.411 172.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -88.9 -25.28 22.2 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -63.42 -57.34 10.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.566 1.147 . . . . 0.0 110.079 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.546 ' HB3' HG22 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -60.16 -43.82 95.49 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.684 0.615 . . . . 0.0 109.828 173.468 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -54.71 -44.15 79.99 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 124.028 0.83 . . . . 0.0 113.195 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.26 -59.39 4.12 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.762 1.225 . . . . 0.0 109.866 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.449 ' O ' ' HG ' ' A' ' 177' ' ' LEU . . . -51.44 -57.05 10.04 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 124.997 1.435 . . . . 0.0 111.834 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -70.29 -25.86 63.53 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.725 0.81 . . . . 0.0 113.101 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.1 -36.62 64.26 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 118.177 0.444 . . . . 0.0 110.452 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.97 -35.09 74.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.908 0.483 . . . . 0.0 109.943 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.759 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 67.8 mt -69.47 -53.22 20.29 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.943 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.51 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 9.8 p -70.28 -29.3 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 48.4 m170 -80.22 2.41 24.51 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.874 0.47 . . . . 0.0 111.304 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 37.6 t . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 124.184 0.994 . . . . 0.0 108.354 171.828 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 120.999 0.428 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.2 m -97.1 120.65 37.86 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.739 0.815 . . . . 0.0 110.048 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -114.35 116.24 28.63 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.437 1.095 . . . . 0.0 109.024 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -76.22 139.36 41.14 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 170.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -152.63 170.61 19.8 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.06 0.457 . . . . 0.0 111.444 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -143.88 162.04 37.13 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -176.022 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.467 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -173.28 -160.71 22.28 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -137.65 151.68 48.54 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.072 0.949 . . . . 0.0 108.495 178.021 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -156.95 133.21 9.78 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.566 0.746 . . . . 0.0 109.298 -170.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 m -83.16 137.78 33.92 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.472 HD11 HG23 ' A' ' 117' ' ' THR . 47.7 pt -137.65 160.88 63.29 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.507 0.723 . . . . 0.0 109.1 -174.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -45.07 -31.29 5.52 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.984 3.123 . . . . 0.0 115.324 174.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 -41.75 65.61 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.042 0.537 . . . . 0.0 111.265 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.93 -150.09 21.67 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.913 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.8 115.82 9.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.587 0.755 . . . . 0.0 109.817 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.78 164.75 18.54 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.677 0.791 . . . . 0.0 110.907 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -112.61 161.95 16.23 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.4 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 p -138.81 128.99 25.5 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.47 0.308 . . . . 0.0 110.655 -168.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 45.5 pt -87.32 135.69 24.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 169.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 3.5 mp -112.99 110.75 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 171.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.9 mt -101.67 109.57 26.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HG3' HD11 ' A' ' 109' ' ' LEU . 59.7 ttm-85 -113.76 148.46 36.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.736 0.814 . . . . 0.0 110.385 -172.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.561 HE21 HD22 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -165.91 138.22 4.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 124.215 0.947 . . . . 0.0 112.496 -176.705 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.494 ' NH1' HD13 ' A' ' 109' ' ' LEU . 46.0 mmt-85 -96.69 115.39 27.35 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.273 1.029 . . . . 0.0 108.84 167.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -93.67 147.93 22.57 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.765 0.826 . . . . 0.0 109.998 170.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.17 28.03 0.86 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.371 0.668 . . . . 0.0 111.352 172.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.46 151.78 44.74 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 124.451 1.1 . . . . 0.0 109.768 176.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.4 ' O ' HG23 ' A' ' 37' ' ' VAL . 61.2 Cg_endo -71.32 152.02 60.69 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.014 1.809 . . . . 0.0 111.026 172.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 80' ' ' PRO . 77.9 t -46.63 -49.85 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 124.444 1.098 . . . . 0.0 111.094 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -49.21 -47.2 46.36 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 125.371 1.669 . . . . 0.0 111.55 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.81 -34.84 72.15 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.305 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 33' ' ' PRO . 24.2 t -75.05 -32.41 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -71.48 -31.24 66.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.428 1.091 . . . . 0.0 110.179 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.8 m -75.09 -37.44 61.55 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -65.03 -44.64 88.47 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.266 0.626 . . . . 0.0 110.744 171.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.9 t -68.13 -24.86 65.05 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -176.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.9 p -113.85 -38.59 4.2 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -172.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.94 122.86 88.57 Favored Pre-proline 0 N--CA 1.484 1.274 0 CA-C-O 119.106 -0.473 . . . . 0.0 110.269 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -49.97 -51.68 10.41 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.868 3.045 . . . . 0.0 114.596 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -52.39 -33.54 43.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.844 1.258 . . . . 0.0 111.841 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.524 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 5.4 mmp_? -81.33 -38.45 26.71 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.862 0.465 . . . . 0.0 111.662 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.3 mt -73.39 -29.51 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -57.68 -24.64 57.79 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.033 1.733 . . . . 0.0 112.084 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -87.89 -60.21 2.03 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.382 0.673 . . . . 0.0 110.208 -173.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.416 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 69.5 p-90 -82.29 -15.04 54.39 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.416 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 14.8 t80 -140.27 -108.41 0.15 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.414 HD13 ' HB2' ' A' ' 69' ' ' ASN . 89.2 mt -143.01 144.25 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.627 0.771 . . . . 0.0 109.52 -169.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -59.44 109.52 2.0 Allowed Pre-proline 0 CA--C 1.57 1.715 0 O-C-N 125.31 1.631 . . . . 0.0 111.654 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HB3' HD23 ' A' ' 66' ' ' LEU . 63.5 Cg_endo -100.06 156.83 0.52 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.208 2.605 . . . . 0.0 113.82 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -144.73 159.0 43.56 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.6 1.16 . . . . 0.0 108.441 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.74 -148.2 19.84 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.62 -53.69 7.28 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.376 0.67 . . . . 0.0 109.423 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt 59.88 19.7 8.65 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.617 1.167 . . . . 0.0 110.962 -170.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -114.55 149.65 36.17 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.678 1.191 . . . . 0.0 109.153 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 42.3 tt0 -59.7 122.27 13.73 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.476 0.71 . . . . 0.0 110.88 -177.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.67 14.77 64.8 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.908 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -115.8 -147.54 9.03 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -151.26 172.64 15.55 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.491 0.662 . . . . 0.0 111.605 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.63 164.94 26.08 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.897 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.37 122.13 9.28 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.037 0.935 . . . . 0.0 109.873 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 54' ' ' PRO . 25.9 mt -89.8 142.11 28.0 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.624 1.17 . . . . 0.0 108.927 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -85.06 101.18 12.21 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.52 32.35 8.77 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.423 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.512 HD21 ' HE1' ' A' ' 89' ' ' TYR . 1.9 t-20 -150.67 -88.09 0.07 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 117.32 0.56 . . . . 0.0 111.689 177.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.77 159.42 40.63 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 121.304 0.573 . . . . 0.0 112.207 -167.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.0 m -125.62 148.53 48.94 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.476 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.88 159.48 30.33 Favored Glycine 0 C--N 1.338 0.673 0 O-C-N 123.196 0.31 . . . . 0.0 112.381 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.43 164.34 14.32 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.638 0.775 . . . . 0.0 110.586 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 mm -106.72 103.75 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 72.2 mt -80.03 -43.08 22.54 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.79 0.436 . . . . 0.0 111.053 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -166.49 146.74 6.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.131 0.572 . . . . 0.0 109.521 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 12.8 p -160.37 110.77 1.82 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.749 0.42 . . . . 0.0 111.155 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.79 112.4 60.3 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 169.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 70.9 Cg_endo -75.52 132.39 14.7 Favored 'Trans proline' 0 CA--C 1.558 1.707 0 C-N-CA 122.153 1.902 . . . . 0.0 111.897 169.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 43.8 Cg_endo -98.97 21.71 23.32 Favored 'Cis proline' 0 C--N 1.375 1.949 0 CA-C-N 119.659 0.914 . . . . 0.0 112.967 -4.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -66.79 -68.41 0.38 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.151 0.98 . . . . 0.0 112.982 -171.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.466 ' HB3' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -154.58 148.96 26.14 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.627 0.648 . . . . 0.0 112.491 -174.358 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.5 tp -108.14 145.45 34.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.342 1.457 . . . . 0.0 108.572 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.7 m -137.49 125.85 23.32 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.2 pt -144.01 147.37 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.502 1.121 . . . . 0.0 110.211 -170.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.3 m -88.33 154.28 20.52 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 43.7 t-105 -134.98 106.74 6.96 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -174.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.02 107.43 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.512 ' HE1' HD21 ' A' ' 69' ' ' ASN . 82.3 t80 -94.34 162.98 13.61 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -48.76 111.24 0.44 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.237 1.415 . . . . 0.0 112.648 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.65 25.4 75.77 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 124.023 0.827 . . . . 0.0 113.88 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -116.03 159.73 38.19 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.796 0.838 . . . . 0.0 110.334 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.33 167.25 26.81 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.323 2.015 . . . . 0.0 110.98 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -69.25 108.88 3.84 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.5 m -83.92 167.02 17.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.381 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.03 119.98 18.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 40.6 t -130.13 145.15 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.591 1.157 . . . . 0.0 109.605 -165.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -135.57 145.25 46.77 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.97 -0.456 . . . . 0.0 109.887 171.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.406 ' HG ' HD21 ' A' ' 110' ' ' LEU . 9.2 tt -123.38 115.64 21.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.466 ' HA ' ' HB3' ' A' ' 82' ' ' ARG . 41.6 ttp180 -121.93 117.47 26.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.98 0.512 . . . . 0.0 110.462 -171.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.4 mt -95.55 132.17 40.96 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.321 1.048 . . . . 0.0 109.525 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.8 m -137.23 125.66 23.46 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.653 1.181 . . . . 0.0 107.985 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.97 152.12 28.61 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.362 1.065 . . . . 0.0 110.45 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -167.19 85.95 0.26 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.403 0.681 . . . . 0.0 110.617 -162.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.31 -137.3 23.56 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -87.68 51.99 2.36 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 166.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.91 -165.24 31.5 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 114.547 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 90.9 m -148.01 132.92 18.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.203 0.601 . . . . 0.0 110.968 -171.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.494 HD13 ' NH1' ' A' ' 29' ' ' ARG . 32.6 tp -83.29 120.24 25.59 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.674 0.79 . . . . 0.0 109.486 167.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.561 HD22 HE21 ' A' ' 28' ' ' GLN . 7.3 tt -102.87 132.59 48.97 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 170.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -128.5 105.63 8.43 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.431 HD22 HD21 ' A' ' 133' ' ' LEU . 41.9 tp -101.47 133.01 46.76 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 33.1 tt0 -131.43 105.47 7.62 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.695 0.798 . . . . 0.0 108.943 175.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -96.26 115.55 27.62 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.54 107.37 15.42 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.575 0.75 . . . . 0.0 110.237 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.0 t -130.92 156.94 44.22 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.086 0.554 . . . . 0.0 109.684 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.472 HG23 HD11 ' A' ' 16' ' ' ILE . 68.7 p -74.35 -31.4 62.4 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.864 0.866 . . . . 0.0 110.535 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 m -79.38 111.41 15.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.999 0.92 . . . . 0.0 111.337 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 122' ' ' LEU . 45.3 tt0 -60.42 -30.93 69.93 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.907 0.883 . . . . 0.0 111.86 176.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -66.96 -49.41 65.53 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.61 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.5 ttt -59.8 -37.29 78.71 Favored 'General case' 0 C--O 1.203 -1.383 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.897 176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 119' ' ' GLU . 25.7 mt -61.54 -38.56 87.87 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 123.43 0.692 . . . . 0.0 112.404 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.6 t -65.85 -49.04 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.427 0.632 . . . . 0.0 109.826 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -62.55 -40.32 96.46 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.934 1.294 . . . . 0.0 111.832 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 m -83.62 -22.63 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.549 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.09 -34.84 85.56 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 168.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.98 -52.16 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.05 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.8 -38.13 95.7 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.339 -172.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -80.77 -39.43 26.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.923 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -61.48 -37.04 82.18 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 119.357 0.98 . . . . 0.0 109.636 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 93.1 mtp -69.4 -35.62 75.96 Favored 'General case' 0 C--O 1.218 -0.584 0 O-C-N 123.758 0.661 . . . . 0.0 110.723 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.84 86.35 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.706 0.402 . . . . 0.0 110.701 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.431 HD21 HD22 ' A' ' 112' ' ' LEU . 3.7 mm? -79.29 -20.38 48.16 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.278 0.631 . . . . 0.0 111.498 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -71.46 -42.92 67.54 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -81.54 -22.82 37.63 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.867 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 32.4 tp -71.26 -31.68 67.8 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -56.76 -52.96 47.49 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.978 164.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 94.4 mmm -63.61 -33.84 76.5 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.922 0.889 . . . . 0.0 112.334 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.422 ' HZ ' ' HD3' ' A' ' 46' ' ' ARG . 43.8 t80 -75.08 -51.42 13.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.766 0.826 . . . . 0.0 110.599 -174.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.0 mt -65.35 -28.97 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.009 0.924 . . . . 0.0 110.769 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 C-N-CA 123.597 0.759 . . . . 0.0 109.593 174.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.401 ' O ' ' HG3' ' A' ' 170' ' ' ARG . 72.9 mt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.3 p -75.84 -53.35 8.59 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -176.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -59.99 -45.62 92.14 Favored 'General case' 0 C--O 1.205 -1.26 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.819 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -42.37 -49.96 5.12 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 124.61 1.164 . . . . 0.0 113.194 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 166' ' ' ILE . 54.3 mtt180 -63.86 -40.05 95.66 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 120.767 0.318 . . . . 0.0 111.084 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.39 -33.15 44.81 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.137 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 12.8 pt-20 -82.91 -18.32 40.56 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.829 0.851 . . . . 0.0 109.896 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.99 -51.45 58.31 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.676 0.79 . . . . 0.0 109.2 172.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -72.73 -34.2 66.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.7 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.504 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -65.25 -28.68 69.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.621 0.369 . . . . 0.0 110.926 174.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -76.62 -43.24 39.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.7 mt -63.63 -41.17 98.28 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.279 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.2 p -90.66 -26.43 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 118.426 0.557 . . . . 0.0 109.632 -166.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -75.35 -17.88 60.12 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.895 0.478 . . . . 0.0 110.795 173.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.8 m . . . . . 0 N--CA 1.476 0.865 0 C-N-CA 123.024 0.53 . . . . 0.0 109.912 172.968 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.509 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.9 m -104.75 104.12 13.86 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.444 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -80.06 135.9 36.45 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.136 0.494 . . . . 0.0 109.989 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -109.21 140.21 43.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.941 1.296 . . . . 0.0 109.227 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.65 -173.22 2.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.287 0.635 . . . . 0.0 111.272 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.622 HD13 HH11 ' A' ' 22' ' ' ARG . 81.3 mt -139.16 163.7 31.76 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.548 1.139 . . . . 0.0 109.502 175.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.68 -163.04 11.34 Favored Glycine 0 C--O 1.241 0.575 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.69 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.53 124.07 9.06 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 7.2 tpt180 -133.29 116.24 15.91 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -175.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.4 m -84.42 120.0 25.77 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 pt -110.88 163.57 16.96 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 124.9 1.28 . . . . 0.0 109.329 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -55.24 -24.19 40.71 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.392 2.728 . . . . 0.0 114.741 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.34 -22.2 61.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.24 0.616 . . . . 0.0 112.189 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.49 170.95 14.71 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -169.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -67.43 116.67 8.44 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 173.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -104.63 152.02 22.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.94 0.496 . . . . 0.0 110.151 -177.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.622 HH11 HD13 ' A' ' 11' ' ' LEU . 22.4 ttm-85 -97.8 154.41 17.64 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.6 p -123.71 143.27 50.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.737 0.415 . . . . 0.0 110.841 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.467 HG23 HD22 ' A' ' 122' ' ' LEU . 2.7 pp -90.92 135.66 26.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 166.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.595 HG13 ' HG2' ' A' ' 113' ' ' GLU . 1.7 mp -114.39 115.8 50.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -174.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.0 mt -114.69 106.46 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 170.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HB3' HD11 ' A' ' 109' ' ' LEU . 52.3 mtp180 -105.21 136.45 44.69 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -144.61 136.47 25.88 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -92.81 103.06 15.45 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -86.39 122.57 30.54 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.191 0.996 . . . . 0.0 110.557 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.39 43.14 0.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.475 171.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.24 143.86 20.13 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' A' ' 36' ' ' GLU . 21.3 Cg_endo -62.58 165.27 16.05 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.1 2.534 . . . . 0.0 114.633 -176.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.49 -45.09 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.405 -174.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.3 -35.51 79.26 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.438 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.603 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 8.5 tp10 -65.12 -62.76 1.36 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.957 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 33' ' ' PRO . 11.3 t -53.37 -35.0 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.042 0.937 . . . . 0.0 111.078 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -62.5 -58.31 8.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.312 0.645 . . . . 0.0 110.664 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.6 p -59.18 -39.37 82.31 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.524 -177.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.4 74.1 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.799 171.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -80.33 -9.56 59.74 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.8 p -104.3 -32.3 9.14 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.824 0.45 . . . . 0.0 111.596 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.472 ' O ' HG13 ' A' ' 47' ' ' ILE . 10.2 t70 -79.96 116.28 60.11 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 123.882 0.873 . . . . 0.0 110.298 -174.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -61.91 -33.25 84.55 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.142 2.561 . . . . 0.0 113.195 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.413 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 13.9 m120 -70.42 -17.51 63.01 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.25 0.62 . . . . 0.0 110.89 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -101.59 -25.59 13.83 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.603 0.761 . . . . 0.0 110.853 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.506 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 76.4 mt -76.96 -40.22 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 122.908 0.483 . . . . 0.0 111.417 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.413 ' ND2' ' HA ' ' A' ' 45' ' ' ASN . 13.9 p30 -59.66 -21.83 61.06 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -60.12 -56.54 20.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.362 0.665 . . . . 0.0 110.91 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.506 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 36.3 p-90 -91.44 -54.74 3.78 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -172.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.449 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 10.7 t80 -108.46 -166.18 1.1 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.11 0.564 . . . . 0.0 109.638 176.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.8 mt -86.12 124.77 40.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 164.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.22 136.23 96.44 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 123.208 0.603 . . . . 0.0 110.695 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.625 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 54.3 Cg_endo -68.67 131.12 22.08 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.227 1.951 . . . . 0.0 111.76 171.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -89.87 155.71 18.96 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.425 0.69 . . . . 0.0 109.294 172.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.0 -163.01 17.87 Favored Glycine 0 N--CA 1.466 0.681 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.057 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.26 -39.34 92.55 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.943 1.297 . . . . 0.0 111.202 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.0 mt 62.75 12.8 5.92 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.008 1.323 . . . . 0.0 114.342 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.0 mmm-85 -108.1 161.51 14.9 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.598 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 39.0 tt0 -67.18 109.38 3.04 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.594 0.757 . . . . 0.0 110.436 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.55 -23.33 11.18 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -175.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.93 -170.63 45.4 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 166.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -132.31 163.1 29.4 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.037 0.918 . . . . 0.0 110.946 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.625 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 20.2 p90 -119.82 165.28 14.79 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.114 175.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.687 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -166.83 102.65 0.56 Allowed 'General case' 0 C--N 1.348 0.524 0 C-N-CA 125.226 1.41 . . . . 0.0 107.824 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.435 HD11 ' CH2' ' A' ' 87' ' ' TRP . 70.7 mt -56.56 -65.74 0.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.397 0.679 . . . . 0.0 111.704 -171.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 132.49 -61.58 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 128.025 2.53 . . . . 0.0 109.177 171.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.86 31.52 8.09 Favored Glycine 0 N--CA 1.473 1.113 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.16 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -158.27 -80.86 0.06 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.83 -167.39 2.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.224 0.61 . . . . 0.0 111.019 -171.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 33.0 t -148.61 -166.11 2.46 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.1 -156.99 27.06 Favored Glycine 0 C--N 1.347 1.163 0 C-N-CA 121.554 -0.355 . . . . 0.0 113.609 171.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -141.45 146.53 36.61 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.917 0.887 . . . . 0.0 109.403 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.468 ' HA ' HG22 ' A' ' 85' ' ' ILE . 10.6 mt -96.61 106.5 18.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-O 121.497 0.665 . . . . 0.0 109.948 -177.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.63 -59.53 2.65 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.929 -171.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -146.3 155.03 42.36 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.268 1.027 . . . . 0.0 110.503 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 21.6 p -155.56 117.11 3.99 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 176.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -108.89 94.49 14.7 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.282 1.433 . . . . 0.0 107.458 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 98.0 Cg_endo -76.28 134.26 15.56 Favored 'Trans proline' 0 CA--C 1.566 2.098 0 C-N-CA 122.709 2.273 . . . . 0.0 113.06 -175.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 24.1 Cg_endo -99.07 24.86 19.44 Favored 'Cis proline' 0 C--N 1.385 2.487 0 CA-C-N 119.808 0.967 . . . . 0.0 112.285 -8.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -67.4 0.49 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.494 1.118 . . . . 0.0 111.084 -170.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -142.61 159.72 41.69 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.232 0.613 . . . . 0.0 110.604 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 tt -136.07 110.81 8.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.6 m -114.42 110.91 20.59 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.185 0.994 . . . . 0.0 109.077 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.468 HG22 ' HA ' ' A' ' 74' ' ' ILE . 23.3 pt -125.55 160.4 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.731 1.212 . . . . 0.0 109.792 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.7 p -83.84 -175.24 5.71 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.906 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.435 ' CH2' HD11 ' A' ' 66' ' ' LEU . 18.9 t-105 -170.18 100.59 0.28 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 120.673 0.273 . . . . 0.0 111.215 -169.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.3 t -92.01 103.5 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.648 0.779 . . . . 0.0 109.09 176.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.582 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -102.57 143.82 31.77 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.108 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -57.5 121.41 10.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.391 1.077 . . . . 0.0 111.778 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.54 -1.04 79.1 Favored Glycine 0 C--N 1.346 1.099 0 O-C-N 123.23 0.331 . . . . 0.0 113.762 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 47.0 mmtm -120.82 163.96 26.22 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.179 0.992 . . . . 0.0 109.598 -175.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.11 -178.26 4.07 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.635 2.224 . . . . 0.0 112.44 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.27 96.97 7.44 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.401 ' OG ' ' HB3' ' A' ' 87' ' ' TRP . 78.4 p -80.58 168.03 19.38 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.895 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.24 119.14 29.3 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.641 0.777 . . . . 0.0 109.637 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.75 142.86 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.28 1.032 . . . . 0.0 109.327 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -139.8 115.84 10.36 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tt -99.36 124.0 44.11 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.656 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 32.3 ttt180 -126.25 105.22 8.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.412 0.685 . . . . 0.0 109.896 -173.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 91.0 mt -88.78 134.27 33.98 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.256 0.623 . . . . 0.0 109.822 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.6 m -125.71 171.89 10.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.706 1.202 . . . . 0.0 109.158 172.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.88 123.46 49.83 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -177.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -141.84 109.34 5.63 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -171.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 53.91 -103.86 0.19 Allowed Glycine 0 CA--C 1.531 1.089 0 O-C-N 123.976 0.797 . . . . 0.0 113.852 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -109.13 -9.12 15.06 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.608 1.163 . . . . 0.0 110.669 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.84 -163.74 13.28 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.064 -171.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.4 m -146.12 126.54 14.05 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.482 1.113 . . . . 0.0 109.225 -172.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 27' ' ' ARG . 44.7 tp -86.81 129.04 35.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.467 HD22 HD11 ' A' ' 133' ' ' LEU . 8.6 tt -108.67 108.81 19.81 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 32.2 mt-10 -107.12 105.63 15.72 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.22 103.58 12.01 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.569 0.748 . . . . 0.0 109.935 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.595 ' HG2' HG13 ' A' ' 25' ' ' ILE . 38.0 mt-10 -100.3 115.1 29.14 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 173.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.408 ' HE2' ' HE2' ' A' ' 121' ' ' MET . 3.5 t-160 -107.85 113.25 26.33 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.18 117.62 33.08 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.91 0.884 . . . . 0.0 111.598 -168.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.7 t -143.6 155.83 44.4 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.663 0.785 . . . . 0.0 110.694 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 p -79.8 -8.38 59.24 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.188 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.2 m -98.62 117.68 33.61 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.652 0.781 . . . . 0.0 110.67 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.39 -37.05 85.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.578 0.751 . . . . 0.0 111.774 -178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -60.54 -54.74 41.85 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.694 173.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.496 ' HE3' ' HD2' ' A' ' 89' ' ' TYR . 26.8 ttt -49.63 -36.81 25.73 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 124.121 0.888 . . . . 0.0 113.026 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.467 HD22 HG23 ' A' ' 24' ' ' ILE . 63.6 mt -60.64 -47.92 84.1 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.916 0.486 . . . . 0.0 111.528 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.466 ' O ' HG23 ' A' ' 127' ' ' VAL . 46.9 t -62.48 -55.2 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 123.505 0.503 . . . . 0.0 109.796 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -43.61 -62.42 1.1 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.559 1.943 . . . . 0.0 113.038 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.2 m -66.52 -33.27 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 122.815 0.446 . . . . 0.0 110.575 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.82 -37.23 90.08 Favored Glycine 0 C--N 1.35 1.349 0 O-C-N 123.723 0.639 . . . . 0.0 112.136 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 123' ' ' VAL . 89.8 t -74.28 -45.7 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.167 0.587 . . . . 0.0 109.648 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.99 -61.25 7.65 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.833 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 20.0 m95 -51.76 -36.99 49.42 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -57.49 -44.18 84.72 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 120.016 1.28 . . . . 0.0 111.21 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 88.5 mtp -64.14 -46.89 82.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 174.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 129' ' ' TRP . . . -68.12 -22.98 64.86 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.667 1.187 . . . . 0.0 112.76 -176.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.467 HD11 HD22 ' A' ' 110' ' ' LEU . 2.7 mm? -86.58 -30.77 21.6 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.6 -37.83 55.8 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.681 0.792 . . . . 0.0 109.637 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -68.48 -46.28 70.14 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.266 0.626 . . . . 0.0 109.735 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.33 -24.24 66.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 122.972 0.509 . . . . 0.0 110.104 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -68.96 -54.8 12.51 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 8.6 mtm -68.52 -33.93 74.99 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.306 0.642 . . . . 0.0 111.332 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -62.62 -55.45 26.95 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.954 0.902 . . . . 0.0 110.686 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.0 tt -72.7 -26.39 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.936 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 . . . . . 0 CA--C 1.538 0.482 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.952 178.315 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.535 0.207 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 46.8 t -62.0 -34.27 75.87 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.113 0.565 . . . . 0.0 111.102 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -72.32 -56.68 5.09 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.094 0.558 . . . . 0.0 110.024 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -48.85 -53.34 19.77 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.381 1.072 . . . . 0.0 112.299 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -70.84 -45.36 64.64 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.226 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -59.07 -58.87 12.23 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 124.148 0.905 . . . . 0.0 114.246 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -54.28 -43.73 71.3 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.152 0.981 . . . . 0.0 111.682 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.01 -38.24 87.9 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 123.675 0.609 . . . . 0.0 111.389 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -78.11 -24.47 47.47 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 119.201 -0.428 . . . . 0.0 112.03 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.91 -42.4 73.39 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -71.34 -26.53 62.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.258 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.498 HD22 ' HG ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -82.65 -49.23 10.03 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.597 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.44 -29.51 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.459 0.704 . . . . 0.0 112.533 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -64.89 -6.99 9.57 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 122.822 0.449 . . . . 0.0 111.321 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.353 0.721 0 C-N-CA 126.993 2.117 . . . . 0.0 112.737 164.43 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 55.5 m -115.27 108.94 17.22 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 124.856 1.262 . . . . 0.0 109.815 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -109.72 124.67 51.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.362 1.065 . . . . 0.0 109.268 -176.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -81.88 154.29 25.91 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.511 0.725 . . . . 0.0 110.895 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -160.06 172.83 16.8 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.31 0.644 . . . . 0.0 109.963 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.5 141.68 25.04 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.887 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.42 -151.52 5.44 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 32.3 ptt180 -144.66 170.81 15.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.353 0.661 . . . . 0.0 109.377 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -163.4 115.32 1.46 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.6 m -86.23 100.94 12.6 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.7 pt -93.88 168.76 11.15 Favored Pre-proline 0 CA--C 1.557 1.225 0 C-N-CA 124.738 1.215 . . . . 0.0 108.682 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.36 -17.49 27.02 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.865 2.376 . . . . 0.0 114.045 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.13 -0.33 56.95 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.95 178.31 15.26 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 118.214 0.461 . . . . 0.0 112.271 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.48 95.29 1.77 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-O 121.737 0.78 . . . . 0.0 109.984 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.65 166.32 19.26 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.29 174.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 20.2 ttm180 -118.42 161.1 20.54 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.448 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 79.7 p -134.11 144.16 48.42 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -173.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 37.4 pt -93.08 150.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 166.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 3.1 mp -129.22 116.03 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.8 mt -109.84 108.35 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 7' ' ' THR . 99.9 mtt180 -95.03 132.77 39.54 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.642 0.777 . . . . 0.0 109.919 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 73.8 mt-30 -143.41 140.19 30.31 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.316 1.01 . . . . 0.0 108.875 172.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -110.77 115.0 28.8 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -87.8 137.36 32.4 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.181 1.393 . . . . 0.0 110.008 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -78.52 38.07 0.3 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 123.936 0.773 . . . . 0.0 111.881 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.43 156.0 53.51 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 123.892 0.877 . . . . 0.0 108.771 -171.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.417 ' O ' HG23 ' A' ' 37' ' ' VAL . 72.5 Cg_endo -70.05 168.39 22.06 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 122.878 2.386 . . . . 0.0 113.695 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' A' ' 80' ' ' PRO . 89.0 t -67.47 -47.59 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.217 -172.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.34 -37.76 84.48 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.069 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -66.52 -63.49 1.06 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.99 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 33' ' ' PRO . 55.1 t -51.62 -34.26 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.739 1.216 . . . . 0.0 111.71 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.428 ' HE3' HD12 ' A' ' 101' ' ' LEU . 51.0 t-105 -58.46 -56.24 24.62 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.453 0.701 . . . . 0.0 110.198 176.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.9 m -57.17 -33.36 67.36 Favored 'General case' 0 CA--C 1.555 1.154 0 O-C-N 124.403 1.064 . . . . 0.0 111.396 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.498 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -68.15 -38.26 81.95 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 174.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.1 m -74.63 -27.76 60.58 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.232 0.613 . . . . 0.0 112.034 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.9 p -99.0 -46.19 5.69 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.196 0.598 . . . . 0.0 112.244 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.84 119.13 51.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 123.221 0.609 . . . . 0.0 110.904 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.68 -29.07 87.63 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 123.621 2.88 . . . . 0.0 112.899 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.4 -52.65 57.12 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.275 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -65.02 -31.0 72.02 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.733 173.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.503 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 40.5 mt -58.27 -41.6 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.255 0.622 . . . . 0.0 110.926 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -57.19 -29.13 63.43 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.994 0.918 . . . . 0.0 112.337 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -75.76 -5.35 45.36 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.667 0.787 . . . . 0.0 112.807 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.512 ' CD1' HD13 ' A' ' 136' ' ' LEU . 59.0 p-90 -149.2 4.31 0.61 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -165.83 -172.74 2.45 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -166.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.534 HD12 HD13 ' A' ' 66' ' ' LEU . 59.4 mt -86.61 140.86 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.076 0.95 . . . . 0.0 110.34 -171.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.68 110.93 3.61 Favored Pre-proline 0 N--CA 1.48 1.051 0 O-C-N 125.021 1.451 . . . . 0.0 110.225 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -90.88 179.61 1.69 Allowed 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.654 2.236 . . . . 0.0 112.799 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -152.39 157.55 41.42 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.101 0.96 . . . . 0.0 109.418 173.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.82 -166.94 25.51 Favored Glycine 0 N--CA 1.462 0.433 0 CA-C-N 116.623 -0.262 . . . . 0.0 113.608 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -78.45 -35.66 46.51 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.17 0.988 . . . . 0.0 110.334 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.7 mt 67.58 10.98 8.14 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.239 1.416 . . . . 0.0 113.453 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -102.34 178.15 4.67 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.721 0.809 . . . . 0.0 110.637 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.48 99.81 0.79 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.577 1.151 . . . . 0.0 109.902 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.55 -11.79 58.08 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.185 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.76 -169.32 30.23 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 169.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 34.7 p30 -128.13 155.2 44.82 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.868 -0.784 . . . . 0.0 112.222 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -119.7 161.77 20.14 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 165.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -163.24 112.85 1.33 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.534 HD13 HD12 ' A' ' 52' ' ' ILE . 72.5 mt -66.42 164.0 17.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.378 0.671 . . . . 0.0 110.935 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -81.3 112.68 18.83 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 40.94 54.97 3.5 Favored Glycine 0 CA--C 1.539 1.581 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -143.97 -76.78 0.23 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 117.197 0.499 . . . . 0.0 110.31 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.405 ' HB2' ' HD1' ' A' ' 89' ' ' TYR . . . -145.36 160.93 40.79 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.287 0.635 . . . . 0.0 109.749 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 35.0 t -127.3 158.04 38.28 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.35 -171.28 31.39 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.222 -0.513 . . . . 0.0 114.043 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 4.4 m-20 -137.94 161.99 35.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.01 0.924 . . . . 0.0 109.621 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -92.87 98.87 8.87 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.426 HD12 HG22 ' A' ' 84' ' ' THR . 97.4 mt -67.69 -46.38 72.43 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.095 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -161.31 115.11 1.97 Allowed 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.687 0.795 . . . . 0.0 109.965 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.3 p -98.12 114.91 27.25 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 164.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -127.12 84.93 62.21 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -170.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 92.3 Cg_endo -78.14 144.66 21.18 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.935 2.424 . . . . 0.0 113.182 -171.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.561 ' HB2' HG12 ' A' ' 34' ' ' VAL . 22.2 Cg_endo -97.78 23.95 22.54 Favored 'Cis proline' 0 C--N 1.374 1.907 0 C-N-CA 124.617 -0.993 . . . . 0.0 112.318 -8.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.684 ' HG2' ' HG3' ' A' ' 82' ' ' ARG . 60.7 ttt180 -73.09 -73.49 0.2 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.852 0.861 . . . . 0.0 111.167 -171.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.684 ' HG3' ' HG2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -155.36 158.7 39.1 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.424 0.69 . . . . 0.0 111.483 -178.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -130.27 129.25 43.04 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.426 HG22 HD12 ' A' ' 75' ' ' LEU . 19.4 m -103.08 135.7 44.25 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.223 1.409 . . . . 0.0 108.179 172.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.3 pt -131.19 163.4 37.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 124.122 0.969 . . . . 0.0 109.648 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.5 t -101.42 148.34 25.29 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 24.7 t-105 -140.65 92.93 2.55 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 109.769 -172.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.8 106.75 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 58.2 t80 -90.05 163.31 14.95 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 169.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.67 118.73 6.95 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.785 0.434 . . . . 0.0 111.027 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.88 25.13 75.48 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.833 0.708 . . . . 0.0 113.287 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 73.8 mmtt -132.43 147.48 65.85 Favored Pre-proline 0 N--CA 1.488 1.438 0 C-N-CA 123.975 0.91 . . . . 0.0 110.003 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.48 -178.18 3.83 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.69 2.26 . . . . 0.0 112.854 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.91 87.74 0.55 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.48 0.712 . . . . 0.0 109.554 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.664 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.4 m -71.86 136.54 47.0 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.699 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -102.45 108.93 20.42 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -172.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.0 t -108.31 136.24 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.111 0.964 . . . . 0.0 108.662 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -138.05 115.93 11.54 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.006 0.922 . . . . 0.0 109.433 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.416 ' HB2' HD13 ' A' ' 112' ' ' LEU . 8.2 tt -105.31 130.56 53.41 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.541 ' HD2' ' HB3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -131.08 143.62 50.81 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.023 0.44 . . . . 0.0 110.392 -177.18 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.502 ' HB3' HG13 ' A' ' 34' ' ' VAL . 97.9 mt -132.43 123.7 27.2 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 125.247 1.419 . . . . 0.0 109.436 -174.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 t -151.97 138.43 18.58 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.872 0.869 . . . . 0.0 108.972 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.08 146.0 44.55 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.04 0.936 . . . . 0.0 111.783 -173.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -153.15 118.04 5.08 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.79 1.236 . . . . 0.0 107.924 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 64.11 -111.84 4.49 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 123.427 0.454 . . . . 0.0 113.003 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -111.74 5.66 19.29 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.035 0.534 . . . . 0.0 110.188 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.39 -153.97 8.87 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.087 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.7 m -147.04 134.39 20.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.122 0.969 . . . . 0.0 109.568 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 42.4 tp -80.77 117.42 21.42 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.7 tt -101.23 106.13 17.31 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 164.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.541 ' HB3' ' HD2' ' A' ' 100' ' ' ARG . 35.6 tt0 -121.95 109.72 14.95 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.416 HD13 ' HB2' ' A' ' 99' ' ' LEU . 52.4 tp -107.17 114.35 28.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.551 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.448 ' HG3' ' HB2' ' A' ' 23' ' ' SER . 34.6 tt0 -94.06 127.2 39.73 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.249 0.62 . . . . 0.0 109.377 168.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -114.64 116.27 28.46 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 168.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.5 120.16 41.65 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.59 0.756 . . . . 0.0 110.291 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.3 t -139.45 154.82 47.83 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.258 0.623 . . . . 0.0 110.114 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.1 m -71.9 -16.29 62.12 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.458 1.103 . . . . 0.0 111.311 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 121' ' ' MET . 17.6 m -100.33 117.84 35.36 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.843 0.857 . . . . 0.0 110.201 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.621 ' HA ' HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -68.48 -29.25 67.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.806 0.842 . . . . 0.0 112.088 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -67.34 -54.41 20.88 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.532 0.52 . . . . 0.0 110.71 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.476 ' HB3' ' HB2' ' A' ' 118' ' ' SER . 28.1 ttt -50.13 -31.94 14.71 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.842 172.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.621 HD12 ' HA ' ' A' ' 119' ' ' GLU . 50.3 mt -65.44 -42.67 92.14 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.952 0.501 . . . . 0.0 111.96 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 127' ' ' VAL . 45.8 t -64.26 -51.05 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -44.31 -57.82 3.27 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.526 1.53 . . . . 0.0 112.754 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 121' ' ' MET . 30.7 m -75.68 -20.03 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 123.848 0.718 . . . . 0.0 110.726 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.72 -39.81 96.95 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 171.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 123' ' ' VAL . 48.4 t -74.73 -53.42 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.36 -61.45 7.21 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 114.537 -1.211 . . . . 0.0 114.207 -176.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -63.99 -39.49 94.24 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 118.405 -0.807 . . . . 0.0 112.922 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -58.57 -45.86 88.12 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 119.549 1.068 . . . . 0.0 110.375 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 40.8 mtm -67.08 -42.82 84.0 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.95 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.37 -61.16 2.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.63 0.772 . . . . 0.0 111.501 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.98 -33.67 69.14 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.205 0.602 . . . . 0.0 112.617 174.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.96 -37.33 82.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 118.321 0.51 . . . . 0.0 110.695 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -66.91 -40.13 87.58 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.985 0.514 . . . . 0.0 109.773 171.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.512 HD13 ' CD1' ' A' ' 50' ' ' TRP . 41.6 tp -64.46 -23.08 67.16 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.06 0.544 . . . . 0.0 110.52 175.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.38 -46.84 11.51 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 79.6 mtp -65.53 -42.17 92.28 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.85 0.86 . . . . 0.0 110.717 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.4 ' HD2' HD12 ' A' ' 136' ' ' LEU . 35.4 t80 -57.4 -55.55 33.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.06 0.944 . . . . 0.0 111.445 -175.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 44.2 mt -71.35 -28.21 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 123.326 0.391 . . . . 0.0 110.367 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 . . . . . 0 CA--C 1.563 1.464 0 C-N-CA 122.936 0.495 . . . . 0.0 110.589 174.003 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.418 ' O ' ' HD3' ' A' ' 170' ' ' ARG . 99.9 mt . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.8 t -64.5 -25.0 67.8 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.358 0.663 . . . . 0.0 112.204 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -73.04 -47.68 42.71 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -58.48 -49.6 76.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.533 0.733 . . . . 0.0 111.658 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 166' ' ' ILE . 9.3 mpt_? -74.67 -48.39 26.45 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.648 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.46 -52.23 29.21 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 123.791 0.682 . . . . 0.0 114.225 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.08 -31.23 67.56 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.518 0.727 . . . . 0.0 112.111 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.74 -56.91 7.44 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.926 0.491 . . . . 0.0 110.54 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -67.71 -22.19 65.27 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.522 0.729 . . . . 0.0 111.829 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.45 84.78 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.999 0.428 . . . . 0.0 110.077 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -75.97 -29.12 58.14 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.11 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 57.7 mt -74.66 -52.3 12.04 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.781 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.26 -29.15 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 122.51 0.324 . . . . 0.0 111.791 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -69.16 -6.82 31.1 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.286 0.634 . . . . 0.0 112.615 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 125.029 1.331 . . . . 0.0 109.433 174.63 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 110.939 -0.023 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -93.84 119.75 33.19 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 3.5 tm-20 -114.87 127.87 55.96 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -106.39 156.52 18.44 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.23 0.538 . . . . 0.0 112.305 -173.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -161.91 -175.41 4.64 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.693 -171.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 mt -140.82 167.34 22.42 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.431 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.83 -162.59 16.19 Favored Glycine 0 C--O 1.246 0.888 0 CA-C-N 113.395 -1.729 . . . . 0.0 109.712 168.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.42 160.68 35.69 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 168.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -162.35 117.54 1.89 Allowed 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -173.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 92.3 m -87.58 98.0 11.17 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.2 pt -78.66 166.08 45.1 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 125.475 1.51 . . . . 0.0 110.537 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.27 -27.71 5.01 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 123.748 2.965 . . . . 0.0 115.038 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.71 -49.58 45.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.013 0.525 . . . . 0.0 110.839 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.99 -160.11 32.15 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-O 119.711 -0.494 . . . . 0.0 112.023 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.66 105.09 0.74 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.204 0.602 . . . . 0.0 111.104 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -107.96 154.41 21.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.935 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 23' ' ' SER . 7.0 tpp180 -83.95 155.66 22.71 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 165.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.469 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 77.0 p -132.41 135.14 45.9 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 110.919 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 2.9 pp -93.71 142.15 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 170.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -123.61 118.17 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -176.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.0 mt -111.27 106.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.583 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 66.9 mtt180 -92.09 147.66 22.78 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -156.42 130.64 8.64 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.86 106.85 19.16 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.544 1.138 . . . . 0.0 108.175 -172.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.71 134.0 34.73 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.691 0.797 . . . . 0.0 110.559 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.36 46.88 0.87 Allowed 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 122.039 0.923 . . . . 0.0 110.236 170.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.27 154.79 57.75 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 123.928 0.891 . . . . 0.0 109.359 -171.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 37' ' ' VAL . 60.8 Cg_endo -71.26 165.74 31.47 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.579 2.186 . . . . 0.0 113.188 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 80' ' ' PRO . 88.7 t -73.21 -40.77 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.564 -172.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.18 -47.95 71.47 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.218 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -65.01 -64.47 0.86 Allowed 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.329 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 33' ' ' PRO . 48.3 t -50.01 -35.22 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.214 1.006 . . . . 0.0 111.667 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -58.62 -57.73 11.71 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.847 0.859 . . . . 0.0 110.209 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 m -61.22 -35.75 78.06 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.392 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -62.57 -33.62 75.33 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 122.05 -0.406 . . . . 0.0 112.082 172.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.443 ' HA ' ' HZ2' ' A' ' 50' ' ' TRP . 83.1 m -85.41 -18.28 34.13 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.663 0.785 . . . . 0.0 113.067 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 p -113.05 -40.21 4.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.18 111.33 5.25 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 123.657 0.783 . . . . 0.0 110.829 175.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.428 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 66.7 Cg_exo -54.13 -33.61 74.93 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 123.703 2.936 . . . . 0.0 113.868 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -61.04 -49.83 75.8 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -65.68 -35.37 80.57 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.516 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.509 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 87.9 mt -66.51 -41.46 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.556 0.743 . . . . 0.0 111.911 -174.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.527 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 27.5 p30 -60.21 -15.38 23.83 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -78.88 -45.78 19.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.828 0.851 . . . . 0.0 111.562 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.509 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 67.8 p-90 -108.59 8.17 27.01 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.258 0.623 . . . . 0.0 112.603 -172.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -174.47 173.83 2.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.319 0.648 . . . . 0.0 109.39 -168.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.1 mt -86.46 123.08 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 32.3 tt0 -63.32 130.35 94.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.793 1.637 . . . . 0.0 112.086 -174.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.601 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 83.0 Cg_endo -81.58 129.28 6.42 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.525 2.15 . . . . 0.0 112.154 175.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -93.85 160.36 14.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.873 1.269 . . . . 0.0 109.45 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.46 -168.79 15.63 Favored Glycine 0 N--CA 1.47 0.964 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.47 -36.79 68.56 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.212 0.605 . . . . 0.0 110.603 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.8 mt 71.9 -10.17 0.89 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.241 1.416 . . . . 0.0 114.095 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -86.39 171.03 11.46 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.535 0.734 . . . . 0.0 109.891 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.715 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 41.2 tt0 -67.82 102.22 1.2 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.248 0.619 . . . . 0.0 110.489 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.54 -15.07 17.56 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.85 -160.43 36.35 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -143.04 155.15 44.57 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.805 1.303 . . . . 0.0 111.188 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.601 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 17.1 p90 -106.02 163.35 12.83 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.464 166.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.94 108.05 0.86 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.218 1.007 . . . . 0.0 109.919 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.1 mt -69.29 170.67 9.82 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.449 0.7 . . . . 0.0 109.65 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -76.51 -17.95 58.99 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 122.084 -0.385 . . . . 0.0 111.805 -169.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.79 47.49 0.04 OUTLIER Glycine 0 N--CA 1.467 0.728 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -128.0 -62.3 1.06 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.156 0.982 . . . . 0.0 108.894 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.11 161.34 36.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.977 0.511 . . . . 0.0 111.205 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.6 p -152.81 130.74 11.75 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 86' ' ' SER . . . -161.19 174.61 37.79 Favored Glycine 0 C--N 1.344 1.005 0 C-N-CA 121.663 -0.304 . . . . 0.0 113.449 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -86.55 159.22 19.33 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.216 1.007 . . . . 0.0 111.05 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 mm -93.22 98.74 8.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.401 HD12 HG22 ' A' ' 84' ' ' THR . 87.0 mt -63.81 -51.78 63.2 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.794 0.838 . . . . 0.0 111.123 -174.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -160.78 152.45 19.58 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.661 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 26.2 p -148.13 138.25 22.65 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.57 0.748 . . . . 0.0 109.209 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -138.56 93.58 10.99 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.87 141.49 13.4 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.94 2.426 . . . . 0.0 112.703 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.422 ' HB2' HG12 ' A' ' 34' ' ' VAL . 18.3 Cg_endo -95.81 25.13 22.64 Favored 'Cis proline' 0 C--N 1.378 2.131 0 CA-C-N 119.537 0.87 . . . . 0.0 112.523 -5.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -78.99 -75.84 0.22 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.427 0.691 . . . . 0.0 111.673 -171.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -142.37 139.53 31.75 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 118.549 0.613 . . . . 0.0 112.39 -169.128 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.6 tp -124.48 124.41 42.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.939 1.696 . . . . 0.0 108.404 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.401 HG22 HD12 ' A' ' 75' ' ' LEU . 61.7 m -113.41 114.05 26.06 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.725 0.81 . . . . 0.0 109.917 175.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.0 pt -110.4 168.78 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 124.483 1.113 . . . . 0.0 110.431 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.447 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 14.4 m -103.51 136.39 43.33 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -175.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 44.6 t-105 -128.5 104.58 7.77 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.612 0.642 . . . . 0.0 110.402 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.29 103.67 15.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.539 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 47.2 t80 -90.22 163.66 14.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.751 0.82 . . . . 0.0 109.886 -177.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -52.52 106.49 0.16 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.864 1.265 . . . . 0.0 111.774 177.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.74 2.45 51.04 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 114.433 0.533 . . . . 0.0 114.433 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 41.5 mmtm -101.09 159.47 29.4 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.145 0.978 . . . . 0.0 109.262 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.95 -176.94 2.86 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.119 1.879 . . . . 0.0 112.113 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.58 144.75 56.24 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.178 174.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.5 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 30.0 p -146.99 156.34 42.96 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.121 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -116.23 117.58 30.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.487 0.715 . . . . 0.0 109.103 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 54.2 t -94.31 130.14 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 36.2 mm-40 -116.72 111.93 20.48 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.131 1.772 . . . . 0.0 107.182 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.497 HD13 HD12 ' A' ' 112' ' ' LEU . 59.6 tp -107.33 114.0 27.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -119.65 137.85 53.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.138 0.975 . . . . 0.0 109.601 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 67.9 mt -127.7 142.8 51.23 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.562 1.145 . . . . 0.0 109.221 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 t -137.03 170.77 15.55 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.956 1.303 . . . . 0.0 108.968 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.69 128.01 56.28 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -141.77 106.32 4.86 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.47 -103.9 0.36 Allowed Glycine 0 CA--C 1.534 1.277 0 CA-C-N 117.845 0.293 . . . . 0.0 113.342 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -115.71 2.27 13.66 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.565 0.746 . . . . 0.0 111.069 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -130.13 -173.58 13.44 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 123.891 0.758 . . . . 0.0 111.911 -174.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 89.0 m -121.33 148.22 44.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.848 0.859 . . . . 0.0 110.424 -176.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.9 tp -103.22 134.58 46.39 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 166.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 tt -119.74 109.73 15.97 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.583 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 31.7 mt-10 -109.54 105.57 14.94 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.499 HD13 HD21 ' A' ' 133' ' ' LEU . 8.6 tt -105.4 107.4 18.37 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' A' ' 23' ' ' SER . 32.8 tt0 -92.4 128.18 38.15 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.898 0.879 . . . . 0.0 108.973 173.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.678 ' HD1' ' HE1' ' A' ' 129' ' ' TRP . 6.2 t60 -113.77 118.42 34.24 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 171.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.12 114.86 29.24 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.083 0.953 . . . . 0.0 110.889 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.696 HG21 ' HG3' ' A' ' 121' ' ' MET . 4.4 t -150.26 150.67 31.86 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.596 0.758 . . . . 0.0 110.921 176.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 74.1 p -73.23 -42.68 62.32 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.922 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.1 m -76.62 131.82 39.09 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.472 0.709 . . . . 0.0 112.384 -165.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -60.78 -50.66 72.56 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.78 1.232 . . . . 0.0 113.243 -170.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -62.49 -53.35 56.11 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.696 ' HG3' HG21 ' A' ' 116' ' ' THR . 13.7 tpt -44.14 -38.94 3.97 Favored 'General case' 0 CA--C 1.56 1.351 0 O-C-N 124.873 1.358 . . . . 0.0 112.711 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HG ' HG23 ' A' ' 116' ' ' THR . 13.4 mt -66.54 -47.07 74.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.541 1.136 . . . . 0.0 112.733 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.5 t -64.16 -51.45 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -46.94 -47.5 21.69 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.647 1.979 . . . . 0.0 113.713 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 m -83.39 -25.77 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.479 0.312 . . . . 0.0 111.491 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.61 -39.73 98.26 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.81 -51.15 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.369 1.068 . . . . 0.0 108.99 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.64 -61.75 6.48 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 114.545 -1.207 . . . . 0.0 114.132 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.678 ' HE1' ' HD1' ' A' ' 114' ' ' HIS . 81.5 m95 -63.74 -44.32 93.87 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 118.69 -0.671 . . . . 0.0 112.439 177.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.21 -39.87 91.85 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.344 0.974 . . . . 0.0 110.944 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.9 ttm -70.99 -37.76 72.7 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.738 0.815 . . . . 0.0 110.48 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.66 -59.5 4.19 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.502 0.721 . . . . 0.0 111.202 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.499 HD21 HD13 ' A' ' 112' ' ' LEU . 3.6 mm? -58.5 -29.16 66.05 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.321 0.648 . . . . 0.0 112.061 173.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.01 -38.5 91.28 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 118.395 0.543 . . . . 0.0 110.607 174.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -64.76 -31.2 72.31 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.178 0.591 . . . . 0.0 110.663 171.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.495 HD11 ' HB1' ' A' ' 40' ' ' ALA . 53.2 tp -66.76 -42.15 86.59 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.855 0.462 . . . . 0.0 110.074 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -47.48 -45.99 22.91 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.304 0.378 . . . . 0.0 113.741 165.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 73.4 mtp -74.15 -30.13 62.13 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 123.589 0.756 . . . . 0.0 111.485 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -71.43 -54.92 9.04 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.195 0.998 . . . . 0.0 110.122 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 40.6 mt -64.14 -31.38 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.416 1.086 . . . . 0.0 110.972 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 70.2 ttt180 . . . . . 0 CA--C 1.554 1.132 0 C-N-CA 123.611 0.765 . . . . 0.0 111.243 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 61.9 mt . . . . . 0 CA--C 1.545 0.759 0 CA-C-O 119.8 -0.143 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 31.1 t -51.62 -42.14 61.78 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.942 0.897 . . . . 0.0 112.471 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -89.47 -29.32 19.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -61.79 -50.26 73.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.666 1.587 . . . . 0.0 110.408 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -60.69 -53.09 61.66 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.42 174.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.66 -50.0 38.39 Favored Glycine 0 C--N 1.351 1.407 0 O-C-N 124.545 1.153 . . . . 0.0 115.204 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.07 -32.96 69.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.033 0.533 . . . . 0.0 111.345 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.38 68.77 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.972 0.509 . . . . 0.0 111.133 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.4 ' CE3' HD12 ' A' ' 177' ' ' LEU . 94.5 m95 -70.72 -27.21 63.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.25 0.62 . . . . 0.0 111.599 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.47 73.71 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 123.506 0.504 . . . . 0.0 110.155 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -70.6 -33.83 71.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.4 0.28 . . . . 0.0 110.499 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.4 HD12 ' CE3' ' A' ' 174' ' ' TRP . 63.1 mt -73.05 -62.12 1.58 Allowed 'General case' 0 C--N 1.349 0.56 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.595 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 122' ' ' LEU . 4.4 p -73.43 -22.17 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -166.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -87.14 4.89 40.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.273 0.629 . . . . 0.0 111.188 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 123.672 0.789 . . . . 0.0 111.299 -179.59 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 29' ' ' ARG . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 121.234 0.54 . . . . 0.0 111.454 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 m -81.94 117.62 22.32 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.743 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 35.6 mt-10 -118.94 110.48 17.19 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.788 0.835 . . . . 0.0 108.847 -175.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -68.62 147.67 51.57 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -157.94 161.65 38.2 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.749 0.419 . . . . 0.0 110.48 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -144.64 143.85 30.96 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.63 171.47 33.65 Favored Glycine 0 C--O 1.238 0.348 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 173.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -94.68 160.41 14.63 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.28 122.06 2.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -169.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.3 m -86.36 129.91 34.69 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 117' ' ' THR . 48.9 pt -125.28 165.43 26.25 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.473 1.109 . . . . 0.0 109.005 -174.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.5 -33.35 38.11 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.054 2.503 . . . . 0.0 114.735 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.17 -31.61 67.87 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.459 0.704 . . . . 0.0 111.935 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.24 -164.66 31.04 Favored Glycine 0 N--CA 1.47 0.9 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -74.86 138.42 42.47 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.033 1.417 . . . . 0.0 109.051 172.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.83 168.17 20.41 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.006 1.322 . . . . 0.0 109.871 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.436 HH21 ' HB2' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -104.59 166.64 10.26 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 168.443 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 23.6 p -140.1 130.21 24.99 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.767 -174.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.546 HG12 HG23 ' A' ' 125' ' ' VAL . 2.6 pp -86.92 135.95 24.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 168.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 4.8 mp -124.98 115.48 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.458 HG12 ' CZ2' ' A' ' 174' ' ' TRP . 25.2 mt -105.68 107.17 22.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.579 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 54.0 mtp180 -95.48 162.0 13.83 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.642 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 29.5 tt0 -168.72 120.9 0.79 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 125.029 1.456 . . . . 0.0 111.039 -178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.609 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 2.5 mpt_? -88.95 103.57 16.16 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 170.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.445 ' HE1' ' HA2' ' A' ' 137' ' ' GLY . 77.6 m-85 -84.08 141.37 31.17 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.661 170.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.36 -11.47 59.93 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 123.69 0.619 . . . . 0.0 111.346 174.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.28 152.61 83.96 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 122.551 0.34 . . . . 0.0 110.774 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.419 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 28.0 Cg_endo -62.61 148.64 93.08 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.818 2.346 . . . . 0.0 112.576 171.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 108' ' ' THR . 68.6 t -47.45 -40.92 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 125.062 1.345 . . . . 0.0 111.981 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -50.04 -50.49 47.48 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.833 1.333 . . . . 0.0 111.111 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.419 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 36.8 mt-10 -71.29 -29.79 65.47 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.264 -177.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.6 t -74.56 -40.01 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.465 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -74.52 -28.24 60.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.671 0.788 . . . . 0.0 109.825 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB3' ' NH1' ' A' ' 46' ' ' ARG . 74.1 m -69.14 -44.09 73.04 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.305 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -44.69 93.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.821 0.848 . . . . 0.0 111.51 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 72.7 m -68.36 -33.83 74.98 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.1 p -111.31 -34.72 6.06 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -169.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.484 ' O ' HG13 ' A' ' 47' ' ' ILE . 32.6 t70 -71.02 114.9 31.1 Favored Pre-proline 0 N--CA 1.486 1.354 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.777 -178.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -52.07 -34.78 59.11 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.568 2.845 . . . . 0.0 113.8 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -72.03 -20.61 61.67 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.318 1.011 . . . . 0.0 110.604 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.409 ' NH1' ' HB3' ' A' ' 39' ' ' SER . 72.8 mtt85 -94.81 -25.98 16.41 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.331 0.652 . . . . 0.0 111.7 172.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 43' ' ' ASP . 82.2 mt -76.61 -31.5 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -73.43 -4.29 32.72 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.263 0.625 . . . . 0.0 112.318 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.34 -30.75 13.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.403 0.681 . . . . 0.0 110.701 -173.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.405 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 67.4 p-90 -119.09 -20.15 8.15 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.125 0.57 . . . . 0.0 111.875 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.405 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 51.4 t80 -127.75 -102.25 0.34 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.272 0.629 . . . . 0.0 109.803 -175.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.495 HD12 HD13 ' A' ' 66' ' ' LEU . 89.5 mt -149.42 142.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 124.157 0.983 . . . . 0.0 108.876 -170.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.06 108.06 1.34 Allowed Pre-proline 0 CA--C 1.561 1.385 0 O-C-N 124.657 1.223 . . . . 0.0 110.753 172.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -96.03 139.37 0.77 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.068 2.512 . . . . 0.0 113.463 -177.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -129.98 141.77 50.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.702 1.201 . . . . 0.0 109.417 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.59 -163.12 35.51 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.51 ' HB3' ' H ' ' A' ' 63' ' ' ASN . 29.3 t70 -75.09 -41.03 59.59 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.1 mt 70.81 -10.01 0.77 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.572 1.549 . . . . 0.0 113.708 170.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -93.59 165.91 12.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.883 0.873 . . . . 0.0 110.064 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.524 ' HG2' ' HA ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -64.78 123.46 19.42 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.815 0.846 . . . . 0.0 109.861 -176.394 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.39 7.14 69.93 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.646 -0.707 . . . . 0.0 112.991 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.66 -147.78 20.5 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 112.149 -0.38 . . . . 0.0 112.149 178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.623 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 26.2 p-10 -139.88 169.88 16.9 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.643 0.777 . . . . 0.0 110.969 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -142.69 154.64 44.5 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.65 142.37 25.58 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.891 0.877 . . . . 0.0 109.824 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.495 HD13 HD12 ' A' ' 52' ' ' ILE . 90.4 mt -94.74 -101.93 0.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.309 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -155.76 -56.68 0.09 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.82 0.848 . . . . 0.0 108.928 174.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.96 43.07 1.16 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.777 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -135.2 -74.04 0.46 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.024 0.93 . . . . 0.0 109.358 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.63 154.31 32.78 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 121.763 0.792 . . . . 0.0 112.713 -169.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.9 m -131.2 154.19 48.67 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 113.153 -1.84 . . . . 0.0 108.182 168.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 86' ' ' SER . . . -169.32 -156.88 11.14 Favored Glycine 0 CA--C 1.504 -0.655 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.073 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 24.8 m-20 -121.88 171.54 8.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.323 0.649 . . . . 0.0 110.462 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.6 mm -103.41 106.65 20.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.8 mt -77.56 -41.03 40.44 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 123.502 0.501 . . . . 0.0 110.212 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.524 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 36.9 ttm180 -175.77 113.96 0.13 Allowed 'General case' 0 C--N 1.363 1.162 0 O-C-N 123.955 0.784 . . . . 0.0 111.508 168.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.3 p -107.05 103.44 12.85 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.529 0.732 . . . . 0.0 109.512 174.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.502 ' HG3' ' HG2' ' A' ' 76' ' ' ARG . 48.8 mt-10 -104.73 112.29 65.3 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.651 1.18 . . . . 0.0 109.517 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 6.1 Cg_exo -79.81 126.33 6.5 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.913 2.408 . . . . 0.0 112.423 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.5 Cg_endo -103.73 25.06 12.07 Favored 'Cis proline' 0 C--N 1.376 1.989 0 CA-C-N 120.421 1.186 . . . . 0.0 112.717 -8.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -61.5 -67.55 0.4 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.156 0.982 . . . . 0.0 112.02 -171.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.493 ' NH2' ' HD2' ' A' ' 76' ' ' ARG . 14.8 ptt180 -152.5 157.15 40.72 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.169 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 tt -119.93 138.18 53.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 169.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.6 m -137.31 130.17 30.38 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.451 HG13 ' HB ' ' A' ' 97' ' ' VAL . 14.1 pt -144.18 146.82 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.296 1.038 . . . . 0.0 109.677 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.444 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 24.6 p -90.86 132.89 35.63 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 171.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 24.4 t-105 -121.68 104.62 9.74 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -171.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.7 t -102.77 103.11 14.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 170.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.532 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 42.8 t80 -77.34 147.11 36.33 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.8 113.59 2.85 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.374 0.669 . . . . 0.0 111.576 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.05 6.7 86.3 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 124.191 0.932 . . . . 0.0 113.354 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 12.4 mmmm -125.98 155.07 73.74 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.519 1.128 . . . . 0.0 109.169 -172.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.1 179.16 4.09 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.635 2.223 . . . . 0.0 114.243 -174.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.62 150.09 39.78 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.253 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.511 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.4 m -140.36 156.91 46.24 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.852 0.72 . . . . 0.0 110.951 178.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -112.06 108.61 17.97 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 165.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 52.6 t -94.33 119.58 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -124.32 115.86 21.68 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.452 0.644 . . . . 0.0 110.418 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -89.78 136.36 33.08 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 57.1 mtt85 -135.42 129.87 33.94 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -177.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 46.5 mt -116.54 147.06 42.16 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.914 0.486 . . . . 0.0 110.401 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.1 t -150.79 125.27 9.54 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.512 0.725 . . . . 0.0 110.528 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.29 124.22 26.02 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 173.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.59 125.79 12.99 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 124.144 0.978 . . . . 0.0 109.051 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.81 -89.14 1.34 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 171.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -160.97 39.88 0.15 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.13 -168.09 33.12 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.395 -172.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.498 HG23 HG22 ' A' ' 34' ' ' VAL . 32.1 m -137.66 131.11 30.99 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.095 0.958 . . . . 0.0 110.498 -166.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 55.1 tp -80.98 106.47 13.01 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 160.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.457 HD22 HD11 ' A' ' 133' ' ' LEU . 7.9 tt -87.45 128.2 35.22 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 160.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 31.7 tt0 -136.4 104.68 5.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.4 131.94 43.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 33.3 tt0 -123.2 143.62 49.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.579 ' HD1' ' HE1' ' A' ' 129' ' ' TRP . 8.6 t60 -138.87 114.71 10.02 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.1 104.52 11.64 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.352 0.661 . . . . 0.0 111.184 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.2 t -131.49 158.71 40.16 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-O 121.499 0.666 . . . . 0.0 109.743 173.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.468 HG23 HD11 ' A' ' 16' ' ' ILE . 40.4 p -80.05 -21.46 43.42 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.052 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.8 t -82.44 113.73 20.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.928 0.491 . . . . 0.0 110.473 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.436 ' HB2' HH21 ' A' ' 22' ' ' ARG . 36.7 tt0 -65.84 -29.3 69.75 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.946 0.899 . . . . 0.0 110.297 175.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -61.45 -50.48 72.61 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.287 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.9 ttt -68.77 -30.25 68.8 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.02 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.9 mt -66.1 -44.14 85.24 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.269 0.628 . . . . 0.0 112.314 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.3 t -65.43 -45.1 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -50.82 -51.55 49.91 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.605 1.162 . . . . 0.0 112.166 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.546 HG23 HG12 ' A' ' 24' ' ' ILE . 33.4 m -79.85 -21.72 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.845 0.458 . . . . 0.0 111.439 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.32 -34.9 86.76 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 168.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.24 -53.63 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 114.415 -0.892 . . . . 0.0 110.054 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.63 86.1 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.604 -0.726 . . . . 0.0 114.281 -175.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.579 ' HE1' ' HD1' ' A' ' 114' ' ' HIS . 34.2 m95 -85.47 -36.39 20.61 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.884 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -69.9 -29.2 66.34 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.112 0.869 . . . . 0.0 110.289 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 65.5 mtm -71.81 -37.43 70.36 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.76 -35.08 79.9 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 122.538 0.335 . . . . 0.0 111.255 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.457 HD11 HD22 ' A' ' 110' ' ' LEU . 3.3 mm? -81.5 -23.38 37.37 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.77 0.828 . . . . 0.0 110.723 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.52 -51.58 41.49 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.106 172.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -71.52 -24.56 61.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.647 0.779 . . . . 0.0 111.424 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -77.94 -31.05 50.73 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.778 0.431 . . . . 0.0 109.876 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.445 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -67.76 -34.34 82.77 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.033 171.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 89.5 mmm -66.35 -49.29 67.43 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.492 0.717 . . . . 0.0 109.474 170.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -56.11 -55.6 31.05 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.972 1.309 . . . . 0.0 111.726 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 59.4 mt -78.87 -55.75 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.459 0.704 . . . . 0.0 111.028 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 . . . . . 0 CA--C 1.551 0.988 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -170.92 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.466 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 71.7 mt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.2 p -71.0 -50.44 34.24 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.353 0.408 . . . . 0.0 110.645 -173.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -57.03 -48.82 77.58 Favored 'General case' 0 CA--C 1.557 1.224 0 O-C-N 124.044 0.84 . . . . 0.0 111.062 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -44.23 -48.03 9.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.315 1.046 . . . . 0.0 112.401 171.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 15.0 mmp_? -60.24 -52.03 67.03 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.375 0.422 . . . . 0.0 111.485 178.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -72.52 -37.85 58.06 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.285 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.17 -25.5 47.24 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.166 0.586 . . . . 0.0 110.985 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.03 -53.12 28.17 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.458 ' CZ2' HG12 ' A' ' 26' ' ' ILE . 97.5 m95 -71.35 -25.65 62.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.495 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.75 -59.56 4.1 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.31 -38.53 42.04 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.779 1.232 . . . . 0.0 112.975 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 53.9 mt -66.95 -49.1 66.53 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.614 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.7 p -81.93 -30.07 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 122.95 0.5 . . . . 0.0 111.218 -165.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -57.56 -30.06 64.92 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.639 0.775 . . . . 0.0 110.925 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.477 0.876 0 C-N-CA 124.274 1.03 . . . . 0.0 112.315 179.553 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.494 ' HB3' ' HD3' ' A' ' 29' ' ' ARG . . . . . . . . 0 C--O 1.242 0.671 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 28' ' ' GLN . 29.7 m -96.11 98.28 10.22 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.764 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.04 140.36 29.72 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.129 175.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.448 ' HG3' HD11 ' A' ' 177' ' ' LEU . 16.9 ptp180 -108.87 147.09 32.67 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 170.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -159.2 -177.84 6.76 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.273 0.559 . . . . 0.0 110.736 -169.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -144.98 150.52 37.07 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.986 -176.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.38 -177.86 23.86 Favored Glycine 0 CA--C 1.507 -0.406 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 175.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 30.6 ptt180 -125.16 131.36 53.24 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 171.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 8.3 tpt180 -135.81 114.83 12.24 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.9 m -78.67 98.19 6.12 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.429 HD11 HG23 ' A' ' 117' ' ' THR . 30.9 pt -81.16 166.9 35.76 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.674 1.59 . . . . 0.0 111.068 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -38.84 -34.42 0.43 Allowed 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 125.028 3.819 . . . . 0.0 115.198 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . . . -67.74 -56.59 8.69 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.682 0.393 . . . . 0.0 110.961 173.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.76 -157.58 30.12 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.494 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.67 105.25 1.2 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.53 0.732 . . . . 0.0 111.326 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -112.8 165.81 11.96 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.887 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 82.6 mtt-85 -105.94 168.01 9.41 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 165.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.3 p -138.5 141.95 39.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.285 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.2 pt -84.77 145.97 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 166.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 48.7 mt -129.92 107.39 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.9 mt -106.28 103.9 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 80.9 mtp180 -95.44 143.77 26.5 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.419 ' HB3' HG23 ' A' ' 7' ' ' THR . 6.9 pt20 -162.65 138.84 7.41 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.2 0.937 . . . . 0.0 111.665 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.494 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 7.5 mpt_? -95.72 105.94 17.99 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.408 ' CE1' HD13 ' A' ' 110' ' ' LEU . 19.6 m-85 -76.04 132.77 40.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.594 0.757 . . . . 0.0 109.7 169.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -79.95 45.09 0.69 Allowed 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.132 0.968 . . . . 0.0 109.787 171.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.66 147.9 34.66 Favored Pre-proline 0 C--O 1.24 0.592 0 C-N-CA 124.102 0.961 . . . . 0.0 109.141 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.8 167.33 21.58 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.844 2.363 . . . . 0.0 112.992 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.93 -50.21 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.315 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.52 -40.01 81.73 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.224 0.953 . . . . 0.0 111.244 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.43 -63.16 1.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 123.847 0.717 . . . . 0.0 111.082 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.5 t -49.99 -41.77 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.648 1.179 . . . . 0.0 111.253 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -58.82 -55.6 33.08 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.976 0.911 . . . . 0.0 110.183 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 t -54.98 -45.34 74.98 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 124.222 0.951 . . . . 0.0 110.975 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.08 -36.28 79.23 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.673 176.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.488 ' SG ' HD21 ' A' ' 136' ' ' LEU . 74.6 m -77.69 -25.2 49.27 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.8 p -108.26 -43.02 4.46 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -168.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.96 126.04 88.0 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 123.209 0.604 . . . . 0.0 111.679 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.1 -38.2 92.51 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.325 2.683 . . . . 0.0 112.802 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -63.37 -22.12 66.69 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.252 1.021 . . . . 0.0 111.676 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.6 mtt85 -100.76 -29.76 12.09 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.804 0.841 . . . . 0.0 109.945 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.465 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 91.9 mt -71.72 -42.37 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.881 0.872 . . . . 0.0 111.642 -178.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 12.4 p30 -57.57 -22.46 44.96 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.418 ' HG2' ' CD1' ' A' ' 139' ' ' PHE . 7.1 tpm_? -68.81 -46.5 68.46 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.577 0.751 . . . . 0.0 111.989 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.465 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 65.1 p-90 -112.5 6.99 18.83 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.598 0.759 . . . . 0.0 112.685 -170.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.429 ' HB3' HG23 ' A' ' 47' ' ' ILE . 20.8 t80 -174.59 173.92 2.79 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -166.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.5 mt -84.61 126.39 40.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 33.4 tt0 -70.31 119.93 75.22 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.716 1.206 . . . . 0.0 109.917 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.599 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 89.9 Cg_endo -78.86 124.34 6.15 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.453 2.102 . . . . 0.0 112.983 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -67.41 145.84 54.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.042 1.337 . . . . 0.0 111.245 172.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.32 -164.89 13.23 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 124.0 0.812 . . . . 0.0 113.427 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.532 ' HB2' ' HA3' ' A' ' 62' ' ' GLY . 34.7 m-20 -75.08 -31.07 61.13 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.709 0.804 . . . . 0.0 111.926 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.0 mt 66.95 12.12 8.76 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.007 1.323 . . . . 0.0 113.049 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -123.35 171.46 9.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.784 0.833 . . . . 0.0 111.153 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.624 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 33.1 tt0 -65.51 106.29 1.39 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.932 0.893 . . . . 0.0 111.811 -171.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.63 -27.94 8.08 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' ' 57' ' ' ASP . . . -84.68 -175.13 50.65 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 167.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 29.0 t-20 -129.48 149.45 51.25 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.266 1.026 . . . . 0.0 110.053 -170.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 20.5 p90 -109.66 154.46 22.81 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 165.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.66 119.61 1.68 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.994 0.815 . . . . 0.0 110.612 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' A' ' 69' ' ' ASN . 61.8 mt -87.02 166.32 15.14 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -88.88 -24.28 22.55 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.143 0.577 . . . . 0.0 109.748 -175.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.28 67.81 0.27 Allowed Glycine 0 C--N 1.342 0.867 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.052 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.488 ' HB3' HD12 ' A' ' 66' ' ' LEU . 54.3 t30 -162.59 -67.38 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.803 0.841 . . . . 0.0 109.542 170.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.02 172.49 6.47 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.796 0.438 . . . . 0.0 111.328 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.3 t -145.36 143.98 30.44 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.564 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.56 164.38 36.22 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 9.0 p-10 -94.91 168.93 10.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 117.925 0.863 . . . . 0.0 110.16 176.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 74' ' ' ILE . 2.8 mp -95.75 106.02 17.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.2 mt -72.36 -53.34 12.59 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.333 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -135.18 132.15 37.6 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.681 1.193 . . . . 0.0 108.474 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.1 p -126.18 118.29 24.88 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 166.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.37 74.75 23.36 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 96.3 Cg_endo -76.72 141.89 22.29 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.215 1.943 . . . . 0.0 112.785 -171.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 27.6 Cg_endo -98.46 28.03 16.17 Favored 'Cis proline' 0 C--N 1.375 1.965 0 CA-C-N 119.269 0.775 . . . . 0.0 112.03 -5.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -79.23 -62.15 1.79 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.044 0.937 . . . . 0.0 110.696 -169.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -153.69 162.89 40.84 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.996 0.918 . . . . 0.0 110.413 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 pp -135.71 143.3 45.3 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 166.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.2 m -122.84 110.17 15.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.6 pt -105.96 173.76 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.049 1.34 . . . . 0.0 110.599 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.7 p -109.57 168.54 9.32 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 34.0 t-105 -156.62 106.07 2.28 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -172.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.2 t -106.89 112.95 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.492 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 62.8 t80 -100.81 162.24 13.05 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 125.029 1.332 . . . . 0.0 108.42 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -50.19 -40.47 47.14 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.61 -6.54 19.39 Favored Glycine 0 N--CA 1.47 0.958 0 CA-C-N 116.529 -0.305 . . . . 0.0 112.75 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.732 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 67.3 mmtt -106.72 104.43 51.19 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.63 -30.32 42.53 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.824 2.349 . . . . 0.0 113.348 -168.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.685 ' HB3' ' HB2' ' A' ' 18' ' ' ALA . 26.2 t70 -152.47 134.94 15.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.269 0.557 . . . . 0.0 110.359 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.588 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 36.7 m -144.07 164.02 31.87 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 125.63 1.572 . . . . 0.0 106.9 169.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -142.92 119.12 10.79 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.5 t -109.16 148.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.279 1.031 . . . . 0.0 109.517 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.08 157.66 41.77 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.63 1.172 . . . . 0.0 110.197 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.3 tp -142.49 118.12 10.4 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.51 ' HE ' ' HB2' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -122.36 117.13 25.31 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.841 0.856 . . . . 0.0 109.597 -174.093 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.4 mt -107.04 136.18 47.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.933 0.893 . . . . 0.0 110.368 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.6 m -143.38 124.24 14.28 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.472 1.109 . . . . 0.0 108.803 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.37 143.72 57.69 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.237 1.415 . . . . 0.0 111.291 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.97 118.45 4.13 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.5 -102.92 0.94 Allowed Glycine 0 C--N 1.347 1.151 0 C-N-CA 123.098 0.38 . . . . 0.0 112.252 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -125.38 7.11 7.71 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.729 0.812 . . . . 0.0 110.278 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -114.92 -165.12 14.78 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.8 m -150.13 135.41 18.03 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.393 0.677 . . . . 0.0 109.777 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 45.7 tp -81.19 128.15 33.46 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 167.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.408 HD13 ' CE1' ' A' ' 30' ' ' TYR . 9.6 tt -115.22 113.59 24.11 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.51 ' HB2' ' HE ' ' A' ' 100' ' ' ARG . 51.2 mt-10 -113.12 105.53 13.56 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 171.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.649 HD13 HD21 ' A' ' 133' ' ' LEU . 7.0 tt -99.44 104.6 16.46 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 171.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -104.46 119.26 38.56 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.696 0.798 . . . . 0.0 109.712 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -109.72 114.93 28.92 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.92 121.68 44.23 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.335 0.654 . . . . 0.0 110.834 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.442 HG23 ' HG ' ' A' ' 122' ' ' LEU . 7.8 t -140.21 158.6 43.79 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.637 0.732 . . . . 0.0 110.176 172.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.429 HG23 HD11 ' A' ' 16' ' ' ILE . 11.9 p -85.23 -3.15 58.72 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.792 -175.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.3 t -105.25 121.88 44.78 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.749 0.82 . . . . 0.0 110.203 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.437 ' HA ' HD12 ' A' ' 122' ' ' LEU . 43.0 tt0 -66.34 -37.4 85.27 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.362 0.665 . . . . 0.0 111.528 -177.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -62.38 -58.57 7.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.253 0.221 . . . . 0.0 110.996 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.732 ' SD ' ' HG3' ' A' ' 92' ' ' LYS . 21.2 ttt -46.72 -41.02 14.45 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.493 1.121 . . . . 0.0 112.176 175.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 116' ' ' THR . 26.9 mt -57.35 -50.9 71.5 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.361 0.664 . . . . 0.0 112.111 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 127' ' ' VAL . 41.4 t -62.53 -50.07 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -61.0 -36.42 79.44 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.182 0.993 . . . . 0.0 113.296 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -80.17 -23.13 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 118.56 0.618 . . . . 0.0 110.031 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 130' ' ' GLU . . . -62.06 -37.75 94.96 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 171.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 123' ' ' VAL . 44.4 t -79.41 -49.52 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.792 0.837 . . . . 0.0 109.204 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.98 -60.32 9.11 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.972 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -61.44 -36.13 79.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.498 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 21.5 tt0 -59.65 -37.59 79.14 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.783 0.72 . . . . 0.0 110.317 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 67.6 mtt -72.25 -39.89 68.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.113 0.565 . . . . 0.0 110.927 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.85 -58.29 9.08 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 123.812 0.695 . . . . 0.0 110.853 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.649 HD21 HD13 ' A' ' 112' ' ' LEU . 3.4 mm? -60.36 -26.16 66.41 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 172.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.15 -38.68 88.71 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -66.71 -36.78 83.31 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.1 0.56 . . . . 0.0 110.234 174.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.488 HD21 ' SG ' ' A' ' 41' ' ' CYS . 42.4 tp -70.91 -56.71 5.65 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.383 0.673 . . . . 0.0 111.14 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -43.52 -42.06 5.67 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 167.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.2 ttm -66.7 -45.11 79.8 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.394 0.677 . . . . 0.0 111.121 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.418 ' CD1' ' HG2' ' A' ' 49' ' ' ARG . 18.1 t80 -61.35 -59.87 4.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.813 0.845 . . . . 0.0 111.087 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.2 mt -57.89 -36.63 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.795 1.238 . . . . 0.0 112.037 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 . . . . . 0 CA--C 1.551 0.993 0 C-N-CA 122.955 0.502 . . . . 0.0 111.019 175.669 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.448 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 82.9 mt . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 110.399 -0.222 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.5 t -59.32 -27.07 65.56 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.94 0.896 . . . . 0.0 111.869 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -77.03 -50.3 13.43 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.541 ' HB2' HH11 ' A' ' 170' ' ' ARG . 45.8 mt-10 -55.65 -50.58 69.84 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 124.168 0.918 . . . . 0.0 110.692 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.541 HH11 ' HB2' ' A' ' 169' ' ' GLU . 15.1 mmt-85 -67.12 -50.28 62.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.776 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -49.46 -44.04 36.19 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 124.193 0.933 . . . . 0.0 114.553 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -67.27 -41.15 85.97 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.777 0.831 . . . . 0.0 111.371 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.1 -41.57 73.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.419 0.688 . . . . 0.0 111.466 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -78.38 -27.36 46.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.502 0.721 . . . . 0.0 111.676 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -71.82 -31.83 66.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.75 0.42 . . . . 0.0 110.373 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -73.3 -31.76 64.22 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.287 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.448 HD11 ' HG3' ' A' ' 9' ' ' ARG . 54.9 mt -71.55 -55.61 7.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.949 0.9 . . . . 0.0 111.51 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.21 -32.32 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -172.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -78.52 -4.12 47.05 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.481 1.107 0 C-N-CA 123.884 0.874 . . . . 0.0 110.527 171.841 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 m -97.72 142.07 29.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.924 0.889 . . . . 0.0 111.99 -172.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -122.91 108.82 13.39 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.157 0.983 . . . . 0.0 108.644 169.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.29 141.92 57.04 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.917 171.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -157.63 164.86 36.8 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.414 HD13 ' H ' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -142.51 149.06 38.65 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.726 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' H ' HD13 ' A' ' 11' ' ' LEU . . . -153.43 -158.32 8.51 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 177.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -135.35 164.93 26.63 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.989 0.915 . . . . 0.0 109.342 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.496 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 15.8 tpt180 -152.39 152.99 32.72 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.978 0.911 . . . . 0.0 108.572 -174.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -111.85 129.61 56.09 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.4 pt -136.05 161.99 59.27 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.015 0.926 . . . . 0.0 109.941 -175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.31 -21.05 16.45 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.533 2.822 . . . . 0.0 114.836 175.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.05 -43.33 58.21 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.004 0.431 . . . . 0.0 110.975 174.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 151.42 -129.24 2.79 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -79.2 136.75 37.17 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.182 0.491 . . . . 0.0 109.891 174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . . . -127.17 155.51 43.27 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 3.9 mpt_? -114.31 161.05 18.38 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 165.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.8 p -134.46 130.27 36.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.183 -168.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.413 ' HA ' HD22 ' A' ' 11' ' ' LEU . 36.9 pt -85.97 135.65 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 168.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 4.0 mp -121.16 119.05 58.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.9 mt -104.76 108.64 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 33.9 mtm105 -105.28 101.78 11.31 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -108.0 118.59 37.15 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.6 tpt85 -91.09 103.53 16.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.406 ' CE1' ' HA2' ' A' ' 137' ' ' GLY . 24.8 m-85 -86.69 149.73 24.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.27 178.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -102.7 72.97 1.26 Allowed 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.15 150.7 5.29 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 125.833 1.653 . . . . 0.0 107.943 -164.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.64 146.0 23.64 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.679 2.253 . . . . 0.0 113.45 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.3 t -49.63 -35.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 124.535 1.134 . . . . 0.0 111.915 173.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -52.81 -42.62 65.27 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 123.508 0.505 . . . . 0.0 110.951 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -86.66 -30.88 21.39 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.08 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.496 HG22 HD13 ' A' ' 140' ' ' ILE . 52.7 t -69.12 -49.48 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 123.601 0.563 . . . . 0.0 110.44 175.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -65.88 -26.29 67.57 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.903 1.281 . . . . 0.0 111.096 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.3 t -65.95 -48.91 69.76 Favored 'General case' 0 C--N 1.353 0.761 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 173.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -59.62 -34.74 73.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.912 0.885 . . . . 0.0 112.515 174.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.468 ' SG ' HD21 ' A' ' 99' ' ' LEU . 79.4 m -69.41 -38.04 77.75 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.2 p -105.73 -43.91 4.79 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -167.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.494 ' O ' HG13 ' A' ' 47' ' ' ILE . 65.4 m-20 -76.32 118.46 71.54 Favored Pre-proline 0 N--CA 1.478 0.933 0 CA-C-O 118.131 -0.938 . . . . 0.0 110.298 -175.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.402 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 25.6 Cg_endo -57.39 -23.78 57.01 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.151 2.568 . . . . 0.0 111.72 174.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -59.46 -44.36 93.0 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.75 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 12.2 mmm180 -89.37 -26.12 21.22 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.283 1.033 . . . . 0.0 111.396 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.495 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 87.0 mt -73.91 -34.72 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -174.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.57 HD21 ' HB3' ' A' ' 53' ' ' GLU . 69.7 m-20 -66.79 2.89 1.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.66 -9.89 33.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.925 0.89 . . . . 0.0 110.833 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.495 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 37.7 p-90 -146.49 -27.57 0.41 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.595 0.758 . . . . 0.0 112.36 -174.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.486 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 16.6 t80 -147.11 -145.06 0.16 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.412 1.085 . . . . 0.0 108.847 -175.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.82 139.74 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.821 0.848 . . . . 0.0 111.813 -159.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.57 ' HB3' HD21 ' A' ' 48' ' ' ASN . 10.0 pt-20 -65.33 110.42 4.3 Favored Pre-proline 0 CA--C 1.566 1.576 0 O-C-N 125.122 1.514 . . . . 0.0 110.555 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HB2' HD21 ' A' ' 58' ' ' LEU . 4.1 Cg_exo -80.23 98.98 1.13 Allowed 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.0 2.467 . . . . 0.0 111.982 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -72.92 97.97 2.38 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 64' ' ' PHE . . . -176.09 169.65 42.32 Favored Glycine 0 C--O 1.241 0.578 0 C-N-CA 121.547 -0.358 . . . . 0.0 112.955 -172.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.69 -34.55 78.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.443 0.697 . . . . 0.0 111.253 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 54' ' ' PRO . 96.1 mt 56.11 70.73 0.61 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.747 1.219 . . . . 0.0 112.718 172.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.455 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 9.3 ptp85 -171.37 171.21 5.63 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.057 0.943 . . . . 0.0 109.495 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.429 ' HG3' ' HA ' ' A' ' 76' ' ' ARG . 28.7 tt0 -54.96 116.17 2.61 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.906 0.882 . . . . 0.0 110.263 174.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.85 8.76 83.83 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 113.945 0.338 . . . . 0.0 113.945 -177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.0 178.16 20.66 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 27.4 p-10 -112.66 177.29 4.68 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 118.043 0.921 . . . . 0.0 112.471 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.512 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 48.4 p90 -149.8 139.31 21.54 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 170.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.09 121.65 24.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.812 0.445 . . . . 0.0 110.721 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.6 mt -94.3 132.55 38.77 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -33.63 -56.97 0.44 Allowed 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 126.264 1.826 . . . . 0.0 114.491 -172.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -136.36 5.56 3.86 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.916 -0.584 . . . . 0.0 113.514 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -90.1 -86.9 0.19 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.984 0.892 . . . . 0.0 110.045 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.74 154.56 39.77 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.241 0.543 . . . . 0.0 111.046 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -131.81 149.5 52.44 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.388 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.52 -154.43 9.18 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.597 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 11.5 m-20 -129.39 178.2 6.62 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.997 0.519 . . . . 0.0 110.214 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.594 HG13 HG22 ' A' ' 85' ' ' ILE . 3.4 mp -108.49 117.46 54.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 173.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 86' ' ' SER . 62.0 mt -74.7 -39.9 61.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.072 0.949 . . . . 0.0 110.282 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.429 ' HA ' ' HG3' ' A' ' 60' ' ' GLU . 16.9 ptm180 -168.32 149.76 5.05 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.922 1.289 . . . . 0.0 108.634 173.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 22.0 p -147.91 119.86 8.19 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.933 0.493 . . . . 0.0 110.388 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -121.18 97.35 47.77 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.173 0.989 . . . . 0.0 109.834 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 91.4 Cg_endo -75.91 142.16 24.88 Favored 'Trans proline' 0 CA--C 1.56 1.813 0 C-N-CA 122.502 2.135 . . . . 0.0 112.297 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 16.1 Cg_endo -97.59 20.96 27.03 Favored 'Cis proline' 0 C--N 1.376 1.983 0 CA-C-N 119.665 0.916 . . . . 0.0 113.043 -5.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -74.43 -60.92 2.05 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.51 0.724 . . . . 0.0 112.199 -169.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -153.19 159.85 42.74 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.859 0.838 . . . . 0.0 111.691 -169.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 99' ' ' LEU . 63.4 tp -134.08 145.44 49.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.626 1.57 . . . . 0.0 107.647 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.419 HG22 HD12 ' A' ' 75' ' ' LEU . 23.9 m -137.11 121.68 18.42 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 172.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.594 HG22 HG13 ' A' ' 74' ' ' ILE . 31.0 pt -134.47 141.88 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.342 1.057 . . . . 0.0 109.703 -176.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.54 ' HB2' HD21 ' A' ' 75' ' ' LEU . 22.7 t -90.73 140.75 29.49 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 168.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 28.5 t-105 -128.97 100.56 5.7 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.178 1.391 . . . . 0.0 107.644 -167.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.3 t -96.35 102.64 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.435 ' HD2' ' HG3' ' A' ' 92' ' ' LYS . 37.4 t80 -98.07 162.04 13.42 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 174.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.44 115.8 4.97 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.386 0.674 . . . . 0.0 112.015 -168.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.93 14.99 79.82 Favored Glycine 0 C--N 1.356 1.664 0 O-C-N 123.71 0.631 . . . . 0.0 113.775 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.486 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 67.1 mmtt -109.28 153.45 42.69 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.793 0.837 . . . . 0.0 109.895 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.96 143.45 60.47 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.181 1.921 . . . . 0.0 110.391 170.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.21 107.62 0.93 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.916 0.865 . . . . 0.0 109.73 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.489 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.5 m -77.75 145.59 36.4 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.427 -172.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -103.53 105.38 15.61 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.0 144.41 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.592 1.157 . . . . 0.0 108.623 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HG2' HG23 ' A' ' 84' ' ' THR . 22.4 mt-10 -132.35 148.62 52.43 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.636 0.774 . . . . 0.0 109.603 171.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 83' ' ' LEU . 39.9 tp -125.3 108.56 11.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -107.27 145.76 32.33 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.545 0.738 . . . . 0.0 110.149 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 110' ' ' LEU . 82.9 mt -134.34 141.35 46.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.696 1.199 . . . . 0.0 109.233 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.2 m -136.54 122.57 20.23 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.126 0.97 . . . . 0.0 109.411 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.57 101.43 9.97 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.69 100.96 7.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.922 -170.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.78 -126.09 8.27 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.806 0.717 . . . . 0.0 112.897 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -90.91 27.09 1.9 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.294 0.638 . . . . 0.0 109.647 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -161.7 -172.05 28.57 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 120.363 -0.923 . . . . 0.0 115.245 -172.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.1 m -136.54 125.17 23.73 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.1 1.36 . . . . 0.0 109.386 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.9 tp -82.27 116.04 21.62 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 167.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 1.7 tm? -83.38 133.97 34.92 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 165.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -140.48 105.37 4.96 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.5 tp -103.9 132.63 49.97 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.292 1.037 . . . . 0.0 109.015 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -129.18 102.67 6.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.254 0.621 . . . . 0.0 110.095 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -95.53 113.96 25.66 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 172.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -117.57 103.79 10.41 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.153 0.581 . . . . 0.0 110.78 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 t -121.52 161.83 21.63 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.684 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 5.94 14.85 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.671 1.188 . . . . 0.0 111.781 -175.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.565 ' HB3' ' HG2' ' A' ' 120' ' ' GLN . 66.6 m -132.37 123.47 26.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.442 0.697 . . . . 0.0 110.7 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.535 ' HA ' HD12 ' A' ' 122' ' ' LEU . 4.7 mp0 -72.53 -29.36 63.53 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.0 0.92 . . . . 0.0 109.828 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.565 ' HG2' ' HB3' ' A' ' 118' ' ' SER . 5.2 pt20 -58.73 -44.91 90.57 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.491 1.119 . . . . 0.0 110.821 173.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 24.3 ttt -71.23 -33.96 70.34 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.778 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 119' ' ' GLU . 36.6 mt -64.74 -39.53 93.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 119' ' ' GLU . 95.0 t -69.58 -41.62 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.303 0.573 . . . . 0.0 109.712 176.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -59.56 -58.35 8.98 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.03 1.332 . . . . 0.0 111.453 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 121' ' ' MET . 18.0 m -74.2 -14.85 16.32 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 C-N-CA 123.262 0.625 . . . . 0.0 110.339 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 130' ' ' GLU . . . -61.61 -37.28 93.95 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 166.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.73 -47.17 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 O-C-N 124.114 0.538 . . . . 0.0 109.732 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.69 -30.38 76.21 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.916 0.76 . . . . 0.0 114.498 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -88.05 -41.04 13.36 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -60.37 -32.64 71.48 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.575 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 41.0 ttm -66.16 -56.03 13.4 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.316 1.046 . . . . 0.0 110.49 175.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.17 79.73 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.88 0.738 . . . . 0.0 111.43 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.549 HD13 HD23 ' A' ' 136' ' ' LEU . 4.5 mm? -82.65 -20.85 35.46 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.422 1.089 . . . . 0.0 110.904 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.65 -51.98 43.58 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -74.29 -24.55 59.26 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.35 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.549 HD23 HD13 ' A' ' 133' ' ' LEU . 31.7 tp -70.82 -41.57 71.37 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 171.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.406 ' HA2' ' CE1' ' A' ' 30' ' ' TYR . . . -58.03 -42.97 95.27 Favored Glycine 0 C--O 1.219 -0.832 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.151 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 87.5 mtp -75.2 -32.96 61.35 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.43 0.692 . . . . 0.0 111.559 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -63.19 -46.25 87.97 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.487 0.715 . . . . 0.0 110.704 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.496 HD13 HG22 ' A' ' 37' ' ' VAL . 80.6 mt -76.46 -61.16 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.148 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 . . . . . 0 N--CA 1.482 1.147 0 C-N-CA 124.178 0.991 . . . . 0.0 109.665 -176.826 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 33.5 mm . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 121.366 0.603 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 10.2 t -73.84 -47.74 36.23 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.194 -177.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -59.02 -60.65 3.54 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.227 0.954 . . . . 0.0 112.67 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -39.57 -53.98 2.04 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 124.19 0.996 . . . . 0.0 113.371 174.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -68.85 -37.1 78.89 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.474 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -72.15 -47.88 28.34 Favored Glycine 0 C--N 1.348 1.212 0 C-N-CA 121.818 -0.23 . . . . 0.0 112.555 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.79 -23.65 67.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.137 1.375 . . . . 0.0 111.428 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.07 -50.75 18.26 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.365 0.666 . . . . 0.0 110.071 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -63.28 -25.13 68.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.303 0.641 . . . . 0.0 111.249 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.89 -59.21 3.22 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.091 0.556 . . . . 0.0 109.99 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.3 -30.64 62.78 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.349 1.06 . . . . 0.0 112.686 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 38.4 mt -66.88 -46.27 75.45 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.855 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.41 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 7.3 p -80.5 -27.97 11.67 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 118.65 0.659 . . . . 0.0 110.369 -171.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -69.27 -27.33 65.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.561 0.744 . . . . 0.0 110.389 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 38.9 t . . . . . 0 CA--C 1.547 0.831 0 C-N-CA 123.56 0.744 . . . . 0.0 110.678 175.343 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 10.3 m -83.87 128.03 34.25 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.593 -1.185 . . . . 0.0 113.638 -165.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 33.5 tt0 -113.57 120.16 39.99 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.538 1.535 . . . . 0.0 107.445 166.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HB3' HD11 ' A' ' 177' ' ' LEU . 66.6 mtt180 -85.52 144.41 27.94 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.159 0.583 . . . . 0.0 110.536 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -158.43 -179.6 8.25 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 122.851 0.46 . . . . 0.0 111.343 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.0 mt -142.59 167.06 22.99 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 122.397 1.094 . . . . 0.0 111.36 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.14 176.81 29.48 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 113.059 -1.882 . . . . 0.0 109.494 166.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 37.0 ttm180 -132.38 122.17 24.6 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.406 ' HD2' ' OE2' ' A' ' 113' ' ' GLU . 31.0 ttt180 -131.36 128.09 38.94 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.576 0.751 . . . . 0.0 109.037 -173.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.2 m -93.21 117.86 30.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -173.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.412 HD11 ' OG1' ' A' ' 117' ' ' THR . 26.2 pt -107.36 164.96 13.69 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.577 1.551 . . . . 0.0 108.036 175.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.46 -26.96 30.12 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.091 2.528 . . . . 0.0 114.127 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.24 -20.98 60.73 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.86 0.864 . . . . 0.0 112.993 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.72 167.83 14.08 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 123.389 0.519 . . . . 0.0 111.938 -172.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.33 95.29 1.3 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.8 163.92 20.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.292 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.479 HH21 HG22 ' A' ' 178' ' ' VAL . 2.7 mpp_? -105.57 170.79 7.68 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 167.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.407 ' HB3' ' HG3' ' A' ' 113' ' ' GLU . 20.3 m -139.27 128.15 23.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.929 -170.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 2.8 pp -88.19 135.2 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 mp -121.58 111.18 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.2 mt -99.76 107.85 21.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.59 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 82.1 mtt180 -94.72 137.38 33.89 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' A' ' 133' ' ' LEU . 58.9 mt-30 -142.87 136.52 28.76 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 166.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -104.96 114.3 28.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.559 0.695 . . . . 0.0 109.453 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -96.95 131.68 43.5 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.238 1.415 . . . . 0.0 110.06 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -77.74 48.89 0.72 Allowed 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.589 1.185 . . . . 0.0 110.073 172.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.59 154.72 41.43 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.425 1.09 . . . . 0.0 108.285 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.418 ' O ' HG23 ' A' ' 37' ' ' VAL . 57.2 Cg_endo -69.46 166.44 27.22 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.745 2.297 . . . . 0.0 113.116 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 101' ' ' LEU . 59.1 t -72.17 -43.4 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.404 -174.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -56.09 -41.54 75.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 124.258 0.974 . . . . 0.0 110.341 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -66.58 -64.57 0.83 Allowed 'General case' 0 C--N 1.348 0.526 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.655 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 33' ' ' PRO . 49.1 t -50.19 -34.73 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.546 1.139 . . . . 0.0 111.315 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.42 ' HE3' HD12 ' A' ' 101' ' ' LEU . 58.5 t-105 -61.96 -57.49 11.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.601 0.76 . . . . 0.0 110.211 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.1 m -58.39 -34.13 70.39 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 123.913 0.758 . . . . 0.0 111.057 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.1 -31.23 71.98 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 174.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.473 ' HB3' HD13 ' A' ' 99' ' ' LEU . 73.7 m -90.8 -14.17 32.45 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.947 0.899 . . . . 0.0 113.152 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.4 ' O ' HD13 ' A' ' 58' ' ' LEU . 49.3 p -110.96 -47.07 3.26 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.198 0.454 . . . . 0.0 111.985 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.424 ' O ' HG13 ' A' ' 47' ' ' ILE . 18.2 t70 -66.16 125.68 90.6 Favored Pre-proline 0 N--CA 1.484 1.244 0 C-N-CA 123.495 0.718 . . . . 0.0 110.47 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.79 -30.09 68.53 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.57 2.847 . . . . 0.0 113.602 -171.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -64.76 -48.61 73.92 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 124.359 1.037 . . . . 0.0 109.073 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -58.62 -38.67 78.53 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.156 171.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.484 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 68.7 mt -71.85 -45.68 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -172.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -61.77 -20.57 63.73 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.768 0.427 . . . . 0.0 111.964 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -57.75 -48.16 80.4 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.153 0.581 . . . . 0.0 110.932 174.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.484 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 22.7 p-90 -105.68 -55.85 2.27 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.355 0.662 . . . . 0.0 111.502 -173.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.433 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 6.6 t80 -91.47 -164.25 1.15 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.087 0.555 . . . . 0.0 110.893 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.477 ' HB ' HD22 ' A' ' 66' ' ' LEU . 40.5 mt -84.57 148.1 5.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 C-N-CA 124.359 1.064 . . . . 0.0 108.358 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.81 112.31 5.96 Favored Pre-proline 0 CA--C 1.566 1.569 0 O-C-N 124.173 0.921 . . . . 0.0 110.649 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.679 ' HG2' HD11 ' A' ' 58' ' ' LEU . 90.8 Cg_endo -90.29 96.11 0.27 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.295 2.663 . . . . 0.0 112.293 -175.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -71.21 109.89 5.53 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.561 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.9 -157.56 27.69 Favored Glycine 0 C--N 1.342 0.872 0 O-C-N 123.564 0.54 . . . . 0.0 113.884 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.81 -48.32 16.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.486 1.514 . . . . 0.0 112.054 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.679 HD11 ' HG2' ' A' ' 54' ' ' PRO . 84.7 mt 63.98 25.46 13.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 124.583 1.177 . . . . 0.0 111.483 -170.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -126.31 155.1 42.51 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.44 1.096 . . . . 0.0 109.894 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.619 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 35.6 tt0 -64.55 106.51 1.17 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.437 0.695 . . . . 0.0 111.101 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.3 -35.68 3.14 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.88 -169.59 45.44 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 114.149 -1.025 . . . . 0.0 112.124 170.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 72' ' ' GLY . 9.1 p30 -144.15 177.53 8.52 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.31 0.576 . . . . 0.0 111.907 -170.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -133.16 172.46 12.63 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.921 169.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -158.3 116.95 3.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.72 0.808 . . . . 0.0 109.276 178.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.477 HD22 ' HB ' ' A' ' 52' ' ' ILE . 70.0 mt -80.94 167.2 20.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.461 0.704 . . . . 0.0 110.862 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -86.8 128.25 35.03 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.879 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.47 39.48 22.29 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.997 1.436 . . . . 0.0 116.158 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -142.2 -79.86 0.23 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' ' HD1' ' A' ' 89' ' ' TYR . . . -161.79 154.89 20.72 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.106 0.562 . . . . 0.0 110.887 -172.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.0 p -100.42 165.46 11.43 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 170.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' ASN . . . -150.65 178.41 28.1 Favored Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -147.31 142.94 27.68 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.167 0.987 . . . . 0.0 109.321 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.458 HG13 HG22 ' A' ' 85' ' ' ILE . 2.6 mp -100.78 94.64 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.54 -34.07 67.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.407 174.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.489 ' HG2' ' HB ' ' A' ' 84' ' ' THR . 7.3 ptp180 -151.48 132.87 14.62 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.044 0.45 . . . . 0.0 111.313 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 26.3 p -128.46 118.73 23.6 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 168.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -133.05 88.5 36.52 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -173.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.63 141.78 38.64 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.534 2.156 . . . . 0.0 111.553 175.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -96.91 20.82 28.63 Favored 'Cis proline' 0 C--N 1.367 1.52 0 C-N-CA 124.938 -0.859 . . . . 0.0 112.998 -4.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -75.49 -71.62 0.36 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.065 0.946 . . . . 0.0 111.974 -167.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -161.74 159.58 27.39 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.478 0.656 . . . . 0.0 110.73 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 tt -133.33 114.56 13.86 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' A' ' 76' ' ' ARG . 23.0 m -108.95 127.38 54.01 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.478 HG13 ' HB ' ' A' ' 97' ' ' VAL . 11.8 pt -123.29 150.26 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 126.723 2.009 . . . . 0.0 109.684 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.5 t -84.87 164.92 18.11 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 167.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 35.7 t-105 -144.39 94.81 2.61 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.086 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.52 101.76 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.502 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 84.8 t80 -102.69 168.06 9.5 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.059 1.344 . . . . 0.0 109.932 -173.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -56.25 103.26 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.111 0.965 . . . . 0.0 110.72 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.23 4.27 83.52 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.019 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 42.1 mmtm -134.67 75.17 63.38 Favored Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 123.916 0.886 . . . . 0.0 110.12 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.52 135.06 25.6 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.371 2.048 . . . . 0.0 112.005 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 66.39 80.71 0.22 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.516 1.126 . . . . 0.0 112.018 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.664 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 35.4 m -109.97 146.18 35.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 168.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -103.44 107.71 18.66 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.153 0.501 . . . . 0.0 111.07 -170.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.478 ' HB ' HG13 ' A' ' 85' ' ' ILE . 10.6 t -112.05 147.97 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.675 1.19 . . . . 0.0 108.413 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -150.84 142.73 23.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.084 0.554 . . . . 0.0 111.075 171.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 41' ' ' CYS . 6.7 tt -109.46 123.79 49.96 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 172.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -122.58 123.0 40.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.471 1.108 . . . . 0.0 109.556 -166.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 34' ' ' VAL . 92.7 mt -123.31 135.04 54.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.542 0.737 . . . . 0.0 110.982 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.6 m -146.87 145.22 29.77 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.191 1.396 . . . . 0.0 108.609 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.47 143.64 44.91 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.774 0.829 . . . . 0.0 109.169 168.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -150.11 111.06 4.34 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.88 -102.12 0.22 Allowed Glycine 0 C--N 1.348 1.199 0 O-C-N 123.353 0.408 . . . . 0.0 112.407 -171.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -117.11 -5.06 11.4 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.612 0.765 . . . . 0.0 110.81 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -117.63 -150.93 9.18 Favored Glycine 0 C--N 1.352 1.424 0 C-N-CA 124.24 0.924 . . . . 0.0 111.436 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.2 m -143.0 121.99 12.79 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.218 1.007 . . . . 0.0 110.227 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.7 tp -81.74 131.65 35.27 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.7 tt -118.85 109.22 15.76 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.59 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 30.6 mt-10 -111.02 105.8 14.68 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 176.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.54 HD13 HD21 ' A' ' 133' ' ' LEU . 6.2 tt -102.3 104.33 14.85 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 175.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 61.2 tt0 -93.65 128.65 39.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.475 177.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -121.88 113.32 19.46 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 170.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.39 119.53 38.9 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.157 0.983 . . . . 0.0 110.046 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.493 HG23 ' HG ' ' A' ' 122' ' ' LEU . 6.0 t -148.08 151.83 36.32 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.584 0.754 . . . . 0.0 109.71 172.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.412 ' OG1' HD11 ' A' ' 16' ' ' ILE . 1.8 m -74.25 -19.41 60.52 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.326 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 121' ' ' MET . 11.7 m -89.83 119.33 30.12 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.027 0.931 . . . . 0.0 110.778 -173.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -64.32 -40.65 96.32 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.065 0.946 . . . . 0.0 112.141 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -63.76 -55.81 20.36 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.079 0.237 . . . . 0.0 111.389 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.578 ' HB3' ' HB2' ' A' ' 118' ' ' SER . 26.1 ttt -51.15 -33.35 26.51 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.01 0.819 . . . . 0.0 112.644 175.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.493 ' HG ' HG23 ' A' ' 116' ' ' THR . 19.9 mt -64.77 -46.24 82.95 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.33 0.652 . . . . 0.0 111.669 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 127' ' ' VAL . 61.4 t -62.89 -53.11 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -44.76 -53.34 7.49 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.51 1.924 . . . . 0.0 113.335 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.8 m -78.68 -25.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 122.794 0.438 . . . . 0.0 110.697 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.22 88.1 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 170.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 123' ' ' VAL . 89.2 t -81.83 -52.66 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.402 0.681 . . . . 0.0 109.4 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.59 -59.7 9.32 Favored Glycine 0 C--N 1.341 0.816 0 O-C-N 124.42 1.075 . . . . 0.0 113.634 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -57.25 -56.34 23.03 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.073 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.04 -30.31 69.1 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 119.905 1.23 . . . . 0.0 112.294 -171.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.443 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 47.2 ttp -70.73 -44.07 67.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.045 0.938 . . . . 0.0 110.187 174.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 50' ' ' TRP . . . -63.06 -63.53 1.17 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.0 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 112' ' ' LEU . 4.3 mm? -42.31 -38.79 1.92 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.499 1.52 . . . . 0.0 113.992 169.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 131' ' ' MET . 12.4 t70 -52.79 -50.15 64.19 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.231 0.613 . . . . 0.0 110.059 173.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -74.43 -19.84 60.26 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.342 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.406 HD13 ' CD1' ' A' ' 50' ' ' TRP . 51.3 tp -72.57 -24.53 61.12 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 169.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.73 -41.37 24.08 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 87.2 mtp -63.05 -40.75 98.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.069 0.948 . . . . 0.0 110.567 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -64.06 -56.02 18.0 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.432 0.693 . . . . 0.0 110.753 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 53.0 mt -69.42 -36.24 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 123.275 0.63 . . . . 0.0 111.725 -173.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 176.66 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 70.5 mt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.308 0.099 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.9 m -68.47 -22.7 64.55 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -80.37 -31.42 37.86 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.38 -42.54 92.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.731 0.412 . . . . 0.0 109.935 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -62.62 -60.79 3.03 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.819 0.699 . . . . 0.0 110.214 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -53.84 -58.88 10.89 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 124.232 0.957 . . . . 0.0 114.022 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.01 -20.97 65.96 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -175.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.94 -55.11 11.99 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.107 0.412 . . . . 0.0 110.663 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.38 -22.29 61.16 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.193 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -70.13 -46.74 64.12 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 123.77 0.669 . . . . 0.0 109.464 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -64.43 -33.38 75.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.098 0.559 . . . . 0.0 110.118 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 9' ' ' ARG . 47.6 mt -68.06 -61.77 1.71 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.625 173.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.479 HG22 HH21 ' A' ' 22' ' ' ARG . 9.6 p -65.04 -31.38 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.034 0.534 . . . . 0.0 112.417 -166.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -67.61 -35.24 78.57 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.721 0.808 . . . . 0.0 110.231 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.482 1.149 0 C-N-CA 123.632 0.773 . . . . 0.0 110.919 175.431 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 121.022 0.439 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.61 63.04 7.76 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.6 p -161.49 170.18 20.42 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.074 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.66 117.44 9.99 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 174.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -62.85 86.81 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.412 0.713 . . . . 0.0 109.644 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 29' ' ' ARG . . . -68.06 87.97 0.27 Allowed 'General case' 0 C--N 1.348 0.531 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.935 -167.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.6 m -88.07 131.16 34.78 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.715 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -119.16 103.6 9.68 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 171.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -83.25 132.48 35.04 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.901 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -143.92 171.36 14.34 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.893 -172.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.597 HD23 ' HB3' ' A' ' 177' ' ' LEU . 0.5 OUTLIER -138.69 165.43 26.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.943 1.297 . . . . 0.0 108.242 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.56 -162.29 30.78 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.174 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -120.35 145.6 46.97 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.231 1.012 . . . . 0.0 109.91 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 12.2 tpt180 -164.27 125.85 2.26 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 20.0 m -77.04 142.2 39.97 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.884 0.474 . . . . 0.0 110.756 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.503 HD11 HG23 ' A' ' 117' ' ' THR . 16.7 pt -133.07 165.75 34.38 Favored Pre-proline 0 CA--C 1.557 1.222 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -49.02 -30.92 19.22 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.355 2.704 . . . . 0.0 115.377 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.401 ' H ' HG13 ' A' ' 16' ' ' ILE . . . -71.5 -37.32 71.27 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.164 0.586 . . . . 0.0 111.995 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.33 -174.95 34.84 Favored Glycine 0 N--CA 1.471 1.014 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 2.8 mp0 -71.65 93.9 1.29 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.82 167.1 22.42 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.888 0.875 . . . . 0.0 113.115 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HB3' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -95.17 149.12 21.65 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.339 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.0 p -134.7 130.77 36.79 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.125 0.421 . . . . 0.0 111.376 -169.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.467 HG23 HD22 ' A' ' 122' ' ' LEU . 2.7 pp -88.86 140.08 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 4.0 mp -126.86 124.27 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.442 HG22 ' HG3' ' A' ' 28' ' ' GLN . 25.6 mt -107.23 107.73 23.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 85.6 mtt180 -106.92 98.78 8.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.442 ' HG3' HG22 ' A' ' 26' ' ' ILE . 73.1 mt-30 -109.98 133.24 53.39 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.991 0.916 . . . . 0.0 109.001 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.506 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 17.5 mmt85 -87.44 127.5 35.22 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.42 0.688 . . . . 0.0 109.837 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -120.14 135.94 54.78 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.403 1.081 . . . . 0.0 108.842 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.7 45.43 1.2 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.372 0.606 . . . . 0.0 111.557 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.07 159.03 72.54 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 124.547 1.139 . . . . 0.0 109.883 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.06 157.05 63.63 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.237 2.625 . . . . 0.0 113.562 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.8 t -49.15 -47.95 17.65 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 C-N-CA 124.688 1.195 . . . . 0.0 110.474 171.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -43.44 -47.3 7.02 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 125.05 1.469 . . . . 0.0 111.754 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.54 -46.46 85.89 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.071 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.3 t -76.86 -31.0 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.513 -171.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -75.29 -30.26 60.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.811 1.244 . . . . 0.0 109.967 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.6 m -65.0 -44.46 89.16 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 172.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -62.94 -38.53 91.43 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.25 0.62 . . . . 0.0 112.584 176.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.468 ' SG ' HD22 ' A' ' 99' ' ' LEU . 65.5 m -71.86 -40.57 68.88 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -175.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.3 p -104.15 -38.93 6.72 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -168.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 47' ' ' ILE . 29.3 t70 -79.03 113.35 35.1 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.812 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 43' ' ' ASP . 4.3 Cg_endo -46.66 -38.55 22.34 Favored 'Trans proline' 0 C--N 1.39 2.719 0 C-N-CA 124.7 3.6 . . . . 0.0 115.227 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -66.14 -24.79 66.73 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 123.651 0.594 . . . . 0.0 110.8 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.553 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 5.8 mmp_? -91.95 -25.07 19.05 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 173.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 43' ' ' ASP . 83.1 mt -74.31 -40.71 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 118.235 0.471 . . . . 0.0 110.53 -172.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -65.37 -14.96 62.03 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.002 0.521 . . . . 0.0 111.895 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -83.18 -5.14 59.01 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.379 0.672 . . . . 0.0 111.181 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.418 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 56.7 p-90 -142.93 -15.84 0.7 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.519 0.727 . . . . 0.0 112.098 175.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.418 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 20.6 t80 -141.27 -122.53 0.1 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -173.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.4 ' HB ' HD22 ' A' ' 66' ' ' LEU . 60.8 mt -132.74 140.57 47.13 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 C-N-CA 123.404 0.681 . . . . 0.0 109.62 -167.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.405 ' HG2' ' HE2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -68.61 105.02 0.83 Allowed Pre-proline 0 CA--C 1.573 1.858 0 O-C-N 124.871 1.357 . . . . 0.0 110.239 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.17 124.1 3.24 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.655 2.237 . . . . 0.0 112.498 -172.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HE2' ' HG2' ' A' ' 53' ' ' GLU . 74.4 mmtt -112.41 117.42 32.39 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.647 0.779 . . . . 0.0 110.304 -175.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.17 -152.18 22.7 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.672 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 8.2 m-20 -66.55 -41.86 88.01 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.386 0.698 . . . . 0.0 110.758 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.7 mt 59.65 22.03 10.74 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.758 1.223 . . . . 0.0 111.792 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.672 ' HG2' ' HB3' ' A' ' 57' ' ' ASP . 17.3 ptp180 -133.48 151.7 51.81 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.511 1.124 . . . . 0.0 108.862 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -66.41 135.02 53.71 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.696 0.622 . . . . 0.0 110.492 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.18 -7.2 81.01 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.588 -167.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.92 -175.73 14.97 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-N 117.119 0.46 . . . . 0.0 112.641 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 11.2 p30 -109.05 171.26 7.54 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.586 0.754 . . . . 0.0 112.228 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -145.66 158.77 43.81 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.712 169.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.77 105.21 4.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.651 0.78 . . . . 0.0 109.514 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.4 HD22 ' HB ' ' A' ' 52' ' ' ILE . 70.4 mt -75.51 127.54 33.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -80.21 112.99 18.05 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.866 0.467 . . . . 0.0 110.564 -172.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.84 46.38 8.52 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.98 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -162.6 -83.71 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.851 0.46 . . . . 0.0 111.449 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' ' HD1' ' A' ' 89' ' ' TYR . . . -154.63 156.71 36.99 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.35 0.595 . . . . 0.0 111.017 -170.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.4 m -109.09 -175.34 2.74 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.484 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.75 -160.06 30.03 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 53.6 m-20 -129.48 174.22 9.84 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.24 0.616 . . . . 0.0 109.454 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.417 HG13 HG22 ' A' ' 85' ' ' ILE . 3.4 mp -110.3 116.2 51.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 86' ' ' SER . 31.6 mt -84.22 -44.47 13.88 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.927 0.891 . . . . 0.0 110.317 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.512 ' HB2' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.37 155.19 44.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.134 1.374 . . . . 0.0 109.223 -177.488 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 26.2 p -157.18 120.78 4.16 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 166.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -141.63 100.48 6.13 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -165.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 85.9 Cg_endo -83.84 135.25 6.61 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.754 2.303 . . . . 0.0 112.849 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 24.9 Cg_endo -100.41 29.47 12.63 Favored 'Cis proline' 0 C--N 1.376 1.976 0 CA-C-N 119.399 0.821 . . . . 0.0 112.561 -4.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -77.85 -66.97 0.77 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.992 0.917 . . . . 0.0 112.397 -168.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.499 ' HB3' ' HG3' ' A' ' 100' ' ' ARG . 16.5 ptt180 -160.86 141.31 11.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.769 0.427 . . . . 0.0 111.073 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 77' ' ' CYS . 2.2 pt? -107.72 144.04 35.39 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 163.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 76' ' ' ARG . 32.8 m -134.79 128.42 32.79 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.107 0.963 . . . . 0.0 108.701 -171.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.417 HG22 HG13 ' A' ' 74' ' ' ILE . 28.7 pt -133.35 146.49 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.451 1.1 . . . . 0.0 109.137 -175.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.477 ' HB2' HD11 ' A' ' 75' ' ' LEU . 33.3 t -96.14 139.54 32.16 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 8.4 t-105 -125.64 109.21 12.36 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.801 1.24 . . . . 0.0 107.891 -163.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.18 102.27 13.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.401 ' HD1' ' HB2' ' A' ' 70' ' ' ALA . 31.2 t80 -93.48 133.65 36.55 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.57 133.68 54.19 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.126 0.57 . . . . 0.0 111.342 -170.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.78 -45.14 3.44 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.306 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 13.2 mptt -80.55 163.0 58.69 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.714 1.206 . . . . 0.0 110.094 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 177.39 5.41 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.36 2.04 . . . . 0.0 112.376 175.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.31 162.57 29.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.805 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.564 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.2 m -141.51 165.21 28.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.579 0.752 . . . . 0.0 110.042 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -125.45 106.83 10.09 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 167.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.39 149.0 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.668 1.587 . . . . 0.0 109.004 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.17 153.08 39.43 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.701 165.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.468 HD22 ' SG ' ' A' ' 41' ' ' CYS . 2.8 tt -114.66 128.31 56.24 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 169.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 36.8 ttt180 -138.39 137.85 37.68 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.272 1.029 . . . . 0.0 108.389 -164.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 110' ' ' LEU . 96.7 mt -129.5 132.5 46.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.872 0.469 . . . . 0.0 110.827 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.4 t -125.25 127.17 46.3 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 172.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -69.92 152.74 44.14 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.73 0.812 . . . . 0.0 109.014 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -167.47 79.36 0.19 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -168.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 65.16 -117.38 10.18 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 123.709 0.671 . . . . 0.0 113.306 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.64 32.66 1.07 Allowed 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.91 -171.9 38.06 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-O 122.001 0.778 . . . . 0.0 114.475 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.2 m -140.43 131.01 25.5 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 113.78 -1.21 . . . . 0.0 109.463 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.498 HD11 ' HB3' ' A' ' 27' ' ' ARG . 64.0 tp -82.77 106.87 14.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.468 171.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.0 tt -84.22 131.98 34.7 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 172.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 22.2 mt-10 -129.32 106.62 8.92 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -174.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.424 HD13 HD21 ' A' ' 133' ' ' LEU . 9.0 tt -115.47 126.45 54.32 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -124.66 137.83 54.34 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.528 ' HD1' ' HE1' ' A' ' 129' ' ' TRP . 7.6 t60 -131.88 114.89 15.21 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . . . -109.96 104.01 12.85 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.118 0.567 . . . . 0.0 110.972 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.433 HG23 ' HG ' ' A' ' 122' ' ' LEU . 5.3 t -124.2 156.13 37.32 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.206 0.527 . . . . 0.0 109.64 171.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.503 HG23 HD11 ' A' ' 16' ' ' ILE . 20.8 p -77.44 -18.57 57.07 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.433 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.5 t -88.49 111.85 22.3 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.333 0.653 . . . . 0.0 110.079 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.411 ' HA ' HD12 ' A' ' 122' ' ' LEU . 37.4 tt0 -62.63 -29.21 70.45 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.397 1.079 . . . . 0.0 110.878 172.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -60.35 -47.89 84.09 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.554 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.404 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 27.4 ttt -68.49 -37.62 80.27 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.787 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.467 HD22 HG23 ' A' ' 24' ' ' ILE . 37.7 mt -61.1 -38.18 85.37 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.591 0.756 . . . . 0.0 112.763 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 68.8 t -64.51 -51.78 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 O-C-N 123.392 0.432 . . . . 0.0 109.888 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -63.65 -41.8 98.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.27 0.628 . . . . 0.0 112.544 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.37 -34.56 58.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 CA-C-O 118.992 -0.528 . . . . 0.0 109.994 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.03 -32.18 74.89 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 121.389 -0.434 . . . . 0.0 112.217 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.09 -54.52 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 123.869 0.393 . . . . 0.0 110.894 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.96 73.45 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.944 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.528 ' HE1' ' HD1' ' A' ' 114' ' ' HIS . 17.4 m95 -80.2 -49.52 11.52 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 38.5 mt-10 -63.35 -23.09 67.26 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 118.415 0.552 . . . . 0.0 111.599 176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 56.4 ttp -66.46 -44.71 82.0 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.074 0.549 . . . . 0.0 109.54 170.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.62 -35.79 81.67 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.036 0.534 . . . . 0.0 111.275 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 130' ' ' GLU . 4.0 mm? -74.75 -18.38 60.5 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.6 1.16 . . . . 0.0 111.367 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -69.87 -55.26 10.23 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -66.15 -32.81 74.48 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.879 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.1 tp -75.01 -37.63 61.76 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.189 0.596 . . . . 0.0 109.931 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.5 -46.52 52.89 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.598 0.562 . . . . 0.0 112.925 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.0 mtp -69.23 -39.71 78.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.94 0.896 . . . . 0.0 111.205 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.62 -33.15 68.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.137 0.575 . . . . 0.0 111.345 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.9 mm -72.51 -63.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 65.0 mmt-85 -154.87 104.47 2.5 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 178.91 -52.46 0.09 OUTLIER Glycine 0 C--O 1.244 0.727 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 175.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.6 t70 141.76 127.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 127.975 2.51 . . . . 0.0 109.012 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -159.57 86.69 2.09 Favored Pre-proline 0 N--CA 1.479 1.003 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.73 -16.62 11.5 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.824 2.349 . . . . 0.0 112.434 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.42 105.02 0.22 Allowed Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -60.76 112.35 4.55 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 119.049 -0.862 . . . . 0.0 112.309 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.18 -29.21 47.61 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.919 2.413 . . . . 0.0 112.1 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.9 m -110.55 106.59 57.94 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 123.769 0.828 . . . . 0.0 109.296 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.2 -58.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.791 2.327 . . . . 0.0 110.989 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -147.97 80.21 1.48 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -137.73 49.0 1.99 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.2 -84.53 0.37 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.609 -1.632 . . . . 0.0 108.357 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -172.47 94.33 0.13 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.652 0.781 . . . . 0.0 109.449 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.75 130.48 35.37 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.665 0.786 . . . . 0.0 110.062 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 65.9 -79.78 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.028 1.331 . . . . 0.0 110.766 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -159.84 90.8 0.94 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -109.67 113.81 57.43 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.743 0.817 . . . . 0.0 108.89 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -44.76 97.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 124.011 3.14 . . . . 0.0 114.318 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.0 p -163.25 108.13 1.0 Allowed Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.751 1.22 . . . . 0.0 108.082 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -49.75 -53.88 6.35 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.997 3.132 . . . . 0.0 114.368 -168.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -63.94 -51.48 64.21 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.347 0.659 . . . . 0.0 110.577 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.2 mmt -72.96 -33.36 65.82 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.721 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 55.7 mtm -66.01 -51.48 57.9 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-O 119.123 -0.465 . . . . 0.0 109.936 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 13.3 ptm180 -63.27 -42.68 99.16 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-O 119.256 -0.402 . . . . 0.0 110.816 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.5 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 64.8 mt -63.03 -36.69 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 122.939 0.496 . . . . 0.0 111.296 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 63.7 p -75.36 -41.6 56.09 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 59.7 mt-30 -55.65 -63.7 1.09 Allowed 'General case' 0 C--O 1.2 -1.524 0 O-C-N 124.123 0.89 . . . . 0.0 110.751 172.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 38.9 mm-40 -41.76 -45.37 3.53 Favored 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 27.7 mmt85 -58.01 -48.26 80.58 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 174.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -81.51 -15.53 75.86 Favored Glycine 0 C--O 1.214 -1.128 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.581 -174.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 36.0 mm-40 -70.66 -39.42 73.59 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 117.699 0.75 . . . . 0.0 108.991 176.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.48 -58.45 7.55 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.188 173.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -62.73 -28.12 69.74 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.955 0.785 . . . . 0.0 113.065 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.54 -64.11 0.94 Allowed 'General case' 0 C--N 1.353 0.724 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -46.9 -41.28 15.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.881 0.872 . . . . 0.0 112.526 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.597 ' HB3' HD23 ' A' ' 11' ' ' LEU . 51.5 mt -65.25 -40.78 94.44 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.0 p -85.66 -28.08 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.023 0.829 . . . . 0.0 109.442 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -67.71 -29.38 68.62 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.077 170.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 66.2 m -83.38 -30.81 27.09 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.23 0.612 . . . . 0.0 109.837 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -61.56 -43.19 99.62 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 124.193 0.933 . . . . 0.0 112.022 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.254 1.297 0 C-N-CA 124.768 1.227 . . . . 0.0 111.989 173.425 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.61 92.2 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.806 1.242 . . . . 0.0 111.216 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.587 ' HA ' ' HB3' ' A' ' 31' ' ' ASP . 60.7 p -74.84 86.3 2.23 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.195 0.598 . . . . 0.0 112.344 -175.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.39 108.71 2.75 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 170.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -75.36 85.76 2.51 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.421 0.689 . . . . 0.0 109.216 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.589 ' HB3' ' HB2' ' A' ' 29' ' ' ARG . . . -76.47 78.22 3.18 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.376 -171.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 m -79.52 119.02 21.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.101 0.56 . . . . 0.0 109.725 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 43.1 mt-10 -114.48 112.65 23.31 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -176.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.418 ' HB3' HD11 ' A' ' 177' ' ' LEU . 97.6 mtt180 -72.44 133.31 44.8 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.266 0.626 . . . . 0.0 109.776 171.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.66 169.69 24.12 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.743 0.652 . . . . 0.0 110.525 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -144.91 150.19 36.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.446 ' H ' HD13 ' A' ' 11' ' ' LEU . . . -158.8 -146.66 4.61 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 174.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -149.27 152.65 36.27 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.441 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 30.6 tpt180 -154.75 135.67 13.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.7 m -78.74 137.64 37.86 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.415 HG13 ' H ' ' A' ' 19' ' ' GLY . 41.5 pt -126.63 159.61 62.75 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 124.081 0.952 . . . . 0.0 109.925 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.32 -27.3 56.91 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.333 2.689 . . . . 0.0 113.644 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.46 -39.23 77.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.965 0.506 . . . . 0.0 111.937 175.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.415 ' H ' HG13 ' A' ' 16' ' ' ILE . . . 164.35 -146.95 11.96 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 -173.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -83.83 137.98 33.44 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.66 160.4 38.22 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.946 0.498 . . . . 0.0 110.838 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -100.49 162.59 12.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 165.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 40.7 t -141.28 133.54 28.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.375 0.27 . . . . 0.0 110.86 -167.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.489 ' HA ' HD22 ' A' ' 11' ' ' LEU . 43.5 pt -85.48 134.84 26.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.17 111.56 36.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.0 mt -103.81 104.66 17.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.559 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 87.9 mtt180 -91.01 159.86 15.92 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 122.999 0.52 . . . . 0.0 109.805 173.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 6.3 tt0 -168.92 119.68 0.74 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.227 1.58 . . . . 0.0 111.477 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.589 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 6.0 mmt180 -88.44 106.23 18.13 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.531 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 91.4 m-85 -85.42 126.56 33.89 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.525 168.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.587 ' HB3' ' HA ' ' A' ' 3' ' ' SER . 11.1 t70 -89.35 76.74 7.5 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 168.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 30' ' ' TYR . . . -179.82 139.83 0.32 Allowed Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -157.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 85.4 Cg_endo -74.18 150.18 42.01 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.223 1.949 . . . . 0.0 113.504 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -47.78 -39.99 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.453 170.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -47.85 -49.3 29.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.393 1.058 . . . . 0.0 111.391 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 31.0 mt-10 -80.64 -29.84 36.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.565 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.7 t -73.13 -32.9 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 123.628 0.58 . . . . 0.0 110.631 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -81.51 -25.9 35.58 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.698 1.199 . . . . 0.0 109.753 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m -68.03 -50.16 57.01 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -60.55 -41.56 94.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.137 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.666 ' SG ' HD23 ' A' ' 99' ' ' LEU . 17.0 t -61.82 -45.18 94.94 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.4 p -104.05 -45.25 4.79 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -165.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 47' ' ' ILE . 5.5 m-20 -68.79 116.7 43.74 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.993 -175.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.88 -34.89 23.29 Favored 'Trans proline' 0 C--N 1.388 2.627 0 C-N-CA 123.622 2.881 . . . . 0.0 113.953 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.57 -33.49 72.78 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.631 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.579 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 30.7 mmt180 -90.0 -33.37 16.39 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.172 0.989 . . . . 0.0 111.512 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 43' ' ' ASP . 71.6 mt -73.3 -36.03 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -168.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -71.67 -1.03 12.33 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.558 0.743 . . . . 0.0 112.715 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.709 ' HD2' HD23 ' A' ' 144' ' ' LEU . 0.2 OUTLIER -89.5 -48.83 7.05 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.433 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 62.7 p-90 -101.56 -16.4 16.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.433 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 44.0 t80 -137.64 -114.16 0.17 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.584 0.754 . . . . 0.0 109.771 -176.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.475 HD12 HD13 ' A' ' 66' ' ' LEU . 49.4 mt -136.96 144.3 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -171.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.96 113.55 12.68 Favored Pre-proline 0 N--CA 1.485 1.295 0 O-C-N 124.801 1.313 . . . . 0.0 110.214 174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.414 ' HB2' HD21 ' A' ' 58' ' ' LEU . 60.5 Cg_endo -92.15 143.51 2.66 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.056 2.504 . . . . 0.0 111.742 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -143.9 135.93 26.5 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.99 -151.93 23.58 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -71.04 -49.1 48.6 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.414 HD21 ' HB2' ' A' ' 54' ' ' PRO . 40.7 mt 59.36 25.43 14.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.239 0.962 . . . . 0.0 110.602 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -122.94 148.66 45.22 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.436 1.495 . . . . 0.0 109.674 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -70.42 130.83 42.96 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.377 0.608 . . . . 0.0 109.771 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.71 -2.08 82.0 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.781 -168.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.24 178.03 18.3 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 8.2 p30 -117.98 178.0 4.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -172.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -150.85 162.39 40.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.04 0.936 . . . . 0.0 109.266 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.88 146.06 36.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.899 0.88 . . . . 0.0 109.513 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.475 HD13 HD12 ' A' ' 52' ' ' ILE . 86.9 mt -83.64 -89.83 0.09 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.175 0.59 . . . . 0.0 110.187 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -140.89 -57.59 0.51 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.27 9.62 0.52 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.412 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.473 ' HB3' HD12 ' A' ' 66' ' ' LEU . 42.6 t-20 -77.37 -85.07 0.06 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.3 158.58 43.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.703 0.763 . . . . 0.0 112.134 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.5 p -132.96 147.98 52.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.421 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.04 171.66 44.56 Favored Glycine 0 N--CA 1.464 0.502 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 24.9 m-20 -85.78 171.35 11.65 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.479 0.657 . . . . 0.0 111.298 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.23 119.53 59.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 168.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 84' ' ' THR . 59.0 mt -84.63 -38.4 19.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.005 0.522 . . . . 0.0 110.622 -176.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -166.18 111.54 0.83 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.493 0.717 . . . . 0.0 109.61 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 10.6 p -107.3 103.1 12.38 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -99.94 102.17 16.63 Favored Pre-proline 0 N--CA 1.482 1.125 0 C-N-CA 124.132 0.973 . . . . 0.0 110.521 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 96.6 Cg_endo -80.66 129.55 7.34 Favored 'Trans proline' 0 CA--C 1.564 2.013 0 C-N-CA 122.786 2.324 . . . . 0.0 112.896 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.56 ' HD2' HH11 ' A' ' 81' ' ' ARG . 16.1 Cg_endo -103.84 33.37 6.97 Favored 'Cis proline' 0 C--N 1.38 2.193 0 CA-C-N 119.802 0.965 . . . . 0.0 112.783 -10.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.56 HH11 ' HD2' ' A' ' 80' ' ' PRO . 3.7 mpt_? -65.93 -69.24 0.31 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.923 0.889 . . . . 0.0 110.437 -176.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.9 ptt-85 -161.86 154.68 20.29 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.322 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 83' ' ' LEU . 1.8 pt? -107.04 146.61 30.96 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 167.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 75' ' ' LEU . 94.1 m -131.53 121.83 25.11 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.664 1.585 . . . . 0.0 107.167 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.9 pt -141.58 142.99 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.779 0.832 . . . . 0.0 109.464 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.9 t -88.84 137.66 32.12 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -123.7 102.83 8.04 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.4 t -99.18 101.48 12.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -93.77 146.19 24.05 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.463 172.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -62.05 121.78 13.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.693 0.797 . . . . 0.0 111.331 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.82 19.65 61.09 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.323 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.46 ' HD2' ' HB2' ' A' ' 121' ' ' MET . 72.8 mmtt -132.4 147.89 67.47 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 123.917 0.887 . . . . 0.0 109.754 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.27 149.8 64.19 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.781 2.321 . . . . 0.0 111.418 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -59.8 116.61 4.21 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.872 0.869 . . . . 0.0 111.818 -169.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.8 m -90.59 160.76 15.76 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.554 -172.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -104.25 140.66 37.53 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.275 1.03 . . . . 0.0 108.361 166.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 54.2 t -138.14 118.37 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -126.46 111.87 14.94 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.666 HD23 ' SG ' ' A' ' 41' ' ' CYS . 38.2 tp -96.91 119.58 35.65 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.5 ttp-105 -127.14 114.57 17.88 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.618 0.767 . . . . 0.0 109.285 -160.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.1 mt -104.77 153.79 20.86 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.464 0.706 . . . . 0.0 110.564 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.6 m -141.85 123.01 14.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.784 0.834 . . . . 0.0 109.859 170.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -83.34 106.31 15.0 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -120.32 80.26 1.58 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.411 1.084 . . . . 0.0 110.238 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.56 -103.18 1.82 Allowed Glycine 0 C--N 1.35 1.31 0 C-N-CA 122.96 0.314 . . . . 0.0 112.539 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -106.47 5.08 28.99 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.416 0.686 . . . . 0.0 109.291 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.32 163.29 12.42 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.39 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 m -140.16 112.83 8.01 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.627 1.171 . . . . 0.0 108.438 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.8 tp -80.74 107.75 13.82 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.1 tt -90.66 131.46 36.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 172.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.545 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 43.9 mt-10 -132.9 109.22 9.44 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.5 tt -95.26 121.2 36.66 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 4.8 tp10 -112.6 102.7 10.76 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.471 ' HB3' HG12 ' A' ' 24' ' ' ILE . 6.5 t60 -114.58 112.67 23.29 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.441 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . . . -114.28 107.68 15.91 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.404 1.082 . . . . 0.0 110.189 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.506 HG23 ' HG ' ' A' ' 122' ' ' LEU . 5.1 t -127.64 156.03 42.96 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.663 0.744 . . . . 0.0 110.528 174.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -23.77 58.87 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.196 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.1 t -91.19 115.89 28.38 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.236 1.015 . . . . 0.0 110.795 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -69.93 -25.58 63.73 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.758 0.823 . . . . 0.0 110.942 175.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -63.45 -47.76 80.53 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.528 171.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.46 ' HB2' ' HD2' ' A' ' 92' ' ' LYS . 23.3 ttt -67.58 -33.61 75.36 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.114 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.506 ' HG ' HG23 ' A' ' 116' ' ' THR . 19.7 mt -63.06 -43.87 97.42 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.255 0.622 . . . . 0.0 112.045 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 127' ' ' VAL . 89.3 t -63.78 -42.23 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.954 173.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.65 -44.99 76.58 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.582 1.153 . . . . 0.0 111.807 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -79.65 -18.84 12.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 C-N-CA 123.37 0.668 . . . . 0.0 109.505 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.49 -34.09 89.02 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 166.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 123' ' ' VAL . 48.7 t -75.6 -50.76 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.97 -33.48 79.45 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 114.676 0.63 . . . . 0.0 114.676 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -86.04 -41.02 15.17 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.703 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.71 -34.05 76.35 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.91 0.777 . . . . 0.0 109.604 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 53.4 ttm -60.83 -50.13 74.67 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.837 0.855 . . . . 0.0 109.74 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.52 90.79 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.739 0.816 . . . . 0.0 112.154 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.16 -21.51 33.52 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.518 0.727 . . . . 0.0 111.6 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.65 -44.4 70.66 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -72.7 -35.82 67.7 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.166 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 29.1 tp -70.43 -38.66 74.61 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.824 0.45 . . . . 0.0 110.557 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.01 -52.77 50.21 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.744 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 31.1 ttp -61.75 -38.89 89.68 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.121 0.568 . . . . 0.0 110.799 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.16 -56.69 18.57 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.857 1.263 . . . . 0.0 111.042 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 58.9 mt -72.46 -19.19 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.8 0.84 . . . . 0.0 111.145 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.03 -39.37 69.17 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 173.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.58 -50.81 0.3 Allowed Glycine 0 C--N 1.356 1.685 0 C-N-CA 121.474 -0.393 . . . . 0.0 113.985 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -105.26 170.73 7.71 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.452 0.701 . . . . 0.0 110.669 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.709 HD23 ' HD2' ' A' ' 49' ' ' ARG . 20.2 tp -159.07 77.79 3.05 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 122.544 0.338 . . . . 0.0 110.626 168.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -101.79 172.94 0.27 Allowed 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 123.436 2.757 . . . . 0.0 113.023 165.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.77 77.63 1.98 Allowed Glycine 0 C--N 1.343 0.919 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 165.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -66.47 -80.67 0.17 Allowed Glycine 0 C--N 1.348 1.228 0 CA-C-O 119.242 -0.754 . . . . 0.0 113.557 -173.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.45 -45.41 11.73 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.232 2.621 . . . . 0.0 112.236 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.452 HG11 ' HB2' ' A' ' 153' ' ' ALA . 14.2 m -78.89 121.32 83.28 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.666 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -82.39 -23.89 3.98 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.927 2.418 . . . . 0.0 113.168 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -83.43 -73.31 0.42 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.787 0.835 . . . . 0.0 110.792 -168.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -175.74 -39.45 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.141 -174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.452 ' HB2' HG11 ' A' ' 149' ' ' VAL . . . 67.38 47.8 1.23 Allowed 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.117 1.367 . . . . 0.0 110.173 -174.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.67 -91.47 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.435 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -158.69 -172.16 3.72 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.002 1.321 . . . . 0.0 109.231 -166.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 56.72 -91.13 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.993 1.717 . . . . 0.0 112.262 169.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -172.04 121.68 0.47 Allowed 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.587 1.155 . . . . 0.0 108.18 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 21.6 mt-10 -108.52 112.26 60.89 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.653 1.181 . . . . 0.0 108.607 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 158' ' ' GLU . 19.6 Cg_endo -57.35 93.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 122.86 2.374 . . . . 0.0 111.748 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 29.8 t -165.04 119.11 0.96 Allowed Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.5 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.74 -38.74 91.53 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.617 2.211 . . . . 0.0 112.193 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -68.97 -49.7 55.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.942 0.497 . . . . 0.0 111.517 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -43.14 74.79 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -173.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -64.13 -35.23 80.1 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -67.05 -43.25 83.21 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.401 0.68 . . . . 0.0 111.562 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 12.2 tt -76.14 -28.89 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 122.428 0.291 . . . . 0.0 111.39 -176.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.9 p -77.78 -40.91 39.2 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -54.63 -59.03 5.26 Favored 'General case' 0 C--O 1.206 -1.211 0 O-C-N 123.922 0.764 . . . . 0.0 110.664 166.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -41.44 -49.58 3.9 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.153 1.381 . . . . 0.0 112.437 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -56.59 -55.79 29.54 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.007 0.523 . . . . 0.0 110.385 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.42 -17.52 79.11 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.435 -168.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.23 -29.07 31.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.023 0.929 . . . . 0.0 110.042 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.52 -53.67 17.96 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.78 0.832 . . . . 0.0 109.503 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -69.1 -25.87 64.64 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.846 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.04 -60.53 3.32 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 172.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.16 12.52 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.662 1.185 . . . . 0.0 112.911 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 78.1 mt -68.7 -46.25 69.48 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.096 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.03 -23.74 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.115 0.871 . . . . 0.0 110.682 -166.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -70.39 -25.25 63.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.424 0.69 . . . . 0.0 110.072 171.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.0 m -96.08 12.35 30.94 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.059 0.944 . . . . 0.0 110.692 172.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.45 -46.67 54.88 Favored Glycine 0 C--N 1.356 1.654 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.473 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.555 1.147 0 CA-C-O 118.355 -0.831 . . . . 0.0 109.268 173.975 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.48 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.32 120.93 28.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.605 1.162 . . . . 0.0 110.989 -172.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.8 m -151.86 2.11 0.37 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.05 0.94 . . . . 0.0 111.623 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.19 42.97 1.17 Allowed Glycine 0 C--N 1.343 0.953 0 N-CA-C 112.027 -0.429 . . . . 0.0 112.027 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.9 32.01 1.27 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.952 0.501 . . . . 0.0 111.455 -175.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.67 71.52 7.56 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.226 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 85.6 m -85.81 122.25 29.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.628 -176.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -124.6 112.06 16.37 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.571 1.548 . . . . 0.0 107.596 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.27 159.54 31.39 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.8 173.26 10.82 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.504 0.722 . . . . 0.0 109.095 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -145.32 154.86 42.78 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -177.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.459 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -162.47 -153.95 7.37 Favored Glycine 0 C--O 1.238 0.404 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.4 ptt85 -157.1 160.28 38.7 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.211 0.604 . . . . 0.0 110.129 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -168.53 162.42 12.1 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.917 171.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.1 m -96.37 144.03 26.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.763 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 117' ' ' THR . 42.5 pt -135.5 162.31 57.95 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.933 1.293 . . . . 0.0 108.497 -174.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.97 -35.37 31.76 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.568 2.845 . . . . 0.0 114.767 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.83 99.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.647 0.779 . . . . 0.0 111.779 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.06 -149.05 18.28 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.66 139.27 38.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 117.314 0.557 . . . . 0.0 109.622 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.12 158.55 44.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.295 0.569 . . . . 0.0 111.479 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -97.11 161.37 13.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 165.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 78.4 p -138.48 124.56 20.17 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.508 HG12 HG23 ' A' ' 125' ' ' VAL . 2.6 pp -86.61 131.0 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mp -113.19 119.58 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.0 mt -105.65 111.03 33.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 61.3 mtt180 -92.18 140.85 29.21 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 123.364 0.415 . . . . 0.0 110.335 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.671 HE22 HD22 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -137.33 139.6 40.94 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 167.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.491 HH12 ' HA3' ' A' ' 107' ' ' GLY . 24.6 tpt85 -107.83 102.79 11.97 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.434 ' HE1' ' HA2' ' A' ' 137' ' ' GLY . 63.1 m-85 -85.95 144.46 27.62 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.931 1.292 . . . . 0.0 110.929 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.527 ' HB3' ' HD3' ' A' ' 141' ' ' ARG . 26.5 t70 -87.82 26.44 1.33 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 123.807 0.692 . . . . 0.0 110.696 170.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.27 155.09 68.79 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.049 0.94 . . . . 0.0 110.604 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.38 156.63 59.0 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.549 2.833 . . . . 0.0 113.174 175.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 101' ' ' LEU . 11.3 t -59.97 -42.51 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 O-C-N 124.473 1.108 . . . . 0.0 110.628 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -48.66 -52.05 25.29 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 125.107 1.504 . . . . 0.0 109.88 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -64.92 -62.87 1.3 Allowed 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.65 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.533 HG22 HD13 ' A' ' 140' ' ' ILE . 62.9 t -46.54 -39.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 C-N-CA 124.697 1.199 . . . . 0.0 112.248 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -65.93 -41.16 91.73 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.114 0.966 . . . . 0.0 110.316 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.4 m -69.78 -25.79 63.97 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 123.469 0.48 . . . . 0.0 110.512 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.56 -47.91 21.02 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.527 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.459 ' HB3' HD21 ' A' ' 99' ' ' LEU . 84.7 m -75.82 -16.9 60.02 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 43.7 p -101.63 -33.22 9.98 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 118.403 0.547 . . . . 0.0 111.66 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 47' ' ' ILE . 19.9 t70 -83.45 112.41 39.12 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 122.75 0.42 . . . . 0.0 110.004 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.484 ' HB2' ' HG3' ' A' ' 53' ' ' GLU . 58.4 Cg_endo -64.46 -27.34 62.37 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.151 2.568 . . . . 0.0 112.869 -171.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -63.9 -39.34 93.95 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.758 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -79.48 -24.29 42.44 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.59 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 43' ' ' ASP . 79.1 mt -74.82 -38.5 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.59 0.356 . . . . 0.0 111.52 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 10.9 p30 -73.87 -0.42 15.94 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -73.26 -29.94 63.09 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.768 0.827 . . . . 0.0 110.714 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 40.7 p-90 -129.31 -11.7 4.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.015 0.926 . . . . 0.0 111.484 -171.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.457 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 16.2 t80 -147.96 -163.72 1.84 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.525 0.73 . . . . 0.0 109.13 -174.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 mt -87.1 171.34 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 31.3 tt0 -108.63 121.51 43.05 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.668 1.187 . . . . 0.0 110.12 -172.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.69 84.69 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.337 2.691 . . . . 0.0 111.0 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -77.47 126.22 30.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.989 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.22 -165.89 36.8 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.633 -0.318 . . . . 0.0 112.722 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.84 -37.96 73.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.443 0.697 . . . . 0.0 110.279 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.0 mt 59.22 -171.37 0.12 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.922 1.289 . . . . 0.0 111.885 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 72.59 166.64 0.3 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.882 1.273 . . . . 0.0 110.598 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 41.3 tt0 -60.02 111.7 1.6 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.165 0.586 . . . . 0.0 111.149 -173.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.08 11.52 58.61 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.436 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.34 -146.56 20.36 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.65 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 29.8 p-10 -156.0 160.42 40.03 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 117.571 0.685 . . . . 0.0 111.705 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -140.07 147.91 40.99 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.72 112.17 5.28 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.756 0.823 . . . . 0.0 109.884 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 69' ' ' ASN . 79.1 mt -78.39 146.89 34.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.706 0.802 . . . . 0.0 109.262 172.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -69.41 122.07 18.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.551 0.74 . . . . 0.0 110.631 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 56.69 40.9 89.45 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 124.29 0.994 . . . . 0.0 114.468 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 66' ' ' LEU . 18.4 t-20 -147.17 -84.27 0.11 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.704 0.252 . . . . 0.0 110.402 -171.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.35 151.03 31.19 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.98 0.419 . . . . 0.0 111.707 -171.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -132.0 145.25 51.34 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.224 1.009 . . . . 0.0 109.796 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.19 -163.08 26.99 Favored Glycine 0 C--O 1.241 0.548 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.65 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 4.8 p-10 -127.04 173.89 9.3 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.158 0.479 . . . . 0.0 110.731 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.475 ' HA ' HG22 ' A' ' 85' ' ' ILE . 19.6 mm -97.49 102.8 13.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.53 -47.84 71.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -167.66 142.52 3.76 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.794 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 22.0 p -127.36 106.24 9.07 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.64 99.47 8.84 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 9.9 Cg_exo -74.56 137.81 23.3 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.147 2.565 . . . . 0.0 112.984 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 42.7 Cg_endo -100.83 30.53 11.11 Favored 'Cis proline' 0 C--N 1.375 1.932 0 CA-C-N 119.481 0.85 . . . . 0.0 112.153 -9.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -71.34 -69.43 0.38 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.285 1.034 . . . . 0.0 111.998 -170.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -152.95 146.9 25.36 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.417 0.627 . . . . 0.0 111.452 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 99' ' ' LEU . 58.1 tp -98.31 143.99 28.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.702 -1.136 . . . . 0.0 107.954 169.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.9 m -134.79 123.34 23.42 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.475 HG22 ' HA ' ' A' ' 74' ' ' ILE . 21.0 pt -143.74 149.56 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.619 0.768 . . . . 0.0 110.285 -174.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 p -88.16 138.51 31.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 36.8 t-105 -130.2 101.02 5.61 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -170.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -107.91 102.46 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -78.74 154.85 29.68 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.63 111.04 1.45 Allowed 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.065 0.46 . . . . 0.0 111.784 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.04 21.99 66.75 Favored Glycine 0 C--N 1.351 1.361 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.375 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.463 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 69.0 mmtt -126.48 153.14 75.08 Favored Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 123.711 0.805 . . . . 0.0 109.593 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.519 ' HG2' ' HB2' ' A' ' 118' ' ' SER . 23.4 Cg_exo -64.72 162.5 31.39 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.962 2.441 . . . . 0.0 113.506 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.93 103.59 1.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.962 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -100.46 179.29 4.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.824 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -142.42 128.81 20.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.974 0.909 . . . . 0.0 108.634 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.6 t -113.66 121.46 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.241 0.544 . . . . 0.0 110.292 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 37.7 mm-40 -91.41 138.66 31.4 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.906 165.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 83' ' ' LEU . 55.0 tp -127.63 110.57 12.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 171.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -128.97 121.91 29.0 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 122.151 -0.343 . . . . 0.0 110.385 -160.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HB3' HG22 ' A' ' 34' ' ' VAL . 90.0 mt -115.61 141.28 48.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.645 0.778 . . . . 0.0 111.233 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.4 t -144.51 115.24 7.74 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.523 1.129 . . . . 0.0 108.791 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -81.96 120.45 25.25 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -129.39 121.81 28.14 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.301 1.44 . . . . 0.0 108.129 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.93 -135.28 16.44 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -102.63 62.57 0.84 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 165.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.491 ' HA3' HH12 ' A' ' 29' ' ' ARG . . . -179.24 -177.79 47.9 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.101 -0.954 . . . . 0.0 114.408 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.3 m -134.26 141.33 46.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.311 1.044 . . . . 0.0 110.081 -170.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.9 tp -102.27 112.98 25.9 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.671 HD22 HE22 ' A' ' 28' ' ' GLN . 7.3 tt -95.89 134.61 38.67 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 173.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.577 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 39.8 mt-10 -132.69 106.28 7.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.642 HD13 HD21 ' A' ' 133' ' ' LEU . 8.9 tt -98.27 122.05 40.96 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 98' ' ' GLU . 38.7 tt0 -122.01 100.78 7.16 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.807 0.843 . . . . 0.0 109.28 -172.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 23' ' ' SER . 8.3 t60 -99.29 113.77 26.25 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 22' ' ' ARG . . . -104.38 111.74 24.51 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.714 1.206 . . . . 0.0 111.095 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.454 HG23 ' HG ' ' A' ' 122' ' ' LEU . 10.6 t -136.99 160.76 37.97 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 170.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.433 HG23 HD11 ' A' ' 16' ' ' ILE . 66.8 p -86.13 -15.08 42.24 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.582 1.153 . . . . 0.0 111.489 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.519 ' HB2' ' HG2' ' A' ' 93' ' ' PRO . 46.4 t -87.17 108.98 19.15 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.062 0.545 . . . . 0.0 109.797 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.507 ' HA ' HD12 ' A' ' 122' ' ' LEU . 39.7 tt0 -62.03 -31.04 71.4 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.787 0.835 . . . . 0.0 110.796 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -61.24 -58.05 9.88 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.158 175.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.463 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 24.3 ttt -64.16 -26.92 68.74 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.706 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 119' ' ' GLU . 13.8 mt -65.15 -44.6 88.05 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.463 0.705 . . . . 0.0 111.864 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.89 -45.44 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.256 0.551 . . . . 0.0 109.81 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.79 -50.5 72.14 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.042 1.337 . . . . 0.0 112.081 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.508 HG23 HG12 ' A' ' 24' ' ' ILE . 35.8 m -72.03 -29.37 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.876 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.7 -38.23 91.36 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 172.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 131' ' ' MET . 59.6 t -75.69 -59.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.051 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.63 -37.04 94.15 Favored Glycine 0 C--N 1.345 1.038 0 O-C-N 123.725 0.64 . . . . 0.0 114.446 -172.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.473 ' HB2' ' O ' ' A' ' 125' ' ' VAL . 10.7 m95 -67.05 -53.38 31.68 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -57.76 -31.47 66.53 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.156 0.285 . . . . 0.0 110.746 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 95.7 mmm -61.48 -48.45 81.06 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.204 0.602 . . . . 0.0 110.331 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.31 -38.96 85.32 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.26 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.642 HD21 HD13 ' A' ' 112' ' ' LEU . 2.8 mm? -77.37 -19.88 55.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.985 0.514 . . . . 0.0 111.731 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 138' ' ' MET . 72.0 m-20 -66.82 -53.5 32.08 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 68.9 m-85 -72.59 -25.4 61.31 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.749 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.402 HD13 ' CZ2' ' A' ' 50' ' ' TRP . 59.1 tp -70.39 -39.21 74.64 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.434 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -58.14 -39.41 92.19 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.615 171.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 89.3 mmm -70.22 -38.16 75.17 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.531 0.732 . . . . 0.0 110.183 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -69.01 -37.26 78.57 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.2 1.0 . . . . 0.0 111.276 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.533 HD13 HG22 ' A' ' 37' ' ' VAL . 50.5 mt -80.03 -57.42 5.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 123.338 0.655 . . . . 0.0 110.193 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.527 ' HD3' ' HB3' ' A' ' 31' ' ' ASP . 21.2 ttt180 -163.42 69.52 0.21 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.709 0.766 . . . . 0.0 110.179 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -154.41 4.35 0.27 Allowed Glycine 0 CA--C 1.527 0.787 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.107 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 65.94 94.77 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.804 1.242 . . . . 0.0 111.268 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.22 121.83 62.37 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 124.467 1.107 . . . . 0.0 110.463 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.49 92.7 0.35 Allowed 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.01 2.473 . . . . 0.0 111.464 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.62 88.67 1.38 Allowed Glycine 0 C--O 1.242 0.615 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.872 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.72 -129.82 1.23 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-O 118.882 -0.955 . . . . 0.0 111.818 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.22 -19.01 39.25 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.694 2.263 . . . . 0.0 113.037 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.9 t 65.69 127.98 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 C-N-CA 125.584 1.553 . . . . 0.0 110.098 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -41.71 -58.53 1.11 Allowed 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 124.278 3.319 . . . . 0.0 114.749 -171.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.464 ' HG2' ' H ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER -109.4 -18.03 13.65 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.9 0.88 . . . . 0.0 110.563 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.9 t70 67.54 7.58 5.72 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.932 1.293 . . . . 0.0 112.037 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.464 ' H ' ' HG2' ' A' ' 151' ' ' GLU . . . 56.33 23.89 7.74 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.892 1.277 . . . . 0.0 111.962 -172.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.69 170.97 8.83 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.893 0.877 . . . . 0.0 111.324 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -93.34 70.39 4.36 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 122.6 1.19 . . . . 0.0 110.169 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -105.5 79.51 1.47 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.071 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -76.51 84.0 3.21 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.146 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 44.0 mt-10 -118.61 147.63 42.47 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.58 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.534 ' HA ' ' SD ' ' A' ' 164' ' ' MET . 5.1 Cg_exo -79.97 38.33 0.74 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.594 2.863 . . . . 0.0 114.04 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.2 m -66.49 105.55 0.86 Allowed Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.506 0.723 . . . . 0.0 109.258 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -57.2 -35.94 98.99 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.249 2.632 . . . . 0.0 114.019 -165.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.82 -54.0 22.5 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 6.7 tpt -62.75 -37.61 87.28 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.028 0.531 . . . . 0.0 110.835 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.534 ' SD ' ' HA ' ' A' ' 159' ' ' PRO . 88.8 mtp -60.79 -55.51 32.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.969 0.507 . . . . 0.0 109.844 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -58.14 -49.66 76.21 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.912 0.757 . . . . 0.0 111.071 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 61.8 mt -55.59 -47.61 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.254 0.622 . . . . 0.0 110.943 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 62.2 p -70.69 -39.76 73.32 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.235 0.334 . . . . 0.0 110.52 -171.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -59.7 -59.7 5.02 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.293 170.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -43.17 -36.75 1.82 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 172.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -64.77 -52.36 57.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.248 0.619 . . . . 0.0 110.733 175.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.25 -20.01 75.92 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.264 -174.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -81.37 -28.17 34.54 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.63 1.172 . . . . 0.0 110.088 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.25 -48.76 55.44 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -69.05 -23.1 64.01 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.035 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.01 -61.08 2.24 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 173.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -47.11 -47.1 23.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.837 1.255 . . . . 0.0 112.733 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 56.6 mt -64.83 -46.51 81.61 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.592 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.9 p -74.57 -26.94 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 118.867 0.758 . . . . 0.0 109.953 -169.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -76.29 -10.09 59.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.64 0.776 . . . . 0.0 111.583 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.6 t -85.69 -21.89 28.11 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.593 0.757 . . . . 0.0 109.54 168.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -80.65 -41.78 10.73 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.446 172.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.247 0.938 0 C-N-CA 124.5 1.12 . . . . 0.0 108.063 176.564 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.05 98.04 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.978 1.311 . . . . 0.0 110.923 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.3 m -128.95 103.47 7.04 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.594 0.757 . . . . 0.0 109.9 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.76 80.74 1.31 Allowed Glycine 0 C--N 1.345 1.038 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 61.94 68.53 0.68 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.359 1.064 . . . . 0.0 110.749 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.51 75.34 4.06 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.382 0.611 . . . . 0.0 110.645 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 m -89.11 130.92 35.47 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.824 0.85 . . . . 0.0 111.161 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 19.8 mt-10 -119.16 109.13 15.52 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 173.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -82.48 136.13 34.97 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.047 0.539 . . . . 0.0 110.259 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.13 179.44 9.23 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 123.843 0.714 . . . . 0.0 110.144 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 178' ' ' VAL . 0.2 OUTLIER -143.61 148.46 35.89 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.55 166.28 23.91 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.516 ' HD3' ' H ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -110.33 148.53 31.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.624 ' HG2' ' HB1' ' A' ' 115' ' ' ALA . 6.5 tpt180 -148.33 150.3 33.35 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.206 0.527 . . . . 0.0 112.134 -164.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.3 m -111.13 137.9 48.22 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 161.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 pt -140.03 159.77 63.01 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -51.1 -26.59 19.62 Favored 'Trans proline' 0 C--N 1.386 2.549 0 C-N-CA 123.065 2.51 . . . . 0.0 114.294 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.71 -44.81 63.52 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.029 0.532 . . . . 0.0 111.307 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.43 -151.21 21.71 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.071 0.232 . . . . 0.0 112.609 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -73.75 123.14 23.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.409 0.684 . . . . 0.0 109.644 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.03 166.95 19.07 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.542 0.737 . . . . 0.0 111.205 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -125.15 171.78 10.03 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 162.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.9 m -134.45 135.67 42.67 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.289 0.636 . . . . 0.0 109.797 -170.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.537 HG12 ' HB3' ' A' ' 114' ' ' HIS . 35.4 pt -85.91 133.69 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 168.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.661 HG13 ' HG2' ' A' ' 113' ' ' GLU . 2.0 mp -110.57 111.8 37.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 174.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.407 HD12 ' HB3' ' A' ' 129' ' ' TRP . 39.5 mt -107.29 106.65 21.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 168.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.521 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 28.4 mtt180 -89.74 161.19 16.18 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.547 174.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 110' ' ' LEU . 4.2 tp-100 -162.11 117.88 1.98 Allowed 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.337 -174.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.402 ' HE ' HD13 ' A' ' 109' ' ' LEU . 26.3 mmt85 -95.4 105.68 17.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 165.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.553 ' HB2' ' HB ' ' A' ' 108' ' ' THR . 50.3 m-85 -87.58 150.7 23.53 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 123.857 0.863 . . . . 0.0 109.398 169.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -114.66 85.74 2.3 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 162.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 179.71 137.45 0.28 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.932 2.093 . . . . 0.0 105.617 -163.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.46 137.07 78.37 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.76 2.307 . . . . 0.0 113.286 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 108' ' ' THR . 54.3 t -48.99 -40.47 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 124.329 1.018 . . . . 0.0 110.528 167.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -48.88 -45.48 41.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.474 1.109 . . . . 0.0 111.308 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.11 -25.64 34.27 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 140' ' ' ILE . 50.6 t -72.29 -44.18 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.074 0.464 . . . . 0.0 110.359 174.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -68.51 -28.02 66.64 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.593 1.157 . . . . 0.0 109.726 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 t -65.79 -48.27 72.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.932 0.893 . . . . 0.0 109.928 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.23 -28.41 63.14 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.338 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.3 t -76.95 -24.39 52.35 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.6 p -111.18 -43.01 3.8 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -172.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.435 ' O ' HG13 ' A' ' 47' ' ' ILE . 15.0 t70 -76.66 120.07 80.11 Favored Pre-proline 0 N--CA 1.483 1.22 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.917 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.1 -46.54 30.42 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.903 3.069 . . . . 0.0 114.391 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.436 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 41.3 t-20 -58.65 -32.64 69.26 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.768 0.827 . . . . 0.0 111.314 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -89.82 -20.06 23.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.219 0.608 . . . . 0.0 111.217 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 43' ' ' ASP . 85.7 mt -75.99 -42.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.059 0.544 . . . . 0.0 110.331 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' A' ' 45' ' ' ASN . 10.6 p30 -69.78 -0.89 7.86 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -172.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -91.82 -11.06 37.63 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.365 0.666 . . . . 0.0 110.246 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.447 ' CE2' HD13 ' A' ' 136' ' ' LEU . 57.9 p-90 -137.17 -25.21 1.07 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.3 1.04 . . . . 0.0 111.338 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.439 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 5.1 t80 -130.66 -160.66 1.06 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.329 1.052 . . . . 0.0 108.523 -177.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.62 143.64 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 122.833 0.453 . . . . 0.0 110.661 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -63.6 115.06 15.59 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 124.753 1.283 . . . . 0.0 109.767 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HG3' HD12 ' A' ' 47' ' ' ILE . 83.9 Cg_endo -83.07 148.06 13.25 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.446 2.097 . . . . 0.0 112.877 178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -134.96 125.87 27.49 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.61 -175.45 39.82 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 121.507 -0.377 . . . . 0.0 112.902 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.8 -44.06 86.82 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.177 0.574 . . . . 0.0 110.307 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.6 mt 66.95 5.15 3.88 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.133 1.373 . . . . 0.0 113.126 171.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -103.71 168.1 9.36 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.297 0.639 . . . . 0.0 109.917 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 77' ' ' CYS . 31.2 mt-10 -58.56 122.76 14.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.746 0.819 . . . . 0.0 110.794 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.35 13.94 77.57 Favored Glycine 0 N--CA 1.469 0.862 0 CA-C-N 116.467 -0.333 . . . . 0.0 113.112 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.95 -168.17 19.03 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.299 -0.32 . . . . 0.0 112.299 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -117.31 167.24 11.41 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.564 0.746 . . . . 0.0 110.095 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -146.95 149.4 33.11 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.15 116.3 9.44 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.203 0.601 . . . . 0.0 111.032 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.403 ' HB2' ' H ' ' A' ' 70' ' ' ALA . 60.3 mt -91.7 133.58 35.46 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.672 1.189 . . . . 0.0 109.3 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -68.23 106.08 2.32 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.565 1.146 . . . . 0.0 110.0 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.81 40.55 84.94 Favored Glycine 0 C--N 1.348 1.206 0 N-CA-C 114.385 0.514 . . . . 0.0 114.385 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -144.54 -86.77 0.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.579 0.352 . . . . 0.0 110.128 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 66' ' ' LEU . . . -147.69 156.31 42.64 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 120.773 0.321 . . . . 0.0 111.631 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.1 m -131.0 143.21 50.55 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.222 1.009 . . . . 0.0 108.538 174.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.93 -153.81 8.09 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.425 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 2.4 m-20 -121.36 171.07 9.02 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.771 0.828 . . . . 0.0 109.828 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.47 ' HA ' HG22 ' A' ' 85' ' ' ILE . 3.5 mp -108.24 112.65 41.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 170.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.599 HD12 HG22 ' A' ' 84' ' ' THR . 74.9 mt -69.95 -49.97 46.53 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.458 ' HD2' ' HB ' ' A' ' 84' ' ' THR . 0.1 OUTLIER -168.65 154.88 6.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.059 0.944 . . . . 0.0 109.376 169.504 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.469 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 24.9 p -146.31 120.36 9.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -121.23 110.14 34.61 Favored Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 16.8 Cg_exo -68.38 129.52 19.28 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.851 2.367 . . . . 0.0 112.693 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 19.9 Cg_endo -103.42 23.96 13.15 Favored 'Cis proline' 0 C--N 1.376 2.014 0 CA-C-N 120.048 1.053 . . . . 0.0 112.626 -13.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -64.18 -67.14 0.46 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.0 0.92 . . . . 0.0 112.006 -171.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -138.03 158.42 44.36 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.588 0.755 . . . . 0.0 110.651 -171.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 tt -142.32 127.5 18.61 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 171.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.599 HG22 HD12 ' A' ' 75' ' ' LEU . 19.3 m -139.46 130.3 26.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.227 0.611 . . . . 0.0 109.378 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 74' ' ' ILE . 10.4 pt -141.24 146.6 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.026 1.33 . . . . 0.0 109.91 -171.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.425 ' OG ' ' HB2' ' A' ' 73' ' ' ASP . 18.0 p -89.95 145.57 25.02 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.673 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 22.0 t-105 -140.98 107.33 5.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.101 0.864 . . . . 0.0 109.397 -159.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.15 103.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.4 ' HB3' ' HE3' ' A' ' 121' ' ' MET . 67.2 t80 -101.51 94.96 6.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.566 1.146 . . . . 0.0 110.432 -169.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 47.8 -73.1 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 126.618 1.967 . . . . 0.0 115.278 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.6 33.58 2.54 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 117.957 0.344 . . . . 0.0 112.553 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.613 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 72.3 mmtt -115.65 159.31 39.24 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 124.174 0.989 . . . . 0.0 110.656 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.12 161.02 41.93 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.419 2.079 . . . . 0.0 112.759 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.58 107.08 1.97 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.901 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.673 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 13.4 m -87.71 155.58 19.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.188 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -116.51 103.08 10.07 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.63 142.7 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.938 0.895 . . . . 0.0 108.622 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -147.83 156.87 43.18 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.253 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.5 tt -139.81 139.85 36.48 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 21.2 tpt180 -135.25 122.86 22.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.777 0.831 . . . . 0.0 109.521 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.4 mt -115.32 137.86 51.58 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.688 0.795 . . . . 0.0 110.16 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 t -143.98 137.1 27.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.172 0.589 . . . . 0.0 109.898 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -84.97 96.14 9.29 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.528 1.131 . . . . 0.0 110.425 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -100.7 78.23 1.96 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.01 -117.42 4.69 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -91.37 9.73 30.41 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 168.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 30' ' ' TYR . . . -100.82 159.32 19.03 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.485 -173.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.617 HG23 HG22 ' A' ' 34' ' ' VAL . 53.1 m -135.15 108.13 7.62 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.757 1.223 . . . . 0.0 108.63 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.402 HD13 ' HE ' ' A' ' 29' ' ' ARG . 39.8 tp -81.04 106.04 12.73 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 170.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 28' ' ' GLN . 8.1 tt -91.0 130.89 36.88 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 42.4 mt-10 -131.67 107.09 8.57 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 tp -104.23 128.68 51.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.998 0.919 . . . . 0.0 109.636 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.661 ' HG2' HG13 ' A' ' 25' ' ' ILE . 45.5 mt-10 -127.12 103.67 7.56 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.775 0.83 . . . . 0.0 109.43 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.537 ' HB3' HG12 ' A' ' 24' ' ' ILE . 6.8 t60 -92.97 111.7 23.42 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.624 ' HB1' ' HG2' ' A' ' 14' ' ' ARG . . . -109.91 101.79 10.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.141 0.576 . . . . 0.0 110.54 -174.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.402 HG23 ' HG ' ' A' ' 122' ' ' LEU . 9.8 t -123.78 152.22 42.44 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.268 0.556 . . . . 0.0 110.77 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.3 m -66.42 -29.32 69.44 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.367 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 t -92.36 125.43 37.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.096 0.558 . . . . 0.0 111.384 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -62.48 -34.04 76.06 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.56 1.144 . . . . 0.0 110.126 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -44.93 81.78 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.212 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.613 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 23.2 ttt -68.48 -32.94 73.29 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.159 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.402 ' HG ' HG23 ' A' ' 116' ' ' THR . 25.5 mt -63.01 -42.52 99.86 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 118.42 0.554 . . . . 0.0 112.104 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.6 t -67.82 -42.13 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-O 121.155 0.502 . . . . 0.0 109.868 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -58.15 -50.17 74.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.18 1.392 . . . . 0.0 111.638 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 121' ' ' MET . 26.4 m -82.6 -18.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.565 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.86 -36.44 92.02 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 169.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.46 -46.81 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 114.669 -0.766 . . . . 0.0 109.94 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.11 -35.81 92.45 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 114.845 0.698 . . . . 0.0 114.845 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.407 ' HB3' HD12 ' A' ' 26' ' ' ILE . 66.8 m95 -87.67 -28.26 21.93 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.987 0.515 . . . . 0.0 110.853 -176.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.464 ' HG3' ' HE1' ' A' ' 174' ' ' TRP . 43.9 mm-40 -62.45 -38.81 91.22 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 72.4 mtm -70.4 -33.96 71.99 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.926 0.766 . . . . 0.0 110.692 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.67 -46.15 83.67 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.028 0.531 . . . . 0.0 111.054 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.91 -22.2 46.2 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.381 0.673 . . . . 0.0 110.741 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.474 ' O ' ' HG2' ' A' ' 138' ' ' MET . 24.8 t70 -65.49 -62.34 1.58 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 171.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -64.75 -29.64 70.63 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.1 0.56 . . . . 0.0 111.846 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.447 HD13 ' CE2' ' A' ' 50' ' ' TRP . 39.5 tp -67.83 -42.64 81.14 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -61.43 -39.05 96.76 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.9 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 97.3 mmm -69.4 -43.18 73.98 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.766 0.826 . . . . 0.0 110.524 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -68.21 -50.76 52.07 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.342 1.057 . . . . 0.0 111.064 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.459 HD13 HG22 ' A' ' 37' ' ' VAL . 67.0 mt -62.6 -43.52 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.309 0.644 . . . . 0.0 110.756 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER -61.83 -41.17 97.47 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.417 0.687 . . . . 0.0 109.264 178.507 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.86 -10.96 12.04 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.884 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -86.79 83.26 7.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.028 0.414 . . . . 0.0 110.359 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.4 81.38 3.6 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 174.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -79.74 -172.83 1.64 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.998 2.466 . . . . 0.0 112.685 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.67 71.05 2.17 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.01 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -98.36 106.44 3.27 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.07 120.68 8.73 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.073 2.516 . . . . 0.0 112.808 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.9 m -67.68 148.34 98.56 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.016 0.526 . . . . 0.0 109.62 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -55.83 -35.92 94.54 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.436 2.091 . . . . 0.0 111.679 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -170.29 -34.68 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.821 0.848 . . . . 0.0 110.427 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.2 t70 67.31 79.37 0.23 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.616 1.166 . . . . 0.0 109.347 -170.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -154.18 99.86 2.27 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.01 94.44 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.364 1.066 . . . . 0.0 112.411 -173.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -128.5 121.75 29.58 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.365 1.066 . . . . 0.0 108.851 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -54.34 -34.69 61.6 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.477 1.111 . . . . 0.0 112.935 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -90.45 32.61 0.94 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.555 0.742 . . . . 0.0 111.786 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -54.65 120.1 25.46 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 124.757 1.223 . . . . 0.0 110.056 174.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -88.21 20.08 1.22 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.099 2.532 . . . . 0.0 113.936 -166.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.6 p -98.97 129.43 29.67 Favored Pre-proline 0 C--O 1.239 0.532 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -54.91 -44.14 52.63 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.433 2.756 . . . . 0.0 113.316 -171.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -67.64 -50.94 55.47 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.395 0.435 . . . . 0.0 111.365 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 6.0 tpt -68.0 -41.91 81.54 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.446 0.298 . . . . 0.0 110.372 -173.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 10.6 tmm? -59.28 -43.17 92.55 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.203 1.001 . . . . 0.0 110.746 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.448 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 31.7 tpt180 -64.71 -54.61 28.8 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.243 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 65.1 mt -58.44 -30.27 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.719 0.808 . . . . 0.0 111.192 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 42.1 t -70.24 -54.79 11.26 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -61.14 -59.77 4.82 Favored 'General case' 0 C--N 1.364 1.207 0 O-C-N 123.676 0.61 . . . . 0.0 111.368 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 15.8 mm-40 -44.35 -47.84 9.68 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.407 ' HD2' ' HG3' ' A' ' 130' ' ' GLU . 13.7 tpp85 -66.17 -41.3 90.51 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.886 0.474 . . . . 0.0 110.675 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -76.74 -26.66 62.34 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.057 -174.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -75.79 -22.36 56.46 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.994 0.518 . . . . 0.0 110.787 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.54 -47.84 58.39 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.208 0.603 . . . . 0.0 109.413 170.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.464 ' HE1' ' HG3' ' A' ' 130' ' ' GLU . 98.9 m95 -69.31 -26.02 64.52 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.792 0.683 . . . . 0.0 112.005 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.83 -58.13 6.34 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -47.38 -42.66 22.29 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.257 1.023 . . . . 0.0 112.923 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.7 -48.22 75.47 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.698 0.623 . . . . 0.0 111.69 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.545 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 12.0 p -79.22 -29.59 13.8 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 C-N-CA 123.595 0.758 . . . . 0.0 111.427 -167.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -66.98 -31.39 71.93 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.373 0.669 . . . . 0.0 109.967 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 27.2 m -81.56 -33.67 31.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.128 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 79.25 1.16 85.36 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.463 -174.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.8 m . . . . . 0 CA--C 1.552 1.03 0 C-N-CA 124.907 1.283 . . . . 0.0 107.999 -177.965 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.447 0.642 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.29 169.74 10.55 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.46 1.104 . . . . 0.0 109.472 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.696 ' HA ' ' HA2' ' A' ' 142' ' ' GLY . 56.2 p -142.0 85.31 1.92 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.121 0.486 . . . . 0.0 110.077 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.56 70.01 3.25 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.614 175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -99.77 87.13 3.46 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.758 0.823 . . . . 0.0 109.844 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -133.32 70.23 1.47 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.373 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 m -96.31 130.02 43.51 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.871 0.868 . . . . 0.0 109.689 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 19.9 mp0 -120.49 110.68 16.77 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.834 0.854 . . . . 0.0 108.75 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.66 149.78 28.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.861 0.363 . . . . 0.0 110.724 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.427 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -157.65 176.59 12.41 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.391 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 177' ' ' LEU . 1.2 tm? -144.69 149.97 36.52 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.53 -162.1 10.95 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -132.0 140.21 48.87 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.279 1.032 . . . . 0.0 108.918 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -155.0 131.03 10.17 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.527 0.731 . . . . 0.0 109.985 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -79.74 141.94 35.87 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.539 HD11 HG23 ' A' ' 117' ' ' THR . 49.8 pt -129.61 160.55 64.03 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.083 0.953 . . . . 0.0 109.365 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -54.1 -28.67 51.98 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 123.233 2.622 . . . . 0.0 114.004 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.85 -34.86 60.08 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.565 0.746 . . . . 0.0 111.918 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.409 ' H ' HG13 ' A' ' 16' ' ' ILE . . . 164.98 -148.9 14.92 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-O 120.015 -0.325 . . . . 0.0 112.321 -175.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.402 ' O ' HG22 ' A' ' 117' ' ' THR . 38.3 mt-10 -87.92 135.38 33.43 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.49 162.97 30.44 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.815 0.446 . . . . 0.0 111.781 -175.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.576 HH11 HG22 ' A' ' 178' ' ' VAL . 91.0 mtt180 -102.44 159.0 15.81 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 166.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.6 p -133.7 125.94 29.7 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -172.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.48 ' HB ' ' CZ3' ' A' ' 174' ' ' TRP . 27.7 pt -85.96 135.2 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 3.5 mp -117.98 116.77 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 129' ' ' TRP . 38.1 mt -106.99 107.19 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 95.1 mtt180 -91.97 161.68 14.7 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.705 174.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 33.3 tt0 -167.29 116.6 0.83 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 125.233 1.583 . . . . 0.0 109.951 176.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -92.23 108.42 19.94 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 60.5 m-85 -92.3 144.2 25.63 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.767 1.227 . . . . 0.0 111.507 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -102.26 72.91 1.32 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 162.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 30' ' ' TYR . . . -166.32 141.26 3.7 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.752 1.621 . . . . 0.0 106.639 -163.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.33 141.92 32.73 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 121.953 1.769 . . . . 0.0 112.579 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 80' ' ' PRO . 56.5 t -50.89 -43.69 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 124.487 1.117 . . . . 0.0 111.742 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -54.11 -35.6 62.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 124.462 1.101 . . . . 0.0 111.514 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -78.57 -32.56 47.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 t -74.63 -30.05 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 123.784 0.677 . . . . 0.0 110.171 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.403 ' HE3' HD12 ' A' ' 101' ' ' LEU . 70.2 t-105 -78.21 -25.93 47.25 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.149 0.979 . . . . 0.0 110.425 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.8 m -65.67 -50.93 63.13 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -59.9 -37.68 80.1 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.421 0.688 . . . . 0.0 112.119 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.78 -45.51 93.59 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.0 p -117.58 -39.53 3.14 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -166.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 47' ' ' ILE . 12.1 t70 -69.21 118.16 59.22 Favored Pre-proline 0 N--CA 1.485 1.285 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.38 -33.55 97.55 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.412 2.741 . . . . 0.0 114.217 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -72.37 -23.28 61.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 123.606 0.567 . . . . 0.0 110.574 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.524 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 12.8 mmt85 -87.46 -30.39 20.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.995 0.918 . . . . 0.0 110.876 174.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 43' ' ' ASP . 60.1 mt -71.5 -41.19 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.187 0.595 . . . . 0.0 110.067 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -70.75 4.21 2.67 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -175.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -97.94 -11.44 23.11 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.828 0.851 . . . . 0.0 111.872 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.448 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 42.9 p-90 -139.04 -24.96 0.88 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.307 0.643 . . . . 0.0 111.614 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.448 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 12.9 t80 -132.57 -172.22 2.85 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.717 1.207 . . . . 0.0 108.839 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.13 144.84 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.043 0.937 . . . . 0.0 111.256 -171.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.71 113.53 5.45 Favored Pre-proline 0 CA--C 1.568 1.653 0 O-C-N 125.138 1.524 . . . . 0.0 111.812 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -93.15 121.41 0.43 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.069 2.513 . . . . 0.0 113.307 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 55' ' ' LYS . 9.7 mmpt? -112.45 125.33 54.11 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 171.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.33 -171.4 36.55 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.37 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.47 ' HB3' ' H ' ' A' ' 63' ' ' ASN . 25.0 t70 -71.2 -43.86 66.58 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 123.936 0.433 . . . . 0.0 110.502 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.1 mt 73.64 -17.12 0.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.047 1.739 . . . . 0.0 113.499 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -97.49 164.71 12.33 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.167 0.587 . . . . 0.0 110.973 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.588 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 35.5 tt0 -55.97 126.2 24.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 112.968 -172.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.85 84.52 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.955 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -103.98 -147.48 17.6 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.47 ' H ' ' HB3' ' A' ' 57' ' ' ASP . 35.6 p-10 -148.39 167.65 24.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.43 0.692 . . . . 0.0 111.301 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -144.24 141.63 29.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.22 120.23 26.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.521 0.729 . . . . 0.0 110.493 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.8 mt -106.14 119.98 40.63 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.691 1.196 . . . . 0.0 108.1 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -69.99 123.83 22.52 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.137 0.975 . . . . 0.0 111.33 -171.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.11 31.46 64.07 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.859 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -149.77 -91.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.548 0.339 . . . . 0.0 110.828 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.13 152.46 18.95 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.147 0.499 . . . . 0.0 111.272 -169.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.9 p -137.77 137.29 38.1 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.36 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.6 -162.59 12.31 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 23.7 m-20 -101.22 172.28 7.1 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.34 0.656 . . . . 0.0 110.869 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 mm -106.97 116.68 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 86' ' ' SER . 85.8 mt -82.09 -51.34 8.09 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.682 0.393 . . . . 0.0 110.951 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.73 120.8 2.42 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -173.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 27.4 p -135.66 110.72 8.88 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.828 0.451 . . . . 0.0 109.941 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -116.57 111.15 41.86 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 65.5 Cg_endo -73.89 137.12 23.93 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.75 2.3 . . . . 0.0 113.096 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.52 ' HB2' HG12 ' A' ' 34' ' ' VAL . 27.2 Cg_endo -100.52 30.01 11.92 Favored 'Cis proline' 0 C--N 1.376 1.977 0 CA-C-N 119.413 0.826 . . . . 0.0 111.818 -9.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -65.22 -71.14 0.2 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.109 1.364 . . . . 0.0 111.991 -169.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 15.5 ptt180 -163.11 156.64 19.72 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.804 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.5 tp -111.12 145.5 38.47 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.232 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.454 HG22 HD12 ' A' ' 75' ' ' LEU . 26.1 m -142.01 130.54 22.58 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.83 149.29 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.355 1.062 . . . . 0.0 110.254 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.472 ' HB2' HD21 ' A' ' 75' ' ' LEU . 46.8 t -91.27 133.03 35.75 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 172.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -123.22 95.98 4.82 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -169.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -91.55 104.26 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -72.25 178.34 3.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.051 0.94 . . . . 0.0 109.791 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.37 -4.43 39.36 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.563 0.745 . . . . 0.0 112.858 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.64 57.97 0.06 OUTLIER Glycine 0 C--N 1.351 1.385 0 C-N-CA 121.783 -0.246 . . . . 0.0 112.974 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.46 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 74.5 mmtt -132.75 156.15 80.39 Favored Pre-proline 0 N--CA 1.496 1.844 0 C-N-CA 123.798 0.839 . . . . 0.0 109.645 173.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -86.87 72.06 3.46 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.614 2.209 . . . . 0.0 111.745 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 67.06 149.36 0.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.651 1.58 . . . . 0.0 113.273 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 63.7 m -136.64 127.09 26.74 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.622 ' HB3' ' HB3' ' A' ' 115' ' ' ALA . 4.6 tp10 -94.0 105.66 17.66 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.83 131.98 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -150.43 145.07 25.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.793 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.524 HD11 ' HG ' ' A' ' 110' ' ' LEU . 30.6 tp -107.86 152.52 24.3 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.668 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 31.0 tpt180 -138.28 122.31 17.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.142 0.977 . . . . 0.0 108.395 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.484 ' HB3' HG13 ' A' ' 34' ' ' VAL . 81.2 mt -121.95 126.86 49.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.671 0.788 . . . . 0.0 109.299 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 m -145.14 125.45 13.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.552 0.741 . . . . 0.0 110.655 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.64 124.93 21.84 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.714 0.806 . . . . 0.0 110.905 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -142.27 128.39 19.71 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.719 0.808 . . . . 0.0 111.08 166.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.87 -135.94 17.23 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.65 -42.95 99.89 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 117.05 0.425 . . . . 0.0 110.923 161.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -107.89 -146.33 12.43 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 115.445 0.938 . . . . 0.0 115.445 -157.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.452 HG23 HG22 ' A' ' 34' ' ' VAL . 99.0 m -130.06 149.85 51.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.664 1.986 . . . . 0.0 109.055 -168.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.3 tp -109.07 127.5 54.19 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 166.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.524 ' HG ' HD11 ' A' ' 99' ' ' LEU . 9.2 tt -100.0 130.57 46.18 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 173.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.668 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 42.2 mt-10 -135.12 107.79 7.45 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.481 HD22 HD21 ' A' ' 133' ' ' LEU . 54.6 tp -102.51 143.07 32.68 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.258 0.623 . . . . 0.0 109.412 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 32.5 tt0 -132.29 142.24 49.29 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.723 0.809 . . . . 0.0 109.64 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -141.95 116.5 9.67 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.622 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . . . -126.42 111.0 13.94 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.97 0.508 . . . . 0.0 112.012 -168.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 t -141.51 164.5 30.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.863 0.465 . . . . 0.0 110.359 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.539 HG23 HD11 ' A' ' 16' ' ' ILE . 58.1 p -74.73 -28.74 60.91 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.817 0.847 . . . . 0.0 110.695 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.6 t -79.86 110.45 15.24 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.832 0.853 . . . . 0.0 110.804 -175.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.77 -28.28 69.34 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.667 0.787 . . . . 0.0 111.04 171.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -59.02 -55.23 37.87 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.17 0.919 . . . . 0.0 109.189 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.46 ' SD ' ' HG3' ' A' ' 92' ' ' LYS . 12.4 tpt -56.63 -52.23 65.68 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.674 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.8 mt -54.5 -47.93 72.47 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.383 1.073 . . . . 0.0 113.614 -173.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.3 t -70.5 -42.98 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 122.413 0.285 . . . . 0.0 110.32 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.7 -49.9 73.27 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.726 0.811 . . . . 0.0 111.249 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 121' ' ' MET . 21.6 m -71.51 -23.12 22.44 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 C-N-CA 123.203 0.601 . . . . 0.0 110.461 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.71 79.41 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.5 t -78.27 -51.95 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.095 -0.553 . . . . 0.0 109.569 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.15 -31.75 81.74 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.753 0.658 . . . . 0.0 114.161 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.511 ' HB3' HD12 ' A' ' 26' ' ' ILE . 15.0 m95 -79.79 -41.17 27.04 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.2 -34.38 72.08 Favored 'General case' 0 C--N 1.368 1.401 0 CA-C-N 118.271 0.487 . . . . 0.0 110.785 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.8 mmt -68.88 -48.52 63.19 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.767 0.667 . . . . 0.0 109.711 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.03 -46.48 75.29 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.324 0.65 . . . . 0.0 111.519 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.481 HD21 HD22 ' A' ' 112' ' ' LEU . 4.1 mm? -80.54 -23.04 40.27 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.459 0.704 . . . . 0.0 111.329 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.65 -54.07 32.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -69.91 -18.47 63.39 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.46 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.0 tp -76.95 -44.08 32.73 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.082 0.401 . . . . 0.0 110.531 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.459 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -60.74 -34.47 86.84 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.484 ' HA ' ' HA3' ' A' ' 142' ' ' GLY . 91.6 mtp -81.29 -25.7 36.3 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.72 0.808 . . . . 0.0 111.809 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -66.45 -54.83 19.65 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.93 -58.01 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.727 -172.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -152.74 32.66 0.5 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 120.546 0.212 . . . . 0.0 111.367 -169.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.696 ' HA2' ' HA ' ' A' ' 3' ' ' SER . . . -130.19 -5.16 4.33 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-O 119.67 -0.516 . . . . 0.0 113.635 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 60.49 88.77 0.08 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.923 1.289 . . . . 0.0 111.241 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 pp -63.38 149.13 92.34 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.089 0.556 . . . . 0.0 110.682 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.03 -20.85 62.68 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.813 2.342 . . . . 0.0 113.728 -171.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.68 29.42 63.47 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.395 173.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -142.2 162.24 27.2 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.477 -0.624 . . . . 0.0 112.738 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.07 105.44 1.93 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.875 2.383 . . . . 0.0 112.101 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.4 m -66.06 111.25 6.05 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 123.096 0.558 . . . . 0.0 110.481 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.13 -24.8 14.42 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.773 2.315 . . . . 0.0 113.157 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -150.44 66.18 0.95 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.769 0.795 . . . . 0.0 109.619 -172.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -88.71 -13.4 39.73 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.971 173.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.0 -42.37 80.17 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 123.207 0.603 . . . . 0.0 109.95 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -158.27 -70.9 0.09 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.519 170.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.05 122.12 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.123 1.369 . . . . 0.0 108.392 -161.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -153.7 1.77 0.25 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.516 0.726 . . . . 0.0 110.286 -177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -78.34 -78.18 0.15 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.635 0.774 . . . . 0.0 109.693 -171.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -171.37 -52.47 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 125.368 1.467 . . . . 0.0 112.29 -170.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.09 -33.52 64.0 Favored 'Trans proline' 0 C--N 1.396 3.076 0 C-N-CA 123.417 2.745 . . . . 0.0 115.61 -164.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.6 t -127.21 85.19 61.57 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.19 -21.25 72.23 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 122.811 2.341 . . . . 0.0 111.974 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -62.1 -56.2 21.22 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.901 173.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 52.1 tpp -73.85 -24.35 59.75 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.256 0.622 . . . . 0.0 110.768 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.455 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 81.9 mtp -58.8 -53.78 54.48 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 171.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 18.2 tpt180 -61.06 -51.34 69.59 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 123.678 0.611 . . . . 0.0 110.418 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.516 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 57.5 mt -51.38 -42.59 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.397 1.079 . . . . 0.0 112.136 -176.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 61.2 p -76.72 -45.92 27.43 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.442 0.464 . . . . 0.0 111.077 -173.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 164' ' ' MET . 14.1 mm100 -46.78 -60.38 2.44 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.033 0.833 . . . . 0.0 110.192 167.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 16.2 mm-40 -42.34 -42.38 3.14 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 20.6 mmt180 -62.59 -59.78 4.45 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.278 0.361 . . . . 0.0 110.346 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.06 -37.42 32.79 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 122.307 -0.246 . . . . 0.0 113.092 -166.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -59.77 -34.98 73.71 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 124.125 0.97 . . . . 0.0 111.181 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.6 -61.25 2.74 Favored 'General case' 0 C--N 1.36 1.038 0 O-C-N 123.932 0.77 . . . . 0.0 109.516 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.48 ' CZ3' ' HB ' ' A' ' 24' ' ' ILE . 95.4 m95 -68.54 -22.56 64.5 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -172.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.17 -63.08 1.13 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.448 ' HA ' ' NE2' ' A' ' 179' ' ' HIS . . . -54.32 -34.7 61.55 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 37.8 mt -69.07 -46.83 66.84 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 118.988 -0.53 . . . . 0.0 110.072 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.576 HG22 HH11 ' A' ' 22' ' ' ARG . 9.4 p -70.18 -31.6 47.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 CA-C-N 119.117 0.871 . . . . 0.0 109.563 -169.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.448 ' NE2' ' HA ' ' A' ' 176' ' ' ALA . 11.3 p80 -92.45 16.72 11.24 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 58.9 m -73.6 145.42 45.45 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 84.44 39.61 8.91 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 -175.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 CA--C 1.558 1.253 0 C-N-CA 124.301 1.041 . . . . 0.0 109.408 -175.519 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.3 mtp . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.35 119.51 8.29 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.508 0.723 . . . . 0.0 109.487 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -79.45 83.28 5.48 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.57 -58.22 4.99 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -169.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -164.0 150.92 11.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.139 1.376 . . . . 0.0 109.017 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.04 28.08 9.07 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.74 0.816 . . . . 0.0 111.142 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 m -93.83 106.38 18.35 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.778 0.831 . . . . 0.0 110.225 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 30.3 mt-10 -96.02 132.56 41.24 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -101.58 147.23 26.65 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.559 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -154.14 122.56 6.15 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 1.4 tm? -98.98 138.29 36.31 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 169.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.77 -178.45 16.31 Favored Glycine 0 C--N 1.333 0.411 0 O-C-N 123.287 0.367 . . . . 0.0 112.429 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.03 166.96 12.11 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 123.581 0.753 . . . . 0.0 109.658 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.644 ' HG2' ' HB1' ' A' ' 115' ' ' ALA . 6.1 tpt180 -163.82 157.07 18.46 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -138.27 94.2 2.84 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.453 HD11 HG23 ' A' ' 117' ' ' THR . 36.5 pt -88.6 161.88 40.79 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.13 -21.93 13.89 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.13 2.553 . . . . 0.0 114.65 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.63 5.8 37.74 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.435 0.694 . . . . 0.0 112.763 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.38 -178.2 16.44 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 123.09 0.376 . . . . 0.0 112.967 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.53 109.39 5.44 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.111 0.564 . . . . 0.0 109.85 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.85 167.35 10.98 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.543 1.137 . . . . 0.0 110.397 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HB2' HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -101.82 170.52 8.1 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 156.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 p -136.25 133.08 36.63 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 29.8 pt -83.86 145.42 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 166.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.677 HG13 ' HG2' ' A' ' 113' ' ' GLU . 4.1 mp -129.96 105.25 11.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 175.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 58.9 mt -104.57 107.2 21.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.613 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 45.2 mtp85 -98.15 134.52 41.1 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.835 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -141.01 140.38 34.3 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.595 HH11 ' HB2' ' A' ' 109' ' ' LEU . 36.0 mmt180 -98.74 103.76 15.74 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.18 125.87 35.61 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.207 1.003 . . . . 0.0 109.958 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.52 59.81 3.66 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.597 1.189 . . . . 0.0 110.672 171.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.25 150.13 33.92 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 113.316 -1.765 . . . . 0.0 106.77 174.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 37' ' ' VAL . 34.7 Cg_endo -64.65 172.24 7.16 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.086 1.857 . . . . 0.0 113.179 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' A' ' 101' ' ' LEU . 67.8 t -70.87 -41.32 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.412 -173.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -58.77 -43.5 90.4 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.184 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.57 -65.86 0.62 Allowed 'General case' 0 C--N 1.356 0.852 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.057 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 33' ' ' PRO . 38.2 t -53.54 -38.26 33.08 Favored 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 124.299 1.04 . . . . 0.0 111.184 -175.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.434 ' HE3' HD12 ' A' ' 101' ' ' LEU . 63.8 t-105 -59.18 -57.2 14.1 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.472 0.709 . . . . 0.0 111.018 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.7 m -59.47 -42.5 92.18 Favored 'General case' 0 C--O 1.21 -1.011 0 O-C-N 124.489 1.118 . . . . 0.0 110.13 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.87 -34.42 73.12 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.437 ' SG ' HD21 ' A' ' 136' ' ' LEU . 84.0 m -85.43 -11.05 55.32 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.993 0.917 . . . . 0.0 113.118 -178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.8 p -113.28 -32.79 6.17 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.329 0.513 . . . . 0.0 112.016 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -66.88 116.82 39.26 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 123.133 0.573 . . . . 0.0 110.506 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.14 -18.31 45.42 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 122.273 1.982 . . . . 0.0 110.991 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -74.81 -15.83 60.73 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.324 1.45 . . . . 0.0 111.3 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -108.55 -21.69 12.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.006 0.522 . . . . 0.0 111.932 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.8 mt -84.88 -32.61 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.253 0.621 . . . . 0.0 110.205 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 28.2 p-10 -60.39 -25.61 66.04 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.092 175.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -63.49 -23.63 67.48 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.509 1.124 . . . . 0.0 112.609 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -128.39 -62.02 1.06 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.059 0.543 . . . . 0.0 112.158 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -102.03 -163.42 1.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.025 0.93 . . . . 0.0 108.979 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.524 HG21 ' H ' ' A' ' 67' ' ' GLN . 36.7 mt -85.94 131.64 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 11.2 pt-20 -63.36 140.21 97.69 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 126.368 1.867 . . . . 0.0 112.328 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 85.8 Cg_endo -89.05 99.19 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.045 2.497 . . . . 0.0 111.668 169.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -82.2 162.42 22.4 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.364 0.602 . . . . 0.0 111.885 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.28 -161.76 15.24 Favored Glycine 0 N--CA 1.465 0.575 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.583 -174.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.89 -48.72 67.86 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.574 1.15 . . . . 0.0 111.358 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt 68.44 3.9 4.0 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 125.543 1.537 . . . . 0.0 112.164 -170.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -100.48 147.4 25.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.323 1.049 . . . . 0.0 108.716 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.767 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 32.0 tt0 -62.58 107.71 1.0 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 123.757 0.661 . . . . 0.0 111.625 -172.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.7 -27.99 6.63 Favored Glycine 0 N--CA 1.476 1.343 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.982 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.39 -167.72 42.13 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -125.67 158.9 33.61 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.384 1.592 . . . . 0.0 111.067 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 13.1 p90 -103.92 168.31 9.21 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 157.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.04 115.35 0.83 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.419 1.088 . . . . 0.0 108.873 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 78.9 mt -70.97 169.69 14.35 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.846 0.459 . . . . 0.0 110.513 170.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.524 ' H ' HG21 ' A' ' 52' ' ' ILE . 16.7 tt0 -74.07 107.14 6.09 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.26 0.624 . . . . 0.0 109.33 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 45.41 25.12 1.18 Allowed Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.511 ' ND2' HD12 ' A' ' 52' ' ' ILE . 98.4 m-20 -107.15 -80.3 0.57 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.733 0.766 . . . . 0.0 109.957 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.79 157.03 47.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.275 0.63 . . . . 0.0 110.257 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.1 t -144.78 143.47 30.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.86 149.54 19.21 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -74.07 156.33 37.57 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.449 0.642 . . . . 0.0 110.216 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.692 ' HA ' HG22 ' A' ' 85' ' ' ILE . 19.3 mm -87.42 94.29 4.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.75 -57.47 10.82 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 124.376 1.048 . . . . 0.0 110.901 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -146.45 113.78 6.28 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.496 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.767 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.4 p -111.27 125.1 53.47 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 171.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -134.53 81.6 47.92 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 62.2 Cg_endo -73.75 140.08 28.7 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.624 2.216 . . . . 0.0 111.895 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 31.1 Cg_endo -94.91 20.54 32.32 Favored 'Cis proline' 0 C--N 1.378 2.091 0 CA-C-N 119.924 1.009 . . . . 0.0 114.358 -3.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 80' ' ' PRO . 5.9 mpt_? -81.89 -84.27 0.11 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -128.1 147.81 50.55 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.741 -0.6 . . . . 0.0 112.035 -164.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.423 ' HB2' ' CH2' ' A' ' 38' ' ' TRP . 65.1 tp -138.18 102.47 4.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.543 1.137 . . . . 0.0 109.251 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.5 m -95.92 119.35 34.27 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 170.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.692 HG22 ' HA ' ' A' ' 74' ' ' ILE . 2.6 pp -128.94 160.5 39.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 124.915 1.286 . . . . 0.0 109.55 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.6 m -81.19 172.13 14.03 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.031 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 34.5 t-105 -154.69 94.26 1.65 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.1 t -105.88 102.95 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -92.3 149.39 21.47 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -90.0 -43.32 10.61 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.268 0.485 . . . . 0.0 111.612 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.14 -37.53 37.27 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.366 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -107.83 161.79 22.04 Favored Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 124.701 1.2 . . . . 0.0 109.085 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HG2' ' OG ' ' A' ' 118' ' ' SER . 52.3 Cg_exo -58.16 -176.89 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.337 2.692 . . . . 0.0 114.646 175.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.68 173.55 12.47 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.927 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.5 t -172.78 173.96 3.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.53 0.732 . . . . 0.0 110.537 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -138.19 127.62 24.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.538 1.135 . . . . 0.0 108.289 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.402 ' HB ' ' CD1' ' A' ' 85' ' ' ILE . 30.3 t -112.51 143.79 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.698 0.799 . . . . 0.0 109.384 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 33.4 mt-10 -131.65 133.38 44.85 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.81 120.33 31.41 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -120.89 132.59 55.05 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.001 0.92 . . . . 0.0 109.994 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.434 HD12 ' HE3' ' A' ' 38' ' ' TRP . 72.1 mt -130.89 132.42 45.13 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.096 0.959 . . . . 0.0 110.067 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.2 t -155.27 148.2 24.51 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.433 1.093 . . . . 0.0 108.142 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -63.79 148.81 48.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.839 0.856 . . . . 0.0 110.818 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -146.9 111.33 5.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 51.89 -103.67 0.12 Allowed Glycine 0 CA--C 1.536 1.349 0 O-C-N 123.562 0.539 . . . . 0.0 114.246 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.62 -10.21 18.59 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.99 0.916 . . . . 0.0 111.208 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.27 -150.84 8.13 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 123.657 0.646 . . . . 0.0 111.714 -172.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 82.7 m -146.83 136.14 22.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.252 1.021 . . . . 0.0 110.015 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.595 ' HB2' HH11 ' A' ' 29' ' ' ARG . 60.7 tp -90.56 137.54 32.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.84 0.856 . . . . 0.0 109.925 174.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tt -123.72 115.17 20.97 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.697 1.199 . . . . 0.0 107.82 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.613 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 33.4 mt-10 -113.78 108.09 16.62 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.577 HD13 HD21 ' A' ' 133' ' ' LEU . 10.0 tt -105.97 112.27 25.25 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.677 ' HG2' HG13 ' A' ' 25' ' ' ILE . 40.9 mt-10 -93.11 137.79 32.14 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 123.752 0.821 . . . . 0.0 110.719 170.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.457 ' CD2' HG21 ' A' ' 125' ' ' VAL . 6.9 t60 -129.84 121.67 27.18 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.644 ' HB1' ' HG2' ' A' ' 14' ' ' ARG . . . -124.53 118.64 27.05 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.386 0.674 . . . . 0.0 111.824 -167.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.402 HG23 ' HG ' ' A' ' 122' ' ' LEU . 6.5 t -151.02 155.93 40.06 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.577 0.751 . . . . 0.0 110.368 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.453 HG23 HD11 ' A' ' 16' ' ' ILE . 75.7 p -79.96 -19.39 48.03 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.433 ' OG ' ' HG2' ' A' ' 93' ' ' PRO . 50.5 m -89.96 122.37 32.92 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.909 0.484 . . . . 0.0 111.349 -174.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -57.83 -45.31 86.37 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.763 1.225 . . . . 0.0 112.545 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.14 -57.92 10.74 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 122.929 0.492 . . . . 0.0 111.068 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.5 ttt -50.38 -35.91 30.24 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 124.284 0.99 . . . . 0.0 112.54 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 22' ' ' ARG . 29.0 mt -61.94 -46.47 89.17 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.678 0.791 . . . . 0.0 112.297 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 127' ' ' VAL . 41.2 t -70.18 -46.93 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -47.93 -52.64 18.72 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.954 1.701 . . . . 0.0 113.132 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.457 HG21 ' CD2' ' A' ' 114' ' ' HIS . 27.9 m -74.94 -25.79 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 123.452 0.47 . . . . 0.0 110.484 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -56.04 -45.97 85.87 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 124.155 0.909 . . . . 0.0 110.829 170.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 123' ' ' VAL . 45.0 t -74.85 -42.32 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.564 0.746 . . . . 0.0 109.678 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.53 -63.1 5.59 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.922 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -64.93 -26.5 68.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.8 0.84 . . . . 0.0 113.005 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -54.26 -51.92 63.02 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.489 0.586 . . . . 0.0 109.858 169.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 29.2 mmt -68.71 -45.11 72.44 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 124.032 0.833 . . . . 0.0 110.716 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.6 -65.2 0.69 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.722 0.809 . . . . 0.0 111.033 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.577 HD21 HD13 ' A' ' 112' ' ' LEU . 3.8 mm? -62.03 -24.55 67.13 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.92 -43.31 65.53 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 118.676 0.671 . . . . 0.0 110.579 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.492 ' HD1' ' SD ' ' A' ' 138' ' ' MET . 20.9 m-85 -68.9 -26.5 65.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.172 0.589 . . . . 0.0 110.672 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.437 HD21 ' SG ' ' A' ' 41' ' ' CYS . 61.5 tp -66.22 -51.65 55.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.976 0.511 . . . . 0.0 109.866 169.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.406 ' O ' ' HG2' ' A' ' 141' ' ' ARG . . . -44.55 -43.29 7.76 Favored Glycine 0 N--CA 1.474 1.213 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 168.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.492 ' SD ' ' HD1' ' A' ' 135' ' ' PHE . 85.2 mtp -63.72 -45.95 87.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.882 0.473 . . . . 0.0 110.179 173.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -63.15 -34.92 78.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.775 0.83 . . . . 0.0 111.498 -176.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 25.6 mt -75.94 -48.47 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.96 0.904 . . . . 0.0 111.11 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 137' ' ' GLY . 12.9 ptp180 -76.17 -14.05 60.17 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.87 9.32 57.44 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-O 120.008 -0.329 . . . . 0.0 113.894 177.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -77.09 -13.74 59.91 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.95 0.9 . . . . 0.0 112.106 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.84 104.9 5.95 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -64.13 -33.83 59.75 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 123.247 2.631 . . . . 0.0 113.883 -173.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 175.97 -54.27 0.12 Allowed Glycine 0 N--CA 1.467 0.711 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -112.44 144.95 17.98 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 166.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.62 -30.14 35.43 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.153 1.902 . . . . 0.0 110.376 173.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.5 m -152.23 147.53 19.8 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.442 1.897 . . . . 0.0 107.457 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.99 -38.7 36.25 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.473 2.115 . . . . 0.0 112.621 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -158.3 -0.72 0.1 Allowed 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -176.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.81 50.56 1.84 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.579 0.704 . . . . 0.0 110.359 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -90.33 7.87 36.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.209 1.004 . . . . 0.0 112.554 -167.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 67.29 153.11 0.08 Allowed 'General case' 0 C--N 1.36 1.035 0 C-N-CA 125.217 1.407 . . . . 0.0 111.795 -173.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -153.85 -62.37 0.14 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -148.85 -67.99 0.22 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -120.22 107.2 12.71 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.509 ' HG2' ' HG2' ' A' ' 163' ' ' MET . 15.7 tp10 -87.35 121.58 71.19 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.393 1.077 . . . . 0.0 109.516 -176.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.67 -10.07 25.13 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.862 2.374 . . . . 0.0 114.978 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.2 p -81.99 118.17 71.08 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-N 118.215 0.461 . . . . 0.0 110.481 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -59.1 -35.88 97.15 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 123.521 2.814 . . . . 0.0 113.354 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.412 ' O ' HG13 ' A' ' 166' ' ' ILE . 1.1 mp0 -68.01 -41.96 81.41 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.896 0.478 . . . . 0.0 111.765 -177.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.509 ' HG2' ' HG2' ' A' ' 158' ' ' GLU . 4.9 tpt -66.31 -38.42 87.66 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 117.894 0.315 . . . . 0.0 110.309 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 72.9 mtm -69.03 -30.8 69.24 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.286 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -68.78 -39.44 80.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.894 0.478 . . . . 0.0 110.659 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 162' ' ' GLU . 19.4 mt -73.04 -37.89 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.8 t -61.27 -32.55 72.37 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.537 0.735 . . . . 0.0 111.842 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -90.4 -30.35 17.44 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -60.83 3.07 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.837 0.855 . . . . 0.0 110.259 172.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -67.51 -33.24 74.69 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.595 0.758 . . . . 0.0 110.173 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.69 -58.38 11.49 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.248 172.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.33 -31.34 71.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.676 0.79 . . . . 0.0 111.448 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.7 -62.39 1.83 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.205 0.941 . . . . 0.0 110.174 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -73.17 -20.06 60.98 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.421 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.41 -41.7 80.07 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.528 0.331 . . . . 0.0 110.504 173.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.07 -40.21 78.61 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.564 0.697 . . . . 0.0 109.687 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 74.7 mt -66.46 -47.73 72.17 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.222 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 4.6 p -70.29 -27.01 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 122.586 0.354 . . . . 0.0 111.242 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -75.95 -22.66 55.74 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.301 0.641 . . . . 0.0 110.69 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.5 m -81.31 -22.8 38.27 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.763 0.425 . . . . 0.0 111.051 171.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -98.52 -0.94 57.85 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.588 -0.562 . . . . 0.0 113.893 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.559 1.294 0 C-N-CA 123.216 0.606 . . . . 0.0 111.54 -176.717 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 mmt . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.85 72.08 0.44 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.207 1.003 . . . . 0.0 111.818 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 m -127.35 151.75 48.37 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.018 -171.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.91 -43.74 0.29 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -92.11 28.25 1.93 Allowed 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.646 0.736 . . . . 0.0 111.024 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -110.6 68.29 0.66 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.202 1.001 . . . . 0.0 108.525 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 m -119.69 109.82 16.1 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.071 -173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.37 129.24 48.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -99.32 156.55 16.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.333 0.653 . . . . 0.0 109.37 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.25 -173.99 1.87 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.977 0.511 . . . . 0.0 111.257 -166.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.9 mt -140.67 168.66 19.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.519 1.127 . . . . 0.0 111.112 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.17 -174.93 26.57 Favored Glycine 0 C--O 1.245 0.807 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.837 170.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.15 139.49 24.65 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 123.699 0.799 . . . . 0.0 108.921 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -168.38 163.09 12.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.85 0.86 . . . . 0.0 109.858 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 23.2 m -105.67 113.82 27.61 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 172.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.8 pt -90.69 167.18 16.97 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -49.07 -23.51 6.42 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.917 2.411 . . . . 0.0 115.043 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.07 -8.01 56.15 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.06 177.85 15.1 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 117.66 0.209 . . . . 0.0 112.732 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 45.1 mt-10 -65.19 108.11 1.78 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.158 0.583 . . . . 0.0 110.343 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.23 142.4 34.24 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.368 1.067 . . . . 0.0 111.175 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -85.03 158.52 20.44 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 163.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.8 p -128.74 130.55 47.24 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 122.544 -0.097 . . . . 0.0 110.814 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 pp -86.2 136.09 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -120.38 122.01 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mt -115.2 107.53 23.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.553 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 95.4 mtt180 -92.61 139.44 30.56 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.736 0.815 . . . . 0.0 109.565 172.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 19.7 tt0 -146.51 139.5 25.5 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.818 0.699 . . . . 0.0 109.211 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.39 128.96 43.8 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.454 ' CE2' ' HA2' ' A' ' 137' ' ' GLY . 83.5 m-85 -116.19 116.86 28.58 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.865 0.866 . . . . 0.0 109.44 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -75.64 49.32 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.24 1.019 . . . . 0.0 110.743 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.51 162.34 51.9 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.445 1.498 . . . . 0.0 108.228 -171.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.487 ' O ' HG23 ' A' ' 37' ' ' VAL . 31.7 Cg_exo -62.34 157.77 43.83 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.375 2.05 . . . . 0.0 113.292 172.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 80' ' ' PRO . 99.1 t -76.65 -37.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.497 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -59.65 -42.18 92.2 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.978 0.799 . . . . 0.0 109.649 174.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -62.51 -64.18 1.0 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.373 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.625 HG22 HG21 ' A' ' 140' ' ' ILE . 58.2 t -48.25 -36.29 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.642 1.177 . . . . 0.0 111.763 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.503 ' HE3' HD12 ' A' ' 101' ' ' LEU . 72.1 t-105 -63.59 -59.48 4.57 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.291 0.636 . . . . 0.0 110.16 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.8 m -53.96 -46.36 71.6 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.774 0.671 . . . . 0.0 110.322 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.659 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -50.36 -39.35 46.22 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.366 175.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.578 ' SG ' HD21 ' A' ' 136' ' ' LEU . 58.0 m -102.65 6.35 39.59 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 47.9 p -120.57 -54.96 2.05 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 118.959 0.799 . . . . 0.0 111.723 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.76 137.92 97.3 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.508 1.123 . . . . 0.0 112.017 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -59.2 -42.29 51.72 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.698 2.932 . . . . 0.0 113.557 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -74.45 -6.42 48.18 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.958 0.903 . . . . 0.0 110.827 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.659 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 14.7 mmt180 -100.31 -42.62 6.57 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.741 1.217 . . . . 0.0 110.626 176.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.563 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 58.1 mt -77.32 -38.07 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.769 0.427 . . . . 0.0 111.47 -171.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -62.81 -20.38 64.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.489 0.493 . . . . 0.0 111.8 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -64.83 -27.18 68.7 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.563 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 39.4 p-90 -122.78 -41.91 2.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.107 0.563 . . . . 0.0 112.136 -174.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.442 ' HE2' HD13 ' A' ' 66' ' ' LEU . 2.1 t80 -106.0 -163.57 0.94 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.358 0.663 . . . . 0.0 110.097 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.414 ' H ' HD12 ' A' ' 52' ' ' ILE . 4.3 mp -83.48 153.8 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -53.87 119.39 18.79 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.572 1.549 . . . . 0.0 112.164 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.0 101.76 1.47 Allowed 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.348 2.032 . . . . 0.0 110.017 169.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -93.3 164.96 13.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.315 0.646 . . . . 0.0 110.887 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.4 -166.81 12.39 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.565 -174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.61 ' HB2' ' HA3' ' A' ' 62' ' ' GLY . 4.5 m-20 -68.2 -37.64 81.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.286 0.634 . . . . 0.0 110.525 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 49.3 mt 64.83 15.04 9.62 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.896 1.278 . . . . 0.0 112.74 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -125.47 167.52 14.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.827 0.851 . . . . 0.0 110.543 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -50.34 107.2 0.15 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.82 1.248 . . . . 0.0 111.427 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.83 -11.05 56.07 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 112.248 -0.341 . . . . 0.0 112.248 174.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.61 ' HA3' ' HB2' ' A' ' 57' ' ' ASP . . . -88.58 -156.33 30.98 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 169.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -144.33 158.23 43.85 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 118.41 1.105 . . . . 0.0 110.745 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -102.81 169.3 8.69 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 165.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.31 144.94 9.66 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.67 1.188 . . . . 0.0 107.951 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.442 HD13 ' HE2' ' A' ' 51' ' ' PHE . 41.3 mt -131.2 157.09 44.14 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.583 1.153 . . . . 0.0 108.279 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -97.96 127.25 43.79 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -173.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.59 10.81 45.79 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.797 -175.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -124.63 -92.92 0.51 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.839 0.456 . . . . 0.0 110.036 -172.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.39 174.94 12.76 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.19 0.45 . . . . 0.0 111.739 -170.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.5 p -149.78 136.58 19.41 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -154.99 161.66 30.46 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -86.87 155.14 20.37 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.528 0.731 . . . . 0.0 111.049 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.486 ' HA ' HG22 ' A' ' 85' ' ' ILE . 11.6 mm -89.28 91.66 3.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 172.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.427 HD12 HG22 ' A' ' 84' ' ' THR . 42.4 mt -70.39 -49.66 46.73 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.134 0.896 . . . . 0.0 109.691 -171.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -158.84 155.29 27.55 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.834 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 7.8 p -155.79 122.08 5.14 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.399 1.079 . . . . 0.0 108.251 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -121.85 88.86 47.71 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 13.1 Cg_exo -72.62 137.38 27.47 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.74 2.293 . . . . 0.0 113.101 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.486 ' HB2' HG12 ' A' ' 34' ' ' VAL . 83.7 Cg_endo -99.64 31.14 11.3 Favored 'Cis proline' 0 C--N 1.374 1.909 0 CA-C-N 119.283 0.78 . . . . 0.0 112.339 -10.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -68.92 -75.14 0.11 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.631 1.172 . . . . 0.0 111.278 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -158.74 160.23 36.12 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.881 0.472 . . . . 0.0 111.337 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.83 146.27 50.48 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.308 1.043 . . . . 0.0 108.28 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.427 HG22 HD12 ' A' ' 75' ' ' LEU . 32.6 m -123.44 111.94 16.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 166.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.486 HG22 ' HA ' ' A' ' 74' ' ' ILE . 22.7 pt -113.64 144.53 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.683 1.193 . . . . 0.0 108.256 173.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.4 t -83.31 172.73 12.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.804 0.335 . . . . 0.0 111.25 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.71 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 25.0 t-105 -153.42 110.25 3.42 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.607 -171.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.7 t -116.39 103.45 15.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 168.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.48 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 18.2 t80 -77.83 90.9 4.09 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 63.14 -82.55 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.751 0.82 . . . . 0.0 110.155 -174.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.85 30.22 1.24 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 48.2 mmtm -95.01 162.62 24.37 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.401 1.081 . . . . 0.0 110.21 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -35.32 129.0 0.28 Allowed 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 125.039 3.826 . . . . 0.0 115.576 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.4 148.13 42.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.98 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.71 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.7 m -145.08 143.86 30.65 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.441 -174.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.51 111.75 24.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.979 0.912 . . . . 0.0 109.185 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 50.8 t -93.95 119.3 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -117.92 131.18 56.55 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.9 tp -125.63 125.4 43.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -130.24 124.18 31.87 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.97 0.508 . . . . 0.0 110.173 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.503 HD12 ' HE3' ' A' ' 38' ' ' TRP . 62.8 mt -120.95 133.03 55.27 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.656 1.182 . . . . 0.0 109.335 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.9 m -144.59 145.64 31.9 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.102 0.961 . . . . 0.0 109.09 177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.24 141.54 58.18 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.177 0.991 . . . . 0.0 111.17 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -136.74 101.49 4.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.63 -98.55 0.05 OUTLIER Glycine 0 CA--C 1.541 1.658 0 CA-C-N 118.846 0.748 . . . . 0.0 111.868 -166.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -125.86 15.22 8.02 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.132 0.968 . . . . 0.0 110.534 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -113.9 -155.66 11.58 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.167 0.889 . . . . 0.0 111.603 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.5 m -147.7 136.39 21.85 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.709 1.204 . . . . 0.0 109.393 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.3 tp -91.55 127.04 36.84 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 164.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' A' ' 101' ' ' LEU . 9.7 tt -108.05 123.26 48.41 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.553 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 31.5 mt-10 -119.68 106.18 11.9 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 169.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.5 tt -103.99 102.56 12.33 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -95.74 142.62 27.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.541 1.137 . . . . 0.0 109.659 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.482 ' CD2' HG21 ' A' ' 125' ' ' VAL . 5.8 t60 -132.74 116.15 16.22 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 171.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.57 117.94 35.41 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.905 0.882 . . . . 0.0 111.383 -174.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.609 HG21 ' HG3' ' A' ' 121' ' ' MET . 8.0 t -146.19 161.31 40.51 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.449 0.7 . . . . 0.0 110.594 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 74.2 p -88.65 -19.97 25.52 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.653 -167.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 m -101.96 133.23 47.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.299 0.64 . . . . 0.0 111.469 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -59.12 -47.78 84.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.552 1.141 . . . . 0.0 113.166 -174.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -64.06 -52.42 59.44 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.816 0.28 . . . . 0.0 110.884 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.609 ' HG3' HG21 ' A' ' 116' ' ' THR . 15.2 tpt -46.16 -37.02 6.47 Favored 'General case' 0 CA--C 1.563 1.472 0 O-C-N 124.152 0.908 . . . . 0.0 111.702 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.448 ' HG ' HG23 ' A' ' 116' ' ' THR . 22.5 mt -67.24 -50.45 60.55 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.79 0.836 . . . . 0.0 112.012 176.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 127' ' ' VAL . 61.7 t -61.49 -56.2 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -47.61 -50.94 22.92 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.73 1.612 . . . . 0.0 113.273 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.482 HG21 ' CD2' ' A' ' 114' ' ' HIS . 33.2 m -72.02 -31.68 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 119.799 -0.144 . . . . 0.0 111.155 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.57 -34.48 90.01 Favored Glycine 0 C--N 1.35 1.313 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 123' ' ' VAL . 97.6 t -71.8 -51.8 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.05 -59.72 8.46 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.694 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.418 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 22.5 m95 -54.31 -32.91 57.69 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 173.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -66.3 -35.3 80.04 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 120.41 1.459 . . . . 0.0 111.957 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -60.78 -52.73 63.87 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 167.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 129' ' ' TRP . . . -58.5 -27.83 64.82 Favored 'General case' 0 C--O 1.208 -1.105 0 C-N-CA 124.127 0.971 . . . . 0.0 112.045 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.31 -27.71 22.71 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.32 0.648 . . . . 0.0 109.914 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.01 -48.67 34.32 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -62.64 -42.56 99.67 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.637 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.578 HD21 ' SG ' ' A' ' 41' ' ' CYS . 51.0 tp -66.14 -27.61 68.17 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.82 0.848 . . . . 0.0 111.303 176.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.454 ' HA2' ' CE2' ' A' ' 30' ' ' TYR . . . -73.89 -46.57 22.69 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.418 ' HB3' ' HB2' ' A' ' 143' ' ' ASP . 86.4 mtp -60.84 -41.2 95.33 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.589 -1.305 . . . . 0.0 110.807 172.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -62.59 -54.57 37.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.607 0.763 . . . . 0.0 111.416 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.625 HG21 HG22 ' A' ' 37' ' ' VAL . 64.1 mt -71.0 -26.95 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.247 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -78.39 -28.27 46.9 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.882 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.48 -7.53 20.43 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 114.052 0.381 . . . . 0.0 114.052 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 138' ' ' MET . 1.0 OUTLIER -61.16 -45.0 96.43 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.31 1.044 . . . . 0.0 110.614 179.136 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.2 tp -103.52 105.36 46.76 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.059 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.11 -25.79 8.35 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.345 2.03 . . . . 0.0 111.454 170.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.01 135.8 1.99 Allowed Glycine 0 C--O 1.245 0.79 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.77 83.57 0.04 OUTLIER Glycine 0 C--N 1.336 0.579 0 CA-C-O 119.553 -0.582 . . . . 0.0 112.034 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -89.28 -158.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 123.067 2.511 . . . . 0.0 110.651 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.9 m -83.05 107.46 9.62 Favored Pre-proline 0 CA--C 1.56 1.337 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 162.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.84 -68.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.151 2.568 . . . . 0.0 112.896 -175.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -151.95 20.14 0.68 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.661 0.385 . . . . 0.0 111.353 -174.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -53.55 -46.4 70.2 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.627 0.771 . . . . 0.0 111.426 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 59.56 13.01 3.08 Favored 'General case' 0 CA--C 1.556 1.176 0 O-C-N 124.492 1.12 . . . . 0.0 112.16 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.03 88.85 7.18 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.275 1.03 . . . . 0.0 110.474 -171.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -111.0 -51.48 2.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.294 -176.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.62 -46.62 0.41 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.016 0.526 . . . . 0.0 112.406 -169.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -68.33 -30.1 69.0 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.836 0.454 . . . . 0.0 110.273 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -86.87 124.41 69.04 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.02 56.1 5.71 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.887 2.392 . . . . 0.0 110.322 173.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.6 m -61.63 107.63 1.21 Allowed Pre-proline 0 C--O 1.21 -0.991 0 C-N-CA 124.579 1.152 . . . . 0.0 109.762 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -64.34 -37.25 40.89 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.8 2.334 . . . . 0.0 113.77 -163.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.481 ' O ' HG12 ' A' ' 166' ' ' ILE . 46.4 mt-10 -72.89 -51.16 19.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.834 0.454 . . . . 0.0 110.018 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.3 tpp -63.41 -29.12 70.46 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.234 0.614 . . . . 0.0 111.133 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 37.5 mmm -63.31 -52.89 60.06 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.511 ' O ' ' HG3' ' A' ' 169' ' ' GLU . 41.2 ttp180 -53.5 -48.78 68.65 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 124.734 1.271 . . . . 0.0 110.772 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.535 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 32.5 mm -65.2 -45.4 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 O-C-N 123.64 0.588 . . . . 0.0 110.055 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 39.6 t -72.66 -19.72 61.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.376 0.67 . . . . 0.0 112.631 -175.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.48 -31.71 17.54 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.116 0.416 . . . . 0.0 110.342 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 165' ' ' ARG . 66.1 mt-10 -50.59 -56.4 11.94 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.39 0.614 . . . . 0.0 110.399 166.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 2.0 mmt180 -73.62 -39.74 64.33 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.113 -175.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -55.35 -55.15 29.89 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.735 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.29 -42.14 90.58 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.878 0.871 . . . . 0.0 111.038 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.53 -54.26 45.49 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.225 0.953 . . . . 0.0 111.799 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -70.22 -25.89 63.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.437 0.695 . . . . 0.0 111.847 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.08 83.82 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.995 0.426 . . . . 0.0 109.86 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -68.69 -35.96 77.88 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.8 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 55.5 mt -72.58 -53.82 10.85 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.232 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -66.28 -32.32 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 122.999 0.519 . . . . 0.0 112.003 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -76.66 -7.09 54.62 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.077 0.551 . . . . 0.0 111.501 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 18.4 m -114.74 -163.64 0.89 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.696 1.198 . . . . 0.0 109.262 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 155.32 -66.97 0.31 Allowed Glycine 0 C--N 1.346 1.134 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 173.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 52.7 m . . . . . 0 C--O 1.252 1.203 0 C-N-CA 124.379 1.072 . . . . 0.0 108.263 176.427 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.0 ttm . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.27 -54.69 15.87 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.271 0.628 . . . . 0.0 109.95 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.5 t 65.21 173.39 0.21 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.943 1.297 . . . . 0.0 112.434 175.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.97 56.05 0.05 OUTLIER Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.31 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 29' ' ' ARG . 27.9 pt20 -70.66 84.26 0.63 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.389 1.09 . . . . 0.0 111.203 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.14 163.09 38.6 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.223 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.6 m -97.4 136.75 37.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.203 1.001 . . . . 0.0 110.306 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 20.1 mp0 -123.95 107.81 11.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 172.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.609 HH22 ' HA ' ' A' ' 170' ' ' ARG . 98.2 mtt180 -74.47 161.75 29.49 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.544 0.211 . . . . 0.0 110.602 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.54 177.99 5.64 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.621 0.768 . . . . 0.0 110.323 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.2 mt -133.22 158.91 41.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.414 1.086 . . . . 0.0 109.413 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.16 138.15 5.24 Favored Glycine 0 C--O 1.223 -0.59 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 173.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -91.7 137.76 32.11 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.5 tpt85 -138.99 128.46 24.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.741 0.816 . . . . 0.0 109.507 -168.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -85.67 136.6 33.3 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.524 HD11 HG23 ' A' ' 117' ' ' THR . 47.5 pt -129.62 159.14 71.05 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -177.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -48.07 -37.01 29.57 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.125 2.55 . . . . 0.0 114.285 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.64 77.13 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.468 0.707 . . . . 0.0 112.443 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.18 -150.82 20.49 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.16 137.88 33.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.82 164.58 27.25 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.777 0.831 . . . . 0.0 109.122 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -120.58 157.56 29.24 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 3.6 m -128.87 145.63 51.16 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 122.682 0.393 . . . . 0.0 110.792 -174.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 2.8 pp -98.05 135.57 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.417 HG13 ' HB3' ' A' ' 113' ' ' GLU . 2.2 mp -121.42 126.24 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 129' ' ' TRP . 57.0 mt -110.48 108.91 26.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.582 ' HB3' HD11 ' A' ' 109' ' ' LEU . 58.9 mtp180 -91.05 153.11 20.35 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -168.88 129.79 1.18 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 125.164 1.54 . . . . 0.0 111.219 174.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 9.7 mpt_? -87.26 105.41 17.21 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 172.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -79.21 150.64 31.57 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.995 0.518 . . . . 0.0 110.118 170.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -87.78 27.03 1.2 Allowed 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.989 0.9 . . . . 0.0 110.325 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.77 148.67 70.87 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.32 1.048 . . . . 0.0 109.782 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.56 165.04 33.18 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.241 2.627 . . . . 0.0 113.147 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.538 HG23 ' HG3' ' A' ' 103' ' ' GLU . 68.6 t -51.26 -44.63 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 114.053 -1.431 . . . . 0.0 112.616 -177.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -56.18 -39.36 72.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.291 0.995 . . . . 0.0 110.071 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -75.49 -36.57 60.59 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.685 0.794 . . . . 0.0 111.167 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.3 -30.48 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.385 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -74.76 -20.7 59.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.192 0.997 . . . . 0.0 109.998 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.5 m -72.17 -47.41 51.02 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.25 77.12 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.298 0.639 . . . . 0.0 111.91 172.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.0 t -63.31 -52.3 62.52 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 59.4 p -94.91 -41.16 9.32 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -167.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.448 ' O ' HG13 ' A' ' 47' ' ' ILE . 26.4 t70 -81.68 115.23 55.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 122.972 0.509 . . . . 0.0 110.889 -169.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.11 -20.39 71.07 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.47 2.78 . . . . 0.0 114.094 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -74.16 -31.2 62.61 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -84.11 -30.02 26.29 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.821 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 43' ' ' ASP . 91.2 mt -71.43 -43.37 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.263 0.625 . . . . 0.0 110.371 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -65.52 -3.29 4.25 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -86.64 -43.06 12.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.891 0.876 . . . . 0.0 110.364 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.447 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 49.7 p-90 -114.65 -25.08 8.45 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.137 0.975 . . . . 0.0 111.414 -173.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.447 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 11.1 t80 -129.55 -171.89 2.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.505 1.122 . . . . 0.0 109.104 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.6 mt -89.5 139.99 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.614 0.766 . . . . 0.0 111.41 -173.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -64.46 110.5 4.07 Favored Pre-proline 0 CA--C 1.566 1.576 0 O-C-N 125.348 1.655 . . . . 0.0 110.993 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -90.89 148.99 3.93 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.354 2.702 . . . . 0.0 113.592 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -130.54 130.47 44.15 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.87 -166.91 32.59 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 121.63 -0.319 . . . . 0.0 112.477 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -69.5 -46.94 65.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.415 0.686 . . . . 0.0 110.948 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.4 mt 62.25 22.85 13.46 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.872 1.269 . . . . 0.0 110.695 -172.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -124.97 146.93 49.16 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.594 1.158 . . . . 0.0 109.749 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.53 117.86 4.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.183 0.993 . . . . 0.0 111.981 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.57 12.14 57.35 Favored Glycine 0 N--CA 1.47 0.907 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.96 -174.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -119.58 -158.21 10.55 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 10.9 p30 -138.34 174.39 10.6 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 117.723 0.761 . . . . 0.0 112.036 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -145.02 153.55 41.6 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.864 1.266 . . . . 0.0 107.894 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.97 109.94 5.1 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.651 0.78 . . . . 0.0 110.878 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.7 mt -77.72 138.11 38.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.697 0.799 . . . . 0.0 109.177 173.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -77.82 110.23 12.52 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.2 56.73 5.06 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.607 0.567 . . . . 0.0 113.356 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -168.77 -84.05 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.965 0.506 . . . . 0.0 111.339 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -152.78 155.68 37.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.275 0.56 . . . . 0.0 111.559 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 m -132.45 143.09 49.55 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.378 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -156.56 -170.51 21.75 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 5.5 m-20 -118.24 168.7 10.35 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.252 0.621 . . . . 0.0 110.749 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.497 ' HA ' HG22 ' A' ' 85' ' ' ILE . 9.8 mm -103.58 107.05 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.1 mt -75.51 -58.11 3.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.71 0.404 . . . . 0.0 110.994 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.07 151.2 13.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.692 0.797 . . . . 0.0 109.41 175.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.5 p -148.3 133.08 17.95 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -107.82 89.84 5.75 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.53 132.39 33.06 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.639 2.226 . . . . 0.0 112.53 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -102.74 22.85 14.97 Favored 'Cis proline' 0 C--N 1.375 1.924 0 CA-C-N 120.031 1.047 . . . . 0.0 113.597 -8.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -67.45 -52.72 36.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.812 1.245 . . . . 0.0 112.366 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.441 ' NH2' ' HD3' ' A' ' 100' ' ' ARG . 26.4 ttm-85 -148.93 154.62 39.68 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.32 0.581 . . . . 0.0 111.134 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.5 tt -135.07 140.97 45.97 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.14 1.376 . . . . 0.0 107.338 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.473 HG23 ' HG2' ' A' ' 98' ' ' GLU . 40.6 m -137.9 134.87 35.54 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.302 0.641 . . . . 0.0 109.287 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.497 HG22 ' HA ' ' A' ' 74' ' ' ILE . 12.6 pt -147.78 147.14 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.055 1.342 . . . . 0.0 109.895 -172.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.5 m -86.86 153.7 21.43 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 163.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 23.1 t-105 -143.13 109.62 5.41 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -167.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.738 HG13 ' HB3' ' A' ' 93' ' ' PRO . 61.1 t -108.79 103.07 14.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -83.85 141.56 31.24 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -58.25 -30.04 66.23 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.94 -53.8 5.14 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.397 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -138.7 119.57 9.96 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.61 0.764 . . . . 0.0 110.349 -174.167 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.738 ' HB3' HG13 ' A' ' 88' ' ' VAL . 3.1 Cg_exo -83.18 -166.86 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.701 2.934 . . . . 0.0 113.016 -176.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.5 t70 52.67 85.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.593 1.557 . . . . 0.0 113.373 174.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 71.0 m -147.09 122.32 10.22 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 171.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -101.33 105.68 16.77 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.2 t -97.69 147.85 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.202 1.001 . . . . 0.0 109.824 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.473 ' HG2' HG23 ' A' ' 84' ' ' THR . 33.9 mt-10 -137.7 155.96 48.54 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.68 0.792 . . . . 0.0 109.603 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.0 tp -126.75 139.24 53.28 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.441 ' HD3' ' NH2' ' A' ' 82' ' ' ARG . 1.5 ttp180 -140.08 106.96 5.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.47 0.708 . . . . 0.0 109.736 -172.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 110' ' ' LEU . 96.2 mt -111.53 131.18 55.42 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.371 1.069 . . . . 0.0 110.78 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.1 t -143.46 128.38 18.43 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.014 0.925 . . . . 0.0 108.796 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.538 ' HG3' HG23 ' A' ' 34' ' ' VAL . 43.9 mt-10 -66.62 124.37 22.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -136.46 117.98 14.83 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.97 -144.77 38.6 Favored Glycine 0 C--N 1.345 1.057 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -86.91 55.38 3.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.566 0.698 . . . . 0.0 109.227 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.64 -154.4 13.25 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 114.939 -1.028 . . . . 0.0 113.689 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.4 m -148.75 129.69 14.34 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.809 0.843 . . . . 0.0 111.119 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 27' ' ' ARG . 43.0 tp -81.21 109.55 15.85 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 101' ' ' LEU . 10.2 tt -88.05 130.97 34.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 170.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.451 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 45.3 mt-10 -132.13 105.86 7.63 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.5 tt -103.97 124.16 48.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 98' ' ' GLU . 9.4 pt-20 -122.06 129.38 52.35 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.481 ' O ' ' HA ' ' A' ' 23' ' ' SER . 8.1 t60 -117.0 111.1 19.1 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.94 102.37 11.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.674 0.79 . . . . 0.0 111.171 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.2 t -130.72 153.33 49.11 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.237 0.542 . . . . 0.0 109.934 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.524 HG23 HD11 ' A' ' 16' ' ' ILE . 76.1 p -71.14 -21.53 62.18 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.166 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.4 p -94.49 118.26 31.38 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.698 0.799 . . . . 0.0 111.137 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 122' ' ' LEU . 45.0 tt0 -65.81 -24.8 66.99 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.256 1.022 . . . . 0.0 111.147 174.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -61.65 -53.75 52.04 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.054 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.411 ' O ' HG22 ' A' ' 125' ' ' VAL . 10.1 tpt -62.63 -41.34 98.96 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.48 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 119' ' ' GLU . 37.0 mt -52.93 -53.03 55.37 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.098 0.959 . . . . 0.0 113.278 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.55 -44.72 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.788 0.435 . . . . 0.0 110.488 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.98 -44.14 96.84 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.541 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 121' ' ' MET . 26.0 m -75.23 -26.87 19.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.06 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.229 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.48 -29.05 60.24 Favored Glycine 0 C--N 1.351 1.361 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 170.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.26 -51.61 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 123.592 0.231 . . . . 0.0 110.396 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.03 -30.17 76.44 Favored Glycine 0 N--CA 1.476 1.353 0 CA-C-N 115.625 -0.716 . . . . 0.0 114.209 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.425 ' HB3' HD12 ' A' ' 26' ' ' ILE . 9.4 m95 -79.13 -46.96 16.95 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.44 ' HG3' ' HE1' ' A' ' 174' ' ' TRP . 27.3 mm-40 -54.9 -38.95 68.24 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.478 0.311 . . . . 0.0 110.785 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.6 tpp -64.99 -41.41 95.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.501 0.72 . . . . 0.0 110.69 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -72.77 -36.02 67.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.42 0.688 . . . . 0.0 111.729 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.56 -25.11 38.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.662 0.785 . . . . 0.0 110.289 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.22 -45.15 77.66 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.543 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.64 -30.57 52.23 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.431 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.1 tp -71.74 -29.64 64.74 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.21 -48.23 81.62 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.633 168.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 90.3 mmm -69.2 -37.11 77.93 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.074 0.95 . . . . 0.0 111.13 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.498 ' HA ' HD21 ' A' ' 144' ' ' LEU . 51.6 t80 -67.52 -56.77 8.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.972 0.909 . . . . 0.0 110.793 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 28.9 mt -67.2 -29.91 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.23 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -62.28 -30.09 70.88 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.64 0.376 . . . . 0.0 110.103 172.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.85 13.32 78.08 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.656 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -122.98 71.61 1.06 Allowed 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.498 HD21 ' HA ' ' A' ' 139' ' ' PHE . 3.9 mm? -75.13 159.8 81.76 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.772 173.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.21 -177.67 0.68 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 122.237 1.958 . . . . 0.0 111.732 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.03 63.61 2.43 Favored Glycine 0 N--CA 1.476 1.328 0 N-CA-C 112.332 -0.307 . . . . 0.0 112.332 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.03 -161.29 12.82 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -169.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -88.41 -167.45 0.31 Allowed 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 123.158 2.572 . . . . 0.0 112.382 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 152' ' ' ASP . 20.8 m -75.89 155.07 84.99 Favored Pre-proline 0 N--CA 1.481 1.115 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 167.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.6 -57.83 1.57 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.249 1.966 . . . . 0.0 111.414 174.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.26 -18.81 0.2 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.343 0.657 . . . . 0.0 111.384 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.454 ' HB2' HG21 ' A' ' 149' ' ' VAL . 27.2 t0 58.75 71.81 0.56 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.832 1.253 . . . . 0.0 110.634 -170.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -179.22 -24.54 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.26 -1.337 . . . . 0.0 110.691 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 66.96 52.93 0.86 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.14 1.376 . . . . 0.0 111.103 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.72 -44.83 14.04 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 174.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -83.18 159.38 22.03 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.955 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 61.72 91.23 0.06 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.868 1.267 . . . . 0.0 111.651 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.412 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 4.1 mp0 -56.51 -45.41 99.93 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 168.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 29.2 Cg_endo -59.97 94.91 0.1 OUTLIER 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 122.478 2.119 . . . . 0.0 111.083 164.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.451 ' N ' ' HD3' ' A' ' 161' ' ' PRO . 22.8 p -150.33 49.98 0.69 Allowed Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 123.319 0.647 . . . . 0.0 110.668 175.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 160' ' ' SER . 14.5 Cg_exo -66.6 -34.01 34.16 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 122.309 2.006 . . . . 0.0 111.289 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 166' ' ' ILE . 46.4 mt-10 -59.49 -54.37 47.42 Favored 'General case' 0 C--O 1.212 -0.87 0 O-C-N 124.382 1.051 . . . . 0.0 110.418 173.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 91.1 mmm -65.46 -44.03 88.48 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.175 0.59 . . . . 0.0 112.423 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 76.6 mtp -61.87 -39.22 91.15 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.694 0.621 . . . . 0.0 110.671 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.487 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 38.4 ttp180 -65.99 -48.79 70.05 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.998 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.527 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 30.5 mm -53.49 -40.01 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.831 0.852 . . . . 0.0 110.504 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.1 m -68.77 -54.49 15.66 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 122.701 0.4 . . . . 0.0 110.396 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 11.6 pt20 -61.5 -56.0 24.92 Favored 'General case' 0 C--O 1.209 -1.072 0 CA-C-O 117.726 -1.13 . . . . 0.0 111.304 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 9.5 mm-40 -43.45 -46.07 6.6 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.942 0.792 . . . . 0.0 113.064 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.609 ' HA ' HH22 ' A' ' 9' ' ' ARG . 4.8 mmp_? -53.64 -52.44 59.89 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.574 0.546 . . . . 0.0 109.841 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -80.95 -17.4 72.51 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 116.284 -0.416 . . . . 0.0 113.65 -173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 24.0 mm-40 -71.7 -37.3 70.69 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.51 0.724 . . . . 0.0 109.712 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.507 ' HB3' ' NH1' ' A' ' 9' ' ' ARG . . . -76.22 -36.21 58.68 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.737 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.44 ' HE1' ' HG3' ' A' ' 130' ' ' GLU . 75.5 m95 -67.09 -29.9 69.78 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 119.249 -0.405 . . . . 0.0 111.43 173.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.42 -61.18 2.62 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 123.59 0.556 . . . . 0.0 109.659 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.39 -35.27 51.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.409 1.084 . . . . 0.0 113.565 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 35.3 mt -66.8 -59.56 3.44 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 123.297 0.373 . . . . 0.0 110.159 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.8 p -72.88 -20.37 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 123.721 0.808 . . . . 0.0 111.357 -158.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -57.38 -21.16 34.19 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.259 1.024 . . . . 0.0 112.104 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 16.3 m -68.35 88.82 0.32 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.568 0.747 . . . . 0.0 109.452 172.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 138.37 36.51 0.15 Allowed Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.946 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.3 t . . . . . 0 C--O 1.249 1.042 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.118 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.908 0.385 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.45 -166.38 2.11 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.728 0.811 . . . . 0.0 109.63 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.0 m -68.3 83.76 0.25 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 168.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.33 112.04 3.49 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.886 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -77.2 73.6 3.78 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-O 123.51 1.624 . . . . 0.0 110.598 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.53 0.73 48.78 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.604 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 24.4 m -79.14 111.37 15.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.317 1.047 . . . . 0.0 110.956 -175.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 30.9 mt-10 -93.8 134.33 36.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.694 1.198 . . . . 0.0 108.56 172.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.405 ' HG2' ' CD1' ' A' ' 177' ' ' LEU . 43.0 ttm105 -99.78 139.44 35.43 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.855 0.462 . . . . 0.0 110.0 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.16 179.35 9.23 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.77 0.428 . . . . 0.0 111.628 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.413 HD13 ' N ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -145.15 153.12 41.04 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.957 -176.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.413 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -167.24 -151.98 7.2 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.45 163.22 35.55 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.207 0.603 . . . . 0.0 109.759 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -166.42 152.46 8.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.874 0.869 . . . . 0.0 109.483 167.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.5 m -82.95 152.66 25.38 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.043 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.8 pt -144.1 155.51 58.46 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.64 -30.29 28.16 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.941 2.428 . . . . 0.0 114.317 175.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.47 -7.84 59.64 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.82 -172.9 28.05 Favored Glycine 0 C--N 1.356 1.678 0 CA-C-N 119.258 0.935 . . . . 0.0 112.577 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -84.57 110.78 18.96 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.17 146.96 23.28 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.991 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -87.98 156.84 19.12 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 164.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 80.4 p -139.17 137.98 36.53 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.954 0.407 . . . . 0.0 111.609 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.597 HG12 HG23 ' A' ' 125' ' ' VAL . 2.9 pp -87.79 141.16 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.265 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.35 111.02 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.463 HG22 ' NE2' ' A' ' 28' ' ' GLN . 42.9 mt -100.91 108.63 23.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.555 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 97.2 mtt180 -99.54 140.59 33.5 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.463 ' NE2' HG22 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -138.78 144.15 39.25 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.294 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.477 HH11 ' HG2' ' A' ' 104' ' ' GLU . 12.2 mmt85 -103.73 101.96 11.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 173.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.46 ' CE1' ' HA2' ' A' ' 137' ' ' GLY . 70.1 m-85 -83.63 129.36 34.96 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.903 0.881 . . . . 0.0 110.624 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.72 48.25 0.67 Allowed 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 122.889 1.328 . . . . 0.0 109.785 170.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.56 152.42 41.7 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.058 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.725 ' HG2' ' HB2' ' A' ' 36' ' ' GLU . 56.4 Cg_endo -71.64 165.75 31.56 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.629 2.219 . . . . 0.0 113.454 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 80' ' ' PRO . 58.1 t -71.89 -43.7 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.954 -169.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -63.87 -34.03 77.02 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 124.055 0.847 . . . . 0.0 110.109 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.725 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -69.53 -62.79 1.24 Allowed 'General case' 0 C--N 1.355 0.813 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.776 179.266 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.7 t -51.17 -33.3 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 124.939 1.296 . . . . 0.0 111.06 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.434 ' HE3' HD12 ' A' ' 101' ' ' LEU . 65.2 t-105 -61.43 -57.42 12.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.19 0.596 . . . . 0.0 110.063 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.2 t -54.35 -40.7 68.33 Favored 'General case' 0 CA--C 1.552 1.023 0 O-C-N 123.92 0.762 . . . . 0.0 110.614 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.04 79.26 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.4 m -93.51 -4.48 51.0 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.752 0.821 . . . . 0.0 112.954 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 77.8 p -116.57 -48.37 2.69 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.439 0.563 . . . . 0.0 111.438 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.439 ' O ' HG12 ' A' ' 47' ' ' ILE . 20.6 t70 -63.12 119.94 56.93 Favored Pre-proline 0 N--CA 1.483 1.197 0 C-N-CA 123.878 0.871 . . . . 0.0 111.033 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.0 -26.76 43.22 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.008 2.472 . . . . 0.0 113.335 -171.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -61.82 -48.06 82.31 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.777 0.673 . . . . 0.0 109.646 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -72.13 -26.05 61.96 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 174.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.579 HG21 ' HD3' ' A' ' 54' ' ' PRO . 36.7 mm -71.24 -42.18 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 118.849 0.75 . . . . 0.0 111.474 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.07 -16.01 64.07 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -80.54 0.91 31.74 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.468 0.707 . . . . 0.0 112.408 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.421 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 46.2 p-90 -141.64 -47.44 0.37 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.916 0.486 . . . . 0.0 110.489 173.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -111.65 -164.28 0.91 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.069 0.948 . . . . 0.0 109.859 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -86.92 126.02 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 166.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 9.3 pt-20 -69.67 139.45 88.76 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 118.87 0.759 . . . . 0.0 111.794 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.579 ' HD3' HG21 ' A' ' 47' ' ' ILE . 15.2 Cg_exo -69.71 101.98 0.97 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.627 2.218 . . . . 0.0 110.932 173.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -74.88 136.01 41.51 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.767 0.827 . . . . 0.0 110.682 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.27 -164.74 27.21 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 116.023 -0.535 . . . . 0.0 114.308 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -68.46 -39.06 81.58 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.721 1.208 . . . . 0.0 111.104 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.3 mt 66.29 12.28 8.49 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -98.97 165.34 11.8 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.234 0.47 . . . . 0.0 110.079 173.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.759 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 38.5 tt0 -71.02 98.03 1.56 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.25 -31.03 4.36 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -170.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.11 -174.01 46.65 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 114.776 -0.712 . . . . 0.0 112.432 169.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 22.9 p-10 -134.96 155.26 51.05 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.842 0.857 . . . . 0.0 111.861 -170.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -116.91 169.6 9.27 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.163 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -163.4 144.23 9.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.701 0.8 . . . . 0.0 109.017 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.8 mt -118.5 153.29 34.41 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -93.28 -45.66 7.74 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.41 -12.27 84.0 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.33 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -127.52 -92.7 0.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 118.106 0.953 . . . . 0.0 111.31 -174.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.61 175.08 14.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.087 0.555 . . . . 0.0 110.821 -169.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 27.7 p -131.96 145.29 51.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.154 0.582 . . . . 0.0 109.616 -172.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.71 -148.87 5.37 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 112.319 -0.313 . . . . 0.0 112.319 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -151.23 163.75 38.16 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.223 0.609 . . . . 0.0 110.861 179.457 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.576 ' HA ' HG22 ' A' ' 85' ' ' ILE . 2.5 mp -94.34 102.42 13.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 86' ' ' SER . 88.4 mt -76.24 -45.53 32.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.785 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -135.45 141.69 45.44 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.511 -173.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.759 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 31.8 p -158.38 122.43 4.06 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.646 ' HG2' ' HD3' ' A' ' 81' ' ' ARG . 41.8 tt0 -144.78 90.46 6.35 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 38.0 Cg_exo -63.46 139.99 73.64 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.973 2.449 . . . . 0.0 111.858 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 27.2 Cg_endo -96.61 27.06 18.63 Favored 'Cis proline' 0 C--N 1.375 1.954 0 CA-C-N 120.097 1.07 . . . . 0.0 113.094 -8.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.646 ' HD3' ' HG2' ' A' ' 78' ' ' GLU . 4.3 mpt_? -77.9 -82.21 0.09 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.569 0.748 . . . . 0.0 111.385 -175.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.5 ptt-85 -150.96 154.11 36.48 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.795 0.438 . . . . 0.0 111.451 -171.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.8 tt -134.86 114.09 12.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -112.82 137.39 51.23 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.139 0.976 . . . . 0.0 108.907 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 74' ' ' ILE . 13.0 pt -133.29 151.56 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.81 1.244 . . . . 0.0 109.885 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.481 ' HB2' HD11 ' A' ' 75' ' ' LEU . 35.2 t -87.96 163.56 16.27 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.991 0.424 . . . . 0.0 109.978 166.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 35.6 t-105 -144.25 96.92 2.96 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -166.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.44 125.06 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.607 0.763 . . . . 0.0 109.373 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.449 ' HB3' ' HE3' ' A' ' 92' ' ' LYS . 59.6 t80 -144.72 171.71 14.03 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.13 0.972 . . . . 0.0 108.655 -176.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.76 154.64 38.27 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 122.531 0.333 . . . . 0.0 110.549 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.44 -63.72 4.1 Favored Glycine 0 N--CA 1.471 1.011 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -103.68 133.64 20.17 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 124.308 1.043 . . . . 0.0 109.708 177.224 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.12 -73.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.019 2.479 . . . . 0.0 112.433 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -125.47 165.93 17.55 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.283 0.563 . . . . 0.0 110.682 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 72.5 m -152.19 169.77 21.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.912 1.685 . . . . 0.0 107.464 175.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -133.83 123.81 25.45 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 118.509 0.595 . . . . 0.0 111.139 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 t -110.83 147.62 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.989 1.316 . . . . 0.0 107.869 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -143.09 127.86 18.21 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.066 0.46 . . . . 0.0 110.98 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.48 119.08 38.22 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.459 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 33.0 ttm180 -124.88 128.5 48.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.996 0.918 . . . . 0.0 109.145 -173.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.459 ' HB3' HG13 ' A' ' 34' ' ' VAL . 72.9 mt -135.6 128.74 31.74 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.934 0.894 . . . . 0.0 110.792 -175.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.2 m -148.82 152.67 36.91 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.653 1.181 . . . . 0.0 108.559 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.03 150.84 32.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.609 0.764 . . . . 0.0 111.291 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.477 ' HG2' HH11 ' A' ' 29' ' ' ARG . 11.0 tp10 -148.09 112.24 5.2 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.83 -101.75 0.2 Allowed Glycine 0 C--N 1.35 1.317 0 O-C-N 123.252 0.345 . . . . 0.0 112.924 -171.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -119.6 2.05 11.16 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.381 0.61 . . . . 0.0 110.345 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -112.88 -150.68 10.9 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.223 0.916 . . . . 0.0 111.718 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.0 m -148.09 127.09 12.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.481 1.112 . . . . 0.0 110.135 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.439 HD13 ' NE ' ' A' ' 29' ' ' ARG . 40.5 tp -82.44 133.34 35.21 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.4 tt -117.84 113.39 21.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.555 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 33.4 mt-10 -109.37 106.2 15.89 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.7 tp -98.83 103.26 15.19 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 38.8 tt0 -101.65 108.85 20.51 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.937 0.895 . . . . 0.0 109.666 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -106.51 122.18 45.78 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 23' ' ' SER . . . -119.42 125.18 48.34 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.561 0.744 . . . . 0.0 111.308 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.9 t -141.69 159.75 41.58 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 123.982 0.802 . . . . 0.0 109.611 173.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.4 p -90.68 -2.51 57.83 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.233 1.013 . . . . 0.0 111.886 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.6 t -97.16 119.19 35.19 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.162 0.985 . . . . 0.0 110.149 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.546 ' HA ' HD12 ' A' ' 122' ' ' LEU . 38.3 tt0 -62.32 -42.4 99.35 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.269 1.027 . . . . 0.0 112.645 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.16 -58.44 8.64 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.425 ' O ' HG22 ' A' ' 125' ' ' VAL . 25.2 ttt -51.32 -29.62 15.64 Favored 'General case' 0 C--O 1.208 -1.115 0 O-C-N 124.794 1.309 . . . . 0.0 112.762 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 119' ' ' GLU . 47.6 mt -64.26 -53.76 43.96 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.394 0.543 . . . . 0.0 111.896 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 127' ' ' VAL . 47.2 t -63.48 -49.58 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.418 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 23.5 tt0 -44.39 -56.16 4.44 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.264 1.826 . . . . 0.0 113.818 175.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.597 HG23 HG12 ' A' ' 24' ' ' ILE . 34.6 m -72.44 -26.39 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 122.265 0.226 . . . . 0.0 110.635 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.51 -39.12 97.42 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 169.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 123' ' ' VAL . 92.6 t -78.09 -60.48 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.37 -57.06 12.48 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 114.436 -1.256 . . . . 0.0 114.517 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -66.03 -40.94 91.44 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.875 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 36.9 tt0 -67.18 -32.17 73.07 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 120.319 1.418 . . . . 0.0 111.125 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.0 mtm -71.98 -35.04 69.4 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.666 0.386 . . . . 0.0 110.272 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.06 -59.82 2.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.357 0.663 . . . . 0.0 110.97 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -54.56 -30.4 54.08 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.089 1.356 . . . . 0.0 113.008 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 24.8 t70 -57.99 -46.62 84.91 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.505 0.722 . . . . 0.0 110.311 169.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -64.18 -37.38 87.25 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.656 172.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 52.5 tp -68.88 -20.66 64.26 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.148 0.579 . . . . 0.0 110.544 175.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.46 ' HA2' ' CE1' ' A' ' 30' ' ' TYR . . . -71.06 -47.27 38.82 Favored Glycine 0 C--N 1.35 1.328 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.3 ptm -80.27 -24.33 40.15 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.499 -0.851 . . . . 0.0 111.58 174.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 82.7 t80 -67.17 -42.77 83.7 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.838 0.455 . . . . 0.0 110.562 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.2 mt -76.74 -51.54 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.781 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.586 ' HA ' ' NE ' ' A' ' 141' ' ' ARG . 0.3 OUTLIER -146.87 99.27 3.16 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-O 121.564 0.697 . . . . 0.0 111.332 177.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.52 -20.69 0.11 Allowed Glycine 0 CA--C 1.523 0.57 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.534 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 68.44 103.9 0.05 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.459 1.903 . . . . 0.0 111.189 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tt -88.97 107.13 15.74 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 123.959 0.904 . . . . 0.0 109.027 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -89.51 130.11 1.91 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.648 2.232 . . . . 0.0 111.27 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.63 -112.12 3.73 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.16 -75.46 0.41 Allowed Glycine 0 C--N 1.345 1.041 0 CA-C-O 119.041 -0.866 . . . . 0.0 112.842 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -46.26 105.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 124.022 3.148 . . . . 0.0 113.95 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.647 ' HB ' ' HB2' ' A' ' 152' ' ' ASP . 16.8 m -80.87 118.62 73.18 Favored Pre-proline 0 CA--C 1.556 1.187 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.597 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.72 -65.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.422 2.081 . . . . 0.0 112.593 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -123.4 1.84 9.03 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.228 0.611 . . . . 0.0 110.557 -173.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.647 ' HB2' ' HB ' ' A' ' 149' ' ' VAL . 2.1 m-20 -72.02 79.61 0.93 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.565 1.146 . . . . 0.0 109.728 -174.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -154.11 43.27 0.54 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.432 -175.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 68.28 77.56 0.24 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.049 1.34 . . . . 0.0 110.866 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 158' ' ' GLU . 2.1 mp0 -82.86 88.28 6.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.975 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -64.99 -61.52 2.11 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.328 -170.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -89.87 -30.37 17.95 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.858 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.635 ' HB2' ' HB3' ' A' ' 155' ' ' GLU . 32.7 mt-10 -71.83 118.17 64.36 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 122.939 0.495 . . . . 0.0 110.139 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.03 89.8 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.789 2.326 . . . . 0.0 112.895 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.5 m -119.48 67.75 10.23 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.133 0.973 . . . . 0.0 108.631 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -38.12 -52.86 1.76 Allowed 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 124.318 3.345 . . . . 0.0 115.128 -162.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.444 ' O ' HG13 ' A' ' 166' ' ' ILE . 37.3 tt0 -72.99 -51.23 19.09 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.253 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 10.3 tpt -69.75 -46.45 65.84 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 118.13 0.423 . . . . 0.0 110.98 -173.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -50.19 -47.01 54.79 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.383 1.073 . . . . 0.0 110.212 171.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 168' ' ' GLN . 60.0 ttt180 -61.67 -45.05 95.65 Favored 'General case' 0 C--O 1.21 -0.994 0 O-C-N 124.145 0.903 . . . . 0.0 110.842 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.511 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 86.9 mt -53.76 -60.05 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 122.809 0.444 . . . . 0.0 110.584 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.3 p -62.12 -27.25 68.8 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.294 1.037 . . . . 0.0 113.787 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 1.4 pp0? -86.69 -33.89 19.9 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.16 -34.5 78.21 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.635 0.774 . . . . 0.0 110.413 174.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 28.7 mmt180 -57.2 -57.77 11.17 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 169.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -53.13 -37.02 53.63 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-N 114.707 -1.133 . . . . 0.0 115.138 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 38.4 mm-40 -67.37 -54.78 17.5 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.069 0.548 . . . . 0.0 110.857 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.48 76.53 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.399 -173.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.404 ' CZ2' ' HG3' ' A' ' 9' ' ' ARG . 67.9 m95 -71.69 -36.13 70.48 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.981 0.513 . . . . 0.0 111.5 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.18 83.52 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.467 0.479 . . . . 0.0 110.569 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -68.32 -40.65 81.59 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.176 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.405 ' CD1' ' HG2' ' A' ' 9' ' ' ARG . 42.2 mt -71.55 -49.79 37.37 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 123.275 0.63 . . . . 0.0 112.228 -176.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 p -61.85 -29.64 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 117.936 0.334 . . . . 0.0 110.804 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -87.74 -11.39 48.3 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 173.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 39.4 t -73.58 92.22 1.91 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 169.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 134.4 -36.89 2.03 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.096 -173.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 C--O 1.254 1.306 0 C-N-CA 123.459 0.704 . . . . 0.0 109.924 -178.647 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.52 0.2 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.44 21.31 4.74 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.517 0.727 . . . . 0.0 111.368 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -67.42 -45.88 74.82 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.076 0.551 . . . . 0.0 110.602 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.95 -58.69 4.79 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.629 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.572 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 22.2 pt20 -148.73 118.58 7.1 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.447 1.099 . . . . 0.0 108.282 173.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -121.34 114.83 21.89 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.789 0.836 . . . . 0.0 108.958 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -103.44 119.37 38.75 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.298 0.639 . . . . 0.0 111.05 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -104.81 122.58 46.04 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 165.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.491 ' HG3' HD11 ' A' ' 177' ' ' LEU . 17.0 ptp180 -91.76 155.11 18.5 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -159.18 -177.75 6.7 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.062 0.458 . . . . 0.0 111.033 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.497 HD12 ' HA3' ' A' ' 181' ' ' GLY . 0.3 OUTLIER -143.88 157.02 44.63 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.03 -176.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.463 ' H ' HD13 ' A' ' 11' ' ' LEU . . . -155.02 -172.95 23.23 Favored Glycine 0 C--O 1.239 0.445 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HD3' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -134.07 136.93 44.3 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -136.37 117.45 14.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -170.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.0 m -92.26 99.4 12.19 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.9 pt -104.06 161.21 23.61 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.233 1.013 . . . . 0.0 108.996 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -50.05 -28.9 20.33 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.36 2.706 . . . . 0.0 114.267 172.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.81 0.32 35.4 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.48 177.82 15.07 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 117.841 0.291 . . . . 0.0 112.894 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.57 91.6 0.8 Allowed 'General case' 0 C--N 1.348 0.516 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.46 157.08 26.3 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.068 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.3 165.7 11.42 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.8 p -136.95 140.7 42.41 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.595 HG12 HG23 ' A' ' 125' ' ' VAL . 2.7 pp -92.4 136.52 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 170.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 mp -122.74 114.93 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.3 mt -106.26 108.48 25.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.45 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 99.6 mtt180 -97.38 134.26 40.88 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 172.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.572 ' NE2' ' HB2' ' A' ' 5' ' ' GLN . 51.8 tt0 -158.91 142.04 14.64 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.023 0.827 . . . . 0.0 110.405 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -116.55 121.77 42.74 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.439 ' O ' ' HA3' ' A' ' 107' ' ' GLY . 57.1 m-85 -94.9 148.23 22.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.689 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.61 34.46 0.49 Allowed 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.921 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.23 146.98 45.15 Favored Pre-proline 0 C--O 1.243 0.718 0 C-N-CA 124.045 0.938 . . . . 0.0 109.251 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' HG2' ' HG2' ' A' ' 36' ' ' GLU . 72.2 Cg_endo -67.86 169.03 17.1 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.871 2.381 . . . . 0.0 112.823 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.1 t -53.0 -53.01 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 114.086 -1.416 . . . . 0.0 111.856 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -48.07 -47.14 34.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 124.283 0.989 . . . . 0.0 112.292 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.479 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 21.6 mm-40 -70.27 -27.52 64.49 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.985 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.458 HG21 ' HB ' ' A' ' 108' ' ' THR . 62.9 t -81.41 -36.08 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 123.862 0.726 . . . . 0.0 110.997 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -68.61 -36.81 79.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.678 0.791 . . . . 0.0 108.884 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -68.78 -55.41 11.35 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.672 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -58.61 -28.96 66.1 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.44 ' SG ' HD22 ' A' ' 99' ' ' LEU . 49.7 t -96.11 -24.95 16.06 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.1 p -105.08 -46.83 4.15 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 119.115 0.871 . . . . 0.0 112.007 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.18 125.77 88.87 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 58.0 Cg_exo -55.59 -35.02 91.93 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.652 2.901 . . . . 0.0 113.052 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.63 -17.88 37.14 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.38 1.472 . . . . 0.0 112.295 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -100.97 -42.42 6.42 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.374 1.07 . . . . 0.0 109.188 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.5 mt -73.69 -36.82 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.544 -167.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -58.25 -18.96 30.32 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -41.46 64.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.21 0.604 . . . . 0.0 112.024 173.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.422 ' CE2' HD13 ' A' ' 136' ' ' LEU . 66.7 p-90 -118.66 14.04 13.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -171.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.1 t80 178.07 -175.31 0.17 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.115 0.566 . . . . 0.0 109.797 -169.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -88.81 131.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 44' ' ' PRO . 13.5 pt-20 -75.64 140.48 71.54 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-N 119.438 1.017 . . . . 0.0 111.634 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.506 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 93.5 Cg_endo -83.75 111.51 1.73 Allowed 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.352 2.701 . . . . 0.0 112.742 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -78.24 133.53 37.7 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.176 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.77 -156.58 24.31 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.927 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.29 -47.95 46.14 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.145 0.978 . . . . 0.0 111.202 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.8 mt 62.69 29.54 16.83 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 124.472 1.107 . . . . 0.0 111.296 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -118.63 151.57 37.68 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.013 0.925 . . . . 0.0 109.129 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.688 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 3.9 tm-20 -64.54 103.66 0.7 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.39 0.676 . . . . 0.0 109.348 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.84 -32.45 4.79 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.99 -170.29 45.84 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.261 -0.469 . . . . 0.0 112.112 171.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 8.8 p30 -131.55 160.23 35.89 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.146 0.973 . . . . 0.0 112.43 -171.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 21.9 p90 -120.91 158.8 26.88 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.092 166.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.06 114.12 0.79 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 69' ' ' ASN . 80.6 mt -57.86 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 118.395 0.543 . . . . 0.0 111.734 -171.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -159.88 -29.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.392 0.615 . . . . 0.0 110.862 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.85 -31.15 0.03 OUTLIER Glycine 0 N--CA 1.466 0.688 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 91.3 m-20 -89.58 119.59 30.14 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 124.033 0.933 . . . . 0.0 108.491 171.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 72.38 122.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.946 1.298 . . . . 0.0 113.258 173.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.4 p -149.57 139.51 21.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.858 0.863 . . . . 0.0 108.847 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.57 -166.72 30.75 Favored Glycine 0 N--CA 1.464 0.551 0 O-C-N 123.233 0.333 . . . . 0.0 112.394 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 17.9 m-20 -109.31 170.1 8.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.297 0.639 . . . . 0.0 110.515 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.504 HG13 HG22 ' A' ' 85' ' ' ILE . 2.3 mp -97.74 110.01 24.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 171.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.36 -59.88 2.5 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.053 0.845 . . . . 0.0 110.627 -173.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -136.49 150.08 48.5 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.567 1.147 . . . . 0.0 108.988 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.9 p -159.77 134.34 7.74 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.366 0.666 . . . . 0.0 109.295 172.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -134.91 98.86 12.82 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 60.3 Cg_endo -71.1 130.85 18.33 Favored 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 122.026 1.817 . . . . 0.0 111.877 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 14.5 Cg_endo -103.97 20.17 13.37 Favored 'Cis proline' 0 C--N 1.371 1.741 0 CA-C-N 119.411 0.825 . . . . 0.0 113.972 -3.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -54.4 -70.35 0.1 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.203 1.001 . . . . 0.0 111.465 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -145.0 159.67 42.57 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.933 0.397 . . . . 0.0 111.666 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 tt -135.91 113.63 11.01 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.8 m -109.26 128.34 54.99 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.424 1.49 . . . . 0.0 109.431 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.504 HG22 HG13 ' A' ' 74' ' ' ILE . 14.2 pt -121.25 173.09 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 125.109 1.364 . . . . 0.0 111.389 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.5 t -112.81 134.35 54.37 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.672 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 42.1 t-105 -126.53 105.67 8.9 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -167.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.9 t -110.88 144.29 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 21.2 t80 -148.75 151.03 34.14 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -65.12 110.37 2.5 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.139 0.576 . . . . 0.0 110.72 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.43 -20.39 50.63 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.3 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.495 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 70.3 mmtt -97.73 131.1 27.53 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.39 -73.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.891 2.394 . . . . 0.0 113.431 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -161.17 147.61 14.67 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.505 0.722 . . . . 0.0 109.364 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.672 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 19.8 m -141.97 158.96 43.16 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.728 0.811 . . . . 0.0 109.707 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -129.85 114.79 16.34 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 t -105.03 148.45 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -148.88 153.19 37.69 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.178 0.514 . . . . 0.0 110.65 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.44 HD22 ' SG ' ' A' ' 41' ' ' CYS . 39.7 tp -123.93 146.42 48.47 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.263 1.425 . . . . 0.0 107.372 175.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -140.97 109.9 6.11 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.53 148.8 22.11 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.686 0.794 . . . . 0.0 110.694 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.1 t -160.64 135.01 7.29 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 167.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.93 146.92 50.83 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.964 0.906 . . . . 0.0 109.831 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -164.52 108.76 0.94 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.907 1.283 . . . . 0.0 108.861 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.95 -132.01 10.83 Favored Glycine 0 C--N 1.342 0.885 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 172.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -92.42 31.59 1.3 Allowed 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.223 1.009 . . . . 0.0 110.245 171.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 30' ' ' TYR . . . -171.62 -150.43 7.14 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 120.452 -0.88 . . . . 0.0 114.883 -174.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.458 ' HB ' HG21 ' A' ' 37' ' ' VAL . 62.8 m -151.09 141.17 22.13 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.204 0.602 . . . . 0.0 111.079 -170.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.38 144.53 25.73 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.033 0.933 . . . . 0.0 109.378 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.437 HD11 ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -127.14 143.64 51.22 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 166.074 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.45 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 40.9 mt-10 -122.57 107.51 12.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 167.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.464 HD22 HD21 ' A' ' 133' ' ' LEU . 27.7 tp -99.16 104.4 16.37 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 50.8 tt0 -102.69 116.95 33.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.357 0.663 . . . . 0.0 110.429 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -108.03 120.07 41.26 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -113.83 118.38 34.07 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.756 0.822 . . . . 0.0 110.831 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.1 t -139.16 159.94 40.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.241 0.616 . . . . 0.0 111.076 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 50.4 p -89.86 -20.61 23.23 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.221 1.008 . . . . 0.0 111.76 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.8 m -86.71 123.5 31.94 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.231 0.612 . . . . 0.0 109.995 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.593 ' HA ' HD12 ' A' ' 122' ' ' LEU . 28.8 tt0 -73.42 -30.39 63.2 Favored 'General case' 0 C--O 1.25 1.102 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -170.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -60.89 -58.9 6.5 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 23.8 ttt -49.44 -32.7 12.41 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 124.782 1.301 . . . . 0.0 112.67 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.593 HD12 ' HA ' ' A' ' 119' ' ' GLU . 36.7 mt -61.24 -52.59 64.11 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.869 0.468 . . . . 0.0 111.896 175.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 127' ' ' VAL . 48.0 t -63.26 -50.04 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -45.05 -54.11 7.06 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.927 1.691 . . . . 0.0 113.574 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.595 HG23 HG12 ' A' ' 24' ' ' ILE . 30.5 m -75.93 -24.18 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 122.422 0.289 . . . . 0.0 110.807 -177.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.17 96.1 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 169.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 123' ' ' VAL . 58.8 t -78.17 -59.33 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.77 -56.45 9.82 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 114.517 -1.22 . . . . 0.0 114.023 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -65.42 -49.73 68.1 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.402 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 119.05 0.841 . . . . 0.0 111.07 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 89.7 mtp -75.56 -35.26 60.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.492 0.317 . . . . 0.0 110.518 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.26 76.06 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.193 0.597 . . . . 0.0 110.89 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 112' ' ' LEU . 4.5 mm? -57.4 -38.14 73.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.332 1.053 . . . . 0.0 112.386 170.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.42 -38.37 90.9 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 120.856 0.36 . . . . 0.0 110.854 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -72.32 -25.18 61.46 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.459 0.704 . . . . 0.0 110.849 173.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.672 HD11 ' HB1' ' A' ' 40' ' ' ALA . 41.5 tp -71.01 -52.33 20.2 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 123.162 0.585 . . . . 0.0 109.561 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.78 -36.23 40.64 Favored Glycine 0 N--CA 1.472 1.081 0 N-CA-C 115.016 0.767 . . . . 0.0 115.016 169.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.2 mmm -61.44 -44.93 96.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.655 0.382 . . . . 0.0 110.47 170.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -68.12 -34.93 77.27 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.663 0.785 . . . . 0.0 111.953 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 67.1 mt -78.16 -61.65 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.346 0.658 . . . . 0.0 110.018 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -144.62 93.89 2.48 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.57 -17.65 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.305 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 68.31 99.14 0.06 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 125.969 1.708 . . . . 0.0 111.089 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 22.8 tp -111.6 94.81 24.7 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -75.15 -21.37 15.65 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.792 2.328 . . . . 0.0 112.367 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.8 -49.24 0.05 OUTLIER Glycine 0 C--N 1.334 0.463 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.41 177.43 50.57 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.735 -0.732 . . . . 0.0 112.698 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.34 -177.18 0.35 Allowed 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.352 2.702 . . . . 0.0 112.344 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.467 HG21 ' HB2' ' A' ' 152' ' ' ASP . 17.2 m -61.3 125.92 85.16 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.188 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.01 -40.28 3.49 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.598 2.198 . . . . 0.0 111.041 171.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -155.61 89.59 1.19 Allowed 'General case' 0 C--N 1.346 0.437 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.467 ' HB2' HG21 ' A' ' 149' ' ' VAL . 21.9 t70 -71.38 -34.72 70.67 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.836 174.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 76.27 18.46 1.88 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.405 1.482 . . . . 0.0 113.049 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.37 79.95 7.6 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.707 0.765 . . . . 0.0 111.26 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -101.87 -63.97 1.1 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.651 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -117.9 84.58 2.19 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.994 0.902 . . . . 0.0 110.303 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -172.03 -64.66 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -134.29 101.62 12.2 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 169.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.416 ' HA ' ' SD ' ' A' ' 164' ' ' MET . 32.3 Cg_exo -59.75 106.13 0.31 Allowed 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.794 2.329 . . . . 0.0 111.322 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.405 ' N ' ' SD ' ' A' ' 164' ' ' MET . 15.9 m -81.12 103.41 1.94 Allowed Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.463 1.105 . . . . 0.0 110.401 -173.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.45 -52.38 7.8 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.005 2.47 . . . . 0.0 114.05 -167.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 166' ' ' ILE . 41.4 tt0 -67.81 -53.81 24.02 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.558 0.343 . . . . 0.0 111.877 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -43.22 76.32 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 123.016 0.198 . . . . 0.0 110.633 -170.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.416 ' SD ' ' HA ' ' A' ' 159' ' ' PRO . 78.6 mtp -63.75 -34.45 77.91 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.36 177.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.486 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 7.3 tpm_? -61.07 -49.89 75.5 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.32 0.387 . . . . 0.0 110.504 173.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 162' ' ' GLU . 36.6 mm -51.67 -52.74 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 124.411 1.084 . . . . 0.0 111.695 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.2 p -65.94 -51.91 54.39 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.586 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -53.56 -30.83 43.89 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 172.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 11.8 mm-40 -58.44 -50.24 74.41 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.641 0.655 . . . . 0.0 109.449 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -60.21 -52.72 64.11 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.185 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.75 -48.0 45.09 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 124.66 1.225 . . . . 0.0 115.955 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.8 -29.2 61.02 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.851 0.46 . . . . 0.0 111.391 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.89 -41.21 68.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.653 0.381 . . . . 0.0 110.037 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -74.79 -23.86 58.57 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.41 0.684 . . . . 0.0 111.255 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.491 ' HA ' HG12 ' A' ' 178' ' ' VAL . . . -75.24 -31.85 60.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.941 0.496 . . . . 0.0 110.393 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.72 72.26 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.289 0.636 . . . . 0.0 109.736 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 9' ' ' ARG . 95.4 mt -71.42 -61.17 1.87 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.102 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 175' ' ' ALA . 11.1 p -57.04 -39.21 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.588 0.755 . . . . 0.0 112.644 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -68.65 -26.66 65.44 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.234 0.614 . . . . 0.0 111.419 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 49.6 m -86.28 -22.64 26.69 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.989 0.516 . . . . 0.0 111.065 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.497 ' HA3' HD12 ' A' ' 11' ' ' LEU . . . -96.34 24.66 29.4 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.224 -0.443 . . . . 0.0 113.062 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.2 m . . . . . 0 CA--C 1.553 1.066 0 C-N-CA 123.454 0.702 . . . . 0.0 109.439 178.338 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.43 ' HG2' ' NH1' ' A' ' 141' ' ' ARG . 63.2 mtt . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 3' ' ' SER . . . 179.39 -14.73 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.232 1.413 . . . . 0.0 110.001 -174.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.404 ' H ' ' H ' ' A' ' 2' ' ' ALA . 23.9 m -54.83 -44.58 74.02 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.14 0.976 . . . . 0.0 111.308 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.96 79.25 1.73 Allowed Glycine 0 C--N 1.337 0.638 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -69.03 94.26 0.63 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 120.931 0.396 . . . . 0.0 110.479 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -70.86 84.47 0.67 Allowed 'General case' 0 C--N 1.346 0.417 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 166.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 33.1 m -130.31 103.12 6.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.86 0.864 . . . . 0.0 110.085 -176.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -92.23 142.04 27.91 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.143 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 145.17 41.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.317 0.647 . . . . 0.0 109.262 170.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -160.24 -175.42 5.04 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.882 0.873 . . . . 0.0 110.636 -170.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.6 mt -141.53 165.8 26.49 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.782 0.833 . . . . 0.0 110.889 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.91 -179.75 36.76 Favored Glycine 0 C--O 1.24 0.515 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.041 173.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -109.93 147.91 32.56 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -146.29 126.66 14.0 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.8 m -72.98 141.75 47.76 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.338 0.655 . . . . 0.0 110.026 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.522 HD11 HG23 ' A' ' 117' ' ' THR . 49.3 pt -143.19 152.45 57.89 Favored Pre-proline 0 N--CA 1.478 0.938 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.26 -15.83 6.07 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.214 2.61 . . . . 0.0 115.042 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 93' ' ' PRO . . . -109.3 9.02 25.87 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.92 -165.58 26.17 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 119.021 0.828 . . . . 0.0 114.229 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -94.81 100.73 12.57 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 175.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.09 155.9 21.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.6 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' HB2' HD11 ' A' ' 122' ' ' LEU . 48.0 mtm180 -101.95 158.24 16.28 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 166.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.5 p -133.53 141.27 47.66 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.41 0.444 . . . . 0.0 111.218 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.527 HD13 HG23 ' A' ' 125' ' ' VAL . 36.0 pt -84.15 148.2 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 47.6 mt -133.83 110.85 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.544 HG22 HE22 ' A' ' 28' ' ' GLN . 7.0 mt -113.32 110.3 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HB3' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -101.53 145.3 29.19 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.128 0.571 . . . . 0.0 110.217 176.541 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.544 HE22 HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -157.31 142.78 17.3 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.76 0.663 . . . . 0.0 110.992 175.018 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -104.57 107.27 18.13 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -87.52 144.3 26.78 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.774 0.83 . . . . 0.0 111.469 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -79.15 40.98 0.43 Allowed 'General case' 0 CA--C 1.566 1.575 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.133 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.0 150.08 70.32 Favored Pre-proline 0 N--CA 1.474 0.769 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.12 170.94 8.32 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.252 1.968 . . . . 0.0 113.168 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.78 -46.38 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.518 -171.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.61 -34.09 76.32 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.821 0.7 . . . . 0.0 110.99 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.73 -63.53 1.14 Allowed 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.443 0.465 . . . . 0.0 111.298 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.1 t -55.77 -31.8 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.194 0.997 . . . . 0.0 111.064 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -59.98 -56.87 16.29 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.962 0.505 . . . . 0.0 109.872 174.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.0 m -52.83 -42.08 64.82 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.035 0.834 . . . . 0.0 110.737 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -60.01 -34.6 73.57 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 82.4 m -95.58 -4.76 44.03 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.635 0.774 . . . . 0.0 113.07 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.2 p -118.02 -51.82 2.44 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 118.314 0.506 . . . . 0.0 111.936 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.51 117.02 30.38 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.784 0.834 . . . . 0.0 110.096 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.27 -20.06 43.4 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.197 2.598 . . . . 0.0 113.869 -170.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -71.38 -49.57 40.82 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -59.02 -37.99 78.23 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.576 172.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.5 mt -67.91 -35.72 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.039 0.535 . . . . 0.0 110.763 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -62.69 -17.45 60.65 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -73.04 -25.61 61.0 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -138.37 11.7 2.77 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -178.87 -178.76 0.56 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.251 0.621 . . . . 0.0 109.402 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.3 mt -91.0 137.01 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.999 0.92 . . . . 0.0 108.565 171.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.65 132.8 85.97 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.119 0.968 . . . . 0.0 111.442 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.12 120.28 2.93 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 122.476 2.117 . . . . 0.0 110.352 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -90.65 158.08 17.13 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.514 0.726 . . . . 0.0 111.062 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.71 -166.09 12.23 Favored Glycine 0 N--CA 1.466 0.634 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.178 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.76 -38.43 91.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.059 0.944 . . . . 0.0 111.755 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.2 mt 66.1 12.53 8.56 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.718 1.207 . . . . 0.0 112.518 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -126.82 154.53 44.19 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.139 0.976 . . . . 0.0 108.646 -176.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.93 121.6 10.95 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 123.869 0.731 . . . . 0.0 112.119 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.47 -27.8 17.64 Favored Glycine 0 N--CA 1.475 1.29 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.946 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -97.87 170.4 25.12 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 165.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -119.17 161.39 20.42 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.617 1.209 . . . . 0.0 112.527 -169.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -105.83 172.17 6.95 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.244 168.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.34 143.27 7.32 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.444 1.098 . . . . 0.0 109.74 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.3 mt -116.84 167.73 10.85 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.073 0.949 . . . . 0.0 109.008 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -73.88 -42.78 60.22 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.023 0.529 . . . . 0.0 111.66 -171.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.17 16.83 2.12 Favored Glycine 0 N--CA 1.467 0.731 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.033 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -126.91 44.95 2.79 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.266 1.026 . . . . 0.0 108.694 -175.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 68.6 179.25 0.24 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.936 1.295 . . . . 0.0 113.729 175.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.3 p -145.09 140.69 28.23 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.542 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.03 177.7 32.13 Favored Glycine 0 N--CA 1.468 0.828 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.905 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -102.67 156.63 17.5 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.98 0.912 . . . . 0.0 110.128 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.3 mp -92.9 110.43 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.6 mt -73.4 -44.16 59.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.23 0.612 . . . . 0.0 109.796 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -160.52 140.18 10.99 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.273 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.8 p -141.54 126.68 18.45 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.21 1.004 . . . . 0.0 109.181 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -126.47 104.41 24.73 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 125.047 1.339 . . . . 0.0 107.39 -170.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 89.7 Cg_endo -80.27 131.32 8.61 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 122.353 2.035 . . . . 0.0 113.254 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 40.8 Cg_endo -101.05 34.32 7.75 Favored 'Cis proline' 0 C--N 1.377 2.066 0 CA-C-N 119.507 0.86 . . . . 0.0 111.482 -10.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -74.04 -77.87 0.11 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.375 1.07 . . . . 0.0 111.298 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -152.11 157.85 42.16 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.197 0.599 . . . . 0.0 110.611 -174.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -141.41 132.13 25.68 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.059 0.543 . . . . 0.0 109.681 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 98' ' ' GLU . 58.5 m -118.73 120.13 36.49 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.298 1.039 . . . . 0.0 108.471 174.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 pt -121.19 144.59 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.865 0 C-N-CA 125.779 1.631 . . . . 0.0 108.63 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 74.5 p -84.01 170.44 13.93 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.149 -0.969 . . . . 0.0 110.169 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -153.04 117.82 5.05 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -166.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.14 103.58 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.552 ' HB3' ' HG3' ' A' ' 92' ' ' LYS . 36.8 t80 -101.6 162.62 12.77 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.836 0.854 . . . . 0.0 109.381 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -51.75 111.64 0.63 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.912 1.285 . . . . 0.0 112.379 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.52 19.47 72.84 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.663 -0.698 . . . . 0.0 114.834 173.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.552 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 11.0 mmpt? -100.5 140.97 21.83 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 117.223 0.511 . . . . 0.0 109.76 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.546 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . 57.7 Cg_endo -69.14 -36.73 11.84 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.433 2.089 . . . . 0.0 112.401 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -174.33 153.94 2.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.117 0.967 . . . . 0.0 109.494 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.7 t -146.3 158.32 43.87 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.921 0.889 . . . . 0.0 108.764 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -147.69 115.09 6.29 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.243 0.617 . . . . 0.0 110.167 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.16 147.93 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.52 ' HB3' HG23 ' A' ' 84' ' ' THR . 0.0 OUTLIER -146.55 156.81 43.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.496 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.4 tt -145.75 137.73 25.33 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -130.11 139.92 50.86 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.754 1.221 . . . . 0.0 108.688 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.0 mt -120.79 132.34 54.97 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.064 0.945 . . . . 0.0 109.084 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 t -129.95 169.41 15.26 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.914 1.285 . . . . 0.0 108.219 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.49 130.52 55.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -173.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -144.12 111.66 6.03 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 58.42 -106.42 0.84 Allowed Glycine 0 C--N 1.346 1.116 0 O-C-N 123.538 0.524 . . . . 0.0 113.264 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -113.1 2.77 15.8 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.566 0.746 . . . . 0.0 111.185 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -127.44 -162.25 11.07 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.7 m -144.48 137.64 27.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.869 0.868 . . . . 0.0 110.523 -171.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 27' ' ' ARG . 43.3 tp -90.07 141.12 28.99 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 173.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -124.69 115.81 21.35 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -108.83 106.12 15.98 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 98' ' ' GLU . 43.7 tp -105.57 104.64 14.4 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.69 0.796 . . . . 0.0 108.933 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 44.3 tt0 -107.75 119.69 40.16 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.272 0.629 . . . . 0.0 110.301 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -119.57 124.85 47.38 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -115.91 129.94 56.62 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.531 1.133 . . . . 0.0 112.04 -170.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.6 t -151.39 158.78 44.18 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.518 0.727 . . . . 0.0 110.335 171.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.522 HG23 HD11 ' A' ' 16' ' ' ILE . 22.0 p -77.52 1.32 19.77 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.435 1.094 . . . . 0.0 112.841 176.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.6 m -109.17 127.55 54.3 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.693 0.797 . . . . 0.0 111.919 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -67.62 -47.79 68.63 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.406 1.083 . . . . 0.0 112.167 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.5 -44.8 70.37 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.125 0.17 . . . . 0.0 111.017 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.403 ' O ' HG22 ' A' ' 125' ' ' VAL . 25.8 ttt -50.77 -41.35 56.7 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.942 0.776 . . . . 0.0 112.061 173.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.501 HD22 HG23 ' A' ' 24' ' ' ILE . 48.6 mt -59.66 -44.32 93.61 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.45 0.3 . . . . 0.0 111.087 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 127' ' ' VAL . 28.3 t -63.37 -56.02 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -48.72 -49.65 37.14 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.208 1.403 . . . . 0.0 112.992 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.527 HG23 HD13 ' A' ' 24' ' ' ILE . 22.5 m -77.23 -27.56 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 122.476 0.311 . . . . 0.0 110.316 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.1 -36.39 92.26 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 123' ' ' VAL . 60.5 t -81.17 -49.65 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.07 -60.08 8.97 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 114.312 -1.313 . . . . 0.0 113.759 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -58.08 -41.75 84.12 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.444 0.698 . . . . 0.0 111.953 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.61 ' HB3' HH11 ' A' ' 170' ' ' ARG . 21.4 mt-10 -64.97 -25.88 68.06 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 119.451 1.023 . . . . 0.0 112.311 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.9 mtt -75.69 -44.39 42.45 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.961 0.504 . . . . 0.0 109.773 174.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.21 -62.44 1.83 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.201 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.62 -26.98 64.27 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.381 1.472 . . . . 0.0 113.132 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 18.0 t70 -60.0 -53.3 59.46 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 169.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -67.21 -26.06 66.42 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.36 0.664 . . . . 0.0 111.628 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.48 HD11 ' HB1' ' A' ' 40' ' ' ALA . 27.4 tp -62.91 -58.01 8.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.266 0.626 . . . . 0.0 110.234 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.28 -43.74 34.27 Favored Glycine 0 N--CA 1.475 1.289 0 N-CA-C 115.057 0.783 . . . . 0.0 115.057 170.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 96.4 mmm -65.27 -30.32 71.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.133 0.573 . . . . 0.0 111.552 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -77.3 -42.98 34.82 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.083 0.953 . . . . 0.0 111.015 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 45.1 mt -57.78 -55.88 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.805 0.842 . . . . 0.0 110.274 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.43 ' NH1' ' HG2' ' A' ' 1' ' ' MET . 48.7 ttp85 -175.53 81.94 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.68 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -148.46 17.66 1.3 Allowed Glycine 0 N--CA 1.464 0.511 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.957 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 32.0 t70 57.96 88.24 0.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.966 0.906 . . . . 0.0 109.841 -174.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.32 101.33 2.99 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 143' ' ' ASP . 75.2 Cg_endo -81.17 -25.84 3.76 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.657 2.238 . . . . 0.0 112.888 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.28 -79.3 0.15 Allowed Glycine 0 C--N 1.343 0.927 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.16 153.9 7.01 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.318 -0.712 . . . . 0.0 111.388 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.562 ' HG2' ' SD ' ' A' ' 163' ' ' MET . 91.2 Cg_endo -78.76 15.7 1.42 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.586 2.857 . . . . 0.0 113.341 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.492 ' HB ' ' HA ' ' A' ' 152' ' ' ASP . 4.4 m -106.32 123.07 40.05 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.33 1.052 . . . . 0.0 110.128 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.07 -50.23 2.26 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.902 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -109.4 -15.24 14.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.443 0.697 . . . . 0.0 110.847 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.492 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 28.8 t70 70.25 82.09 0.16 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.717 1.207 . . . . 0.0 110.498 -173.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -108.63 -41.11 4.89 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.675 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 62.81 16.77 9.35 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.793 1.237 . . . . 0.0 112.134 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -94.03 -16.49 23.82 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.338 1.055 . . . . 0.0 110.561 -175.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 70.26 23.05 5.23 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.216 1.407 . . . . 0.0 108.545 -162.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -76.16 -38.88 56.11 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -59.73 121.16 55.65 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.511 168.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.603 ' HA ' ' SD ' ' A' ' 164' ' ' MET . 77.2 Cg_endo -84.02 28.28 0.58 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.453 2.102 . . . . 0.0 112.074 172.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.9 p -73.91 112.82 18.18 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.396 1.078 . . . . 0.0 110.306 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -42.51 -56.34 2.15 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 124.766 3.644 . . . . 0.0 115.566 -171.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 166' ' ' ILE . 44.8 tt0 -63.26 -43.92 96.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 123.488 0.493 . . . . 0.0 112.186 -175.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.562 ' SD ' ' HG2' ' A' ' 148' ' ' PRO . 5.0 tpt -65.48 -41.95 92.74 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.131 0.491 . . . . 0.0 110.456 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.603 ' SD ' ' HA ' ' A' ' 159' ' ' PRO . 80.4 mtp -65.78 -35.37 80.52 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.575 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -63.28 -38.23 90.35 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.822 0.849 . . . . 0.0 110.558 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.451 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 42.7 mm -63.23 -45.44 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 175.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.6 t -63.91 -30.99 72.02 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.514 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -71.47 -59.96 2.49 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.348 0.659 . . . . 0.0 110.173 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.17 -43.63 87.57 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.924 0.89 . . . . 0.0 112.481 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.61 HH11 ' HB3' ' A' ' 130' ' ' GLU . 19.7 mmt85 -74.08 -41.37 61.8 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -56.0 -35.65 64.74 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.408 -0.814 . . . . 0.0 113.721 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -78.24 -42.92 29.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.699 0.8 . . . . 0.0 110.475 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.7 72.0 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 124.18 0.925 . . . . 0.0 110.934 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.413 ' CZ2' HG12 ' A' ' 26' ' ' ILE . 97.1 m95 -83.44 -27.37 29.57 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.904 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.35 87.75 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 171.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.76 93.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.476 0.71 . . . . 0.0 110.773 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.08 -57.62 6.47 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.546 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.96 -31.79 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 122.847 0.459 . . . . 0.0 111.915 -168.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -66.65 -29.2 69.16 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.356 0.662 . . . . 0.0 110.668 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 33.4 t -76.44 85.06 3.17 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 171.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 176.7 23.95 0.03 OUTLIER Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.626 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--O 1.254 1.334 0 C-N-CA 123.942 0.897 . . . . 0.0 109.001 -178.886 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.38 -35.99 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.958 0.903 . . . . 0.0 110.148 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m -75.15 77.66 2.3 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.142 0.577 . . . . 0.0 109.639 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.99 56.91 0.03 OUTLIER Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.156 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 29' ' ' ARG . 98.9 mt-30 59.56 58.38 2.93 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.073 1.349 . . . . 0.0 112.455 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.46 158.42 18.97 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.884 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.1 m -120.33 115.35 23.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.555 0.742 . . . . 0.0 110.451 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 32.1 mt-10 -89.55 136.95 32.73 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -111.3 142.13 43.94 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.811 0.445 . . . . 0.0 110.313 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.37 127.57 7.7 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.931 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.759 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -85.56 121.97 29.01 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.697 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.59 -154.82 12.1 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-O 121.332 0.407 . . . . 0.0 113.376 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -148.09 148.28 30.46 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.245 1.018 . . . . 0.0 109.712 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 27.8 tpt180 -168.93 120.39 0.75 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.429 0.691 . . . . 0.0 109.46 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.2 m -83.21 97.6 8.94 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.9 pt -78.3 160.44 73.05 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.369 1.068 . . . . 0.0 110.295 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.3 -21.24 22.3 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.453 2.769 . . . . 0.0 114.463 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.9 -53.14 22.77 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 170.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.7 -157.38 27.62 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.225 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.472 ' HB3' HH22 ' A' ' 22' ' ' ARG . 48.9 mt-10 -68.74 106.15 2.55 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.253 0.621 . . . . 0.0 110.651 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -114.71 153.42 30.3 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.572 0.749 . . . . 0.0 111.401 -175.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.472 HH22 ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -91.67 169.71 10.51 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 164.781 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -141.71 142.49 33.31 Favored 'General case' 0 C--O 1.217 -0.63 0 O-C-N 122.305 -0.247 . . . . 0.0 110.946 -172.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.553 HG12 HG23 ' A' ' 125' ' ' VAL . 2.7 pp -98.73 144.8 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 168.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.519 HG12 ' HG3' ' A' ' 113' ' ' GLU . 44.3 mt -131.79 106.28 11.26 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.6 mt -101.7 107.54 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 49.0 mtp180 -107.17 133.56 51.58 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.292 1.037 . . . . 0.0 108.791 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -141.25 152.97 44.98 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.768 0.427 . . . . 0.0 110.068 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.547 ' NH1' HD13 ' A' ' 109' ' ' LEU . 67.3 mmt-85 -108.48 102.33 11.43 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -79.17 124.32 28.22 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.15 44.79 0.25 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 123.916 0.76 . . . . 0.0 111.295 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.88 148.06 37.57 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 125.292 1.437 . . . . 0.0 107.143 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.45 175.62 2.64 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.8 2.334 . . . . 0.0 114.487 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -73.59 -42.71 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.921 -171.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.35 -43.6 98.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.687 0.795 . . . . 0.0 110.508 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -59.96 -63.97 1.11 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.686 175.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.47 -34.49 46.85 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 124.177 0.991 . . . . 0.0 111.936 -175.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.407 ' HE3' HD12 ' A' ' 101' ' ' LEU . 67.7 t-105 -61.31 -58.47 8.1 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.994 0.518 . . . . 0.0 110.206 178.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 80.0 p -57.91 -46.11 85.48 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.886 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.557 ' HA ' ' HD2' ' A' ' 46' ' ' ARG . . . -53.43 -40.23 65.0 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 79.9 m -78.95 -16.81 56.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 50.3 p -108.31 -26.53 10.48 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 1.2 p30 -85.54 124.24 71.66 Favored Pre-proline 0 N--CA 1.484 1.241 0 CA-C-N 118.533 0.606 . . . . 0.0 110.325 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 50.9 Cg_exo -55.71 -27.34 60.83 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.971 3.114 . . . . 0.0 114.278 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -63.48 -53.51 50.97 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.322 1.014 . . . . 0.0 110.665 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.557 ' HD2' ' HA ' ' A' ' 40' ' ' ALA . 65.8 mtt85 -71.32 -32.27 68.38 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.117 175.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.473 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 82.7 mt -65.04 -39.43 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 118.129 0.422 . . . . 0.0 111.837 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.5 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 13.8 p30 -67.07 -11.68 57.82 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 15.4 mmt180 -72.14 -41.39 67.21 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.475 0.71 . . . . 0.0 111.161 170.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.505 ' HB2' ' O ' ' A' ' 132' ' ' ALA . 70.5 p-90 -115.77 9.35 15.1 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -170.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -173.42 180.0 2.01 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -170.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.1 mt -84.88 133.59 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 34.0 tt0 -67.34 127.23 93.41 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.724 1.21 . . . . 0.0 111.001 -171.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 89.9 Cg_endo -79.88 102.14 1.43 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.797 2.332 . . . . 0.0 111.045 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.43 160.49 24.02 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.634 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.19 -171.76 15.09 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.96 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.52 -47.91 66.36 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.001 1.72 . . . . 0.0 112.277 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.9 mt 69.23 0.66 2.93 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.293 1.437 . . . . 0.0 113.474 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -103.01 154.83 18.84 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.703 0.801 . . . . 0.0 110.028 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -63.96 107.09 1.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.615 0.766 . . . . 0.0 111.233 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.2 -24.48 6.96 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.0 -161.74 37.72 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -141.13 157.32 45.44 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.95 1.375 . . . . 0.0 111.212 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 25.8 p90 -101.32 171.72 7.42 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.59 163.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -165.83 135.39 3.35 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.596 1.159 . . . . 0.0 109.024 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.9 mt -93.05 174.63 7.13 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.597 0.759 . . . . 0.0 109.817 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -106.18 134.37 49.43 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 171.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 53.84 36.34 55.14 Favored Glycine 0 CA--C 1.532 1.1 0 O-C-N 124.927 1.392 . . . . 0.0 114.873 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -149.95 -95.66 0.07 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.04 -179.16 5.93 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.195 0.598 . . . . 0.0 110.841 -171.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.1 p -152.05 146.2 25.36 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.61 146.73 15.81 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 118.823 0.738 . . . . 0.0 112.346 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -80.94 148.81 29.66 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.501 0.721 . . . . 0.0 110.278 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mm -83.26 95.05 3.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 86' ' ' SER . 67.2 mt -70.77 -50.0 40.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.38 0.672 . . . . 0.0 110.41 -173.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -155.76 130.31 9.02 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.37 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 88.7 m -116.25 136.05 53.35 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 167.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -133.34 88.15 36.06 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 95.0 Cg_endo -76.75 136.63 17.14 Favored 'Trans proline' 0 CA--C 1.559 1.768 0 C-N-CA 122.775 2.317 . . . . 0.0 112.425 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 40.8 Cg_endo -102.81 27.76 11.52 Favored 'Cis proline' 0 C--N 1.381 2.26 0 CA-C-N 119.468 0.846 . . . . 0.0 113.256 -5.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.43 ' NH1' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -77.14 -74.63 0.24 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.349 0.66 . . . . 0.0 110.179 -174.03 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -147.9 160.75 42.46 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.25 0.62 . . . . 0.0 110.772 -171.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -141.95 127.91 19.5 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.494 0.718 . . . . 0.0 109.215 171.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.7 m -104.5 112.26 25.25 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.514 HG13 ' HB ' ' A' ' 97' ' ' VAL . 15.3 pt -110.05 170.56 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.465 1.106 . . . . 0.0 109.544 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.495 ' HB3' HD11 ' A' ' 75' ' ' LEU . 23.3 p -105.37 170.9 7.62 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 69.3 t-105 -146.04 92.85 2.25 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -175.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.65 101.92 13.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -117.71 127.37 53.85 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.14 126.99 30.38 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.909 0.883 . . . . 0.0 110.855 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.38 -54.18 0.81 Allowed Glycine 0 C--N 1.349 1.287 0 O-C-N 123.496 0.497 . . . . 0.0 112.512 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.577 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 0.0 OUTLIER -99.27 148.56 34.81 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 123.993 0.917 . . . . 0.0 110.0 -173.455 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -50.53 140.88 34.99 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 123.882 3.055 . . . . 0.0 114.21 -173.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.43 117.96 5.45 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.55 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 8.2 m -100.41 173.81 6.4 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.141 0.977 . . . . 0.0 110.636 -173.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -128.07 117.38 21.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.514 ' HB ' HG13 ' A' ' 85' ' ' ILE . 40.7 t -98.34 135.51 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.74 114.71 10.1 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.412 HD12 HD12 ' A' ' 112' ' ' LEU . 6.4 tt -111.43 126.51 55.02 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.43 ' HG2' ' NH1' ' A' ' 81' ' ' ARG . 23.8 ttm180 -132.42 105.32 7.2 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.899 0.88 . . . . 0.0 110.09 -165.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 110' ' ' LEU . 88.5 mt -97.1 139.25 33.38 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 110.985 176.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.7 t -138.68 174.16 10.83 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.695 1.198 . . . . 0.0 108.353 172.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -104.74 132.89 50.44 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.433 ' HG2' ' HE ' ' A' ' 29' ' ' ARG . 13.3 tp10 -147.69 99.64 3.13 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -169.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 58.47 -105.72 0.7 Allowed Glycine 0 C--N 1.35 1.314 0 C-N-CA 123.317 0.484 . . . . 0.0 113.966 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -100.93 -15.14 17.63 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.189 0.996 . . . . 0.0 110.43 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.62 -161.01 12.24 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.719 -169.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.2 m -142.79 134.2 26.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.248 1.019 . . . . 0.0 109.71 -173.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.547 HD13 ' NH1' ' A' ' 29' ' ' ARG . 33.6 tp -89.3 122.86 32.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 101' ' ' LEU . 9.0 tt -111.61 108.82 18.43 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.561 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 28.1 mt-10 -109.62 104.85 13.94 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.471 HD13 HD21 ' A' ' 133' ' ' LEU . 8.0 tt -102.0 101.05 11.39 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 171.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.519 ' HG3' HG12 ' A' ' 25' ' ' ILE . 32.7 tt0 -97.23 117.61 31.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.322 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.436 ' ND1' HG22 ' A' ' 97' ' ' VAL . 5.2 t60 -116.74 118.62 33.03 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.4 132.32 54.53 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.371 0.668 . . . . 0.0 111.328 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.711 HG21 ' HG3' ' A' ' 121' ' ' MET . 7.6 t -154.73 161.15 41.64 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.055 0.942 . . . . 0.0 110.27 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.7 p -88.53 -0.2 56.98 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.881 -166.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.0 m -120.19 129.61 54.18 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.589 0.756 . . . . 0.0 110.963 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -61.46 -41.23 96.9 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.095 0.958 . . . . 0.0 112.187 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -63.68 -56.67 13.94 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.174 0.589 . . . . 0.0 111.229 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.711 ' HG3' HG21 ' A' ' 116' ' ' THR . 14.9 tpt -49.79 -34.25 18.93 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 123.939 0.775 . . . . 0.0 112.369 174.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.529 ' HG ' HG23 ' A' ' 116' ' ' THR . 17.5 mt -67.01 -47.27 71.99 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.678 0.791 . . . . 0.0 112.06 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 127' ' ' VAL . 59.8 t -60.86 -50.39 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -50.21 -46.18 54.38 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.28 1.432 . . . . 0.0 113.222 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.553 HG23 HG12 ' A' ' 24' ' ' ILE . 35.9 m -81.26 -26.41 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.693 0.397 . . . . 0.0 110.913 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.71 -38.33 96.28 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 171.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 170' ' ' ARG . 62.0 t -78.42 -50.71 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.679 0.792 . . . . 0.0 109.499 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.48 -62.32 6.32 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.9 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -63.27 -40.12 96.49 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 118.417 -0.801 . . . . 0.0 112.313 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.1 -40.73 96.86 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.868 1.213 . . . . 0.0 110.864 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 47.3 ttm -68.91 -36.92 78.58 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.744 0.818 . . . . 0.0 110.078 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 50' ' ' TRP . . . -65.07 -65.02 0.73 Allowed 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.864 0.727 . . . . 0.0 110.449 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.471 HD21 HD13 ' A' ' 112' ' ' LEU . 4.0 mm? -55.19 -30.24 59.53 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.05 0.94 . . . . 0.0 112.53 174.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.31 -45.2 84.44 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.216 0.462 . . . . 0.0 110.973 171.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -65.2 -31.52 72.73 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.519 0.512 . . . . 0.0 111.224 175.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.27 -48.09 79.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 172.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -45.59 -52.7 8.92 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.715 0.634 . . . . 0.0 113.982 166.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.52 -34.42 77.75 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.96 0.904 . . . . 0.0 111.603 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -69.66 -52.02 29.51 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.355 0.662 . . . . 0.0 110.209 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.4 mt -64.97 -29.39 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 124.186 0.994 . . . . 0.0 110.757 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.3 OUTLIER -65.93 -29.18 69.55 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.266 1.026 . . . . 0.0 109.6 175.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.32 1.21 62.65 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.847 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.38 -45.75 75.33 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.147 0.979 . . . . 0.0 111.023 -176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.1 mt -72.6 111.07 9.72 Favored Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 122.976 0.51 . . . . 0.0 109.875 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -97.69 -173.58 0.18 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 123.556 2.838 . . . . 0.0 112.901 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.67 77.98 2.05 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.87 168.59 33.43 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.219 -0.767 . . . . 0.0 111.924 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.73 157.7 46.12 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 123.641 2.894 . . . . 0.0 113.522 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 152' ' ' ASP . 28.9 m -75.09 121.04 84.4 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.554 175.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.09 -47.06 13.38 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.975 2.45 . . . . 0.0 113.724 -168.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.08 -17.59 61.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.636 0.774 . . . . 0.0 110.96 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.495 ' HA ' HG23 ' A' ' 149' ' ' VAL . 33.3 t70 60.2 40.52 17.97 Favored 'General case' 0 C--N 1.367 1.345 0 C-N-CA 124.978 1.311 . . . . 0.0 110.439 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.47 ' HB3' ' HG2' ' A' ' 158' ' ' GLU . . . -164.89 96.85 0.73 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.594 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.86 -17.34 62.73 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.543 165.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -67.85 -28.71 67.78 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.075 1.35 . . . . 0.0 111.93 173.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 157' ' ' PHE . 3.7 tt0 70.75 -158.71 0.14 Allowed 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -166.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.431 ' H ' ' HG2' ' A' ' 156' ' ' GLU . 68.1 t80 65.91 54.74 1.0 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.376 1.084 . . . . 0.0 109.654 176.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 153' ' ' ALA . 0.0 OUTLIER -147.84 154.92 44.36 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.601 -174.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.54 87.04 1.3 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.199 1.933 . . . . 0.0 113.165 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 63.2 m -139.85 118.47 8.7 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 168.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -47.07 -43.26 25.32 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 124.165 3.243 . . . . 0.0 113.748 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 166' ' ' ILE . 7.8 mp0 -64.2 -54.46 33.2 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.396 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.5 mmt -70.73 -31.47 68.32 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 122.992 0.517 . . . . 0.0 112.051 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 75.5 mtm -70.45 -36.5 73.98 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.654 173.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.442 ' HA ' ' HG2' ' A' ' 168' ' ' GLN . 31.5 ttt180 -68.97 -43.66 74.51 Favored 'General case' 0 C--O 1.205 -1.266 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.63 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 162' ' ' GLU . 50.6 mm -59.65 -43.22 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 122.868 0.467 . . . . 0.0 110.06 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.1 t -51.53 -47.3 63.41 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.421 1.088 . . . . 0.0 112.411 172.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.442 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 10.4 pt20 -88.9 -25.28 22.2 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -63.42 -57.34 10.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.566 1.147 . . . . 0.0 110.079 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.546 ' HB3' HG22 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -60.16 -43.82 95.49 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.684 0.615 . . . . 0.0 109.828 173.468 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -54.71 -44.15 79.99 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 124.028 0.83 . . . . 0.0 113.195 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.26 -59.39 4.12 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.762 1.225 . . . . 0.0 109.866 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.449 ' O ' ' HG ' ' A' ' 177' ' ' LEU . . . -51.44 -57.05 10.04 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 124.997 1.435 . . . . 0.0 111.834 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -70.29 -25.86 63.53 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.725 0.81 . . . . 0.0 113.101 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.1 -36.62 64.26 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 118.177 0.444 . . . . 0.0 110.452 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.97 -35.09 74.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.908 0.483 . . . . 0.0 109.943 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.759 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 67.8 mt -69.47 -53.22 20.29 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.943 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.51 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 9.8 p -70.28 -29.3 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 48.4 m170 -80.22 2.41 24.51 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.874 0.47 . . . . 0.0 111.304 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 37.6 t -117.76 121.7 41.51 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.184 0.994 . . . . 0.0 108.354 171.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -114.52 70.62 0.24 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 112.195 -0.362 . . . . 0.0 112.195 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 CA--C 1.556 1.198 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.811 178.085 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.36 -31.76 54.57 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.275 0.63 . . . . 0.0 110.845 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.9 m 73.42 -73.2 0.1 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.038 1.335 . . . . 0.0 112.933 175.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.74 79.13 1.35 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -168.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -64.01 93.95 0.09 Allowed 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.405 0.621 . . . . 0.0 110.879 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -78.11 73.34 4.67 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.294 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.2 m -97.1 120.65 37.86 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.739 0.815 . . . . 0.0 110.048 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -114.35 116.24 28.63 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.437 1.095 . . . . 0.0 109.024 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -76.22 139.36 41.14 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 170.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -152.63 170.61 19.8 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.06 0.457 . . . . 0.0 111.444 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -143.88 162.04 37.13 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -176.022 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.467 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -173.28 -160.71 22.28 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -137.65 151.68 48.54 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.072 0.949 . . . . 0.0 108.495 178.021 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -156.95 133.21 9.78 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.566 0.746 . . . . 0.0 109.298 -170.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 m -83.16 137.78 33.92 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.472 HD11 HG23 ' A' ' 117' ' ' THR . 47.7 pt -137.65 160.88 63.29 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.507 0.723 . . . . 0.0 109.1 -174.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -45.07 -31.29 5.52 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.984 3.123 . . . . 0.0 115.324 174.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 -41.75 65.61 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.042 0.537 . . . . 0.0 111.265 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.93 -150.09 21.67 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.913 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.8 115.82 9.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.587 0.755 . . . . 0.0 109.817 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.78 164.75 18.54 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.677 0.791 . . . . 0.0 110.907 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -112.61 161.95 16.23 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.4 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 p -138.81 128.99 25.5 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.47 0.308 . . . . 0.0 110.655 -168.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 45.5 pt -87.32 135.69 24.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 169.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 3.5 mp -112.99 110.75 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 171.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.9 mt -101.67 109.57 26.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HG3' HD11 ' A' ' 109' ' ' LEU . 59.7 ttm-85 -113.76 148.46 36.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.736 0.814 . . . . 0.0 110.385 -172.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.561 HE21 HD22 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -165.91 138.22 4.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 124.215 0.947 . . . . 0.0 112.496 -176.705 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.494 ' NH1' HD13 ' A' ' 109' ' ' LEU . 46.0 mmt-85 -96.69 115.39 27.35 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.273 1.029 . . . . 0.0 108.84 167.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -93.67 147.93 22.57 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.765 0.826 . . . . 0.0 109.998 170.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.17 28.03 0.86 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.371 0.668 . . . . 0.0 111.352 172.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.46 151.78 44.74 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 124.451 1.1 . . . . 0.0 109.768 176.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' O ' HG23 ' A' ' 37' ' ' VAL . 61.2 Cg_endo -71.32 152.02 60.69 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.014 1.809 . . . . 0.0 111.026 172.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 80' ' ' PRO . 77.9 t -46.63 -49.85 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 124.444 1.098 . . . . 0.0 111.094 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -49.21 -47.2 46.36 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 125.371 1.669 . . . . 0.0 111.55 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.81 -34.84 72.15 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.305 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 33' ' ' PRO . 24.2 t -75.05 -32.41 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -71.48 -31.24 66.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.428 1.091 . . . . 0.0 110.179 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.8 m -75.09 -37.44 61.55 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -65.03 -44.64 88.47 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.266 0.626 . . . . 0.0 110.744 171.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.9 t -68.13 -24.86 65.05 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -176.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.9 p -113.85 -38.59 4.2 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -172.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.94 122.86 88.57 Favored Pre-proline 0 N--CA 1.484 1.274 0 CA-C-O 119.106 -0.473 . . . . 0.0 110.269 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -49.97 -51.68 10.41 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.868 3.045 . . . . 0.0 114.596 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -52.39 -33.54 43.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.844 1.258 . . . . 0.0 111.841 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.524 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 5.4 mmp_? -81.33 -38.45 26.71 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.862 0.465 . . . . 0.0 111.662 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.3 mt -73.39 -29.51 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -57.68 -24.64 57.79 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.033 1.733 . . . . 0.0 112.084 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -87.89 -60.21 2.03 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.382 0.673 . . . . 0.0 110.208 -173.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.416 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 69.5 p-90 -82.29 -15.04 54.39 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.416 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 14.8 t80 -140.27 -108.41 0.15 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.414 HD13 ' HB2' ' A' ' 69' ' ' ASN . 89.2 mt -143.01 144.25 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.627 0.771 . . . . 0.0 109.52 -169.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -59.44 109.52 2.0 Allowed Pre-proline 0 CA--C 1.57 1.715 0 O-C-N 125.31 1.631 . . . . 0.0 111.654 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HB3' HD23 ' A' ' 66' ' ' LEU . 63.5 Cg_endo -100.06 156.83 0.52 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.208 2.605 . . . . 0.0 113.82 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -144.73 159.0 43.56 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.6 1.16 . . . . 0.0 108.441 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.74 -148.2 19.84 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.62 -53.69 7.28 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.376 0.67 . . . . 0.0 109.423 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt 59.88 19.7 8.65 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.617 1.167 . . . . 0.0 110.962 -170.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -114.55 149.65 36.17 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.678 1.191 . . . . 0.0 109.153 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 42.3 tt0 -59.7 122.27 13.73 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.476 0.71 . . . . 0.0 110.88 -177.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.67 14.77 64.8 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.908 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -115.8 -147.54 9.03 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -151.26 172.64 15.55 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.491 0.662 . . . . 0.0 111.605 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.63 164.94 26.08 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.897 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.37 122.13 9.28 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.037 0.935 . . . . 0.0 109.873 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 54' ' ' PRO . 25.9 mt -89.8 142.11 28.0 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.624 1.17 . . . . 0.0 108.927 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -85.06 101.18 12.21 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.52 32.35 8.77 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.423 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.512 HD21 ' HE1' ' A' ' 89' ' ' TYR . 1.9 t-20 -150.67 -88.09 0.07 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 117.32 0.56 . . . . 0.0 111.689 177.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.77 159.42 40.63 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 121.304 0.573 . . . . 0.0 112.207 -167.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.0 m -125.62 148.53 48.94 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.476 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.88 159.48 30.33 Favored Glycine 0 C--N 1.338 0.673 0 O-C-N 123.196 0.31 . . . . 0.0 112.381 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.43 164.34 14.32 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.638 0.775 . . . . 0.0 110.586 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 mm -106.72 103.75 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 72.2 mt -80.03 -43.08 22.54 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.79 0.436 . . . . 0.0 111.053 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -166.49 146.74 6.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.131 0.572 . . . . 0.0 109.521 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 12.8 p -160.37 110.77 1.82 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.749 0.42 . . . . 0.0 111.155 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.79 112.4 60.3 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 169.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 70.9 Cg_endo -75.52 132.39 14.7 Favored 'Trans proline' 0 CA--C 1.558 1.707 0 C-N-CA 122.153 1.902 . . . . 0.0 111.897 169.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 43.8 Cg_endo -98.97 21.71 23.32 Favored 'Cis proline' 0 C--N 1.375 1.949 0 CA-C-N 119.659 0.914 . . . . 0.0 112.967 -4.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -66.79 -68.41 0.38 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.151 0.98 . . . . 0.0 112.982 -171.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.466 ' HB3' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -154.58 148.96 26.14 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.627 0.648 . . . . 0.0 112.491 -174.358 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.5 tp -108.14 145.45 34.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.342 1.457 . . . . 0.0 108.572 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.7 m -137.49 125.85 23.32 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.2 pt -144.01 147.37 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.502 1.121 . . . . 0.0 110.211 -170.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.3 m -88.33 154.28 20.52 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 43.7 t-105 -134.98 106.74 6.96 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -174.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.02 107.43 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.512 ' HE1' HD21 ' A' ' 69' ' ' ASN . 82.3 t80 -94.34 162.98 13.61 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -48.76 111.24 0.44 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.237 1.415 . . . . 0.0 112.648 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.65 25.4 75.77 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 124.023 0.827 . . . . 0.0 113.88 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -116.03 159.73 38.19 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.796 0.838 . . . . 0.0 110.334 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.33 167.25 26.81 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.323 2.015 . . . . 0.0 110.98 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -69.25 108.88 3.84 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.5 m -83.92 167.02 17.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.381 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.03 119.98 18.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 40.6 t -130.13 145.15 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.591 1.157 . . . . 0.0 109.605 -165.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -135.57 145.25 46.77 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.97 -0.456 . . . . 0.0 109.887 171.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.406 ' HG ' HD21 ' A' ' 110' ' ' LEU . 9.2 tt -123.38 115.64 21.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.466 ' HA ' ' HB3' ' A' ' 82' ' ' ARG . 41.6 ttp180 -121.93 117.47 26.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.98 0.512 . . . . 0.0 110.462 -171.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.4 mt -95.55 132.17 40.96 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.321 1.048 . . . . 0.0 109.525 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.8 m -137.23 125.66 23.46 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.653 1.181 . . . . 0.0 107.985 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.97 152.12 28.61 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.362 1.065 . . . . 0.0 110.45 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -167.19 85.95 0.26 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.403 0.681 . . . . 0.0 110.617 -162.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.31 -137.3 23.56 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -87.68 51.99 2.36 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 166.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.91 -165.24 31.5 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 114.547 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 90.9 m -148.01 132.92 18.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.203 0.601 . . . . 0.0 110.968 -171.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.494 HD13 ' NH1' ' A' ' 29' ' ' ARG . 32.6 tp -83.29 120.24 25.59 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.674 0.79 . . . . 0.0 109.486 167.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.561 HD22 HE21 ' A' ' 28' ' ' GLN . 7.3 tt -102.87 132.59 48.97 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 170.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -128.5 105.63 8.43 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.431 HD22 HD21 ' A' ' 133' ' ' LEU . 41.9 tp -101.47 133.01 46.76 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 33.1 tt0 -131.43 105.47 7.62 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.695 0.798 . . . . 0.0 108.943 175.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -96.26 115.55 27.62 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.54 107.37 15.42 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.575 0.75 . . . . 0.0 110.237 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.0 t -130.92 156.94 44.22 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.086 0.554 . . . . 0.0 109.684 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.472 HG23 HD11 ' A' ' 16' ' ' ILE . 68.7 p -74.35 -31.4 62.4 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.864 0.866 . . . . 0.0 110.535 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 m -79.38 111.41 15.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.999 0.92 . . . . 0.0 111.337 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 122' ' ' LEU . 45.3 tt0 -60.42 -30.93 69.93 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.907 0.883 . . . . 0.0 111.86 176.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -66.96 -49.41 65.53 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.61 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.5 ttt -59.8 -37.29 78.71 Favored 'General case' 0 C--O 1.203 -1.383 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.897 176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 119' ' ' GLU . 25.7 mt -61.54 -38.56 87.87 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 123.43 0.692 . . . . 0.0 112.404 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.6 t -65.85 -49.04 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.427 0.632 . . . . 0.0 109.826 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -62.55 -40.32 96.46 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.934 1.294 . . . . 0.0 111.832 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 m -83.62 -22.63 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.549 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.09 -34.84 85.56 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 168.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.98 -52.16 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.05 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.8 -38.13 95.7 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.339 -172.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -80.77 -39.43 26.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.923 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -61.48 -37.04 82.18 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 119.357 0.98 . . . . 0.0 109.636 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 93.1 mtp -69.4 -35.62 75.96 Favored 'General case' 0 C--O 1.218 -0.584 0 O-C-N 123.758 0.661 . . . . 0.0 110.723 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.84 86.35 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.706 0.402 . . . . 0.0 110.701 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.431 HD21 HD22 ' A' ' 112' ' ' LEU . 3.7 mm? -79.29 -20.38 48.16 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.278 0.631 . . . . 0.0 111.498 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -71.46 -42.92 67.54 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -81.54 -22.82 37.63 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.867 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 32.4 tp -71.26 -31.68 67.8 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -56.76 -52.96 47.49 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.978 164.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 94.4 mmm -63.61 -33.84 76.5 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.922 0.889 . . . . 0.0 112.334 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.422 ' HZ ' ' HD3' ' A' ' 46' ' ' ARG . 43.8 t80 -75.08 -51.42 13.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.766 0.826 . . . . 0.0 110.599 -174.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.0 mt -65.35 -28.97 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.009 0.924 . . . . 0.0 110.769 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER -63.04 -26.23 68.75 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.597 0.759 . . . . 0.0 109.593 174.438 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.4 2.74 41.07 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.162 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -93.44 -87.23 0.24 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.133 0.573 . . . . 0.0 110.424 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 45.45 76.1 0.58 Allowed Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 124.445 1.098 . . . . 0.0 110.531 -163.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.43 -0.67 10.81 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.271 2.648 . . . . 0.0 112.187 172.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.34 -114.6 4.77 Favored Glycine 0 C--O 1.24 0.474 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -110.48 94.39 0.79 Allowed Glycine 0 C--N 1.338 0.641 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.01 114.99 4.13 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.27 1.98 . . . . 0.0 110.879 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.1 m -64.12 111.55 5.67 Favored Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 123.141 0.576 . . . . 0.0 110.439 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.421 ' HG2' ' HG3' ' A' ' 151' ' ' GLU . 72.0 Cg_endo -71.6 -29.58 15.97 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.679 2.253 . . . . 0.0 112.821 -174.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.588 ' HG2' ' HB2' ' A' ' 162' ' ' GLU . 0.0 OUTLIER -110.24 -34.16 6.44 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.168 0.987 . . . . 0.0 111.019 -174.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.6 t70 55.44 88.21 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.152 1.381 . . . . 0.0 111.07 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -141.2 97.51 3.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.701 0.8 . . . . 0.0 109.444 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.06 140.39 41.87 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.96 101.64 1.43 Allowed 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.407 0.623 . . . . 0.0 111.676 -172.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -94.53 -38.85 10.69 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.285 172.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -141.54 -60.59 0.48 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -89.57 130.62 42.71 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.934 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.71 -83.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.61 2.873 . . . . 0.0 113.436 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.4 m -154.14 85.94 3.8 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -174.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.86 -50.14 13.41 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.149 2.566 . . . . 0.0 112.768 -169.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.588 ' HB2' ' HG2' ' A' ' 151' ' ' GLU . 13.0 mp0 -72.01 -37.6 69.78 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.4 -175.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 15.0 tpt -72.58 -39.6 67.27 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 118.175 0.443 . . . . 0.0 111.058 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 59.0 mtm -60.91 -36.5 79.44 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 173.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -68.22 -47.19 68.52 Favored 'General case' 0 C--O 1.206 -1.203 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.862 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.401 ' O ' ' HG3' ' A' ' 170' ' ' ARG . 72.9 mt -59.72 -35.35 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 124.468 1.107 . . . . 0.0 111.776 -178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.3 p -75.84 -53.35 8.59 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -176.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -59.99 -45.62 92.14 Favored 'General case' 0 C--O 1.205 -1.26 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.819 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -42.37 -49.96 5.12 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 124.61 1.164 . . . . 0.0 113.194 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 166' ' ' ILE . 54.3 mtt180 -63.86 -40.05 95.66 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 120.767 0.318 . . . . 0.0 111.084 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.39 -33.15 44.81 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.137 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 12.8 pt-20 -82.91 -18.32 40.56 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.829 0.851 . . . . 0.0 109.896 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.99 -51.45 58.31 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.676 0.79 . . . . 0.0 109.2 172.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -72.73 -34.2 66.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.7 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.504 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -65.25 -28.68 69.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.621 0.369 . . . . 0.0 110.926 174.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -76.62 -43.24 39.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.7 mt -63.63 -41.17 98.28 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.279 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.2 p -90.66 -26.43 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 118.426 0.557 . . . . 0.0 109.632 -166.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -75.35 -17.88 60.12 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.895 0.478 . . . . 0.0 110.795 173.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.8 m -83.76 -62.24 1.62 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.024 0.53 . . . . 0.0 109.912 172.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 63.5 36.66 93.67 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.095 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.249 1.049 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -175.783 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.97 95.43 6.78 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.1 p 66.78 -68.57 0.14 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 126.379 1.872 . . . . 0.0 112.887 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.48 9.71 71.91 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 -170.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -130.76 23.2 5.01 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.352 0.661 . . . . 0.0 110.22 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.67 88.61 7.37 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.136 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.9 m -104.75 104.12 13.86 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.444 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -80.06 135.9 36.45 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.136 0.494 . . . . 0.0 109.989 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -109.21 140.21 43.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.941 1.296 . . . . 0.0 109.227 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.65 -173.22 2.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.287 0.635 . . . . 0.0 111.272 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.622 HD13 HH11 ' A' ' 22' ' ' ARG . 81.3 mt -139.16 163.7 31.76 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.548 1.139 . . . . 0.0 109.502 175.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.68 -163.04 11.34 Favored Glycine 0 C--O 1.241 0.575 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.69 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.53 124.07 9.06 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 7.2 tpt180 -133.29 116.24 15.91 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -175.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.4 m -84.42 120.0 25.77 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 pt -110.88 163.57 16.96 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 124.9 1.28 . . . . 0.0 109.329 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -55.24 -24.19 40.71 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.392 2.728 . . . . 0.0 114.741 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.34 -22.2 61.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.24 0.616 . . . . 0.0 112.189 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.49 170.95 14.71 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -169.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -67.43 116.67 8.44 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 173.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -104.63 152.02 22.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.94 0.496 . . . . 0.0 110.151 -177.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.622 HH11 HD13 ' A' ' 11' ' ' LEU . 22.4 ttm-85 -97.8 154.41 17.64 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.6 p -123.71 143.27 50.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.737 0.415 . . . . 0.0 110.841 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.467 HG23 HD22 ' A' ' 122' ' ' LEU . 2.7 pp -90.92 135.66 26.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 166.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.595 HG13 ' HG2' ' A' ' 113' ' ' GLU . 1.7 mp -114.39 115.8 50.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -174.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.0 mt -114.69 106.46 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 170.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HB3' HD11 ' A' ' 109' ' ' LEU . 52.3 mtp180 -105.21 136.45 44.69 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -144.61 136.47 25.88 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -92.81 103.06 15.45 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -86.39 122.57 30.54 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.191 0.996 . . . . 0.0 110.557 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.39 43.14 0.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.475 171.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.24 143.86 20.13 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' A' ' 36' ' ' GLU . 21.3 Cg_endo -62.58 165.27 16.05 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.1 2.534 . . . . 0.0 114.633 -176.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.49 -45.09 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.405 -174.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.3 -35.51 79.26 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.438 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.603 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 8.5 tp10 -65.12 -62.76 1.36 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.957 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 33' ' ' PRO . 11.3 t -53.37 -35.0 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.042 0.937 . . . . 0.0 111.078 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -62.5 -58.31 8.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.312 0.645 . . . . 0.0 110.664 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.6 p -59.18 -39.37 82.31 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.524 -177.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.4 74.1 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.799 171.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -80.33 -9.56 59.74 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.8 p -104.3 -32.3 9.14 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.824 0.45 . . . . 0.0 111.596 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.472 ' O ' HG13 ' A' ' 47' ' ' ILE . 10.2 t70 -79.96 116.28 60.11 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 123.882 0.873 . . . . 0.0 110.298 -174.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -61.91 -33.25 84.55 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.142 2.561 . . . . 0.0 113.195 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.413 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 13.9 m120 -70.42 -17.51 63.01 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.25 0.62 . . . . 0.0 110.89 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -101.59 -25.59 13.83 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.603 0.761 . . . . 0.0 110.853 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.506 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 76.4 mt -76.96 -40.22 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 122.908 0.483 . . . . 0.0 111.417 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.413 ' ND2' ' HA ' ' A' ' 45' ' ' ASN . 13.9 p30 -59.66 -21.83 61.06 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -60.12 -56.54 20.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.362 0.665 . . . . 0.0 110.91 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.506 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 36.3 p-90 -91.44 -54.74 3.78 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -172.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.449 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 10.7 t80 -108.46 -166.18 1.1 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.11 0.564 . . . . 0.0 109.638 176.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.8 mt -86.12 124.77 40.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 164.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.22 136.23 96.44 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 123.208 0.603 . . . . 0.0 110.695 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.625 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 54.3 Cg_endo -68.67 131.12 22.08 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.227 1.951 . . . . 0.0 111.76 171.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -89.87 155.71 18.96 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.425 0.69 . . . . 0.0 109.294 172.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.0 -163.01 17.87 Favored Glycine 0 N--CA 1.466 0.681 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.057 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.26 -39.34 92.55 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.943 1.297 . . . . 0.0 111.202 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.0 mt 62.75 12.8 5.92 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.008 1.323 . . . . 0.0 114.342 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.0 mmm-85 -108.1 161.51 14.9 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.598 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 39.0 tt0 -67.18 109.38 3.04 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.594 0.757 . . . . 0.0 110.436 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.55 -23.33 11.18 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -175.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.93 -170.63 45.4 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 166.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -132.31 163.1 29.4 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.037 0.918 . . . . 0.0 110.946 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.625 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 20.2 p90 -119.82 165.28 14.79 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.114 175.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.687 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -166.83 102.65 0.56 Allowed 'General case' 0 C--N 1.348 0.524 0 C-N-CA 125.226 1.41 . . . . 0.0 107.824 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.435 HD11 ' CH2' ' A' ' 87' ' ' TRP . 70.7 mt -56.56 -65.74 0.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.397 0.679 . . . . 0.0 111.704 -171.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 132.49 -61.58 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 128.025 2.53 . . . . 0.0 109.177 171.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.86 31.52 8.09 Favored Glycine 0 N--CA 1.473 1.113 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.16 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -158.27 -80.86 0.06 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.83 -167.39 2.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.224 0.61 . . . . 0.0 111.019 -171.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 33.0 t -148.61 -166.11 2.46 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.1 -156.99 27.06 Favored Glycine 0 C--N 1.347 1.163 0 C-N-CA 121.554 -0.355 . . . . 0.0 113.609 171.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -141.45 146.53 36.61 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.917 0.887 . . . . 0.0 109.403 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.468 ' HA ' HG22 ' A' ' 85' ' ' ILE . 10.6 mt -96.61 106.5 18.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-O 121.497 0.665 . . . . 0.0 109.948 -177.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.63 -59.53 2.65 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.929 -171.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -146.3 155.03 42.36 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.268 1.027 . . . . 0.0 110.503 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 21.6 p -155.56 117.11 3.99 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 176.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -108.89 94.49 14.7 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.282 1.433 . . . . 0.0 107.458 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 98.0 Cg_endo -76.28 134.26 15.56 Favored 'Trans proline' 0 CA--C 1.566 2.098 0 C-N-CA 122.709 2.273 . . . . 0.0 113.06 -175.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 24.1 Cg_endo -99.07 24.86 19.44 Favored 'Cis proline' 0 C--N 1.385 2.487 0 CA-C-N 119.808 0.967 . . . . 0.0 112.285 -8.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -67.4 0.49 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.494 1.118 . . . . 0.0 111.084 -170.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -142.61 159.72 41.69 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.232 0.613 . . . . 0.0 110.604 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 tt -136.07 110.81 8.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.6 m -114.42 110.91 20.59 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.185 0.994 . . . . 0.0 109.077 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.468 HG22 ' HA ' ' A' ' 74' ' ' ILE . 23.3 pt -125.55 160.4 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.731 1.212 . . . . 0.0 109.792 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.7 p -83.84 -175.24 5.71 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.906 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.435 ' CH2' HD11 ' A' ' 66' ' ' LEU . 18.9 t-105 -170.18 100.59 0.28 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 120.673 0.273 . . . . 0.0 111.215 -169.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.3 t -92.01 103.5 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.648 0.779 . . . . 0.0 109.09 176.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.582 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -102.57 143.82 31.77 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.108 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -57.5 121.41 10.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.391 1.077 . . . . 0.0 111.778 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.54 -1.04 79.1 Favored Glycine 0 C--N 1.346 1.099 0 O-C-N 123.23 0.331 . . . . 0.0 113.762 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 47.0 mmtm -120.82 163.96 26.22 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.179 0.992 . . . . 0.0 109.598 -175.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.11 -178.26 4.07 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.635 2.224 . . . . 0.0 112.44 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.27 96.97 7.44 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.401 ' OG ' ' HB3' ' A' ' 87' ' ' TRP . 78.4 p -80.58 168.03 19.38 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.895 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.24 119.14 29.3 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.641 0.777 . . . . 0.0 109.637 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.75 142.86 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.28 1.032 . . . . 0.0 109.327 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -139.8 115.84 10.36 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tt -99.36 124.0 44.11 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.656 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 32.3 ttt180 -126.25 105.22 8.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.412 0.685 . . . . 0.0 109.896 -173.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 91.0 mt -88.78 134.27 33.98 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.256 0.623 . . . . 0.0 109.822 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.6 m -125.71 171.89 10.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.706 1.202 . . . . 0.0 109.158 172.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.88 123.46 49.83 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -177.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -141.84 109.34 5.63 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -171.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 53.91 -103.86 0.19 Allowed Glycine 0 CA--C 1.531 1.089 0 O-C-N 123.976 0.797 . . . . 0.0 113.852 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -109.13 -9.12 15.06 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.608 1.163 . . . . 0.0 110.669 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.84 -163.74 13.28 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.064 -171.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.4 m -146.12 126.54 14.05 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.482 1.113 . . . . 0.0 109.225 -172.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 27' ' ' ARG . 44.7 tp -86.81 129.04 35.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.467 HD22 HD11 ' A' ' 133' ' ' LEU . 8.6 tt -108.67 108.81 19.81 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 32.2 mt-10 -107.12 105.63 15.72 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.22 103.58 12.01 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.569 0.748 . . . . 0.0 109.935 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.595 ' HG2' HG13 ' A' ' 25' ' ' ILE . 38.0 mt-10 -100.3 115.1 29.14 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 173.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.408 ' HE2' ' HE2' ' A' ' 121' ' ' MET . 3.5 t-160 -107.85 113.25 26.33 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.18 117.62 33.08 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.91 0.884 . . . . 0.0 111.598 -168.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.7 t -143.6 155.83 44.4 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.663 0.785 . . . . 0.0 110.694 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 p -79.8 -8.38 59.24 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.188 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.2 m -98.62 117.68 33.61 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.652 0.781 . . . . 0.0 110.67 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.39 -37.05 85.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.578 0.751 . . . . 0.0 111.774 -178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -60.54 -54.74 41.85 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.694 173.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.496 ' HE3' ' HD2' ' A' ' 89' ' ' TYR . 26.8 ttt -49.63 -36.81 25.73 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 124.121 0.888 . . . . 0.0 113.026 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.467 HD22 HG23 ' A' ' 24' ' ' ILE . 63.6 mt -60.64 -47.92 84.1 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.916 0.486 . . . . 0.0 111.528 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.466 ' O ' HG23 ' A' ' 127' ' ' VAL . 46.9 t -62.48 -55.2 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 123.505 0.503 . . . . 0.0 109.796 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -43.61 -62.42 1.1 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.559 1.943 . . . . 0.0 113.038 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.2 m -66.52 -33.27 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 122.815 0.446 . . . . 0.0 110.575 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.82 -37.23 90.08 Favored Glycine 0 C--N 1.35 1.349 0 O-C-N 123.723 0.639 . . . . 0.0 112.136 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 123' ' ' VAL . 89.8 t -74.28 -45.7 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.167 0.587 . . . . 0.0 109.648 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.99 -61.25 7.65 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.833 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 20.0 m95 -51.76 -36.99 49.42 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -57.49 -44.18 84.72 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 120.016 1.28 . . . . 0.0 111.21 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 88.5 mtp -64.14 -46.89 82.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 174.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 129' ' ' TRP . . . -68.12 -22.98 64.86 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.667 1.187 . . . . 0.0 112.76 -176.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.467 HD11 HD22 ' A' ' 110' ' ' LEU . 2.7 mm? -86.58 -30.77 21.6 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.6 -37.83 55.8 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.681 0.792 . . . . 0.0 109.637 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -68.48 -46.28 70.14 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.266 0.626 . . . . 0.0 109.735 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.33 -24.24 66.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 122.972 0.509 . . . . 0.0 110.104 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -68.96 -54.8 12.51 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 8.6 mtm -68.52 -33.93 74.99 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.306 0.642 . . . . 0.0 111.332 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -62.62 -55.45 26.95 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.954 0.902 . . . . 0.0 110.686 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.0 tt -72.7 -26.39 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.936 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -77.28 -27.26 53.05 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.952 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.73 -84.14 0.07 OUTLIER Glycine 0 C--N 1.349 1.277 0 O-C-N 123.216 0.322 . . . . 0.0 113.808 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -95.92 -113.03 0.13 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 118.456 -0.783 . . . . 0.0 111.408 -162.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 50.0 87.57 0.13 Allowed Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 125.496 1.518 . . . . 0.0 111.417 -174.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.05 -13.62 15.57 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.854 2.369 . . . . 0.0 112.16 174.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.14 -178.31 18.67 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.278 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.29 62.78 0.07 OUTLIER Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.427 -0.652 . . . . 0.0 112.11 173.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.94 -52.64 1.15 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 122.802 2.335 . . . . 0.0 112.259 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.7 m -117.25 136.15 23.34 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 123.992 0.917 . . . . 0.0 110.367 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.599 ' HG3' ' HG3' ' A' ' 163' ' ' MET . 32.5 Cg_exo -62.39 -58.2 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.585 2.857 . . . . 0.0 112.753 174.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -134.03 -35.0 0.96 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.591 0.756 . . . . 0.0 110.604 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 31.5 t70 63.19 70.27 0.55 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.794 1.238 . . . . 0.0 110.166 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.78 53.53 1.68 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.461 1.105 . . . . 0.0 109.587 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 61.75 80.9 0.21 Allowed 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.993 -175.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.747 ' HB2' ' HA ' ' A' ' 159' ' ' PRO . 8.1 pt-20 -151.26 79.34 1.3 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.902 1.334 . . . . 0.0 110.737 -168.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -106.4 -62.02 1.44 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.874 -176.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -61.4 -44.45 97.12 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.656 1.183 . . . . 0.0 111.643 -171.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.483 ' HB2' ' SD ' ' A' ' 164' ' ' MET . 10.7 pt-20 -151.74 92.83 3.57 Favored Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 123.885 0.874 . . . . 0.0 108.794 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.747 ' HA ' ' HB2' ' A' ' 155' ' ' GLU . 35.5 Cg_exo -59.67 -76.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.996 2.464 . . . . 0.0 114.951 -172.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 43.2 m -147.77 147.4 27.15 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-O 118.545 -0.74 . . . . 0.0 109.458 -168.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.39 -46.24 32.64 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 124.167 3.244 . . . . 0.0 114.714 -166.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -68.72 -42.31 77.86 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.612 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.599 ' HG3' ' HG3' ' A' ' 150' ' ' PRO . 25.6 mmt -67.05 -35.85 80.78 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.242 0.617 . . . . 0.0 110.851 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.483 ' SD ' ' HB2' ' A' ' 158' ' ' GLU . 78.7 mtp -67.76 -41.2 83.72 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.608 0.763 . . . . 0.0 110.114 177.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -65.2 -46.38 80.93 Favored 'General case' 0 C--O 1.216 -0.687 0 O-C-N 123.805 0.69 . . . . 0.0 110.535 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 68.5 mt -58.98 -41.54 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.558 0.743 . . . . 0.0 111.046 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 46.8 t -62.0 -34.27 75.87 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.113 0.565 . . . . 0.0 111.102 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 164' ' ' MET . 78.7 mm-40 -72.32 -56.68 5.09 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.094 0.558 . . . . 0.0 110.024 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -48.85 -53.34 19.77 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.381 1.072 . . . . 0.0 112.299 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -70.84 -45.36 64.64 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.226 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -59.07 -58.87 12.23 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 124.148 0.905 . . . . 0.0 114.246 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -54.28 -43.73 71.3 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.152 0.981 . . . . 0.0 111.682 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.01 -38.24 87.9 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 123.675 0.609 . . . . 0.0 111.389 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -78.11 -24.47 47.47 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 119.201 -0.428 . . . . 0.0 112.03 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.91 -42.4 73.39 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -71.34 -26.53 62.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.258 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.498 HD22 ' HG ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -82.65 -49.23 10.03 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.597 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.44 -29.51 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.459 0.704 . . . . 0.0 112.533 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -64.89 -6.99 9.57 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 122.822 0.449 . . . . 0.0 111.321 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.5 t 74.92 102.67 0.07 Allowed 'General case' 0 C--N 1.353 0.721 0 C-N-CA 126.993 2.117 . . . . 0.0 112.737 164.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.8 21.36 11.45 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.528 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 35.8 p . . . . . 0 CA--C 1.556 1.19 0 C-N-CA 123.791 0.837 . . . . 0.0 110.232 175.904 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 tpp . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.81 73.61 2.75 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.565 0.746 . . . . 0.0 110.251 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -111.35 9.78 21.57 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.519 1.127 . . . . 0.0 110.31 -175.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.408 ' O ' ' HD2' ' A' ' 29' ' ' ARG . . . -86.4 57.17 4.74 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 29' ' ' ARG . 10.1 mm100 -110.49 98.49 7.68 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -174.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -153.54 -173.68 4.67 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.597 0.759 . . . . 0.0 110.567 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 55.5 m -115.27 108.94 17.22 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 124.856 1.262 . . . . 0.0 109.815 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -109.72 124.67 51.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.362 1.065 . . . . 0.0 109.268 -176.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -81.88 154.29 25.91 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.511 0.725 . . . . 0.0 110.895 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -160.06 172.83 16.8 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.31 0.644 . . . . 0.0 109.963 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.425 HD12 ' HA2' ' A' ' 181' ' ' GLY . 0.3 OUTLIER -148.5 141.68 25.04 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.887 -175.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.42 -151.52 5.44 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 32.3 ptt180 -144.66 170.81 15.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.353 0.661 . . . . 0.0 109.377 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -163.4 115.32 1.46 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.6 m -86.23 100.94 12.6 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.7 pt -93.88 168.76 11.15 Favored Pre-proline 0 CA--C 1.557 1.225 0 C-N-CA 124.738 1.215 . . . . 0.0 108.682 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.36 -17.49 27.02 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.865 2.376 . . . . 0.0 114.045 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.13 -0.33 56.95 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.95 178.31 15.26 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 118.214 0.461 . . . . 0.0 112.271 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.48 95.29 1.77 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-O 121.737 0.78 . . . . 0.0 109.984 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.65 166.32 19.26 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.29 174.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 20.2 ttm180 -118.42 161.1 20.54 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.448 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 79.7 p -134.11 144.16 48.42 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -173.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 37.4 pt -93.08 150.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 166.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 3.1 mp -129.22 116.03 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.8 mt -109.84 108.35 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 7' ' ' THR . 99.9 mtt180 -95.03 132.77 39.54 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.642 0.777 . . . . 0.0 109.919 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 73.8 mt-30 -143.41 140.19 30.31 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.316 1.01 . . . . 0.0 108.875 172.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.436 ' HB2' ' HA ' ' A' ' 5' ' ' GLN . 72.3 mtt180 -110.77 115.0 28.8 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -87.8 137.36 32.4 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.181 1.393 . . . . 0.0 110.008 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -78.52 38.07 0.3 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 123.936 0.773 . . . . 0.0 111.881 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.43 156.0 53.51 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 123.892 0.877 . . . . 0.0 108.771 -171.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.417 ' O ' HG23 ' A' ' 37' ' ' VAL . 72.5 Cg_endo -70.05 168.39 22.06 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 122.878 2.386 . . . . 0.0 113.695 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' A' ' 80' ' ' PRO . 89.0 t -67.47 -47.59 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.217 -172.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.34 -37.76 84.48 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.069 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -66.52 -63.49 1.06 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.99 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 33' ' ' PRO . 55.1 t -51.62 -34.26 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.739 1.216 . . . . 0.0 111.71 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.428 ' HE3' HD12 ' A' ' 101' ' ' LEU . 51.0 t-105 -58.46 -56.24 24.62 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.453 0.701 . . . . 0.0 110.198 176.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.9 m -57.17 -33.36 67.36 Favored 'General case' 0 CA--C 1.555 1.154 0 O-C-N 124.403 1.064 . . . . 0.0 111.396 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -68.15 -38.26 81.95 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 174.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.1 m -74.63 -27.76 60.58 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.232 0.613 . . . . 0.0 112.034 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.9 p -99.0 -46.19 5.69 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.196 0.598 . . . . 0.0 112.244 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.84 119.13 51.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 123.221 0.609 . . . . 0.0 110.904 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.68 -29.07 87.63 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 123.621 2.88 . . . . 0.0 112.899 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.4 -52.65 57.12 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.275 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -65.02 -31.0 72.02 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.733 173.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.503 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 40.5 mt -58.27 -41.6 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.255 0.622 . . . . 0.0 110.926 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -57.19 -29.13 63.43 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.994 0.918 . . . . 0.0 112.337 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -75.76 -5.35 45.36 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.667 0.787 . . . . 0.0 112.807 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.512 ' CD1' HD13 ' A' ' 136' ' ' LEU . 59.0 p-90 -149.2 4.31 0.61 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -165.83 -172.74 2.45 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -166.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.534 HD12 HD13 ' A' ' 66' ' ' LEU . 59.4 mt -86.61 140.86 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.076 0.95 . . . . 0.0 110.34 -171.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.68 110.93 3.61 Favored Pre-proline 0 N--CA 1.48 1.051 0 O-C-N 125.021 1.451 . . . . 0.0 110.225 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -90.88 179.61 1.69 Allowed 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.654 2.236 . . . . 0.0 112.799 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -152.39 157.55 41.42 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.101 0.96 . . . . 0.0 109.418 173.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.82 -166.94 25.51 Favored Glycine 0 N--CA 1.462 0.433 0 CA-C-N 116.623 -0.262 . . . . 0.0 113.608 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -78.45 -35.66 46.51 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.17 0.988 . . . . 0.0 110.334 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.7 mt 67.58 10.98 8.14 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.239 1.416 . . . . 0.0 113.453 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -102.34 178.15 4.67 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.721 0.809 . . . . 0.0 110.637 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.48 99.81 0.79 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.577 1.151 . . . . 0.0 109.902 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.55 -11.79 58.08 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.185 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.76 -169.32 30.23 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 169.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 34.7 p30 -128.13 155.2 44.82 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.868 -0.784 . . . . 0.0 112.222 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -119.7 161.77 20.14 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 165.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -163.24 112.85 1.33 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.534 HD13 HD12 ' A' ' 52' ' ' ILE . 72.5 mt -66.42 164.0 17.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.378 0.671 . . . . 0.0 110.935 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -81.3 112.68 18.83 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 40.94 54.97 3.5 Favored Glycine 0 CA--C 1.539 1.581 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -143.97 -76.78 0.23 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 117.197 0.499 . . . . 0.0 110.31 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.405 ' HB2' ' HD1' ' A' ' 89' ' ' TYR . . . -145.36 160.93 40.79 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.287 0.635 . . . . 0.0 109.749 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 35.0 t -127.3 158.04 38.28 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.35 -171.28 31.39 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.222 -0.513 . . . . 0.0 114.043 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 4.4 m-20 -137.94 161.99 35.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.01 0.924 . . . . 0.0 109.621 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -92.87 98.87 8.87 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.426 HD12 HG22 ' A' ' 84' ' ' THR . 97.4 mt -67.69 -46.38 72.43 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.095 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -161.31 115.11 1.97 Allowed 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.687 0.795 . . . . 0.0 109.965 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.3 p -98.12 114.91 27.25 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 164.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -127.12 84.93 62.21 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -170.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 92.3 Cg_endo -78.14 144.66 21.18 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.935 2.424 . . . . 0.0 113.182 -171.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.561 ' HB2' HG12 ' A' ' 34' ' ' VAL . 22.2 Cg_endo -97.78 23.95 22.54 Favored 'Cis proline' 0 C--N 1.374 1.907 0 C-N-CA 124.617 -0.993 . . . . 0.0 112.318 -8.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.684 ' HG2' ' HG3' ' A' ' 82' ' ' ARG . 60.7 ttt180 -73.09 -73.49 0.2 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.852 0.861 . . . . 0.0 111.167 -171.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.684 ' HG3' ' HG2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -155.36 158.7 39.1 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.424 0.69 . . . . 0.0 111.483 -178.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -130.27 129.25 43.04 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.426 HG22 HD12 ' A' ' 75' ' ' LEU . 19.4 m -103.08 135.7 44.25 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.223 1.409 . . . . 0.0 108.179 172.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.3 pt -131.19 163.4 37.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 124.122 0.969 . . . . 0.0 109.648 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.5 t -101.42 148.34 25.29 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 24.7 t-105 -140.65 92.93 2.55 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 109.769 -172.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.8 106.75 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 58.2 t80 -90.05 163.31 14.95 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 169.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.67 118.73 6.95 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.785 0.434 . . . . 0.0 111.027 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.88 25.13 75.48 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.833 0.708 . . . . 0.0 113.287 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 73.8 mmtt -132.43 147.48 65.85 Favored Pre-proline 0 N--CA 1.488 1.438 0 C-N-CA 123.975 0.91 . . . . 0.0 110.003 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.48 -178.18 3.83 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.69 2.26 . . . . 0.0 112.854 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.91 87.74 0.55 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.48 0.712 . . . . 0.0 109.554 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.664 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.4 m -71.86 136.54 47.0 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.699 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -102.45 108.93 20.42 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -172.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.0 t -108.31 136.24 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.111 0.964 . . . . 0.0 108.662 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -138.05 115.93 11.54 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.006 0.922 . . . . 0.0 109.433 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.416 ' HB2' HD13 ' A' ' 112' ' ' LEU . 8.2 tt -105.31 130.56 53.41 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.541 ' HD2' ' HB3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -131.08 143.62 50.81 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.023 0.44 . . . . 0.0 110.392 -177.18 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.502 ' HB3' HG13 ' A' ' 34' ' ' VAL . 97.9 mt -132.43 123.7 27.2 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 125.247 1.419 . . . . 0.0 109.436 -174.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 t -151.97 138.43 18.58 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.872 0.869 . . . . 0.0 108.972 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.08 146.0 44.55 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.04 0.936 . . . . 0.0 111.783 -173.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -153.15 118.04 5.08 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.79 1.236 . . . . 0.0 107.924 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 64.11 -111.84 4.49 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 123.427 0.454 . . . . 0.0 113.003 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -111.74 5.66 19.29 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.035 0.534 . . . . 0.0 110.188 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.39 -153.97 8.87 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.087 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.7 m -147.04 134.39 20.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.122 0.969 . . . . 0.0 109.568 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 42.4 tp -80.77 117.42 21.42 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.7 tt -101.23 106.13 17.31 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 164.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.541 ' HB3' ' HD2' ' A' ' 100' ' ' ARG . 35.6 tt0 -121.95 109.72 14.95 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.416 HD13 ' HB2' ' A' ' 99' ' ' LEU . 52.4 tp -107.17 114.35 28.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.551 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.448 ' HG3' ' HB2' ' A' ' 23' ' ' SER . 34.6 tt0 -94.06 127.2 39.73 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.249 0.62 . . . . 0.0 109.377 168.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -114.64 116.27 28.46 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 168.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.5 120.16 41.65 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.59 0.756 . . . . 0.0 110.291 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.3 t -139.45 154.82 47.83 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.258 0.623 . . . . 0.0 110.114 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.1 m -71.9 -16.29 62.12 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.458 1.103 . . . . 0.0 111.311 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 121' ' ' MET . 17.6 m -100.33 117.84 35.36 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.843 0.857 . . . . 0.0 110.201 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.621 ' HA ' HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -68.48 -29.25 67.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.806 0.842 . . . . 0.0 112.088 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -67.34 -54.41 20.88 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.532 0.52 . . . . 0.0 110.71 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.476 ' HB3' ' HB2' ' A' ' 118' ' ' SER . 28.1 ttt -50.13 -31.94 14.71 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.842 172.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.621 HD12 ' HA ' ' A' ' 119' ' ' GLU . 50.3 mt -65.44 -42.67 92.14 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.952 0.501 . . . . 0.0 111.96 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 127' ' ' VAL . 45.8 t -64.26 -51.05 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -44.31 -57.82 3.27 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.526 1.53 . . . . 0.0 112.754 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 121' ' ' MET . 30.7 m -75.68 -20.03 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 123.848 0.718 . . . . 0.0 110.726 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.72 -39.81 96.95 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 171.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 123' ' ' VAL . 48.4 t -74.73 -53.42 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.36 -61.45 7.21 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 114.537 -1.211 . . . . 0.0 114.207 -176.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -63.99 -39.49 94.24 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 118.405 -0.807 . . . . 0.0 112.922 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -58.57 -45.86 88.12 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 119.549 1.068 . . . . 0.0 110.375 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 40.8 mtm -67.08 -42.82 84.0 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.95 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.37 -61.16 2.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.63 0.772 . . . . 0.0 111.501 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.98 -33.67 69.14 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.205 0.602 . . . . 0.0 112.617 174.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.96 -37.33 82.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 118.321 0.51 . . . . 0.0 110.695 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -66.91 -40.13 87.58 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.985 0.514 . . . . 0.0 109.773 171.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.512 HD13 ' CD1' ' A' ' 50' ' ' TRP . 41.6 tp -64.46 -23.08 67.16 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.06 0.544 . . . . 0.0 110.52 175.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.38 -46.84 11.51 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.449 ' HB3' ' HB3' ' A' ' 143' ' ' ASP . 79.6 mtp -65.53 -42.17 92.28 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.85 0.86 . . . . 0.0 110.717 173.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.4 ' HD2' HD12 ' A' ' 136' ' ' LEU . 35.4 t80 -57.4 -55.55 33.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.06 0.944 . . . . 0.0 111.445 -175.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 44.2 mt -71.35 -28.21 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 123.326 0.391 . . . . 0.0 110.367 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -67.84 -16.58 64.16 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 122.936 0.495 . . . . 0.0 110.589 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.71 43.88 2.21 Favored Glycine 0 C--N 1.355 1.62 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 173.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 138' ' ' MET . 1.4 t70 -130.85 -168.48 2.0 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.746 0.818 . . . . 0.0 108.818 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.2 mt 66.96 73.34 0.38 Allowed Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 125.132 1.373 . . . . 0.0 111.26 -174.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.02 -38.48 94.66 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.141 2.561 . . . . 0.0 112.932 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -104.19 -56.69 0.73 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.434 -0.667 . . . . 0.0 111.434 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.59 -169.88 13.59 Favored Glycine 0 C--N 1.349 1.274 0 C-N-CA 123.762 0.696 . . . . 0.0 111.987 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -72.81 139.58 30.74 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.881 2.388 . . . . 0.0 111.669 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.1 m -62.22 147.25 91.41 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 122.677 0.391 . . . . 0.0 110.393 172.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.64 -24.49 77.87 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.348 2.032 . . . . 0.0 112.335 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -98.16 19.96 13.24 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.112 0.965 . . . . 0.0 111.539 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.87 82.94 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.955 1.302 . . . . 0.0 111.557 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -175.67 -40.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 112.922 -1.945 . . . . 0.0 109.478 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 64.15 -150.76 0.3 Allowed 'General case' 0 C--N 1.363 1.173 0 C-N-CA 124.744 1.217 . . . . 0.0 110.727 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 67.08 16.71 10.34 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.05 0.94 . . . . 0.0 111.9 175.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -50.34 -62.54 1.52 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.615 1.566 . . . . 0.0 110.315 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -166.75 -45.57 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -67.06 116.72 38.79 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.893 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.53 85.35 0.28 Allowed 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.662 2.241 . . . . 0.0 111.13 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.6 m -66.4 103.88 0.52 Allowed Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.908 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.75 -49.96 15.41 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.41 2.74 . . . . 0.0 114.13 -161.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.416 ' HA ' ' NH1' ' A' ' 165' ' ' ARG . 4.9 mp0 -65.81 -53.96 33.2 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.415 -176.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.0 tpt -76.84 -32.84 57.84 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.782 -169.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.403 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 21.6 ptm -71.04 -36.22 72.26 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 41.4 ttm105 -55.64 -47.8 76.02 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.895 0.878 . . . . 0.0 110.278 173.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.418 ' O ' ' HD3' ' A' ' 170' ' ' ARG . 99.9 mt -57.32 -52.31 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 124.17 0.918 . . . . 0.0 110.267 175.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.8 t -64.5 -25.0 67.8 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.358 0.663 . . . . 0.0 112.204 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 164' ' ' MET . 19.9 mm-40 -73.04 -47.68 42.71 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 174.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 12.1 mm-40 -58.48 -49.6 76.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.533 0.733 . . . . 0.0 111.658 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 166' ' ' ILE . 9.3 mpt_? -74.67 -48.39 26.45 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.648 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.46 -52.23 29.21 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 123.791 0.682 . . . . 0.0 114.225 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.08 -31.23 67.56 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.518 0.727 . . . . 0.0 112.111 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.74 -56.91 7.44 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.926 0.491 . . . . 0.0 110.54 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -67.71 -22.19 65.27 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.522 0.729 . . . . 0.0 111.829 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.45 84.78 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.999 0.428 . . . . 0.0 110.077 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -75.97 -29.12 58.14 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.11 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 57.7 mt -74.66 -52.3 12.04 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.781 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.26 -29.15 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 122.51 0.324 . . . . 0.0 111.791 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -69.16 -6.82 31.1 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.286 0.634 . . . . 0.0 112.615 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.9 m -136.44 -164.24 1.53 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.029 1.331 . . . . 0.0 109.433 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.425 ' HA2' HD12 ' A' ' 11' ' ' LEU . . . -140.25 69.13 0.47 Allowed Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 177.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 C--O 1.251 1.137 0 C-N-CA 123.944 0.898 . . . . 0.0 109.498 -175.449 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.81 -61.92 1.68 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.15 0.58 . . . . 0.0 109.834 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -80.34 91.07 5.61 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . -171.31 48.65 0.19 Allowed Glycine 0 C--N 1.343 0.964 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.048 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -175.94 92.09 0.05 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.276 1.03 . . . . 0.0 108.807 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -156.15 114.09 3.31 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.939 -176.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -93.84 119.75 33.19 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 3.5 tm-20 -114.87 127.87 55.96 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -106.39 156.52 18.44 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.23 0.538 . . . . 0.0 112.305 -173.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -161.91 -175.41 4.64 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.693 -171.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 mt -140.82 167.34 22.42 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.431 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.83 -162.59 16.19 Favored Glycine 0 C--O 1.246 0.888 0 CA-C-N 113.395 -1.729 . . . . 0.0 109.712 168.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.42 160.68 35.69 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 168.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -162.35 117.54 1.89 Allowed 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -173.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 92.3 m -87.58 98.0 11.17 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.2 pt -78.66 166.08 45.1 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 125.475 1.51 . . . . 0.0 110.537 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.27 -27.71 5.01 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 123.748 2.965 . . . . 0.0 115.038 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.71 -49.58 45.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.013 0.525 . . . . 0.0 110.839 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.99 -160.11 32.15 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-O 119.711 -0.494 . . . . 0.0 112.023 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.66 105.09 0.74 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.204 0.602 . . . . 0.0 111.104 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -107.96 154.41 21.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.935 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 23' ' ' SER . 7.0 tpp180 -83.95 155.66 22.71 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 165.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.469 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 77.0 p -132.41 135.14 45.9 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 110.919 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 2.9 pp -93.71 142.15 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 170.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -123.61 118.17 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -176.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.0 mt -111.27 106.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.583 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 66.9 mtt180 -92.09 147.66 22.78 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -156.42 130.64 8.64 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.86 106.85 19.16 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.544 1.138 . . . . 0.0 108.175 -172.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.71 134.0 34.73 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.691 0.797 . . . . 0.0 110.559 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.497 ' HB2' ' HA3' ' A' ' 4' ' ' GLY . 10.4 t70 -80.36 46.88 0.87 Allowed 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 122.039 0.923 . . . . 0.0 110.236 170.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.27 154.79 57.75 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 123.928 0.891 . . . . 0.0 109.359 -171.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 37' ' ' VAL . 60.8 Cg_endo -71.26 165.74 31.47 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.579 2.186 . . . . 0.0 113.188 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 80' ' ' PRO . 88.7 t -73.21 -40.77 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.564 -172.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.18 -47.95 71.47 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.218 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -65.01 -64.47 0.86 Allowed 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.329 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 33' ' ' PRO . 48.3 t -50.01 -35.22 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.214 1.006 . . . . 0.0 111.667 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -58.62 -57.73 11.71 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.847 0.859 . . . . 0.0 110.209 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 m -61.22 -35.75 78.06 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.392 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -62.57 -33.62 75.33 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 122.05 -0.406 . . . . 0.0 112.082 172.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.443 ' HA ' ' HZ2' ' A' ' 50' ' ' TRP . 83.1 m -85.41 -18.28 34.13 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.663 0.785 . . . . 0.0 113.067 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 p -113.05 -40.21 4.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.18 111.33 5.25 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 123.657 0.783 . . . . 0.0 110.829 175.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.428 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 66.7 Cg_exo -54.13 -33.61 74.93 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 123.703 2.936 . . . . 0.0 113.868 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -61.04 -49.83 75.8 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -65.68 -35.37 80.57 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.516 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.509 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 87.9 mt -66.51 -41.46 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.556 0.743 . . . . 0.0 111.911 -174.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.527 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 27.5 p30 -60.21 -15.38 23.83 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -78.88 -45.78 19.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.828 0.851 . . . . 0.0 111.562 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.509 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 67.8 p-90 -108.59 8.17 27.01 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.258 0.623 . . . . 0.0 112.603 -172.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -174.47 173.83 2.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.319 0.648 . . . . 0.0 109.39 -168.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.1 mt -86.46 123.08 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 32.3 tt0 -63.32 130.35 94.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.793 1.637 . . . . 0.0 112.086 -174.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.601 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 83.0 Cg_endo -81.58 129.28 6.42 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.525 2.15 . . . . 0.0 112.154 175.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -93.85 160.36 14.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.873 1.269 . . . . 0.0 109.45 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.46 -168.79 15.63 Favored Glycine 0 N--CA 1.47 0.964 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.47 -36.79 68.56 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.212 0.605 . . . . 0.0 110.603 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.8 mt 71.9 -10.17 0.89 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.241 1.416 . . . . 0.0 114.095 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -86.39 171.03 11.46 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.535 0.734 . . . . 0.0 109.891 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.715 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 41.2 tt0 -67.82 102.22 1.2 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.248 0.619 . . . . 0.0 110.489 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.54 -15.07 17.56 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.85 -160.43 36.35 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -143.04 155.15 44.57 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.805 1.303 . . . . 0.0 111.188 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.601 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 17.1 p90 -106.02 163.35 12.83 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.464 166.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.94 108.05 0.86 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.218 1.007 . . . . 0.0 109.919 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.1 mt -69.29 170.67 9.82 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.449 0.7 . . . . 0.0 109.65 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -76.51 -17.95 58.99 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 122.084 -0.385 . . . . 0.0 111.805 -169.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.79 47.49 0.04 OUTLIER Glycine 0 N--CA 1.467 0.728 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -128.0 -62.3 1.06 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.156 0.982 . . . . 0.0 108.894 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.11 161.34 36.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.977 0.511 . . . . 0.0 111.205 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.6 p -152.81 130.74 11.75 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 86' ' ' SER . . . -161.19 174.61 37.79 Favored Glycine 0 C--N 1.344 1.005 0 C-N-CA 121.663 -0.304 . . . . 0.0 113.449 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -86.55 159.22 19.33 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.216 1.007 . . . . 0.0 111.05 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 mm -93.22 98.74 8.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.401 HD12 HG22 ' A' ' 84' ' ' THR . 87.0 mt -63.81 -51.78 63.2 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.794 0.838 . . . . 0.0 111.123 -174.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -160.78 152.45 19.58 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.661 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 26.2 p -148.13 138.25 22.65 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.57 0.748 . . . . 0.0 109.209 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -138.56 93.58 10.99 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.87 141.49 13.4 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.94 2.426 . . . . 0.0 112.703 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.422 ' HB2' HG12 ' A' ' 34' ' ' VAL . 18.3 Cg_endo -95.81 25.13 22.64 Favored 'Cis proline' 0 C--N 1.378 2.131 0 CA-C-N 119.537 0.87 . . . . 0.0 112.523 -5.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -78.99 -75.84 0.22 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.427 0.691 . . . . 0.0 111.673 -171.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -142.37 139.53 31.75 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 118.549 0.613 . . . . 0.0 112.39 -169.128 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.6 tp -124.48 124.41 42.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.939 1.696 . . . . 0.0 108.404 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.401 HG22 HD12 ' A' ' 75' ' ' LEU . 61.7 m -113.41 114.05 26.06 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.725 0.81 . . . . 0.0 109.917 175.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.0 pt -110.4 168.78 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 124.483 1.113 . . . . 0.0 110.431 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.447 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 14.4 m -103.51 136.39 43.33 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -175.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 44.6 t-105 -128.5 104.58 7.77 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.612 0.642 . . . . 0.0 110.402 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.29 103.67 15.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.539 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 47.2 t80 -90.22 163.66 14.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.751 0.82 . . . . 0.0 109.886 -177.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -52.52 106.49 0.16 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.864 1.265 . . . . 0.0 111.774 177.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.74 2.45 51.04 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 114.433 0.533 . . . . 0.0 114.433 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 41.5 mmtm -101.09 159.47 29.4 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.145 0.978 . . . . 0.0 109.262 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.95 -176.94 2.86 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.119 1.879 . . . . 0.0 112.113 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.58 144.75 56.24 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.178 174.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.5 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 30.0 p -146.99 156.34 42.96 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.121 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -116.23 117.58 30.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.487 0.715 . . . . 0.0 109.103 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 54.2 t -94.31 130.14 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 36.2 mm-40 -116.72 111.93 20.48 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.131 1.772 . . . . 0.0 107.182 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.497 HD13 HD12 ' A' ' 112' ' ' LEU . 59.6 tp -107.33 114.0 27.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -119.65 137.85 53.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.138 0.975 . . . . 0.0 109.601 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 67.9 mt -127.7 142.8 51.23 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.562 1.145 . . . . 0.0 109.221 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 t -137.03 170.77 15.55 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.956 1.303 . . . . 0.0 108.968 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.69 128.01 56.28 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -141.77 106.32 4.86 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.47 -103.9 0.36 Allowed Glycine 0 CA--C 1.534 1.277 0 CA-C-N 117.845 0.293 . . . . 0.0 113.342 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -115.71 2.27 13.66 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.565 0.746 . . . . 0.0 111.069 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -130.13 -173.58 13.44 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 123.891 0.758 . . . . 0.0 111.911 -174.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 89.0 m -121.33 148.22 44.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.848 0.859 . . . . 0.0 110.424 -176.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.9 tp -103.22 134.58 46.39 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 166.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 tt -119.74 109.73 15.97 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.583 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 31.7 mt-10 -109.54 105.57 14.94 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.499 HD13 HD21 ' A' ' 133' ' ' LEU . 8.6 tt -105.4 107.4 18.37 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' A' ' 23' ' ' SER . 32.8 tt0 -92.4 128.18 38.15 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.898 0.879 . . . . 0.0 108.973 173.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.678 ' HD1' ' HE1' ' A' ' 129' ' ' TRP . 6.2 t60 -113.77 118.42 34.24 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 171.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.12 114.86 29.24 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.083 0.953 . . . . 0.0 110.889 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.696 HG21 ' HG3' ' A' ' 121' ' ' MET . 4.4 t -150.26 150.67 31.86 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.596 0.758 . . . . 0.0 110.921 176.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 74.1 p -73.23 -42.68 62.32 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.922 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.1 m -76.62 131.82 39.09 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.472 0.709 . . . . 0.0 112.384 -165.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -60.78 -50.66 72.56 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.78 1.232 . . . . 0.0 113.243 -170.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -62.49 -53.35 56.11 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.696 ' HG3' HG21 ' A' ' 116' ' ' THR . 13.7 tpt -44.14 -38.94 3.97 Favored 'General case' 0 CA--C 1.56 1.351 0 O-C-N 124.873 1.358 . . . . 0.0 112.711 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HG ' HG23 ' A' ' 116' ' ' THR . 13.4 mt -66.54 -47.07 74.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.541 1.136 . . . . 0.0 112.733 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.5 t -64.16 -51.45 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -46.94 -47.5 21.69 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.647 1.979 . . . . 0.0 113.713 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 m -83.39 -25.77 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.479 0.312 . . . . 0.0 111.491 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.61 -39.73 98.26 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.81 -51.15 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.369 1.068 . . . . 0.0 108.99 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.64 -61.75 6.48 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 114.545 -1.207 . . . . 0.0 114.132 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.678 ' HE1' ' HD1' ' A' ' 114' ' ' HIS . 81.5 m95 -63.74 -44.32 93.87 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 118.69 -0.671 . . . . 0.0 112.439 177.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.21 -39.87 91.85 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.344 0.974 . . . . 0.0 110.944 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.9 ttm -70.99 -37.76 72.7 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.738 0.815 . . . . 0.0 110.48 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.66 -59.5 4.19 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.502 0.721 . . . . 0.0 111.202 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.499 HD21 HD13 ' A' ' 112' ' ' LEU . 3.6 mm? -58.5 -29.16 66.05 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.321 0.648 . . . . 0.0 112.061 173.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.01 -38.5 91.28 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 118.395 0.543 . . . . 0.0 110.607 174.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -64.76 -31.2 72.31 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.178 0.591 . . . . 0.0 110.663 171.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.495 HD11 ' HB1' ' A' ' 40' ' ' ALA . 53.2 tp -66.76 -42.15 86.59 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.855 0.462 . . . . 0.0 110.074 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -47.48 -45.99 22.91 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.304 0.378 . . . . 0.0 113.741 165.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 73.4 mtp -74.15 -30.13 62.13 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 123.589 0.756 . . . . 0.0 111.485 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -71.43 -54.92 9.04 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.195 0.998 . . . . 0.0 110.122 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 40.6 mt -64.14 -31.38 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.416 1.086 . . . . 0.0 110.972 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 70.2 ttt180 -62.99 -24.63 68.0 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.611 0.765 . . . . 0.0 111.243 175.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.07 39.33 32.75 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -173.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -108.91 -33.84 6.81 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.983 0.913 . . . . 0.0 111.013 -169.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.8 mt -75.59 115.21 43.72 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 123.491 0.717 . . . . 0.0 111.456 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -87.03 -8.84 6.51 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.754 2.302 . . . . 0.0 111.318 164.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.05 -175.51 44.06 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.288 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.17 114.07 3.78 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.986 -0.897 . . . . 0.0 111.63 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -83.39 7.84 4.97 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.121 2.547 . . . . 0.0 113.672 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.3 m -82.1 134.28 49.62 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 122.661 0.384 . . . . 0.0 110.222 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -85.55 11.23 3.41 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.683 2.255 . . . . 0.0 112.997 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 77.06 65.45 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.844 1.658 . . . . 0.0 109.598 170.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.426 ' HB2' ' HG2' ' A' ' 163' ' ' MET . 43.0 m-20 -103.78 61.05 0.75 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.153 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -70.18 -33.82 72.2 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.496 171.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -87.06 120.67 28.57 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 164.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.3 -42.2 99.16 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 122.908 0.483 . . . . 0.0 111.75 -175.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 61.97 162.81 0.08 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 125.205 1.402 . . . . 0.0 113.532 170.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -72.15 89.78 1.18 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.809 0.843 . . . . 0.0 109.932 171.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.467 ' HA ' ' SD ' ' A' ' 164' ' ' MET . 37.0 tt0 50.38 68.28 3.56 Favored Pre-proline 0 CA--C 1.569 1.681 0 C-N-CA 125.599 1.559 . . . . 0.0 113.267 172.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.666 ' HD2' ' SD ' ' A' ' 164' ' ' MET . 47.7 Cg_endo -87.55 -29.42 0.36 Allowed 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.296 2.664 . . . . 0.0 113.953 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.7 t -159.33 104.46 1.52 Allowed Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 124.479 1.112 . . . . 0.0 108.264 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.5 -42.21 63.58 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.83 2.353 . . . . 0.0 112.655 -176.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -63.58 -48.66 76.48 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.622 0.769 . . . . 0.0 111.931 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.426 ' HG2' ' HB2' ' A' ' 152' ' ' ASP . 6.2 tpt -66.48 -43.37 85.61 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.399 0.437 . . . . 0.0 110.714 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.666 ' SD ' ' HD2' ' A' ' 159' ' ' PRO . 61.9 mtm -65.94 -37.2 85.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.665 0.386 . . . . 0.0 111.162 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -55.22 -58.13 8.94 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.503 1.127 . . . . 0.0 109.17 -178.177 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 61.9 mt -63.28 -45.77 97.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 O-C-N 124.609 1.193 . . . . 0.0 111.053 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 31.1 t -51.62 -42.14 61.78 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.942 0.897 . . . . 0.0 112.471 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -89.47 -29.32 19.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 4.9 tm-20 -61.79 -50.26 73.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.666 1.587 . . . . 0.0 110.408 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -60.69 -53.09 61.66 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.42 174.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.66 -50.0 38.39 Favored Glycine 0 C--N 1.351 1.407 0 O-C-N 124.545 1.153 . . . . 0.0 115.204 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.07 -32.96 69.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.033 0.533 . . . . 0.0 111.345 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.38 68.77 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.972 0.509 . . . . 0.0 111.133 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.4 ' CE3' HD12 ' A' ' 177' ' ' LEU . 94.5 m95 -70.72 -27.21 63.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.25 0.62 . . . . 0.0 111.599 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.47 73.71 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 123.506 0.504 . . . . 0.0 110.155 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -70.6 -33.83 71.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.4 0.28 . . . . 0.0 110.499 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.4 HD12 ' CE3' ' A' ' 174' ' ' TRP . 63.1 mt -73.05 -62.12 1.58 Allowed 'General case' 0 C--N 1.349 0.56 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.595 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 122' ' ' LEU . 4.4 p -73.43 -22.17 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -166.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -87.14 4.89 40.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.273 0.629 . . . . 0.0 111.188 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 28.8 t -92.85 175.93 6.62 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.672 0.789 . . . . 0.0 111.299 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 160.64 -39.2 0.44 Allowed Glycine 0 C--N 1.342 0.877 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 C--O 1.251 1.152 0 C-N-CA 124.118 0.967 . . . . 0.0 109.276 176.819 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.04 97.06 1.83 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.523 0.729 . . . . 0.0 110.672 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.4 m -73.35 -59.24 2.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.257 0.623 . . . . 0.0 109.817 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.49 142.19 3.59 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.302 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -88.19 92.1 9.03 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 165.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 29' ' ' ARG . . . -68.69 80.8 0.28 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.234 0.54 . . . . 0.0 111.454 -171.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 m -81.94 117.62 22.32 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.743 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 35.6 mt-10 -118.94 110.48 17.19 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.788 0.835 . . . . 0.0 108.847 -175.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -68.62 147.67 51.57 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -157.94 161.65 38.2 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.749 0.419 . . . . 0.0 110.48 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -144.64 143.85 30.96 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.63 171.47 33.65 Favored Glycine 0 C--O 1.238 0.348 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 173.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -94.68 160.41 14.63 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.28 122.06 2.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -169.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.3 m -86.36 129.91 34.69 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 117' ' ' THR . 48.9 pt -125.28 165.43 26.25 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.473 1.109 . . . . 0.0 109.005 -174.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.5 -33.35 38.11 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.054 2.503 . . . . 0.0 114.735 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.17 -31.61 67.87 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.459 0.704 . . . . 0.0 111.935 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.24 -164.66 31.04 Favored Glycine 0 N--CA 1.47 0.9 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -74.86 138.42 42.47 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.033 1.417 . . . . 0.0 109.051 172.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.83 168.17 20.41 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.006 1.322 . . . . 0.0 109.871 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.436 HH21 ' HB2' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -104.59 166.64 10.26 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 168.443 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 23.6 p -140.1 130.21 24.99 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.767 -174.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.546 HG12 HG23 ' A' ' 125' ' ' VAL . 2.6 pp -86.92 135.95 24.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 168.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 4.8 mp -124.98 115.48 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.458 HG12 ' CZ2' ' A' ' 174' ' ' TRP . 25.2 mt -105.68 107.17 22.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.579 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 54.0 mtp180 -95.48 162.0 13.83 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.642 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 5.1 tt0 -168.72 120.9 0.79 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 125.029 1.456 . . . . 0.0 111.039 -178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.609 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 2.5 mpt_? -88.95 103.57 16.16 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 170.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.445 ' HE1' ' HA2' ' A' ' 137' ' ' GLY . 77.6 m-85 -84.08 141.37 31.17 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.661 170.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.36 -11.47 59.93 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 123.69 0.619 . . . . 0.0 111.346 174.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.28 152.61 83.96 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 122.551 0.34 . . . . 0.0 110.774 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.419 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 28.0 Cg_endo -62.61 148.64 93.08 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.818 2.346 . . . . 0.0 112.576 171.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 108' ' ' THR . 68.6 t -47.45 -40.92 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 125.062 1.345 . . . . 0.0 111.981 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -50.04 -50.49 47.48 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.833 1.333 . . . . 0.0 111.111 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.419 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 36.8 mt-10 -71.29 -29.79 65.47 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.264 -177.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.6 t -74.56 -40.01 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.465 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -74.52 -28.24 60.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.671 0.788 . . . . 0.0 109.825 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB3' ' NH1' ' A' ' 46' ' ' ARG . 74.1 m -69.14 -44.09 73.04 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.305 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -44.69 93.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.821 0.848 . . . . 0.0 111.51 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 72.7 m -68.36 -33.83 74.98 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.1 p -111.31 -34.72 6.06 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -169.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.484 ' O ' HG13 ' A' ' 47' ' ' ILE . 32.6 t70 -71.02 114.9 31.1 Favored Pre-proline 0 N--CA 1.486 1.354 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.777 -178.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -52.07 -34.78 59.11 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.568 2.845 . . . . 0.0 113.8 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -72.03 -20.61 61.67 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.318 1.011 . . . . 0.0 110.604 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.409 ' NH1' ' HB3' ' A' ' 39' ' ' SER . 72.8 mtt85 -94.81 -25.98 16.41 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.331 0.652 . . . . 0.0 111.7 172.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 43' ' ' ASP . 82.2 mt -76.61 -31.5 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -73.43 -4.29 32.72 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.263 0.625 . . . . 0.0 112.318 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.34 -30.75 13.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.403 0.681 . . . . 0.0 110.701 -173.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.405 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 67.4 p-90 -119.09 -20.15 8.15 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.125 0.57 . . . . 0.0 111.875 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.405 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 51.4 t80 -127.75 -102.25 0.34 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.272 0.629 . . . . 0.0 109.803 -175.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.495 HD12 HD13 ' A' ' 66' ' ' LEU . 89.5 mt -149.42 142.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 124.157 0.983 . . . . 0.0 108.876 -170.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.06 108.06 1.34 Allowed Pre-proline 0 CA--C 1.561 1.385 0 O-C-N 124.657 1.223 . . . . 0.0 110.753 172.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -96.03 139.37 0.77 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.068 2.512 . . . . 0.0 113.463 -177.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -129.98 141.77 50.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.702 1.201 . . . . 0.0 109.417 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.59 -163.12 35.51 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.51 ' HB3' ' H ' ' A' ' 63' ' ' ASN . 29.3 t70 -75.09 -41.03 59.59 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.1 mt 70.81 -10.01 0.77 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.572 1.549 . . . . 0.0 113.708 170.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -93.59 165.91 12.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.883 0.873 . . . . 0.0 110.064 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.524 ' HG2' ' HA ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -64.78 123.46 19.42 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.815 0.846 . . . . 0.0 109.861 -176.394 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.39 7.14 69.93 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.646 -0.707 . . . . 0.0 112.991 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.66 -147.78 20.5 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 112.149 -0.38 . . . . 0.0 112.149 178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.623 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 26.2 p-10 -139.88 169.88 16.9 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.643 0.777 . . . . 0.0 110.969 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -142.69 154.64 44.5 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.65 142.37 25.58 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.891 0.877 . . . . 0.0 109.824 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.495 HD13 HD12 ' A' ' 52' ' ' ILE . 90.4 mt -94.74 -101.93 0.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.309 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -155.76 -56.68 0.09 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.82 0.848 . . . . 0.0 108.928 174.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.96 43.07 1.16 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.777 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -135.2 -74.04 0.46 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.024 0.93 . . . . 0.0 109.358 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.63 154.31 32.78 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 121.763 0.792 . . . . 0.0 112.713 -169.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.9 m -131.2 154.19 48.67 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 113.153 -1.84 . . . . 0.0 108.182 168.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 86' ' ' SER . . . -169.32 -156.88 11.14 Favored Glycine 0 CA--C 1.504 -0.655 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.073 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 24.8 m-20 -121.88 171.54 8.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.323 0.649 . . . . 0.0 110.462 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.6 mm -103.41 106.65 20.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.8 mt -77.56 -41.03 40.44 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 123.502 0.501 . . . . 0.0 110.212 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.524 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 36.9 ttm180 -175.77 113.96 0.13 Allowed 'General case' 0 C--N 1.363 1.162 0 O-C-N 123.955 0.784 . . . . 0.0 111.508 168.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.3 p -107.05 103.44 12.85 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.529 0.732 . . . . 0.0 109.512 174.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.502 ' HG3' ' HG2' ' A' ' 76' ' ' ARG . 48.8 mt-10 -104.73 112.29 65.3 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.651 1.18 . . . . 0.0 109.517 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 6.1 Cg_exo -79.81 126.33 6.5 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.913 2.408 . . . . 0.0 112.423 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.5 Cg_endo -103.73 25.06 12.07 Favored 'Cis proline' 0 C--N 1.376 1.989 0 CA-C-N 120.421 1.186 . . . . 0.0 112.717 -8.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -61.5 -67.55 0.4 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.156 0.982 . . . . 0.0 112.02 -171.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.493 ' NH2' ' HD2' ' A' ' 76' ' ' ARG . 14.8 ptt180 -152.5 157.15 40.72 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.169 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 tt -119.93 138.18 53.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 169.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.6 m -137.31 130.17 30.38 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.451 HG13 ' HB ' ' A' ' 97' ' ' VAL . 14.1 pt -144.18 146.82 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.296 1.038 . . . . 0.0 109.677 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.444 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 24.6 p -90.86 132.89 35.63 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 171.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 24.4 t-105 -121.68 104.62 9.74 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -171.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.7 t -102.77 103.11 14.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 170.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.532 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 42.8 t80 -77.34 147.11 36.33 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.8 113.59 2.85 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.374 0.669 . . . . 0.0 111.576 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.05 6.7 86.3 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 124.191 0.932 . . . . 0.0 113.354 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 12.4 mmmm -125.98 155.07 73.74 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.519 1.128 . . . . 0.0 109.169 -172.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.1 179.16 4.09 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.635 2.223 . . . . 0.0 114.243 -174.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.62 150.09 39.78 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.253 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.511 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.4 m -140.36 156.91 46.24 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.852 0.72 . . . . 0.0 110.951 178.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -112.06 108.61 17.97 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 165.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 52.6 t -94.33 119.58 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -124.32 115.86 21.68 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.452 0.644 . . . . 0.0 110.418 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -89.78 136.36 33.08 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 57.1 mtt85 -135.42 129.87 33.94 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -177.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 46.5 mt -116.54 147.06 42.16 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.914 0.486 . . . . 0.0 110.401 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.1 t -150.79 125.27 9.54 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.512 0.725 . . . . 0.0 110.528 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.29 124.22 26.02 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 173.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.59 125.79 12.99 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 124.144 0.978 . . . . 0.0 109.051 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.81 -89.14 1.34 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 171.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -160.97 39.88 0.15 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.13 -168.09 33.12 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.395 -172.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.498 HG23 HG22 ' A' ' 34' ' ' VAL . 32.1 m -137.66 131.11 30.99 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.095 0.958 . . . . 0.0 110.498 -166.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 55.1 tp -80.98 106.47 13.01 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 160.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.457 HD22 HD11 ' A' ' 133' ' ' LEU . 7.9 tt -87.45 128.2 35.22 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 160.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 31.7 tt0 -136.4 104.68 5.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.4 131.94 43.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 33.3 tt0 -123.2 143.62 49.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.579 ' HD1' ' HE1' ' A' ' 129' ' ' TRP . 8.6 t60 -138.87 114.71 10.02 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.1 104.52 11.64 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.352 0.661 . . . . 0.0 111.184 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.2 t -131.49 158.71 40.16 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-O 121.499 0.666 . . . . 0.0 109.743 173.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.468 HG23 HD11 ' A' ' 16' ' ' ILE . 40.4 p -80.05 -21.46 43.42 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.052 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.8 t -82.44 113.73 20.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.928 0.491 . . . . 0.0 110.473 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.436 ' HB2' HH21 ' A' ' 22' ' ' ARG . 36.7 tt0 -65.84 -29.3 69.75 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.946 0.899 . . . . 0.0 110.297 175.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -61.45 -50.48 72.61 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.287 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.9 ttt -68.77 -30.25 68.8 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.02 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.9 mt -66.1 -44.14 85.24 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.269 0.628 . . . . 0.0 112.314 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.3 t -65.43 -45.1 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -50.82 -51.55 49.91 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.605 1.162 . . . . 0.0 112.166 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.546 HG23 HG12 ' A' ' 24' ' ' ILE . 33.4 m -79.85 -21.72 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.845 0.458 . . . . 0.0 111.439 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.32 -34.9 86.76 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 168.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.24 -53.63 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 114.415 -0.892 . . . . 0.0 110.054 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.63 86.1 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.604 -0.726 . . . . 0.0 114.281 -175.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.579 ' HE1' ' HD1' ' A' ' 114' ' ' HIS . 34.2 m95 -85.47 -36.39 20.61 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.884 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -69.9 -29.2 66.34 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.112 0.869 . . . . 0.0 110.289 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 65.5 mtm -71.81 -37.43 70.36 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.76 -35.08 79.9 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 122.538 0.335 . . . . 0.0 111.255 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.457 HD11 HD22 ' A' ' 110' ' ' LEU . 3.3 mm? -81.5 -23.38 37.37 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.77 0.828 . . . . 0.0 110.723 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.52 -51.58 41.49 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.106 172.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -71.52 -24.56 61.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.647 0.779 . . . . 0.0 111.424 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -77.94 -31.05 50.73 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.778 0.431 . . . . 0.0 109.876 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.445 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -67.76 -34.34 82.77 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.033 171.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 89.5 mmm -66.35 -49.29 67.43 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.492 0.717 . . . . 0.0 109.474 170.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -56.11 -55.6 31.05 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.972 1.309 . . . . 0.0 111.726 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 59.4 mt -78.87 -55.75 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.459 0.704 . . . . 0.0 111.028 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -97.53 -75.04 0.55 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -170.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.47 13.64 6.15 Favored Glycine 0 N--CA 1.474 1.215 0 CA-C-O 118.87 -0.961 . . . . 0.0 115.489 -161.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 69.14 128.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.195 1.398 . . . . 0.0 111.153 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.4 tt -111.01 90.99 12.05 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -87.96 -2.32 7.2 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.279 1.986 . . . . 0.0 112.055 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.71 83.98 1.66 Allowed Glycine 0 C--N 1.333 0.417 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -172.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -137.12 72.47 0.45 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -87.11 -172.94 1.0 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 123.025 2.483 . . . . 0.0 111.675 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.9 m -65.05 111.34 5.68 Favored Pre-proline 0 CA--C 1.561 1.369 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 170.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.13 -19.15 39.5 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.159 2.573 . . . . 0.0 113.332 -168.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -108.77 6.7 25.85 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.898 1.279 . . . . 0.0 110.29 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.8 t70 73.14 -2.91 2.59 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 124.723 1.209 . . . . 0.0 111.388 -173.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 71.11 -69.84 0.17 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.279 1.831 . . . . 0.0 110.739 -174.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 56.83 -162.24 0.19 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.479 1.112 . . . . 0.0 111.758 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -120.66 -30.43 4.49 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.253 0.621 . . . . 0.0 111.79 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -106.22 91.22 3.63 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.628 0.371 . . . . 0.0 110.478 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -147.07 115.4 6.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.368 0.667 . . . . 0.0 110.148 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -84.84 -54.79 0.44 Allowed Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.715 0.806 . . . . 0.0 112.15 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -85.84 18.06 1.64 Allowed 'Trans proline' 0 C--N 1.4 3.245 0 C-N-CA 123.242 2.628 . . . . 0.0 113.045 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.1 t -106.46 88.79 3.55 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.29 -40.76 5.63 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.786 2.324 . . . . 0.0 112.43 -171.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -66.21 -46.88 75.72 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 124.122 0.889 . . . . 0.0 110.815 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 6.6 tpt -69.28 -40.96 77.44 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.393 0.277 . . . . 0.0 110.777 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 59.8 mmm -54.21 -44.13 71.37 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.582 0.551 . . . . 0.0 110.202 171.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -69.56 -57.1 5.62 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 124.113 0.883 . . . . 0.0 111.008 -173.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.466 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 71.7 mt -51.92 -46.52 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.698 0.799 . . . . 0.0 111.982 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.2 p -71.0 -50.44 34.24 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.353 0.408 . . . . 0.0 110.645 -173.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -57.03 -48.82 77.58 Favored 'General case' 0 CA--C 1.557 1.224 0 O-C-N 124.044 0.84 . . . . 0.0 111.062 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -44.23 -48.03 9.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.315 1.046 . . . . 0.0 112.401 171.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 15.0 mmp_? -60.24 -52.03 67.03 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.375 0.422 . . . . 0.0 111.485 178.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -72.52 -37.85 58.06 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.285 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.17 -25.5 47.24 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.166 0.586 . . . . 0.0 110.985 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.03 -53.12 28.17 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.458 ' CZ2' HG12 ' A' ' 26' ' ' ILE . 97.5 m95 -71.35 -25.65 62.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.495 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.75 -59.56 4.1 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.31 -38.53 42.04 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.779 1.232 . . . . 0.0 112.975 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 53.9 mt -66.95 -49.1 66.53 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.614 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.7 p -81.93 -30.07 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 122.95 0.5 . . . . 0.0 111.218 -165.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -57.56 -30.06 64.92 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.639 0.775 . . . . 0.0 110.925 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 17.6 m -62.43 -26.18 68.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.274 1.03 . . . . 0.0 112.315 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -85.51 16.79 38.15 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 114.238 0.455 . . . . 0.0 114.238 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.255 1.382 0 C-N-CA 123.739 0.816 . . . . 0.0 108.877 175.049 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.1 78.64 3.63 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 169.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.7 m -148.48 17.35 1.04 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.267 -172.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.67 118.66 11.96 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.64 125.73 32.91 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.502 0.667 . . . . 0.0 110.868 -175.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.494 ' HB3' ' HD3' ' A' ' 29' ' ' ARG . . . -153.51 75.25 1.04 Allowed 'General case' 0 C--O 1.242 0.671 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 28' ' ' GLN . 29.7 m -96.11 98.28 10.22 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.764 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.04 140.36 29.72 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.129 175.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.448 ' HG3' HD11 ' A' ' 177' ' ' LEU . 16.9 ptp180 -108.87 147.09 32.67 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 170.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -159.2 -177.84 6.76 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.273 0.559 . . . . 0.0 110.736 -169.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -144.98 150.52 37.07 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.986 -176.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.38 -177.86 23.86 Favored Glycine 0 CA--C 1.507 -0.406 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 175.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 30.6 ptt180 -125.16 131.36 53.24 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 171.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 8.3 tpt180 -135.81 114.83 12.24 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.9 m -78.67 98.19 6.12 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.429 HD11 HG23 ' A' ' 117' ' ' THR . 30.9 pt -81.16 166.9 35.76 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.674 1.59 . . . . 0.0 111.068 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -38.84 -34.42 0.43 Allowed 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 125.028 3.819 . . . . 0.0 115.198 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . . . -67.74 -56.59 8.69 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.682 0.393 . . . . 0.0 110.961 173.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.76 -157.58 30.12 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.494 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.67 105.25 1.2 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.53 0.732 . . . . 0.0 111.326 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -112.8 165.81 11.96 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.887 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 82.6 mtt-85 -105.94 168.01 9.41 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 165.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.3 p -138.5 141.95 39.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.285 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.2 pt -84.77 145.97 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 166.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 48.7 mt -129.92 107.39 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.9 mt -106.28 103.9 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 80.9 mtp180 -95.44 143.77 26.5 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.419 ' HB3' HG23 ' A' ' 7' ' ' THR . 6.9 pt20 -162.65 138.84 7.41 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.2 0.937 . . . . 0.0 111.665 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.494 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 7.5 mpt_? -95.72 105.94 17.99 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.408 ' CE1' HD13 ' A' ' 110' ' ' LEU . 19.6 m-85 -76.04 132.77 40.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.594 0.757 . . . . 0.0 109.7 169.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -79.95 45.09 0.69 Allowed 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.132 0.968 . . . . 0.0 109.787 171.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.66 147.9 34.66 Favored Pre-proline 0 C--O 1.24 0.592 0 C-N-CA 124.102 0.961 . . . . 0.0 109.141 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.8 167.33 21.58 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.844 2.363 . . . . 0.0 112.992 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.93 -50.21 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.315 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.52 -40.01 81.73 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.224 0.953 . . . . 0.0 111.244 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.43 -63.16 1.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 123.847 0.717 . . . . 0.0 111.082 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.5 t -49.99 -41.77 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.648 1.179 . . . . 0.0 111.253 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -58.82 -55.6 33.08 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.976 0.911 . . . . 0.0 110.183 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 t -54.98 -45.34 74.98 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 124.222 0.951 . . . . 0.0 110.975 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.08 -36.28 79.23 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.673 176.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.488 ' SG ' HD21 ' A' ' 136' ' ' LEU . 74.6 m -77.69 -25.2 49.27 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.8 p -108.26 -43.02 4.46 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -168.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.96 126.04 88.0 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 123.209 0.604 . . . . 0.0 111.679 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.1 -38.2 92.51 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.325 2.683 . . . . 0.0 112.802 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -63.37 -22.12 66.69 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.252 1.021 . . . . 0.0 111.676 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.6 mtt85 -100.76 -29.76 12.09 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.804 0.841 . . . . 0.0 109.945 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.465 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 91.9 mt -71.72 -42.37 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.881 0.872 . . . . 0.0 111.642 -178.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 12.4 p30 -57.57 -22.46 44.96 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.418 ' HG2' ' CD1' ' A' ' 139' ' ' PHE . 7.1 tpm_? -68.81 -46.5 68.46 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.577 0.751 . . . . 0.0 111.989 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.465 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 65.1 p-90 -112.5 6.99 18.83 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.598 0.759 . . . . 0.0 112.685 -170.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.429 ' HB3' HG23 ' A' ' 47' ' ' ILE . 20.8 t80 -174.59 173.92 2.79 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -166.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.5 mt -84.61 126.39 40.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 33.4 tt0 -70.31 119.93 75.22 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.716 1.206 . . . . 0.0 109.917 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.599 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 89.9 Cg_endo -78.86 124.34 6.15 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.453 2.102 . . . . 0.0 112.983 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -67.41 145.84 54.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.042 1.337 . . . . 0.0 111.245 172.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.32 -164.89 13.23 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 124.0 0.812 . . . . 0.0 113.427 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.532 ' HB2' ' HA3' ' A' ' 62' ' ' GLY . 34.7 m-20 -75.08 -31.07 61.13 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.709 0.804 . . . . 0.0 111.926 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.0 mt 66.95 12.12 8.76 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.007 1.323 . . . . 0.0 113.049 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -123.35 171.46 9.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.784 0.833 . . . . 0.0 111.153 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.624 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 33.1 tt0 -65.51 106.29 1.39 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.932 0.893 . . . . 0.0 111.811 -171.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.63 -27.94 8.08 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' ' 57' ' ' ASP . . . -84.68 -175.13 50.65 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 167.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 29.0 t-20 -129.48 149.45 51.25 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.266 1.026 . . . . 0.0 110.053 -170.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 20.5 p90 -109.66 154.46 22.81 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 165.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.66 119.61 1.68 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.994 0.815 . . . . 0.0 110.612 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' A' ' 69' ' ' ASN . 61.8 mt -87.02 166.32 15.14 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -88.88 -24.28 22.55 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.143 0.577 . . . . 0.0 109.748 -175.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.28 67.81 0.27 Allowed Glycine 0 C--N 1.342 0.867 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.052 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.488 ' HB3' HD12 ' A' ' 66' ' ' LEU . 54.3 t30 -162.59 -67.38 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.803 0.841 . . . . 0.0 109.542 170.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.02 172.49 6.47 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.796 0.438 . . . . 0.0 111.328 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.3 t -145.36 143.98 30.44 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.564 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.56 164.38 36.22 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 9.0 p-10 -94.91 168.93 10.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 117.925 0.863 . . . . 0.0 110.16 176.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 74' ' ' ILE . 2.8 mp -95.75 106.02 17.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.2 mt -72.36 -53.34 12.59 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.333 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -135.18 132.15 37.6 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.681 1.193 . . . . 0.0 108.474 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.1 p -126.18 118.29 24.88 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 166.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.37 74.75 23.36 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 96.3 Cg_endo -76.72 141.89 22.29 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.215 1.943 . . . . 0.0 112.785 -171.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 27.6 Cg_endo -98.46 28.03 16.17 Favored 'Cis proline' 0 C--N 1.375 1.965 0 CA-C-N 119.269 0.775 . . . . 0.0 112.03 -5.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -79.23 -62.15 1.79 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.044 0.937 . . . . 0.0 110.696 -169.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -153.69 162.89 40.84 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.996 0.918 . . . . 0.0 110.413 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 pp -135.71 143.3 45.3 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 166.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.2 m -122.84 110.17 15.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.6 pt -105.96 173.76 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.049 1.34 . . . . 0.0 110.599 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.7 p -109.57 168.54 9.32 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 34.0 t-105 -156.62 106.07 2.28 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -172.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.2 t -106.89 112.95 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.492 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 62.8 t80 -100.81 162.24 13.05 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 125.029 1.332 . . . . 0.0 108.42 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -50.19 -40.47 47.14 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.61 -6.54 19.39 Favored Glycine 0 N--CA 1.47 0.958 0 CA-C-N 116.529 -0.305 . . . . 0.0 112.75 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.732 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 67.3 mmtt -106.72 104.43 51.19 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.63 -30.32 42.53 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.824 2.349 . . . . 0.0 113.348 -168.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.685 ' HB3' ' HB2' ' A' ' 18' ' ' ALA . 26.2 t70 -152.47 134.94 15.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.269 0.557 . . . . 0.0 110.359 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.588 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 36.7 m -144.07 164.02 31.87 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 125.63 1.572 . . . . 0.0 106.9 169.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -142.92 119.12 10.79 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.5 t -109.16 148.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.279 1.031 . . . . 0.0 109.517 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.08 157.66 41.77 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.63 1.172 . . . . 0.0 110.197 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.3 tp -142.49 118.12 10.4 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.51 ' HE ' ' HB2' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -122.36 117.13 25.31 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.841 0.856 . . . . 0.0 109.597 -174.093 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.4 mt -107.04 136.18 47.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.933 0.893 . . . . 0.0 110.368 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.6 m -143.38 124.24 14.28 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.472 1.109 . . . . 0.0 108.803 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.37 143.72 57.69 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.237 1.415 . . . . 0.0 111.291 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.97 118.45 4.13 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.5 -102.92 0.94 Allowed Glycine 0 C--N 1.347 1.151 0 C-N-CA 123.098 0.38 . . . . 0.0 112.252 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -125.38 7.11 7.71 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.729 0.812 . . . . 0.0 110.278 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -114.92 -165.12 14.78 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.8 m -150.13 135.41 18.03 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.393 0.677 . . . . 0.0 109.777 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 45.7 tp -81.19 128.15 33.46 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 167.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.408 HD13 ' CE1' ' A' ' 30' ' ' TYR . 9.6 tt -115.22 113.59 24.11 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.51 ' HB2' ' HE ' ' A' ' 100' ' ' ARG . 51.2 mt-10 -113.12 105.53 13.56 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 171.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.649 HD13 HD21 ' A' ' 133' ' ' LEU . 7.0 tt -99.44 104.6 16.46 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 171.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -104.46 119.26 38.56 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.696 0.798 . . . . 0.0 109.712 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -109.72 114.93 28.92 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.92 121.68 44.23 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.335 0.654 . . . . 0.0 110.834 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.442 HG23 ' HG ' ' A' ' 122' ' ' LEU . 7.8 t -140.21 158.6 43.79 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.637 0.732 . . . . 0.0 110.176 172.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.429 HG23 HD11 ' A' ' 16' ' ' ILE . 11.9 p -85.23 -3.15 58.72 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.792 -175.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.3 t -105.25 121.88 44.78 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.749 0.82 . . . . 0.0 110.203 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.437 ' HA ' HD12 ' A' ' 122' ' ' LEU . 43.0 tt0 -66.34 -37.4 85.27 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.362 0.665 . . . . 0.0 111.528 -177.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -62.38 -58.57 7.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.253 0.221 . . . . 0.0 110.996 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.732 ' SD ' ' HG3' ' A' ' 92' ' ' LYS . 21.2 ttt -46.72 -41.02 14.45 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.493 1.121 . . . . 0.0 112.176 175.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 116' ' ' THR . 26.9 mt -57.35 -50.9 71.5 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.361 0.664 . . . . 0.0 112.111 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 127' ' ' VAL . 41.4 t -62.53 -50.07 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -61.0 -36.42 79.44 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.182 0.993 . . . . 0.0 113.296 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -80.17 -23.13 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 118.56 0.618 . . . . 0.0 110.031 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 130' ' ' GLU . . . -62.06 -37.75 94.96 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 171.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 123' ' ' VAL . 44.4 t -79.41 -49.52 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.792 0.837 . . . . 0.0 109.204 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.98 -60.32 9.11 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.972 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -61.44 -36.13 79.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.498 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 21.5 tt0 -59.65 -37.59 79.14 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.783 0.72 . . . . 0.0 110.317 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 67.6 mtt -72.25 -39.89 68.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.113 0.565 . . . . 0.0 110.927 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.85 -58.29 9.08 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 123.812 0.695 . . . . 0.0 110.853 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.649 HD21 HD13 ' A' ' 112' ' ' LEU . 3.4 mm? -60.36 -26.16 66.41 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 172.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.15 -38.68 88.71 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -66.71 -36.78 83.31 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.1 0.56 . . . . 0.0 110.234 174.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.488 HD21 ' SG ' ' A' ' 41' ' ' CYS . 42.4 tp -70.91 -56.71 5.65 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.383 0.673 . . . . 0.0 111.14 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -43.52 -42.06 5.67 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 167.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.432 ' HG2' ' HB2' ' A' ' 144' ' ' LEU . 50.2 ttm -66.7 -45.11 79.8 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.394 0.677 . . . . 0.0 111.121 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.418 ' CD1' ' HG2' ' A' ' 49' ' ' ARG . 18.1 t80 -61.35 -59.87 4.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.813 0.845 . . . . 0.0 111.087 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.2 mt -57.89 -36.63 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.795 1.238 . . . . 0.0 112.037 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -58.75 -35.24 72.42 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.955 0.502 . . . . 0.0 111.019 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 123.28 33.92 0.8 Allowed Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.046 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 29.5 t0 -135.08 -167.88 2.07 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.432 ' HB2' ' HG2' ' A' ' 138' ' ' MET . 18.3 tp 65.15 47.34 0.59 Allowed Pre-proline 0 CA--C 1.576 1.959 0 C-N-CA 125.359 1.463 . . . . 0.0 112.01 -172.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -85.29 -18.92 3.89 Favored 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 121.777 1.651 . . . . 0.0 112.798 177.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.61 50.01 0.89 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -112.58 77.69 0.24 Allowed Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -70.82 -20.11 30.26 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.186 2.591 . . . . 0.0 113.414 -167.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.4 m -122.12 119.76 28.57 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 122.907 0.483 . . . . 0.0 110.317 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.02 -11.3 29.0 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.76 2.307 . . . . 0.0 111.842 165.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -88.48 26.53 1.44 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.202 1.001 . . . . 0.0 109.606 171.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.48 -15.9 52.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.609 1.164 . . . . 0.0 111.642 169.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.04 -12.94 9.31 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 124.418 1.087 . . . . 0.0 112.104 169.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 79.21 -26.13 0.18 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.612 1.565 . . . . 0.0 114.176 165.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 69.88 143.08 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.917 1.287 . . . . 0.0 110.039 -163.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -73.6 76.21 1.49 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.658 1.183 . . . . 0.0 111.089 -173.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -164.95 174.53 10.42 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.56 1.944 . . . . 0.0 108.049 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 59.8 102.92 0.03 OUTLIER Pre-proline 0 N--CA 1.479 1.018 0 C-N-CA 125.292 1.437 . . . . 0.0 111.082 -175.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.649 ' HA ' ' SD ' ' A' ' 164' ' ' MET . 18.7 Cg_endo -57.52 84.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.143 2.562 . . . . 0.0 112.943 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.9 m -104.07 109.84 63.08 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.577 1.151 . . . . 0.0 108.095 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -50.74 -55.41 4.1 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.419 2.746 . . . . 0.0 113.918 -170.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.45 -40.89 85.43 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.246 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 12.2 tpt -71.76 -46.2 59.23 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 120.57 0.224 . . . . 0.0 111.036 -175.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.649 ' SD ' ' HA ' ' A' ' 159' ' ' PRO . 89.5 mtp -59.29 -41.08 88.1 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.396 175.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.481 ' O ' ' HG3' ' A' ' 169' ' ' GLU . 19.7 tpp180 -52.83 -52.02 58.67 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.878 0.736 . . . . 0.0 110.541 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.448 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 82.9 mt -59.36 -52.26 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 124.013 0.82 . . . . 0.0 110.399 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.5 t -59.32 -27.07 65.56 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.94 0.896 . . . . 0.0 111.869 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -77.03 -50.3 13.43 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.541 ' HB2' HH11 ' A' ' 170' ' ' ARG . 45.8 mt-10 -55.65 -50.58 69.84 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 124.168 0.918 . . . . 0.0 110.692 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.541 HH11 ' HB2' ' A' ' 169' ' ' GLU . 15.1 mmt-85 -67.12 -50.28 62.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.776 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -49.46 -44.04 36.19 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 124.193 0.933 . . . . 0.0 114.553 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -67.27 -41.15 85.97 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.777 0.831 . . . . 0.0 111.371 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.1 -41.57 73.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.419 0.688 . . . . 0.0 111.466 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -78.38 -27.36 46.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.502 0.721 . . . . 0.0 111.676 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -71.82 -31.83 66.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.75 0.42 . . . . 0.0 110.373 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -73.3 -31.76 64.22 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.287 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.448 HD11 ' HG3' ' A' ' 9' ' ' ARG . 54.9 mt -71.55 -55.61 7.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.949 0.9 . . . . 0.0 111.51 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.21 -32.32 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -172.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -78.52 -4.12 47.05 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.7 m -100.73 -172.7 2.23 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.884 0.874 . . . . 0.0 110.527 171.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.8 -61.62 2.69 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.477 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 CA--C 1.562 1.415 0 C-N-CA 124.823 1.249 . . . . 0.0 112.2 -179.737 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ptm . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.46 -75.26 0.33 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 169.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.9 m -114.56 64.02 0.67 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.59 -62.99 2.66 Favored Glycine 0 C--N 1.35 1.328 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -172.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -121.98 -169.68 1.92 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.883 1.273 . . . . 0.0 109.441 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.26 56.54 1.0 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 m -97.72 142.07 29.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.924 0.889 . . . . 0.0 111.99 -172.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -122.91 108.82 13.39 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.157 0.983 . . . . 0.0 108.644 169.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.29 141.92 57.04 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.917 171.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -157.63 164.86 36.8 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.463 HD12 ' HA3' ' A' ' 181' ' ' GLY . 0.2 OUTLIER -142.51 149.06 38.65 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.726 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' H ' HD13 ' A' ' 11' ' ' LEU . . . -153.43 -158.32 8.51 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 177.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -135.35 164.93 26.63 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.989 0.915 . . . . 0.0 109.342 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.496 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 15.8 tpt180 -152.39 152.99 32.72 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.978 0.911 . . . . 0.0 108.572 -174.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -111.85 129.61 56.09 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.4 pt -136.05 161.99 59.27 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.015 0.926 . . . . 0.0 109.941 -175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.31 -21.05 16.45 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.533 2.822 . . . . 0.0 114.836 175.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.05 -43.33 58.21 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.004 0.431 . . . . 0.0 110.975 174.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 151.42 -129.24 2.79 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -79.2 136.75 37.17 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.182 0.491 . . . . 0.0 109.891 174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . . . -127.17 155.51 43.27 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 3.9 mpt_? -114.31 161.05 18.38 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 165.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.8 p -134.46 130.27 36.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.183 -168.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.413 ' HA ' HD22 ' A' ' 11' ' ' LEU . 36.9 pt -85.97 135.65 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 168.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 4.0 mp -121.16 119.05 58.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.9 mt -104.76 108.64 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 33.9 mtm105 -105.28 101.78 11.31 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -108.0 118.59 37.15 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.6 tpt85 -91.09 103.53 16.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.406 ' CE1' ' HA2' ' A' ' 137' ' ' GLY . 24.8 m-85 -86.69 149.73 24.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.27 178.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -102.7 72.97 1.26 Allowed 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.15 150.7 5.29 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 125.833 1.653 . . . . 0.0 107.943 -164.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.64 146.0 23.64 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.679 2.253 . . . . 0.0 113.45 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.3 t -49.63 -35.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 124.535 1.134 . . . . 0.0 111.915 173.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -52.81 -42.62 65.27 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 123.508 0.505 . . . . 0.0 110.951 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -86.66 -30.88 21.39 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.08 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.496 HG22 HD13 ' A' ' 140' ' ' ILE . 52.7 t -69.12 -49.48 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 123.601 0.563 . . . . 0.0 110.44 175.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -65.88 -26.29 67.57 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.903 1.281 . . . . 0.0 111.096 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.3 t -65.95 -48.91 69.76 Favored 'General case' 0 C--N 1.353 0.761 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 173.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -59.62 -34.74 73.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.912 0.885 . . . . 0.0 112.515 174.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.468 ' SG ' HD21 ' A' ' 99' ' ' LEU . 79.4 m -69.41 -38.04 77.75 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.2 p -105.73 -43.91 4.79 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -167.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.494 ' O ' HG13 ' A' ' 47' ' ' ILE . 65.4 m-20 -76.32 118.46 71.54 Favored Pre-proline 0 N--CA 1.478 0.933 0 CA-C-O 118.131 -0.938 . . . . 0.0 110.298 -175.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.402 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 25.6 Cg_endo -57.39 -23.78 57.01 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.151 2.568 . . . . 0.0 111.72 174.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -59.46 -44.36 93.0 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.75 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 12.2 mmm180 -89.37 -26.12 21.22 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.283 1.033 . . . . 0.0 111.396 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.495 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 87.0 mt -73.91 -34.72 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -174.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.57 HD21 ' HB3' ' A' ' 53' ' ' GLU . 69.7 m-20 -66.79 2.89 1.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.66 -9.89 33.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.925 0.89 . . . . 0.0 110.833 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.495 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 37.7 p-90 -146.49 -27.57 0.41 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.595 0.758 . . . . 0.0 112.36 -174.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.486 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 16.6 t80 -147.11 -145.06 0.16 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.412 1.085 . . . . 0.0 108.847 -175.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.82 139.74 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.821 0.848 . . . . 0.0 111.813 -159.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.57 ' HB3' HD21 ' A' ' 48' ' ' ASN . 10.0 pt-20 -65.33 110.42 4.3 Favored Pre-proline 0 CA--C 1.566 1.576 0 O-C-N 125.122 1.514 . . . . 0.0 110.555 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HB2' HD21 ' A' ' 58' ' ' LEU . 4.1 Cg_exo -80.23 98.98 1.13 Allowed 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.0 2.467 . . . . 0.0 111.982 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -72.92 97.97 2.38 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 64' ' ' PHE . . . -176.09 169.65 42.32 Favored Glycine 0 C--O 1.241 0.578 0 C-N-CA 121.547 -0.358 . . . . 0.0 112.955 -172.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.69 -34.55 78.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.443 0.697 . . . . 0.0 111.253 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 54' ' ' PRO . 96.1 mt 56.11 70.73 0.61 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.747 1.219 . . . . 0.0 112.718 172.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.455 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 9.3 ptp85 -171.37 171.21 5.63 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.057 0.943 . . . . 0.0 109.495 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.429 ' HG3' ' HA ' ' A' ' 76' ' ' ARG . 28.7 tt0 -54.96 116.17 2.61 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.906 0.882 . . . . 0.0 110.263 174.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.85 8.76 83.83 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 113.945 0.338 . . . . 0.0 113.945 -177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.0 178.16 20.66 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 27.4 p-10 -112.66 177.29 4.68 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 118.043 0.921 . . . . 0.0 112.471 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.512 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 48.4 p90 -149.8 139.31 21.54 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 170.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.09 121.65 24.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.812 0.445 . . . . 0.0 110.721 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.6 mt -94.3 132.55 38.77 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -33.63 -56.97 0.44 Allowed 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 126.264 1.826 . . . . 0.0 114.491 -172.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -136.36 5.56 3.86 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.916 -0.584 . . . . 0.0 113.514 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -90.1 -86.9 0.19 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.984 0.892 . . . . 0.0 110.045 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.74 154.56 39.77 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.241 0.543 . . . . 0.0 111.046 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -131.81 149.5 52.44 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.388 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.52 -154.43 9.18 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.597 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 11.5 m-20 -129.39 178.2 6.62 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.997 0.519 . . . . 0.0 110.214 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.594 HG13 HG22 ' A' ' 85' ' ' ILE . 3.4 mp -108.49 117.46 54.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 173.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 86' ' ' SER . 62.0 mt -74.7 -39.9 61.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.072 0.949 . . . . 0.0 110.282 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.429 ' HA ' ' HG3' ' A' ' 60' ' ' GLU . 16.9 ptm180 -168.32 149.76 5.05 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.922 1.289 . . . . 0.0 108.634 173.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 22.0 p -147.91 119.86 8.19 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.933 0.493 . . . . 0.0 110.388 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -121.18 97.35 47.77 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.173 0.989 . . . . 0.0 109.834 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 91.4 Cg_endo -75.91 142.16 24.88 Favored 'Trans proline' 0 CA--C 1.56 1.813 0 C-N-CA 122.502 2.135 . . . . 0.0 112.297 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 16.1 Cg_endo -97.59 20.96 27.03 Favored 'Cis proline' 0 C--N 1.376 1.983 0 CA-C-N 119.665 0.916 . . . . 0.0 113.043 -5.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -74.43 -60.92 2.05 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.51 0.724 . . . . 0.0 112.199 -169.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -153.19 159.85 42.74 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.859 0.838 . . . . 0.0 111.691 -169.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 99' ' ' LEU . 63.4 tp -134.08 145.44 49.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.626 1.57 . . . . 0.0 107.647 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.419 HG22 HD12 ' A' ' 75' ' ' LEU . 23.9 m -137.11 121.68 18.42 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 172.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.594 HG22 HG13 ' A' ' 74' ' ' ILE . 31.0 pt -134.47 141.88 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.342 1.057 . . . . 0.0 109.703 -176.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.54 ' HB2' HD21 ' A' ' 75' ' ' LEU . 22.7 t -90.73 140.75 29.49 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 168.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 28.5 t-105 -128.97 100.56 5.7 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.178 1.391 . . . . 0.0 107.644 -167.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.3 t -96.35 102.64 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.435 ' HD2' ' HG3' ' A' ' 92' ' ' LYS . 37.4 t80 -98.07 162.04 13.42 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 174.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.44 115.8 4.97 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.386 0.674 . . . . 0.0 112.015 -168.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.93 14.99 79.82 Favored Glycine 0 C--N 1.356 1.664 0 O-C-N 123.71 0.631 . . . . 0.0 113.775 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.486 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 67.1 mmtt -109.28 153.45 42.69 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.793 0.837 . . . . 0.0 109.895 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.96 143.45 60.47 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.181 1.921 . . . . 0.0 110.391 170.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.21 107.62 0.93 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.916 0.865 . . . . 0.0 109.73 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.489 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.5 m -77.75 145.59 36.4 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.427 -172.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -103.53 105.38 15.61 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.0 144.41 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.592 1.157 . . . . 0.0 108.623 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HG2' HG23 ' A' ' 84' ' ' THR . 22.4 mt-10 -132.35 148.62 52.43 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.636 0.774 . . . . 0.0 109.603 171.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 83' ' ' LEU . 39.9 tp -125.3 108.56 11.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -107.27 145.76 32.33 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.545 0.738 . . . . 0.0 110.149 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 110' ' ' LEU . 82.9 mt -134.34 141.35 46.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.696 1.199 . . . . 0.0 109.233 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.2 m -136.54 122.57 20.23 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.126 0.97 . . . . 0.0 109.411 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.57 101.43 9.97 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.69 100.96 7.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.922 -170.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.78 -126.09 8.27 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.806 0.717 . . . . 0.0 112.897 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -90.91 27.09 1.9 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.294 0.638 . . . . 0.0 109.647 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -161.7 -172.05 28.57 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 120.363 -0.923 . . . . 0.0 115.245 -172.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.1 m -136.54 125.17 23.73 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.1 1.36 . . . . 0.0 109.386 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.9 tp -82.27 116.04 21.62 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 167.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 1.7 tm? -83.38 133.97 34.92 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 165.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -140.48 105.37 4.96 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.5 tp -103.9 132.63 49.97 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.292 1.037 . . . . 0.0 109.015 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -129.18 102.67 6.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.254 0.621 . . . . 0.0 110.095 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -95.53 113.96 25.66 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 172.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -117.57 103.79 10.41 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.153 0.581 . . . . 0.0 110.78 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 t -121.52 161.83 21.63 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.684 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 5.94 14.85 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.671 1.188 . . . . 0.0 111.781 -175.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.565 ' HB3' ' HG2' ' A' ' 120' ' ' GLN . 66.6 m -132.37 123.47 26.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.442 0.697 . . . . 0.0 110.7 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.535 ' HA ' HD12 ' A' ' 122' ' ' LEU . 4.7 mp0 -72.53 -29.36 63.53 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.0 0.92 . . . . 0.0 109.828 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.565 ' HG2' ' HB3' ' A' ' 118' ' ' SER . 5.2 pt20 -58.73 -44.91 90.57 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.491 1.119 . . . . 0.0 110.821 173.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 24.3 ttt -71.23 -33.96 70.34 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.778 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 119' ' ' GLU . 36.6 mt -64.74 -39.53 93.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 119' ' ' GLU . 95.0 t -69.58 -41.62 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.303 0.573 . . . . 0.0 109.712 176.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -59.56 -58.35 8.98 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.03 1.332 . . . . 0.0 111.453 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 121' ' ' MET . 18.0 m -74.2 -14.85 16.32 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 C-N-CA 123.262 0.625 . . . . 0.0 110.339 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 130' ' ' GLU . . . -61.61 -37.28 93.95 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 166.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.73 -47.17 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 O-C-N 124.114 0.538 . . . . 0.0 109.732 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.69 -30.38 76.21 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.916 0.76 . . . . 0.0 114.498 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -88.05 -41.04 13.36 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -60.37 -32.64 71.48 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.575 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 41.0 ttm -66.16 -56.03 13.4 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.316 1.046 . . . . 0.0 110.49 175.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.17 79.73 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.88 0.738 . . . . 0.0 111.43 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.549 HD13 HD23 ' A' ' 136' ' ' LEU . 4.5 mm? -82.65 -20.85 35.46 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.422 1.089 . . . . 0.0 110.904 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.65 -51.98 43.58 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -74.29 -24.55 59.26 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.35 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.549 HD23 HD13 ' A' ' 133' ' ' LEU . 31.7 tp -70.82 -41.57 71.37 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 171.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.406 ' HA2' ' CE1' ' A' ' 30' ' ' TYR . . . -58.03 -42.97 95.27 Favored Glycine 0 C--O 1.219 -0.832 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.151 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 87.5 mtp -75.2 -32.96 61.35 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.43 0.692 . . . . 0.0 111.559 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -63.19 -46.25 87.97 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.487 0.715 . . . . 0.0 110.704 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.496 HD13 HG22 ' A' ' 37' ' ' VAL . 80.6 mt -76.46 -61.16 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.148 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -148.76 93.36 2.11 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.178 0.991 . . . . 0.0 109.665 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.12 5.73 0.05 OUTLIER Glycine 0 N--CA 1.474 1.181 0 CA-C-O 119.685 -0.509 . . . . 0.0 113.839 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 61.36 82.43 0.17 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.976 1.31 . . . . 0.0 111.706 174.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.04 -47.73 96.28 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 124.078 0.951 . . . . 0.0 111.324 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.44 -7.86 20.42 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 122.254 1.969 . . . . 0.0 113.208 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.56 59.63 Favored Glycine 0 C--N 1.349 1.297 0 O-C-N 123.378 0.424 . . . . 0.0 112.318 171.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.92 76.83 0.19 Allowed Glycine 0 C--N 1.347 1.146 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.99 -12.55 23.79 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.909 2.406 . . . . 0.0 112.255 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.27 149.89 72.58 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.95 1.3 . . . . 0.0 108.577 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.57 -59.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.242 1.961 . . . . 0.0 108.706 164.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 172.06 82.36 0.0 OUTLIER 'General case' 0 C--N 1.342 0.251 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 167.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -77.68 68.71 3.81 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.688 0.756 . . . . 0.0 110.958 -173.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.21 -50.29 14.87 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.455 170.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -165.91 130.5 2.3 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.8 169.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.417 ' HG2' ' HG3' ' A' ' 156' ' ' GLU . 38.1 tt0 -78.98 -50.19 11.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.917 1.287 . . . . 0.0 110.435 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.417 ' HG3' ' HG2' ' A' ' 155' ' ' GLU . 48.1 mt-10 -133.59 160.04 38.66 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.475 1.11 . . . . 0.0 110.731 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 74.32 -44.92 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 126.756 2.022 . . . . 0.0 113.601 174.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 31.3 mt-10 -99.32 124.7 43.91 Favored Pre-proline 0 C--O 1.244 0.772 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.417 ' HA ' ' HG3' ' A' ' 164' ' ' MET . 2.6 Cg_exo -74.37 84.35 1.56 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.871 2.381 . . . . 0.0 112.444 -177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.7 m -90.31 96.23 0.86 Allowed Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 168.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -30.74 -60.83 0.14 Allowed 'Trans proline' 0 C--N 1.387 2.56 1 C-N-CA 125.315 4.01 . . . . 0.0 115.648 -161.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.481 ' O ' HG12 ' A' ' 166' ' ' ILE . 9.9 tp10 -78.62 -44.91 22.8 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.22 -172.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 12.0 tpt -68.89 -44.61 72.88 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 118.747 0.703 . . . . 0.0 110.843 -173.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.417 ' HG3' ' HA ' ' A' ' 159' ' ' PRO . 3.4 tmm? -54.69 -44.31 73.26 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.37 173.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -63.47 -44.75 93.54 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.133 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 162' ' ' GLU . 33.5 mm -54.78 -43.05 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 C-N-CA 123.917 0.887 . . . . 0.0 110.605 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 10.2 t -73.84 -47.74 36.23 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.194 -177.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -59.02 -60.65 3.54 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.227 0.954 . . . . 0.0 112.67 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -39.57 -53.98 2.04 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 124.19 0.996 . . . . 0.0 113.371 174.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -68.85 -37.1 78.89 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.474 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -72.15 -47.88 28.34 Favored Glycine 0 C--N 1.348 1.212 0 C-N-CA 121.818 -0.23 . . . . 0.0 112.555 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.79 -23.65 67.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.137 1.375 . . . . 0.0 111.428 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.07 -50.75 18.26 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.365 0.666 . . . . 0.0 110.071 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -63.28 -25.13 68.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.303 0.641 . . . . 0.0 111.249 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.89 -59.21 3.22 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.091 0.556 . . . . 0.0 109.99 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.3 -30.64 62.78 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.349 1.06 . . . . 0.0 112.686 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 38.4 mt -66.88 -46.27 75.45 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.855 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.41 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 7.3 p -80.5 -27.97 11.67 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 118.65 0.659 . . . . 0.0 110.369 -171.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -69.27 -27.33 65.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.561 0.744 . . . . 0.0 110.389 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 38.9 t -90.26 -24.15 21.02 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.56 0.744 . . . . 0.0 110.678 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.463 ' HA3' HD12 ' A' ' 11' ' ' LEU . . . -101.4 7.42 56.26 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-O 119.609 -0.551 . . . . 0.0 114.337 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.6 p . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.921 176.233 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' A' ' 143' ' ' ASP . . . -78.4 78.85 4.86 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.105 0.562 . . . . 0.0 109.692 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.2 p -77.83 114.28 16.53 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.976 0.911 . . . . 0.0 110.139 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.743 ' HA2' HH11 ' A' ' 141' ' ' ARG . . . -116.1 -13.25 8.53 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 123.191 0.307 . . . . 0.0 113.352 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -70.5 150.13 46.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.583 0.753 . . . . 0.0 111.446 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.552 ' H ' HE21 ' A' ' 28' ' ' GLN . . . -141.14 52.22 1.58 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.34 1.056 . . . . 0.0 108.555 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 10.3 m -83.87 128.03 34.25 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.593 -1.185 . . . . 0.0 113.638 -165.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 33.5 tt0 -113.57 120.16 39.99 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.538 1.535 . . . . 0.0 107.445 166.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HB3' HD11 ' A' ' 177' ' ' LEU . 66.6 mtt180 -85.52 144.41 27.94 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.159 0.583 . . . . 0.0 110.536 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -158.43 -179.6 8.25 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 122.851 0.46 . . . . 0.0 111.343 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.0 mt -142.59 167.06 22.99 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 122.397 1.094 . . . . 0.0 111.36 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.14 176.81 29.48 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 113.059 -1.882 . . . . 0.0 109.494 166.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 37.0 ttm180 -132.38 122.17 24.6 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.406 ' HD2' ' OE2' ' A' ' 113' ' ' GLU . 31.0 ttt180 -131.36 128.09 38.94 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.576 0.751 . . . . 0.0 109.037 -173.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.2 m -93.21 117.86 30.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -173.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.412 HD11 ' OG1' ' A' ' 117' ' ' THR . 26.2 pt -107.36 164.96 13.69 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.577 1.551 . . . . 0.0 108.036 175.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.46 -26.96 30.12 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.091 2.528 . . . . 0.0 114.127 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.24 -20.98 60.73 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.86 0.864 . . . . 0.0 112.993 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.72 167.83 14.08 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 123.389 0.519 . . . . 0.0 111.938 -172.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.33 95.29 1.3 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.8 163.92 20.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.292 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.479 HH21 HG22 ' A' ' 178' ' ' VAL . 2.7 mpp_? -105.57 170.79 7.68 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 167.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.407 ' HB3' ' HG3' ' A' ' 113' ' ' GLU . 20.3 m -139.27 128.15 23.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.929 -170.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 2.8 pp -88.19 135.2 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 mp -121.58 111.18 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.2 mt -99.76 107.85 21.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.59 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 82.1 mtt180 -94.72 137.38 33.89 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.552 HE21 ' H ' ' A' ' 6' ' ' ALA . 58.9 mt-30 -142.87 136.52 28.76 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 166.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -104.96 114.3 28.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.559 0.695 . . . . 0.0 109.453 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -96.95 131.68 43.5 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.238 1.415 . . . . 0.0 110.06 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -77.74 48.89 0.72 Allowed 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.589 1.185 . . . . 0.0 110.073 172.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.59 154.72 41.43 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.425 1.09 . . . . 0.0 108.285 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.418 ' O ' HG23 ' A' ' 37' ' ' VAL . 57.2 Cg_endo -69.46 166.44 27.22 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.745 2.297 . . . . 0.0 113.116 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 101' ' ' LEU . 59.1 t -72.17 -43.4 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.404 -174.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -56.09 -41.54 75.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 124.258 0.974 . . . . 0.0 110.341 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -66.58 -64.57 0.83 Allowed 'General case' 0 C--N 1.348 0.526 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.655 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 33' ' ' PRO . 49.1 t -50.19 -34.73 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.546 1.139 . . . . 0.0 111.315 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.42 ' HE3' HD12 ' A' ' 101' ' ' LEU . 58.5 t-105 -61.96 -57.49 11.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.601 0.76 . . . . 0.0 110.211 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.1 m -58.39 -34.13 70.39 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 123.913 0.758 . . . . 0.0 111.057 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.1 -31.23 71.98 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 174.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.473 ' HB3' HD13 ' A' ' 99' ' ' LEU . 73.7 m -90.8 -14.17 32.45 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.947 0.899 . . . . 0.0 113.152 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.4 ' O ' HD13 ' A' ' 58' ' ' LEU . 49.3 p -110.96 -47.07 3.26 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.198 0.454 . . . . 0.0 111.985 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.424 ' O ' HG13 ' A' ' 47' ' ' ILE . 18.2 t70 -66.16 125.68 90.6 Favored Pre-proline 0 N--CA 1.484 1.244 0 C-N-CA 123.495 0.718 . . . . 0.0 110.47 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.79 -30.09 68.53 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.57 2.847 . . . . 0.0 113.602 -171.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -64.76 -48.61 73.92 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 124.359 1.037 . . . . 0.0 109.073 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -58.62 -38.67 78.53 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.156 171.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.484 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 68.7 mt -71.85 -45.68 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -172.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -61.77 -20.57 63.73 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.768 0.427 . . . . 0.0 111.964 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -57.75 -48.16 80.4 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.153 0.581 . . . . 0.0 110.932 174.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.484 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 22.7 p-90 -105.68 -55.85 2.27 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.355 0.662 . . . . 0.0 111.502 -173.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.433 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 6.6 t80 -91.47 -164.25 1.15 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.087 0.555 . . . . 0.0 110.893 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.477 ' HB ' HD22 ' A' ' 66' ' ' LEU . 40.5 mt -84.57 148.1 5.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 C-N-CA 124.359 1.064 . . . . 0.0 108.358 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.81 112.31 5.96 Favored Pre-proline 0 CA--C 1.566 1.569 0 O-C-N 124.173 0.921 . . . . 0.0 110.649 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.679 ' HG2' HD11 ' A' ' 58' ' ' LEU . 90.8 Cg_endo -90.29 96.11 0.27 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.295 2.663 . . . . 0.0 112.293 -175.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -71.21 109.89 5.53 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.561 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.9 -157.56 27.69 Favored Glycine 0 C--N 1.342 0.872 0 O-C-N 123.564 0.54 . . . . 0.0 113.884 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.81 -48.32 16.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.486 1.514 . . . . 0.0 112.054 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.679 HD11 ' HG2' ' A' ' 54' ' ' PRO . 84.7 mt 63.98 25.46 13.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 124.583 1.177 . . . . 0.0 111.483 -170.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -126.31 155.1 42.51 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.44 1.096 . . . . 0.0 109.894 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.619 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 35.6 tt0 -64.55 106.51 1.17 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.437 0.695 . . . . 0.0 111.101 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.3 -35.68 3.14 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.88 -169.59 45.44 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 114.149 -1.025 . . . . 0.0 112.124 170.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 72' ' ' GLY . 9.1 p30 -144.15 177.53 8.52 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.31 0.576 . . . . 0.0 111.907 -170.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -133.16 172.46 12.63 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.921 169.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -158.3 116.95 3.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.72 0.808 . . . . 0.0 109.276 178.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.477 HD22 ' HB ' ' A' ' 52' ' ' ILE . 70.0 mt -80.94 167.2 20.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.461 0.704 . . . . 0.0 110.862 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -86.8 128.25 35.03 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.879 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.47 39.48 22.29 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.997 1.436 . . . . 0.0 116.158 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -142.2 -79.86 0.23 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' ' HD1' ' A' ' 89' ' ' TYR . . . -161.79 154.89 20.72 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.106 0.562 . . . . 0.0 110.887 -172.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.0 p -100.42 165.46 11.43 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 170.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' ASN . . . -150.65 178.41 28.1 Favored Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -147.31 142.94 27.68 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.167 0.987 . . . . 0.0 109.321 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.458 HG13 HG22 ' A' ' 85' ' ' ILE . 2.6 mp -100.78 94.64 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.54 -34.07 67.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.407 174.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.489 ' HG2' ' HB ' ' A' ' 84' ' ' THR . 7.3 ptp180 -151.48 132.87 14.62 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.044 0.45 . . . . 0.0 111.313 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 26.3 p -128.46 118.73 23.6 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 168.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -133.05 88.5 36.52 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -173.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.63 141.78 38.64 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.534 2.156 . . . . 0.0 111.553 175.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -96.91 20.82 28.63 Favored 'Cis proline' 0 C--N 1.367 1.52 0 C-N-CA 124.938 -0.859 . . . . 0.0 112.998 -4.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -75.49 -71.62 0.36 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.065 0.946 . . . . 0.0 111.974 -167.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -161.74 159.58 27.39 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.478 0.656 . . . . 0.0 110.73 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 tt -133.33 114.56 13.86 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' A' ' 76' ' ' ARG . 23.0 m -108.95 127.38 54.01 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.478 HG13 ' HB ' ' A' ' 97' ' ' VAL . 11.8 pt -123.29 150.26 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 126.723 2.009 . . . . 0.0 109.684 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.5 t -84.87 164.92 18.11 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 167.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 35.7 t-105 -144.39 94.81 2.61 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.086 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.52 101.76 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.502 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 84.8 t80 -102.69 168.06 9.5 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.059 1.344 . . . . 0.0 109.932 -173.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -56.25 103.26 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.111 0.965 . . . . 0.0 110.72 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.23 4.27 83.52 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.019 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 42.1 mmtm -134.67 75.17 63.38 Favored Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 123.916 0.886 . . . . 0.0 110.12 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.52 135.06 25.6 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.371 2.048 . . . . 0.0 112.005 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 66.39 80.71 0.22 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.516 1.126 . . . . 0.0 112.018 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.664 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 35.4 m -109.97 146.18 35.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 168.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -103.44 107.71 18.66 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.153 0.501 . . . . 0.0 111.07 -170.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.478 ' HB ' HG13 ' A' ' 85' ' ' ILE . 10.6 t -112.05 147.97 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.675 1.19 . . . . 0.0 108.413 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -150.84 142.73 23.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.084 0.554 . . . . 0.0 111.075 171.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 41' ' ' CYS . 6.7 tt -109.46 123.79 49.96 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 172.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -122.58 123.0 40.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.471 1.108 . . . . 0.0 109.556 -166.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 34' ' ' VAL . 92.7 mt -123.31 135.04 54.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.542 0.737 . . . . 0.0 110.982 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.6 m -146.87 145.22 29.77 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.191 1.396 . . . . 0.0 108.609 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.47 143.64 44.91 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.774 0.829 . . . . 0.0 109.169 168.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -150.11 111.06 4.34 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.88 -102.12 0.22 Allowed Glycine 0 C--N 1.348 1.199 0 O-C-N 123.353 0.408 . . . . 0.0 112.407 -171.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -117.11 -5.06 11.4 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.612 0.765 . . . . 0.0 110.81 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -117.63 -150.93 9.18 Favored Glycine 0 C--N 1.352 1.424 0 C-N-CA 124.24 0.924 . . . . 0.0 111.436 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.2 m -143.0 121.99 12.79 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.218 1.007 . . . . 0.0 110.227 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.7 tp -81.74 131.65 35.27 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.7 tt -118.85 109.22 15.76 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.59 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 30.6 mt-10 -111.02 105.8 14.68 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 176.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.54 HD13 HD21 ' A' ' 133' ' ' LEU . 6.2 tt -102.3 104.33 14.85 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 175.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 61.2 tt0 -93.65 128.65 39.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.475 177.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -121.88 113.32 19.46 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 170.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.39 119.53 38.9 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.157 0.983 . . . . 0.0 110.046 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.493 HG23 ' HG ' ' A' ' 122' ' ' LEU . 6.0 t -148.08 151.83 36.32 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.584 0.754 . . . . 0.0 109.71 172.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.412 ' OG1' HD11 ' A' ' 16' ' ' ILE . 1.8 m -74.25 -19.41 60.52 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.326 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 121' ' ' MET . 11.7 m -89.83 119.33 30.12 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.027 0.931 . . . . 0.0 110.778 -173.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -64.32 -40.65 96.32 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.065 0.946 . . . . 0.0 112.141 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -63.76 -55.81 20.36 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.079 0.237 . . . . 0.0 111.389 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.578 ' HB3' ' HB2' ' A' ' 118' ' ' SER . 26.1 ttt -51.15 -33.35 26.51 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.01 0.819 . . . . 0.0 112.644 175.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.493 ' HG ' HG23 ' A' ' 116' ' ' THR . 19.9 mt -64.77 -46.24 82.95 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.33 0.652 . . . . 0.0 111.669 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 127' ' ' VAL . 61.4 t -62.89 -53.11 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -44.76 -53.34 7.49 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.51 1.924 . . . . 0.0 113.335 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.8 m -78.68 -25.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 122.794 0.438 . . . . 0.0 110.697 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.22 88.1 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 170.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 123' ' ' VAL . 89.2 t -81.83 -52.66 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.402 0.681 . . . . 0.0 109.4 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.59 -59.7 9.32 Favored Glycine 0 C--N 1.341 0.816 0 O-C-N 124.42 1.075 . . . . 0.0 113.634 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -57.25 -56.34 23.03 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.073 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.04 -30.31 69.1 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 119.905 1.23 . . . . 0.0 112.294 -171.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.443 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 47.2 ttp -70.73 -44.07 67.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.045 0.938 . . . . 0.0 110.187 174.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 50' ' ' TRP . . . -63.06 -63.53 1.17 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.0 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 112' ' ' LEU . 4.3 mm? -42.31 -38.79 1.92 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.499 1.52 . . . . 0.0 113.992 169.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 131' ' ' MET . 12.4 t70 -52.79 -50.15 64.19 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.231 0.613 . . . . 0.0 110.059 173.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.52 ' HE1' ' HD3' ' A' ' 150' ' ' PRO . 71.5 m-85 -74.43 -19.84 60.26 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.342 176.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.406 HD13 ' CD1' ' A' ' 50' ' ' TRP . 51.3 tp -72.57 -24.53 61.12 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 169.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.73 -41.37 24.08 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 87.2 mtp -63.05 -40.75 98.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.069 0.948 . . . . 0.0 110.567 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -64.06 -56.02 18.0 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.432 0.693 . . . . 0.0 110.753 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 53.0 mt -69.42 -36.24 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 123.275 0.63 . . . . 0.0 111.725 -173.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.743 HH11 ' HA2' ' A' ' 4' ' ' GLY . 49.2 mtp180 -81.27 -14.34 57.51 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 176.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.29 12.88 75.12 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 114.028 0.371 . . . . 0.0 114.028 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.589 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 14.0 m-20 -63.82 -38.04 89.62 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.098 0.559 . . . . 0.0 110.683 173.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -56.94 108.58 1.27 Allowed Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 125.114 1.365 . . . . 0.0 111.498 -169.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -93.03 -14.94 1.03 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.733 2.289 . . . . 0.0 112.496 170.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.26 -171.4 28.7 Favored Glycine 0 C--N 1.346 1.095 0 C-N-CA 123.982 0.801 . . . . 0.0 111.355 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.98 112.39 0.22 Allowed Glycine 0 CA--C 1.536 1.389 0 CA-C-O 119.044 -0.864 . . . . 0.0 112.395 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.49 -47.87 0.65 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.422 2.081 . . . . 0.0 112.864 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.9 m -124.69 148.57 59.57 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.724 0.81 . . . . 0.0 110.861 -168.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.52 ' HD3' ' HE1' ' A' ' 135' ' ' PHE . 84.7 Cg_endo -79.25 -23.38 7.57 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.517 2.145 . . . . 0.0 111.955 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.401 ' HA ' ' SD ' ' A' ' 163' ' ' MET . 25.5 tt0 -111.97 -77.41 0.59 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.107 0.963 . . . . 0.0 109.915 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 27.9 t70 174.68 -23.92 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.373 1.069 . . . . 0.0 109.235 -162.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 76.61 29.37 0.67 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.092 1.357 . . . . 0.0 110.131 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -90.41 -174.14 4.03 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.633 171.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -41.84 5.44 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.017 0.527 . . . . 0.0 110.085 173.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -149.05 78.58 1.39 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.963 0.905 . . . . 0.0 109.768 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -138.35 167.67 21.38 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.833 0.853 . . . . 0.0 109.104 172.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 62.25 90.9 0.08 OUTLIER Pre-proline 0 CA--C 1.556 1.178 0 O-C-N 124.53 1.144 . . . . 0.0 109.943 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.61 7.59 1.51 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.256 2.637 . . . . 0.0 113.241 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 50.1 m -62.7 129.82 93.21 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.707 1.203 . . . . 0.0 110.939 176.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -60.92 -64.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.425 2.75 . . . . 0.0 114.039 -168.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -69.53 -19.91 63.7 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.078 0.551 . . . . 0.0 112.329 -172.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.401 ' SD ' ' HA ' ' A' ' 151' ' ' GLU . 0.0 OUTLIER -72.94 -57.95 3.68 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.515 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 52.8 mtm -52.78 -40.56 63.29 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.517 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.534 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 6.8 tpt180 -50.46 -47.91 56.79 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 124.676 1.235 . . . . 0.0 111.441 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 70.5 mt -55.25 -50.65 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 123.848 0.718 . . . . 0.0 110.835 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.9 m -68.47 -22.7 64.55 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 164' ' ' MET . 14.0 mm100 -80.37 -31.42 37.86 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 13.6 mm-40 -65.38 -42.54 92.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.731 0.412 . . . . 0.0 109.935 174.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -62.62 -60.79 3.03 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.819 0.699 . . . . 0.0 110.214 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -53.84 -58.88 10.89 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 124.232 0.957 . . . . 0.0 114.022 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.01 -20.97 65.96 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -175.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.94 -55.11 11.99 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.107 0.412 . . . . 0.0 110.663 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.38 -22.29 61.16 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.193 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -70.13 -46.74 64.12 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 123.77 0.669 . . . . 0.0 109.464 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -64.43 -33.38 75.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.098 0.559 . . . . 0.0 110.118 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 9' ' ' ARG . 47.6 mt -68.06 -61.77 1.71 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.625 173.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.479 HG22 HH21 ' A' ' 22' ' ' ARG . 9.6 p -65.04 -31.38 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.034 0.534 . . . . 0.0 112.417 -166.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -67.61 -35.24 78.57 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.721 0.808 . . . . 0.0 110.231 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.5 m -84.54 -20.14 32.03 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.632 0.773 . . . . 0.0 110.919 175.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -76.27 -14.34 82.43 Favored Glycine 0 C--N 1.358 1.753 0 C-N-CA 123.351 0.501 . . . . 0.0 113.413 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.25 1.106 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 29' ' ' ARG . . . . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 121.14 0.495 . . . . 0.0 111.935 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.6 m -88.07 131.16 34.78 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.715 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -119.16 103.6 9.68 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 171.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -83.25 132.48 35.04 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.901 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -143.92 171.36 14.34 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.893 -172.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.597 HD23 ' HB3' ' A' ' 177' ' ' LEU . 0.5 OUTLIER -138.69 165.43 26.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.943 1.297 . . . . 0.0 108.242 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.56 -162.29 30.78 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.174 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -120.35 145.6 46.97 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.231 1.012 . . . . 0.0 109.91 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 12.2 tpt180 -164.27 125.85 2.26 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 20.0 m -77.04 142.2 39.97 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.884 0.474 . . . . 0.0 110.756 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.503 HD11 HG23 ' A' ' 117' ' ' THR . 16.7 pt -133.07 165.75 34.38 Favored Pre-proline 0 CA--C 1.557 1.222 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -49.02 -30.92 19.22 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.355 2.704 . . . . 0.0 115.377 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.401 ' H ' HG13 ' A' ' 16' ' ' ILE . . . -71.5 -37.32 71.27 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.164 0.586 . . . . 0.0 111.995 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.33 -174.95 34.84 Favored Glycine 0 N--CA 1.471 1.014 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 2.8 mp0 -71.65 93.9 1.29 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.82 167.1 22.42 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.888 0.875 . . . . 0.0 113.115 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HB3' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -95.17 149.12 21.65 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.339 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.0 p -134.7 130.77 36.79 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.125 0.421 . . . . 0.0 111.376 -169.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.467 HG23 HD22 ' A' ' 122' ' ' LEU . 2.7 pp -88.86 140.08 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 4.0 mp -126.86 124.27 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.442 HG22 ' HG3' ' A' ' 28' ' ' GLN . 25.6 mt -107.23 107.73 23.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 85.6 mtt180 -106.92 98.78 8.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.442 ' HG3' HG22 ' A' ' 26' ' ' ILE . 73.1 mt-30 -109.98 133.24 53.39 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.991 0.916 . . . . 0.0 109.001 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.506 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 17.5 mmt85 -87.44 127.5 35.22 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.42 0.688 . . . . 0.0 109.837 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -120.14 135.94 54.78 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.403 1.081 . . . . 0.0 108.842 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.7 45.43 1.2 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.372 0.606 . . . . 0.0 111.557 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.07 159.03 72.54 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 124.547 1.139 . . . . 0.0 109.883 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.06 157.05 63.63 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.237 2.625 . . . . 0.0 113.562 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.8 t -49.15 -47.95 17.65 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 C-N-CA 124.688 1.195 . . . . 0.0 110.474 171.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -43.44 -47.3 7.02 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 125.05 1.469 . . . . 0.0 111.754 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.54 -46.46 85.89 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.071 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.3 t -76.86 -31.0 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.513 -171.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -75.29 -30.26 60.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.811 1.244 . . . . 0.0 109.967 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.6 m -65.0 -44.46 89.16 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 172.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -62.94 -38.53 91.43 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.25 0.62 . . . . 0.0 112.584 176.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.468 ' SG ' HD22 ' A' ' 99' ' ' LEU . 65.5 m -71.86 -40.57 68.88 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -175.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.3 p -104.15 -38.93 6.72 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -168.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 47' ' ' ILE . 29.3 t70 -79.03 113.35 35.1 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.812 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 43' ' ' ASP . 4.3 Cg_endo -46.66 -38.55 22.34 Favored 'Trans proline' 0 C--N 1.39 2.719 0 C-N-CA 124.7 3.6 . . . . 0.0 115.227 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -66.14 -24.79 66.73 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 123.651 0.594 . . . . 0.0 110.8 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.553 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 5.8 mmp_? -91.95 -25.07 19.05 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 173.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 43' ' ' ASP . 83.1 mt -74.31 -40.71 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 118.235 0.471 . . . . 0.0 110.53 -172.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -65.37 -14.96 62.03 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.002 0.521 . . . . 0.0 111.895 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -83.18 -5.14 59.01 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.379 0.672 . . . . 0.0 111.181 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.418 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 56.7 p-90 -142.93 -15.84 0.7 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.519 0.727 . . . . 0.0 112.098 175.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.418 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 20.6 t80 -141.27 -122.53 0.1 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -173.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.4 ' HB ' HD22 ' A' ' 66' ' ' LEU . 60.8 mt -132.74 140.57 47.13 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 C-N-CA 123.404 0.681 . . . . 0.0 109.62 -167.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.405 ' HG2' ' HE2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -68.61 105.02 0.83 Allowed Pre-proline 0 CA--C 1.573 1.858 0 O-C-N 124.871 1.357 . . . . 0.0 110.239 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.17 124.1 3.24 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.655 2.237 . . . . 0.0 112.498 -172.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HE2' ' HG2' ' A' ' 53' ' ' GLU . 74.4 mmtt -112.41 117.42 32.39 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.647 0.779 . . . . 0.0 110.304 -175.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.17 -152.18 22.7 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.672 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 8.2 m-20 -66.55 -41.86 88.01 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.386 0.698 . . . . 0.0 110.758 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.7 mt 59.65 22.03 10.74 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.758 1.223 . . . . 0.0 111.792 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.672 ' HG2' ' HB3' ' A' ' 57' ' ' ASP . 17.3 ptp180 -133.48 151.7 51.81 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.511 1.124 . . . . 0.0 108.862 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -66.41 135.02 53.71 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.696 0.622 . . . . 0.0 110.492 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.18 -7.2 81.01 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.588 -167.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.92 -175.73 14.97 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-N 117.119 0.46 . . . . 0.0 112.641 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 11.2 p30 -109.05 171.26 7.54 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.586 0.754 . . . . 0.0 112.228 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -145.66 158.77 43.81 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.712 169.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.77 105.21 4.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.651 0.78 . . . . 0.0 109.514 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.4 HD22 ' HB ' ' A' ' 52' ' ' ILE . 70.4 mt -75.51 127.54 33.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -80.21 112.99 18.05 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.866 0.467 . . . . 0.0 110.564 -172.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.84 46.38 8.52 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.98 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -162.6 -83.71 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.851 0.46 . . . . 0.0 111.449 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' ' HD1' ' A' ' 89' ' ' TYR . . . -154.63 156.71 36.99 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.35 0.595 . . . . 0.0 111.017 -170.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.4 m -109.09 -175.34 2.74 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.484 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.75 -160.06 30.03 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 53.6 m-20 -129.48 174.22 9.84 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.24 0.616 . . . . 0.0 109.454 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.417 HG13 HG22 ' A' ' 85' ' ' ILE . 3.4 mp -110.3 116.2 51.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 86' ' ' SER . 31.6 mt -84.22 -44.47 13.88 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.927 0.891 . . . . 0.0 110.317 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.512 ' HB2' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.37 155.19 44.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.134 1.374 . . . . 0.0 109.223 -177.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 26.2 p -157.18 120.78 4.16 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 166.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -141.63 100.48 6.13 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -165.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 85.9 Cg_endo -83.84 135.25 6.61 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.754 2.303 . . . . 0.0 112.849 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 24.9 Cg_endo -100.41 29.47 12.63 Favored 'Cis proline' 0 C--N 1.376 1.976 0 CA-C-N 119.399 0.821 . . . . 0.0 112.561 -4.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -77.85 -66.97 0.77 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.992 0.917 . . . . 0.0 112.397 -168.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.499 ' HB3' ' HG3' ' A' ' 100' ' ' ARG . 16.5 ptt180 -160.86 141.31 11.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.769 0.427 . . . . 0.0 111.073 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 77' ' ' CYS . 2.2 pt? -107.72 144.04 35.39 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 163.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 76' ' ' ARG . 32.8 m -134.79 128.42 32.79 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.107 0.963 . . . . 0.0 108.701 -171.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.417 HG22 HG13 ' A' ' 74' ' ' ILE . 28.7 pt -133.35 146.49 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.451 1.1 . . . . 0.0 109.137 -175.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.477 ' HB2' HD11 ' A' ' 75' ' ' LEU . 33.3 t -96.14 139.54 32.16 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 8.4 t-105 -125.64 109.21 12.36 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.801 1.24 . . . . 0.0 107.891 -163.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.18 102.27 13.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.401 ' HD1' ' HB2' ' A' ' 70' ' ' ALA . 31.2 t80 -93.48 133.65 36.55 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.57 133.68 54.19 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.126 0.57 . . . . 0.0 111.342 -170.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.78 -45.14 3.44 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.306 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 13.2 mptt -80.55 163.0 58.69 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.714 1.206 . . . . 0.0 110.094 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 177.39 5.41 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.36 2.04 . . . . 0.0 112.376 175.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.31 162.57 29.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.805 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.564 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.2 m -141.51 165.21 28.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.579 0.752 . . . . 0.0 110.042 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -125.45 106.83 10.09 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 167.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.39 149.0 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.668 1.587 . . . . 0.0 109.004 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.17 153.08 39.43 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.701 165.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.468 HD22 ' SG ' ' A' ' 41' ' ' CYS . 2.8 tt -114.66 128.31 56.24 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 169.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 36.8 ttt180 -138.39 137.85 37.68 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.272 1.029 . . . . 0.0 108.389 -164.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 110' ' ' LEU . 96.7 mt -129.5 132.5 46.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.872 0.469 . . . . 0.0 110.827 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.4 t -125.25 127.17 46.3 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 172.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -69.92 152.74 44.14 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.73 0.812 . . . . 0.0 109.014 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -167.47 79.36 0.19 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -168.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 65.16 -117.38 10.18 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 123.709 0.671 . . . . 0.0 113.306 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.64 32.66 1.07 Allowed 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.91 -171.9 38.06 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-O 122.001 0.778 . . . . 0.0 114.475 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.2 m -140.43 131.01 25.5 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 113.78 -1.21 . . . . 0.0 109.463 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.498 HD11 ' HB3' ' A' ' 27' ' ' ARG . 64.0 tp -82.77 106.87 14.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.468 171.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.0 tt -84.22 131.98 34.7 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 172.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 22.2 mt-10 -129.32 106.62 8.92 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -174.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.424 HD13 HD21 ' A' ' 133' ' ' LEU . 9.0 tt -115.47 126.45 54.32 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -124.66 137.83 54.34 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.528 ' HD1' ' HE1' ' A' ' 129' ' ' TRP . 7.6 t60 -131.88 114.89 15.21 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . . . -109.96 104.01 12.85 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.118 0.567 . . . . 0.0 110.972 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.433 HG23 ' HG ' ' A' ' 122' ' ' LEU . 5.3 t -124.2 156.13 37.32 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.206 0.527 . . . . 0.0 109.64 171.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.503 HG23 HD11 ' A' ' 16' ' ' ILE . 20.8 p -77.44 -18.57 57.07 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.433 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.5 t -88.49 111.85 22.3 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.333 0.653 . . . . 0.0 110.079 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.411 ' HA ' HD12 ' A' ' 122' ' ' LEU . 37.4 tt0 -62.63 -29.21 70.45 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.397 1.079 . . . . 0.0 110.878 172.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -60.35 -47.89 84.09 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.554 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.404 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 27.4 ttt -68.49 -37.62 80.27 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.787 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.467 HD22 HG23 ' A' ' 24' ' ' ILE . 37.7 mt -61.1 -38.18 85.37 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.591 0.756 . . . . 0.0 112.763 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 68.8 t -64.51 -51.78 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 O-C-N 123.392 0.432 . . . . 0.0 109.888 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -63.65 -41.8 98.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.27 0.628 . . . . 0.0 112.544 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.37 -34.56 58.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 CA-C-O 118.992 -0.528 . . . . 0.0 109.994 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.03 -32.18 74.89 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 121.389 -0.434 . . . . 0.0 112.217 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.09 -54.52 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 123.869 0.393 . . . . 0.0 110.894 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.96 73.45 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.944 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.528 ' HE1' ' HD1' ' A' ' 114' ' ' HIS . 17.4 m95 -80.2 -49.52 11.52 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 38.5 mt-10 -63.35 -23.09 67.26 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 118.415 0.552 . . . . 0.0 111.599 176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 56.4 ttp -66.46 -44.71 82.0 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.074 0.549 . . . . 0.0 109.54 170.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.62 -35.79 81.67 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.036 0.534 . . . . 0.0 111.275 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 130' ' ' GLU . 4.0 mm? -74.75 -18.38 60.5 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.6 1.16 . . . . 0.0 111.367 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -69.87 -55.26 10.23 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -66.15 -32.81 74.48 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.879 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.1 tp -75.01 -37.63 61.76 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.189 0.596 . . . . 0.0 109.931 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.5 -46.52 52.89 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.598 0.562 . . . . 0.0 112.925 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.0 mtp -69.23 -39.71 78.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.94 0.896 . . . . 0.0 111.205 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.62 -33.15 68.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.137 0.575 . . . . 0.0 111.345 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.9 mm -72.51 -63.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 65.0 mmt-85 . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.739 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.5 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 64.8 mt . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 119.477 -0.297 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 63.7 p -75.36 -41.6 56.09 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 48.1 mt-30 -55.65 -63.7 1.09 Allowed 'General case' 0 C--O 1.2 -1.524 0 O-C-N 124.123 0.89 . . . . 0.0 110.751 172.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -41.76 -45.37 3.53 Favored 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 27.7 mmt85 -58.01 -48.26 80.58 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 174.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -81.51 -15.53 75.86 Favored Glycine 0 C--O 1.214 -1.128 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.581 -174.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 36.0 mm-40 -70.66 -39.42 73.59 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 117.699 0.75 . . . . 0.0 108.991 176.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.48 -58.45 7.55 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.188 173.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -62.73 -28.12 69.74 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.955 0.785 . . . . 0.0 113.065 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.54 -64.11 0.94 Allowed 'General case' 0 C--N 1.353 0.724 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -46.9 -41.28 15.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.881 0.872 . . . . 0.0 112.526 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.597 ' HB3' HD23 ' A' ' 11' ' ' LEU . 51.5 mt -65.25 -40.78 94.44 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.0 p -85.66 -28.08 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.023 0.829 . . . . 0.0 109.442 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -67.71 -29.38 68.62 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.077 170.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.475 0.799 0 C-N-CA 123.23 0.612 . . . . 0.0 109.837 176.079 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.589 ' HB3' ' HB2' ' A' ' 29' ' ' ARG . . . . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 120.637 0.256 . . . . 0.0 111.376 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 m -79.52 119.02 21.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.101 0.56 . . . . 0.0 109.725 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 43.1 mt-10 -114.48 112.65 23.31 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -176.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.418 ' HB3' HD11 ' A' ' 177' ' ' LEU . 97.6 mtt180 -72.44 133.31 44.8 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.266 0.626 . . . . 0.0 109.776 171.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.66 169.69 24.12 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.743 0.652 . . . . 0.0 110.525 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -144.91 150.19 36.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.446 ' H ' HD13 ' A' ' 11' ' ' LEU . . . -158.8 -146.66 4.61 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 174.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -149.27 152.65 36.27 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.441 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 30.6 tpt180 -154.75 135.67 13.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.7 m -78.74 137.64 37.86 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.415 HG13 ' H ' ' A' ' 19' ' ' GLY . 41.5 pt -126.63 159.61 62.75 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 124.081 0.952 . . . . 0.0 109.925 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.32 -27.3 56.91 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.333 2.689 . . . . 0.0 113.644 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.46 -39.23 77.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.965 0.506 . . . . 0.0 111.937 175.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.415 ' H ' HG13 ' A' ' 16' ' ' ILE . . . 164.35 -146.95 11.96 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 -173.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -83.83 137.98 33.44 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.66 160.4 38.22 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.946 0.498 . . . . 0.0 110.838 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -100.49 162.59 12.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 165.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 40.7 t -141.28 133.54 28.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.375 0.27 . . . . 0.0 110.86 -167.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.489 ' HA ' HD22 ' A' ' 11' ' ' LEU . 43.5 pt -85.48 134.84 26.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.17 111.56 36.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.0 mt -103.81 104.66 17.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.559 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 87.9 mtt180 -91.01 159.86 15.92 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 122.999 0.52 . . . . 0.0 109.805 173.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 6.3 tt0 -168.92 119.68 0.74 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.227 1.58 . . . . 0.0 111.477 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.589 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 6.0 mmt180 -88.44 106.23 18.13 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.531 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 91.4 m-85 -85.42 126.56 33.89 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.525 168.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -89.35 76.74 7.5 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 168.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 30' ' ' TYR . . . -179.82 139.83 0.32 Allowed Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -157.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 85.4 Cg_endo -74.18 150.18 42.01 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.223 1.949 . . . . 0.0 113.504 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -47.78 -39.99 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.453 170.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -47.85 -49.3 29.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.393 1.058 . . . . 0.0 111.391 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 31.0 mt-10 -80.64 -29.84 36.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.565 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.7 t -73.13 -32.9 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 123.628 0.58 . . . . 0.0 110.631 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -81.51 -25.9 35.58 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.698 1.199 . . . . 0.0 109.753 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m -68.03 -50.16 57.01 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -60.55 -41.56 94.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.137 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.666 ' SG ' HD23 ' A' ' 99' ' ' LEU . 17.0 t -61.82 -45.18 94.94 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.4 p -104.05 -45.25 4.79 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -165.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 47' ' ' ILE . 5.5 m-20 -68.79 116.7 43.74 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.993 -175.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.88 -34.89 23.29 Favored 'Trans proline' 0 C--N 1.388 2.627 0 C-N-CA 123.622 2.881 . . . . 0.0 113.953 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.57 -33.49 72.78 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.631 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.579 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 30.7 mmt180 -90.0 -33.37 16.39 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.172 0.989 . . . . 0.0 111.512 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 43' ' ' ASP . 71.6 mt -73.3 -36.03 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -168.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -71.67 -1.03 12.33 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.558 0.743 . . . . 0.0 112.715 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.5 -48.83 7.05 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.433 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 62.7 p-90 -101.56 -16.4 16.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.433 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 44.0 t80 -137.64 -114.16 0.17 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.584 0.754 . . . . 0.0 109.771 -176.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.475 HD12 HD13 ' A' ' 66' ' ' LEU . 49.4 mt -136.96 144.3 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -171.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.96 113.55 12.68 Favored Pre-proline 0 N--CA 1.485 1.295 0 O-C-N 124.801 1.313 . . . . 0.0 110.214 174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.414 ' HB2' HD21 ' A' ' 58' ' ' LEU . 60.5 Cg_endo -92.15 143.51 2.66 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.056 2.504 . . . . 0.0 111.742 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -143.9 135.93 26.5 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.99 -151.93 23.58 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -71.04 -49.1 48.6 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.414 HD21 ' HB2' ' A' ' 54' ' ' PRO . 40.7 mt 59.36 25.43 14.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.239 0.962 . . . . 0.0 110.602 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -122.94 148.66 45.22 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.436 1.495 . . . . 0.0 109.674 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -70.42 130.83 42.96 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.377 0.608 . . . . 0.0 109.771 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.71 -2.08 82.0 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.781 -168.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.24 178.03 18.3 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 8.2 p30 -117.98 178.0 4.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -172.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -150.85 162.39 40.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.04 0.936 . . . . 0.0 109.266 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.88 146.06 36.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.899 0.88 . . . . 0.0 109.513 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.475 HD13 HD12 ' A' ' 52' ' ' ILE . 86.9 mt -83.64 -89.83 0.09 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.175 0.59 . . . . 0.0 110.187 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -140.89 -57.59 0.51 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.27 9.62 0.52 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.412 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.473 ' HB3' HD12 ' A' ' 66' ' ' LEU . 42.6 t-20 -77.37 -85.07 0.06 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.3 158.58 43.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.703 0.763 . . . . 0.0 112.134 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.5 p -132.96 147.98 52.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.421 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.04 171.66 44.56 Favored Glycine 0 N--CA 1.464 0.502 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 24.9 m-20 -85.78 171.35 11.65 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.479 0.657 . . . . 0.0 111.298 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.23 119.53 59.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 168.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 84' ' ' THR . 59.0 mt -84.63 -38.4 19.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.005 0.522 . . . . 0.0 110.622 -176.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -166.18 111.54 0.83 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.493 0.717 . . . . 0.0 109.61 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 10.6 p -107.3 103.1 12.38 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -99.94 102.17 16.63 Favored Pre-proline 0 N--CA 1.482 1.125 0 C-N-CA 124.132 0.973 . . . . 0.0 110.521 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 96.6 Cg_endo -80.66 129.55 7.34 Favored 'Trans proline' 0 CA--C 1.564 2.013 0 C-N-CA 122.786 2.324 . . . . 0.0 112.896 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.56 ' HD2' HH11 ' A' ' 81' ' ' ARG . 16.1 Cg_endo -103.84 33.37 6.97 Favored 'Cis proline' 0 C--N 1.38 2.193 0 CA-C-N 119.802 0.965 . . . . 0.0 112.783 -10.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.56 HH11 ' HD2' ' A' ' 80' ' ' PRO . 3.7 mpt_? -65.93 -69.24 0.31 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.923 0.889 . . . . 0.0 110.437 -176.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.9 ptt-85 -161.86 154.68 20.29 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.322 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.553 ' H ' HD23 ' A' ' 83' ' ' LEU . 1.8 pt? -107.04 146.61 30.96 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 167.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 75' ' ' LEU . 94.1 m -131.53 121.83 25.11 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.664 1.585 . . . . 0.0 107.167 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.9 pt -141.58 142.99 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.779 0.832 . . . . 0.0 109.464 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.9 t -88.84 137.66 32.12 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -123.7 102.83 8.04 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.4 t -99.18 101.48 12.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -93.77 146.19 24.05 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.463 172.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -62.05 121.78 13.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.693 0.797 . . . . 0.0 111.331 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.82 19.65 61.09 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.323 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.46 ' HD2' ' HB2' ' A' ' 121' ' ' MET . 72.8 mmtt -132.4 147.89 67.47 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 123.917 0.887 . . . . 0.0 109.754 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.27 149.8 64.19 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.781 2.321 . . . . 0.0 111.418 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -59.8 116.61 4.21 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.872 0.869 . . . . 0.0 111.818 -169.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.8 m -90.59 160.76 15.76 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.554 -172.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -104.25 140.66 37.53 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.275 1.03 . . . . 0.0 108.361 166.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 54.2 t -138.14 118.37 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -126.46 111.87 14.94 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.666 HD23 ' SG ' ' A' ' 41' ' ' CYS . 38.2 tp -96.91 119.58 35.65 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.5 ttp-105 -127.14 114.57 17.88 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.618 0.767 . . . . 0.0 109.285 -160.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.1 mt -104.77 153.79 20.86 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.464 0.706 . . . . 0.0 110.564 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.6 m -141.85 123.01 14.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.784 0.834 . . . . 0.0 109.859 170.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -83.34 106.31 15.0 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -120.32 80.26 1.58 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.411 1.084 . . . . 0.0 110.238 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.56 -103.18 1.82 Allowed Glycine 0 C--N 1.35 1.31 0 C-N-CA 122.96 0.314 . . . . 0.0 112.539 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -106.47 5.08 28.99 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.416 0.686 . . . . 0.0 109.291 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.32 163.29 12.42 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.39 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 m -140.16 112.83 8.01 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.627 1.171 . . . . 0.0 108.438 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.8 tp -80.74 107.75 13.82 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.1 tt -90.66 131.46 36.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 172.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.545 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 43.9 mt-10 -132.9 109.22 9.44 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.5 tt -95.26 121.2 36.66 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 4.8 tp10 -112.6 102.7 10.76 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.471 ' HB3' HG12 ' A' ' 24' ' ' ILE . 6.5 t60 -114.58 112.67 23.29 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.441 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . . . -114.28 107.68 15.91 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.404 1.082 . . . . 0.0 110.189 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.506 HG23 ' HG ' ' A' ' 122' ' ' LEU . 5.1 t -127.64 156.03 42.96 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.663 0.744 . . . . 0.0 110.528 174.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -23.77 58.87 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.196 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.1 t -91.19 115.89 28.38 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.236 1.015 . . . . 0.0 110.795 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -69.93 -25.58 63.73 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.758 0.823 . . . . 0.0 110.942 175.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -63.45 -47.76 80.53 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.528 171.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.46 ' HB2' ' HD2' ' A' ' 92' ' ' LYS . 23.3 ttt -67.58 -33.61 75.36 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.114 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.506 ' HG ' HG23 ' A' ' 116' ' ' THR . 19.7 mt -63.06 -43.87 97.42 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.255 0.622 . . . . 0.0 112.045 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 127' ' ' VAL . 89.3 t -63.78 -42.23 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.954 173.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.65 -44.99 76.58 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.582 1.153 . . . . 0.0 111.807 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -79.65 -18.84 12.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 C-N-CA 123.37 0.668 . . . . 0.0 109.505 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.49 -34.09 89.02 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 166.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 123' ' ' VAL . 48.7 t -75.6 -50.76 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.97 -33.48 79.45 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 114.676 0.63 . . . . 0.0 114.676 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -86.04 -41.02 15.17 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.703 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.71 -34.05 76.35 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.91 0.777 . . . . 0.0 109.604 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 53.4 ttm -60.83 -50.13 74.67 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.837 0.855 . . . . 0.0 109.74 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.52 90.79 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.739 0.816 . . . . 0.0 112.154 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.16 -21.51 33.52 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.518 0.727 . . . . 0.0 111.6 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.65 -44.4 70.66 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -72.7 -35.82 67.7 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.166 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 29.1 tp -70.43 -38.66 74.61 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.824 0.45 . . . . 0.0 110.557 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.01 -52.77 50.21 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.744 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 31.1 ttp -61.75 -38.89 89.68 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.121 0.568 . . . . 0.0 110.799 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.16 -56.69 18.57 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.857 1.263 . . . . 0.0 111.042 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 58.9 mt -72.46 -19.19 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.8 0.84 . . . . 0.0 111.145 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.553 1.083 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 12.2 tt . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 111.39 0.144 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.9 p -77.78 -40.91 39.2 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -54.63 -59.03 5.26 Favored 'General case' 0 C--O 1.206 -1.211 0 O-C-N 123.922 0.764 . . . . 0.0 110.664 166.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -41.44 -49.58 3.9 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.153 1.381 . . . . 0.0 112.437 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -56.59 -55.79 29.54 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.007 0.523 . . . . 0.0 110.385 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.42 -17.52 79.11 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.435 -168.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.23 -29.07 31.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.023 0.929 . . . . 0.0 110.042 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.52 -53.67 17.96 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.78 0.832 . . . . 0.0 109.503 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -69.1 -25.87 64.64 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.846 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.04 -60.53 3.32 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 172.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.16 12.52 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.662 1.185 . . . . 0.0 112.911 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 78.1 mt -68.7 -46.25 69.48 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.096 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.03 -23.74 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.115 0.871 . . . . 0.0 110.682 -166.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -70.39 -25.25 63.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.424 0.69 . . . . 0.0 110.072 171.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 CA--C 1.556 1.18 0 C-N-CA 124.059 0.944 . . . . 0.0 110.692 172.025 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 85.6 m -85.81 122.25 29.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.628 -176.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -124.6 112.06 16.37 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.571 1.548 . . . . 0.0 107.596 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.27 159.54 31.39 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.8 173.26 10.82 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.504 0.722 . . . . 0.0 109.095 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -145.32 154.86 42.78 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -177.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.459 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -162.47 -153.95 7.37 Favored Glycine 0 C--O 1.238 0.404 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.4 ptt85 -157.1 160.28 38.7 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.211 0.604 . . . . 0.0 110.129 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -168.53 162.42 12.1 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.917 171.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.1 m -96.37 144.03 26.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.763 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 117' ' ' THR . 42.5 pt -135.5 162.31 57.95 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.933 1.293 . . . . 0.0 108.497 -174.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.97 -35.37 31.76 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.568 2.845 . . . . 0.0 114.767 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.83 99.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.647 0.779 . . . . 0.0 111.779 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.06 -149.05 18.28 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.66 139.27 38.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 117.314 0.557 . . . . 0.0 109.622 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.12 158.55 44.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.295 0.569 . . . . 0.0 111.479 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -97.11 161.37 13.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 165.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 78.4 p -138.48 124.56 20.17 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.508 HG12 HG23 ' A' ' 125' ' ' VAL . 2.6 pp -86.61 131.0 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mp -113.19 119.58 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.0 mt -105.65 111.03 33.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 61.3 mtt180 -92.18 140.85 29.21 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 123.364 0.415 . . . . 0.0 110.335 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.671 HE22 HD22 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -137.33 139.6 40.94 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 167.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.491 HH12 ' HA3' ' A' ' 107' ' ' GLY . 24.6 tpt85 -107.83 102.79 11.97 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.434 ' HE1' ' HA2' ' A' ' 137' ' ' GLY . 63.1 m-85 -85.95 144.46 27.62 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.931 1.292 . . . . 0.0 110.929 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.527 ' HB3' ' HD3' ' A' ' 141' ' ' ARG . 26.5 t70 -87.82 26.44 1.33 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 123.807 0.692 . . . . 0.0 110.696 170.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.27 155.09 68.79 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.049 0.94 . . . . 0.0 110.604 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.38 156.63 59.0 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.549 2.833 . . . . 0.0 113.174 175.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 101' ' ' LEU . 11.3 t -59.97 -42.51 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 O-C-N 124.473 1.108 . . . . 0.0 110.628 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -48.66 -52.05 25.29 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 125.107 1.504 . . . . 0.0 109.88 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -64.92 -62.87 1.3 Allowed 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.65 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.533 HG22 HD13 ' A' ' 140' ' ' ILE . 62.9 t -46.54 -39.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 C-N-CA 124.697 1.199 . . . . 0.0 112.248 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -65.93 -41.16 91.73 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.114 0.966 . . . . 0.0 110.316 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.4 m -69.78 -25.79 63.97 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 123.469 0.48 . . . . 0.0 110.512 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.56 -47.91 21.02 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.527 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.459 ' HB3' HD21 ' A' ' 99' ' ' LEU . 84.7 m -75.82 -16.9 60.02 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 43.7 p -101.63 -33.22 9.98 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 118.403 0.547 . . . . 0.0 111.66 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 47' ' ' ILE . 19.9 t70 -83.45 112.41 39.12 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 122.75 0.42 . . . . 0.0 110.004 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.484 ' HB2' ' HG3' ' A' ' 53' ' ' GLU . 58.4 Cg_endo -64.46 -27.34 62.37 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.151 2.568 . . . . 0.0 112.869 -171.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -63.9 -39.34 93.95 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.758 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -79.48 -24.29 42.44 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.59 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 43' ' ' ASP . 79.1 mt -74.82 -38.5 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.59 0.356 . . . . 0.0 111.52 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 10.9 p30 -73.87 -0.42 15.94 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -73.26 -29.94 63.09 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.768 0.827 . . . . 0.0 110.714 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 40.7 p-90 -129.31 -11.7 4.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.015 0.926 . . . . 0.0 111.484 -171.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.457 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 16.2 t80 -147.96 -163.72 1.84 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.525 0.73 . . . . 0.0 109.13 -174.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 mt -87.1 171.34 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 31.3 tt0 -108.63 121.51 43.05 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.668 1.187 . . . . 0.0 110.12 -172.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.69 84.69 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.337 2.691 . . . . 0.0 111.0 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -77.47 126.22 30.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.989 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.22 -165.89 36.8 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.633 -0.318 . . . . 0.0 112.722 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.84 -37.96 73.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.443 0.697 . . . . 0.0 110.279 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.0 mt 59.22 -171.37 0.12 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.922 1.289 . . . . 0.0 111.885 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 72.59 166.64 0.3 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.882 1.273 . . . . 0.0 110.598 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 41.3 tt0 -60.02 111.7 1.6 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.165 0.586 . . . . 0.0 111.149 -173.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.08 11.52 58.61 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.436 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.34 -146.56 20.36 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.65 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 29.8 p-10 -156.0 160.42 40.03 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 117.571 0.685 . . . . 0.0 111.705 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -140.07 147.91 40.99 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.72 112.17 5.28 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.756 0.823 . . . . 0.0 109.884 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 69' ' ' ASN . 79.1 mt -78.39 146.89 34.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.706 0.802 . . . . 0.0 109.262 172.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -69.41 122.07 18.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.551 0.74 . . . . 0.0 110.631 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 56.69 40.9 89.45 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 124.29 0.994 . . . . 0.0 114.468 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 66' ' ' LEU . 18.4 t-20 -147.17 -84.27 0.11 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.704 0.252 . . . . 0.0 110.402 -171.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.35 151.03 31.19 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.98 0.419 . . . . 0.0 111.707 -171.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -132.0 145.25 51.34 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.224 1.009 . . . . 0.0 109.796 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.19 -163.08 26.99 Favored Glycine 0 C--O 1.241 0.548 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.65 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 4.8 p-10 -127.04 173.89 9.3 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.158 0.479 . . . . 0.0 110.731 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.475 ' HA ' HG22 ' A' ' 85' ' ' ILE . 19.6 mm -97.49 102.8 13.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.53 -47.84 71.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -167.66 142.52 3.76 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.794 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 22.0 p -127.36 106.24 9.07 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.64 99.47 8.84 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 9.9 Cg_exo -74.56 137.81 23.3 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.147 2.565 . . . . 0.0 112.984 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 42.7 Cg_endo -100.83 30.53 11.11 Favored 'Cis proline' 0 C--N 1.375 1.932 0 CA-C-N 119.481 0.85 . . . . 0.0 112.153 -9.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -71.34 -69.43 0.38 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.285 1.034 . . . . 0.0 111.998 -170.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -152.95 146.9 25.36 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.417 0.627 . . . . 0.0 111.452 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 99' ' ' LEU . 58.1 tp -98.31 143.99 28.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.702 -1.136 . . . . 0.0 107.954 169.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.9 m -134.79 123.34 23.42 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.475 HG22 ' HA ' ' A' ' 74' ' ' ILE . 21.0 pt -143.74 149.56 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.619 0.768 . . . . 0.0 110.285 -174.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 p -88.16 138.51 31.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 36.8 t-105 -130.2 101.02 5.61 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -170.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -107.91 102.46 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -78.74 154.85 29.68 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.63 111.04 1.45 Allowed 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.065 0.46 . . . . 0.0 111.784 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.04 21.99 66.75 Favored Glycine 0 C--N 1.351 1.361 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.375 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.463 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 69.0 mmtt -126.48 153.14 75.08 Favored Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 123.711 0.805 . . . . 0.0 109.593 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.519 ' HG2' ' HB2' ' A' ' 118' ' ' SER . 23.4 Cg_exo -64.72 162.5 31.39 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.962 2.441 . . . . 0.0 113.506 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.93 103.59 1.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.962 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -100.46 179.29 4.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.824 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -142.42 128.81 20.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.974 0.909 . . . . 0.0 108.634 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.6 t -113.66 121.46 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.241 0.544 . . . . 0.0 110.292 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 37.7 mm-40 -91.41 138.66 31.4 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.906 165.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 83' ' ' LEU . 55.0 tp -127.63 110.57 12.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 171.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -128.97 121.91 29.0 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 122.151 -0.343 . . . . 0.0 110.385 -160.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HB3' HG22 ' A' ' 34' ' ' VAL . 90.0 mt -115.61 141.28 48.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.645 0.778 . . . . 0.0 111.233 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.4 t -144.51 115.24 7.74 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.523 1.129 . . . . 0.0 108.791 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -81.96 120.45 25.25 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -129.39 121.81 28.14 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.301 1.44 . . . . 0.0 108.129 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.93 -135.28 16.44 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -102.63 62.57 0.84 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 165.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.491 ' HA3' HH12 ' A' ' 29' ' ' ARG . . . -179.24 -177.79 47.9 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.101 -0.954 . . . . 0.0 114.408 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.3 m -134.26 141.33 46.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.311 1.044 . . . . 0.0 110.081 -170.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.9 tp -102.27 112.98 25.9 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.671 HD22 HE22 ' A' ' 28' ' ' GLN . 7.3 tt -95.89 134.61 38.67 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 173.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.577 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 39.8 mt-10 -132.69 106.28 7.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.642 HD13 HD21 ' A' ' 133' ' ' LEU . 8.9 tt -98.27 122.05 40.96 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 98' ' ' GLU . 38.7 tt0 -122.01 100.78 7.16 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.807 0.843 . . . . 0.0 109.28 -172.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 23' ' ' SER . 8.3 t60 -99.29 113.77 26.25 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 22' ' ' ARG . . . -104.38 111.74 24.51 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.714 1.206 . . . . 0.0 111.095 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.454 HG23 ' HG ' ' A' ' 122' ' ' LEU . 10.6 t -136.99 160.76 37.97 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 170.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.433 HG23 HD11 ' A' ' 16' ' ' ILE . 66.8 p -86.13 -15.08 42.24 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.582 1.153 . . . . 0.0 111.489 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.519 ' HB2' ' HG2' ' A' ' 93' ' ' PRO . 46.4 t -87.17 108.98 19.15 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.062 0.545 . . . . 0.0 109.797 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.507 ' HA ' HD12 ' A' ' 122' ' ' LEU . 39.7 tt0 -62.03 -31.04 71.4 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.787 0.835 . . . . 0.0 110.796 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -61.24 -58.05 9.88 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.158 175.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.463 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 24.3 ttt -64.16 -26.92 68.74 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.706 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 119' ' ' GLU . 13.8 mt -65.15 -44.6 88.05 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.463 0.705 . . . . 0.0 111.864 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.89 -45.44 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.256 0.551 . . . . 0.0 109.81 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.79 -50.5 72.14 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.042 1.337 . . . . 0.0 112.081 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.508 HG23 HG12 ' A' ' 24' ' ' ILE . 35.8 m -72.03 -29.37 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.876 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.7 -38.23 91.36 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 172.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 131' ' ' MET . 59.6 t -75.69 -59.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.051 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.63 -37.04 94.15 Favored Glycine 0 C--N 1.345 1.038 0 O-C-N 123.725 0.64 . . . . 0.0 114.446 -172.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.473 ' HB2' ' O ' ' A' ' 125' ' ' VAL . 10.7 m95 -67.05 -53.38 31.68 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -57.76 -31.47 66.53 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.156 0.285 . . . . 0.0 110.746 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 95.7 mmm -61.48 -48.45 81.06 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.204 0.602 . . . . 0.0 110.331 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.31 -38.96 85.32 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.26 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.642 HD21 HD13 ' A' ' 112' ' ' LEU . 2.8 mm? -77.37 -19.88 55.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.985 0.514 . . . . 0.0 111.731 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 138' ' ' MET . 72.0 m-20 -66.82 -53.5 32.08 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 68.9 m-85 -72.59 -25.4 61.31 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.749 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.402 HD13 ' CZ2' ' A' ' 50' ' ' TRP . 59.1 tp -70.39 -39.21 74.64 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.434 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -58.14 -39.41 92.19 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.615 171.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 89.3 mmm -70.22 -38.16 75.17 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.531 0.732 . . . . 0.0 110.183 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -69.01 -37.26 78.57 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.2 1.0 . . . . 0.0 111.276 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.533 HD13 HG22 ' A' ' 37' ' ' VAL . 50.5 mt -80.03 -57.42 5.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 123.338 0.655 . . . . 0.0 110.193 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.527 ' HD3' ' HB3' ' A' ' 31' ' ' ASP . 21.2 ttt180 . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 121.709 0.766 . . . . 0.0 110.179 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 61.8 mt . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 119.751 -0.166 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 62.2 p -70.69 -39.76 73.32 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.235 0.334 . . . . 0.0 110.52 -171.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -59.7 -59.7 5.02 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.293 170.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -43.17 -36.75 1.82 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 172.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -64.77 -52.36 57.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.248 0.619 . . . . 0.0 110.733 175.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.25 -20.01 75.92 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.264 -174.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -81.37 -28.17 34.54 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.63 1.172 . . . . 0.0 110.088 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.25 -48.76 55.44 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -69.05 -23.1 64.01 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.035 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.01 -61.08 2.24 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 173.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -47.11 -47.1 23.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.837 1.255 . . . . 0.0 112.733 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 56.6 mt -64.83 -46.51 81.61 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.592 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.9 p -74.57 -26.94 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 118.867 0.758 . . . . 0.0 109.953 -169.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -76.29 -10.09 59.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.64 0.776 . . . . 0.0 111.583 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 CA--C 1.549 0.909 0 C-N-CA 123.593 0.757 . . . . 0.0 109.54 168.889 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 121.382 0.611 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 m -89.11 130.92 35.47 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.824 0.85 . . . . 0.0 111.161 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 19.8 mt-10 -119.16 109.13 15.52 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 173.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -82.48 136.13 34.97 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.047 0.539 . . . . 0.0 110.259 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.13 179.44 9.23 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 123.843 0.714 . . . . 0.0 110.144 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 178' ' ' VAL . 0.2 OUTLIER -143.61 148.46 35.89 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.55 166.28 23.91 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.516 ' HD3' ' H ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -110.33 148.53 31.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.624 ' HG2' ' HB1' ' A' ' 115' ' ' ALA . 6.5 tpt180 -148.33 150.3 33.35 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.206 0.527 . . . . 0.0 112.134 -164.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.3 m -111.13 137.9 48.22 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 161.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 pt -140.03 159.77 63.01 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -51.1 -26.59 19.62 Favored 'Trans proline' 0 C--N 1.386 2.549 0 C-N-CA 123.065 2.51 . . . . 0.0 114.294 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.71 -44.81 63.52 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.029 0.532 . . . . 0.0 111.307 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.43 -151.21 21.71 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.071 0.232 . . . . 0.0 112.609 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -73.75 123.14 23.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.409 0.684 . . . . 0.0 109.644 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.03 166.95 19.07 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.542 0.737 . . . . 0.0 111.205 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -125.15 171.78 10.03 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 162.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.9 m -134.45 135.67 42.67 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.289 0.636 . . . . 0.0 109.797 -170.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.537 HG12 ' HB3' ' A' ' 114' ' ' HIS . 35.4 pt -85.91 133.69 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 168.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.661 HG13 ' HG2' ' A' ' 113' ' ' GLU . 2.0 mp -110.57 111.8 37.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 174.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.407 HD12 ' HB3' ' A' ' 129' ' ' TRP . 39.5 mt -107.29 106.65 21.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 168.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.521 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 28.4 mtt180 -89.74 161.19 16.18 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.547 174.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 110' ' ' LEU . 4.2 tp-100 -162.11 117.88 1.98 Allowed 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.337 -174.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.402 ' HE ' HD13 ' A' ' 109' ' ' LEU . 26.3 mmt85 -95.4 105.68 17.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 165.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.553 ' HB2' ' HB ' ' A' ' 108' ' ' THR . 50.3 m-85 -87.58 150.7 23.53 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 123.857 0.863 . . . . 0.0 109.398 169.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -114.66 85.74 2.3 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 162.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 179.71 137.45 0.28 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.932 2.093 . . . . 0.0 105.617 -163.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.46 137.07 78.37 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.76 2.307 . . . . 0.0 113.286 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 108' ' ' THR . 54.3 t -48.99 -40.47 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 124.329 1.018 . . . . 0.0 110.528 167.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -48.88 -45.48 41.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.474 1.109 . . . . 0.0 111.308 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.11 -25.64 34.27 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 140' ' ' ILE . 50.6 t -72.29 -44.18 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.074 0.464 . . . . 0.0 110.359 174.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -68.51 -28.02 66.64 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.593 1.157 . . . . 0.0 109.726 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 t -65.79 -48.27 72.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.932 0.893 . . . . 0.0 109.928 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.23 -28.41 63.14 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.338 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.3 t -76.95 -24.39 52.35 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.6 p -111.18 -43.01 3.8 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -172.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.435 ' O ' HG13 ' A' ' 47' ' ' ILE . 15.0 t70 -76.66 120.07 80.11 Favored Pre-proline 0 N--CA 1.483 1.22 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.917 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.1 -46.54 30.42 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.903 3.069 . . . . 0.0 114.391 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.436 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 41.3 t-20 -58.65 -32.64 69.26 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.768 0.827 . . . . 0.0 111.314 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -89.82 -20.06 23.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.219 0.608 . . . . 0.0 111.217 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 43' ' ' ASP . 85.7 mt -75.99 -42.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.059 0.544 . . . . 0.0 110.331 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' A' ' 45' ' ' ASN . 10.6 p30 -69.78 -0.89 7.86 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -172.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -91.82 -11.06 37.63 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.365 0.666 . . . . 0.0 110.246 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.447 ' CE2' HD13 ' A' ' 136' ' ' LEU . 57.9 p-90 -137.17 -25.21 1.07 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.3 1.04 . . . . 0.0 111.338 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.439 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 5.1 t80 -130.66 -160.66 1.06 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.329 1.052 . . . . 0.0 108.523 -177.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.62 143.64 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 122.833 0.453 . . . . 0.0 110.661 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -63.6 115.06 15.59 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 124.753 1.283 . . . . 0.0 109.767 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HG3' HD12 ' A' ' 47' ' ' ILE . 83.9 Cg_endo -83.07 148.06 13.25 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.446 2.097 . . . . 0.0 112.877 178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -134.96 125.87 27.49 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.61 -175.45 39.82 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 121.507 -0.377 . . . . 0.0 112.902 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.8 -44.06 86.82 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.177 0.574 . . . . 0.0 110.307 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.6 mt 66.95 5.15 3.88 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.133 1.373 . . . . 0.0 113.126 171.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -103.71 168.1 9.36 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.297 0.639 . . . . 0.0 109.917 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 77' ' ' CYS . 31.2 mt-10 -58.56 122.76 14.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.746 0.819 . . . . 0.0 110.794 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.35 13.94 77.57 Favored Glycine 0 N--CA 1.469 0.862 0 CA-C-N 116.467 -0.333 . . . . 0.0 113.112 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.95 -168.17 19.03 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.299 -0.32 . . . . 0.0 112.299 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -117.31 167.24 11.41 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.564 0.746 . . . . 0.0 110.095 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -146.95 149.4 33.11 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.15 116.3 9.44 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.203 0.601 . . . . 0.0 111.032 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.403 ' HB2' ' H ' ' A' ' 70' ' ' ALA . 60.3 mt -91.7 133.58 35.46 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.672 1.189 . . . . 0.0 109.3 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -68.23 106.08 2.32 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.565 1.146 . . . . 0.0 110.0 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.81 40.55 84.94 Favored Glycine 0 C--N 1.348 1.206 0 N-CA-C 114.385 0.514 . . . . 0.0 114.385 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -144.54 -86.77 0.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.579 0.352 . . . . 0.0 110.128 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 66' ' ' LEU . . . -147.69 156.31 42.64 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 120.773 0.321 . . . . 0.0 111.631 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.1 m -131.0 143.21 50.55 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.222 1.009 . . . . 0.0 108.538 174.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.93 -153.81 8.09 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.425 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 2.4 m-20 -121.36 171.07 9.02 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.771 0.828 . . . . 0.0 109.828 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.47 ' HA ' HG22 ' A' ' 85' ' ' ILE . 3.5 mp -108.24 112.65 41.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 170.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.599 HD12 HG22 ' A' ' 84' ' ' THR . 74.9 mt -69.95 -49.97 46.53 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.458 ' HD2' ' HB ' ' A' ' 84' ' ' THR . 0.1 OUTLIER -168.65 154.88 6.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.059 0.944 . . . . 0.0 109.376 169.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.469 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 24.9 p -146.31 120.36 9.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -121.23 110.14 34.61 Favored Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 16.8 Cg_exo -68.38 129.52 19.28 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.851 2.367 . . . . 0.0 112.693 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 19.9 Cg_endo -103.42 23.96 13.15 Favored 'Cis proline' 0 C--N 1.376 2.014 0 CA-C-N 120.048 1.053 . . . . 0.0 112.626 -13.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -64.18 -67.14 0.46 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.0 0.92 . . . . 0.0 112.006 -171.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -138.03 158.42 44.36 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.588 0.755 . . . . 0.0 110.651 -171.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 tt -142.32 127.5 18.61 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 171.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.599 HG22 HD12 ' A' ' 75' ' ' LEU . 19.3 m -139.46 130.3 26.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.227 0.611 . . . . 0.0 109.378 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 74' ' ' ILE . 10.4 pt -141.24 146.6 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.026 1.33 . . . . 0.0 109.91 -171.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.425 ' OG ' ' HB2' ' A' ' 73' ' ' ASP . 18.0 p -89.95 145.57 25.02 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.673 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 22.0 t-105 -140.98 107.33 5.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.101 0.864 . . . . 0.0 109.397 -159.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.15 103.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.4 ' HB3' ' HE3' ' A' ' 121' ' ' MET . 67.2 t80 -101.51 94.96 6.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.566 1.146 . . . . 0.0 110.432 -169.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 47.8 -73.1 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 126.618 1.967 . . . . 0.0 115.278 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.6 33.58 2.54 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 117.957 0.344 . . . . 0.0 112.553 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.613 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 72.3 mmtt -115.65 159.31 39.24 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 124.174 0.989 . . . . 0.0 110.656 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.12 161.02 41.93 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.419 2.079 . . . . 0.0 112.759 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.58 107.08 1.97 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.901 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.673 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 13.4 m -87.71 155.58 19.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.188 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -116.51 103.08 10.07 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.63 142.7 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.938 0.895 . . . . 0.0 108.622 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -147.83 156.87 43.18 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.253 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.5 tt -139.81 139.85 36.48 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 21.2 tpt180 -135.25 122.86 22.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.777 0.831 . . . . 0.0 109.521 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.4 mt -115.32 137.86 51.58 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.688 0.795 . . . . 0.0 110.16 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 t -143.98 137.1 27.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.172 0.589 . . . . 0.0 109.898 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -84.97 96.14 9.29 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.528 1.131 . . . . 0.0 110.425 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -100.7 78.23 1.96 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.01 -117.42 4.69 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -91.37 9.73 30.41 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 168.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 30' ' ' TYR . . . -100.82 159.32 19.03 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.485 -173.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.617 HG23 HG22 ' A' ' 34' ' ' VAL . 53.1 m -135.15 108.13 7.62 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.757 1.223 . . . . 0.0 108.63 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.402 HD13 ' HE ' ' A' ' 29' ' ' ARG . 39.8 tp -81.04 106.04 12.73 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 170.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 28' ' ' GLN . 8.1 tt -91.0 130.89 36.88 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 42.4 mt-10 -131.67 107.09 8.57 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 tp -104.23 128.68 51.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.998 0.919 . . . . 0.0 109.636 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.661 ' HG2' HG13 ' A' ' 25' ' ' ILE . 45.5 mt-10 -127.12 103.67 7.56 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.775 0.83 . . . . 0.0 109.43 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.537 ' HB3' HG12 ' A' ' 24' ' ' ILE . 6.8 t60 -92.97 111.7 23.42 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.624 ' HB1' ' HG2' ' A' ' 14' ' ' ARG . . . -109.91 101.79 10.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.141 0.576 . . . . 0.0 110.54 -174.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.402 HG23 ' HG ' ' A' ' 122' ' ' LEU . 9.8 t -123.78 152.22 42.44 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.268 0.556 . . . . 0.0 110.77 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.3 m -66.42 -29.32 69.44 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.367 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 t -92.36 125.43 37.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.096 0.558 . . . . 0.0 111.384 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -62.48 -34.04 76.06 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.56 1.144 . . . . 0.0 110.126 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -44.93 81.78 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.212 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.613 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 23.2 ttt -68.48 -32.94 73.29 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.159 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.402 ' HG ' HG23 ' A' ' 116' ' ' THR . 25.5 mt -63.01 -42.52 99.86 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 118.42 0.554 . . . . 0.0 112.104 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.6 t -67.82 -42.13 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-O 121.155 0.502 . . . . 0.0 109.868 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -58.15 -50.17 74.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.18 1.392 . . . . 0.0 111.638 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 121' ' ' MET . 26.4 m -82.6 -18.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.565 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.86 -36.44 92.02 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 169.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.46 -46.81 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 114.669 -0.766 . . . . 0.0 109.94 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.11 -35.81 92.45 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 114.845 0.698 . . . . 0.0 114.845 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.407 ' HB3' HD12 ' A' ' 26' ' ' ILE . 66.8 m95 -87.67 -28.26 21.93 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.987 0.515 . . . . 0.0 110.853 -176.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.464 ' HG3' ' HE1' ' A' ' 174' ' ' TRP . 43.9 mm-40 -62.45 -38.81 91.22 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 72.4 mtm -70.4 -33.96 71.99 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.926 0.766 . . . . 0.0 110.692 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.67 -46.15 83.67 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.028 0.531 . . . . 0.0 111.054 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.91 -22.2 46.2 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.381 0.673 . . . . 0.0 110.741 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.474 ' O ' ' HG2' ' A' ' 138' ' ' MET . 24.8 t70 -65.49 -62.34 1.58 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 171.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -64.75 -29.64 70.63 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.1 0.56 . . . . 0.0 111.846 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.447 HD13 ' CE2' ' A' ' 50' ' ' TRP . 39.5 tp -67.83 -42.64 81.14 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -61.43 -39.05 96.76 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.9 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 97.3 mmm -69.4 -43.18 73.98 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.766 0.826 . . . . 0.0 110.524 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -68.21 -50.76 52.07 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.342 1.057 . . . . 0.0 111.064 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.459 HD13 HG22 ' A' ' 37' ' ' VAL . 67.0 mt -62.6 -43.52 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.309 0.644 . . . . 0.0 110.756 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 C-N-CA 123.417 0.687 . . . . 0.0 109.264 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 119.79 -0.148 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 42.1 t -70.24 -54.79 11.26 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -61.14 -59.77 4.82 Favored 'General case' 0 C--N 1.364 1.207 0 O-C-N 123.676 0.61 . . . . 0.0 111.368 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -44.35 -47.84 9.68 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.407 ' HD2' ' HG3' ' A' ' 130' ' ' GLU . 13.7 tpp85 -66.17 -41.3 90.51 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.886 0.474 . . . . 0.0 110.675 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -76.74 -26.66 62.34 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.057 -174.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -75.79 -22.36 56.46 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.994 0.518 . . . . 0.0 110.787 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.54 -47.84 58.39 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.208 0.603 . . . . 0.0 109.413 170.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.464 ' HE1' ' HG3' ' A' ' 130' ' ' GLU . 98.9 m95 -69.31 -26.02 64.52 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.792 0.683 . . . . 0.0 112.005 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.83 -58.13 6.34 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -47.38 -42.66 22.29 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.257 1.023 . . . . 0.0 112.923 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.7 -48.22 75.47 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.698 0.623 . . . . 0.0 111.69 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.545 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 12.0 p -79.22 -29.59 13.8 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 C-N-CA 123.595 0.758 . . . . 0.0 111.427 -167.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -66.98 -31.39 71.93 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.373 0.669 . . . . 0.0 109.967 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.47 0.526 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.128 176.925 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 m -96.31 130.02 43.51 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.871 0.868 . . . . 0.0 109.689 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 19.9 mp0 -120.49 110.68 16.77 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.834 0.854 . . . . 0.0 108.75 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.66 149.78 28.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.861 0.363 . . . . 0.0 110.724 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.427 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -157.65 176.59 12.41 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.391 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 177' ' ' LEU . 1.2 tm? -144.69 149.97 36.52 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.53 -162.1 10.95 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -132.0 140.21 48.87 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.279 1.032 . . . . 0.0 108.918 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -155.0 131.03 10.17 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.527 0.731 . . . . 0.0 109.985 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -79.74 141.94 35.87 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.539 HD11 HG23 ' A' ' 117' ' ' THR . 49.8 pt -129.61 160.55 64.03 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.083 0.953 . . . . 0.0 109.365 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -54.1 -28.67 51.98 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 123.233 2.622 . . . . 0.0 114.004 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.85 -34.86 60.08 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.565 0.746 . . . . 0.0 111.918 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.409 ' H ' HG13 ' A' ' 16' ' ' ILE . . . 164.98 -148.9 14.92 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-O 120.015 -0.325 . . . . 0.0 112.321 -175.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.402 ' O ' HG22 ' A' ' 117' ' ' THR . 38.3 mt-10 -87.92 135.38 33.43 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.49 162.97 30.44 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.815 0.446 . . . . 0.0 111.781 -175.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.576 HH11 HG22 ' A' ' 178' ' ' VAL . 91.0 mtt180 -102.44 159.0 15.81 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 166.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.6 p -133.7 125.94 29.7 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -172.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.48 ' HB ' ' CZ3' ' A' ' 174' ' ' TRP . 27.7 pt -85.96 135.2 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 3.5 mp -117.98 116.77 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 129' ' ' TRP . 38.1 mt -106.99 107.19 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 95.1 mtt180 -91.97 161.68 14.7 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.705 174.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 5.6 tt0 -167.29 116.6 0.83 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 125.233 1.583 . . . . 0.0 109.951 176.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -92.23 108.42 19.94 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 60.5 m-85 -92.3 144.2 25.63 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.767 1.227 . . . . 0.0 111.507 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -102.26 72.91 1.32 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 162.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 30' ' ' TYR . . . -166.32 141.26 3.7 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.752 1.621 . . . . 0.0 106.639 -163.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.33 141.92 32.73 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 121.953 1.769 . . . . 0.0 112.579 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 80' ' ' PRO . 56.5 t -50.89 -43.69 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 124.487 1.117 . . . . 0.0 111.742 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -54.11 -35.6 62.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 124.462 1.101 . . . . 0.0 111.514 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -78.57 -32.56 47.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 t -74.63 -30.05 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 123.784 0.677 . . . . 0.0 110.171 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.403 ' HE3' HD12 ' A' ' 101' ' ' LEU . 70.2 t-105 -78.21 -25.93 47.25 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.149 0.979 . . . . 0.0 110.425 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.8 m -65.67 -50.93 63.13 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -59.9 -37.68 80.1 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.421 0.688 . . . . 0.0 112.119 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.78 -45.51 93.59 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.0 p -117.58 -39.53 3.14 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -166.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 47' ' ' ILE . 12.1 t70 -69.21 118.16 59.22 Favored Pre-proline 0 N--CA 1.485 1.285 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.38 -33.55 97.55 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.412 2.741 . . . . 0.0 114.217 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -72.37 -23.28 61.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 123.606 0.567 . . . . 0.0 110.574 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.524 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 12.8 mmt85 -87.46 -30.39 20.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.995 0.918 . . . . 0.0 110.876 174.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 43' ' ' ASP . 60.1 mt -71.5 -41.19 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.187 0.595 . . . . 0.0 110.067 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -70.75 4.21 2.67 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -175.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -97.94 -11.44 23.11 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.828 0.851 . . . . 0.0 111.872 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.448 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 42.9 p-90 -139.04 -24.96 0.88 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.307 0.643 . . . . 0.0 111.614 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.448 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 12.9 t80 -132.57 -172.22 2.85 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.717 1.207 . . . . 0.0 108.839 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.13 144.84 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.043 0.937 . . . . 0.0 111.256 -171.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.71 113.53 5.45 Favored Pre-proline 0 CA--C 1.568 1.653 0 O-C-N 125.138 1.524 . . . . 0.0 111.812 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -93.15 121.41 0.43 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.069 2.513 . . . . 0.0 113.307 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HE2' ' HA ' ' A' ' 55' ' ' LYS . 9.7 mmpt? -112.45 125.33 54.11 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 171.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.33 -171.4 36.55 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.37 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.47 ' HB3' ' H ' ' A' ' 63' ' ' ASN . 25.0 t70 -71.2 -43.86 66.58 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 123.936 0.433 . . . . 0.0 110.502 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.1 mt 73.64 -17.12 0.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.047 1.739 . . . . 0.0 113.499 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -97.49 164.71 12.33 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.167 0.587 . . . . 0.0 110.973 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.588 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 35.5 tt0 -55.97 126.2 24.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 112.968 -172.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.85 84.52 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.955 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -103.98 -147.48 17.6 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.47 ' H ' ' HB3' ' A' ' 57' ' ' ASP . 35.6 p-10 -148.39 167.65 24.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.43 0.692 . . . . 0.0 111.301 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -144.24 141.63 29.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.22 120.23 26.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.521 0.729 . . . . 0.0 110.493 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.8 mt -106.14 119.98 40.63 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.691 1.196 . . . . 0.0 108.1 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -69.99 123.83 22.52 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.137 0.975 . . . . 0.0 111.33 -171.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.11 31.46 64.07 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.859 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -149.77 -91.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.548 0.339 . . . . 0.0 110.828 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.13 152.46 18.95 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.147 0.499 . . . . 0.0 111.272 -169.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.9 p -137.77 137.29 38.1 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.36 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.6 -162.59 12.31 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 23.7 m-20 -101.22 172.28 7.1 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.34 0.656 . . . . 0.0 110.869 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 mm -106.97 116.68 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 86' ' ' SER . 85.8 mt -82.09 -51.34 8.09 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.682 0.393 . . . . 0.0 110.951 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.73 120.8 2.42 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -173.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 27.4 p -135.66 110.72 8.88 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.828 0.451 . . . . 0.0 109.941 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -116.57 111.15 41.86 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 65.5 Cg_endo -73.89 137.12 23.93 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.75 2.3 . . . . 0.0 113.096 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.52 ' HB2' HG12 ' A' ' 34' ' ' VAL . 27.2 Cg_endo -100.52 30.01 11.92 Favored 'Cis proline' 0 C--N 1.376 1.977 0 CA-C-N 119.413 0.826 . . . . 0.0 111.818 -9.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -65.22 -71.14 0.2 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.109 1.364 . . . . 0.0 111.991 -169.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 15.5 ptt180 -163.11 156.64 19.72 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.804 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.5 tp -111.12 145.5 38.47 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.232 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.454 HG22 HD12 ' A' ' 75' ' ' LEU . 26.1 m -142.01 130.54 22.58 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.83 149.29 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.355 1.062 . . . . 0.0 110.254 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.472 ' HB2' HD21 ' A' ' 75' ' ' LEU . 46.8 t -91.27 133.03 35.75 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 172.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -123.22 95.98 4.82 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -169.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -91.55 104.26 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -72.25 178.34 3.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.051 0.94 . . . . 0.0 109.791 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.37 -4.43 39.36 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.563 0.745 . . . . 0.0 112.858 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.64 57.97 0.06 OUTLIER Glycine 0 C--N 1.351 1.385 0 C-N-CA 121.783 -0.246 . . . . 0.0 112.974 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.46 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 74.5 mmtt -132.75 156.15 80.39 Favored Pre-proline 0 N--CA 1.496 1.844 0 C-N-CA 123.798 0.839 . . . . 0.0 109.645 173.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -86.87 72.06 3.46 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.614 2.209 . . . . 0.0 111.745 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 67.06 149.36 0.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.651 1.58 . . . . 0.0 113.273 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 63.7 m -136.64 127.09 26.74 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.622 ' HB3' ' HB3' ' A' ' 115' ' ' ALA . 4.6 tp10 -94.0 105.66 17.66 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.83 131.98 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -150.43 145.07 25.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.793 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.524 HD11 ' HG ' ' A' ' 110' ' ' LEU . 30.6 tp -107.86 152.52 24.3 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.668 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 31.0 tpt180 -138.28 122.31 17.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.142 0.977 . . . . 0.0 108.395 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.484 ' HB3' HG13 ' A' ' 34' ' ' VAL . 81.2 mt -121.95 126.86 49.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.671 0.788 . . . . 0.0 109.299 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 m -145.14 125.45 13.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.552 0.741 . . . . 0.0 110.655 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.64 124.93 21.84 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.714 0.806 . . . . 0.0 110.905 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -142.27 128.39 19.71 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.719 0.808 . . . . 0.0 111.08 166.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.87 -135.94 17.23 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.65 -42.95 99.89 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 117.05 0.425 . . . . 0.0 110.923 161.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -107.89 -146.33 12.43 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 115.445 0.938 . . . . 0.0 115.445 -157.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.452 HG23 HG22 ' A' ' 34' ' ' VAL . 99.0 m -130.06 149.85 51.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.664 1.986 . . . . 0.0 109.055 -168.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.3 tp -109.07 127.5 54.19 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 166.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.524 ' HG ' HD11 ' A' ' 99' ' ' LEU . 9.2 tt -100.0 130.57 46.18 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 173.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.668 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 42.2 mt-10 -135.12 107.79 7.45 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.481 HD22 HD21 ' A' ' 133' ' ' LEU . 54.6 tp -102.51 143.07 32.68 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.258 0.623 . . . . 0.0 109.412 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 32.5 tt0 -132.29 142.24 49.29 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.723 0.809 . . . . 0.0 109.64 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -141.95 116.5 9.67 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.622 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . . . -126.42 111.0 13.94 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.97 0.508 . . . . 0.0 112.012 -168.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 t -141.51 164.5 30.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.863 0.465 . . . . 0.0 110.359 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.539 HG23 HD11 ' A' ' 16' ' ' ILE . 58.1 p -74.73 -28.74 60.91 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.817 0.847 . . . . 0.0 110.695 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.6 t -79.86 110.45 15.24 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.832 0.853 . . . . 0.0 110.804 -175.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.77 -28.28 69.34 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.667 0.787 . . . . 0.0 111.04 171.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -59.02 -55.23 37.87 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.17 0.919 . . . . 0.0 109.189 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.46 ' SD ' ' HG3' ' A' ' 92' ' ' LYS . 12.4 tpt -56.63 -52.23 65.68 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.674 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.8 mt -54.5 -47.93 72.47 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.383 1.073 . . . . 0.0 113.614 -173.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.3 t -70.5 -42.98 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 122.413 0.285 . . . . 0.0 110.32 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.7 -49.9 73.27 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.726 0.811 . . . . 0.0 111.249 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 121' ' ' MET . 21.6 m -71.51 -23.12 22.44 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 C-N-CA 123.203 0.601 . . . . 0.0 110.461 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.71 79.41 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.5 t -78.27 -51.95 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.095 -0.553 . . . . 0.0 109.569 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.15 -31.75 81.74 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.753 0.658 . . . . 0.0 114.161 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.511 ' HB3' HD12 ' A' ' 26' ' ' ILE . 15.0 m95 -79.79 -41.17 27.04 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.2 -34.38 72.08 Favored 'General case' 0 C--N 1.368 1.401 0 CA-C-N 118.271 0.487 . . . . 0.0 110.785 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.8 mmt -68.88 -48.52 63.19 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.767 0.667 . . . . 0.0 109.711 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.03 -46.48 75.29 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.324 0.65 . . . . 0.0 111.519 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.481 HD21 HD22 ' A' ' 112' ' ' LEU . 4.1 mm? -80.54 -23.04 40.27 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.459 0.704 . . . . 0.0 111.329 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.65 -54.07 32.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -69.91 -18.47 63.39 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.46 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.0 tp -76.95 -44.08 32.73 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.082 0.401 . . . . 0.0 110.531 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.459 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -60.74 -34.47 86.84 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.6 mtp -81.29 -25.7 36.3 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.72 0.808 . . . . 0.0 111.809 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -66.45 -54.83 19.65 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.93 -58.01 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.727 -172.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 120.546 0.212 . . . . 0.0 111.367 -169.82 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.516 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 57.5 mt . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 61.2 p -76.72 -45.92 27.43 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.442 0.464 . . . . 0.0 111.077 -173.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -46.78 -60.38 2.44 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.033 0.833 . . . . 0.0 110.192 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -42.34 -42.38 3.14 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 20.6 mmt180 -62.59 -59.78 4.45 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.278 0.361 . . . . 0.0 110.346 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.06 -37.42 32.79 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 122.307 -0.246 . . . . 0.0 113.092 -166.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -59.77 -34.98 73.71 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 124.125 0.97 . . . . 0.0 111.181 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.6 -61.25 2.74 Favored 'General case' 0 C--N 1.36 1.038 0 O-C-N 123.932 0.77 . . . . 0.0 109.516 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.48 ' CZ3' ' HB ' ' A' ' 24' ' ' ILE . 95.4 m95 -68.54 -22.56 64.5 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -172.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.17 -63.08 1.13 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.448 ' HA ' ' NE2' ' A' ' 179' ' ' HIS . . . -54.32 -34.7 61.55 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 37.8 mt -69.07 -46.83 66.84 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 118.988 -0.53 . . . . 0.0 110.072 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.576 HG22 HH11 ' A' ' 22' ' ' ARG . 9.4 p -70.18 -31.6 47.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 CA-C-N 119.117 0.871 . . . . 0.0 109.563 -169.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . 0.448 ' NE2' ' HA ' ' A' ' 176' ' ' ALA . 11.3 p80 -92.45 16.72 11.24 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 58.9 m . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 169.575 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.831 0.348 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 m -93.83 106.38 18.35 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.778 0.831 . . . . 0.0 110.225 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 30.3 mt-10 -96.02 132.56 41.24 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -101.58 147.23 26.65 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.559 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -154.14 122.56 6.15 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 1.4 tm? -98.98 138.29 36.31 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 169.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.77 -178.45 16.31 Favored Glycine 0 C--N 1.333 0.411 0 O-C-N 123.287 0.367 . . . . 0.0 112.429 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.03 166.96 12.11 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 123.581 0.753 . . . . 0.0 109.658 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.644 ' HG2' ' HB1' ' A' ' 115' ' ' ALA . 6.1 tpt180 -163.82 157.07 18.46 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -138.27 94.2 2.84 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.453 HD11 HG23 ' A' ' 117' ' ' THR . 36.5 pt -88.6 161.88 40.79 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.13 -21.93 13.89 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.13 2.553 . . . . 0.0 114.65 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.63 5.8 37.74 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.435 0.694 . . . . 0.0 112.763 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.38 -178.2 16.44 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 123.09 0.376 . . . . 0.0 112.967 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.53 109.39 5.44 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.111 0.564 . . . . 0.0 109.85 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.85 167.35 10.98 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.543 1.137 . . . . 0.0 110.397 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HB2' HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -101.82 170.52 8.1 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 156.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 p -136.25 133.08 36.63 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 29.8 pt -83.86 145.42 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 166.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.677 HG13 ' HG2' ' A' ' 113' ' ' GLU . 4.1 mp -129.96 105.25 11.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 175.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 58.9 mt -104.57 107.2 21.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.613 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 45.2 mtp85 -98.15 134.52 41.1 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.835 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -141.01 140.38 34.3 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.595 HH11 ' HB2' ' A' ' 109' ' ' LEU . 36.0 mmt180 -98.74 103.76 15.74 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.18 125.87 35.61 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.207 1.003 . . . . 0.0 109.958 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.52 59.81 3.66 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.597 1.189 . . . . 0.0 110.672 171.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.25 150.13 33.92 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 113.316 -1.765 . . . . 0.0 106.77 174.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 37' ' ' VAL . 34.7 Cg_endo -64.65 172.24 7.16 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.086 1.857 . . . . 0.0 113.179 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' A' ' 101' ' ' LEU . 67.8 t -70.87 -41.32 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.412 -173.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -58.77 -43.5 90.4 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.184 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.57 -65.86 0.62 Allowed 'General case' 0 C--N 1.356 0.852 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.057 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 33' ' ' PRO . 38.2 t -53.54 -38.26 33.08 Favored 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 124.299 1.04 . . . . 0.0 111.184 -175.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.434 ' HE3' HD12 ' A' ' 101' ' ' LEU . 63.8 t-105 -59.18 -57.2 14.1 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.472 0.709 . . . . 0.0 111.018 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.7 m -59.47 -42.5 92.18 Favored 'General case' 0 C--O 1.21 -1.011 0 O-C-N 124.489 1.118 . . . . 0.0 110.13 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.87 -34.42 73.12 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.437 ' SG ' HD21 ' A' ' 136' ' ' LEU . 84.0 m -85.43 -11.05 55.32 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.993 0.917 . . . . 0.0 113.118 -178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.8 p -113.28 -32.79 6.17 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.329 0.513 . . . . 0.0 112.016 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -66.88 116.82 39.26 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 123.133 0.573 . . . . 0.0 110.506 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.14 -18.31 45.42 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 122.273 1.982 . . . . 0.0 110.991 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -74.81 -15.83 60.73 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.324 1.45 . . . . 0.0 111.3 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -108.55 -21.69 12.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.006 0.522 . . . . 0.0 111.932 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.8 mt -84.88 -32.61 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.253 0.621 . . . . 0.0 110.205 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 28.2 p-10 -60.39 -25.61 66.04 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.092 175.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -63.49 -23.63 67.48 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.509 1.124 . . . . 0.0 112.609 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -128.39 -62.02 1.06 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.059 0.543 . . . . 0.0 112.158 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -102.03 -163.42 1.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.025 0.93 . . . . 0.0 108.979 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.524 HG21 ' H ' ' A' ' 67' ' ' GLN . 36.7 mt -85.94 131.64 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 11.2 pt-20 -63.36 140.21 97.69 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 126.368 1.867 . . . . 0.0 112.328 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 85.8 Cg_endo -89.05 99.19 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.045 2.497 . . . . 0.0 111.668 169.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -82.2 162.42 22.4 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.364 0.602 . . . . 0.0 111.885 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.28 -161.76 15.24 Favored Glycine 0 N--CA 1.465 0.575 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.583 -174.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.89 -48.72 67.86 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.574 1.15 . . . . 0.0 111.358 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt 68.44 3.9 4.0 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 125.543 1.537 . . . . 0.0 112.164 -170.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -100.48 147.4 25.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.323 1.049 . . . . 0.0 108.716 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.767 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 32.0 tt0 -62.58 107.71 1.0 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 123.757 0.661 . . . . 0.0 111.625 -172.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.7 -27.99 6.63 Favored Glycine 0 N--CA 1.476 1.343 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.982 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.39 -167.72 42.13 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -125.67 158.9 33.61 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.384 1.592 . . . . 0.0 111.067 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 13.1 p90 -103.92 168.31 9.21 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 157.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.04 115.35 0.83 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.419 1.088 . . . . 0.0 108.873 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 78.9 mt -70.97 169.69 14.35 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.846 0.459 . . . . 0.0 110.513 170.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.524 ' H ' HG21 ' A' ' 52' ' ' ILE . 16.7 tt0 -74.07 107.14 6.09 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.26 0.624 . . . . 0.0 109.33 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 45.41 25.12 1.18 Allowed Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.511 ' ND2' HD12 ' A' ' 52' ' ' ILE . 98.4 m-20 -107.15 -80.3 0.57 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.733 0.766 . . . . 0.0 109.957 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.79 157.03 47.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.275 0.63 . . . . 0.0 110.257 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.1 t -144.78 143.47 30.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.86 149.54 19.21 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -74.07 156.33 37.57 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.449 0.642 . . . . 0.0 110.216 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.692 ' HA ' HG22 ' A' ' 85' ' ' ILE . 19.3 mm -87.42 94.29 4.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.75 -57.47 10.82 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 124.376 1.048 . . . . 0.0 110.901 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -146.45 113.78 6.28 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.496 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.767 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.4 p -111.27 125.1 53.47 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 171.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -134.53 81.6 47.92 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 62.2 Cg_endo -73.75 140.08 28.7 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.624 2.216 . . . . 0.0 111.895 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 31.1 Cg_endo -94.91 20.54 32.32 Favored 'Cis proline' 0 C--N 1.378 2.091 0 CA-C-N 119.924 1.009 . . . . 0.0 114.358 -3.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 80' ' ' PRO . 5.9 mpt_? -81.89 -84.27 0.11 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -128.1 147.81 50.55 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.741 -0.6 . . . . 0.0 112.035 -164.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.423 ' HB2' ' CH2' ' A' ' 38' ' ' TRP . 65.1 tp -138.18 102.47 4.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.543 1.137 . . . . 0.0 109.251 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.5 m -95.92 119.35 34.27 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 170.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.692 HG22 ' HA ' ' A' ' 74' ' ' ILE . 2.6 pp -128.94 160.5 39.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 124.915 1.286 . . . . 0.0 109.55 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.6 m -81.19 172.13 14.03 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.031 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 34.5 t-105 -154.69 94.26 1.65 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.1 t -105.88 102.95 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -92.3 149.39 21.47 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -90.0 -43.32 10.61 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.268 0.485 . . . . 0.0 111.612 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.14 -37.53 37.27 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.366 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -107.83 161.79 22.04 Favored Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 124.701 1.2 . . . . 0.0 109.085 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HG2' ' OG ' ' A' ' 118' ' ' SER . 52.3 Cg_exo -58.16 -176.89 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.337 2.692 . . . . 0.0 114.646 175.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.68 173.55 12.47 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.927 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.5 t -172.78 173.96 3.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.53 0.732 . . . . 0.0 110.537 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -138.19 127.62 24.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.538 1.135 . . . . 0.0 108.289 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.402 ' HB ' ' CD1' ' A' ' 85' ' ' ILE . 30.3 t -112.51 143.79 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.698 0.799 . . . . 0.0 109.384 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 33.4 mt-10 -131.65 133.38 44.85 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.81 120.33 31.41 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -120.89 132.59 55.05 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.001 0.92 . . . . 0.0 109.994 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.434 HD12 ' HE3' ' A' ' 38' ' ' TRP . 72.1 mt -130.89 132.42 45.13 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.096 0.959 . . . . 0.0 110.067 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.2 t -155.27 148.2 24.51 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.433 1.093 . . . . 0.0 108.142 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -63.79 148.81 48.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.839 0.856 . . . . 0.0 110.818 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -146.9 111.33 5.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 51.89 -103.67 0.12 Allowed Glycine 0 CA--C 1.536 1.349 0 O-C-N 123.562 0.539 . . . . 0.0 114.246 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.62 -10.21 18.59 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.99 0.916 . . . . 0.0 111.208 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.27 -150.84 8.13 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 123.657 0.646 . . . . 0.0 111.714 -172.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 82.7 m -146.83 136.14 22.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.252 1.021 . . . . 0.0 110.015 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.595 ' HB2' HH11 ' A' ' 29' ' ' ARG . 60.7 tp -90.56 137.54 32.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.84 0.856 . . . . 0.0 109.925 174.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tt -123.72 115.17 20.97 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.697 1.199 . . . . 0.0 107.82 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.613 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 33.4 mt-10 -113.78 108.09 16.62 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.577 HD13 HD21 ' A' ' 133' ' ' LEU . 10.0 tt -105.97 112.27 25.25 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.677 ' HG2' HG13 ' A' ' 25' ' ' ILE . 40.9 mt-10 -93.11 137.79 32.14 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 123.752 0.821 . . . . 0.0 110.719 170.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.457 ' CD2' HG21 ' A' ' 125' ' ' VAL . 6.9 t60 -129.84 121.67 27.18 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.644 ' HB1' ' HG2' ' A' ' 14' ' ' ARG . . . -124.53 118.64 27.05 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.386 0.674 . . . . 0.0 111.824 -167.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.402 HG23 ' HG ' ' A' ' 122' ' ' LEU . 6.5 t -151.02 155.93 40.06 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.577 0.751 . . . . 0.0 110.368 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.453 HG23 HD11 ' A' ' 16' ' ' ILE . 75.7 p -79.96 -19.39 48.03 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.433 ' OG ' ' HG2' ' A' ' 93' ' ' PRO . 50.5 m -89.96 122.37 32.92 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.909 0.484 . . . . 0.0 111.349 -174.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -57.83 -45.31 86.37 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.763 1.225 . . . . 0.0 112.545 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.14 -57.92 10.74 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 122.929 0.492 . . . . 0.0 111.068 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.5 ttt -50.38 -35.91 30.24 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 124.284 0.99 . . . . 0.0 112.54 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 22' ' ' ARG . 29.0 mt -61.94 -46.47 89.17 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.678 0.791 . . . . 0.0 112.297 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 127' ' ' VAL . 41.2 t -70.18 -46.93 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -47.93 -52.64 18.72 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.954 1.701 . . . . 0.0 113.132 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.457 HG21 ' CD2' ' A' ' 114' ' ' HIS . 27.9 m -74.94 -25.79 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 123.452 0.47 . . . . 0.0 110.484 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -56.04 -45.97 85.87 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 124.155 0.909 . . . . 0.0 110.829 170.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 123' ' ' VAL . 45.0 t -74.85 -42.32 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.564 0.746 . . . . 0.0 109.678 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.53 -63.1 5.59 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.922 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -64.93 -26.5 68.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.8 0.84 . . . . 0.0 113.005 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -54.26 -51.92 63.02 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.489 0.586 . . . . 0.0 109.858 169.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 29.2 mmt -68.71 -45.11 72.44 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 124.032 0.833 . . . . 0.0 110.716 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.6 -65.2 0.69 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.722 0.809 . . . . 0.0 111.033 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.577 HD21 HD13 ' A' ' 112' ' ' LEU . 3.8 mm? -62.03 -24.55 67.13 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.92 -43.31 65.53 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 118.676 0.671 . . . . 0.0 110.579 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.492 ' HD1' ' SD ' ' A' ' 138' ' ' MET . 20.9 m-85 -68.9 -26.5 65.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.172 0.589 . . . . 0.0 110.672 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.437 HD21 ' SG ' ' A' ' 41' ' ' CYS . 61.5 tp -66.22 -51.65 55.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.976 0.511 . . . . 0.0 109.866 169.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.406 ' O ' ' HG2' ' A' ' 141' ' ' ARG . . . -44.55 -43.29 7.76 Favored Glycine 0 N--CA 1.474 1.213 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 168.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.492 ' SD ' ' HD1' ' A' ' 135' ' ' PHE . 85.2 mtp -63.72 -45.95 87.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.882 0.473 . . . . 0.0 110.179 173.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -63.15 -34.92 78.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.775 0.83 . . . . 0.0 111.498 -176.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 25.6 mt -75.94 -48.47 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.96 0.904 . . . . 0.0 111.11 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 137' ' ' GLY . 12.9 ptp180 . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 19.4 mt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.8 t -61.27 -32.55 72.37 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.537 0.735 . . . . 0.0 111.842 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -90.4 -30.35 17.44 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -60.83 3.07 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.837 0.855 . . . . 0.0 110.259 172.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -67.51 -33.24 74.69 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.595 0.758 . . . . 0.0 110.173 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.69 -58.38 11.49 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.248 172.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.33 -31.34 71.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.676 0.79 . . . . 0.0 111.448 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.7 -62.39 1.83 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.205 0.941 . . . . 0.0 110.174 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -73.17 -20.06 60.98 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.421 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.41 -41.7 80.07 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.528 0.331 . . . . 0.0 110.504 173.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.07 -40.21 78.61 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.564 0.697 . . . . 0.0 109.687 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 74.7 mt -66.46 -47.73 72.17 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.222 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 4.6 p -70.29 -27.01 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 122.586 0.354 . . . . 0.0 111.242 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -75.95 -22.66 55.74 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.301 0.641 . . . . 0.0 110.69 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 CA--C 1.549 0.907 0 C-N-CA 122.763 0.425 . . . . 0.0 111.051 171.795 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 m -119.69 109.82 16.1 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.071 -173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.37 129.24 48.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -99.32 156.55 16.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.333 0.653 . . . . 0.0 109.37 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.25 -173.99 1.87 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.977 0.511 . . . . 0.0 111.257 -166.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.9 mt -140.67 168.66 19.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.519 1.127 . . . . 0.0 111.112 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.17 -174.93 26.57 Favored Glycine 0 C--O 1.245 0.807 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.837 170.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.15 139.49 24.65 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 123.699 0.799 . . . . 0.0 108.921 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -168.38 163.09 12.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.85 0.86 . . . . 0.0 109.858 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 23.2 m -105.67 113.82 27.61 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 172.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.8 pt -90.69 167.18 16.97 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -49.07 -23.51 6.42 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.917 2.411 . . . . 0.0 115.043 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.07 -8.01 56.15 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.06 177.85 15.1 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 117.66 0.209 . . . . 0.0 112.732 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 45.1 mt-10 -65.19 108.11 1.78 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.158 0.583 . . . . 0.0 110.343 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.23 142.4 34.24 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.368 1.067 . . . . 0.0 111.175 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -85.03 158.52 20.44 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 163.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.8 p -128.74 130.55 47.24 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 122.544 -0.097 . . . . 0.0 110.814 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 pp -86.2 136.09 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -120.38 122.01 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mt -115.2 107.53 23.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.553 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 95.4 mtt180 -92.61 139.44 30.56 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.736 0.815 . . . . 0.0 109.565 172.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 19.7 tt0 -146.51 139.5 25.5 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.818 0.699 . . . . 0.0 109.211 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.39 128.96 43.8 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.454 ' CE2' ' HA2' ' A' ' 137' ' ' GLY . 83.5 m-85 -116.19 116.86 28.58 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.865 0.866 . . . . 0.0 109.44 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -75.64 49.32 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.24 1.019 . . . . 0.0 110.743 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.51 162.34 51.9 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.445 1.498 . . . . 0.0 108.228 -171.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.487 ' O ' HG23 ' A' ' 37' ' ' VAL . 31.7 Cg_exo -62.34 157.77 43.83 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.375 2.05 . . . . 0.0 113.292 172.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 80' ' ' PRO . 99.1 t -76.65 -37.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.497 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -59.65 -42.18 92.2 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.978 0.799 . . . . 0.0 109.649 174.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -62.51 -64.18 1.0 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.373 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.625 HG22 HG21 ' A' ' 140' ' ' ILE . 58.2 t -48.25 -36.29 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.642 1.177 . . . . 0.0 111.763 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.503 ' HE3' HD12 ' A' ' 101' ' ' LEU . 72.1 t-105 -63.59 -59.48 4.57 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.291 0.636 . . . . 0.0 110.16 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.8 m -53.96 -46.36 71.6 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.774 0.671 . . . . 0.0 110.322 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.659 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -50.36 -39.35 46.22 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.366 175.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.578 ' SG ' HD21 ' A' ' 136' ' ' LEU . 58.0 m -102.65 6.35 39.59 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 47.9 p -120.57 -54.96 2.05 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 118.959 0.799 . . . . 0.0 111.723 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.76 137.92 97.3 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.508 1.123 . . . . 0.0 112.017 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -59.2 -42.29 51.72 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.698 2.932 . . . . 0.0 113.557 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -74.45 -6.42 48.18 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.958 0.903 . . . . 0.0 110.827 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.659 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 14.7 mmt180 -100.31 -42.62 6.57 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.741 1.217 . . . . 0.0 110.626 176.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.563 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 58.1 mt -77.32 -38.07 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.769 0.427 . . . . 0.0 111.47 -171.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -62.81 -20.38 64.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.489 0.493 . . . . 0.0 111.8 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -64.83 -27.18 68.7 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.563 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 39.4 p-90 -122.78 -41.91 2.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.107 0.563 . . . . 0.0 112.136 -174.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.442 ' HE2' HD13 ' A' ' 66' ' ' LEU . 2.1 t80 -106.0 -163.57 0.94 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.358 0.663 . . . . 0.0 110.097 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.414 ' H ' HD12 ' A' ' 52' ' ' ILE . 4.3 mp -83.48 153.8 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -53.87 119.39 18.79 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.572 1.549 . . . . 0.0 112.164 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.0 101.76 1.47 Allowed 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.348 2.032 . . . . 0.0 110.017 169.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -93.3 164.96 13.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.315 0.646 . . . . 0.0 110.887 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.4 -166.81 12.39 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.565 -174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.61 ' HB2' ' HA3' ' A' ' 62' ' ' GLY . 4.5 m-20 -68.2 -37.64 81.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.286 0.634 . . . . 0.0 110.525 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 49.3 mt 64.83 15.04 9.62 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.896 1.278 . . . . 0.0 112.74 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -125.47 167.52 14.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.827 0.851 . . . . 0.0 110.543 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -50.34 107.2 0.15 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.82 1.248 . . . . 0.0 111.427 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.83 -11.05 56.07 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 112.248 -0.341 . . . . 0.0 112.248 174.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.61 ' HA3' ' HB2' ' A' ' 57' ' ' ASP . . . -88.58 -156.33 30.98 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 169.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -144.33 158.23 43.85 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 118.41 1.105 . . . . 0.0 110.745 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -102.81 169.3 8.69 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 165.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.31 144.94 9.66 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.67 1.188 . . . . 0.0 107.951 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.442 HD13 ' HE2' ' A' ' 51' ' ' PHE . 41.3 mt -131.2 157.09 44.14 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.583 1.153 . . . . 0.0 108.279 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -97.96 127.25 43.79 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -173.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.59 10.81 45.79 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.797 -175.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -124.63 -92.92 0.51 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.839 0.456 . . . . 0.0 110.036 -172.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.39 174.94 12.76 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.19 0.45 . . . . 0.0 111.739 -170.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.5 p -149.78 136.58 19.41 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -154.99 161.66 30.46 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -86.87 155.14 20.37 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.528 0.731 . . . . 0.0 111.049 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.486 ' HA ' HG22 ' A' ' 85' ' ' ILE . 11.6 mm -89.28 91.66 3.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 172.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.427 HD12 HG22 ' A' ' 84' ' ' THR . 42.4 mt -70.39 -49.66 46.73 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.134 0.896 . . . . 0.0 109.691 -171.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -158.84 155.29 27.55 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.834 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 7.8 p -155.79 122.08 5.14 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.399 1.079 . . . . 0.0 108.251 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -121.85 88.86 47.71 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 13.1 Cg_exo -72.62 137.38 27.47 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.74 2.293 . . . . 0.0 113.101 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.486 ' HB2' HG12 ' A' ' 34' ' ' VAL . 83.7 Cg_endo -99.64 31.14 11.3 Favored 'Cis proline' 0 C--N 1.374 1.909 0 CA-C-N 119.283 0.78 . . . . 0.0 112.339 -10.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -68.92 -75.14 0.11 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.631 1.172 . . . . 0.0 111.278 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -158.74 160.23 36.12 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.881 0.472 . . . . 0.0 111.337 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.83 146.27 50.48 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.308 1.043 . . . . 0.0 108.28 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.427 HG22 HD12 ' A' ' 75' ' ' LEU . 32.6 m -123.44 111.94 16.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 166.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.486 HG22 ' HA ' ' A' ' 74' ' ' ILE . 22.7 pt -113.64 144.53 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.683 1.193 . . . . 0.0 108.256 173.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.4 t -83.31 172.73 12.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.804 0.335 . . . . 0.0 111.25 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.71 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 25.0 t-105 -153.42 110.25 3.42 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.607 -171.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.7 t -116.39 103.45 15.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 168.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.48 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 18.2 t80 -77.83 90.9 4.09 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 63.14 -82.55 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.751 0.82 . . . . 0.0 110.155 -174.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.85 30.22 1.24 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 48.2 mmtm -95.01 162.62 24.37 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.401 1.081 . . . . 0.0 110.21 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -35.32 129.0 0.28 Allowed 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 125.039 3.826 . . . . 0.0 115.576 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.4 148.13 42.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.98 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.71 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.7 m -145.08 143.86 30.65 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.441 -174.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.51 111.75 24.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.979 0.912 . . . . 0.0 109.185 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 50.8 t -93.95 119.3 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -117.92 131.18 56.55 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.9 tp -125.63 125.4 43.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -130.24 124.18 31.87 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.97 0.508 . . . . 0.0 110.173 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.503 HD12 ' HE3' ' A' ' 38' ' ' TRP . 62.8 mt -120.95 133.03 55.27 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.656 1.182 . . . . 0.0 109.335 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.9 m -144.59 145.64 31.9 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.102 0.961 . . . . 0.0 109.09 177.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.24 141.54 58.18 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.177 0.991 . . . . 0.0 111.17 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -136.74 101.49 4.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.63 -98.55 0.05 OUTLIER Glycine 0 CA--C 1.541 1.658 0 CA-C-N 118.846 0.748 . . . . 0.0 111.868 -166.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -125.86 15.22 8.02 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.132 0.968 . . . . 0.0 110.534 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -113.9 -155.66 11.58 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.167 0.889 . . . . 0.0 111.603 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.5 m -147.7 136.39 21.85 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.709 1.204 . . . . 0.0 109.393 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.3 tp -91.55 127.04 36.84 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 164.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' A' ' 101' ' ' LEU . 9.7 tt -108.05 123.26 48.41 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.553 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 31.5 mt-10 -119.68 106.18 11.9 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 169.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.5 tt -103.99 102.56 12.33 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -95.74 142.62 27.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.541 1.137 . . . . 0.0 109.659 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.482 ' CD2' HG21 ' A' ' 125' ' ' VAL . 5.8 t60 -132.74 116.15 16.22 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 171.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.57 117.94 35.41 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.905 0.882 . . . . 0.0 111.383 -174.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.609 HG21 ' HG3' ' A' ' 121' ' ' MET . 8.0 t -146.19 161.31 40.51 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.449 0.7 . . . . 0.0 110.594 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 74.2 p -88.65 -19.97 25.52 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.653 -167.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 m -101.96 133.23 47.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.299 0.64 . . . . 0.0 111.469 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -59.12 -47.78 84.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.552 1.141 . . . . 0.0 113.166 -174.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -64.06 -52.42 59.44 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.816 0.28 . . . . 0.0 110.884 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.609 ' HG3' HG21 ' A' ' 116' ' ' THR . 15.2 tpt -46.16 -37.02 6.47 Favored 'General case' 0 CA--C 1.563 1.472 0 O-C-N 124.152 0.908 . . . . 0.0 111.702 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.448 ' HG ' HG23 ' A' ' 116' ' ' THR . 22.5 mt -67.24 -50.45 60.55 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.79 0.836 . . . . 0.0 112.012 176.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 127' ' ' VAL . 61.7 t -61.49 -56.2 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -47.61 -50.94 22.92 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.73 1.612 . . . . 0.0 113.273 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.482 HG21 ' CD2' ' A' ' 114' ' ' HIS . 33.2 m -72.02 -31.68 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 119.799 -0.144 . . . . 0.0 111.155 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.57 -34.48 90.01 Favored Glycine 0 C--N 1.35 1.313 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 123' ' ' VAL . 97.6 t -71.8 -51.8 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.05 -59.72 8.46 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.694 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.418 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 22.5 m95 -54.31 -32.91 57.69 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 173.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -66.3 -35.3 80.04 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 120.41 1.459 . . . . 0.0 111.957 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -60.78 -52.73 63.87 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 167.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 129' ' ' TRP . . . -58.5 -27.83 64.82 Favored 'General case' 0 C--O 1.208 -1.105 0 C-N-CA 124.127 0.971 . . . . 0.0 112.045 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.31 -27.71 22.71 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.32 0.648 . . . . 0.0 109.914 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.01 -48.67 34.32 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -62.64 -42.56 99.67 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.637 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.578 HD21 ' SG ' ' A' ' 41' ' ' CYS . 51.0 tp -66.14 -27.61 68.17 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.82 0.848 . . . . 0.0 111.303 176.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.454 ' HA2' ' CE2' ' A' ' 30' ' ' TYR . . . -73.89 -46.57 22.69 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 86.4 mtp -60.84 -41.2 95.33 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.589 -1.305 . . . . 0.0 110.807 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -62.59 -54.57 37.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.607 0.763 . . . . 0.0 111.416 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.625 HG21 HG22 ' A' ' 37' ' ' VAL . 64.1 mt -71.0 -26.95 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.247 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 . . . . . 0 N--CA 1.476 0.864 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.882 175.882 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.535 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 32.5 mm . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 39.6 t -72.66 -19.72 61.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.376 0.67 . . . . 0.0 112.631 -175.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.48 -31.71 17.54 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.116 0.416 . . . . 0.0 110.342 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -50.59 -56.4 11.94 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.39 0.614 . . . . 0.0 110.399 166.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 2.0 mmt180 -73.62 -39.74 64.33 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.113 -175.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -55.35 -55.15 29.89 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.735 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.29 -42.14 90.58 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.878 0.871 . . . . 0.0 111.038 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.53 -54.26 45.49 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.225 0.953 . . . . 0.0 111.799 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -70.22 -25.89 63.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.437 0.695 . . . . 0.0 111.847 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.08 83.82 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.995 0.426 . . . . 0.0 109.86 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -68.69 -35.96 77.88 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.8 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 55.5 mt -72.58 -53.82 10.85 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.232 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -66.28 -32.32 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 122.999 0.519 . . . . 0.0 112.003 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -76.66 -7.09 54.62 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.077 0.551 . . . . 0.0 111.501 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 CA--C 1.553 1.085 0 C-N-CA 124.696 1.198 . . . . 0.0 109.262 169.847 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.589 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.6 m -97.4 136.75 37.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.203 1.001 . . . . 0.0 110.306 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 20.1 mp0 -123.95 107.81 11.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 172.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.609 HH22 ' HA ' ' A' ' 170' ' ' ARG . 98.2 mtt180 -74.47 161.75 29.49 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.544 0.211 . . . . 0.0 110.602 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.54 177.99 5.64 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.621 0.768 . . . . 0.0 110.323 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.2 mt -133.22 158.91 41.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.414 1.086 . . . . 0.0 109.413 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.16 138.15 5.24 Favored Glycine 0 C--O 1.223 -0.59 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 173.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -91.7 137.76 32.11 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.5 tpt85 -138.99 128.46 24.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.741 0.816 . . . . 0.0 109.507 -168.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -85.67 136.6 33.3 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.524 HD11 HG23 ' A' ' 117' ' ' THR . 47.5 pt -129.62 159.14 71.05 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -177.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -48.07 -37.01 29.57 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.125 2.55 . . . . 0.0 114.285 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.64 77.13 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.468 0.707 . . . . 0.0 112.443 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.18 -150.82 20.49 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.16 137.88 33.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.82 164.58 27.25 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.777 0.831 . . . . 0.0 109.122 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -120.58 157.56 29.24 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 3.6 m -128.87 145.63 51.16 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 122.682 0.393 . . . . 0.0 110.792 -174.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 2.8 pp -98.05 135.57 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.417 HG13 ' HB3' ' A' ' 113' ' ' GLU . 2.2 mp -121.42 126.24 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 129' ' ' TRP . 57.0 mt -110.48 108.91 26.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.582 ' HB3' HD11 ' A' ' 109' ' ' LEU . 58.9 mtp180 -91.05 153.11 20.35 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -168.88 129.79 1.18 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 125.164 1.54 . . . . 0.0 111.219 174.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.493 ' HD2' HD13 ' A' ' 109' ' ' LEU . 9.7 mpt_? -87.26 105.41 17.21 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 172.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -79.21 150.64 31.57 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.995 0.518 . . . . 0.0 110.118 170.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -87.78 27.03 1.2 Allowed 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.989 0.9 . . . . 0.0 110.325 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.77 148.67 70.87 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.32 1.048 . . . . 0.0 109.782 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.56 165.04 33.18 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.241 2.627 . . . . 0.0 113.147 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.538 HG23 ' HG3' ' A' ' 103' ' ' GLU . 68.6 t -51.26 -44.63 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 114.053 -1.431 . . . . 0.0 112.616 -177.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -56.18 -39.36 72.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.291 0.995 . . . . 0.0 110.071 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -75.49 -36.57 60.59 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.685 0.794 . . . . 0.0 111.167 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.3 -30.48 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.385 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -74.76 -20.7 59.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.192 0.997 . . . . 0.0 109.998 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.5 m -72.17 -47.41 51.02 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.25 77.12 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.298 0.639 . . . . 0.0 111.91 172.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.0 t -63.31 -52.3 62.52 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 59.4 p -94.91 -41.16 9.32 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -167.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.448 ' O ' HG13 ' A' ' 47' ' ' ILE . 26.4 t70 -81.68 115.23 55.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 122.972 0.509 . . . . 0.0 110.889 -169.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.11 -20.39 71.07 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.47 2.78 . . . . 0.0 114.094 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -74.16 -31.2 62.61 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -84.11 -30.02 26.29 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.821 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 43' ' ' ASP . 91.2 mt -71.43 -43.37 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.263 0.625 . . . . 0.0 110.371 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -65.52 -3.29 4.25 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -86.64 -43.06 12.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.891 0.876 . . . . 0.0 110.364 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.447 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 49.7 p-90 -114.65 -25.08 8.45 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.137 0.975 . . . . 0.0 111.414 -173.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.447 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 11.1 t80 -129.55 -171.89 2.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.505 1.122 . . . . 0.0 109.104 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.6 mt -89.5 139.99 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.614 0.766 . . . . 0.0 111.41 -173.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -64.46 110.5 4.07 Favored Pre-proline 0 CA--C 1.566 1.576 0 O-C-N 125.348 1.655 . . . . 0.0 110.993 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -90.89 148.99 3.93 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.354 2.702 . . . . 0.0 113.592 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -130.54 130.47 44.15 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.87 -166.91 32.59 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 121.63 -0.319 . . . . 0.0 112.477 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -69.5 -46.94 65.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.415 0.686 . . . . 0.0 110.948 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.4 mt 62.25 22.85 13.46 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.872 1.269 . . . . 0.0 110.695 -172.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -124.97 146.93 49.16 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.594 1.158 . . . . 0.0 109.749 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.53 117.86 4.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.183 0.993 . . . . 0.0 111.981 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.57 12.14 57.35 Favored Glycine 0 N--CA 1.47 0.907 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.96 -174.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -119.58 -158.21 10.55 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 10.9 p30 -138.34 174.39 10.6 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 117.723 0.761 . . . . 0.0 112.036 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -145.02 153.55 41.6 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.864 1.266 . . . . 0.0 107.894 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.97 109.94 5.1 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.651 0.78 . . . . 0.0 110.878 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.7 mt -77.72 138.11 38.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.697 0.799 . . . . 0.0 109.177 173.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -77.82 110.23 12.52 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.2 56.73 5.06 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.607 0.567 . . . . 0.0 113.356 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -168.77 -84.05 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.965 0.506 . . . . 0.0 111.339 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -152.78 155.68 37.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.275 0.56 . . . . 0.0 111.559 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 m -132.45 143.09 49.55 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.378 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -156.56 -170.51 21.75 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 5.5 m-20 -118.24 168.7 10.35 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.252 0.621 . . . . 0.0 110.749 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.497 ' HA ' HG22 ' A' ' 85' ' ' ILE . 9.8 mm -103.58 107.05 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.1 mt -75.51 -58.11 3.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.71 0.404 . . . . 0.0 110.994 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.07 151.2 13.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.692 0.797 . . . . 0.0 109.41 175.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.5 p -148.3 133.08 17.95 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -107.82 89.84 5.75 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.53 132.39 33.06 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.639 2.226 . . . . 0.0 112.53 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -102.74 22.85 14.97 Favored 'Cis proline' 0 C--N 1.375 1.924 0 CA-C-N 120.031 1.047 . . . . 0.0 113.597 -8.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -67.45 -52.72 36.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.812 1.245 . . . . 0.0 112.366 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.441 ' NH2' ' HD3' ' A' ' 100' ' ' ARG . 26.4 ttm-85 -148.93 154.62 39.68 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.32 0.581 . . . . 0.0 111.134 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.5 tt -135.07 140.97 45.97 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.14 1.376 . . . . 0.0 107.338 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.473 HG23 ' HG2' ' A' ' 98' ' ' GLU . 40.6 m -137.9 134.87 35.54 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.302 0.641 . . . . 0.0 109.287 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.497 HG22 ' HA ' ' A' ' 74' ' ' ILE . 12.6 pt -147.78 147.14 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.055 1.342 . . . . 0.0 109.895 -172.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.5 m -86.86 153.7 21.43 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 163.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 23.1 t-105 -143.13 109.62 5.41 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -167.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.738 HG13 ' HB3' ' A' ' 93' ' ' PRO . 61.1 t -108.79 103.07 14.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -83.85 141.56 31.24 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -58.25 -30.04 66.23 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.94 -53.8 5.14 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.397 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -138.7 119.57 9.96 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.61 0.764 . . . . 0.0 110.349 -174.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.738 ' HB3' HG13 ' A' ' 88' ' ' VAL . 3.1 Cg_exo -83.18 -166.86 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.701 2.934 . . . . 0.0 113.016 -176.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.5 t70 52.67 85.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.593 1.557 . . . . 0.0 113.373 174.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 71.0 m -147.09 122.32 10.22 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 171.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -101.33 105.68 16.77 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.2 t -97.69 147.85 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.202 1.001 . . . . 0.0 109.824 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.473 ' HG2' HG23 ' A' ' 84' ' ' THR . 33.9 mt-10 -137.7 155.96 48.54 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.68 0.792 . . . . 0.0 109.603 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.0 tp -126.75 139.24 53.28 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.441 ' HD3' ' NH2' ' A' ' 82' ' ' ARG . 1.5 ttp180 -140.08 106.96 5.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.47 0.708 . . . . 0.0 109.736 -172.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 110' ' ' LEU . 96.2 mt -111.53 131.18 55.42 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.371 1.069 . . . . 0.0 110.78 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.1 t -143.46 128.38 18.43 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.014 0.925 . . . . 0.0 108.796 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.538 ' HG3' HG23 ' A' ' 34' ' ' VAL . 43.9 mt-10 -66.62 124.37 22.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -136.46 117.98 14.83 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.97 -144.77 38.6 Favored Glycine 0 C--N 1.345 1.057 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -86.91 55.38 3.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.566 0.698 . . . . 0.0 109.227 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.64 -154.4 13.25 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 114.939 -1.028 . . . . 0.0 113.689 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.4 m -148.75 129.69 14.34 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.809 0.843 . . . . 0.0 111.119 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 27' ' ' ARG . 43.0 tp -81.21 109.55 15.85 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 101' ' ' LEU . 10.2 tt -88.05 130.97 34.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 170.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.451 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 45.3 mt-10 -132.13 105.86 7.63 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.5 tt -103.97 124.16 48.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 98' ' ' GLU . 9.4 pt-20 -122.06 129.38 52.35 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.481 ' O ' ' HA ' ' A' ' 23' ' ' SER . 8.1 t60 -117.0 111.1 19.1 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.94 102.37 11.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.674 0.79 . . . . 0.0 111.171 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.2 t -130.72 153.33 49.11 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.237 0.542 . . . . 0.0 109.934 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.524 HG23 HD11 ' A' ' 16' ' ' ILE . 76.1 p -71.14 -21.53 62.18 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.166 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.4 p -94.49 118.26 31.38 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.698 0.799 . . . . 0.0 111.137 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 122' ' ' LEU . 45.0 tt0 -65.81 -24.8 66.99 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.256 1.022 . . . . 0.0 111.147 174.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -61.65 -53.75 52.04 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.054 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.411 ' O ' HG22 ' A' ' 125' ' ' VAL . 10.1 tpt -62.63 -41.34 98.96 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.48 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 119' ' ' GLU . 37.0 mt -52.93 -53.03 55.37 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.098 0.959 . . . . 0.0 113.278 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.55 -44.72 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.788 0.435 . . . . 0.0 110.488 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.98 -44.14 96.84 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.541 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 121' ' ' MET . 26.0 m -75.23 -26.87 19.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.06 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.229 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.48 -29.05 60.24 Favored Glycine 0 C--N 1.351 1.361 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 170.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.26 -51.61 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 123.592 0.231 . . . . 0.0 110.396 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.03 -30.17 76.44 Favored Glycine 0 N--CA 1.476 1.353 0 CA-C-N 115.625 -0.716 . . . . 0.0 114.209 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.425 ' HB3' HD12 ' A' ' 26' ' ' ILE . 9.4 m95 -79.13 -46.96 16.95 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.44 ' HG3' ' HE1' ' A' ' 174' ' ' TRP . 27.3 mm-40 -54.9 -38.95 68.24 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.478 0.311 . . . . 0.0 110.785 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.6 tpp -64.99 -41.41 95.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.501 0.72 . . . . 0.0 110.69 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -72.77 -36.02 67.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.42 0.688 . . . . 0.0 111.729 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.56 -25.11 38.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.662 0.785 . . . . 0.0 110.289 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.22 -45.15 77.66 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.543 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.64 -30.57 52.23 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.431 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.1 tp -71.74 -29.64 64.74 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.21 -48.23 81.62 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.633 168.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 90.3 mmm -69.2 -37.11 77.93 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.074 0.95 . . . . 0.0 111.13 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -67.52 -56.77 8.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.972 0.909 . . . . 0.0 110.793 -175.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 28.9 mt -67.2 -29.91 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.23 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? . . . . . 0 N--CA 1.486 1.333 0 C-N-CA 122.64 0.376 . . . . 0.0 110.103 172.654 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.527 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 30.5 mm . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.1 m -68.77 -54.49 15.66 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 122.701 0.4 . . . . 0.0 110.396 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 11.6 pt20 -61.5 -56.0 24.92 Favored 'General case' 0 C--O 1.209 -1.072 0 CA-C-O 117.726 -1.13 . . . . 0.0 111.304 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -43.45 -46.07 6.6 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.942 0.792 . . . . 0.0 113.064 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.609 ' HA ' HH22 ' A' ' 9' ' ' ARG . 4.8 mmp_? -53.64 -52.44 59.89 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.574 0.546 . . . . 0.0 109.841 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -80.95 -17.4 72.51 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 116.284 -0.416 . . . . 0.0 113.65 -173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 24.0 mm-40 -71.7 -37.3 70.69 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.51 0.724 . . . . 0.0 109.712 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.507 ' HB3' ' NH1' ' A' ' 9' ' ' ARG . . . -76.22 -36.21 58.68 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.737 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.44 ' HE1' ' HG3' ' A' ' 130' ' ' GLU . 75.5 m95 -67.09 -29.9 69.78 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 119.249 -0.405 . . . . 0.0 111.43 173.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.42 -61.18 2.62 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 123.59 0.556 . . . . 0.0 109.659 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.39 -35.27 51.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.409 1.084 . . . . 0.0 113.565 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 35.3 mt -66.8 -59.56 3.44 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 123.297 0.373 . . . . 0.0 110.159 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.8 p -72.88 -20.37 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 123.721 0.808 . . . . 0.0 111.357 -158.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -57.38 -21.16 34.19 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.259 1.024 . . . . 0.0 112.104 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 CA--C 1.547 0.834 0 C-N-CA 123.568 0.747 . . . . 0.0 109.452 172.161 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 120.636 0.255 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 24.4 m -79.14 111.37 15.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.317 1.047 . . . . 0.0 110.956 -175.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 30.9 mt-10 -93.8 134.33 36.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.694 1.198 . . . . 0.0 108.56 172.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.405 ' HG2' ' CD1' ' A' ' 177' ' ' LEU . 43.0 ttm105 -99.78 139.44 35.43 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.855 0.462 . . . . 0.0 110.0 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.16 179.35 9.23 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.77 0.428 . . . . 0.0 111.628 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.413 HD13 ' N ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -145.15 153.12 41.04 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.957 -176.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.413 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -167.24 -151.98 7.2 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.45 163.22 35.55 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.207 0.603 . . . . 0.0 109.759 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -166.42 152.46 8.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.874 0.869 . . . . 0.0 109.483 167.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.5 m -82.95 152.66 25.38 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.043 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.8 pt -144.1 155.51 58.46 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.64 -30.29 28.16 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.941 2.428 . . . . 0.0 114.317 175.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.47 -7.84 59.64 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.82 -172.9 28.05 Favored Glycine 0 C--N 1.356 1.678 0 CA-C-N 119.258 0.935 . . . . 0.0 112.577 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -84.57 110.78 18.96 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.17 146.96 23.28 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.991 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -87.98 156.84 19.12 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 164.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 80.4 p -139.17 137.98 36.53 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.954 0.407 . . . . 0.0 111.609 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.597 HG12 HG23 ' A' ' 125' ' ' VAL . 2.9 pp -87.79 141.16 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.265 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.35 111.02 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.9 mt -100.91 108.63 23.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.555 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 97.2 mtt180 -99.54 140.59 33.5 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.488 HE22 HD22 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -138.78 144.15 39.25 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.477 HH11 ' HG2' ' A' ' 104' ' ' GLU . 12.2 mmt85 -103.73 101.96 11.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 173.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.46 ' CE1' ' HA2' ' A' ' 137' ' ' GLY . 70.1 m-85 -83.63 129.36 34.96 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.903 0.881 . . . . 0.0 110.624 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.72 48.25 0.67 Allowed 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 122.889 1.328 . . . . 0.0 109.785 170.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.56 152.42 41.7 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.058 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.725 ' HG2' ' HB2' ' A' ' 36' ' ' GLU . 56.4 Cg_endo -71.64 165.75 31.56 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.629 2.219 . . . . 0.0 113.454 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 80' ' ' PRO . 58.1 t -71.89 -43.7 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.954 -169.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -63.87 -34.03 77.02 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 124.055 0.847 . . . . 0.0 110.109 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.725 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -69.53 -62.79 1.24 Allowed 'General case' 0 C--N 1.355 0.813 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.776 179.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.7 t -51.17 -33.3 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 124.939 1.296 . . . . 0.0 111.06 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.434 ' HE3' HD12 ' A' ' 101' ' ' LEU . 65.2 t-105 -61.43 -57.42 12.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.19 0.596 . . . . 0.0 110.063 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.2 t -54.35 -40.7 68.33 Favored 'General case' 0 CA--C 1.552 1.023 0 O-C-N 123.92 0.762 . . . . 0.0 110.614 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.04 79.26 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.4 m -93.51 -4.48 51.0 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.752 0.821 . . . . 0.0 112.954 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 77.8 p -116.57 -48.37 2.69 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.439 0.563 . . . . 0.0 111.438 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.439 ' O ' HG12 ' A' ' 47' ' ' ILE . 20.6 t70 -63.12 119.94 56.93 Favored Pre-proline 0 N--CA 1.483 1.197 0 C-N-CA 123.878 0.871 . . . . 0.0 111.033 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.0 -26.76 43.22 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.008 2.472 . . . . 0.0 113.335 -171.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -61.82 -48.06 82.31 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.777 0.673 . . . . 0.0 109.646 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -72.13 -26.05 61.96 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 174.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.579 HG21 ' HD3' ' A' ' 54' ' ' PRO . 36.7 mm -71.24 -42.18 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 118.849 0.75 . . . . 0.0 111.474 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.07 -16.01 64.07 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -80.54 0.91 31.74 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.468 0.707 . . . . 0.0 112.408 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.421 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 46.2 p-90 -141.64 -47.44 0.37 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.916 0.486 . . . . 0.0 110.489 173.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -111.65 -164.28 0.91 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.069 0.948 . . . . 0.0 109.859 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -86.92 126.02 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 166.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 9.3 pt-20 -69.67 139.45 88.76 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 118.87 0.759 . . . . 0.0 111.794 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.579 ' HD3' HG21 ' A' ' 47' ' ' ILE . 15.2 Cg_exo -69.71 101.98 0.97 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.627 2.218 . . . . 0.0 110.932 173.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -74.88 136.01 41.51 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.767 0.827 . . . . 0.0 110.682 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.27 -164.74 27.21 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 116.023 -0.535 . . . . 0.0 114.308 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -68.46 -39.06 81.58 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.721 1.208 . . . . 0.0 111.104 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.3 mt 66.29 12.28 8.49 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -98.97 165.34 11.8 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.234 0.47 . . . . 0.0 110.079 173.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.759 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 38.5 tt0 -71.02 98.03 1.56 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.25 -31.03 4.36 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -170.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.11 -174.01 46.65 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 114.776 -0.712 . . . . 0.0 112.432 169.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 22.9 p-10 -134.96 155.26 51.05 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.842 0.857 . . . . 0.0 111.861 -170.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -116.91 169.6 9.27 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.163 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -163.4 144.23 9.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.701 0.8 . . . . 0.0 109.017 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.485 HD13 HD22 ' A' ' 69' ' ' ASN . 68.8 mt -118.5 153.29 34.41 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -93.28 -45.66 7.74 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.41 -12.27 84.0 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.33 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.485 HD22 HD13 ' A' ' 66' ' ' LEU . 80.8 m-20 -127.52 -92.7 0.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 118.106 0.953 . . . . 0.0 111.31 -174.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.61 175.08 14.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.087 0.555 . . . . 0.0 110.821 -169.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 27.7 p -131.96 145.29 51.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.154 0.582 . . . . 0.0 109.616 -172.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.71 -148.87 5.37 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 112.319 -0.313 . . . . 0.0 112.319 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -151.23 163.75 38.16 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.223 0.609 . . . . 0.0 110.861 179.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.576 ' HA ' HG22 ' A' ' 85' ' ' ILE . 2.5 mp -94.34 102.42 13.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 86' ' ' SER . 88.4 mt -76.24 -45.53 32.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.785 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -135.45 141.69 45.44 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.511 -173.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.759 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 31.8 p -158.38 122.43 4.06 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.646 ' HG2' ' HD3' ' A' ' 81' ' ' ARG . 41.8 tt0 -144.78 90.46 6.35 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 38.0 Cg_exo -63.46 139.99 73.64 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.973 2.449 . . . . 0.0 111.858 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 27.2 Cg_endo -96.61 27.06 18.63 Favored 'Cis proline' 0 C--N 1.375 1.954 0 CA-C-N 120.097 1.07 . . . . 0.0 113.094 -8.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.646 ' HD3' ' HG2' ' A' ' 78' ' ' GLU . 4.3 mpt_? -77.9 -82.21 0.09 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.569 0.748 . . . . 0.0 111.385 -175.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.5 ptt-85 -150.96 154.11 36.48 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.795 0.438 . . . . 0.0 111.451 -171.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.8 tt -134.86 114.09 12.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -112.82 137.39 51.23 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.139 0.976 . . . . 0.0 108.907 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 74' ' ' ILE . 13.0 pt -133.29 151.56 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.81 1.244 . . . . 0.0 109.885 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.481 ' HB2' HD11 ' A' ' 75' ' ' LEU . 35.2 t -87.96 163.56 16.27 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.991 0.424 . . . . 0.0 109.978 166.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 35.6 t-105 -144.25 96.92 2.96 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -166.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.44 125.06 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.607 0.763 . . . . 0.0 109.373 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.449 ' HB3' ' HE3' ' A' ' 92' ' ' LYS . 59.6 t80 -144.72 171.71 14.03 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.13 0.972 . . . . 0.0 108.655 -176.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.76 154.64 38.27 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 122.531 0.333 . . . . 0.0 110.549 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.44 -63.72 4.1 Favored Glycine 0 N--CA 1.471 1.011 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -103.68 133.64 20.17 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 124.308 1.043 . . . . 0.0 109.708 177.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.12 -73.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.019 2.479 . . . . 0.0 112.433 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -125.47 165.93 17.55 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.283 0.563 . . . . 0.0 110.682 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 72.5 m -152.19 169.77 21.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.912 1.685 . . . . 0.0 107.464 175.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -133.83 123.81 25.45 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 118.509 0.595 . . . . 0.0 111.139 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 t -110.83 147.62 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.989 1.316 . . . . 0.0 107.869 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -143.09 127.86 18.21 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.066 0.46 . . . . 0.0 110.98 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.48 119.08 38.22 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.459 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 33.0 ttm180 -124.88 128.5 48.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.996 0.918 . . . . 0.0 109.145 -173.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.459 ' HB3' HG13 ' A' ' 34' ' ' VAL . 72.9 mt -135.6 128.74 31.74 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.934 0.894 . . . . 0.0 110.792 -175.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.2 m -148.82 152.67 36.91 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.653 1.181 . . . . 0.0 108.559 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.03 150.84 32.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.609 0.764 . . . . 0.0 111.291 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.477 ' HG2' HH11 ' A' ' 29' ' ' ARG . 11.0 tp10 -148.09 112.24 5.2 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.83 -101.75 0.2 Allowed Glycine 0 C--N 1.35 1.317 0 O-C-N 123.252 0.345 . . . . 0.0 112.924 -171.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -119.6 2.05 11.16 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.381 0.61 . . . . 0.0 110.345 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -112.88 -150.68 10.9 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.223 0.916 . . . . 0.0 111.718 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.0 m -148.09 127.09 12.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.481 1.112 . . . . 0.0 110.135 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.439 HD13 ' NE ' ' A' ' 29' ' ' ARG . 40.5 tp -82.44 133.34 35.21 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.4 tt -117.84 113.39 21.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.555 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 33.4 mt-10 -109.37 106.2 15.89 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.7 tp -98.83 103.26 15.19 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 38.8 tt0 -101.65 108.85 20.51 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.937 0.895 . . . . 0.0 109.666 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -106.51 122.18 45.78 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 23' ' ' SER . . . -119.42 125.18 48.34 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.561 0.744 . . . . 0.0 111.308 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.9 t -141.69 159.75 41.58 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 123.982 0.802 . . . . 0.0 109.611 173.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.4 p -90.68 -2.51 57.83 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.233 1.013 . . . . 0.0 111.886 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.6 t -97.16 119.19 35.19 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.162 0.985 . . . . 0.0 110.149 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.546 ' HA ' HD12 ' A' ' 122' ' ' LEU . 38.3 tt0 -62.32 -42.4 99.35 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.269 1.027 . . . . 0.0 112.645 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.16 -58.44 8.64 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.425 ' O ' HG22 ' A' ' 125' ' ' VAL . 25.2 ttt -51.32 -29.62 15.64 Favored 'General case' 0 C--O 1.208 -1.115 0 O-C-N 124.794 1.309 . . . . 0.0 112.762 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 119' ' ' GLU . 47.6 mt -64.26 -53.76 43.96 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.394 0.543 . . . . 0.0 111.896 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 127' ' ' VAL . 47.2 t -63.48 -49.58 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.418 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 23.5 tt0 -44.39 -56.16 4.44 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.264 1.826 . . . . 0.0 113.818 175.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.597 HG23 HG12 ' A' ' 24' ' ' ILE . 34.6 m -72.44 -26.39 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 122.265 0.226 . . . . 0.0 110.635 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.51 -39.12 97.42 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 169.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 123' ' ' VAL . 92.6 t -78.09 -60.48 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.37 -57.06 12.48 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 114.436 -1.256 . . . . 0.0 114.517 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -66.03 -40.94 91.44 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.875 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 36.9 tt0 -67.18 -32.17 73.07 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 120.319 1.418 . . . . 0.0 111.125 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.0 mtm -71.98 -35.04 69.4 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.666 0.386 . . . . 0.0 110.272 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.06 -59.82 2.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.357 0.663 . . . . 0.0 110.97 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.472 HD12 HE22 ' A' ' 28' ' ' GLN . 3.8 mm? -54.56 -30.4 54.08 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.089 1.356 . . . . 0.0 113.008 172.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 24.8 t70 -57.99 -46.62 84.91 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.505 0.722 . . . . 0.0 110.311 169.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -64.18 -37.38 87.25 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.656 172.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 52.5 tp -68.88 -20.66 64.26 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.148 0.579 . . . . 0.0 110.544 175.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.46 ' HA2' ' CE1' ' A' ' 30' ' ' TYR . . . -71.06 -47.27 38.82 Favored Glycine 0 C--N 1.35 1.328 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.3 ptm -80.27 -24.33 40.15 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.499 -0.851 . . . . 0.0 111.58 174.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 82.7 t80 -67.17 -42.77 83.7 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.838 0.455 . . . . 0.0 110.562 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.2 mt -76.74 -51.54 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.781 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.586 ' NE ' ' HA ' ' A' ' 141' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.356 0.878 0 CA-C-O 121.564 0.697 . . . . 0.0 111.332 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.511 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 86.9 mt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.442 0.163 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.3 p -62.12 -27.25 68.8 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.294 1.037 . . . . 0.0 113.787 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 1.4 pp0? -86.69 -33.89 19.9 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.16 -34.5 78.21 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.635 0.774 . . . . 0.0 110.413 174.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 28.7 mmt180 -57.2 -57.77 11.17 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 169.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -53.13 -37.02 53.63 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-N 114.707 -1.133 . . . . 0.0 115.138 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 38.4 mm-40 -67.37 -54.78 17.5 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.069 0.548 . . . . 0.0 110.857 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.48 76.53 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.399 -173.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.404 ' CZ2' ' HG3' ' A' ' 9' ' ' ARG . 67.9 m95 -71.69 -36.13 70.48 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.981 0.513 . . . . 0.0 111.5 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.18 83.52 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.467 0.479 . . . . 0.0 110.569 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -68.32 -40.65 81.59 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.176 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.405 ' CD1' ' HG2' ' A' ' 9' ' ' ARG . 42.2 mt -71.55 -49.79 37.37 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 123.275 0.63 . . . . 0.0 112.228 -176.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 p -61.85 -29.64 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 117.936 0.334 . . . . 0.0 110.804 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -87.74 -11.39 48.3 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 173.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 39.4 t . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 169.784 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -103.44 119.37 38.75 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.298 0.639 . . . . 0.0 111.05 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -104.81 122.58 46.04 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 165.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.491 ' HG3' HD11 ' A' ' 177' ' ' LEU . 17.0 ptp180 -91.76 155.11 18.5 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -159.18 -177.75 6.7 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.062 0.458 . . . . 0.0 111.033 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.463 HD13 ' H ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -143.88 157.02 44.63 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.03 -176.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.463 ' H ' HD13 ' A' ' 11' ' ' LEU . . . -155.02 -172.95 23.23 Favored Glycine 0 C--O 1.239 0.445 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HD3' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -134.07 136.93 44.3 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -136.37 117.45 14.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -170.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.0 m -92.26 99.4 12.19 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.9 pt -104.06 161.21 23.61 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.233 1.013 . . . . 0.0 108.996 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -50.05 -28.9 20.33 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.36 2.706 . . . . 0.0 114.267 172.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.81 0.32 35.4 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.48 177.82 15.07 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 117.841 0.291 . . . . 0.0 112.894 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.57 91.6 0.8 Allowed 'General case' 0 C--N 1.348 0.516 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.46 157.08 26.3 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.068 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.3 165.7 11.42 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.8 p -136.95 140.7 42.41 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.595 HG12 HG23 ' A' ' 125' ' ' VAL . 2.7 pp -92.4 136.52 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 170.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 mp -122.74 114.93 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.3 mt -106.26 108.48 25.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.45 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 99.6 mtt180 -97.38 134.26 40.88 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 172.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 10.0 tt0 -158.91 142.04 14.64 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.023 0.827 . . . . 0.0 110.405 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -116.55 121.77 42.74 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.439 ' O ' ' HA3' ' A' ' 107' ' ' GLY . 57.1 m-85 -94.9 148.23 22.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.689 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.61 34.46 0.49 Allowed 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.921 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.23 146.98 45.15 Favored Pre-proline 0 C--O 1.243 0.718 0 C-N-CA 124.045 0.938 . . . . 0.0 109.251 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.479 ' HG2' ' HG2' ' A' ' 36' ' ' GLU . 72.2 Cg_endo -67.86 169.03 17.1 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.871 2.381 . . . . 0.0 112.823 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.1 t -53.0 -53.01 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 114.086 -1.416 . . . . 0.0 111.856 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -48.07 -47.14 34.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 124.283 0.989 . . . . 0.0 112.292 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.479 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 21.6 mm-40 -70.27 -27.52 64.49 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.985 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.458 HG21 ' HB ' ' A' ' 108' ' ' THR . 62.9 t -81.41 -36.08 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 123.862 0.726 . . . . 0.0 110.997 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -68.61 -36.81 79.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.678 0.791 . . . . 0.0 108.884 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -68.78 -55.41 11.35 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.672 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -58.61 -28.96 66.1 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.44 ' SG ' HD22 ' A' ' 99' ' ' LEU . 49.7 t -96.11 -24.95 16.06 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.1 p -105.08 -46.83 4.15 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 119.115 0.871 . . . . 0.0 112.007 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.18 125.77 88.87 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 58.0 Cg_exo -55.59 -35.02 91.93 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.652 2.901 . . . . 0.0 113.052 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.63 -17.88 37.14 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.38 1.472 . . . . 0.0 112.295 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -100.97 -42.42 6.42 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.374 1.07 . . . . 0.0 109.188 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.5 mt -73.69 -36.82 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.544 -167.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -58.25 -18.96 30.32 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -41.46 64.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.21 0.604 . . . . 0.0 112.024 173.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.422 ' CE2' HD13 ' A' ' 136' ' ' LEU . 66.7 p-90 -118.66 14.04 13.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -171.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.1 t80 178.07 -175.31 0.17 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.115 0.566 . . . . 0.0 109.797 -169.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -88.81 131.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 44' ' ' PRO . 13.5 pt-20 -75.64 140.48 71.54 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-N 119.438 1.017 . . . . 0.0 111.634 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.506 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 93.5 Cg_endo -83.75 111.51 1.73 Allowed 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.352 2.701 . . . . 0.0 112.742 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -78.24 133.53 37.7 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.176 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.77 -156.58 24.31 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.927 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.29 -47.95 46.14 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.145 0.978 . . . . 0.0 111.202 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.8 mt 62.69 29.54 16.83 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 124.472 1.107 . . . . 0.0 111.296 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -118.63 151.57 37.68 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.013 0.925 . . . . 0.0 109.129 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.688 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 3.9 tm-20 -64.54 103.66 0.7 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.39 0.676 . . . . 0.0 109.348 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.84 -32.45 4.79 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.99 -170.29 45.84 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.261 -0.469 . . . . 0.0 112.112 171.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 8.8 p30 -131.55 160.23 35.89 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.146 0.973 . . . . 0.0 112.43 -171.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 21.9 p90 -120.91 158.8 26.88 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.092 166.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.06 114.12 0.79 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 69' ' ' ASN . 80.6 mt -57.86 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 118.395 0.543 . . . . 0.0 111.734 -171.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -159.88 -29.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.392 0.615 . . . . 0.0 110.862 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.85 -31.15 0.03 OUTLIER Glycine 0 N--CA 1.466 0.688 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 91.3 m-20 -89.58 119.59 30.14 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 124.033 0.933 . . . . 0.0 108.491 171.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 72.38 122.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.946 1.298 . . . . 0.0 113.258 173.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.4 p -149.57 139.51 21.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.858 0.863 . . . . 0.0 108.847 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.57 -166.72 30.75 Favored Glycine 0 N--CA 1.464 0.551 0 O-C-N 123.233 0.333 . . . . 0.0 112.394 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 17.9 m-20 -109.31 170.1 8.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.297 0.639 . . . . 0.0 110.515 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.504 HG13 HG22 ' A' ' 85' ' ' ILE . 2.3 mp -97.74 110.01 24.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 171.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.36 -59.88 2.5 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.053 0.845 . . . . 0.0 110.627 -173.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -136.49 150.08 48.5 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.567 1.147 . . . . 0.0 108.988 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.9 p -159.77 134.34 7.74 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.366 0.666 . . . . 0.0 109.295 172.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -134.91 98.86 12.82 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 60.3 Cg_endo -71.1 130.85 18.33 Favored 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 122.026 1.817 . . . . 0.0 111.877 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 14.5 Cg_endo -103.97 20.17 13.37 Favored 'Cis proline' 0 C--N 1.371 1.741 0 CA-C-N 119.411 0.825 . . . . 0.0 113.972 -3.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -54.4 -70.35 0.1 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.203 1.001 . . . . 0.0 111.465 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -145.0 159.67 42.57 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.933 0.397 . . . . 0.0 111.666 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 tt -135.91 113.63 11.01 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.8 m -109.26 128.34 54.99 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.424 1.49 . . . . 0.0 109.431 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.504 HG22 HG13 ' A' ' 74' ' ' ILE . 14.2 pt -121.25 173.09 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 125.109 1.364 . . . . 0.0 111.389 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.5 t -112.81 134.35 54.37 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.672 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 42.1 t-105 -126.53 105.67 8.9 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -167.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.9 t -110.88 144.29 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 21.2 t80 -148.75 151.03 34.14 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -65.12 110.37 2.5 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.139 0.576 . . . . 0.0 110.72 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.43 -20.39 50.63 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.3 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.495 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 70.3 mmtt -97.73 131.1 27.53 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.39 -73.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.891 2.394 . . . . 0.0 113.431 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -161.17 147.61 14.67 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.505 0.722 . . . . 0.0 109.364 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.672 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 19.8 m -141.97 158.96 43.16 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.728 0.811 . . . . 0.0 109.707 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -129.85 114.79 16.34 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 t -105.03 148.45 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -148.88 153.19 37.69 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.178 0.514 . . . . 0.0 110.65 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.44 HD22 ' SG ' ' A' ' 41' ' ' CYS . 39.7 tp -123.93 146.42 48.47 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.263 1.425 . . . . 0.0 107.372 175.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -140.97 109.9 6.11 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.53 148.8 22.11 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.686 0.794 . . . . 0.0 110.694 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.1 t -160.64 135.01 7.29 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 167.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.93 146.92 50.83 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.964 0.906 . . . . 0.0 109.831 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -164.52 108.76 0.94 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.907 1.283 . . . . 0.0 108.861 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.95 -132.01 10.83 Favored Glycine 0 C--N 1.342 0.885 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 172.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -92.42 31.59 1.3 Allowed 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.223 1.009 . . . . 0.0 110.245 171.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 30' ' ' TYR . . . -171.62 -150.43 7.14 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 120.452 -0.88 . . . . 0.0 114.883 -174.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.458 ' HB ' HG21 ' A' ' 37' ' ' VAL . 62.8 m -151.09 141.17 22.13 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.204 0.602 . . . . 0.0 111.079 -170.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.38 144.53 25.73 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.033 0.933 . . . . 0.0 109.378 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.437 HD11 ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -127.14 143.64 51.22 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 166.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.45 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 40.9 mt-10 -122.57 107.51 12.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 167.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.464 HD22 HD21 ' A' ' 133' ' ' LEU . 27.7 tp -99.16 104.4 16.37 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 50.8 tt0 -102.69 116.95 33.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.357 0.663 . . . . 0.0 110.429 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -108.03 120.07 41.26 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -113.83 118.38 34.07 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.756 0.822 . . . . 0.0 110.831 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.1 t -139.16 159.94 40.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.241 0.616 . . . . 0.0 111.076 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 50.4 p -89.86 -20.61 23.23 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.221 1.008 . . . . 0.0 111.76 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.8 m -86.71 123.5 31.94 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.231 0.612 . . . . 0.0 109.995 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.593 ' HA ' HD12 ' A' ' 122' ' ' LEU . 28.8 tt0 -73.42 -30.39 63.2 Favored 'General case' 0 C--O 1.25 1.102 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -170.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -60.89 -58.9 6.5 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 23.8 ttt -49.44 -32.7 12.41 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 124.782 1.301 . . . . 0.0 112.67 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.593 HD12 ' HA ' ' A' ' 119' ' ' GLU . 36.7 mt -61.24 -52.59 64.11 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.869 0.468 . . . . 0.0 111.896 175.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 127' ' ' VAL . 48.0 t -63.26 -50.04 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -45.05 -54.11 7.06 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.927 1.691 . . . . 0.0 113.574 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.595 HG23 HG12 ' A' ' 24' ' ' ILE . 30.5 m -75.93 -24.18 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 122.422 0.289 . . . . 0.0 110.807 -177.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.17 96.1 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 169.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 123' ' ' VAL . 58.8 t -78.17 -59.33 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.77 -56.45 9.82 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 114.517 -1.22 . . . . 0.0 114.023 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -65.42 -49.73 68.1 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.402 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 119.05 0.841 . . . . 0.0 111.07 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 89.7 mtp -75.56 -35.26 60.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.492 0.317 . . . . 0.0 110.518 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.26 76.06 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.193 0.597 . . . . 0.0 110.89 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 112' ' ' LEU . 4.5 mm? -57.4 -38.14 73.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.332 1.053 . . . . 0.0 112.386 170.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.42 -38.37 90.9 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 120.856 0.36 . . . . 0.0 110.854 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -72.32 -25.18 61.46 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.459 0.704 . . . . 0.0 110.849 173.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.672 HD11 ' HB1' ' A' ' 40' ' ' ALA . 41.5 tp -71.01 -52.33 20.2 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 123.162 0.585 . . . . 0.0 109.561 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.78 -36.23 40.64 Favored Glycine 0 N--CA 1.472 1.081 0 N-CA-C 115.016 0.767 . . . . 0.0 115.016 169.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.2 mmm -61.44 -44.93 96.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.655 0.382 . . . . 0.0 110.47 170.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -68.12 -34.93 77.27 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.663 0.785 . . . . 0.0 111.953 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 67.1 mt -78.16 -61.65 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.346 0.658 . . . . 0.0 110.018 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.559 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.6 mm . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.609 0.719 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.2 p -65.94 -51.91 54.39 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.586 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -53.56 -30.83 43.89 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 172.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -58.44 -50.24 74.41 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.641 0.655 . . . . 0.0 109.449 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -60.21 -52.72 64.11 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.185 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.75 -48.0 45.09 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 124.66 1.225 . . . . 0.0 115.955 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.8 -29.2 61.02 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.851 0.46 . . . . 0.0 111.391 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.89 -41.21 68.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.653 0.381 . . . . 0.0 110.037 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -74.79 -23.86 58.57 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.41 0.684 . . . . 0.0 111.255 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.491 ' HA ' HG12 ' A' ' 178' ' ' VAL . . . -75.24 -31.85 60.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.941 0.496 . . . . 0.0 110.393 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.72 72.26 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.289 0.636 . . . . 0.0 109.736 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 9' ' ' ARG . 95.4 mt -71.42 -61.17 1.87 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.102 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 175' ' ' ALA . 11.1 p -57.04 -39.21 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.588 0.755 . . . . 0.0 112.644 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -68.65 -26.66 65.44 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.234 0.614 . . . . 0.0 111.419 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.484 1.263 0 C-N-CA 122.989 0.516 . . . . 0.0 111.065 175.477 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 C--O 1.225 -0.23 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 33.1 m -130.31 103.12 6.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.86 0.864 . . . . 0.0 110.085 -176.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -92.23 142.04 27.91 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.143 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 145.17 41.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.317 0.647 . . . . 0.0 109.262 170.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -160.24 -175.42 5.04 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.882 0.873 . . . . 0.0 110.636 -170.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.6 mt -141.53 165.8 26.49 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.782 0.833 . . . . 0.0 110.889 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.91 -179.75 36.76 Favored Glycine 0 C--O 1.24 0.515 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.041 173.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -109.93 147.91 32.56 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -146.29 126.66 14.0 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.8 m -72.98 141.75 47.76 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.338 0.655 . . . . 0.0 110.026 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.522 HD11 HG23 ' A' ' 117' ' ' THR . 49.3 pt -143.19 152.45 57.89 Favored Pre-proline 0 N--CA 1.478 0.938 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.26 -15.83 6.07 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.214 2.61 . . . . 0.0 115.042 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 93' ' ' PRO . . . -109.3 9.02 25.87 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.92 -165.58 26.17 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 119.021 0.828 . . . . 0.0 114.229 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -94.81 100.73 12.57 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 175.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.09 155.9 21.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.6 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.471 ' HB2' HD11 ' A' ' 122' ' ' LEU . 48.0 mtm180 -101.95 158.24 16.28 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 166.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.5 p -133.53 141.27 47.66 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.41 0.444 . . . . 0.0 111.218 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.527 HD13 HG23 ' A' ' 125' ' ' VAL . 36.0 pt -84.15 148.2 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 47.6 mt -133.83 110.85 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.544 HG22 HE22 ' A' ' 28' ' ' GLN . 7.0 mt -113.32 110.3 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HB3' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -101.53 145.3 29.19 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.128 0.571 . . . . 0.0 110.217 176.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.544 HE22 HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -157.31 142.78 17.3 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.76 0.663 . . . . 0.0 110.992 175.018 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -104.57 107.27 18.13 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -87.52 144.3 26.78 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.774 0.83 . . . . 0.0 111.469 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -79.15 40.98 0.43 Allowed 'General case' 0 CA--C 1.566 1.575 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.133 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.0 150.08 70.32 Favored Pre-proline 0 N--CA 1.474 0.769 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.12 170.94 8.32 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.252 1.968 . . . . 0.0 113.168 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.78 -46.38 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.518 -171.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.61 -34.09 76.32 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.821 0.7 . . . . 0.0 110.99 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.73 -63.53 1.14 Allowed 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.443 0.465 . . . . 0.0 111.298 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.1 t -55.77 -31.8 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.194 0.997 . . . . 0.0 111.064 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -59.98 -56.87 16.29 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.962 0.505 . . . . 0.0 109.872 174.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.0 m -52.83 -42.08 64.82 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.035 0.834 . . . . 0.0 110.737 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -60.01 -34.6 73.57 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 82.4 m -95.58 -4.76 44.03 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.635 0.774 . . . . 0.0 113.07 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.2 p -118.02 -51.82 2.44 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 118.314 0.506 . . . . 0.0 111.936 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.51 117.02 30.38 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.784 0.834 . . . . 0.0 110.096 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.27 -20.06 43.4 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.197 2.598 . . . . 0.0 113.869 -170.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -71.38 -49.57 40.82 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -59.02 -37.99 78.23 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.576 172.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.5 mt -67.91 -35.72 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.039 0.535 . . . . 0.0 110.763 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -62.69 -17.45 60.65 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -73.04 -25.61 61.0 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -138.37 11.7 2.77 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -178.87 -178.76 0.56 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.251 0.621 . . . . 0.0 109.402 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.3 mt -91.0 137.01 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.999 0.92 . . . . 0.0 108.565 171.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.65 132.8 85.97 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.119 0.968 . . . . 0.0 111.442 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.12 120.28 2.93 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 122.476 2.117 . . . . 0.0 110.352 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -90.65 158.08 17.13 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.514 0.726 . . . . 0.0 111.062 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.71 -166.09 12.23 Favored Glycine 0 N--CA 1.466 0.634 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.178 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.76 -38.43 91.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.059 0.944 . . . . 0.0 111.755 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.2 mt 66.1 12.53 8.56 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.718 1.207 . . . . 0.0 112.518 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -126.82 154.53 44.19 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.139 0.976 . . . . 0.0 108.646 -176.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.93 121.6 10.95 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 123.869 0.731 . . . . 0.0 112.119 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.47 -27.8 17.64 Favored Glycine 0 N--CA 1.475 1.29 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.946 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -97.87 170.4 25.12 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 165.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -119.17 161.39 20.42 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.617 1.209 . . . . 0.0 112.527 -169.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -105.83 172.17 6.95 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.244 168.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.34 143.27 7.32 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.444 1.098 . . . . 0.0 109.74 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.3 mt -116.84 167.73 10.85 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.073 0.949 . . . . 0.0 109.008 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -73.88 -42.78 60.22 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.023 0.529 . . . . 0.0 111.66 -171.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.17 16.83 2.12 Favored Glycine 0 N--CA 1.467 0.731 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.033 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -126.91 44.95 2.79 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.266 1.026 . . . . 0.0 108.694 -175.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 68.6 179.25 0.24 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.936 1.295 . . . . 0.0 113.729 175.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.3 p -145.09 140.69 28.23 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.542 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.03 177.7 32.13 Favored Glycine 0 N--CA 1.468 0.828 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.905 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -102.67 156.63 17.5 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.98 0.912 . . . . 0.0 110.128 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.3 mp -92.9 110.43 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.6 mt -73.4 -44.16 59.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.23 0.612 . . . . 0.0 109.796 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -160.52 140.18 10.99 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.273 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.8 p -141.54 126.68 18.45 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.21 1.004 . . . . 0.0 109.181 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -126.47 104.41 24.73 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 125.047 1.339 . . . . 0.0 107.39 -170.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 89.7 Cg_endo -80.27 131.32 8.61 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 122.353 2.035 . . . . 0.0 113.254 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 40.8 Cg_endo -101.05 34.32 7.75 Favored 'Cis proline' 0 C--N 1.377 2.066 0 CA-C-N 119.507 0.86 . . . . 0.0 111.482 -10.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -74.04 -77.87 0.11 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.375 1.07 . . . . 0.0 111.298 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -152.11 157.85 42.16 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.197 0.599 . . . . 0.0 110.611 -174.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -141.41 132.13 25.68 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.059 0.543 . . . . 0.0 109.681 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 98' ' ' GLU . 58.5 m -118.73 120.13 36.49 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.298 1.039 . . . . 0.0 108.471 174.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 pt -121.19 144.59 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.865 0 C-N-CA 125.779 1.631 . . . . 0.0 108.63 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 74.5 p -84.01 170.44 13.93 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.149 -0.969 . . . . 0.0 110.169 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -153.04 117.82 5.05 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -166.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.14 103.58 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.552 ' HB3' ' HG3' ' A' ' 92' ' ' LYS . 36.8 t80 -101.6 162.62 12.77 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.836 0.854 . . . . 0.0 109.381 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -51.75 111.64 0.63 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.912 1.285 . . . . 0.0 112.379 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.52 19.47 72.84 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.663 -0.698 . . . . 0.0 114.834 173.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.552 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 11.0 mmpt? -100.5 140.97 21.83 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 117.223 0.511 . . . . 0.0 109.76 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.546 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . 57.7 Cg_endo -69.14 -36.73 11.84 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.433 2.089 . . . . 0.0 112.401 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -174.33 153.94 2.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.117 0.967 . . . . 0.0 109.494 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.7 t -146.3 158.32 43.87 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.921 0.889 . . . . 0.0 108.764 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -147.69 115.09 6.29 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.243 0.617 . . . . 0.0 110.167 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.16 147.93 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.52 ' HB3' HG23 ' A' ' 84' ' ' THR . 0.0 OUTLIER -146.55 156.81 43.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.4 tt -145.75 137.73 25.33 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -130.11 139.92 50.86 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.754 1.221 . . . . 0.0 108.688 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.0 mt -120.79 132.34 54.97 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.064 0.945 . . . . 0.0 109.084 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 t -129.95 169.41 15.26 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.914 1.285 . . . . 0.0 108.219 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.49 130.52 55.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -173.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -144.12 111.66 6.03 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 58.42 -106.42 0.84 Allowed Glycine 0 C--N 1.346 1.116 0 O-C-N 123.538 0.524 . . . . 0.0 113.264 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -113.1 2.77 15.8 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.566 0.746 . . . . 0.0 111.185 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -127.44 -162.25 11.07 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.7 m -144.48 137.64 27.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.869 0.868 . . . . 0.0 110.523 -171.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 27' ' ' ARG . 43.3 tp -90.07 141.12 28.99 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 173.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -124.69 115.81 21.35 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -108.83 106.12 15.98 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 98' ' ' GLU . 43.7 tp -105.57 104.64 14.4 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.69 0.796 . . . . 0.0 108.933 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 44.3 tt0 -107.75 119.69 40.16 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.272 0.629 . . . . 0.0 110.301 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -119.57 124.85 47.38 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -115.91 129.94 56.62 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.531 1.133 . . . . 0.0 112.04 -170.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.6 t -151.39 158.78 44.18 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.518 0.727 . . . . 0.0 110.335 171.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.522 HG23 HD11 ' A' ' 16' ' ' ILE . 22.0 p -77.52 1.32 19.77 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.435 1.094 . . . . 0.0 112.841 176.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.6 m -109.17 127.55 54.3 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.693 0.797 . . . . 0.0 111.919 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -67.62 -47.79 68.63 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.406 1.083 . . . . 0.0 112.167 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.5 -44.8 70.37 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.125 0.17 . . . . 0.0 111.017 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.403 ' O ' HG22 ' A' ' 125' ' ' VAL . 25.8 ttt -50.77 -41.35 56.7 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.942 0.776 . . . . 0.0 112.061 173.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.501 HD22 HG23 ' A' ' 24' ' ' ILE . 48.6 mt -59.66 -44.32 93.61 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.45 0.3 . . . . 0.0 111.087 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 127' ' ' VAL . 28.3 t -63.37 -56.02 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -48.72 -49.65 37.14 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.208 1.403 . . . . 0.0 112.992 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.527 HG23 HD13 ' A' ' 24' ' ' ILE . 22.5 m -77.23 -27.56 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 122.476 0.311 . . . . 0.0 110.316 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.1 -36.39 92.26 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 123' ' ' VAL . 60.5 t -81.17 -49.65 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.07 -60.08 8.97 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 114.312 -1.313 . . . . 0.0 113.759 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -58.08 -41.75 84.12 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.444 0.698 . . . . 0.0 111.953 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.61 ' HB3' HH11 ' A' ' 170' ' ' ARG . 21.4 mt-10 -64.97 -25.88 68.06 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 119.451 1.023 . . . . 0.0 112.311 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.9 mtt -75.69 -44.39 42.45 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.961 0.504 . . . . 0.0 109.773 174.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.21 -62.44 1.83 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.201 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.62 -26.98 64.27 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.381 1.472 . . . . 0.0 113.132 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 18.0 t70 -60.0 -53.3 59.46 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 169.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -67.21 -26.06 66.42 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.36 0.664 . . . . 0.0 111.628 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.48 HD11 ' HB1' ' A' ' 40' ' ' ALA . 27.4 tp -62.91 -58.01 8.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.266 0.626 . . . . 0.0 110.234 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.28 -43.74 34.27 Favored Glycine 0 N--CA 1.475 1.289 0 N-CA-C 115.057 0.783 . . . . 0.0 115.057 170.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 96.4 mmm -65.27 -30.32 71.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.133 0.573 . . . . 0.0 111.552 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -77.3 -42.98 34.82 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.083 0.953 . . . . 0.0 111.015 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 45.1 mt -57.78 -55.88 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.805 0.842 . . . . 0.0 110.274 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 48.7 ttp85 . . . . . 0 C--O 1.216 -0.68 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.883 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.451 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 42.7 mm . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.6 t -63.91 -30.99 72.02 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.514 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -71.47 -59.96 2.49 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.348 0.659 . . . . 0.0 110.173 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.17 -43.63 87.57 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.924 0.89 . . . . 0.0 112.481 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.61 HH11 ' HB3' ' A' ' 130' ' ' GLU . 19.7 mmt85 -74.08 -41.37 61.8 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -56.0 -35.65 64.74 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.408 -0.814 . . . . 0.0 113.721 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -78.24 -42.92 29.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.699 0.8 . . . . 0.0 110.475 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.7 72.0 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 124.18 0.925 . . . . 0.0 110.934 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.413 ' CZ2' HG12 ' A' ' 26' ' ' ILE . 97.1 m95 -83.44 -27.37 29.57 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.904 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.35 87.75 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 171.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.76 93.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.476 0.71 . . . . 0.0 110.773 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.08 -57.62 6.47 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.546 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.96 -31.79 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 122.847 0.459 . . . . 0.0 111.915 -168.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -66.65 -29.2 69.16 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.356 0.662 . . . . 0.0 110.668 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 171.204 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.1 m -120.33 115.35 23.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.555 0.742 . . . . 0.0 110.451 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 32.1 mt-10 -89.55 136.95 32.73 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -111.3 142.13 43.94 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.811 0.445 . . . . 0.0 110.313 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.37 127.57 7.7 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.931 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.759 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -85.56 121.97 29.01 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.59 -154.82 12.1 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-O 121.332 0.407 . . . . 0.0 113.376 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -148.09 148.28 30.46 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.245 1.018 . . . . 0.0 109.712 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 27.8 tpt180 -168.93 120.39 0.75 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.429 0.691 . . . . 0.0 109.46 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.2 m -83.21 97.6 8.94 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.9 pt -78.3 160.44 73.05 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.369 1.068 . . . . 0.0 110.295 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.3 -21.24 22.3 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.453 2.769 . . . . 0.0 114.463 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.9 -53.14 22.77 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 170.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.7 -157.38 27.62 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.225 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.472 ' HB3' HH22 ' A' ' 22' ' ' ARG . 48.9 mt-10 -68.74 106.15 2.55 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.253 0.621 . . . . 0.0 110.651 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -114.71 153.42 30.3 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.572 0.749 . . . . 0.0 111.401 -175.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.472 HH22 ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -91.67 169.71 10.51 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 164.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -141.71 142.49 33.31 Favored 'General case' 0 C--O 1.217 -0.63 0 O-C-N 122.305 -0.247 . . . . 0.0 110.946 -172.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.553 HG12 HG23 ' A' ' 125' ' ' VAL . 2.7 pp -98.73 144.8 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 168.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.519 HG12 ' HG3' ' A' ' 113' ' ' GLU . 44.3 mt -131.79 106.28 11.26 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.6 mt -101.7 107.54 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 49.0 mtp180 -107.17 133.56 51.58 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.292 1.037 . . . . 0.0 108.791 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.4 ' NE2' ' HB3' ' A' ' 133' ' ' LEU . 43.4 mt-30 -141.25 152.97 44.98 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.768 0.427 . . . . 0.0 110.068 176.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.547 ' NH1' HD13 ' A' ' 109' ' ' LEU . 67.3 mmt-85 -108.48 102.33 11.43 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -79.17 124.32 28.22 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.15 44.79 0.25 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 123.916 0.76 . . . . 0.0 111.295 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.88 148.06 37.57 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 125.292 1.437 . . . . 0.0 107.143 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.45 175.62 2.64 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.8 2.334 . . . . 0.0 114.487 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -73.59 -42.71 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.921 -171.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.35 -43.6 98.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.687 0.795 . . . . 0.0 110.508 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -59.96 -63.97 1.11 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.686 175.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.47 -34.49 46.85 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 124.177 0.991 . . . . 0.0 111.936 -175.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.407 ' HE3' HD12 ' A' ' 101' ' ' LEU . 67.7 t-105 -61.31 -58.47 8.1 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.994 0.518 . . . . 0.0 110.206 178.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 80.0 p -57.91 -46.11 85.48 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.886 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.557 ' HA ' ' HD2' ' A' ' 46' ' ' ARG . . . -53.43 -40.23 65.0 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 79.9 m -78.95 -16.81 56.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 50.3 p -108.31 -26.53 10.48 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 1.2 p30 -85.54 124.24 71.66 Favored Pre-proline 0 N--CA 1.484 1.241 0 CA-C-N 118.533 0.606 . . . . 0.0 110.325 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 50.9 Cg_exo -55.71 -27.34 60.83 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.971 3.114 . . . . 0.0 114.278 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -63.48 -53.51 50.97 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.322 1.014 . . . . 0.0 110.665 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.557 ' HD2' ' HA ' ' A' ' 40' ' ' ALA . 65.8 mtt85 -71.32 -32.27 68.38 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.117 175.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.473 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 82.7 mt -65.04 -39.43 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 118.129 0.422 . . . . 0.0 111.837 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.5 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 13.8 p30 -67.07 -11.68 57.82 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 15.4 mmt180 -72.14 -41.39 67.21 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.475 0.71 . . . . 0.0 111.161 170.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.505 ' HB2' ' O ' ' A' ' 132' ' ' ALA . 70.5 p-90 -115.77 9.35 15.1 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -170.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -173.42 180.0 2.01 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -170.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.1 mt -84.88 133.59 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 34.0 tt0 -67.34 127.23 93.41 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.724 1.21 . . . . 0.0 111.001 -171.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 89.9 Cg_endo -79.88 102.14 1.43 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.797 2.332 . . . . 0.0 111.045 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.43 160.49 24.02 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.634 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.19 -171.76 15.09 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.96 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.52 -47.91 66.36 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.001 1.72 . . . . 0.0 112.277 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.9 mt 69.23 0.66 2.93 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.293 1.437 . . . . 0.0 113.474 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -103.01 154.83 18.84 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.703 0.801 . . . . 0.0 110.028 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -63.96 107.09 1.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.615 0.766 . . . . 0.0 111.233 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.2 -24.48 6.96 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.0 -161.74 37.72 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -141.13 157.32 45.44 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.95 1.375 . . . . 0.0 111.212 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 25.8 p90 -101.32 171.72 7.42 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.59 163.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -165.83 135.39 3.35 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.596 1.159 . . . . 0.0 109.024 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.9 mt -93.05 174.63 7.13 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.597 0.759 . . . . 0.0 109.817 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -106.18 134.37 49.43 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 171.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 53.84 36.34 55.14 Favored Glycine 0 CA--C 1.532 1.1 0 O-C-N 124.927 1.392 . . . . 0.0 114.873 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -149.95 -95.66 0.07 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.04 -179.16 5.93 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.195 0.598 . . . . 0.0 110.841 -171.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.1 p -152.05 146.2 25.36 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.61 146.73 15.81 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 118.823 0.738 . . . . 0.0 112.346 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -80.94 148.81 29.66 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.501 0.721 . . . . 0.0 110.278 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mm -83.26 95.05 3.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 86' ' ' SER . 67.2 mt -70.77 -50.0 40.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.38 0.672 . . . . 0.0 110.41 -173.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -155.76 130.31 9.02 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.37 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 88.7 m -116.25 136.05 53.35 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 167.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -133.34 88.15 36.06 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 95.0 Cg_endo -76.75 136.63 17.14 Favored 'Trans proline' 0 CA--C 1.559 1.768 0 C-N-CA 122.775 2.317 . . . . 0.0 112.425 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 40.8 Cg_endo -102.81 27.76 11.52 Favored 'Cis proline' 0 C--N 1.381 2.26 0 CA-C-N 119.468 0.846 . . . . 0.0 113.256 -5.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.43 ' NH1' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -77.14 -74.63 0.24 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.349 0.66 . . . . 0.0 110.179 -174.03 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -147.9 160.75 42.46 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.25 0.62 . . . . 0.0 110.772 -171.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -141.95 127.91 19.5 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.494 0.718 . . . . 0.0 109.215 171.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.7 m -104.5 112.26 25.25 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.514 HG13 ' HB ' ' A' ' 97' ' ' VAL . 15.3 pt -110.05 170.56 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.465 1.106 . . . . 0.0 109.544 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.495 ' HB3' HD11 ' A' ' 75' ' ' LEU . 23.3 p -105.37 170.9 7.62 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 69.3 t-105 -146.04 92.85 2.25 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -175.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.65 101.92 13.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -117.71 127.37 53.85 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.14 126.99 30.38 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.909 0.883 . . . . 0.0 110.855 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.38 -54.18 0.81 Allowed Glycine 0 C--N 1.349 1.287 0 O-C-N 123.496 0.497 . . . . 0.0 112.512 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.577 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 0.0 OUTLIER -99.27 148.56 34.81 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 123.993 0.917 . . . . 0.0 110.0 -173.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -50.53 140.88 34.99 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 123.882 3.055 . . . . 0.0 114.21 -173.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.43 117.96 5.45 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.55 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 8.2 m -100.41 173.81 6.4 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.141 0.977 . . . . 0.0 110.636 -173.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -128.07 117.38 21.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.514 ' HB ' HG13 ' A' ' 85' ' ' ILE . 40.7 t -98.34 135.51 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.74 114.71 10.1 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.412 HD12 HD12 ' A' ' 112' ' ' LEU . 6.4 tt -111.43 126.51 55.02 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.43 ' HG2' ' NH1' ' A' ' 81' ' ' ARG . 23.8 ttm180 -132.42 105.32 7.2 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.899 0.88 . . . . 0.0 110.09 -165.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 110' ' ' LEU . 88.5 mt -97.1 139.25 33.38 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 110.985 176.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.7 t -138.68 174.16 10.83 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.695 1.198 . . . . 0.0 108.353 172.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -104.74 132.89 50.44 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.433 ' HG2' ' HE ' ' A' ' 29' ' ' ARG . 13.3 tp10 -147.69 99.64 3.13 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -169.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 58.47 -105.72 0.7 Allowed Glycine 0 C--N 1.35 1.314 0 C-N-CA 123.317 0.484 . . . . 0.0 113.966 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -100.93 -15.14 17.63 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.189 0.996 . . . . 0.0 110.43 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.62 -161.01 12.24 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.719 -169.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.2 m -142.79 134.2 26.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.248 1.019 . . . . 0.0 109.71 -173.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.547 HD13 ' NH1' ' A' ' 29' ' ' ARG . 33.6 tp -89.3 122.86 32.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 101' ' ' LEU . 9.0 tt -111.61 108.82 18.43 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.561 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 28.1 mt-10 -109.62 104.85 13.94 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.471 HD13 HD21 ' A' ' 133' ' ' LEU . 8.0 tt -102.0 101.05 11.39 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 171.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.519 ' HG3' HG12 ' A' ' 25' ' ' ILE . 32.7 tt0 -97.23 117.61 31.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.322 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.436 ' ND1' HG22 ' A' ' 97' ' ' VAL . 5.2 t60 -116.74 118.62 33.03 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.4 132.32 54.53 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.371 0.668 . . . . 0.0 111.328 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.711 HG21 ' HG3' ' A' ' 121' ' ' MET . 7.6 t -154.73 161.15 41.64 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.055 0.942 . . . . 0.0 110.27 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.7 p -88.53 -0.2 56.98 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.881 -166.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.0 m -120.19 129.61 54.18 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.589 0.756 . . . . 0.0 110.963 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -61.46 -41.23 96.9 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.095 0.958 . . . . 0.0 112.187 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -63.68 -56.67 13.94 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.174 0.589 . . . . 0.0 111.229 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.711 ' HG3' HG21 ' A' ' 116' ' ' THR . 14.9 tpt -49.79 -34.25 18.93 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 123.939 0.775 . . . . 0.0 112.369 174.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.529 ' HG ' HG23 ' A' ' 116' ' ' THR . 17.5 mt -67.01 -47.27 71.99 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.678 0.791 . . . . 0.0 112.06 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 127' ' ' VAL . 59.8 t -60.86 -50.39 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -50.21 -46.18 54.38 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.28 1.432 . . . . 0.0 113.222 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.553 HG23 HG12 ' A' ' 24' ' ' ILE . 35.9 m -81.26 -26.41 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.693 0.397 . . . . 0.0 110.913 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.71 -38.33 96.28 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 171.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 170' ' ' ARG . 62.0 t -78.42 -50.71 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.679 0.792 . . . . 0.0 109.499 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.48 -62.32 6.32 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.9 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -63.27 -40.12 96.49 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 118.417 -0.801 . . . . 0.0 112.313 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.1 -40.73 96.86 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.868 1.213 . . . . 0.0 110.864 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 47.3 ttm -68.91 -36.92 78.58 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.744 0.818 . . . . 0.0 110.078 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 50' ' ' TRP . . . -65.07 -65.02 0.73 Allowed 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.864 0.727 . . . . 0.0 110.449 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.471 HD21 HD13 ' A' ' 112' ' ' LEU . 4.0 mm? -55.19 -30.24 59.53 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.05 0.94 . . . . 0.0 112.53 174.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.31 -45.2 84.44 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.216 0.462 . . . . 0.0 110.973 171.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -65.2 -31.52 72.73 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.519 0.512 . . . . 0.0 111.224 175.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.27 -48.09 79.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 172.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -45.59 -52.7 8.92 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.715 0.634 . . . . 0.0 113.982 166.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.52 -34.42 77.75 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.96 0.904 . . . . 0.0 111.603 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -69.66 -52.02 29.51 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.355 0.662 . . . . 0.0 110.209 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.4 mt -64.97 -29.39 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 124.186 0.994 . . . . 0.0 110.757 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.247 0 C-N-CA 124.266 1.026 . . . . 0.0 109.6 175.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 50.6 mm . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.1 t -51.53 -47.3 63.41 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.421 1.088 . . . . 0.0 112.411 172.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -88.9 -25.28 22.2 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -63.42 -57.34 10.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.566 1.147 . . . . 0.0 110.079 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.546 ' HB3' HG22 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -60.16 -43.82 95.49 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.684 0.615 . . . . 0.0 109.828 173.468 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -54.71 -44.15 79.99 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 124.028 0.83 . . . . 0.0 113.195 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.26 -59.39 4.12 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.762 1.225 . . . . 0.0 109.866 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.449 ' O ' ' HG ' ' A' ' 177' ' ' LEU . . . -51.44 -57.05 10.04 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 124.997 1.435 . . . . 0.0 111.834 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -70.29 -25.86 63.53 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.725 0.81 . . . . 0.0 113.101 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.1 -36.62 64.26 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 118.177 0.444 . . . . 0.0 110.452 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.97 -35.09 74.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.908 0.483 . . . . 0.0 109.943 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.759 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 67.8 mt -69.47 -53.22 20.29 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.943 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.51 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 9.8 p -70.28 -29.3 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 48.4 m170 -80.22 2.41 24.51 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.874 0.47 . . . . 0.0 111.304 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 37.6 t . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 124.184 0.994 . . . . 0.0 108.354 171.828 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 120.999 0.428 . . . . 0.0 110.294 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.2 m -97.1 120.65 37.86 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.739 0.815 . . . . 0.0 110.048 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -114.35 116.24 28.63 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.437 1.095 . . . . 0.0 109.024 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -76.22 139.36 41.14 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 170.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -152.63 170.61 19.8 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.06 0.457 . . . . 0.0 111.444 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -143.88 162.04 37.13 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -176.022 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.467 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -173.28 -160.71 22.28 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -137.65 151.68 48.54 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.072 0.949 . . . . 0.0 108.495 178.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -156.95 133.21 9.78 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.566 0.746 . . . . 0.0 109.298 -170.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 m -83.16 137.78 33.92 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.472 HD11 HG23 ' A' ' 117' ' ' THR . 47.7 pt -137.65 160.88 63.29 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.507 0.723 . . . . 0.0 109.1 -174.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -45.07 -31.29 5.52 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.984 3.123 . . . . 0.0 115.324 174.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 -41.75 65.61 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.042 0.537 . . . . 0.0 111.265 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.93 -150.09 21.67 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.913 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.8 115.82 9.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.587 0.755 . . . . 0.0 109.817 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.78 164.75 18.54 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.677 0.791 . . . . 0.0 110.907 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -112.61 161.95 16.23 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 p -138.81 128.99 25.5 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.47 0.308 . . . . 0.0 110.655 -168.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 45.5 pt -87.32 135.69 24.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 169.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 3.5 mp -112.99 110.75 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 171.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.9 mt -101.67 109.57 26.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HG3' HD11 ' A' ' 109' ' ' LEU . 59.7 ttm-85 -113.76 148.46 36.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.736 0.814 . . . . 0.0 110.385 -172.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.561 HE21 HD22 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -165.91 138.22 4.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 124.215 0.947 . . . . 0.0 112.496 -176.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.494 ' NH1' HD13 ' A' ' 109' ' ' LEU . 46.0 mmt-85 -96.69 115.39 27.35 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.273 1.029 . . . . 0.0 108.84 167.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -93.67 147.93 22.57 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.765 0.826 . . . . 0.0 109.998 170.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.17 28.03 0.86 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.371 0.668 . . . . 0.0 111.352 172.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.46 151.78 44.74 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 124.451 1.1 . . . . 0.0 109.768 176.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.4 ' O ' HG23 ' A' ' 37' ' ' VAL . 61.2 Cg_endo -71.32 152.02 60.69 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.014 1.809 . . . . 0.0 111.026 172.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 80' ' ' PRO . 77.9 t -46.63 -49.85 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 124.444 1.098 . . . . 0.0 111.094 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -49.21 -47.2 46.36 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 125.371 1.669 . . . . 0.0 111.55 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.81 -34.84 72.15 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.305 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 33' ' ' PRO . 24.2 t -75.05 -32.41 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -71.48 -31.24 66.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.428 1.091 . . . . 0.0 110.179 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.8 m -75.09 -37.44 61.55 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -65.03 -44.64 88.47 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.266 0.626 . . . . 0.0 110.744 171.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.9 t -68.13 -24.86 65.05 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -176.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.9 p -113.85 -38.59 4.2 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -172.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.94 122.86 88.57 Favored Pre-proline 0 N--CA 1.484 1.274 0 CA-C-O 119.106 -0.473 . . . . 0.0 110.269 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -49.97 -51.68 10.41 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.868 3.045 . . . . 0.0 114.596 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -52.39 -33.54 43.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.844 1.258 . . . . 0.0 111.841 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.524 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 5.4 mmp_? -81.33 -38.45 26.71 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.862 0.465 . . . . 0.0 111.662 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.3 mt -73.39 -29.51 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -57.68 -24.64 57.79 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.033 1.733 . . . . 0.0 112.084 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -87.89 -60.21 2.03 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.382 0.673 . . . . 0.0 110.208 -173.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.416 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 69.5 p-90 -82.29 -15.04 54.39 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.416 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 14.8 t80 -140.27 -108.41 0.15 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.414 HD13 ' HB2' ' A' ' 69' ' ' ASN . 89.2 mt -143.01 144.25 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.627 0.771 . . . . 0.0 109.52 -169.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -59.44 109.52 2.0 Allowed Pre-proline 0 CA--C 1.57 1.715 0 O-C-N 125.31 1.631 . . . . 0.0 111.654 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HB3' HD23 ' A' ' 66' ' ' LEU . 63.5 Cg_endo -100.06 156.83 0.52 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.208 2.605 . . . . 0.0 113.82 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -144.73 159.0 43.56 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.6 1.16 . . . . 0.0 108.441 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.74 -148.2 19.84 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.62 -53.69 7.28 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.376 0.67 . . . . 0.0 109.423 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt 59.88 19.7 8.65 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.617 1.167 . . . . 0.0 110.962 -170.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -114.55 149.65 36.17 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.678 1.191 . . . . 0.0 109.153 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 42.3 tt0 -59.7 122.27 13.73 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.476 0.71 . . . . 0.0 110.88 -177.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.67 14.77 64.8 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.908 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -115.8 -147.54 9.03 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -151.26 172.64 15.55 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.491 0.662 . . . . 0.0 111.605 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.63 164.94 26.08 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.897 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.37 122.13 9.28 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.037 0.935 . . . . 0.0 109.873 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.564 HD13 HD22 ' A' ' 69' ' ' ASN . 25.9 mt -89.8 142.11 28.0 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.624 1.17 . . . . 0.0 108.927 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.06 101.18 12.21 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.52 32.35 8.77 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.423 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.564 HD22 HD13 ' A' ' 66' ' ' LEU . 64.1 t30 -150.67 -88.09 0.07 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 117.32 0.56 . . . . 0.0 111.689 177.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.77 159.42 40.63 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 121.304 0.573 . . . . 0.0 112.207 -167.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.0 m -125.62 148.53 48.94 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.476 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.88 159.48 30.33 Favored Glycine 0 C--N 1.338 0.673 0 O-C-N 123.196 0.31 . . . . 0.0 112.381 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.43 164.34 14.32 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.638 0.775 . . . . 0.0 110.586 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 mm -106.72 103.75 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 72.2 mt -80.03 -43.08 22.54 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.79 0.436 . . . . 0.0 111.053 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -166.49 146.74 6.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.131 0.572 . . . . 0.0 109.521 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 12.8 p -160.37 110.77 1.82 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.749 0.42 . . . . 0.0 111.155 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.79 112.4 60.3 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 169.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 70.9 Cg_endo -75.52 132.39 14.7 Favored 'Trans proline' 0 CA--C 1.558 1.707 0 C-N-CA 122.153 1.902 . . . . 0.0 111.897 169.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 43.8 Cg_endo -98.97 21.71 23.32 Favored 'Cis proline' 0 C--N 1.375 1.949 0 CA-C-N 119.659 0.914 . . . . 0.0 112.967 -4.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -66.79 -68.41 0.38 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.151 0.98 . . . . 0.0 112.982 -171.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.466 ' HB3' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -154.58 148.96 26.14 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.627 0.648 . . . . 0.0 112.491 -174.358 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.5 tp -108.14 145.45 34.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.342 1.457 . . . . 0.0 108.572 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.7 m -137.49 125.85 23.32 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.2 pt -144.01 147.37 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.502 1.121 . . . . 0.0 110.211 -170.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.3 m -88.33 154.28 20.52 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 43.7 t-105 -134.98 106.74 6.96 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -174.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.02 107.43 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -94.34 162.98 13.61 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -48.76 111.24 0.44 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.237 1.415 . . . . 0.0 112.648 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.65 25.4 75.77 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 124.023 0.827 . . . . 0.0 113.88 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -116.03 159.73 38.19 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.796 0.838 . . . . 0.0 110.334 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.33 167.25 26.81 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.323 2.015 . . . . 0.0 110.98 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -69.25 108.88 3.84 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.5 m -83.92 167.02 17.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.381 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.03 119.98 18.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 40.6 t -130.13 145.15 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.591 1.157 . . . . 0.0 109.605 -165.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -135.57 145.25 46.77 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.97 -0.456 . . . . 0.0 109.887 171.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.406 ' HG ' HD21 ' A' ' 110' ' ' LEU . 9.2 tt -123.38 115.64 21.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.466 ' HA ' ' HB3' ' A' ' 82' ' ' ARG . 41.6 ttp180 -121.93 117.47 26.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.98 0.512 . . . . 0.0 110.462 -171.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.4 mt -95.55 132.17 40.96 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.321 1.048 . . . . 0.0 109.525 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.8 m -137.23 125.66 23.46 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.653 1.181 . . . . 0.0 107.985 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.97 152.12 28.61 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.362 1.065 . . . . 0.0 110.45 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -167.19 85.95 0.26 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.403 0.681 . . . . 0.0 110.617 -162.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.31 -137.3 23.56 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -87.68 51.99 2.36 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 166.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.91 -165.24 31.5 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 114.547 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 90.9 m -148.01 132.92 18.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.203 0.601 . . . . 0.0 110.968 -171.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.494 HD13 ' NH1' ' A' ' 29' ' ' ARG . 32.6 tp -83.29 120.24 25.59 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.674 0.79 . . . . 0.0 109.486 167.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.561 HD22 HE21 ' A' ' 28' ' ' GLN . 7.3 tt -102.87 132.59 48.97 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 170.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -128.5 105.63 8.43 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.431 HD22 HD21 ' A' ' 133' ' ' LEU . 41.9 tp -101.47 133.01 46.76 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 33.1 tt0 -131.43 105.47 7.62 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.695 0.798 . . . . 0.0 108.943 175.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -96.26 115.55 27.62 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.54 107.37 15.42 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.575 0.75 . . . . 0.0 110.237 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.0 t -130.92 156.94 44.22 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.086 0.554 . . . . 0.0 109.684 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.472 HG23 HD11 ' A' ' 16' ' ' ILE . 68.7 p -74.35 -31.4 62.4 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.864 0.866 . . . . 0.0 110.535 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 m -79.38 111.41 15.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.999 0.92 . . . . 0.0 111.337 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 122' ' ' LEU . 45.3 tt0 -60.42 -30.93 69.93 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.907 0.883 . . . . 0.0 111.86 176.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -66.96 -49.41 65.53 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.61 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.5 ttt -59.8 -37.29 78.71 Favored 'General case' 0 C--O 1.203 -1.383 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.897 176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 119' ' ' GLU . 25.7 mt -61.54 -38.56 87.87 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 123.43 0.692 . . . . 0.0 112.404 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.6 t -65.85 -49.04 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.427 0.632 . . . . 0.0 109.826 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -62.55 -40.32 96.46 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.934 1.294 . . . . 0.0 111.832 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 m -83.62 -22.63 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.549 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.09 -34.84 85.56 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 168.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.98 -52.16 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.05 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.8 -38.13 95.7 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.339 -172.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -80.77 -39.43 26.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.923 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -61.48 -37.04 82.18 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 119.357 0.98 . . . . 0.0 109.636 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 93.1 mtp -69.4 -35.62 75.96 Favored 'General case' 0 C--O 1.218 -0.584 0 O-C-N 123.758 0.661 . . . . 0.0 110.723 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.84 86.35 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.706 0.402 . . . . 0.0 110.701 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.431 HD21 HD22 ' A' ' 112' ' ' LEU . 3.7 mm? -79.29 -20.38 48.16 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.278 0.631 . . . . 0.0 111.498 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -71.46 -42.92 67.54 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -81.54 -22.82 37.63 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.867 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 32.4 tp -71.26 -31.68 67.8 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -56.76 -52.96 47.49 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.978 164.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 94.4 mmm -63.61 -33.84 76.5 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.922 0.889 . . . . 0.0 112.334 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.422 ' HZ ' ' HD3' ' A' ' 46' ' ' ARG . 43.8 t80 -75.08 -51.42 13.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.766 0.826 . . . . 0.0 110.599 -174.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.0 mt -65.35 -28.97 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.009 0.924 . . . . 0.0 110.769 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 C-N-CA 123.597 0.759 . . . . 0.0 109.593 174.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.401 ' O ' ' HG3' ' A' ' 170' ' ' ARG . 72.9 mt . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.3 p -75.84 -53.35 8.59 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -176.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -59.99 -45.62 92.14 Favored 'General case' 0 C--O 1.205 -1.26 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.819 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -42.37 -49.96 5.12 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 124.61 1.164 . . . . 0.0 113.194 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 166' ' ' ILE . 54.3 mtt180 -63.86 -40.05 95.66 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 120.767 0.318 . . . . 0.0 111.084 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.39 -33.15 44.81 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.137 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 12.8 pt-20 -82.91 -18.32 40.56 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.829 0.851 . . . . 0.0 109.896 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.99 -51.45 58.31 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.676 0.79 . . . . 0.0 109.2 172.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -72.73 -34.2 66.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.7 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.504 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -65.25 -28.68 69.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.621 0.369 . . . . 0.0 110.926 174.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -76.62 -43.24 39.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.7 mt -63.63 -41.17 98.28 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.279 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.2 p -90.66 -26.43 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 118.426 0.557 . . . . 0.0 109.632 -166.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -75.35 -17.88 60.12 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.895 0.478 . . . . 0.0 110.795 173.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.8 m . . . . . 0 N--CA 1.476 0.865 0 C-N-CA 123.024 0.53 . . . . 0.0 109.912 172.968 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.509 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.9 m -104.75 104.12 13.86 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.444 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -80.06 135.9 36.45 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.136 0.494 . . . . 0.0 109.989 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -109.21 140.21 43.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.941 1.296 . . . . 0.0 109.227 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.65 -173.22 2.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.287 0.635 . . . . 0.0 111.272 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.622 HD13 HH11 ' A' ' 22' ' ' ARG . 81.3 mt -139.16 163.7 31.76 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.548 1.139 . . . . 0.0 109.502 175.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.68 -163.04 11.34 Favored Glycine 0 C--O 1.241 0.575 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.69 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.53 124.07 9.06 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 7.2 tpt180 -133.29 116.24 15.91 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -175.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.4 m -84.42 120.0 25.77 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 pt -110.88 163.57 16.96 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 124.9 1.28 . . . . 0.0 109.329 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -55.24 -24.19 40.71 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.392 2.728 . . . . 0.0 114.741 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.34 -22.2 61.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.24 0.616 . . . . 0.0 112.189 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.49 170.95 14.71 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -169.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -67.43 116.67 8.44 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 173.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -104.63 152.02 22.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.94 0.496 . . . . 0.0 110.151 -177.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.622 HH11 HD13 ' A' ' 11' ' ' LEU . 22.4 ttm-85 -97.8 154.41 17.64 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.6 p -123.71 143.27 50.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.737 0.415 . . . . 0.0 110.841 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.467 HG23 HD22 ' A' ' 122' ' ' LEU . 2.7 pp -90.92 135.66 26.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 166.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.595 HG13 ' HG2' ' A' ' 113' ' ' GLU . 1.7 mp -114.39 115.8 50.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -174.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.0 mt -114.69 106.46 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 170.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HB3' HD11 ' A' ' 109' ' ' LEU . 52.3 mtp180 -105.21 136.45 44.69 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.423 HE22 ' HB3' ' A' ' 133' ' ' LEU . 26.1 tt0 -144.61 136.47 25.88 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -176.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -92.81 103.06 15.45 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -86.39 122.57 30.54 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.191 0.996 . . . . 0.0 110.557 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.39 43.14 0.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.475 171.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.24 143.86 20.13 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' A' ' 36' ' ' GLU . 21.3 Cg_endo -62.58 165.27 16.05 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.1 2.534 . . . . 0.0 114.633 -176.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.49 -45.09 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.405 -174.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.3 -35.51 79.26 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.438 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.603 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 8.5 tp10 -65.12 -62.76 1.36 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.957 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 33' ' ' PRO . 11.3 t -53.37 -35.0 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.042 0.937 . . . . 0.0 111.078 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -62.5 -58.31 8.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.312 0.645 . . . . 0.0 110.664 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.6 p -59.18 -39.37 82.31 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.524 -177.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.4 74.1 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.799 171.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -80.33 -9.56 59.74 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.8 p -104.3 -32.3 9.14 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.824 0.45 . . . . 0.0 111.596 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.472 ' O ' HG13 ' A' ' 47' ' ' ILE . 10.2 t70 -79.96 116.28 60.11 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 123.882 0.873 . . . . 0.0 110.298 -174.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -61.91 -33.25 84.55 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.142 2.561 . . . . 0.0 113.195 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.413 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 13.9 m120 -70.42 -17.51 63.01 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.25 0.62 . . . . 0.0 110.89 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -101.59 -25.59 13.83 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.603 0.761 . . . . 0.0 110.853 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.506 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 76.4 mt -76.96 -40.22 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 122.908 0.483 . . . . 0.0 111.417 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.413 ' ND2' ' HA ' ' A' ' 45' ' ' ASN . 13.9 p30 -59.66 -21.83 61.06 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -60.12 -56.54 20.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.362 0.665 . . . . 0.0 110.91 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.506 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 36.3 p-90 -91.44 -54.74 3.78 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -172.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.449 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 10.7 t80 -108.46 -166.18 1.1 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.11 0.564 . . . . 0.0 109.638 176.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.8 mt -86.12 124.77 40.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 164.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.22 136.23 96.44 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 123.208 0.603 . . . . 0.0 110.695 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.625 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 54.3 Cg_endo -68.67 131.12 22.08 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.227 1.951 . . . . 0.0 111.76 171.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -89.87 155.71 18.96 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.425 0.69 . . . . 0.0 109.294 172.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.0 -163.01 17.87 Favored Glycine 0 N--CA 1.466 0.681 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.057 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.26 -39.34 92.55 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.943 1.297 . . . . 0.0 111.202 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.0 mt 62.75 12.8 5.92 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.008 1.323 . . . . 0.0 114.342 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.0 mmm-85 -108.1 161.51 14.9 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.598 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 39.0 tt0 -67.18 109.38 3.04 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.594 0.757 . . . . 0.0 110.436 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.55 -23.33 11.18 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -175.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.93 -170.63 45.4 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 166.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -132.31 163.1 29.4 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.037 0.918 . . . . 0.0 110.946 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.625 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 20.2 p90 -119.82 165.28 14.79 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.114 175.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.687 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -166.83 102.65 0.56 Allowed 'General case' 0 C--N 1.348 0.524 0 C-N-CA 125.226 1.41 . . . . 0.0 107.824 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.435 HD11 ' CH2' ' A' ' 87' ' ' TRP . 70.7 mt -56.56 -65.74 0.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.397 0.679 . . . . 0.0 111.704 -171.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 132.49 -61.58 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 128.025 2.53 . . . . 0.0 109.177 171.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.86 31.52 8.09 Favored Glycine 0 N--CA 1.473 1.113 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.16 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -158.27 -80.86 0.06 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.83 -167.39 2.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.224 0.61 . . . . 0.0 111.019 -171.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 33.0 t -148.61 -166.11 2.46 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.1 -156.99 27.06 Favored Glycine 0 C--N 1.347 1.163 0 C-N-CA 121.554 -0.355 . . . . 0.0 113.609 171.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -141.45 146.53 36.61 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.917 0.887 . . . . 0.0 109.403 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.468 ' HA ' HG22 ' A' ' 85' ' ' ILE . 10.6 mt -96.61 106.5 18.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-O 121.497 0.665 . . . . 0.0 109.948 -177.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.63 -59.53 2.65 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.929 -171.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -146.3 155.03 42.36 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.268 1.027 . . . . 0.0 110.503 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 21.6 p -155.56 117.11 3.99 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 176.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -108.89 94.49 14.7 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.282 1.433 . . . . 0.0 107.458 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 98.0 Cg_endo -76.28 134.26 15.56 Favored 'Trans proline' 0 CA--C 1.566 2.098 0 C-N-CA 122.709 2.273 . . . . 0.0 113.06 -175.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 24.1 Cg_endo -99.07 24.86 19.44 Favored 'Cis proline' 0 C--N 1.385 2.487 0 CA-C-N 119.808 0.967 . . . . 0.0 112.285 -8.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -67.4 0.49 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.494 1.118 . . . . 0.0 111.084 -170.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -142.61 159.72 41.69 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.232 0.613 . . . . 0.0 110.604 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 tt -136.07 110.81 8.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.6 m -114.42 110.91 20.59 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.185 0.994 . . . . 0.0 109.077 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.468 HG22 ' HA ' ' A' ' 74' ' ' ILE . 23.3 pt -125.55 160.4 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.731 1.212 . . . . 0.0 109.792 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.7 p -83.84 -175.24 5.71 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.906 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.435 ' CH2' HD11 ' A' ' 66' ' ' LEU . 18.9 t-105 -170.18 100.59 0.28 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 120.673 0.273 . . . . 0.0 111.215 -169.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.3 t -92.01 103.5 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.648 0.779 . . . . 0.0 109.09 176.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.582 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -102.57 143.82 31.77 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -57.5 121.41 10.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.391 1.077 . . . . 0.0 111.778 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.54 -1.04 79.1 Favored Glycine 0 C--N 1.346 1.099 0 O-C-N 123.23 0.331 . . . . 0.0 113.762 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 47.0 mmtm -120.82 163.96 26.22 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.179 0.992 . . . . 0.0 109.598 -175.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.11 -178.26 4.07 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.635 2.224 . . . . 0.0 112.44 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.27 96.97 7.44 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.401 ' OG ' ' HB3' ' A' ' 87' ' ' TRP . 78.4 p -80.58 168.03 19.38 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.895 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.24 119.14 29.3 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.641 0.777 . . . . 0.0 109.637 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.75 142.86 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.28 1.032 . . . . 0.0 109.327 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -139.8 115.84 10.36 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tt -99.36 124.0 44.11 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.656 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 32.3 ttt180 -126.25 105.22 8.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.412 0.685 . . . . 0.0 109.896 -173.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 91.0 mt -88.78 134.27 33.98 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.256 0.623 . . . . 0.0 109.822 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.6 m -125.71 171.89 10.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.706 1.202 . . . . 0.0 109.158 172.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.88 123.46 49.83 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -177.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -141.84 109.34 5.63 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -171.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 53.91 -103.86 0.19 Allowed Glycine 0 CA--C 1.531 1.089 0 O-C-N 123.976 0.797 . . . . 0.0 113.852 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -109.13 -9.12 15.06 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.608 1.163 . . . . 0.0 110.669 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.84 -163.74 13.28 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.064 -171.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.4 m -146.12 126.54 14.05 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.482 1.113 . . . . 0.0 109.225 -172.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 27' ' ' ARG . 44.7 tp -86.81 129.04 35.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.467 HD22 HD11 ' A' ' 133' ' ' LEU . 8.6 tt -108.67 108.81 19.81 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 32.2 mt-10 -107.12 105.63 15.72 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.22 103.58 12.01 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.569 0.748 . . . . 0.0 109.935 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.595 ' HG2' HG13 ' A' ' 25' ' ' ILE . 38.0 mt-10 -100.3 115.1 29.14 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 173.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.408 ' HE2' ' HE2' ' A' ' 121' ' ' MET . 3.5 t-160 -107.85 113.25 26.33 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.18 117.62 33.08 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.91 0.884 . . . . 0.0 111.598 -168.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.7 t -143.6 155.83 44.4 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.663 0.785 . . . . 0.0 110.694 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 p -79.8 -8.38 59.24 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.188 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.2 m -98.62 117.68 33.61 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.652 0.781 . . . . 0.0 110.67 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.39 -37.05 85.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.578 0.751 . . . . 0.0 111.774 -178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -60.54 -54.74 41.85 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.694 173.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.496 ' HE3' ' HD2' ' A' ' 89' ' ' TYR . 26.8 ttt -49.63 -36.81 25.73 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 124.121 0.888 . . . . 0.0 113.026 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.467 HD22 HG23 ' A' ' 24' ' ' ILE . 63.6 mt -60.64 -47.92 84.1 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.916 0.486 . . . . 0.0 111.528 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.466 ' O ' HG23 ' A' ' 127' ' ' VAL . 46.9 t -62.48 -55.2 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 123.505 0.503 . . . . 0.0 109.796 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -43.61 -62.42 1.1 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.559 1.943 . . . . 0.0 113.038 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.2 m -66.52 -33.27 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 122.815 0.446 . . . . 0.0 110.575 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.82 -37.23 90.08 Favored Glycine 0 C--N 1.35 1.349 0 O-C-N 123.723 0.639 . . . . 0.0 112.136 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 123' ' ' VAL . 89.8 t -74.28 -45.7 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.167 0.587 . . . . 0.0 109.648 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.99 -61.25 7.65 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.833 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 20.0 m95 -51.76 -36.99 49.42 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -57.49 -44.18 84.72 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 120.016 1.28 . . . . 0.0 111.21 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 88.5 mtp -64.14 -46.89 82.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 174.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 129' ' ' TRP . . . -68.12 -22.98 64.86 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.667 1.187 . . . . 0.0 112.76 -176.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.467 HD11 HD22 ' A' ' 110' ' ' LEU . 2.7 mm? -86.58 -30.77 21.6 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.6 -37.83 55.8 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.681 0.792 . . . . 0.0 109.637 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -68.48 -46.28 70.14 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.266 0.626 . . . . 0.0 109.735 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.33 -24.24 66.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 122.972 0.509 . . . . 0.0 110.104 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -68.96 -54.8 12.51 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 8.6 mtm -68.52 -33.93 74.99 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.306 0.642 . . . . 0.0 111.332 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -62.62 -55.45 26.95 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.954 0.902 . . . . 0.0 110.686 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.0 tt -72.7 -26.39 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.936 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 . . . . . 0 CA--C 1.538 0.482 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.952 178.315 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.535 0.207 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 46.8 t -62.0 -34.27 75.87 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.113 0.565 . . . . 0.0 111.102 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -72.32 -56.68 5.09 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.094 0.558 . . . . 0.0 110.024 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -48.85 -53.34 19.77 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.381 1.072 . . . . 0.0 112.299 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -70.84 -45.36 64.64 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.226 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -59.07 -58.87 12.23 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 124.148 0.905 . . . . 0.0 114.246 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -54.28 -43.73 71.3 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.152 0.981 . . . . 0.0 111.682 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.01 -38.24 87.9 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 123.675 0.609 . . . . 0.0 111.389 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -78.11 -24.47 47.47 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 119.201 -0.428 . . . . 0.0 112.03 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.91 -42.4 73.39 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -71.34 -26.53 62.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.258 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.498 HD22 ' HG ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -82.65 -49.23 10.03 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.597 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.44 -29.51 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.459 0.704 . . . . 0.0 112.533 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -64.89 -6.99 9.57 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 122.822 0.449 . . . . 0.0 111.321 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.353 0.721 0 C-N-CA 126.993 2.117 . . . . 0.0 112.737 164.43 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 55.5 m -115.27 108.94 17.22 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 124.856 1.262 . . . . 0.0 109.815 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -109.72 124.67 51.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.362 1.065 . . . . 0.0 109.268 -176.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -81.88 154.29 25.91 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.511 0.725 . . . . 0.0 110.895 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -160.06 172.83 16.8 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.31 0.644 . . . . 0.0 109.963 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.5 141.68 25.04 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.887 -175.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.42 -151.52 5.44 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 32.3 ptt180 -144.66 170.81 15.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.353 0.661 . . . . 0.0 109.377 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -163.4 115.32 1.46 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.6 m -86.23 100.94 12.6 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.7 pt -93.88 168.76 11.15 Favored Pre-proline 0 CA--C 1.557 1.225 0 C-N-CA 124.738 1.215 . . . . 0.0 108.682 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.36 -17.49 27.02 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.865 2.376 . . . . 0.0 114.045 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.13 -0.33 56.95 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.95 178.31 15.26 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 118.214 0.461 . . . . 0.0 112.271 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.48 95.29 1.77 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-O 121.737 0.78 . . . . 0.0 109.984 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.65 166.32 19.26 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.29 174.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 20.2 ttm180 -118.42 161.1 20.54 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.448 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 79.7 p -134.11 144.16 48.42 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -173.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 37.4 pt -93.08 150.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 166.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 3.1 mp -129.22 116.03 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.8 mt -109.84 108.35 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 7' ' ' THR . 99.9 mtt180 -95.03 132.77 39.54 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.642 0.777 . . . . 0.0 109.919 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 73.8 mt-30 -143.41 140.19 30.31 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.316 1.01 . . . . 0.0 108.875 172.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -110.77 115.0 28.8 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -87.8 137.36 32.4 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.181 1.393 . . . . 0.0 110.008 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -78.52 38.07 0.3 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 123.936 0.773 . . . . 0.0 111.881 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.43 156.0 53.51 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 123.892 0.877 . . . . 0.0 108.771 -171.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.417 ' O ' HG23 ' A' ' 37' ' ' VAL . 72.5 Cg_endo -70.05 168.39 22.06 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 122.878 2.386 . . . . 0.0 113.695 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' A' ' 80' ' ' PRO . 89.0 t -67.47 -47.59 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.217 -172.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.34 -37.76 84.48 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.069 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -66.52 -63.49 1.06 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.99 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 33' ' ' PRO . 55.1 t -51.62 -34.26 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.739 1.216 . . . . 0.0 111.71 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.428 ' HE3' HD12 ' A' ' 101' ' ' LEU . 51.0 t-105 -58.46 -56.24 24.62 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.453 0.701 . . . . 0.0 110.198 176.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.9 m -57.17 -33.36 67.36 Favored 'General case' 0 CA--C 1.555 1.154 0 O-C-N 124.403 1.064 . . . . 0.0 111.396 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.498 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -68.15 -38.26 81.95 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 174.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.1 m -74.63 -27.76 60.58 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.232 0.613 . . . . 0.0 112.034 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.9 p -99.0 -46.19 5.69 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.196 0.598 . . . . 0.0 112.244 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.84 119.13 51.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 123.221 0.609 . . . . 0.0 110.904 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.68 -29.07 87.63 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 123.621 2.88 . . . . 0.0 112.899 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.4 -52.65 57.12 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.275 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -65.02 -31.0 72.02 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.733 173.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.503 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 40.5 mt -58.27 -41.6 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.255 0.622 . . . . 0.0 110.926 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -57.19 -29.13 63.43 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.994 0.918 . . . . 0.0 112.337 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -75.76 -5.35 45.36 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.667 0.787 . . . . 0.0 112.807 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.512 ' CD1' HD13 ' A' ' 136' ' ' LEU . 59.0 p-90 -149.2 4.31 0.61 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -165.83 -172.74 2.45 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -166.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.534 HD12 HD13 ' A' ' 66' ' ' LEU . 59.4 mt -86.61 140.86 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.076 0.95 . . . . 0.0 110.34 -171.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.68 110.93 3.61 Favored Pre-proline 0 N--CA 1.48 1.051 0 O-C-N 125.021 1.451 . . . . 0.0 110.225 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -90.88 179.61 1.69 Allowed 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.654 2.236 . . . . 0.0 112.799 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -152.39 157.55 41.42 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.101 0.96 . . . . 0.0 109.418 173.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.82 -166.94 25.51 Favored Glycine 0 N--CA 1.462 0.433 0 CA-C-N 116.623 -0.262 . . . . 0.0 113.608 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -78.45 -35.66 46.51 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.17 0.988 . . . . 0.0 110.334 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.7 mt 67.58 10.98 8.14 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.239 1.416 . . . . 0.0 113.453 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -102.34 178.15 4.67 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.721 0.809 . . . . 0.0 110.637 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.48 99.81 0.79 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.577 1.151 . . . . 0.0 109.902 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.55 -11.79 58.08 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.185 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.76 -169.32 30.23 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 169.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 34.7 p30 -128.13 155.2 44.82 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.868 -0.784 . . . . 0.0 112.222 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -119.7 161.77 20.14 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 165.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -163.24 112.85 1.33 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.534 HD13 HD12 ' A' ' 52' ' ' ILE . 72.5 mt -66.42 164.0 17.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.378 0.671 . . . . 0.0 110.935 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -81.3 112.68 18.83 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 40.94 54.97 3.5 Favored Glycine 0 CA--C 1.539 1.581 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -143.97 -76.78 0.23 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 117.197 0.499 . . . . 0.0 110.31 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.405 ' HB2' ' HD1' ' A' ' 89' ' ' TYR . . . -145.36 160.93 40.79 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.287 0.635 . . . . 0.0 109.749 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 35.0 t -127.3 158.04 38.28 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.35 -171.28 31.39 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.222 -0.513 . . . . 0.0 114.043 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 4.4 m-20 -137.94 161.99 35.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.01 0.924 . . . . 0.0 109.621 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -92.87 98.87 8.87 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.426 HD12 HG22 ' A' ' 84' ' ' THR . 97.4 mt -67.69 -46.38 72.43 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.095 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -161.31 115.11 1.97 Allowed 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.687 0.795 . . . . 0.0 109.965 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.3 p -98.12 114.91 27.25 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 164.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -127.12 84.93 62.21 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -170.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 92.3 Cg_endo -78.14 144.66 21.18 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.935 2.424 . . . . 0.0 113.182 -171.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.561 ' HB2' HG12 ' A' ' 34' ' ' VAL . 22.2 Cg_endo -97.78 23.95 22.54 Favored 'Cis proline' 0 C--N 1.374 1.907 0 C-N-CA 124.617 -0.993 . . . . 0.0 112.318 -8.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.684 ' HG2' ' HG3' ' A' ' 82' ' ' ARG . 60.7 ttt180 -73.09 -73.49 0.2 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.852 0.861 . . . . 0.0 111.167 -171.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.684 ' HG3' ' HG2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -155.36 158.7 39.1 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.424 0.69 . . . . 0.0 111.483 -178.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -130.27 129.25 43.04 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.426 HG22 HD12 ' A' ' 75' ' ' LEU . 19.4 m -103.08 135.7 44.25 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.223 1.409 . . . . 0.0 108.179 172.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.3 pt -131.19 163.4 37.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 124.122 0.969 . . . . 0.0 109.648 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.5 t -101.42 148.34 25.29 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 24.7 t-105 -140.65 92.93 2.55 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 109.769 -172.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.8 106.75 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 58.2 t80 -90.05 163.31 14.95 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 169.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.67 118.73 6.95 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.785 0.434 . . . . 0.0 111.027 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.88 25.13 75.48 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.833 0.708 . . . . 0.0 113.287 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 73.8 mmtt -132.43 147.48 65.85 Favored Pre-proline 0 N--CA 1.488 1.438 0 C-N-CA 123.975 0.91 . . . . 0.0 110.003 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.48 -178.18 3.83 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.69 2.26 . . . . 0.0 112.854 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.91 87.74 0.55 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.48 0.712 . . . . 0.0 109.554 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.664 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.4 m -71.86 136.54 47.0 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.699 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -102.45 108.93 20.42 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -172.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.0 t -108.31 136.24 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.111 0.964 . . . . 0.0 108.662 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -138.05 115.93 11.54 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.006 0.922 . . . . 0.0 109.433 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.416 ' HB2' HD13 ' A' ' 112' ' ' LEU . 8.2 tt -105.31 130.56 53.41 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.541 ' HD2' ' HB3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -131.08 143.62 50.81 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.023 0.44 . . . . 0.0 110.392 -177.18 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.502 ' HB3' HG13 ' A' ' 34' ' ' VAL . 97.9 mt -132.43 123.7 27.2 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 125.247 1.419 . . . . 0.0 109.436 -174.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 t -151.97 138.43 18.58 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.872 0.869 . . . . 0.0 108.972 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.08 146.0 44.55 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.04 0.936 . . . . 0.0 111.783 -173.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -153.15 118.04 5.08 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.79 1.236 . . . . 0.0 107.924 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 64.11 -111.84 4.49 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 123.427 0.454 . . . . 0.0 113.003 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -111.74 5.66 19.29 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.035 0.534 . . . . 0.0 110.188 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.39 -153.97 8.87 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.087 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.7 m -147.04 134.39 20.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.122 0.969 . . . . 0.0 109.568 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 42.4 tp -80.77 117.42 21.42 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.7 tt -101.23 106.13 17.31 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 164.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.541 ' HB3' ' HD2' ' A' ' 100' ' ' ARG . 35.6 tt0 -121.95 109.72 14.95 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.416 HD13 ' HB2' ' A' ' 99' ' ' LEU . 52.4 tp -107.17 114.35 28.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.551 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.448 ' HG3' ' HB2' ' A' ' 23' ' ' SER . 34.6 tt0 -94.06 127.2 39.73 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.249 0.62 . . . . 0.0 109.377 168.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -114.64 116.27 28.46 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 168.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.5 120.16 41.65 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.59 0.756 . . . . 0.0 110.291 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.3 t -139.45 154.82 47.83 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.258 0.623 . . . . 0.0 110.114 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.1 m -71.9 -16.29 62.12 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.458 1.103 . . . . 0.0 111.311 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 121' ' ' MET . 17.6 m -100.33 117.84 35.36 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.843 0.857 . . . . 0.0 110.201 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.621 ' HA ' HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -68.48 -29.25 67.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.806 0.842 . . . . 0.0 112.088 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -67.34 -54.41 20.88 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.532 0.52 . . . . 0.0 110.71 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.476 ' HB3' ' HB2' ' A' ' 118' ' ' SER . 28.1 ttt -50.13 -31.94 14.71 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.842 172.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.621 HD12 ' HA ' ' A' ' 119' ' ' GLU . 50.3 mt -65.44 -42.67 92.14 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.952 0.501 . . . . 0.0 111.96 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 127' ' ' VAL . 45.8 t -64.26 -51.05 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -44.31 -57.82 3.27 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.526 1.53 . . . . 0.0 112.754 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 121' ' ' MET . 30.7 m -75.68 -20.03 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 123.848 0.718 . . . . 0.0 110.726 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.72 -39.81 96.95 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 171.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 123' ' ' VAL . 48.4 t -74.73 -53.42 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.36 -61.45 7.21 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 114.537 -1.211 . . . . 0.0 114.207 -176.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -63.99 -39.49 94.24 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 118.405 -0.807 . . . . 0.0 112.922 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -58.57 -45.86 88.12 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 119.549 1.068 . . . . 0.0 110.375 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 40.8 mtm -67.08 -42.82 84.0 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.95 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.37 -61.16 2.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.63 0.772 . . . . 0.0 111.501 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.98 -33.67 69.14 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.205 0.602 . . . . 0.0 112.617 174.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.96 -37.33 82.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 118.321 0.51 . . . . 0.0 110.695 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -66.91 -40.13 87.58 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.985 0.514 . . . . 0.0 109.773 171.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.512 HD13 ' CD1' ' A' ' 50' ' ' TRP . 41.6 tp -64.46 -23.08 67.16 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.06 0.544 . . . . 0.0 110.52 175.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.38 -46.84 11.51 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 79.6 mtp -65.53 -42.17 92.28 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.85 0.86 . . . . 0.0 110.717 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.4 ' HD2' HD12 ' A' ' 136' ' ' LEU . 35.4 t80 -57.4 -55.55 33.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.06 0.944 . . . . 0.0 111.445 -175.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 44.2 mt -71.35 -28.21 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 123.326 0.391 . . . . 0.0 110.367 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 . . . . . 0 CA--C 1.563 1.464 0 C-N-CA 122.936 0.495 . . . . 0.0 110.589 174.003 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.418 ' O ' ' HD3' ' A' ' 170' ' ' ARG . 99.9 mt . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.8 t -64.5 -25.0 67.8 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.358 0.663 . . . . 0.0 112.204 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -73.04 -47.68 42.71 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -58.48 -49.6 76.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.533 0.733 . . . . 0.0 111.658 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 166' ' ' ILE . 9.3 mpt_? -74.67 -48.39 26.45 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.648 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.46 -52.23 29.21 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 123.791 0.682 . . . . 0.0 114.225 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.08 -31.23 67.56 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.518 0.727 . . . . 0.0 112.111 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.74 -56.91 7.44 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.926 0.491 . . . . 0.0 110.54 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -67.71 -22.19 65.27 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.522 0.729 . . . . 0.0 111.829 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.45 84.78 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.999 0.428 . . . . 0.0 110.077 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -75.97 -29.12 58.14 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.11 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 57.7 mt -74.66 -52.3 12.04 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.781 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.26 -29.15 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 122.51 0.324 . . . . 0.0 111.791 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -69.16 -6.82 31.1 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.286 0.634 . . . . 0.0 112.615 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 125.029 1.331 . . . . 0.0 109.433 174.63 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 110.939 -0.023 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -93.84 119.75 33.19 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 3.5 tm-20 -114.87 127.87 55.96 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -106.39 156.52 18.44 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.23 0.538 . . . . 0.0 112.305 -173.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -161.91 -175.41 4.64 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.693 -171.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 mt -140.82 167.34 22.42 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.431 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.83 -162.59 16.19 Favored Glycine 0 C--O 1.246 0.888 0 CA-C-N 113.395 -1.729 . . . . 0.0 109.712 168.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.42 160.68 35.69 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 168.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -162.35 117.54 1.89 Allowed 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -173.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 92.3 m -87.58 98.0 11.17 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.2 pt -78.66 166.08 45.1 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 125.475 1.51 . . . . 0.0 110.537 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.27 -27.71 5.01 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 123.748 2.965 . . . . 0.0 115.038 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.71 -49.58 45.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.013 0.525 . . . . 0.0 110.839 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.99 -160.11 32.15 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-O 119.711 -0.494 . . . . 0.0 112.023 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.66 105.09 0.74 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.204 0.602 . . . . 0.0 111.104 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -107.96 154.41 21.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.935 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 23' ' ' SER . 7.0 tpp180 -83.95 155.66 22.71 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 165.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.469 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 77.0 p -132.41 135.14 45.9 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 110.919 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 2.9 pp -93.71 142.15 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 170.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -123.61 118.17 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -176.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.0 mt -111.27 106.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.583 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 66.9 mtt180 -92.09 147.66 22.78 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -156.42 130.64 8.64 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.86 106.85 19.16 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.544 1.138 . . . . 0.0 108.175 -172.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.71 134.0 34.73 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.691 0.797 . . . . 0.0 110.559 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -80.36 46.88 0.87 Allowed 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 122.039 0.923 . . . . 0.0 110.236 170.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.27 154.79 57.75 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 123.928 0.891 . . . . 0.0 109.359 -171.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 37' ' ' VAL . 60.8 Cg_endo -71.26 165.74 31.47 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.579 2.186 . . . . 0.0 113.188 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 80' ' ' PRO . 88.7 t -73.21 -40.77 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.564 -172.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.18 -47.95 71.47 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.218 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -65.01 -64.47 0.86 Allowed 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.329 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 33' ' ' PRO . 48.3 t -50.01 -35.22 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.214 1.006 . . . . 0.0 111.667 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -58.62 -57.73 11.71 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.847 0.859 . . . . 0.0 110.209 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 m -61.22 -35.75 78.06 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.392 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -62.57 -33.62 75.33 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 122.05 -0.406 . . . . 0.0 112.082 172.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.443 ' HA ' ' HZ2' ' A' ' 50' ' ' TRP . 83.1 m -85.41 -18.28 34.13 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.663 0.785 . . . . 0.0 113.067 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 p -113.05 -40.21 4.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.18 111.33 5.25 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 123.657 0.783 . . . . 0.0 110.829 175.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.428 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 66.7 Cg_exo -54.13 -33.61 74.93 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 123.703 2.936 . . . . 0.0 113.868 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -61.04 -49.83 75.8 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -65.68 -35.37 80.57 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.516 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.509 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 87.9 mt -66.51 -41.46 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.556 0.743 . . . . 0.0 111.911 -174.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.527 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 27.5 p30 -60.21 -15.38 23.83 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -78.88 -45.78 19.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.828 0.851 . . . . 0.0 111.562 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.509 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 67.8 p-90 -108.59 8.17 27.01 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.258 0.623 . . . . 0.0 112.603 -172.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -174.47 173.83 2.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.319 0.648 . . . . 0.0 109.39 -168.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.1 mt -86.46 123.08 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 32.3 tt0 -63.32 130.35 94.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.793 1.637 . . . . 0.0 112.086 -174.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.601 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 83.0 Cg_endo -81.58 129.28 6.42 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.525 2.15 . . . . 0.0 112.154 175.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -93.85 160.36 14.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.873 1.269 . . . . 0.0 109.45 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.46 -168.79 15.63 Favored Glycine 0 N--CA 1.47 0.964 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.47 -36.79 68.56 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.212 0.605 . . . . 0.0 110.603 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.8 mt 71.9 -10.17 0.89 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.241 1.416 . . . . 0.0 114.095 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -86.39 171.03 11.46 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.535 0.734 . . . . 0.0 109.891 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.715 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 41.2 tt0 -67.82 102.22 1.2 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.248 0.619 . . . . 0.0 110.489 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.54 -15.07 17.56 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.85 -160.43 36.35 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -143.04 155.15 44.57 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.805 1.303 . . . . 0.0 111.188 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.601 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 17.1 p90 -106.02 163.35 12.83 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.464 166.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.94 108.05 0.86 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.218 1.007 . . . . 0.0 109.919 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.1 mt -69.29 170.67 9.82 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.449 0.7 . . . . 0.0 109.65 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -76.51 -17.95 58.99 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 122.084 -0.385 . . . . 0.0 111.805 -169.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.79 47.49 0.04 OUTLIER Glycine 0 N--CA 1.467 0.728 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -128.0 -62.3 1.06 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.156 0.982 . . . . 0.0 108.894 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.11 161.34 36.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.977 0.511 . . . . 0.0 111.205 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.6 p -152.81 130.74 11.75 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 86' ' ' SER . . . -161.19 174.61 37.79 Favored Glycine 0 C--N 1.344 1.005 0 C-N-CA 121.663 -0.304 . . . . 0.0 113.449 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -86.55 159.22 19.33 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.216 1.007 . . . . 0.0 111.05 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 mm -93.22 98.74 8.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.401 HD12 HG22 ' A' ' 84' ' ' THR . 87.0 mt -63.81 -51.78 63.2 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.794 0.838 . . . . 0.0 111.123 -174.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -160.78 152.45 19.58 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.661 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 26.2 p -148.13 138.25 22.65 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.57 0.748 . . . . 0.0 109.209 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -138.56 93.58 10.99 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.87 141.49 13.4 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.94 2.426 . . . . 0.0 112.703 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.422 ' HB2' HG12 ' A' ' 34' ' ' VAL . 18.3 Cg_endo -95.81 25.13 22.64 Favored 'Cis proline' 0 C--N 1.378 2.131 0 CA-C-N 119.537 0.87 . . . . 0.0 112.523 -5.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -78.99 -75.84 0.22 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.427 0.691 . . . . 0.0 111.673 -171.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -142.37 139.53 31.75 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 118.549 0.613 . . . . 0.0 112.39 -169.128 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.6 tp -124.48 124.41 42.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.939 1.696 . . . . 0.0 108.404 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.401 HG22 HD12 ' A' ' 75' ' ' LEU . 61.7 m -113.41 114.05 26.06 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.725 0.81 . . . . 0.0 109.917 175.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.0 pt -110.4 168.78 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 124.483 1.113 . . . . 0.0 110.431 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.447 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 14.4 m -103.51 136.39 43.33 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -175.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 44.6 t-105 -128.5 104.58 7.77 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.612 0.642 . . . . 0.0 110.402 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.29 103.67 15.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.539 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 47.2 t80 -90.22 163.66 14.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.751 0.82 . . . . 0.0 109.886 -177.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -52.52 106.49 0.16 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.864 1.265 . . . . 0.0 111.774 177.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.74 2.45 51.04 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 114.433 0.533 . . . . 0.0 114.433 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 41.5 mmtm -101.09 159.47 29.4 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.145 0.978 . . . . 0.0 109.262 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.95 -176.94 2.86 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.119 1.879 . . . . 0.0 112.113 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.58 144.75 56.24 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.178 174.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.5 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 30.0 p -146.99 156.34 42.96 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.121 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -116.23 117.58 30.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.487 0.715 . . . . 0.0 109.103 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 54.2 t -94.31 130.14 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 36.2 mm-40 -116.72 111.93 20.48 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.131 1.772 . . . . 0.0 107.182 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.497 HD13 HD12 ' A' ' 112' ' ' LEU . 59.6 tp -107.33 114.0 27.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -119.65 137.85 53.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.138 0.975 . . . . 0.0 109.601 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 67.9 mt -127.7 142.8 51.23 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.562 1.145 . . . . 0.0 109.221 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 t -137.03 170.77 15.55 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.956 1.303 . . . . 0.0 108.968 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.69 128.01 56.28 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -141.77 106.32 4.86 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.47 -103.9 0.36 Allowed Glycine 0 CA--C 1.534 1.277 0 CA-C-N 117.845 0.293 . . . . 0.0 113.342 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -115.71 2.27 13.66 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.565 0.746 . . . . 0.0 111.069 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -130.13 -173.58 13.44 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 123.891 0.758 . . . . 0.0 111.911 -174.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 89.0 m -121.33 148.22 44.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.848 0.859 . . . . 0.0 110.424 -176.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.9 tp -103.22 134.58 46.39 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 166.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 tt -119.74 109.73 15.97 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.583 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 31.7 mt-10 -109.54 105.57 14.94 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.499 HD13 HD21 ' A' ' 133' ' ' LEU . 8.6 tt -105.4 107.4 18.37 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' A' ' 23' ' ' SER . 32.8 tt0 -92.4 128.18 38.15 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.898 0.879 . . . . 0.0 108.973 173.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.678 ' HD1' ' HE1' ' A' ' 129' ' ' TRP . 6.2 t60 -113.77 118.42 34.24 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 171.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.12 114.86 29.24 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.083 0.953 . . . . 0.0 110.889 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.696 HG21 ' HG3' ' A' ' 121' ' ' MET . 4.4 t -150.26 150.67 31.86 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.596 0.758 . . . . 0.0 110.921 176.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 74.1 p -73.23 -42.68 62.32 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.922 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.1 m -76.62 131.82 39.09 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.472 0.709 . . . . 0.0 112.384 -165.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -60.78 -50.66 72.56 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.78 1.232 . . . . 0.0 113.243 -170.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -62.49 -53.35 56.11 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.696 ' HG3' HG21 ' A' ' 116' ' ' THR . 13.7 tpt -44.14 -38.94 3.97 Favored 'General case' 0 CA--C 1.56 1.351 0 O-C-N 124.873 1.358 . . . . 0.0 112.711 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HG ' HG23 ' A' ' 116' ' ' THR . 13.4 mt -66.54 -47.07 74.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.541 1.136 . . . . 0.0 112.733 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.5 t -64.16 -51.45 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -46.94 -47.5 21.69 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.647 1.979 . . . . 0.0 113.713 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 m -83.39 -25.77 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.479 0.312 . . . . 0.0 111.491 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.61 -39.73 98.26 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.81 -51.15 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.369 1.068 . . . . 0.0 108.99 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.64 -61.75 6.48 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 114.545 -1.207 . . . . 0.0 114.132 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.678 ' HE1' ' HD1' ' A' ' 114' ' ' HIS . 81.5 m95 -63.74 -44.32 93.87 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 118.69 -0.671 . . . . 0.0 112.439 177.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.21 -39.87 91.85 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.344 0.974 . . . . 0.0 110.944 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.9 ttm -70.99 -37.76 72.7 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.738 0.815 . . . . 0.0 110.48 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.66 -59.5 4.19 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.502 0.721 . . . . 0.0 111.202 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.499 HD21 HD13 ' A' ' 112' ' ' LEU . 3.6 mm? -58.5 -29.16 66.05 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.321 0.648 . . . . 0.0 112.061 173.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.01 -38.5 91.28 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 118.395 0.543 . . . . 0.0 110.607 174.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -64.76 -31.2 72.31 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.178 0.591 . . . . 0.0 110.663 171.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.495 HD11 ' HB1' ' A' ' 40' ' ' ALA . 53.2 tp -66.76 -42.15 86.59 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.855 0.462 . . . . 0.0 110.074 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -47.48 -45.99 22.91 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.304 0.378 . . . . 0.0 113.741 165.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 73.4 mtp -74.15 -30.13 62.13 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 123.589 0.756 . . . . 0.0 111.485 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -71.43 -54.92 9.04 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.195 0.998 . . . . 0.0 110.122 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 40.6 mt -64.14 -31.38 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.416 1.086 . . . . 0.0 110.972 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 70.2 ttt180 . . . . . 0 CA--C 1.554 1.132 0 C-N-CA 123.611 0.765 . . . . 0.0 111.243 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 61.9 mt . . . . . 0 CA--C 1.545 0.759 0 CA-C-O 119.8 -0.143 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 31.1 t -51.62 -42.14 61.78 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.942 0.897 . . . . 0.0 112.471 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -89.47 -29.32 19.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -61.79 -50.26 73.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.666 1.587 . . . . 0.0 110.408 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -60.69 -53.09 61.66 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.42 174.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.66 -50.0 38.39 Favored Glycine 0 C--N 1.351 1.407 0 O-C-N 124.545 1.153 . . . . 0.0 115.204 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.07 -32.96 69.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.033 0.533 . . . . 0.0 111.345 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.38 68.77 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.972 0.509 . . . . 0.0 111.133 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.4 ' CE3' HD12 ' A' ' 177' ' ' LEU . 94.5 m95 -70.72 -27.21 63.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.25 0.62 . . . . 0.0 111.599 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.47 73.71 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 123.506 0.504 . . . . 0.0 110.155 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -70.6 -33.83 71.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.4 0.28 . . . . 0.0 110.499 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.4 HD12 ' CE3' ' A' ' 174' ' ' TRP . 63.1 mt -73.05 -62.12 1.58 Allowed 'General case' 0 C--N 1.349 0.56 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.595 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 122' ' ' LEU . 4.4 p -73.43 -22.17 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -166.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -87.14 4.89 40.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.273 0.629 . . . . 0.0 111.188 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 123.672 0.789 . . . . 0.0 111.299 -179.59 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 29' ' ' ARG . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 121.234 0.54 . . . . 0.0 111.454 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 m -81.94 117.62 22.32 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.743 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 35.6 mt-10 -118.94 110.48 17.19 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.788 0.835 . . . . 0.0 108.847 -175.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -68.62 147.67 51.57 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -157.94 161.65 38.2 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.749 0.419 . . . . 0.0 110.48 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -144.64 143.85 30.96 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.63 171.47 33.65 Favored Glycine 0 C--O 1.238 0.348 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 173.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -94.68 160.41 14.63 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.28 122.06 2.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -169.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.3 m -86.36 129.91 34.69 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 117' ' ' THR . 48.9 pt -125.28 165.43 26.25 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.473 1.109 . . . . 0.0 109.005 -174.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.5 -33.35 38.11 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.054 2.503 . . . . 0.0 114.735 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.17 -31.61 67.87 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.459 0.704 . . . . 0.0 111.935 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.24 -164.66 31.04 Favored Glycine 0 N--CA 1.47 0.9 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -74.86 138.42 42.47 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.033 1.417 . . . . 0.0 109.051 172.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.83 168.17 20.41 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.006 1.322 . . . . 0.0 109.871 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.436 HH21 ' HB2' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -104.59 166.64 10.26 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 168.443 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 23.6 p -140.1 130.21 24.99 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.767 -174.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.546 HG12 HG23 ' A' ' 125' ' ' VAL . 2.6 pp -86.92 135.95 24.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 168.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 4.8 mp -124.98 115.48 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.458 HG12 ' CZ2' ' A' ' 174' ' ' TRP . 25.2 mt -105.68 107.17 22.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.579 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 54.0 mtp180 -95.48 162.0 13.83 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.642 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 5.1 tt0 -168.72 120.9 0.79 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 125.029 1.456 . . . . 0.0 111.039 -178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.609 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 2.5 mpt_? -88.95 103.57 16.16 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 170.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.445 ' HE1' ' HA2' ' A' ' 137' ' ' GLY . 77.6 m-85 -84.08 141.37 31.17 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.661 170.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.36 -11.47 59.93 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 123.69 0.619 . . . . 0.0 111.346 174.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.28 152.61 83.96 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 122.551 0.34 . . . . 0.0 110.774 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.419 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 28.0 Cg_endo -62.61 148.64 93.08 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.818 2.346 . . . . 0.0 112.576 171.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 108' ' ' THR . 68.6 t -47.45 -40.92 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 125.062 1.345 . . . . 0.0 111.981 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -50.04 -50.49 47.48 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.833 1.333 . . . . 0.0 111.111 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.419 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 36.8 mt-10 -71.29 -29.79 65.47 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.264 -177.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.6 t -74.56 -40.01 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.465 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -74.52 -28.24 60.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.671 0.788 . . . . 0.0 109.825 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB3' ' NH1' ' A' ' 46' ' ' ARG . 74.1 m -69.14 -44.09 73.04 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.305 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -44.69 93.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.821 0.848 . . . . 0.0 111.51 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 72.7 m -68.36 -33.83 74.98 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.1 p -111.31 -34.72 6.06 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -169.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.484 ' O ' HG13 ' A' ' 47' ' ' ILE . 32.6 t70 -71.02 114.9 31.1 Favored Pre-proline 0 N--CA 1.486 1.354 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.777 -178.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -52.07 -34.78 59.11 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.568 2.845 . . . . 0.0 113.8 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -72.03 -20.61 61.67 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.318 1.011 . . . . 0.0 110.604 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.409 ' NH1' ' HB3' ' A' ' 39' ' ' SER . 72.8 mtt85 -94.81 -25.98 16.41 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.331 0.652 . . . . 0.0 111.7 172.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 43' ' ' ASP . 82.2 mt -76.61 -31.5 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -73.43 -4.29 32.72 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.263 0.625 . . . . 0.0 112.318 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.34 -30.75 13.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.403 0.681 . . . . 0.0 110.701 -173.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.405 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 67.4 p-90 -119.09 -20.15 8.15 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.125 0.57 . . . . 0.0 111.875 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.405 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 51.4 t80 -127.75 -102.25 0.34 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.272 0.629 . . . . 0.0 109.803 -175.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.495 HD12 HD13 ' A' ' 66' ' ' LEU . 89.5 mt -149.42 142.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 124.157 0.983 . . . . 0.0 108.876 -170.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.06 108.06 1.34 Allowed Pre-proline 0 CA--C 1.561 1.385 0 O-C-N 124.657 1.223 . . . . 0.0 110.753 172.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -96.03 139.37 0.77 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.068 2.512 . . . . 0.0 113.463 -177.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -129.98 141.77 50.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.702 1.201 . . . . 0.0 109.417 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.59 -163.12 35.51 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.51 ' HB3' ' H ' ' A' ' 63' ' ' ASN . 29.3 t70 -75.09 -41.03 59.59 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.1 mt 70.81 -10.01 0.77 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.572 1.549 . . . . 0.0 113.708 170.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -93.59 165.91 12.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.883 0.873 . . . . 0.0 110.064 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.524 ' HG2' ' HA ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -64.78 123.46 19.42 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.815 0.846 . . . . 0.0 109.861 -176.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.39 7.14 69.93 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.646 -0.707 . . . . 0.0 112.991 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.66 -147.78 20.5 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 112.149 -0.38 . . . . 0.0 112.149 178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.623 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 26.2 p-10 -139.88 169.88 16.9 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.643 0.777 . . . . 0.0 110.969 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -142.69 154.64 44.5 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.65 142.37 25.58 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.891 0.877 . . . . 0.0 109.824 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.495 HD13 HD12 ' A' ' 52' ' ' ILE . 90.4 mt -94.74 -101.93 0.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.309 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -155.76 -56.68 0.09 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.82 0.848 . . . . 0.0 108.928 174.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.96 43.07 1.16 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.777 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -135.2 -74.04 0.46 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.024 0.93 . . . . 0.0 109.358 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.63 154.31 32.78 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 121.763 0.792 . . . . 0.0 112.713 -169.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.9 m -131.2 154.19 48.67 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 113.153 -1.84 . . . . 0.0 108.182 168.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 86' ' ' SER . . . -169.32 -156.88 11.14 Favored Glycine 0 CA--C 1.504 -0.655 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.073 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 24.8 m-20 -121.88 171.54 8.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.323 0.649 . . . . 0.0 110.462 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.6 mm -103.41 106.65 20.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.8 mt -77.56 -41.03 40.44 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 123.502 0.501 . . . . 0.0 110.212 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.524 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 36.9 ttm180 -175.77 113.96 0.13 Allowed 'General case' 0 C--N 1.363 1.162 0 O-C-N 123.955 0.784 . . . . 0.0 111.508 168.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.3 p -107.05 103.44 12.85 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.529 0.732 . . . . 0.0 109.512 174.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.502 ' HG3' ' HG2' ' A' ' 76' ' ' ARG . 48.8 mt-10 -104.73 112.29 65.3 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.651 1.18 . . . . 0.0 109.517 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 6.1 Cg_exo -79.81 126.33 6.5 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.913 2.408 . . . . 0.0 112.423 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.5 Cg_endo -103.73 25.06 12.07 Favored 'Cis proline' 0 C--N 1.376 1.989 0 CA-C-N 120.421 1.186 . . . . 0.0 112.717 -8.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -61.5 -67.55 0.4 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.156 0.982 . . . . 0.0 112.02 -171.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.493 ' NH2' ' HD2' ' A' ' 76' ' ' ARG . 14.8 ptt180 -152.5 157.15 40.72 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.169 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 tt -119.93 138.18 53.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 169.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.6 m -137.31 130.17 30.38 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.451 HG13 ' HB ' ' A' ' 97' ' ' VAL . 14.1 pt -144.18 146.82 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.296 1.038 . . . . 0.0 109.677 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.444 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 24.6 p -90.86 132.89 35.63 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 171.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 24.4 t-105 -121.68 104.62 9.74 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -171.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.7 t -102.77 103.11 14.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 170.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.532 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 42.8 t80 -77.34 147.11 36.33 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.8 113.59 2.85 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.374 0.669 . . . . 0.0 111.576 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.05 6.7 86.3 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 124.191 0.932 . . . . 0.0 113.354 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 12.4 mmmm -125.98 155.07 73.74 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.519 1.128 . . . . 0.0 109.169 -172.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.1 179.16 4.09 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.635 2.223 . . . . 0.0 114.243 -174.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.62 150.09 39.78 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.253 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.511 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.4 m -140.36 156.91 46.24 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.852 0.72 . . . . 0.0 110.951 178.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -112.06 108.61 17.97 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 165.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 52.6 t -94.33 119.58 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -124.32 115.86 21.68 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.452 0.644 . . . . 0.0 110.418 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -89.78 136.36 33.08 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 57.1 mtt85 -135.42 129.87 33.94 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -177.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 46.5 mt -116.54 147.06 42.16 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.914 0.486 . . . . 0.0 110.401 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.1 t -150.79 125.27 9.54 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.512 0.725 . . . . 0.0 110.528 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.29 124.22 26.02 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 173.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.59 125.79 12.99 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 124.144 0.978 . . . . 0.0 109.051 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.81 -89.14 1.34 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 171.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -160.97 39.88 0.15 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.13 -168.09 33.12 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.395 -172.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.498 HG23 HG22 ' A' ' 34' ' ' VAL . 32.1 m -137.66 131.11 30.99 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.095 0.958 . . . . 0.0 110.498 -166.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 55.1 tp -80.98 106.47 13.01 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 160.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.457 HD22 HD11 ' A' ' 133' ' ' LEU . 7.9 tt -87.45 128.2 35.22 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 160.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 31.7 tt0 -136.4 104.68 5.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.4 131.94 43.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 33.3 tt0 -123.2 143.62 49.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.579 ' HD1' ' HE1' ' A' ' 129' ' ' TRP . 8.6 t60 -138.87 114.71 10.02 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.1 104.52 11.64 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.352 0.661 . . . . 0.0 111.184 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.2 t -131.49 158.71 40.16 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-O 121.499 0.666 . . . . 0.0 109.743 173.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.468 HG23 HD11 ' A' ' 16' ' ' ILE . 40.4 p -80.05 -21.46 43.42 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.052 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.8 t -82.44 113.73 20.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.928 0.491 . . . . 0.0 110.473 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.436 ' HB2' HH21 ' A' ' 22' ' ' ARG . 36.7 tt0 -65.84 -29.3 69.75 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.946 0.899 . . . . 0.0 110.297 175.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -61.45 -50.48 72.61 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.287 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.9 ttt -68.77 -30.25 68.8 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.02 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.9 mt -66.1 -44.14 85.24 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.269 0.628 . . . . 0.0 112.314 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.3 t -65.43 -45.1 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -50.82 -51.55 49.91 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.605 1.162 . . . . 0.0 112.166 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.546 HG23 HG12 ' A' ' 24' ' ' ILE . 33.4 m -79.85 -21.72 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.845 0.458 . . . . 0.0 111.439 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.32 -34.9 86.76 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 168.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.24 -53.63 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 114.415 -0.892 . . . . 0.0 110.054 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.63 86.1 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.604 -0.726 . . . . 0.0 114.281 -175.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.579 ' HE1' ' HD1' ' A' ' 114' ' ' HIS . 34.2 m95 -85.47 -36.39 20.61 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.884 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -69.9 -29.2 66.34 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.112 0.869 . . . . 0.0 110.289 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 65.5 mtm -71.81 -37.43 70.36 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.76 -35.08 79.9 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 122.538 0.335 . . . . 0.0 111.255 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.457 HD11 HD22 ' A' ' 110' ' ' LEU . 3.3 mm? -81.5 -23.38 37.37 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.77 0.828 . . . . 0.0 110.723 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.52 -51.58 41.49 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.106 172.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -71.52 -24.56 61.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.647 0.779 . . . . 0.0 111.424 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -77.94 -31.05 50.73 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.778 0.431 . . . . 0.0 109.876 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.445 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -67.76 -34.34 82.77 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.033 171.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 89.5 mmm -66.35 -49.29 67.43 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.492 0.717 . . . . 0.0 109.474 170.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -56.11 -55.6 31.05 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.972 1.309 . . . . 0.0 111.726 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 59.4 mt -78.87 -55.75 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.459 0.704 . . . . 0.0 111.028 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 . . . . . 0 CA--C 1.551 0.988 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -170.92 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.466 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 71.7 mt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.2 p -71.0 -50.44 34.24 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.353 0.408 . . . . 0.0 110.645 -173.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -57.03 -48.82 77.58 Favored 'General case' 0 CA--C 1.557 1.224 0 O-C-N 124.044 0.84 . . . . 0.0 111.062 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -44.23 -48.03 9.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.315 1.046 . . . . 0.0 112.401 171.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 15.0 mmp_? -60.24 -52.03 67.03 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.375 0.422 . . . . 0.0 111.485 178.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -72.52 -37.85 58.06 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.285 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.17 -25.5 47.24 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.166 0.586 . . . . 0.0 110.985 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.03 -53.12 28.17 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.458 ' CZ2' HG12 ' A' ' 26' ' ' ILE . 97.5 m95 -71.35 -25.65 62.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.495 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.75 -59.56 4.1 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.31 -38.53 42.04 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.779 1.232 . . . . 0.0 112.975 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 53.9 mt -66.95 -49.1 66.53 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.614 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.7 p -81.93 -30.07 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 122.95 0.5 . . . . 0.0 111.218 -165.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -57.56 -30.06 64.92 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.639 0.775 . . . . 0.0 110.925 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.477 0.876 0 C-N-CA 124.274 1.03 . . . . 0.0 112.315 179.553 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.494 ' HB3' ' HD3' ' A' ' 29' ' ' ARG . . . . . . . . 0 C--O 1.242 0.671 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 28' ' ' GLN . 29.7 m -96.11 98.28 10.22 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.764 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.04 140.36 29.72 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.129 175.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.448 ' HG3' HD11 ' A' ' 177' ' ' LEU . 16.9 ptp180 -108.87 147.09 32.67 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 170.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -159.2 -177.84 6.76 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.273 0.559 . . . . 0.0 110.736 -169.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -144.98 150.52 37.07 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.986 -176.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.38 -177.86 23.86 Favored Glycine 0 CA--C 1.507 -0.406 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 175.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 30.6 ptt180 -125.16 131.36 53.24 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 171.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 8.3 tpt180 -135.81 114.83 12.24 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.9 m -78.67 98.19 6.12 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.429 HD11 HG23 ' A' ' 117' ' ' THR . 30.9 pt -81.16 166.9 35.76 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.674 1.59 . . . . 0.0 111.068 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -38.84 -34.42 0.43 Allowed 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 125.028 3.819 . . . . 0.0 115.198 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . . . -67.74 -56.59 8.69 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.682 0.393 . . . . 0.0 110.961 173.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.76 -157.58 30.12 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.494 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.67 105.25 1.2 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.53 0.732 . . . . 0.0 111.326 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -112.8 165.81 11.96 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.887 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 82.6 mtt-85 -105.94 168.01 9.41 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 165.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.3 p -138.5 141.95 39.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.285 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.2 pt -84.77 145.97 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 166.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 48.7 mt -129.92 107.39 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.9 mt -106.28 103.9 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 80.9 mtp180 -95.44 143.77 26.5 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.419 ' HB3' HG23 ' A' ' 7' ' ' THR . 6.9 pt20 -162.65 138.84 7.41 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.2 0.937 . . . . 0.0 111.665 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.494 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 7.5 mpt_? -95.72 105.94 17.99 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.408 ' CE1' HD13 ' A' ' 110' ' ' LEU . 19.6 m-85 -76.04 132.77 40.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.594 0.757 . . . . 0.0 109.7 169.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -79.95 45.09 0.69 Allowed 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.132 0.968 . . . . 0.0 109.787 171.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.66 147.9 34.66 Favored Pre-proline 0 C--O 1.24 0.592 0 C-N-CA 124.102 0.961 . . . . 0.0 109.141 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.8 167.33 21.58 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.844 2.363 . . . . 0.0 112.992 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.93 -50.21 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.315 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.52 -40.01 81.73 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.224 0.953 . . . . 0.0 111.244 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.43 -63.16 1.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 123.847 0.717 . . . . 0.0 111.082 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.5 t -49.99 -41.77 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.648 1.179 . . . . 0.0 111.253 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -58.82 -55.6 33.08 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.976 0.911 . . . . 0.0 110.183 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 t -54.98 -45.34 74.98 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 124.222 0.951 . . . . 0.0 110.975 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.08 -36.28 79.23 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.673 176.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.488 ' SG ' HD21 ' A' ' 136' ' ' LEU . 74.6 m -77.69 -25.2 49.27 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.8 p -108.26 -43.02 4.46 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -168.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.96 126.04 88.0 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 123.209 0.604 . . . . 0.0 111.679 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.1 -38.2 92.51 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.325 2.683 . . . . 0.0 112.802 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -63.37 -22.12 66.69 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.252 1.021 . . . . 0.0 111.676 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.6 mtt85 -100.76 -29.76 12.09 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.804 0.841 . . . . 0.0 109.945 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.465 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 91.9 mt -71.72 -42.37 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.881 0.872 . . . . 0.0 111.642 -178.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 12.4 p30 -57.57 -22.46 44.96 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.418 ' HG2' ' CD1' ' A' ' 139' ' ' PHE . 7.1 tpm_? -68.81 -46.5 68.46 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.577 0.751 . . . . 0.0 111.989 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.465 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 65.1 p-90 -112.5 6.99 18.83 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.598 0.759 . . . . 0.0 112.685 -170.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.429 ' HB3' HG23 ' A' ' 47' ' ' ILE . 20.8 t80 -174.59 173.92 2.79 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -166.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.5 mt -84.61 126.39 40.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 33.4 tt0 -70.31 119.93 75.22 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.716 1.206 . . . . 0.0 109.917 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.599 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 89.9 Cg_endo -78.86 124.34 6.15 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.453 2.102 . . . . 0.0 112.983 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -67.41 145.84 54.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.042 1.337 . . . . 0.0 111.245 172.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.32 -164.89 13.23 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 124.0 0.812 . . . . 0.0 113.427 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.532 ' HB2' ' HA3' ' A' ' 62' ' ' GLY . 34.7 m-20 -75.08 -31.07 61.13 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.709 0.804 . . . . 0.0 111.926 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.0 mt 66.95 12.12 8.76 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.007 1.323 . . . . 0.0 113.049 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -123.35 171.46 9.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.784 0.833 . . . . 0.0 111.153 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.624 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 33.1 tt0 -65.51 106.29 1.39 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.932 0.893 . . . . 0.0 111.811 -171.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.63 -27.94 8.08 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' ' 57' ' ' ASP . . . -84.68 -175.13 50.65 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 167.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 8.2 t30 -129.48 149.45 51.25 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.266 1.026 . . . . 0.0 110.053 -170.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 20.5 p90 -109.66 154.46 22.81 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 165.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.66 119.61 1.68 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.994 0.815 . . . . 0.0 110.612 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' A' ' 69' ' ' ASN . 61.8 mt -87.02 166.32 15.14 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -88.88 -24.28 22.55 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.143 0.577 . . . . 0.0 109.748 -175.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.28 67.81 0.27 Allowed Glycine 0 C--N 1.342 0.867 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.052 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.488 ' HB3' HD12 ' A' ' 66' ' ' LEU . 54.3 t30 -162.59 -67.38 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.803 0.841 . . . . 0.0 109.542 170.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.02 172.49 6.47 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.796 0.438 . . . . 0.0 111.328 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.3 t -145.36 143.98 30.44 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.564 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.56 164.38 36.22 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 9.0 p-10 -94.91 168.93 10.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 117.925 0.863 . . . . 0.0 110.16 176.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 74' ' ' ILE . 2.8 mp -95.75 106.02 17.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.2 mt -72.36 -53.34 12.59 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.333 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -135.18 132.15 37.6 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.681 1.193 . . . . 0.0 108.474 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.1 p -126.18 118.29 24.88 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 166.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.37 74.75 23.36 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 96.3 Cg_endo -76.72 141.89 22.29 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.215 1.943 . . . . 0.0 112.785 -171.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 27.6 Cg_endo -98.46 28.03 16.17 Favored 'Cis proline' 0 C--N 1.375 1.965 0 CA-C-N 119.269 0.775 . . . . 0.0 112.03 -5.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -79.23 -62.15 1.79 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.044 0.937 . . . . 0.0 110.696 -169.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -153.69 162.89 40.84 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.996 0.918 . . . . 0.0 110.413 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 pp -135.71 143.3 45.3 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 166.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.2 m -122.84 110.17 15.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.6 pt -105.96 173.76 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.049 1.34 . . . . 0.0 110.599 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.7 p -109.57 168.54 9.32 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 34.0 t-105 -156.62 106.07 2.28 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -172.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.2 t -106.89 112.95 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.492 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 62.8 t80 -100.81 162.24 13.05 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 125.029 1.332 . . . . 0.0 108.42 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -50.19 -40.47 47.14 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.61 -6.54 19.39 Favored Glycine 0 N--CA 1.47 0.958 0 CA-C-N 116.529 -0.305 . . . . 0.0 112.75 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.732 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 67.3 mmtt -106.72 104.43 51.19 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.63 -30.32 42.53 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.824 2.349 . . . . 0.0 113.348 -168.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.685 ' HB3' ' HB2' ' A' ' 18' ' ' ALA . 26.2 t70 -152.47 134.94 15.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.269 0.557 . . . . 0.0 110.359 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.588 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 36.7 m -144.07 164.02 31.87 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 125.63 1.572 . . . . 0.0 106.9 169.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -142.92 119.12 10.79 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.5 t -109.16 148.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.279 1.031 . . . . 0.0 109.517 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.08 157.66 41.77 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.63 1.172 . . . . 0.0 110.197 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.3 tp -142.49 118.12 10.4 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.51 ' HE ' ' HB2' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -122.36 117.13 25.31 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.841 0.856 . . . . 0.0 109.597 -174.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.4 mt -107.04 136.18 47.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.933 0.893 . . . . 0.0 110.368 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.6 m -143.38 124.24 14.28 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.472 1.109 . . . . 0.0 108.803 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.37 143.72 57.69 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.237 1.415 . . . . 0.0 111.291 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.97 118.45 4.13 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.5 -102.92 0.94 Allowed Glycine 0 C--N 1.347 1.151 0 C-N-CA 123.098 0.38 . . . . 0.0 112.252 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -125.38 7.11 7.71 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.729 0.812 . . . . 0.0 110.278 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -114.92 -165.12 14.78 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.8 m -150.13 135.41 18.03 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.393 0.677 . . . . 0.0 109.777 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 45.7 tp -81.19 128.15 33.46 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 167.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.408 HD13 ' CE1' ' A' ' 30' ' ' TYR . 9.6 tt -115.22 113.59 24.11 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.51 ' HB2' ' HE ' ' A' ' 100' ' ' ARG . 51.2 mt-10 -113.12 105.53 13.56 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 171.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.649 HD13 HD21 ' A' ' 133' ' ' LEU . 7.0 tt -99.44 104.6 16.46 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 171.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -104.46 119.26 38.56 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.696 0.798 . . . . 0.0 109.712 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -109.72 114.93 28.92 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.92 121.68 44.23 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.335 0.654 . . . . 0.0 110.834 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.442 HG23 ' HG ' ' A' ' 122' ' ' LEU . 7.8 t -140.21 158.6 43.79 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.637 0.732 . . . . 0.0 110.176 172.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.429 HG23 HD11 ' A' ' 16' ' ' ILE . 11.9 p -85.23 -3.15 58.72 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.792 -175.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.3 t -105.25 121.88 44.78 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.749 0.82 . . . . 0.0 110.203 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.437 ' HA ' HD12 ' A' ' 122' ' ' LEU . 43.0 tt0 -66.34 -37.4 85.27 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.362 0.665 . . . . 0.0 111.528 -177.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -62.38 -58.57 7.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.253 0.221 . . . . 0.0 110.996 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.732 ' SD ' ' HG3' ' A' ' 92' ' ' LYS . 21.2 ttt -46.72 -41.02 14.45 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.493 1.121 . . . . 0.0 112.176 175.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 116' ' ' THR . 26.9 mt -57.35 -50.9 71.5 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.361 0.664 . . . . 0.0 112.111 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 127' ' ' VAL . 41.4 t -62.53 -50.07 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -61.0 -36.42 79.44 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.182 0.993 . . . . 0.0 113.296 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -80.17 -23.13 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 118.56 0.618 . . . . 0.0 110.031 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 130' ' ' GLU . . . -62.06 -37.75 94.96 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 171.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 123' ' ' VAL . 44.4 t -79.41 -49.52 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.792 0.837 . . . . 0.0 109.204 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.98 -60.32 9.11 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.972 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -61.44 -36.13 79.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.498 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 21.5 tt0 -59.65 -37.59 79.14 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.783 0.72 . . . . 0.0 110.317 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 67.6 mtt -72.25 -39.89 68.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.113 0.565 . . . . 0.0 110.927 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.85 -58.29 9.08 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 123.812 0.695 . . . . 0.0 110.853 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.649 HD21 HD13 ' A' ' 112' ' ' LEU . 3.4 mm? -60.36 -26.16 66.41 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 172.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.15 -38.68 88.71 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -66.71 -36.78 83.31 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.1 0.56 . . . . 0.0 110.234 174.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.488 HD21 ' SG ' ' A' ' 41' ' ' CYS . 42.4 tp -70.91 -56.71 5.65 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.383 0.673 . . . . 0.0 111.14 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -43.52 -42.06 5.67 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 167.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 50.2 ttm -66.7 -45.11 79.8 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.394 0.677 . . . . 0.0 111.121 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.418 ' CD1' ' HG2' ' A' ' 49' ' ' ARG . 18.1 t80 -61.35 -59.87 4.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.813 0.845 . . . . 0.0 111.087 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.2 mt -57.89 -36.63 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.795 1.238 . . . . 0.0 112.037 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 . . . . . 0 CA--C 1.551 0.993 0 C-N-CA 122.955 0.502 . . . . 0.0 111.019 175.669 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.448 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 82.9 mt . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 110.399 -0.222 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.5 t -59.32 -27.07 65.56 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.94 0.896 . . . . 0.0 111.869 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -77.03 -50.3 13.43 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.541 ' HB2' HH11 ' A' ' 170' ' ' ARG . 45.8 mt-10 -55.65 -50.58 69.84 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 124.168 0.918 . . . . 0.0 110.692 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.541 HH11 ' HB2' ' A' ' 169' ' ' GLU . 15.1 mmt-85 -67.12 -50.28 62.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.776 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -49.46 -44.04 36.19 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 124.193 0.933 . . . . 0.0 114.553 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -67.27 -41.15 85.97 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.777 0.831 . . . . 0.0 111.371 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.1 -41.57 73.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.419 0.688 . . . . 0.0 111.466 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -78.38 -27.36 46.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.502 0.721 . . . . 0.0 111.676 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -71.82 -31.83 66.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.75 0.42 . . . . 0.0 110.373 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -73.3 -31.76 64.22 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.287 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.448 HD11 ' HG3' ' A' ' 9' ' ' ARG . 54.9 mt -71.55 -55.61 7.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.949 0.9 . . . . 0.0 111.51 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.21 -32.32 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -172.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -78.52 -4.12 47.05 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.481 1.107 0 C-N-CA 123.884 0.874 . . . . 0.0 110.527 171.841 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 m -97.72 142.07 29.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.924 0.889 . . . . 0.0 111.99 -172.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -122.91 108.82 13.39 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.157 0.983 . . . . 0.0 108.644 169.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.29 141.92 57.04 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.917 171.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -157.63 164.86 36.8 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.414 HD13 ' H ' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -142.51 149.06 38.65 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' H ' HD13 ' A' ' 11' ' ' LEU . . . -153.43 -158.32 8.51 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 177.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -135.35 164.93 26.63 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.989 0.915 . . . . 0.0 109.342 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.496 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 15.8 tpt180 -152.39 152.99 32.72 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.978 0.911 . . . . 0.0 108.572 -174.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -111.85 129.61 56.09 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.4 pt -136.05 161.99 59.27 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.015 0.926 . . . . 0.0 109.941 -175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.31 -21.05 16.45 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.533 2.822 . . . . 0.0 114.836 175.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.05 -43.33 58.21 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.004 0.431 . . . . 0.0 110.975 174.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 151.42 -129.24 2.79 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -79.2 136.75 37.17 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.182 0.491 . . . . 0.0 109.891 174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . . . -127.17 155.51 43.27 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 3.9 mpt_? -114.31 161.05 18.38 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 165.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.8 p -134.46 130.27 36.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.183 -168.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.413 ' HA ' HD22 ' A' ' 11' ' ' LEU . 36.9 pt -85.97 135.65 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 168.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 4.0 mp -121.16 119.05 58.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.9 mt -104.76 108.64 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 33.9 mtm105 -105.28 101.78 11.31 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.465 ' NE2' ' HB3' ' A' ' 133' ' ' LEU . 70.8 mt-30 -108.0 118.59 37.15 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.6 tpt85 -91.09 103.53 16.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.406 ' CE1' ' HA2' ' A' ' 137' ' ' GLY . 24.8 m-85 -86.69 149.73 24.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.27 178.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -102.7 72.97 1.26 Allowed 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.15 150.7 5.29 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 125.833 1.653 . . . . 0.0 107.943 -164.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.64 146.0 23.64 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.679 2.253 . . . . 0.0 113.45 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.3 t -49.63 -35.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 124.535 1.134 . . . . 0.0 111.915 173.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -52.81 -42.62 65.27 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 123.508 0.505 . . . . 0.0 110.951 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -86.66 -30.88 21.39 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.08 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.496 HG22 HD13 ' A' ' 140' ' ' ILE . 52.7 t -69.12 -49.48 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 123.601 0.563 . . . . 0.0 110.44 175.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -65.88 -26.29 67.57 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.903 1.281 . . . . 0.0 111.096 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.3 t -65.95 -48.91 69.76 Favored 'General case' 0 C--N 1.353 0.761 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 173.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -59.62 -34.74 73.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.912 0.885 . . . . 0.0 112.515 174.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.468 ' SG ' HD21 ' A' ' 99' ' ' LEU . 79.4 m -69.41 -38.04 77.75 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.2 p -105.73 -43.91 4.79 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -167.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.494 ' O ' HG13 ' A' ' 47' ' ' ILE . 65.4 m-20 -76.32 118.46 71.54 Favored Pre-proline 0 N--CA 1.478 0.933 0 CA-C-O 118.131 -0.938 . . . . 0.0 110.298 -175.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.402 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 25.6 Cg_endo -57.39 -23.78 57.01 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.151 2.568 . . . . 0.0 111.72 174.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -59.46 -44.36 93.0 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.75 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 12.2 mmm180 -89.37 -26.12 21.22 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.283 1.033 . . . . 0.0 111.396 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.495 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 87.0 mt -73.91 -34.72 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -174.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.57 HD21 ' HB3' ' A' ' 53' ' ' GLU . 69.7 m-20 -66.79 2.89 1.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.66 -9.89 33.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.925 0.89 . . . . 0.0 110.833 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.495 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 37.7 p-90 -146.49 -27.57 0.41 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.595 0.758 . . . . 0.0 112.36 -174.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.486 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 16.6 t80 -147.11 -145.06 0.16 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.412 1.085 . . . . 0.0 108.847 -175.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.82 139.74 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.821 0.848 . . . . 0.0 111.813 -159.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.57 ' HB3' HD21 ' A' ' 48' ' ' ASN . 10.0 pt-20 -65.33 110.42 4.3 Favored Pre-proline 0 CA--C 1.566 1.576 0 O-C-N 125.122 1.514 . . . . 0.0 110.555 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HB2' HD21 ' A' ' 58' ' ' LEU . 4.1 Cg_exo -80.23 98.98 1.13 Allowed 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.0 2.467 . . . . 0.0 111.982 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -72.92 97.97 2.38 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 64' ' ' PHE . . . -176.09 169.65 42.32 Favored Glycine 0 C--O 1.241 0.578 0 C-N-CA 121.547 -0.358 . . . . 0.0 112.955 -172.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.69 -34.55 78.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.443 0.697 . . . . 0.0 111.253 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 54' ' ' PRO . 96.1 mt 56.11 70.73 0.61 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.747 1.219 . . . . 0.0 112.718 172.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.455 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 9.3 ptp85 -171.37 171.21 5.63 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.057 0.943 . . . . 0.0 109.495 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.429 ' HG3' ' HA ' ' A' ' 76' ' ' ARG . 28.7 tt0 -54.96 116.17 2.61 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.906 0.882 . . . . 0.0 110.263 174.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.85 8.76 83.83 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 113.945 0.338 . . . . 0.0 113.945 -177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.0 178.16 20.66 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 27.4 p-10 -112.66 177.29 4.68 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 118.043 0.921 . . . . 0.0 112.471 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.512 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 48.4 p90 -149.8 139.31 21.54 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 170.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.09 121.65 24.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.812 0.445 . . . . 0.0 110.721 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.6 mt -94.3 132.55 38.77 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -33.63 -56.97 0.44 Allowed 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 126.264 1.826 . . . . 0.0 114.491 -172.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -136.36 5.56 3.86 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.916 -0.584 . . . . 0.0 113.514 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -90.1 -86.9 0.19 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.984 0.892 . . . . 0.0 110.045 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.74 154.56 39.77 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.241 0.543 . . . . 0.0 111.046 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -131.81 149.5 52.44 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.388 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.52 -154.43 9.18 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.597 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 11.5 m-20 -129.39 178.2 6.62 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.997 0.519 . . . . 0.0 110.214 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.594 HG13 HG22 ' A' ' 85' ' ' ILE . 3.4 mp -108.49 117.46 54.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 173.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 86' ' ' SER . 62.0 mt -74.7 -39.9 61.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.072 0.949 . . . . 0.0 110.282 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.429 ' HA ' ' HG3' ' A' ' 60' ' ' GLU . 16.9 ptm180 -168.32 149.76 5.05 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.922 1.289 . . . . 0.0 108.634 173.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 22.0 p -147.91 119.86 8.19 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.933 0.493 . . . . 0.0 110.388 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -121.18 97.35 47.77 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.173 0.989 . . . . 0.0 109.834 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 91.4 Cg_endo -75.91 142.16 24.88 Favored 'Trans proline' 0 CA--C 1.56 1.813 0 C-N-CA 122.502 2.135 . . . . 0.0 112.297 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 16.1 Cg_endo -97.59 20.96 27.03 Favored 'Cis proline' 0 C--N 1.376 1.983 0 CA-C-N 119.665 0.916 . . . . 0.0 113.043 -5.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -74.43 -60.92 2.05 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.51 0.724 . . . . 0.0 112.199 -169.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -153.19 159.85 42.74 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.859 0.838 . . . . 0.0 111.691 -169.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 99' ' ' LEU . 63.4 tp -134.08 145.44 49.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.626 1.57 . . . . 0.0 107.647 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.419 HG22 HD12 ' A' ' 75' ' ' LEU . 23.9 m -137.11 121.68 18.42 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 172.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.594 HG22 HG13 ' A' ' 74' ' ' ILE . 31.0 pt -134.47 141.88 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.342 1.057 . . . . 0.0 109.703 -176.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.54 ' HB2' HD21 ' A' ' 75' ' ' LEU . 22.7 t -90.73 140.75 29.49 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 168.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 28.5 t-105 -128.97 100.56 5.7 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.178 1.391 . . . . 0.0 107.644 -167.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.3 t -96.35 102.64 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.435 ' HD2' ' HG3' ' A' ' 92' ' ' LYS . 37.4 t80 -98.07 162.04 13.42 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 174.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.44 115.8 4.97 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.386 0.674 . . . . 0.0 112.015 -168.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.93 14.99 79.82 Favored Glycine 0 C--N 1.356 1.664 0 O-C-N 123.71 0.631 . . . . 0.0 113.775 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.486 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 67.1 mmtt -109.28 153.45 42.69 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.793 0.837 . . . . 0.0 109.895 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.96 143.45 60.47 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.181 1.921 . . . . 0.0 110.391 170.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.21 107.62 0.93 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.916 0.865 . . . . 0.0 109.73 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.489 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.5 m -77.75 145.59 36.4 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.427 -172.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -103.53 105.38 15.61 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.0 144.41 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.592 1.157 . . . . 0.0 108.623 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HG2' HG23 ' A' ' 84' ' ' THR . 22.4 mt-10 -132.35 148.62 52.43 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.636 0.774 . . . . 0.0 109.603 171.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 83' ' ' LEU . 39.9 tp -125.3 108.56 11.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -107.27 145.76 32.33 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.545 0.738 . . . . 0.0 110.149 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 110' ' ' LEU . 82.9 mt -134.34 141.35 46.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.696 1.199 . . . . 0.0 109.233 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.2 m -136.54 122.57 20.23 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.126 0.97 . . . . 0.0 109.411 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.57 101.43 9.97 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.69 100.96 7.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.922 -170.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.78 -126.09 8.27 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.806 0.717 . . . . 0.0 112.897 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -90.91 27.09 1.9 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.294 0.638 . . . . 0.0 109.647 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -161.7 -172.05 28.57 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 120.363 -0.923 . . . . 0.0 115.245 -172.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.1 m -136.54 125.17 23.73 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.1 1.36 . . . . 0.0 109.386 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.9 tp -82.27 116.04 21.62 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 167.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 1.7 tm? -83.38 133.97 34.92 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 165.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -140.48 105.37 4.96 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.5 tp -103.9 132.63 49.97 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.292 1.037 . . . . 0.0 109.015 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -129.18 102.67 6.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.254 0.621 . . . . 0.0 110.095 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -95.53 113.96 25.66 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 172.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -117.57 103.79 10.41 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.153 0.581 . . . . 0.0 110.78 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 t -121.52 161.83 21.63 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.684 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 5.94 14.85 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.671 1.188 . . . . 0.0 111.781 -175.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.565 ' HB3' ' HG2' ' A' ' 120' ' ' GLN . 66.6 m -132.37 123.47 26.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.442 0.697 . . . . 0.0 110.7 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.535 ' HA ' HD12 ' A' ' 122' ' ' LEU . 4.7 mp0 -72.53 -29.36 63.53 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.0 0.92 . . . . 0.0 109.828 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.565 ' HG2' ' HB3' ' A' ' 118' ' ' SER . 5.2 pt20 -58.73 -44.91 90.57 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.491 1.119 . . . . 0.0 110.821 173.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 24.3 ttt -71.23 -33.96 70.34 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.778 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 119' ' ' GLU . 36.6 mt -64.74 -39.53 93.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 119' ' ' GLU . 95.0 t -69.58 -41.62 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.303 0.573 . . . . 0.0 109.712 176.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -59.56 -58.35 8.98 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.03 1.332 . . . . 0.0 111.453 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 121' ' ' MET . 18.0 m -74.2 -14.85 16.32 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 C-N-CA 123.262 0.625 . . . . 0.0 110.339 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 130' ' ' GLU . . . -61.61 -37.28 93.95 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 166.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.73 -47.17 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 O-C-N 124.114 0.538 . . . . 0.0 109.732 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.69 -30.38 76.21 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.916 0.76 . . . . 0.0 114.498 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -88.05 -41.04 13.36 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -60.37 -32.64 71.48 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.575 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 41.0 ttm -66.16 -56.03 13.4 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.316 1.046 . . . . 0.0 110.49 175.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.17 79.73 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.88 0.738 . . . . 0.0 111.43 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.549 HD13 HD23 ' A' ' 136' ' ' LEU . 4.5 mm? -82.65 -20.85 35.46 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.422 1.089 . . . . 0.0 110.904 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.65 -51.98 43.58 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -74.29 -24.55 59.26 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.35 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.549 HD23 HD13 ' A' ' 133' ' ' LEU . 31.7 tp -70.82 -41.57 71.37 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 171.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.406 ' HA2' ' CE1' ' A' ' 30' ' ' TYR . . . -58.03 -42.97 95.27 Favored Glycine 0 C--O 1.219 -0.832 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.151 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 87.5 mtp -75.2 -32.96 61.35 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.43 0.692 . . . . 0.0 111.559 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -63.19 -46.25 87.97 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.487 0.715 . . . . 0.0 110.704 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.496 HD13 HG22 ' A' ' 37' ' ' VAL . 80.6 mt -76.46 -61.16 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.148 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 . . . . . 0 N--CA 1.482 1.147 0 C-N-CA 124.178 0.991 . . . . 0.0 109.665 -176.826 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 33.5 mm . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 121.366 0.603 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 10.2 t -73.84 -47.74 36.23 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.194 -177.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -59.02 -60.65 3.54 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.227 0.954 . . . . 0.0 112.67 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -39.57 -53.98 2.04 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 124.19 0.996 . . . . 0.0 113.371 174.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -68.85 -37.1 78.89 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.474 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -72.15 -47.88 28.34 Favored Glycine 0 C--N 1.348 1.212 0 C-N-CA 121.818 -0.23 . . . . 0.0 112.555 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.79 -23.65 67.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.137 1.375 . . . . 0.0 111.428 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.07 -50.75 18.26 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.365 0.666 . . . . 0.0 110.071 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -63.28 -25.13 68.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.303 0.641 . . . . 0.0 111.249 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.89 -59.21 3.22 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.091 0.556 . . . . 0.0 109.99 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.3 -30.64 62.78 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.349 1.06 . . . . 0.0 112.686 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 38.4 mt -66.88 -46.27 75.45 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.855 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.41 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 7.3 p -80.5 -27.97 11.67 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 118.65 0.659 . . . . 0.0 110.369 -171.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -69.27 -27.33 65.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.561 0.744 . . . . 0.0 110.389 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 38.9 t . . . . . 0 CA--C 1.547 0.831 0 C-N-CA 123.56 0.744 . . . . 0.0 110.678 175.343 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 10.3 m -83.87 128.03 34.25 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.593 -1.185 . . . . 0.0 113.638 -165.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 33.5 tt0 -113.57 120.16 39.99 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.538 1.535 . . . . 0.0 107.445 166.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HB3' HD11 ' A' ' 177' ' ' LEU . 66.6 mtt180 -85.52 144.41 27.94 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.159 0.583 . . . . 0.0 110.536 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -158.43 -179.6 8.25 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 122.851 0.46 . . . . 0.0 111.343 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.0 mt -142.59 167.06 22.99 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 122.397 1.094 . . . . 0.0 111.36 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.14 176.81 29.48 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 113.059 -1.882 . . . . 0.0 109.494 166.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 37.0 ttm180 -132.38 122.17 24.6 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.406 ' HD2' ' OE2' ' A' ' 113' ' ' GLU . 31.0 ttt180 -131.36 128.09 38.94 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.576 0.751 . . . . 0.0 109.037 -173.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.2 m -93.21 117.86 30.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -173.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.412 HD11 ' OG1' ' A' ' 117' ' ' THR . 26.2 pt -107.36 164.96 13.69 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.577 1.551 . . . . 0.0 108.036 175.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.46 -26.96 30.12 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.091 2.528 . . . . 0.0 114.127 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.24 -20.98 60.73 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.86 0.864 . . . . 0.0 112.993 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.72 167.83 14.08 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 123.389 0.519 . . . . 0.0 111.938 -172.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.33 95.29 1.3 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.8 163.92 20.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.292 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.479 HH21 HG22 ' A' ' 178' ' ' VAL . 2.7 mpp_? -105.57 170.79 7.68 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 167.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.407 ' HB3' ' HG3' ' A' ' 113' ' ' GLU . 20.3 m -139.27 128.15 23.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.929 -170.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 2.8 pp -88.19 135.2 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 mp -121.58 111.18 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.2 mt -99.76 107.85 21.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.59 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 82.1 mtt180 -94.72 137.38 33.89 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.641 ' NE2' ' HB3' ' A' ' 133' ' ' LEU . 40.4 mt-30 -142.87 136.52 28.76 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 166.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -104.96 114.3 28.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.559 0.695 . . . . 0.0 109.453 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -96.95 131.68 43.5 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.238 1.415 . . . . 0.0 110.06 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -77.74 48.89 0.72 Allowed 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.589 1.185 . . . . 0.0 110.073 172.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.59 154.72 41.43 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.425 1.09 . . . . 0.0 108.285 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.418 ' O ' HG23 ' A' ' 37' ' ' VAL . 57.2 Cg_endo -69.46 166.44 27.22 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.745 2.297 . . . . 0.0 113.116 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 101' ' ' LEU . 59.1 t -72.17 -43.4 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.404 -174.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -56.09 -41.54 75.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 124.258 0.974 . . . . 0.0 110.341 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -66.58 -64.57 0.83 Allowed 'General case' 0 C--N 1.348 0.526 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.655 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 33' ' ' PRO . 49.1 t -50.19 -34.73 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.546 1.139 . . . . 0.0 111.315 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.42 ' HE3' HD12 ' A' ' 101' ' ' LEU . 58.5 t-105 -61.96 -57.49 11.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.601 0.76 . . . . 0.0 110.211 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.1 m -58.39 -34.13 70.39 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 123.913 0.758 . . . . 0.0 111.057 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.1 -31.23 71.98 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 174.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.473 ' HB3' HD13 ' A' ' 99' ' ' LEU . 73.7 m -90.8 -14.17 32.45 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.947 0.899 . . . . 0.0 113.152 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.4 ' O ' HD13 ' A' ' 58' ' ' LEU . 49.3 p -110.96 -47.07 3.26 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.198 0.454 . . . . 0.0 111.985 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.424 ' O ' HG13 ' A' ' 47' ' ' ILE . 18.2 t70 -66.16 125.68 90.6 Favored Pre-proline 0 N--CA 1.484 1.244 0 C-N-CA 123.495 0.718 . . . . 0.0 110.47 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.79 -30.09 68.53 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.57 2.847 . . . . 0.0 113.602 -171.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -64.76 -48.61 73.92 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 124.359 1.037 . . . . 0.0 109.073 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -58.62 -38.67 78.53 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.156 171.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.484 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 68.7 mt -71.85 -45.68 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -172.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -61.77 -20.57 63.73 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.768 0.427 . . . . 0.0 111.964 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -57.75 -48.16 80.4 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.153 0.581 . . . . 0.0 110.932 174.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.484 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 22.7 p-90 -105.68 -55.85 2.27 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.355 0.662 . . . . 0.0 111.502 -173.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.433 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 6.6 t80 -91.47 -164.25 1.15 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.087 0.555 . . . . 0.0 110.893 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.477 ' HB ' HD22 ' A' ' 66' ' ' LEU . 40.5 mt -84.57 148.1 5.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 C-N-CA 124.359 1.064 . . . . 0.0 108.358 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.81 112.31 5.96 Favored Pre-proline 0 CA--C 1.566 1.569 0 O-C-N 124.173 0.921 . . . . 0.0 110.649 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.679 ' HG2' HD11 ' A' ' 58' ' ' LEU . 90.8 Cg_endo -90.29 96.11 0.27 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.295 2.663 . . . . 0.0 112.293 -175.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -71.21 109.89 5.53 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.561 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.9 -157.56 27.69 Favored Glycine 0 C--N 1.342 0.872 0 O-C-N 123.564 0.54 . . . . 0.0 113.884 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.81 -48.32 16.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.486 1.514 . . . . 0.0 112.054 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.679 HD11 ' HG2' ' A' ' 54' ' ' PRO . 84.7 mt 63.98 25.46 13.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 124.583 1.177 . . . . 0.0 111.483 -170.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -126.31 155.1 42.51 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.44 1.096 . . . . 0.0 109.894 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.619 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 35.6 tt0 -64.55 106.51 1.17 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.437 0.695 . . . . 0.0 111.101 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.3 -35.68 3.14 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.88 -169.59 45.44 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 114.149 -1.025 . . . . 0.0 112.124 170.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 72' ' ' GLY . 9.1 p30 -144.15 177.53 8.52 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.31 0.576 . . . . 0.0 111.907 -170.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -133.16 172.46 12.63 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.921 169.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -158.3 116.95 3.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.72 0.808 . . . . 0.0 109.276 178.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.477 HD22 ' HB ' ' A' ' 52' ' ' ILE . 70.0 mt -80.94 167.2 20.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.461 0.704 . . . . 0.0 110.862 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -86.8 128.25 35.03 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.879 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.47 39.48 22.29 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.997 1.436 . . . . 0.0 116.158 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -142.2 -79.86 0.23 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' ' HD1' ' A' ' 89' ' ' TYR . . . -161.79 154.89 20.72 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.106 0.562 . . . . 0.0 110.887 -172.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.0 p -100.42 165.46 11.43 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 170.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' ASN . . . -150.65 178.41 28.1 Favored Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -147.31 142.94 27.68 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.167 0.987 . . . . 0.0 109.321 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.458 HG13 HG22 ' A' ' 85' ' ' ILE . 2.6 mp -100.78 94.64 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.54 -34.07 67.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.407 174.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.489 ' HG2' ' HB ' ' A' ' 84' ' ' THR . 7.3 ptp180 -151.48 132.87 14.62 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.044 0.45 . . . . 0.0 111.313 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 26.3 p -128.46 118.73 23.6 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 168.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -133.05 88.5 36.52 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -173.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.63 141.78 38.64 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.534 2.156 . . . . 0.0 111.553 175.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -96.91 20.82 28.63 Favored 'Cis proline' 0 C--N 1.367 1.52 0 C-N-CA 124.938 -0.859 . . . . 0.0 112.998 -4.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -75.49 -71.62 0.36 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.065 0.946 . . . . 0.0 111.974 -167.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -161.74 159.58 27.39 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.478 0.656 . . . . 0.0 110.73 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 tt -133.33 114.56 13.86 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' A' ' 76' ' ' ARG . 23.0 m -108.95 127.38 54.01 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.478 HG13 ' HB ' ' A' ' 97' ' ' VAL . 11.8 pt -123.29 150.26 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 126.723 2.009 . . . . 0.0 109.684 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.5 t -84.87 164.92 18.11 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 167.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 35.7 t-105 -144.39 94.81 2.61 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.086 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.52 101.76 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.502 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 84.8 t80 -102.69 168.06 9.5 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.059 1.344 . . . . 0.0 109.932 -173.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -56.25 103.26 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.111 0.965 . . . . 0.0 110.72 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.23 4.27 83.52 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.019 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 42.1 mmtm -134.67 75.17 63.38 Favored Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 123.916 0.886 . . . . 0.0 110.12 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.52 135.06 25.6 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.371 2.048 . . . . 0.0 112.005 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 66.39 80.71 0.22 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.516 1.126 . . . . 0.0 112.018 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.664 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 35.4 m -109.97 146.18 35.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 168.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -103.44 107.71 18.66 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.153 0.501 . . . . 0.0 111.07 -170.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.478 ' HB ' HG13 ' A' ' 85' ' ' ILE . 10.6 t -112.05 147.97 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.675 1.19 . . . . 0.0 108.413 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -150.84 142.73 23.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.084 0.554 . . . . 0.0 111.075 171.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 41' ' ' CYS . 6.7 tt -109.46 123.79 49.96 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 172.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -122.58 123.0 40.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.471 1.108 . . . . 0.0 109.556 -166.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 34' ' ' VAL . 92.7 mt -123.31 135.04 54.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.542 0.737 . . . . 0.0 110.982 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.6 m -146.87 145.22 29.77 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.191 1.396 . . . . 0.0 108.609 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.47 143.64 44.91 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.774 0.829 . . . . 0.0 109.169 168.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -150.11 111.06 4.34 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.88 -102.12 0.22 Allowed Glycine 0 C--N 1.348 1.199 0 O-C-N 123.353 0.408 . . . . 0.0 112.407 -171.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -117.11 -5.06 11.4 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.612 0.765 . . . . 0.0 110.81 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -117.63 -150.93 9.18 Favored Glycine 0 C--N 1.352 1.424 0 C-N-CA 124.24 0.924 . . . . 0.0 111.436 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.2 m -143.0 121.99 12.79 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.218 1.007 . . . . 0.0 110.227 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.7 tp -81.74 131.65 35.27 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.7 tt -118.85 109.22 15.76 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.59 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 30.6 mt-10 -111.02 105.8 14.68 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 176.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.54 HD13 HD21 ' A' ' 133' ' ' LEU . 6.2 tt -102.3 104.33 14.85 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 175.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 61.2 tt0 -93.65 128.65 39.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.475 177.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -121.88 113.32 19.46 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 170.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.39 119.53 38.9 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.157 0.983 . . . . 0.0 110.046 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.493 HG23 ' HG ' ' A' ' 122' ' ' LEU . 6.0 t -148.08 151.83 36.32 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.584 0.754 . . . . 0.0 109.71 172.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.412 ' OG1' HD11 ' A' ' 16' ' ' ILE . 1.8 m -74.25 -19.41 60.52 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.326 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 121' ' ' MET . 11.7 m -89.83 119.33 30.12 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.027 0.931 . . . . 0.0 110.778 -173.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -64.32 -40.65 96.32 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.065 0.946 . . . . 0.0 112.141 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -63.76 -55.81 20.36 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.079 0.237 . . . . 0.0 111.389 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.578 ' HB3' ' HB2' ' A' ' 118' ' ' SER . 26.1 ttt -51.15 -33.35 26.51 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.01 0.819 . . . . 0.0 112.644 175.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.493 ' HG ' HG23 ' A' ' 116' ' ' THR . 19.9 mt -64.77 -46.24 82.95 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.33 0.652 . . . . 0.0 111.669 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 127' ' ' VAL . 61.4 t -62.89 -53.11 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -44.76 -53.34 7.49 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.51 1.924 . . . . 0.0 113.335 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.8 m -78.68 -25.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 122.794 0.438 . . . . 0.0 110.697 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.22 88.1 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 170.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 123' ' ' VAL . 89.2 t -81.83 -52.66 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.402 0.681 . . . . 0.0 109.4 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.59 -59.7 9.32 Favored Glycine 0 C--N 1.341 0.816 0 O-C-N 124.42 1.075 . . . . 0.0 113.634 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -57.25 -56.34 23.03 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.073 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.04 -30.31 69.1 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 119.905 1.23 . . . . 0.0 112.294 -171.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.443 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 47.2 ttp -70.73 -44.07 67.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.045 0.938 . . . . 0.0 110.187 174.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 50' ' ' TRP . . . -63.06 -63.53 1.17 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.0 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.641 ' HB3' ' NE2' ' A' ' 28' ' ' GLN . 4.3 mm? -42.31 -38.79 1.92 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.499 1.52 . . . . 0.0 113.992 169.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 131' ' ' MET . 12.4 t70 -52.79 -50.15 64.19 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.231 0.613 . . . . 0.0 110.059 173.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -74.43 -19.84 60.26 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.342 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.406 HD13 ' CD1' ' A' ' 50' ' ' TRP . 51.3 tp -72.57 -24.53 61.12 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 169.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.73 -41.37 24.08 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 87.2 mtp -63.05 -40.75 98.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.069 0.948 . . . . 0.0 110.567 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -64.06 -56.02 18.0 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.432 0.693 . . . . 0.0 110.753 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 53.0 mt -69.42 -36.24 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 123.275 0.63 . . . . 0.0 111.725 -173.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 176.66 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 70.5 mt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.308 0.099 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.9 m -68.47 -22.7 64.55 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -80.37 -31.42 37.86 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.38 -42.54 92.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.731 0.412 . . . . 0.0 109.935 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -62.62 -60.79 3.03 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.819 0.699 . . . . 0.0 110.214 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -53.84 -58.88 10.89 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 124.232 0.957 . . . . 0.0 114.022 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.01 -20.97 65.96 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -175.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.94 -55.11 11.99 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.107 0.412 . . . . 0.0 110.663 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.38 -22.29 61.16 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.193 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -70.13 -46.74 64.12 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 123.77 0.669 . . . . 0.0 109.464 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -64.43 -33.38 75.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.098 0.559 . . . . 0.0 110.118 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 9' ' ' ARG . 47.6 mt -68.06 -61.77 1.71 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.625 173.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.479 HG22 HH21 ' A' ' 22' ' ' ARG . 9.6 p -65.04 -31.38 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.034 0.534 . . . . 0.0 112.417 -166.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -67.61 -35.24 78.57 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.721 0.808 . . . . 0.0 110.231 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.482 1.149 0 C-N-CA 123.632 0.773 . . . . 0.0 110.919 175.431 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 121.022 0.439 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.61 63.04 7.76 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.6 p -161.49 170.18 20.42 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.074 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.66 117.44 9.99 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 174.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -62.85 86.81 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.412 0.713 . . . . 0.0 109.644 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 29' ' ' ARG . . . -68.06 87.97 0.27 Allowed 'General case' 0 C--N 1.348 0.531 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.935 -167.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.6 m -88.07 131.16 34.78 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.715 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -119.16 103.6 9.68 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 171.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -83.25 132.48 35.04 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.901 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -143.92 171.36 14.34 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.893 -172.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.597 HD23 ' HB3' ' A' ' 177' ' ' LEU . 0.5 OUTLIER -138.69 165.43 26.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.943 1.297 . . . . 0.0 108.242 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.56 -162.29 30.78 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.174 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 ptt-85 -120.35 145.6 46.97 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.231 1.012 . . . . 0.0 109.91 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.467 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 12.2 tpt180 -164.27 125.85 2.26 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 20.0 m -77.04 142.2 39.97 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.884 0.474 . . . . 0.0 110.756 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.503 HD11 HG23 ' A' ' 117' ' ' THR . 16.7 pt -133.07 165.75 34.38 Favored Pre-proline 0 CA--C 1.557 1.222 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -49.02 -30.92 19.22 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 123.355 2.704 . . . . 0.0 115.377 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.401 ' H ' HG13 ' A' ' 16' ' ' ILE . . . -71.5 -37.32 71.27 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.164 0.586 . . . . 0.0 111.995 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.33 -174.95 34.84 Favored Glycine 0 N--CA 1.471 1.014 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 2.8 mp0 -71.65 93.9 1.29 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.82 167.1 22.42 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.888 0.875 . . . . 0.0 113.115 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.438 ' HB3' HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -95.17 149.12 21.65 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.339 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.0 p -134.7 130.77 36.79 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.125 0.421 . . . . 0.0 111.376 -169.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.467 HG23 HD22 ' A' ' 122' ' ' LEU . 2.7 pp -88.86 140.08 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 4.0 mp -126.86 124.27 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.442 HG22 ' HG3' ' A' ' 28' ' ' GLN . 25.6 mt -107.23 107.73 23.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 85.6 mtt180 -106.92 98.78 8.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.442 ' HG3' HG22 ' A' ' 26' ' ' ILE . 73.1 mt-30 -109.98 133.24 53.39 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.991 0.916 . . . . 0.0 109.001 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.506 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 17.5 mmt85 -87.44 127.5 35.22 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.42 0.688 . . . . 0.0 109.837 178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -120.14 135.94 54.78 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.403 1.081 . . . . 0.0 108.842 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.7 45.43 1.2 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.372 0.606 . . . . 0.0 111.557 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.07 159.03 72.54 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 124.547 1.139 . . . . 0.0 109.883 171.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.06 157.05 63.63 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.237 2.625 . . . . 0.0 113.562 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.8 t -49.15 -47.95 17.65 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.305 0 C-N-CA 124.688 1.195 . . . . 0.0 110.474 171.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -43.44 -47.3 7.02 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 125.05 1.469 . . . . 0.0 111.754 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.54 -46.46 85.89 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.071 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.3 t -76.86 -31.0 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.513 -171.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -75.29 -30.26 60.35 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.811 1.244 . . . . 0.0 109.967 -175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.6 m -65.0 -44.46 89.16 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 172.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -62.94 -38.53 91.43 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.25 0.62 . . . . 0.0 112.584 176.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.468 ' SG ' HD22 ' A' ' 99' ' ' LEU . 65.5 m -71.86 -40.57 68.88 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -175.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.3 p -104.15 -38.93 6.72 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -168.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 47' ' ' ILE . 29.3 t70 -79.03 113.35 35.1 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.812 -175.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 43' ' ' ASP . 4.3 Cg_endo -46.66 -38.55 22.34 Favored 'Trans proline' 0 C--N 1.39 2.719 0 C-N-CA 124.7 3.6 . . . . 0.0 115.227 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -66.14 -24.79 66.73 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 123.651 0.594 . . . . 0.0 110.8 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.553 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 5.8 mmp_? -91.95 -25.07 19.05 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 173.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 43' ' ' ASP . 83.1 mt -74.31 -40.71 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 118.235 0.471 . . . . 0.0 110.53 -172.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -65.37 -14.96 62.03 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.002 0.521 . . . . 0.0 111.895 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -83.18 -5.14 59.01 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.379 0.672 . . . . 0.0 111.181 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.418 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 56.7 p-90 -142.93 -15.84 0.7 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.519 0.727 . . . . 0.0 112.098 175.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.418 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 20.6 t80 -141.27 -122.53 0.1 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -173.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.4 ' HB ' HD22 ' A' ' 66' ' ' LEU . 60.8 mt -132.74 140.57 47.13 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 C-N-CA 123.404 0.681 . . . . 0.0 109.62 -167.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.405 ' HG2' ' HE2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -68.61 105.02 0.83 Allowed Pre-proline 0 CA--C 1.573 1.858 0 O-C-N 124.871 1.357 . . . . 0.0 110.239 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.17 124.1 3.24 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.655 2.237 . . . . 0.0 112.498 -172.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' HE2' ' HG2' ' A' ' 53' ' ' GLU . 74.4 mmtt -112.41 117.42 32.39 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.647 0.779 . . . . 0.0 110.304 -175.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.17 -152.18 22.7 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.672 ' HB3' ' HG2' ' A' ' 59' ' ' ARG . 8.2 m-20 -66.55 -41.86 88.01 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 124.386 0.698 . . . . 0.0 110.758 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.7 mt 59.65 22.03 10.74 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.758 1.223 . . . . 0.0 111.792 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.672 ' HG2' ' HB3' ' A' ' 57' ' ' ASP . 17.3 ptp180 -133.48 151.7 51.81 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.511 1.124 . . . . 0.0 108.862 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -66.41 135.02 53.71 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.696 0.622 . . . . 0.0 110.492 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.18 -7.2 81.01 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.588 -167.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.92 -175.73 14.97 Favored Glycine 0 C--N 1.352 1.472 0 CA-C-N 117.119 0.46 . . . . 0.0 112.641 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 11.2 p30 -109.05 171.26 7.54 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.586 0.754 . . . . 0.0 112.228 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -145.66 158.77 43.81 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.712 169.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.77 105.21 4.1 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.651 0.78 . . . . 0.0 109.514 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.4 HD22 ' HB ' ' A' ' 52' ' ' ILE . 70.4 mt -75.51 127.54 33.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -80.21 112.99 18.05 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.866 0.467 . . . . 0.0 110.564 -172.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.84 46.38 8.52 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.98 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -162.6 -83.71 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.851 0.46 . . . . 0.0 111.449 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' ' HD1' ' A' ' 89' ' ' TYR . . . -154.63 156.71 36.99 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.35 0.595 . . . . 0.0 111.017 -170.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.4 m -109.09 -175.34 2.74 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.484 173.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.75 -160.06 30.03 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 53.6 m-20 -129.48 174.22 9.84 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.24 0.616 . . . . 0.0 109.454 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.417 HG13 HG22 ' A' ' 85' ' ' ILE . 3.4 mp -110.3 116.2 51.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 86' ' ' SER . 31.6 mt -84.22 -44.47 13.88 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.927 0.891 . . . . 0.0 110.317 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.512 ' HB2' ' HB ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -143.37 155.19 44.36 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.134 1.374 . . . . 0.0 109.223 -177.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 83' ' ' LEU . 26.2 p -157.18 120.78 4.16 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 166.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -141.63 100.48 6.13 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -165.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 85.9 Cg_endo -83.84 135.25 6.61 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.754 2.303 . . . . 0.0 112.849 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 24.9 Cg_endo -100.41 29.47 12.63 Favored 'Cis proline' 0 C--N 1.376 1.976 0 CA-C-N 119.399 0.821 . . . . 0.0 112.561 -4.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -77.85 -66.97 0.77 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.992 0.917 . . . . 0.0 112.397 -168.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.499 ' HB3' ' HG3' ' A' ' 100' ' ' ARG . 16.5 ptt180 -160.86 141.31 11.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.769 0.427 . . . . 0.0 111.073 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 77' ' ' CYS . 2.2 pt? -107.72 144.04 35.39 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 163.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 76' ' ' ARG . 32.8 m -134.79 128.42 32.79 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.107 0.963 . . . . 0.0 108.701 -171.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.417 HG22 HG13 ' A' ' 74' ' ' ILE . 28.7 pt -133.35 146.49 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.451 1.1 . . . . 0.0 109.137 -175.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.477 ' HB2' HD11 ' A' ' 75' ' ' LEU . 33.3 t -96.14 139.54 32.16 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 8.4 t-105 -125.64 109.21 12.36 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.801 1.24 . . . . 0.0 107.891 -163.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.3 t -103.18 102.27 13.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.401 ' HD1' ' HB2' ' A' ' 70' ' ' ALA . 31.2 t80 -93.48 133.65 36.55 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -63.57 133.68 54.19 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.126 0.57 . . . . 0.0 111.342 -170.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.78 -45.14 3.44 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.306 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 13.2 mptt -80.55 163.0 58.69 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.714 1.206 . . . . 0.0 110.094 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 177.39 5.41 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.36 2.04 . . . . 0.0 112.376 175.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -73.31 162.57 29.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.805 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.564 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.2 m -141.51 165.21 28.13 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.579 0.752 . . . . 0.0 110.042 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -125.45 106.83 10.09 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 167.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.39 149.0 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.668 1.587 . . . . 0.0 109.004 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.17 153.08 39.43 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.07 0.462 . . . . 0.0 110.701 165.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.468 HD22 ' SG ' ' A' ' 41' ' ' CYS . 2.8 tt -114.66 128.31 56.24 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 169.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 36.8 ttt180 -138.39 137.85 37.68 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.272 1.029 . . . . 0.0 108.389 -164.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 110' ' ' LEU . 96.7 mt -129.5 132.5 46.91 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.872 0.469 . . . . 0.0 110.827 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.4 t -125.25 127.17 46.3 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 172.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -69.92 152.74 44.14 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.73 0.812 . . . . 0.0 109.014 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -167.47 79.36 0.19 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -168.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 65.16 -117.38 10.18 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 123.709 0.671 . . . . 0.0 113.306 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -91.64 32.66 1.07 Allowed 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.91 -171.9 38.06 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-O 122.001 0.778 . . . . 0.0 114.475 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.2 m -140.43 131.01 25.5 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 113.78 -1.21 . . . . 0.0 109.463 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.498 HD11 ' HB3' ' A' ' 27' ' ' ARG . 64.0 tp -82.77 106.87 14.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.468 171.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.0 tt -84.22 131.98 34.7 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 172.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 22.2 mt-10 -129.32 106.62 8.92 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -174.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.424 HD13 HD21 ' A' ' 133' ' ' LEU . 9.0 tt -115.47 126.45 54.32 Favored 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -124.66 137.83 54.34 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.528 ' HD1' ' HE1' ' A' ' 129' ' ' TRP . 7.6 t60 -131.88 114.89 15.21 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . . . -109.96 104.01 12.85 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.118 0.567 . . . . 0.0 110.972 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.433 HG23 ' HG ' ' A' ' 122' ' ' LEU . 5.3 t -124.2 156.13 37.32 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.206 0.527 . . . . 0.0 109.64 171.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.503 HG23 HD11 ' A' ' 16' ' ' ILE . 20.8 p -77.44 -18.57 57.07 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.433 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.5 t -88.49 111.85 22.3 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.333 0.653 . . . . 0.0 110.079 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.411 ' HA ' HD12 ' A' ' 122' ' ' LEU . 37.4 tt0 -62.63 -29.21 70.45 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.397 1.079 . . . . 0.0 110.878 172.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -60.35 -47.89 84.09 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.554 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.404 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 27.4 ttt -68.49 -37.62 80.27 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.787 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.467 HD22 HG23 ' A' ' 24' ' ' ILE . 37.7 mt -61.1 -38.18 85.37 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.591 0.756 . . . . 0.0 112.763 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 68.8 t -64.51 -51.78 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 O-C-N 123.392 0.432 . . . . 0.0 109.888 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -63.65 -41.8 98.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.27 0.628 . . . . 0.0 112.544 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.37 -34.56 58.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 CA-C-O 118.992 -0.528 . . . . 0.0 109.994 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.03 -32.18 74.89 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 121.389 -0.434 . . . . 0.0 112.217 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.09 -54.52 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 123.869 0.393 . . . . 0.0 110.894 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.14 -24.96 73.45 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.944 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.528 ' HE1' ' HD1' ' A' ' 114' ' ' HIS . 17.4 m95 -80.2 -49.52 11.52 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 133' ' ' LEU . 38.5 mt-10 -63.35 -23.09 67.26 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 118.415 0.552 . . . . 0.0 111.599 176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 56.4 ttp -66.46 -44.71 82.0 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.074 0.549 . . . . 0.0 109.54 170.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.62 -35.79 81.67 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.036 0.534 . . . . 0.0 111.275 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 130' ' ' GLU . 4.0 mm? -74.75 -18.38 60.5 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.6 1.16 . . . . 0.0 111.367 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -69.87 -55.26 10.23 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -66.15 -32.81 74.48 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.879 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.1 tp -75.01 -37.63 61.76 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.189 0.596 . . . . 0.0 109.931 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.5 -46.52 52.89 Favored Glycine 0 C--N 1.344 0.978 0 O-C-N 123.598 0.562 . . . . 0.0 112.925 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.0 mtp -69.23 -39.71 78.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.94 0.896 . . . . 0.0 111.205 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.62 -33.15 68.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.137 0.575 . . . . 0.0 111.345 -175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.9 mm -72.51 -63.46 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 65.0 mmt-85 -154.87 104.47 2.5 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 178.91 -52.46 0.09 OUTLIER Glycine 0 C--O 1.244 0.727 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 175.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.6 t70 141.76 127.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 127.975 2.51 . . . . 0.0 109.012 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -159.57 86.69 2.09 Favored Pre-proline 0 N--CA 1.479 1.003 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.73 -16.62 11.5 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.824 2.349 . . . . 0.0 112.434 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.42 105.02 0.22 Allowed Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -60.76 112.35 4.55 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 119.049 -0.862 . . . . 0.0 112.309 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.18 -29.21 47.61 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.919 2.413 . . . . 0.0 112.1 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.9 m -110.55 106.59 57.94 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 123.769 0.828 . . . . 0.0 109.296 173.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.2 -58.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.791 2.327 . . . . 0.0 110.989 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -147.97 80.21 1.48 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -137.73 49.0 1.99 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.2 -84.53 0.37 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 113.609 -1.632 . . . . 0.0 108.357 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -172.47 94.33 0.13 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.652 0.781 . . . . 0.0 109.449 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.75 130.48 35.37 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.665 0.786 . . . . 0.0 110.062 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 65.9 -79.78 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.028 1.331 . . . . 0.0 110.766 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -159.84 90.8 0.94 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -109.67 113.81 57.43 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.743 0.817 . . . . 0.0 108.89 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -44.76 97.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 124.011 3.14 . . . . 0.0 114.318 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.0 p -163.25 108.13 1.0 Allowed Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.751 1.22 . . . . 0.0 108.082 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -49.75 -53.88 6.35 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.997 3.132 . . . . 0.0 114.368 -168.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -63.94 -51.48 64.21 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.347 0.659 . . . . 0.0 110.577 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.2 mmt -72.96 -33.36 65.82 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.721 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 55.7 mtm -66.01 -51.48 57.9 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-O 119.123 -0.465 . . . . 0.0 109.936 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 13.3 ptm180 -63.27 -42.68 99.16 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-O 119.256 -0.402 . . . . 0.0 110.816 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.5 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 64.8 mt -63.03 -36.69 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 122.939 0.496 . . . . 0.0 111.296 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 63.7 p -75.36 -41.6 56.09 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 48.1 mt-30 -55.65 -63.7 1.09 Allowed 'General case' 0 C--O 1.2 -1.524 0 O-C-N 124.123 0.89 . . . . 0.0 110.751 172.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 38.9 mm-40 -41.76 -45.37 3.53 Favored 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 27.7 mmt85 -58.01 -48.26 80.58 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 174.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -81.51 -15.53 75.86 Favored Glycine 0 C--O 1.214 -1.128 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.581 -174.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 36.0 mm-40 -70.66 -39.42 73.59 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 117.699 0.75 . . . . 0.0 108.991 176.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.48 -58.45 7.55 Favored 'General case' 0 C--N 1.356 0.869 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.188 173.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -62.73 -28.12 69.74 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.955 0.785 . . . . 0.0 113.065 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.54 -64.11 0.94 Allowed 'General case' 0 C--N 1.353 0.724 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -46.9 -41.28 15.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.881 0.872 . . . . 0.0 112.526 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.597 ' HB3' HD23 ' A' ' 11' ' ' LEU . 51.5 mt -65.25 -40.78 94.44 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.0 p -85.66 -28.08 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.023 0.829 . . . . 0.0 109.442 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -67.71 -29.38 68.62 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.077 170.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 66.2 m -83.38 -30.81 27.09 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.23 0.612 . . . . 0.0 109.837 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -61.56 -43.19 99.62 Favored Glycine 0 C--N 1.349 1.26 0 O-C-N 124.193 0.933 . . . . 0.0 112.022 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.254 1.297 0 C-N-CA 124.768 1.227 . . . . 0.0 111.989 173.425 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.61 92.2 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.806 1.242 . . . . 0.0 111.216 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.587 ' HA ' ' HB3' ' A' ' 31' ' ' ASP . 60.7 p -74.84 86.3 2.23 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.195 0.598 . . . . 0.0 112.344 -175.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.39 108.71 2.75 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 170.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -75.36 85.76 2.51 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.421 0.689 . . . . 0.0 109.216 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.589 ' HB3' ' HB2' ' A' ' 29' ' ' ARG . . . -76.47 78.22 3.18 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.376 -171.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 m -79.52 119.02 21.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.101 0.56 . . . . 0.0 109.725 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 43.1 mt-10 -114.48 112.65 23.31 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -176.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.418 ' HB3' HD11 ' A' ' 177' ' ' LEU . 97.6 mtt180 -72.44 133.31 44.8 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.266 0.626 . . . . 0.0 109.776 171.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.66 169.69 24.12 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.743 0.652 . . . . 0.0 110.525 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -144.91 150.19 36.6 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.446 ' H ' HD13 ' A' ' 11' ' ' LEU . . . -158.8 -146.66 4.61 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 174.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -149.27 152.65 36.27 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.441 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 30.6 tpt180 -154.75 135.67 13.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.7 m -78.74 137.64 37.86 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.415 HG13 ' H ' ' A' ' 19' ' ' GLY . 41.5 pt -126.63 159.61 62.75 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 124.081 0.952 . . . . 0.0 109.925 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.32 -27.3 56.91 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.333 2.689 . . . . 0.0 113.644 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.46 -39.23 77.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.965 0.506 . . . . 0.0 111.937 175.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.415 ' H ' HG13 ' A' ' 16' ' ' ILE . . . 164.35 -146.95 11.96 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 -173.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -83.83 137.98 33.44 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.66 160.4 38.22 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.946 0.498 . . . . 0.0 110.838 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -100.49 162.59 12.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 165.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 40.7 t -141.28 133.54 28.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.375 0.27 . . . . 0.0 110.86 -167.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.489 ' HA ' HD22 ' A' ' 11' ' ' LEU . 43.5 pt -85.48 134.84 26.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mp -111.17 111.56 36.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 171.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.0 mt -103.81 104.66 17.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.559 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 87.9 mtt180 -91.01 159.86 15.92 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 122.999 0.52 . . . . 0.0 109.805 173.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 6.3 tt0 -168.92 119.68 0.74 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.227 1.58 . . . . 0.0 111.477 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.589 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 6.0 mmt180 -88.44 106.23 18.13 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.531 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 91.4 m-85 -85.42 126.56 33.89 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.525 168.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.587 ' HB3' ' HA ' ' A' ' 3' ' ' SER . 11.1 t70 -89.35 76.74 7.5 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 168.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 30' ' ' TYR . . . -179.82 139.83 0.32 Allowed Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 -157.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 85.4 Cg_endo -74.18 150.18 42.01 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.223 1.949 . . . . 0.0 113.504 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -47.78 -39.99 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.453 170.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -47.85 -49.3 29.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.393 1.058 . . . . 0.0 111.391 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 31.0 mt-10 -80.64 -29.84 36.69 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.565 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.7 t -73.13 -32.9 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 123.628 0.58 . . . . 0.0 110.631 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -81.51 -25.9 35.58 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.698 1.199 . . . . 0.0 109.753 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m -68.03 -50.16 57.01 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -60.55 -41.56 94.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.137 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.666 ' SG ' HD23 ' A' ' 99' ' ' LEU . 17.0 t -61.82 -45.18 94.94 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.4 p -104.05 -45.25 4.79 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -165.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 47' ' ' ILE . 5.5 m-20 -68.79 116.7 43.74 Favored Pre-proline 0 N--CA 1.487 1.395 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.993 -175.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.88 -34.89 23.29 Favored 'Trans proline' 0 C--N 1.388 2.627 0 C-N-CA 123.622 2.881 . . . . 0.0 113.953 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.57 -33.49 72.78 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.631 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.579 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 30.7 mmt180 -90.0 -33.37 16.39 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.172 0.989 . . . . 0.0 111.512 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 43' ' ' ASP . 71.6 mt -73.3 -36.03 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -168.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -71.67 -1.03 12.33 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.558 0.743 . . . . 0.0 112.715 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.709 ' HD2' HD23 ' A' ' 144' ' ' LEU . 0.2 OUTLIER -89.5 -48.83 7.05 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.433 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 62.7 p-90 -101.56 -16.4 16.77 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.433 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 44.0 t80 -137.64 -114.16 0.17 Allowed 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.584 0.754 . . . . 0.0 109.771 -176.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.475 HD12 HD13 ' A' ' 66' ' ' LEU . 49.4 mt -136.96 144.3 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -171.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.96 113.55 12.68 Favored Pre-proline 0 N--CA 1.485 1.295 0 O-C-N 124.801 1.313 . . . . 0.0 110.214 174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.414 ' HB2' HD21 ' A' ' 58' ' ' LEU . 60.5 Cg_endo -92.15 143.51 2.66 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.056 2.504 . . . . 0.0 111.742 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -143.9 135.93 26.5 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.99 -151.93 23.58 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -71.04 -49.1 48.6 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.414 HD21 ' HB2' ' A' ' 54' ' ' PRO . 40.7 mt 59.36 25.43 14.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 124.239 0.962 . . . . 0.0 110.602 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -122.94 148.66 45.22 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.436 1.495 . . . . 0.0 109.674 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -70.42 130.83 42.96 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.377 0.608 . . . . 0.0 109.771 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.71 -2.08 82.0 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.781 -168.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -132.24 178.03 18.3 Favored Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 8.2 p30 -117.98 178.0 4.58 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -172.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -150.85 162.39 40.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.04 0.936 . . . . 0.0 109.266 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -140.88 146.06 36.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.899 0.88 . . . . 0.0 109.513 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.475 HD13 HD12 ' A' ' 52' ' ' ILE . 86.9 mt -83.64 -89.83 0.09 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.175 0.59 . . . . 0.0 110.187 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -140.89 -57.59 0.51 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.27 9.62 0.52 Allowed Glycine 0 C--N 1.337 0.617 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.412 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.473 ' HB3' HD12 ' A' ' 66' ' ' LEU . 42.6 t-20 -77.37 -85.07 0.06 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.3 158.58 43.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.703 0.763 . . . . 0.0 112.134 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 81.5 p -132.96 147.98 52.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.421 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.04 171.66 44.56 Favored Glycine 0 N--CA 1.464 0.502 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 24.9 m-20 -85.78 171.35 11.65 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.479 0.657 . . . . 0.0 111.298 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.23 119.53 59.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 168.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 84' ' ' THR . 59.0 mt -84.63 -38.4 19.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.005 0.522 . . . . 0.0 110.622 -176.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -166.18 111.54 0.83 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.493 0.717 . . . . 0.0 109.61 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 10.6 p -107.3 103.1 12.38 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -99.94 102.17 16.63 Favored Pre-proline 0 N--CA 1.482 1.125 0 C-N-CA 124.132 0.973 . . . . 0.0 110.521 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 96.6 Cg_endo -80.66 129.55 7.34 Favored 'Trans proline' 0 CA--C 1.564 2.013 0 C-N-CA 122.786 2.324 . . . . 0.0 112.896 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.56 ' HD2' HH11 ' A' ' 81' ' ' ARG . 16.1 Cg_endo -103.84 33.37 6.97 Favored 'Cis proline' 0 C--N 1.38 2.193 0 CA-C-N 119.802 0.965 . . . . 0.0 112.783 -10.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.56 HH11 ' HD2' ' A' ' 80' ' ' PRO . 3.7 mpt_? -65.93 -69.24 0.31 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.923 0.889 . . . . 0.0 110.437 -176.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.9 ptt-85 -161.86 154.68 20.29 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.322 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.553 ' H ' HD23 ' A' ' 83' ' ' LEU . 1.8 pt? -107.04 146.61 30.96 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 167.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 75' ' ' LEU . 94.1 m -131.53 121.83 25.11 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.664 1.585 . . . . 0.0 107.167 -176.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.9 pt -141.58 142.99 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.779 0.832 . . . . 0.0 109.464 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.9 t -88.84 137.66 32.12 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 169.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -123.7 102.83 8.04 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.4 t -99.18 101.48 12.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -93.77 146.19 24.05 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.463 172.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -62.05 121.78 13.87 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.693 0.797 . . . . 0.0 111.331 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.82 19.65 61.09 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.323 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.46 ' HD2' ' HB2' ' A' ' 121' ' ' MET . 72.8 mmtt -132.4 147.89 67.47 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 123.917 0.887 . . . . 0.0 109.754 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.27 149.8 64.19 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.781 2.321 . . . . 0.0 111.418 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -59.8 116.61 4.21 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.872 0.869 . . . . 0.0 111.818 -169.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.8 m -90.59 160.76 15.76 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.554 -172.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -104.25 140.66 37.53 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.275 1.03 . . . . 0.0 108.361 166.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 54.2 t -138.14 118.37 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -126.46 111.87 14.94 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.666 HD23 ' SG ' ' A' ' 41' ' ' CYS . 38.2 tp -96.91 119.58 35.65 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.5 ttp-105 -127.14 114.57 17.88 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.618 0.767 . . . . 0.0 109.285 -160.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.1 mt -104.77 153.79 20.86 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.464 0.706 . . . . 0.0 110.564 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.6 m -141.85 123.01 14.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.784 0.834 . . . . 0.0 109.859 170.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -83.34 106.31 15.0 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -120.32 80.26 1.58 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.411 1.084 . . . . 0.0 110.238 -174.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.56 -103.18 1.82 Allowed Glycine 0 C--N 1.35 1.31 0 C-N-CA 122.96 0.314 . . . . 0.0 112.539 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -106.47 5.08 28.99 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.416 0.686 . . . . 0.0 109.291 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.32 163.29 12.42 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.39 -172.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 m -140.16 112.83 8.01 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.627 1.171 . . . . 0.0 108.438 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.8 tp -80.74 107.75 13.82 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.1 tt -90.66 131.46 36.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 172.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.545 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 43.9 mt-10 -132.9 109.22 9.44 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.5 tt -95.26 121.2 36.66 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 4.8 tp10 -112.6 102.7 10.76 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.471 ' HB3' HG12 ' A' ' 24' ' ' ILE . 6.5 t60 -114.58 112.67 23.29 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.441 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . . . -114.28 107.68 15.91 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.404 1.082 . . . . 0.0 110.189 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.506 HG23 ' HG ' ' A' ' 122' ' ' LEU . 5.1 t -127.64 156.03 42.96 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.663 0.744 . . . . 0.0 110.528 174.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -23.77 58.87 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.196 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.1 t -91.19 115.89 28.38 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.236 1.015 . . . . 0.0 110.795 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -69.93 -25.58 63.73 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.758 0.823 . . . . 0.0 110.942 175.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -63.45 -47.76 80.53 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.528 171.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.46 ' HB2' ' HD2' ' A' ' 92' ' ' LYS . 23.3 ttt -67.58 -33.61 75.36 Favored 'General case' 0 C--O 1.204 -1.342 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.114 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.506 ' HG ' HG23 ' A' ' 116' ' ' THR . 19.7 mt -63.06 -43.87 97.42 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.255 0.622 . . . . 0.0 112.045 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 127' ' ' VAL . 89.3 t -63.78 -42.23 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.954 173.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.65 -44.99 76.58 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.582 1.153 . . . . 0.0 111.807 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.0 m -79.65 -18.84 12.6 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.565 0 C-N-CA 123.37 0.668 . . . . 0.0 109.505 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.49 -34.09 89.02 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 166.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 123' ' ' VAL . 48.7 t -75.6 -50.76 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.97 -33.48 79.45 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 114.676 0.63 . . . . 0.0 114.676 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -86.04 -41.02 15.17 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 118.88 -0.581 . . . . 0.0 109.703 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.71 -34.05 76.35 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 118.91 0.777 . . . . 0.0 109.604 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 53.4 ttm -60.83 -50.13 74.67 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.837 0.855 . . . . 0.0 109.74 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.52 90.79 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.739 0.816 . . . . 0.0 112.154 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.16 -21.51 33.52 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.518 0.727 . . . . 0.0 111.6 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.65 -44.4 70.66 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 172.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -72.7 -35.82 67.7 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.166 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 29.1 tp -70.43 -38.66 74.61 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.824 0.45 . . . . 0.0 110.557 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.01 -52.77 50.21 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.744 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 31.1 ttp -61.75 -38.89 89.68 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.121 0.568 . . . . 0.0 110.799 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -57.16 -56.69 18.57 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.857 1.263 . . . . 0.0 111.042 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 58.9 mt -72.46 -19.19 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.8 0.84 . . . . 0.0 111.145 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.03 -39.37 69.17 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 173.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.58 -50.81 0.3 Allowed Glycine 0 C--N 1.356 1.685 0 C-N-CA 121.474 -0.393 . . . . 0.0 113.985 175.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -105.26 170.73 7.71 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.452 0.701 . . . . 0.0 110.669 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.709 HD23 ' HD2' ' A' ' 49' ' ' ARG . 20.2 tp -159.07 77.79 3.05 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 122.544 0.338 . . . . 0.0 110.626 168.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -101.79 172.94 0.27 Allowed 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 123.436 2.757 . . . . 0.0 113.023 165.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.77 77.63 1.98 Allowed Glycine 0 C--N 1.343 0.919 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 165.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -66.47 -80.67 0.17 Allowed Glycine 0 C--N 1.348 1.228 0 CA-C-O 119.242 -0.754 . . . . 0.0 113.557 -173.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.45 -45.41 11.73 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.232 2.621 . . . . 0.0 112.236 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.452 HG11 ' HB2' ' A' ' 153' ' ' ALA . 14.2 m -78.89 121.32 83.28 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.666 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -82.39 -23.89 3.98 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.927 2.418 . . . . 0.0 113.168 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -83.43 -73.31 0.42 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.787 0.835 . . . . 0.0 110.792 -168.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -175.74 -39.45 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.141 -174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.452 ' HB2' HG11 ' A' ' 149' ' ' VAL . . . 67.38 47.8 1.23 Allowed 'General case' 0 C--N 1.352 0.708 0 C-N-CA 125.117 1.367 . . . . 0.0 110.173 -174.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.67 -91.47 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.435 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -158.69 -172.16 3.72 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.002 1.321 . . . . 0.0 109.231 -166.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 56.72 -91.13 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.993 1.717 . . . . 0.0 112.262 169.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -172.04 121.68 0.47 Allowed 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.587 1.155 . . . . 0.0 108.18 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.413 ' HA ' ' HD2' ' A' ' 159' ' ' PRO . 21.6 mt-10 -108.52 112.26 60.89 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.653 1.181 . . . . 0.0 108.607 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 158' ' ' GLU . 19.6 Cg_endo -57.35 93.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 122.86 2.374 . . . . 0.0 111.748 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 29.8 t -165.04 119.11 0.96 Allowed Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.5 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.74 -38.74 91.53 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.617 2.211 . . . . 0.0 112.193 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -68.97 -49.7 55.57 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.942 0.497 . . . . 0.0 111.517 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.19 -43.14 74.79 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -173.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -64.13 -35.23 80.1 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 36.5 ttp180 -67.05 -43.25 83.21 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.401 0.68 . . . . 0.0 111.562 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 12.2 tt -76.14 -28.89 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 122.428 0.291 . . . . 0.0 111.39 -176.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.9 p -77.78 -40.91 39.2 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -54.63 -59.03 5.26 Favored 'General case' 0 C--O 1.206 -1.211 0 O-C-N 123.922 0.764 . . . . 0.0 110.664 166.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -41.44 -49.58 3.9 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.153 1.381 . . . . 0.0 112.437 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -56.59 -55.79 29.54 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.007 0.523 . . . . 0.0 110.385 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.42 -17.52 79.11 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 120.032 -0.316 . . . . 0.0 113.435 -168.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -82.23 -29.07 31.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.023 0.929 . . . . 0.0 110.042 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.52 -53.67 17.96 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.78 0.832 . . . . 0.0 109.503 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -69.1 -25.87 64.64 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.846 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.04 -60.53 3.32 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 172.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.16 12.52 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.662 1.185 . . . . 0.0 112.911 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 78.1 mt -68.7 -46.25 69.48 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.096 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.03 -23.74 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.115 0.871 . . . . 0.0 110.682 -166.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -70.39 -25.25 63.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.424 0.69 . . . . 0.0 110.072 171.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.0 m -96.08 12.35 30.94 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.059 0.944 . . . . 0.0 110.692 172.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -69.45 -46.67 54.88 Favored Glycine 0 C--N 1.356 1.654 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.473 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.555 1.147 0 CA-C-O 118.355 -0.831 . . . . 0.0 109.268 173.975 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.48 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.32 120.93 28.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.605 1.162 . . . . 0.0 110.989 -172.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.8 m -151.86 2.11 0.37 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.05 0.94 . . . . 0.0 111.623 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.19 42.97 1.17 Allowed Glycine 0 C--N 1.343 0.953 0 N-CA-C 112.027 -0.429 . . . . 0.0 112.027 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.9 32.01 1.27 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.952 0.501 . . . . 0.0 111.455 -175.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.67 71.52 7.56 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.226 174.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 85.6 m -85.81 122.25 29.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.628 -176.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -124.6 112.06 16.37 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.571 1.548 . . . . 0.0 107.596 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.27 159.54 31.39 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.8 173.26 10.82 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.504 0.722 . . . . 0.0 109.095 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -145.32 154.86 42.78 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -177.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.459 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -162.47 -153.95 7.37 Favored Glycine 0 C--O 1.238 0.404 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.4 ptt85 -157.1 160.28 38.7 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.211 0.604 . . . . 0.0 110.129 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -168.53 162.42 12.1 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.917 171.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.1 m -96.37 144.03 26.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.763 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 117' ' ' THR . 42.5 pt -135.5 162.31 57.95 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.933 1.293 . . . . 0.0 108.497 -174.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.97 -35.37 31.76 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.568 2.845 . . . . 0.0 114.767 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.07 -42.83 99.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.647 0.779 . . . . 0.0 111.779 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.06 -149.05 18.28 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.66 139.27 38.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 117.314 0.557 . . . . 0.0 109.622 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.12 158.55 44.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.295 0.569 . . . . 0.0 111.479 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -97.11 161.37 13.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 165.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 78.4 p -138.48 124.56 20.17 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.508 HG12 HG23 ' A' ' 125' ' ' VAL . 2.6 pp -86.61 131.0 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mp -113.19 119.58 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.0 mt -105.65 111.03 33.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 61.3 mtt180 -92.18 140.85 29.21 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 123.364 0.415 . . . . 0.0 110.335 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.671 HE22 HD22 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -137.33 139.6 40.94 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 167.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.491 HH12 ' HA3' ' A' ' 107' ' ' GLY . 24.6 tpt85 -107.83 102.79 11.97 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.434 ' HE1' ' HA2' ' A' ' 137' ' ' GLY . 63.1 m-85 -85.95 144.46 27.62 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.931 1.292 . . . . 0.0 110.929 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.527 ' HB3' ' HD3' ' A' ' 141' ' ' ARG . 26.5 t70 -87.82 26.44 1.33 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 123.807 0.692 . . . . 0.0 110.696 170.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.27 155.09 68.79 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 124.049 0.94 . . . . 0.0 110.604 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.38 156.63 59.0 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.549 2.833 . . . . 0.0 113.174 175.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 101' ' ' LEU . 11.3 t -59.97 -42.51 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 O-C-N 124.473 1.108 . . . . 0.0 110.628 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -48.66 -52.05 25.29 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 125.107 1.504 . . . . 0.0 109.88 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -64.92 -62.87 1.3 Allowed 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.65 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.533 HG22 HD13 ' A' ' 140' ' ' ILE . 62.9 t -46.54 -39.09 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 C-N-CA 124.697 1.199 . . . . 0.0 112.248 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -65.93 -41.16 91.73 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.114 0.966 . . . . 0.0 110.316 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.4 m -69.78 -25.79 63.97 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 123.469 0.48 . . . . 0.0 110.512 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.56 -47.91 21.02 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.527 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.459 ' HB3' HD21 ' A' ' 99' ' ' LEU . 84.7 m -75.82 -16.9 60.02 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 43.7 p -101.63 -33.22 9.98 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 118.403 0.547 . . . . 0.0 111.66 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 47' ' ' ILE . 19.9 t70 -83.45 112.41 39.12 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 122.75 0.42 . . . . 0.0 110.004 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.484 ' HB2' ' HG3' ' A' ' 53' ' ' GLU . 58.4 Cg_endo -64.46 -27.34 62.37 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.151 2.568 . . . . 0.0 112.869 -171.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -63.9 -39.34 93.95 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.758 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -79.48 -24.29 42.44 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.59 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 43' ' ' ASP . 79.1 mt -74.82 -38.5 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.59 0.356 . . . . 0.0 111.52 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 10.9 p30 -73.87 -0.42 15.94 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -73.26 -29.94 63.09 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.768 0.827 . . . . 0.0 110.714 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 40.7 p-90 -129.31 -11.7 4.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.015 0.926 . . . . 0.0 111.484 -171.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.457 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 16.2 t80 -147.96 -163.72 1.84 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.525 0.73 . . . . 0.0 109.13 -174.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 mt -87.1 171.34 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 31.3 tt0 -108.63 121.51 43.05 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.668 1.187 . . . . 0.0 110.12 -172.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.69 84.69 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.337 2.691 . . . . 0.0 111.0 173.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -77.47 126.22 30.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.989 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.22 -165.89 36.8 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.633 -0.318 . . . . 0.0 112.722 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.84 -37.96 73.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.443 0.697 . . . . 0.0 110.279 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.0 mt 59.22 -171.37 0.12 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.922 1.289 . . . . 0.0 111.885 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 72.59 166.64 0.3 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.882 1.273 . . . . 0.0 110.598 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 41.3 tt0 -60.02 111.7 1.6 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.165 0.586 . . . . 0.0 111.149 -173.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.08 11.52 58.61 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.436 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.34 -146.56 20.36 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.65 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 29.8 p-10 -156.0 160.42 40.03 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 117.571 0.685 . . . . 0.0 111.705 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -140.07 147.91 40.99 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.72 112.17 5.28 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.756 0.823 . . . . 0.0 109.884 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 69' ' ' ASN . 79.1 mt -78.39 146.89 34.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.706 0.802 . . . . 0.0 109.262 172.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -69.41 122.07 18.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.551 0.74 . . . . 0.0 110.631 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 56.69 40.9 89.45 Favored Glycine 0 C--N 1.341 0.815 0 O-C-N 124.29 0.994 . . . . 0.0 114.468 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 66' ' ' LEU . 18.4 t-20 -147.17 -84.27 0.11 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.704 0.252 . . . . 0.0 110.402 -171.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.35 151.03 31.19 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.98 0.419 . . . . 0.0 111.707 -171.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -132.0 145.25 51.34 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.224 1.009 . . . . 0.0 109.796 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.19 -163.08 26.99 Favored Glycine 0 C--O 1.241 0.548 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.65 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 4.8 p-10 -127.04 173.89 9.3 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.158 0.479 . . . . 0.0 110.731 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.475 ' HA ' HG22 ' A' ' 85' ' ' ILE . 19.6 mm -97.49 102.8 13.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.53 -47.84 71.62 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -167.66 142.52 3.76 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.794 169.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 22.0 p -127.36 106.24 9.07 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.64 99.47 8.84 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 9.9 Cg_exo -74.56 137.81 23.3 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.147 2.565 . . . . 0.0 112.984 -176.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 42.7 Cg_endo -100.83 30.53 11.11 Favored 'Cis proline' 0 C--N 1.375 1.932 0 CA-C-N 119.481 0.85 . . . . 0.0 112.153 -9.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -71.34 -69.43 0.38 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.285 1.034 . . . . 0.0 111.998 -170.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -152.95 146.9 25.36 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.417 0.627 . . . . 0.0 111.452 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 99' ' ' LEU . 58.1 tp -98.31 143.99 28.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.702 -1.136 . . . . 0.0 107.954 169.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.9 m -134.79 123.34 23.42 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.475 HG22 ' HA ' ' A' ' 74' ' ' ILE . 21.0 pt -143.74 149.56 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.619 0.768 . . . . 0.0 110.285 -174.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 p -88.16 138.51 31.38 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 36.8 t-105 -130.2 101.02 5.61 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -170.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -107.91 102.46 14.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -78.74 154.85 29.68 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.63 111.04 1.45 Allowed 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.065 0.46 . . . . 0.0 111.784 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.04 21.99 66.75 Favored Glycine 0 C--N 1.351 1.361 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.375 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.463 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 69.0 mmtt -126.48 153.14 75.08 Favored Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 123.711 0.805 . . . . 0.0 109.593 -175.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.519 ' HG2' ' HB2' ' A' ' 118' ' ' SER . 23.4 Cg_exo -64.72 162.5 31.39 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.962 2.441 . . . . 0.0 113.506 -177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.93 103.59 1.18 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.962 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -100.46 179.29 4.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.824 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -142.42 128.81 20.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.974 0.909 . . . . 0.0 108.634 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.6 t -113.66 121.46 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 121.241 0.544 . . . . 0.0 110.292 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 37.7 mm-40 -91.41 138.66 31.4 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.906 165.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 83' ' ' LEU . 55.0 tp -127.63 110.57 12.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 171.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -128.97 121.91 29.0 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 122.151 -0.343 . . . . 0.0 110.385 -160.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HB3' HG22 ' A' ' 34' ' ' VAL . 90.0 mt -115.61 141.28 48.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.645 0.778 . . . . 0.0 111.233 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.4 t -144.51 115.24 7.74 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.523 1.129 . . . . 0.0 108.791 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -81.96 120.45 25.25 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -129.39 121.81 28.14 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.301 1.44 . . . . 0.0 108.129 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.93 -135.28 16.44 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -102.63 62.57 0.84 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 165.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.491 ' HA3' HH12 ' A' ' 29' ' ' ARG . . . -179.24 -177.79 47.9 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.101 -0.954 . . . . 0.0 114.408 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.3 m -134.26 141.33 46.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.311 1.044 . . . . 0.0 110.081 -170.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.9 tp -102.27 112.98 25.9 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 169.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.671 HD22 HE22 ' A' ' 28' ' ' GLN . 7.3 tt -95.89 134.61 38.67 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 173.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.577 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 39.8 mt-10 -132.69 106.28 7.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.642 HD13 HD21 ' A' ' 133' ' ' LEU . 8.9 tt -98.27 122.05 40.96 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 98' ' ' GLU . 38.7 tt0 -122.01 100.78 7.16 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.807 0.843 . . . . 0.0 109.28 -172.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 23' ' ' SER . 8.3 t60 -99.29 113.77 26.25 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 22' ' ' ARG . . . -104.38 111.74 24.51 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.714 1.206 . . . . 0.0 111.095 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.454 HG23 ' HG ' ' A' ' 122' ' ' LEU . 10.6 t -136.99 160.76 37.97 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 170.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.433 HG23 HD11 ' A' ' 16' ' ' ILE . 66.8 p -86.13 -15.08 42.24 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.582 1.153 . . . . 0.0 111.489 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.519 ' HB2' ' HG2' ' A' ' 93' ' ' PRO . 46.4 t -87.17 108.98 19.15 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.062 0.545 . . . . 0.0 109.797 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.507 ' HA ' HD12 ' A' ' 122' ' ' LEU . 39.7 tt0 -62.03 -31.04 71.4 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.787 0.835 . . . . 0.0 110.796 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -61.24 -58.05 9.88 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.158 175.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.463 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 24.3 ttt -64.16 -26.92 68.74 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.706 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 119' ' ' GLU . 13.8 mt -65.15 -44.6 88.05 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.463 0.705 . . . . 0.0 111.864 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.89 -45.44 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.256 0.551 . . . . 0.0 109.81 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -56.79 -50.5 72.14 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.042 1.337 . . . . 0.0 112.081 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.508 HG23 HG12 ' A' ' 24' ' ' ILE . 35.8 m -72.03 -29.37 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.876 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.7 -38.23 91.36 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 172.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.469 ' O ' ' HG2' ' A' ' 131' ' ' MET . 59.6 t -75.69 -59.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.051 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.63 -37.04 94.15 Favored Glycine 0 C--N 1.345 1.038 0 O-C-N 123.725 0.64 . . . . 0.0 114.446 -172.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.473 ' HB2' ' O ' ' A' ' 125' ' ' VAL . 10.7 m95 -67.05 -53.38 31.68 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -57.76 -31.47 66.53 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.156 0.285 . . . . 0.0 110.746 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 95.7 mmm -61.48 -48.45 81.06 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.204 0.602 . . . . 0.0 110.331 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.31 -38.96 85.32 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.26 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.642 HD21 HD13 ' A' ' 112' ' ' LEU . 2.8 mm? -77.37 -19.88 55.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.985 0.514 . . . . 0.0 111.731 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 138' ' ' MET . 72.0 m-20 -66.82 -53.5 32.08 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 170.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.448 ' HB3' ' HB2' ' A' ' 50' ' ' TRP . 68.9 m-85 -72.59 -25.4 61.31 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.749 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.402 HD13 ' CZ2' ' A' ' 50' ' ' TRP . 59.1 tp -70.39 -39.21 74.64 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.434 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -58.14 -39.41 92.19 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.615 171.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 89.3 mmm -70.22 -38.16 75.17 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.531 0.732 . . . . 0.0 110.183 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -69.01 -37.26 78.57 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.2 1.0 . . . . 0.0 111.276 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.533 HD13 HG22 ' A' ' 37' ' ' VAL . 50.5 mt -80.03 -57.42 5.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 123.338 0.655 . . . . 0.0 110.193 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.527 ' HD3' ' HB3' ' A' ' 31' ' ' ASP . 21.2 ttt180 -163.42 69.52 0.21 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.709 0.766 . . . . 0.0 110.179 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -154.41 4.35 0.27 Allowed Glycine 0 CA--C 1.527 0.787 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.107 172.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 65.94 94.77 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.804 1.242 . . . . 0.0 111.268 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.22 121.83 62.37 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 124.467 1.107 . . . . 0.0 110.463 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.49 92.7 0.35 Allowed 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.01 2.473 . . . . 0.0 111.464 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.62 88.67 1.38 Allowed Glycine 0 C--O 1.242 0.615 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.872 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.72 -129.82 1.23 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-O 118.882 -0.955 . . . . 0.0 111.818 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.22 -19.01 39.25 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.694 2.263 . . . . 0.0 113.037 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.9 t 65.69 127.98 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 C-N-CA 125.584 1.553 . . . . 0.0 110.098 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -41.71 -58.53 1.11 Allowed 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 124.278 3.319 . . . . 0.0 114.749 -171.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.464 ' HG2' ' H ' ' A' ' 153' ' ' ALA . 0.0 OUTLIER -109.4 -18.03 13.65 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.9 0.88 . . . . 0.0 110.563 179.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.9 t70 67.54 7.58 5.72 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.932 1.293 . . . . 0.0 112.037 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.464 ' H ' ' HG2' ' A' ' 151' ' ' GLU . . . 56.33 23.89 7.74 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.892 1.277 . . . . 0.0 111.962 -172.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.69 170.97 8.83 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.893 0.877 . . . . 0.0 111.324 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -93.34 70.39 4.36 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 122.6 1.19 . . . . 0.0 110.169 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -105.5 79.51 1.47 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.071 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -76.51 84.0 3.21 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.146 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 44.0 mt-10 -118.61 147.63 42.47 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.58 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.534 ' HA ' ' SD ' ' A' ' 164' ' ' MET . 5.1 Cg_exo -79.97 38.33 0.74 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.594 2.863 . . . . 0.0 114.04 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.2 m -66.49 105.55 0.86 Allowed Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.506 0.723 . . . . 0.0 109.258 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -57.2 -35.94 98.99 Favored 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 123.249 2.632 . . . . 0.0 114.019 -165.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.82 -54.0 22.5 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 6.7 tpt -62.75 -37.61 87.28 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.028 0.531 . . . . 0.0 110.835 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.534 ' SD ' ' HA ' ' A' ' 159' ' ' PRO . 88.8 mtp -60.79 -55.51 32.23 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.969 0.507 . . . . 0.0 109.844 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -58.14 -49.66 76.21 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 123.912 0.757 . . . . 0.0 111.071 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 61.8 mt -55.59 -47.61 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.254 0.622 . . . . 0.0 110.943 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 62.2 p -70.69 -39.76 73.32 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.235 0.334 . . . . 0.0 110.52 -171.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -59.7 -59.7 5.02 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.293 170.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -43.17 -36.75 1.82 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 172.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -64.77 -52.36 57.35 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.248 0.619 . . . . 0.0 110.733 175.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.25 -20.01 75.92 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.264 -174.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -81.37 -28.17 34.54 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.63 1.172 . . . . 0.0 110.088 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.25 -48.76 55.44 Favored 'General case' 0 C--N 1.345 0.39 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -69.05 -23.1 64.01 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.035 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.01 -61.08 2.24 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 173.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -47.11 -47.1 23.32 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.837 1.255 . . . . 0.0 112.733 172.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 56.6 mt -64.83 -46.51 81.61 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.592 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.9 p -74.57 -26.94 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 118.867 0.758 . . . . 0.0 109.953 -169.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -76.29 -10.09 59.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.64 0.776 . . . . 0.0 111.583 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.6 t -85.69 -21.89 28.11 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.593 0.757 . . . . 0.0 109.54 168.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -80.65 -41.78 10.73 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.446 172.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.247 0.938 0 C-N-CA 124.5 1.12 . . . . 0.0 108.063 176.564 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.05 98.04 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.978 1.311 . . . . 0.0 110.923 -176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.3 m -128.95 103.47 7.04 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.594 0.757 . . . . 0.0 109.9 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.76 80.74 1.31 Allowed Glycine 0 C--N 1.345 1.038 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 61.94 68.53 0.68 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.359 1.064 . . . . 0.0 110.749 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.51 75.34 4.06 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.382 0.611 . . . . 0.0 110.645 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 m -89.11 130.92 35.47 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.824 0.85 . . . . 0.0 111.161 -173.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 19.8 mt-10 -119.16 109.13 15.52 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 173.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -82.48 136.13 34.97 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.047 0.539 . . . . 0.0 110.259 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.13 179.44 9.23 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 123.843 0.714 . . . . 0.0 110.144 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 178' ' ' VAL . 0.2 OUTLIER -143.61 148.46 35.89 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -133.55 166.28 23.91 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.516 ' HD3' ' H ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -110.33 148.53 31.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.624 ' HG2' ' HB1' ' A' ' 115' ' ' ALA . 6.5 tpt180 -148.33 150.3 33.35 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.206 0.527 . . . . 0.0 112.134 -164.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 87.3 m -111.13 137.9 48.22 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 161.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 pt -140.03 159.77 63.01 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -51.1 -26.59 19.62 Favored 'Trans proline' 0 C--N 1.386 2.549 0 C-N-CA 123.065 2.51 . . . . 0.0 114.294 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.71 -44.81 63.52 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.029 0.532 . . . . 0.0 111.307 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.43 -151.21 21.71 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.071 0.232 . . . . 0.0 112.609 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -73.75 123.14 23.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.409 0.684 . . . . 0.0 109.644 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.03 166.95 19.07 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.542 0.737 . . . . 0.0 111.205 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -125.15 171.78 10.03 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 162.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.9 m -134.45 135.67 42.67 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.289 0.636 . . . . 0.0 109.797 -170.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.537 HG12 ' HB3' ' A' ' 114' ' ' HIS . 35.4 pt -85.91 133.69 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 168.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.661 HG13 ' HG2' ' A' ' 113' ' ' GLU . 2.0 mp -110.57 111.8 37.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 174.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.407 HD12 ' HB3' ' A' ' 129' ' ' TRP . 39.5 mt -107.29 106.65 21.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 168.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.521 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 28.4 mtt180 -89.74 161.19 16.18 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.547 174.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 110' ' ' LEU . 4.2 tp-100 -162.11 117.88 1.98 Allowed 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.337 -174.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.402 ' HE ' HD13 ' A' ' 109' ' ' LEU . 26.3 mmt85 -95.4 105.68 17.67 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 165.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.553 ' HB2' ' HB ' ' A' ' 108' ' ' THR . 50.3 m-85 -87.58 150.7 23.53 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 123.857 0.863 . . . . 0.0 109.398 169.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -114.66 85.74 2.3 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 162.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 179.71 137.45 0.28 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.932 2.093 . . . . 0.0 105.617 -163.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.46 137.07 78.37 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.76 2.307 . . . . 0.0 113.286 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 108' ' ' THR . 54.3 t -48.99 -40.47 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 124.329 1.018 . . . . 0.0 110.528 167.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -48.88 -45.48 41.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 124.474 1.109 . . . . 0.0 111.308 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.11 -25.64 34.27 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.459 HG22 HD13 ' A' ' 140' ' ' ILE . 50.6 t -72.29 -44.18 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.074 0.464 . . . . 0.0 110.359 174.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -68.51 -28.02 66.64 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.593 1.157 . . . . 0.0 109.726 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.5 t -65.79 -48.27 72.35 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.932 0.893 . . . . 0.0 109.928 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.23 -28.41 63.14 Favored 'General case' 0 C--N 1.351 0.633 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.338 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.3 t -76.95 -24.39 52.35 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.6 p -111.18 -43.01 3.8 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -172.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.435 ' O ' HG13 ' A' ' 47' ' ' ILE . 15.0 t70 -76.66 120.07 80.11 Favored Pre-proline 0 N--CA 1.483 1.22 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.917 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.1 -46.54 30.42 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.903 3.069 . . . . 0.0 114.391 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.436 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 41.3 t-20 -58.65 -32.64 69.26 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.768 0.827 . . . . 0.0 111.314 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -89.82 -20.06 23.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.219 0.608 . . . . 0.0 111.217 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 43' ' ' ASP . 85.7 mt -75.99 -42.67 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.059 0.544 . . . . 0.0 110.331 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' A' ' 45' ' ' ASN . 10.6 p30 -69.78 -0.89 7.86 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -172.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -91.82 -11.06 37.63 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.365 0.666 . . . . 0.0 110.246 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.447 ' CE2' HD13 ' A' ' 136' ' ' LEU . 57.9 p-90 -137.17 -25.21 1.07 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.3 1.04 . . . . 0.0 111.338 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.439 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 5.1 t80 -130.66 -160.66 1.06 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.329 1.052 . . . . 0.0 108.523 -177.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.62 143.64 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 122.833 0.453 . . . . 0.0 110.661 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -63.6 115.06 15.59 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 124.753 1.283 . . . . 0.0 109.767 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HG3' HD12 ' A' ' 47' ' ' ILE . 83.9 Cg_endo -83.07 148.06 13.25 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.446 2.097 . . . . 0.0 112.877 178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -134.96 125.87 27.49 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.61 -175.45 39.82 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 121.507 -0.377 . . . . 0.0 112.902 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.8 -44.06 86.82 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.177 0.574 . . . . 0.0 110.307 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.6 mt 66.95 5.15 3.88 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.133 1.373 . . . . 0.0 113.126 171.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -103.71 168.1 9.36 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.297 0.639 . . . . 0.0 109.917 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 77' ' ' CYS . 31.2 mt-10 -58.56 122.76 14.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.746 0.819 . . . . 0.0 110.794 176.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.35 13.94 77.57 Favored Glycine 0 N--CA 1.469 0.862 0 CA-C-N 116.467 -0.333 . . . . 0.0 113.112 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.95 -168.17 19.03 Favored Glycine 0 C--N 1.348 1.197 0 N-CA-C 112.299 -0.32 . . . . 0.0 112.299 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -117.31 167.24 11.41 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.564 0.746 . . . . 0.0 110.095 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -146.95 149.4 33.11 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -142.15 116.3 9.44 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.203 0.601 . . . . 0.0 111.032 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.403 ' HB2' ' H ' ' A' ' 70' ' ' ALA . 60.3 mt -91.7 133.58 35.46 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.672 1.189 . . . . 0.0 109.3 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -68.23 106.08 2.32 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.565 1.146 . . . . 0.0 110.0 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.81 40.55 84.94 Favored Glycine 0 C--N 1.348 1.206 0 N-CA-C 114.385 0.514 . . . . 0.0 114.385 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -144.54 -86.77 0.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.579 0.352 . . . . 0.0 110.128 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 66' ' ' LEU . . . -147.69 156.31 42.64 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 120.773 0.321 . . . . 0.0 111.631 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.1 m -131.0 143.21 50.55 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.222 1.009 . . . . 0.0 108.538 174.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.93 -153.81 8.09 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.425 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 2.4 m-20 -121.36 171.07 9.02 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.771 0.828 . . . . 0.0 109.828 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.47 ' HA ' HG22 ' A' ' 85' ' ' ILE . 3.5 mp -108.24 112.65 41.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 170.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.599 HD12 HG22 ' A' ' 84' ' ' THR . 74.9 mt -69.95 -49.97 46.53 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.458 ' HD2' ' HB ' ' A' ' 84' ' ' THR . 0.1 OUTLIER -168.65 154.88 6.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.059 0.944 . . . . 0.0 109.376 169.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.469 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 24.9 p -146.31 120.36 9.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -121.23 110.14 34.61 Favored Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 16.8 Cg_exo -68.38 129.52 19.28 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.851 2.367 . . . . 0.0 112.693 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 19.9 Cg_endo -103.42 23.96 13.15 Favored 'Cis proline' 0 C--N 1.376 2.014 0 CA-C-N 120.048 1.053 . . . . 0.0 112.626 -13.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -64.18 -67.14 0.46 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.0 0.92 . . . . 0.0 112.006 -171.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -138.03 158.42 44.36 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.588 0.755 . . . . 0.0 110.651 -171.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 tt -142.32 127.5 18.61 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 171.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.599 HG22 HD12 ' A' ' 75' ' ' LEU . 19.3 m -139.46 130.3 26.15 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.227 0.611 . . . . 0.0 109.378 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 74' ' ' ILE . 10.4 pt -141.24 146.6 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.026 1.33 . . . . 0.0 109.91 -171.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.425 ' OG ' ' HB2' ' A' ' 73' ' ' ASP . 18.0 p -89.95 145.57 25.02 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.673 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 22.0 t-105 -140.98 107.33 5.26 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.101 0.864 . . . . 0.0 109.397 -159.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.15 103.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.4 ' HB3' ' HE3' ' A' ' 121' ' ' MET . 67.2 t80 -101.51 94.96 6.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.566 1.146 . . . . 0.0 110.432 -169.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 47.8 -73.1 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 126.618 1.967 . . . . 0.0 115.278 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.6 33.58 2.54 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 117.957 0.344 . . . . 0.0 112.553 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.613 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 72.3 mmtt -115.65 159.31 39.24 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 124.174 0.989 . . . . 0.0 110.656 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -66.12 161.02 41.93 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.419 2.079 . . . . 0.0 112.759 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.58 107.08 1.97 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.901 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.673 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 13.4 m -87.71 155.58 19.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.188 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -116.51 103.08 10.07 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.3 t -105.63 142.7 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.938 0.895 . . . . 0.0 108.622 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -147.83 156.87 43.18 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.253 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.5 tt -139.81 139.85 36.48 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 21.2 tpt180 -135.25 122.86 22.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.777 0.831 . . . . 0.0 109.521 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.4 mt -115.32 137.86 51.58 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.688 0.795 . . . . 0.0 110.16 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 t -143.98 137.1 27.5 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.172 0.589 . . . . 0.0 109.898 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -84.97 96.14 9.29 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.528 1.131 . . . . 0.0 110.425 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -100.7 78.23 1.96 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.01 -117.42 4.69 Favored Glycine 0 C--N 1.352 1.46 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -91.37 9.73 30.41 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 168.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 30' ' ' TYR . . . -100.82 159.32 19.03 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.485 -173.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.617 HG23 HG22 ' A' ' 34' ' ' VAL . 53.1 m -135.15 108.13 7.62 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.757 1.223 . . . . 0.0 108.63 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.402 HD13 ' HE ' ' A' ' 29' ' ' ARG . 39.8 tp -81.04 106.04 12.73 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 170.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 28' ' ' GLN . 8.1 tt -91.0 130.89 36.88 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 42.4 mt-10 -131.67 107.09 8.57 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.9 tp -104.23 128.68 51.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.998 0.919 . . . . 0.0 109.636 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.661 ' HG2' HG13 ' A' ' 25' ' ' ILE . 45.5 mt-10 -127.12 103.67 7.56 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.775 0.83 . . . . 0.0 109.43 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.537 ' HB3' HG12 ' A' ' 24' ' ' ILE . 6.8 t60 -92.97 111.7 23.42 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 171.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.624 ' HB1' ' HG2' ' A' ' 14' ' ' ARG . . . -109.91 101.79 10.6 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.141 0.576 . . . . 0.0 110.54 -174.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.402 HG23 ' HG ' ' A' ' 122' ' ' LEU . 9.8 t -123.78 152.22 42.44 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.268 0.556 . . . . 0.0 110.77 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.3 m -66.42 -29.32 69.44 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.367 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 t -92.36 125.43 37.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.096 0.558 . . . . 0.0 111.384 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -62.48 -34.04 76.06 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.56 1.144 . . . . 0.0 110.126 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -44.93 81.78 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.212 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.613 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 23.2 ttt -68.48 -32.94 73.29 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.159 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.402 ' HG ' HG23 ' A' ' 116' ' ' THR . 25.5 mt -63.01 -42.52 99.86 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 118.42 0.554 . . . . 0.0 112.104 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.6 t -67.82 -42.13 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-O 121.155 0.502 . . . . 0.0 109.868 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -58.15 -50.17 74.44 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.18 1.392 . . . . 0.0 111.638 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 121' ' ' MET . 26.4 m -82.6 -18.24 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.565 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.86 -36.44 92.02 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 169.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.46 -46.81 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 114.669 -0.766 . . . . 0.0 109.94 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.11 -35.81 92.45 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 114.845 0.698 . . . . 0.0 114.845 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.407 ' HB3' HD12 ' A' ' 26' ' ' ILE . 66.8 m95 -87.67 -28.26 21.93 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.987 0.515 . . . . 0.0 110.853 -176.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.464 ' HG3' ' HE1' ' A' ' 174' ' ' TRP . 43.9 mm-40 -62.45 -38.81 91.22 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 72.4 mtm -70.4 -33.96 71.99 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.926 0.766 . . . . 0.0 110.692 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.67 -46.15 83.67 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.028 0.531 . . . . 0.0 111.054 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.91 -22.2 46.2 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.381 0.673 . . . . 0.0 110.741 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.474 ' O ' ' HG2' ' A' ' 138' ' ' MET . 24.8 t70 -65.49 -62.34 1.58 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 171.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -64.75 -29.64 70.63 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.1 0.56 . . . . 0.0 111.846 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.447 HD13 ' CE2' ' A' ' 50' ' ' TRP . 39.5 tp -67.83 -42.64 81.14 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -61.43 -39.05 96.76 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.9 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 97.3 mmm -69.4 -43.18 73.98 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.766 0.826 . . . . 0.0 110.524 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -68.21 -50.76 52.07 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.342 1.057 . . . . 0.0 111.064 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.459 HD13 HG22 ' A' ' 37' ' ' VAL . 67.0 mt -62.6 -43.52 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.309 0.644 . . . . 0.0 110.756 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER -61.83 -41.17 97.47 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.417 0.687 . . . . 0.0 109.264 178.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 118.86 -10.96 12.04 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.884 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -86.79 83.26 7.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.028 0.414 . . . . 0.0 110.359 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.4 81.38 3.6 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 174.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -79.74 -172.83 1.64 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.998 2.466 . . . . 0.0 112.685 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.67 71.05 2.17 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.01 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -98.36 106.44 3.27 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.07 120.68 8.73 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.073 2.516 . . . . 0.0 112.808 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 23.9 m -67.68 148.34 98.56 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.016 0.526 . . . . 0.0 109.62 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -55.83 -35.92 94.54 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.436 2.091 . . . . 0.0 111.679 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -170.29 -34.68 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.821 0.848 . . . . 0.0 110.427 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 38.2 t70 67.31 79.37 0.23 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.616 1.166 . . . . 0.0 109.347 -170.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -154.18 99.86 2.27 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.01 94.44 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.364 1.066 . . . . 0.0 112.411 -173.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -128.5 121.75 29.58 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.365 1.066 . . . . 0.0 108.851 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -54.34 -34.69 61.6 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.477 1.111 . . . . 0.0 112.935 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -90.45 32.61 0.94 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.555 0.742 . . . . 0.0 111.786 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -54.65 120.1 25.46 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 124.757 1.223 . . . . 0.0 110.056 174.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -88.21 20.08 1.22 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.099 2.532 . . . . 0.0 113.936 -166.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.6 p -98.97 129.43 29.67 Favored Pre-proline 0 C--O 1.239 0.532 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -54.91 -44.14 52.63 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.433 2.756 . . . . 0.0 113.316 -171.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -67.64 -50.94 55.47 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 123.395 0.435 . . . . 0.0 111.365 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 6.0 tpt -68.0 -41.91 81.54 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.446 0.298 . . . . 0.0 110.372 -173.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 10.6 tmm? -59.28 -43.17 92.55 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.203 1.001 . . . . 0.0 110.746 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.448 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 31.7 tpt180 -64.71 -54.61 28.8 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.243 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 65.1 mt -58.44 -30.27 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.719 0.808 . . . . 0.0 111.192 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 42.1 t -70.24 -54.79 11.26 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -61.14 -59.77 4.82 Favored 'General case' 0 C--N 1.364 1.207 0 O-C-N 123.676 0.61 . . . . 0.0 111.368 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 15.8 mm-40 -44.35 -47.84 9.68 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.407 ' HD2' ' HG3' ' A' ' 130' ' ' GLU . 13.7 tpp85 -66.17 -41.3 90.51 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.886 0.474 . . . . 0.0 110.675 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -76.74 -26.66 62.34 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.057 -174.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -75.79 -22.36 56.46 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.994 0.518 . . . . 0.0 110.787 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.54 -47.84 58.39 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 123.208 0.603 . . . . 0.0 109.413 170.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.464 ' HE1' ' HG3' ' A' ' 130' ' ' GLU . 98.9 m95 -69.31 -26.02 64.52 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 123.792 0.683 . . . . 0.0 112.005 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.83 -58.13 6.34 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -47.38 -42.66 22.29 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.257 1.023 . . . . 0.0 112.923 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.7 -48.22 75.47 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.698 0.623 . . . . 0.0 111.69 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.545 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 12.0 p -79.22 -29.59 13.8 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 C-N-CA 123.595 0.758 . . . . 0.0 111.427 -167.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -66.98 -31.39 71.93 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 123.373 0.669 . . . . 0.0 109.967 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 27.2 m -81.56 -33.67 31.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.128 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 79.25 1.16 85.36 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.463 -174.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.8 m . . . . . 0 CA--C 1.552 1.03 0 C-N-CA 124.907 1.283 . . . . 0.0 107.999 -177.965 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.447 0.642 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.29 169.74 10.55 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.46 1.104 . . . . 0.0 109.472 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.696 ' HA ' ' HA2' ' A' ' 142' ' ' GLY . 56.2 p -142.0 85.31 1.92 Allowed 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.121 0.486 . . . . 0.0 110.077 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.56 70.01 3.25 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.614 175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -99.77 87.13 3.46 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.758 0.823 . . . . 0.0 109.844 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -133.32 70.23 1.47 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.373 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 m -96.31 130.02 43.51 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.871 0.868 . . . . 0.0 109.689 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 19.9 mp0 -120.49 110.68 16.77 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.834 0.854 . . . . 0.0 108.75 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.66 149.78 28.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.861 0.363 . . . . 0.0 110.724 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.427 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -157.65 176.59 12.41 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.391 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 177' ' ' LEU . 1.2 tm? -144.69 149.97 36.52 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.53 -162.1 10.95 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -132.0 140.21 48.87 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.279 1.032 . . . . 0.0 108.918 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -155.0 131.03 10.17 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.527 0.731 . . . . 0.0 109.985 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -79.74 141.94 35.87 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 169.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.539 HD11 HG23 ' A' ' 117' ' ' THR . 49.8 pt -129.61 160.55 64.03 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.083 0.953 . . . . 0.0 109.365 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -54.1 -28.67 51.98 Favored 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 123.233 2.622 . . . . 0.0 114.004 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.85 -34.86 60.08 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.565 0.746 . . . . 0.0 111.918 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.409 ' H ' HG13 ' A' ' 16' ' ' ILE . . . 164.98 -148.9 14.92 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-O 120.015 -0.325 . . . . 0.0 112.321 -175.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.402 ' O ' HG22 ' A' ' 117' ' ' THR . 38.3 mt-10 -87.92 135.38 33.43 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.49 162.97 30.44 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.815 0.446 . . . . 0.0 111.781 -175.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.576 HH11 HG22 ' A' ' 178' ' ' VAL . 91.0 mtt180 -102.44 159.0 15.81 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 166.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.6 p -133.7 125.94 29.7 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -172.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.48 ' HB ' ' CZ3' ' A' ' 174' ' ' TRP . 27.7 pt -85.96 135.2 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 3.5 mp -117.98 116.77 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 129' ' ' TRP . 38.1 mt -106.99 107.19 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 95.1 mtt180 -91.97 161.68 14.7 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.705 174.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 5.6 tt0 -167.29 116.6 0.83 Allowed 'General case' 0 N--CA 1.466 0.343 0 O-C-N 125.233 1.583 . . . . 0.0 109.951 176.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -92.23 108.42 19.94 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 60.5 m-85 -92.3 144.2 25.63 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.767 1.227 . . . . 0.0 111.507 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -102.26 72.91 1.32 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 162.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 30' ' ' TYR . . . -166.32 141.26 3.7 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.752 1.621 . . . . 0.0 106.639 -163.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.33 141.92 32.73 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 121.953 1.769 . . . . 0.0 112.579 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 80' ' ' PRO . 56.5 t -50.89 -43.69 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 124.487 1.117 . . . . 0.0 111.742 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -54.11 -35.6 62.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 124.462 1.101 . . . . 0.0 111.514 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -78.57 -32.56 47.8 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 t -74.63 -30.05 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 123.784 0.677 . . . . 0.0 110.171 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.403 ' HE3' HD12 ' A' ' 101' ' ' LEU . 70.2 t-105 -78.21 -25.93 47.25 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.149 0.979 . . . . 0.0 110.425 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.8 m -65.67 -50.93 63.13 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -59.9 -37.68 80.1 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.421 0.688 . . . . 0.0 112.119 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.9 t -61.78 -45.51 93.59 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.0 p -117.58 -39.53 3.14 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -166.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 47' ' ' ILE . 12.1 t70 -69.21 118.16 59.22 Favored Pre-proline 0 N--CA 1.485 1.285 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -59.38 -33.55 97.55 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.412 2.741 . . . . 0.0 114.217 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -72.37 -23.28 61.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 123.606 0.567 . . . . 0.0 110.574 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.524 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 12.8 mmt85 -87.46 -30.39 20.69 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.995 0.918 . . . . 0.0 110.876 174.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 43' ' ' ASP . 60.1 mt -71.5 -41.19 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.187 0.595 . . . . 0.0 110.067 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -70.75 4.21 2.67 Favored 'General case' 0 CA--C 1.56 1.338 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -175.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -97.94 -11.44 23.11 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.828 0.851 . . . . 0.0 111.872 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.448 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 42.9 p-90 -139.04 -24.96 0.88 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.307 0.643 . . . . 0.0 111.614 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.448 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 12.9 t80 -132.57 -172.22 2.85 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.717 1.207 . . . . 0.0 108.839 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.13 144.84 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.043 0.937 . . . . 0.0 111.256 -171.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -54.71 113.53 5.45 Favored Pre-proline 0 CA--C 1.568 1.653 0 O-C-N 125.138 1.524 . . . . 0.0 111.812 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -93.15 121.41 0.43 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.069 2.513 . . . . 0.0 113.307 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HE2' ' HA ' ' A' ' 55' ' ' LYS . 9.7 mmpt? -112.45 125.33 54.11 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 171.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 160.33 -171.4 36.55 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.37 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.47 ' HB3' ' H ' ' A' ' 63' ' ' ASN . 25.0 t70 -71.2 -43.86 66.58 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 123.936 0.433 . . . . 0.0 110.502 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.1 mt 73.64 -17.12 0.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 126.047 1.739 . . . . 0.0 113.499 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -97.49 164.71 12.33 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.167 0.587 . . . . 0.0 110.973 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.588 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 35.5 tt0 -55.97 126.2 24.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 112.968 -172.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.85 84.52 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.955 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -103.98 -147.48 17.6 Favored Glycine 0 C--N 1.342 0.906 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.47 ' H ' ' HB3' ' A' ' 57' ' ' ASP . 35.6 p-10 -148.39 167.65 24.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.43 0.692 . . . . 0.0 111.301 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -144.24 141.63 29.98 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.22 120.23 26.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.521 0.729 . . . . 0.0 110.493 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.8 mt -106.14 119.98 40.63 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.691 1.196 . . . . 0.0 108.1 178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -69.99 123.83 22.52 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.137 0.975 . . . . 0.0 111.33 -171.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.11 31.46 64.07 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.859 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -149.77 -91.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.548 0.339 . . . . 0.0 110.828 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.13 152.46 18.95 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.147 0.499 . . . . 0.0 111.272 -169.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.9 p -137.77 137.29 38.1 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.36 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.6 -162.59 12.31 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 23.7 m-20 -101.22 172.28 7.1 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.34 0.656 . . . . 0.0 110.869 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 mm -106.97 116.68 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 86' ' ' SER . 85.8 mt -82.09 -51.34 8.09 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.682 0.393 . . . . 0.0 110.951 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.73 120.8 2.42 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -173.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 27.4 p -135.66 110.72 8.88 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.828 0.451 . . . . 0.0 109.941 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -116.57 111.15 41.86 Favored Pre-proline 0 N--CA 1.476 0.862 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 65.5 Cg_endo -73.89 137.12 23.93 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.75 2.3 . . . . 0.0 113.096 175.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.52 ' HB2' HG12 ' A' ' 34' ' ' VAL . 27.2 Cg_endo -100.52 30.01 11.92 Favored 'Cis proline' 0 C--N 1.376 1.977 0 CA-C-N 119.413 0.826 . . . . 0.0 111.818 -9.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -65.22 -71.14 0.2 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.109 1.364 . . . . 0.0 111.991 -169.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 15.5 ptt180 -163.11 156.64 19.72 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.804 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.5 tp -111.12 145.5 38.47 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.232 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.454 HG22 HD12 ' A' ' 75' ' ' LEU . 26.1 m -142.01 130.54 22.58 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.83 149.29 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.355 1.062 . . . . 0.0 110.254 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.472 ' HB2' HD21 ' A' ' 75' ' ' LEU . 46.8 t -91.27 133.03 35.75 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 172.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -123.22 95.98 4.82 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -169.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.2 t -91.55 104.26 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -72.25 178.34 3.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.051 0.94 . . . . 0.0 109.791 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.37 -4.43 39.36 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.563 0.745 . . . . 0.0 112.858 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.64 57.97 0.06 OUTLIER Glycine 0 C--N 1.351 1.385 0 C-N-CA 121.783 -0.246 . . . . 0.0 112.974 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.46 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 74.5 mmtt -132.75 156.15 80.39 Favored Pre-proline 0 N--CA 1.496 1.844 0 C-N-CA 123.798 0.839 . . . . 0.0 109.645 173.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -86.87 72.06 3.46 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.614 2.209 . . . . 0.0 111.745 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 67.06 149.36 0.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.651 1.58 . . . . 0.0 113.273 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 63.7 m -136.64 127.09 26.74 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.622 ' HB3' ' HB3' ' A' ' 115' ' ' ALA . 4.6 tp10 -94.0 105.66 17.66 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.83 131.98 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -150.43 145.07 25.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 110.793 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.524 HD11 ' HG ' ' A' ' 110' ' ' LEU . 30.6 tp -107.86 152.52 24.3 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.668 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 31.0 tpt180 -138.28 122.31 17.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.142 0.977 . . . . 0.0 108.395 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.484 ' HB3' HG13 ' A' ' 34' ' ' VAL . 81.2 mt -121.95 126.86 49.55 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.671 0.788 . . . . 0.0 109.299 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.0 m -145.14 125.45 13.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.552 0.741 . . . . 0.0 110.655 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.64 124.93 21.84 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.714 0.806 . . . . 0.0 110.905 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -142.27 128.39 19.71 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.719 0.808 . . . . 0.0 111.08 166.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.87 -135.94 17.23 Favored Glycine 0 C--N 1.351 1.371 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.65 -42.95 99.89 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 117.05 0.425 . . . . 0.0 110.923 161.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -107.89 -146.33 12.43 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 115.445 0.938 . . . . 0.0 115.445 -157.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.452 HG23 HG22 ' A' ' 34' ' ' VAL . 99.0 m -130.06 149.85 51.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.664 1.986 . . . . 0.0 109.055 -168.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.3 tp -109.07 127.5 54.19 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 166.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.524 ' HG ' HD11 ' A' ' 99' ' ' LEU . 9.2 tt -100.0 130.57 46.18 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 173.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.668 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 42.2 mt-10 -135.12 107.79 7.45 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.481 HD22 HD21 ' A' ' 133' ' ' LEU . 54.6 tp -102.51 143.07 32.68 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.258 0.623 . . . . 0.0 109.412 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 32.5 tt0 -132.29 142.24 49.29 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.723 0.809 . . . . 0.0 109.64 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -141.95 116.5 9.67 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.622 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . . . -126.42 111.0 13.94 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.97 0.508 . . . . 0.0 112.012 -168.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.6 t -141.51 164.5 30.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.863 0.465 . . . . 0.0 110.359 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.539 HG23 HD11 ' A' ' 16' ' ' ILE . 58.1 p -74.73 -28.74 60.91 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.817 0.847 . . . . 0.0 110.695 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.6 t -79.86 110.45 15.24 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.832 0.853 . . . . 0.0 110.804 -175.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.77 -28.28 69.34 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.667 0.787 . . . . 0.0 111.04 171.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -59.02 -55.23 37.87 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.17 0.919 . . . . 0.0 109.189 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.46 ' SD ' ' HG3' ' A' ' 92' ' ' LYS . 12.4 tpt -56.63 -52.23 65.68 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.674 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.8 mt -54.5 -47.93 72.47 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.383 1.073 . . . . 0.0 113.614 -173.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.3 t -70.5 -42.98 78.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 122.413 0.285 . . . . 0.0 110.32 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.7 -49.9 73.27 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.726 0.811 . . . . 0.0 111.249 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 121' ' ' MET . 21.6 m -71.51 -23.12 22.44 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 C-N-CA 123.203 0.601 . . . . 0.0 110.461 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.71 79.41 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.5 t -78.27 -51.95 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.095 -0.553 . . . . 0.0 109.569 176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.15 -31.75 81.74 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.753 0.658 . . . . 0.0 114.161 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.511 ' HB3' HD12 ' A' ' 26' ' ' ILE . 15.0 m95 -79.79 -41.17 27.04 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.2 -34.38 72.08 Favored 'General case' 0 C--N 1.368 1.401 0 CA-C-N 118.271 0.487 . . . . 0.0 110.785 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.8 mmt -68.88 -48.52 63.19 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.767 0.667 . . . . 0.0 109.711 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.03 -46.48 75.29 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.324 0.65 . . . . 0.0 111.519 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.481 HD21 HD22 ' A' ' 112' ' ' LEU . 4.1 mm? -80.54 -23.04 40.27 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.459 0.704 . . . . 0.0 111.329 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.65 -54.07 32.72 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -69.91 -18.47 63.39 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.46 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.0 tp -76.95 -44.08 32.73 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.082 0.401 . . . . 0.0 110.531 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.459 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -60.74 -34.47 86.84 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.859 -0.496 . . . . 0.0 111.859 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.484 ' HA ' ' HA3' ' A' ' 142' ' ' GLY . 91.6 mtp -81.29 -25.7 36.3 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.72 0.808 . . . . 0.0 111.809 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -66.45 -54.83 19.65 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 66.2 mt -68.93 -58.01 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.727 -172.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -152.74 32.66 0.5 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 120.546 0.212 . . . . 0.0 111.367 -169.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.696 ' HA2' ' HA ' ' A' ' 3' ' ' SER . . . -130.19 -5.16 4.33 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-O 119.67 -0.516 . . . . 0.0 113.635 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 60.49 88.77 0.08 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.923 1.289 . . . . 0.0 111.241 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 pp -63.38 149.13 92.34 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.089 0.556 . . . . 0.0 110.682 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.03 -20.85 62.68 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.813 2.342 . . . . 0.0 113.728 -171.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.68 29.42 63.47 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.395 173.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -142.2 162.24 27.2 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.477 -0.624 . . . . 0.0 112.738 -176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.07 105.44 1.93 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.875 2.383 . . . . 0.0 112.101 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.4 m -66.06 111.25 6.05 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 123.096 0.558 . . . . 0.0 110.481 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.13 -24.8 14.42 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.773 2.315 . . . . 0.0 113.157 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -150.44 66.18 0.95 Allowed 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.769 0.795 . . . . 0.0 109.619 -172.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -88.71 -13.4 39.73 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.971 173.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.0 -42.37 80.17 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 123.207 0.603 . . . . 0.0 109.95 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -158.27 -70.9 0.09 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.519 170.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.05 122.12 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.123 1.369 . . . . 0.0 108.392 -161.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -153.7 1.77 0.25 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.516 0.726 . . . . 0.0 110.286 -177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -78.34 -78.18 0.15 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.635 0.774 . . . . 0.0 109.693 -171.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -171.37 -52.47 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 125.368 1.467 . . . . 0.0 112.29 -170.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.09 -33.52 64.0 Favored 'Trans proline' 0 C--N 1.396 3.076 0 C-N-CA 123.417 2.745 . . . . 0.0 115.61 -164.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.6 t -127.21 85.19 61.57 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.19 -21.25 72.23 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 122.811 2.341 . . . . 0.0 111.974 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -62.1 -56.2 21.22 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.901 173.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 52.1 tpp -73.85 -24.35 59.75 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.256 0.622 . . . . 0.0 110.768 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.455 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 81.9 mtp -58.8 -53.78 54.48 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 171.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 18.2 tpt180 -61.06 -51.34 69.59 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 123.678 0.611 . . . . 0.0 110.418 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.516 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 57.5 mt -51.38 -42.59 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.397 1.079 . . . . 0.0 112.136 -176.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 61.2 p -76.72 -45.92 27.43 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.442 0.464 . . . . 0.0 111.077 -173.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 164' ' ' MET . 14.1 mm100 -46.78 -60.38 2.44 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 124.033 0.833 . . . . 0.0 110.192 167.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 16.2 mm-40 -42.34 -42.38 3.14 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 173.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 20.6 mmt180 -62.59 -59.78 4.45 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 123.278 0.361 . . . . 0.0 110.346 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.06 -37.42 32.79 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 122.307 -0.246 . . . . 0.0 113.092 -166.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -59.77 -34.98 73.71 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 124.125 0.97 . . . . 0.0 111.181 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.6 -61.25 2.74 Favored 'General case' 0 C--N 1.36 1.038 0 O-C-N 123.932 0.77 . . . . 0.0 109.516 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.48 ' CZ3' ' HB ' ' A' ' 24' ' ' ILE . 95.4 m95 -68.54 -22.56 64.5 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -172.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.17 -63.08 1.13 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 173.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.448 ' HA ' ' NE2' ' A' ' 179' ' ' HIS . . . -54.32 -34.7 61.55 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 173.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 37.8 mt -69.07 -46.83 66.84 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 118.988 -0.53 . . . . 0.0 110.072 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.576 HG22 HH11 ' A' ' 22' ' ' ARG . 9.4 p -70.18 -31.6 47.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 CA-C-N 119.117 0.871 . . . . 0.0 109.563 -169.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.448 ' NE2' ' HA ' ' A' ' 176' ' ' ALA . 11.3 p80 -92.45 16.72 11.24 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 58.9 m -73.6 145.42 45.45 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 84.44 39.61 8.91 Favored Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 -175.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 CA--C 1.558 1.253 0 C-N-CA 124.301 1.041 . . . . 0.0 109.408 -175.519 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.3 mtp . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.35 119.51 8.29 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.508 0.723 . . . . 0.0 109.487 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -79.45 83.28 5.48 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.57 -58.22 4.99 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -169.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -164.0 150.92 11.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.139 1.376 . . . . 0.0 109.017 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.04 28.08 9.07 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.74 0.816 . . . . 0.0 111.142 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 m -93.83 106.38 18.35 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.778 0.831 . . . . 0.0 110.225 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 30.3 mt-10 -96.02 132.56 41.24 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 176.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -101.58 147.23 26.65 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.559 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -154.14 122.56 6.15 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 1.4 tm? -98.98 138.29 36.31 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 169.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.77 -178.45 16.31 Favored Glycine 0 C--N 1.333 0.411 0 O-C-N 123.287 0.367 . . . . 0.0 112.429 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.03 166.96 12.11 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 123.581 0.753 . . . . 0.0 109.658 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.644 ' HG2' ' HB1' ' A' ' 115' ' ' ALA . 6.1 tpt180 -163.82 157.07 18.46 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.3 m -138.27 94.2 2.84 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.453 HD11 HG23 ' A' ' 117' ' ' THR . 36.5 pt -88.6 161.88 40.79 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -52.13 -21.93 13.89 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.13 2.553 . . . . 0.0 114.65 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.63 5.8 37.74 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.435 0.694 . . . . 0.0 112.763 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.38 -178.2 16.44 Favored Glycine 0 C--N 1.348 1.217 0 C-N-CA 123.09 0.376 . . . . 0.0 112.967 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.53 109.39 5.44 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.111 0.564 . . . . 0.0 109.85 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.85 167.35 10.98 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.543 1.137 . . . . 0.0 110.397 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HB2' HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -101.82 170.52 8.1 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 156.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 p -136.25 133.08 36.63 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 29.8 pt -83.86 145.42 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 166.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.677 HG13 ' HG2' ' A' ' 113' ' ' GLU . 4.1 mp -129.96 105.25 11.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 175.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 58.9 mt -104.57 107.2 21.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.613 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 45.2 mtp85 -98.15 134.52 41.1 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.553 -1.203 . . . . 0.0 108.835 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -141.01 140.38 34.3 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.595 HH11 ' HB2' ' A' ' 109' ' ' LEU . 36.0 mmt180 -98.74 103.76 15.74 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 173.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -90.18 125.87 35.61 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.207 1.003 . . . . 0.0 109.958 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.52 59.81 3.66 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.597 1.189 . . . . 0.0 110.672 171.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.25 150.13 33.92 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 113.316 -1.765 . . . . 0.0 106.77 174.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 37' ' ' VAL . 34.7 Cg_endo -64.65 172.24 7.16 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.086 1.857 . . . . 0.0 113.179 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' A' ' 101' ' ' LEU . 67.8 t -70.87 -41.32 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.412 -173.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -58.77 -43.5 90.4 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.184 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.57 -65.86 0.62 Allowed 'General case' 0 C--N 1.356 0.852 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.057 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 33' ' ' PRO . 38.2 t -53.54 -38.26 33.08 Favored 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 124.299 1.04 . . . . 0.0 111.184 -175.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.434 ' HE3' HD12 ' A' ' 101' ' ' LEU . 63.8 t-105 -59.18 -57.2 14.1 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.472 0.709 . . . . 0.0 111.018 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.7 m -59.47 -42.5 92.18 Favored 'General case' 0 C--O 1.21 -1.011 0 O-C-N 124.489 1.118 . . . . 0.0 110.13 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.87 -34.42 73.12 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.437 ' SG ' HD21 ' A' ' 136' ' ' LEU . 84.0 m -85.43 -11.05 55.32 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.993 0.917 . . . . 0.0 113.118 -178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.8 p -113.28 -32.79 6.17 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.329 0.513 . . . . 0.0 112.016 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -66.88 116.82 39.26 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 123.133 0.573 . . . . 0.0 110.506 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.14 -18.31 45.42 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 122.273 1.982 . . . . 0.0 110.991 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -74.81 -15.83 60.73 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.324 1.45 . . . . 0.0 111.3 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -108.55 -21.69 12.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.006 0.522 . . . . 0.0 111.932 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.8 mt -84.88 -32.61 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.253 0.621 . . . . 0.0 110.205 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 53' ' ' GLU . 28.2 p-10 -60.39 -25.61 66.04 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.092 175.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -63.49 -23.63 67.48 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.509 1.124 . . . . 0.0 112.609 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -128.39 -62.02 1.06 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.059 0.543 . . . . 0.0 112.158 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -102.03 -163.42 1.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.025 0.93 . . . . 0.0 108.979 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.524 HG21 ' H ' ' A' ' 67' ' ' GLN . 36.7 mt -85.94 131.64 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 11.2 pt-20 -63.36 140.21 97.69 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 126.368 1.867 . . . . 0.0 112.328 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 85.8 Cg_endo -89.05 99.19 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.045 2.497 . . . . 0.0 111.668 169.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -82.2 162.42 22.4 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.364 0.602 . . . . 0.0 111.885 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.28 -161.76 15.24 Favored Glycine 0 N--CA 1.465 0.575 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.583 -174.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.89 -48.72 67.86 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.574 1.15 . . . . 0.0 111.358 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt 68.44 3.9 4.0 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 125.543 1.537 . . . . 0.0 112.164 -170.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -100.48 147.4 25.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.323 1.049 . . . . 0.0 108.716 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.767 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 32.0 tt0 -62.58 107.71 1.0 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 123.757 0.661 . . . . 0.0 111.625 -172.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.7 -27.99 6.63 Favored Glycine 0 N--CA 1.476 1.343 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.982 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.39 -167.72 42.13 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -125.67 158.9 33.61 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.384 1.592 . . . . 0.0 111.067 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 13.1 p90 -103.92 168.31 9.21 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 157.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.04 115.35 0.83 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.419 1.088 . . . . 0.0 108.873 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 78.9 mt -70.97 169.69 14.35 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.846 0.459 . . . . 0.0 110.513 170.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.524 ' H ' HG21 ' A' ' 52' ' ' ILE . 16.7 tt0 -74.07 107.14 6.09 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.26 0.624 . . . . 0.0 109.33 -178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 45.41 25.12 1.18 Allowed Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.511 ' ND2' HD12 ' A' ' 52' ' ' ILE . 98.4 m-20 -107.15 -80.3 0.57 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.733 0.766 . . . . 0.0 109.957 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.79 157.03 47.86 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.275 0.63 . . . . 0.0 110.257 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.1 t -144.78 143.47 30.67 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.86 149.54 19.21 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -74.07 156.33 37.57 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.449 0.642 . . . . 0.0 110.216 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.692 ' HA ' HG22 ' A' ' 85' ' ' ILE . 19.3 mm -87.42 94.29 4.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.75 -57.47 10.82 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 124.376 1.048 . . . . 0.0 110.901 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -146.45 113.78 6.28 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.496 -175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.767 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.4 p -111.27 125.1 53.47 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 171.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -134.53 81.6 47.92 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 62.2 Cg_endo -73.75 140.08 28.7 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.624 2.216 . . . . 0.0 111.895 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 31.1 Cg_endo -94.91 20.54 32.32 Favored 'Cis proline' 0 C--N 1.378 2.091 0 CA-C-N 119.924 1.009 . . . . 0.0 114.358 -3.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 80' ' ' PRO . 5.9 mpt_? -81.89 -84.27 0.11 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -128.1 147.81 50.55 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.741 -0.6 . . . . 0.0 112.035 -164.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.423 ' HB2' ' CH2' ' A' ' 38' ' ' TRP . 65.1 tp -138.18 102.47 4.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.543 1.137 . . . . 0.0 109.251 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 92.5 m -95.92 119.35 34.27 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 170.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.692 HG22 ' HA ' ' A' ' 74' ' ' ILE . 2.6 pp -128.94 160.5 39.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 124.915 1.286 . . . . 0.0 109.55 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.6 m -81.19 172.13 14.03 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.031 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 34.5 t-105 -154.69 94.26 1.65 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.1 t -105.88 102.95 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 173.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -92.3 149.39 21.47 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -90.0 -43.32 10.61 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 118.268 0.485 . . . . 0.0 111.612 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.14 -37.53 37.27 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.366 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -107.83 161.79 22.04 Favored Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 124.701 1.2 . . . . 0.0 109.085 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HG2' ' OG ' ' A' ' 118' ' ' SER . 52.3 Cg_exo -58.16 -176.89 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.337 2.692 . . . . 0.0 114.646 175.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -79.68 173.55 12.47 Favored 'General case' 0 C--O 1.248 0.976 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.927 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.5 t -172.78 173.96 3.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.53 0.732 . . . . 0.0 110.537 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -138.19 127.62 24.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.538 1.135 . . . . 0.0 108.289 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.402 ' HB ' ' CD1' ' A' ' 85' ' ' ILE . 30.3 t -112.51 143.79 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.698 0.799 . . . . 0.0 109.384 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 112' ' ' LEU . 33.4 mt-10 -131.65 133.38 44.85 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.81 120.33 31.41 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -120.89 132.59 55.05 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.001 0.92 . . . . 0.0 109.994 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.434 HD12 ' HE3' ' A' ' 38' ' ' TRP . 72.1 mt -130.89 132.42 45.13 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.096 0.959 . . . . 0.0 110.067 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.2 t -155.27 148.2 24.51 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.433 1.093 . . . . 0.0 108.142 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -63.79 148.81 48.33 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.839 0.856 . . . . 0.0 110.818 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -146.9 111.33 5.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 51.89 -103.67 0.12 Allowed Glycine 0 CA--C 1.536 1.349 0 O-C-N 123.562 0.539 . . . . 0.0 114.246 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.62 -10.21 18.59 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.99 0.916 . . . . 0.0 111.208 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.27 -150.84 8.13 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 123.657 0.646 . . . . 0.0 111.714 -172.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 82.7 m -146.83 136.14 22.72 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.252 1.021 . . . . 0.0 110.015 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.595 ' HB2' HH11 ' A' ' 29' ' ' ARG . 60.7 tp -90.56 137.54 32.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.84 0.856 . . . . 0.0 109.925 174.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.5 tt -123.72 115.17 20.97 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.697 1.199 . . . . 0.0 107.82 177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.613 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 33.4 mt-10 -113.78 108.09 16.62 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.577 HD13 HD21 ' A' ' 133' ' ' LEU . 10.0 tt -105.97 112.27 25.25 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.677 ' HG2' HG13 ' A' ' 25' ' ' ILE . 40.9 mt-10 -93.11 137.79 32.14 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 123.752 0.821 . . . . 0.0 110.719 170.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.457 ' CD2' HG21 ' A' ' 125' ' ' VAL . 6.9 t60 -129.84 121.67 27.18 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.644 ' HB1' ' HG2' ' A' ' 14' ' ' ARG . . . -124.53 118.64 27.05 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.386 0.674 . . . . 0.0 111.824 -167.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.402 HG23 ' HG ' ' A' ' 122' ' ' LEU . 6.5 t -151.02 155.93 40.06 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.577 0.751 . . . . 0.0 110.368 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.453 HG23 HD11 ' A' ' 16' ' ' ILE . 75.7 p -79.96 -19.39 48.03 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.433 ' OG ' ' HG2' ' A' ' 93' ' ' PRO . 50.5 m -89.96 122.37 32.92 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.909 0.484 . . . . 0.0 111.349 -174.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -57.83 -45.31 86.37 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.763 1.225 . . . . 0.0 112.545 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.14 -57.92 10.74 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 122.929 0.492 . . . . 0.0 111.068 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 23.5 ttt -50.38 -35.91 30.24 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 124.284 0.99 . . . . 0.0 112.54 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 22' ' ' ARG . 29.0 mt -61.94 -46.47 89.17 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.678 0.791 . . . . 0.0 112.297 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 127' ' ' VAL . 41.2 t -70.18 -46.93 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -47.93 -52.64 18.72 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.954 1.701 . . . . 0.0 113.132 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.457 HG21 ' CD2' ' A' ' 114' ' ' HIS . 27.9 m -74.94 -25.79 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 123.452 0.47 . . . . 0.0 110.484 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -56.04 -45.97 85.87 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 124.155 0.909 . . . . 0.0 110.829 170.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 123' ' ' VAL . 45.0 t -74.85 -42.32 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.564 0.746 . . . . 0.0 109.678 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.53 -63.1 5.59 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.922 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -64.93 -26.5 68.33 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.8 0.84 . . . . 0.0 113.005 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -54.26 -51.92 63.02 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.489 0.586 . . . . 0.0 109.858 169.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 29.2 mmt -68.71 -45.11 72.44 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 124.032 0.833 . . . . 0.0 110.716 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.6 -65.2 0.69 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.722 0.809 . . . . 0.0 111.033 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.577 HD21 HD13 ' A' ' 112' ' ' LEU . 3.8 mm? -62.03 -24.55 67.13 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.92 -43.31 65.53 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 118.676 0.671 . . . . 0.0 110.579 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.492 ' HD1' ' SD ' ' A' ' 138' ' ' MET . 20.9 m-85 -68.9 -26.5 65.13 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.172 0.589 . . . . 0.0 110.672 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.437 HD21 ' SG ' ' A' ' 41' ' ' CYS . 61.5 tp -66.22 -51.65 55.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.976 0.511 . . . . 0.0 109.866 169.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.406 ' O ' ' HG2' ' A' ' 141' ' ' ARG . . . -44.55 -43.29 7.76 Favored Glycine 0 N--CA 1.474 1.213 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 168.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.492 ' SD ' ' HD1' ' A' ' 135' ' ' PHE . 85.2 mtp -63.72 -45.95 87.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.882 0.473 . . . . 0.0 110.179 173.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -63.15 -34.92 78.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.775 0.83 . . . . 0.0 111.498 -176.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 25.6 mt -75.94 -48.47 28.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.96 0.904 . . . . 0.0 111.11 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 137' ' ' GLY . 12.9 ptp180 -76.17 -14.05 60.17 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.87 9.32 57.44 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-O 120.008 -0.329 . . . . 0.0 113.894 177.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -77.09 -13.74 59.91 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.95 0.9 . . . . 0.0 112.106 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.84 104.9 5.95 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -64.13 -33.83 59.75 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 123.247 2.631 . . . . 0.0 113.883 -173.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 175.97 -54.27 0.12 Allowed Glycine 0 N--CA 1.467 0.711 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -112.44 144.95 17.98 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 166.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -67.62 -30.14 35.43 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.153 1.902 . . . . 0.0 110.376 173.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.5 m -152.23 147.53 19.8 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.442 1.897 . . . . 0.0 107.457 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.99 -38.7 36.25 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.473 2.115 . . . . 0.0 112.621 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -158.3 -0.72 0.1 Allowed 'General case' 0 CA--C 1.559 1.31 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -176.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.81 50.56 1.84 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.579 0.704 . . . . 0.0 110.359 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -90.33 7.87 36.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.209 1.004 . . . . 0.0 112.554 -167.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 67.29 153.11 0.08 Allowed 'General case' 0 C--N 1.36 1.035 0 C-N-CA 125.217 1.407 . . . . 0.0 111.795 -173.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -153.85 -62.37 0.14 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -148.85 -67.99 0.22 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -120.22 107.2 12.71 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.509 ' HG2' ' HG2' ' A' ' 163' ' ' MET . 15.7 tp10 -87.35 121.58 71.19 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.393 1.077 . . . . 0.0 109.516 -176.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.67 -10.07 25.13 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.862 2.374 . . . . 0.0 114.978 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.2 p -81.99 118.17 71.08 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-N 118.215 0.461 . . . . 0.0 110.481 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -59.1 -35.88 97.15 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 123.521 2.814 . . . . 0.0 113.354 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.412 ' O ' HG13 ' A' ' 166' ' ' ILE . 1.1 mp0 -68.01 -41.96 81.41 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.896 0.478 . . . . 0.0 111.765 -177.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.509 ' HG2' ' HG2' ' A' ' 158' ' ' GLU . 4.9 tpt -66.31 -38.42 87.66 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 117.894 0.315 . . . . 0.0 110.309 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 72.9 mtm -69.03 -30.8 69.24 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.286 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -68.78 -39.44 80.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.894 0.478 . . . . 0.0 110.659 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 162' ' ' GLU . 19.4 mt -73.04 -37.89 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.8 t -61.27 -32.55 72.37 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.537 0.735 . . . . 0.0 111.842 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -90.4 -30.35 17.44 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -60.83 3.07 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.837 0.855 . . . . 0.0 110.259 172.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -67.51 -33.24 74.69 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.595 0.758 . . . . 0.0 110.173 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.69 -58.38 11.49 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.293 -0.867 . . . . 0.0 113.248 172.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.33 -31.34 71.56 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.676 0.79 . . . . 0.0 111.448 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.7 -62.39 1.83 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.205 0.941 . . . . 0.0 110.174 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -73.17 -20.06 60.98 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.421 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.41 -41.7 80.07 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.528 0.331 . . . . 0.0 110.504 173.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.07 -40.21 78.61 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.564 0.697 . . . . 0.0 109.687 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 74.7 mt -66.46 -47.73 72.17 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.222 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 4.6 p -70.29 -27.01 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 122.586 0.354 . . . . 0.0 111.242 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -75.95 -22.66 55.74 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.301 0.641 . . . . 0.0 110.69 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.5 m -81.31 -22.8 38.27 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.763 0.425 . . . . 0.0 111.051 171.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -98.52 -0.94 57.85 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.588 -0.562 . . . . 0.0 113.893 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.559 1.294 0 C-N-CA 123.216 0.606 . . . . 0.0 111.54 -176.717 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 mmt . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.85 72.08 0.44 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.207 1.003 . . . . 0.0 111.818 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 m -127.35 151.75 48.37 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.018 -171.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.91 -43.74 0.29 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -92.11 28.25 1.93 Allowed 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.646 0.736 . . . . 0.0 111.024 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -110.6 68.29 0.66 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.202 1.001 . . . . 0.0 108.525 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 m -119.69 109.82 16.1 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.071 -173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.37 129.24 48.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.2 ptp85 -99.32 156.55 16.94 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.333 0.653 . . . . 0.0 109.37 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.25 -173.99 1.87 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.977 0.511 . . . . 0.0 111.257 -166.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.9 mt -140.67 168.66 19.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.519 1.127 . . . . 0.0 111.112 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.17 -174.93 26.57 Favored Glycine 0 C--O 1.245 0.807 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.837 170.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.15 139.49 24.65 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 123.699 0.799 . . . . 0.0 108.921 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -168.38 163.09 12.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.85 0.86 . . . . 0.0 109.858 -175.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 23.2 m -105.67 113.82 27.61 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 172.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.8 pt -90.69 167.18 16.97 Favored Pre-proline 0 CA--C 1.554 1.103 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -49.07 -23.51 6.42 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.917 2.411 . . . . 0.0 115.043 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.07 -8.01 56.15 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.06 177.85 15.1 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 117.66 0.209 . . . . 0.0 112.732 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 15' ' ' THR . 45.1 mt-10 -65.19 108.11 1.78 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.158 0.583 . . . . 0.0 110.343 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.23 142.4 34.24 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.368 1.067 . . . . 0.0 111.175 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -85.03 158.52 20.44 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 163.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.8 p -128.74 130.55 47.24 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 122.544 -0.097 . . . . 0.0 110.814 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.6 pp -86.2 136.09 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -120.38 122.01 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.2 mt -115.2 107.53 23.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.553 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 95.4 mtt180 -92.61 139.44 30.56 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.736 0.815 . . . . 0.0 109.565 172.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 19.7 tt0 -146.51 139.5 25.5 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.818 0.699 . . . . 0.0 109.211 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.39 128.96 43.8 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.454 ' CE2' ' HA2' ' A' ' 137' ' ' GLY . 83.5 m-85 -116.19 116.86 28.58 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.865 0.866 . . . . 0.0 109.44 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -75.64 49.32 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.24 1.019 . . . . 0.0 110.743 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.51 162.34 51.9 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.445 1.498 . . . . 0.0 108.228 -171.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.487 ' O ' HG23 ' A' ' 37' ' ' VAL . 31.7 Cg_exo -62.34 157.77 43.83 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.375 2.05 . . . . 0.0 113.292 172.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 80' ' ' PRO . 99.1 t -76.65 -37.63 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.497 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -59.65 -42.18 92.2 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.978 0.799 . . . . 0.0 109.649 174.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -62.51 -64.18 1.0 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.373 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.625 HG22 HG21 ' A' ' 140' ' ' ILE . 58.2 t -48.25 -36.29 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.642 1.177 . . . . 0.0 111.763 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.503 ' HE3' HD12 ' A' ' 101' ' ' LEU . 72.1 t-105 -63.59 -59.48 4.57 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.291 0.636 . . . . 0.0 110.16 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.8 m -53.96 -46.36 71.6 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.774 0.671 . . . . 0.0 110.322 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.659 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -50.36 -39.35 46.22 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.366 175.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.578 ' SG ' HD21 ' A' ' 136' ' ' LEU . 58.0 m -102.65 6.35 39.59 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 47.9 p -120.57 -54.96 2.05 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 118.959 0.799 . . . . 0.0 111.723 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.76 137.92 97.3 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.508 1.123 . . . . 0.0 112.017 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -59.2 -42.29 51.72 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.698 2.932 . . . . 0.0 113.557 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -74.45 -6.42 48.18 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.958 0.903 . . . . 0.0 110.827 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.659 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 14.7 mmt180 -100.31 -42.62 6.57 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.741 1.217 . . . . 0.0 110.626 176.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.563 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 58.1 mt -77.32 -38.07 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.769 0.427 . . . . 0.0 111.47 -171.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -62.81 -20.38 64.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.489 0.493 . . . . 0.0 111.8 -176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -64.83 -27.18 68.7 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.563 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 39.4 p-90 -122.78 -41.91 2.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.107 0.563 . . . . 0.0 112.136 -174.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.442 ' HE2' HD13 ' A' ' 66' ' ' LEU . 2.1 t80 -106.0 -163.57 0.94 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.358 0.663 . . . . 0.0 110.097 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.414 ' H ' HD12 ' A' ' 52' ' ' ILE . 4.3 mp -83.48 153.8 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -53.87 119.39 18.79 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.572 1.549 . . . . 0.0 112.164 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.0 101.76 1.47 Allowed 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 122.348 2.032 . . . . 0.0 110.017 169.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -93.3 164.96 13.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.315 0.646 . . . . 0.0 110.887 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.4 -166.81 12.39 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.565 -174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.61 ' HB2' ' HA3' ' A' ' 62' ' ' GLY . 4.5 m-20 -68.2 -37.64 81.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.286 0.634 . . . . 0.0 110.525 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 49.3 mt 64.83 15.04 9.62 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.896 1.278 . . . . 0.0 112.74 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -125.47 167.52 14.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.827 0.851 . . . . 0.0 110.543 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -50.34 107.2 0.15 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.82 1.248 . . . . 0.0 111.427 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.83 -11.05 56.07 Favored Glycine 0 N--CA 1.477 1.386 0 N-CA-C 112.248 -0.341 . . . . 0.0 112.248 174.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.61 ' HA3' ' HB2' ' A' ' 57' ' ' ASP . . . -88.58 -156.33 30.98 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 169.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -144.33 158.23 43.85 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 118.41 1.105 . . . . 0.0 110.745 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -102.81 169.3 8.69 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 165.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.31 144.94 9.66 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.67 1.188 . . . . 0.0 107.951 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.442 HD13 ' HE2' ' A' ' 51' ' ' PHE . 41.3 mt -131.2 157.09 44.14 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.583 1.153 . . . . 0.0 108.279 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -97.96 127.25 43.79 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -173.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.59 10.81 45.79 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.147 -0.933 . . . . 0.0 114.797 -175.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -124.63 -92.92 0.51 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 122.839 0.456 . . . . 0.0 110.036 -172.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.39 174.94 12.76 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.19 0.45 . . . . 0.0 111.739 -170.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.5 p -149.78 136.58 19.41 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -154.99 161.66 30.46 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -86.87 155.14 20.37 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.528 0.731 . . . . 0.0 111.049 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.486 ' HA ' HG22 ' A' ' 85' ' ' ILE . 11.6 mm -89.28 91.66 3.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 172.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.427 HD12 HG22 ' A' ' 84' ' ' THR . 42.4 mt -70.39 -49.66 46.73 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.134 0.896 . . . . 0.0 109.691 -171.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -158.84 155.29 27.55 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.834 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 7.8 p -155.79 122.08 5.14 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.399 1.079 . . . . 0.0 108.251 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -121.85 88.86 47.71 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 13.1 Cg_exo -72.62 137.38 27.47 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.74 2.293 . . . . 0.0 113.101 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.486 ' HB2' HG12 ' A' ' 34' ' ' VAL . 83.7 Cg_endo -99.64 31.14 11.3 Favored 'Cis proline' 0 C--N 1.374 1.909 0 CA-C-N 119.283 0.78 . . . . 0.0 112.339 -10.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -68.92 -75.14 0.11 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.631 1.172 . . . . 0.0 111.278 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -158.74 160.23 36.12 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.881 0.472 . . . . 0.0 111.337 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.83 146.27 50.48 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.308 1.043 . . . . 0.0 108.28 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.427 HG22 HD12 ' A' ' 75' ' ' LEU . 32.6 m -123.44 111.94 16.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 166.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.486 HG22 ' HA ' ' A' ' 74' ' ' ILE . 22.7 pt -113.64 144.53 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.683 1.193 . . . . 0.0 108.256 173.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.4 t -83.31 172.73 12.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.804 0.335 . . . . 0.0 111.25 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.71 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 25.0 t-105 -153.42 110.25 3.42 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.607 -171.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.7 t -116.39 103.45 15.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 168.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.48 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 18.2 t80 -77.83 90.9 4.09 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 63.14 -82.55 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.751 0.82 . . . . 0.0 110.155 -174.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.85 30.22 1.24 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 48.2 mmtm -95.01 162.62 24.37 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.401 1.081 . . . . 0.0 110.21 -177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -35.32 129.0 0.28 Allowed 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 125.039 3.826 . . . . 0.0 115.576 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.4 148.13 42.65 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.98 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.71 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.7 m -145.08 143.86 30.65 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.441 -174.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.51 111.75 24.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.979 0.912 . . . . 0.0 109.185 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 50.8 t -93.95 119.3 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -117.92 131.18 56.55 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.9 tp -125.63 125.4 43.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -130.24 124.18 31.87 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.97 0.508 . . . . 0.0 110.173 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.503 HD12 ' HE3' ' A' ' 38' ' ' TRP . 62.8 mt -120.95 133.03 55.27 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.656 1.182 . . . . 0.0 109.335 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.9 m -144.59 145.64 31.9 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.102 0.961 . . . . 0.0 109.09 177.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.24 141.54 58.18 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.177 0.991 . . . . 0.0 111.17 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -136.74 101.49 4.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 54.63 -98.55 0.05 OUTLIER Glycine 0 CA--C 1.541 1.658 0 CA-C-N 118.846 0.748 . . . . 0.0 111.868 -166.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -125.86 15.22 8.02 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.132 0.968 . . . . 0.0 110.534 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -113.9 -155.66 11.58 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.167 0.889 . . . . 0.0 111.603 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.5 m -147.7 136.39 21.85 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.709 1.204 . . . . 0.0 109.393 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.3 tp -91.55 127.04 36.84 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 164.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' A' ' 101' ' ' LEU . 9.7 tt -108.05 123.26 48.41 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.553 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 31.5 mt-10 -119.68 106.18 11.9 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 169.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.5 tt -103.99 102.56 12.33 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -95.74 142.62 27.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.541 1.137 . . . . 0.0 109.659 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.482 ' CD2' HG21 ' A' ' 125' ' ' VAL . 5.8 t60 -132.74 116.15 16.22 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 171.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.57 117.94 35.41 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.905 0.882 . . . . 0.0 111.383 -174.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.609 HG21 ' HG3' ' A' ' 121' ' ' MET . 8.0 t -146.19 161.31 40.51 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.449 0.7 . . . . 0.0 110.594 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 74.2 p -88.65 -19.97 25.52 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.653 -167.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 m -101.96 133.23 47.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.299 0.64 . . . . 0.0 111.469 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -59.12 -47.78 84.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.552 1.141 . . . . 0.0 113.166 -174.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -64.06 -52.42 59.44 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 117.816 0.28 . . . . 0.0 110.884 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.609 ' HG3' HG21 ' A' ' 116' ' ' THR . 15.2 tpt -46.16 -37.02 6.47 Favored 'General case' 0 CA--C 1.563 1.472 0 O-C-N 124.152 0.908 . . . . 0.0 111.702 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.448 ' HG ' HG23 ' A' ' 116' ' ' THR . 22.5 mt -67.24 -50.45 60.55 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.79 0.836 . . . . 0.0 112.012 176.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 127' ' ' VAL . 61.7 t -61.49 -56.2 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -47.61 -50.94 22.92 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.73 1.612 . . . . 0.0 113.273 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.482 HG21 ' CD2' ' A' ' 114' ' ' HIS . 33.2 m -72.02 -31.68 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 119.799 -0.144 . . . . 0.0 111.155 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.57 -34.48 90.01 Favored Glycine 0 C--N 1.35 1.313 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 123' ' ' VAL . 97.6 t -71.8 -51.8 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.05 -59.72 8.46 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.694 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.418 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 22.5 m95 -54.31 -32.91 57.69 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 173.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -66.3 -35.3 80.04 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 120.41 1.459 . . . . 0.0 111.957 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -60.78 -52.73 63.87 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 167.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 129' ' ' TRP . . . -58.5 -27.83 64.82 Favored 'General case' 0 C--O 1.208 -1.105 0 C-N-CA 124.127 0.971 . . . . 0.0 112.045 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.31 -27.71 22.71 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.32 0.648 . . . . 0.0 109.914 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.01 -48.67 34.32 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -62.64 -42.56 99.67 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.637 174.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.578 HD21 ' SG ' ' A' ' 41' ' ' CYS . 51.0 tp -66.14 -27.61 68.17 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.82 0.848 . . . . 0.0 111.303 176.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.454 ' HA2' ' CE2' ' A' ' 30' ' ' TYR . . . -73.89 -46.57 22.69 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.418 ' HB3' ' HB2' ' A' ' 143' ' ' ASP . 86.4 mtp -60.84 -41.2 95.33 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 113.589 -1.305 . . . . 0.0 110.807 172.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -62.59 -54.57 37.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.607 0.763 . . . . 0.0 111.416 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.625 HG21 HG22 ' A' ' 37' ' ' VAL . 64.1 mt -71.0 -26.95 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.247 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -78.39 -28.27 46.9 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 116.774 -0.194 . . . . 0.0 110.882 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 115.48 -7.53 20.43 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 114.052 0.381 . . . . 0.0 114.052 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 138' ' ' MET . 1.0 OUTLIER -61.16 -45.0 96.43 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.31 1.044 . . . . 0.0 110.614 179.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 42.2 tp -103.52 105.36 46.76 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.059 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.11 -25.79 8.35 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.345 2.03 . . . . 0.0 111.454 170.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.01 135.8 1.99 Allowed Glycine 0 C--O 1.245 0.79 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.77 83.57 0.04 OUTLIER Glycine 0 C--N 1.336 0.579 0 CA-C-O 119.553 -0.582 . . . . 0.0 112.034 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -89.28 -158.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 123.067 2.511 . . . . 0.0 110.651 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.9 m -83.05 107.46 9.62 Favored Pre-proline 0 CA--C 1.56 1.337 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 162.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.84 -68.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.151 2.568 . . . . 0.0 112.896 -175.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -151.95 20.14 0.68 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.661 0.385 . . . . 0.0 111.353 -174.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -53.55 -46.4 70.2 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.627 0.771 . . . . 0.0 111.426 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 59.56 13.01 3.08 Favored 'General case' 0 CA--C 1.556 1.176 0 O-C-N 124.492 1.12 . . . . 0.0 112.16 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.03 88.85 7.18 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.275 1.03 . . . . 0.0 110.474 -171.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -111.0 -51.48 2.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.294 -176.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.62 -46.62 0.41 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.016 0.526 . . . . 0.0 112.406 -169.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -68.33 -30.1 69.0 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.836 0.454 . . . . 0.0 110.273 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -86.87 124.41 69.04 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 169.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.02 56.1 5.71 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.887 2.392 . . . . 0.0 110.322 173.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.6 m -61.63 107.63 1.21 Allowed Pre-proline 0 C--O 1.21 -0.991 0 C-N-CA 124.579 1.152 . . . . 0.0 109.762 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -64.34 -37.25 40.89 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.8 2.334 . . . . 0.0 113.77 -163.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.481 ' O ' HG12 ' A' ' 166' ' ' ILE . 46.4 mt-10 -72.89 -51.16 19.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.834 0.454 . . . . 0.0 110.018 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.3 tpp -63.41 -29.12 70.46 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.234 0.614 . . . . 0.0 111.133 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 37.5 mmm -63.31 -52.89 60.06 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.511 ' O ' ' HG3' ' A' ' 169' ' ' GLU . 41.2 ttp180 -53.5 -48.78 68.65 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 124.734 1.271 . . . . 0.0 110.772 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.535 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 32.5 mm -65.2 -45.4 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 O-C-N 123.64 0.588 . . . . 0.0 110.055 -177.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 39.6 t -72.66 -19.72 61.38 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.376 0.67 . . . . 0.0 112.631 -175.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.48 -31.71 17.54 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.116 0.416 . . . . 0.0 110.342 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 165' ' ' ARG . 66.1 mt-10 -50.59 -56.4 11.94 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.39 0.614 . . . . 0.0 110.399 166.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 2.0 mmt180 -73.62 -39.74 64.33 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 114.715 -1.129 . . . . 0.0 109.113 -175.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -55.35 -55.15 29.89 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.735 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -59.29 -42.14 90.58 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.878 0.871 . . . . 0.0 111.038 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.53 -54.26 45.49 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.225 0.953 . . . . 0.0 111.799 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -70.22 -25.89 63.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.437 0.695 . . . . 0.0 111.847 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.08 83.82 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.995 0.426 . . . . 0.0 109.86 173.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -68.69 -35.96 77.88 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.8 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 55.5 mt -72.58 -53.82 10.85 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.232 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.1 p -66.28 -32.32 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 122.999 0.519 . . . . 0.0 112.003 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -76.66 -7.09 54.62 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.077 0.551 . . . . 0.0 111.501 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 18.4 m -114.74 -163.64 0.89 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.696 1.198 . . . . 0.0 109.262 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 155.32 -66.97 0.31 Allowed Glycine 0 C--N 1.346 1.134 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 173.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 52.7 m . . . . . 0 C--O 1.252 1.203 0 C-N-CA 124.379 1.072 . . . . 0.0 108.263 176.427 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.0 ttm . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.27 -54.69 15.87 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.271 0.628 . . . . 0.0 109.95 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.5 t 65.21 173.39 0.21 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.943 1.297 . . . . 0.0 112.434 175.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.97 56.05 0.05 OUTLIER Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.31 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 29' ' ' ARG . 27.9 pt20 -70.66 84.26 0.63 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.389 1.09 . . . . 0.0 111.203 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.14 163.09 38.6 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.223 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.6 m -97.4 136.75 37.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.203 1.001 . . . . 0.0 110.306 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 20.1 mp0 -123.95 107.81 11.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 172.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.609 HH22 ' HA ' ' A' ' 170' ' ' ARG . 98.2 mtt180 -74.47 161.75 29.49 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.544 0.211 . . . . 0.0 110.602 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.54 177.99 5.64 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.621 0.768 . . . . 0.0 110.323 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.2 mt -133.22 158.91 41.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.414 1.086 . . . . 0.0 109.413 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.16 138.15 5.24 Favored Glycine 0 C--O 1.223 -0.59 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 173.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -91.7 137.76 32.11 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.5 tpt85 -138.99 128.46 24.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.741 0.816 . . . . 0.0 109.507 -168.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.1 m -85.67 136.6 33.3 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.524 HD11 HG23 ' A' ' 117' ' ' THR . 47.5 pt -129.62 159.14 71.05 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -177.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -48.07 -37.01 29.57 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.125 2.55 . . . . 0.0 114.285 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.64 77.13 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.468 0.707 . . . . 0.0 112.443 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.18 -150.82 20.49 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.16 137.88 33.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.82 164.58 27.25 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.777 0.831 . . . . 0.0 109.122 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -120.58 157.56 29.24 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 172.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 3.6 m -128.87 145.63 51.16 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 122.682 0.393 . . . . 0.0 110.792 -174.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 2.8 pp -98.05 135.57 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.417 HG13 ' HB3' ' A' ' 113' ' ' GLU . 2.2 mp -121.42 126.24 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -174.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.425 HD12 ' HB3' ' A' ' 129' ' ' TRP . 57.0 mt -110.48 108.91 26.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.582 ' HB3' HD11 ' A' ' 109' ' ' LEU . 58.9 mtp180 -91.05 153.11 20.35 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 170.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -168.88 129.79 1.18 Allowed 'General case' 0 N--CA 1.474 0.752 0 O-C-N 125.164 1.54 . . . . 0.0 111.219 174.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 9.7 mpt_? -87.26 105.41 17.21 Favored 'General case' 0 C--O 1.214 -0.78 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 172.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -79.21 150.64 31.57 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.995 0.518 . . . . 0.0 110.118 170.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -87.78 27.03 1.2 Allowed 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.989 0.9 . . . . 0.0 110.325 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.77 148.67 70.87 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.32 1.048 . . . . 0.0 109.782 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.56 165.04 33.18 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 123.241 2.627 . . . . 0.0 113.147 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.538 HG23 ' HG3' ' A' ' 103' ' ' GLU . 68.6 t -51.26 -44.63 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 114.053 -1.431 . . . . 0.0 112.616 -177.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -56.18 -39.36 72.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 124.291 0.995 . . . . 0.0 110.071 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -75.49 -36.57 60.59 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.685 0.794 . . . . 0.0 111.167 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.3 -30.48 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.385 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -74.76 -20.7 59.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.192 0.997 . . . . 0.0 109.998 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.5 m -72.17 -47.41 51.02 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.25 77.12 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.298 0.639 . . . . 0.0 111.91 172.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 44.0 t -63.31 -52.3 62.52 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 59.4 p -94.91 -41.16 9.32 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -167.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.448 ' O ' HG13 ' A' ' 47' ' ' ILE . 26.4 t70 -81.68 115.23 55.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 122.972 0.509 . . . . 0.0 110.889 -169.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.11 -20.39 71.07 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.47 2.78 . . . . 0.0 114.094 -173.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -74.16 -31.2 62.61 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -84.11 -30.02 26.29 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.821 175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 43' ' ' ASP . 91.2 mt -71.43 -43.37 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.263 0.625 . . . . 0.0 110.371 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -65.52 -3.29 4.25 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -86.64 -43.06 12.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.891 0.876 . . . . 0.0 110.364 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.447 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 49.7 p-90 -114.65 -25.08 8.45 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.137 0.975 . . . . 0.0 111.414 -173.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.447 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 11.1 t80 -129.55 -171.89 2.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.505 1.122 . . . . 0.0 109.104 -175.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.6 mt -89.5 139.99 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.614 0.766 . . . . 0.0 111.41 -173.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -64.46 110.5 4.07 Favored Pre-proline 0 CA--C 1.566 1.576 0 O-C-N 125.348 1.655 . . . . 0.0 110.993 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -90.89 148.99 3.93 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.354 2.702 . . . . 0.0 113.592 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -130.54 130.47 44.15 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.87 -166.91 32.59 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 121.63 -0.319 . . . . 0.0 112.477 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -69.5 -46.94 65.42 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.415 0.686 . . . . 0.0 110.948 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.4 mt 62.25 22.85 13.46 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.872 1.269 . . . . 0.0 110.695 -172.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -124.97 146.93 49.16 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.594 1.158 . . . . 0.0 109.749 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.53 117.86 4.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.183 0.993 . . . . 0.0 111.981 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.57 12.14 57.35 Favored Glycine 0 N--CA 1.47 0.907 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.96 -174.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -119.58 -158.21 10.55 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 10.9 p30 -138.34 174.39 10.6 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 117.723 0.761 . . . . 0.0 112.036 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -145.02 153.55 41.6 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.864 1.266 . . . . 0.0 107.894 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -144.97 109.94 5.1 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.651 0.78 . . . . 0.0 110.878 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 78.7 mt -77.72 138.11 38.86 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.697 0.799 . . . . 0.0 109.177 173.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -77.82 110.23 12.52 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.2 56.73 5.06 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.607 0.567 . . . . 0.0 113.356 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -168.77 -84.05 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.965 0.506 . . . . 0.0 111.339 174.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -152.78 155.68 37.62 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.275 0.56 . . . . 0.0 111.559 -168.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 m -132.45 143.09 49.55 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.378 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -156.56 -170.51 21.75 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 5.5 m-20 -118.24 168.7 10.35 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.252 0.621 . . . . 0.0 110.749 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.497 ' HA ' HG22 ' A' ' 85' ' ' ILE . 9.8 mm -103.58 107.05 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.1 mt -75.51 -58.11 3.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.71 0.404 . . . . 0.0 110.994 -175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.07 151.2 13.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.692 0.797 . . . . 0.0 109.41 175.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.5 p -148.3 133.08 17.95 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -107.82 89.84 5.75 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -64.53 132.39 33.06 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.639 2.226 . . . . 0.0 112.53 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -102.74 22.85 14.97 Favored 'Cis proline' 0 C--N 1.375 1.924 0 CA-C-N 120.031 1.047 . . . . 0.0 113.597 -8.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -67.45 -52.72 36.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.812 1.245 . . . . 0.0 112.366 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.441 ' NH2' ' HD3' ' A' ' 100' ' ' ARG . 26.4 ttm-85 -148.93 154.62 39.68 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.32 0.581 . . . . 0.0 111.134 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.5 tt -135.07 140.97 45.97 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.14 1.376 . . . . 0.0 107.338 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.473 HG23 ' HG2' ' A' ' 98' ' ' GLU . 40.6 m -137.9 134.87 35.54 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.302 0.641 . . . . 0.0 109.287 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.497 HG22 ' HA ' ' A' ' 74' ' ' ILE . 12.6 pt -147.78 147.14 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.055 1.342 . . . . 0.0 109.895 -172.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.5 m -86.86 153.7 21.43 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 163.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 23.1 t-105 -143.13 109.62 5.41 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -167.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.738 HG13 ' HB3' ' A' ' 93' ' ' PRO . 61.1 t -108.79 103.07 14.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -83.85 141.56 31.24 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -58.25 -30.04 66.23 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.94 -53.8 5.14 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.397 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 0.0 OUTLIER -138.7 119.57 9.96 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.61 0.764 . . . . 0.0 110.349 -174.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.738 ' HB3' HG13 ' A' ' 88' ' ' VAL . 3.1 Cg_exo -83.18 -166.86 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 123.701 2.934 . . . . 0.0 113.016 -176.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.5 t70 52.67 85.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.593 1.557 . . . . 0.0 113.373 174.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 71.0 m -147.09 122.32 10.22 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 171.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -101.33 105.68 16.77 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.2 t -97.69 147.85 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.202 1.001 . . . . 0.0 109.824 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.473 ' HG2' HG23 ' A' ' 84' ' ' THR . 33.9 mt-10 -137.7 155.96 48.54 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.68 0.792 . . . . 0.0 109.603 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.0 tp -126.75 139.24 53.28 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.441 ' HD3' ' NH2' ' A' ' 82' ' ' ARG . 1.5 ttp180 -140.08 106.96 5.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.47 0.708 . . . . 0.0 109.736 -172.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 110' ' ' LEU . 96.2 mt -111.53 131.18 55.42 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.371 1.069 . . . . 0.0 110.78 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.1 t -143.46 128.38 18.43 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.014 0.925 . . . . 0.0 108.796 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.538 ' HG3' HG23 ' A' ' 34' ' ' VAL . 43.9 mt-10 -66.62 124.37 22.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -136.46 117.98 14.83 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.97 -144.77 38.6 Favored Glycine 0 C--N 1.345 1.057 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -86.91 55.38 3.54 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.566 0.698 . . . . 0.0 109.227 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.64 -154.4 13.25 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 114.939 -1.028 . . . . 0.0 113.689 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.4 m -148.75 129.69 14.34 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.809 0.843 . . . . 0.0 111.119 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 27' ' ' ARG . 43.0 tp -81.21 109.55 15.85 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 101' ' ' LEU . 10.2 tt -88.05 130.97 34.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 170.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.451 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 45.3 mt-10 -132.13 105.86 7.63 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 8.5 tt -103.97 124.16 48.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 98' ' ' GLU . 9.4 pt-20 -122.06 129.38 52.35 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.481 ' O ' ' HA ' ' A' ' 23' ' ' SER . 8.1 t60 -117.0 111.1 19.1 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.94 102.37 11.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.674 0.79 . . . . 0.0 111.171 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.2 t -130.72 153.33 49.11 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.237 0.542 . . . . 0.0 109.934 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.524 HG23 HD11 ' A' ' 16' ' ' ILE . 76.1 p -71.14 -21.53 62.18 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.166 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.4 p -94.49 118.26 31.38 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.698 0.799 . . . . 0.0 111.137 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 122' ' ' LEU . 45.0 tt0 -65.81 -24.8 66.99 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.256 1.022 . . . . 0.0 111.147 174.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -61.65 -53.75 52.04 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.054 175.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.411 ' O ' HG22 ' A' ' 125' ' ' VAL . 10.1 tpt -62.63 -41.34 98.96 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.48 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 119' ' ' GLU . 37.0 mt -52.93 -53.03 55.37 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.098 0.959 . . . . 0.0 113.278 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.55 -44.72 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 122.788 0.435 . . . . 0.0 110.488 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -62.98 -44.14 96.84 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.541 -174.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 121' ' ' MET . 26.0 m -75.23 -26.87 19.09 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.06 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.229 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -57.48 -29.05 60.24 Favored Glycine 0 C--N 1.351 1.361 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 170.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.26 -51.61 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 123.592 0.231 . . . . 0.0 110.396 175.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.03 -30.17 76.44 Favored Glycine 0 N--CA 1.476 1.353 0 CA-C-N 115.625 -0.716 . . . . 0.0 114.209 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.425 ' HB3' HD12 ' A' ' 26' ' ' ILE . 9.4 m95 -79.13 -46.96 16.95 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.44 ' HG3' ' HE1' ' A' ' 174' ' ' TRP . 27.3 mm-40 -54.9 -38.95 68.24 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.478 0.311 . . . . 0.0 110.785 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.6 tpp -64.99 -41.41 95.43 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.501 0.72 . . . . 0.0 110.69 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -72.77 -36.02 67.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.42 0.688 . . . . 0.0 111.729 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.56 -25.11 38.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.662 0.785 . . . . 0.0 110.289 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.22 -45.15 77.66 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.543 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.64 -30.57 52.23 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.431 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.1 tp -71.74 -29.64 64.74 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.21 -48.23 81.62 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.633 168.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 90.3 mmm -69.2 -37.11 77.93 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.074 0.95 . . . . 0.0 111.13 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.498 ' HA ' HD21 ' A' ' 144' ' ' LEU . 51.6 t80 -67.52 -56.77 8.17 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.972 0.909 . . . . 0.0 110.793 -175.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 28.9 mt -67.2 -29.91 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.23 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -62.28 -30.09 70.88 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.64 0.376 . . . . 0.0 110.103 172.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.85 13.32 78.08 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.656 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -122.98 71.61 1.06 Allowed 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.498 HD21 ' HA ' ' A' ' 139' ' ' PHE . 3.9 mm? -75.13 159.8 81.76 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.772 173.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.21 -177.67 0.68 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 122.237 1.958 . . . . 0.0 111.732 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.03 63.61 2.43 Favored Glycine 0 N--CA 1.476 1.328 0 N-CA-C 112.332 -0.307 . . . . 0.0 112.332 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.03 -161.29 12.82 Favored Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -169.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -88.41 -167.45 0.31 Allowed 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 123.158 2.572 . . . . 0.0 112.382 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 152' ' ' ASP . 20.8 m -75.89 155.07 84.99 Favored Pre-proline 0 N--CA 1.481 1.115 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 167.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.6 -57.83 1.57 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.249 1.966 . . . . 0.0 111.414 174.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.26 -18.81 0.2 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.343 0.657 . . . . 0.0 111.384 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.454 ' HB2' HG21 ' A' ' 149' ' ' VAL . 27.2 t0 58.75 71.81 0.56 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.832 1.253 . . . . 0.0 110.634 -170.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -179.22 -24.54 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.26 -1.337 . . . . 0.0 110.691 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 66.96 52.93 0.86 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.14 1.376 . . . . 0.0 111.103 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.72 -44.83 14.04 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 174.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -83.18 159.38 22.03 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.955 169.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 61.72 91.23 0.06 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.868 1.267 . . . . 0.0 111.651 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.412 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 4.1 mp0 -56.51 -45.41 99.93 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 168.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 158' ' ' GLU . 29.2 Cg_endo -59.97 94.91 0.1 OUTLIER 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 122.478 2.119 . . . . 0.0 111.083 164.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.451 ' N ' ' HD3' ' A' ' 161' ' ' PRO . 22.8 p -150.33 49.98 0.69 Allowed Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 123.319 0.647 . . . . 0.0 110.668 175.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 160' ' ' SER . 14.5 Cg_exo -66.6 -34.01 34.16 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 122.309 2.006 . . . . 0.0 111.289 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 166' ' ' ILE . 46.4 mt-10 -59.49 -54.37 47.42 Favored 'General case' 0 C--O 1.212 -0.87 0 O-C-N 124.382 1.051 . . . . 0.0 110.418 173.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 91.1 mmm -65.46 -44.03 88.48 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.175 0.59 . . . . 0.0 112.423 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 76.6 mtp -61.87 -39.22 91.15 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.694 0.621 . . . . 0.0 110.671 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.487 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 38.4 ttp180 -65.99 -48.79 70.05 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.998 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.527 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 30.5 mm -53.49 -40.01 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.831 0.852 . . . . 0.0 110.504 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.1 m -68.77 -54.49 15.66 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 122.701 0.4 . . . . 0.0 110.396 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 11.6 pt20 -61.5 -56.0 24.92 Favored 'General case' 0 C--O 1.209 -1.072 0 CA-C-O 117.726 -1.13 . . . . 0.0 111.304 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 9.5 mm-40 -43.45 -46.07 6.6 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 118.942 0.792 . . . . 0.0 113.064 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.609 ' HA ' HH22 ' A' ' 9' ' ' ARG . 4.8 mmp_? -53.64 -52.44 59.89 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.574 0.546 . . . . 0.0 109.841 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -80.95 -17.4 72.51 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 116.284 -0.416 . . . . 0.0 113.65 -173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 24.0 mm-40 -71.7 -37.3 70.69 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.51 0.724 . . . . 0.0 109.712 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.507 ' HB3' ' NH1' ' A' ' 9' ' ' ARG . . . -76.22 -36.21 58.68 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.737 177.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.44 ' HE1' ' HG3' ' A' ' 130' ' ' GLU . 75.5 m95 -67.09 -29.9 69.78 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 119.249 -0.405 . . . . 0.0 111.43 173.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.42 -61.18 2.62 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 123.59 0.556 . . . . 0.0 109.659 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.39 -35.27 51.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.409 1.084 . . . . 0.0 113.565 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 35.3 mt -66.8 -59.56 3.44 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 123.297 0.373 . . . . 0.0 110.159 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.8 p -72.88 -20.37 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 123.721 0.808 . . . . 0.0 111.357 -158.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -57.38 -21.16 34.19 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.259 1.024 . . . . 0.0 112.104 175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 16.3 m -68.35 88.82 0.32 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.568 0.747 . . . . 0.0 109.452 172.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 138.37 36.51 0.15 Allowed Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.946 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.3 t . . . . . 0 C--O 1.249 1.042 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.118 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.908 0.385 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.45 -166.38 2.11 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.728 0.811 . . . . 0.0 109.63 -175.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.0 m -68.3 83.76 0.25 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 168.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.33 112.04 3.49 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.886 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -77.2 73.6 3.78 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-O 123.51 1.624 . . . . 0.0 110.598 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.53 0.73 48.78 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.604 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 24.4 m -79.14 111.37 15.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.317 1.047 . . . . 0.0 110.956 -175.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 30.9 mt-10 -93.8 134.33 36.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.694 1.198 . . . . 0.0 108.56 172.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.405 ' HG2' ' CD1' ' A' ' 177' ' ' LEU . 43.0 ttm105 -99.78 139.44 35.43 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.855 0.462 . . . . 0.0 110.0 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.16 179.35 9.23 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.77 0.428 . . . . 0.0 111.628 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.413 HD13 ' N ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -145.15 153.12 41.04 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.957 -176.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.413 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -167.24 -151.98 7.2 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.45 163.22 35.55 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.207 0.603 . . . . 0.0 109.759 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -166.42 152.46 8.68 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.874 0.869 . . . . 0.0 109.483 167.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.5 m -82.95 152.66 25.38 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.043 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.8 pt -144.1 155.51 58.46 Favored Pre-proline 0 CA--C 1.556 1.196 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -50.64 -30.29 28.16 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.941 2.428 . . . . 0.0 114.317 175.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.47 -7.84 59.64 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.82 -172.9 28.05 Favored Glycine 0 C--N 1.356 1.678 0 CA-C-N 119.258 0.935 . . . . 0.0 112.577 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -84.57 110.78 18.96 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.17 146.96 23.28 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.991 -175.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -87.98 156.84 19.12 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 164.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 115' ' ' ALA . 80.4 p -139.17 137.98 36.53 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.954 0.407 . . . . 0.0 111.609 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.597 HG12 HG23 ' A' ' 125' ' ' VAL . 2.9 pp -87.79 141.16 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.265 170.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.35 111.02 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.9 mt -100.91 108.63 23.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.555 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 97.2 mtt180 -99.54 140.59 33.5 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.488 HE22 HD22 ' A' ' 110' ' ' LEU . 0.3 OUTLIER -138.78 144.15 39.25 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 169.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.477 HH11 ' HG2' ' A' ' 104' ' ' GLU . 12.2 mmt85 -103.73 101.96 11.8 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 173.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.46 ' CE1' ' HA2' ' A' ' 137' ' ' GLY . 70.1 m-85 -83.63 129.36 34.96 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.903 0.881 . . . . 0.0 110.624 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -77.72 48.25 0.67 Allowed 'General case' 0 CA--C 1.571 1.775 0 CA-C-O 122.889 1.328 . . . . 0.0 109.785 170.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.56 152.42 41.7 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.058 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.725 ' HG2' ' HB2' ' A' ' 36' ' ' GLU . 56.4 Cg_endo -71.64 165.75 31.56 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.629 2.219 . . . . 0.0 113.454 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 80' ' ' PRO . 58.1 t -71.89 -43.7 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.954 -169.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -63.87 -34.03 77.02 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 124.055 0.847 . . . . 0.0 110.109 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.725 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -69.53 -62.79 1.24 Allowed 'General case' 0 C--N 1.355 0.813 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.776 179.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.7 t -51.17 -33.3 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 124.939 1.296 . . . . 0.0 111.06 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.434 ' HE3' HD12 ' A' ' 101' ' ' LEU . 65.2 t-105 -61.43 -57.42 12.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.19 0.596 . . . . 0.0 110.063 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.2 t -54.35 -40.7 68.33 Favored 'General case' 0 CA--C 1.552 1.023 0 O-C-N 123.92 0.762 . . . . 0.0 110.614 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.04 79.26 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.4 m -93.51 -4.48 51.0 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.752 0.821 . . . . 0.0 112.954 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 77.8 p -116.57 -48.37 2.69 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.439 0.563 . . . . 0.0 111.438 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.439 ' O ' HG12 ' A' ' 47' ' ' ILE . 20.6 t70 -63.12 119.94 56.93 Favored Pre-proline 0 N--CA 1.483 1.197 0 C-N-CA 123.878 0.871 . . . . 0.0 111.033 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.0 -26.76 43.22 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.008 2.472 . . . . 0.0 113.335 -171.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -61.82 -48.06 82.31 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.777 0.673 . . . . 0.0 109.646 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -72.13 -26.05 61.96 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 174.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.579 HG21 ' HD3' ' A' ' 54' ' ' PRO . 36.7 mm -71.24 -42.18 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 118.849 0.75 . . . . 0.0 111.474 -177.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.07 -16.01 64.07 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -80.54 0.91 31.74 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.468 0.707 . . . . 0.0 112.408 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.421 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 46.2 p-90 -141.64 -47.44 0.37 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.916 0.486 . . . . 0.0 110.489 173.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -111.65 -164.28 0.91 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.069 0.948 . . . . 0.0 109.859 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -86.92 126.02 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 166.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 9.3 pt-20 -69.67 139.45 88.76 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 118.87 0.759 . . . . 0.0 111.794 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.579 ' HD3' HG21 ' A' ' 47' ' ' ILE . 15.2 Cg_exo -69.71 101.98 0.97 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.627 2.218 . . . . 0.0 110.932 173.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -74.88 136.01 41.51 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.767 0.827 . . . . 0.0 110.682 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.27 -164.74 27.21 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 116.023 -0.535 . . . . 0.0 114.308 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -68.46 -39.06 81.58 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.721 1.208 . . . . 0.0 111.104 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.3 mt 66.29 12.28 8.49 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -98.97 165.34 11.8 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.234 0.47 . . . . 0.0 110.079 173.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.759 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 38.5 tt0 -71.02 98.03 1.56 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.25 -31.03 4.36 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -170.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.11 -174.01 46.65 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 114.776 -0.712 . . . . 0.0 112.432 169.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 22.9 p-10 -134.96 155.26 51.05 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.842 0.857 . . . . 0.0 111.861 -170.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -116.91 169.6 9.27 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.163 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -163.4 144.23 9.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.701 0.8 . . . . 0.0 109.017 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.485 HD13 HD22 ' A' ' 69' ' ' ASN . 68.8 mt -118.5 153.29 34.41 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -93.28 -45.66 7.74 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.41 -12.27 84.0 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.33 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.485 HD22 HD13 ' A' ' 66' ' ' LEU . 80.8 m-20 -127.52 -92.7 0.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 118.106 0.953 . . . . 0.0 111.31 -174.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.61 175.08 14.37 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.087 0.555 . . . . 0.0 110.821 -169.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 27.7 p -131.96 145.29 51.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.154 0.582 . . . . 0.0 109.616 -172.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -159.71 -148.87 5.37 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 112.319 -0.313 . . . . 0.0 112.319 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 0.9 OUTLIER -151.23 163.75 38.16 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.223 0.609 . . . . 0.0 110.861 179.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.576 ' HA ' HG22 ' A' ' 85' ' ' ILE . 2.5 mp -94.34 102.42 13.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 86' ' ' SER . 88.4 mt -76.24 -45.53 32.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.785 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -135.45 141.69 45.44 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.511 -173.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.759 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 31.8 p -158.38 122.43 4.06 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 171.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.646 ' HG2' ' HD3' ' A' ' 81' ' ' ARG . 41.8 tt0 -144.78 90.46 6.35 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 38.0 Cg_exo -63.46 139.99 73.64 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.973 2.449 . . . . 0.0 111.858 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 27.2 Cg_endo -96.61 27.06 18.63 Favored 'Cis proline' 0 C--N 1.375 1.954 0 CA-C-N 120.097 1.07 . . . . 0.0 113.094 -8.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.646 ' HD3' ' HG2' ' A' ' 78' ' ' GLU . 4.3 mpt_? -77.9 -82.21 0.09 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.569 0.748 . . . . 0.0 111.385 -175.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.5 ptt-85 -150.96 154.11 36.48 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.795 0.438 . . . . 0.0 111.451 -171.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.8 tt -134.86 114.09 12.23 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -112.82 137.39 51.23 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.139 0.976 . . . . 0.0 108.907 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 74' ' ' ILE . 13.0 pt -133.29 151.56 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.81 1.244 . . . . 0.0 109.885 -176.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.481 ' HB2' HD11 ' A' ' 75' ' ' LEU . 35.2 t -87.96 163.56 16.27 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.991 0.424 . . . . 0.0 109.978 166.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 35.6 t-105 -144.25 96.92 2.96 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -166.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.44 125.06 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.607 0.763 . . . . 0.0 109.373 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.449 ' HB3' ' HE3' ' A' ' 92' ' ' LYS . 59.6 t80 -144.72 171.71 14.03 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.13 0.972 . . . . 0.0 108.655 -176.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.76 154.64 38.27 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 122.531 0.333 . . . . 0.0 110.549 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.44 -63.72 4.1 Favored Glycine 0 N--CA 1.471 1.011 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -103.68 133.64 20.17 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 124.308 1.043 . . . . 0.0 109.708 177.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.12 -73.23 0.03 OUTLIER 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.019 2.479 . . . . 0.0 112.433 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -125.47 165.93 17.55 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.283 0.563 . . . . 0.0 110.682 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 72.5 m -152.19 169.77 21.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.912 1.685 . . . . 0.0 107.464 175.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -133.83 123.81 25.45 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 118.509 0.595 . . . . 0.0 111.139 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 t -110.83 147.62 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.989 1.316 . . . . 0.0 107.869 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -143.09 127.86 18.21 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.066 0.46 . . . . 0.0 110.98 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -101.48 119.08 38.22 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.459 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 33.0 ttm180 -124.88 128.5 48.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.996 0.918 . . . . 0.0 109.145 -173.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.459 ' HB3' HG13 ' A' ' 34' ' ' VAL . 72.9 mt -135.6 128.74 31.74 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.934 0.894 . . . . 0.0 110.792 -175.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.2 m -148.82 152.67 36.91 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.653 1.181 . . . . 0.0 108.559 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.03 150.84 32.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.609 0.764 . . . . 0.0 111.291 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.477 ' HG2' HH11 ' A' ' 29' ' ' ARG . 11.0 tp10 -148.09 112.24 5.2 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.83 -101.75 0.2 Allowed Glycine 0 C--N 1.35 1.317 0 O-C-N 123.252 0.345 . . . . 0.0 112.924 -171.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -119.6 2.05 11.16 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.381 0.61 . . . . 0.0 110.345 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -112.88 -150.68 10.9 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.223 0.916 . . . . 0.0 111.718 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.0 m -148.09 127.09 12.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.481 1.112 . . . . 0.0 110.135 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.439 HD13 ' NE ' ' A' ' 29' ' ' ARG . 40.5 tp -82.44 133.34 35.21 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.4 tt -117.84 113.39 21.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.555 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 33.4 mt-10 -109.37 106.2 15.89 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.7 tp -98.83 103.26 15.19 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 38.8 tt0 -101.65 108.85 20.51 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.937 0.895 . . . . 0.0 109.666 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -106.51 122.18 45.78 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 23' ' ' SER . . . -119.42 125.18 48.34 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.561 0.744 . . . . 0.0 111.308 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.9 t -141.69 159.75 41.58 Favored 'General case' 0 C--O 1.246 0.899 0 O-C-N 123.982 0.802 . . . . 0.0 109.611 173.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.4 p -90.68 -2.51 57.83 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.233 1.013 . . . . 0.0 111.886 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.6 t -97.16 119.19 35.19 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.162 0.985 . . . . 0.0 110.149 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.546 ' HA ' HD12 ' A' ' 122' ' ' LEU . 38.3 tt0 -62.32 -42.4 99.35 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.269 1.027 . . . . 0.0 112.645 -174.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.16 -58.44 8.64 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.425 ' O ' HG22 ' A' ' 125' ' ' VAL . 25.2 ttt -51.32 -29.62 15.64 Favored 'General case' 0 C--O 1.208 -1.115 0 O-C-N 124.794 1.309 . . . . 0.0 112.762 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 119' ' ' GLU . 47.6 mt -64.26 -53.76 43.96 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.394 0.543 . . . . 0.0 111.896 176.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 127' ' ' VAL . 47.2 t -63.48 -49.58 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.418 ' HB3' ' HA ' ' A' ' 121' ' ' MET . 23.5 tt0 -44.39 -56.16 4.44 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.264 1.826 . . . . 0.0 113.818 175.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.597 HG23 HG12 ' A' ' 24' ' ' ILE . 34.6 m -72.44 -26.39 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 122.265 0.226 . . . . 0.0 110.635 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.51 -39.12 97.42 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 169.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 123' ' ' VAL . 92.6 t -78.09 -60.48 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.37 -57.06 12.48 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 114.436 -1.256 . . . . 0.0 114.517 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -66.03 -40.94 91.44 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.875 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 36.9 tt0 -67.18 -32.17 73.07 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 120.319 1.418 . . . . 0.0 111.125 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.0 mtm -71.98 -35.04 69.4 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.666 0.386 . . . . 0.0 110.272 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.06 -59.82 2.67 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.357 0.663 . . . . 0.0 110.97 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.472 HD12 HE22 ' A' ' 28' ' ' GLN . 3.8 mm? -54.56 -30.4 54.08 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.089 1.356 . . . . 0.0 113.008 172.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 24.8 t70 -57.99 -46.62 84.91 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.505 0.722 . . . . 0.0 110.311 169.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -64.18 -37.38 87.25 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.656 172.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 52.5 tp -68.88 -20.66 64.26 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.148 0.579 . . . . 0.0 110.544 175.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.46 ' HA2' ' CE1' ' A' ' 30' ' ' TYR . . . -71.06 -47.27 38.82 Favored Glycine 0 C--N 1.35 1.328 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.3 ptm -80.27 -24.33 40.15 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.499 -0.851 . . . . 0.0 111.58 174.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 82.7 t80 -67.17 -42.77 83.7 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.838 0.455 . . . . 0.0 110.562 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.2 mt -76.74 -51.54 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.781 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.586 ' NE ' ' HA ' ' A' ' 141' ' ' ARG . 0.3 OUTLIER -146.87 99.27 3.16 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-O 121.564 0.697 . . . . 0.0 111.332 177.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.52 -20.69 0.11 Allowed Glycine 0 CA--C 1.523 0.57 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.534 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 68.44 103.9 0.05 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.459 1.903 . . . . 0.0 111.189 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tt -88.97 107.13 15.74 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 123.959 0.904 . . . . 0.0 109.027 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -89.51 130.11 1.91 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.648 2.232 . . . . 0.0 111.27 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.63 -112.12 3.73 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.16 -75.46 0.41 Allowed Glycine 0 C--N 1.345 1.041 0 CA-C-O 119.041 -0.866 . . . . 0.0 112.842 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -46.26 105.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 124.022 3.148 . . . . 0.0 113.95 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.647 ' HB ' ' HB2' ' A' ' 152' ' ' ASP . 16.8 m -80.87 118.62 73.18 Favored Pre-proline 0 CA--C 1.556 1.187 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.597 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.72 -65.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.422 2.081 . . . . 0.0 112.593 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -123.4 1.84 9.03 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.228 0.611 . . . . 0.0 110.557 -173.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.647 ' HB2' ' HB ' ' A' ' 149' ' ' VAL . 2.1 m-20 -72.02 79.61 0.93 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.565 1.146 . . . . 0.0 109.728 -174.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -154.11 43.27 0.54 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.432 -175.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 68.28 77.56 0.24 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.049 1.34 . . . . 0.0 110.866 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 158' ' ' GLU . 2.1 mp0 -82.86 88.28 6.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.975 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -64.99 -61.52 2.11 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.328 -170.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -89.87 -30.37 17.95 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.858 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.635 ' HB2' ' HB3' ' A' ' 155' ' ' GLU . 32.7 mt-10 -71.83 118.17 64.36 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 122.939 0.495 . . . . 0.0 110.139 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.03 89.8 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.789 2.326 . . . . 0.0 112.895 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.5 m -119.48 67.75 10.23 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.133 0.973 . . . . 0.0 108.631 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -38.12 -52.86 1.76 Allowed 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 124.318 3.345 . . . . 0.0 115.128 -162.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.444 ' O ' HG13 ' A' ' 166' ' ' ILE . 37.3 tt0 -72.99 -51.23 19.09 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.253 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 10.3 tpt -69.75 -46.45 65.84 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 118.13 0.423 . . . . 0.0 110.98 -173.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -50.19 -47.01 54.79 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.383 1.073 . . . . 0.0 110.212 171.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 168' ' ' GLN . 60.0 ttt180 -61.67 -45.05 95.65 Favored 'General case' 0 C--O 1.21 -0.994 0 O-C-N 124.145 0.903 . . . . 0.0 110.842 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.511 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 86.9 mt -53.76 -60.05 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 122.809 0.444 . . . . 0.0 110.584 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.3 p -62.12 -27.25 68.8 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.294 1.037 . . . . 0.0 113.787 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 1.4 pp0? -86.69 -33.89 19.9 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.16 -34.5 78.21 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.635 0.774 . . . . 0.0 110.413 174.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 28.7 mmt180 -57.2 -57.77 11.17 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 169.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -53.13 -37.02 53.63 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-N 114.707 -1.133 . . . . 0.0 115.138 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 168' ' ' GLN . 38.4 mm-40 -67.37 -54.78 17.5 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.069 0.548 . . . . 0.0 110.857 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.48 76.53 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.399 -173.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.404 ' CZ2' ' HG3' ' A' ' 9' ' ' ARG . 67.9 m95 -71.69 -36.13 70.48 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.981 0.513 . . . . 0.0 111.5 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.89 -36.18 83.52 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.467 0.479 . . . . 0.0 110.569 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -68.32 -40.65 81.59 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.176 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.405 ' CD1' ' HG2' ' A' ' 9' ' ' ARG . 42.2 mt -71.55 -49.79 37.37 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 123.275 0.63 . . . . 0.0 112.228 -176.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 p -61.85 -29.64 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 117.936 0.334 . . . . 0.0 110.804 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -87.74 -11.39 48.3 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 173.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 39.4 t -73.58 92.22 1.91 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 169.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 134.4 -36.89 2.03 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.096 -173.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 C--O 1.254 1.306 0 C-N-CA 123.459 0.704 . . . . 0.0 109.924 -178.647 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.52 0.2 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.44 21.31 4.74 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.517 0.727 . . . . 0.0 111.368 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -67.42 -45.88 74.82 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.076 0.551 . . . . 0.0 110.602 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.95 -58.69 4.79 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.629 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.433 ' HB2' ' OE1' ' A' ' 28' ' ' GLN . 22.2 pt20 -148.73 118.58 7.1 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.447 1.099 . . . . 0.0 108.282 173.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -121.34 114.83 21.89 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.789 0.836 . . . . 0.0 108.958 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -103.44 119.37 38.75 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.298 0.639 . . . . 0.0 111.05 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -104.81 122.58 46.04 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 165.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.491 ' HG3' HD11 ' A' ' 177' ' ' LEU . 17.0 ptp180 -91.76 155.11 18.5 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -159.18 -177.75 6.7 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.062 0.458 . . . . 0.0 111.033 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.497 HD12 ' HA3' ' A' ' 181' ' ' GLY . 0.3 OUTLIER -143.88 157.02 44.63 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.03 -176.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.463 ' H ' HD13 ' A' ' 11' ' ' LEU . . . -155.02 -172.95 23.23 Favored Glycine 0 C--O 1.239 0.445 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HD3' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -134.07 136.93 44.3 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -178.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -136.37 117.45 14.37 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -170.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.0 m -92.26 99.4 12.19 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.9 pt -104.06 161.21 23.61 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.233 1.013 . . . . 0.0 108.996 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -50.05 -28.9 20.33 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.36 2.706 . . . . 0.0 114.267 172.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.81 0.32 35.4 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.48 177.82 15.07 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 117.841 0.291 . . . . 0.0 112.894 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -70.57 91.6 0.8 Allowed 'General case' 0 C--N 1.348 0.516 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.46 157.08 26.3 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.068 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.3 165.7 11.42 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.8 p -136.95 140.7 42.41 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.595 HG12 HG23 ' A' ' 125' ' ' VAL . 2.7 pp -92.4 136.52 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 170.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 mp -122.74 114.93 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.3 mt -106.26 108.48 25.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.45 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 99.6 mtt180 -97.38 134.26 40.88 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 172.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 10.0 tt0 -158.91 142.04 14.64 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 124.023 0.827 . . . . 0.0 110.405 177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -116.55 121.77 42.74 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.439 ' O ' ' HA3' ' A' ' 107' ' ' GLY . 57.1 m-85 -94.9 148.23 22.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.689 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -83.61 34.46 0.49 Allowed 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.921 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.23 146.98 45.15 Favored Pre-proline 0 C--O 1.243 0.718 0 C-N-CA 124.045 0.938 . . . . 0.0 109.251 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.479 ' HG2' ' HG2' ' A' ' 36' ' ' GLU . 72.2 Cg_endo -67.86 169.03 17.1 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.871 2.381 . . . . 0.0 112.823 -175.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.1 t -53.0 -53.01 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 114.086 -1.416 . . . . 0.0 111.856 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -48.07 -47.14 34.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 124.283 0.989 . . . . 0.0 112.292 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.479 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 21.6 mm-40 -70.27 -27.52 64.49 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.985 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.458 HG21 ' HB ' ' A' ' 108' ' ' THR . 62.9 t -81.41 -36.08 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 123.862 0.726 . . . . 0.0 110.997 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -68.61 -36.81 79.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.678 0.791 . . . . 0.0 108.884 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -68.78 -55.41 11.35 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.672 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -58.61 -28.96 66.1 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.44 ' SG ' HD22 ' A' ' 99' ' ' LEU . 49.7 t -96.11 -24.95 16.06 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.1 p -105.08 -46.83 4.15 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 119.115 0.871 . . . . 0.0 112.007 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.18 125.77 88.87 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -176.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 58.0 Cg_exo -55.59 -35.02 91.93 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.652 2.901 . . . . 0.0 113.052 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -59.63 -17.88 37.14 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.38 1.472 . . . . 0.0 112.295 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -100.97 -42.42 6.42 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.374 1.07 . . . . 0.0 109.188 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.5 mt -73.69 -36.82 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.544 -167.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -58.25 -18.96 30.32 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -41.46 64.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.21 0.604 . . . . 0.0 112.024 173.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.422 ' CE2' HD13 ' A' ' 136' ' ' LEU . 66.7 p-90 -118.66 14.04 13.44 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -171.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.1 t80 178.07 -175.31 0.17 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.115 0.566 . . . . 0.0 109.797 -169.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -88.81 131.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HB2' ' HB3' ' A' ' 44' ' ' PRO . 13.5 pt-20 -75.64 140.48 71.54 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-N 119.438 1.017 . . . . 0.0 111.634 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.506 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 93.5 Cg_endo -83.75 111.51 1.73 Allowed 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.352 2.701 . . . . 0.0 112.742 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -78.24 133.53 37.7 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.176 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.77 -156.58 24.31 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.927 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.29 -47.95 46.14 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.145 0.978 . . . . 0.0 111.202 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.8 mt 62.69 29.54 16.83 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 124.472 1.107 . . . . 0.0 111.296 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -118.63 151.57 37.68 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.013 0.925 . . . . 0.0 109.129 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.688 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 3.9 tm-20 -64.54 103.66 0.7 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.39 0.676 . . . . 0.0 109.348 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.84 -32.45 4.79 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -175.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.99 -170.29 45.84 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.261 -0.469 . . . . 0.0 112.112 171.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 8.8 p30 -131.55 160.23 35.89 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.146 0.973 . . . . 0.0 112.43 -171.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 21.9 p90 -120.91 158.8 26.88 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.092 166.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.06 114.12 0.79 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 69' ' ' ASN . 80.6 mt -57.86 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 118.395 0.543 . . . . 0.0 111.734 -171.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -159.88 -29.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.392 0.615 . . . . 0.0 110.862 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -174.85 -31.15 0.03 OUTLIER Glycine 0 N--CA 1.466 0.688 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 91.3 m-20 -89.58 119.59 30.14 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 124.033 0.933 . . . . 0.0 108.491 171.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 72.38 122.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.946 1.298 . . . . 0.0 113.258 173.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.4 p -149.57 139.51 21.96 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.858 0.863 . . . . 0.0 108.847 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.57 -166.72 30.75 Favored Glycine 0 N--CA 1.464 0.551 0 O-C-N 123.233 0.333 . . . . 0.0 112.394 177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.532 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 17.9 m-20 -109.31 170.1 8.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.297 0.639 . . . . 0.0 110.515 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.504 HG13 HG22 ' A' ' 85' ' ' ILE . 2.3 mp -97.74 110.01 24.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 171.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.36 -59.88 2.5 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.053 0.845 . . . . 0.0 110.627 -173.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -136.49 150.08 48.5 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.567 1.147 . . . . 0.0 108.988 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.9 p -159.77 134.34 7.74 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.366 0.666 . . . . 0.0 109.295 172.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -134.91 98.86 12.82 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 60.3 Cg_endo -71.1 130.85 18.33 Favored 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 122.026 1.817 . . . . 0.0 111.877 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 14.5 Cg_endo -103.97 20.17 13.37 Favored 'Cis proline' 0 C--N 1.371 1.741 0 CA-C-N 119.411 0.825 . . . . 0.0 113.972 -3.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -54.4 -70.35 0.1 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.203 1.001 . . . . 0.0 111.465 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -145.0 159.67 42.57 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.933 0.397 . . . . 0.0 111.666 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 tt -135.91 113.63 11.01 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.8 m -109.26 128.34 54.99 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.424 1.49 . . . . 0.0 109.431 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.504 HG22 HG13 ' A' ' 74' ' ' ILE . 14.2 pt -121.25 173.09 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 125.109 1.364 . . . . 0.0 111.389 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.5 t -112.81 134.35 54.37 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.672 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 42.1 t-105 -126.53 105.67 8.9 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -167.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.9 t -110.88 144.29 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 21.2 t80 -148.75 151.03 34.14 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -65.12 110.37 2.5 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.139 0.576 . . . . 0.0 110.72 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 98.43 -20.39 50.63 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.3 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.495 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 70.3 mmtt -97.73 131.1 27.53 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.39 -73.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.891 2.394 . . . . 0.0 113.431 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -161.17 147.61 14.67 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.505 0.722 . . . . 0.0 109.364 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.672 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 19.8 m -141.97 158.96 43.16 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.728 0.811 . . . . 0.0 109.707 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -129.85 114.79 16.34 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 t -105.03 148.45 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -148.88 153.19 37.69 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.178 0.514 . . . . 0.0 110.65 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.44 HD22 ' SG ' ' A' ' 41' ' ' CYS . 39.7 tp -123.93 146.42 48.47 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 125.263 1.425 . . . . 0.0 107.372 175.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -140.97 109.9 6.11 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.53 148.8 22.11 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.686 0.794 . . . . 0.0 110.694 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.1 t -160.64 135.01 7.29 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 167.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.93 146.92 50.83 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.964 0.906 . . . . 0.0 109.831 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -164.52 108.76 0.94 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.907 1.283 . . . . 0.0 108.861 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.95 -132.01 10.83 Favored Glycine 0 C--N 1.342 0.885 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 172.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -92.42 31.59 1.3 Allowed 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.223 1.009 . . . . 0.0 110.245 171.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 30' ' ' TYR . . . -171.62 -150.43 7.14 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 120.452 -0.88 . . . . 0.0 114.883 -174.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.458 ' HB ' HG21 ' A' ' 37' ' ' VAL . 62.8 m -151.09 141.17 22.13 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.204 0.602 . . . . 0.0 111.079 -170.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.5 tp -90.38 144.53 25.73 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.033 0.933 . . . . 0.0 109.378 171.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.437 HD11 ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -127.14 143.64 51.22 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 166.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.45 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 40.9 mt-10 -122.57 107.51 12.07 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 167.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.464 HD22 HD21 ' A' ' 133' ' ' LEU . 27.7 tp -99.16 104.4 16.37 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 50.8 tt0 -102.69 116.95 33.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.357 0.663 . . . . 0.0 110.429 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -108.03 120.07 41.26 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -113.83 118.38 34.07 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.756 0.822 . . . . 0.0 110.831 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.1 t -139.16 159.94 40.98 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.241 0.616 . . . . 0.0 111.076 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 50.4 p -89.86 -20.61 23.23 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.221 1.008 . . . . 0.0 111.76 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.8 m -86.71 123.5 31.94 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.231 0.612 . . . . 0.0 109.995 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.593 ' HA ' HD12 ' A' ' 122' ' ' LEU . 28.8 tt0 -73.42 -30.39 63.2 Favored 'General case' 0 C--O 1.25 1.102 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -170.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -60.89 -58.9 6.5 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 23.8 ttt -49.44 -32.7 12.41 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 124.782 1.301 . . . . 0.0 112.67 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.593 HD12 ' HA ' ' A' ' 119' ' ' GLU . 36.7 mt -61.24 -52.59 64.11 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.869 0.468 . . . . 0.0 111.896 175.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 127' ' ' VAL . 48.0 t -63.26 -50.04 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -45.05 -54.11 7.06 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.927 1.691 . . . . 0.0 113.574 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.595 HG23 HG12 ' A' ' 24' ' ' ILE . 30.5 m -75.93 -24.18 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 122.422 0.289 . . . . 0.0 110.807 -177.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.17 96.1 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 169.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 123' ' ' VAL . 58.8 t -78.17 -59.33 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -48.77 -56.45 9.82 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 114.517 -1.22 . . . . 0.0 114.023 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -65.42 -49.73 68.1 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-O 118.829 -0.605 . . . . 0.0 112.402 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 119.05 0.841 . . . . 0.0 111.07 -171.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 89.7 mtp -75.56 -35.26 60.69 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.492 0.317 . . . . 0.0 110.518 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.72 -46.26 76.06 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.193 0.597 . . . . 0.0 110.89 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 112' ' ' LEU . 4.5 mm? -57.4 -38.14 73.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.332 1.053 . . . . 0.0 112.386 170.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.42 -38.37 90.9 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 120.856 0.36 . . . . 0.0 110.854 173.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -72.32 -25.18 61.46 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.459 0.704 . . . . 0.0 110.849 173.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.672 HD11 ' HB1' ' A' ' 40' ' ' ALA . 41.5 tp -71.01 -52.33 20.2 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 123.162 0.585 . . . . 0.0 109.561 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.78 -36.23 40.64 Favored Glycine 0 N--CA 1.472 1.081 0 N-CA-C 115.016 0.767 . . . . 0.0 115.016 169.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 85.2 mmm -61.44 -44.93 96.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.655 0.382 . . . . 0.0 110.47 170.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -68.12 -34.93 77.27 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.663 0.785 . . . . 0.0 111.953 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 67.1 mt -78.16 -61.65 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.346 0.658 . . . . 0.0 110.018 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -144.62 93.89 2.48 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.57 -17.65 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.305 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 68.31 99.14 0.06 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 125.969 1.708 . . . . 0.0 111.089 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 22.8 tp -111.6 94.81 24.7 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -75.15 -21.37 15.65 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 122.792 2.328 . . . . 0.0 112.367 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.8 -49.24 0.05 OUTLIER Glycine 0 C--N 1.334 0.463 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.41 177.43 50.57 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.735 -0.732 . . . . 0.0 112.698 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.34 -177.18 0.35 Allowed 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.352 2.702 . . . . 0.0 112.344 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.467 HG21 ' HB2' ' A' ' 152' ' ' ASP . 17.2 m -61.3 125.92 85.16 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.188 -177.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.01 -40.28 3.49 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.598 2.198 . . . . 0.0 111.041 171.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -155.61 89.59 1.19 Allowed 'General case' 0 C--N 1.346 0.437 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.467 ' HB2' HG21 ' A' ' 149' ' ' VAL . 21.9 t70 -71.38 -34.72 70.67 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.836 174.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 76.27 18.46 1.88 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.405 1.482 . . . . 0.0 113.049 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.37 79.95 7.6 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.707 0.765 . . . . 0.0 111.26 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -101.87 -63.97 1.1 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.651 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -117.9 84.58 2.19 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.994 0.902 . . . . 0.0 110.303 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -172.03 -64.66 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -134.29 101.62 12.2 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 169.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.416 ' HA ' ' SD ' ' A' ' 164' ' ' MET . 32.3 Cg_exo -59.75 106.13 0.31 Allowed 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.794 2.329 . . . . 0.0 111.322 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.405 ' N ' ' SD ' ' A' ' 164' ' ' MET . 15.9 m -81.12 103.41 1.94 Allowed Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.463 1.105 . . . . 0.0 110.401 -173.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.45 -52.38 7.8 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.005 2.47 . . . . 0.0 114.05 -167.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.413 ' O ' HG12 ' A' ' 166' ' ' ILE . 41.4 tt0 -67.81 -53.81 24.02 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.558 0.343 . . . . 0.0 111.877 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -43.22 76.32 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 123.016 0.198 . . . . 0.0 110.633 -170.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.416 ' SD ' ' HA ' ' A' ' 159' ' ' PRO . 78.6 mtp -63.75 -34.45 77.91 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.36 177.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.486 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 7.3 tpm_? -61.07 -49.89 75.5 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.32 0.387 . . . . 0.0 110.504 173.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 162' ' ' GLU . 36.6 mm -51.67 -52.74 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 124.411 1.084 . . . . 0.0 111.695 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.2 p -65.94 -51.91 54.39 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.586 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -53.56 -30.83 43.89 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 172.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 11.8 mm-40 -58.44 -50.24 74.41 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.641 0.655 . . . . 0.0 109.449 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -60.21 -52.72 64.11 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.185 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.75 -48.0 45.09 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 124.66 1.225 . . . . 0.0 115.955 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -74.8 -29.2 61.02 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.851 0.46 . . . . 0.0 111.391 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.89 -41.21 68.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.653 0.381 . . . . 0.0 110.037 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -74.79 -23.86 58.57 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.41 0.684 . . . . 0.0 111.255 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.491 ' HA ' HG12 ' A' ' 178' ' ' VAL . . . -75.24 -31.85 60.94 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.941 0.496 . . . . 0.0 110.393 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.72 72.26 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.289 0.636 . . . . 0.0 109.736 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 9' ' ' ARG . 95.4 mt -71.42 -61.17 1.87 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.102 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 175' ' ' ALA . 11.1 p -57.04 -39.21 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.588 0.755 . . . . 0.0 112.644 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -68.65 -26.66 65.44 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.234 0.614 . . . . 0.0 111.419 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 49.6 m -86.28 -22.64 26.69 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.989 0.516 . . . . 0.0 111.065 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.497 ' HA3' HD12 ' A' ' 11' ' ' LEU . . . -96.34 24.66 29.4 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 116.224 -0.443 . . . . 0.0 113.062 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.2 m . . . . . 0 CA--C 1.553 1.066 0 C-N-CA 123.454 0.702 . . . . 0.0 109.439 178.338 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.43 ' HG2' ' NH1' ' A' ' 141' ' ' ARG . 63.2 mtt . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 3' ' ' SER . . . 179.39 -14.73 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.232 1.413 . . . . 0.0 110.001 -174.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.404 ' H ' ' H ' ' A' ' 2' ' ' ALA . 23.9 m -54.83 -44.58 74.02 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.14 0.976 . . . . 0.0 111.308 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.96 79.25 1.73 Allowed Glycine 0 C--N 1.337 0.638 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -69.03 94.26 0.63 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 120.931 0.396 . . . . 0.0 110.479 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -70.86 84.47 0.67 Allowed 'General case' 0 C--N 1.346 0.417 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 166.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 33.1 m -130.31 103.12 6.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.86 0.864 . . . . 0.0 110.085 -176.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -92.23 142.04 27.91 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.143 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.76 145.17 41.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.317 0.647 . . . . 0.0 109.262 170.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -160.24 -175.42 5.04 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.882 0.873 . . . . 0.0 110.636 -170.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.6 mt -141.53 165.8 26.49 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.782 0.833 . . . . 0.0 110.889 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.91 -179.75 36.76 Favored Glycine 0 C--O 1.24 0.515 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.041 173.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -109.93 147.91 32.56 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 169.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -146.29 126.66 14.0 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -174.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.8 m -72.98 141.75 47.76 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.338 0.655 . . . . 0.0 110.026 175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.522 HD11 HG23 ' A' ' 117' ' ' THR . 49.3 pt -143.19 152.45 57.89 Favored Pre-proline 0 N--CA 1.478 0.938 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.26 -15.83 6.07 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.214 2.61 . . . . 0.0 115.042 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 93' ' ' PRO . . . -109.3 9.02 25.87 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -174.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.92 -165.58 26.17 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 119.021 0.828 . . . . 0.0 114.229 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -94.81 100.73 12.57 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 175.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.09 155.9 21.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.6 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' HB2' HD11 ' A' ' 122' ' ' LEU . 48.0 mtm180 -101.95 158.24 16.28 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 166.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.5 p -133.53 141.27 47.66 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.41 0.444 . . . . 0.0 111.218 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.527 HD13 HG23 ' A' ' 125' ' ' VAL . 36.0 pt -84.15 148.2 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 47.6 mt -133.83 110.85 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.544 HG22 HE22 ' A' ' 28' ' ' GLN . 7.0 mt -113.32 110.3 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.467 ' HB3' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -101.53 145.3 29.19 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.128 0.571 . . . . 0.0 110.217 176.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.544 HE22 HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -157.31 142.78 17.3 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 123.76 0.663 . . . . 0.0 110.992 175.018 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -104.57 107.27 18.13 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -87.52 144.3 26.78 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.774 0.83 . . . . 0.0 111.469 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -79.15 40.98 0.43 Allowed 'General case' 0 CA--C 1.566 1.575 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.133 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.0 150.08 70.32 Favored Pre-proline 0 N--CA 1.474 0.769 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -64.12 170.94 8.32 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.252 1.968 . . . . 0.0 113.168 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.78 -46.38 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.518 -171.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.61 -34.09 76.32 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.821 0.7 . . . . 0.0 110.99 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -63.73 -63.53 1.14 Allowed 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.443 0.465 . . . . 0.0 111.298 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.1 t -55.77 -31.8 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.194 0.997 . . . . 0.0 111.064 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -59.98 -56.87 16.29 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.962 0.505 . . . . 0.0 109.872 174.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.0 m -52.83 -42.08 64.82 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 124.035 0.834 . . . . 0.0 110.737 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -60.01 -34.6 73.57 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 82.4 m -95.58 -4.76 44.03 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.635 0.774 . . . . 0.0 113.07 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.2 p -118.02 -51.82 2.44 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 118.314 0.506 . . . . 0.0 111.936 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.51 117.02 30.38 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 123.784 0.834 . . . . 0.0 110.096 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -68.27 -20.06 43.4 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.197 2.598 . . . . 0.0 113.869 -170.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -71.38 -49.57 40.82 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -59.02 -37.99 78.23 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.576 172.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 73.5 mt -67.91 -35.72 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.039 0.535 . . . . 0.0 110.763 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -62.69 -17.45 60.65 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -73.04 -25.61 61.0 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -138.37 11.7 2.77 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -178.87 -178.76 0.56 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.251 0.621 . . . . 0.0 109.402 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.3 mt -91.0 137.01 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.999 0.92 . . . . 0.0 108.565 171.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.65 132.8 85.97 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.119 0.968 . . . . 0.0 111.442 175.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.12 120.28 2.93 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 122.476 2.117 . . . . 0.0 110.352 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -90.65 158.08 17.13 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.514 0.726 . . . . 0.0 111.062 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.71 -166.09 12.23 Favored Glycine 0 N--CA 1.466 0.634 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.178 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.76 -38.43 91.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.059 0.944 . . . . 0.0 111.755 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.2 mt 66.1 12.53 8.56 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.718 1.207 . . . . 0.0 112.518 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -126.82 154.53 44.19 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.139 0.976 . . . . 0.0 108.646 -176.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.93 121.6 10.95 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 123.869 0.731 . . . . 0.0 112.119 -175.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.47 -27.8 17.64 Favored Glycine 0 N--CA 1.475 1.29 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.946 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -97.87 170.4 25.12 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 165.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -119.17 161.39 20.42 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.617 1.209 . . . . 0.0 112.527 -169.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -105.83 172.17 6.95 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.244 168.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.34 143.27 7.32 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.444 1.098 . . . . 0.0 109.74 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.3 mt -116.84 167.73 10.85 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.073 0.949 . . . . 0.0 109.008 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -73.88 -42.78 60.22 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.023 0.529 . . . . 0.0 111.66 -171.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.17 16.83 2.12 Favored Glycine 0 N--CA 1.467 0.731 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.033 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -126.91 44.95 2.79 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.266 1.026 . . . . 0.0 108.694 -175.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 68.6 179.25 0.24 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.936 1.295 . . . . 0.0 113.729 175.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.3 p -145.09 140.69 28.23 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.542 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.03 177.7 32.13 Favored Glycine 0 N--CA 1.468 0.828 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.905 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -102.67 156.63 17.5 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.98 0.912 . . . . 0.0 110.128 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.3 mp -92.9 110.43 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.6 mt -73.4 -44.16 59.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.23 0.612 . . . . 0.0 109.796 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -160.52 140.18 10.99 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.273 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.8 p -141.54 126.68 18.45 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.21 1.004 . . . . 0.0 109.181 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -126.47 104.41 24.73 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 125.047 1.339 . . . . 0.0 107.39 -170.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 89.7 Cg_endo -80.27 131.32 8.61 Favored 'Trans proline' 0 CA--C 1.557 1.633 0 C-N-CA 122.353 2.035 . . . . 0.0 113.254 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 40.8 Cg_endo -101.05 34.32 7.75 Favored 'Cis proline' 0 C--N 1.377 2.066 0 CA-C-N 119.507 0.86 . . . . 0.0 111.482 -10.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -74.04 -77.87 0.11 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.375 1.07 . . . . 0.0 111.298 -170.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -152.11 157.85 42.16 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.197 0.599 . . . . 0.0 110.611 -174.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -141.41 132.13 25.68 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.059 0.543 . . . . 0.0 109.681 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 98' ' ' GLU . 58.5 m -118.73 120.13 36.49 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.298 1.039 . . . . 0.0 108.471 174.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 pt -121.19 144.59 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.865 0 C-N-CA 125.779 1.631 . . . . 0.0 108.63 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 74.5 p -84.01 170.44 13.93 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.149 -0.969 . . . . 0.0 110.169 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 30.4 t-105 -153.04 117.82 5.05 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -166.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.14 103.58 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.552 ' HB3' ' HG3' ' A' ' 92' ' ' LYS . 36.8 t80 -101.6 162.62 12.77 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.836 0.854 . . . . 0.0 109.381 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -51.75 111.64 0.63 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.912 1.285 . . . . 0.0 112.379 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.52 19.47 72.84 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.663 -0.698 . . . . 0.0 114.834 173.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.552 ' HG3' ' HB3' ' A' ' 89' ' ' TYR . 11.0 mmpt? -100.5 140.97 21.83 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 117.223 0.511 . . . . 0.0 109.76 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.546 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . 57.7 Cg_endo -69.14 -36.73 11.84 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.433 2.089 . . . . 0.0 112.401 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -174.33 153.94 2.05 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.117 0.967 . . . . 0.0 109.494 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.7 t -146.3 158.32 43.87 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.921 0.889 . . . . 0.0 108.764 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -147.69 115.09 6.29 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.243 0.617 . . . . 0.0 110.167 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.16 147.93 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.52 ' HB3' HG23 ' A' ' 84' ' ' THR . 0.0 OUTLIER -146.55 156.81 43.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.4 tt -145.75 137.73 25.33 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -130.11 139.92 50.86 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.754 1.221 . . . . 0.0 108.688 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 75.0 mt -120.79 132.34 54.97 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.064 0.945 . . . . 0.0 109.084 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.6 t -129.95 169.41 15.26 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.914 1.285 . . . . 0.0 108.219 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.49 130.52 55.54 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -173.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -144.12 111.66 6.03 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 58.42 -106.42 0.84 Allowed Glycine 0 C--N 1.346 1.116 0 O-C-N 123.538 0.524 . . . . 0.0 113.264 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -113.1 2.77 15.8 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.566 0.746 . . . . 0.0 111.185 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -127.44 -162.25 11.07 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.7 m -144.48 137.64 27.07 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.869 0.868 . . . . 0.0 110.523 -171.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 27' ' ' ARG . 43.3 tp -90.07 141.12 28.99 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 173.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.9 tt -124.69 115.81 21.35 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -108.83 106.12 15.98 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 98' ' ' GLU . 43.7 tp -105.57 104.64 14.4 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.69 0.796 . . . . 0.0 108.933 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 44.3 tt0 -107.75 119.69 40.16 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.272 0.629 . . . . 0.0 110.301 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -119.57 124.85 47.38 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -115.91 129.94 56.62 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.531 1.133 . . . . 0.0 112.04 -170.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.6 t -151.39 158.78 44.18 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.518 0.727 . . . . 0.0 110.335 171.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.522 HG23 HD11 ' A' ' 16' ' ' ILE . 22.0 p -77.52 1.32 19.77 Favored 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.435 1.094 . . . . 0.0 112.841 176.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.6 m -109.17 127.55 54.3 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.693 0.797 . . . . 0.0 111.919 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -67.62 -47.79 68.63 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.406 1.083 . . . . 0.0 112.167 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.5 -44.8 70.37 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.125 0.17 . . . . 0.0 111.017 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.403 ' O ' HG22 ' A' ' 125' ' ' VAL . 25.8 ttt -50.77 -41.35 56.7 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.942 0.776 . . . . 0.0 112.061 173.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.501 HD22 HG23 ' A' ' 24' ' ' ILE . 48.6 mt -59.66 -44.32 93.61 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.45 0.3 . . . . 0.0 111.087 175.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 127' ' ' VAL . 28.3 t -63.37 -56.02 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -48.72 -49.65 37.14 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.208 1.403 . . . . 0.0 112.992 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.527 HG23 HD13 ' A' ' 24' ' ' ILE . 22.5 m -77.23 -27.56 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 122.476 0.311 . . . . 0.0 110.316 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.1 -36.39 92.26 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 123' ' ' VAL . 60.5 t -81.17 -49.65 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.07 -60.08 8.97 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 114.312 -1.313 . . . . 0.0 113.759 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -58.08 -41.75 84.12 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 123.444 0.698 . . . . 0.0 111.953 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.61 ' HB3' HH11 ' A' ' 170' ' ' ARG . 21.4 mt-10 -64.97 -25.88 68.06 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 119.451 1.023 . . . . 0.0 112.311 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.9 mtt -75.69 -44.39 42.45 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.961 0.504 . . . . 0.0 109.773 174.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -61.21 -62.44 1.83 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.201 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.62 -26.98 64.27 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.381 1.472 . . . . 0.0 113.132 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 130' ' ' GLU . 18.0 t70 -60.0 -53.3 59.46 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 169.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -67.21 -26.06 66.42 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.36 0.664 . . . . 0.0 111.628 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.48 HD11 ' HB1' ' A' ' 40' ' ' ALA . 27.4 tp -62.91 -58.01 8.82 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.266 0.626 . . . . 0.0 110.234 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.28 -43.74 34.27 Favored Glycine 0 N--CA 1.475 1.289 0 N-CA-C 115.057 0.783 . . . . 0.0 115.057 170.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 96.4 mmm -65.27 -30.32 71.18 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.133 0.573 . . . . 0.0 111.552 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -77.3 -42.98 34.82 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.083 0.953 . . . . 0.0 111.015 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 45.1 mt -57.78 -55.88 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.805 0.842 . . . . 0.0 110.274 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.43 ' NH1' ' HG2' ' A' ' 1' ' ' MET . 48.7 ttp85 -175.53 81.94 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.68 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -148.46 17.66 1.3 Allowed Glycine 0 N--CA 1.464 0.511 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.957 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 32.0 t70 57.96 88.24 0.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.966 0.906 . . . . 0.0 109.841 -174.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.32 101.33 2.99 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 143' ' ' ASP . 75.2 Cg_endo -81.17 -25.84 3.76 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.657 2.238 . . . . 0.0 112.888 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.28 -79.3 0.15 Allowed Glycine 0 C--N 1.343 0.927 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.16 153.9 7.01 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.318 -0.712 . . . . 0.0 111.388 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.562 ' HG2' ' SD ' ' A' ' 163' ' ' MET . 91.2 Cg_endo -78.76 15.7 1.42 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.586 2.857 . . . . 0.0 113.341 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.492 ' HB ' ' HA ' ' A' ' 152' ' ' ASP . 4.4 m -106.32 123.07 40.05 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.33 1.052 . . . . 0.0 110.128 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -65.07 -50.23 2.26 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.902 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -109.4 -15.24 14.28 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.443 0.697 . . . . 0.0 110.847 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.492 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 28.8 t70 70.25 82.09 0.16 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.717 1.207 . . . . 0.0 110.498 -173.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -108.63 -41.11 4.89 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.675 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 62.81 16.77 9.35 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.793 1.237 . . . . 0.0 112.134 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -94.03 -16.49 23.82 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.338 1.055 . . . . 0.0 110.561 -175.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 70.26 23.05 5.23 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.216 1.407 . . . . 0.0 108.545 -162.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -76.16 -38.88 56.11 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -59.73 121.16 55.65 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.511 168.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.603 ' HA ' ' SD ' ' A' ' 164' ' ' MET . 77.2 Cg_endo -84.02 28.28 0.58 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.453 2.102 . . . . 0.0 112.074 172.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.9 p -73.91 112.82 18.18 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.396 1.078 . . . . 0.0 110.306 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -42.51 -56.34 2.15 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 124.766 3.644 . . . . 0.0 115.566 -171.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.427 ' O ' HG12 ' A' ' 166' ' ' ILE . 44.8 tt0 -63.26 -43.92 96.62 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 123.488 0.493 . . . . 0.0 112.186 -175.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.562 ' SD ' ' HG2' ' A' ' 148' ' ' PRO . 5.0 tpt -65.48 -41.95 92.74 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.131 0.491 . . . . 0.0 110.456 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.603 ' SD ' ' HA ' ' A' ' 159' ' ' PRO . 80.4 mtp -65.78 -35.37 80.52 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.575 176.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -63.28 -38.23 90.35 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.822 0.849 . . . . 0.0 110.558 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.451 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 42.7 mm -63.23 -45.44 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 175.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.6 t -63.91 -30.99 72.02 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.514 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -71.47 -59.96 2.49 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.348 0.659 . . . . 0.0 110.173 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.17 -43.63 87.57 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.924 0.89 . . . . 0.0 112.481 -175.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.61 HH11 ' HB3' ' A' ' 130' ' ' GLU . 19.7 mmt85 -74.08 -41.37 61.8 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -56.0 -35.65 64.74 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.408 -0.814 . . . . 0.0 113.721 174.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -78.24 -42.92 29.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.699 0.8 . . . . 0.0 110.475 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -54.26 -47.7 72.0 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 124.18 0.925 . . . . 0.0 110.934 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.413 ' CZ2' HG12 ' A' ' 26' ' ' ILE . 97.1 m95 -83.44 -27.37 29.57 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.904 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.35 87.75 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 171.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.9 -45.76 93.36 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.476 0.71 . . . . 0.0 110.773 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.08 -57.62 6.47 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.546 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.96 -31.79 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 122.847 0.459 . . . . 0.0 111.915 -168.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -66.65 -29.2 69.16 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.356 0.662 . . . . 0.0 110.668 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 33.4 t -76.44 85.06 3.17 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 171.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 176.7 23.95 0.03 OUTLIER Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.626 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--O 1.254 1.334 0 C-N-CA 123.942 0.897 . . . . 0.0 109.001 -178.886 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.38 -35.99 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.958 0.903 . . . . 0.0 110.148 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m -75.15 77.66 2.3 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.142 0.577 . . . . 0.0 109.639 175.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.99 56.91 0.03 OUTLIER Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.156 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 29' ' ' ARG . 98.9 mt-30 59.56 58.38 2.93 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.073 1.349 . . . . 0.0 112.455 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.46 158.42 18.97 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.884 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.1 m -120.33 115.35 23.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.555 0.742 . . . . 0.0 110.451 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 32.1 mt-10 -89.55 136.95 32.73 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -111.3 142.13 43.94 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.811 0.445 . . . . 0.0 110.313 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.37 127.57 7.7 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.931 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.759 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -85.56 121.97 29.01 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.59 -154.82 12.1 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-O 121.332 0.407 . . . . 0.0 113.376 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 48.3 ptt85 -148.09 148.28 30.46 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.245 1.018 . . . . 0.0 109.712 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 27.8 tpt180 -168.93 120.39 0.75 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.429 0.691 . . . . 0.0 109.46 -176.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.2 m -83.21 97.6 8.94 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.9 pt -78.3 160.44 73.05 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.369 1.068 . . . . 0.0 110.295 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.3 -21.24 22.3 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.453 2.769 . . . . 0.0 114.463 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.9 -53.14 22.77 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 170.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.7 -157.38 27.62 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.225 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.472 ' HB3' HH22 ' A' ' 22' ' ' ARG . 48.9 mt-10 -68.74 106.15 2.55 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.253 0.621 . . . . 0.0 110.651 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -114.71 153.42 30.3 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.572 0.749 . . . . 0.0 111.401 -175.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.472 HH22 ' HB3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -91.67 169.71 10.51 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 164.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -141.71 142.49 33.31 Favored 'General case' 0 C--O 1.217 -0.63 0 O-C-N 122.305 -0.247 . . . . 0.0 110.946 -172.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.553 HG12 HG23 ' A' ' 125' ' ' VAL . 2.7 pp -98.73 144.8 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 168.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.519 HG12 ' HG3' ' A' ' 113' ' ' GLU . 44.3 mt -131.79 106.28 11.26 Favored 'Isoleucine or valine' 0 C--O 1.248 0.991 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -175.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 64.6 mt -101.7 107.54 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 49.0 mtp180 -107.17 133.56 51.58 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.292 1.037 . . . . 0.0 108.791 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.4 ' NE2' ' HB3' ' A' ' 133' ' ' LEU . 43.4 mt-30 -141.25 152.97 44.98 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.768 0.427 . . . . 0.0 110.068 176.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.547 ' NH1' HD13 ' A' ' 109' ' ' LEU . 67.3 mmt-85 -108.48 102.33 11.43 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -79.17 124.32 28.22 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.15 44.79 0.25 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 123.916 0.76 . . . . 0.0 111.295 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.88 148.06 37.57 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 125.292 1.437 . . . . 0.0 107.143 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.45 175.62 2.64 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.8 2.334 . . . . 0.0 114.487 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -73.59 -42.71 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.921 -171.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.35 -43.6 98.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.687 0.795 . . . . 0.0 110.508 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -59.96 -63.97 1.11 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.686 175.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.47 -34.49 46.85 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 124.177 0.991 . . . . 0.0 111.936 -175.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.407 ' HE3' HD12 ' A' ' 101' ' ' LEU . 67.7 t-105 -61.31 -58.47 8.1 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.994 0.518 . . . . 0.0 110.206 178.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 80.0 p -57.91 -46.11 85.48 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.886 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.557 ' HA ' ' HD2' ' A' ' 46' ' ' ARG . . . -53.43 -40.23 65.0 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 79.9 m -78.95 -16.81 56.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 50.3 p -108.31 -26.53 10.48 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 1.2 p30 -85.54 124.24 71.66 Favored Pre-proline 0 N--CA 1.484 1.241 0 CA-C-N 118.533 0.606 . . . . 0.0 110.325 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 50.9 Cg_exo -55.71 -27.34 60.83 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.971 3.114 . . . . 0.0 114.278 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -63.48 -53.51 50.97 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.322 1.014 . . . . 0.0 110.665 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.557 ' HD2' ' HA ' ' A' ' 40' ' ' ALA . 65.8 mtt85 -71.32 -32.27 68.38 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 118.954 -0.546 . . . . 0.0 112.117 175.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.473 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 82.7 mt -65.04 -39.43 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 118.129 0.422 . . . . 0.0 111.837 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.5 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 13.8 p30 -67.07 -11.68 57.82 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 15.4 mmt180 -72.14 -41.39 67.21 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.475 0.71 . . . . 0.0 111.161 170.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.505 ' HB2' ' O ' ' A' ' 132' ' ' ALA . 70.5 p-90 -115.77 9.35 15.1 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -170.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -173.42 180.0 2.01 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -170.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.1 mt -84.88 133.59 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 170.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 34.0 tt0 -67.34 127.23 93.41 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.724 1.21 . . . . 0.0 111.001 -171.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 89.9 Cg_endo -79.88 102.14 1.43 Allowed 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.797 2.332 . . . . 0.0 111.045 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.43 160.49 24.02 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.634 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.19 -171.76 15.09 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.96 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.52 -47.91 66.36 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.001 1.72 . . . . 0.0 112.277 -174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.9 mt 69.23 0.66 2.93 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.293 1.437 . . . . 0.0 113.474 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -103.01 154.83 18.84 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.703 0.801 . . . . 0.0 110.028 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -63.96 107.09 1.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.615 0.766 . . . . 0.0 111.233 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 122.2 -24.48 6.96 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -176.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.0 -161.74 37.72 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -141.13 157.32 45.44 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.95 1.375 . . . . 0.0 111.212 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 25.8 p90 -101.32 171.72 7.42 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 114.155 -1.384 . . . . 0.0 107.59 163.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -165.83 135.39 3.35 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.596 1.159 . . . . 0.0 109.024 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.9 mt -93.05 174.63 7.13 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.597 0.759 . . . . 0.0 109.817 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -106.18 134.37 49.43 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 171.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 53.84 36.34 55.14 Favored Glycine 0 CA--C 1.532 1.1 0 O-C-N 124.927 1.392 . . . . 0.0 114.873 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -149.95 -95.66 0.07 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.04 -179.16 5.93 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.195 0.598 . . . . 0.0 110.841 -171.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.1 p -152.05 146.2 25.36 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -151.61 146.73 15.81 Favored Glycine 0 N--CA 1.47 0.965 0 CA-C-N 118.823 0.738 . . . . 0.0 112.346 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -80.94 148.81 29.66 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.501 0.721 . . . . 0.0 110.278 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mm -83.26 95.05 3.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 86' ' ' SER . 67.2 mt -70.77 -50.0 40.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.38 0.672 . . . . 0.0 110.41 -173.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -155.76 130.31 9.02 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.37 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 88.7 m -116.25 136.05 53.35 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 167.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -133.34 88.15 36.06 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 95.0 Cg_endo -76.75 136.63 17.14 Favored 'Trans proline' 0 CA--C 1.559 1.768 0 C-N-CA 122.775 2.317 . . . . 0.0 112.425 -175.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 40.8 Cg_endo -102.81 27.76 11.52 Favored 'Cis proline' 0 C--N 1.381 2.26 0 CA-C-N 119.468 0.846 . . . . 0.0 113.256 -5.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.43 ' NH1' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -77.14 -74.63 0.24 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.349 0.66 . . . . 0.0 110.179 -174.03 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -147.9 160.75 42.46 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.25 0.62 . . . . 0.0 110.772 -171.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -141.95 127.91 19.5 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.494 0.718 . . . . 0.0 109.215 171.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.7 m -104.5 112.26 25.25 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.514 HG13 ' HB ' ' A' ' 97' ' ' VAL . 15.3 pt -110.05 170.56 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.465 1.106 . . . . 0.0 109.544 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.495 ' HB3' HD11 ' A' ' 75' ' ' LEU . 23.3 p -105.37 170.9 7.62 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 69.3 t-105 -146.04 92.85 2.25 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -175.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.65 101.92 13.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -117.71 127.37 53.85 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.14 126.99 30.38 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.909 0.883 . . . . 0.0 110.855 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.38 -54.18 0.81 Allowed Glycine 0 C--N 1.349 1.287 0 O-C-N 123.496 0.497 . . . . 0.0 112.512 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.577 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 0.0 OUTLIER -99.27 148.56 34.81 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 123.993 0.917 . . . . 0.0 110.0 -173.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -50.53 140.88 34.99 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 123.882 3.055 . . . . 0.0 114.21 -173.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.43 117.96 5.45 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.55 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 8.2 m -100.41 173.81 6.4 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.141 0.977 . . . . 0.0 110.636 -173.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -128.07 117.38 21.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.514 ' HB ' HG13 ' A' ' 85' ' ' ILE . 40.7 t -98.34 135.51 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.74 114.71 10.1 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.412 HD12 HD12 ' A' ' 112' ' ' LEU . 6.4 tt -111.43 126.51 55.02 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.43 ' HG2' ' NH1' ' A' ' 81' ' ' ARG . 23.8 ttm180 -132.42 105.32 7.2 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.899 0.88 . . . . 0.0 110.09 -165.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 110' ' ' LEU . 88.5 mt -97.1 139.25 33.38 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 110.985 176.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.7 t -138.68 174.16 10.83 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.695 1.198 . . . . 0.0 108.353 172.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -104.74 132.89 50.44 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.433 ' HG2' ' HE ' ' A' ' 29' ' ' ARG . 13.3 tp10 -147.69 99.64 3.13 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -169.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 58.47 -105.72 0.7 Allowed Glycine 0 C--N 1.35 1.314 0 C-N-CA 123.317 0.484 . . . . 0.0 113.966 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -100.93 -15.14 17.63 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.189 0.996 . . . . 0.0 110.43 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.62 -161.01 12.24 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.719 -169.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.2 m -142.79 134.2 26.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.248 1.019 . . . . 0.0 109.71 -173.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.547 HD13 ' NH1' ' A' ' 29' ' ' ARG . 33.6 tp -89.3 122.86 32.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 101' ' ' LEU . 9.0 tt -111.61 108.82 18.43 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.561 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 28.1 mt-10 -109.62 104.85 13.94 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.471 HD13 HD21 ' A' ' 133' ' ' LEU . 8.0 tt -102.0 101.05 11.39 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 171.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.519 ' HG3' HG12 ' A' ' 25' ' ' ILE . 32.7 tt0 -97.23 117.61 31.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.322 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.436 ' ND1' HG22 ' A' ' 97' ' ' VAL . 5.2 t60 -116.74 118.62 33.03 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.4 132.32 54.53 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.371 0.668 . . . . 0.0 111.328 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.711 HG21 ' HG3' ' A' ' 121' ' ' MET . 7.6 t -154.73 161.15 41.64 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.055 0.942 . . . . 0.0 110.27 176.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 75.7 p -88.53 -0.2 56.98 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.881 -166.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.0 m -120.19 129.61 54.18 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.589 0.756 . . . . 0.0 110.963 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -61.46 -41.23 96.9 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.095 0.958 . . . . 0.0 112.187 -174.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -63.68 -56.67 13.94 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.174 0.589 . . . . 0.0 111.229 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.711 ' HG3' HG21 ' A' ' 116' ' ' THR . 14.9 tpt -49.79 -34.25 18.93 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 123.939 0.775 . . . . 0.0 112.369 174.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.529 ' HG ' HG23 ' A' ' 116' ' ' THR . 17.5 mt -67.01 -47.27 71.99 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.678 0.791 . . . . 0.0 112.06 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 127' ' ' VAL . 59.8 t -60.86 -50.39 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -50.21 -46.18 54.38 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.28 1.432 . . . . 0.0 113.222 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.553 HG23 HG12 ' A' ' 24' ' ' ILE . 35.9 m -81.26 -26.41 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.693 0.397 . . . . 0.0 110.913 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.71 -38.33 96.28 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 171.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 170' ' ' ARG . 62.0 t -78.42 -50.71 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.679 0.792 . . . . 0.0 109.499 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.48 -62.32 6.32 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 114.412 -1.267 . . . . 0.0 113.9 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -63.27 -40.12 96.49 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 118.417 -0.801 . . . . 0.0 112.313 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.1 -40.73 96.86 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.868 1.213 . . . . 0.0 110.864 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 47.3 ttm -68.91 -36.92 78.58 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.744 0.818 . . . . 0.0 110.078 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 50' ' ' TRP . . . -65.07 -65.02 0.73 Allowed 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.864 0.727 . . . . 0.0 110.449 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.471 HD21 HD13 ' A' ' 112' ' ' LEU . 4.0 mm? -55.19 -30.24 59.53 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.05 0.94 . . . . 0.0 112.53 174.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.31 -45.2 84.44 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 118.216 0.462 . . . . 0.0 110.973 171.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -65.2 -31.52 72.73 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 123.519 0.512 . . . . 0.0 111.224 175.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.27 -48.09 79.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 172.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -45.59 -52.7 8.92 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.715 0.634 . . . . 0.0 113.982 166.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 91.2 mtp -63.52 -34.42 77.75 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.96 0.904 . . . . 0.0 111.603 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -69.66 -52.02 29.51 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.355 0.662 . . . . 0.0 110.209 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.4 mt -64.97 -29.39 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 124.186 0.994 . . . . 0.0 110.757 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.3 OUTLIER -65.93 -29.18 69.55 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.266 1.026 . . . . 0.0 109.6 175.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.32 1.21 62.65 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.847 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.38 -45.75 75.33 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.147 0.979 . . . . 0.0 111.023 -176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.1 mt -72.6 111.07 9.72 Favored Pre-proline 0 N--CA 1.485 1.3 0 C-N-CA 122.976 0.51 . . . . 0.0 109.875 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -97.69 -173.58 0.18 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 123.556 2.838 . . . . 0.0 112.901 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.67 77.98 2.05 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.87 168.59 33.43 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.219 -0.767 . . . . 0.0 111.924 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.73 157.7 46.12 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 123.641 2.894 . . . . 0.0 113.522 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 152' ' ' ASP . 28.9 m -75.09 121.04 84.4 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.554 175.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.09 -47.06 13.38 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.975 2.45 . . . . 0.0 113.724 -168.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.08 -17.59 61.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.636 0.774 . . . . 0.0 110.96 -177.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.495 ' HA ' HG23 ' A' ' 149' ' ' VAL . 33.3 t70 60.2 40.52 17.97 Favored 'General case' 0 C--N 1.367 1.345 0 C-N-CA 124.978 1.311 . . . . 0.0 110.439 177.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.47 ' HB3' ' HG2' ' A' ' 158' ' ' GLU . . . -164.89 96.85 0.73 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.594 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.86 -17.34 62.73 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.543 165.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -67.85 -28.71 67.78 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.075 1.35 . . . . 0.0 111.93 173.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 157' ' ' PHE . 3.7 tt0 70.75 -158.71 0.14 Allowed 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -166.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.431 ' H ' ' HG2' ' A' ' 156' ' ' GLU . 68.1 t80 65.91 54.74 1.0 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.376 1.084 . . . . 0.0 109.654 176.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 153' ' ' ALA . 0.0 OUTLIER -147.84 154.92 44.36 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.601 -174.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.54 87.04 1.3 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.199 1.933 . . . . 0.0 113.165 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 63.2 m -139.85 118.47 8.7 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 168.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -47.07 -43.26 25.32 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 124.165 3.243 . . . . 0.0 113.748 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 166' ' ' ILE . 7.8 mp0 -64.2 -54.46 33.2 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.396 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.5 mmt -70.73 -31.47 68.32 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 122.992 0.517 . . . . 0.0 112.051 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 75.5 mtm -70.45 -36.5 73.98 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.654 173.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.442 ' HA ' ' HG2' ' A' ' 168' ' ' GLN . 31.5 ttt180 -68.97 -43.66 74.51 Favored 'General case' 0 C--O 1.205 -1.266 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.63 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 162' ' ' GLU . 50.6 mm -59.65 -43.22 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 122.868 0.467 . . . . 0.0 110.06 177.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 33.1 t -51.53 -47.3 63.41 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.421 1.088 . . . . 0.0 112.411 172.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.442 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 10.4 pt20 -88.9 -25.28 22.2 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -63.42 -57.34 10.59 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.566 1.147 . . . . 0.0 110.079 173.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.546 ' HB3' HG22 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -60.16 -43.82 95.49 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.684 0.615 . . . . 0.0 109.828 173.468 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -54.71 -44.15 79.99 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 124.028 0.83 . . . . 0.0 113.195 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.26 -59.39 4.12 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.762 1.225 . . . . 0.0 109.866 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.449 ' O ' ' HG ' ' A' ' 177' ' ' LEU . . . -51.44 -57.05 10.04 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 124.997 1.435 . . . . 0.0 111.834 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -70.29 -25.86 63.53 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.725 0.81 . . . . 0.0 113.101 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.1 -36.62 64.26 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 118.177 0.444 . . . . 0.0 110.452 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.97 -35.09 74.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.908 0.483 . . . . 0.0 109.943 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.759 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 67.8 mt -69.47 -53.22 20.29 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.943 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.51 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 9.8 p -70.28 -29.3 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -173.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 48.4 m170 -80.22 2.41 24.51 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.874 0.47 . . . . 0.0 111.304 176.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 37.6 t -117.76 121.7 41.51 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.184 0.994 . . . . 0.0 108.354 171.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -114.52 70.62 0.24 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 112.195 -0.362 . . . . 0.0 112.195 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 CA--C 1.556 1.198 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.811 178.085 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.36 -31.76 54.57 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.275 0.63 . . . . 0.0 110.845 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.9 m 73.42 -73.2 0.1 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.038 1.335 . . . . 0.0 112.933 175.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.74 79.13 1.35 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -168.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -64.01 93.95 0.09 Allowed 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.405 0.621 . . . . 0.0 110.879 -175.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -78.11 73.34 4.67 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.294 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.2 m -97.1 120.65 37.86 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.739 0.815 . . . . 0.0 110.048 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -114.35 116.24 28.63 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.437 1.095 . . . . 0.0 109.024 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -76.22 139.36 41.14 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 170.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -152.63 170.61 19.8 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.06 0.457 . . . . 0.0 111.444 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 12' ' ' GLY . 0.7 OUTLIER -143.88 162.04 37.13 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -176.022 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.467 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -173.28 -160.71 22.28 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -137.65 151.68 48.54 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.072 0.949 . . . . 0.0 108.495 178.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -156.95 133.21 9.78 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.566 0.746 . . . . 0.0 109.298 -170.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 m -83.16 137.78 33.92 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 171.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.472 HD11 HG23 ' A' ' 117' ' ' THR . 47.7 pt -137.65 160.88 63.29 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.507 0.723 . . . . 0.0 109.1 -174.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -45.07 -31.29 5.52 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.984 3.123 . . . . 0.0 115.324 174.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.5 -41.75 65.61 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.042 0.537 . . . . 0.0 111.265 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.93 -150.09 21.67 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.913 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.8 115.82 9.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.587 0.755 . . . . 0.0 109.817 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -123.78 164.75 18.54 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.677 0.791 . . . . 0.0 110.907 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -112.61 161.95 16.23 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 168.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 p -138.81 128.99 25.5 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.47 0.308 . . . . 0.0 110.655 -168.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 45.5 pt -87.32 135.69 24.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 169.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 3.5 mp -112.99 110.75 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 171.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.9 mt -101.67 109.57 26.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HG3' HD11 ' A' ' 109' ' ' LEU . 59.7 ttm-85 -113.76 148.46 36.47 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.736 0.814 . . . . 0.0 110.385 -172.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.561 HE21 HD22 ' A' ' 110' ' ' LEU . 0.6 OUTLIER -165.91 138.22 4.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 124.215 0.947 . . . . 0.0 112.496 -176.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.494 ' NH1' HD13 ' A' ' 109' ' ' LEU . 46.0 mmt-85 -96.69 115.39 27.35 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.273 1.029 . . . . 0.0 108.84 167.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -93.67 147.93 22.57 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.765 0.826 . . . . 0.0 109.998 170.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.17 28.03 0.86 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.371 0.668 . . . . 0.0 111.352 172.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.46 151.78 44.74 Favored Pre-proline 0 N--CA 1.47 0.546 0 C-N-CA 124.451 1.1 . . . . 0.0 109.768 176.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' O ' HG23 ' A' ' 37' ' ' VAL . 61.2 Cg_endo -71.32 152.02 60.69 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.014 1.809 . . . . 0.0 111.026 172.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 80' ' ' PRO . 77.9 t -46.63 -49.85 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 124.444 1.098 . . . . 0.0 111.094 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -49.21 -47.2 46.36 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 125.371 1.669 . . . . 0.0 111.55 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.81 -34.84 72.15 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.305 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 33' ' ' PRO . 24.2 t -75.05 -32.41 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -71.48 -31.24 66.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.428 1.091 . . . . 0.0 110.179 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.8 m -75.09 -37.44 61.55 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -65.03 -44.64 88.47 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.266 0.626 . . . . 0.0 110.744 171.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.9 t -68.13 -24.86 65.05 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -176.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.9 p -113.85 -38.59 4.2 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -172.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.94 122.86 88.57 Favored Pre-proline 0 N--CA 1.484 1.274 0 CA-C-O 119.106 -0.473 . . . . 0.0 110.269 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -49.97 -51.68 10.41 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.868 3.045 . . . . 0.0 114.596 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -52.39 -33.54 43.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.844 1.258 . . . . 0.0 111.841 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.524 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 5.4 mmp_? -81.33 -38.45 26.71 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.862 0.465 . . . . 0.0 111.662 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 63.3 mt -73.39 -29.51 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -57.68 -24.64 57.79 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.033 1.733 . . . . 0.0 112.084 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -87.89 -60.21 2.03 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.382 0.673 . . . . 0.0 110.208 -173.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.416 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 69.5 p-90 -82.29 -15.04 54.39 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.416 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 14.8 t80 -140.27 -108.41 0.15 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.414 HD13 ' HB2' ' A' ' 69' ' ' ASN . 89.2 mt -143.01 144.25 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.627 0.771 . . . . 0.0 109.52 -169.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -59.44 109.52 2.0 Allowed Pre-proline 0 CA--C 1.57 1.715 0 O-C-N 125.31 1.631 . . . . 0.0 111.654 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HB3' HD23 ' A' ' 66' ' ' LEU . 63.5 Cg_endo -100.06 156.83 0.52 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.208 2.605 . . . . 0.0 113.82 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -144.73 159.0 43.56 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.6 1.16 . . . . 0.0 108.441 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 144.74 -148.2 19.84 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -77.62 -53.69 7.28 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.376 0.67 . . . . 0.0 109.423 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt 59.88 19.7 8.65 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.617 1.167 . . . . 0.0 110.962 -170.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -114.55 149.65 36.17 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.678 1.191 . . . . 0.0 109.153 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 42.3 tt0 -59.7 122.27 13.73 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.476 0.71 . . . . 0.0 110.88 -177.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.67 14.77 64.8 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.908 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -115.8 -147.54 9.03 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -151.26 172.64 15.55 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.491 0.662 . . . . 0.0 111.605 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.63 164.94 26.08 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.897 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.37 122.13 9.28 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.037 0.935 . . . . 0.0 109.873 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.564 HD13 HD22 ' A' ' 69' ' ' ASN . 25.9 mt -89.8 142.11 28.0 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.624 1.17 . . . . 0.0 108.927 176.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.06 101.18 12.21 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.52 32.35 8.77 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.423 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.564 HD22 HD13 ' A' ' 66' ' ' LEU . 64.1 t30 -150.67 -88.09 0.07 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 117.32 0.56 . . . . 0.0 111.689 177.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.77 159.42 40.63 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 121.304 0.573 . . . . 0.0 112.207 -167.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.0 m -125.62 148.53 48.94 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.476 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.88 159.48 30.33 Favored Glycine 0 C--N 1.338 0.673 0 O-C-N 123.196 0.31 . . . . 0.0 112.381 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.43 164.34 14.32 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.638 0.775 . . . . 0.0 110.586 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 mm -106.72 103.75 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 72.2 mt -80.03 -43.08 22.54 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.79 0.436 . . . . 0.0 111.053 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -166.49 146.74 6.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.131 0.572 . . . . 0.0 109.521 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 12.8 p -160.37 110.77 1.82 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.749 0.42 . . . . 0.0 111.155 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.79 112.4 60.3 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 169.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 70.9 Cg_endo -75.52 132.39 14.7 Favored 'Trans proline' 0 CA--C 1.558 1.707 0 C-N-CA 122.153 1.902 . . . . 0.0 111.897 169.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 43.8 Cg_endo -98.97 21.71 23.32 Favored 'Cis proline' 0 C--N 1.375 1.949 0 CA-C-N 119.659 0.914 . . . . 0.0 112.967 -4.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 91.9 mtt-85 -66.79 -68.41 0.38 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.151 0.98 . . . . 0.0 112.982 -171.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.466 ' HB3' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -154.58 148.96 26.14 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 118.627 0.648 . . . . 0.0 112.491 -174.358 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 66.5 tp -108.14 145.45 34.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.342 1.457 . . . . 0.0 108.572 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.7 m -137.49 125.85 23.32 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.2 pt -144.01 147.37 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.502 1.121 . . . . 0.0 110.211 -170.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.3 m -88.33 154.28 20.52 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 166.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 43.7 t-105 -134.98 106.74 6.96 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -174.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.02 107.43 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -94.34 162.98 13.61 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -48.76 111.24 0.44 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.237 1.415 . . . . 0.0 112.648 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.65 25.4 75.77 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 124.023 0.827 . . . . 0.0 113.88 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -116.03 159.73 38.19 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.796 0.838 . . . . 0.0 110.334 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.33 167.25 26.81 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.323 2.015 . . . . 0.0 110.98 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -69.25 108.88 3.84 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.415 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.5 m -83.92 167.02 17.35 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.381 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.03 119.98 18.57 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 40.6 t -130.13 145.15 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.591 1.157 . . . . 0.0 109.605 -165.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -135.57 145.25 46.77 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.97 -0.456 . . . . 0.0 109.887 171.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.406 ' HG ' HD21 ' A' ' 110' ' ' LEU . 9.2 tt -123.38 115.64 21.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 172.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.466 ' HA ' ' HB3' ' A' ' 82' ' ' ARG . 41.6 ttp180 -121.93 117.47 26.51 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.98 0.512 . . . . 0.0 110.462 -171.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.4 mt -95.55 132.17 40.96 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.321 1.048 . . . . 0.0 109.525 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.8 m -137.23 125.66 23.46 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.653 1.181 . . . . 0.0 107.985 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.97 152.12 28.61 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.362 1.065 . . . . 0.0 110.45 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -167.19 85.95 0.26 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.403 0.681 . . . . 0.0 110.617 -162.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.31 -137.3 23.56 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -87.68 51.99 2.36 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 166.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.91 -165.24 31.5 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 114.547 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 90.9 m -148.01 132.92 18.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.203 0.601 . . . . 0.0 110.968 -171.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.494 HD13 ' NH1' ' A' ' 29' ' ' ARG . 32.6 tp -83.29 120.24 25.59 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.674 0.79 . . . . 0.0 109.486 167.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.561 HD22 HE21 ' A' ' 28' ' ' GLN . 7.3 tt -102.87 132.59 48.97 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 170.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -128.5 105.63 8.43 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.431 HD22 HD21 ' A' ' 133' ' ' LEU . 41.9 tp -101.47 133.01 46.76 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 33.1 tt0 -131.43 105.47 7.62 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.695 0.798 . . . . 0.0 108.943 175.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -96.26 115.55 27.62 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.54 107.37 15.42 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.575 0.75 . . . . 0.0 110.237 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.0 t -130.92 156.94 44.22 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.086 0.554 . . . . 0.0 109.684 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.472 HG23 HD11 ' A' ' 16' ' ' ILE . 68.7 p -74.35 -31.4 62.4 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.864 0.866 . . . . 0.0 110.535 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 m -79.38 111.41 15.6 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.999 0.92 . . . . 0.0 111.337 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 122' ' ' LEU . 45.3 tt0 -60.42 -30.93 69.93 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.907 0.883 . . . . 0.0 111.86 176.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -66.96 -49.41 65.53 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.61 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.5 ttt -59.8 -37.29 78.71 Favored 'General case' 0 C--O 1.203 -1.383 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.897 176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 119' ' ' GLU . 25.7 mt -61.54 -38.56 87.87 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 123.43 0.692 . . . . 0.0 112.404 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 62.6 t -65.85 -49.04 79.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.427 0.632 . . . . 0.0 109.826 173.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -62.55 -40.32 96.46 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.934 1.294 . . . . 0.0 111.832 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.8 m -83.62 -22.63 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.549 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.09 -34.84 85.56 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 168.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.5 t -80.98 -52.16 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.05 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.8 -38.13 95.7 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.339 -172.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -80.77 -39.43 26.84 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.923 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -61.48 -37.04 82.18 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 119.357 0.98 . . . . 0.0 109.636 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 93.1 mtp -69.4 -35.62 75.96 Favored 'General case' 0 C--O 1.218 -0.584 0 O-C-N 123.758 0.661 . . . . 0.0 110.723 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -58.68 -46.84 86.35 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.706 0.402 . . . . 0.0 110.701 174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.431 HD21 HD22 ' A' ' 112' ' ' LEU . 3.7 mm? -79.29 -20.38 48.16 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.278 0.631 . . . . 0.0 111.498 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -71.46 -42.92 67.54 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -81.54 -22.82 37.63 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.867 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 32.4 tp -71.26 -31.68 67.8 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -56.76 -52.96 47.49 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.978 164.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 94.4 mmm -63.61 -33.84 76.5 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.922 0.889 . . . . 0.0 112.334 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.422 ' HZ ' ' HD3' ' A' ' 46' ' ' ARG . 43.8 t80 -75.08 -51.42 13.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.766 0.826 . . . . 0.0 110.599 -174.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.0 mt -65.35 -28.97 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.009 0.924 . . . . 0.0 110.769 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER -63.04 -26.23 68.75 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.597 0.759 . . . . 0.0 109.593 174.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.4 2.74 41.07 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.162 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -93.44 -87.23 0.24 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.133 0.573 . . . . 0.0 110.424 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 45.45 76.1 0.58 Allowed Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 124.445 1.098 . . . . 0.0 110.531 -163.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.43 -0.67 10.81 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.271 2.648 . . . . 0.0 112.187 172.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.34 -114.6 4.77 Favored Glycine 0 C--O 1.24 0.474 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -169.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -110.48 94.39 0.79 Allowed Glycine 0 C--N 1.338 0.641 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.01 114.99 4.13 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.27 1.98 . . . . 0.0 110.879 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 21.1 m -64.12 111.55 5.67 Favored Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 123.141 0.576 . . . . 0.0 110.439 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.421 ' HG2' ' HG3' ' A' ' 151' ' ' GLU . 72.0 Cg_endo -71.6 -29.58 15.97 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.679 2.253 . . . . 0.0 112.821 -174.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.588 ' HG2' ' HB2' ' A' ' 162' ' ' GLU . 0.0 OUTLIER -110.24 -34.16 6.44 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.168 0.987 . . . . 0.0 111.019 -174.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 34.6 t70 55.44 88.21 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.152 1.381 . . . . 0.0 111.07 -174.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -141.2 97.51 3.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.701 0.8 . . . . 0.0 109.444 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.06 140.39 41.87 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.96 101.64 1.43 Allowed 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.407 0.623 . . . . 0.0 111.676 -172.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -94.53 -38.85 10.69 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.285 172.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -141.54 -60.59 0.48 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -89.57 130.62 42.71 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.934 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.71 -83.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.61 2.873 . . . . 0.0 113.436 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.4 m -154.14 85.94 3.8 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -174.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.86 -50.14 13.41 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.149 2.566 . . . . 0.0 112.768 -169.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.588 ' HB2' ' HG2' ' A' ' 151' ' ' GLU . 13.0 mp0 -72.01 -37.6 69.78 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.4 -175.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 15.0 tpt -72.58 -39.6 67.27 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 118.175 0.443 . . . . 0.0 111.058 -177.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 59.0 mtm -60.91 -36.5 79.44 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 173.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -68.22 -47.19 68.52 Favored 'General case' 0 C--O 1.206 -1.203 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.862 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.401 ' O ' ' HG3' ' A' ' 170' ' ' ARG . 72.9 mt -59.72 -35.35 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 124.468 1.107 . . . . 0.0 111.776 -178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.3 p -75.84 -53.35 8.59 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -176.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -59.99 -45.62 92.14 Favored 'General case' 0 C--O 1.205 -1.26 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.819 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -42.37 -49.96 5.12 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 124.61 1.164 . . . . 0.0 113.194 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 166' ' ' ILE . 54.3 mtt180 -63.86 -40.05 95.66 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 120.767 0.318 . . . . 0.0 111.084 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -77.39 -33.15 44.81 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.137 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 12.8 pt-20 -82.91 -18.32 40.56 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 123.829 0.851 . . . . 0.0 109.896 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.99 -51.45 58.31 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.676 0.79 . . . . 0.0 109.2 172.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -72.73 -34.2 66.91 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.7 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.504 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -65.25 -28.68 69.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.621 0.369 . . . . 0.0 110.926 174.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -76.62 -43.24 39.18 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.7 mt -63.63 -41.17 98.28 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.279 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.2 p -90.66 -26.43 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 118.426 0.557 . . . . 0.0 109.632 -166.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -75.35 -17.88 60.12 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.895 0.478 . . . . 0.0 110.795 173.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.8 m -83.76 -62.24 1.62 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.024 0.53 . . . . 0.0 109.912 172.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 63.5 36.66 93.67 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.095 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.249 1.049 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -175.783 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.97 95.43 6.78 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.1 p 66.78 -68.57 0.14 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 126.379 1.872 . . . . 0.0 112.887 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.48 9.71 71.91 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 -170.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -130.76 23.2 5.01 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.352 0.661 . . . . 0.0 110.22 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.67 88.61 7.37 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.136 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.9 m -104.75 104.12 13.86 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.444 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -80.06 135.9 36.45 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.136 0.494 . . . . 0.0 109.989 174.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -109.21 140.21 43.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.941 1.296 . . . . 0.0 109.227 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.65 -173.22 2.66 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.287 0.635 . . . . 0.0 111.272 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.622 HD13 HH11 ' A' ' 22' ' ' ARG . 81.3 mt -139.16 163.7 31.76 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.548 1.139 . . . . 0.0 109.502 175.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.68 -163.04 11.34 Favored Glycine 0 C--O 1.241 0.575 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.69 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.53 124.07 9.06 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 7.2 tpt180 -133.29 116.24 15.91 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -175.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.4 m -84.42 120.0 25.77 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 pt -110.88 163.57 16.96 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 124.9 1.28 . . . . 0.0 109.329 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -55.24 -24.19 40.71 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.392 2.728 . . . . 0.0 114.741 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.34 -22.2 61.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.24 0.616 . . . . 0.0 112.189 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.49 170.95 14.71 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -169.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -67.43 116.67 8.44 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 173.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -104.63 152.02 22.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.94 0.496 . . . . 0.0 110.151 -177.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.622 HH11 HD13 ' A' ' 11' ' ' LEU . 22.4 ttm-85 -97.8 154.41 17.64 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.6 p -123.71 143.27 50.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.737 0.415 . . . . 0.0 110.841 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.467 HG23 HD22 ' A' ' 122' ' ' LEU . 2.7 pp -90.92 135.66 26.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 166.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.595 HG13 ' HG2' ' A' ' 113' ' ' GLU . 1.7 mp -114.39 115.8 50.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -174.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.0 mt -114.69 106.46 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 170.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HB3' HD11 ' A' ' 109' ' ' LEU . 52.3 mtp180 -105.21 136.45 44.69 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.423 HE22 ' HB3' ' A' ' 133' ' ' LEU . 26.1 tt0 -144.61 136.47 25.88 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -176.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -92.81 103.06 15.45 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -86.39 122.57 30.54 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.191 0.996 . . . . 0.0 110.557 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.39 43.14 0.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.475 171.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.24 143.86 20.13 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 -174.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' A' ' 36' ' ' GLU . 21.3 Cg_endo -62.58 165.27 16.05 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.1 2.534 . . . . 0.0 114.633 -176.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.49 -45.09 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.405 -174.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.3 -35.51 79.26 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.438 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.603 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 8.5 tp10 -65.12 -62.76 1.36 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.957 -178.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 33' ' ' PRO . 11.3 t -53.37 -35.0 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.042 0.937 . . . . 0.0 111.078 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -62.5 -58.31 8.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.312 0.645 . . . . 0.0 110.664 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.6 p -59.18 -39.37 82.31 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.524 -177.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.4 74.1 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.799 171.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -80.33 -9.56 59.74 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 48.8 p -104.3 -32.3 9.14 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 122.824 0.45 . . . . 0.0 111.596 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.472 ' O ' HG13 ' A' ' 47' ' ' ILE . 10.2 t70 -79.96 116.28 60.11 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 123.882 0.873 . . . . 0.0 110.298 -174.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -61.91 -33.25 84.55 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 123.142 2.561 . . . . 0.0 113.195 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.413 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 13.9 m120 -70.42 -17.51 63.01 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.25 0.62 . . . . 0.0 110.89 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -101.59 -25.59 13.83 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.603 0.761 . . . . 0.0 110.853 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.506 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 76.4 mt -76.96 -40.22 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 122.908 0.483 . . . . 0.0 111.417 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.413 ' ND2' ' HA ' ' A' ' 45' ' ' ASN . 13.9 p30 -59.66 -21.83 61.06 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -60.12 -56.54 20.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.362 0.665 . . . . 0.0 110.91 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.506 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 36.3 p-90 -91.44 -54.74 3.78 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -172.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.449 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 10.7 t80 -108.46 -166.18 1.1 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.11 0.564 . . . . 0.0 109.638 176.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.8 mt -86.12 124.77 40.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 164.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.22 136.23 96.44 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 123.208 0.603 . . . . 0.0 110.695 176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.625 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 54.3 Cg_endo -68.67 131.12 22.08 Favored 'Trans proline' 0 C--N 1.362 1.251 0 C-N-CA 122.227 1.951 . . . . 0.0 111.76 171.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -89.87 155.71 18.96 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.425 0.69 . . . . 0.0 109.294 172.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.0 -163.01 17.87 Favored Glycine 0 N--CA 1.466 0.681 0 CA-C-N 116.364 -0.38 . . . . 0.0 113.057 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -62.26 -39.34 92.55 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.943 1.297 . . . . 0.0 111.202 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.0 mt 62.75 12.8 5.92 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.008 1.323 . . . . 0.0 114.342 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.0 mmm-85 -108.1 161.51 14.9 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.598 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 39.0 tt0 -67.18 109.38 3.04 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.594 0.757 . . . . 0.0 110.436 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.55 -23.33 11.18 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -175.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.93 -170.63 45.4 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 166.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -132.31 163.1 29.4 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.037 0.918 . . . . 0.0 110.946 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.625 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 20.2 p90 -119.82 165.28 14.79 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.114 175.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.687 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -166.83 102.65 0.56 Allowed 'General case' 0 C--N 1.348 0.524 0 C-N-CA 125.226 1.41 . . . . 0.0 107.824 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.435 HD11 ' CH2' ' A' ' 87' ' ' TRP . 70.7 mt -56.56 -65.74 0.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.397 0.679 . . . . 0.0 111.704 -171.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 132.49 -61.58 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 128.025 2.53 . . . . 0.0 109.177 171.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.86 31.52 8.09 Favored Glycine 0 N--CA 1.473 1.113 0 CA-C-N 114.643 -1.162 . . . . 0.0 113.16 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -158.27 -80.86 0.06 Allowed 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.83 -167.39 2.65 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.224 0.61 . . . . 0.0 111.019 -171.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 33.0 t -148.61 -166.11 2.46 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.1 -156.99 27.06 Favored Glycine 0 C--N 1.347 1.163 0 C-N-CA 121.554 -0.355 . . . . 0.0 113.609 171.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -141.45 146.53 36.61 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.917 0.887 . . . . 0.0 109.403 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.468 ' HA ' HG22 ' A' ' 85' ' ' ILE . 10.6 mt -96.61 106.5 18.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-O 121.497 0.665 . . . . 0.0 109.948 -177.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.63 -59.53 2.65 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.929 -171.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -146.3 155.03 42.36 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.268 1.027 . . . . 0.0 110.503 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 21.6 p -155.56 117.11 3.99 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 176.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -108.89 94.49 14.7 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.282 1.433 . . . . 0.0 107.458 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 98.0 Cg_endo -76.28 134.26 15.56 Favored 'Trans proline' 0 CA--C 1.566 2.098 0 C-N-CA 122.709 2.273 . . . . 0.0 113.06 -175.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 24.1 Cg_endo -99.07 24.86 19.44 Favored 'Cis proline' 0 C--N 1.385 2.487 0 CA-C-N 119.808 0.967 . . . . 0.0 112.285 -8.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -67.4 0.49 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.494 1.118 . . . . 0.0 111.084 -170.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -142.61 159.72 41.69 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.232 0.613 . . . . 0.0 110.604 -175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 tt -136.07 110.81 8.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.6 m -114.42 110.91 20.59 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.185 0.994 . . . . 0.0 109.077 -174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.468 HG22 ' HA ' ' A' ' 74' ' ' ILE . 23.3 pt -125.55 160.4 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.731 1.212 . . . . 0.0 109.792 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 58.7 p -83.84 -175.24 5.71 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.906 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.435 ' CH2' HD11 ' A' ' 66' ' ' LEU . 18.9 t-105 -170.18 100.59 0.28 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 120.673 0.273 . . . . 0.0 111.215 -169.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.3 t -92.01 103.5 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.648 0.779 . . . . 0.0 109.09 176.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.582 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -102.57 143.82 31.77 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -57.5 121.41 10.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.391 1.077 . . . . 0.0 111.778 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.54 -1.04 79.1 Favored Glycine 0 C--N 1.346 1.099 0 O-C-N 123.23 0.331 . . . . 0.0 113.762 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 47.0 mmtm -120.82 163.96 26.22 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 124.179 0.992 . . . . 0.0 109.598 -175.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.11 -178.26 4.07 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.635 2.224 . . . . 0.0 112.44 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.27 96.97 7.44 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.401 ' OG ' ' HB3' ' A' ' 87' ' ' TRP . 78.4 p -80.58 168.03 19.38 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.923 0.889 . . . . 0.0 110.895 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.24 119.14 29.3 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.641 0.777 . . . . 0.0 109.637 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.75 142.86 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.28 1.032 . . . . 0.0 109.327 177.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -139.8 115.84 10.36 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tt -99.36 124.0 44.11 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.656 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 32.3 ttt180 -126.25 105.22 8.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.412 0.685 . . . . 0.0 109.896 -173.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 91.0 mt -88.78 134.27 33.98 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.256 0.623 . . . . 0.0 109.822 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.6 m -125.71 171.89 10.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.706 1.202 . . . . 0.0 109.158 172.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.88 123.46 49.83 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -177.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -141.84 109.34 5.63 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -171.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 53.91 -103.86 0.19 Allowed Glycine 0 CA--C 1.531 1.089 0 O-C-N 123.976 0.797 . . . . 0.0 113.852 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -109.13 -9.12 15.06 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.608 1.163 . . . . 0.0 110.669 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.84 -163.74 13.28 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.064 -171.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.4 m -146.12 126.54 14.05 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.482 1.113 . . . . 0.0 109.225 -172.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 27' ' ' ARG . 44.7 tp -86.81 129.04 35.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 176.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.467 HD22 HD11 ' A' ' 133' ' ' LEU . 8.6 tt -108.67 108.81 19.81 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 100' ' ' ARG . 32.2 mt-10 -107.12 105.63 15.72 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.22 103.58 12.01 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.569 0.748 . . . . 0.0 109.935 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.595 ' HG2' HG13 ' A' ' 25' ' ' ILE . 38.0 mt-10 -100.3 115.1 29.14 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 173.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.408 ' HE2' ' HE2' ' A' ' 121' ' ' MET . 3.5 t-160 -107.85 113.25 26.33 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 172.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.18 117.62 33.08 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.91 0.884 . . . . 0.0 111.598 -168.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.7 t -143.6 155.83 44.4 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.663 0.785 . . . . 0.0 110.694 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 p -79.8 -8.38 59.24 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.188 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.2 m -98.62 117.68 33.61 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.652 0.781 . . . . 0.0 110.67 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.39 -37.05 85.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.578 0.751 . . . . 0.0 111.774 -178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -60.54 -54.74 41.85 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.694 173.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.496 ' HE3' ' HD2' ' A' ' 89' ' ' TYR . 26.8 ttt -49.63 -36.81 25.73 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 124.121 0.888 . . . . 0.0 113.026 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.467 HD22 HG23 ' A' ' 24' ' ' ILE . 63.6 mt -60.64 -47.92 84.1 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.916 0.486 . . . . 0.0 111.528 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.466 ' O ' HG23 ' A' ' 127' ' ' VAL . 46.9 t -62.48 -55.2 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 123.505 0.503 . . . . 0.0 109.796 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -43.61 -62.42 1.1 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.559 1.943 . . . . 0.0 113.038 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.2 m -66.52 -33.27 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 122.815 0.446 . . . . 0.0 110.575 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -58.82 -37.23 90.08 Favored Glycine 0 C--N 1.35 1.349 0 O-C-N 123.723 0.639 . . . . 0.0 112.136 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 123' ' ' VAL . 89.8 t -74.28 -45.7 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.167 0.587 . . . . 0.0 109.648 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.99 -61.25 7.65 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.833 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.463 ' HA ' ' HB3' ' A' ' 132' ' ' ALA . 20.0 m95 -51.76 -36.99 49.42 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -57.49 -44.18 84.72 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 120.016 1.28 . . . . 0.0 111.21 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 88.5 mtp -64.14 -46.89 82.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.698 174.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 129' ' ' TRP . . . -68.12 -22.98 64.86 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.667 1.187 . . . . 0.0 112.76 -176.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.467 HD11 HD22 ' A' ' 110' ' ' LEU . 2.7 mm? -86.58 -30.77 21.6 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.6 -37.83 55.8 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.681 0.792 . . . . 0.0 109.637 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -68.48 -46.28 70.14 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.266 0.626 . . . . 0.0 109.735 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.33 -24.24 66.49 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 122.972 0.509 . . . . 0.0 110.104 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -68.96 -54.8 12.51 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 8.6 mtm -68.52 -33.93 74.99 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.306 0.642 . . . . 0.0 111.332 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -62.62 -55.45 26.95 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.954 0.902 . . . . 0.0 110.686 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.0 tt -72.7 -26.39 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.936 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -77.28 -27.26 53.05 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.952 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.73 -84.14 0.07 OUTLIER Glycine 0 C--N 1.349 1.277 0 O-C-N 123.216 0.322 . . . . 0.0 113.808 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -95.92 -113.03 0.13 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 118.456 -0.783 . . . . 0.0 111.408 -162.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 50.0 87.57 0.13 Allowed Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 125.496 1.518 . . . . 0.0 111.417 -174.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.05 -13.62 15.57 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.854 2.369 . . . . 0.0 112.16 174.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.14 -178.31 18.67 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.278 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.29 62.78 0.07 OUTLIER Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.427 -0.652 . . . . 0.0 112.11 173.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.94 -52.64 1.15 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 122.802 2.335 . . . . 0.0 112.259 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.7 m -117.25 136.15 23.34 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 123.992 0.917 . . . . 0.0 110.367 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.599 ' HG3' ' HG3' ' A' ' 163' ' ' MET . 32.5 Cg_exo -62.39 -58.2 0.38 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.585 2.857 . . . . 0.0 112.753 174.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -134.03 -35.0 0.96 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.591 0.756 . . . . 0.0 110.604 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 31.5 t70 63.19 70.27 0.55 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.794 1.238 . . . . 0.0 110.166 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.78 53.53 1.68 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.461 1.105 . . . . 0.0 109.587 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 61.75 80.9 0.21 Allowed 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.993 -175.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.747 ' HB2' ' HA ' ' A' ' 159' ' ' PRO . 8.1 pt-20 -151.26 79.34 1.3 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.902 1.334 . . . . 0.0 110.737 -168.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -106.4 -62.02 1.44 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.874 -176.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -61.4 -44.45 97.12 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.656 1.183 . . . . 0.0 111.643 -171.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.483 ' HB2' ' SD ' ' A' ' 164' ' ' MET . 10.7 pt-20 -151.74 92.83 3.57 Favored Pre-proline 0 CA--C 1.557 1.242 0 C-N-CA 123.885 0.874 . . . . 0.0 108.794 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.747 ' HA ' ' HB2' ' A' ' 155' ' ' GLU . 35.5 Cg_exo -59.67 -76.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.996 2.464 . . . . 0.0 114.951 -172.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 43.2 m -147.77 147.4 27.15 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-O 118.545 -0.74 . . . . 0.0 109.458 -168.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.39 -46.24 32.64 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 124.167 3.244 . . . . 0.0 114.714 -166.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -68.72 -42.31 77.86 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.612 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.599 ' HG3' ' HG3' ' A' ' 150' ' ' PRO . 25.6 mmt -67.05 -35.85 80.78 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.242 0.617 . . . . 0.0 110.851 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.483 ' SD ' ' HB2' ' A' ' 158' ' ' GLU . 78.7 mtp -67.76 -41.2 83.72 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.608 0.763 . . . . 0.0 110.114 177.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -65.2 -46.38 80.93 Favored 'General case' 0 C--O 1.216 -0.687 0 O-C-N 123.805 0.69 . . . . 0.0 110.535 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 68.5 mt -58.98 -41.54 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.558 0.743 . . . . 0.0 111.046 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 46.8 t -62.0 -34.27 75.87 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.113 0.565 . . . . 0.0 111.102 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 164' ' ' MET . 78.7 mm-40 -72.32 -56.68 5.09 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.094 0.558 . . . . 0.0 110.024 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -48.85 -53.34 19.77 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.381 1.072 . . . . 0.0 112.299 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -70.84 -45.36 64.64 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.226 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -59.07 -58.87 12.23 Favored Glycine 0 C--N 1.35 1.36 0 O-C-N 124.148 0.905 . . . . 0.0 114.246 -177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -54.28 -43.73 71.3 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.152 0.981 . . . . 0.0 111.682 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.01 -38.24 87.9 Favored 'General case' 0 CA--C 1.55 0.979 0 O-C-N 123.675 0.609 . . . . 0.0 111.389 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -78.11 -24.47 47.47 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 119.201 -0.428 . . . . 0.0 112.03 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.91 -42.4 73.39 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -71.34 -26.53 62.86 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.258 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.498 HD22 ' HG ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -82.65 -49.23 10.03 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.597 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.44 -29.51 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.459 0.704 . . . . 0.0 112.533 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -64.89 -6.99 9.57 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 122.822 0.449 . . . . 0.0 111.321 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 8.5 t 74.92 102.67 0.07 Allowed 'General case' 0 C--N 1.353 0.721 0 C-N-CA 126.993 2.117 . . . . 0.0 112.737 164.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.8 21.36 11.45 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.528 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 35.8 p . . . . . 0 CA--C 1.556 1.19 0 C-N-CA 123.791 0.837 . . . . 0.0 110.232 175.904 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 tpp . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.81 73.61 2.75 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.565 0.746 . . . . 0.0 110.251 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -111.35 9.78 21.57 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.519 1.127 . . . . 0.0 110.31 -175.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.408 ' O ' ' HD2' ' A' ' 29' ' ' ARG . . . -86.4 57.17 4.74 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 29' ' ' ARG . 10.1 mm100 -110.49 98.49 7.68 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -174.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -153.54 -173.68 4.67 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.597 0.759 . . . . 0.0 110.567 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 55.5 m -115.27 108.94 17.22 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 124.856 1.262 . . . . 0.0 109.815 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -109.72 124.67 51.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.362 1.065 . . . . 0.0 109.268 -176.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -81.88 154.29 25.91 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.511 0.725 . . . . 0.0 110.895 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -160.06 172.83 16.8 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.31 0.644 . . . . 0.0 109.963 178.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.425 HD12 ' HA2' ' A' ' 181' ' ' GLY . 0.3 OUTLIER -148.5 141.68 25.04 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.887 -175.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.42 -151.52 5.44 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 175.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 32.3 ptt180 -144.66 170.81 15.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.353 0.661 . . . . 0.0 109.377 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -163.4 115.32 1.46 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 39.6 m -86.23 100.94 12.6 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.7 pt -93.88 168.76 11.15 Favored Pre-proline 0 CA--C 1.557 1.225 0 C-N-CA 124.738 1.215 . . . . 0.0 108.682 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.36 -17.49 27.02 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.865 2.376 . . . . 0.0 114.045 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.13 -0.33 56.95 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.95 178.31 15.26 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 118.214 0.461 . . . . 0.0 112.271 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -72.48 95.29 1.77 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-O 121.737 0.78 . . . . 0.0 109.984 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.65 166.32 19.26 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.29 174.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 20.2 ttm180 -118.42 161.1 20.54 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.448 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 79.7 p -134.11 144.16 48.42 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -173.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 37.4 pt -93.08 150.73 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 166.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 3.1 mp -129.22 116.03 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 59.8 mt -109.84 108.35 25.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 7' ' ' THR . 99.9 mtt180 -95.03 132.77 39.54 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.642 0.777 . . . . 0.0 109.919 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 73.8 mt-30 -143.41 140.19 30.31 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.316 1.01 . . . . 0.0 108.875 172.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.436 ' HB2' ' HA ' ' A' ' 5' ' ' GLN . 72.3 mtt180 -110.77 115.0 28.8 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 172.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -87.8 137.36 32.4 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.181 1.393 . . . . 0.0 110.008 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -78.52 38.07 0.3 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 123.936 0.773 . . . . 0.0 111.881 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.43 156.0 53.51 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 123.892 0.877 . . . . 0.0 108.771 -171.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.417 ' O ' HG23 ' A' ' 37' ' ' VAL . 72.5 Cg_endo -70.05 168.39 22.06 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 122.878 2.386 . . . . 0.0 113.695 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' A' ' 80' ' ' PRO . 89.0 t -67.47 -47.59 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.217 -172.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.34 -37.76 84.48 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.069 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -66.52 -63.49 1.06 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.99 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 33' ' ' PRO . 55.1 t -51.62 -34.26 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.739 1.216 . . . . 0.0 111.71 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.428 ' HE3' HD12 ' A' ' 101' ' ' LEU . 51.0 t-105 -58.46 -56.24 24.62 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.453 0.701 . . . . 0.0 110.198 176.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.9 m -57.17 -33.36 67.36 Favored 'General case' 0 CA--C 1.555 1.154 0 O-C-N 124.403 1.064 . . . . 0.0 111.396 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -68.15 -38.26 81.95 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 174.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.1 m -74.63 -27.76 60.58 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.232 0.613 . . . . 0.0 112.034 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.9 p -99.0 -46.19 5.69 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.196 0.598 . . . . 0.0 112.244 -172.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -63.84 119.13 51.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 123.221 0.609 . . . . 0.0 110.904 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.68 -29.07 87.63 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 123.621 2.88 . . . . 0.0 112.899 -176.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.4 -52.65 57.12 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.275 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -65.02 -31.0 72.02 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.733 173.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.503 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 40.5 mt -58.27 -41.6 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.255 0.622 . . . . 0.0 110.926 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -57.19 -29.13 63.43 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.994 0.918 . . . . 0.0 112.337 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -75.76 -5.35 45.36 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 123.667 0.787 . . . . 0.0 112.807 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.512 ' CD1' HD13 ' A' ' 136' ' ' LEU . 59.0 p-90 -149.2 4.31 0.61 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -165.83 -172.74 2.45 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -166.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.534 HD12 HD13 ' A' ' 66' ' ' LEU . 59.4 mt -86.61 140.86 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.076 0.95 . . . . 0.0 110.34 -171.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.68 110.93 3.61 Favored Pre-proline 0 N--CA 1.48 1.051 0 O-C-N 125.021 1.451 . . . . 0.0 110.225 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -90.88 179.61 1.69 Allowed 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.654 2.236 . . . . 0.0 112.799 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -152.39 157.55 41.42 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.101 0.96 . . . . 0.0 109.418 173.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.82 -166.94 25.51 Favored Glycine 0 N--CA 1.462 0.433 0 CA-C-N 116.623 -0.262 . . . . 0.0 113.608 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -78.45 -35.66 46.51 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.17 0.988 . . . . 0.0 110.334 178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.7 mt 67.58 10.98 8.14 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.239 1.416 . . . . 0.0 113.453 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -102.34 178.15 4.67 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.721 0.809 . . . . 0.0 110.637 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.48 99.81 0.79 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.577 1.151 . . . . 0.0 109.902 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.55 -11.79 58.08 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.185 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.76 -169.32 30.23 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 169.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 34.7 p30 -128.13 155.2 44.82 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.868 -0.784 . . . . 0.0 112.222 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -119.7 161.77 20.14 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 165.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -163.24 112.85 1.33 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.534 HD13 HD12 ' A' ' 52' ' ' ILE . 72.5 mt -66.42 164.0 17.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.378 0.671 . . . . 0.0 110.935 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -81.3 112.68 18.83 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 40.94 54.97 3.5 Favored Glycine 0 CA--C 1.539 1.581 0 N-CA-C 116.278 1.271 . . . . 0.0 116.278 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -143.97 -76.78 0.23 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 117.197 0.499 . . . . 0.0 110.31 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.405 ' HB2' ' HD1' ' A' ' 89' ' ' TYR . . . -145.36 160.93 40.79 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.287 0.635 . . . . 0.0 109.749 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 35.0 t -127.3 158.04 38.28 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.35 -171.28 31.39 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.222 -0.513 . . . . 0.0 114.043 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 4.4 m-20 -137.94 161.99 35.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.01 0.924 . . . . 0.0 109.621 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp -92.87 98.87 8.87 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.426 HD12 HG22 ' A' ' 84' ' ' THR . 97.4 mt -67.69 -46.38 72.43 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.095 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -161.31 115.11 1.97 Allowed 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 123.687 0.795 . . . . 0.0 109.965 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.3 p -98.12 114.91 27.25 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 164.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -127.12 84.93 62.21 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -170.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 92.3 Cg_endo -78.14 144.66 21.18 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.935 2.424 . . . . 0.0 113.182 -171.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.561 ' HB2' HG12 ' A' ' 34' ' ' VAL . 22.2 Cg_endo -97.78 23.95 22.54 Favored 'Cis proline' 0 C--N 1.374 1.907 0 C-N-CA 124.617 -0.993 . . . . 0.0 112.318 -8.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.684 ' HG2' ' HG3' ' A' ' 82' ' ' ARG . 60.7 ttt180 -73.09 -73.49 0.2 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.852 0.861 . . . . 0.0 111.167 -171.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.684 ' HG3' ' HG2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -155.36 158.7 39.1 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.424 0.69 . . . . 0.0 111.483 -178.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -130.27 129.25 43.04 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.426 HG22 HD12 ' A' ' 75' ' ' LEU . 19.4 m -103.08 135.7 44.25 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.223 1.409 . . . . 0.0 108.179 172.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.3 pt -131.19 163.4 37.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 C-N-CA 124.122 0.969 . . . . 0.0 109.648 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.5 t -101.42 148.34 25.29 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 24.7 t-105 -140.65 92.93 2.55 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 109.769 -172.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.8 106.75 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 58.2 t80 -90.05 163.31 14.95 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 169.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.67 118.73 6.95 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.785 0.434 . . . . 0.0 111.027 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.88 25.13 75.48 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.833 0.708 . . . . 0.0 113.287 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 73.8 mmtt -132.43 147.48 65.85 Favored Pre-proline 0 N--CA 1.488 1.438 0 C-N-CA 123.975 0.91 . . . . 0.0 110.003 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.48 -178.18 3.83 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.69 2.26 . . . . 0.0 112.854 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.91 87.74 0.55 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.48 0.712 . . . . 0.0 109.554 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.664 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.4 m -71.86 136.54 47.0 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.699 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -102.45 108.93 20.42 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -172.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.0 t -108.31 136.24 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.111 0.964 . . . . 0.0 108.662 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -138.05 115.93 11.54 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.006 0.922 . . . . 0.0 109.433 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.416 ' HB2' HD13 ' A' ' 112' ' ' LEU . 8.2 tt -105.31 130.56 53.41 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.541 ' HD2' ' HB3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -131.08 143.62 50.81 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.023 0.44 . . . . 0.0 110.392 -177.18 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.502 ' HB3' HG13 ' A' ' 34' ' ' VAL . 97.9 mt -132.43 123.7 27.2 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 125.247 1.419 . . . . 0.0 109.436 -174.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 t -151.97 138.43 18.58 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.872 0.869 . . . . 0.0 108.972 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.08 146.0 44.55 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.04 0.936 . . . . 0.0 111.783 -173.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -153.15 118.04 5.08 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.79 1.236 . . . . 0.0 107.924 172.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 64.11 -111.84 4.49 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 123.427 0.454 . . . . 0.0 113.003 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -111.74 5.66 19.29 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.035 0.534 . . . . 0.0 110.188 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.39 -153.97 8.87 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.087 -173.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.7 m -147.04 134.39 20.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.122 0.969 . . . . 0.0 109.568 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 42.4 tp -80.77 117.42 21.42 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 171.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.7 tt -101.23 106.13 17.31 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 164.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.541 ' HB3' ' HD2' ' A' ' 100' ' ' ARG . 35.6 tt0 -121.95 109.72 14.95 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.416 HD13 ' HB2' ' A' ' 99' ' ' LEU . 52.4 tp -107.17 114.35 28.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.551 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.448 ' HG3' ' HB2' ' A' ' 23' ' ' SER . 34.6 tt0 -94.06 127.2 39.73 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.249 0.62 . . . . 0.0 109.377 168.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -114.64 116.27 28.46 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 168.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.5 120.16 41.65 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.59 0.756 . . . . 0.0 110.291 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.3 t -139.45 154.82 47.83 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.258 0.623 . . . . 0.0 110.114 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.1 m -71.9 -16.29 62.12 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.458 1.103 . . . . 0.0 111.311 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 121' ' ' MET . 17.6 m -100.33 117.84 35.36 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.843 0.857 . . . . 0.0 110.201 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.621 ' HA ' HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -68.48 -29.25 67.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.806 0.842 . . . . 0.0 112.088 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -67.34 -54.41 20.88 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.532 0.52 . . . . 0.0 110.71 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.476 ' HB3' ' HB2' ' A' ' 118' ' ' SER . 28.1 ttt -50.13 -31.94 14.71 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.842 172.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.621 HD12 ' HA ' ' A' ' 119' ' ' GLU . 50.3 mt -65.44 -42.67 92.14 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.952 0.501 . . . . 0.0 111.96 174.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 127' ' ' VAL . 45.8 t -64.26 -51.05 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -44.31 -57.82 3.27 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.526 1.53 . . . . 0.0 112.754 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 121' ' ' MET . 30.7 m -75.68 -20.03 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 123.848 0.718 . . . . 0.0 110.726 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.72 -39.81 96.95 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 171.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 123' ' ' VAL . 48.4 t -74.73 -53.42 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.36 -61.45 7.21 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 114.537 -1.211 . . . . 0.0 114.207 -176.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -63.99 -39.49 94.24 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 118.405 -0.807 . . . . 0.0 112.922 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -58.57 -45.86 88.12 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 119.549 1.068 . . . . 0.0 110.375 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 40.8 mtm -67.08 -42.82 84.0 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.95 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.37 -61.16 2.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.63 0.772 . . . . 0.0 111.501 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.98 -33.67 69.14 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.205 0.602 . . . . 0.0 112.617 174.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.96 -37.33 82.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 118.321 0.51 . . . . 0.0 110.695 175.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -66.91 -40.13 87.58 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.985 0.514 . . . . 0.0 109.773 171.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.512 HD13 ' CD1' ' A' ' 50' ' ' TRP . 41.6 tp -64.46 -23.08 67.16 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.06 0.544 . . . . 0.0 110.52 175.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.38 -46.84 11.51 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -176.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.449 ' HB3' ' HB3' ' A' ' 143' ' ' ASP . 79.6 mtp -65.53 -42.17 92.28 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.85 0.86 . . . . 0.0 110.717 173.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.4 ' HD2' HD12 ' A' ' 136' ' ' LEU . 35.4 t80 -57.4 -55.55 33.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.06 0.944 . . . . 0.0 111.445 -175.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 44.2 mt -71.35 -28.21 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 123.326 0.391 . . . . 0.0 110.367 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -67.84 -16.58 64.16 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 122.936 0.495 . . . . 0.0 110.589 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.71 43.88 2.21 Favored Glycine 0 C--N 1.355 1.62 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 173.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 138' ' ' MET . 1.4 t70 -130.85 -168.48 2.0 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.746 0.818 . . . . 0.0 108.818 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.2 mt 66.96 73.34 0.38 Allowed Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 125.132 1.373 . . . . 0.0 111.26 -174.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.02 -38.48 94.66 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.141 2.561 . . . . 0.0 112.932 174.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -104.19 -56.69 0.73 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.434 -0.667 . . . . 0.0 111.434 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.59 -169.88 13.59 Favored Glycine 0 C--N 1.349 1.274 0 C-N-CA 123.762 0.696 . . . . 0.0 111.987 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -72.81 139.58 30.74 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.881 2.388 . . . . 0.0 111.669 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.1 m -62.22 147.25 91.41 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 122.677 0.391 . . . . 0.0 110.393 172.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.64 -24.49 77.87 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.348 2.032 . . . . 0.0 112.335 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -98.16 19.96 13.24 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.112 0.965 . . . . 0.0 111.539 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.87 82.94 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.955 1.302 . . . . 0.0 111.557 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -175.67 -40.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 112.922 -1.945 . . . . 0.0 109.478 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 64.15 -150.76 0.3 Allowed 'General case' 0 C--N 1.363 1.173 0 C-N-CA 124.744 1.217 . . . . 0.0 110.727 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 67.08 16.71 10.34 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.05 0.94 . . . . 0.0 111.9 175.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -50.34 -62.54 1.52 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.615 1.566 . . . . 0.0 110.315 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -166.75 -45.57 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -67.06 116.72 38.79 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.893 171.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.53 85.35 0.28 Allowed 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.662 2.241 . . . . 0.0 111.13 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.6 m -66.4 103.88 0.52 Allowed Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.908 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.75 -49.96 15.41 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.41 2.74 . . . . 0.0 114.13 -161.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.416 ' HA ' ' NH1' ' A' ' 165' ' ' ARG . 4.9 mp0 -65.81 -53.96 33.2 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.415 -176.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.0 tpt -76.84 -32.84 57.84 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.782 -169.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.403 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 21.6 ptm -71.04 -36.22 72.26 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 41.4 ttm105 -55.64 -47.8 76.02 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.895 0.878 . . . . 0.0 110.278 173.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.418 ' O ' ' HD3' ' A' ' 170' ' ' ARG . 99.9 mt -57.32 -52.31 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 O-C-N 124.17 0.918 . . . . 0.0 110.267 175.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.8 t -64.5 -25.0 67.8 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.358 0.663 . . . . 0.0 112.204 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 164' ' ' MET . 19.9 mm-40 -73.04 -47.68 42.71 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 174.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 12.1 mm-40 -58.48 -49.6 76.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.533 0.733 . . . . 0.0 111.658 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 166' ' ' ILE . 9.3 mpt_? -74.67 -48.39 26.45 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.648 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.46 -52.23 29.21 Favored Glycine 0 CA--C 1.535 1.332 0 O-C-N 123.791 0.682 . . . . 0.0 114.225 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -71.08 -31.23 67.56 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.518 0.727 . . . . 0.0 112.111 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.74 -56.91 7.44 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.926 0.491 . . . . 0.0 110.54 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -67.71 -22.19 65.27 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.522 0.729 . . . . 0.0 111.829 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.45 84.78 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.999 0.428 . . . . 0.0 110.077 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -75.97 -29.12 58.14 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.11 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 57.7 mt -74.66 -52.3 12.04 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.781 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.26 -29.15 45.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 122.51 0.324 . . . . 0.0 111.791 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -69.16 -6.82 31.1 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.286 0.634 . . . . 0.0 112.615 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.9 m -136.44 -164.24 1.53 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.029 1.331 . . . . 0.0 109.433 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.425 ' HA2' HD12 ' A' ' 11' ' ' LEU . . . -140.25 69.13 0.47 Allowed Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 177.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.0 t . . . . . 0 C--O 1.251 1.137 0 C-N-CA 123.944 0.898 . . . . 0.0 109.498 -175.449 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.81 -61.92 1.68 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.15 0.58 . . . . 0.0 109.834 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -80.34 91.07 5.61 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 31' ' ' ASP . . . -171.31 48.65 0.19 Allowed Glycine 0 C--N 1.343 0.964 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.048 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -175.94 92.09 0.05 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.276 1.03 . . . . 0.0 108.807 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -156.15 114.09 3.31 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.939 -176.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.6 m -93.84 119.75 33.19 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 3.5 tm-20 -114.87 127.87 55.96 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -106.39 156.52 18.44 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.23 0.538 . . . . 0.0 112.305 -173.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -161.91 -175.41 4.64 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.693 -171.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 mt -140.82 167.34 22.42 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.431 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.83 -162.59 16.19 Favored Glycine 0 C--O 1.246 0.888 0 CA-C-N 113.395 -1.729 . . . . 0.0 109.712 168.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.42 160.68 35.69 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 168.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -162.35 117.54 1.89 Allowed 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -173.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 92.3 m -87.58 98.0 11.17 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.2 pt -78.66 166.08 45.1 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 125.475 1.51 . . . . 0.0 110.537 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -46.27 -27.71 5.01 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 123.748 2.965 . . . . 0.0 115.038 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.71 -49.58 45.46 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.013 0.525 . . . . 0.0 110.839 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.99 -160.11 32.15 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-O 119.711 -0.494 . . . . 0.0 112.023 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.66 105.09 0.74 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.204 0.602 . . . . 0.0 111.104 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -107.96 154.41 21.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.935 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 23' ' ' SER . 7.0 tpp180 -83.95 155.66 22.71 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 165.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.469 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 77.0 p -132.41 135.14 45.9 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 110.919 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 2.9 pp -93.71 142.15 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 170.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -123.61 118.17 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -176.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.0 mt -111.27 106.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.583 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 66.9 mtt180 -92.09 147.66 22.78 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -156.42 130.64 8.64 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.86 106.85 19.16 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.544 1.138 . . . . 0.0 108.175 -172.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -90.71 134.0 34.73 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.691 0.797 . . . . 0.0 110.559 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.497 ' HB2' ' HA3' ' A' ' 4' ' ' GLY . 10.4 t70 -80.36 46.88 0.87 Allowed 'General case' 0 CA--C 1.563 1.447 0 CA-C-O 122.039 0.923 . . . . 0.0 110.236 170.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.27 154.79 57.75 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 123.928 0.891 . . . . 0.0 109.359 -171.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' O ' HG23 ' A' ' 37' ' ' VAL . 60.8 Cg_endo -71.26 165.74 31.47 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.579 2.186 . . . . 0.0 113.188 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 80' ' ' PRO . 88.7 t -73.21 -40.77 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.564 -172.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.18 -47.95 71.47 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.218 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -65.01 -64.47 0.86 Allowed 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.329 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 33' ' ' PRO . 48.3 t -50.01 -35.22 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.214 1.006 . . . . 0.0 111.667 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -58.62 -57.73 11.71 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.847 0.859 . . . . 0.0 110.209 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 m -61.22 -35.75 78.06 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.392 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.495 ' HB1' HD11 ' A' ' 136' ' ' LEU . . . -62.57 -33.62 75.33 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 122.05 -0.406 . . . . 0.0 112.082 172.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.443 ' HA ' ' HZ2' ' A' ' 50' ' ' TRP . 83.1 m -85.41 -18.28 34.13 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.663 0.785 . . . . 0.0 113.067 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 p -113.05 -40.21 4.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.18 111.33 5.25 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 123.657 0.783 . . . . 0.0 110.829 175.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.428 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 66.7 Cg_exo -54.13 -33.61 74.93 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 123.703 2.936 . . . . 0.0 113.868 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -61.04 -49.83 75.8 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -65.68 -35.37 80.57 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.516 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.509 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 87.9 mt -66.51 -41.46 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.556 0.743 . . . . 0.0 111.911 -174.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.527 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 27.5 p30 -60.21 -15.38 23.83 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -78.88 -45.78 19.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.828 0.851 . . . . 0.0 111.562 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.509 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 67.8 p-90 -108.59 8.17 27.01 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.258 0.623 . . . . 0.0 112.603 -172.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -174.47 173.83 2.87 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.319 0.648 . . . . 0.0 109.39 -168.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.1 mt -86.46 123.08 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 172.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 32.3 tt0 -63.32 130.35 94.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 125.793 1.637 . . . . 0.0 112.086 -174.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.601 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 83.0 Cg_endo -81.58 129.28 6.42 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.525 2.15 . . . . 0.0 112.154 175.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -93.85 160.36 14.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.873 1.269 . . . . 0.0 109.45 174.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.46 -168.79 15.63 Favored Glycine 0 N--CA 1.47 0.964 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -72.47 -36.79 68.56 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.212 0.605 . . . . 0.0 110.603 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.8 mt 71.9 -10.17 0.89 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.241 1.416 . . . . 0.0 114.095 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -86.39 171.03 11.46 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.535 0.734 . . . . 0.0 109.891 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.715 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 41.2 tt0 -67.82 102.22 1.2 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.248 0.619 . . . . 0.0 110.489 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.54 -15.07 17.56 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.85 -160.43 36.35 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -143.04 155.15 44.57 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.805 1.303 . . . . 0.0 111.188 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.601 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 17.1 p90 -106.02 163.35 12.83 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.464 166.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.94 108.05 0.86 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.218 1.007 . . . . 0.0 109.919 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.1 mt -69.29 170.67 9.82 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.449 0.7 . . . . 0.0 109.65 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -76.51 -17.95 58.99 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 122.084 -0.385 . . . . 0.0 111.805 -169.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.79 47.49 0.04 OUTLIER Glycine 0 N--CA 1.467 0.728 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -128.0 -62.3 1.06 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.156 0.982 . . . . 0.0 108.894 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.11 161.34 36.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.977 0.511 . . . . 0.0 111.205 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.6 p -152.81 130.74 11.75 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 86' ' ' SER . . . -161.19 174.61 37.79 Favored Glycine 0 C--N 1.344 1.005 0 C-N-CA 121.663 -0.304 . . . . 0.0 113.449 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -86.55 159.22 19.33 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.216 1.007 . . . . 0.0 111.05 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 mm -93.22 98.74 8.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.401 HD12 HG22 ' A' ' 84' ' ' THR . 87.0 mt -63.81 -51.78 63.2 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.794 0.838 . . . . 0.0 111.123 -174.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -160.78 152.45 19.58 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.661 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 26.2 p -148.13 138.25 22.65 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.57 0.748 . . . . 0.0 109.209 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -138.56 93.58 10.99 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.87 141.49 13.4 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.94 2.426 . . . . 0.0 112.703 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.422 ' HB2' HG12 ' A' ' 34' ' ' VAL . 18.3 Cg_endo -95.81 25.13 22.64 Favored 'Cis proline' 0 C--N 1.378 2.131 0 CA-C-N 119.537 0.87 . . . . 0.0 112.523 -5.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -78.99 -75.84 0.22 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.427 0.691 . . . . 0.0 111.673 -171.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -142.37 139.53 31.75 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 118.549 0.613 . . . . 0.0 112.39 -169.128 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.6 tp -124.48 124.41 42.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.939 1.696 . . . . 0.0 108.404 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.401 HG22 HD12 ' A' ' 75' ' ' LEU . 61.7 m -113.41 114.05 26.06 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.725 0.81 . . . . 0.0 109.917 175.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.0 pt -110.4 168.78 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 124.483 1.113 . . . . 0.0 110.431 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.447 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 14.4 m -103.51 136.39 43.33 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -175.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 44.6 t-105 -128.5 104.58 7.77 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.612 0.642 . . . . 0.0 110.402 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.29 103.67 15.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.539 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 47.2 t80 -90.22 163.66 14.71 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.751 0.82 . . . . 0.0 109.886 -177.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -52.52 106.49 0.16 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.864 1.265 . . . . 0.0 111.774 177.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.74 2.45 51.04 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 114.433 0.533 . . . . 0.0 114.433 175.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 41.5 mmtm -101.09 159.47 29.4 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.145 0.978 . . . . 0.0 109.262 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.95 -176.94 2.86 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.119 1.879 . . . . 0.0 112.113 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.58 144.75 56.24 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.178 174.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.5 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 30.0 p -146.99 156.34 42.96 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.121 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -116.23 117.58 30.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.487 0.715 . . . . 0.0 109.103 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 54.2 t -94.31 130.14 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 113' ' ' GLU . 36.2 mm-40 -116.72 111.93 20.48 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.131 1.772 . . . . 0.0 107.182 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.497 HD13 HD12 ' A' ' 112' ' ' LEU . 59.6 tp -107.33 114.0 27.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -119.65 137.85 53.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.138 0.975 . . . . 0.0 109.601 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 67.9 mt -127.7 142.8 51.23 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.562 1.145 . . . . 0.0 109.221 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.2 t -137.03 170.77 15.55 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.956 1.303 . . . . 0.0 108.968 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.69 128.01 56.28 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -141.77 106.32 4.86 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.47 -103.9 0.36 Allowed Glycine 0 CA--C 1.534 1.277 0 CA-C-N 117.845 0.293 . . . . 0.0 113.342 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -115.71 2.27 13.66 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.565 0.746 . . . . 0.0 111.069 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -130.13 -173.58 13.44 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 123.891 0.758 . . . . 0.0 111.911 -174.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 89.0 m -121.33 148.22 44.64 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.848 0.859 . . . . 0.0 110.424 -176.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.9 tp -103.22 134.58 46.39 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 166.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 tt -119.74 109.73 15.97 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.583 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 31.7 mt-10 -109.54 105.57 14.94 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.499 HD13 HD21 ' A' ' 133' ' ' LEU . 8.6 tt -105.4 107.4 18.37 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 176.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' A' ' 23' ' ' SER . 32.8 tt0 -92.4 128.18 38.15 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.898 0.879 . . . . 0.0 108.973 173.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.678 ' HD1' ' HE1' ' A' ' 129' ' ' TRP . 6.2 t60 -113.77 118.42 34.24 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 171.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.12 114.86 29.24 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.083 0.953 . . . . 0.0 110.889 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.696 HG21 ' HG3' ' A' ' 121' ' ' MET . 4.4 t -150.26 150.67 31.86 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.596 0.758 . . . . 0.0 110.921 176.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 74.1 p -73.23 -42.68 62.32 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.922 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.1 m -76.62 131.82 39.09 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.472 0.709 . . . . 0.0 112.384 -165.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -60.78 -50.66 72.56 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.78 1.232 . . . . 0.0 113.243 -170.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -62.49 -53.35 56.11 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.696 ' HG3' HG21 ' A' ' 116' ' ' THR . 13.7 tpt -44.14 -38.94 3.97 Favored 'General case' 0 CA--C 1.56 1.351 0 O-C-N 124.873 1.358 . . . . 0.0 112.711 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HG ' HG23 ' A' ' 116' ' ' THR . 13.4 mt -66.54 -47.07 74.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.541 1.136 . . . . 0.0 112.733 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 36.5 t -64.16 -51.45 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -46.94 -47.5 21.69 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.647 1.979 . . . . 0.0 113.713 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 m -83.39 -25.77 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.479 0.312 . . . . 0.0 111.491 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.61 -39.73 98.26 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 76.2 t -78.81 -51.15 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.369 1.068 . . . . 0.0 108.99 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.64 -61.75 6.48 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 114.545 -1.207 . . . . 0.0 114.132 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.678 ' HE1' ' HD1' ' A' ' 114' ' ' HIS . 81.5 m95 -63.74 -44.32 93.87 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 118.69 -0.671 . . . . 0.0 112.439 177.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -61.21 -39.87 91.85 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.344 0.974 . . . . 0.0 110.944 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.9 ttm -70.99 -37.76 72.7 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.738 0.815 . . . . 0.0 110.48 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.66 -59.5 4.19 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.502 0.721 . . . . 0.0 111.202 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.499 HD21 HD13 ' A' ' 112' ' ' LEU . 3.6 mm? -58.5 -29.16 66.05 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.321 0.648 . . . . 0.0 112.061 173.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.01 -38.5 91.28 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 118.395 0.543 . . . . 0.0 110.607 174.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -64.76 -31.2 72.31 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.178 0.591 . . . . 0.0 110.663 171.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.495 HD11 ' HB1' ' A' ' 40' ' ' ALA . 53.2 tp -66.76 -42.15 86.59 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.855 0.462 . . . . 0.0 110.074 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 141' ' ' ARG . . . -47.48 -45.99 22.91 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.304 0.378 . . . . 0.0 113.741 165.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 73.4 mtp -74.15 -30.13 62.13 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 123.589 0.756 . . . . 0.0 111.485 179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -71.43 -54.92 9.04 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.195 0.998 . . . . 0.0 110.122 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 40.6 mt -64.14 -31.38 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.416 1.086 . . . . 0.0 110.972 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 137' ' ' GLY . 70.2 ttt180 -62.99 -24.63 68.0 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.611 0.765 . . . . 0.0 111.243 175.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.07 39.33 32.75 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -173.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -108.91 -33.84 6.81 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.983 0.913 . . . . 0.0 111.013 -169.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.8 mt -75.59 115.21 43.72 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 123.491 0.717 . . . . 0.0 111.456 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -87.03 -8.84 6.51 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.754 2.302 . . . . 0.0 111.318 164.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.05 -175.51 44.06 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.288 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.17 114.07 3.78 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.986 -0.897 . . . . 0.0 111.63 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -83.39 7.84 4.97 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 123.121 2.547 . . . . 0.0 113.672 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.3 m -82.1 134.28 49.62 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 122.661 0.384 . . . . 0.0 110.222 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -85.55 11.23 3.41 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.683 2.255 . . . . 0.0 112.997 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 77.06 65.45 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.844 1.658 . . . . 0.0 109.598 170.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.426 ' HB2' ' HG2' ' A' ' 163' ' ' MET . 43.0 m-20 -103.78 61.05 0.75 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.153 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -70.18 -33.82 72.2 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.496 171.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -87.06 120.67 28.57 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 164.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.3 -42.2 99.16 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 122.908 0.483 . . . . 0.0 111.75 -175.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 61.97 162.81 0.08 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 125.205 1.402 . . . . 0.0 113.532 170.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -72.15 89.78 1.18 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.809 0.843 . . . . 0.0 109.932 171.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.467 ' HA ' ' SD ' ' A' ' 164' ' ' MET . 37.0 tt0 50.38 68.28 3.56 Favored Pre-proline 0 CA--C 1.569 1.681 0 C-N-CA 125.599 1.559 . . . . 0.0 113.267 172.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.666 ' HD2' ' SD ' ' A' ' 164' ' ' MET . 47.7 Cg_endo -87.55 -29.42 0.36 Allowed 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.296 2.664 . . . . 0.0 113.953 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.7 t -159.33 104.46 1.52 Allowed Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 124.479 1.112 . . . . 0.0 108.264 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.5 -42.21 63.58 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.83 2.353 . . . . 0.0 112.655 -176.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -63.58 -48.66 76.48 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.622 0.769 . . . . 0.0 111.931 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.426 ' HG2' ' HB2' ' A' ' 152' ' ' ASP . 6.2 tpt -66.48 -43.37 85.61 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.399 0.437 . . . . 0.0 110.714 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.666 ' SD ' ' HD2' ' A' ' 159' ' ' PRO . 61.9 mtm -65.94 -37.2 85.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.665 0.386 . . . . 0.0 111.162 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -55.22 -58.13 8.94 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.503 1.127 . . . . 0.0 109.17 -178.177 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 61.9 mt -63.28 -45.77 97.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 O-C-N 124.609 1.193 . . . . 0.0 111.053 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 31.1 t -51.62 -42.14 61.78 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.942 0.897 . . . . 0.0 112.471 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -89.47 -29.32 19.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 4.9 tm-20 -61.79 -50.26 73.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.666 1.587 . . . . 0.0 110.408 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -60.69 -53.09 61.66 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.42 174.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.66 -50.0 38.39 Favored Glycine 0 C--N 1.351 1.407 0 O-C-N 124.545 1.153 . . . . 0.0 115.204 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.07 -32.96 69.77 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.033 0.533 . . . . 0.0 111.345 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.69 -49.38 68.77 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.972 0.509 . . . . 0.0 111.133 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.4 ' CE3' HD12 ' A' ' 177' ' ' LEU . 94.5 m95 -70.72 -27.21 63.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.25 0.62 . . . . 0.0 111.599 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.82 -34.47 73.71 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 123.506 0.504 . . . . 0.0 110.155 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -70.6 -33.83 71.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.4 0.28 . . . . 0.0 110.499 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.4 HD12 ' CE3' ' A' ' 174' ' ' TRP . 63.1 mt -73.05 -62.12 1.58 Allowed 'General case' 0 C--N 1.349 0.56 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.595 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 122' ' ' LEU . 4.4 p -73.43 -22.17 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -166.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -87.14 4.89 40.5 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.273 0.629 . . . . 0.0 111.188 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 28.8 t -92.85 175.93 6.62 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.672 0.789 . . . . 0.0 111.299 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 160.64 -39.2 0.44 Allowed Glycine 0 C--N 1.342 0.877 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 C--O 1.251 1.152 0 C-N-CA 124.118 0.967 . . . . 0.0 109.276 176.819 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.04 97.06 1.83 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.523 0.729 . . . . 0.0 110.672 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.4 m -73.35 -59.24 2.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.257 0.623 . . . . 0.0 109.817 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.49 142.19 3.59 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.302 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -88.19 92.1 9.03 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 165.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 29' ' ' ARG . . . -68.69 80.8 0.28 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.234 0.54 . . . . 0.0 111.454 -171.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 m -81.94 117.62 22.32 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.743 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 35.6 mt-10 -118.94 110.48 17.19 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.788 0.835 . . . . 0.0 108.847 -175.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -68.62 147.67 51.57 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -157.94 161.65 38.2 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.749 0.419 . . . . 0.0 110.48 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -144.64 143.85 30.96 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.63 171.47 33.65 Favored Glycine 0 C--O 1.238 0.348 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 173.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -94.68 160.41 14.63 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.28 122.06 2.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -169.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.3 m -86.36 129.91 34.69 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.468 HD11 HG23 ' A' ' 117' ' ' THR . 48.9 pt -125.28 165.43 26.25 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.473 1.109 . . . . 0.0 109.005 -174.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.5 -33.35 38.11 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.054 2.503 . . . . 0.0 114.735 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.17 -31.61 67.87 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.459 0.704 . . . . 0.0 111.935 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.24 -164.66 31.04 Favored Glycine 0 N--CA 1.47 0.9 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -175.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -74.86 138.42 42.47 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.033 1.417 . . . . 0.0 109.051 172.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.83 168.17 20.41 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.006 1.322 . . . . 0.0 109.871 -174.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.436 HH21 ' HB2' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -104.59 166.64 10.26 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 168.443 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 114' ' ' HIS . 23.6 p -140.1 130.21 24.99 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.767 -174.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.546 HG12 HG23 ' A' ' 125' ' ' VAL . 2.6 pp -86.92 135.95 24.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 168.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 4.8 mp -124.98 115.48 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.458 HG12 ' CZ2' ' A' ' 174' ' ' TRP . 25.2 mt -105.68 107.17 22.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.579 ' HB2' ' HB2' ' A' ' 8' ' ' GLU . 54.0 mtp180 -95.48 162.0 13.83 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.642 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 5.1 tt0 -168.72 120.9 0.79 Allowed 'General case' 0 N--CA 1.472 0.659 0 O-C-N 125.029 1.456 . . . . 0.0 111.039 -178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.609 ' HB2' ' HB3' ' A' ' 6' ' ' ALA . 2.5 mpt_? -88.95 103.57 16.16 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 170.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.445 ' HE1' ' HA2' ' A' ' 137' ' ' GLY . 77.6 m-85 -84.08 141.37 31.17 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.661 170.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.36 -11.47 59.93 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 123.69 0.619 . . . . 0.0 111.346 174.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.28 152.61 83.96 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 122.551 0.34 . . . . 0.0 110.774 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.419 ' HG2' ' HG3' ' A' ' 36' ' ' GLU . 28.0 Cg_endo -62.61 148.64 93.08 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.818 2.346 . . . . 0.0 112.576 171.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 108' ' ' THR . 68.6 t -47.45 -40.92 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 125.062 1.345 . . . . 0.0 111.981 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -50.04 -50.49 47.48 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.833 1.333 . . . . 0.0 111.111 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.419 ' HG3' ' HG2' ' A' ' 33' ' ' PRO . 36.8 mt-10 -71.29 -29.79 65.47 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.264 -177.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.6 t -74.56 -40.01 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.465 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -74.52 -28.24 60.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.671 0.788 . . . . 0.0 109.825 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB3' ' NH1' ' A' ' 46' ' ' ARG . 74.1 m -69.14 -44.09 73.04 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.305 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -44.69 93.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.821 0.848 . . . . 0.0 111.51 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 72.7 m -68.36 -33.83 74.98 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.1 p -111.31 -34.72 6.06 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -169.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.484 ' O ' HG13 ' A' ' 47' ' ' ILE . 32.6 t70 -71.02 114.9 31.1 Favored Pre-proline 0 N--CA 1.486 1.354 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.777 -178.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -52.07 -34.78 59.11 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.568 2.845 . . . . 0.0 113.8 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -72.03 -20.61 61.67 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 124.318 1.011 . . . . 0.0 110.604 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.409 ' NH1' ' HB3' ' A' ' 39' ' ' SER . 72.8 mtt85 -94.81 -25.98 16.41 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.331 0.652 . . . . 0.0 111.7 172.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 43' ' ' ASP . 82.2 mt -76.61 -31.5 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -173.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -73.43 -4.29 32.72 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.263 0.625 . . . . 0.0 112.318 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.34 -30.75 13.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.403 0.681 . . . . 0.0 110.701 -173.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.405 ' CE3' ' HB2' ' A' ' 51' ' ' PHE . 67.4 p-90 -119.09 -20.15 8.15 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.125 0.57 . . . . 0.0 111.875 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.405 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 51.4 t80 -127.75 -102.25 0.34 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.272 0.629 . . . . 0.0 109.803 -175.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.495 HD12 HD13 ' A' ' 66' ' ' LEU . 89.5 mt -149.42 142.73 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 124.157 0.983 . . . . 0.0 108.876 -170.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.06 108.06 1.34 Allowed Pre-proline 0 CA--C 1.561 1.385 0 O-C-N 124.657 1.223 . . . . 0.0 110.753 172.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -96.03 139.37 0.77 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.068 2.512 . . . . 0.0 113.463 -177.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -129.98 141.77 50.72 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.702 1.201 . . . . 0.0 109.417 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.59 -163.12 35.51 Favored Glycine 0 C--N 1.335 0.495 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.51 ' HB3' ' H ' ' A' ' 63' ' ' ASN . 29.3 t70 -75.09 -41.03 59.59 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 174.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 70.1 mt 70.81 -10.01 0.77 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.572 1.549 . . . . 0.0 113.708 170.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -93.59 165.91 12.5 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.883 0.873 . . . . 0.0 110.064 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.524 ' HG2' ' HA ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -64.78 123.46 19.42 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.815 0.846 . . . . 0.0 109.861 -176.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.39 7.14 69.93 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 115.646 -0.707 . . . . 0.0 112.991 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.66 -147.78 20.5 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 112.149 -0.38 . . . . 0.0 112.149 178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.623 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 26.2 p-10 -139.88 169.88 16.9 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.643 0.777 . . . . 0.0 110.969 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -142.69 154.64 44.5 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.65 142.37 25.58 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.891 0.877 . . . . 0.0 109.824 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.495 HD13 HD12 ' A' ' 52' ' ' ILE . 90.4 mt -94.74 -101.93 0.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.309 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -155.76 -56.68 0.09 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.82 0.848 . . . . 0.0 108.928 174.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.96 43.07 1.16 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.777 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -135.2 -74.04 0.46 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.024 0.93 . . . . 0.0 109.358 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -154.63 154.31 32.78 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 121.763 0.792 . . . . 0.0 112.713 -169.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.9 m -131.2 154.19 48.67 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 113.153 -1.84 . . . . 0.0 108.182 168.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 86' ' ' SER . . . -169.32 -156.88 11.14 Favored Glycine 0 CA--C 1.504 -0.655 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.073 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 24.8 m-20 -121.88 171.54 8.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.323 0.649 . . . . 0.0 110.462 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.6 mm -103.41 106.65 20.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.8 mt -77.56 -41.03 40.44 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 123.502 0.501 . . . . 0.0 110.212 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.524 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 36.9 ttm180 -175.77 113.96 0.13 Allowed 'General case' 0 C--N 1.363 1.162 0 O-C-N 123.955 0.784 . . . . 0.0 111.508 168.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 13.3 p -107.05 103.44 12.85 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.529 0.732 . . . . 0.0 109.512 174.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.502 ' HG3' ' HG2' ' A' ' 76' ' ' ARG . 48.8 mt-10 -104.73 112.29 65.3 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.651 1.18 . . . . 0.0 109.517 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 6.1 Cg_exo -79.81 126.33 6.5 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.913 2.408 . . . . 0.0 112.423 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.5 Cg_endo -103.73 25.06 12.07 Favored 'Cis proline' 0 C--N 1.376 1.989 0 CA-C-N 120.421 1.186 . . . . 0.0 112.717 -8.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -61.5 -67.55 0.4 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.156 0.982 . . . . 0.0 112.02 -171.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.493 ' NH2' ' HD2' ' A' ' 76' ' ' ARG . 14.8 ptt180 -152.5 157.15 40.72 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.169 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.9 tt -119.93 138.18 53.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 169.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.6 m -137.31 130.17 30.38 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.451 HG13 ' HB ' ' A' ' 97' ' ' VAL . 14.1 pt -144.18 146.82 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.296 1.038 . . . . 0.0 109.677 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.444 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 24.6 p -90.86 132.89 35.63 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 171.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 24.4 t-105 -121.68 104.62 9.74 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -171.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.7 t -102.77 103.11 14.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 170.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.532 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 42.8 t80 -77.34 147.11 36.33 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -61.8 113.59 2.85 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.374 0.669 . . . . 0.0 111.576 -172.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.05 6.7 86.3 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 124.191 0.932 . . . . 0.0 113.354 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 12.4 mmmm -125.98 155.07 73.74 Favored Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.519 1.128 . . . . 0.0 109.169 -172.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.1 179.16 4.09 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.635 2.223 . . . . 0.0 114.243 -174.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.62 150.09 39.78 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.253 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.511 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 16.4 m -140.36 156.91 46.24 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.852 0.72 . . . . 0.0 110.951 178.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -112.06 108.61 17.97 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 165.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 52.6 t -94.33 119.58 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -124.32 115.86 21.68 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.452 0.644 . . . . 0.0 110.418 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -89.78 136.36 33.08 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.427 ' HB2' ' HB3' ' A' ' 111' ' ' GLU . 57.1 mtt85 -135.42 129.87 33.94 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -177.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 46.5 mt -116.54 147.06 42.16 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.914 0.486 . . . . 0.0 110.401 176.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.1 t -150.79 125.27 9.54 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.512 0.725 . . . . 0.0 110.528 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.29 124.22 26.02 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 173.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.59 125.79 12.99 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 124.144 0.978 . . . . 0.0 109.051 176.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.81 -89.14 1.34 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 171.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -160.97 39.88 0.15 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.13 -168.09 33.12 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.395 -172.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.498 HG23 HG22 ' A' ' 34' ' ' VAL . 32.1 m -137.66 131.11 30.99 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.095 0.958 . . . . 0.0 110.498 -166.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 55.1 tp -80.98 106.47 13.01 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 160.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.457 HD22 HD11 ' A' ' 133' ' ' LEU . 7.9 tt -87.45 128.2 35.22 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 160.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 31.7 tt0 -136.4 104.68 5.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.4 131.94 43.58 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 33.3 tt0 -123.2 143.62 49.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.579 ' HD1' ' HE1' ' A' ' 129' ' ' TRP . 8.6 t60 -138.87 114.71 10.02 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.1 104.52 11.64 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.352 0.661 . . . . 0.0 111.184 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.2 t -131.49 158.71 40.16 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-O 121.499 0.666 . . . . 0.0 109.743 173.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.468 HG23 HD11 ' A' ' 16' ' ' ILE . 40.4 p -80.05 -21.46 43.42 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.052 -178.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.8 t -82.44 113.73 20.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.928 0.491 . . . . 0.0 110.473 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.436 ' HB2' HH21 ' A' ' 22' ' ' ARG . 36.7 tt0 -65.84 -29.3 69.75 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.946 0.899 . . . . 0.0 110.297 175.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -61.45 -50.48 72.61 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.287 175.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 27.9 ttt -68.77 -30.25 68.8 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.02 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 28.9 mt -66.1 -44.14 85.24 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.269 0.628 . . . . 0.0 112.314 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 85.3 t -65.43 -45.1 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -50.82 -51.55 49.91 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.605 1.162 . . . . 0.0 112.166 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.546 HG23 HG12 ' A' ' 24' ' ' ILE . 33.4 m -79.85 -21.72 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.845 0.458 . . . . 0.0 111.439 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.32 -34.9 86.76 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 168.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.24 -53.63 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 114.415 -0.892 . . . . 0.0 110.054 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.63 86.1 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.604 -0.726 . . . . 0.0 114.281 -175.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.579 ' HE1' ' HD1' ' A' ' 114' ' ' HIS . 34.2 m95 -85.47 -36.39 20.61 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.884 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -69.9 -29.2 66.34 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.112 0.869 . . . . 0.0 110.289 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 65.5 mtm -71.81 -37.43 70.36 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.76 -35.08 79.9 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 122.538 0.335 . . . . 0.0 111.255 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.457 HD11 HD22 ' A' ' 110' ' ' LEU . 3.3 mm? -81.5 -23.38 37.37 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.77 0.828 . . . . 0.0 110.723 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.52 -51.58 41.49 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.106 172.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -71.52 -24.56 61.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.647 0.779 . . . . 0.0 111.424 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.1 tp -77.94 -31.05 50.73 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.778 0.431 . . . . 0.0 109.876 172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.445 ' HA2' ' HE1' ' A' ' 30' ' ' TYR . . . -67.76 -34.34 82.77 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.033 171.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 89.5 mmm -66.35 -49.29 67.43 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.492 0.717 . . . . 0.0 109.474 170.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -56.11 -55.6 31.05 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.972 1.309 . . . . 0.0 111.726 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 59.4 mt -78.87 -55.75 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 123.459 0.704 . . . . 0.0 111.028 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -97.53 -75.04 0.55 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -170.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.47 13.64 6.15 Favored Glycine 0 N--CA 1.474 1.215 0 CA-C-O 118.87 -0.961 . . . . 0.0 115.489 -161.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 69.14 128.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.195 1.398 . . . . 0.0 111.153 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.4 tt -111.01 90.99 12.05 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -87.96 -2.32 7.2 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.279 1.986 . . . . 0.0 112.055 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.71 83.98 1.66 Allowed Glycine 0 C--N 1.333 0.417 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -172.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -137.12 72.47 0.45 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -87.11 -172.94 1.0 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 123.025 2.483 . . . . 0.0 111.675 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.9 m -65.05 111.34 5.68 Favored Pre-proline 0 CA--C 1.561 1.369 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 170.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.13 -19.15 39.5 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.159 2.573 . . . . 0.0 113.332 -168.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -108.77 6.7 25.85 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.898 1.279 . . . . 0.0 110.29 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.8 t70 73.14 -2.91 2.59 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 124.723 1.209 . . . . 0.0 111.388 -173.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 71.11 -69.84 0.17 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.279 1.831 . . . . 0.0 110.739 -174.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 56.83 -162.24 0.19 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.479 1.112 . . . . 0.0 111.758 -174.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -120.66 -30.43 4.49 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.253 0.621 . . . . 0.0 111.79 -176.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -106.22 91.22 3.63 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.628 0.371 . . . . 0.0 110.478 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -147.07 115.4 6.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.368 0.667 . . . . 0.0 110.148 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -84.84 -54.79 0.44 Allowed Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.715 0.806 . . . . 0.0 112.15 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -85.84 18.06 1.64 Allowed 'Trans proline' 0 C--N 1.4 3.245 0 C-N-CA 123.242 2.628 . . . . 0.0 113.045 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.1 t -106.46 88.79 3.55 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.29 -40.76 5.63 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.786 2.324 . . . . 0.0 112.43 -171.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -66.21 -46.88 75.72 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 124.122 0.889 . . . . 0.0 110.815 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 6.6 tpt -69.28 -40.96 77.44 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.393 0.277 . . . . 0.0 110.777 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 59.8 mmm -54.21 -44.13 71.37 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.582 0.551 . . . . 0.0 110.202 171.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -69.56 -57.1 5.62 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 124.113 0.883 . . . . 0.0 111.008 -173.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.466 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 71.7 mt -51.92 -46.52 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 123.698 0.799 . . . . 0.0 111.982 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.2 p -71.0 -50.44 34.24 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.353 0.408 . . . . 0.0 110.645 -173.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -57.03 -48.82 77.58 Favored 'General case' 0 CA--C 1.557 1.224 0 O-C-N 124.044 0.84 . . . . 0.0 111.062 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -44.23 -48.03 9.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.315 1.046 . . . . 0.0 112.401 171.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 166' ' ' ILE . 15.0 mmp_? -60.24 -52.03 67.03 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 123.375 0.422 . . . . 0.0 111.485 178.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -72.52 -37.85 58.06 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.285 -169.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.17 -25.5 47.24 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.166 0.586 . . . . 0.0 110.985 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.03 -53.12 28.17 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.458 ' CZ2' HG12 ' A' ' 26' ' ' ILE . 97.5 m95 -71.35 -25.65 62.48 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.495 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.75 -59.56 4.1 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.31 -38.53 42.04 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.779 1.232 . . . . 0.0 112.975 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 53.9 mt -66.95 -49.1 66.53 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.614 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.7 p -81.93 -30.07 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 122.95 0.5 . . . . 0.0 111.218 -165.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -57.56 -30.06 64.92 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.639 0.775 . . . . 0.0 110.925 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 17.6 m -62.43 -26.18 68.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.274 1.03 . . . . 0.0 112.315 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -85.51 16.79 38.15 Favored Glycine 0 C--N 1.347 1.15 0 N-CA-C 114.238 0.455 . . . . 0.0 114.238 -177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.255 1.382 0 C-N-CA 123.739 0.816 . . . . 0.0 108.877 175.049 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.1 78.64 3.63 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 169.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.7 m -148.48 17.35 1.04 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.267 -172.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.67 118.66 11.96 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.64 125.73 32.91 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.502 0.667 . . . . 0.0 110.868 -175.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.494 ' HB3' ' HD3' ' A' ' 29' ' ' ARG . . . -153.51 75.25 1.04 Allowed 'General case' 0 C--O 1.242 0.671 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 28' ' ' GLN . 29.7 m -96.11 98.28 10.22 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.764 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.04 140.36 29.72 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.129 175.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.448 ' HG3' HD11 ' A' ' 177' ' ' LEU . 16.9 ptp180 -108.87 147.09 32.67 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 170.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -159.2 -177.84 6.76 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.273 0.559 . . . . 0.0 110.736 -169.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -144.98 150.52 37.07 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.986 -176.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -149.38 -177.86 23.86 Favored Glycine 0 CA--C 1.507 -0.406 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 175.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 30.6 ptt180 -125.16 131.36 53.24 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 171.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 8.3 tpt180 -135.81 114.83 12.24 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.9 m -78.67 98.19 6.12 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.429 HD11 HG23 ' A' ' 117' ' ' THR . 30.9 pt -81.16 166.9 35.76 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.674 1.59 . . . . 0.0 111.068 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -38.84 -34.42 0.43 Allowed 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 125.028 3.819 . . . . 0.0 115.198 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . . . -67.74 -56.59 8.69 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.682 0.393 . . . . 0.0 110.961 173.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.76 -157.58 30.12 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.494 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.67 105.25 1.2 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.53 0.732 . . . . 0.0 111.326 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 14' ' ' ARG . . . -112.8 165.81 11.96 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.887 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 82.6 mtt-85 -105.94 168.01 9.41 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 165.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.3 p -138.5 141.95 39.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.285 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.2 pt -84.77 145.97 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 166.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 48.7 mt -129.92 107.39 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.9 mt -106.28 103.9 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 80.9 mtp180 -95.44 143.77 26.5 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.419 ' HB3' HG23 ' A' ' 7' ' ' THR . 6.9 pt20 -162.65 138.84 7.41 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.2 0.937 . . . . 0.0 111.665 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.494 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 7.5 mpt_? -95.72 105.94 17.99 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.408 ' CE1' HD13 ' A' ' 110' ' ' LEU . 19.6 m-85 -76.04 132.77 40.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.594 0.757 . . . . 0.0 109.7 169.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -79.95 45.09 0.69 Allowed 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 122.132 0.968 . . . . 0.0 109.787 171.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.66 147.9 34.66 Favored Pre-proline 0 C--O 1.24 0.592 0 C-N-CA 124.102 0.961 . . . . 0.0 109.141 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.8 167.33 21.58 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.844 2.363 . . . . 0.0 112.992 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.93 -50.21 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.315 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.52 -40.01 81.73 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.224 0.953 . . . . 0.0 111.244 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.43 -63.16 1.16 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 123.847 0.717 . . . . 0.0 111.082 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.5 t -49.99 -41.77 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.648 1.179 . . . . 0.0 111.253 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -58.82 -55.6 33.08 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.976 0.911 . . . . 0.0 110.183 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 t -54.98 -45.34 74.98 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 124.222 0.951 . . . . 0.0 110.975 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.08 -36.28 79.23 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.673 176.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.488 ' SG ' HD21 ' A' ' 136' ' ' LEU . 74.6 m -77.69 -25.2 49.27 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.8 p -108.26 -43.02 4.46 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -168.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.96 126.04 88.0 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 123.209 0.604 . . . . 0.0 111.679 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.1 -38.2 92.51 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.325 2.683 . . . . 0.0 112.802 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -63.37 -22.12 66.69 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.252 1.021 . . . . 0.0 111.676 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.6 mtt85 -100.76 -29.76 12.09 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.804 0.841 . . . . 0.0 109.945 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.465 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 91.9 mt -71.72 -42.37 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.881 0.872 . . . . 0.0 111.642 -178.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 53' ' ' GLU . 12.4 p30 -57.57 -22.46 44.96 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.418 ' HG2' ' CD1' ' A' ' 139' ' ' PHE . 7.1 tpm_? -68.81 -46.5 68.46 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.577 0.751 . . . . 0.0 111.989 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.465 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 65.1 p-90 -112.5 6.99 18.83 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.598 0.759 . . . . 0.0 112.685 -170.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.429 ' HB3' HG23 ' A' ' 47' ' ' ILE . 20.8 t80 -174.59 173.92 2.79 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -166.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.5 mt -84.61 126.39 40.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 48' ' ' ASN . 33.4 tt0 -70.31 119.93 75.22 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.716 1.206 . . . . 0.0 109.917 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.599 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 89.9 Cg_endo -78.86 124.34 6.15 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.453 2.102 . . . . 0.0 112.983 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -67.41 145.84 54.64 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.042 1.337 . . . . 0.0 111.245 172.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.32 -164.89 13.23 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 124.0 0.812 . . . . 0.0 113.427 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.532 ' HB2' ' HA3' ' A' ' 62' ' ' GLY . 34.7 m-20 -75.08 -31.07 61.13 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.709 0.804 . . . . 0.0 111.926 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 36.0 mt 66.95 12.12 8.76 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.007 1.323 . . . . 0.0 113.049 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -123.35 171.46 9.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.784 0.833 . . . . 0.0 111.153 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.624 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 33.1 tt0 -65.51 106.29 1.39 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.932 0.893 . . . . 0.0 111.811 -171.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.63 -27.94 8.08 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' ' 57' ' ' ASP . . . -84.68 -175.13 50.65 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 167.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 8.2 t30 -129.48 149.45 51.25 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.266 1.026 . . . . 0.0 110.053 -170.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 54' ' ' PRO . 20.5 p90 -109.66 154.46 22.81 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 165.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.66 119.61 1.68 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.994 0.815 . . . . 0.0 110.612 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' A' ' 69' ' ' ASN . 61.8 mt -87.02 166.32 15.14 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -88.88 -24.28 22.55 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.143 0.577 . . . . 0.0 109.748 -175.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -159.28 67.81 0.27 Allowed Glycine 0 C--N 1.342 0.867 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.052 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.488 ' HB3' HD12 ' A' ' 66' ' ' LEU . 54.3 t30 -162.59 -67.38 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.803 0.841 . . . . 0.0 109.542 170.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.02 172.49 6.47 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.796 0.438 . . . . 0.0 111.328 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.3 t -145.36 143.98 30.44 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.564 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.56 164.38 36.22 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 9.0 p-10 -94.91 168.93 10.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 117.925 0.863 . . . . 0.0 110.16 176.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 74' ' ' ILE . 2.8 mp -95.75 106.02 17.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.2 mt -72.36 -53.34 12.59 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.333 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -135.18 132.15 37.6 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.681 1.193 . . . . 0.0 108.474 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 28.1 p -126.18 118.29 24.88 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 166.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.37 74.75 23.36 Favored Pre-proline 0 CA--C 1.549 0.923 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 96.3 Cg_endo -76.72 141.89 22.29 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.215 1.943 . . . . 0.0 112.785 -171.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 27.6 Cg_endo -98.46 28.03 16.17 Favored 'Cis proline' 0 C--N 1.375 1.965 0 CA-C-N 119.269 0.775 . . . . 0.0 112.03 -5.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -79.23 -62.15 1.79 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.044 0.937 . . . . 0.0 110.696 -169.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -153.69 162.89 40.84 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.996 0.918 . . . . 0.0 110.413 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 pp -135.71 143.3 45.3 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 166.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.2 m -122.84 110.17 15.11 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 173.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.6 pt -105.96 173.76 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.049 1.34 . . . . 0.0 110.599 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.7 p -109.57 168.54 9.32 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 34.0 t-105 -156.62 106.07 2.28 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -172.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 94.2 t -106.89 112.95 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.492 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 62.8 t80 -100.81 162.24 13.05 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 125.029 1.332 . . . . 0.0 108.42 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -50.19 -40.47 47.14 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.61 -6.54 19.39 Favored Glycine 0 N--CA 1.47 0.958 0 CA-C-N 116.529 -0.305 . . . . 0.0 112.75 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.732 ' HG3' ' SD ' ' A' ' 121' ' ' MET . 67.3 mmtt -106.72 104.43 51.19 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.63 -30.32 42.53 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.824 2.349 . . . . 0.0 113.348 -168.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.685 ' HB3' ' HB2' ' A' ' 18' ' ' ALA . 26.2 t70 -152.47 134.94 15.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.269 0.557 . . . . 0.0 110.359 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.588 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 36.7 m -144.07 164.02 31.87 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 125.63 1.572 . . . . 0.0 106.9 169.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -142.92 119.12 10.79 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.5 t -109.16 148.51 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.279 1.031 . . . . 0.0 109.517 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -130.08 157.66 41.77 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.63 1.172 . . . . 0.0 110.197 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.3 tp -142.49 118.12 10.4 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.51 ' HE ' ' HB2' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -122.36 117.13 25.31 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.841 0.856 . . . . 0.0 109.597 -174.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 25.4 mt -107.04 136.18 47.33 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.933 0.893 . . . . 0.0 110.368 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.6 m -143.38 124.24 14.28 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.472 1.109 . . . . 0.0 108.803 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.37 143.72 57.69 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.237 1.415 . . . . 0.0 111.291 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.97 118.45 4.13 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 175.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.5 -102.92 0.94 Allowed Glycine 0 C--N 1.347 1.151 0 C-N-CA 123.098 0.38 . . . . 0.0 112.252 -176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -125.38 7.11 7.71 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.729 0.812 . . . . 0.0 110.278 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -114.92 -165.12 14.78 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.8 m -150.13 135.41 18.03 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.393 0.677 . . . . 0.0 109.777 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 45.7 tp -81.19 128.15 33.46 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 167.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.408 HD13 ' CE1' ' A' ' 30' ' ' TYR . 9.6 tt -115.22 113.59 24.11 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.51 ' HB2' ' HE ' ' A' ' 100' ' ' ARG . 51.2 mt-10 -113.12 105.53 13.56 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 171.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.649 HD13 HD21 ' A' ' 133' ' ' LEU . 7.0 tt -99.44 104.6 16.46 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 171.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -104.46 119.26 38.56 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.696 0.798 . . . . 0.0 109.712 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -109.72 114.93 28.92 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.92 121.68 44.23 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.335 0.654 . . . . 0.0 110.834 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.442 HG23 ' HG ' ' A' ' 122' ' ' LEU . 7.8 t -140.21 158.6 43.79 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.637 0.732 . . . . 0.0 110.176 172.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.429 HG23 HD11 ' A' ' 16' ' ' ILE . 11.9 p -85.23 -3.15 58.72 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.792 -175.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.3 t -105.25 121.88 44.78 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.749 0.82 . . . . 0.0 110.203 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.437 ' HA ' HD12 ' A' ' 122' ' ' LEU . 43.0 tt0 -66.34 -37.4 85.27 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.362 0.665 . . . . 0.0 111.528 -177.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -62.38 -58.57 7.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.253 0.221 . . . . 0.0 110.996 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.732 ' SD ' ' HG3' ' A' ' 92' ' ' LYS . 21.2 ttt -46.72 -41.02 14.45 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.493 1.121 . . . . 0.0 112.176 175.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 116' ' ' THR . 26.9 mt -57.35 -50.9 71.5 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.361 0.664 . . . . 0.0 112.111 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 127' ' ' VAL . 41.4 t -62.53 -50.07 81.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -61.0 -36.42 79.44 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.182 0.993 . . . . 0.0 113.296 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -80.17 -23.13 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 118.56 0.618 . . . . 0.0 110.031 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 130' ' ' GLU . . . -62.06 -37.75 94.96 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 171.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 123' ' ' VAL . 44.4 t -79.41 -49.52 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.792 0.837 . . . . 0.0 109.204 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -55.98 -60.32 9.11 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.445 -1.252 . . . . 0.0 113.972 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -61.44 -36.13 79.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.498 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 21.5 tt0 -59.65 -37.59 79.14 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.783 0.72 . . . . 0.0 110.317 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 67.6 mtt -72.25 -39.89 68.11 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.113 0.565 . . . . 0.0 110.927 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.85 -58.29 9.08 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 123.812 0.695 . . . . 0.0 110.853 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.649 HD21 HD13 ' A' ' 112' ' ' LEU . 3.4 mm? -60.36 -26.16 66.41 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 172.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.15 -38.68 88.71 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -66.71 -36.78 83.31 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.1 0.56 . . . . 0.0 110.234 174.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.488 HD21 ' SG ' ' A' ' 41' ' ' CYS . 42.4 tp -70.91 -56.71 5.65 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.383 0.673 . . . . 0.0 111.14 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -43.52 -42.06 5.67 Favored Glycine 0 N--CA 1.474 1.197 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 167.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.432 ' HG2' ' HB2' ' A' ' 144' ' ' LEU . 50.2 ttm -66.7 -45.11 79.8 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.394 0.677 . . . . 0.0 111.121 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.418 ' CD1' ' HG2' ' A' ' 49' ' ' ARG . 18.1 t80 -61.35 -59.87 4.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.813 0.845 . . . . 0.0 111.087 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.2 mt -57.89 -36.63 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.795 1.238 . . . . 0.0 112.037 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -58.75 -35.24 72.42 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.955 0.502 . . . . 0.0 111.019 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 123.28 33.92 0.8 Allowed Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.046 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 139' ' ' PHE . 29.5 t0 -135.08 -167.88 2.07 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.432 ' HB2' ' HG2' ' A' ' 138' ' ' MET . 18.3 tp 65.15 47.34 0.59 Allowed Pre-proline 0 CA--C 1.576 1.959 0 C-N-CA 125.359 1.463 . . . . 0.0 112.01 -172.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -85.29 -18.92 3.89 Favored 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 121.777 1.651 . . . . 0.0 112.798 177.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.61 50.01 0.89 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -112.58 77.69 0.24 Allowed Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -70.82 -20.11 30.26 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.186 2.591 . . . . 0.0 113.414 -167.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.4 m -122.12 119.76 28.57 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 122.907 0.483 . . . . 0.0 110.317 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.02 -11.3 29.0 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.76 2.307 . . . . 0.0 111.842 165.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -88.48 26.53 1.44 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.202 1.001 . . . . 0.0 109.606 171.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.48 -15.9 52.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.609 1.164 . . . . 0.0 111.642 169.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.04 -12.94 9.31 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 124.418 1.087 . . . . 0.0 112.104 169.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 79.21 -26.13 0.18 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.612 1.565 . . . . 0.0 114.176 165.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 69.88 143.08 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.917 1.287 . . . . 0.0 110.039 -163.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -73.6 76.21 1.49 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.658 1.183 . . . . 0.0 111.089 -173.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -164.95 174.53 10.42 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.56 1.944 . . . . 0.0 108.049 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 59.8 102.92 0.03 OUTLIER Pre-proline 0 N--CA 1.479 1.018 0 C-N-CA 125.292 1.437 . . . . 0.0 111.082 -175.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.649 ' HA ' ' SD ' ' A' ' 164' ' ' MET . 18.7 Cg_endo -57.52 84.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.143 2.562 . . . . 0.0 112.943 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.9 m -104.07 109.84 63.08 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.577 1.151 . . . . 0.0 108.095 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -50.74 -55.41 4.1 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.419 2.746 . . . . 0.0 113.918 -170.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.45 -40.89 85.43 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.246 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 12.2 tpt -71.76 -46.2 59.23 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 120.57 0.224 . . . . 0.0 111.036 -175.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.649 ' SD ' ' HA ' ' A' ' 159' ' ' PRO . 89.5 mtp -59.29 -41.08 88.1 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.396 175.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.481 ' O ' ' HG3' ' A' ' 169' ' ' GLU . 19.7 tpp180 -52.83 -52.02 58.67 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.878 0.736 . . . . 0.0 110.541 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.448 ' O ' ' HG2' ' A' ' 170' ' ' ARG . 82.9 mt -59.36 -52.26 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 124.013 0.82 . . . . 0.0 110.399 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.5 t -59.32 -27.07 65.56 Favored 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 123.94 0.896 . . . . 0.0 111.869 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -77.03 -50.3 13.43 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.541 ' HB2' HH11 ' A' ' 170' ' ' ARG . 45.8 mt-10 -55.65 -50.58 69.84 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 124.168 0.918 . . . . 0.0 110.692 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.541 HH11 ' HB2' ' A' ' 169' ' ' GLU . 15.1 mmt-85 -67.12 -50.28 62.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.776 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -49.46 -44.04 36.19 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 124.193 0.933 . . . . 0.0 114.553 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -67.27 -41.15 85.97 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.777 0.831 . . . . 0.0 111.371 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.1 -41.57 73.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.419 0.688 . . . . 0.0 111.466 -176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -78.38 -27.36 46.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.502 0.721 . . . . 0.0 111.676 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -71.82 -31.83 66.94 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.75 0.42 . . . . 0.0 110.373 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -73.3 -31.76 64.22 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.287 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.448 HD11 ' HG3' ' A' ' 9' ' ' ARG . 54.9 mt -71.55 -55.61 7.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.949 0.9 . . . . 0.0 111.51 176.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.21 -32.32 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -172.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -78.52 -4.12 47.05 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.7 m -100.73 -172.7 2.23 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.884 0.874 . . . . 0.0 110.527 171.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.8 -61.62 2.69 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.477 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 CA--C 1.562 1.415 0 C-N-CA 124.823 1.249 . . . . 0.0 112.2 -179.737 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ptm . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.46 -75.26 0.33 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 169.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.9 m -114.56 64.02 0.67 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.59 -62.99 2.66 Favored Glycine 0 C--N 1.35 1.328 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -172.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.669 HE22 ' HA3' ' A' ' 137' ' ' GLY . 15.2 mm100 -121.98 -169.68 1.92 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.883 1.273 . . . . 0.0 109.441 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -149.26 56.54 1.0 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 m -97.72 142.07 29.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.924 0.889 . . . . 0.0 111.99 -172.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -122.91 108.82 13.39 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.157 0.983 . . . . 0.0 108.644 169.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.29 141.92 57.04 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.917 171.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . . . -157.63 164.86 36.8 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.463 HD12 ' HA3' ' A' ' 181' ' ' GLY . 0.2 OUTLIER -142.51 149.06 38.65 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' H ' HD13 ' A' ' 11' ' ' LEU . . . -153.43 -158.32 8.51 Favored Glycine 0 C--N 1.334 0.441 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 177.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -135.35 164.93 26.63 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.989 0.915 . . . . 0.0 109.342 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.496 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 15.8 tpt180 -152.39 152.99 32.72 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.978 0.911 . . . . 0.0 108.572 -174.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.7 m -111.85 129.61 56.09 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 170.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.4 pt -136.05 161.99 59.27 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.015 0.926 . . . . 0.0 109.941 -175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.31 -21.05 16.45 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.533 2.822 . . . . 0.0 114.836 175.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.05 -43.33 58.21 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.004 0.431 . . . . 0.0 110.975 174.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 151.42 -129.24 2.79 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -79.2 136.75 37.17 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.182 0.491 . . . . 0.0 109.891 174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 14' ' ' ARG . . . -127.17 155.51 43.27 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 169.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 3.9 mpt_? -114.31 161.05 18.38 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 165.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.8 p -134.46 130.27 36.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.183 -168.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.413 ' HA ' HD22 ' A' ' 11' ' ' LEU . 36.9 pt -85.97 135.65 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 168.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' A' ' 10' ' ' ALA . 4.0 mp -121.16 119.05 58.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.9 mt -104.76 108.64 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 110' ' ' LEU . 33.9 mtm105 -105.28 101.78 11.31 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.465 ' NE2' ' HB3' ' A' ' 133' ' ' LEU . 70.8 mt-30 -108.0 118.59 37.15 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.6 tpt85 -91.09 103.53 16.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.406 ' CE1' ' HA2' ' A' ' 137' ' ' GLY . 24.8 m-85 -86.69 149.73 24.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.27 178.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -102.7 72.97 1.26 Allowed 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 168.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.15 150.7 5.29 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 125.833 1.653 . . . . 0.0 107.943 -164.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.64 146.0 23.64 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.679 2.253 . . . . 0.0 113.45 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.3 t -49.63 -35.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 124.535 1.134 . . . . 0.0 111.915 173.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -52.81 -42.62 65.27 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 123.508 0.505 . . . . 0.0 110.951 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -86.66 -30.88 21.39 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.08 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.496 HG22 HD13 ' A' ' 140' ' ' ILE . 52.7 t -69.12 -49.48 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 123.601 0.563 . . . . 0.0 110.44 175.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -65.88 -26.29 67.57 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.903 1.281 . . . . 0.0 111.096 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.3 t -65.95 -48.91 69.76 Favored 'General case' 0 C--N 1.353 0.761 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 173.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . . . -59.62 -34.74 73.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.912 0.885 . . . . 0.0 112.515 174.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.468 ' SG ' HD21 ' A' ' 99' ' ' LEU . 79.4 m -69.41 -38.04 77.75 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.2 p -105.73 -43.91 4.79 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.429 0.899 . . . . 0.0 113.429 -167.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.494 ' O ' HG13 ' A' ' 47' ' ' ILE . 65.4 m-20 -76.32 118.46 71.54 Favored Pre-proline 0 N--CA 1.478 0.933 0 CA-C-O 118.131 -0.938 . . . . 0.0 110.298 -175.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.402 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . 25.6 Cg_endo -57.39 -23.78 57.01 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.151 2.568 . . . . 0.0 111.72 174.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -59.46 -44.36 93.0 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.75 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 12.2 mmm180 -89.37 -26.12 21.22 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.283 1.033 . . . . 0.0 111.396 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.495 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 87.0 mt -73.91 -34.72 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -174.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.57 HD21 ' HB3' ' A' ' 53' ' ' GLU . 69.7 m-20 -66.79 2.89 1.2 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.66 -9.89 33.52 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.925 0.89 . . . . 0.0 110.833 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.495 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 37.7 p-90 -146.49 -27.57 0.41 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.595 0.758 . . . . 0.0 112.36 -174.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.486 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 16.6 t80 -147.11 -145.06 0.16 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.412 1.085 . . . . 0.0 108.847 -175.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.6 mt -120.82 139.74 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 123.821 0.848 . . . . 0.0 111.813 -159.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.57 ' HB3' HD21 ' A' ' 48' ' ' ASN . 10.0 pt-20 -65.33 110.42 4.3 Favored Pre-proline 0 CA--C 1.566 1.576 0 O-C-N 125.122 1.514 . . . . 0.0 110.555 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HB2' HD21 ' A' ' 58' ' ' LEU . 4.1 Cg_exo -80.23 98.98 1.13 Allowed 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.0 2.467 . . . . 0.0 111.982 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -72.92 97.97 2.38 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 64' ' ' PHE . . . -176.09 169.65 42.32 Favored Glycine 0 C--O 1.241 0.578 0 C-N-CA 121.547 -0.358 . . . . 0.0 112.955 -172.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.69 -34.55 78.45 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.443 0.697 . . . . 0.0 111.253 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 54' ' ' PRO . 96.1 mt 56.11 70.73 0.61 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.747 1.219 . . . . 0.0 112.718 172.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.455 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 9.3 ptp85 -171.37 171.21 5.63 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.057 0.943 . . . . 0.0 109.495 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.429 ' HG3' ' HA ' ' A' ' 76' ' ' ARG . 28.7 tt0 -54.96 116.17 2.61 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.906 0.882 . . . . 0.0 110.263 174.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.85 8.76 83.83 Favored Glycine 0 N--CA 1.478 1.448 0 N-CA-C 113.945 0.338 . . . . 0.0 113.945 -177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.0 178.16 20.66 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 27.4 p-10 -112.66 177.29 4.68 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 118.043 0.921 . . . . 0.0 112.471 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.512 ' HA ' ' HA3' ' A' ' 56' ' ' GLY . 48.4 p90 -149.8 139.31 21.54 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 170.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.09 121.65 24.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.812 0.445 . . . . 0.0 110.721 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.6 mt -94.3 132.55 38.77 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 173.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -33.63 -56.97 0.44 Allowed 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 126.264 1.826 . . . . 0.0 114.491 -172.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -136.36 5.56 3.86 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 115.916 -0.584 . . . . 0.0 113.514 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -90.1 -86.9 0.19 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.984 0.892 . . . . 0.0 110.045 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.74 154.56 39.77 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.241 0.543 . . . . 0.0 111.046 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -131.81 149.5 52.44 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.388 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.52 -154.43 9.18 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.597 ' HA ' ' HA ' ' A' ' 63' ' ' ASN . 11.5 m-20 -129.39 178.2 6.62 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.997 0.519 . . . . 0.0 110.214 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.594 HG13 HG22 ' A' ' 85' ' ' ILE . 3.4 mp -108.49 117.46 54.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 173.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 86' ' ' SER . 62.0 mt -74.7 -39.9 61.68 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.072 0.949 . . . . 0.0 110.282 -177.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.429 ' HA ' ' HG3' ' A' ' 60' ' ' GLU . 16.9 ptm180 -168.32 149.76 5.05 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.922 1.289 . . . . 0.0 108.634 173.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 22.0 p -147.91 119.86 8.19 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.933 0.493 . . . . 0.0 110.388 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -121.18 97.35 47.77 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.173 0.989 . . . . 0.0 109.834 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 91.4 Cg_endo -75.91 142.16 24.88 Favored 'Trans proline' 0 CA--C 1.56 1.813 0 C-N-CA 122.502 2.135 . . . . 0.0 112.297 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 16.1 Cg_endo -97.59 20.96 27.03 Favored 'Cis proline' 0 C--N 1.376 1.983 0 CA-C-N 119.665 0.916 . . . . 0.0 113.043 -5.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -74.43 -60.92 2.05 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.51 0.724 . . . . 0.0 112.199 -169.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -153.19 159.85 42.74 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.859 0.838 . . . . 0.0 111.691 -169.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 99' ' ' LEU . 63.4 tp -134.08 145.44 49.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.626 1.57 . . . . 0.0 107.647 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.419 HG22 HD12 ' A' ' 75' ' ' LEU . 23.9 m -137.11 121.68 18.42 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 172.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.594 HG22 HG13 ' A' ' 74' ' ' ILE . 31.0 pt -134.47 141.88 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.342 1.057 . . . . 0.0 109.703 -176.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.54 ' HB2' HD21 ' A' ' 75' ' ' LEU . 22.7 t -90.73 140.75 29.49 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 168.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 28.5 t-105 -128.97 100.56 5.7 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.178 1.391 . . . . 0.0 107.644 -167.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.3 t -96.35 102.64 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.435 ' HD2' ' HG3' ' A' ' 92' ' ' LYS . 37.4 t80 -98.07 162.04 13.42 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 174.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -63.44 115.8 4.97 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.386 0.674 . . . . 0.0 112.015 -168.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.93 14.99 79.82 Favored Glycine 0 C--N 1.356 1.664 0 O-C-N 123.71 0.631 . . . . 0.0 113.775 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.486 ' HB3' ' SD ' ' A' ' 121' ' ' MET . 67.1 mmtt -109.28 153.45 42.69 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 123.793 0.837 . . . . 0.0 109.895 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.96 143.45 60.47 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.181 1.921 . . . . 0.0 110.391 170.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.21 107.62 0.93 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.916 0.865 . . . . 0.0 109.73 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.489 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 15.5 m -77.75 145.59 36.4 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.427 -172.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -103.53 105.38 15.61 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.0 144.41 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.592 1.157 . . . . 0.0 108.623 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.41 ' HG2' HG23 ' A' ' 84' ' ' THR . 22.4 mt-10 -132.35 148.62 52.43 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.636 0.774 . . . . 0.0 109.603 171.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 83' ' ' LEU . 39.9 tp -125.3 108.56 11.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -107.27 145.76 32.33 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.545 0.738 . . . . 0.0 110.149 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 110' ' ' LEU . 82.9 mt -134.34 141.35 46.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.696 1.199 . . . . 0.0 109.233 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.2 m -136.54 122.57 20.23 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.126 0.97 . . . . 0.0 109.411 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.57 101.43 9.97 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.69 100.96 7.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.922 -170.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.78 -126.09 8.27 Favored Glycine 0 C--N 1.341 0.811 0 C-N-CA 123.806 0.717 . . . . 0.0 112.897 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -90.91 27.09 1.9 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.294 0.638 . . . . 0.0 109.647 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -161.7 -172.05 28.57 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 120.363 -0.923 . . . . 0.0 115.245 -172.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.1 m -136.54 125.17 23.73 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.1 1.36 . . . . 0.0 109.386 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.9 tp -82.27 116.04 21.62 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 167.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 1.7 tm? -83.38 133.97 34.92 Favored 'General case' 0 C--N 1.334 -0.094 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 165.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -140.48 105.37 4.96 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.5 tp -103.9 132.63 49.97 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.292 1.037 . . . . 0.0 109.015 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -129.18 102.67 6.57 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.254 0.621 . . . . 0.0 110.095 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -95.53 113.96 25.66 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 172.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -117.57 103.79 10.41 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.153 0.581 . . . . 0.0 110.78 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 t -121.52 161.83 21.63 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.684 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 5.94 14.85 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.671 1.188 . . . . 0.0 111.781 -175.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.565 ' HB3' ' HG2' ' A' ' 120' ' ' GLN . 66.6 m -132.37 123.47 26.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.442 0.697 . . . . 0.0 110.7 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.535 ' HA ' HD12 ' A' ' 122' ' ' LEU . 4.7 mp0 -72.53 -29.36 63.53 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.0 0.92 . . . . 0.0 109.828 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.565 ' HG2' ' HB3' ' A' ' 118' ' ' SER . 5.2 pt20 -58.73 -44.91 90.57 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 124.491 1.119 . . . . 0.0 110.821 173.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' A' ' 92' ' ' LYS . 24.3 ttt -71.23 -33.96 70.34 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.778 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 119' ' ' GLU . 36.6 mt -64.74 -39.53 93.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 119' ' ' GLU . 95.0 t -69.58 -41.62 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.303 0.573 . . . . 0.0 109.712 176.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -59.56 -58.35 8.98 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.03 1.332 . . . . 0.0 111.453 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 121' ' ' MET . 18.0 m -74.2 -14.85 16.32 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 C-N-CA 123.262 0.625 . . . . 0.0 110.339 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 130' ' ' GLU . . . -61.61 -37.28 93.95 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 166.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.73 -47.17 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 O-C-N 124.114 0.538 . . . . 0.0 109.732 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.69 -30.38 76.21 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.916 0.76 . . . . 0.0 114.498 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -88.05 -41.04 13.36 Favored 'General case' 0 C--O 1.213 -0.855 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -60.37 -32.64 71.48 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.575 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 41.0 ttm -66.16 -56.03 13.4 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.316 1.046 . . . . 0.0 110.49 175.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.17 79.73 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.88 0.738 . . . . 0.0 111.43 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.549 HD13 HD23 ' A' ' 136' ' ' LEU . 4.5 mm? -82.65 -20.85 35.46 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.422 1.089 . . . . 0.0 110.904 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.65 -51.98 43.58 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -74.29 -24.55 59.26 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.35 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.549 HD23 HD13 ' A' ' 133' ' ' LEU . 31.7 tp -70.82 -41.57 71.37 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 171.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.669 ' HA3' HE22 ' A' ' 5' ' ' GLN . . . -58.03 -42.97 95.27 Favored Glycine 0 C--O 1.219 -0.832 0 CA-C-N 114.825 -1.08 . . . . 0.0 112.151 176.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 87.5 mtp -75.2 -32.96 61.35 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.43 0.692 . . . . 0.0 111.559 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -63.19 -46.25 87.97 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.487 0.715 . . . . 0.0 110.704 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.496 HD13 HG22 ' A' ' 37' ' ' VAL . 80.6 mt -76.46 -61.16 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.148 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -148.76 93.36 2.11 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.178 0.991 . . . . 0.0 109.665 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.12 5.73 0.05 OUTLIER Glycine 0 N--CA 1.474 1.181 0 CA-C-O 119.685 -0.509 . . . . 0.0 113.839 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 61.36 82.43 0.17 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.976 1.31 . . . . 0.0 111.706 174.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.04 -47.73 96.28 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 124.078 0.951 . . . . 0.0 111.324 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -67.44 -7.86 20.42 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 122.254 1.969 . . . . 0.0 113.208 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.56 59.63 Favored Glycine 0 C--N 1.349 1.297 0 O-C-N 123.378 0.424 . . . . 0.0 112.318 171.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.92 76.83 0.19 Allowed Glycine 0 C--N 1.347 1.146 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.99 -12.55 23.79 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.909 2.406 . . . . 0.0 112.255 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.27 149.89 72.58 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.95 1.3 . . . . 0.0 108.577 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.57 -59.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.242 1.961 . . . . 0.0 108.706 164.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 172.06 82.36 0.0 OUTLIER 'General case' 0 C--N 1.342 0.251 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 167.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -77.68 68.71 3.81 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.688 0.756 . . . . 0.0 110.958 -173.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.21 -50.29 14.87 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.455 170.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -165.91 130.5 2.3 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.572 -1.195 . . . . 0.0 108.8 169.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.417 ' HG2' ' HG3' ' A' ' 156' ' ' GLU . 38.1 tt0 -78.98 -50.19 11.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.917 1.287 . . . . 0.0 110.435 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.417 ' HG3' ' HG2' ' A' ' 155' ' ' GLU . 48.1 mt-10 -133.59 160.04 38.66 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.475 1.11 . . . . 0.0 110.731 -175.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 74.32 -44.92 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 126.756 2.022 . . . . 0.0 113.601 174.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 159' ' ' PRO . 31.3 mt-10 -99.32 124.7 43.91 Favored Pre-proline 0 C--O 1.244 0.772 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.417 ' HA ' ' HG3' ' A' ' 164' ' ' MET . 2.6 Cg_exo -74.37 84.35 1.56 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.871 2.381 . . . . 0.0 112.444 -177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.7 m -90.31 96.23 0.86 Allowed Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 168.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -30.74 -60.83 0.14 Allowed 'Trans proline' 0 C--N 1.387 2.56 1 C-N-CA 125.315 4.01 . . . . 0.0 115.648 -161.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.481 ' O ' HG12 ' A' ' 166' ' ' ILE . 9.9 tp10 -78.62 -44.91 22.8 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 118.876 -0.583 . . . . 0.0 112.22 -172.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 12.0 tpt -68.89 -44.61 72.88 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 118.747 0.703 . . . . 0.0 110.843 -173.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.417 ' HG3' ' HA ' ' A' ' 159' ' ' PRO . 3.4 tmm? -54.69 -44.31 73.26 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.37 173.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -63.47 -44.75 93.54 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.133 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 162' ' ' GLU . 33.5 mm -54.78 -43.05 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 C-N-CA 123.917 0.887 . . . . 0.0 110.605 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 10.2 t -73.84 -47.74 36.23 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.194 -177.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -59.02 -60.65 3.54 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.227 0.954 . . . . 0.0 112.67 177.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -39.57 -53.98 2.04 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 124.19 0.996 . . . . 0.0 113.371 174.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -68.85 -37.1 78.89 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.474 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -72.15 -47.88 28.34 Favored Glycine 0 C--N 1.348 1.212 0 C-N-CA 121.818 -0.23 . . . . 0.0 112.555 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.79 -23.65 67.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.137 1.375 . . . . 0.0 111.428 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.07 -50.75 18.26 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.365 0.666 . . . . 0.0 110.071 172.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -63.28 -25.13 68.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.303 0.641 . . . . 0.0 111.249 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.89 -59.21 3.22 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.091 0.556 . . . . 0.0 109.99 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.3 -30.64 62.78 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.349 1.06 . . . . 0.0 112.686 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 38.4 mt -66.88 -46.27 75.45 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.855 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.41 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . 7.3 p -80.5 -27.97 11.67 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 118.65 0.659 . . . . 0.0 110.369 -171.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -69.27 -27.33 65.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.561 0.744 . . . . 0.0 110.389 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 38.9 t -90.26 -24.15 21.02 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.56 0.744 . . . . 0.0 110.678 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.463 ' HA3' HD12 ' A' ' 11' ' ' LEU . . . -101.4 7.42 56.26 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-O 119.609 -0.551 . . . . 0.0 114.337 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.6 p . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.635 -0.698 . . . . 0.0 109.921 176.233 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' A' ' 143' ' ' ASP . . . -78.4 78.85 4.86 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.105 0.562 . . . . 0.0 109.692 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.2 p -77.83 114.28 16.53 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.976 0.911 . . . . 0.0 110.139 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.743 ' HA2' HH11 ' A' ' 141' ' ' ARG . . . -116.1 -13.25 8.53 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 123.191 0.307 . . . . 0.0 113.352 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.465 ' H ' ' NE2' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -70.5 150.13 46.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.583 0.753 . . . . 0.0 111.446 -177.063 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 28' ' ' GLN . . . -141.14 52.22 1.58 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.34 1.056 . . . . 0.0 108.555 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 10.3 m -83.87 128.03 34.25 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.593 -1.185 . . . . 0.0 113.638 -165.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 33.5 tt0 -113.57 120.16 39.99 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.538 1.535 . . . . 0.0 107.445 166.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HB3' HD11 ' A' ' 177' ' ' LEU . 66.6 mtt180 -85.52 144.41 27.94 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.159 0.583 . . . . 0.0 110.536 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -158.43 -179.6 8.25 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 122.851 0.46 . . . . 0.0 111.343 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.0 mt -142.59 167.06 22.99 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 122.397 1.094 . . . . 0.0 111.36 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.14 176.81 29.48 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 113.059 -1.882 . . . . 0.0 109.494 166.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 37.0 ttm180 -132.38 122.17 24.6 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.406 ' HD2' ' OE2' ' A' ' 113' ' ' GLU . 31.0 ttt180 -131.36 128.09 38.94 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.576 0.751 . . . . 0.0 109.037 -173.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.2 m -93.21 117.86 30.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -173.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.412 HD11 ' OG1' ' A' ' 117' ' ' THR . 26.2 pt -107.36 164.96 13.69 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.577 1.551 . . . . 0.0 108.036 175.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.46 -26.96 30.12 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.091 2.528 . . . . 0.0 114.127 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.24 -20.98 60.73 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.86 0.864 . . . . 0.0 112.993 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.72 167.83 14.08 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 123.389 0.519 . . . . 0.0 111.938 -172.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.33 95.29 1.3 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.8 163.92 20.91 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.292 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.479 HH21 HG22 ' A' ' 178' ' ' VAL . 2.7 mpp_? -105.57 170.79 7.68 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 167.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.407 ' HB3' ' HG3' ' A' ' 113' ' ' GLU . 20.3 m -139.27 128.15 23.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.929 -170.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 2.8 pp -88.19 135.2 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 mp -121.58 111.18 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.2 mt -99.76 107.85 21.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 176.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.59 ' HG2' ' HG2' ' A' ' 111' ' ' GLU . 82.1 mtt180 -94.72 137.38 33.89 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.641 ' NE2' ' HB3' ' A' ' 133' ' ' LEU . 40.4 mt-30 -142.87 136.52 28.76 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 166.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -104.96 114.3 28.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.559 0.695 . . . . 0.0 109.453 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -96.95 131.68 43.5 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.238 1.415 . . . . 0.0 110.06 -172.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -77.74 48.89 0.72 Allowed 'General case' 0 CA--C 1.568 1.646 0 CA-C-O 122.589 1.185 . . . . 0.0 110.073 172.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.59 154.72 41.43 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.425 1.09 . . . . 0.0 108.285 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.418 ' O ' HG23 ' A' ' 37' ' ' VAL . 57.2 Cg_endo -69.46 166.44 27.22 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.745 2.297 . . . . 0.0 113.116 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.515 HG13 ' HB3' ' A' ' 101' ' ' LEU . 59.1 t -72.17 -43.4 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.404 -174.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -56.09 -41.54 75.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 124.258 0.974 . . . . 0.0 110.341 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -66.58 -64.57 0.83 Allowed 'General case' 0 C--N 1.348 0.526 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.655 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 33' ' ' PRO . 49.1 t -50.19 -34.73 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 124.546 1.139 . . . . 0.0 111.315 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.42 ' HE3' HD12 ' A' ' 101' ' ' LEU . 58.5 t-105 -61.96 -57.49 11.49 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.601 0.76 . . . . 0.0 110.211 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.1 m -58.39 -34.13 70.39 Favored 'General case' 0 CA--C 1.556 1.194 0 O-C-N 123.913 0.758 . . . . 0.0 111.057 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.1 -31.23 71.98 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 174.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.473 ' HB3' HD13 ' A' ' 99' ' ' LEU . 73.7 m -90.8 -14.17 32.45 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.947 0.899 . . . . 0.0 113.152 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.4 ' O ' HD13 ' A' ' 58' ' ' LEU . 49.3 p -110.96 -47.07 3.26 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.198 0.454 . . . . 0.0 111.985 -173.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.424 ' O ' HG13 ' A' ' 47' ' ' ILE . 18.2 t70 -66.16 125.68 90.6 Favored Pre-proline 0 N--CA 1.484 1.244 0 C-N-CA 123.495 0.718 . . . . 0.0 110.47 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -63.79 -30.09 68.53 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.57 2.847 . . . . 0.0 113.602 -171.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -64.76 -48.61 73.92 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 124.359 1.037 . . . . 0.0 109.073 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -58.62 -38.67 78.53 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.156 171.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.484 ' HA ' ' NE1' ' A' ' 50' ' ' TRP . 68.7 mt -71.85 -45.68 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -172.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -61.77 -20.57 63.73 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.768 0.427 . . . . 0.0 111.964 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -57.75 -48.16 80.4 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.153 0.581 . . . . 0.0 110.932 174.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.484 ' NE1' ' HA ' ' A' ' 47' ' ' ILE . 22.7 p-90 -105.68 -55.85 2.27 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.355 0.662 . . . . 0.0 111.502 -173.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.433 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 6.6 t80 -91.47 -164.25 1.15 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.087 0.555 . . . . 0.0 110.893 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.477 ' HB ' HD22 ' A' ' 66' ' ' LEU . 40.5 mt -84.57 148.1 5.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 C-N-CA 124.359 1.064 . . . . 0.0 108.358 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -61.81 112.31 5.96 Favored Pre-proline 0 CA--C 1.566 1.569 0 O-C-N 124.173 0.921 . . . . 0.0 110.649 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.679 ' HG2' HD11 ' A' ' 58' ' ' LEU . 90.8 Cg_endo -90.29 96.11 0.27 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.295 2.663 . . . . 0.0 112.293 -175.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -71.21 109.89 5.53 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.561 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.9 -157.56 27.69 Favored Glycine 0 C--N 1.342 0.872 0 O-C-N 123.564 0.54 . . . . 0.0 113.884 177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.81 -48.32 16.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.486 1.514 . . . . 0.0 112.054 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.679 HD11 ' HG2' ' A' ' 54' ' ' PRO . 84.7 mt 63.98 25.46 13.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 124.583 1.177 . . . . 0.0 111.483 -170.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -126.31 155.1 42.51 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.44 1.096 . . . . 0.0 109.894 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.619 ' HB2' ' SG ' ' A' ' 77' ' ' CYS . 35.6 tt0 -64.55 106.51 1.17 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.437 0.695 . . . . 0.0 111.101 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.3 -35.68 3.14 Favored Glycine 0 N--CA 1.47 0.914 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -87.88 -169.59 45.44 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 114.149 -1.025 . . . . 0.0 112.124 170.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 72' ' ' GLY . 9.1 p30 -144.15 177.53 8.52 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.31 0.576 . . . . 0.0 111.907 -170.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -133.16 172.46 12.63 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.921 169.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 71' ' ' SER . . . -158.3 116.95 3.07 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.72 0.808 . . . . 0.0 109.276 178.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.477 HD22 ' HB ' ' A' ' 52' ' ' ILE . 70.0 mt -80.94 167.2 20.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.461 0.704 . . . . 0.0 110.862 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -86.8 128.25 35.03 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.879 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.47 39.48 22.29 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.997 1.436 . . . . 0.0 116.158 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -142.2 -79.86 0.23 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' ' HD1' ' A' ' 89' ' ' TYR . . . -161.79 154.89 20.72 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.106 0.562 . . . . 0.0 110.887 -172.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 25.0 p -100.42 165.46 11.43 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 170.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' ASN . . . -150.65 178.41 28.1 Favored Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -147.31 142.94 27.68 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.167 0.987 . . . . 0.0 109.321 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.458 HG13 HG22 ' A' ' 85' ' ' ILE . 2.6 mp -100.78 94.64 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.54 -34.07 67.3 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.407 174.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.489 ' HG2' ' HB ' ' A' ' 84' ' ' THR . 7.3 ptp180 -151.48 132.87 14.62 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.044 0.45 . . . . 0.0 111.313 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 60' ' ' GLU . 26.3 p -128.46 118.73 23.6 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 168.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -133.05 88.5 36.52 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -173.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.63 141.78 38.64 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.534 2.156 . . . . 0.0 111.553 175.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -96.91 20.82 28.63 Favored 'Cis proline' 0 C--N 1.367 1.52 0 C-N-CA 124.938 -0.859 . . . . 0.0 112.998 -4.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -75.49 -71.62 0.36 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.065 0.946 . . . . 0.0 111.974 -167.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -161.74 159.58 27.39 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.478 0.656 . . . . 0.0 110.73 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 tt -133.33 114.56 13.86 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.489 ' HB ' ' HG2' ' A' ' 76' ' ' ARG . 23.0 m -108.95 127.38 54.01 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.478 HG13 ' HB ' ' A' ' 97' ' ' VAL . 11.8 pt -123.29 150.26 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 126.723 2.009 . . . . 0.0 109.684 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.5 t -84.87 164.92 18.11 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 167.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 35.7 t-105 -144.39 94.81 2.61 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.086 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.5 t -90.52 101.76 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.502 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 84.8 t80 -102.69 168.06 9.5 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.059 1.344 . . . . 0.0 109.932 -173.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -56.25 103.26 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.111 0.965 . . . . 0.0 110.72 174.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.23 4.27 83.52 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.019 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 42.1 mmtm -134.67 75.17 63.38 Favored Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 123.916 0.886 . . . . 0.0 110.12 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.52 135.06 25.6 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.371 2.048 . . . . 0.0 112.005 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.5 t70 66.39 80.71 0.22 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.516 1.126 . . . . 0.0 112.018 170.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.664 ' HB2' ' HB3' ' A' ' 87' ' ' TRP . 35.4 m -109.97 146.18 35.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 168.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -103.44 107.71 18.66 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.153 0.501 . . . . 0.0 111.07 -170.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.478 ' HB ' HG13 ' A' ' 85' ' ' ILE . 10.6 t -112.05 147.97 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.675 1.19 . . . . 0.0 108.413 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -150.84 142.73 23.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.084 0.554 . . . . 0.0 111.075 171.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 41' ' ' CYS . 6.7 tt -109.46 123.79 49.96 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 172.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -122.58 123.0 40.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.471 1.108 . . . . 0.0 109.556 -166.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 34' ' ' VAL . 92.7 mt -123.31 135.04 54.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.542 0.737 . . . . 0.0 110.982 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.6 m -146.87 145.22 29.77 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.191 1.396 . . . . 0.0 108.609 172.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.47 143.64 44.91 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.774 0.829 . . . . 0.0 109.169 168.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -150.11 111.06 4.34 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 57.88 -102.12 0.22 Allowed Glycine 0 C--N 1.348 1.199 0 O-C-N 123.353 0.408 . . . . 0.0 112.407 -171.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -117.11 -5.06 11.4 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.612 0.765 . . . . 0.0 110.81 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -117.63 -150.93 9.18 Favored Glycine 0 C--N 1.352 1.424 0 C-N-CA 124.24 0.924 . . . . 0.0 111.436 -175.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 42.2 m -143.0 121.99 12.79 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.218 1.007 . . . . 0.0 110.227 -175.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.7 tp -81.74 131.65 35.27 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 9.7 tt -118.85 109.22 15.76 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.59 ' HG2' ' HG2' ' A' ' 27' ' ' ARG . 30.6 mt-10 -111.02 105.8 14.68 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 176.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.54 HD13 HD21 ' A' ' 133' ' ' LEU . 6.2 tt -102.3 104.33 14.85 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 175.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 61.2 tt0 -93.65 128.65 39.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.475 177.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -121.88 113.32 19.46 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 170.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.39 119.53 38.9 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.157 0.983 . . . . 0.0 110.046 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.493 HG23 ' HG ' ' A' ' 122' ' ' LEU . 6.0 t -148.08 151.83 36.32 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.584 0.754 . . . . 0.0 109.71 172.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.412 ' OG1' HD11 ' A' ' 16' ' ' ILE . 1.8 m -74.25 -19.41 60.52 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.326 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 121' ' ' MET . 11.7 m -89.83 119.33 30.12 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.027 0.931 . . . . 0.0 110.778 -173.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -64.32 -40.65 96.32 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.065 0.946 . . . . 0.0 112.141 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -63.76 -55.81 20.36 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.079 0.237 . . . . 0.0 111.389 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.578 ' HB3' ' HB2' ' A' ' 118' ' ' SER . 26.1 ttt -51.15 -33.35 26.51 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.01 0.819 . . . . 0.0 112.644 175.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.493 ' HG ' HG23 ' A' ' 116' ' ' THR . 19.9 mt -64.77 -46.24 82.95 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.33 0.652 . . . . 0.0 111.669 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 127' ' ' VAL . 61.4 t -62.89 -53.11 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 175.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -44.76 -53.34 7.49 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.51 1.924 . . . . 0.0 113.335 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.8 m -78.68 -25.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 122.794 0.438 . . . . 0.0 110.697 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.22 88.1 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 170.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 123' ' ' VAL . 89.2 t -81.83 -52.66 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.402 0.681 . . . . 0.0 109.4 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.59 -59.7 9.32 Favored Glycine 0 C--N 1.341 0.816 0 O-C-N 124.42 1.075 . . . . 0.0 113.634 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -57.25 -56.34 23.03 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.073 172.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -60.04 -30.31 69.1 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 119.905 1.23 . . . . 0.0 112.294 -171.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.443 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 47.2 ttp -70.73 -44.07 67.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.045 0.938 . . . . 0.0 110.187 174.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 50' ' ' TRP . . . -63.06 -63.53 1.17 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.0 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.641 ' HB3' ' NE2' ' A' ' 28' ' ' GLN . 4.3 mm? -42.31 -38.79 1.92 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.499 1.52 . . . . 0.0 113.992 169.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 131' ' ' MET . 12.4 t70 -52.79 -50.15 64.19 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 123.231 0.613 . . . . 0.0 110.059 173.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.52 ' HE1' ' HD3' ' A' ' 150' ' ' PRO . 71.5 m-85 -74.43 -19.84 60.26 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.342 176.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.406 HD13 ' CD1' ' A' ' 50' ' ' TRP . 51.3 tp -72.57 -24.53 61.12 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 169.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -76.73 -41.37 24.08 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 87.2 mtp -63.05 -40.75 98.64 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.069 0.948 . . . . 0.0 110.567 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -64.06 -56.02 18.0 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.432 0.693 . . . . 0.0 110.753 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 53.0 mt -69.42 -36.24 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 123.275 0.63 . . . . 0.0 111.725 -173.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.743 HH11 ' HA2' ' A' ' 4' ' ' GLY . 49.2 mtp180 -81.27 -14.34 57.51 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 176.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.29 12.88 75.12 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 114.028 0.371 . . . . 0.0 114.028 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.589 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 14.0 m-20 -63.82 -38.04 89.62 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.098 0.559 . . . . 0.0 110.683 173.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -56.94 108.58 1.27 Allowed Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 125.114 1.365 . . . . 0.0 111.498 -169.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -93.03 -14.94 1.03 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.733 2.289 . . . . 0.0 112.496 170.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.26 -171.4 28.7 Favored Glycine 0 C--N 1.346 1.095 0 C-N-CA 123.982 0.801 . . . . 0.0 111.355 -175.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.98 112.39 0.22 Allowed Glycine 0 CA--C 1.536 1.389 0 CA-C-O 119.044 -0.864 . . . . 0.0 112.395 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.49 -47.87 0.65 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.422 2.081 . . . . 0.0 112.864 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 17.9 m -124.69 148.57 59.57 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.724 0.81 . . . . 0.0 110.861 -168.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.52 ' HD3' ' HE1' ' A' ' 135' ' ' PHE . 84.7 Cg_endo -79.25 -23.38 7.57 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.517 2.145 . . . . 0.0 111.955 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.401 ' HA ' ' SD ' ' A' ' 163' ' ' MET . 25.5 tt0 -111.97 -77.41 0.59 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.107 0.963 . . . . 0.0 109.915 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 27.9 t70 174.68 -23.92 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.373 1.069 . . . . 0.0 109.235 -162.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . 76.61 29.37 0.67 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.092 1.357 . . . . 0.0 110.131 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -90.41 -174.14 4.03 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.633 171.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -41.84 5.44 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.017 0.527 . . . . 0.0 110.085 173.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -149.05 78.58 1.39 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.963 0.905 . . . . 0.0 109.768 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -138.35 167.67 21.38 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.833 0.853 . . . . 0.0 109.104 172.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 62.25 90.9 0.08 OUTLIER Pre-proline 0 CA--C 1.556 1.178 0 O-C-N 124.53 1.144 . . . . 0.0 109.943 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.61 7.59 1.51 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.256 2.637 . . . . 0.0 113.241 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 50.1 m -62.7 129.82 93.21 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.707 1.203 . . . . 0.0 110.939 176.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -60.92 -64.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.425 2.75 . . . . 0.0 114.039 -168.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -69.53 -19.91 63.7 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.078 0.551 . . . . 0.0 112.329 -172.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.401 ' SD ' ' HA ' ' A' ' 151' ' ' GLU . 0.0 OUTLIER -72.94 -57.95 3.68 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.515 ' O ' ' HG2' ' A' ' 168' ' ' GLN . 52.8 mtm -52.78 -40.56 63.29 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.517 175.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.534 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 6.8 tpt180 -50.46 -47.91 56.79 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 124.676 1.235 . . . . 0.0 111.441 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 70.5 mt -55.25 -50.65 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 123.848 0.718 . . . . 0.0 110.835 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.9 m -68.47 -22.7 64.55 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 164' ' ' MET . 14.0 mm100 -80.37 -31.42 37.86 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 13.6 mm-40 -65.38 -42.54 92.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.731 0.412 . . . . 0.0 109.935 174.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -62.62 -60.79 3.03 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 123.819 0.699 . . . . 0.0 110.214 177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -53.84 -58.88 10.89 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 124.232 0.957 . . . . 0.0 114.022 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.01 -20.97 65.96 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -175.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.94 -55.11 11.99 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.107 0.412 . . . . 0.0 110.663 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.38 -22.29 61.16 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.193 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -70.13 -46.74 64.12 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 123.77 0.669 . . . . 0.0 109.464 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -64.43 -33.38 75.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.098 0.559 . . . . 0.0 110.118 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 9' ' ' ARG . 47.6 mt -68.06 -61.77 1.71 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.625 173.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.479 HG22 HH21 ' A' ' 22' ' ' ARG . 9.6 p -65.04 -31.38 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.034 0.534 . . . . 0.0 112.417 -166.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.9 m-70 -67.61 -35.24 78.57 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.721 0.808 . . . . 0.0 110.231 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.5 m -84.54 -20.14 32.03 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.632 0.773 . . . . 0.0 110.919 175.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -76.27 -14.34 82.43 Favored Glycine 0 C--N 1.358 1.753 0 C-N-CA 123.351 0.501 . . . . 0.0 113.413 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.25 1.106 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.936 . . . . . . . . 0 0 . 1 stop_ save_